PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, JY; Passalacqua, KD; Hanna, PC; Sherman, DH				Lee, Jung Yeop; Passalacqua, Karla D.; Hanna, Philip C.; Sherman, David H.			Regulation of Petrobactin and Bacillibactin Biosynthesis in Bacillus anthracis under Iron and Oxygen Variation	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; FERRIC UPTAKE REGULATION; ESCHERICHIA-COLI; SIDEROPHORE BIOSYNTHESIS; STERNE 34F(2); SODB GENES; RESISTANCE; HEME; FUR; EXPRESSION	Background: Bacillus anthracis produces two catecholate siderophores, petrobactin and bacillibactin, under iron-limited conditions. Here, we investigate how variable iron and oxygen concentrations influence the biosynthetic output of both siderophores in B. anthracis. In addition, we describe the differential levels of transcription of select genes within the B. anthracis siderophore biosynthetic operons that are responsible for synthesis of petrobactin and bacillibactin, during variable growth conditions. Methodology/Principal Findings: Accumulation of bacillibactin in B. anthracis Sterne (34F(2)) and in a mutant lacking the major superoxide dismutase (Delta sodA1) was almost completely repressed by the addition of 20 mu M of iron. In contrast, petrobactin synthesis in both strains continued up to 20 mM of iron. Accumulation of petrobactin and bacillibactin showed a slight increase with addition of low levels of paraquat-induced oxidative stress in wild type B. anthracis Sterne. Cultures grown with high aeration resulted in greater accumulation of petrobactin relative to low aeration cultures, and delayed the repressive effect of added iron. Conversely, iron-depleted cultures grown with low aeration resulted in increased levels of bacillibactin. No difference was found in overall superoxide dismutase (SOD) activity or transcriptional levels of the sodA1 and sodA2 genes between iron-depleted and iron-replete conditions at high or low aeration, suggesting that SOD regulation and iron metabolism are separate in B. anthracis. The highest transcription of the gene asbB, part of the petrobactin biosynthetic operon, occurred under iron-limitation with high aeration, but transcription was readily detectable even under iron-replete conditions and in low aeration. The gene dhbC, a member of the bacillibactin biosynthetic operon, was only transcribed under conditions of iron-depletion, regardless of growth aeration. Conclusion: These data suggest that bacillibactin regulation is highly sensitive to iron-concentration. In contrast, although regulation of petrobactin is less dependent on iron, it is likely subject to additional levels of regulation that may contribute to virulence of B. anthracis.	[Lee, Jung Yeop; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lee, Jung Yeop; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Lee, Jung Yeop; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Passalacqua, Karla D.; Hanna, Philip C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, JY (corresponding author), Evolva Inc, Palo Alto, CA USA.	davidhs@umich.edu; jylee309@gmail.com	Passalacqua, Karla/AAU-8156-2021	Passalacqua, Karla/0000-0002-2672-3261	Great Lakes Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research [U54AI57153]; Hans W. Vahlteich Professorship; University of Michigan; HHS [N266200400059C-N01-AI-40059]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	Great Lakes Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research; Hans W. Vahlteich Professorship; University of Michigan(University of Michigan System); HHS(United States Department of Health & Human Services); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Great Lakes Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (Grant U54AI57153), and the Hans W. Vahlteich Professorship (D. H. S.). K. D. P. was supported by the University of Michigan F. G. Novy Fellowship, and HHS contract N266200400059C-N01-AI-40059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; ATKIN CL, 1970, J BACTERIOL, V103, P722, DOI 10.1128/JB.103.3.722-733.1970; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; BEYER W, 1991, PROG NUCLEIC ACID RE, V40, P221; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; BUDDE AD, 1989, MYCOPATHOLOGIA, V108, P125; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Dao KHT, 1999, ECOL APPL, V9, P441, DOI 10.2307/2641132; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DRECHSEL H, 1995, J IND MICROBIOL, V14, P105, DOI 10.1007/BF01569891; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; HASSETT DJ, 1993, J BACTERIOL, V175, P7658, DOI 10.1128/JB.175.23.7658-7665.1993; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Koppisch AT, 2005, BIOMETALS, V18, P577, DOI 10.1007/s10534-005-1782-6; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; STERNE MAX, 1939, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V13, P313; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; TARDAT B, 1991, MOL MICROBIOL, V5, P455, DOI 10.1111/j.1365-2958.1991.tb02129.x; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; VANHEYNINGEN WE, 1948, NATURE, V162, P114, DOI 10.1038/162114b0; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Wiebe MG, 2002, BIOCHEM SOC T, V30, P696, DOI 10.1042/bst0300696	40	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20777	10.1371/journal.pone.0020777	http://dx.doi.org/10.1371/journal.pone.0020777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673962	Green Submitted, Green Published, gold			2022-12-27	WOS:000291356400028
J	Xie, XF; Molina, J; Hernandez, R; Reynolds, A; Boyko, AR; Bustamante, CD; Purugganan, MD				Xie, Xianfa; Molina, Jeanmaire; Hernandez, Ryan; Reynolds, Andy; Boyko, Adam R.; Bustamante, Carlos D.; Purugganan, Michael D.			Levels and Patterns of Nucleotide Variation in Domestication QTL Regions on Rice Chromosome 3 Suggest Lineage-Specific Selection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADVANCED BACKCROSS POPULATION; ARTIFICIAL SELECTION; ORYZA-RUFIPOGON; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; YIELD COMPONENTS; CULTIVATED RICE; MAIZE; WILD	Oryza sativa or Asian cultivated rice is one of the major cereal grass species domesticated for human food use during the Neolithic. Domestication of this species from the wild grass Oryza rufipogon was accompanied by changes in several traits, including seed shattering, percent seed set, tillering, grain weight, and flowering time. Quantitative trait locus (QTL) mapping has identified three genomic regions in chromosome 3 that appear to be associated with these traits. We would like to study whether these regions show signatures of selection and whether the same genetic basis underlies the domestication of different rice varieties. Fragments of 88 genes spanning these three genomic regions were sequenced from multiple accessions of two major varietal groups in O. sativa-indica and tropical japonica-as well as the ancestral wild rice species O. rufipogon. In tropical japonica, the levels of nucleotide variation in these three QTL regions are significantly lower compared to genome-wide levels, and coalescent simulations based on a complex demographic model of rice domestication indicate that these patterns are consistent with selection. In contrast, there is no significant reduction in nucleotide diversity in the homologous regions in indica rice. These results suggest that there are differences in the genetic and selective basis for domestication between these two Asian rice varietal groups.	[Xie, Xianfa; Molina, Jeanmaire; Purugganan, Michael D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hernandez, Ryan] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Reynolds, Andy] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Boyko, Adam R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	New York University; University of Chicago; Cornell University; Stanford University	Xie, XF (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	Xianfa.Xie@gmail.com		Bustamante, Carlos D./0000-0002-4187-7920	National Science Foundation [MCB-0701382]	National Science Foundation(National Science Foundation (NSF))	Funding: This work was funded by a grant from the National Science Foundation Plant Genome Research Program (MCB-0701382, www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Camus-Kulandaivelu L, 2008, GENETICS, V180, P1107, DOI 10.1534/genetics.108.088849; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Darwin C, 1859, ORIGIN SPECIES MEANS; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; DOEBLEY J, 1993, GENETICS, V134, P559; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doust AN, 2005, GENETICS, V169, P1659, DOI 10.1534/genetics.104.035543; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kohn MH, 2000, P NATL ACAD SCI USA, V97, P7911, DOI 10.1073/pnas.97.14.7911; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MATSUO T, 1997, BIOL RICE PLANT; Monna L, 2006, DNA RES, V13, P43, DOI 10.1093/dnares/dsi030; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Oka H. I., 1988, Origin of cultivated rice.; OKA HI, 1982, EUPHYTICA, V31, P41, DOI 10.1007/BF00028305; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2002, NEW PHYTOL, V154, P591, DOI 10.1046/j.1469-8137.2002.00420.x; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Poncet V, 1998, HEREDITY, V81, P648, DOI 10.1046/j.1365-2540.1998.00445.x; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rozen S, 2000, BIOINFORMATICS METHO; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shimamoto K, 2002, ANNU REV PLANT BIOL, V53, P399, DOI 10.1146/annurev.arplant.53.092401.134447; Shin JH, 2006, J STAT SOFTWARE, P16; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wakeley J., 2008, COALESCENT THEORY IN; WANG ZY, 1992, THEOR APPL GENET, V83, P565, DOI 10.1007/BF00226900; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242	59	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20670	10.1371/journal.pone.0020670	http://dx.doi.org/10.1371/journal.pone.0020670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674010	Green Submitted, Green Published, gold			2022-12-27	WOS:000291356400016
J	Tang, XL; Li, M; Tucker, L; Ramratnam, B				Tang, Xiaoli; Li, Ming; Tucker, Lynne; Ramratnam, Bharat			Glycogen Synthase Kinase 3 Beta (GSK3 beta) Phosphorylates the RNAase III Enzyme Drosha at S300 and S302	PLOS ONE			English	Article							MICRORNAS; REGULATOR; SURVIVAL; GSK-3	The canonical microRNA (miRNA) pathway commences with the enzymatic cleavage of the primary gene transcript (primiRNA) by the RNAase III enzyme Drosha in the nucleus into shorter pre-miRNA species that are subsequently exported to the cytoplasm for further processing into shorter, mature miRNA molecules. Using a series of reporter constructs, we have previously demonstrated that phosphorylation of Drosha at Ser 300 and 302 was required for its nuclear localization. Here, we identify GSK3 beta as the culprit kinase. We demonstrate that Drosha is unable to selectively localize to the nucleus in cells deficient in GSK3 beta. These findings expand the substrate base of GSK3 beta to include a central component of the miRNA biogenesis pathway.	[Tang, Xiaoli; Li, Ming; Tucker, Lynne; Ramratnam, Bharat] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Tang, XL (corresponding author), Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA.	BRamratnam@Lifespan.org	Xie, Huangming/B-2260-2012		National Institutes of Health (NIH) [P20RR025179, R01AI058697, T32DA013911]; Lifespan/Brown/Tufts CFAR [NIH P30AI042853]; Alcohol Research Center on HIV, Brown University [P01 AA019072]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, R01AI058697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P01AA019072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Brown/Tufts CFAR; Alcohol Research Center on HIV, Brown University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) (P20RR025179 and R01AI058697). The authors thank the Lifespan/Brown/Tufts CFAR (NIH P30AI042853) and the Alcohol Research Center on HIV, Brown University (P01 AA019072), for assay support. XT was supported by a training grant from NIH (T32DA013911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dugo L, 2007, SHOCK, V27, P113, DOI 10.1097/01.shk.0000238059.23837.68; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	32	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20391	10.1371/journal.pone.0020391	http://dx.doi.org/10.1371/journal.pone.0020391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674040	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500013
J	Neff, CP; Kurisu, T; Ndolo, T; Fox, K; Akkina, R				Neff, C. Preston; Kurisu, Theresa; Ndolo, Thomas; Fox, Kami; Akkina, Ramesh			A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice	PLOS ONE			English	Article							T-CELL DEPLETION; MOUSE MODEL; REVERSE-TRANSCRIPTASE; IMMUNE-RESPONSES; SCID MICE; BLT MICE; INFECTION; CHALLENGES; INHIBITOR; THERAPY	For prevention of HIV infection many currently licensed anti-HIV drugs and new ones in the pipeline show potential as topically applied microbicides. While macaque models have been the gold standard for in vivo microbicide testing, they are expensive and sufficient numbers are not available. Therefore, a small animal model that facilitates rapid evaluation of potential candidates for their preliminary efficacy is urgently needed in the microbicide field. We previously demonstrated that RAG-hu humanized mouse model permits HIV-1 mucosal transmission via both vaginal and rectal routes and that oral pre-exposure chemo-prophylactic strategies could be tested in this system. Here in these proof-of-concept studies, we extended this system for topical microbicide testing using HIV-1 as the challenge virus. Maraviroc, a clinically approved CCR5 inhibitor drug for HIV treatment, was formulated as a microbicide gel at 5 mM concentration in 2.2% hydroxyl ethyl cellulose. Female RAG-hu mice were challenged vaginally with HIV-1 an hour after intravaginal application of the maraviroc gel. Our results showed that maraviroc gel treated mice were fully protected against vaginal HIV-1 challenge in contrast to placebo gel treated mice which all became infected. These findings highlight the utility of the humanized mouse models for microbicide testing and, together with the recent data from macaque studies, suggest that maraviroc is a promising candidate for future microbicide clinical trials in the field.	[Neff, C. Preston; Kurisu, Theresa; Ndolo, Thomas; Fox, Kami; Akkina, Ramesh] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Neff, CP (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	akkina@colostate.edu			National Institutes of Health [AI057066, AI073255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057066, R01AI073255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Studies described here were supported by National Institutes of Health RO1 grants AI057066 and AI073255 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; D'Cruz OJ, 2007, AM J REPROD IMMUNOL, V57, P353, DOI 10.1111/j.1600-0897.2007.00478.x; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Di Fabio S, 2003, AIDS, V17, P1597, DOI 10.1097/00002030-200307250-00003; Di Fabio S, 2001, AIDS, V15, P2231, DOI 10.1097/00002030-200111230-00003; Friend DR, 2010, PHARM DEV TECHNOL, V15, P562, DOI 10.3109/10837450903369879; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	32	66	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20209	10.1371/journal.pone.0020209	http://dx.doi.org/10.1371/journal.pone.0020209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673796	Green Submitted, gold, Green Published			2022-12-27	WOS:000291309900005
J	Cao, YA; Kusy, S; Luong, R; Wong, RJ; Stevenson, DK; Contag, CH				Cao, Yu-An; Kusy, Sophie; Luong, Richard; Wong, Ronald J.; Stevenson, David K.; Contag, Christopher H.			Heme Oxygenase-1 Deletion Affects Stress Erythropoiesis	PLOS ONE			English	Article							ENDOTHELIAL-CELL ACTIVATION; IN-VIVO; ERYTHROID-DIFFERENTIATION; CARBON-MONOXIDE; EXPRESSION; PROGENITORS; FIBRONECTIN; DEFICIENCY; INTEGRINS; ANEMIA	Background: Homeostatic erythropoiesis leads to the formation of mature red blood cells under non-stress conditions, and the production of new erythrocytes occurs as the need arises. In response to environmental stimuli, such as bone marrow transplantation, myelosuppression, or anemia, erythroid progenitors proliferate rapidly in a process referred to as stress erythropoiesis. We have previously demonstrated that heme oxygenase-1 (HO-1) deficiency leads to disrupted stress hematopoiesis. Here, we describe the specific effects of HO-1 deficiency on stress erythropoiesis. Methodology/Principal Findings: We used a transplant model to induce stress conditions. In irradiated recipients that received hmox(+/-) or hmox(+/+) bone marrow cells, we evaluated (i) the erythrocyte parameters in the peripheral blood; (ii) the staining intensity of CD71-, Ter119-, and CD49d-specific surface markers during erythroblast differentiation; (iii) the patterns of histological iron staining; and (iv) the number of Mac-1(+)-cells expressing TNF-alpha. In the spleens of mice that received hmox(+/-) cells, we show (i) decreases in the proerythroblast, basophilic, and polychromatophilic erythroblast populations; (ii) increases in the insoluble iron levels and decreases in the soluble iron levels; (iii) increased numbers of Mac-1+-cells expressing TNF-a; and (iv) decreased levels of CD49d expression in the basophilic and polychromatophilic erythroblast populations. Conclusions/Significance: As reflected by effects on secreted and cell surface proteins, HO-1 deletion likely affects stress erythropoiesis through the retention of erythroblasts in the erythroblastic islands of the spleen. Thus, HO-1 may serve as a therapeutic target for controlling erythropoiesis, and the dysregulation of HO-1 may be a predisposing condition for hematologic diseases.	[Cao, Yu-An; Kusy, Sophie; Wong, Ronald J.; Stevenson, David K.; Contag, Christopher H.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Dept Comparat Med, Sch Med, Stanford, CA USA	Stanford University; Stanford University	Cao, YA (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	ccontag@stanford.edu		Contag, Christopher/0000-0002-1011-8278	National Institutes of Health [NIH/NIDD071716]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH/NIDD071716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; AKAHANE K, 1987, INT J CELL CLONING, V5, P16, DOI 10.1002/stem.5530050103; ALLEN TD, 1982, DIFFERENTIATION, V21, P86, DOI 10.1111/j.1432-0436.1982.tb01201.x; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Broudy VC, 1996, BLOOD, V88, P75; Cao YA, 2008, BLOOD, V112, P4494, DOI 10.1182/blood-2007-12-127621; Delforge M, 2005, LEUKEMIA, V19, P57, DOI 10.1038/sj.leu.2403551; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Gambero S, 2007, EUR J HAEMATOL, V78, P144, DOI 10.1111/j.1600-0609.2006.00788.x; Hamamura K, 1996, BLOOD, V87, P2513, DOI 10.1182/blood.V87.6.2513.bloodjournal8762513; HARA H, 1976, AM J HEMATOL, V1, P453, DOI 10.1002/ajh.2830010410; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; MOLDAWER LL, 1989, FASEB J, V3, P1637, DOI 10.1096/fasebj.3.5.2784116; Obinata M, 1999, CELL STRUCT FUNCT, V24, P171, DOI 10.1247/csf.24.171; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; PAPAYANNOPOULOU T, 1992, BLOOD, V79, P1686; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; ROSEMBLATT M, 1991, J CLIN INVEST, V87, P6, DOI 10.1172/JCI115002; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Soares MP, 2007, FRONT BIOSCI, V12, P4932, DOI 10.2741/2439; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TSAI S, 1987, BLOOD, V69, P1587; ULICH TR, 1990, EXP HEMATOL, V18, P311; VUILLETGAUGLER MH, 1990, BLOOD, V75, P865; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165	41	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20634	10.1371/journal.pone.0020634	http://dx.doi.org/10.1371/journal.pone.0020634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655188	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600112
J	Ferreira, L; Sanchez-Juanes, F; Garcia-Fraile, P; Rivas, R; Mateos, PF; Martinez-Molina, E; Gonzalez-Buitrago, JM; Velazquez, E				Ferreira, Laura; Sanchez-Juanes, Fernando; Garcia-Fraile, Paula; Rivas, Raul; Mateos, Pedro F.; Martinez-Molina, Eustoquio; Manuel Gonzalez-Buitrago, Jose; Velazquez, Encarna			MALDI-TOF Mass Spectrometry Is a Fast and Reliable Platform for Identification and Ecological Studies of Species from Family Rhizobiaceae	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CLOSE PHYLOGENETIC RELATIONSHIP; MULTILOCUS SEQUENCE-ANALYSIS; KUMMEROWIAE SP-NOV.; RIBOSOMAL-RNA GENE; PHASEOLUS-VULGARIS; SINORHIZOBIUM-MELILOTI; RAPID IDENTIFICATION; SP. NOV.; AGROBACTERIUM-TUMEFACIENS	Family Rhizobiaceae includes fast growing bacteria currently arranged into three genera, Rhizobium, Ensifer and Shinella, that contain pathogenic, symbiotic and saprophytic species. The identification of these species is not possible on the basis of physiological or biochemical traits and should be based on sequencing of several genes. Therefore alternative methods are necessary for rapid and reliable identification of members from family Rhizobiaceae. In this work we evaluated the suitability of Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for this purpose. Firstly, we evaluated the capability of this methodology to differentiate among species of family Rhizobiaceae including those closely related and then we extended the database of MALDI Biotyper 2.0 including the type strains of 56 species from genera Rhizobium, Ensifer and Shinella. Secondly, we evaluated the identification potential of this methodology by using several strains isolated from different sources previously identified on the basis of their rrs, recA and atpD gene sequences. The 100% of these strains were correctly identified showing that MALDI-TOF MS is an excellent tool for identification of fast growing rhizobia applicable to large populations of isolates in ecological and taxonomic studies.	[Ferreira, Laura; Sanchez-Juanes, Fernando; Manuel Gonzalez-Buitrago, Jose] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain; [Garcia-Fraile, Paula; Rivas, Raul; Mateos, Pedro F.; Martinez-Molina, Eustoquio; Velazquez, Encarna] Univ Salamanca, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Manuel Gonzalez-Buitrago, Jose] Univ Salamanca, Dept Bioquim & Biol Mol, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca	Ferreira, L (corresponding author), Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain.	evp@usal.es	Rivas, Raúl/B-1869-2017; Fraile, Paula Garcia/N-8193-2014; Velázquez, Encarna/B-3669-2017; Mateos, Pedro/L-6001-2014; Sánchez-Juanes, Fernando/AAO-2626-2020	Rivas, Raúl/0000-0003-2202-1470; Fraile, Paula Garcia/0000-0002-9576-2184; Velázquez, Encarna/0000-0002-5946-7241; Mateos, Pedro/0000-0003-1628-598X; Gonzalez-Buitrago, Jose Manuel/0000-0003-4674-071X; Sanchez-Juanes, Fernando/0000-0003-1687-5891; Martinez-Molina, Eustoquio/0000-0002-0983-9780	MICINN; PFMG; JCYL; Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, SPAIN) (Ayuda de Infraestructura)	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); PFMG; JCYL(Junta de Castilla y Leon); Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, SPAIN) (Ayuda de Infraestructura)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by MICINN to EV and PFMG and JCYL to EMM and RR and by the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, SPAIN) (Ayuda de Infraestructura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez ER, 2009, ARCH MICROBIOL, V191, P659, DOI 10.1007/s00203-009-0495-6; Amarger N, 1997, INT J SYST BACTERIOL, V47, P996, DOI 10.1099/00207713-47-4-996; An DS, 2006, INT J SYST EVOL MICR, V56, P443, DOI 10.1099/ijs.0.63942-0; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Bouzar H, 2001, INT J SYST EVOL MICR, V51, P1023, DOI 10.1099/00207713-51-3-1023; CASIDA LE, 1982, INT J SYST BACTERIOL, V32, P339, DOI 10.1099/00207713-32-3-339; Chen WX, 1997, INT J SYST BACTERIOL, V47, P870, DOI 10.1099/00207713-47-3-870; CHEN WX, 1988, INT J SYST BACTERIOL, V38, P392, DOI 10.1099/00207713-38-4-392; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; CRABTREE K., 1967, INT J SYST BACTERIOL, V17, P1; del Villar M, 2008, FEMS MICROBIOL LETT, V282, P273, DOI 10.1111/j.1574-6968.2008.01139.x; DELAJUDIE P, 1994, INT J SYST BACTERIOL, V44, P715, DOI 10.1099/00207713-44-4-715; DELAJUDIE P, 1992, INT J SYST BACTERIOL, V42, P93; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; FERREIRA L, 2010, CLIN MICROBIOL INFEC; Ferreira L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014235; Ferreira L, 2010, ENFERM INFEC MICR CL, V28, P492, DOI 10.1016/j.eimc.2009.12.009; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Garcia-Fraile P, 2007, INT J SYST EVOL MICR, V57, P844, DOI 10.1099/ijs.0.64680-0; Garcia-Fraile P, 2010, CAN J MICROBIOL, V56, P657, DOI [10.1139/W10-048, 10.1139/w10-048]; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gu CT, 2008, INT J SYST EVOL MICR, V58, P1364, DOI 10.1099/ijs.0.65661-0; Han TX, 2008, INT J SYST EVOL MICR, V58, P1693, DOI 10.1099/ijs.0.65568-0; Ramirez-Bahena MH, 2008, INT J SYST EVOL MICR, V58, P2484, DOI 10.1099/ijs.0.65621-0; Hilderrand EM, 1940, J AGRIC RES, V61, P0685; HIRSCH P, 1985, SYST APPL MICROBIOL, V6, P281, DOI 10.1016/S0723-2020(85)80032-1; Hou BC, 2009, INT J SYST EVOL MICR, V59, P3051, DOI 10.1099/ijs.0.009647-0; Hunter WJ, 2007, CURR MICROBIOL, V55, P455, DOI 10.1007/s00284-007-9020-9; Iglesias O, 2007, FEMS MICROBIOL LETT, V277, P210, DOI 10.1111/j.1574-6968.2007.00968.x; Jordan D.C., 1984, BERGEYS MANUAL SYSTE; Judicial Commission of the International Committee on Systematics of Prokaryotes, 2008, Int J Syst Evol Microbiol, V58, P1973, DOI 10.1099/ijs.0.2008/005991-0; Kaur J, 2011, INT J SYST EVOL MICR, V61, P1218, DOI 10.1099/ijs.0.017491-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P324; Kwon SW, 2005, INT J SYST EVOL MICR, V55, P263, DOI 10.1099/ijs.0.63097-0; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Lin DX, 2008, INT J SYST EVOL MICR, V58, P1409, DOI 10.1099/ijs.0.65723-0; Lin DX, 2009, INT J SYST EVOL MICR, V59, P1919, DOI 10.1099/ijs.0.006387-0; LINDSTROM K, 1989, INT J SYST BACTERIOL, V39, P365, DOI 10.1099/00207713-39-3-365; Lu YL, 2009, INT J SYST EVOL MICR, V59, P3006, DOI 10.1099/ijs.0.007237-0; Zurdo-Pineiro JL, 2009, APPL ENVIRON MICROB, V75, P2354, DOI 10.1128/AEM.02811-08; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; Matsui T, 2009, INT J SYST EVOL MICR, V59, P536, DOI 10.1099/ijs.0.65510-0; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Merabet C, 2010, INT J SYST EVOL MICR, V60, P664, DOI 10.1099/ijs.0.012088-0; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nick G, 1999, INT J SYST BACTERIOL, V49, P1359, DOI 10.1099/00207713-49-4-1359; OPHEL K, 1990, INT J SYST BACTERIOL, V40, P236, DOI 10.1099/00207713-40-3-236; Peng GX, 2008, INT J SYST EVOL MICR, V58, P2158, DOI 10.1099/ijs.0.65632-0; Peng GX, 2002, INT J SYST EVOL MICR, V52, P457, DOI 10.1099/00207713-52-2-457; Quan ZX, 2005, INT J SYST EVOL MICR, V55, P2543, DOI 10.1099/ijs.0.63667-0; Ramirez-Bahena MH, 2009, CAN J MICROBIOL, V55, P1207, DOI [10.1139/W09-074, 10.1139/w09-074]; Ren DW, 2011, INT J SYST EVOL MICR, V61, P580, DOI 10.1099/ijs.0.023143-0; Rivas R, 2007, LETT APPL MICROBIOL, V44, P181, DOI 10.1111/j.1472-765X.2006.02050.x; Rome S, 1996, INT J SYST BACTERIOL, V46, P972, DOI 10.1099/00207713-46-4-972; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAWADA H, 1993, INT J SYST BACTERIOL, V43, P694, DOI 10.1099/00207713-43-4-694; SCHOLLA MH, 1984, INT J SYST BACTERIOL, V34, P484, DOI 10.1099/00207713-34-4-484; SEGOVIA L, 1993, INT J SYST BACTERIOL, V43, P374, DOI 10.1099/00207713-43-2-374; Seibold E, 2010, J CLIN MICROBIOL, V48, P1061, DOI 10.1128/JCM.01953-09; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Snoeck C, 2003, APPL ENVIRON MICROB, V69, P2006, DOI 10.1128/AEM.69.4.2006-2014.2003; Squartini A, 2002, INT J SYST EVOL MICR, V52, P1267, DOI 10.1099/00207713-52-4-1267; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan ZY, 2001, INT J SYST EVOL MICR, V51, P909, DOI 10.1099/00207713-51-3-909; Tanigawa K, 2010, APPL ENVIRON MICROB, V76, P4055, DOI 10.1128/AEM.02698-09; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian CF, 2008, INT J SYST EVOL MICR, V58, P2871, DOI 10.1099/ijs.0.2008/000703-0; Toledo I, 2003, SYST APPL MICROBIOL, V26, P54, DOI 10.1078/072320203322337317; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2631, DOI 10.1099/ijs.0.64402-0; van Berkum P, 1998, INT J SYST BACTERIOL, V48, P13, DOI 10.1099/00207713-48-1-13; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; VANRHIJN PJS, 1993, J BACTERIOL, V175, P438, DOI 10.1128/JB.175.2.438-447.1993; Vaz-Moreira I, 2010, INT J SYST EVOL MICR, V60, P144, DOI 10.1099/ijs.0.009498-0; Velazquez E, 2005, MOL PLANT MICROBE IN, V18, P1325, DOI 10.1094/MPMI-18-1325; Velazquez E, 2001, EUR J PLANT PATHOL, V107, P931, DOI 10.1023/A:1013140709873; Velazquez E, 2010, SYST APPL MICROBIOL, V33, P247, DOI 10.1016/j.syapm.2010.04.004; VINCENT J. M., 1970, A manual for the practical study of the root-nodule bacteria.; Wang ET, 1998, INT J SYST BACTERIOL, V48, P687, DOI 10.1099/00207713-48-3-687; Wang ET, 2002, INT J SYST EVOL MICR, V52, P1687, DOI 10.1099/ijs.0.01954-0; Wei GH, 2003, INT J SYST EVOL MICR, V53, P1575, DOI 10.1099/ijs.0.02031-0; Wei GH, 2002, INT J SYST EVOL MICR, V52, P2231, DOI [10.1099/ijs.0.02030-0, 10.1099/00207713-52-6-2231]; Young JM, 2004, INT J SYST EVOL MICR, V54, P149, DOI 10.1099/ijs.0.02870-0; Young JM, 2003, INT J SYST EVOL MICR, V53, P2107, DOI 10.1099/ijs.0.02665-0; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89; Zhang GX, 2011, INT J SYST EVOL MICR, V61, P816, DOI 10.1099/ijs.0.022228-0; Zhang RJ, 2011, INT J SYST EVOL MICR, V61, P512, DOI 10.1099/ijs.0.020156-0	95	72	73	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20223	10.1371/journal.pone.0020223	http://dx.doi.org/10.1371/journal.pone.0020223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655291	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600031
J	Lorey, B; Pilgramm, S; Bischoff, M; Stark, R; Vaitl, D; Kindermann, S; Munzert, J; Zentgraf, K				Lorey, Britta; Pilgramm, Sebastian; Bischoff, Matthias; Stark, Rudolf; Vaitl, Dieter; Kindermann, Stefan; Munzert, Joern; Zentgraf, Karen			Activation of the Parieto-Premotor Network Is Associated with Vivid Motor Imagery-A Parametric fMRI Study	PLOS ONE			English	Article							MOVEMENTS; REPRESENTATIONS; ABILITY; MODELS	The present study examined the neural basis of vivid motor imagery with parametrical functional magnetic resonance imaging. 22 participants performed motor imagery (MI) of six different right-hand movements that differed in terms of pointing accuracy needs and object involvement, i.e., either none, two big or two small squares had to be pointed at in alternation either with or without an object grasped with the fingers. After each imagery trial, they rated the perceived vividness of motor imagery on a 7-point scale. Results showed that increased perceived imagery vividness was parametrically associated with increasing neural activation within the left putamen, the left premotor cortex (PMC), the posterior parietal cortex of the left hemisphere, the left primary motor cortex, the left somatosensory cortex, and the left cerebellum. Within the right hemisphere, activation was found within the right cerebellum, the right putamen, and the right PMC. It is concluded that the perceived vividness of MI is parametrically associated with neural activity within sensorimotor areas. The results corroborate the hypothesis that MI is an outcome of neural computations based on movement representations located within motor areas.	[Lorey, Britta; Pilgramm, Sebastian; Bischoff, Matthias; Kindermann, Stefan; Munzert, Joern] Univ Giessen, Inst Sports Sci, Giessen, Germany; [Lorey, Britta; Pilgramm, Sebastian; Bischoff, Matthias; Stark, Rudolf; Vaitl, Dieter; Zentgraf, Karen] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany; [Zentgraf, Karen] Univ Bern, Inst Sports Sci, Bern, Switzerland	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Bern	Lorey, B (corresponding author), Univ Giessen, Inst Sports Sci, Giessen, Germany.	Britta.Lorey@sport.uni-giessen.de			German Research Foundation (DFG) [GRK 885]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG), Research Training Group GRK 885: NeuroAct - Neuronal Representation and Action Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz-Zadeh L, 2008, J PHYSIOL-PARIS, V102, P35, DOI 10.1016/j.jphysparis.2008.03.012; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Daprati E, 2010, NEUROPSYCHOLOGIA, V48, P756, DOI 10.1016/j.neuropsychologia.2009.10.008; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety J, 1996, BEHAV BRAIN RES, V72, P127; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GOSS S, 1986, MEM COGNITION, V14, P469, DOI 10.3758/BF03202518; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Lorey B, 2010, NEUROIMAGE, V49, P3239, DOI 10.1016/j.neuroimage.2009.11.038; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Munroe KJ, 2000, SPORT PSYCHOL, V14, P119, DOI 10.1123/tsp.14.2.119; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; MURPHY SM, 1994, MED SCI SPORT EXER, V26, P486; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Rodgers W., 1991, J APPL SPORT PSYCHOL, V3, P109, DOI [DOI 10.1080/10413209108406438, 10.1080/10413209108406438]; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	34	60	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20368	10.1371/journal.pone.0020368	http://dx.doi.org/10.1371/journal.pone.0020368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655298	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600054
J	Qi, XP; Ma, JM; Du, ZF; Ying, RB; Fei, J; Jin, HY; Han, JS; Wang, JQ; Chen, XL; Chen, CY; Liu, WT; Lu, JJ; Zhang, JG; Zhang, XN				Qi, Xiao-Ping; Ma, Ju-Ming; Du, Zhen-Fang; Ying, Rong-Biao; Fei, Jun; Jin, Hang-Yang; Han, Jian-Shan; Wang, Jin-Quan; Chen, Xiao-Ling; Chen, Chun-Yue; Liu, Wen-Ting; Lu, Jia-Jun; Zhang, Jian-Guo; Zhang, Xian-Ning			RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family	PLOS ONE			English	Article							CODON 918 MUTATION; MEN 2A; PROTOONCOGENE MUTATIONS; GENETIC MODIFIERS; 2B; ALLELE; PHEOCHROMOCYTOMA; POLYMORPHISMS; DISEASE; GUIDELINES	Background: Whole exome sequencing provides a labor-saving and direct means of genetic diagnosis of hereditary disorders in which the pathogenic gene harbors a large cohort of exons. We set out to demonstrate a suitable example of genetic diagnosis of MEN 2A/FMTC (multiple endocrine neoplasia type 2/familial medullary thyroid carcinoma) using this approach. Methodology/Principal Findings: We sequenced the whole exome of six individuals from a large Chinese MEN2A/FMTC pedigree to identify the variants of the RET (REarranged during Transfection) protooncogene and followed this by validation. Then prophylactic or surgical thyroidectomy with modified or level VI lymph node dissection and adrenalectomy were performed for the carriers. The cases were closely followed up. Massively parallel sequencing revealed four missense mutations of RET. We unexpectedly discovered that the proband's daughter with MEN 2A-related MTC presented a novel p. C634Y/V292M/R67H/R982C compound mutation, due to the involvement of p. C634Y in the proband with MEN 2A and p. V292M/R67H/R982C in the proband's husband with FMTC. In the maternal origin, p. C634Y caused bilateral MTC in all 5 cases and bilateral pheochromocytoma in 2 of the 5; the earliest onset age was 28 years. In the paternal origin, one of the six p. V292M/R67H/R982C carriers presented bilateral MTC (70 years old), one only had bilateral C-cell hyperplasia (44 years), two had bilateral multi-nodules (46 and 48 years) and two showed no abnormality (22 and 19 years). Conclusions/Significance: The results confirmed the successful clinical utility of whole exome sequencing, and our data suggested that the p. C634Y/V292M/R67H/R982C mutation of RET exhibited a more aggressive clinical phenotype than p. C634Y or p. V292M/R67H/R982C, while p. V292M/R67H/R982C presented a relatively milder pathogenicity of MTC and likely predisposed to FMTC.	[Qi, Xiao-Ping; Ma, Ju-Ming; Fei, Jun; Jin, Hang-Yang; Han, Jian-Shan; Wang, Jin-Quan] 117th PLA Hosp, Dept Urol Surg, Hangzhou, Zhejiang, Peoples R China; [Qi, Xiao-Ping; Ma, Ju-Ming; Fei, Jun; Jin, Hang-Yang; Han, Jian-Shan; Wang, Jin-Quan] 117th PLA Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Du, Zhen-Fang; Chen, Xiao-Ling; Chen, Chun-Yue; Liu, Wen-Ting; Lu, Jia-Jun; Zhang, Xian-Ning] Zhejiang Univ, Sch Med, Zhejiang Univ Adinovoctr Genet & Genom Med, Natl Educ Base Basic Med Sci,Dept Biochem & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Ying, Rong-Biao] Tumor Hosp Taizhou, Dept Surg Oncol, Wenling, Zhejiang, Peoples R China; [Zhang, Jian-Guo] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Zhejiang University; Beijing Genomics Institute (BGI)	Zhang, XN (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Univ Adinovoctr Genet & Genom Med, Natl Educ Base Basic Med Sci,Dept Biochem & Genet, Hangzhou 310003, Zhejiang, Peoples R China.	qxplmd@vip.sina.com; zhangxianning@zju.edu.cn			Key Scientific Research Project of Nanjing Military Command, China [09Z038]	Key Scientific Research Project of Nanjing Military Command, China	This study was supported by the Key Scientific Research Project of Nanjing Military Command, China (09Z038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch DK, 2000, EXP CLIN ENDOCR DIAB, V108, P128, DOI 10.1055/s-2000-5806; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Castellone MD, 2010, CLIN ENDOCRINOL, V73, P529, DOI 10.1111/j.1365-2265.2009.03757.x; Cebrian A, 2005, J CLIN ENDOCR METAB, V90, P6268, DOI 10.1210/jc.2004-2449; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cranston AN, 2006, CANCER RES, V66, P10179, DOI 10.1158/0008-5472.CAN-06-0884; DELELLIS RA, WHO CLASSIFICATION T, P321; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Dvorakova S, 2005, J ENDOCRINOL INVEST, V28, P905, DOI 10.1007/BF03345322; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P3579, DOI 10.1210/jc.2003-031898; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Erlic Z, 2010, J CLIN ENDOCR METAB, V95, P308, DOI 10.1210/jc.2009-1728; Frank-Raue K, 2011, HUM MUTAT, V32, P51, DOI 10.1002/humu.21385; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gimm O, 1997, J CLIN ENDOCR METAB, V82, P3902, DOI 10.1210/jc.82.11.3902; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Iwashita T, 2000, BIOCHEM BIOPH RES CO, V268, P804, DOI 10.1006/bbrc.2000.2227; Kasprzak L, 2001, J MED GENET, V38, P784, DOI 10.1136/jmg.38.11.784; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; Koch CA, 2001, ONCOGENE, V20, P7809, DOI 10.1038/sj.onc.1204991; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lesueur F, 2006, CANCER RES, V66, P1177, DOI 10.1158/0008-5472.CAN-05-2995; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Menko FH, 2002, J CLIN ENDOCR METAB, V87, P393, DOI 10.1210/jc.87.1.393; Miyauchi A, 1999, JPN J CANCER RES, V90, P1; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nunes AB, 2002, J CLIN ENDOCR METAB, V87, P5658, DOI 10.1210/JC.2002-020345; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Poturnajova M, 2005, J MOL MED, V83, P287, DOI 10.1007/s00109-004-0604-6; Punales MK, 2003, J CLIN ENDOCR METAB, V88, P2644, DOI 10.1210/jc.2002-021422; Robledo M, 2003, CANCER RES, V63, P1814; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sasaki A, 2003, HUM GENET, V114, P22, DOI 10.1007/s00439-003-1036-z; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tessitore A, 1999, J CLIN ENDOCR METAB, V84, P3522, DOI 10.1210/jc.84.10.3522; Toledo RA, 2010, J CLIN ENDOCR METAB, V95, P1318, DOI 10.1210/jc.2009-1355; Zhou YL, 2007, CLIN ENDOCRINOL, V67, P570, DOI 10.1111/j.1365-2265.2007.02927.x	42	39	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20353	10.1371/journal.pone.0020353	http://dx.doi.org/10.1371/journal.pone.0020353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655256	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600050
J	Shimizu, S; Brown, M; Sengupta, R; Penfold, ME; Meucci, O				Shimizu, Saori; Brown, Michael; Sengupta, Rajarshi; Penfold, Mark E.; Meucci, Olimpia			CXCR7 Protein Expression in Human Adult Brain and Differentiated Neurons	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; N-GLYCOSYLATION; OPIOID RECEPTORS; NERVOUS-SYSTEM; MIGRATION; CXCL12; SURVIVAL; CELLS; RDC1; TRAFFICKING	Background: CXCR7 and CXCR4 are receptors for the chemokine CXCL12, which is involved in essential functions of the immune and nervous systems. Although CXCR7 transcripts are widely expressed throughout the central nervous system, little is known about its protein distribution and function in the adult brain. To evaluate its potential involvement in CXCL12/CXCR4 signaling in differentiated neurons, we studied CXCR7 protein expression in human brain and cultured neurons. Methodology/Principal Findings: Immunohistochemistry and RT-PCR analyses of cortex and hippocampus from control and HIV-positive subjects provided the first evidence of CXCR7 protein expression in human adult neurons, under normal and pathological conditions. Furthermore, confocal microscopy and binding assays in cultured neurons show that CXCR7 protein is mainly located into cytoplasm, while little to no protein expression is found on neuronal plasma membrane. Interestingly, specific CXCR7 ligands that inhibit CXCL12 binding to CXCR7 do not alter CXCR4-activated survival signaling (pERK/pAkt) in rat cortical neurons. Neuronal CXCR7 co-localizes to some extent with the endoplasmic reticulum marker ERp29, but not with early/late endosome markers. Additionally, large areas of overlap are detected in the intracellular pattern of CXCR7 and CXCR4 expression. Conclusions/Significance: Overall, these results implicate CXCR4 as the main CXCL12 signaling receptor on the surface of differentiated neurons and suggest that CXCR7 may interact with CXCR4 at the intracellular level, possibly affecting CXCR4 trafficking and/or coupling to other proteins.	[Shimizu, Saori; Brown, Michael; Sengupta, Rajarshi; Meucci, Olimpia] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Meucci, Olimpia] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Penfold, Mark E.] ChemoCentryx, Mountain View, CA USA	Drexel University; Drexel University	Shimizu, S (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	olimpia.meucci@drexelmed.edu			National Institutes of Health [DA15014, DA19808]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015014, R01DA019808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health Grants DA15014 and DA19808 (to O.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Penfold is employed by ChemoCentryx; he has provided specific reagents for this study (i.e., one of the anti-CXCR7 Ab and the CXCR7 ligands) and valuable technical & intellectual support.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; BERAHOVICH RD, 2010, IMMUNOL LETT; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Burbassi S, 2008, J NEUROIMMUNE PHARM, V3, P26, DOI 10.1007/s11481-007-9083-1; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cai GQ, 2005, FEBS J, V272, P1625, DOI 10.1111/j.1742-4658.2005.04595.x; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hauser KF, 2006, J NEUROIMMUNE PHARM, V1, P98, DOI 10.1007/s11481-005-9000-4; Holtback U, 1999, P NATL ACAD SCI USA, V96, P7271, DOI 10.1073/pnas.96.13.7271; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kitabatake Y, 2004, BIOL PHARM BULL, V27, P896, DOI 10.1248/bpb.27.896; Klein RS, 2004, TRENDS IMMUNOL, V25, P306, DOI 10.1016/j.it.2004.04.002; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Ludwig A, 2000, J IMMUNOL, V165, P1044, DOI 10.4049/jimmunol.165.2.1044; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; LUKER KE, 2010, ONCOGENE; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MacLeod JC, 2004, J COMP NEUROL, V477, P29, DOI 10.1002/cne.20222; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miller RJ, 2008, J NEUROSCI, V28, P11792, DOI 10.1523/JNEUROSCI.3588-08.2008; Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nicolai J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.10; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shimizu N, 2000, J VIROL, V74, P619, DOI 10.1128/JVI.74.2.619-626.2000; Shimizu S, 2007, NEUROBIOL DIS, V25, P17, DOI 10.1016/j.nbd.2006.08.004; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tiveron MC, 2010, J NEUROIMMUNOL, V224, P72, DOI 10.1016/j.jneuroim.2010.05.011; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	50	53	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20680	10.1371/journal.pone.0020680	http://dx.doi.org/10.1371/journal.pone.0020680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655198	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600121
J	Davis, NF; Mooney, R; Callanan, A; Flood, HD; McGloughlin, TM				Davis, Niall F.; Mooney, Rory; Callanan, Anthony; Flood, Hugh D.; McGloughlin, Tim M.			Augmentation Cystoplasty and Extracellular Matrix Scaffolds: An Ex Vivo Comparative Study with Autogenous Detubularised Ileum	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; BIAXIAL MECHANICAL-BEHAVIOR; DEGRADATION; MODEL	Background: Augmentation cystoplasty (AC) with autogenous ileum remains the current gold standard surgical treatment for many patients with end-stage bladder disease. However, the presence of mucus-secreting epithelium within the bladder is associated with debilitating long-term complications. Currently, decellularised biological materials derived from porcine extracellular matrix (ECM) are under investigation as potential augmentation scaffolds. Important biomechanical limitations of ECMs are decreased bladder capacity and poor compliance after implantation. Methodology/Principal Findings: In the present ex vivo study a novel concept was investigated where a two-fold increase in ECM scaffold surface-area relative to the resected ileal segment was compared in ovine bladder models after AC. Results showed that bladder capacity increased by 40 +/- 4% and 37 +/- 11% at 10 mmHg and compliance by 40.4 +/- 4% and 39.7 +/- 6% (Delta P = 0-10 mmHg) after AC with ileum and porcine urinary bladder matrix (UBM) respectively (p <0.05). Comparative assessment between ileum and UBM demonstrated no significant differences in bladder capacity or compliance increases after AC (p > 0.05). Conclusions: These findings may have important clinical implications as metabolic, infective and malignant complications precipitated by mucus-secreting epithelium are potentially avoided after augmentation with ECM scaffolds.	[Davis, Niall F.; Flood, Hugh D.] Midwestern Reg Hosp, Dept Urol, Limerick, Ireland; [Davis, Niall F.; Mooney, Rory; Callanan, Anthony; McGloughlin, Tim M.] Univ Limerick, Ctr Appl Biomed Engn Res, Limerick, Ireland; [Davis, Niall F.; Mooney, Rory; Callanan, Anthony; McGloughlin, Tim M.] Univ Limerick, MSSI, Limerick, Ireland	University of Limerick; University of Limerick; University of Limerick	Davis, NF (corresponding author), Midwestern Reg Hosp, Dept Urol, Limerick, Ireland.	tim.mcgloughlin@ul.ie	Callanan, Anthony/D-8670-2013; McGloughlin, Tim/G-9526-2015; McGloughlin, Tim M/D-3639-2009	McGloughlin, Tim/0000-0002-6632-2075; McGloughlin, Tim M/0000-0002-6632-2075; Davis, Niall/0000-0002-5298-1475; McGloughlin, Tim/0000-0003-3519-8988				Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; AYYILDIZ A, 2006, INT BRAZ J UROL, V32, P92; Ayyildiz Ali, 2006, Int. braz j urol., V32, P88, DOI 10.1590/S1677-55382006000100015; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519; Coburn JC, 2007, J BIOMED MATER RES A, V81A, P250, DOI 10.1002/jbm.a.30943; Davis NF, 2011, J MECH BEHAV BIOMED, V4, P375, DOI 10.1016/j.jmbbm.2010.11.005; Davis NF, 2010, J UROLOGY, V184, P2246, DOI 10.1016/j.juro.2010.07.038; DAVIS NF, 2011, UROLOGY         0120; FLOOD HD, 1995, NEUROUROL URODYNAM, V14, P297, DOI 10.1002/nau.1930140402; Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015; Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885; Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022; Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; John TT, 2008, UROLOGY, V72, P1036, DOI 10.1016/j.urology.2008.07.043; Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2; Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008; NEUHOF H, 1917, SURG GYNECOL OBSTET, V25, P383; PAREKH A, 2010, J BIOMECH; Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2; RINK RC, 1990, ROLE ENTEROCYSTOPLAS; Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7; Shaikh FM, 2010, ARTIF ORGANS, V34, P153, DOI 10.1111/j.1525-1594.2009.00766.x; Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054; Wahl EF, 2004, BJU INT, V94, P898, DOI 10.1111/j.1464-410X.2004.05055.x; Wang DS, 2007, BJU INT, V99, P628, DOI 10.1111/j.1464-410X.2006.06662.x; Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20323	10.1371/journal.pone.0020323	http://dx.doi.org/10.1371/journal.pone.0020323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633510	Green Published, gold			2022-12-27	WOS:000291006500055
J	Fung, H; Weinstock, DM				Fung, Hua; Weinstock, David M.			Repair at Single Targeted DNA Double-Strand Breaks in Pluripotent and Differentiated Human Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; MECHANISM; PATHWAY; CULTURE; TRANSGENESIS; EXPRESSION; INHIBITOR; NUCLEASES	Differences in ex vivo cell culture conditions can drastically affect stem cell physiology. We sought to establish an assay for measuring the effects of chemical, environmental, and genetic manipulations on the precision of repair at a single DNA double-strand break (DSB) in pluripotent and somatic human cells. DSBs in mammalian cells are primarily repaired by either homologous recombination (HR) or nonhomologous end-joining (NHEJ). For the most part, previous studies of DSB repair in human cells have utilized nonspecific clastogens like ionizing radiation, which are highly nonphysiologic, or assayed repair at randomly integrated reporters. Measuring repair after random integration is potentially confounded by locus-specific effects on the efficiency and precision of repair. We show that the frequency of HR at a single DSB differs up to 20-fold between otherwise isogenic human embryonic stem cells (hESCs) based on the site of the DSB within the genome. To overcome locus-specific effects on DSB repair, we used zinc finger nucleases to efficiently target a DSB repair reporter to a safe-harbor locus in hESCs and a panel of somatic human cell lines. We demonstrate that repair at a targeted DSB is highly precise in hESCs, compared to either the somatic human cells or murine embryonic stem cells. Differentiation of hESCs harboring the targeted reporter into astrocytes reduces both the efficiency and precision of repair. Thus, the phenotype of repair at a single DSB can differ based on either the site of damage within the genome or the stage of cellular differentiation. Our approach to single DSB analysis has broad utility for defining the effects of genetic and environmental modifications on repair precision in pluripotent cells and their differentiated progeny.	[Fung, Hua; Weinstock, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Fung, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	dweinstock@partners.org			Harvard Stem Cell Institute; Burroughs Wellcome Fund	Harvard Stem Cell Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by a Seed Grant from the Harvard Stem Cell Institute (http://www.hsci.harvard.edu) and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (www.BWFund.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Adams Bret R, 2010, Aging (Albany NY), V2, P582; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Braam SR, 2008, NAT PROTOC, V3, P1435, DOI 10.1038/nprot.2008.140; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Carroll Dana, 2004, Methods Mol Biol, V262, P195; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Lane AA, 2010, CELL, V142, P360, DOI 10.1016/j.cell.2010.07.030; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 2005, METH MOL B, V291, P373; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Van Hoof D, 2008, STEM CELLS, V26, P2777, DOI 10.1634/stemcells.2008-0365; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107	49	30	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20514	10.1371/journal.pone.0020514	http://dx.doi.org/10.1371/journal.pone.0020514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633706	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500067
J	Handel, IG; Bronsvoort, BMD; Forbes, JF; Woolhouse, MEJ				Handel, Ian G.; Bronsvoort, Barend M. de C.; Forbes, John F.; Woolhouse, Mark E. J.			Risk-Targeted Selection of Agricultural Holdings for Post-Epidemic Surveillance: Estimation of Efficiency Gains	PLOS ONE			English	Article							SAMPLE-SIZE CALCULATIONS; SUBSTANTIATE FREEDOM; DISEASE FREEDOM; FOOT; TESTS	Current post-epidemic sero-surveillance uses random selection of animal holdings. A better strategy may be to estimate the benefits gained by sampling each farm and use this to target selection. In this study we estimate the probability of undiscovered infection for sheep farms in Devon after the 2001 foot-and-mouth disease outbreak using the combination of a previously published model of daily infection risk and a simple model of probability of discovery of infection during the outbreak. This allows comparison of the system sensitivity (ability to detect infection in the area) of arbitrary, random sampling compared to risk-targeted selection across a full range of sampling budgets. We show that it is possible to achieve 95% system sensitivity by sampling, on average, 945 farms with random sampling and 184 farms with risk-targeted sampling. We also examine the effect of ordering samples by risk to expedite return to a disease-free status. Risk ordering the sampling process results in detection of positive farms, if present, 15.6 days sooner than with randomly ordered sampling, assuming 50 farms are tested per day.	[Handel, Ian G.; Bronsvoort, Barend M. de C.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Handel, Ian G.; Bronsvoort, Barend M. de C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Forbes, John F.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Handel, IG (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	ian.handel@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485	DEFRA/Scottish Funding Council Veterinary Training and Research Initiative [VT 0101]	DEFRA/Scottish Funding Council Veterinary Training and Research Initiative(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by DEFRA/Scottish Funding Council Veterinary Training and Research Initiative grant VT 0101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD ME, 2007, P BIOL SCI; Branscum AJ, 2006, STAT MED, V25, P2658, DOI 10.1002/sim.2449; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cameron AR, 1998, PREV VET MED, V34, P19, DOI 10.1016/S0167-5877(97)00073-1; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon RM, 2002, PREV VET MED, V52, P227, DOI 10.1016/S0167-5877(01)00262-8; *DEFRA, 2002, FOOT MOUTH DIS UK 1; Diggle PJ, 2006, STAT METHODS MED RES, V15, P325, DOI 10.1191/0962280206sm454oa; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Greiner M, 2005, PREV VET MED, V70, P223, DOI 10.1016/j.prevetmed.2005.03.007; Humphry RW, 2004, PREV VET MED, V65, P173, DOI 10.1016/j.prevetmed.2004.07.003; Johnson WO, 2004, BIOMETRICS, V60, P165, DOI 10.1111/j.0006-341X.2004.00143.x; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; MARTIN SW, 1992, PREV VET MED, V14, P33, DOI 10.1016/0167-5877(92)90082-Q; OIE, 2010, MAN DIAGN TESTS VACC; *OIE, 2010, TER AN HLTH COD; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; R Core Team, 2020, R LANG ENV STAT COMP; Schuppers ME, 2010, EPIDEMIOL INFECT, V138, P1242, DOI 10.1017/S0950268809991518; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Williams MS, 2009, PREV VET MED, V89, P34, DOI 10.1016/j.prevetmed.2009.01.005	23	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20064	10.1371/journal.pone.0020064	http://dx.doi.org/10.1371/journal.pone.0020064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21674022	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500023
J	Pramanik, KC; Boreddy, SR; Srivastava, SK				Pramanik, Kartick C.; Boreddy, Srinivas Reddy; Srivastava, Sanjay K.			Role of Mitochondrial Electron Transport Chain Complexes in Capsaicin Mediated Oxidative Stress Leading to Apoptosis in Pancreatic Cancer Cells	PLOS ONE			English	Article							BENZYL ISOTHIOCYANATE; CYCLE ARREST; GASTRIC-CANCER; IN-VITRO; INDUCTION; ACTIVATION; GENERATION; PEPPER; DEATH; CHILI	We evaluated the mechanism of capsaicin-mediated ROS generation in pancreatic cancer cells. The generation of ROS was about 4-6 fold more as compared to control and as early as 1 h after capsaicin treatment in BxPC-3 and AsPC-1 cells but not in normal HPDE-6 cells. The generation of ROS was inhibited by catalase and EUK-134. To delineate the mechanism of ROS generation, enzymatic activities of mitochondrial complex-I and complex-III were determined in the pure mitochondria. Our results shows that capsaicin inhibits about 2.5-9% and 5-20% of complex-I activity and 8-75% of complex-III activity in BxPC-3 and AsPC-1 cells respectively, which was attenuable by SOD, catalase and EUK-134. On the other hand, capsaicin treatment failed to inhibit complex-I or complex-III activities in normal HPDE-6 cells. The ATP levels were drastically suppressed by capsaicin treatment in both BxPC-3 and AsPC-1 cells and attenuated by catalase or EUK-134. Oxidation of mitochondria-specific cardiolipin was substantially higher in capsaicin treated cells. BxPC-3 derived rho(o) cells, which lack mitochondrial DNA, were completely resistant to capsaicin mediated ROS generation and apoptosis. Our results reveal that the release of cytochrome c and cleavage of both caspase-9 and caspase-3 due to disruption of mitochondrial membrane potential were significantly blocked by catalase and EUK-134 in BxPC-3 cells. Our results further demonstrate that capsaicin treatment not only inhibit the enzymatic activity and expression of SOD, catalase and glutathione peroxidase but also reduce glutathione level. Over-expression of catalase by transient transfection protected the cells from capsaicin-mediated ROS generation and apoptosis. Furthermore, tumors from mice orally fed with 2.5 mg/kg capsaicin show decreased SOD activity and an increase in GSSG/GSH levels as compared to controls. Taken together, our results suggest the involvement of mitochondrial complex-I and III in capsaicin-mediated ROS generation and decrease in antioxidant levels resulting in severe mitochondrial damage leading to apoptosis in pancreatic cancer cells.	[Pramanik, Kartick C.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Sch Pharm, Amarillo, TX USA; Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Sch Pharm, Amarillo, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Pramanik, KC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Sch Pharm, Amarillo, TX USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020		National Cancer Institute, National Institutes of Health [R01 CA129038, R01 CA106953]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health R01 CA129038; R01 CA106953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409; BUSCH SHB, 1983, TRENDS PHARMACOL SCI, V4, P4; CERINIC MM, 1995, J RHEUMATOL, V22, P1447; CHUNGMAN HJ, 2001, CANCER RES, V61, P8578; CORDELL GA, 1993, ANN PHARMACOTHER, V27, P330, DOI 10.1177/106002809302700316; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; Hail N, 2002, JNCI-J NATL CANCER I, V94, P1281, DOI 10.1093/jnci/94.17.1281; Hail N, 2001, CANCER RES, V61, P6698; Hartel M, 2006, GUT, V55, P519, DOI 10.1136/gut.2005.073205; Hatefi Y, 1978, Methods Enzymol, V53, P21; HOLZER P, 1991, PHARMACOL REV, V43, P143; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Ito K, 2004, CANCER RES, V64, P1071, DOI 10.1158/0008-5472.CAN-03-1670; JEMAL A, 2010, CA CANC J CLIN; Jung MY, 2001, CANCER LETT, V165, P139, DOI 10.1016/S0304-3835(01)00426-8; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kang HJ, 2003, INT J CANCER, V103, P475, DOI 10.1002/ijc.10855; KANG JY, 1995, DIGEST DIS SCI, V40, P576, DOI 10.1007/BF02064373; KELSEN D, 1994, SEMIN ONCOL, V21, P58; Kim CS, 2004, J MED FOOD, V7, P267, DOI 10.1089/jmf.2004.7.267; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; Lee YS, 2004, FREE RADICAL RES, V38, P405, DOI 10.1080/10715760410001665262; Lo YC, 2005, WORLD J GASTROENTERO, V11, P6254, DOI 10.3748/wjg.v11.i40.6254; LOPEZCARRILLO L, 1994, AM J EPIDEMIOL, V139, P263, DOI 10.1093/oxfordjournals.aje.a116993; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; MONSEREENUSORN Y, 1983, RES COMMUN CHEM PATH, V41, P95; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Mozsik G, 2005, WORLD J GASTROENTERO, V11, P5180; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; RAGAN CI, 1987, SUBFRACTIONATION MIT, P79; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Sathyanarayana MN, 2006, CRIT REV FOOD SCI, V46, P275, DOI 10.1080/1040-830491379236; SICUTERI F, 1989, CLIN J PAIN, V5, P49, DOI 10.1097/00002508-198903000-00010; Surh YJ, 1998, MUTAT RES-FUND MOL M, V402, P259, DOI 10.1016/S0027-5107(97)00305-9; Surh YJ, 2002, J NATL CANCER I, V94, P1263, DOI 10.1093/jnci/94.17.1263; SUZUKI T, 1994, CONSTITUTION RED PEP, P227; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Thoennissen NH, 2010, ONCOGENE, V29, P285, DOI 10.1038/onc.2009.335; Toogood PL, 2008, CURR OPIN CHEM BIOL, V12, P457, DOI 10.1016/j.cbpa.2008.06.002; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; WATSON CPN, 1988, PAIN, V33, P333, DOI 10.1016/0304-3959(88)90292-8; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wharton D C, 1978, Methods Enzymol, V53, P646; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Yun TK, 1999, ANN NY ACAD SCI, V889, P157, DOI 10.1111/j.1749-6632.1999.tb08734.x; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6	53	134	140	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20151	10.1371/journal.pone.0020151	http://dx.doi.org/10.1371/journal.pone.0020151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647434	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500031
J	Kato, J; Okada, K				Kato, Junko; Okada, Kensuke			Simplification and Shift in Cognition of Political Difference: Applying the Geometric Modeling to the Analysis of Semantic Similarity Judgment	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; DISTANCE; AGENDA	Perceiving differences by means of spatial analogies is intrinsic to human cognition. Multi-dimensional scaling (MDS) analysis based on Minkowski geometry has been used primarily on data on sensory similarity judgments, leaving judgments on abstractive differences unanalyzed. Indeed, analysts have failed to find appropriate experimental or real-life data in this regard. Our MDS analysis used survey data on political scientists' judgments of the similarities and differences between political positions expressed in terms of distance. Both distance smoothing and majorization techniques were applied to a three-way dataset of similarity judgments provided by at least seven experts on at least five parties' positions on at least seven policies (i.e., originally yielding 245 dimensions) to substantially reduce the risk of local minima. The analysis found two dimensions, which were sufficient for mapping differences, and fit the city-block dimensions better than the Euclidean metric in all datasets obtained from 13 countries. Most city-block dimensions were highly correlated with the simplified criterion (i.e., the left-right ideology) for differences that are actually used in real politics. The isometry of the city-block and dominance metrics in two-dimensional space carries further implications. More specifically, individuals may pay attention to two dimensions (if represented in the city-block metric) or focus on a single dimension (if represented in the dominance metric) when judging differences between the same objects. Switching between metrics may be expected to occur during cognitive processing as frequently as the apparent discontinuities and shifts in human attention that may underlie changing judgments in real situations occur. Consequently, the result has extended strong support for the validity of the geometric models to represent an important social cognition, i.e., the one of political differences, which is deeply rooted in human nature.	[Kato, Junko] Univ Tokyo, Grad Sch Law, Bunkyo Ku, Tokyo, Japan; [Kato, Junko] Univ Tokyo, Grad Sch Polit, Bunkyo Ku, Tokyo, Japan; [Okada, Kensuke] Senshu Univ, Sch Human Sci, Dept Psychol, Kawasaki Ku, Kanagawa, Japan	University of Tokyo; University of Tokyo	Kato, J (corresponding author), Univ Tokyo, Grad Sch Law, Bunkyo Ku, Tokyo, Japan.	katoj@j.u-tokyo.ac.jp		Okada, Kensuke/0000-0003-1663-5812	Japanese government [16530077]; Japan Society for the Promotion of Science [090100000119]; Grants-in-Aid for Scientific Research [22830085] Funding Source: KAKEN	Japanese government; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported by Grants-in-Aid for Basic Research (C) from the Japanese government (to JK 16530077) and sponsored by the Japan Society for the Promotion of Science (090100000119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ARABIE P, 1991, PSYCHOMETRIKA, V56, P567, DOI 10.1007/BF02294491; ARNOLD JB, 1971, J EXP PSYCHOL, V90, P349, DOI 10.1037/h0031565; ASHBY FG, 1994, PSYCHOL SCI, V5, P144, DOI 10.1111/j.1467-9280.1994.tb00651.x; Black D., 1958, THEORY COMMITTEE ELE; BORG I, 1980, PSYCHOMETRIKA, V45, P25, DOI 10.1007/BF02293597; Borg I, 2010, MODERN MULTIDIMENSIO; CASTLES FG, 1984, EUR J POLIT RES, V12, P73, DOI 10.1111/j.1475-6765.1984.tb00080.x; Cox Gary W., 2007, POSITIVE CHANGES POL, P19; Danger R, 2006, LECT NOTES ARTIF INT, V4177, P280; DELEEUW J, 1988, J CLASSIF, V5, P163, DOI 10.1007/BF01897162; Downs A., 1957, EC THEORY DEMOCRACY; Ekman G, 1954, J PSYCHOL, V38, P467, DOI 10.1080/00223980.1954.9712953; ENELOW JM, 1988, J POLIT, V50, P1057, DOI 10.2307/2131392; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; FERGUSON E, 1997, J MANAGERIAL PSYCHOL, V0012, P00204, DOI DOI 10.1108/02683949710174829; Gardenfors P., 2004, CONCEPTUAL SPACES GE; Gardenfors P, 2006, LECT NOTES ARTIF INT, V4211, P16; Garner W. R., 1974, PROCESSING INFORM ST; Green P., 1989, MULTIDIMENSIONAL SCA; Greene KF, 2008, AM J POLIT SCI, V52, P16, DOI 10.1111/j.1540-5907.2007.00296.x; Groenen PJF, 1996, PSYCHOMETRIKA, V61, P529, DOI 10.1007/BF02294553; GROENEN PJF, 1995, J CLASSIF, V12, P3, DOI 10.1007/BF01202265; Groenen PJF, 1999, J CLASSIF, V16, P225, DOI 10.1007/s003579900055; Grynaviski JD, 2006, POLIT ANAL, V14, P393, DOI 10.1093/pan/mpl003; Hinich MJ, 2008, MATH COMPUT MODEL, V48, P1510, DOI 10.1016/j.mcm.2008.05.022; HUBER J, 1995, PARTY POLIT, V1, P73, DOI 10.1177/1354068895001001004; HUBERT L, 1992, J CLASSIF, V9, P211, DOI 10.1007/BF02621407; Humphreys M, 2010, BRIT J POLIT SCI, V40, P11, DOI 10.1017/S0007123409990263; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Laver M., 1992, POLICY PARTY COMPETI; Laver M, 2001, ESTIMATING POLICY PO; Laver Michael J., 2006, PARTY POLICY MODERN; McKelvey R. D., 1976, Mathematics of Operations Research, V1, P144, DOI 10.1287/moor.1.2.144; MCKELVEY RD, 1976, J ECON THEORY, V12, P472, DOI 10.1016/0022-0531(76)90040-5; MOUW CJ, 1992, AM POLIT SCI REV, V86, P87, DOI 10.2307/1964017; Myung IJ, 2000, MEM COGNITION, V28, P832, DOI 10.3758/BF03198418; NOSOFSKY RM, 1992, ANNU REV PSYCHOL, V43, P25, DOI 10.1146/annurev.ps.43.020192.000325; Pedersen MN, 1997, EUR J POLIT RES, V31, P147, DOI 10.1111/1475-6765.00310; Pliner V, 1996, J CLASSIF, V13, P3, DOI 10.1007/BF01202579; PLINER VM, 1986, AUTOMAT REM CONTR+, V47, P560; Pothos EM, 2000, J EXP PSYCHOL LEARN, V26, P847, DOI 10.1037//0278-7393.26.4.847; RAE D, 1971, BRIT J POLIT SCI, V1, P71, DOI 10.1017/S0007123400008954; Rickard JT, 2007, INFORM SCIENCES, V177, P4539, DOI 10.1016/j.ins.2007.05.023; Riker W.R., 1962, THEORY POLITICAL COA; SARTORI G, 1970, AM POLIT SCI REV, V64, P1033, DOI 10.2307/1958356; Schofield N., 2007, SPATIAL MODEL POLITI; SHEPARD RN, 1974, PSYCHOMETRIKA, V39, P373, DOI 10.1007/BF02291665; SHEPARD RN, 1991, PERCEPTION OF STRUCTURE, P53, DOI 10.1037/10101-003; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; TORGERSON W, 1958, THEORY METHODS SCALI; TORGERSON WS, 1965, PSYCHOMETRIKA, V30, P379, DOI 10.1007/BF02289530; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Westholm A, 1997, AM POLIT SCI REV, V91, P865, DOI 10.2307/2952170; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20693	10.1371/journal.pone.0020693	http://dx.doi.org/10.1371/journal.pone.0020693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774BN	21673959	Green Submitted, Green Published, gold			2022-12-27	WOS:000291356400018
J	Mangia, CMF; Kissoon, N; Branchini, OA; Andrade, MC; Kopelman, BI; Carcillo, J				Ferreira Mangia, Cristina Malzoni; Kissoon, Niranjan; Branchini, Otavio Augusto; Andrade, Maria Cristina; Kopelman, Benjamin Israel; Carcillo, Joe			Bacterial Sepsis in Brazilian Children: A Trend Analysis from 1992 to 2006	PLOS ONE			English	Article							GUIDELINES; DISEASE; CARE	Background: The objective of this study was to determine the epidemiology of hospitalized pediatric sepsis in Brazil (19922006) and to compare mortality caused by sepsis to that caused by other major childhood diseases. Methods and Findings: We performed a retrospective descriptive study of hospital admissions using a government database of all hospital affiliated with the Brazilian health system. We studied all hospitalizations in children from 28 days through 19 years with diagnosis of bacterial sepsis defined by the criteria of the International Classification of Diseases (ICD), (Appendix S1). Based on the data studied from 1992 through 2006, the pediatric hospital mortality rate was 1.23% and there were 556,073 pediatric admissions with bacterial sepsis with a mean mortality rate of 19.9%. There was a case reduction of 67% over. 1992-2006 (p<0.001); however, the mortality rate remained unchanged (from 1992-1996, 20.5%; and from 20022006, 19.7%). Sepsis-hospital mortality rate was substantially higher than pneumonia (0.5%), HIV (3.3%), diarrhea (0.3%), undernutrition (2.3%), malaria (0.2%) and measles (0.7%). The human development index (HDI) and mortality rates (MR) by region were: North region 0.76 and 21.7%; Northeast region 0.72 and 27.1%; Central-West 0.81 and 23.5%; South region 0.83 and 12.2% and Southeast region 0.82 and 14.8%, respectively. Conclusions: We concluded that sepsis remains an important health problem in children in Brazil. The institution of universal primary care programs has been associated with substantially reduced sepsis incidence and therefore deaths; however, hospital mortality rates in children with sepsis remain unchanged. Implementation of additional health initiatives to reduce sepsis mortality in hospitalized patients could have great impact on childhood mortality rates in Brazil.	[Ferreira Mangia, Cristina Malzoni; Andrade, Maria Cristina; Kopelman, Benjamin Israel] Univ Fed Sao Paulo, Dept Pediat, Escola Paulista Med, Sao Paulo, Brazil; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat, Div Crit Care, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Branchini, Otavio Augusto] Hosp Emilio Ribas, Sao Paulo, Brazil; [Carcillo, Joe] Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA	Universidade Federal de Sao Paulo (UNIFESP); Child & Family Research Institute; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mangia, CMF (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Escola Paulista Med, Sao Paulo, Brazil.	nkissoon@cw.bc.ca	Kissoon, Niranjan/AAC-6140-2021	Kissoon, Niranjan/0000-0001-8847-9973				Barbosa Arnaldo Prata, 2004, J. Pediatr. (Rio J.), V80, P437, DOI 10.1590/S0021-75572004000800002; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buysse CMP, 2008, ARCH PEDIAT ADOL MED, V162, P1036, DOI 10.1001/archpedi.162.11.1036; Carcillo JA, 2003, CRIT CARE CLIN, V19, P413, DOI 10.1016/S0749-0704(03)00013-7; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; Carcillo JA, 1997, CRIT CARE CLIN, V13, P553, DOI 10.1016/S0749-0704(05)70328-6; Carcillo Joseph A., 2002, J. Pediatr. (Rio J.), V78, P449, DOI 10.1590/S0021-75572002000600004; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Fischer Joachim E, 2005, Pediatr Crit Care Med, V6, pS120, DOI 10.1097/01.PCC.0000161583.34305.A0; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; HAYDEN WR, 1994, J PEDIATR-US, V124, P657, DOI 10.1016/S0022-3476(05)83159-2; Teles JMM, 2008, SHOCK, V30, P47, DOI 10.1097/SHK.0b013e318181a128; *MIN SAUD, PORT SAUD SAMU 192 P; Ministerio da Saude, INF SAUD; Molyneux E, 2001, LANCET, V357, P86, DOI 10.1016/S0140-6736(00)03536-4; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Opal Steven M, 2005, Pediatr Crit Care Med, V6, pS55, DOI 10.1097/01.PCC.0000161580.79526.4C; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Ferrer APS, 2010, CLINICS, V65, P35, DOI 10.1590/S1807-59322010000100007; *UNICEF, 2006, CHILD DEV IND; United Nation, 2001, ROAD MAP IMPL UN MIL; United Nations Development Programme, HUM DEV REP; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; CRIT CARE MED, V27, P639	30	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e14817	10.1371/journal.pone.0014817	http://dx.doi.org/10.1371/journal.pone.0014817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674036	Green Accepted, Green Published, gold			2022-12-27	WOS:000291355500001
J	Carrai, M; Steinke, V; Vodicka, P; Pardini, B; Rahner, N; Holinski-Feder, E; Morak, M; Schackert, HK; Gorgens, H; Stemmler, S; Betz, B; Kloor, M; Engel, C; Buttner, R; Naccarati, A; Vodickova, L; Novotny, J; Stein, A; Hemminki, K; Propping, P; Forsti, A; Canzian, F; Barale, R; Campa, D				Carrai, Maura; Steinke, Verena; Vodicka, Pavel; Pardini, Barbara; Rahner, Nils; Holinski-Feder, Elke; Morak, Monika; Schackert, Hans K.; Goergens, Heike; Stemmler, Susanne; Betz, Beate; Kloor, Matthias; Engel, Christoph; Buettner, Reinhard; Naccarati, Alessio; Vodickova, Ludmila; Novotny, Jan; Stein, Angelika; Hemminki, Kari; Propping, Peter; Foersti, Asta; Canzian, Federico; Barale, Roberto; Campa, Daniele			Association Between TAS2R38 Gene Polymorphisms and Colorectal Cancer Risk: A Case-Control Study in Two Independent Populations of Caucasian Origin	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BITTER TASTE RECEPTORS; RAT SMALL-INTESTINE; INDIVIDUAL-DIFFERENCES; ALPHA-GUSTDUCIN; PERCEPTION; GUT; 6-N-PROPYLTHIOURACIL; SUSCEPTIBILITY; ABSORPTION	Molecular sensing in the lingual mucosa and in the gastro-intestinal tract play a role in the detection of ingested harmful drugs and toxins. Therefore, genetic polymorphisms affecting the capability of initiating these responses may be critical for the subsequent efficiency of avoiding and/or eliminating possible threats to the organism. By using a tagging approach in the region of Taste Receptor 2R38 (TAS2R38) gene, we investigated all the common genetic variation of this gene region in relation to colorectal cancer risk with a case-control study in a German population (709 controls and 602 cases) and in a Czech population (623 controls and 601 cases). We found that there were no significant associations between individual SNPs of the TAS2R38 gene and colorectal cancer in the Czech or in the German population, nor in the joint analysis. However, when we analyzed the diplotypes and the phenotypes we found that the non-taster group had an increased risk of colorectal cancer in comparison to the taster group. This association was borderline significant in the Czech population, (OR = 1.28, 95% CI 0.99-1.67; P(value) = 0.058) and statistically significant in the German population (OR = 1.36, 95% CI 1.06-1.75; P(value) = 0.016) and in the joint analysis (OR = 1.34, 95% CI 1.12-1.61; P(value) = 0.001). In conclusion, we found a suggestive association between the human bitter tasting phenotype and the risk of CRC in two different populations of Caucasian origin.	[Carrai, Maura; Barale, Roberto; Campa, Daniele] Univ Pisa, Dept Biol, Pisa, Italy; [Steinke, Verena; Rahner, Nils; Propping, Peter] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Vodicka, Pavel; Pardini, Barbara; Naccarati, Alessio; Vodickova, Ludmila] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Vodicka, Pavel; Vodickova, Ludmila] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Holinski-Feder, Elke; Morak, Monika] Univ Munich, Univ Hosp, Dept Internal Med, Munich, Germany; [Holinski-Feder, Elke; Morak, Monika] Med Genet Zentrum MGZ, Ctr Med Genet, Munich, Germany; [Schackert, Hans K.; Goergens, Heike] Tech Univ Dresden, Dept Surg Res, Dresden, Germany; [Stemmler, Susanne] Humangenet Ruhr Univ Bochum, Bochum, Germany; [Betz, Beate] Univ Dusseldorf, Inst Human Genet, Dusseldorf, Germany; [Kloor, Matthias] Univ Heidelberg, Inst Pathol, Dept Appl Tumour Biol, D-6900 Heidelberg, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Buettner, Reinhard] Univ Bonn, Inst Pathol, Bonn, Germany; [Novotny, Jan] Charles Univ Prague, Dept Oncol, Fac Med 1, Prague, Czech Republic; [Stein, Angelika; Hemminki, Kari; Foersti, Asta; Canzian, Federico; Campa, Daniele] Deutsch Krebsforschungszentrum DKFZ, German Canc Res Ctr, Heidelberg, Germany; [Hemminki, Kari; Foersti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	University of Pisa; University of Bonn; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; University of Munich; Technische Universitat Dresden; Ruhr University Bochum; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Leipzig University; University of Bonn; Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University	Carrai, M (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	d.campa@dkfz.de	Campa, Daniele/K-1617-2016; Pardini, Barbara/K-9451-2016; Vodicka, Pavel/H-3370-2014; Carrai, Maura/AGZ-4973-2022; Vodickova, Ludmila/H-3083-2014; Pardini, Barbara/ABI-2295-2020; Canzian, Federico/I-2804-2014	Campa, Daniele/0000-0003-3220-9944; Pardini, Barbara/0000-0001-9571-4257; Pardini, Barbara/0000-0001-9571-4257; Engel, Christoph/0000-0002-7247-282X; Carrai, Maura/0000-0001-6663-0353; Canzian, Federico/0000-0002-4261-4583; BARALE, Roberto/0000-0003-4161-2241; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243	Grant Agency of the Czech Republic [CZ:GACR:GA310/07/1430]; European Economic Area/Norway Grants; Czech Republic state budget [A/CZ0046/2/0012]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Economic Area/Norway Grants; Czech Republic state budget	This project was partially supported by the Grant Agency of the Czech Republic: CZ:GACR:GA310/07/1430, by the European Economic Area/Norway Grants and the Czech Republic state budget by means of the Research Support Fund: A/CZ0046/2/0012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basson MD, 2005, DIGEST DIS SCI, V50, P483, DOI 10.1007/s10620-005-2462-7; Behrens M, 2010, RESULTS PROBL CELL D, V52, P87, DOI 10.1007/978-3-642-14426-4_8; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campa D, 2008, MUTAT RES-FUND MOL M, V645, P56, DOI 10.1016/j.mrfmmm.2008.08.001; Campa D, 2008, EUR J CANCER, V44, P854, DOI 10.1016/j.ejca.2008.02.004; Campa D, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-112; Campa D, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-88; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drewnowski A, 2001, DRUG METAB DISPOS, V29, P535; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Eaden JA, 2001, J GASTROEN HEPATOL, V16, P573; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANC; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; Kim UK, 2005, CLIN GENET, V67, P275, DOI 10.1111/j.1399-0004.2004.00361.x; Kim UK, 2006, CHEM SENSES, V31, P599, DOI 10.1093/chemse/bjj065; Kiyohara C, 2000, J Epidemiol, V10, P349; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P959, DOI 10.1023/B:CACO.0000007983.16045.a1; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P138, DOI 10.1158/1055-9965.EPI-05-0428; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Sacerdote C, 2007, AM J EPIDEMIOL, V166, P576, DOI 10.1093/aje/kwm113; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Strate LL, 2005, CANCER CAUSE CONTROL, V16, P201, DOI 10.1007/s10552-004-3488-4; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Ueda T, 2001, BIOCHEM BIOPH RES CO, V285, P147, DOI 10.1006/bbrc.2001.5136; WARDWELL L, 2009, INT J FOOD SCI NUTR, P1; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092	46	57	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20464	10.1371/journal.pone.0020464	http://dx.doi.org/10.1371/journal.pone.0020464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674048	Green Published, Green Submitted, gold			2022-12-27	WOS:000291310600010
J	Scott-Samuel, NE; Baddeley, R; Palmer, CE; Cuthill, IC				Scott-Samuel, Nicholas E.; Baddeley, Roland; Palmer, Chloe E.; Cuthill, Innes C.			Dazzle Camouflage Affects Speed Perception	PLOS ONE			English	Article							ANIMAL CAMOUFLAGE	Movement is the enemy of camouflage: most attempts at concealment are disrupted by motion of the target. Faced with this problem, navies in both World Wars in the twentieth century painted their warships with high contrast geometric patterns: so-called "dazzle camouflage". Rather than attempting to hide individual units, it was claimed that this patterning would disrupt the perception of their range, heading, size, shape and speed, and hence reduce losses from, in particular, torpedo attacks by submarines. Similar arguments had been advanced earlier for biological camouflage. Whilst there are good reasons to believe that most of these perceptual distortions may have occurred, there is no evidence for the last claim: changing perceived speed. Here we show that dazzle patterns can distort speed perception, and that this effect is greatest at high speeds. The effect should obtain in predators launching ballistic attacks against rapidly moving prey, or modern, low-tech battlefields where handheld weapons are fired from short ranges against moving vehicles. In the latter case, we demonstrate that in a typical situation involving an RPG7 attack on a Land Rover the reduction in perceived speed is sufficient to make the grenade miss where it was aimed by about a metre, which could be the difference between survival or not for the occupants of the vehicle.	[Scott-Samuel, Nicholas E.; Baddeley, Roland; Palmer, Chloe E.; Cuthill, Innes C.] Univ Bristol, Bristol, Avon, England	University of Bristol	Scott-Samuel, NE (corresponding author), Univ Bristol, Bristol, Avon, England.	n.e.scott-samuel@bris.ac.uk		Scott-Samuel, Nicholas/0000-0002-8270-8437	Biotechnology and Biological Sciences Research Council [BB/E02100X/1] Funding Source: Medline; BBSRC [BB/E02100X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Behrens Roy R., 2009, CAMOUPEDIA COMPENDIU; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN JF, 2008, PSYCHOL FORSCH, V14, P199; Cuthill IC., 2009, INT J DES NAT ECODYN, V4, P183, DOI [10.2495/DNE-V4-N3-183-202, DOI 10.2495/DNE-V4-N3-183-202]; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Forbes Peter, 2009, DAZZLED DECEIVED MIM; Georges S, 2002, VISION RES, V42, P2757, DOI 10.1016/S0042-6989(02)00303-6; Hartcup G, 1979, CAMOUFLAGE HIST CONC; Houston AI, 2007, BEHAV ECOL, V18, P769, DOI 10.1093/beheco/arm039; Merilaita S, 2001, EVOL ECOL, V15, P103, DOI 10.1023/A:1013814623311; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Regan David, 2000, HUMAN PERCEPTION OBJ; Rottman G., 2010, ROCKET PROPELLED GRE; Stevens M, 2008, P ROY SOC B-BIOL SCI, V275, P2639, DOI 10.1098/rspb.2008.0877; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Taya S, 2007, PERCEPTION, V36, P3, DOI 10.1068/p5597; THAYER GH, 2009, CONCEALING COLOURATI; Thompson B, 2008, J VISION, V8, DOI 10.1167/8.4.22; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; WATT RJ, 2004, CURRENT PSYCHOL REV, V1, P205; Williams D., 2001, NAVAL CAMOUFLAGE 191	22	72	72	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20233	10.1371/journal.pone.0020233	http://dx.doi.org/10.1371/journal.pone.0020233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673797	gold, Green Published			2022-12-27	WOS:000291309900007
J	Chatenay-Lapointe, M; Shadel, GS				Chatenay-Lapointe, Marc; Shadel, Gerald S.			Repression of Mitochondrial Translation, Respiration and a Metabolic Cycle-Regulated Gene, SLF1, by the Yeast Pumilio-Family Protein Puf3p	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; MESSENGER-RNA TURNOVER; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL NETWORK; BINDING PROTEINS; EXPRESSION; BIOGENESIS; POLYMERASE; MACHINERY	Synthesis and assembly of the mitochondrial oxidative phosphorylation (OXPHOS) system requires genes located both in the nuclear and mitochondrial genomes, but how gene expression is coordinated between these two compartments is not fully understood. One level of control is through regulated expression mitochondrial ribosomal proteins and other factors required for mitochondrial translation and OXPHOS assembly, which are all products of nuclear genes that are subsequently imported into mitochondria. Interestingly, this cadre of genes in budding yeast has in common a 3'-UTR element that is bound by the Pumilio family protein, Puf3p, and is coordinately regulated under many conditions, including during the yeast metabolic cycle. Multiple functions have been assigned to Puf3p, including promoting mRNA degradation, localizing nucleus-encoded mitochondrial transcripts to the outer mitochondrial membrane, and facilitating mitochondria-cytoskeletal interactions and motility. Here we show that Puf3p has a general repressive effect on mitochondrial OXPHOS abundance, translation, and respiration that does not involve changes in overall mitochondrial biogenesis and largely independent of TORC1-mitochondrial signaling. We also identified the cytoplasmic translation factor Slf1p as yeast metabolic cycle-regulated gene that is repressed by Puf3p at the post-transcriptional level and promotes respiration and extension of yeast chronological life span when over-expressed. Altogether, these results should facilitate future studies on which of the many functions of Puf3p is most relevant for regulating mitochondrial gene expression and the role of nuclear-mitochondrial communication in aging and longevity.	[Chatenay-Lapointe, Marc; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Chatenay-Lapointe, Marc; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	gerald.shadel@yale.edu	WONG, WEY LIM/C-1054-2010; Wong, Wey-Lim/S-7445-2017	WONG, WEY LIM/0000-0002-2722-3517; Wong, Wey-Lim/0000-0002-2722-3517	National Institutes of Health (NIH) [HL-059655, T32 GM007499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant HL-059655 awarded to GSS. MCL was supported by NIH pre-doctoral Genetics training grant T32 GM007499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cereghino GP, 1996, EMBO J, V15, P363, DOI 10.1002/j.1460-2075.1996.tb00366.x; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Deng YP, 2005, INT J MOL MED, V15, P123; Devaux F, 2010, FEBS LETT, V584, P4273, DOI 10.1016/j.febslet.2010.09.030; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; GRIVELL LA, 1995, CRIT REV BIOCHEM MOL, V30, P121, DOI 10.3109/10409239509085141; Hagen I, 2004, MOL MICROBIOL, V52, P1413, DOI 10.1111/j.1365-2958.2004.04064.x; Ho SW, 2006, P NATL ACAD SCI USA, V103, P9940, DOI 10.1073/pnas.0509185103; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lelandais G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000409; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Russo A, 2006, BBA-MOL CELL RES, V1763, P833, DOI 10.1016/j.bbamcr.2006.05.010; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571; Sobel SG, 1999, MOL BIOL CELL, V10, P3849, DOI 10.1091/mbc.10.11.3849; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Zarnack K, 2007, MOL GENET GENOMICS, V278, P347, DOI 10.1007/s00438-007-0271-8	40	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20441	10.1371/journal.pone.0020441	http://dx.doi.org/10.1371/journal.pone.0020441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655263	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600069
J	Guo, G; Gehle, P; Doelken, S; Martin-Ventura, JL; von Kodolitsch, Y; Hetzer, R; Robinson, PN				Guo, Gao; Gehle, Petra; Doelken, Sandra; Martin-Ventura, Jose Luis; von Kodolitsch, Yskert; Hetzer, Roland; Robinson, Peter N.			Induction of Macrophage Chemotaxis by Aortic Extracts from Patients with Marfan Syndrome Is Related to Elastin Binding Protein	PLOS ONE			English	Article							GROWTH-FACTOR MODULES; FACTOR-LIKE DOMAINS; MOUSE MODEL; MATRIX METALLOPROTEINASE-1; HUMAN FIBRILLIN-1; THORACIC AORTA; CELL-ADHESION; IN-VITRO; PATHOGENESIS; MUTATIONS	Marfan syndrome is an autosomal dominantly inherited disorder of connective tissue with prominent skeletal, ocular, and cardiovascular manifestations. Aortic aneurysm and dissection are the major determinants of premature death in untreated patients. In previous work, we showed that extracts of aortic tissues from the mgR mouse model of Marfan syndrome showed increased chemotactic stimulatory activity related to the elastin-binding protein. Aortic samples were collected from 6 patients with Marfan syndrome and 8 with isolated aneurysms of the ascending aorta. Control samples were obtained from 11 organ donors without known vascular or connective tissue diseases. Soluble proteins extracted from the aortic samples of the two patient groups were compared against buffer controls and against the aortic samples from controls with respect to the ability to induce macrophage chemotaxis as measured using a modified Boyden chamber, as well as the reactivity to a monoclonal antibody BA4 against bioactive elastin peptides using ELISA. Samples from Marfan patients displayed a statistically significant increase in chemotactic inductive activity compared to control samples. Additionally, reactivity to BA4 was significantly increased. Similar statistically significant increases were identified for the samples from patients with idiopathic thoracic aortic aneurysm. There was a significant correlation between the chemotactic index and BA4 reactivity, and the increases in chemotactic activity of extracts from Marfan patients could be inhibited by pretreatment with lactose, VGVAPG peptides, or BA4, which indicates the involvement of EBP in mediating the effects. Our results demonstrate that aortic extracts of patients with Marfan syndrome can elicit macrophage chemotaxis, similar to our previous study on aortic extracts of the mgR mouse model of Marfan syndrome (Guo et al., Circulation 2006; 114: 1855-62).	[Guo, Gao; Doelken, Sandra; Robinson, Peter N.] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Gehle, Petra; Hetzer, Roland] German Heart Inst Berlin, DHZB, Berlin, Germany; [Gehle, Petra; Hetzer, Roland; Robinson, Peter N.] DHZB, Marfan Zentrum, Berlin, Germany; [Gehle, Petra; Hetzer, Roland; Robinson, Peter N.] Charite, Berlin, Germany; [Doelken, Sandra; Robinson, Peter N.] Max Planck Inst Mol Genet, Berlin, Germany; [Doelken, Sandra; Robinson, Peter N.] Charite, BCRT, D-13353 Berlin, Germany; [Martin-Ventura, Jose Luis] Univ Autonoma Madrid, Fdn Jimenez Diaz, Inst Invest Sanitaria, Vasc Res Lab, Madrid, Spain; [von Kodolitsch, Yskert] Univ Hosp Hamburg Eppendorf, Dept Cardiol Angiol, Ctr Cardiol & Cardiovasc Surg, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Autonomous University of Madrid; Fundacion Jimenez Diaz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Guo, G (corresponding author), Charite, Inst Med & Human Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de	MARTIN-VENTURA, JOSE LUIS/Z-2386-2019	Robinson, Peter/0000-0002-0736-9199; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641	European Commission [HEALTH-F2-2008-200647]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was supported by a grant from the European Commission (FAD; HEALTH-F2-2008-200647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSAMIT RR, 1981, J IMMUNOL, V126, P2194; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Booms P, 2006, J MOL CELL CARDIOL, V40, P234, DOI 10.1016/j.yjmcc.2005.11.009; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Booms P, 2000, HUM GENET, V107, P216, DOI 10.1007/s004390000368; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Chung AWY, 2007, BRIT J PHARMACOL, V152, P305, DOI 10.1038/sj.bjp.0707391; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; D'Arrigo C, 1998, CONNECT TISSUE RES, V37, P29, DOI 10.3109/03008209809028898; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DILLON TJ, 1992, AM REV RESPIR DIS, V146, P1143, DOI 10.1164/ajrccm/146.5_Pt_1.1143; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Fleischer KJ, 1997, ANN THORAC SURG, V63, P1012, DOI 10.1016/S0003-4975(97)00061-1; Fulop T, 2005, PATHOL BIOL, V53, P416, DOI 10.1016/j.patbio.2004.12.023; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; LONG MM, 1988, BIOCHIM BIOPHYS ACTA, V968, P300, DOI 10.1016/0167-4889(88)90021-3; MARIKO B, 2010, AM J PHYSL CELL PHYS; Matyas G, 2007, HUM GENET, V122, P23, DOI 10.1007/s00439-007-0371-x; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; McGowan SE, 2008, AM J RESP CELL MOL, V38, P435, DOI 10.1165/rcmb.2007-0281OC; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Robinson PN, 2002, HUM MUTAT, V20, P153, DOI 10.1002/humu.10113; Robinson PN, 2001, CELL MOL LIFE SCI, V58, P1698, DOI 10.1007/PL00000807; SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P13, DOI 10.1016/S0002-9149(77)80004-0; Segura AM, 1998, CIRCULATION, V98, pII331; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Shinohara T, 2003, ARTERIOSCL THROM VAS, V23, P1839, DOI 10.1161/01.ATV.0000085016.02363.80; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Varga Z, 1997, EXP GERONTOL, V32, P653, DOI 10.1016/S0531-5565(97)00042-9; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; von Kodolitsch Y, 2010, VASA, V39, P17, DOI 10.1024/0301-1526/a000002; von Kodolitsch Y, 2007, HEART, V93, P755, DOI 10.1136/hrt.2006.098798; WEI SM, 1993, J IMMUNOL METHODS, V164, P175; Whiteman P, 2001, J BIOL CHEM, V276, P17156, DOI 10.1074/jbc.M006547200; Whiteman P, 1998, J BIOL CHEM, V273, P7807, DOI 10.1074/jbc.273.14.7807; WRENN DS, 1986, BIOCHEMISTRY-US, V25, P5172, DOI 10.1021/bi00366a028; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Yang HHC, 2010, VASC PHARMACOL, V52, P37, DOI 10.1016/j.vph.2009.10.005	61	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20138	10.1371/journal.pone.0020138	http://dx.doi.org/10.1371/journal.pone.0020138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647416	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500034
J	Jacobsson, JA; Almen, MS; Benedict, C; Hedberg, LA; Michaelsson, K; Brooks, S; Kullberg, J; Axelsson, T; Johansson, L; Ahlstrom, H; Fredriksson, R; Lind, L; Schioth, HB				Jacobsson, Josefin A.; Almen, Markus Sallman; Benedict, Christian; Hedberg, Lilia A.; Michaelsson, Karl; Brooks, Samantha; Kullberg, Joel; Axelsson, Tomas; Johansson, Lars; Ahlstrom, Hakan; Fredriksson, Robert; Lind, Lars; Schioth, Helgi B.			Detailed Analysis of Variants in FTO in Association with Body Composition in a Cohort of 70-Year-Olds Suggests a Weakened Effect among Elderly	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MASS INDEX; FAT MASS; PHYSICAL-ACTIVITY; GENETIC-VARIATION; ADIPOSE-TISSUE; ENERGY-INTAKE; SAMPLE-SIZE; OBESITY; CHILDREN	Background: The rs9939609 single-nucleotide polymorphism (SNP) in the fat mass and obesity (FTO) gene has previously been associated with higher BMI levels in children and young adults. In contrast, this association was not found in elderly men. BMI is a measure of overweight in relation to the individuals' height, but offers no insight into the regional body fat composition or distribution. Objective: To examine whether the FTO gene is associated with overweight and body composition-related phenotypes rather than BMI, we measured waist circumference, total fat mass, trunk fat mass, leg fat mass, visceral and subcutaneous adipose tissue, and daily energy intake in 985 humans (493 women) at the age of 70 years. In total, 733 SNPs located in the FTO gene were genotyped in order to examine whether rs9939609 alone or the other SNPs, or their combinations, are linked to obesity-related measures in elderly humans. Design: Cross-sectional analysis of the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) cohort. Results: Neither a single SNP, such as rs9939609, nor a SNP combination was significantly linked to overweight, body composition-related measures, or daily energy intake in elderly humans. Of note, these observations hold both among men and women. Conclusions: Due to the diversity of measurements included in the study, our findings strengthen the view that the effect of FTO on body composition appears to be less profound in later life compared to younger ages and that this is seemingly independent of gender.	[Jacobsson, Josefin A.; Almen, Markus Sallman; Benedict, Christian; Brooks, Samantha; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Hedberg, Lilia A.] Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Solna, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Axelsson, Tomas; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Kullberg, Joel; Johansson, Lars; Ahlstrom, Hakan] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden; [Johansson, Lars] AstraZeneca R&D, Molndal, Sweden	Uppsala University; Royal Institute of Technology; Uppsala University; Uppsala University; Uppsala University; AstraZeneca	Jacobsson, JA (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	helgi.schioth@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019; Benedict, Christian/K-2190-2017; Brooks, Samantha/AAJ-2159-2020; Michaelsson, Karl/AAM-9094-2021; Johansson, Lars/AAF-4845-2019; Schioth, Helgi/AAQ-7239-2020; Kullberg, Joel/ABE-3997-2021	Fredriksson, Robert/0000-0002-2810-3226; Benedict, Christian/0000-0002-8911-4068; Brooks, Samantha/0000-0002-9146-6257; Michaelsson, Karl/0000-0003-2815-1217; Sallman Almen, Markus/0000-0001-9591-9228	Swedish Research Council; Novo Nordisk; Tore Nilsons Foundation; Ahlens Foundation; Goran Gustafsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk(Novo Nordisk); Tore Nilsons Foundation; Ahlens Foundation; Goran Gustafsson Foundation	The study was supported by the Swedish Research Council, Novo Nordisk, Tore Nilsons Foundation and Ahlens Foundation. RF was supported by the Goran Gustafsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, DIABETES, V59, P1549, DOI 10.2337/db09-1252; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; BARLETT HL, 1991, AM J CLIN NUTR, V53, P1112, DOI 10.1093/ajcn/53.5.1112; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker W., 1998, Scandinavian Journal of Nutrition/Naringsforskning, V42, P145; BECKER W, 1994, METHODS ANAL; Belfer I, 2004, J HUM GENET, V49, P232, DOI 10.1007/s10038-004-0140-9; Bollepalli S, 2010, OBESITY, V18, P1959, DOI 10.1038/oby.2010.82; Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5; Clasey JL, 1999, J APPL PHYSIOL, V86, P1728, DOI 10.1152/jappl.1999.86.5.1728; Coady SA, 2002, OBES RES, V10, P675, DOI 10.1038/oby.2002.91; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Hennig BJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-21; HIND K, 2010, EUR J CLIN NUTR; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hubacek JA, 2011, PHYSIOL RES, V60, P175, DOI 10.33549/physiolres.932066; Iacobellis G., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P345, DOI 10.2174/1568006054553408; JACOBSSON JA, 2008, INT J OBES LOND; Jacobsson JA, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-131; Kullberg J, 2006, J MAGN RESON IMAGING, V24, P394, DOI 10.1002/jmri.20644; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Ouyang C, 2006, PHARMACOGENET GENOM, V16, P667, DOI 10.1097/01.fpc.0000220569.82842.9b; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Schaid DJ, 2006, ANN HUM GENET, V70, P116, DOI 10.1111/j.1529-8817.2005.00215.x; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; WARDLE J, 2008, INT J OBES LOND; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Zhang J, 2005, HUM HERED, V59, P144, DOI 10.1159/000085938; Zimmermann E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004428	51	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20158	10.1371/journal.pone.0020158	http://dx.doi.org/10.1371/journal.pone.0020158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637715	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500035
J	Joseph, J; Seervi, M; Sobhan, PK; Retnabai, ST				Joseph, Jeena; Seervi, Mahendra; Sobhan, Praveen K.; Retnabai, Santhoshkumar Thankayyan			High Throughput Ratio Imaging to Profile Caspase Activity: Potential Application in Multiparameter High Content Apoptosis Analysis and Drug Screening	PLOS ONE			English	Article							CYTOCHROME-C; CELL-DEATH; FRET; VARIABILITY; ACTIVATION; GOSSYPOL; RELEASE; ORIGINS; ASSAY	Recent advancement in the area of green fluorescent protein techniques coupled with microscopic imaging has significantly contributed in defining and dissecting subcellular changes of apoptosis with high spatio-temporal resolution. Although single cell based studies using EGFP and associated techniques have provided valuable information of initiation and hierarchical changes of apoptosis, they are yet to be exploited for multiparameter cell based real time analysis for possible drug screening or pathway defining in a high throughput manner. Here we have developed multiple cancer cell lines expressing FRET sensors for active caspases and adapted them for high throughput live cell ratio imaging, enabling high content image based multiparameter analysis. Sensitivity of the system to detect live cell caspase activation was substantiated by confocal acceptor bleaching as well as wide field FRET imaging. Multiple caspase-specific activities of DEVDase, IETDase and LEHDase were analysed simultaneously with other decisive events of cell death. Through simultaneous analysis of caspase activation by FRET ratio change coupled with detection of mitochondrial membrane potential loss or superoxide generation, we identified several antitumor agents that induced caspase activation with or without membrane potential loss or superoxide generation. Also, cells that escaped the initial drug-induced caspase activation could be easily followed up for defining long term fate. Employing such a revisit imaging strategy of the same area, we have tracked the caspase surviving fractions with multiple drugs and its subsequent response to retreatment, revealing drug-dependent diverging fate of surviving cells. This thereby indicates towards a complex control of drug induced tumor resistance. The technique described here has wider application in both screening of compound libraries as well as in defining apoptotic pathways by linking multiple signaling to identify non-classical apoptosis inducing agents, the greatest advantage being that the high content information obtained are from individual cells rather than being population based.	[Joseph, Jeena; Seervi, Mahendra; Sobhan, Praveen K.; Retnabai, Santhoshkumar Thankayyan] Rajiv Gandhi Ctr Biotechnol, Integrated Canc Res Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Joseph, J (corresponding author), Rajiv Gandhi Ctr Biotechnol, Integrated Canc Res Program, Thycaud PO, Thiruvananthapuram, Kerala, India.	trsanthosh@rgcb.res.in	Seervi, Mahendra/K-8812-2019	Seervi, Mahendra/0000-0002-0266-2062	Dept. of Biotechnology, Govt. of India	Dept. of Biotechnology, Govt. of India	This work was supported by grants from Innovative Young Biotechnologist Award, Dept. of Biotechnology, Govt. of India to STR, CSIR SRF, Govt. of India to JJ, UGC SRF, Govt. of India to MS and ICMR SRF, and Govt. of India to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angres B, 2009, CYTOM PART A, V75A, P420, DOI 10.1002/cyto.a.20698; BATES SE, 1995, J CANCER RES CLIN, V121, P495, DOI 10.1007/BF01197759; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; DEPEYSTER A, 1984, BIOCHEM BIOPH RES CO, V118, P573, DOI 10.1016/0006-291X(84)91341-X; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GRANKVIST K, 1989, INT J BIOCHEM, V21, P853, DOI 10.1016/0020-711X(89)90283-8; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; He LS, 2004, AM J PATHOL, V164, P1901, DOI 10.1016/S0002-9440(10)63751-0; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Huitema C, 2010, J BIOMOL SCREEN, V15, P224, DOI 10.1177/1087057109357790; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jones J, 2000, J BIOMOL SCREEN, V5, P307, DOI 10.1177/108705710000500502; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tian H, 2007, BRIT J PHARMACOL, V150, P321, DOI 10.1038/sj.bjp.0706988; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	36	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20114	10.1371/journal.pone.0020114	http://dx.doi.org/10.1371/journal.pone.0020114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637712	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500031
J	Wu, XM; Hu, CP; Li, XZ; Zou, YQ; Zou, JT; Li, YY; Feng, JT				Wu, Xiu-Ming; Hu, Cheng-Ping; Li, Xiao-Zhao; Zou, Ye-Qiang; Zou, Jun-Tao; Li, Yuan-Yuan; Feng, Jun-Tao			Asthma Pregnancy Alters Postnatal Development of Chromaffin Cells in the Rat Adrenal Medulla	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; NGF; EXPRESSION; DYSFUNCTION; HYPOXIA; NEURONS; ATOPY; MICE	Background: Adrenal neuroendocrine plays an important role in asthma. The activity of the sympathoadrenal system could be altered by early life events. The effects of maternal asthma during pregnancy on the adrenal medulla of offspring remain unknown. Methodology/Principal Findings: This study aims to explore the influence of maternal asthma during pregnancy on the development and function of adrenal medulla in offspring from postnatal day 3 (P3) to postnatal day 60 (P60). Asthmatic pregnant rats (AP), nerve growth factor (NGF)-treated pregnant rats (NP) and NGF antibody-treated pregnant rats (ANP) were sensitized and challenged with ovalbumin (OVA); NP and ANP were treated with NGF and NGF antibody respectively. Offspring rats from the maternal group were divided into four groups: offspring from control pregnant rats (OCP), offspring from AP (OAP), offspring from NP (ONP), and offspring from ANP (OANP). The expressions of phenylethanolamine N-methyltransferase (PNMT) protein in adrenal medulla were analyzed. The concentrations of epinephrine (EPI), corticosterone and NGF in serum were measured. Adrenal medulla chromaffin cells (AMCC) were prone to differentiate into sympathetic nerve cells in OAP and ONP. Both EPI and PNMT were decreased in OAP from P3 to P14, and then reached normal level gradually from P30 to P60, which were lower from birth to adulthood in ONP. Corticosterone concentration increased significantly in OAP and ONP. Conclusion/Significance: Asthma pregnancy may promote AMCC to differentiate into sympathetic neurons in offspring rats and inhibit the synthesis of EPI, resulting in dysfunction of bronchial relaxation.	[Wu, Xiu-Ming; Hu, Cheng-Ping; Li, Xiao-Zhao; Zou, Ye-Qiang; Zou, Jun-Tao; Li, Yuan-Yuan; Feng, Jun-Tao] Cent South Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China	Central South University	Wu, XM (corresponding author), Cent South Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China.	jtfeng1976@hotmail.com			National Natural Science Foundation of China [30800502, 30801505, 81070026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30800502, No. 30801505 and No. 81070026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MB, 1999, J NEUROENDOCRINOL, V11, P569; ALOE L, 1979, P NATL ACAD SCI USA, V76, P1246, DOI 10.1073/pnas.76.3.1246; Bjerg A, 2007, PEDIATRICS, V120, P741, DOI 10.1542/peds.2006-3742; Buttigieg J, 2008, FASEB J, V22, P1317, DOI 10.1096/fj.07-9194com; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; de la Calzada Dolores Garcia, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P343; de Vries A, 2006, CLIN EXP ALLERGY, V36, P1192, DOI 10.1111/j.1365-2222.2006.02549.x; Evinger MJ, 2007, EXP CELL RES, V313, P772, DOI 10.1016/j.yexcr.2006.11.013; Fan JM, 2009, NEUROSCIENCE, V159, P1363, DOI 10.1016/j.neuroscience.2009.02.009; Feng JT, 2005, MED HYPOTHESES, V65, P1043, DOI 10.1016/j.mehy.2005.06.029; Freund V, 2004, REV MAL RESPIR, V21, P328; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Hamada K, 2007, J TOXICOL ENV HEAL A, V70, P688, DOI 10.1080/15287390600974692; HERMAN MAR, 1992, BRAIN RES, V575, P257, DOI 10.1016/0006-8993(92)90088-Q; Hodel A, 2001, J NEUROENDOCRINOL, V13, P217; HOFMANN HD, 1989, J ELECTRON MICR TECH, V12, P397, DOI 10.1002/jemt.1060120412; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; Isidoro-Garcia M, 2007, ALLERGOL IMMUNOPATH, V35, P254, DOI 10.1157/13112992; JAMES G, 2002, J IMMUNOL, V169, P3963; Joachim RA, 2008, CLIN EXP ALLERGY, V38, P283, DOI 10.1111/j.1365-2222.2007.02899.x; Kvetnansky R, 2006, CELL MOL NEUROBIOL, V26, P735, DOI 10.1007/s10571-006-9063-7; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; LIN L, 2010, ALLERGY ASTHMA CLIN, V6, P1; Molendi-Coste O, 2009, NEUROENDOCRINOLOGY, V90, P54, DOI 10.1159/000209222; MORIMOTO M, 1994, NEUROREPORT, V5, P954, DOI 10.1097/00001756-199404000-00025; Morrison SF, 2000, AM J PHYSIOL-REG I, V279, pR1763, DOI 10.1152/ajpregu.2000.279.5.R1763; Ronchetti R, 2009, ALLERGY ASTHMA PROC, V30, P55, DOI 10.2500/aap.2009.30.3197; Sleiman PMA, 2010, CURR OPIN PEDIATR, V22, P307, DOI 10.1097/MOP.0b013e328339553d; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Vaag A, 2006, HORM RES, V65, P137, DOI 10.1159/000091519; Wang Jun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P812; Yamaguchi-Shima N, 2007, EUR J PHARMACOL, V564, P94, DOI 10.1016/j.ejphar.2007.02.021; Ziegler CG, 2008, ENDOCRINOLOGY, V149, P320, DOI 10.1210/en.2007-0645; Ziegler MG, 2002, ANN NY ACAD SCI, V971, P76, DOI 10.1111/j.1749-6632.2002.tb04437.x	35	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20337	10.1371/journal.pone.0020337	http://dx.doi.org/10.1371/journal.pone.0020337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647384	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500047
J	Pittman, SJ; Brown, KA				Pittman, Simon J.; Brown, Kerry A.			Multi-Scale Approach for Predicting Fish Species Distributions across Coral Reef Seascapes	PLOS ONE			English	Article							REGION-WIDE DECLINES; GREAT-BARRIER-REEF; HABITAT COMPLEXITY; MARINE; COMMUNITIES; RICHNESS; MANAGEMENT; AREAS; ASSEMBLAGES; DIVERSITY	Two of the major limitations to effective management of coral reef ecosystems are a lack of information on the spatial distribution of marine species and a paucity of data on the interacting environmental variables that drive distributional patterns. Advances in marine remote sensing, together with the novel integration of landscape ecology and advanced niche modelling techniques provide an unprecedented opportunity to reliably model and map marine species distributions across many kilometres of coral reef ecosystems. We developed a multi-scale approach using three-dimensional seafloor morphology and across-shelf location to predict spatial distributions for five common Caribbean fish species. Seascape topography was quantified from high resolution bathymetry at five spatial scales (5-300 m radii) surrounding fish survey sites. Model performance and map accuracy was assessed for two high performing machine-learning algorithms: Boosted Regression Trees (BRT) and Maximum Entropy Species Distribution Modelling (MaxEnt). The three most important predictors were geographical location across the shelf, followed by a measure of topographic complexity. Predictor contribution differed among species, yet rarely changed across spatial scales. BRT provided 'outstanding' model predictions (AUC = > 0.9) for three of five fish species. MaxEnt provided 'outstanding' model predictions for two of five species, with the remaining three models considered 'excellent' (AUC = 0.8-0.9). In contrast, MaxEnt spatial predictions were markedly more accurate (92% map accuracy) than BRT (68% map accuracy). We demonstrate that reliable spatial predictions for a range of key fish species can be achieved by modelling the interaction between the geographical location across the shelf and the topographic heterogeneity of seafloor structure. This multi-scale, analytic approach is an important new cost-effective tool to accurately delineate essential fish habitat and support conservation prioritization in marine protected area design, zoning in marine spatial planning, and ecosystem-based fisheries management.	[Pittman, Simon J.] NOAA, Biogeog Branch, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA; [Pittman, Simon J.] Univ Virgin Isl, Ctr Marine Sci, St Thomas, VI USA; [Brown, Kerry A.] Kingston Univ London, Sch Geog Geol & Environm, Kingston upon Thames, Surrey, England	National Oceanic Atmospheric Admin (NOAA) - USA; University of the Virgin Islands; Kingston University	Pittman, SJ (corresponding author), NOAA, Biogeog Branch, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA.	simon.pittman@noaa.gov	Brown, Kerry/U-5082-2019	BROWN, KERRY/0000-0002-6342-8966; Pittman, Simon/0000-0002-4113-6970	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The field monitoring program was funded by National Oceanic and Atmospheric Administration Coral Reef Conservation Program (http://coralreef.noaa.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2010, R LANG ENV STAT COMP; BOOTH DJ, 1994, CORAL REEFS, V13, P81, DOI 10.1007/BF00300765; Brock JC, 2009, J COASTAL RES, V25, P1, DOI [10.2112/SI53-001.1, 10.2112/S153-001.1]; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Christensen John D., 2003, Gulf and Caribbean Research, V14, P9; Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015; Douvere F, 2007, MAR POLICY, V31, P582, DOI 10.1016/j.marpol.2007.02.001; DUBIN RE, 1982, B MAR SCI, V32, P572; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Geselbracht L, 2009, AQUAT CONSERV, V19, P408, DOI 10.1002/aqc.992; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Klein CJ, 2009, BIOL CONSERV, V142, P1282, DOI 10.1016/j.biocon.2009.01.035; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Lindeman Kenyon C., 1998, Proceedings of the Gulf and Caribbean Fisheries Institute, V50, P385; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; Mellin C, 2008, ECOL MODEL, V218, P182, DOI 10.1016/j.ecolmodel.2008.07.021; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2007, MAR ECOL PROG SER, V348, P273, DOI 10.3354/meps07052; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Valiela I, 2001, SCI MAR, V65, P215, DOI 10.3989/scimar.2001.65s2215; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025; WILLIAMS AH, 1978, J EXP MAR BIOL ECOL, V34, P197, DOI 10.1016/S0022-0981(78)80002-1; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239	51	167	169	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20583	10.1371/journal.pone.0020583	http://dx.doi.org/10.1371/journal.pone.0020583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637787	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000291052200079
J	Church, TS; Thomas, DM; Tudor-Locke, C; Katzmarzyk, PT; Earnest, CP; Rodarte, RQ; Martin, CK; Blair, SN; Bouchard, C				Church, Timothy S.; Thomas, Diana M.; Tudor-Locke, Catrine; Katzmarzyk, Peter T.; Earnest, Conrad P.; Rodarte, Ruben Q.; Martin, Corby K.; Blair, Steven N.; Bouchard, Claude			Trends over 5 Decades in US Occupation-Related Physical Activity and Their Associations with Obesity	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; ADULTS	Background: The true causes of the obesity epidemic are not well understood and there are few longitudinal population-based data published examining this issue. The objective of this analysis was to examine trends in occupational physical activity during the past 5 decades and explore how these trends relate to concurrent changes in body weight in the U.S. Methodology/Principal Findings: Analysis of energy expenditure for occupations in U.S. private industry since 1960 using data from the U.S. Bureau of Labor Statistics. Mean body weight was derived from the U.S. National Health and Nutrition Examination Surveys (NHANES). In the early 1960's almost half the jobs in private industry in the U.S. required at least moderate intensity physical activity whereas now less than 20% demand this level of energy expenditure. Since 1960 the estimated mean daily energy expenditure due to work related physical activity has dropped by more than 100 calories in both women and men. Energy balance model predicted weights based on change in occupation-related daily energy expenditure since 1960 for each NHANES examination period closely matched the actual change in weight for 40-50 year old men and women. For example from 1960-62 to 2003-06 we estimated that the occupation-related daily energy expenditure decreased by 142 calories in men. Given a baseline weight of 76.9 kg in 1960-02, we estimated that a 142 calories reduction would result in an increase in mean weight to 89.7 kg, which closely matched the mean NHANES weight of 91.8 kg in 2003-06. The results were similar for women. Conclusion: Over the last 50 years in the U.S. we estimate that daily occupation-related energy expenditure has decreased by more than 100 calories, and this reduction in energy expenditure accounts for a significant portion of the increase in mean U.S. body weights for women and men.	[Church, Timothy S.; Tudor-Locke, Catrine; Katzmarzyk, Peter T.; Earnest, Conrad P.; Rodarte, Ruben Q.; Martin, Corby K.; Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Thomas, Diana M.] Montclair State Univ, Dept Math Sci, Montclair, NJ USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol Biostat, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Montclair State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Church, TS (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	tim.church@pbrc.edu	Bouchard, Claude/A-7637-2009; Martin, Corby K./N-1976-2017; Katzmarzyk, Peter T/N-1974-2017; Earnest, Conrad P./M-6849-2017; Bouchard, Claude/AAE-2035-2019	Bouchard, Claude/0000-0002-0048-491X; Martin, Corby K./0000-0002-8125-4015; Katzmarzyk, Peter T/0000-0002-9280-6022; Earnest, Conrad P./0000-0002-6546-1268; 				American College., 2006, ACSMS GUID EX TEST P; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; *CDCP, 2008, US PHYS ACT STAT 199; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; LEE MA, POPULATION B US LABO; McDowell MA., 2008, NATL HLTH STAT REPOR; *NAT CTR HLTH STAT, 2009, PREV OV OB EXTR OB A; OGDEN CL, 2004, MEAN BODY WEIGHT HEI, P1; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; THOMAS DM, 2010, COMPUTATIONAL MODEL; THOMAS DM, 2010, J BIOL DYNAMICS; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; TUDORLOCKE C, 2010, J PHYS ACTIVITY HLTH; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A, P1, DOI DOI 10.1017/CB09781107415324.004; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Westerterp KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004745	20	739	757	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19657	10.1371/journal.pone.0019657	http://dx.doi.org/10.1371/journal.pone.0019657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647427	Green Submitted, gold, Green Published			2022-12-27	WOS:000291006500006
J	Bharrhan, S; Koul, A; Chopra, K; Rishi, P				Bharrhan, Sushma; Koul, Ashwani; Chopra, Kanwaljit; Rishi, Praveen			Catechin Suppresses an Array of Signalling Molecules and Modulates Alcohol-Induced Endotoxin Mediated Liver Injury in a Rat Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; INDUCED OXIDATIVE STRESS; NITRIC-OXIDE SYNTHASE; FACTOR-ALPHA; TRANSCRIPTION FACTOR; EXTRACT PROTECTS; KUPFFER CELLS; DISEASE; MECHANISMS	Induction of nuclear factor kappa B (NF-kappa B)-mediated gene expression has been implicated in the pathogenesis of alcoholic liver disease through enhanced production of reactive oxygen species and pro-inflammatory mediators. The present study was carried out to investigate the role of catechin as a chain breaking inhibitor against experimental alcoholic liver injury. Rats were administered 35% v/v ethanol orally at a dose of 10 g/Kg/day for two weeks, followed by 14 g/Kg/day for 10 weeks. Catechin (50 mg/Kg) was co-supplemented after 4 weeks of alcohol treatment till the end of the dosing period. Following chronic alcohol exposure, rats developed endotoxemia and severe pathological changes in the liver such as pronounced fatty change, vacuolar degeneration and inflammation. These changes were accompanied by activation of NF-kappa B and induction of inflammatory and cytotoxic mediators leading to increased level of tumor necrosis factor-alpha, enhanced formation of malondialdehyde in the liver followed by drastic alterations in the hepatic antioxidant defense systems. Additionally, nitrite levels and lactate dehydrogenase activities were also significantly elevated on chronic alcohol consumption. Alcohol exposure also increased the number of micronucleated cells indicating that alcohol abuse may again be associated with the nuclear changes. Supplementation with catechin ameliorated the alcohol-induced liver injury by downregulating the endotoxin-mediated activation of initial signalling molecule NF-kappa B and further going downstream the signalling cascade including tumor necrosis factor-alpha, nitric oxide and reactive oxygen species and by enhancing the antioxidant profile. These observations correlated well with the histological findings. Moreover, a remarkable decrease in the percentage of micronucleated cells was observed with catechin supplementation indicating an apparent protection against alcohol-induced toxicity. These findings suggest that catechin may alleviate experimental alcoholic liver disease by suppressing induction of NF-kappa B, a key component of signalling pathway, thus forming a pharmacological basis for designing novel therapeutic agents against alcohol induced endotoxin-mediated liver injury.	[Bharrhan, Sushma; Rishi, Praveen] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Koul, Ashwani] Panjab Univ, Dept Biophys, Chandigarh 160014, India; [Chopra, Kanwaljit] Panjab Univ, Pharmacol Res Lab, Univ Inst Pharmaceut Sci, UGC Ctr Adv Study, Chandigarh 160014, India	Panjab University; Panjab University; Panjab University	Bharrhan, S (corresponding author), Panjab Univ, Dept Microbiol, Basic Med Sci Block, Chandigarh 160014, India.	rishipraveen@yahoo.com	Lin, KuanYu/L-9195-2016	Lin, KuanYu/0000-0002-5291-0909; Rishi, Praveen/0000-0001-5425-8064; Koul, Ashwani/0000-0001-7522-412X	Indian Council of Medical Research (ICMR), New Delhi, India [3/1/2(3)/GAS/2008-NCD-II]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This research was supported by the Indian Council of Medical Research (ICMR), New Delhi, India, under extramural research projects (Grant no. 3/1/2(3)/GAS/2008-NCD-II). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 2002, BIOL CHEM, V383, P663, DOI 10.1515/BC.2002.068; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baltaziak Marek, 2004, Folia Morphol (Warsz), V63, P123; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barve A, 2008, ANN HEPATOL, V7, P5, DOI 10.1016/S1665-2681(19)31883-6; BAUCHINGER M, 1975, MUTAT RES, V27, P103, DOI 10.1016/0027-5107(75)90277-8; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; BERGMEYER HU, 1971, METHOD ENZYMAT AN, P736; Bharrhan S, 2012, INNATE IMMUN-LONDON, V18, P70, DOI 10.1177/1753425910393369; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Castelli E, 1999, HEPATO-GASTROENTEROL, V46, P1664; Chanana V, 2007, MOL IMMUNOL, V44, P1551, DOI 10.1016/j.molimm.2006.08.022; Chanana V, 2006, FEMS IMMUNOL MED MIC, V47, P278, DOI 10.1111/j.1574-695X.2006.00090.x; Chen T, 2003, CURR MOL MED, V3, P519, DOI 10.2174/1566524033479582; Chen X, 2010, PHARMACOGN MAG, V6, P135, DOI 10.4103/0973-1296.62900; COLMAN JC, 1980, GUT, V21, P965, DOI 10.1136/gut.21.11.965; Diehl AM, 2002, ALCOHOL, V27, P7, DOI 10.1016/S0741-8329(02)00204-5; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; Gonzalez-Gallego J, 2007, NUTR HOSP, V22, P287; Gramenzi A, 2006, ALIMENT PHARM THER, V24, P1151, DOI 10.1111/j.1365-2036.2006.03110.x; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GUARNER C, 1993, HEPATOLOGY, V18, P1139; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hill DB, 1999, CLIN BIOCHEM, V32, P563, DOI 10.1016/S0009-9120(99)00056-9; Hines IN, 2004, AM J PHYSIOL-GASTR L, V287, pG310, DOI 10.1152/ajpgi.00094.2004; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Huttner E, 1999, ALCOHOL CLIN EXP RES, V23, P344, DOI 10.1111/j.1530-0277.1999.tb04120.x; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Jovanovic SV, 1998, ANTIOX HEALTH DIS, P137; Kasdallah-Grissa A, 2007, LIFE SCI, V80, P1033, DOI 10.1016/j.lfs.2006.11.044; Kaviarasan S, 2008, TOXICOL MECH METHOD, V18, P645, DOI 10.1080/15376510701884985; KIM SJ, 1995, BIOSCI BIOTECH BIOCH, V59, P822, DOI 10.1271/bbb.59.822; Kobayashi H, 2010, PHYTOMEDICINE, V17, P197, DOI 10.1016/j.phymed.2009.12.006; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Lee JS, 2005, MUTAT RES-FUND MOL M, V579, P214, DOI 10.1016/j.mrfmmm.2005.03.027; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; MACSWEEN RNM, 1986, SEMIN LIVER DIS, V6, P221, DOI 10.1055/s-2008-1040605; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/j.gastro.2003.08.030; McKim SE, 2002, ARCH BIOCHEM BIOPHYS, V406, P40, DOI 10.1016/S0003-9861(02)00425-3; Mullen KD, 1998, CLIN LIVER DIS, V2, P851; Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; NORDMANN R, 1994, ALCOHOL ALCOHOLISM, V29, P513; Ozaras R, 2003, WORLD J GASTROENTERO, V9, P125, DOI 10.3748/wjg.v9.i1.125; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Szabo G, 2000, J LAB CLIN MED, V135, P367, DOI 10.1067/mlc.2000.106452; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Uesugi T, 2001, HEPATOLOGY, V34, P1149, DOI 10.1053/jhep.2001.29400; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; WANG JF, 1995, ALCOHOL CLIN EXP RES, V19, P387, DOI 10.1111/j.1530-0277.1995.tb01520.x; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; WORLD MJ, 1987, ALCOHOL ALCOHOLISM, V22, P331; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Yuan Guang-Jin, 2006, Hepatobiliary Pancreat Dis Int, V5, P262; Yuan GJ, 2006, INT J MOL SCI, V7, P204, DOI 10.3390/i7070204; Zhang Xing-Guo, 2006, Hepatobiliary Pancreat Dis Int, V5, P268; Zhen MC, 2007, J NUTR BIOCHEM, V18, P795, DOI 10.1016/j.jnutbio.2006.12.016; Zhong Z, 2002, AM J PHYSIOL-GASTR L, V283, pG957, DOI 10.1152/ajpgi.00216.2001	78	62	68	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20635	10.1371/journal.pone.0020635	http://dx.doi.org/10.1371/journal.pone.0020635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673994	gold, Green Submitted, Green Published			2022-12-27	WOS:000291355500027
J	Siamakpour-Reihani, S; Caster, J; Nepal, DB; Courtwright, A; Hilliard, E; Usary, J; Ketelsen, D; Darr, D; Shen, XJ; Patterson, C; Klauber-DeMore, N				Siamakpour-Reihani, Sharareh; Caster, Joseph; Nepal, Desh Bandhu; Courtwright, Andrew; Hilliard, Eleanor; Usary, Jerry; Ketelsen, David; Darr, David; Shen, Xiang Jun; Patterson, Cam; Klauber-DeMore, Nancy			The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis-A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus	PLOS ONE			English	Article							ACTIVATED T-CELLS; SIGNALING PATHWAY; NUCLEAR FACTOR; PROTEIN-2 SFRP2; GROWTH; EXPRESSION; CARCINOMA; PROLIFERATION; TRANSCRIPTION; TUMORS	Tacrolimus (FK506) is an immunosuppressive drug that binds to the immunophilin FKBPB12. The FK506-FKBP12 complex associates with calcineurin and inhibits its phosphatase activity, resulting in inhibition of nuclear translocation of nuclear factor of activated T-cells (NFAT). There is increasing data supporting a critical role of NFAT in mediating angiogenic responses stimulated by both vascular endothelial growth factor (VEGF) and a novel angiogenesis factor, secreted frizzled-related protein 2 (SFRP2). Since both VEGF and SFRP2 are expressed in breast carcinomas, we hypothesized that tacrolimus would inhibit breast carcinoma growth. Using IHC (IHC) with antibodies to FKBP12 on breast carcinomas we found that FKBP12 localizes to breast tumor vasculature. Treatment of MMTV-neu transgenic mice with tacrolimus (3 mg/kg i.p. daily) (n = 19) resulted in a 73% reduction in the growth rate for tacrolimus treated mice compared to control (n = 15), p = 0.003; which was associated with an 82% reduction in tumor microvascular density (p<0.001) by IHC. Tacrolimus (1 mu M) inhibited SFRP2 induced endothelial tube formation by 71% (p = 0.005) and inhibited VEGF induced endothelial tube formation by 67% (p = 0.004). To show that NFATc3 is required for SFRP2 stimulated angiogenesis, NFATc3 was silenced with shRNA in endothelial cells. Sham transfected cells responded to SFRP2 stimulation in a tube formation assay with an increase in the number of branch points (p<0.003), however, cells transfected with shRNA to NFATc3 showed no increase in tube formation in response to SFRP2. This demonstrates that NFATc3 is required for SFRP2 induced tube formation, and tacrolimus inhibits angiogenesis in vitro and breast carcinoma growth in vivo. This provides a rationale for examining the therapeutic potential of tacrolimus at inhibiting breast carcinoma growth in humans.	[Siamakpour-Reihani, Sharareh; Usary, Jerry; Ketelsen, David; Darr, David; Shen, Xiang Jun; Patterson, Cam; Klauber-DeMore, Nancy] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Caster, Joseph; Nepal, Desh Bandhu; Courtwright, Andrew; Klauber-DeMore, Nancy] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Hilliard, Eleanor; Patterson, Cam; Klauber-DeMore, Nancy] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Siamakpour-Reihani, S (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	nancy_demore@med.unc.edu		Siamakpour-Reihani, Sharareh/0000-0002-2837-443X; caster, joseph/0000-0001-6880-6770	National Cancer Institute [1R01CA142657-01A1]; NIH National Cancer Institute [P50-CA58223]; NATIONAL CANCER INSTITUTE [P50CA058223, R01CA142657] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Cancer Institute (1R01CA142657-01A1) and NIH National Cancer Institute Breast Cancer Specialized Program of Research Excellence grants P50-CA58223 to NK-D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Cao Xiao-Wei, 2005, Hepatobiliary Pancreat Dis Int, V4, P269; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Gehmert S, 2008, BIOCHEM BIOPH RES CO, V371, P752, DOI 10.1016/j.bbrc.2008.04.151; Higgins JPT, 2003, AM J SURG PATHOL, V27, P58, DOI 10.1097/00000478-200301000-00007; Jain AB, 1998, TRANSPLANTATION, V66, P1193, DOI 10.1097/00007890-199811150-00014; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klauber N, 1997, CANCER RES, V57, P81; Klauber N, 1997, NAT MED, V3, P443, DOI 10.1038/nm0497-443; Klauber-DeMore N, 2001, CLIN CANCER RES, V7, P2434; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Moran TP, 2007, VACCINE, V25, P6604, DOI 10.1016/j.vaccine.2007.06.058; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Rafii S, 2003, NAT MED, V9, P166, DOI 10.1038/nm0203-166; Sakai Manabu, 2004, Journal of Medical Investigation, V51, P63, DOI 10.2152/jmi.51.63; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474	32	65	67	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20412	10.1371/journal.pone.0020412	http://dx.doi.org/10.1371/journal.pone.0020412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673995	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500016
J	Ludvig, EA; Spetch, ML				Ludvig, Elliot A.; Spetch, Marcia L.			Of Black Swans and Tossed Coins: Is the Description-Experience Gap in Risky Choice Limited to Rare Events?	PLOS ONE			English	Article							SOMATIC MARKER HYPOTHESIS; PROSPECT-THEORY; PREFERENCES; DECISIONS	When faced with risky decisions, people tend to be risk averse for gains and risk seeking for losses (the reflection effect). Studies examining this risk-sensitive decision making, however, typically ask people directly what they would do in hypothetical choice scenarios. A recent flurry of studies has shown that when these risky decisions include rare outcomes, people make different choices for explicitly described probabilities than for experienced probabilistic outcomes. Specifically, rare outcomes are overweighted when described and underweighted when experienced. In two experiments, we examined risk-sensitive decision making when the risky option had two equally probable (50%) outcomes. For experience-based decisions, there was a reversal of the reflection effect with greater risk seeking for gains than for losses, as compared to description-based decisions. This fundamental difference in experienced and described choices cannot be explained by the weighting of rare events and suggests a separate subjective utility curve for experience.	[Ludvig, Elliot A.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Ludvig, Elliot A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Spetch, Marcia L.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	Princeton University; Princeton University; University of Alberta	Ludvig, EA (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	eludvig@princeton.edu	Ludvig, Elliot A./S-7711-2018	Ludvig, Elliot A./0000-0002-0031-6713	Natural Sciences and Engineering Research Council of Canada [38861]; Alberta Gaming Research Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Gaming Research Institute	This research was funded by Natural Sciences and Engineering Research Council of Canada Discovery Grant #38861 (MLS) and the Alberta Gaming Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron G, 2003, J BEHAV DECIS MAKING, V16, P215, DOI 10.1002/bdm.443; BATESON M, 1995, J EXP ANAL BEHAV, V63, P313, DOI 10.1901/jeab.1995.63-313; Baucells M, 2010, THEOR DECIS, V68, P193, DOI 10.1007/s11238-009-9153-3; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Camilleri A., 2009, COGNITIVE SCI SOC, V31, P449; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen JD, 2005, J ECON PERSPECT, V19, P3, DOI 10.1257/089533005775196750; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Garling Tommy, 2009, Psychol Sci Public Interest, V10, P1, DOI 10.1177/1529100610378437; Hau R, 2010, J BEHAV DECIS MAKING, V23, P48, DOI 10.1002/bdm.665; Hau R, 2008, J BEHAV DECIS MAKING, V21, P493, DOI 10.1002/bdm.598; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Hertwig R, 2009, TRENDS COGN SCI, V13, P517, DOI 10.1016/j.tics.2009.09.004; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; K?hberger A., 1997, DECISION MAKING COGN, P128; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirman A, 2010, CESIFO ECON STUD, V56, P498, DOI 10.1093/cesifo/ifq017; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; McCloy R, 2010, J EXP PSYCHOL LEARN, V36, P1043, DOI 10.1037/a0019693; Rakow T, 2010, J BEHAV DECIS MAKING, V23, P69, DOI 10.1002/bdm.672; Rakow T, 2010, J BEHAV DECIS MAKING, V23, P1, DOI 10.1002/bdm.681; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; STRACK F, 2010, PSYCHOL SCI PUBL INT, V10, pR1; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Ungemach C, 2009, PSYCHOL SCI, V20, P473, DOI 10.1111/j.1467-9280.2009.02319.x; WASON PC, 1971, Q J EXP PSYCHOL, V23, P63, DOI 10.1080/00335557143000068; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430	36	68	69	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20262	10.1371/journal.pone.0020262	http://dx.doi.org/10.1371/journal.pone.0020262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	773LX	21673807	Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900009
J	Coutsinos, D; Invernizzi, CF; Moisi, D; Oliveira, M; Martinez-Cajas, JL; Brenner, BG; Wainberg, MA				Coutsinos, Dimitrios; Invernizzi, Cedric F.; Moisi, Daniela; Oliveira, Maureen; Martinez-Cajas, Jorge L.; Brenner, Bluma G.; Wainberg, Mark A.			A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE MUTATIONS; THYMIDINE-ANALOG MUTATIONS; TREATMENT-NAIVE PATIENTS; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; TENOFOVIR DF; IN-VITRO; REPLICATIVE FITNESS; BASE SUBSTITUTION	Numerous studies have suggested that the K65R reverse transcriptase (RT) mutation develops more readily in subtype C than subtype B HIV-1. We recently showed that this discrepancy lies partly in the subtype C template coding sequence that predisposes RT to pause at the site of K65R mutagenesis. However, the mechanism underlying this observation and the elevated rates of K65R development remained unknown. Here, we report that DNA synthesis performed with subtype C templates consistently produced more K65R-containing transcripts than subtype B templates, regardless of the subtype-origin of the RT enzymes employed. These findings confirm that the mechanism involved is template-specific and RT-independent. In addition, a pattern of DNA synthesis characteristic of site-specific primer/template slippage and dislocation was only observed with the subtype C sequence. Analysis of RNA secondary structure suggested that the latter was unlikely to impact on K65R development between subtypes and that Streisinger strand slippage during DNA synthesis at the homopolymeric nucleotide stretch of the subtype C K65 region might occur, resulting in misalignment of the primer and template. Consequently, slippage would lead to a deletion of the middle adenine of codon K65 and the production of a -1 frameshift mutation, which upon dislocation and realignment of the primer and template, would lead to development of the K65R mutation. These findings provide additional mechanistic evidence for the facilitated development of the K65R mutation in subtype C HIV-1.	[Coutsinos, Dimitrios; Invernizzi, Cedric F.; Moisi, Daniela; Oliveira, Maureen; Martinez-Cajas, Jorge L.; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; [Coutsinos, Dimitrios; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, Dept Microbiol, Montreal, PQ H3A 2T5, Canada; [Coutsinos, Dimitrios; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, Dept Immunol, Montreal, PQ, Canada; [Coutsinos, Dimitrios; Invernizzi, Cedric F.; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Martinez-Cajas, Jorge L.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Queens University - Canada	Coutsinos, D (corresponding author), McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada.	mark.wainberg@mcgill.ca	Brenner, Bluma/I-8714-2019	Invernizzi, Cedric/0000-0002-9807-5195	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by grants to M.A.W. from the Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html). D.C. is the recipient of a CIHR M.D./Ph.D. fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript. Work by D.C. was performed in partial fulfillment of the requirements for a Ph.D. degree from the Faculty of Graduate Studies and Research, McGill University, Montreal, Quebec, Canada.	Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Antinori A, 2007, ANTIVIR THER, V12, P1175; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BEBENEK K, 1993, J BIOL CHEM, V268, P10324; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; BUISER RG, 1993, BIOCHIM BIOPHYS ACTA, V1216, P20, DOI 10.1016/0167-4781(93)90033-A; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Coutsinos Dimitrios, 2010, Antiviral Chemistry & Chemotherapy, V20, P117, DOI 10.3851/IMP1443; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; De Mendoza C, 2007, AIDS RES HUM RETROV, V23, P879, DOI 10.1089/aid.2005.0072; Deshpande A, 2010, AIDS RES HUM RETROV, V26, P343, DOI 10.1089/aid.2009.0217; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Feng JY, 2006, NUCLEOS NUCLEOT NUCL, V25, P89, DOI 10.1080/15257770500379157; Frankel Fernando A., 2007, Antiviral Chemistry & Chemotherapy, V18, P93; Frankel FA, 2007, AIDS, V21, P665, DOI 10.1097/QAD.0b013e3280187505; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gonzales MJ, 2001, J INFECT DIS, V184, P998, DOI 10.1086/323601; GRANT PM, 2010, ANTIMICROB AGENTS CH; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; HERMAN BD, 2010, J BIOL CHEM; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kagan RM, 2007, ANTIVIR RES, V75, P210, DOI 10.1016/j.antiviral.2007.03.006; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Kozal MJ, 2010, ANTIVIR THER, V15, pA34; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Margot NA, 2002, AIDS, V16, P1227, DOI 10.1097/00002030-200206140-00004; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Mathews David H, 2007, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1102s28; McColl DJ, 2008, ANTIVIR THER, V13, P189; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; OKADA Y, 1968, SCIENCE, V162, P807, DOI 10.1126/science.162.3855.807; Orrell C, 2009, ANTIVIR THER, V14, P523; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Parikh UM, 2006, J INFECT DIS, V194, P651, DOI 10.1086/505711; Parikh UM, 2006, J VIROL, V80, P4971, DOI 10.1128/JVI.80.10.4971-4977.2006; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SCHINAZI RF, 1994, ANTIMICROB AGENTS CH, V38, P268, DOI 10.1128/AAC.38.2.268; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TALBOTT R, 1993, P NATL ACAD SCI USA, V90, P4226, DOI 10.1073/pnas.90.9.4226; Toni TA, 2010, ANTIMICROB AGENTS CH, V54, P907, DOI 10.1128/AAC.01080-09; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Wallis CL, 2010, ANTIVIR THER, V15, pA35; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; White KL, 2006, ANTIVIR THER, V11, P155; White KL, 2005, AIDS, V19, P1751, DOI 10.1097/01.aids.0000189851.21441.f1; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682; Winters MA, 1997, ANTIMICROB AGENTS CH, V41, P757, DOI 10.1128/AAC.41.4.757; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14	79	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20208	10.1371/journal.pone.0020208	http://dx.doi.org/10.1371/journal.pone.0020208			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655292	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600029
J	Miyata, S; Koyama, Y; Takemoto, K; Yoshikawa, K; Ishikawa, T; Taniguchi, M; Inoue, K; Aoki, M; Hori, O; Katayama, T; Tohyama, M				Miyata, Shingo; Koyama, Yoshihisa; Takemoto, Kana; Yoshikawa, Keiko; Ishikawa, Toshiko; Taniguchi, Manabu; Inoue, Kiyoshi; Aoki, Miwa; Hori, Osamu; Katayama, Taiichi; Tohyama, Masaya			Plasma Corticosterone Activates SGK1 and Induces Morphological Changes in Oligodendrocytes in Corpus Callosum	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PITUITARY-ADRENAL AXIS; KINASE GENE FAMILY; PROTEIN-KINASE; MESSENGER-RNA; CELL-VOLUME; DIFFERENTIAL EXPRESSION; RAT HIPPOCAMPUS; CHRONIC STRESS; SERUM	Repeated stressful events are known to be associated with onset of depression. Further, stress activates the hypothalamic-pituitary-adrenocortical (HPA) system by elevating plasma cortisol levels. However, little is known about the related downstream molecular pathway. In this study, by using repeated water-immersion and restraint stress (WIRS) as a stressor for mice, we attempted to elucidate the molecular pathway induced by elevated plasma corticosterone levels. We observed the following effects both, in vivo and in vitro: (1) repeated exposure to WIRS activates the 3-phosphoinositide-dependent protein kinase (PDK1)-serum glucocorticoid regulated kinase (SGK1)-N-myc downstream-regulated gene 1 (NDRG1)-adhesion molecule (i.e., N-cadherin, alpha-catenin, and beta-catenin) stabilization pathway via an increase in plasma corticosterone levels; (2) the activation of this signaling pathway induces morphological changes in oligodendrocytes; and (3) after recovery from chronic stress, the abnormal arborization of oligodendrocytes and depression-like symptoms return to the control levels. Our data strongly suggest that these abnomalities of oligodendrocytes are possibly related to depression-like symptoms.	[Miyata, Shingo; Koyama, Yoshihisa; Takemoto, Kana; Yoshikawa, Keiko; Ishikawa, Toshiko; Taniguchi, Manabu; Aoki, Miwa; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Miyata, Shingo; Tohyama, Masaya] Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Dept Clin Disorder Res, Osaka, Japan; [Inoue, Kiyoshi] Emory Univ, Yerkes Natl Primate Res Ctr, Ctr Behav Neurosci, Atlanta, GA 30322 USA; [Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa, Japan; [Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan; [Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Osaka, Japan	Osaka University; Emory University; Kanazawa University; Hamamatsu University School of Medicine; Kanazawa University; Osaka University	Miyata, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	smiyata@anat2.med.osaka-u.ac.jp			Osaka Medical Research Foundation for Incurable Diseases; Japan Society for the Promotion of Science [20700335]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Osaka Medical Research Foundation for Incurable Diseases; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by the Osaka Medical Research Foundation for Incurable Diseases, Grant-in-Aid for Scientific research (No. 20700335) from Japan Society for the Promotion of Science, and the Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding for this study.	Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; BARTANUSZ V, 1993, ENDOCRINOLOGY, V132, P895, DOI 10.1210/en.132.2.895; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Berger P, 2004, NEUROBIOL DIS, V17, P290, DOI 10.1016/j.nbd.2004.07.014; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chu JW, 2001, J CLIN ENDOCR METAB, V86, P3568, DOI 10.1210/jc.86.8.3568; Cowling RT, 2000, J LEUKOCYTE BIOL, V67, P240, DOI 10.1002/jlb.67.2.240; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Gold PW, 2002, AM J PSYCHIAT, V159, P1826, DOI 10.1176/appi.ajp.159.11.1826; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Hollister RD, 1997, NEUROSCIENCE, V79, P1111, DOI 10.1016/S0306-4522(97)00014-6; HOLSBOERTRACHSLER E, 1991, PSYCHIAT RES, V38, P163, DOI 10.1016/0165-1781(91)90041-M; Honer WG, 1999, NEUROSCIENCE, V91, P1247, DOI 10.1016/S0306-4522(98)00679-4; Ikenaka K, 2006, NEUROSCIENCE, V141, P1971, DOI 10.1016/j.neuroscience.2006.05.022; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Iwata SI, 2004, SYNAPSE, V51, P279, DOI 10.1002/syn.10307; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kawabata K, 2010, J NUTR BIOCHEM, V21, P374, DOI 10.1016/j.jnutbio.2009.01.008; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Koyama Y, 2008, J CHEM NEUROANAT, V36, P209, DOI 10.1016/j.jchemneu.2008.08.006; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Lang F, 2000, P NATL ACAD SCI USA, V97, P8157, DOI 10.1073/pnas.97.14.8157; Lang F, 2001, SCI STKE, V108, P1; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leussis MP, 2008, SYNAPSE, V62, P22, DOI 10.1002/syn.20462; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Mizoguchi K, 2001, PSYCHONEUROENDOCRINO, V26, P443, DOI 10.1016/S0306-4530(01)00004-X; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nishida Y, 2004, MOL BRAIN RES, V123, P121, DOI 10.1016/j.molbrainres.2004.01.008; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Song Y, 2010, HUM PATHOL, V41, P214, DOI 10.1016/j.humpath.2009.07.011; Stichel CC, 2005, EUR J NEUROSCI, V21, P301, DOI 10.1111/j.1460-9568.2005.03859.x; Van Gemert NG, 2006, STRESS, V9, P165, DOI 10.1080/10253890600966169; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Warntges S, 2002, PFLUG ARCH EUR J PHY, V443, P617, DOI 10.1007/s00424-001-0737-1; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031	50	82	84	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19859	10.1371/journal.pone.0019859	http://dx.doi.org/10.1371/journal.pone.0019859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655274	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600008
J	Zha, WJ; Peng, XX; Chen, RZ; Du, B; Zhu, LL; He, GC				Zha, Wenjun; Peng, Xinxin; Chen, Rongzhi; Du, Bo; Zhu, Lili; He, Guangcun			Knockdown of Midgut Genes by dsRNA-Transgenic Plant-Mediated RNA Interference in the Hemipteran Insect Nilaparvata lugens	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BROWN PLANTHOPPER; CONFERS RESISTANCE; SYSTEMIC RNAI; EXPRESSION; MARKER; DNA; IDENTIFICATION; MECHANISMS; AUBERGINE	Background: RNA interference (RNAi) is a powerful technique for functional genomics research in insects. Transgenic plants producing double-stranded RNA (dsRNA) directed against insect genes have been reported for lepidopteran and coleopteran insects, showing potential for field-level control of insect pests, but this has not been reported for other insect orders. Methodology/Principal Findings: The Hemipteran insect brown planthopper (Nilaparvata lugens Stal) is a typical phloem sap feeder specific to rice (Oryza sativa L.). To analyze the potential of exploiting RNAi-mediated effects in this insect, we identified genes (Nlsid-1 and Nlaub) encoding proteins that might be involved in the RNAi pathway in N. lugens. Both genes are expressed ubiquitously in nymphs and adult insects. Three genes (the hexose transporter gene NlHT1, the carboxypeptidase gene Nlcar and the trypsin-like serine protease gene Nltry) that are highly expressed in the N. lugens midgut were isolated and used to develop dsRNA constructs for transforming rice. RNA blot analysis showed that the dsRNAs were transcribed and some of them were processed to siRNAs in the transgenic lines. When nymphs were fed on rice plants expressing dsRNA, levels of transcripts of the targeted genes in the midgut were reduced; however, lethal phenotypic effects after dsRNA feeding were not observed. Conclusions: Our study shows that genes for the RNAi pathway (Nlsid-1 and Nlaub) are present in N. lugens. When insects were fed on rice plant materials expressing dsRNAs, RNA interference was triggered and the target genes transcript levels were suppressed. The gene knockdown technique described here may prove to be a valuable tool for further investigations in N. lugens. The results demonstrate the potential of dsRNA-mediated RNAi for field-level control of planthoppers, but appropriate target genes must be selected when designing the dsRNA-transgenic plants.	[Zha, Wenjun; Peng, Xinxin; Chen, Rongzhi; Du, Bo; Zhu, Lili; He, Guangcun] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Zha, WJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	gche@whu.edu.cn		He, Guangcun/0000-0001-6395-4774; Chen, Rongzhi/0000-0002-0122-4415; PENG, XINXIN/0000-0002-1503-5404	Ministry of Agriculture of China [1104002, 200803003]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Fundamental Research Funds for the Central University of China (grant no. 1104002) and the Special Fund for Commonwealth Industry (grant no. 200803003) from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Cha YS, 2008, MOL CELLS, V26, P146; Chakraborti D, 2006, AFR J BIOTECHNOL, V5, P585; CHEN J, 2010, INSECT MOL BIOL; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fire AZ, 2007, ANGEW CHEM INT EDIT, V46, P6967, DOI 10.1002/anie.200701979; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Kikuta S, 2010, INSECT BIOCHEM MOLEC, V40, P805, DOI 10.1016/j.ibmb.2010.07.008; Lechtenberg B, 2003, PLANT J, V34, P507, DOI 10.1046/j.1365-313X.2003.01746.x; Lee SI, 1999, MOL BREEDING, V5, P1; Liao Z, 2010, ARCH INSECT BIOCHEM, V74, P91, DOI 10.1002/arch.20362; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; LIU S, 2010, INSECT BIOCH MOL BIO; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; May RC, 2005, METHOD ENZYMOL, V392, P308, DOI 10.1016/S0076-6879(04)92018-6; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; RICHARDSON PT, 1982, J EXPT BOT, V33, P202; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saha P, 2006, PLANTA, V223, P1329, DOI 10.1007/s00425-005-0182-z; Senthil-Nathan S, 2009, ECOTOX ENVIRON SAFE, V72, P1707, DOI 10.1016/j.ecoenv.2009.04.024; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Silva CP, 2004, ARTHROPOD STRUCT DEV, V33, P139, DOI 10.1016/j.asd.2003.12.002; Specchia V, 2008, GENETICS, V178, P1271, DOI 10.1534/genetics.107.078626; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013; Yang ZF, 2010, Z NATURFORSCH C, V65, P109; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	65	216	237	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20504	10.1371/journal.pone.0020504	http://dx.doi.org/10.1371/journal.pone.0020504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655219	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600083
J	Dabrunz, A; Duester, L; Prasse, C; Seitz, F; Rosenfeldt, R; Schilde, C; Schaumann, GE; Schulz, R				Dabrunz, Andre; Duester, Lars; Prasse, Carsten; Seitz, Frank; Rosenfeldt, Ricki; Schilde, Carsten; Schaumann, Gabriele E.; Schulz, Ralf			Biological Surface Coating and Molting Inhibition as Mechanisms of TiO2 Nanoparticle Toxicity in Daphnia magna	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; ENGINEERED NANOPARTICLES; OXIDE NANOPARTICLES; ONCORHYNCHUS-MYKISS; AQUATIC ENVIRONMENT; GOLD NANOPARTICLES; FULLERENE C-60; RAINBOW-TROUT; ECOTOXICOLOGY; NANOMATERIALS	The production and use of nanoparticles (NP) has steadily increased within the last decade; however, knowledge about risks of NP to human health and ecosystems is still scarce. Common knowledge concerning NP effects on freshwater organisms is largely limited to standard short-term (<= 48 h) toxicity tests, which lack both NP fate characterization and an understanding of the mechanisms underlying toxicity. Employing slightly longer exposure times (72 to 96 h), we found that suspensions of nanosized (similar to 100 nm initial mean diameter) titanium dioxide (nTiO(2)) led to toxicity in Daphnia magna at nominal concentrations of 3.8 (72-h EC50) and 0.73 mg/L (96-h EC50). However, nTiO(2) disappeared quickly from the ISO-medium water phase, resulting in toxicity levels as low as 0.24 mg/L (96-h EC50) based on measured concentrations. Moreover, we showed that nTiO(2) (similar to 100 nm) is significantly more toxic than non-nanosized TiO2 (similar to 200 nm) prepared from the same stock suspension. Most importantly, we hypothesized a mechanistic chain of events for nTiO(2) toxicity in D. magna that involves the coating of the organism surface with nTiO(2) combined with a molting disruption. Neonate D. magna (<= 6 h) exposed to 2 mg/L nTiO(2) exhibited a "biological surface coating" that disappeared within 36 h, during which the first molting was successfully managed by 100% of the exposed organisms. Continued exposure up to 96 h led to a renewed formation of the surface coating and significantly reduced the molting rate to 10%, resulting in 90% mortality. Because coating of aquatic organisms by manmade NP might be ubiquitous in nature, this form of physical NP toxicity might result in widespread negative impacts on environmental health.	[Dabrunz, Andre; Duester, Lars; Prasse, Carsten; Seitz, Frank; Rosenfeldt, Ricki; Schaumann, Gabriele E.; Schulz, Ralf] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Duester, Lars; Prasse, Carsten] Fed Inst Hydrol, Dept Aquat Chem, Koblenz, Germany; [Schilde, Carsten] Tech Univ Carolo Wilhelmina Braunschweig, Inst Particle Technol, Braunschweig, Germany	University of Koblenz & Landau; Braunschweig University of Technology	Dabrunz, A (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	R.Schulz@uni-landau.de	Prasse, Carsten/AAR-9120-2020; Schaumann, Gabriele E/B-4283-2015; Schulz, Ralf/ABI-4526-2020; Duester, Lars/I-3478-2014; Prasse, Carsten/M-7847-2015; Schulz, Ralf/G-3674-2011	Schaumann, Gabriele E/0000-0003-1788-2751; Schulz, Ralf/0000-0002-6348-6971; Duester, Lars/0000-0001-7025-3810; Schulz, Ralf/0000-0002-6348-6971; Prasse, Carsten/0000-0002-1470-141X; Seitz, Frank/0000-0002-3181-0140; Schilde, Carsten/0000-0003-0851-8042	Ministry of Science Rhineland-Palatinate research initiative INTERNANO	Ministry of Science Rhineland-Palatinate research initiative INTERNANO	This research was financially supported by the Ministry of Science Rhineland-Palatinate research initiative INTERNANO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouni ZE, 2009, COLLOID SURFACE B, V68, P83, DOI 10.1016/j.colsurfb.2008.09.014; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; BUIKEMA AJ, 1973, HYDROBIOLOGIA, V41, P391, DOI 10.1007/BF00016626; DEJONG F, 2008, 601506009 RIVM NAT I; Drobne D, 2009, ENVIRON POLLUT, V157, P1157, DOI 10.1016/j.envpol.2008.10.018; DUESTER L, 2011, J ENV MONIT IN PRESS; European Chemicals Bureau, 2003, TECHN GUID DOC RIS 2; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Handy RD, 2008, ECOTOXICOLOGY, V17, P315, DOI 10.1007/s10646-008-0206-0; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Hussain M, 2010, CHEM ENG J, V157, P45, DOI 10.1016/j.cej.2009.10.043; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Lampert W, 2007, LIMNOECOLOGY, V2ed; Lazorchak JM, 2009, ENVIRON TOXICOL CHEM, V28, P1028, DOI 10.1897/08-296.1; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster E, 2006, CARBON, V44, P1112, DOI 10.1016/j.carbon.2005.11.008; Oberdorster G, 2007, ENVIRON HEALTH PERSP, V115, pA290, DOI 10.1289/ehp.115-a290a; OECD Organization for Economic Cooperation and Development, 2004, GUID TEST CHEM 202 D; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Rand G.M., 1985, HEMISPHERE; Ritz C, 2005, J STAT SOFTWARE, V12; Scheringer M, 2008, NAT NANOTECHNOL, V3, P322, DOI 10.1038/nnano.2008.145; *SCI COMM EM NEWL, 2007, OP SCI ASP EX PROP D; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Smith CJ, 2007, AQUAT TOXICOL, V82, P94, DOI 10.1016/j.aquatox.2007.02.003; SMITH FE, 1963, ECOLOGY, V44, P651, DOI 10.2307/1933011; Stone V, 2010, SCI TOTAL ENVIRON, V408, P1745, DOI 10.1016/j.scitotenv.2009.10.035; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Zhu XS, 2010, CHEMOSPHERE, V79, P928, DOI 10.1016/j.chemosphere.2010.03.022; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	41	143	149	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20112	10.1371/journal.pone.0020112	http://dx.doi.org/10.1371/journal.pone.0020112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647422	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500030
J	An, XJ; Deng, ZY; Wang, T				An, Xiao Jing; Deng, Zhu Yun; Wang, Tai			OsSpo11-4, a Rice Homologue of the Archaeal TopVIA Protein, Mediates Double-Strand DNA Cleavage and Interacts with OsTopVIB	PLOS ONE			English	Article							TOPOISOMERASE-VI COMPLEX; TRANSGENIC ARABIDOPSIS PLANTS; MEIOTIC RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SYNAPSIS; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; SULFOLOBUS-SHIBATAE; STRESS TOLERANCE; GENE-EXPRESSION	DNA topoisomerase VI from Archaea, a heterotetrameric complex composed of two TopVIA and two TopVIB subunits, is involved in altering DNA topology during replication, transcription and chromosome segregation by catalyzing DNA strand transfer through transient double-strand breaks. The sequenced yeast and animal genomes encode only one homologue of the archaeal TopVIA subunit, namely Spo11, and no homologue of the archaeal TopVIB subunit. In yeast, Spo11 is essential for initiating meiotic recombination and this function appears conserved among other eukaryotes. In contrast to yeast and animals, studies in Arabidopsis and rice have identified three Spo11/TopVIA homologues and one TopVIB homologue in plants. Here, we further identified two novel Spo11/TopVIA homologues (named OsSpo11-4 and OsSpo11-5, respectively) that exist just in the monocot model plant Oryza sativa, indicating that at least five Spo11/TopVIA homologues are present in the rice genome. To reveal the biochemical function of the two novel Spo11/TopVIA homologues, we first examined the interactions among OsSpo11-1, OsSpo11-4, OsSpo11-5, and OsTopVIB by yeast two-hybrid assay. The results showed that OsSpo11-4 and OsTopVIB can self-interact strongly and among the 3 examined OsSpo11 proteins, only OsSpo11-4 interacted with OsTopVIB. Pull-down assay confirmed the interaction between OsSpo11-4 and OsTopVIB, which indicates that OsSpo11-4 may interact with OsTopVIB in vivo. Further in vitro enzymatic analysis revealed that among the above 4 proteins, only OsSpo11-4 exhibited double-strand DNA cleavage activity and its enzymatic activity appears dependent on Mg(2+) and independent of OsTopVIB, despite its interaction with OsTopVIB. We further analyzed the biological function of OsSpo11-4 by RNA interference and found that down-regulated expression of OsSpo11-4 led to defects in male meiosis, indicating OsSpo11-4 is required for meiosis.	[An, Xiao Jing; Deng, Zhu Yun; Wang, Tai] Chinese Acad Sci, Res Ctr Mol & Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing, Peoples R China; [An, Xiao Jing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, XJ (corresponding author), Chinese Acad Sci, Res Ctr Mol & Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing, Peoples R China.	twang@ibcas.ac.cn	Wang, Tai/G-2544-2010		Chinese Ministry of Science and Technology [2007CB947601]; Natural Science Fundation of China [30821007]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by grants from the Chinese Ministry of Science and Technology (grant Number: 2007CB947601) and Natural Science Fundation of China (grant Number: 30821007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Arencibia A, 1998, MOL BREEDING, V4, P99, DOI 10.1023/A:1009627409668; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Azumi Y, 2002, EMBO J, V21, P3081, DOI 10.1093/emboj/cdf285; BERGERAT A, 1994, J BIOL CHEM, V269, P27663; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Buhler C, 1998, NUCLEIC ACIDS RES, V26, P5157, DOI 10.1093/nar/26.22.5157; Celerin M, 2000, EMBO J, V19, P2739, DOI 10.1093/emboj/19.11.2739; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Connelly JC, 2004, MOL CELL, V13, P307, DOI 10.1016/S1097-2765(04)00056-5; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Corbett KD, 2003, EMBO J, V22, P151, DOI 10.1093/emboj/cdg008; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Ding ZJ, 2002, SEX PLANT REPROD, V15, P205, DOI 10.1007/s00497-002-0156-2; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Grishin NV, 2000, NUCLEIC ACIDS RES, V28, P2229, DOI 10.1093/nar/28.11.2229; Hartung F, 2000, NUCLEIC ACIDS RES, V28, P1548, DOI 10.1093/nar/28.7.1548; Hartung F, 2002, CURR BIOL, V12, P1787, DOI 10.1016/S0960-9822(02)01218-6; Hartung F, 2001, GENE, V271, P81, DOI 10.1016/S0378-1119(01)00496-6; Hartung F, 2007, PLANT CELL, V19, P3090, DOI 10.1105/tpc.107.054817; Inagaki A, 2010, EPIGENETICS-US, V5, P255, DOI 10.4161/epi.5.4.11518; Jain M, 2008, PLANT CELL REP, V27, P767, DOI 10.1007/s00299-007-0491-8; Jain M, 2006, FEBS J, V273, P5245, DOI 10.1111/j.1742-4658.2006.05518.x; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kirik V, 2007, PLANT CELL, V19, P3100, DOI 10.1105/tpc.107.054361; Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049; Kuroda K, 2006, APPL MICROBIOL BIOT, V71, P127, DOI 10.1007/s00253-006-0395-5; Li WX, 2005, PLANT PHYSIOL, V138, P965, DOI 10.1104/pp.104.058347; LIN YK, 1994, GENETICS, V136, P769; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Lu Q, 1997, GENE, V200, P135, DOI 10.1016/S0378-1119(97)00393-4; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Malik SB, 2007, MOL BIOL EVOL, V24, P2827, DOI 10.1093/molbev/msm217; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Nag DK, 2006, MOL GENET GENOMICS, V276, P313, DOI 10.1007/s00438-006-0143-7; NELSON T, 1984, J CELL BIOL, V98, P558, DOI 10.1083/jcb.98.2.558; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Sasanuma H, 2007, NUCLEIC ACIDS RES, V35, P1119, DOI 10.1093/nar/gkl1162; Shannon M, 1999, FEBS LETT, V462, P329, DOI 10.1016/S0014-5793(99)01546-X; Stacey NJ, 2006, PLANT J, V48, P206, DOI 10.1111/j.1365-313X.2006.02867.x; Sugimoto-Shirasu K, 2005, P NATL ACAD SCI USA, V102, P18736, DOI 10.1073/pnas.0505883102; Sugimoto-Shirasu K, 2002, CURR BIOL, V12, P1782, DOI 10.1016/S0960-9822(02)01198-3; Tao JY, 2007, PLANT J, V51, P919, DOI 10.1111/j.1365-313X.2007.03190.x; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yin YH, 2002, P NATL ACAD SCI USA, V99, P10191, DOI 10.1073/pnas.152337599; Yu HX, 2010, CHROMOSOMA, V119, P625, DOI 10.1007/s00412-010-0284-7; Zhang LR, 2006, PLANT MOL BIOL, V60, P533, DOI 10.1007/s11103-005-4922-z	57	28	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20327	10.1371/journal.pone.0020327	http://dx.doi.org/10.1371/journal.pone.0020327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637817	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052200053
J	Chang, SS; Hsu, HL; Cheng, JC; Tseng, CP				Chang, Shy-Shin; Hsu, Hsung-Ling; Cheng, Ju-Chien; Tseng, Ching-Ping			An Efficient Strategy for Broad-Range Detection of Low Abundance Bacteria without DNA Decontamination of PCR Reagents	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; RESOLUTION MELTING ANALYSIS; RAPID IDENTIFICATION; TAQ POLYMERASE; MULTIPLEX PCR; AMPLIFICATION; DIAGNOSIS; CONTAMINATION; PATHOGENS	Background: Bacterial DNA contamination in PCR reagents has been a long standing problem that hampers the adoption of broad-range PCR in clinical and applied microbiology, particularly in detection of low abundance bacteria. Although several DNA decontamination protocols have been reported, they all suffer from compromised PCR efficiency or detection limits. To date, no satisfactory solution has been found. Methodology/Principal Findings: We herein describe a method that solves this long standing problem by employing a broad-range primer extension-PCR (PE-PCR) strategy that obviates the need for DNA decontamination. In this method, we first devise a fusion probe having a 3'-end complementary to the template bacterial sequence and a 5'-end non-bacterial tag sequence. We then hybridize the probes to template DNA, carry out primer extension and remove the excess probes using an optimized enzyme mix of Klenow DNA polymerase and exonuclease I. This strategy allows the templates to be distinguished from the PCR reagent contaminants and selectively amplified by PCR. To prove the concept, we spiked the PCR reagents with Staphylococcus aureus genomic DNA and applied PE-PCR to amplify template bacterial DNA. The spiking DNA neither interfered with template DNA amplification nor caused false positive of the reaction. Broad-range PE-PCR amplification of the 16S rRNA gene was also validated and minute quantities of template DNA (10-100 fg) were detectable without false positives. When adapting to real-time and high-resolution melting (HRM) analytical platforms, the unique melting profiles for the PE-PCR product can be used as the molecular fingerprints to further identify individual bacterial species. Conclusions/Significance: Broad-range PE-PCR is simple, efficient, and completely obviates the need to decontaminate PCR reagents. When coupling with real-time and HRM analyses, it offers a new avenue for bacterial species identification with a limited source of bacterial DNA, making it suitable for use in clinical and applied microbiology laboratories.	[Chang, Shy-Shin] Chang Gung Univ, Dept Med, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Chang, Shy-Shin] Chang Gung Mem Hosp, Dept Family Med & Emergency Med, Tao Yuan, Taiwan; [Hsu, Hsung-Ling; Tseng, Ching-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Cheng, Ju-Chien] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; China Medical University Taiwan	Chang, SS (corresponding author), Chang Gung Univ, Dept Med, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan.	ctseng@mail.cgu.edu.tw		TSENG, CHING-PING/0000-0002-2587-210X	Chang Gung Memorial Hospital [CMRPD170133, CMRPD180421]; Chang Gung Molecular Medicine Research Center [EMRPD190151]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung Molecular Medicine Research Center	This work was carried out with support from Chang Gung Memorial Hospital (CMRPD170133 and CMRPD180421) (http://www.cgmh.org.tw) and Chang Gung Molecular Medicine Research Center (EMRPD190151) (http://www.cgu.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2000, J CLIN MICROBIOL, V38, P781, DOI 10.1128/JCM.38.2.781-788.2000; BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Cherkaoui A, 2009, J MICROBIOL METH, V79, P227, DOI 10.1016/j.mimet.2009.09.014; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Glushkov SA, 2009, ANAL BIOCHEM, V393, P135, DOI 10.1016/j.ab.2009.06.005; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; MAIWALD M, 1994, MOL CELL PROBE, V8, P11, DOI 10.1006/mcpr.1994.1002; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; McCabe KM, 1999, MOL GENET METAB, V66, P205, DOI 10.1006/mgme.1998.2795; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; OU CY, 1991, BIOTECHNIQUES, V10, P442; Pandit L, 2005, J MED MICROBIOL, V54, P539, DOI 10.1099/jmm.0.45599-0; Philipp S, 2010, TRANSFUS MED HEMOTH, V37, P21, DOI 10.1159/000265571; RELLO J, 1993, INTENS CARE MED, V19, P22, DOI 10.1007/BF01709273; Reno WL, 2001, AM SURGEON, V67, P508; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Silkie SS, 2008, J MICROBIOL METH, V72, P275, DOI 10.1016/j.mimet.2007.12.011; Sleigh J, 2001, INTENS CARE MED, V27, P1269, DOI 10.1007/s001340100981; Sontakke S, 2009, J MICROBIOL METH, V76, P217, DOI 10.1016/j.mimet.2008.11.002; Spangler R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007010; Steinman CR, 1997, ANAL BIOCHEM, V244, P328, DOI 10.1006/abio.1996.9896; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Trevini S., 2000, TXB DIAGNOSTIC MICRO, P998; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Wang Q, 2010, J CLIN MICROBIOL, V48, P2066, DOI 10.1128/JCM.02014-09; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Yang S, 2009, J CLIN MICROBIOL, V47, P2252, DOI 10.1128/JCM.00033-09	43	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20303	10.1371/journal.pone.0020303	http://dx.doi.org/10.1371/journal.pone.0020303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637859	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200050
J	Muhlfeld, C; Das, SK; Heinzel, FR; Schmidt, A; Post, H; Schauer, S; Papadakis, T; Kummer, W; Hoefler, G				Muehlfeld, Christian; Das, Suman Kumar; Heinzel, Frank R.; Schmidt, Albrecht; Post, Heiner; Schauer, Silvia; Papadakis, Tamara; Kummer, Wolfgang; Hoefler, Gerald			Cancer Induces Cardiomyocyte Remodeling and Hypoinnervation in the Left Ventricle of the Mouse Heart	PLOS ONE			English	Article							NEUROPEPTIDE-Y; TNF-ALPHA; STEREOLOGICAL ESTIMATION; LIPOTOXIC DISEASES; CACHEXIA; NUMBER; TUMOR; INNERVATION; ANOREXIA; MUSCLE	Cancer is often associated with cachexia, cardiovascular symptoms and autonomic dysregulation. We tested whether extracardiac cancer directly affects the innervation of left ventricular myocardium. Mice injected with Lewis lung carcinoma cells (tumor group, TG) or PBS (control group, CG) were analyzed after 21 days. Cardiac function (echocardiography), serum levels of TNF-alpha and Il-6 (ELISA), structural alterations of cardiomyocytes and their innervation (design-based stereology) and levels of innervation-related mRNA (quantitative RT-PCR) were analysed. The groups did not differ in various functional parameters. Serum levels of TNF-alpha and Il-6 were elevated in TG. The total length of axons in the left ventricle was reduced. The number of dense core vesicles per axon profile was reduced. Decreased myofibrillar volume, increased sarcoplasmic volume and increased volume of lipid droplets were indicative of metabolic alterations of TG cardiomyocytes. In the heart, the mRNA level of nerve growth factor was reduced whereas that of beta 1-adrenergic receptor was unchanged in TG. In the stellate ganglion of TG, mRNA levels of nerve growth factor and neuropeptide Y were decreased and that of tyrosine hydroxylase was increased. In summary, cancer induces a systemic pro-inflammatory state, a significant reduction in myocardial innervation and a catabolic phenotype of cardiomyocytes in the mouse. Reduced expression of nerve growth factor may account for the reduced myocardial innervation.	[Muehlfeld, Christian; Papadakis, Tamara; Kummer, Wolfgang] Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany; [Das, Suman Kumar; Schauer, Silvia; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Heinzel, Frank R.; Schmidt, Albrecht; Post, Heiner] Med Univ Graz, Div Cardiol, Graz, Austria	Justus Liebig University Giessen; Medical University of Graz; Medical University of Graz	Muhlfeld, C (corresponding author), Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany.	christian.muehlfeld@anatomie.med.uni-giessen.de	Hoefler, Gerald/B-7006-2008; Hoefler, Gerald/H-1796-2016; das, suman kumar/E-1270-2015	Hoefler, Gerald/0000-0002-9056-3063; das, suman kumar/0000-0002-0539-5174; Heinzel, Frank R./0000-0002-4529-5282; Schmidt, Albrecht/0000-0003-4783-4603; Kummer, Wolfgang/0000-0002-3946-0683	Excellence Cluster Cardiopulmonary System; Verein zur Forderung der Krebsforschung in Giessen e.V.; Medical University of Graz	Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Verein zur Forderung der Krebsforschung in Giessen e.V.; Medical University of Graz	This study was supported by the Excellence Cluster Cardiopulmonary System (WK) and by the Verein zur Forderung der Krebsforschung in Giessen e.V. (CM). SD was funded in part by the PhD program Molecular Medicine of the Medical University of Graz. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI A, 1987, PROG CARDIOVASC DIS, V30, P45, DOI 10.1016/0033-0620(87)90010-7; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Bettermann H, 2001, CLIN PHYSIOL, V21, P411, DOI 10.1046/j.1365-2281.2001.00342.x; Brinks H, 2009, J THORAC CARDIOV SUR, V137, P742, DOI 10.1016/j.jtcvs.2008.09.020; Bruel A, 2005, BASIC RES CARDIOL, V100, P311, DOI 10.1007/s00395-005-0524-9; BRUERA E, 1986, CANCER TREAT REP, V70, P1383; BUDZYNSKI W, 1982, ARCH IMMUNOL THER EX, V30, P363; BURCH GE, 1968, CHEST, V54, P5; Carbo N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167; DONALD DE, 1974, CIRC RES, V34, P417, DOI 10.1161/01.RES.34.4.417; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x; Fukuda T, 2009, INT J ONCOL, V34, P61, DOI 10.3892/ijo_00000129; Goldberg Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1207, DOI 10.1152/ajpcell.1998.275.5.C1207; GOULD GA, 1986, THORAX, V41, P372, DOI 10.1136/thx.41.5.372; GROS D, 1982, J HISTOCHEM CYTOCHEM, V30, P193, DOI 10.1177/30.3.7061821; GULBENKIAN S, 1987, J AUTONOM NERV SYST, V18, P235, DOI 10.1016/0165-1838(87)90122-6; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Inui A, 1999, MOL MED TODAY, V5, P79, DOI 10.1016/S1357-4310(98)01395-1; Jatoi A, 2001, CANCER-AM CANCER SOC, V92, P629, DOI 10.1002/1097-0142(20010801)92:3<629::AID-CNCR1363>3.0.CO;2-M; Laviano A, 2003, LANCET ONCOL, V4, P686, DOI 10.1016/S1470-2045(03)01247-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; McDermott BJ, 2007, CURR TOP MED CHEM, V7, P1692, DOI 10.2174/156802607782340939; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; MENDEZ J, 1960, METABOLISM, V9, P184; MILLAR BC, 1994, AM J PHYSIOL, V266, pC1271, DOI 10.1152/ajpcell.1994.266.5.C1271; Momose M, 2001, BASIC RES CARDIOL, V96, P539, DOI 10.1007/s003950170004; Muehlfeld C, 2010, CARDIOVASC PATHOL, V19, P65, DOI 10.1016/j.carpath.2008.10.015; Muhlfeld C, 2010, J APPL PHYSIOL, V108, P1402, DOI 10.1152/japplphysiol.01013.2009; Nevruz O, 2007, TOHOKU J EXP MED, V211, P121, DOI 10.1620/tjem.211.121; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Pajak B, 2008, J PHYSIOL PHARMACOL, V59, P251; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; PETERS SR, 1980, CARDIOLOGY, V65, P85, DOI 10.1159/000170798; Schmidt AG, 2000, J MOL CELL CARDIOL, V32, P1735, DOI 10.1006/jmcc.2000.1209; Schuenemann M, 2008, NAT CLIN PRACT ONCOL, V5, P632, DOI 10.1038/ncponc1226; SJOSTROM M, 1987, J SURG RES, V42, P304, DOI 10.1016/0022-4804(87)90148-X; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Takei Y, 2008, TRENDS MOL MED, V14, P381, DOI 10.1016/j.molmed.2008.07.002; Takei Y, 2008, MOL BIOL CELL, V19, P855, DOI 10.1091/mbc.E07-06-0624; Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952; TESSITORE L, 1993, ARCH BIOCHEM BIOPHYS, V306, P52, DOI 10.1006/abbi.1993.1479; Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Weibel ER, 1979, PRACTICAL METHODS BI, V1; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; WHARTON J, 1987, EXPERIENTIA, V43, P821, DOI 10.1007/BF01945360	52	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20424	10.1371/journal.pone.0020424	http://dx.doi.org/10.1371/journal.pone.0020424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637823	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200063
J	Xu, W; Xu, JJ; Liu, SF; Chen, B; Wang, XL; Li, Y; Qian, Y; Zhao, WH; Wu, JQ				Xu, Wei; Xu, Jijun; Liu, Shifeng; Chen, Bo; Wang, Xueli; Li, Yan; Qian, Yun; Zhao, Weihong; Wu, Jianqing			Effects of Common Polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on Cancer Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; GENETIC-VARIANTS; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; MICRORNA GENES; BREAST-CANCER; RISK; EXPRESSION; ASSOCIATION; POPULATION	Background: MicroRNAs regulate gene expression at the post-transcriptional level and involved in diverse biological and pathological processes, including tumorigenesis. Rs11614913 in miR-196a2 and rs2910164 in miR-146a are shown to associate with increased/decreased cancer risk. We performed a meta-analysis to systematically summarize the possible association. Methodology/Principal Findings: We assessed published studies of the association between these microRNA polymorphisms and cancer risk from eleven studies with 16,771 subjects for miR-196a2 and from ten studies with 15,126 subjects for miR-146a. As for rs11614913, the contrast of homozygote (TT vs CC: OR = 0.92, 95% CI = 0.85-0.99, P(heterogeneity) = 0.45), allele (T vs C: OR = 0.96, 95% CI = 0.92-0.99, P(heterogeneity) = 0.61) and recessive model (OR = 0.90, 95% CI = 0.84-0.97, P(heterogeneity) = 0.50) produced statistically association. Subgroup analysis by ethnicity, statistically significantly decreased cancer risks were found among Asians for allele contrast (OR = 0.95, 95% CI = 0.90-0.99, P(heterogeneity) = 0.74) and the recessive genetic model (OR = 0.90, 95% CI = 0.82-0.98, P(heterogeneity) = 0.85). According to subgroup analysis by tumor types, the protective effect of C/T polymorphism was only found in breast cancer under allele contrast (T vs C: OR = 0.94, 95% CI = 0.88-0.99, P(heterogeneity) = 0.26). For rs2910164, no significant associations were found among overall analysis model with relatively large heterogeneity. Through the stratified analysis, heterogeneity decreased significantly. In the subgroup analyses by cancer types, the C allele of rs2910164 was associated with protection from digestive cancer in allele contrast (C vs G: OR = 0.86, 95% CI = 0.77-0.96, P(heterogeneity) = 0.51). Conclusions/Significance: Our meta-analysis suggests that the rs11614913 most likely contributes to decreased susceptibility to cancer, especially in Asians and breast cancer. Besides, the C allele of the rs2910164 might be associated with a protection from digestive cancer.	[Xu, Wei; Liu, Shifeng; Chen, Bo; Wang, Xueli; Li, Yan; Qian, Yun; Zhao, Weihong; Wu, Jianqing] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China; [Xu, Jijun] Nanjing Agr Univ, Coll Econ & Management, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Agricultural University	Xu, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China.	jwuny@njmu.edu.cn			National Natural Science Foundation of China [30971320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30971320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Kim MJ, 2010, LUNG CANCER, V69, P127, DOI 10.1016/j.lungcan.2010.04.015; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Lee HC, 2010, J CANCER RES CLIN, V136, P1073, DOI 10.1007/s00432-009-0754-6; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MANTEL N, 1959, J NATL CANCER I, V22, P719; Paranjape T, 2009, GUT, V58, P1546, DOI 10.1136/gut.2009.179531; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	35	68	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20471	10.1371/journal.pone.0020471	http://dx.doi.org/10.1371/journal.pone.0020471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637771	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200069
J	Carlander, B; Puech-Cathala, AM; Jaussent, I; Scholz, S; Bayard, S; Cochen, V; Dauvilliers, Y				Carlander, Bertrand; Puech-Cathala, Anne Marie; Jaussent, Isabelle; Scholz, Sabine; Bayard, Sophie; Cochen, Valerie; Dauvilliers, Yves			Low Vitamin D in Narcolepsy with Cataplexy	PLOS ONE			English	Article							RECEPTOR; ONSET	Background: Narcolepsy with cataplexy (NC) is currently thought to be an autoimmune-mediated disorder in which environmental risk factors make a significant contribution to its development. It was proposed that vitamin D deficiency plays a role in autoimmune diseases. Here we investigated whether NC can be associated with 25-hydroxyvitamin D (25(OH)D) level deficiency in patients with NC compared with gender-and age-matched normal controls. Methodology: Serum level of 25 (OH)D was determined in 51 European patients with typical NC compared to 55 age-, gender-, and ethnicity-matched healthy controls. Demographic and clinical data (age at onset, duration and severity of disease at baseline, and treatment intake at time of study) and season of blood sampling were collected to control for confounding variables. Principal Findings: Serum 25(OH)D concentration was lower in NC compared to controls (median, 59.45 nmol/l [extreme values 24.05-124.03] vs. 74.73 nmol/l [26.88-167.48] p = 0.0039). Patients with NC had significantly greater vitamin D deficiency (<75 nmol/l) than controls (72.5% vs 50.9%, p = 0.0238). Division into quartiles of the whole sample revealed that the risk of being affected with NC increased with lower 25(OH)D level, with a 5.34 OR [1.65-17.27] for the lowest quartile (p = 0.0051). Further adjustment for BMI did not modify the strength of the association (OR: 3.63, 95% CI = 1.06-12.46, p = 0.0191). No between BMI and 25(OH)D interaction, and no correlation between 25(OH)D level and disease duration or severity or treatment intake were found in NC. Conclusion: We found a higher frequency of vitamin D deficiency in NC. Further studies are needed to assess the contribution of hypovitaminosis D to the risk of developing narcolepsy, and to focus on the utility of assessing vitamin D status to correct potential deficiency.	[Carlander, Bertrand; Scholz, Sabine; Bayard, Sophie; Cochen, Valerie; Dauvilliers, Yves] CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France; [Puech-Cathala, Anne Marie] CHU Montpellier, Hop Lapeyronie, Lab Hormonol, Montpellier, France; [Jaussent, Isabelle; Bayard, Sophie; Dauvilliers, Yves] Univ Montpellier 1, INSERM, U1061, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France.	ydauvilliers@yahoo.fr		Jaussent, Isabelle/0000-0002-8205-7590; Bayard, Sophie/0000-0003-0767-4924; Dauvilliers, yves/0000-0003-0683-6506				Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dauvilliers Y, 2009, NEUROLOGY, V73, P1333, DOI 10.1212/WNL.0b013e3181bd1344; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Iber C., 2007, AASM MANUAL SCORING; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; *LUNG BLOOD I, CLIN GUID ID EV TREA; Pierrot-Deseilligny C, 2010, BRAIN, V133, P1869, DOI 10.1093/brain/awq147; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851	17	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20433	10.1371/journal.pone.0020433	http://dx.doi.org/10.1371/journal.pone.0020433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633708	Green Submitted, gold, Green Published			2022-12-27	WOS:000291006500062
J	Wellenreuther, M; Sanchez-Guillen, RA; Cordero-Rivera, A; Svensson, EI; Hansson, B				Wellenreuther, Maren; Sanchez-Guillen, Rosa A.; Cordero-Rivera, Adolfo; Svensson, Erik I.; Hansson, Bengt			Environmental and Climatic Determinants of Molecular Diversity and Genetic Population Structure in a Coenagrionid Damselfly	PLOS ONE			English	Article							RANGE EXPANSION; EVOLUTIONARY DYNAMICS; GEOGRAPHICAL RANGES; FEMALE POLYMORPHISM; COLOR POLYMORPHISM; PATTERNS; DIFFERENTIATION; DISPERSAL; DISTANCE; ODONATA	Identifying environmental factors that structure intraspecific genetic diversity is of interest for both habitat preservation and biodiversity conservation. Recent advances in statistical and geographical genetics make it possible to investigate how environmental factors affect geographic organisation and population structure of molecular genetic diversity within species. Here we present a study on a common and wide ranging insect, the blue tailed damselfly Ischnura elegans, which has been the target of many ecological and evolutionary studies. We addressed the following questions: (i) Is the population structure affected by longitudinal or latitudinal gradients?; (ii) Do geographic boundaries limit gene flow?; (iii) Does geographic distance affect connectivity and is there a signature of past bottlenecks?; (iv) Is there evidence of a recent range expansion and (vi) what is the effect of geography and climatic factors on population structure? We found low to moderate genetic sub-structuring between populations (mean F-ST = 0.06, D-est = 0.12), and an effect of longitude, but not latitude, on genetic diversity. No significant effects of geographic boundaries (e.g. water bodies) were found. F-ST-and D-est-values increased with geographic distance; however, there was no evidence for recent bottlenecks. Finally, we did not detect any molecular signatures of range expansions or an effect of geographic suitability, although local precipitation had a strong effect on genetic differentiation. The population structure of this small insect has probably been shaped by ecological factors that are correlated with longitudinal gradients, geographic distances, and local precipitation. The relatively weak global population structure and high degree of genetic variation within populations suggest that I. elegans has high dispersal ability, which is consistent with this species being an effective and early coloniser of new habitats.	[Wellenreuther, Maren; Svensson, Erik I.; Hansson, Bengt] Lund Univ, Dept Biol, Lund, Sweden; [Sanchez-Guillen, Rosa A.; Cordero-Rivera, Adolfo] Univ Vigo, Dept Ecoloxia & Bioloxia Anim, Pontevedra, Spain	Lund University; Universidade de Vigo	Wellenreuther, M (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	maren.wellenreuther@biol.lu.se	Hansson, Bengt/L-8874-2013; Svensson, Erik/E-8324-2010; Wellenreuther, Maren/H-2710-2019; Wellenreuther, Maren/A-5555-2009; Wellenreuther, Maren/AAD-8360-2021; Guillén, Rosa Ana Sánchez/Q-5714-2018; Cordero-Rivera, Adolfo/K-4182-2014	Hansson, Bengt/0000-0001-6694-8169; Svensson, Erik/0000-0001-9006-016X; Wellenreuther, Maren/0000-0002-2764-8291; Guillén, Rosa Ana Sánchez/0000-0001-6024-8321; Cordero-Rivera, Adolfo/0000-0002-5087-3550	Wenner-Gren Foundation; The Tryggers Foundation; Swedish Research Council; Spanish Ministry of Science and Innovation [CGL2008-02799, CGL2008-03197-E]	Wenner-Gren Foundation; The Tryggers Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding was provided by a postdoctoral scholarship from the Wenner-Gren Foundation (http://www.wennergren.org/), The Tryggers Foundation (http://www.carltryggersstiftelse.se/) and the Swedish Research Council (http://www.vr.se) to MW, by Spanish Ministry of Science and Innovation (http://www.micinn.es), grant CGL2008-02799 and CGL2008-03197-E (AC-R), and the Swedish Research Council (BH, EIS). RAS-G is supported by a grant (Formacion de Personal Investigador) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Askew R. R., 2004, DRAGONFLIES EUROPE; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORDERO A, 1995, ANIM BEHAV, V49, P437, DOI 10.1006/anbe.1995.0057; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Dunkle S.W., 1990, DAMSELFLIES FLORIDA; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Genner MJ, 2004, ECOGRAPHY, V27, P601, DOI 10.1111/j.0906-7590.2004.03824.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J., FSTAT PROGRAM ESTIMA; GRIBBIN SD, 1990, FRESHWATER BIOL, V24, P295, DOI 10.1111/j.1365-2427.1990.tb00710.x; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hansson B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002794; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; HINNEKINT BON, 1987, HYDROBIOLOGIA, V146, P3, DOI 10.1007/BF00007574; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keller D, 2010, BIOL CONSERV, V143, P2658, DOI 10.1016/j.biocon.2010.07.008; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kittlein MJ, 2008, P ROY SOC B-BIOL SCI, V275, P2633, DOI 10.1098/rspb.2008.0816; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mimura M, 2007, HEREDITY, V99, P224, DOI 10.1038/sj.hdy.6800987; Monetti L, 2002, BIOL J LINN SOC, V76, P225, DOI 10.1111/j.1095-8312.2002.tb02084.x; MOPPER S, 1998, GENETIC VARIATION LO; Palmer MA, 1996, TRENDS ECOL EVOL, V11, P322, DOI 10.1016/0169-5347(96)10038-0; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Rivera AC, 2005, ODONATOLOGICA, V34, P1; Rivera AC, 2007, ANIM BEHAV, V74, P247, DOI 10.1016/j.anbehav.2006.06.023; Rousset F, 1997, GENETICS, V145, P1219; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; SANCHEZGUILLEN R, HEREDITY IN PRESS; SANCHEZGUILLEN RA, ADMIXTURE A IN PRESS; SANCHEZGUILLEN RA, BMC EVOLUTI IN PRESS; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Slatkin M, 1994, GENE FLOW POPULATION; Smallshire D., 2004, BRITAINS DRAGONFLIES; Stettmer C, 1996, EUR J ENTOMOL, V93, P579; Svensson EI, 2005, J EVOLUTION BIOL, V18, P1503, DOI 10.1111/j.1420-9101.2005.00946.x; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; Svensson EI, 2009, EVOL ECOL, V23, P93, DOI 10.1007/s10682-007-9208-2; Watts PC, 2005, ECOL ENTOMOL, V30, P541, DOI 10.1111/j.0307-6946.2005.00721.x; Watts PC, 2004, MOL ECOL, V13, P2931, DOI 10.1111/j.1365-294X.2004.02300.x; Watts PC, 2010, BIOL INVASIONS, V12, P3887, DOI 10.1007/s10530-010-9779-7; WELLENREUTHER M, 2010, MOL ECOLOGY RESOURCE; Wellenreuther M, 2010, EVOLUTION, V64, P242, DOI 10.1111/j.1558-5646.2009.00815.x; Wright S, 1943, GENETICS, V28, P114	79	42	44	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20440	10.1371/journal.pone.0020440	http://dx.doi.org/10.1371/journal.pone.0020440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21655216	Green Published, Green Submitted, gold			2022-12-27	WOS:000291611500026
J	Dutt, A; Ramos, AH; Hammerman, PS; Mermel, C; Cho, J; Sharifnia, T; Chande, A; Tanaka, KE; Stransky, N; Greulich, H; Gray, NS; Meyerson, M				Dutt, Amit; Ramos, Alex H.; Hammerman, Peter S.; Mermel, Craig; Cho, Jeonghee; Sharifnia, Tanaz; Chande, Ajit; Tanaka, Kumiko Elisa; Stransky, Nicolas; Greulich, Heidi; Gray, Nathanael S.; Meyerson, Matthew			Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ACTIVATING MUTATIONS; THERAPEUTIC TARGET; MULTIPLE-MYELOMA; OVARIAN-CANCER; RECEPTOR; RESISTANCE; GEFITINIB; GENE; TRASTUZUMAB; CARCINOMAS	Background: Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. Methodology/Principal Findings: Using SNP array analysis, we found that a region of chromosome segment 8p11-12 containing three genes-WHSC1L1, LETM2, and FGFR1-is amplified in 3% of lung adenocarcinomas and 21% of squamous cell lung carcinomas. Furthermore, we demonstrated that a non-small cell lung carcinoma cell line harboring focal amplification of FGFR1 is dependent on FGFR1 activity for cell growth, as treatment of this cell line either with FGFR1-specific shRNAs or with FGFR small molecule enzymatic inhibitors leads to cell growth inhibition. Conclusions/Significance: These studies show that FGFR1 amplification is common in squamous cell lung cancer, and that FGFR1 may represent a promising therapeutic target in non-small cell lung cancer.	[Dutt, Amit; Ramos, Alex H.; Hammerman, Peter S.; Mermel, Craig; Cho, Jeonghee; Sharifnia, Tanaz; Tanaka, Kumiko Elisa; Greulich, Heidi; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dutt, Amit; Ramos, Alex H.; Mermel, Craig; Sharifnia, Tanaz; Tanaka, Kumiko Elisa; Stransky, Nicolas; Greulich, Heidi; Meyerson, Matthew] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Greulich, Heidi] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Greulich, Heidi] Harvard Univ, Sch Med, Boston, MA USA; [Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Ramos, Alex H.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Dutt, Amit] Tata Mem Hosp, Adv Ctr Treatment Res & Educ, Kharghar, Navi Mumbai, India	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tata Memorial Centre (TMC); Tata Memorial Hospital	Dutt, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	adutt@actrec.gov.in; matthew_meyerson@dfci.harvard.edu	Dutt, Amit/I-1911-2013; Chande, Ajit/K-5031-2014; Meyerson, Matthew L/E-7123-2012; Mermel, Craig/AAZ-7322-2020	Dutt, Amit/0000-0002-1119-4774; Chande, Ajit/0000-0003-2210-5180; Mermel, Craig/0000-0002-0816-3395; Meyerson, Matthew/0000-0002-9133-8108	Novartis Pharmaceuticals; American Lung Association; Uniting Against Lung Cancer; Sarah Thomas Monopoli Fund; Seaman Foundation; Genentech; Department of Biotechnology, Ministry of Science, Government of India; National Lung Cancer Partnership; Novartis; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); American Lung Association; Uniting Against Lung Cancer; Sarah Thomas Monopoli Fund; Seaman Foundation; Genentech(Roche HoldingGenentech); Department of Biotechnology, Ministry of Science, Government of India; National Lung Cancer Partnership; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources for this work include support from Novartis Pharmaceuticals, the American Lung Association, Uniting Against Lung Cancer, the Sarah Thomas Monopoli Fund, the Seaman Foundation and Genentech to M. M. A. D. is supported by a Ramalingaswami fellowship from the Department of Biotechnology, Ministry of Science, Government of India. P. S. H. is supported by a Young Investigator Award from the National Lung Cancer Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. M. is a consultant to Novartis and receives research support from Novartis, receives research support from Genentech, and is a founding advisor and consultant, and an equity holder in Foundation Medicine. N.G. laboratory receives sponsored research from Novartis. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chen J, 2005, ONCOGENE, V24, P8259, DOI 10.1038/sj.onc.1208989; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Ishizuka T, 2002, BIOCHEM BIOPH RES CO, V296, P152, DOI 10.1016/S0006-291X(02)00836-7; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kim SM, 2006, BIOCHEM BIOPH RES CO, V345, P318, DOI 10.1016/j.bbrc.2006.04.095; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machida S, 2005, INT J CANCER, V114, P224, DOI 10.1002/ijc.20751; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; McDermott U, 2009, CANCER RES, V69, P3937, DOI 10.1158/0008-5472.CAN-08-4327; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Missiaglia E, 2009, GENE CHROMOSOME CANC, V48, P455, DOI 10.1002/gcc.20655; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Phelps RM, 1996, J CELL BIOCHEM, P32; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Richelda R, 1997, BLOOD, V90, P4062, DOI 10.1182/blood.V90.10.4062; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Selvaggi G, 2009, ONCOLOGY-NY, V23, P1133; Simon R, 2001, CANCER RES, V61, P4514; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2011, SCI TRANSL MED, V3; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; ZHENG J, 1994, AM J PATHOL, V145, P1444; Zhou WJ, 2010, CHEM BIOL, V17, P285, DOI 10.1016/j.chembiol.2010.02.007	61	295	323	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20351	10.1371/journal.pone.0020351	http://dx.doi.org/10.1371/journal.pone.0020351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666749	Green Published, gold			2022-12-27	WOS:000291607000005
J	Dai, L; Chen, DF; Liu, YL; Zhao, Y; Yang, F; Yang, JS; Yang, WJ				Dai, Li; Chen, Dian-Fu; Liu, Yu-Lei; Zhao, Yang; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun			Extracellular Matrix Peptides of Artemia Cyst Shell Participate in Protecting Encysted Embryos from Extreme Environments	PLOS ONE			English	Article							SHOCK/ALPHA-CRYSTALLIN PROTEIN; BRINE SHRIMP; TERTIARY ENVELOPE; BIOMINERALIZATION; ANOSTRACA; FRANCISCANA; MEMBRANES; DIAPAUSE; STRAINS; PCR	Background: Many species of the brine shrimp Artemia are found in various severe environments in many parts of the world where extreme salinity, high UV radiation levels, high pH, anoxia, large temperature fluctuations, and intermittent dry conditions are often recorded. To withstand adverse environments, Artemia undergoes an oviparous developmental pathway to release cysts whereas, under favorable conditions, swimming nauplius larvae are formed directly via an ovoviviparous pathway. In the former case these cysts have an extraordinary ability to keep the embryos protected from the harsh environment for long periods. This is achieved through the protection by a complex out-wrapping cyst shell. However, the formation and function of the cyst shell is complex; the details remain largely unclear. Principal Finding: A shell gland-specific gene (SGEG2) was cloned and identified from a suppression subtractive hybridization library. Western blot analysis showed that SGEG2 presumably requires post-translational proteolysis in order to be processed into two mature peptides (SGEG2a and 2b). The three matrix peptides (SGEG1 reported previously, 2a, and 2b) were found to distribute throughout the cyst shell. The results of gene knockdown by RNAi and subsequent resistance to environmental stresses assays indicated that these matrix peptides are required for cyst shell formation and are involved in protecting the encysted embryos from environmental stress. Conclusions/Significance: This study revealed that extracellular matrix peptides participate in protecting embryos from extreme salinity, UV radiation, large temperature fluctuations and dry environments, thereby facilitating their survival. The cyst shell provides an excellent opportunity to link the ecological setting of an organism to the underlying physiological and biochemical processes enabling its survival. The cyst shell material has also a high potential to become an excellent new biomaterial with a high number of prospective uses due, specifically, to such biological characteristics.	[Dai, Li; Chen, Dian-Fu; Liu, Yu-Lei; Zhao, Yang; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Wei-Jun] Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Dai, L (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737	National Natural Sciences Foundation of China [40730212]; National Basic Research Program of China (973 Program) [2010CB833803]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Funding: This work was supported by the National Natural Sciences Foundation of China (40730212) and National Basic Research Program of China (973 Program, 2010CB833803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON E, 1970, J ULTRA MOL STRUCT R, V32, P497, DOI 10.1016/S0022-5320(70)80025-9; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clegg J.S., 1986, P169; Clegg James S., 2002, P129; Clegg JS, 1999, AM ZOOL, V39, P836; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; CROWE JH, 1998, ISOPOW, V6, P440; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Drinkwater L.E., 1991, P93; Gaubin Y, 1996, ADV SPACE RES, V18, P221, DOI 10.1016/0273-1177(96)00043-9; HOFMANN GE, 1990, J EXP ZOOL, V253, P287, DOI 10.1002/jez.1402530308; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; LAVENS P, 1986, MAR ECOL-PROG SER, V31, P179; LEE KW, 1994, PROC ANN MEET MSA, P362; Lenz P.H., 1991, P237; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MORRIS JE, 1967, J ULTRA MOL STRUCT R, V20, P244, DOI 10.1016/S0022-5320(67)90285-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; STAPPEN GV, 2002, ARTEMIA BASIC APPL B, P171; Sugumar V, 2006, MICROSC RES TECHNIQ, V69, P957, DOI 10.1002/jemt.20371; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tajik H, 2008, MOLECULES, V13, P1263, DOI 10.3390/molecules13061263; Tanguay JA, 2004, J BIOSCIENCES, V29, P489, DOI 10.1007/BF02712121; Triantaphyllidis GV, 1998, J BIOGEOGR, V25, P213, DOI 10.1046/j.1365-2699.1998.252190.x; Wang SF, 2007, MICROSC RES TECHNIQ, V70, P663, DOI 10.1002/jemt.20451; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; WILLIAMS WD, 1981, HYDROBIOLOGIA, V81-2, P1, DOI 10.1007/BF00048701; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	33	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20187	10.1371/journal.pone.0020187	http://dx.doi.org/10.1371/journal.pone.0020187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673998	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400002
J	Dao, TMA; Waget, A; Klopp, P; Serino, M; Vachoux, C; Pechere, L; Drucker, DJ; Champion, S; Barthelemy, S; Barra, Y; Burcelin, R; Seree, E				Dao, Thi-Mai Anh; Waget, Aurelie; Klopp, Pascale; Serino, Matteo; Vachoux, Christelle; Pechere, Laurent; Drucker, Daniel J.; Champion, Serge; Barthelemy, Sylvain; Barra, Yves; Burcelin, Remy; Seree, Eric			Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MITOCHONDRIAL-FUNCTION; INSULIN-SECRETION; SIRT1; OBESITY; INFLAMMATION; EXPRESSION; ACTIVATOR; DISEASE	Resveratrol (RSV) is a potent anti-diabetic agent when used at high doses. However, the direct targets primarily responsible for the beneficial actions of RSV remain unclear. We used a formulation that increases oral bioavailability to assess the mechanisms involved in the glucoregulatory action of RSV in high-fat diet (HFD)-fed diabetic wild type mice. Administration of RSV for 5 weeks reduced the development of glucose intolerance, and increased portal vein concentrations of both Glucagon-like peptid-1 (GLP-1) and insulin, and intestinal content of active GLP-1. This was associated with increased levels of colonic proglucagon mRNA transcripts. RSV-mediated glucoregulation required a functional GLP-1 receptor (Glp1r) as neither glucose nor insulin levels were modulated in Glp1r-/- mice. Conversely, levels of active GLP-1 and control of glycemia were further improved when the Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin was co-administered with RSV. In addition, RSV treatment modified gut microbiota and decreased the inflammatory status of mice. Our data suggest that RSV exerts its actions in part through modulation of the enteroendocrine axis in vivo.	[Dao, Thi-Mai Anh; Waget, Aurelie; Klopp, Pascale; Serino, Matteo; Vachoux, Christelle; Burcelin, Remy] Fac Med Toulouse, INSERM, U1048, Inst Rech Malad Metab & Cardiovasc,I2MC, F-31073 Toulouse, France; [Dao, Thi-Mai Anh; Waget, Aurelie; Klopp, Pascale; Serino, Matteo; Vachoux, Christelle; Burcelin, Remy] Univ Toulouse, UPS, Inst Malad Metab & Cardiovasc, Hop Rangueil, Toulouse, France; [Dao, Thi-Mai Anh; Champion, Serge; Barra, Yves; Seree, Eric] Inst Natl Rech Agron 1260, Fac Pharm, Marseille, France; [Pechere, Laurent] ENTERONOVA SAS, Toulouse, France; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Barthelemy, Sylvain] YVERY SARL, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Dao, TMA (corresponding author), Fac Med Toulouse, INSERM, U1048, Inst Rech Malad Metab & Cardiovasc,I2MC, U317, F-31073 Toulouse, France.	remy.burcelin@inserm.fr; eric.Seree@univmed.fr	burcelin, remy/M-6013-2014; Serino, Matteo/O-3310-2018; Drucker, Daniel J/A-4092-2010	Serino, Matteo/0000-0003-4644-8532; Klopp, Pascale/0000-0002-3515-6115	Agence Nationale de la Recherche [GLP-1]; Merck Sharp and Dohm	Agence Nationale de la Recherche(French National Research Agency (ANR)); Merck Sharp and Dohm	Funding: Remy Burcelin is the recipient of subsidies from the Agence Nationale de la Recherche (Program Brain GLP-1). This manuscript was partly funded by a grant (IISP program) from Merck Sharp and Dohm to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2008, EXPERT OPIN EMERG DR, V13, P593, DOI 10.1517/14728210802584126 ; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Argmann C, 2006, CELL, V126, P837, DOI 10.1016/j.cell.2006.08.031; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; BRUBAKER PL, 1991, ENDOCRINOLOGY, V128, P3175, DOI 10.1210/endo-128-6-3175; Burcelin R, 2005, BRIT J NUTR, V93, pS147, DOI 10.1079/BJN20041340; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, MOL CELL ENDOCRINOL, V276, P18, DOI 10.1016/j.mce.2007.06.003; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Casper RF, 1999, MOL PHARMACOL, V56, P784; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Khalil A, 2010, TOXICOL LETT, V196, P161, DOI 10.1016/j.toxlet.2010.04.010; Knauf C, 2008, ENDOCRINOLOGY, V149, P4768, DOI 10.1210/en.2008-0180; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LANGCAKE P, 1977, EXPERIENTIA, V33, P151, DOI 10.1007/BF02124034; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nauck M, 1996, DIABETIC MED, V13, pS39; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vitrac X, 2003, LIFE SCI, V72, P2219, DOI 10.1016/S0024-3205(03)00096-1; Wang WB, 2006, J MED MICROBIOL, V55, P1313, DOI 10.1099/jmm.0.46661-0; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yasuda N, 2002, BIOCHEM BIOPH RES CO, V298, P779, DOI 10.1016/S0006-291X(02)02565-2	44	114	119	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20700	10.1371/journal.pone.0020700	http://dx.doi.org/10.1371/journal.pone.0020700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673955	Green Published, gold			2022-12-27	WOS:000291356400019
J	Lekprasert, P; Mayhew, M; Ohler, U				Lekprasert, Parawee; Mayhew, Michael; Ohler, Uwe			Assessing the Utility of Thermodynamic Features for microRNA Target Prediction under Relaxed Seed and No Conservation Requirements	PLOS ONE			English	Article							BASE-PAIRING PROBABILITIES; SITE ACCESSIBILITY; POSTTRANSCRIPTIONAL REGULATION; PROTEIN; DETERMINANTS; IMPACT; LIN-14	Background: Many computational microRNA target prediction tools are focused on several key features, including complementarity to 5'seed of miRNAs and evolutionary conservation. While these features allow for successful target identification, not all miRNA target sites are conserved and adhere to canonical seed complementarity. Several studies have propagated the use of energy features of mRNA: miRNA duplexes as an alternative feature. However, different independent evaluations reported conflicting results on the reliability of energy-based predictions. Here, we reassess the usefulness of energy features for mammalian target prediction, aiming to relax or eliminate the need for perfect seed matches and conservation requirement. Methodology/Principal Findings: We detect significant differences of energy features at experimentally supported human miRNA target sites and at genome-wide sites of AGO protein interaction. This trend is confirmed on datasets that assay the effect of miRNAs on mRNA and protein expression changes, and a simple linear regression model leads to significant correlation of predicted versus observed expression change. Compared to 6-mer seed matches as baseline, application of our energy-based model leads to similar to 3-5-fold enrichment on highly down-regulated targets, and allows for prediction of strictly imperfect targets with enrichment above baseline. Conclusions/Significance: In conclusion, our results indicate significant promise for energy-based miRNA target prediction that includes a broader range of targets without having to use conservation or impose stringent seed match rules.	[Lekprasert, Parawee; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Lekprasert, Parawee; Mayhew, Michael] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC USA; [Ohler, Uwe] Duke Univ, Dept Biostat, Durham, NC USA; [Ohler, Uwe] Duke Univ, Dept Bioinformat, Durham, NC USA; [Ohler, Uwe] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Lekprasert, P (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	uwe.ohler@duke.edu			National Science Foundation [MCB-0822033]; Thai government	National Science Foundation(National Science Foundation (NSF)); Thai government	Funding: This work was supported by the National Science Foundation (MCB-0822033 to U.O.). P. L. is the recipient of a Thai government scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005681; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo H., 2010, NATURE, V466, P835; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hofacker I.L., 1994, MONATSH CHEM, V125, P22; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Neplioueva V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011710; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RHEAD B, 2009, NUCL ACIDS RES; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	44	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20622	10.1371/journal.pone.0020622	http://dx.doi.org/10.1371/journal.pone.0020622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674004	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400011
J	Perez-Martinez, P; Delgado-Lista, J; Garcia-Rios, A; Mc Monagle, J; Gulseth, HL; Ordovas, JM; Shaw, DI; Karlstrom, B; Kiec-Wilk, B; Blaak, EE; Helal, O; Malczewska-Malec, M; Defoort, C; Riserus, U; Saris, WHM; Lovegrove, JA; Drevon, CA; Roche, HM; Lopez-Miranda, J				Perez-Martinez, Pablo; Delgado-Lista, Javier; Garcia-Rios, Antonio; Mc Monagle, Jolene; Gulseth, Hanne L.; Ordovas, Jose M.; Shaw, Danielle I.; Karlstrom, Brita; Kiec-Wilk, Beata; Blaak, Ellen E.; Helal, Olfa; Malczewska-Malec, Malgorzata; Defoort, Catherine; Riserus, Ulf; Saris, Wim H. M.; Lovegrove, Julie A.; Drevon, Christian A.; Roche, Helen M.; Lopez-Miranda, Jose			Glucokinase Regulatory Protein Genetic Variant Interacts with Omega-3 PUFA to Influence Insulin Resistance and Inflammation in Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FASTING PLASMA-GLUCOSE; FATTY-ACID-COMPOSITION; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE LEVELS; RISK; LOCI; OMEGA-3-FATTY-ACIDS; POLYMORPHISMS; ASSOCIATION	Glucokinase Regulatory Protein (GCKR) plays a central role regulating both hepatic triglyceride and glucose metabolism. Fatty acids are key metabolic regulators, which interact with genetic factors and influence glucose metabolism and other metabolic traits. Omega-3 polyunsaturated fatty acids (n-3 PUFA) have been of considerable interest, due to their potential to reduce metabolic syndrome (MetS) risk. Objective: To examine whether genetic variability at the GCKR gene locus was associated with the degree of insulin resistance, plasma concentrations of C-reactive protein (CRP) and n-3 PUFA in MetS subjects. Design: Homeostasis model assessment of insulin resistance (HOMA-IR), HOMA-B, plasma concentrations of C-peptide, CRP, fatty acid composition and the GCKR rs1260326-P446L polymorphism, were determined in a cross-sectional analysis of 379 subjects with MetS participating in the LIPGENE dietary cohort. Results: Among subjects with n-3 PUFA levels below the population median, carriers of the common C/C genotype had higher plasma concentrations of fasting insulin (P = 0.019), C-peptide (P = 0.004), HOMA-IR (P = 0.008) and CRP (P = 0.032) as compared with subjects carrying the minor T-allele (Leu446). In contrast, homozygous C/C carriers with n-3 PUFA levels above the median showed lower plasma concentrations of fasting insulin, peptide C, HOMA-IR and CRP, as compared with individuals with the T-allele. Conclusions: We have demonstrated a significant interaction between the GCKR rs1260326-P446L polymorphism and plasma n-3 PUFA levels modulating insulin resistance and inflammatory markers in MetS subjects. Further studies are needed to confirm this gene-diet interaction in the general population and whether targeted dietary recommendations can prevent MetS in genetically susceptible individuals.	[Perez-Martinez, Pablo; Delgado-Lista, Javier; Garcia-Rios, Antonio; Lopez-Miranda, Jose] Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain; [Perez-Martinez, Pablo; Delgado-Lista, Javier; Garcia-Rios, Antonio; Lopez-Miranda, Jose] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain; [Mc Monagle, Jolene; Roche, Helen M.] Univ Coll Dublin, Nutrigen Res Grp, UCD Sch Publ Hlth & Populat Sci, UCD Conway Inst, Dublin 2, Ireland; [Gulseth, Hanne L.] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, Dept Epidemiol & Populat Genet, Madrid, Spain; [Shaw, Danielle I.; Lovegrove, Julie A.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Shaw, Danielle I.; Lovegrove, Julie A.] Univ Reading, ICMR, Reading, Berks, England; [Karlstrom, Brita; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Kiec-Wilk, Beata; Malczewska-Malec, Malgorzata] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Kiec-Wilk, Beata; Malczewska-Malec, Malgorzata] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland; [Blaak, Ellen E.; Saris, Wim H. M.] NUTRIM, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Helal, Olfa; Defoort, Catherine] Univ Mediterranee, INRA, INSERM 476, Marseille, France; [Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University College Dublin; University of Oslo; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Reading; University of Reading; Uppsala University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Maastricht University; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Oslo	Perez-Martinez, P (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain.	jlopezmir@uco.es	Roche, Helen M/AAF-4164-2019; Lopez-Miranda, Jose/Y-8306-2019; Shaw, Danielle/HGA-4994-2022; Ordovas, Jose/B-8727-2013; Blaak, Ellen/E-3459-2015	Roche, Helen M/0000-0002-0628-3318; Lopez-Miranda, Jose/0000-0002-8844-0718; Perez Martinez, Pablo/0000-0001-7716-8117; Ordovas, Jose/0000-0002-7581-5680; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Blaak, Ellen/0000-0002-2496-3464	European community [505944]; Spanish Ministry of Science and Innovation [AGL2006-01979/ALI, AGL2009-12270, PI10/01041]; Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia [P06-CTS-01425]; Consejeria de Salud, Junta de Andalucia [07/43, PI 0193/09, PI-0252/2009, PI-0058-2010]; Centro de Excelencia Investigadora en Aceite de Oliva y Salud (CEAS); Aktieselskabet Freia Chocolade Fabrik's Medical Foundation; Throne-Holst Foundation for Nutrition Research; Science Foundation Ireland Principal Investigator Programme [06/IM.1/B105]; ISCIII (Programa Rio-Hortega); NIH [HL54776, DK075030]; U.S. Department of Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075030] Funding Source: NIH RePORTER	European community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Centro de Excelencia Investigadora en Aceite de Oliva y Salud (CEAS); Aktieselskabet Freia Chocolade Fabrik's Medical Foundation; Throne-Holst Foundation for Nutrition Research; Science Foundation Ireland Principal Investigator Programme(Science Foundation Ireland); ISCIII (Programa Rio-Hortega)(Instituto de Salud Carlos III); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported in part by research grants from the European community (LIPGENE European Integrated Project-505944), grants from the Spanish Ministry of Science and Innovation (AGL2006-01979/ALI, AGL2009-12270 to JL-M and PI10/01041 to PP-M), Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia (P06-CTS-01425 to JL-M); Consejeria de Salud, Junta de Andalucia (07/43, PI 0193/09 to JL-M, PI-0252/2009 to JD-L and PI-0058-2010 to PP-M). This study was also supported by Centro de Excelencia Investigadora en Aceite de Oliva y Salud (CEAS), Aktieselskabet Freia Chocolade Fabrik's Medical Foundation, and Throne-Holst Foundation for Nutrition Research. HRM is a recipient by Science Foundation Ireland Principal Investigator Programme (06/IM.1/B105). AG-R is supported by a research contract of ISCIII (Programa Rio-Hortega). JMO is supported by NIH grants HL54776 and DK075030 and by the U.S. Department of Agriculture Research Service (contracts 53-K06-5-10 and 58-1950-9-001).	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ferguson JF, 2010, ATHEROSCLEROSIS, V211, P539, DOI 10.1016/j.atherosclerosis.2010.03.027; Ferguson JF, 2010, AM J CLIN NUTR, V91, P794, DOI 10.3945/ajcn.2009.28255; Jenkins DJA, 2008, J AM COLL NUTR, V27, P367, DOI 10.1080/07315724.2008.10719713; JUMP DB, 1994, J LIPID RES, V35, P1076; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; Lopez-Miranda J, 2007, J MOL MED, V85, P209, DOI 10.1007/s00109-006-0138-1; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Noel SE, 2010, J NUTR, V140, P1846, DOI 10.3945/jn.110.124297; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perez-Martinez P, 2008, J NUTR, V138, P1609, DOI 10.1093/jn/138.9.1609; Perez-Martinez P, 2010, ATHEROSCLEROSIS, V209, P533, DOI 10.1016/j.atherosclerosis.2009.09.023; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reaven G, 2002, CIRCULATION, V106, P286, DOI 10.1161/01.CIR.0000019884.36724.D9; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shaw DI, 2009, BRIT J NUTR, V101, P750, DOI 10.1017/S0007114508039962; Tierney AC, 2010, INT J OBES LOND; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wang L, 2003, AM J CLIN NUTR, V78, P91	33	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20555	10.1371/journal.pone.0020555	http://dx.doi.org/10.1371/journal.pone.0020555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674002	Green Published, gold			2022-12-27	WOS:000291356400007
J	Simon, A; Britton, R; Gozlan, R; Oosterhout, C; Volckaert, FAM; Hanfling, B				Simon, Andrea; Britton, Robert; Gozlan, Rodolphe; van Oosterhout, Cock; Volckaert, Filip A. M.; Haenfling, Bernd			Invasive Cyprinid Fish in Europe Originate from the Single Introduction of an Admixed Source Population Followed by a Complex Pattern of Spread	PLOS ONE			English	Article							PSEUDORASBORA-PARVA; GENETIC DIVERSITY; EVOLUTIONARY GENETICS; DNA; PHYLOGEOGRAPHY; HISTORY; FRESH; HYBRIDIZATION; SUBSTITUTIONS; DISTANCE	The Asian cyprinid fish, the topmouth gudgeon (Pseudorasbora parva), was introduced into Europe in the 1960s. A highly invasive freshwater fish, it is currently found in at least 32 countries outside its native range. Here we analyse a 700 base pair fragment of the mitochondrial cytochrome b gene to examine different models of colonisation and spread within the invasive range, and to investigate the factors that may have contributed to their invasion success. Haplotype and nucleotide diversity of the introduced populations from continental Europe was higher than that of the native populations, although two recently introduced populations from the British Isles showed low levels of variability. Based on coalescent theory, all introduced and some native populations showed a relative excess of nucleotide diversity compared to haplotype diversity. This suggests that these populations are not in mutation-drift equilibrium, but rather that the relative inflated level of nucleotide diversity is consistent with recent admixture. This study elucidates the colonisation patterns of P. parva in Europe and provides an evolutionary framework of their invasion. It supports the hypothesis that their European colonisation was initiated by their introduction to a single location or small geographic area with subsequent complex pattern of spread including both long distance and stepping-stone dispersal. Furthermore, it was preceded by, or associated with, the admixture of genetically diverse source populations that may have augmented its invasive-potential.	[Simon, Andrea; Haenfling, Bernd] Univ Hull, Dept Biol Sci, Evolutionary Biol Grp, Kingston Upon Hull HU6 7RX, N Humberside, England; [Britton, Robert; Gozlan, Rodolphe] Bournemouth Univ, Sch Conservat Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Volckaert, Filip A. M.] Katholieke Univ Leuven, Cent Lab Anim Divers & Systemat, Leuven, Belgium; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Hull; Bournemouth University; KU Leuven; University of East Anglia	Simon, A (corresponding author), Univ Hull, Dept Biol Sci, Evolutionary Biol Grp, Kingston Upon Hull HU6 7RX, N Humberside, England.	a.simon@2007.hull.ac.uk	Volckaert, Filip/AAC-7691-2019; Britton, Robert/AAO-6673-2020; Britton, Robert/B-5040-2009	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; Hanfling, Bernd/0000-0001-7630-9360; van Oosterhout, Cock/0000-0002-5653-738X	Natural Environment Research Council [NE/007094/1]; Ministry of the Flemish Community [VLINA/AMINAL/NATUUR/00/11]; Fisheries Society of the British Isles	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Ministry of the Flemish Community; Fisheries Society of the British Isles	The work was funded by The Natural Environment Research Council (project NE/007094/1), Ministry of the Flemish Community (project VLINA/AMINAL/NATUUR/00/11), and Fisheries Society of the British Isles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BANARESCU P., 1965, REV ROUMAINE BIOL SER ZOOL, V10, P219; Banarescu P.M., 1999, FRESHWATER FISHES EU; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Benejam Lluis, 2005, Limnetica, V24, P273; BERG LS, 1949, RYBY PRESNYCH VOD SS, P477; Briolay J, 1998, MOL PHYLOGENET EVOL, V9, P100, DOI 10.1006/mpev.1997.0441; Britton JR, 2007, AQUAT CONSERV, V17, P749, DOI 10.1002/aqc.809; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Broughton RE, 2000, SYST BIOL, V49, P617, DOI 10.1080/106351500750049734; Brown JE, 2008, MOL ECOL, V17, P2598, DOI 10.1111/j.1365-294X.2008.03777.x; Cesco H, 2001, PARASITE, V8, P75, DOI 10.1051/parasite/2001081075; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Durand JD, 2002, MOL PHYLOGENET EVOL, V25, P218, DOI 10.1016/S1055-7903(02)00343-3; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ficetola GF, 2008, MOL ECOL, V17, P773, DOI 10.1111/j.1365-294X.2007.03622.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 2006, FOLIA ZOOL, V55, P53; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2002, J FISH BIOL, V61, P298, DOI 10.1006/jfbi.2002.2042; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Gozlan RE, 2009, INT J PARASITOL, V39, P1055, DOI 10.1016/j.ijpara.2009.04.012; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Hanfling B, 1998, HEREDITY, V80, P110; Hanfling Bernd, 2002, Trends in Ecology and Evolution, V17, P545, DOI 10.1016/S0169-5347(02)02644-7; Haynes GD, 2009, J FISH BIOL, V75, P295, DOI 10.1111/j.1095-8649.2009.02276.x; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hua X, 2009, J FISH BIOL, V75, P354, DOI 10.1111/j.1095-8649.2009.02323.x; Hudson RR, 1990, OXFORD SURVEYS EVOLU, V1, P1; Jamandre BW, 2009, J FISH BIOL, V75, P393, DOI 10.1111/j.1095-8649.2009.02332.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lin CJ, 2010, ZOOL SCR, V39, P23, DOI 10.1111/j.1463-6409.2009.00407.x; Liu HZ, 2010, CHINESE SCI BULL, V55, P1501, DOI 10.1007/s11434-010-3159-7; Liu JY, 2009, BIOCHEM SYST ECOL, V37, P556, DOI 10.1016/j.bse.2009.09.002; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1989, MOL BIOL EVOL, V6, P290; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosecchi E, 2001, FRESHWATER BIOL, V46, P845, DOI 10.1046/j.1365-2427.2001.00715.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saillant E, 2005, COPEIA, P20, DOI 10.1643/CG-04-200R1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; Watanabe K, 2000, ICHTHYOL RES, V47, P43, DOI 10.1007/BF02674312; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Wright S, 1943, GENETICS, V28, P114; Yang L, 2008, MOL PHYLOGENET EVOL, V49, P393, DOI 10.1016/j.ympev.2008.05.032; Zidana H, 2009, MOL ECOL, V18, P4380, DOI 10.1111/j.1365-294X.2009.04362.x	71	45	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e18560	10.1371/journal.pone.0018560	http://dx.doi.org/10.1371/journal.pone.0018560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674031	Green Published, Green Accepted, gold			2022-12-27	WOS:000291355500002
J	Pacheco, SE; Houseman, EA; Christensen, BC; Marsit, CJ; Kelsey, KT; Sigman, M; Boekelheide, K				Pacheco, Sara E.; Houseman, E. Andres; Christensen, Brock C.; Marsit, Carmen J.; Kelsey, Karl T.; Sigman, Mark; Boekelheide, Kim			Integrative DNA Methylation and Gene Expression Analyses Identify DNA Packaging and Epigenetic Regulatory Genes Associated with Low Motility Sperm	PLOS ONE			English	Article							MALE GERM-CELLS; SPERMATOZOAL RNA; IMPRINTED GENES; MESSENGER-RNA; INFERTILE MEN; SPERMATOGENESIS; FERTILE; EXPOSURE; PROTEIN; INSIGHTS	Background: In previous studies using candidate gene approaches, low sperm count (oligospermia) has been associated with altered sperm mRNA content and DNA methylation in both imprinted and non-imprinted genes. We performed a genome-wide analysis of sperm DNA methylation and mRNA content to test for associations with sperm function. Methods and Results: Sperm DNA and mRNA were isolated from 21 men with a range of semen parameters presenting to a tertiary male reproductive health clinic. DNA methylation was measured with the Illumina Infinium array at 27,578 CpG loci. Unsupervised clustering of methylation data differentiated the 21 sperm samples by their motility values. Recursively partitioned mixture modeling (RPMM) of methylation data resulted in four distinct methylation profiles that were significantly associated with sperm motility (P = 0.01). Linear models of microarray analysis (LIMMA) was performed based on motility and identified 9,189 CpG loci with significantly altered methylation (Q<0.05) in the low motility samples. In addition, the majority of these disrupted CpG loci (80%) were hypomethylated. Of the aberrantly methylated CpGs, 194 were associated with imprinted genes and were almost equally distributed into hypermethylated (predominantly paternally expressed) and hypomethylated (predominantly maternally expressed) groups. Sperm mRNA was measured with the Human Gene 1.0 ST Affymetrix GeneChip Array. LIMMA analysis identified 20 candidate transcripts as differentially present in low motility sperm, including HDAC1 (NCBI 3065), SIRT3 (NCBI 23410), and DNMT3A (NCBI 1788). There was a trend among altered expression of these epigenetic regulatory genes and RPMM DNA methylation class. Conclusions: Using integrative genome-wide approaches we identified CpG methylation profiles and mRNA alterations associated with low sperm motility.	[Pacheco, Sara E.; Marsit, Carmen J.; Kelsey, Karl T.; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Houseman, E. Andres; Christensen, Brock C.; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Sigman, Mark] Brown Univ, Div Urol, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Pacheco, SE (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kim_Boekelheide@Brown.edu	Sigman, Mark/P-3343-2019; Christensen, Brock/B-8460-2009; Kelsey, Karl T/I-1252-2014	Marsit, Carmen/0000-0003-4566-150X; Houseman, Eugene Andres/0000-0003-0703-1830	National Institutes of Health/The National Institute of Environmental Health Sciences (NIH/NIEHS) [P42ES013660];  [5R01CA121147-5];  [T32ES007272-17]; NATIONAL CANCER INSTITUTE [R01CA121147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272, P42ES013660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	National Institutes of Health/The National Institute of Environmental Health Sciences (NIH/NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by 5R01CA121147-5 and the Superfund Basic Research Program National Institutes of Health/The National Institute of Environmental Health Sciences (NIH/NIEHS) grant P42ES013660. SP was supported by T32ES007272-17 for "Training in Environmental Pathology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki VW, 2006, MOL HUM REPROD, V12, P41, DOI 10.1093/molehr/gah258; Avendano C, 2009, HUM REPROD, V24, P270, DOI 10.1093/humrep/den381; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Bonaparte E, 2010, HUM REPROD, V25, P1398, DOI 10.1093/humrep/deq074; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Choi E, 2008, J BIOL CHEM, V283, P35283, DOI 10.1074/jbc.M805590200; Christensen BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001043; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dadoune JP, 2004, INT REV CYTOL, V237, P1, DOI 10.1016/S0074-7696(04)37001-4; Doerksen T, 2000, ENDOCRINOLOGY, V141, P3235, DOI 10.1210/en.141.9.3235; du Plessis SS, 2010, ANDROLOGIA, V42, P206, DOI 10.1111/j.1439-0272.2009.00980.x; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kempisty B, 2008, REPROD FERT DEVELOP, V20, P513, DOI 10.1071/RD07211; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lalancette C, 2009, J MOL MED, V87, P735, DOI 10.1007/s00109-009-0485-9; LEUSHUIS E, 2010, FERTIL STERIL, DOI DOI 10.1016/J.FERTN-STERT.2010.03.021; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2010, FERTIL STERIL, V94, P585, DOI 10.1016/j.fertnstert.2009.02.051; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; Miller D, 2006, Gynecol Obstet Fertil, V34, P840, DOI 10.1016/j.gyobfe.2006.07.013; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Miller D, 1997, MOL HUM REPROD, V3, P669, DOI 10.1093/molehr/3.8.669; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; PATHAK S, 2008, FERTIL STERIL, DOI DOI 10.1016/J.FERTN-STERT.2008.07.1709; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Sato A, 2011, FERTIL STERIL, V95, P129, DOI 10.1016/j.fertnstert.2010.06.076; Schumacker PT, 2010, CANCER CELL, V17, P5, DOI 10.1016/j.ccr.2009.12.032; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Steger K, 2008, HUM REPROD, V23, P11, DOI 10.1093/humrep/dem363; Steilmann C, 2010, REPRODUCTION, V140, P435, DOI 10.1530/REP-10-0139; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swan SH, 2006, INT J ANDROL, V29, P62, DOI 10.1111/j.1365-2605.2005.00620.x; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Wang H, 2004, J MOL MED, V82, P317, DOI 10.1007/s00109-004-0526-3; World Health Organization DoRHaR, 2010, WHO LAB MAN EX PROC; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884	53	103	110	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20280	10.1371/journal.pone.0020280	http://dx.doi.org/10.1371/journal.pone.0020280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674046	Green Submitted, Green Published, gold			2022-12-27	WOS:000291310600007
J	De Mukhopadhyay, K; Bandyopadhyay, A; Chang, TTA; Elkahloun, AG; Cornell, JE; Yang, JH; Goins, BA; Yeh, IT; Sun, LZ				De Mukhopadhyay, Keya; Bandyopadhyay, Abhik; Chang, Ting-Tung A.; Elkahloun, Abdel G.; Cornell, John E.; Yang, Junhua; Goins, Beth A.; Yeh, I-Tien; Sun, Lu-Zhe			Isolation and Characterization of a Metastatic Hybrid Cell Line Generated by ER Negative and ER Positive Breast Cancer Cells in Mouse Bone Marrow	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; STEM-CELLS; PROSPECTIVE IDENTIFICATION; SPONTANEOUS FUSION; IN-VITRO; EXPRESSION; HYPOTHESIS; VARIANT	Background: The origin and the contribution of breast tumor heterogeneity to its progression are not clear. We investigated the effect of a growing orthotopic tumor formed by an aggressive estrogen receptor (ER)-negative breast cancer cell line on the metastatic potential of a less aggressive ER-positive breast cancer cell line for the elucidation of how the presence of heterogeneous cancer cells might affect each other's metastatic behavior. Methods: ER positive ZR-75-1/GFP/puro cells, resistant to puromycin and non-tumorigenic/non-metastatic without exogenous estrogen supplementation, were injected intracardiacally into mice bearing growing orthotopic tumors, formed by ER negative MDA-MB-231/GFP/Neo cells resistant to G418. A variant cell line B6, containing both estrogen-dependent and -independent cells, were isolated from GFP expressing cells in the bone marrow and re-inoculated in nude mice to generate an estrogen-independent cell line B6TC. Results: The presence of ER negative orthotopic tumors resulted in bone metastasis of ZR-75-1 without estrogen supplementation. The newly established B6TC cell line was tumorigenic without estrogen supplementation and resistant to both puromycin and G418 suggesting its origin from the fusion of MDA-MB-231/GFP/Neo and ZR-75-1/GFP/puro in the mouse bone marrow. Compared to parental cells, B6TC cells were more metastatic to lung and bone after intracardiac inoculation. More significantly, B6TC mice also developed brain metastasis, which was not observed in the MDA-MB-231/GFP/Neo cell-inoculated mice. Low expression of ER alpha and CD24, and high expression of EMT-related markers such as Vimentin, CXCR4, and Integrin-beta 1 along with high CD44 and ALDH expression indicated stem cell-like characteristics of B6TC. Gene microarray analysis demonstrated a significantly different gene expression profile of B6TC in comparison to those of parental cell lines. Conclusions: Spontaneous generation of the novel hybrid cell line B6TC, in a metastatic site with stem cell-like properties and propensity to metastasize to brain, suggest that cell fusion can contribute to tumor heterogeneity.	[De Mukhopadhyay, Keya; Bandyopadhyay, Abhik; Yang, Junhua; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Chang, Ting-Tung A.; Goins, Beth A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Elkahloun, Abdel G.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Cornell, John E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Yeh, I-Tien] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	De Mukhopadhyay, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	SUNL@uthscsa.edu	, LuZhe/AAW-4095-2021		National Institutes of Health (NIH) [R01CA079683, R01CA075253, P01CA040035]; Department of Defense Breast Cancer Research [W81XWH-06-1-0616]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through National Cancer Institute Cancer Center [P30CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA075253, P01CA040035, R01CA079683] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by National Institutes of Health (NIH) grants R01CA079683, R01CA075253, P01CA040035; Department of Defense Breast Cancer Research Program Concept Award W81XWH-06-1-0616; and the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the National Cancer Institute Cancer Center Support Grant P30CA054174. Additional support was provided by the Intramural Program of the National Human Genome Research Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Bandyopadhyay A, 2005, CANCER BIOL THER, V4, P168; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Bolstad B, 2005, BIOINFORMATICS COMPU; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Friedl P, 2005, LANCET ONCOL, V6, P916, DOI 10.1016/S1470-2045(05)70439-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; He XH, 2005, J EXP THER ONCOL, V5, P101; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kirsch David G, 2005, Clin Breast Cancer, V6, P115, DOI 10.3816/CBC.2005.n.013; Klos KJ, 2004, NEUROLOGIST, V10, P31, DOI 10.1097/01.nrl.0000106922.83090.71; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Magni M, 1996, BLOOD, V87, P1097, DOI 10.1182/blood.V87.3.1097.bloodjournal8731097; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MILLER FR, 1989, CANCER RES, V49, P4316; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Palmieri Diane, 2006, Breast Dis, V26, P139; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Parris GE, 2006, MED HYPOTHESES, V66, P76, DOI 10.1016/j.mehy.2005.08.009; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x	48	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20473	10.1371/journal.pone.0020473	http://dx.doi.org/10.1371/journal.pone.0020473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673810	Green Published, gold, Green Submitted			2022-12-27	WOS:000291309900022
J	Arellano-Anaya, ZE; Savistchenko, J; Mathey, J; Huor, A; Lacroux, C; Andreoletti, O; Vilette, D				Arellano-Anaya, Zaira E.; Savistchenko, Jimmy; Mathey, Jacinthe; Huor, Alvina; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier			A Simple, Versatile and Sensitive Cell-Based Assay for Prions from Various Species	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; INFECTIVITY ASSAY; SCRAPIE PRIONS; STRAIN DISCRIMINATION; SURGICAL-STEEL; SHEEP SCRAPIE; PANEL ASSAY; PROTEIN; PRP; CULTURE	Detection and quantification of prion infectivity is a crucial step for various fundamental and applied aspects of prion research. Identification of cell lines highly sensitive to prion infection led to the development of cell-based titration procedures aiming at replacing animal bioassays, usually performed in mice or hamsters. However, most of these cell lines are only permissive to mouse-adapted prions strains and do not allow titration of prions from other species. In this study, we show that epithelial RK13, a cell line permissive to mouse and bank vole prion strains and to natural prion agents from sheep and cervids, enables a robust and sensitive detection of mouse and ovine-derived prions. Importantly, the cell culture work is strongly reduced as the RK13 cell assay procedure designed here does not require subcultivation of the inoculated cultures. We also show that prions effectively bind to culture plastic vessel and are quantitatively detected by the cell assay. The possibility to easily quantify a wider range of prions, including rodent experimental strains but also natural agents from sheep and cervids, should prompt the spread of cell assays for routine prion titration and lead to valuable information in fundamental and applied studies.	[Arellano-Anaya, Zaira E.; Savistchenko, Jimmy; Mathey, Jacinthe; Huor, Alvina; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier] ENVT, INRA, UMR 1225, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Arellano-Anaya, ZE (corresponding author), ENVT, INRA, UMR 1225, Toulouse, France.	d.vilette@envt.fr		ARELLANO-ANAYA, Zaira E/0000-0001-7847-0342	Mexican CONACYT;  [ANR-08-MIEN-010]	Mexican CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	This work was partly supported by a grant from ANR-08-MIEN-010 (France) and Z. Arellano was a recipient of a fellowship from Mexican CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Anaya ZEA, 2011, J BIOL CHEM, V286, P8141, DOI 10.1074/jbc.M110.165233; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Edgeworth JA, 2011, J GEN VIROL, V92, P718, DOI 10.1099/vir.0.027201-0; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mahal Sukhvir P., 2008, V459, P49, DOI 10.1007/978-1-59745-234-2_4; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Neale MH, 2010, J VIROL, V84, P2444, DOI 10.1128/JVI.01855-09; Paquet S, 2004, J VIROL, V78, P7148, DOI 10.1128/JVI.78.13.7148-7152.2004; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1992, BIOCHEMISTRY-US, V31, P12277, DOI 10.1021/bi00164a001; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Sowemimo-Coker SO, 2010, TRANSFUSION, V50, P980, DOI 10.1111/j.1537-2995.2009.02525.x; Sun R, 2008, VIRAL IMMUNOL, V21, P293, DOI 10.1089/vim.2008.0039; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; You B, 2010, J VIROL METHODS, V164, P1, DOI 10.1016/j.jviromet.2009.10.010; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	57	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20563	10.1371/journal.pone.0020563	http://dx.doi.org/10.1371/journal.pone.0020563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655184	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600099
J	Bryant, PA; Smyth, GK; Robins-Browne, R; Curtis, N				Bryant, Penelope A.; Smyth, Gordon K.; Robins-Browne, Roy; Curtis, Nigel			Technical Variability Is Greater than Biological Variability in a Microarray Experiment but Both Are Outweighed by Changes Induced by Stimulation	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HUMAN GENE-EXPRESSION; GENDER-DIFFERENCES; LIPOPOLYSACCHARIDE; DESIGN; RATS; LPS	Introduction: A central issue in the design of microarray-based analysis of global gene expression is that variability resulting from experimental processes may obscure changes resulting from the effect being investigated. This study quantified the variability in gene expression at each level of a typical in vitro stimulation experiment using human peripheral blood mononuclear cells (PBMC). The primary objective was to determine the magnitude of biological and technical variability relative to the effect being investigated, namely gene expression changes resulting from stimulation with lipopolysaccharide (LPS). Methods and Results: Human PBMC were stimulated in vitro with LPS, with replication at 5 levels: 5 subjects each on 2 separate days with technical replication of LPS stimulation, amplification and hybridisation. RNA from samples stimulated with LPS and unstimulated samples were hybridised against common reference RNA on oligonucleotide microarrays. There was a closer correlation in gene expression between replicate hybridisations (0.86-0.93) than between different subjects (0.66-0.78). Deconstruction of the variability at each level of the experimental process showed that technical variability (standard deviation (SD) 0.16) was greater than biological variability (SD 0.06), although both were low (SD<0.1 for all individual components). There was variability in gene expression both at baseline and after stimulation with LPS and proportion of cell subsets in PBMC was likely partly responsible for this. However, gene expression changes after stimulation with LPS were much greater than the variability from any source, either individually or combined. Conclusions: Variability in gene expression was very low and likely to improve further as technical advances are made. The finding that stimulation with LPS has a markedly greater effect on gene expression than the degree of variability provides confidence that microarray-based studies can be used to detect changes in gene expression of biological interest in infectious diseases.	[Bryant, Penelope A.; Curtis, Nigel] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bryant, Penelope A.; Robins-Browne, Roy; Curtis, Nigel] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bryant, Penelope A.; Curtis, Nigel] Royal Childrens Hosp, Dept Gen Med, Infect Dis Unit, Melbourne, Vic, Australia; [Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Bryant, PA (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.	nigel.curtis@rch.org.au	Robinsbrowne, Roy/ABF-8434-2020; Curtis, Nigel/B-3491-2012; Smyth, Gordon/B-5276-2008	Robinsbrowne, Roy/0000-0001-9179-7884; Curtis, Nigel/0000-0003-3446-4594; Smyth, Gordon/0000-0001-9221-2892	National Heart Foundation of Australia; Australian National Health and Medical Research Council [216716]; European Society of Paediatric Infectious Diseases	National Heart Foundation of Australia(National Heart Foundation of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Society of Paediatric Infectious Diseases	This study was supported by a grant from the National Heart Foundation of Australia (www.heartfoundation.org.au) and the Australian National Health and Medical Research Council (no. 216716, www.nhmrc.gov.au). Dr Bryant was the recipient of a European Society of Paediatric Infectious Diseases Fellowship Award (www.espid.org) and a University of Melbourne Research Scholarship (www.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Asai K, 2001, SHOCK, V16, P340, DOI 10.1097/00024382-200116050-00003; Ashdown H, 2007, AM J PHYSIOL-REG I, V292, pR1667, DOI 10.1152/ajpregu.00274.2006; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Bryant PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004427; Casciano DA, 2006, NAT BIOTECHNOL, V24, P1103, DOI 10.1038/nbt0906-1103; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; DEFEO P, 1992, AM J PHYSIOL, V263, pE794, DOI 10.1152/ajpendo.1992.263.4.E794; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Holloway AJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-511; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kerkhoven RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001980; Kim KY, 2009, J BIOSCI BIOENG, V108, P252, DOI 10.1016/j.jbiosc.2009.03.017; Kimura Y, 1999, SURG TODAY, V29, P10, DOI 10.1007/BF02482963; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Moller-Levet CS, 2007, BIOINFORMATICS, V23, P2733, DOI 10.1093/bioinformatics/btm441; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; SCHOBER I, 1984, EXP CELL RES, V152, P348, DOI 10.1016/0014-4827(84)90636-0; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SU SD, 1990, J IMMUNOL, V145, P2994; SUREDA A, 2007, BR J SPORTS MED; Von Aulock S, 2006, J INTERF CYTOK RES, V26, P887, DOI 10.1089/jir.2006.26.887; Wachulec M, 1997, AM J PHYSIOL-REG I, V272, pR1252, DOI 10.1152/ajpregu.1997.272.4.R1252; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yang ZY, 2000, EXP CLIN IMMUNOGENET, V17, P1, DOI 10.1159/000019119	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19556	10.1371/journal.pone.0019556	http://dx.doi.org/10.1371/journal.pone.0019556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655321	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600006
J	Dufresne, F; Markova, S; Vergilino, R; Ventura, M; Kotlik, P				Dufresne, France; Markova, Silvia; Vergilino, Roland; Ventura, Marc; Kotlik, Petr			Diversity in the Reproductive Modes of European Daphnia pulicaria Deviates from the Geographical Parthenogenesis	PLOS ONE			English	Article							BREEDING SYSTEM DIVERSITY; MACROGEOGRAPHIC PATTERNS; PHYLOGENETIC ANALYSIS; COMPUTER-PROGRAM; PULEX GROUP; POLYPLOIDY; HISTORY; POPULATIONS; ASEXUALITY; CLONALITY	Background: Multiple transitions to obligate parthenogenesis have occurred in the Daphnia pulex complex in North America. These newly formed asexual lineages are differentially distributed being found predominantly at high latitudes. This conforms to the rule of geographical parthenogenesis postulating prevalence of asexuals at high latitudes and altitudes. While the reproductive mode of high-latitude populations is relatively well studied, little is known about the reproduction mode in high altitudes. This study aimed to assess the reproductive mode of Daphnia pulicaria, a species of the D. pulex complex, from high altitude lakes in Europe. Methodology/Principal Findings: Variation at eight microsatellite loci revealed that D. pulicaria from the High Tatra Mountains (HTM) had low genotype richness and showed excess of heterozygotes and significant deviations from Hardy-Weinberg expectations, and was thus congruent with reproduction by obligate parthenogenesis. By contrast, populations from the Pyrenees (Pyr) were generally in Hardy-Weinberg equilibrium and had higher genotypic richness, suggesting that they are cyclic parthenogens. Four lakes from lowland areas (LLaP) had populations with an uncertain or mixed breeding mode. All D. pulicaria had mtDNA ND5 haplotypes of the European D. pulicaria lineage. Pyr were distinct from LLaP and HTM at the ND5 gene. By contrast, HTM shared two haplotypes with LLaP and one with Pyr. Principal Coordinate Analysis of the microsatellite data revealed clear genetic differentiation into three groups. HTM isolates were intermediate to Pyr and LLaP, congruent with a hybrid origin. Conclusion/Significance: Inferred transitions to obligate parthenogenesis have occurred only in HTM, most likely as a result of hybridizations. In contrast to North American populations, these transitions do not appear to involve meiosis suppressor genes and have not been accompanied by polyploidy. The absence of obligate parthenogenesis in Pyr, an environment highly similar to the HTM, may be due to the lack of opportunities for hybridization.	[Dufresne, France; Markova, Silvia; Vergilino, Roland] Univ Quebec Rimouski, Ctr Etud Nord, Dept Biol, Quebec City, PQ, Canada; [Markova, Silvia; Kotlik, Petr] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Dept Vertebrate Evolutionary Biol & Genet, Lab Fish Genet, Libechov, Czech Republic; [Ventura, Marc] Spanish Res Council CEAB CSIC, Ctr Adv Studies Blanes, Biodivers & Biogeodynam Grp, Girona, Catalonia, Spain; [Ventura, Marc] Univ Barcelona, Inst Recerca Aigua, Barcelona, Catalonia, Spain	University of Quebec; Universite du Quebec a Rimouski; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Dufresne, F (corresponding author), Univ Quebec Rimouski, Ctr Etud Nord, Dept Biol, Quebec City, PQ, Canada.	france_dufresne@uqar.qc.ca	Kotlík, Petr/AAP-1342-2021; Ventura, Marc/A-5660-2008; Markova, Silvia/G-3875-2014; Kotlik, Petr/B-4633-2009	Kotlík, Petr/0000-0001-9429-0667; Ventura, Marc/0000-0003-1401-414X; Kotlik, Petr/0000-0001-9429-0667	Natural Sciences and Engineering Research Council of Canada; Academy of Sciences of the Czech Republic [KJB600450901, IRP IAPG AV0Z 50450515]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The study was supported by grants to FD from Natural Sciences and Engineering Research Council of Canada and by the Academy of Sciences of the Czech Republic postdoctoral grant (KJB600450901) to SM. Additional support to the laboratory of SM and PK was provided by the Academy of Sciences of the Czech Republic (Grant IRP IAPG AV0Z 50450515). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aguilera X, 2007, LIMNOL OCEANOGR, V52, P2079, DOI 10.4319/lo.2007.52.5.2079; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BEATON MJ, 1988, AM NAT, V132, P837, DOI 10.1086/284892; BELKHIR K, LOGICIEL WINDOWS GEN; Bell G, 1982, MASTERPIECE NATURE E; BIERZYCHUDEK P, 1985, EXPERIENTIA, V41, P1255, DOI 10.1007/BF01952068; Buntjer J.B., 2001, PHYLOGENETIC COMPUTE; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CERNY M, 1993, HEREDITY, V71, P497, DOI 10.1038/hdy.1993.168; Colbourne JK, 2004, MOL ECOL NOTES, V4, P485, DOI 10.1111/j.1471-8286.2004.00721.x; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; CUELLAR O, 1976, SCIENCE, V193, P150, DOI 10.1126/science.779030; Deffontaine V, 2009, MOL ECOL, V18, P2489, DOI 10.1111/j.1365-294X.2009.04162.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dufresne F, 1998, ECOSCIENCE, V5, P433, DOI 10.1080/11956860.1998.11682481; Dufresne F, 1997, P ROY SOC B-BIOL SCI, V264, P201, DOI 10.1098/rspb.1997.0028; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hebert PDN, 2007, LIMNOL OCEANOGR, V52, P2507, DOI 10.4319/lo.2007.52.6.2507; HEBERT PDN, 1993, HEREDITY, V70, P148, DOI 10.1038/hdy.1993.24; Hebert PDN, 2001, HEREDITY, V87, P153, DOI 10.1046/j.1365-2540.2001.00885.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; Legendre P., 1998, NUMERICAL ECOLOGY; Lehto MP, 2010, J ANIM ECOL, V79, P1241, DOI 10.1111/j.1365-2656.2010.01726.x; Markova S, 2007, MOL PHYLOGENET EVOL, V44, P42, DOI 10.1016/j.ympev.2006.12.025; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Paland S, 2005, EVOLUTION, V59, P800; Palsson S, 2000, MOL ECOL, V9, P1075, DOI 10.1046/j.1365-294x.2000.00969.x; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; Posada D., 2003, CURRENT PROTOCOLS BI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; SWOFFORD DL, 2003, PAUP PHYL AN US PARS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WARD RD, 1994, HEREDITY, V73, P532, DOI 10.1038/hdy.1994.152; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x	57	21	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20049	10.1371/journal.pone.0020049	http://dx.doi.org/10.1371/journal.pone.0020049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655327	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600015
J	Hosseinpoor, AR; Parker, LA; d'Espaignet, ET; Chatterji, S				Hosseinpoor, Ahmad Reza; Anne Parker, Lucy; d'Espaignet, Edouard Tursan; Chatterji, Somnath			Social Determinants of Smoking in Low- and Middle-Income Countries: Results from the World Health Survey	PLOS ONE			English	Article							TOBACCO; DISEASE; EQUITY; LEVEL; WOMEN	Introduction: Tobacco smoking is a leading cause of premature death and disability, and over 80% of the world's smokers live in low-or middle-income countries. The objective of this study is to assess demographic and socioeconomic determinants of current smoking in low-and middle-income countries. Methods: We used data, from the World Health Survey in 48 low-income and middle-income countries, to explore the impact of demographic and socioeconomic factors on the current smoking status of respondents. The data from these surveys provided information on 213,807 respondents aged 18 years or above that were divided into 4 pooled datasets according to their sex and country income group. The overall proportion of current smokers, as well as the proportion by each relevant demographic and socioeconomic determinant, was calculated within each of the pooled datasets, and multivariable logistic regression was used to assess the association between current smoking and these determinants. Results: The odds of smoking were not equal in all demographic or socioeconomic groups. Some factors were fairly stable across the four datasets studied: for example, individuals were more likely to smoke if they had little or no education, regardless of if they were male or female, or lived in a low or a middle income country. Nevertheless, other factors, notably age and wealth, showed a differential effect on smoking by sex or country income level. While women in the low-income country group were twice as likely to smoke if they were in the lowest wealth quintile compared with the highest, the association was absent in the middle-income country group. Conclusion: Information on how smoking is distributed among low-or middle-income countries will allow policy makers to tailor future policies, and target the most vulnerable populations.	[Hosseinpoor, Ahmad Reza; Chatterji, Somnath] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Anne Parker, Lucy] Univ Miguel Hernandez, Dept Publ Hlth, Alicante, Spain; [Anne Parker, Lucy] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [d'Espaignet, Edouard Tursan] WHO, Tobacco Free Initiat, CH-1211 Geneva, Switzerland	World Health Organization; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; World Health Organization	Hosseinpoor, AR (corresponding author), WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland.	hosseinpoora@who.int	Hosseinpoor, Ahmad Reza/AFP-8422-2022; d'Espaignet, Edouard Tursan/V-3857-2019; CHATTERJI, Somnath/ABE-6832-2020; Parker, Lucy Anne/R-3622-2017	Hosseinpoor, Ahmad Reza/0000-0001-7322-672X; Parker, Lucy Anne/0000-0002-2362-4057	World Health Organization	World Health Organization(World Health Organization)	This study was funded by World Health Organization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WORLD HLTH STAT 2010; Silva GAE, 2009, REV SAUDE PUBL, V43, P48, DOI 10.1590/S0034-89102009000900007; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; David A, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P199; Ernster V, 2000, B WORLD HEALTH ORGAN, V78, P891; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ferguson B, 2003, HLTH SYSTEMS PERFORM; Food and Agriculture Organization of the United Nations, 2003, PROJ TOB PROD CONS T; Gilman SE, 2003, J EPIDEMIOL COMMUN H, V57, P802, DOI 10.1136/jech.57.10.802; Gilman SE, 2008, INT J EPIDEMIOL, V37, P615, DOI 10.1093/ije/dym250; GUINDOND GE, 2003, 6 HNP; Hajat A, 2010, SOC SCI MED, V71, P1935, DOI 10.1016/j.socscimed.2010.09.027; Hassmiller KM, 2003, AM J PUBLIC HEALTH, V93, P1321, DOI 10.2105/AJPH.93.8.1321; Hu TW, 2005, TOB CONTROL, V14, P247, DOI 10.1136/tc.2004.010777; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Mackay J, 2002, TOBACCO ATLAS; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray C., 2003, HLTH SYSTEMS PERFORM, P115; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Roux AVD, 2003, AM J EPIDEMIOL, V157, P315, DOI 10.1093/aje/kwf207; *STEPWISE, STEPWISE APPR SURV; Toll BA, 2005, TOB CONTROL, V14, P172, DOI 10.1136/tc.2004.008953; Volzke H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-146; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Word Bank, 2004, WORLD DEV REP 2005 B; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zhu Shu-Hong, 2010, Glob Health Promot, V17, P29, DOI 10.1177/1757975909358361	31	79	81	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20331	10.1371/journal.pone.0020331	http://dx.doi.org/10.1371/journal.pone.0020331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655299	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600045
J	Courtes, S; Vernerey, J; Pujadas, L; Magalon, K; Cremer, H; Soriano, E; Durbec, P; Cayre, M				Courtes, Sandrine; Vernerey, Julien; Pujadas, Lluis; Magalon, Karine; Cremer, Harold; Soriano, Eduardo; Durbec, Pascale; Cayre, Myriam			Reelin Controls Progenitor Cell Migration in the Healthy and Pathological Adult Mouse Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; NEURONAL PRECURSORS; CHAIN-MIGRATION; CEREBRAL-CORTEX; DENTATE GYRUS; NEUROGENESIS; EXPRESSION; DIFFERENTIATION; DEMYELINATION	Understanding the signals that control migration of neural progenitor cells in the adult brain may provide new therapeutic opportunities. Reelin is best known for its role in regulating cell migration during brain development, but we now demonstrate a novel function for reelin in the injured adult brain. First, we show that Reelin is upregulated around lesions. Second, experimentally increasing Reelin expression levels in healthy mouse brain leads to a change in the migratory behavior of subventricular zone-derived progenitors, triggering them to leave the rostral migratory stream (RMS) to which they are normally restricted during their migration to the olfactory bulb. Third, we reveal that Reelin increases endogenous progenitor cell dispersal in periventricular structures independently of any chemoattraction but via cell detachment and chemokinetic action, and thereby potentiates spontaneous cell recruitment to demyelination lesions in the corpus callosum. Conversely, animals lacking Reelin signaling exhibit reduced endogenous progenitor recruitment at the lesion site. Altogether, these results demonstrate that beyond its known role during brain development, Reelin is a key player in post-lesional cell migration in the adult brain. Finally our findings provide proof of concept that allowing progenitors to escape from the RMS is a potential therapeutic approach to promote myelin repair.	[Courtes, Sandrine; Vernerey, Julien; Magalon, Karine; Cremer, Harold; Durbec, Pascale; Cayre, Myriam] Univ Mediterranee, Inst Biol Dev Marseille Luminy, CNRS, Marseille, France; [Pujadas, Lluis; Soriano, Eduardo] Inst Res Biomed, Barcelona, Spain; [Pujadas, Lluis; Soriano, Eduardo] Univ Barcelona, Ctr Invest Red Endfermedades Neurodegenerat, Barcelona, Spain; [Pujadas, Lluis; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona	Courtes, S (corresponding author), Univ Mediterranee, Inst Biol Dev Marseille Luminy, CNRS, Marseille, France.	myriam.cayre@ibdml.univmed.fr	Pujadas, Lluís/O-7442-2015; Soriano, Eduardo/AAB-3216-2019; PUJADAS, LLUÍS/AAE-1595-2020; Cayre, Myriam/AAG-4614-2021	Pujadas, Lluís/0000-0003-3890-8279; Soriano, Eduardo/0000-0002-3204-9285; PUJADAS, LLUÍS/0000-0003-3890-8279; vernerey, Julien/0000-0002-5413-4210; Cremer, Harold/0000-0002-8673-5176	"Direction Generale de l'Armement'' (DGA); Association for Research on Cancer (ARC); Federation pour la Recherche sur le Cerveau [FRC 1B1/0887]; MICINN [BFU2008-3980]; Fundacio Obra Social Caixa Catalunya	"Direction Generale de l'Armement'' (DGA)(General Electric); Association for Research on Cancer (ARC); Federation pour la Recherche sur le Cerveau; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacio Obra Social Caixa Catalunya	SC is the recipient of a doctoral fellowship from the "Direction Generale de l'Armement'' (DGA) and of a one year fellowship from the Association for Research on Cancer (ARC). This work was supported by grants from the "Federation pour la Recherche sur le Cerveau'' (FRC 1B1/0887). ES was supported by MICINN (BFU2008-3980) and the "Fundacio Obra Social Caixa Catalunya''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Cayre M, 2006, MOL CELL NEUROSCI, V31, P748, DOI 10.1016/j.mcn.2006.01.004; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chazal G, 2000, J NEUROSCI, V20, P1446; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Curtis MA, 2007, SCIENCE, V318, DOI 10.1126/science.1145164; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Decker L, 2002, MOL CELL NEUROSCI, V19, P225, DOI 10.1006/mcne.2001.1072; Durbec P, 2001, MOL CELL NEUROSCI, V17, P561, DOI 10.1006/mcne.2000.0951; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kam M, 2009, J CHEM NEUROANAT, V37, P196, DOI 10.1016/j.jchemneu.2008.12.009; Kobold D, 2002, J HEPATOL, V36, P607, DOI 10.1016/S0168-8278(02)00050-8; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Magalon K, 2007, EUR J NEUROSCI, V25, P761, DOI 10.1111/j.1460-9568.2007.05335.x; MASSALINI S, 2009, MOL CELL NEUROSCI; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Ourednik V, 2007, CELL TRANSPLANT, V16, P263, DOI 10.3727/000000007783464696; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pulido JS, 2007, GRAEF ARCH CLIN EXP, V245, P889, DOI 10.1007/s00417-006-0458-4; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; SALIN P, 1992, P NATL ACAD SCI USA, V89, P9954, DOI 10.1073/pnas.89.20.9954; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Won SJ, 2006, EXP NEUROL, V198, P250, DOI 10.1016/j.expneurol.2005.12.008; Zhao C, 2006, NEUROBIOL AGING, V27, P1298, DOI 10.1016/j.neurobiolaging.2005.06.008; Zhao ST, 2006, J COMP NEUROL, V495, P1, DOI 10.1002/cne.20846	53	48	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20430	10.1371/journal.pone.0020430	http://dx.doi.org/10.1371/journal.pone.0020430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647369	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500059
J	Nilsson, L; Karshikoff, A				Nilsson, Lennart; Karshikoff, Andrey			Multiple pH Regime Molecular Dynamics Simulation for pK Calculations	PLOS ONE			English	Article							PROTEIN PK(A) CALCULATIONS; ACTIVE-SITE; CONFORMATIONAL FLEXIBILITY; ELECTROSTATIC INTERACTIONS; IONIZATION PROPERTIES; TITRATION CURVES; LIMITATIONS; PREDICTION; STABILITY; ALGORITHM	Ionisation equilibria in proteins are influenced by conformational flexibility, which can in principle be accounted for by molecular dynamics simulation. One problem in this method is the bias arising from the fixed protonation state during the simulation. Its effect is mostly exhibited when the ionisation behaviour of the titratable groups is extrapolated to pH regions where the predetermined protonation state of the protein may not be statistically relevant, leading to conformational sampling that is not representative of the true state. In this work we consider a simple approach which can essentially reduce this problem. Three molecular dynamics structure sets are generated, each with a different protonation state of the protein molecule expected to be relevant at three pH regions, and pK calculations from the three sets are combined to predict pK over the entire pH range of interest. This multiple pH molecular dynamics approach was tested on the GCN4 leucine zipper, a protein for which a full data set of experimental data is available. The pK values were predicted with a mean deviation from the experimental data of 0.29 pH units, and with a precision of 0.13 pH units, evaluated on the basis of equivalent sites in the dimeric GCN4 leucine zipper.	[Nilsson, Lennart; Karshikoff, Andrey] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden; [Karshikoff, Andrey] Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria	Karolinska Institutet; Bulgarian Academy of Sciences	Nilsson, L (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden.	Lennart.Nilsson@ki.se	Karshikoff, Andrey D/C-4387-2016; Nilsson, Lennart/B-7208-2009	Nilsson, Lennart/0000-0002-5067-6397	Swedish Research Council [621-2009-4590]; Bulgarian Science Fund [DRG-02/5]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bulgarian Science Fund(National Science Fund of Bulgaria)	This work was supported by grant (621-2009-4590) from the Swedish Research Council (http://www.vr.se/), and by grant (DRG-02/5) from the Bulgarian Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov A, 2010, J PHYS CHEM B, V114, P10634, DOI 10.1021/jp104406x; Alexov E, 2003, PROTEINS, V50, P94, DOI 10.1002/prot.10265; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Baptista AM, 1997, PROTEINS, V27, P523, DOI 10.1002/(SICI)1097-0134(199704)27:4<523::AID-PROT6>3.0.CO;2-B; Barth P, 2007, P NATL ACAD SCI USA, V104, P4898, DOI 10.1073/pnas.0700188104; BASHFORD D, 1991, J PHYS CHEM-US, V95, P9556, DOI 10.1021/j100176a093; Bjelic S, 2008, PROTEINS, V70, P810, DOI 10.1002/prot.21585; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Hajjar E, 2009, J PHYS CHEM A, V113, P11783, DOI 10.1021/jp902930u; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamerlin SCL, 2009, J PHYS CHEM B, V113, P1253, DOI 10.1021/jp8071712; KARSHIKOFF A, 1995, PROTEIN ENG, V8, P243, DOI 10.1093/protein/8.3.243; Karshikoff A., 2007, PROTEIN STRUCTURES M, P71; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Khandogin J, 2006, BIOCHEMISTRY-US, V45, P9363, DOI 10.1021/bi060706r; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Koumanov A, 2002, PROTEINS, V46, P85, DOI 10.1002/prot.10034; Koumanov A, 2001, J PHYS CHEM B, V105, P9339, DOI 10.1021/jp010949n; Koumanov A, 2001, EUR BIOPHYS J BIOPHY, V30, P198, DOI 10.1007/s002490100139; Lee MS, 2004, PROTEINS, V56, P738, DOI 10.1002/prot.20128; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matousek WM, 2007, J MOL BIOL, V374, P206, DOI 10.1016/j.jmb.2007.09.007; Mitra R, 2008, CURR COMPUT-AID DRUG, V4, P169, DOI 10.2174/157340908785747393; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2003, PROTEIN SCI, V12, P313, DOI 10.1110/ps.0229903; RASHIN AA, 1986, BIOCHEMISTRY-US, V25, P3619, DOI 10.1021/bi00360a021; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandberg L, 1997, BIOPHYS CHEM, V65, P189, DOI 10.1016/S0301-4622(96)02262-4; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; TANFORD C, 1957, J AM CHEM SOC, V79, P5333, DOI 10.1021/ja01577a001; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; van Vlijmen HWT, 1998, PROTEINS, V33, P145, DOI 10.1002/(SICI)1097-0134(19981101)33:2<145::AID-PROT1>3.0.CO;2-I; WARSHEL A, 1984, P NATL ACAD SCI-BIOL, V81, P4785, DOI 10.1073/pnas.81.15.4785; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Williams SL, 2010, J CHEM THEORY COMPUT, V6, P560, DOI 10.1021/ct9005294; YANG AS, 1993, PROTEINS, V15, P252, DOI 10.1002/prot.340150304	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20116	10.1371/journal.pone.0020116	http://dx.doi.org/10.1371/journal.pone.0020116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647418	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052500032
J	Dhahbi, JM; Atamna, H; Boffelli, D; Magis, W; Spindler, SR; Martin, DIK				Dhahbi, Joseph M.; Atamna, Hani; Boffelli, Dario; Magis, Wendy; Spindler, Stephen R.; Martin, David I. K.			Deep Sequencing Reveals Novel MicroRNAs and Regulation of MicroRNA Expression during Cell Senescence	PLOS ONE			English	Article							MIR-17-92 CLUSTER; GENE-EXPRESSION; CANCER; ROLES; DIFFERENTIATION; MICROARRAY; DISCOVERY; ONCOGENES; BIOMARKER; SKELETAL	In cell senescence, cultured cells cease proliferating and acquire aberrant gene expression patterns. MicroRNAs (miRNAs) modulate gene expression through translational repression or mRNA degradation and have been implicated in senescence. We used deep sequencing to carry out a comprehensive survey of miRNA expression and involvement in cell senescence. Informatic analysis of small RNA sequence datasets from young and senescent IMR90 human fibroblasts identifies many miRNAs that are regulated (either up or down) with cell senescence. Comparison with mRNA expression profiles reveals potential mRNA targets of these senescence-regulated miRNAs. The target mRNAs are enriched for genes involved in biological processes associated with cell senescence. This result greatly extends existing information on the role of miRNAs in cell senescence and is consistent with miRNAs having a causal role in the process.	[Dhahbi, Joseph M.; Boffelli, Dario; Magis, Wendy; Martin, David I. K.] Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA; [Atamna, Hani] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Dhahbi, Joseph M.; Spindler, Stephen R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Geisinger Commonwealth School of Medicine; University of California System; University of California Riverside	Dhahbi, JM (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA.	jdhahbi@chori.org; hatamna@tcmedc.org; dimartin@chori.org			NIH [ES016581, CA115768, DK080428, HL084474]; NATIONAL CANCER INSTITUTE [R01CA115768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants ES016581, CA115768, DK080428 (DM) and HL084474 (DB). JD was a Scholar of the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Drummond MJ, 2010, PHYSL GENOMICS; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Gruber HE, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-5; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Laser J, 2010, FERTIL STERIL, V93, P2020, DOI 10.1016/j.fertnstert.2008.12.116; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Martins PAD, 2010, CURR DRUG TARGETS, V11, P900, DOI 10.2174/138945010791591322; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Ortholan C, 2009, CURR MED CHEM, V16, P1047, DOI 10.2174/092986709787581833; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rizzo M, 2010, J CELL MOL MED, V14, P2633, DOI 10.1111/j.1582-4934.2010.01173.x; Ryu SJ, 2009, EXPERT OPIN THER TAR, V13, P479, DOI [10.1517/14728220902832705 , 10.1517/14728220902832705]; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Silahtaroglu A, 2010, ESSAYS BIOCHEM, V48, P165, DOI [10.1042/BSE0480165, 10.1042/bse0480165]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XY, 2010, MOL CELL BIOCHEM, V345, P283, DOI 10.1007/s11010-010-0582-7; WANG Y, 2010, INT J RADIAT ONCOL B; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wittmann J, 2010, THESCIENTIFICWORLDJO, V10, P1239, DOI 10.1100/tsw.2010.101; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	67	66	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20509	10.1371/journal.pone.0020509	http://dx.doi.org/10.1371/journal.pone.0020509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637828	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200073
J	Elberse, KEM; Nunes, S; Sa-Leao, R; van der Heide, HGJ; Schouls, LM				Elberse, Karin E. M.; Nunes, Sonia; Sa-Leao, Raquel; van der Heide, Han G. J.; Schouls, Leo M.			Multiple-Locus Variable Number Tandem Repeat Analysis for Streptococcus pneumoniae: Comparison with PFGE and MLST	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; DETERMINING CAPSULAR SEROTYPES; DAY-CARE-CENTERS; TYPING METHODS; GENETIC RELATEDNESS; DRUG-RESISTANCE; IDENTIFICATION; CLONES; CHILDREN; STRAINS	In the era of pneumococcal conjugate vaccines, surveillance of pneumococcal disease and carriage remains of utmost importance as important changes may occur in the population. To monitor these alterations reliable genotyping methods are required for large-scale applications. We introduced a high throughput multiple-locus variable number tandem repeat analysis (MLVA) and compared this method with pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The MLVA described here is based on 8 BOX loci that are amplified in two multiplex PCRs. The labeled PCR products are sized on an automated DNA sequencer to accurately determine the number of tandem repeats. The composite of the number of repeats of the BOX loci makes up a numerical profile that is used for identification and clustering. In this study, MLVA was performed on 263 carriage isolates that were previously characterized by MLST and PFGE. MLVA, MLST and PFGE (cut-off of 80%) yielded 164, 120, and 87 types, respectively. The three typing methods had Simpson's diversity indices of 98.5% or higher. Congruence between MLST and MLVA was high. The Wallace of MLVA to MLST was 0.874, meaning that if two strains had the same MLVA type they had an 88% chance of having the same MLST type. Furthermore, the Wallace of MLVA to clonal complex of MLST was even higher: 99.5%. For some isolates belonging to a single MLST clonal complex although displaying different serotypes, MLVA was more discriminatory, generating groups according to serotype or serogroup. Overall, MLVA is a promising genotyping method that is easy to perform and a relatively cheap alternative to PFGE and MLST. In the companion paper published simultaneously in this issue we applied the MLVA to assess the pneumococcal population structure of isolates causing invasive disease in the Netherlands before the introduction of the 7-valent conjugate vaccine.	[Elberse, Karin E. M.; van der Heide, Han G. J.; Schouls, Leo M.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [Nunes, Sonia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Netherlands National Institute for Public Health & the Environment; Universidade Nova de Lisboa	Elberse, KEM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands.	Karin.Elberse@rivm.nl	Sá-Leão, Raquel/A-9341-2011	Sá-Leão, Raquel/0000-0001-9804-827X	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/SAU-ESA/65048/2006]; FCT [SFRH/BD/40706/2007]; European Society for Clinical Microbiology and Infectious Diseases (ESCMID)	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Society for Clinical Microbiology and Infectious Diseases (ESCMID)	This work was partially supported by grant PTDC/SAU-ESA/65048/2006 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal (awarded to RSL). SN is the recipient of a PhD grant from FCT (SFRH/BD/40706/2007) and received support from the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) to visit RIVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Enright MC, 2000, EUR J CLIN MICROBIOL, V19, P627, DOI 10.1007/s100960000321; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Farlow J, 2002, J CLIN MICROBIOL, V40, P4612, DOI 10.1128/JCM.40.12.4612-4618.2002; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hall LMC, 1996, J CLIN MICROBIOL, V34, P853, DOI 10.1128/JCM.34.4.853-859.1996; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Knutsen E, 2006, J BACTERIOL, V188, P8307, DOI 10.1128/JB.00850-06; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Nunes S, 2005, J CLIN MICROBIOL, V43, P1285, DOI 10.1128/JCM.43.3.1285-1293.2005; Overduin P, 2004, J CLIN MICROBIOL, V42, P5022, DOI 10.1128/JCM.42.11.5022-5028.2004; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Pichon B, 2010, J CLIN MICROBIOL, V48, P1926, DOI 10.1128/JCM.02054-09; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; Sa-Leao R, 2006, MICROBIOL-SGM, V152, P367, DOI 10.1099/mic.0.28596-0; Sadowy E, 2010, ANTIMICROB AGENTS CH, V54, P1720, DOI 10.1128/AAC.01340-09; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schouls LM, 2005, J CLIN MICROBIOL, V43, P2741, DOI 10.1128/JCM.43.6.2741-2749.2005; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; vanBelkum A, 1996, J CLIN MICROBIOL, V34, P1176, DOI 10.1128/JCM.34.5.1176-1179.1996	45	38	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19668	10.1371/journal.pone.0019668	http://dx.doi.org/10.1371/journal.pone.0019668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637335	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200011
J	Knauer, SK; Fetz, V; Rabenstein, J; Friedl, S; Hofmann, B; Sabiani, S; Schroder, E; Kunst, L; Proschak, E; Thines, E; Kindler, T; Schneider, G; Marschalek, R; Stauber, RH; Bier, C				Knauer, Shirley K.; Fetz, Verena; Rabenstein, Jens; Friedl, Sandra; Hofmann, Bettina; Sabiani, Samaneh; Schroeder, Elisabeth; Kunst, Lena; Proschak, Eugen; Thines, Eckhard; Kindler, Thomas; Schneider, Gisbert; Marschalek, Rolf; Stauber, Roland H.; Bier, Carolin			Bioassays to Monitor Taspase1 Function for the Identification of Pharmacogenetic Inhibitors	PLOS ONE			English	Article							NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVATION; PROTEIN STABILITY; NATURAL-PRODUCTS; SYSTEMS BIOLOGY; MLL; PROTEASES; CLEAVAGE; ROLES; ZETA	Background: Threonine Aspartase 1 (Taspase1) mediates cleavage of the mixed lineage leukemia (MLL) protein and leukemia provoking MLL-fusions. In contrast to other proteases, the understanding of Taspase1's (patho) biological relevance and function is limited, since neither small molecule inhibitors nor cell based functional assays for Taspase1 are currently available. Methodology/Findings: Efficient cell-based assays to probe Taspase1 function in vivo are presented here. These are composed of glutathione S-transferase, autofluorescent protein variants, Taspase1 cleavage sites and rational combinations of nuclear import and export signals. The biosensors localize predominantly to the cytoplasm, whereas expression of biologically active Taspase1 but not of inactive Taspase1 mutants or of the protease Caspase3 triggers their proteolytic cleavage and nuclear accumulation. Compared to in vitro assays using recombinant components the in vivo assay was highly efficient. Employing an optimized nuclear translocation algorithm, the triple-color assay could be adapted to a high-throughput microscopy platform (Z'factor = 0.63). Automated high-content data analysis was used to screen a focused compound library, selected by an in silico pharmacophor screening approach, as well as a collection of fungal extracts. Screening identified two compounds, N-[2-[(4-amino-6-oxo-3H-pyrimidin-2-yl)sulfanyl]ethyl]benzenesulfonamide and 2-benzyltriazole-4,5-dicarboxylic acid, which partially inhibited Taspase1 cleavage in living cells. Additionally, the assay was exploited to probe endogenous Taspase1 in solid tumor cell models and to identify an improved consensus sequence for efficient Taspase1 cleavage. This allowed the in silico identification of novel putative Taspase1 targets. Those include the FERM Domain-Containing Protein 4B, the Tyrosine-Protein Phosphatase Zeta, and DNA Polymerase Zeta. Cleavage site recognition and proteolytic processing of these substrates were verified in the context of the biosensor. Conclusions: The assay not only allows to genetically probe Taspase1 structure function in vivo, but is also applicable for high-content screening to identify Taspase1 inhibitors. Such tools will provide novel insights into Taspase1's function and its potential therapeutic relevance.	[Knauer, Shirley K.; Schroeder, Elisabeth; Kunst, Lena] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, Essen, Germany; [Fetz, Verena; Friedl, Sandra; Stauber, Roland H.; Bier, Carolin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, MSC, Mainz, Germany; [Rabenstein, Jens; Sabiani, Samaneh; Marschalek, Rolf] Goethe Univ Frankfurt, Inst Pharmaceut Biol ZAFES, Frankfurt, Germany; [Hofmann, Bettina; Proschak, Eugen; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol ZAFES, Frankfurt, Germany; [Thines, Eckhard] Inst Biotechnol & Drug Res Kaiserslautern IBWF, Kaiserslautern, Germany; [Kindler, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Hematol Oncol, Mainz, Germany	University of Duisburg Essen; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Goethe University Frankfurt; Johannes Gutenberg University of Mainz	Knauer, SK (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, Essen, Germany.	rstauber@uni-mainz.de; bier@uni-mainz.de	Knauer, Shirley K/E-7931-2012; Marschalek, Rolf/D-3404-2011; Kindler, Thomas/K-5995-2013	Knauer, Shirley K/0000-0003-4321-0924; Marschalek, Rolf/0000-0003-4870-3445; Schneider, Gisbert/0000-0001-6706-1084; Stauber, Roland/0000-0002-1341-4523; Thines, Eckhard/0000-0002-4003-2272	German Cancer Aid [FKZ102362]; Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry; Stiftung Rheinland-Pfalz fur Innovationen; DFG [KN973/1-1, INST371/5-1FUGG]; Alexander-Karl-Foundation; University Mainz	German Cancer Aid(Deutsche Krebshilfe); Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry; Stiftung Rheinland-Pfalz fur Innovationen; DFG(German Research Foundation (DFG)); Alexander-Karl-Foundation; University Mainz	Grant support: German Cancer Aid - http://www.krebshilfe.de/(FKZ102362 to R. S. and R. M.), Head and Neck Cancer Foundation - http://www.stiftung-tumorforschung.de/(to C. B.), Wilhelm-Sander Foundation - http://www.sanst.de, Funds of the Chemical Industry - http://fonds.vci.de, Stiftung Rheinland-Pfalz fur Innovationen - http://www.stiftung-innovation.rlp.de, DFG KN973/1-1 and INST371/5-1FUGG, donation from R. Patzke, Alexander-Karl-Foundation - http://www.foerdern-und-stiften.uni-mainz.de/225.php, and the University Mainz Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Doucet A, 2008, MOL ASPECTS MED, V29, P339, DOI 10.1016/j.mam.2008.04.003; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fetz V, 2009, SENSORS-BASEL, V9, P5423, DOI 10.3390/s90705423; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Giuliano KA, 2007, METH MOL B, V356, P189; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Haase D, 2007, ONCOGENE, V26, P4464, DOI 10.1038/sj.onc.1210225; Habtemichael N, 2010, GENE, V469, P9, DOI 10.1016/j.gene.2010.08.007; Habtemichael N, 2010, MOL CELL NEUROSCI, V45, P297, DOI 10.1016/j.mcn.2010.07.003; He JT, 2010, J PROTEOME RES, V9, P2565, DOI 10.1021/pr100012p; Heger P, 2001, TRAFFIC, V2, P544, DOI 10.1034/j.1600-0854.2001.20804.x; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.25; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liermann JC, 2009, J NAT PROD, V72, P1905, DOI 10.1021/np9005234; Lin XJ, 2006, CLIN CANCER RES, V12, P563, DOI 10.1158/1078-0432.CCR-05-1380; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Meyer C, 2006, LEUKEMIA, V20, P777, DOI 10.1038/sj.leu.2404150; Muller S, 2004, EXPERT OPIN THER TAR, V8, P211, DOI 10.1517/14728222.8.3.211; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Rucker E, 2001, PROTEIN EXPRES PURIF, V21, P220, DOI 10.1006/prep.2000.1373; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schlingemann J, 2005, LAB INVEST, V85, P1024, DOI 10.1038/labinvest.3700293; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	49	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e18253	10.1371/journal.pone.0018253	http://dx.doi.org/10.1371/journal.pone.0018253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647428	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500001
J	Chen, BY; Chen, JK; Zhu, MZ; Zhang, DL; Sun, JS; Pei, JM; Feng, HS; Zhu, XX; Jin, J; Yu, J				Chen, Bao-Ying; Chen, Jian-Kang; Zhu, Miao-Zhang; Zhang, Dong-Liang; Sun, Jie-Shen; Pei, Jian-Ming; Feng, Hua-Song; Zhu, Xiao-Xing; Jin, Jian; Yu, Jun			AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions	PLOS ONE			English	Article							VASONATRIN PEPTIDE; ATRIAL	The aim of this study was to evaluate the cardiovascular and renal activities of a newly designed natriuretic peptide (NP). Here, we engineered a novel 28-amino acid chimeric peptide, termed AC-NP that combined the 17-amino acid ring of C type natriuretic peptide (CNP) with the 6-amino acid N-terminus and 5-amino acid C-terminus of atrial natriuretic peptide (ANP). Both in vitro and in vivo experiments were performed to determine the actions of AC-NP. In normal rats, AC-NP proved to be more potentially diuretic, natriuretic and hypotensive compared with other NPs, such as ANP, CNP and vasonatrin peptide (VNP), which is another man-made NP. In relaxation of isolated abdominal aorta from rat, AC-NP was equally effective to ANP, CNP and VNP. Elevated levels of 39,59-guanosine monophosphate (cGMP) in plasma and urine cGMP excretion indicated the participation of cGMP in the functions of AC-NP. Taken together, innovative designed AD-NP might be a new candidate therapeutic peptide against cardiorenal disorders.	[Chen, Bao-Ying; Yu, Jun] Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China; [Chen, Bao-Ying; Chen, Jian-Kang; Zhang, Dong-Liang; Sun, Jie-Shen] Fourth Mil Med Univ, Sch Basic Med Sci, Ctr Teaching Expt, Xian 710032, Peoples R China; [Zhu, Miao-Zhang; Pei, Jian-Ming] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Feng, Hua-Song] Gen Hosp Navy Force, Dept Resp Dis, Beijing, Peoples R China; [Zhu, Xiao-Xing] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Peoples R China; [Jin, Jian] Jiangnan Univ, Mol Pharmacol Lab, Sch Med & Pharmaceut, Wuxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital; Air Force Military Medical University; Jiangnan University	Chen, BY (corresponding author), Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China.	jmpei8@fmmu.edu.cn; jinjian31@126.com; pclamper@163.com			Chinese Natural Science Fund [30870902, 30801385]; New Medicine Research Fund [2009ZX09103-671]; Natural Science Fund of Shaan'xi Province [2010JM4050]	Chinese Natural Science Fund(National Natural Science Foundation of China (NSFC)); New Medicine Research Fund; Natural Science Fund of Shaan'xi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the Chinese Natural Science Fund (No. 30870902, 30801385), New Medicine Research Fund (No. 2009ZX09103-671), and Natural Science Fund of Shaan'xi Province (No. 2010JM4050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerrigter Guido, 2009, Heart Fail Clin, V5, P501, DOI 10.1016/j.hfc.2009.04.002; Chen BY, 2010, REGUL PEPTIDES, V164, P139, DOI 10.1016/j.regpep.2010.06.007; CLAVELL AL, 1993, AM J PHYSIOL, V264, pR290, DOI 10.1152/ajpregu.1993.264.2.R290; Duda T, 2010, MOL CELL BIOCHEM, V334, P37, DOI 10.1007/s11010-009-0335-7; Foran SE, 2000, P NATL ACAD SCI USA, V97, P7621, DOI 10.1073/pnas.130181897; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Igaki T, 1998, HYPERTENS RES-CLIN E, V21, P7, DOI 10.1291/hypres.21.7; Kilic A, 2010, CARDIOVASC RES, V88, P434, DOI 10.1093/cvr/cvq254; La Villa G, 1998, CLIN SCI, V95, P595; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; WARSHAW DM, 1979, CIRC RES, V45, P250, DOI 10.1161/01.RES.45.2.250; WEI CM, 1993, J CLIN INVEST, V92, P2048, DOI 10.1172/JCI116800; Woodard GE, 2005, REGUL PEPTIDES, V129, P183, DOI 10.1016/j.regpep.2005.02.006; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x	15	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20477	10.1371/journal.pone.0020477	http://dx.doi.org/10.1371/journal.pone.0020477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647224	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800053
J	Luo, BQ; Lam, BS; Lee, SH; Wey, S; Zhou, H; Wang, M; Chen, SY; Adams, GB; Lee, AS				Luo, Biquan; Lam, Ben S.; Lee, Sung Hyung; Wey, Shiuan; Zhou, Hui; Wang, Miao; Chen, Si-Yi; Adams, Gregor B.; Lee, Amy S.			The Endoplasmic Reticulum Chaperone Protein GRP94 Is Required for Maintaining Hematopoietic Stem Cell Interactions with the Adult Bone Marrow Niche	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SELF-RENEWAL; B-CELL; STEM/PROGENITOR CELLS; REGULATOR GRP78/BIP; MASTER CHAPERONE; GP96; QUIESCENCE; LINEAGE; MICE	Hematopoietic stem cell (HSC) homeostasis in the adult bone marrow (BM) is regulated by both intrinsic gene expression products and interactions with extrinsic factors in the HSC niche. GRP94, an endoplasmic reticulum chaperone, has been reported to be essential for the expression of specific integrins and to selectively regulate early T and B lymphopoiesis. In GRP94 deficient BM chimeras, multipotent hematopoietic progenitors persisted and even increased, however, the mechanism is not well understood. Here we employed a conditional knockout (KO) strategy to acutely eliminate GRP94 in the hematopoietic system. We observed an increase in HSCs and granulocyte-monocyte progenitors in the Grp94 KO BM, correlating with an increased number of colony forming units. Cell cycle analysis revealed that a loss of quiescence and an increase in proliferation led to an increase in Grp94 KO HSCs. This expansion of the HSC pool can be attributed to the impaired interaction of HSCs with the niche, evidenced by enhanced HSC mobilization and severely compromised homing and lodging ability of primitive hematopoietic cells. Transplanting wild-type (WT) hematopoietic cells into a GRP94 null microenvironment yielded a normal hematology profile and comparable numbers of HSCs as compared to WT control, suggesting that GRP94 in HSCs, but not niche cells, is required for maintaining HSC homeostasis. Investigating this, we further determined that there was a near complete loss of integrin alpha 4 expression on the cell surface of Grp94 KO HSCs, which showed impaired binding with fibronectin, an extracellular matrix molecule known to play a role in mediating HSC-niche interactions. Furthermore, the Grp94 KO mice displayed altered myeloid and lymphoid differentiation. Collectively, our studies establish GRP94 as a novel cell intrinsic factor required to maintain the interaction of HSCs with their niche, and thus regulate their physiology.	[Luo, Biquan; Wey, Shiuan; Zhou, Hui; Wang, Miao; Lee, Amy S.] Univ So Calif Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Luo, Biquan; Wey, Shiuan; Zhou, Hui; Wang, Miao; Lee, Amy S.] Univ So Calif Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Lam, Ben S.; Adams, Gregor B.] Univ So Calif Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, USC, Los Angeles, CA USA; [Lee, Sung Hyung; Chen, Si-Yi] Univ So Calif Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Luo, BQ (corresponding author), Univ So Calif Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607]; American Society of Hematology; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089, R37CA027607, R01CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported from the National Institutes of Health CA027607 (ASL) and the American Society of Hematology (GBA). The USC core facilities described were supported in part by P30CA014089 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baker-LePain JC, 2003, CURR OPIN IMMUNOL, V15, P89, DOI 10.1016/S0952791502000067; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2008, GENE THER, V15, P67, DOI 10.1038/sj.gt.3303066; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Forsberg EC, 2009, HAEMATOL-HEMATOL J, V94, P1477, DOI 10.3324/haematol.2009.013730; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Guo W, 2006, PEDIATR RES, V59, p59R, DOI 10.1203/01.pdr.0000203592.04530.06; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jiang Y, 2009, BLOOD, V114, P3773, DOI 10.1182/blood-2009-05-219840; Jockheck-Clark AR, 2010, J IMMUNOL, V185, P6819, DOI 10.4049/jimmunol.1000448; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mao CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010852; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PERKINS S, 1988, J CLIN INVEST, V81, P1072, DOI 10.1172/JCI113419; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Srivastava PK, 2006, CURR OPIN IMMUNOL, V18, P201, DOI 10.1016/j.coi.2006.01.009; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wierenga PK, 2006, BONE MARROW TRANSPL, V38, P789, DOI 10.1038/sj.bmt.1705534; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	59	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20364	10.1371/journal.pone.0020364	http://dx.doi.org/10.1371/journal.pone.0020364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647226	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005800045
J	Li, R; Ackerman, WE; Summerfield, TL; Yu, LB; Gulati, P; Zhang, J; Huang, K; Romero, R; Kniss, DA				Li, Ruth; Ackerman, William E.; Summerfield, Taryn L.; Yu, Lianbo; Gulati, Parul; Zhang, Jie; Huang, Kun; Romero, Roberto; Kniss, Douglas A.			Inflammatory Gene Regulatory Networks in Amnion Cells Following Cytokine Stimulation: Translational Systems Approach to Modeling Human Parturition	PLOS ONE			English	Article							FACTOR-KAPPA-B; FACTOR-BINDING SITES; NECROSIS-FACTOR-ALPHA; INDEPENDENT COMPONENT ANALYSIS; SINGULAR-VALUE DECOMPOSITION; AP-2 TRANSCRIPTION FACTORS; TOLL-LIKE RECEPTOR-2; OXIDATIVE STRESS; EXPRESSION DATA; PRETERM LABOR	A majority of the studies examining the molecular regulation of human labor have been conducted using single gene approaches. While the technology to produce multi-dimensional datasets is readily available, the means for facile analysis of such data are limited. The objective of this study was to develop a systems approach to infer regulatory mechanisms governing global gene expression in cytokine-challenged cells in vitro, and to apply these methods to predict gene regulatory networks (GRNs) in intrauterine tissues during term parturition. To this end, microarray analysis was applied to human amnion mesenchymal cells (AMCs) stimulated with interleukin-1 beta, and differentially expressed transcripts were subjected to hierarchical clustering, temporal expression profiling, and motif enrichment analysis, from which a GRN was constructed. These methods were then applied to fetal membrane specimens collected in the absence or presence of spontaneous term labor. Analysis of cytokine-responsive genes in AMCs revealed a sterile immune response signature, with promoters enriched in response elements for several inflammation-associated transcription factors. In comparison to the fetal membrane dataset, there were 34 genes commonly upregulated, many of which were part of an acute inflammation gene expression signature. Binding motifs for nuclear factor-kappa B were prominent in the gene interaction and regulatory networks for both datasets; however, we found little evidence to support the utilization of pathogen-associated molecular pattern (PAMP) signaling. The tissue specimens were also enriched for transcripts governed by hypoxia-inducible factor. The approach presented here provides an uncomplicated means to infer global relationships among gene clusters involved in cellular responses to labor-associated signals.	[Li, Ruth; Ackerman, William E.; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Div Maternal Fetal Med, Columbus, OH 43210 USA; [Li, Ruth; Ackerman, William E.; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Lab Perinatal Res, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Kniss, Douglas A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Yu, Lianbo; Gulati, Parul] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Zhang, Jie; Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Intramural Div, NIH,Dept Hlth & Human Serv, Bethesda, MD USA; [Romero, Roberto] Hutzel Womens Hosp, Detroit, MI USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, R (corresponding author), Ohio State Univ, Div Maternal Fetal Med, Columbus, OH 43210 USA.	kniss.1@osu.edu	yu, lianbo/B-3472-2010; Huang, Kun/E-3272-2011; Gulati, Parul/K-7375-2013; Ackerman, William/E-2612-2011; Romero, Roberto/A-5268-2019	Gulati, Parul/0000-0001-9341-9844; Romero, Roberto/0000-0002-4448-5121; Ackerman, William/0000-0001-7366-3903	National Institute of Child Health and Human Development [WSU07043, N01-HD-2-3342]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS; NIH [K08 HD049628]; Ohio State University Perinatal Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD049628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Perinatal Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by subcontract WSU07043 under National Institute of Child Health and Human Development Contract N01-HD-2-3342 and Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. Additional support was provided by NIH K08 HD049628 (WEA) and The Ohio State University Perinatal Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman VE, 2004, BIOL REPROD, V71, P2079, DOI 10.1095/biolreprod.104.030841; Ackerman WE, 2007, PLACENTA, V28, P465, DOI 10.1016/j.placenta.2006.06.009; Ackerman WE, 2005, BIOL REPROD, V73, P527, DOI 10.1095/biolreprod.104.039032; Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; Bollopragada S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.032; BRAR HS, 1988, AM J OBSTET GYNECOL, V158, P952, DOI 10.1016/0002-9378(88)90100-7; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; Brown CT, 2008, METHOD CELL BIOL, V87, P337, DOI 10.1016/S0091-679X(08)00218-5; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chabane N, 2009, J CELL BIOCHEM, V106, P453, DOI 10.1002/jcb.22027; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chang LW, 2007, NUCLEIC ACIDS RES, V35, pW238, DOI 10.1093/nar/gkm308; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chua G, 2004, CURR OPIN MICROBIOL, V7, P638, DOI 10.1016/j.mib.2004.10.009; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Coppe A, 2009, NUCLEIC ACIDS RES, V37, P533, DOI 10.1093/nar/gkn948; Cora D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-110; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; FLEISCHER A, 1987, AM J OBSTET GYNECOL, V157, P40, DOI 10.1016/S0002-9378(87)80342-3; Frigyesi A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-290; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P822, DOI 10.1016/j.ajog.2006.06.053; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; HEAPS BR, 2007, PRETERM BIRTH MECH M, P70; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Iams JD, 2003, OBSTET GYNECOL, V101, P402, DOI 10.1016/S0029-7844(02)02505-X; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; KENNARD EA, 1995, AM J REPROD IMMUNOL, V34, P65, DOI 10.1111/j.1600-0897.1995.tb00920.x; KHANJANI S, 2010, J CELL MOL MED; Khatri P, 2006, NUCLEIC ACIDS RES, V34, pW626, DOI 10.1093/nar/gkl213; Kim SY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-330; Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kniss DA, 1999, J SOC GYNECOL INVEST, V6, P285, DOI 10.1177/107155769900600602; Kniss DA, 2001, PLACENTA, V22, P80, DOI 10.1053/plac.2000.0591; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Krediet TG, 2007, PEDIATR RES, V62, P474, DOI 10.1203/PDR.0b013e31813c9401; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lang CT, 2009, PLACENTA, V30, P711, DOI 10.1016/j.placenta.2009.05.008; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Lappas M, 2009, PLACENTA, V30, pS90, DOI 10.1016/j.placenta.2008.10.005; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lee NH, 2005, PHARMACOGENOMICS, V6, P245, DOI 10.1517/14622416.6.3.245; Lee SI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r76; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Lee YW, 2001, J MOL CELL CARDIOL, V33, P83, DOI 10.1006/jmcc.2000.1278; Li H, 2008, FRONT BIOSCI-LANDMRK, V13, P263, DOI 10.2741/2677; Li H, 2007, BIOINFORMATICS, V23, P473, DOI 10.1093/bioinformatics/btl640; LIGGINS GC, 1988, ONSET LABOR CELLULAR, P1; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; LYE SJ, 2007, PRETERM BIRTH MECH M, P3; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Mendelson CR, 2005, J STEROID BIOCHEM, V93, P113, DOI 10.1016/j.jsbmb.2004.12.027; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mitchell CM, 2008, MOL HUM REPROD, V14, P53, DOI 10.1093/molehr/gam086; MITTAL P, 2010, J PERINAT MED; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nhan-Chang CL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.045; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perera PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3039; Perkins DJ, 1997, PROSTAG OTH LIPID M, V54, P727, DOI 10.1016/S0090-6980(97)00144-5; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Posch S, 2007, J BIOINF COMPUT BIOL, V5, P561, DOI 10.1142/S0219720007002886; R Core Team, 2018, R LANG ENV STAT COMP; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; Robinson JM, 2009, PLACENTA, V30, pS83, DOI 10.1016/j.placenta.2008.10.017; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; ROMERO R, 1993, J REPROD MED, V38, P543; Romero R, 1996, PROSTAG LEUKOTR ESS, V54, P187, DOI 10.1016/S0952-3278(96)90015-0; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shankar R, 2010, REPROD SCI, V17, P297, DOI 10.1177/1933719109353454; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su Gang, 2006, In Silico Biology, V6, P307; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tonon L, 2010, NUCLEIC ACIDS RES, V38, pW286, DOI 10.1093/nar/gkq473; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; VAN NE, 2007, BMC BIOINFORM S6, V8, pS4; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Vora S, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-8; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Weiner CP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.034; Wenke AK, 2010, FEBS J, V277, P894, DOI 10.1111/j.1742-4658.2009.07509.x; Whittle WL, 2001, BIOL REPROD, V64, P1019, DOI 10.1095/biolreprod64.4.1019; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Wognum S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005852; Yan X, 2002, PLACENTA, V23, P288, DOI 10.1053/plac.2002.0789; Yan XF, 2007, BIOINFORMATICS, V23, pI577, DOI 10.1093/bioinformatics/btm227; Yao B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-99; Young SL, 2009, REPROD SCI, V16, P809, DOI 10.1177/1933719109342405; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang CZ, 2010, INT J ONCOL, V36, P1503, DOI 10.3892/ijo_00000637; Zhang MQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S3; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287; Zhu Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-383	157	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20560	10.1371/journal.pone.0020560	http://dx.doi.org/10.1371/journal.pone.0020560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655103	Green Published, Green Submitted, gold			2022-12-27	WOS:000291310600016
J	Kistemaker, DA; Rozendaal, LA				Kistemaker, Dinant A.; Rozendaal, Leonard A.			In Vivo Dynamics of the Musculoskeletal System Cannot Be Adequately Described Using a Stiffness-Damping-Inertia Model	PLOS ONE			English	Article							HUMAN ELBOW JOINT; MECHANICAL-PROPERTIES; ANKLE STIFFNESS; LIMB STIFFNESS; MULTIJOINT ARM; SOLEUS MUSCLE; MOVEMENTS; REFLEX; STRETCH; FORCE	Background: Visco-elastic properties of the (neuro-)musculoskeletal system play a fundamental role in the control of posture and movement. Often, these properties are described and identified using stiffness-damping-inertia (KBI) models. In such an approach, perturbations are applied to the (neuro-)musculoskeletal system and subsequently KBI-model parameters are optimized to obtain a best fit between simulated and experimentally observed responses. Problems with this approach may arise because a KBI-model neglects critical aspects of the real musculoskeletal system. Methodology/Principal Findings: The purpose of this study was to analyze the relation between the musculoskeletal properties and the stiffness and damping estimated using a KBI-model, to analyze how this relation is affected by the nature of the perturbation and to assess the sensitivity of the estimated stiffness and damping to measurement errors. Our analyses show that the estimated stiffness and damping using KBI-models do not resemble any of the dynamical parameters of the underlying system, not even when the responses are very accurately fitted by the KBI-model. Furthermore, the stiffness and damping depend non-linearly on all the dynamical parameters of the underlying system, influenced by the nature of the perturbation and the time interval over which the KBI-model is optimized. Moreover, our analyses predict a very high sensitivity of estimated parameters to measurement errors. Conclusions/Significance: The results of this study suggest that the usage of stiffness-damping-inertia models to investigate the dynamical properties of the musculoskeletal system under control by the CNS should be reconsidered.	[Kistemaker, Dinant A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Kistemaker, Dinant A.; Rozendaal, Leonard A.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands	Western University (University of Western Ontario); Vrije Universiteit Amsterdam	Kistemaker, DA (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	dinant.kistemaker@gmail.com			Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	A. Kistemaker was supported by the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL GC, 1977, J PHYSIOL-LONDON, V268, P151, DOI 10.1113/jphysiol.1977.sp011852; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; CAPADAY C, 1986, J NEUROSCI, V6, P1308; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; GOTTLIEB GL, 1978, J BIOMECH, V11, P177, DOI 10.1016/0021-9290(78)90010-6; Granata KP, 2004, J ELECTROMYOGR KINES, V14, P599, DOI 10.1016/j.jelekin.2004.03.005; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Herzog W, 2000, J BIOMECH, V33, P531, DOI 10.1016/S0021-9290(99)00221-3; HOFFER JA, 1981, J NEUROPHYSIOL, V45, P267, DOI 10.1152/jn.1981.45.2.267; HOUK JC, 1979, ANNU REV PHYSIOL, V41, P99, DOI 10.1146/annurev.ph.41.030179.000531; HUNTER IW, 1982, J BIOMECH, V15, P747, DOI 10.1016/0021-9290(82)90089-6; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; KEARNEY RE, 1990, CRIT REV BIOMED ENG, V18, P55; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; Kistemaker DA, 2005, J BIOMECH, V38, P1816, DOI 10.1016/j.jbiomech.2004.08.025; Kistemaker DA, 2007, J NEUROPHYSIOL, V98, P1075, DOI 10.1152/jn.00287.2007; Kistemaker DA, 2007, BIOL CYBERN, V96, P341, DOI 10.1007/s00422-006-0120-6; LACQUANITI F, 1982, BIOL CYBERN, V44, P35, DOI 10.1007/BF00353954; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Milner TE, 2002, EXP BRAIN RES, V143, P406, DOI 10.1007/s00221-002-1001-4; MURRAY WM, 1995, J BIOMECH, V28, P513, DOI 10.1016/0021-9290(94)00114-J; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; Nijhof EJ, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P363; Pandy MG, 2001, ANNU REV BIOMED ENG, V3, P245, DOI 10.1146/annurev.bioeng.3.1.245; Perreault EJ, 1999, BIOL CYBERN, V80, P327, DOI 10.1007/s004220050529; Perreault EJ, 2000, IEEE T BIO-MED ENG, V47, P1413, DOI 10.1109/TBME.2000.880092; Popescu F, 2003, EXP BRAIN RES, V152, P17, DOI 10.1007/s00221-003-1507-4; Prochazka A, 1981, Int Rev Physiol, V25, P47; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; RACK PMH, 1969, J PHYSIOL-LONDON, V204, P443, DOI 10.1113/jphysiol.1969.sp008923; Rassier DE, 2005, J APPL PHYSIOL, V99, P1769, DOI 10.1152/japplphysiol.00010.2005; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; TSUJII T, 1995, MOL CELL ENDOCRINOL, V113, P123, DOI 10.1016/0303-7207(95)03613-C; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; WINTERS JM, 1988, J BIOMECH, V21, P1027, DOI 10.1016/0021-9290(88)90249-7; Wong J, 2009, J NEUROPHYSIOL, V101, P246, DOI 10.1152/jn.90371.2008; Zajac FE, 2002, J BIOMECH, V35, P1011, DOI 10.1016/S0021-9290(02)00046-5; Zinder SM, 2007, J BIOMECH, V40, P463, DOI 10.1016/j.jbiomech.2005.12.007	43	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19568	10.1371/journal.pone.0019568	http://dx.doi.org/10.1371/journal.pone.0019568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637750	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500008
J	Sharma, K; Akerstrom, S; Sharma, AK; Chow, VTK; Teow, S; Abrenica, B; Booth, SA; Booth, TF; Mirazimi, A; Lal, SK				Sharma, Kulbhushan; Akerstrom, Sara; Sharma, Anuj Kumar; Chow, Vincent T. K.; Teow, Shumein; Abrenica, Bernard; Booth, Stephanie A.; Booth, Timothy F.; Mirazimi, Ali; Lal, Sunil K.			SARS-CoV 9b Protein Diffuses into Nucleus, Undergoes Active Crm1 Mediated Nucleocytoplasmic Export and Triggers Apoptosis When Retained in the Nucleus	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; SUBCELLULAR-LOCALIZATION; SYNDROME CORONAVIRUS; BOVINE CORONAVIRUS; VIRAL REPLICATION; ACCESSORY PROTEIN; TRANSPORT; IMPORT; CELLS; APHIDICOLIN	Background: 9b is an accessory protein of the SARS-CoV. It is a small protein of 98 amino acids and its structure has been solved recently. 9b is known to localize in the extra-nuclear region and has been postulated to possess a nuclear export signal (NES), however the role of NES in 9b functioning is not well understood. Principal Findings/Methodology: In this report, we demonstrate that 9b in the absence of any nuclear localization signal (NLS) enters the nucleus by passive transport. Using various cell cycle inhibitors, we have shown that the nuclear entry of 9b is independent of the cell cycle. Further, we found that 9b interacts with the cellular protein Crm1 and gets exported out of the nucleus using an active NES. We have also revealed that this NES activity influences the half-life of 9b and affects host cell death. We found that an export signal deficient SARS-CoV 9b protein induces apoptosis in transiently transfected cells and showed elevated caspase-3 activity. Conclusion/Significance: Here, we showed that nuclear shuttling of 9b and its interaction with Crm1 are essential for the proper degradation of 9b and blocking the nuclear export of this protein induces apoptosis. This phenomenon may be critical in providing a novel role to the 9b accessory protein of SARS-CoV.	[Sharma, Kulbhushan; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Akerstrom, Sara; Mirazimi, Ali] Swedish Inst Communicable Dis Control, Solna, Sweden; [Sharma, Anuj Kumar] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Chow, Vincent T. K.] Natl Univ Singapore, YLL Sch Med, Singapore 117548, Singapore; [Teow, Shumein; Abrenica, Bernard; Booth, Stephanie A.; Booth, Timothy F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Booth, Stephanie A.; Booth, Timothy F.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Swedish Institute for Infectious Disease Control; Jawaharlal Nehru University, New Delhi; National University of Singapore; Public Health Agency of Canada; University of Manitoba	Sharma, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	sunillal@icgeb.res.in	SHARMA, KULBHUSHAN/AAD-7713-2019; Booth, Stephanie/AAX-6671-2020; Sharma, Anuj/G-3043-2011	SHARMA, KULBHUSHAN/0000-0001-5226-4209; Sharma, Anuj/0000-0001-5061-9731; Booth, Stephanie/0000-0001-8108-5955; Chow, Vincent/0000-0003-2634-6213; , Ali/0000-0003-2371-6055	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology; Department of Biotechnology at ICGEB	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology; Department of Biotechnology at ICGEB	This work was supported by internal funds from the International Centre for Genetic Engineering and Biotechnology, New Delhi, and a research grant on SARS from the Department of Biotechnology to S. K. L. The FACS facility funded by Department of Biotechnology at ICGEB was very useful and is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P97; Beswick RW, 2006, LEUKEMIA RES, V30, P427, DOI 10.1016/j.leukres.2005.08.009; Chan WS, 2005, MODERN PATHOL, V18, P1432, DOI 10.1038/modpathol.3800439; de Haan CAM, 2002, VIROLOGY, V296, P177, DOI 10.1006/viro.2002.1412; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; Depienne C, 2001, J BIOL CHEM, V276, P18102, DOI 10.1074/jbc.M009029200; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Fischer F, 1997, J VIROL, V71, P996, DOI 10.1128/JVI.71.2.996-1003.1997; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Kalatzis V, 2004, HUM MOL GENET, V13, P1361, DOI 10.1093/hmg/ddh152; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; Moshynskyy I, 2007, VIRUS RES, V127, P116, DOI 10.1016/j.virusres.2007.03.011; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; NISHI K, 1994, J BIOL CHEM, V269, P6320; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; OGURO M, 1979, EUR J BIOCHEM, V97, P603, DOI 10.1111/j.1432-1033.1979.tb13149.x; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Prieve MG, 1998, MOL CELL BIOL, V18, P4819, DOI 10.1128/MCB.18.8.4819; Qiu MF, 2005, MICROBES INFECT, V7, P882, DOI 10.1016/j.micinf.2005.02.006; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SEKI S, 1980, BIOCHIM BIOPHYS ACTA, V610, P413, DOI 10.1016/0005-2787(80)90022-2; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; SENANAYAKE SD, 1992, J VIROL, V66, P5277, DOI 10.1128/JVI.66.9.5277-5283.1992; Senanayake SD, 1997, VIRUS RES, V48, P101, DOI 10.1016/S0168-1702(96)01423-2; Sharma K, 2007, BIOCHEMISTRY-US, V46, P6488, DOI 10.1021/bi062057p; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Stauber RH, 2006, TRAFFIC, V7, P1461, DOI 10.1111/j.1600-0854.2006.00486.x; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Xu K, 2009, VIROLOGY, V388, P279, DOI 10.1016/j.virol.2009.03.032; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yuan XL, 2005, VIRUS RES, V109, P191, DOI 10.1016/j.virusres.2005.01.001; Zhao J, 2000, J CELL SCI, V113, P4363; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005	51	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19436	10.1371/journal.pone.0019436	http://dx.doi.org/10.1371/journal.pone.0019436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637748	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500005
J	Suzuki, K; Matsuzaki, H; Iwata, K; Kameno, Y; Shimmura, C; Kawai, S; Yoshihara, Y; Wakuda, T; Takebayashi, K; Takagai, S; Matsumoto, K; Tsuchiya, KJ; Iwata, Y; Nakamura, K; Tsujii, M; Sugiyama, T; Mori, N				Suzuki, Katsuaki; Matsuzaki, Hideo; Iwata, Keiko; Kameno, Yosuke; Shimmura, Chie; Kawai, Satomi; Yoshihara, Yujiro; Wakuda, Tomoyasu; Takebayashi, Kiyokazu; Takagai, Shu; Matsumoto, Kaori; Tsuchiya, Kenji J.; Iwata, Yasuhide; Nakamura, Kazuhiko; Tsujii, Masatsugu; Sugiyama, Toshirou; Mori, Norio			Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders	PLOS ONE			English	Article							T-CELLS; INTERFERON-GAMMA; IMMUNE-RESPONSE; CHILDREN; SERUM; INTERLEUKIN-12; INFLAMMATION; ACTIVATION; INNATE; BRAIN	Background: Accumulating evidence suggests that dysregulation of the immune system is involved in the pathophysiology of autism spectrum disorders (ASD). The aim of the study was to explore immunological markers in peripheral plasma samples from non-medicated subjects with high-functioning ASD. Methodology/Principal Findings: A multiplex assay for cytokines and chemokines was applied to plasma samples from male subjects with high-functioning ASD (n = 28) and matched controls (n = 28). Among a total of 48 analytes examined, the plasma concentrations of IL-1 beta, IL-1RA, IL-5, IL-8, IL-12(p70), IL-13, IL-17 and GRO-alpha were significantly higher in subjects with ASD compared with the corresponding values of matched controls after correction for multiple comparisons. Conclusion/Significance: The results suggest that abnormal immune responses as assessed by multiplex analysis of cytokines may serve as one of the biological trait markers for ASD.	[Suzuki, Katsuaki; Matsuzaki, Hideo; Iwata, Keiko; Takebayashi, Kiyokazu; Matsumoto, Kaori; Tsuchiya, Kenji J.; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Kameno, Yosuke; Shimmura, Chie; Wakuda, Tomoyasu; Takagai, Shu; Iwata, Yasuhide; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Kawai, Satomi] Natl Hosp Org Tenryu Hosp, Dept Psychiat, Hamamatsu, Shizuoka, Japan; [Yoshihara, Yujiro] Koujin Hosp, Dept Psychiat, Nagoya, Aichi, Japan; [Tsujii, Masatsugu] Chukyo Univ, Fac Sociol, Toyota, Japan; [Sugiyama, Toshirou] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Chukyo University; Hamamatsu University School of Medicine	Suzuki, K (corresponding author), Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan.	k-suzuki@hama-med.ac.jp	Tsuchiya, Kenji J./I-9123-2019; MATSUZAKI, HIDEO/AAE-5246-2020	Tsuchiya, Kenji J./0000-0002-1314-4199; MATSUZAKI, HIDEO/0000-0002-6869-1261; Wakuda, Tomoyasu/0000-0002-1924-8167	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390221]; Grants-in-Aid for Scientific Research [22390222] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to KS (#22390221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1997, US GUID STRUCT CLIN; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Croonenberghs J, 2002, NEUROPSYCHOBIOLOGY, V45, P1, DOI 10.1159/000048665; Croonenberghs J, 2002, PSYCHOL MED, V32, P1457, DOI 10.1017/S0033291702006037; Di Nisio M, 2005, CANCER-AM CANCER SOC, V104, P2275, DOI 10.1002/cncr.21485; Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033; Enstrom Amanda, 2008, Am J Biochem Biotechnol, V4, P114; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Fujita-Shimizu A, 2010, PROG NEURO-PSYCHOPH, V34, P455, DOI 10.1016/j.pnpbp.2009.12.020; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Gupta S, 1998, J NEUROIMMUNOL, V85, P106, DOI 10.1016/S0165-5728(98)00021-6; Hart JP, 2005, INT J RADIAT ONCOL, V63, P1448, DOI 10.1016/j.ijrobp.2005.05.032; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Li LQ, 2010, J IMMUNOL, V185, P4148, DOI 10.4049/jimmunol.1001536; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Magalhaes ES, 2009, J NEUROIMMUNOL, V216, P108, DOI 10.1016/j.jneuroim.2009.09.015; Molloy CA, 2006, J NEUROIMMUNOL, V172, P198, DOI 10.1016/j.jneuroim.2005.11.007; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Onore C, 2009, J NEUROIMMUNOL, V216, P126, DOI 10.1016/j.jneuroim.2009.09.005; RENZONI E, 1995, J AUTISM DEV DISORD, V25, P327; SCHWARZ E, 2010, MOL PSYCHIAT; SINGH VK, 1991, CLIN IMMUNOL IMMUNOP, V61, P448, DOI 10.1016/S0090-1229(05)80015-7; Singh VK, 1996, J NEUROIMMUNOL, V66, P143, DOI 10.1016/0165-5728(96)00014-8; Sweeten TL, 2004, BIOL PSYCHIAT, V55, P434, DOI 10.1016/j.biopsych.2003.09.001; Sweeten TL, 2003, AM J PSYCHIAT, V160, P1691, DOI 10.1176/appi.ajp.160.9.1691; Theoharides T. C., 2010, BIOCH BIOPHYS ACTA; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wechsler D., 1991, WISC 3 WECHSLER INTE; Zimmerman AW, 2005, PEDIATR NEUROL, V33, P195, DOI 10.1016/j.pediatrneurol.2005.03.014; ZIMMERMAN AW, 2006, NEUROBIOLOGY AUTISM	40	158	160	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20470	10.1371/journal.pone.0020470	http://dx.doi.org/10.1371/journal.pone.0020470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647375	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500062
J	Bami, M; Episkopou, V; Gavalas, A; Gouti, M				Bami, Myrto; Episkopou, Vasso; Gavalas, Anthony; Gouti, Mina			Directed Neural Differentiation of Mouse Embryonic Stem Cells Is a Sensitive System for the Identification of Novel Hox Gene Effectors	PLOS ONE			English	Article							ACID-BINDING PROTEIN; LIM-HOMEOBOX GENES; RESPONSE ELEMENT; CRABP-I; DOWNSTREAM GENES; POOL IDENTITY; EXPRESSION; MOTOR; TARGET; TRANSFORMATION	The evolutionarily conserved Hox family of homeodomain transcription factors plays fundamental roles in regulating cell specification along the anterior posterior axis during development of all bilaterian animals by controlling cell fate choices in a highly localized, extracellular signal and cell context dependent manner. Some studies have established downstream target genes in specific systems but their identification is insufficient to explain either the ability of Hox genes to direct homeotic transformations or the breadth of their patterning potential. To begin delineating Hox gene function in neural development we used a mouse ES cell based system that combines efficient neural differentiation with inducible Hoxb1 expression. Gene expression profiling suggested that Hoxb1 acted as both activator and repressor in the short term but predominantly as a repressor in the long run. Activated and repressed genes segregated in distinct processes suggesting that, in the context examined, Hoxb1 blocked differentiation while activating genes related to early developmental processes, wnt and cell surface receptor linked signal transduction and cell-to-cell communication. To further elucidate aspects of Hoxb1 function we used loss and gain of function approaches in the mouse and chick embryos. We show that Hoxb1 acts as an activator to establish the full expression domain of CRABPI and II in rhombomere 4 and as a repressor to restrict expression of Lhx5 and Lhx9. Thus the Hoxb1 patterning activity includes the regulation of the cellular response to retinoic acid and the delay of the expression of genes that commit cells to neural differentiation. The results of this study show that ES neural differentiation and inducible Hox gene expression can be used as a sensitive model system to systematically identify Hox novel target genes, delineate their interactions with signaling pathways in dictating cell fate and define the extent of functional overlap among different Hox genes.	[Bami, Myrto; Gavalas, Anthony; Gouti, Mina] Biomed Res Fdn Acad Athens BRFAA, Dev Biol Lab, Athens, Greece; [Episkopou, Vasso] Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, London, England	Academy of Athens; Imperial College London	Bami, M (corresponding author), Biomed Res Fdn Acad Athens BRFAA, Dev Biol Lab, Athens, Greece.	mgouti@bioacademy.gr	Gavalas, Anthony/F-5817-2015; Gouti, Mina/D-3235-2018	Gouti, Mina/0000-0001-7422-1605; Gavalas, Anthony/0000-0003-4897-0359	Wellcome Trust [WT083464MA]; European Community [03ED 394]; MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by a Wellcome Trust Project Grant (WT083464MA) and by a General Secretariat for Research and Technology Grant (03ED 394, 3rd European Community Support Framework). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BOYLAN JF, 1992, J BIOL CHEM, V267, P21486; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dawid IB, 2001, NEURON, V30, P301, DOI 10.1016/S0896-6273(01)00307-5; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DELVA L, 1993, BLOOD, V82, P2175; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gaufo GO, 2003, DEVELOPMENT, V130, P5191, DOI 10.1242/dev.00730; Gavalas A, 2003, DEVELOPMENT, V130, P5663, DOI 10.1242/dev.00802; Gavalas A, 2001, DEVELOPMENT, V128, P3017; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; Gouti M, 2011, STEM CELLS, V29, P858, DOI 10.1002/stem.630; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grienenberger A, 2003, DEVELOPMENT, V130, P5445, DOI 10.1242/dev.00760; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Joulia L, 2006, DEV GENES EVOL, V216, P431, DOI 10.1007/s00427-006-0086-3; KESSEL M, 1993, NEURON, V10, P379, DOI 10.1016/0896-6273(93)90328-O; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; Lei HY, 2005, P NATL ACAD SCI USA, V102, P2420, DOI 10.1073/pnas.0409700102; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; Marty T, 2001, DEVELOPMENT, V128, P2833; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521; POPPERL H, 1993, MOL CELL BIOL, V13, P257; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; RUBERTE E, 1992, DEVELOPMENT, V115, P973; Samad OA, 2004, DEVELOPMENT, V131, P4071, DOI 10.1242/dev.01282; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Sun X, 2008, INT J DEV BIOL, V52, P33, DOI 10.1387/ijdb.072386xs; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Taghli-Lamallem O, 2008, DEV GENES EVOL, V218, P321, DOI 10.1007/s00427-008-0224-1; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; VAESSEN MJ, 1990, DEVELOPMENT, V110, P371; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Wagmaister JA, 2006, MECH DEVELOP, V123, P135, DOI 10.1016/j.mod.2005.11.003; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wang N, 2006, EMBO J, V25, P1469, DOI 10.1038/sj.emboj.7601037; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	62	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20197	10.1371/journal.pone.0020197	http://dx.doi.org/10.1371/journal.pone.0020197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637844	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000291052200038
J	Rodgers, A; Patel, A; Berwanger, O; Bots, M; Grimm, R; Grobbee, DE; Jackson, R; Neal, B; Neaton, J; Poulter, N; Rafter, N; Raju, PK; Reddy, S; Thom, S; Vander Hoorn, S; Webster, R				Rodgers, Anthony; Patel, Anushka; Berwanger, Otavio; Bots, Michiel; Grimm, Richard; Grobbee, Diederick E.; Jackson, Rod; Neal, Bruce; Neaton, Jim; Poulter, Neil; Rafter, Natasha; Raju, P. Krishnam; Reddy, Srinath; Thom, Simon; Vander Hoorn, Stephen; Webster, Ruth		PILL Collaborative Grp	An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill ("Polypill") in People with Raised Cardiovascular Risk	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; PRESSURE-LOWERING DRUGS; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; DISEASE PREVENTION; GLOBAL REGISTRY; DOUBLE-BLIND; NEW-ZEALAND; METAANALYSIS	Background: There has been widespread interest in the potential of combination cardiovascular medications containing aspirin and agents to lower blood pressure and cholesterol ('polypills') to reduce cardiovascular disease. However, no reliable placebo-controlled data are available on both efficacy and tolerability. Methods: We conducted a randomised, double-blind placebo-controlled trial of a polypill (containing aspirin 75 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg and simvastatin 20 mg) in 378 individuals without an indication for any component of the polypill, but who had an estimated 5-year cardiovascular disease risk over 7.5%. The primary outcomes were systolic blood pressure (SBP), LDL-cholesterol and tolerability (proportion discontinued randomised therapy) at 12 weeks follow-up. Findings: At baseline, mean BP was 134/81 mmHg and mean LDL-cholesterol was 3.7 mmol/L. Over 12 weeks, polypill treatment reduced SBP by 9.9 (95% CI: 7.7 to 12.1) mmHg and LDL-cholesterol by 0.8 (95% CI 0.6 to 0.9) mmol/L. The discontinuation rates in the polypill group compared to placebo were 23% vs 18% (RR 1.33, 95% CI 0.89 to 2.00, p = 0.2). There was an excess of side effects known to the component medicines (58% vs 42%, p = 0.001), which was mostly apparent within a few weeks, and usually did not warrant cessation of trial treatment. Conclusions: This polypill achieved sizeable reductions in SBP and LDL-cholesterol but caused side effects in about 1 in 6 people. The halving in predicted cardiovascular risk is moderately lower than previous estimates and the side effect rate is moderately higher. Nonetheless, substantial net benefits would be expected among patients at high risk.	[Rodgers, Anthony; Patel, Anushka; Neal, Bruce; Webster, Ruth] George Inst Global Hlth, Sydney, NSW, Australia; [Berwanger, Otavio] Hosp Coracao, Sao Paulo, Brazil; [Bots, Michiel; Grobbee, Diederick E.] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Grimm, Richard] Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; [Jackson, Rod] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Neaton, Jim] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Poulter, Neil] Int Ctr Circulatory Hlth, London, England; [Rafter, Natasha; Vander Hoorn, Stephen] Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; [Raju, P. Krishnam] Care Hosp, Hyderabad, Andhra Pradesh, India; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India; [Thom, Simon] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England	George Institute for Global Health; University of Sydney; Hospital do Coracao - HCor; University of Auckland; University of Minnesota System; University of Minnesota Twin Cities; Imperial College London; University of Auckland; Public Health Foundation of India; Imperial College London	Rodgers, A (corresponding author), George Inst Global Hlth, Sydney, NSW, Australia.	arodgers@georgeinstitute.org	Iats, Inct/K-2300-2013; Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468; Thom, Simon/0000-0002-3020-1351; Abdul Salam, Mohammad/0000-0002-5870-7936; Patel, Anushka/0000-0003-3825-4092; Reddy, K Srinath/0000-0003-3416-3548; Neal, Bruce/0000-0002-0490-7465; Webster, Ruth/0000-0002-7444-3037; Rodgers, Anthony/0000-0003-1282-1896	Wellcome Trust; Health Research Council of New Zealand; National Heart Foundation of New Zealand; National Health and Medical Research Council of Australia; Brazilian Ministry of Health; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Council of New Zealand(Health Research Council of New Zealand); National Heart Foundation of New Zealand; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Brazilian Ministry of Health; British Heart Foundation(British Heart Foundation)	The trial was funded by The Wellcome Trust, the Health Research Council of New Zealand, the National Heart Foundation of New Zealand, the National Health and Medical Research Council of Australia, The Brazilian Ministry of Health (Projeto Hospitais de Excelencia) and the British Heart Foundation. The polypill and matching placebo were provided free of charge by Dr. Reddy's Laboratories, Hyderabad, India. None of these parties had any role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data in the study. The Steering Committee had final responsibility for the decision to submit for publication.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Andraws R, 2007, AM J CARDIOL, V99, P1006, DOI 10.1016/j.amjcard.2006.10.068; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BEAGLEHOLE R, LANCENT, V370, P2152; BOISSEL JP, APPARENT EFFECT BLOO; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; *EMA, 2008, GUID EV MED PROD CAR; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Goldberg RJ, 2004, AM J CARDIOL, V93, P288, DOI 10.1016/j.amjcard.2003.10.006; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kumar Amit, 2009, Crit Pathw Cardiol, V8, P104, DOI 10.1097/HPC.0b013e3181b8395d; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Law M, 2005, CIRCULATION, V112, P2301, DOI 10.1161/CIRCULATIONAHA.104.529628; Law M, 2003, Health Technol Assess, V7, P1; LAW M, LOWERING BLOOD PRESS; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2002, ARCH INTERN MED, V162, P2405, DOI 10.1001/archinte.162.21.2405; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; LAW MR, 2003, BRIT MED J, V7; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewis JD, 2002, AM J GASTROENTEROL, V97, P2540; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; LONGSTRETH GF, 1995, AM J GASTROENTEROL, V90, P206; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT VASC DIS PREV, 2004, AUSTR FAMILY PHYS, V33; New Zealand Guidelines Group, 2003, EV BAS BEST PRACT GU; Riddell T, 2010, NEW ZEAL MED J, V123, P50; Rodgers A, 2005, CIRCULATION, V112, P3384, DOI 10.1161/CIRCULATIONHA.105.537472; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Selak V, 2009, NEW ZEAL MED J, V122, P41; Sharma KK, 2009, VASC HEALTH RISK MAN, V5, P1007; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WALD NJ, 2001, FORMULATION PREVENTI; Webster RJ, 2009, MED J AUSTRALIA, V191, P324, DOI 10.5694/j.1326-5377.2009.tb02816.x; Wells Susan, 2006, N Z Med J, V119, pU1935; *WHO, 2002, WHO WELLC TRUST M RE; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; World Health Organization, 2003, ADHERENCE LONG TERM; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; 2007, THERAPEUTICS LET MAR	61	101	102	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19857	10.1371/journal.pone.0019857	http://dx.doi.org/10.1371/journal.pone.0019857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647425	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500009
J	Ullal, P; Vilella-Mitjana, F; Jarmuz, A; Aragon, L				Ullal, Pranav; Vilella-Mitjana, Felipe; Jarmuz, Adam; Aragon, Luis			RETRACTED: Rtt107 Phosphorylation Promotes Localisation to DNA Double-Stranded Breaks (DSBs) and Recombinational Repair between Sister Chromatids (Retracted article. See vol. 12, art no e0176035, 2017)	PLOS ONE			English	Article; Retracted Publication							SMC5/6 COMPLEX; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; CHECKPOINT; REPLICATION; PROTEINS; COHESIN; RECRUITMENT	Efficient repair of DNA double-stranded breaks (DSB) requires a coordinated response at the site of lesion. Nucleolytic resection commits repair towards homologous recombination, which preferentially occurs between sister chromatids. DSB resection promotes recruitment of the Mec1 checkpoint kinase to the break. Rtt107 is a target of Mec1 and serves as a scaffold during repair. Rtt107 plays an important role during rescue of damaged replication forks, however whether Rtt107 contributes to the repair of DSBs is unknown. Here we show that Rtt107 is recruited to DSBs induced by the HO endonuclease. Rtt107 phosphorylation by Mec1 and its interaction with the Smc5-Smc6 complex are both required for Rtt107 loading to breaks, while Rtt107 regulators Slx4 and Rtt101 are not. We demonstrate that Rtt107 has an effect on the efficiency of sister chromatid recombination (SCR) and propose that its recruitment to DSBs, together with the Smc5-Smc6 complex is important for repair through the SCR pathway.	[Ullal, Pranav; Vilella-Mitjana, Felipe; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, MRC, Ctr Clin Sci, London, England	Imperial College London	Ullal, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, MRC, Ctr Clin Sci, London, England.	luis.aragon@csc.mrc.ac.uk	Vilella, Felipe/C-2970-2018	Vilella, Felipe/0000-0002-0039-9846	European Research Council ERC [202337]; Medical Research Council UK; Medical Research Council [MC_U120074328] Funding Source: researchfish	European Research Council ERC(European Research Council (ERC)European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by European Research Council ERC starting grant 202337 (LA) and by the Medical Research Council UK (LA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez-Lopez M, 2010, NUCLEIC ACIDS RES, V38, P6502, DOI 10.1093/nar/gkq546; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haber JE, 1998, TRENDS GENET, V14, P317, DOI 10.1016/S0168-9525(98)01501-7; Herzberg K, 2006, MOL CELL BIOL, V26, P8396, DOI 10.1128/MCB.01317-06; JENSEN R, 1983, P NATL ACAD SCI-BIOL, V80, P3035, DOI 10.1073/pnas.80.10.3035; KADYK LC, 1992, GENETICS, V132, P387; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Melo JA, 2001, GENE DEV, V15, P2809; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mozlin AM, 2008, GENETICS, V178, P113, DOI 10.1534/genetics.107.082677; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40	34	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20152	10.1371/journal.pone.0020152	http://dx.doi.org/10.1371/journal.pone.0020152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647453	Green Published, gold			2022-12-27	WOS:000291006500032
J	de Jong, S; Kas, MJH; Kiernan, J; de Mooij-van Malsen, AG; Oppelaar, H; Janson, E; Vukobradovic, I; Farber, CR; Stanford, WL; Ophoff, RA				de Jong, Simone; Kas, Martien J. H.; Kiernan, Jeffrey; de Mooij-van Malsen, Annetrude G.; Oppelaar, Hugo; Janson, Esther; Vukobradovic, Igor; Farber, Charles R.; Stanford, William L.; Ophoff, Roel A.			Hippocampal Gene Expression Analysis Highlights Ly6a/Sca-1 as Candidate Gene for Previously Mapped Novelty Induced Behaviors in Mice	PLOS ONE			English	Article							CHROMOSOME SUBSTITUTION STRAINS; COEXPRESSION NETWORK ANALYSIS; QUANTITATIVE TRAIT LOCI; STEM-CELL; EXPLORATORY-BEHAVIOR; ILLUMINA MICROARRAY; INBRED STRAINS; MOTOR-ACTIVITY; ANXIETY; MOUSE	In this study, we show that the covariance between behavior and gene expression in the brain can help further unravel the determinants of neurobehavioral traits. Previously, a QTL for novelty induced motor activity levels was identified on murine chromosome 15 using consomic strains. With the goal of narrowing down the linked region and possibly identifying the gene underlying the quantitative trait, gene expression data from this F-2-population was collected and used for expression QTL analysis. While genetic variation in these mice was limited to chromosome 15, eQTL analysis of gene expression showed strong cis-effects as well as trans-effects elsewhere in the genome. Using weighted gene co-expression network analysis, we were able to identify modules of co-expressed genes related to novelty induced motor activity levels. In eQTL analyses, the expression of Ly6a (a.k.a. Sca-1) was found to be cis-regulated by chromosome 15. Ly6a also surfaced in a group of genes resulting from the network analysis that was correlated with behavior. Behavioral analysis of Ly6a knock-out mice revealed reduced novelty induced motor activity levels when compared to wild type controls, confirming functional importance of Ly6a in this behavior, possibly through regulating other genes in a pathway. This study shows that gene expression profiling can be used to narrow down a previously identified behavioral QTL in mice, providing support for Ly6a as a candidate gene for functional involvement in novelty responsiveness.	[de Jong, Simone; Janson, Esther; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Kas, Martien J. H.; Oppelaar, Hugo] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Kiernan, Jeffrey; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [de Mooij-van Malsen, Annetrude G.] Nijmegen Ctr Neurosci, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, Nijmegen, Netherlands; [Vukobradovic, Igor] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Modeling Human Dis, Toronto, ON M5G 1X5, Canada; [Farber, Charles R.] Univ Virginia, Dept Med, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; Radboud University Nijmegen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Virginia; University of Virginia; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	de Jong, S (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	ROphoff@mednet.ucla.edu	Kas, Martien J./G-8269-2018	Kas, Martien J./0000-0002-4471-8618; de Jong, Simone/0000-0002-8002-7195; Farber, Charles/0000-0002-6748-4711; de Mooij-van Malsen, Johanne Gertrude/0000-0003-0960-6431; Stanford, William/0000-0002-5813-8016	Canadian Institutes of Health Research [FRN62788]; Van Walree Fund; Royal Netherlands Academy of Arts and Sciences; Utrecht University; National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Van Walree Fund; Royal Netherlands Academy of Arts and Sciences; Utrecht University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The study was supported by the Canadian Institutes of Health Research (FRN62788) to WLS, by travel grants to SDJ from the Van Walree Fund, the Royal Netherlands Academy of Arts and Sciences, and Utrecht University's California Research Cooperation Fund, and research funding from the National Institutes of Health to RAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly W, 2006, AMYOTROPH LATERAL SC, V7, P112, DOI 10.1080/14660820500443000; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; de Jong S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-20; de Mooij-van Malsen A, 2008, EUR J PHARMACOL, V585, P436, DOI 10.1016/j.ejphar.2008.01.057; DEMOOIJVANMALSE.AJ, 2009, BIOL PSYCHIAT; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gatti DM, 2009, MAMM GENOME, V20, P437, DOI 10.1007/s00335-009-9199-0; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Holmes C, 2007, J BONE MINER RES, V22, P1373, DOI 10.1359/JBMR.070604; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kas MJH, 2009, GENES BRAIN BEHAV, V8, P13, DOI 10.1111/j.1601-183X.2008.00435.x; Kas MJH, 2008, BEHAV NEUROSCI, V122, P769, DOI 10.1037/0735-7044.122.4.769; Kobayashi K, 2006, EUR J NEUROSCI, V24, P1867, DOI 10.1111/j.1460-9568.2006.05079.x; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lynch M., 1998, GENETICS ANAL QUANTI; MATHIS C, 1994, BEHAV GENET, V24, P171, DOI 10.1007/BF01067821; Miller BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014458; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Turri MG, 1999, MAMM GENOME, V10, P1098, DOI 10.1007/s003359901169; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20716	10.1371/journal.pone.0020716	http://dx.doi.org/10.1371/journal.pone.0020716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673958	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400022
J	Baddeley, D; Crossman, D; Rossberger, S; Cheyne, JE; Montgomery, JM; Jayasinghe, ID; Cremer, C; Cannell, MB; Soeller, C				Baddeley, David; Crossman, David; Rossberger, Sabrina; Cheyne, Juliette E.; Montgomery, Johanna M.; Jayasinghe, Isuru D.; Cremer, Christoph; Cannell, Mark B.; Soeller, Christian			4D Super-Resolution Microscopy with Conventional Fluorophores and Single Wavelength Excitation in Optically Thick Cells and Tissues	PLOS ONE			English	Article							RECONSTRUCTION MICROSCOPY; LOCALIZATION MICROSCOPY; FLUORESCENT-PROBES; DIFFRACTION-LIMIT; CARDIAC MYOCYTES; LIVING CELLS; RESOLUTION; RAT; NANOSTRUCTURES; GLUTAMATE	Background: Optical super-resolution imaging of fluorescently stained biological samples is rapidly becoming an important tool to investigate protein distribution at the molecular scale. It is therefore important to develop practical super-resolution methods that allow capturing the full three-dimensional nature of biological systems and also can visualize multiple protein species in the same sample. Methodology/Principal Findings: We show that the use of a combination of conventional near-infrared dyes, such as Alexa 647, Alexa 680 and Alexa 750, all excited with a 671 nm diode laser, enables 3D multi-colour super-resolution imaging of complex biological samples. Optically thick samples, including human tissue sections, cardiac rat myocytes and densely grown neuronal cultures were imaged with lateral resolutions of,15 nm (std. dev.) while reducing marker cross-talk to <1%. Using astigmatism an axial resolution of similar to 15 nm (std. dev.) was routinely achieved. The number of marker species that can be distinguished depends on the mean photon number of single molecule events. With the typical photon yields from Alexa 680 of similar to 2000 up to 5 markers may in principle be resolved with <2% crosstalk. Conclusions/Significance: Our approach is based entirely on the use of conventional, commercially available markers and requires only a single laser. It provides a very straightforward way to investigate biological samples at the nanometre scale and should help establish practical 4D super-resolution microscopy as a routine research tool in many laboratories.	[Baddeley, David; Crossman, David; Cheyne, Juliette E.; Montgomery, Johanna M.; Jayasinghe, Isuru D.; Cannell, Mark B.; Soeller, Christian] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Rossberger, Sabrina; Cremer, Christoph] Univ Heidelberg, Kirchhoff Inst Phys, Heidelberg, Germany	University of Auckland; Ruprecht Karls University Heidelberg	Baddeley, D (corresponding author), Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand.	c.soeller@auckland.ac.nz	Soeller, Christian/G-5525-2011; Jayasinghe, Izzy/K-6661-2019	Jayasinghe, Izzy/0000-0003-2461-478X; Soeller, Christian/0000-0002-9302-2203; Crossman, David/0000-0003-3811-5455; Cheyne, Juliette/0000-0002-2355-7253	Marsden Fund; Health Research Council; Maurice and Phyllis Paykel Trust	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council; Maurice and Phyllis Paykel Trust	Funding to support this study was provided by the Marsden Fund administered by the Royal Society, NZ, the Health Research Council and the Maurice and Phyllis Paykel Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY D, 2011, NANO RES, DOI DOI 10.1007/S12274-12011-10115-Z; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Baddeley D, 2009, P NATL ACAD SCI USA, V106, P22275, DOI 10.1073/pnas.0908971106; Baddeley D, 2009, BIOPHYS J, V96, pL22, DOI 10.1016/j.bpj.2008.11.002; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bossi M, 2008, NANO LETT; Cheyne JE, 2008, MOL CELL NEUROSCI, V37, P432, DOI 10.1016/j.mcn.2007.10.015; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Esa A, 2000, J MICROSC-OXFORD, V199, P96, DOI 10.1046/j.1365-2818.2000.00707.x; Evans AM, 1997, CARDIOVASC RES, V35, P294, DOI 10.1016/S0008-6363(97)00117-X; FOLLING J, 2008, NATURE METHODS; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Gunkel Manuel, 2009, Biotechnology Journal, V4, P927, DOI 10.1002/biot.200900005; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jayasinghe ID, 2009, BIOPHYS J, V97, P2664, DOI 10.1016/j.bpj.2009.08.036; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Mlodzianoski MJ, 2009, OPT EXPRESS, V17, P8264, DOI 10.1364/OE.17.008264; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Testa I, 2010, BIOPHYS J, V99, P2686, DOI 10.1016/j.bpj.2010.08.012; Thompson S, 1899, P PHYS SOC LOND, V17, P81; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Vallotton P, 2008, J MICROSC-OXFORD, V232, P235, DOI 10.1111/j.1365-2818.2008.02094.x; van de Linde S, 2008, APPL PHYS B-LASERS O, V93, P725, DOI 10.1007/s00340-008-3250-9; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009	35	109	113	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20645	10.1371/journal.pone.0020645	http://dx.doi.org/10.1371/journal.pone.0020645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655189	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600114
J	Lull, ME; Levesque, S; Surace, MJ; Block, ML				Lull, Melinda E.; Levesque, Shannon; Surace, Michael J.; Block, Michelle L.			Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)(SL) Mice	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; ALZHEIMERS-DISEASE; NADPH OXIDASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; DOPAMINERGIC NEUROTOXICITY; ACTIVATED NEUTROPHILS; TETRAZOLIUM SALT; GENE-EXPRESSION; TRANSGENIC MICE	Background: NADPH oxidase is implicated in neurotoxic microglial activation and the progressive nature of Alzheimer's Disease (AD). Here, we test the ability of two NADPH oxidase inhibitors, apocynin and dextromethorphan (DM), to reduce learning deficits and neuropathology in transgenic mice overexpressing human amyloid precursor protein with the Swedish and London mutations (hAPP(751)(SL)). Methods: Four month old hAPP(751)(SL) mice were treated daily with saline, 15 mg/kg DM, 7.5 mg/kg DM, or 10 mg/kg apocynin by gavage for four months. Results: Only hAPP(751)(SL) mice treated with apocynin showed reduced plaque size and a reduction in the number of cortical microglia, when compared to the saline treated group. Analysis of whole brain homogenates from all treatments tested (saline, DM, and apocynin) demonstrated low levels of TNF alpha, protein nitration, lipid peroxidation, and NADPH oxidase activation, indicating a low level of neuroinflammation and oxidative stress in hAPP(751) SL mice at 8 months of age that was not significantly affected by any drug treatment. Despite in vitro analyses demonstrating that apocynin and DM ameliorate A beta-induced extracellular superoxide production and neurotoxicity, both DM and apocynin failed to significantly affect learning and memory tasks or synaptic density in hAPP(751)(SL) mice. To discern how apocynin was affecting plaque levels (plaque load) and microglial number in vivo, in vitro analysis of microglia was performed, revealing no apocynin effects on beta-amyloid (A beta) phagocytosis, microglial proliferation, or microglial survival. Conclusions: Together, this study suggests that while hAPP(751)(SL) mice show increases in microglial number and plaque load, they fail to exhibit elevated markers of neuroinflammation consistent with AD at 8 months of age, which may be a limitation of this animal model. Despite absence of clear neuroinflammation, apocynin was still able to reduce both plaque size and microglial number, suggesting that apocynin may have additional therapeutic effects independent of anti-inflammatory characteristics.	[Lull, Melinda E.; Levesque, Shannon; Surace, Michael J.; Block, Michelle L.] Virginia Commonwealth Univ Med Campus, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Virginia Commonwealth University	Lull, ME (corresponding author), Virginia Commonwealth Univ Med Campus, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	mblock@vcu.edu		Block, Michelle/0000-0001-8303-7914	Alzheimer's Drug Discovery Foundation; Institute for the Study of Aging and National Institute of Environmental Health Sciences/National Institutes of Health [R00ES01540]	Alzheimer's Drug Discovery Foundation; Institute for the Study of Aging and National Institute of Environmental Health Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Alzheimer's Drug Discovery Foundation and the Institute for the Study of Aging and National Institute of Environmental Health Sciences/National Institutes of Health R00ES01540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Goepfert E, 1998, BIOCHEM PHARMACOL, V56, P141, DOI 10.1016/S0006-2952(98)00024-0; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cheepsunthorn P, 2001, GLIA, V35, P53, DOI 10.1002/glia.1070; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Deshusses JMP, 2003, PROTEOMICS, V3, P1418, DOI 10.1002/pmic.200300492; DHEEN ST, 2004, GLIA; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Gao HM, 2003, FASEB J, V17, P1957, DOI 10.1096/fj.03-0203fje; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Ii M, 1996, BRAIN RES, V720, P93, DOI 10.1016/0006-8993(96)00156-4; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; JANTARATNOTAI N, 2010, CURR ALZHEIMER RES; LEE CY, J NEURAL TRANSM, V117, P949; Levesque S, 2010, BRAIN, V133, P808, DOI 10.1093/brain/awp333; Li GR, 2005, FASEB J, V19, P489, DOI 10.1096/fj.04-2555com; Liu B, 2003, METH MOLEC MED, V79, P387; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu SL, 2009, CARDIOVASC RES, V82, P161, DOI 10.1093/cvr/cvp043; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Pei Z, 2003, J PINEAL RES, V34, P194, DOI 10.1034/j.1600-079X.2003.00026.x; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Sasaki A, 1997, ACTA NEUROPATHOL, V94, P316, DOI 10.1007/s004010050713; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Sultana R, 2009, METHODS MOL BIOL, V566, P123, DOI 10.1007/978-1-59745-562-6_9; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; VALTIER D, 1992, BRAIN RES, V588, P115, DOI 10.1016/0006-8993(92)91350-N; Van den Worm E, 2001, EUR J PHARMACOL, V433, P225, DOI 10.1016/S0014-2999(01)01516-3; Wedenig M, 2004, NEUROBIOL AGING, V25, pS233, DOI 10.1016/S0197-4580(04)80780-2; Werner Erica, 2003, Sci STKE, V2003, pPL3, DOI 10.1126/stke.2003.168.pl3; WILKINSON BL, 2010, NEUROBIOL AGING; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Willis M, 2007, BRAIN RES, V1143, P199, DOI 10.1016/j.brainres.2007.01.080; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1989, NEUROBIOL AGING, V10, P470, DOI 10.1016/0197-4580(89)90101-2; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	65	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20153	10.1371/journal.pone.0020153	http://dx.doi.org/10.1371/journal.pone.0020153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655287	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600024
J	Sugita, S; Kamei, Y; Akaike, F; Suganami, T; Kanai, S; Hattori, M; Manabe, Y; Fujii, N; Takai-Igarashi, T; Tadaishi, M; Oka, J; Aburatani, H; Yamada, T; Katagiri, H; Kakehi, S; Tamura, Y; Kubo, H; Nishida, K; Miura, S; Ezaki, O; Ogawa, Y				Sugita, Satoshi; Kamei, Yasutomi; Akaike, Fumiko; Suganami, Takayoshi; Kanai, Sayaka; Hattori, Maki; Manabe, Yasuko; Fujii, Nobuharu; Takai-Igarashi, Takako; Tadaishi, Miki; Oka, Jun-ichiro; Aburatani, Hiroyuki; Yamada, Tetsuya; Katagiri, Hideki; Kakehi, Saori; Tamura, Yoshifumi; Kubo, Hideo; Nishida, Kenichi; Miura, Shinji; Ezaki, Osamu; Ogawa, Yoshihiro			Increased Systemic Glucose Tolerance with Increased Muscle Glucose Uptake in Transgenic Mice Overexpressing RXR gamma in Skeletal Muscle	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; X-RECEPTOR; TRIGLYCERIDE SYNTHESIS; TRANSCRIPTION FACTOR; ENERGY-EXPENDITURE; METABOLIC SYNDROME; OBESE MICE; LIVER; SENSITIVITY; TRANSPORT	Background: Retinoid X receptor (RXR) gamma is a nuclear receptor-type transcription factor expressed mostly in skeletal muscle, and regulated by nutritional conditions. Previously, we established transgenic mice overexpressing RXR gamma in skeletal muscle (RXR gamma mice), which showed lower blood glucose than the control mice. Here we investigated their glucose metabolism. Methodology/Principal Findings: RXR gamma mice were subjected to glucose and insulin tolerance tests, and glucose transporter expression levels, hyperinsulinemic-euglycemic clamp and glucose uptake were analyzed. Microarray and bioinformatics analyses were done. The glucose tolerance test revealed higher glucose disposal in RXR gamma mice than in control mice, but insulin tolerance test revealed no difference in the insulin-induced hypoglycemic response. In the hyperinsulinemic-euglycemic clamp study, the basal glucose disposal rate was higher in RXR gamma mice than in control mice, indicating an insulin-independent increase in glucose uptake. There was no difference in the rate of glucose infusion needed to maintain euglycemia (glucose infusion rate) between the RXR gamma and control mice, which is consistent with the result of the insulin tolerance test. Skeletal muscle from RXR gamma mice showed increased Glut1 expression, with increased glucose uptake, in an insulin-independent manner. Moreover, we performed in vivo luciferase reporter analysis using Glut1 promoter (Glut1-Luc). Combination of RXR gamma and PPAR delta resulted in an increase in Glut1-Luc activity in skeletal muscle in vivo. Microarray data showed that RXR gamma overexpression increased a diverse set of genes, including glucose metabolism genes, whose promoter contained putative PPAR-binding motifs. Conclusions/Significance: Systemic glucose metabolism was increased in transgenic mice overexpressing RXR gamma. The enhanced glucose tolerance in RXR gamma mice may be mediated at least in part by increased Glut1 in skeletal muscle. These results show the importance of skeletal muscle gene regulation in systemic glucose metabolism. Increasing RXR gamma expression may be a novel therapeutic strategy against type 2 diabetes.	[Sugita, Satoshi; Kamei, Yasutomi; Akaike, Fumiko; Suganami, Takayoshi; Kanai, Sayaka; Hattori, Maki; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Tokyo, Japan; [Akaike, Fumiko; Hattori, Maki; Oka, Jun-ichiro] Tokyo Univ Sci, Pharmacol Lab, Fac Pharmaceut Sci, Chiba, Japan; [Manabe, Yasuko; Fujii, Nobuharu] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo 158, Japan; [Takai-Igarashi, Takako] Tokyo Med & Dent Univ, Dept Bioinformat, Grad Sch Biomed Sci, Tokyo, Japan; [Tadaishi, Miki; Miura, Shinji; Ezaki, Osamu] Natl Inst Hlth & Nutr, Nutr Sci Program, Tokyo 162, Japan; [Tadaishi, Miki] Tokyo Univ Agr, Dept Nutr Sci, Fac Appl Biosci, Tokyo, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Metab Dis, Dept Metab Dis, Sendai, Miyagi 980, Japan; [Kakehi, Saori; Tamura, Yoshifumi] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 113, Japan; [Tamura, Yoshifumi] Juntendo Univ, Sportol Ctr, Tokyo, Japan; [Kubo, Hideo; Nishida, Kenichi] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Med Res Inst, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo University of Science; Tokyo Metropolitan University; Tokyo Medical & Dental University (TMDU); National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture; University of Tokyo; Tohoku University; Juntendo University; Juntendo University; Daiichi Sankyo Company Limited; Tokyo Medical & Dental University (TMDU)	Kamei, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Tokyo, Japan.	kamei.mmm@mri.tmd.ac.jp	Fujii, Nobuharu/J-2724-2014; Tamura, Yoshifumi/AFK-2430-2022; Miura, Shinji/K-6516-2013; SUGANAMI, Takayoshi/A-9475-2016	Fujii, Nobuharu/0000-0002-0974-3033; Miura, Shinji/0000-0001-8806-9763; Ogawa, Yoshihiro/0000-0002-0834-2836; Tamura, Yoshifumi/0000-0002-1685-7821	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan); Japanese Ministry of Health, Labor and Welfare; Institute for Molecular and Cellular Regulation, Gunma University; Grants-in-Aid for Scientific Research [23591293] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Institute for Molecular and Cellular Regulation, Gunma University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for scientific research KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan), research grants from the Japanese Ministry of Health, Labor and Welfare, and by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University. S. Sugita is a Research Fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; KASLOW HR, 1985, J BIOL CHEM, V260, P9953; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Lowry O. H., 1972, FLEXIBLE SYSTEM ENZY, P1; Marshall BA, 1999, AM J PHYSIOL-ENDOC M, V276, pE390, DOI 10.1152/ajpendo.1999.276.2.E390; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; REN JM, 1993, J BIOL CHEM, V268, P16113; Salway J.G., 2017, METABOLISM GLANCE; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shen Q, 2004, J BIOL CHEM, V279, P19721, DOI 10.1074/jbc.M311729200; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Stannard SR, 2004, J PHYSIOL-LONDON, V554, P595, DOI 10.1113/jphysiol.2003.053926; Suzuki R, 2004, J BIOL CHEM, V279, P25039, DOI 10.1074/jbc.M311956200; Szanto A, 2004, CELL DEATH DIFFER, V11, pS126, DOI 10.1038/sj.cdd.4401533; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	32	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20467	10.1371/journal.pone.0020467	http://dx.doi.org/10.1371/journal.pone.0020467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655215	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600074
J	Volman, V; Perc, M; Bazhenov, M				Volman, Vladislav; Perc, Matjaz; Bazhenov, Maxim			Gap Junctions and Epileptic Seizures - Two Sides of the Same Coin?	PLOS ONE			English	Article							ELECTRICAL SYNAPSES; PYRAMIDAL NEURON; OSCILLATIONS; EXPRESSION; NETWORKS; FREQUENCY; NEOCORTEX; CONNEXIN-43; MECHANISMS; SYNCHRONY	Electrical synapses (gap junctions) play a pivotal role in the synchronization of neuronal ensembles which also makes them likely agonists of pathological brain activity. Although large body of experimental data and theoretical considerations indicate that coupling neurons by electrical synapses promotes synchronous activity (and thus is potentially epileptogenic), some recent evidence questions the hypothesis of gap junctions being among purely epileptogenic factors. In particular, an expression of inter-neuronal gap junctions is often found to be higher after the experimentally induced seizures than before. Here we used a computational modeling approach to address the role of neuronal gap junctions in shaping the stability of a network to perturbations that are often associated with the onset of epileptic seizures. We show that under some circumstances, the addition of gap junctions can increase the dynamical stability of a network and thus suppress the collective electrical activity associated with seizures. This implies that the experimentally observed post-seizure additions of gap junctions could serve to prevent further escalations, suggesting furthermore that they are a consequence of an adaptive response of the neuronal network to the pathological activity. However, if the seizures are strong and persistent, our model predicts the existence of a critical tipping point after which additional gap junctions no longer suppress but strongly facilitate the escalation of epileptic seizures. Our results thus reveal a complex role of electrical coupling in relation to epileptiform events. Which dynamic scenario (seizure suppression or seizure escalation) is ultimately adopted by the network depends critically on the strength and duration of seizures, in turn emphasizing the importance of temporal and causal aspects when linking gap junctions with epilepsy.	[Volman, Vladislav; Bazhenov, Maxim] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Volman, Vladislav] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	Salk Institute; University of California System; University of California San Diego; University of Maribor; University of California System; University of California Riverside	Volman, V (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	volman@salk.edu	Perc, Matjaz/A-5148-2009	Perc, Matjaz/0000-0002-3087-541X	National Institutes of Health (NIH) [R01 NS059740]; NSF; Slovenian Research Agency [Z1-2032]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by the National Institutes of Health (NIH) grant R01 NS059740 (MB and VV). VV acknowledges support from the NSF-sponsored Center for Theoretical Biological Physics at the University of California San Diego. MP acknowledges support from the Slovenian Research Agency (grant number Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CONNORS BW, 1983, J NEUROSCI, V3, P773; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Goldberg M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000909; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HOGE G, 2011, J NEUROPHYS IN PRESS; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Kandel E., 2000, PRINCIPLES NEURAL SC; Kapral R., 1995, CHEM WAVES PATTERNS; KEPLER TB, 1990, SCIENCE, V248, P83, DOI 10.1126/science.2321028; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; KRINSKY V, 1991, WAVES PATTERNS BIOL; Lau T, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016015; Lewis TJ, 2000, NETWORK-COMP NEURAL, V11, P299, DOI 10.1088/0954-898X/11/4/304; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Mylvaganam S, 2010, J NEUROCHEM, V112, P92, DOI 10.1111/j.1471-4159.2009.06431.x; Pinto DJ, 2001, SIAM J APPL MATH, V62, P206, DOI 10.1137/S0036139900346453; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; Reif F., 1985, FUNDAMENTALS STAT TH; Samoilova M, 2003, J NEUROCHEM, V86, P687, DOI 10.1046/j.1471-4159.2003.01893.x; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Winfree A.T., 2000, GEOMETRY BIOL TIME	39	79	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20572	10.1371/journal.pone.0020572	http://dx.doi.org/10.1371/journal.pone.0020572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655239	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600101
J	Corona, R; Larriva-Sahd, J; Paredes, RG				Corona, Rebeca; Larriva-Sahd, Jorge; Paredes, Raul G.			Paced-Mating Increases the Number of Adult New Born Cells in the Internal Cellular (Granular) Layer of the Accessory Olfactory Bulb	PLOS ONE			English	Article							NEWLY-GENERATED NEURONS; VOMERONASAL PROJECTION PATHWAY; EXPERIENCE-DEPENDENT SURVIVAL; ROSTRAL MIGRATORY STREAM; FOS EXPRESSION; FEMALE RAT; C-FOS; STIMULATED NEUROGENESIS; POSTNATAL NEUROGENESIS; SUBEPENDYMAL LAYER	The continuous production and addition of new neurons during life in the olfactory bulb is well accepted and has been extensively studied in rodents. This process could allow the animals to adapt to a changing environment. Olfactory neurogenesis begins in the subventricular zone where stem cells proliferate and give rise to young undifferentiated neuroblasts that migrate along the rostral migratory stream to the olfactory bulb ( OB). Olfaction is crucial for the expression of sexual behavior in rodents. In female rats, the ability to control the rate of sexual interactions (pacing) has important physiological and behavioral consequences. In the present experiment we evaluated if pacing behavior modifies the rate of new cells that reach the main and accessory olfactory bulb. The BrdU marker was injected before and after different behavioral tests which included: females placed in a mating cage (control), females allowed to pace the sexual interaction, females that mated but were not able to control the rate of the sexual interaction and females exposed to a sexually active male. Subjects were sacrificed fifteen days after the behavioral test. We observed a significant increase in the density of BrdU positive cells in the internal cellular layer of the accessory olfactory bulb when females paced the sexual interaction in comparison to the other 3 groups. No differences in the cell density in the main olfactory bulb were found. These results suggest that pacing behavior promotes an increase in density of the new cells in the accessory olfactory bulb.	[Corona, Rebeca; Larriva-Sahd, Jorge; Paredes, Raul G.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Corona, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico.	rparedes@unam.mx		Corona, Rebeca/0000-0003-2005-5802	Consejo Nacional de Ciencia y Tecnologia [53547]; Direccion General de Asuntos del Personal Academico [IN213609]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico	This work was supported by grants 53547 from Consejo Nacional de Ciencia y Tecnologia and IN213609 from Direccion General de Asuntos del Personal Academico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; DAS GD, 1971, BRAIN RES, V30, P323, DOI 10.1016/0006-8993(71)90082-5; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; Doetsch F, 1997, J NEUROSCI, V17, P5046; DUDLEY CA, 1992, MOL CELL NEUROSCI, V3, P360, DOI 10.1016/1044-7431(92)90034-Y; DUDLEY CA, 1994, BRAIN RES, V642, P29, DOI 10.1016/0006-8993(94)90902-4; Erskine MS, 2004, BEHAV BRAIN RES, V153, P295, DOI 10.1016/j.bbr.2004.01.026; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; Erskine MS, 1997, J NEUROENDOCRINOL, V9, P903, DOI 10.1046/j.1365-2826.1997.00660.x; ERSKINE MS, 1995, ENDOCR REV, V16, P508, DOI 10.1210/er.16.4.508; Garcia-Horsman SP, 2008, HORM BEHAV, V54, P709, DOI 10.1016/j.yhbeh.2008.07.011; Gheusi G, 2009, BEHAV BRAIN RES, V200, P315, DOI 10.1016/j.bbr.2009.02.006; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GuevaraGuzman R, 1997, BRAIN RES BULL, V44, P141, DOI 10.1016/S0361-9230(97)00103-2; HARDY DF, 1972, J COMP PHYSIOL PSYCH, V78, P400, DOI 10.1037/h0032536; Honda N, 2008, EUR J NEUROSCI, V27, P1980, DOI 10.1111/j.1460-9568.2008.06169.x; Huang LY, 2002, HORM BEHAV, V41, P343, DOI 10.1006/hbeh.2002.1767; Hurtazo HA, 2005, NEUROSCIENCE, V135, P1035, DOI 10.1016/j.neuroscience.2005.07.012; Kang N, 2009, EUR J NEUROSCI, V29, P624, DOI 10.1111/j.1460-9568.2009.06638.x; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lledo Pierre-Marie, 2008, V52, P425; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; Martinez I, 2001, HORM BEHAV, V40, P510, DOI 10.1006/hbeh.2001.1712; Matsuoka M, 2002, NEUROSCI LETT, V335, P111, DOI 10.1016/S0304-3940(02)01187-4; Matsuoka M, 2002, NEUROSCIENCE, V111, P251, DOI 10.1016/S0306-4522(01)00620-0; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P398, DOI 10.1016/S0003-3472(82)80051-1; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Paredes RG, 1998, HORM BEHAV, V33, P48, DOI 10.1006/hbeh.1998.1435; Peretto P, 2001, CELL TISSUE RES, V306, P385, DOI 10.1007/s00441-001-0471-1; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Petreanu L, 2002, J NEUROSCI, V22, P6106; Polston EK, 2001, J NEUROSCI, V21, P4104, DOI 10.1523/JNEUROSCI.21-11-04104.2001; Portillo W, 2004, HORM BEHAV, V46, P330, DOI 10.1016/j.yhbeh.2004.03.001; SCHELLINCK HM, 1993, DEV BRAIN RES, V74, P138; Shapiro LA, 2009, EPILEPSY BEHAV, V14, P74, DOI 10.1016/j.yebeh.2008.09.011; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102	53	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19380	10.1371/journal.pone.0019380	http://dx.doi.org/10.1371/journal.pone.0019380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637743	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500004
J	Hoerter, JAH; Krishnan, V; Lionberger, TA; Walter, NG				Hoerter, John A. H.; Krishnan, Vishalakshi; Lionberger, Troy A.; Walter, Nils G.			siRNA-Like Double-Stranded RNAs Are Specifically Protected Against Degradation in Human Cell Extract	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RISC-LOADING COMPLEX; DELTA VIRUS RIBOZYME; CHEMICAL-MODIFICATION; MAMMALIAN-CELLS; IN-VITRO; INTERFERENCE; GENE; THERAPEUTICS; ASYMMETRY	RNA interference (RNAi) is a set of intracellular pathways in eukaryotes that controls both exogenous and endogenous gene expression. The power of RNAi to knock down (silence) any gene of interest by the introduction of synthetic small-interfering (si) RNAs has afforded powerful insight into biological function through reverse genetic approaches and has borne a new field of gene therapeutics. A number of questions are outstanding concerning the potency of siRNAs, necessitating an understanding of how short double-stranded RNAs are processed by the cell. Recent work suggests unmodified siRNAs are protected in the intracellular environment, although the mechanism of protection still remains unclear. We have developed a set of doubly-fluorophore labeled RNAs (more precisely, RNA/DNA chimeras) to probe in real-time the stability of siRNAs and related molecules by fluorescence resonance energy transfer (FRET). We find that these RNA probes are substrates for relevant cellular degradative processes, including the RNase H1 mediated degradation of an DNA/RNA hybrid and Dicer-mediated cleavage of a 24-nucleotide (per strand) double-stranded RNA. In addition, we find that 21- and 24-nucleotide double-stranded RNAs are relatively protected in human cytosolic cell extract, but less so in blood serum, whereas an 18-nucleotide double-stranded RNA is less protected in both fluids. These results suggest that RNAi effector RNAs are specifically protected in the cellular environment and may provide an explanation for recent results showing that unmodified siRNAs in cells persist intact for extended periods of time.	[Hoerter, John A. H.; Krishnan, Vishalakshi; Walter, Nils G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lionberger, Troy A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hoerter, JAH (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	nwalter@umich.edu	Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275	Camille Dreyfus Teacher-Scholar award; NIH [GM081025]; Eli Lilly; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081025] Funding Source: NIH RePORTER	Camille Dreyfus Teacher-Scholar award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Camille Dreyfus Teacher-Scholar award and NIH grant GM081025 to N.G.W., an Eli Lilly Predoctoral Fellowship to J.A.H.H., and an NIH Cellular and Molecular Biology training fellowship to T.A.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Bartlett DW, 2007, BIOTECHNOL BIOENG, V97, P909, DOI 10.1002/bit.21285; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Harris DA, 2004, J MOL BIOL, V341, P389, DOI 10.1016/j.jmb.2004.05.074; Hoerter JAH, 2004, BIOCHEMISTRY-US, V43, P14624, DOI 10.1021/bi048533y; Hoerter JAH, 2007, RNA, V13, P1887, DOI 10.1261/rna.602307; Jarve A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm694; Jagannath A, 2009, MOL BIOL CELL, V20, P521, DOI 10.1091/mbc.E08-08-0796; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee SK, 2009, ADV DRUG DELIVER REV, V61, P650, DOI 10.1016/j.addr.2009.03.016; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Ohrt T, 2006, NUCLEIC ACIDS RES, V34, P1369, DOI 10.1093/nar/gkl001; Ohrt T, 2008, CURR PHARM DESIGN, V14, P3674, DOI 10.2174/138161208786898798; Pellino JL, 2005, RNA, V11, P1719, DOI 10.1261/rna.2102805; Pereira MJB, 2002, BIOCHEMISTRY-US, V41, P730, DOI 10.1021/bi011963t; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pileur F, 2003, NUCLEIC ACIDS RES, V31, P5776, DOI 10.1093/nar/gkg748; Potenza N, 2008, INT J MOL SCI, V9, P299, DOI 10.3390/ijms9030299; Raemdonck K, 2006, BIOCHEMISTRY-US, V45, P10614, DOI 10.1021/bi060351b; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ramirez-Carrozzi V, 2001, METHODS, V25, P31, DOI 10.1006/meth.2001.1213; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; RAWLINGS RA, 2011, J MOL BIOL IN PRESS; Schein CH, 1997, NAT BIOTECHNOL, V15, P529, DOI 10.1038/nbt0697-529; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Uhler SA, 2003, J AM CHEM SOC, V125, P14230, DOI 10.1021/ja036854b; Walter NG, 2000, METHOD ENZYMOL, V317, P409; WALTER NG, 2002, CURR PROTOC NUCL ACI; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Watts JK, 2008, DRUG DISCOV TODAY, V13, P842, DOI 10.1016/j.drudis.2008.05.007; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	45	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20359	10.1371/journal.pone.0020359	http://dx.doi.org/10.1371/journal.pone.0020359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647381	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500051
J	Iturria-Medina, Y; Fernandez, AP; Hernandez, PV; Penton, LG; Canales-Rodriguez, EJ; Melie-Garcia, L; Castellanos, AL; Ortega, MO				Iturria-Medina, Yasser; Perez Fernandez, Alejandro; Valdes Hernandez, Pedro; Garcia Penton, Lorna; Canales-Rodriguez, Erick J.; Melie-Garcia, Lester; Lage Castellanos, Agustin; Ontivero Ortega, Marlis			Automated Discrimination of Brain Pathological State Attending to Complex Structural Brain Network Properties: The Shiverer Mutant Mouse Case	PLOS ONE			English	Article							DISTURBED FUNCTIONAL CONNECTIVITY; TEMPORAL-LOBE EPILEPSY; DIFFUSION-TENSOR; SMALL-WORLD; MULTIPLE-SCLEROSIS; CORTICAL THICKNESS; ALZHEIMERS-DISEASE; MRI; ABNORMALITIES; TRACKING	Neuroimaging classification procedures between normal and pathological subjects are sparse and highly dependent of an expert's clinical criterion. Here, we aimed to investigate whether possible brain structural network differences in the shiverer mouse mutant, a relevant animal model of myelin related diseases, can reflect intrinsic individual brain properties that allow the automatic discrimination between the shiverer and normal subjects. Common structural networks properties between shiverer (C3Fe. SWV Mbp(shi)/Mbp(shi), n = 6) and background control (C3HeB. FeJ, n = 6) mice are estimated and compared by means of three diffusion weighted MRI (DW-MRI) fiber tractography algorithms and a graph framework. Firstly, we found that brain networks of control group are significantly more clustered, modularized, efficient and optimized than those of the shiverer group, which presented significantly increased characteristic path length. These results are in line with previous structural/functional complex brain networks analysis that have revealed topologic differences and brain network randomization associated to specific states of human brain pathology. In addition, by means of network measures spatial representations and discrimination analysis, we show that it is possible to classify with high accuracy to which group each subject belongs, providing also a probability value of being a normal or shiverer subject as an individual anatomical classifier. The obtained correct predictions (e. g., around 91.6-100%) and clear spatial subdivisions between control and shiverer mice, suggest that there might exist specific network subspaces corresponding to specific brain disorders, supporting also the point of view that complex brain network analyses constitutes promising tools in the future creation of interpretable imaging biomarkers.	[Iturria-Medina, Yasser; Valdes Hernandez, Pedro; Melie-Garcia, Lester] Cuban Neurosci Ctr, Neuroimaging Dept, Havana, Cuba; [Perez Fernandez, Alejandro] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Basque Country, Spain; [Perez Fernandez, Alejandro; Garcia Penton, Lorna] Univ Diego Portales, Cognit Neurosci Lab, Santiago, Chile; [Lage Castellanos, Agustin] Cuban Neurosci Ctr, Neurostat Dept, Havana, Cuba; [Canales-Rodriguez, Erick J.] Ctr Invest Biomed Red Salud Mental CIBERSam, Madrid, Spain; [Canales-Rodriguez, Erick J.] Benito Menni Complex Assistencial Salut Mental, Barcelona, Spain; [Ontivero Ortega, Marlis] Cuban Neurosci Ctr, Neuroengn Dept, Havana, Cuba	University Diego Portales; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Iturria-Medina, Y (corresponding author), Cuban Neurosci Ctr, Neuroimaging Dept, Havana, Cuba.	iturria.medina@gmail.com	Melie-Garcia, Lester/U-5804-2019; Penton, Lorna Garcia/I-3269-2015; Canales-Rodríguez, Erick Jorge/F-7278-2010; Pérez, Alejandro/H-2202-2015; Garcia-Penton, Lorna/I-7662-2018	Penton, Lorna Garcia/0000-0001-9296-9318; Canales-Rodríguez, Erick Jorge/0000-0001-6421-2633; Pérez, Alejandro/0000-0001-6631-9653; Garcia-Penton, Lorna/0000-0001-9296-9318; Melie-Garcia, Lester/0000-0001-5602-8916; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Iturria Medina, Yasser/0000-0002-9345-0347	National Center for Research Resources at the National Institutes of Health, United States of America [U24-RR021760]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Data used for this study were downloaded from the Mouse BIRN Data Repository, supported by grants to the Mouse BIRN (U24-RR021760) Testbed funded by the National Center for Research Resources at the National Institutes of Health, United States of America. The funders and sponsors of the Mouse BIRN Data Repository, from which the authors downloaded the data, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Almendinger S, 2010, CLIN IMMUNOL, V135, pS81, DOI 10.1016/j.clim.2010.03.243; [Anonymous], THESIS; Assaf Y, 2005, MAGN RESON IMAGING, V23, P703, DOI 10.1016/j.mri.2005.04.008; Bar-Shir A, 2009, NEUROIMAGE, V48, P109, DOI 10.1016/j.neuroimage.2009.06.019; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bishop Christopher M., 2006, PATTERN RECOGNITION; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Commowick O, 2008, LECT NOTES COMPUT SC, V5241, P975, DOI 10.1007/978-3-540-85988-8_116; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Costa LD, 2005, EUR PHYS J B, V48, P567, DOI 10.1140/epjb/e2006-00017-1; Crofts JJ, 2009, J R SOC INTERFACE, V6, P411, DOI 10.1098/rsif.2008.0484; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Galan L, 1997, ELECTROEN CLIN NEURO, V102, P240, DOI 10.1016/S0013-4694(96)95155-3; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gross DW, 2005, EPILEPSIA, V46, P332; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; HAGMANN P, 2006, P 14 M INT SOC MAGN, P436; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; JOHNSON G, 2010, NEUROIMAGE IN PRESS; Jones CT, 2003, NEUROL CLIN, V21, P745, DOI 10.1016/S0733-8619(03)00007-0; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; ORMEROD IEC, 1987, BRAIN, V110, P1579, DOI 10.1093/brain/110.6.1579; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Savadjiev P, 2008, NEUROIMAGE, V41, P58, DOI 10.1016/j.neuroimage.2008.01.028; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894	68	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19071	10.1371/journal.pone.0019071	http://dx.doi.org/10.1371/journal.pone.0019071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637753	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500002
J	Sartore, RC; Campos, PB; Trujillo, CA; Ramalho, BL; Negraes, PD; Paulsen, BS; Meletti, T; Costa, ES; Chicaybam, L; Bonamino, MH; Ulrich, H; Rehen, SK				Sartore, Rafaela C.; Campos, Priscila B.; Trujillo, Cleber A.; Ramalho, Bia L.; Negraes, Priscilla D.; Paulsen, Bruna S.; Meletti, Tamara; Costa, Elaine S.; Chicaybam, Leonardo; Bonamino, Martin H.; Ulrich, Henning; Rehen, Stevens K.			Retinoic Acid-Treated Pluripotent Stem Cells Undergoing Neurogenesis Present Increased Aneuploidy and Micronuclei Formation	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; NEURAL PROGENITOR CELLS; NEURONAL DIFFERENTIATION; ES CELLS; SEGREGATION DEFECTS; SPINDLE CHECKPOINT; GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE EMBRYOS; HUMAN BRAIN	The existence of loss and gain of chromosomes, known as aneuploidy, has been previously described within the central nervous system. During development, at least one-third of neural progenitor cells (NPCs) are aneuploid. Notably, aneuploid NPCs may survive and functionally integrate into the mature neural circuitry. Given the unanswered significance of this phenomenon, we tested the hypothesis that neural differentiation induced by all-trans retinoic acid (RA) in pluripotent stem cells is accompanied by increased levels of aneuploidy, as previously described for cortical NPCs in vivo. In this work we used embryonal carcinoma (EC) cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells undergoing differentiation into NPCs. Ploidy analysis revealed a 2-fold increase in the rate of aneuploidy, with the prevalence of chromosome loss in RA primed stem cells when compared to naive cells. In an attempt to understand the basis of neurogenic aneuploidy, micronuclei formation and survivin expression was assessed in pluripotent stem cells exposed to RA. RA increased micronuclei occurrence by almost 2-fold while decreased survivin expression by 50%, indicating possible mechanisms by which stem cells lose their chromosomes during neural differentiation. DNA fragmentation analysis demonstrated no increase in apoptosis on embryoid bodies treated with RA, indicating that cell death is not the mandatory fate of aneuploid NPCs derived from pluripotent cells. In order to exclude that the increase in aneuploidy was a spurious consequence of RA treatment, not related to neurogenesis, mouse embryonic fibroblasts were treated with RA under the same conditions and no alterations in chromosome gain or loss were observed. These findings indicate a correlation amongst neural differentiation, aneuploidy, micronuclei formation and survivin downregulation in pluripotent stem cells exposed to RA, providing evidence that somatically generated chromosomal variation accompanies neurogenesis in vitro.	[Sartore, Rafaela C.; Campos, Priscila B.; Ramalho, Bia L.; Paulsen, Bruna S.; Meletti, Tamara; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Trujillo, Cleber A.; Negraes, Priscilla D.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Costa, Elaine S.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Chicaybam, Leonardo; Bonamino, Martin H.] Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Sartore, RC (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	srehen@lance-ufrj.org	COSTA, ELAINE SOBRAL/AAE-9574-2021; Ulrich, Henning/AAX-8586-2021; Ulrich, Henning/C-5245-2013; Sartore, Rafaela/AAV-5609-2021; Rehen, Stevens/J-5874-2012; Sobral da Costa, Elaine/O-6523-2014	Ulrich, Henning/0000-0002-2114-3815; Ulrich, Henning/0000-0002-2114-3815; Sartore, Rafaela/0000-0002-1801-8650; Rehen, Stevens/0000-0003-4216-9501; Sobral da Costa, Elaine/0000-0002-5340-5816; Ramalho, Bia/0000-0002-9609-961X; Chicaybam Peixoto, Leonardo/0000-0002-1541-9029	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/111.556/2008, E26/103.081/2008]; Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq) [573.975/2008-6, 573476/08-0, MCT/CNPq 01/2005 - Institutos do Milenio]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61285-9]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ - E26/111.556/2008; E26/103.081/2008); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq - 573.975/2008-6; 573476/08-0; MCT/CNPq 01/2005 - Institutos do Milenio); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2006/61285-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Andollo N, 2005, APOPTOSIS, V10, P417, DOI 10.1007/s10495-005-0815-5; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Campos PB, 2009, J VIS EXP; Capparelli R, 1997, CYTOMETRY, V29, P261, DOI 10.1002/(SICI)1097-0320(19971101)29:3<261::AID-CYTO9>3.0.CO;2-E; *CCS UFFRJ COM BIO, 2003, GUID CAR US MAMM NEU, P209; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Gupta RK, 2008, CANCER BIOL THER, V7, P1473, DOI 10.4161/cbt.7.9.6428; Herget T, 1998, J NEUROCHEM, V70, P47; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kim M, 2009, DEV BIOL, V328, P456, DOI 10.1016/j.ydbio.2009.02.001; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955; PAULSEN BS, 2011, STEM CELLS DEV  0318; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pratt MAC, 2006, APOPTOSIS, V11, P589, DOI 10.1007/s10495-006-4603-7; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; Rebuzzini P, 2008, CYTOTECHNOLOGY, V58, P17, DOI 10.1007/s10616-008-9164-x; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Resende RR, 2008, INT J DEV NEUROSCI, V26, P763, DOI 10.1016/j.ijdevneu.2008.07.008; Resende RR, 2008, CELL CALCIUM, V43, P107, DOI 10.1016/j.ceca.2007.04.007; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V70, P99; Saito T, 2008, BRIT J CANCER, V98, P345, DOI 10.1038/sj.bjc.6604160; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sun SC, 2009, CELL CYCLE, V8, P3365, DOI 10.4161/cc.8.20.9855; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Westra JW, 2008, J COMP NEUROL, V507, P1944, DOI 10.1002/cne.21648; Wilson L, 2004, DEV BIOL, V269, P433, DOI 10.1016/j.ydbio.2004.01.034; Yang AH, 2003, J NEUROSCI, V23, P10454; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x	58	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20667	10.1371/journal.pone.0020667	http://dx.doi.org/10.1371/journal.pone.0020667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674001	gold, Green Published			2022-12-27	WOS:000291356400014
J	Kommadath, A; Nie, HS; Groenen, MAM; Pas, MFWT; Veerkamp, RF; Smits, MA				Kommadath, Arun; Nie, Haisheng; Groenen, Martien A. M.; Pas, Marinus F. W. Te; Veerkamp, Roel F.; Smits, Mari A.			Regional Regulation of Transcription in the Bovine Genome	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; COEXPRESSED GENES; DNA-SEQUENCE; SELECTION; CLUSTERS; BIOLOGY; BIOCONDUCTOR; UNIFICATION; EXPRESSION; MAP	Eukaryotic genes are distributed along chromosomes as clusters of highly expressed genes termed RIDGEs (Regions of IncreaseD Gene Expression) and lowly expressed genes termed anti-RIDGEs, interspersed among genes expressed at intermediate levels or not expressed. Previous studies based on this observation suggested a dual mechanism of gene regulation, where, in addition to transcription factors, the chromosomal domain influences the expression level of their embedded genes. The objectives here were to provide evidence for the existence of chromosomal regional regulation of transcription in the bovine genome, to analyse the genomic features of genes located within RIDGEs versus anti-RIDGEs and tissue-specific genes versus housekeeping and to examine the genomic distribution of genes subject to positive selection in bovines. Gene expression analysis of four brain tissues and the anterior pituitary of 28 cows identified 70 RIDGEs and 41 anti-RIDGEs (harbouring 3735 and 1793 bovine genes respectively) across the bovine genome which are significantly higher than expected by chance. Housekeeping genes (defined here as genes expressed in all five tissues) were over-represented within RIDGEs but tissue-specific genes (genes expressed in only one of the five tissues) were not. Housekeeping genes and genes within RIDGEs had, in general, higher expression levels and GC content but shorter gene lengths and intron lengths than tissue-specific genes and genes within anti-RIDGES. Our findings suggest the existence of chromosomal regional regulation of transcription in the bovine genome. The genomic features observed for genes within RIDGEs and housekeeping genes in bovines agree with previous studies in several other species further strengthening the hypothesis of selective pressure to keep the highly and widely expressed genes short and compact for transcriptional efficiency. Further, positively selected genes were found non-randomly distributed on the genome with a preference for RIDGEs and regions of intermediate gene expression compared to anti-RIDGEs.	[Kommadath, Arun; Pas, Marinus F. W. Te; Veerkamp, Roel F.; Smits, Mari A.] Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands; [Nie, Haisheng; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kommadath, A (corresponding author), Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands.	arun.kommadath@wur.nl	Veerkamp, Roel/ABC-9073-2020; Groenen, Martien/D-8408-2012; veerkamp, roel/D-9313-2012; smits, mari/J-4892-2013; Kommadath, Arun/I-4644-2019	Veerkamp, Roel/0000-0002-5240-6534; Groenen, Martien/0000-0003-0484-4545; smits, mari/0000-0002-3493-291X; Kommadath, Arun/0000-0003-3587-6670	European Commission [FOOD-CT-2006-016250, FOOD-CT-2004-506416]; Dutch Ministry of Agriculture, Nature and Food Quality [KB-04-004-012]; International cattle breeding - CRV BV	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Agriculture, Nature and Food Quality; International cattle breeding - CRV BV	This work was co-financed by the European Commission funded projects SABRE (www.sabre-eu.eu/) (contract No. FOOD-CT-2006-016250) and EADGENE (www.eadgene.info/) (contract No. FOOD-CT-2004-506416), the Dutch Ministry of Agriculture, Nature and Food Quality (www.minlnv.nl) (KB-04-004-012) and the International cattle breeding co-operative - CRV BV (www.crv4all.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Donthu Ravikiran, 2009, BMC Res Notes, V2, P148, DOI 10.1186/1756-0500-2-148; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Folle GA, 2010, CYTOGENET GENOME RES, V128, P17, DOI 10.1159/000296072; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kommadath A, 2010, ANIMAL, V4, P1297, DOI 10.1017/S1751731110000303; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Nie HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011990; Nie HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-28; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20413	10.1371/journal.pone.0020413	http://dx.doi.org/10.1371/journal.pone.0020413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673989	gold, Green Published, Green Submitted			2022-12-27	WOS:000291355500017
J	Lopez-Munguia, A; Hernandez-Romero, Y; Pedraza-Chaverri, J; Miranda-Molina, A; Regla, I; Martinez, A; Castillo, E				Lopez-Munguia, Agustin; Hernandez-Romero, Yanet; Pedraza-Chaverri, Jose; Miranda-Molina, Alfonso; Regla, Ignacio; Martinez, Ana; Castillo, Edmundo			Phenylpropanoid Glycoside Analogues: Enzymatic Synthesis, Antioxidant Activity and Theoretical Study of Their Free Radical Scavenger Mechanism	PLOS ONE			English	Article							LIPASE-CATALYZED SYNTHESIS; PHENOLIC-ACIDS; CANDIDA-ANTARCTICA; DERIVATIVES	Phenylpropanoid glycosides (PPGs) are natural compounds present in several medicinal plants that have high antioxidant power and diverse biological activities. Because of their low content in plants (less than 5% w/w), several chemical synthetic routes to produce PPGs have been developed, but their synthesis is a time consuming process and the achieved yields are often low. In this study, an alternative and efficient two-step biosynthetic route to obtain natural PPG analogues is reported for the first time. Two galactosides were initially synthesized from vanillyl alcohol and homovanillyl alcohol by a transgalactosylation reaction catalyzed by Kluyveromyces lactis beta-galactosidase in saturated lactose solutions with a 30%-35% yield. To synthesize PPGs, the galactoconjugates were esterified with saturated and unsaturated hydroxycinnamic acid derivatives using Candida antarctica Lipase B (CaL-B) as a biocatalyst with 40%-60% yields. The scavenging ability of the phenolic raw materials, intermediates and PPGs was evaluated by the 2,2-diphenyl-1-picrylhydrazyl radical (DPPHN.) method. It was found that the biosynthesized PPGs had higher scavenging abilities when compared to ascorbic acid, the reference compound, while their antioxidant activities were found similar to that of natural PPGs. Moreover, density functional theory (DFT) calculations were used to determine that the PPGs antioxidant mechanism proceeds through a sequential proton loss single electron transfer (SPLET). The enzymatic process reported in this study is an efficient and versatile route to obtain PPGs from different phenylpropanoid acids, sugars and phenolic alcohols.	[Lopez-Munguia, Agustin; Hernandez-Romero, Yanet; Miranda-Molina, Alfonso; Castillo, Edmundo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico; [Pedraza-Chaverri, Jose] Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City 04510, DF, Mexico; [Martinez, Ana] Univ Nacl Autonoma Mexico, Dept Mat Condensada & Criogenia, Inst Invest Mat, Mexico City 04510, DF, Mexico; [Regla, Ignacio] Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lopez-Munguia, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	martina@iim.unam.mx; edmundo@ibt.unam.mx	, Regla/L-5486-2019; Regla, Ignacio/C-4878-2011	Martinez, Ana/0000-0002-0515-1946; Miranda, Alfonso/0000-0003-0418-6386; Lopez Munguia, Agustin/0000-0003-4204-4936; Castillo, Edmundo/0000-0002-8274-4307; Hernandez-Romero, Yanet/0000-0002-5826-0062	PAPIIT-UNAM (MEXICO) [IN226706-3]	PAPIIT-UNAM (MEXICO)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work has been supported by the grant IN226706-3 PAPIIT-UNAM (MEXICO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligiannis N, 2003, J AGR FOOD CHEM, V51, P7308, DOI 10.1021/jf034528+; BALAN K, 2006, Patent No. 20060280820; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bojarova P, 2009, TRENDS BIOTECHNOL, V27, P199, DOI 10.1016/j.tibtech.2008.12.003; Bridiau N, 2006, BIOTECHNOL PROGR, V22, P326, DOI 10.1021/bp050230n; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Cassani J, 2007, ELECTRON J BIOTECHN, V10, P508, DOI 10.2225/vol10-issue4-fulltext-3; Castillo E, 2003, J BIOTECHNOL, V102, P251, DOI 10.1016/S0168-1656(03)00050-6; Castillo E, 2007, FOOD CHEM, V100, P1202, DOI 10.1016/j.foodchem.2005.11.026; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Delazar A, 2008, J NAT MED-TOKYO, V62, P464, DOI 10.1007/s11418-008-0255-y; Duynstee HI, 1999, EUR J ORG CHEM, V1999, P2623; Ersoz T, 2003, Z NATURFORSCH C, V58, P471; Galano A, 2009, CHEM PHYS, V363, P13, DOI 10.1016/j.chemphys.2009.07.003; Gotor-Fernandez V, 2006, J MOL CATAL B-ENZYM, V40, P111, DOI 10.1016/j.molcatb.2006.02.010; Kawada T, 1999, J ORG CHEM, V64, P9268, DOI 10.1021/jo9906983; Kawada T, 2002, J WOOD SCI, V48, P512, DOI 10.1007/BF00766648; Kawada T, 2000, EUR J ORG CHEM, V2000, P2723, DOI 10.1002/1099-0690(200008)2000:15<2723::AID-EJOC2723>3.0.CO;2-Y; Kawada T, 2006, HOLZFORSCHUNG, V60, P492, DOI 10.1515/HF.2006.081; Kennedy JF, 2006, J CHEM TECHNOL BIOT, V81, P866, DOI 10.1002/jctb.1473; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Kurkin VA, 2003, CHEM NAT COMPD+, V39, P123, DOI 10.1023/A:1024876810579; Laporta O, 2004, AGRO FOOD IND HI TEC, V15, P30; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee GS, 2006, BIOTECHNOL LETT, V28, P581, DOI 10.1007/s10529-006-0019-2; Lee S, 2007, B KOR CHEM SOC, V28, P1787; Li Q, 2005, CARBOHYD RES, V340, P1601, DOI 10.1016/j.carres.2005.04.011; Li ZJ, 1998, ACTA CHIM SINICA, V56, P1128; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Martinez A, 2010, J PHYS CHEM C, V114, P8184, DOI 10.1021/jp100168q; Martinez A, 2009, J PHYS CHEM B, V113, P12113, DOI 10.1021/jp903958h; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; MOON JK, 2010, MOLECULES, V15, P4324; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Nenadis N, 2003, J AM OIL CHEM SOC, V80, P451, DOI 10.1007/s11746-003-0719-8; Otto RT, 2000, J MOL CATAL B-ENZYM, V8, P201, DOI 10.1016/S1381-1177(99)00058-2; Pan J, 2003, PHARMAZIE, V58, P767; Rolland Y., 2004, Patent WO, Patent No. [2004/069218 A1, 2004069218]; Sabally K, 2007, BIOCATAL BIOTRANSFOR, V25, P211, DOI 10.1080/10242420701379916; Shi YM, 1999, SCI CHINA SER C, V42, P420, DOI 10.1007/BF02882062; Shimoji Y, 2002, J AGR FOOD CHEM, V50, P6501, DOI 10.1021/jf020458f; Silva FAM, 2000, J AGR FOOD CHEM, V48, P2122, DOI 10.1021/jf9913110; Stamatis H, 2001, J MOL CATAL B-ENZYM, V11, P323, DOI 10.1016/S1381-1177(00)00016-3; Stevenson DE, 2006, ENZYME MICROB TECH, V39, P1236, DOI 10.1016/j.enzmictec.2006.03.006; STEVENSON DE, 1993, BIOTECHNOL BIOENG, V42, P657, DOI 10.1002/bit.260420514; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; WILDMAN REC, 2006, HDB NUTRACEUTICALS F, P1; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; Zhang SQ, 1997, CARBOHYD RES, V299, P281, DOI 10.1016/S0008-6215(97)00032-3; Zhang SQ, 1998, CARBOHYD RES, V308, P281, DOI 10.1016/S0008-6215(98)00092-5; Zhou FY, 2006, CARBOHYD RES, V341, P2469, DOI 10.1016/j.carres.2006.08.006	53	39	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20115	10.1371/journal.pone.0020115	http://dx.doi.org/10.1371/journal.pone.0020115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674039	Green Published, gold, Green Submitted			2022-12-27	WOS:000291355500006
J	Vladimirov, N; Traub, RD; Tu, YH				Vladimirov, Nikita; Traub, Roger D.; Tu, Yuhai			Wave Speed in Excitable Random Networks with Spatially Constrained Connections	PLOS ONE			English	Article							OSCILLATIONS; MODEL; DIFFUSION; PATTERNS	Very fast oscillations (VFO) in neocortex are widely observed before epileptic seizures, and there is growing evidence that they are caused by networks of pyramidal neurons connected by gap junctions between their axons. We are motivated by the spatio-temporal waves of activity recorded using electrocorticography (ECoG), and study the speed of activity propagation through a network of neurons axonally coupled by gap junctions. We simulate wave propagation by excitable cellular automata (CA) on random (Erdos-Renyi) networks of special type, with spatially constrained connections. From the cellular automaton model, we derive a mean field theory to predict wave propagation. The governing equation resolved by the Fisher-Kolmogorov PDE fails to describe wave speed. A new (hyperbolic) PDE is suggested, which provides adequate wave speed v(< k >) that saturates with network degree < k >, in agreement with intuitive expectations and CA simulations. We further show that the maximum length of connection is a much better predictor of the wave speed than the mean length. When tested in networks with various degree distributions, wave speeds are found to strongly depend on the ratio of network moments < k(2)>/< k > rather than on mean degree < k >, which is explained by general network theory. The wave speeds are strikingly similar in a diverse set of networks, including regular, Poisson, exponential and power law distributions, supporting our theory for various network topologies. Our results suggest practical predictions for networks of electrically coupled neurons, and our mean field method can be readily applied for a wide class of similar problems, such as spread of epidemics through spatial networks.	[Vladimirov, Nikita; Traub, Roger D.; Tu, Yuhai] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA	International Business Machines (IBM)	Vladimirov, N (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY USA.	nikita.vladimirov@gmail.com			NIH/NINDS [R01NS062955, R01NS44133, R01GM081747]; Alexander von Humboldt Stiftung; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062955, R01NS044133] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants NIH/NINDS (http://nih.gov) R01NS062955 to NV and RDT, R01NS44133 to RDT, R01GM081747 to YT, and Alexander von Humboldt Stiftung (www.humboldt-foundation.de) to RDT. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are employed by the IBM T.J. Watson Research Center and contributed to all aspects of the study.	ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Berg, 2018, RANDOM WALKS BIOL; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; dos Santos RMZ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168102; Furtado LS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011907; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; Hua H, 2009, P NATL ACAD SCI USA, V106, P1318, DOI 10.1073/pnas.0811973106; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Lewis TJ, 2000, NETWORK-COMP NEURAL, V11, P299, DOI 10.1088/0954-898X/11/4/304; Munro E, 2010, J COMPUT NEUROSCI, V28, P539, DOI 10.1007/s10827-010-0235-6; Murray J. D., 2001, MATH BIOL, V18; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roopun AK, 2009, EPILEPSY BEHAV, V14, P39, DOI 10.1016/j.yebeh.2008.09.008; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun XJ, 2008, CHAOS, V18, DOI 10.1063/1.2900402; Traub R.D., 2010, CORTICAL OSCILLATION; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Traub RD, 2008, EUR J NEUROSCI, V28, P1603, DOI 10.1111/j.1460-9568.2008.06477.x; Traub RD, 2010, EPILEPSIA, V51, P1587, DOI 10.1111/j.1528-1167.2009.02420.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; Zegura EW, 1996, IEEE INFOCOM SER, P594, DOI 10.1109/INFCOM.1996.493353	29	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20536	10.1371/journal.pone.0020536	http://dx.doi.org/10.1371/journal.pone.0020536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674028	gold, Green Submitted, Green Published			2022-12-27	WOS:000291355500021
J	Wang, ZW; Banerjee, S; Ahmad, A; Li, YW; Azmi, AS; Gunn, JR; Kong, DJ; Bao, B; Ali, S; Gao, JK; Mohammad, RM; Miele, L; Korc, M; Sarkar, FH				Wang, Zhiwei; Banerjee, Sanjeev; Ahmad, Aamir; Li, Yiwei; Azmi, Asfar S.; Gunn, Jason R.; Kong, Dejuan; Bao, Bin; Ali, Shadan; Gao, Jiankun; Mohammad, Ramzi M.; Miele, Lucio; Korc, Murray; Sarkar, Fazlul H.			Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-kappa B Signaling Pathways	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTRAEPITHELIAL NEOPLASIA; DOWN-REGULATION; GROWTH-FACTOR; CELL-GROWTH; MOUSE MODEL; KRAS; GEMCITABINE; PROGRESSION; DIFFERENTIATION	Background: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the United States, suggesting that novel strategies for the prevention and treatment of PDAC are urgently needed. K-ras mutations are observed in >90% of pancreatic cancer, suggesting its role in the initiation and early developmental stages of PDAC. In order to gain mechanistic insight as to the role of mutated K-ras, several mouse models have been developed by targeting a conditionally mutated K-ras(G12D) for recapitulating PDAC. A significant co-operativity has been shown in tumor development and metastasis in a compound mouse model with activated K-ras and Ink4a/Arf deficiency. However, the molecular mechanism(s) by which K-ras and Ink4a/Arf deficiency contribute to PDAC has not been fully elucidated. Methodology/Principal Findings: To assess the molecular mechanism(s) that are involved in the development of PDAC in the compound transgenic mice with activated K-ras and Ink4a/Arf deficiency, we used multiple methods, such as Real-time RT-PCR, western blotting assay, immunohistochemistry, MTT assay, invasion, EMSA and ELISA. We found that the deletion of Ink4a/Arf in K-ras(G12D) expressing mice leads to PDAC, which is in part mediated through the activation of Notch and NF-kappa B signaling pathways. Moreover, we found down-regulation of miR-200 family, which could also play important roles in tumor development and progression of PDAC in the compound transgenic mice. Conclusions/Significance: Our results suggest that the activation of Notch and NF-kappa B together with the loss of miR-200 family is mechanistically linked with the development and progression of PDAC in the compound K-ras(G12D) and Ink4a/Arf deficient transgenic mice.	[Wang, Zhiwei; Banerjee, Sanjeev; Ahmad, Aamir; Li, Yiwei; Azmi, Asfar S.; Kong, Dejuan; Bao, Bin; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Sch Med, Karmanos Canc Inst, Detroit, MI 48202 USA; [Ali, Shadan; Gao, Jiankun; Mohammad, Ramzi M.] Wayne State Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Detroit, MI 48201 USA; [Gao, Jiankun] Sichuan Coll Trandit Chinese Med, Mianyang, Sichuan, Peoples R China; [Miele, Lucio] Univ Mississippi, Inst Canc, Jackson, MS 39216 USA; [Gunn, Jason R.; Korc, Murray] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Gunn, Jason R.; Korc, Murray] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH USA; [Gunn, Jason R.; Korc, Murray] Dartmouth Hitchcock Med Ctr, Norris Cotton Comprehs Canc Ctr, Lebanon, NH 03766 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Mississippi; Dartmouth College; Dartmouth College; Dartmouth College	Wang, ZW (corresponding author), Wayne State Univ, Dept Pathol, Sch Med, Karmanos Canc Inst, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu	Gao, Jiankun/AAQ-5596-2021	AZMI, ASFAR/0000-0003-1178-9505; Miele, Lucio/0000-0002-5853-7287	National Cancer Institute, National Institutes of Health [5R01CA131151, 5R01CA131151-S02, 5R01CA132794, CA-075059]; Puschelberg and Guido foundations; NATIONAL CANCER INSTITUTE [R37CA075059, R01CA131151, R01CA132794, R01CA075059] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Puschelberg and Guido foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health grants 5R01CA131151, 5R01CA131151-S02, and 5R01CA132794 (F.H. Sarkar) and CA-075059 to M. Korc. The authors thank Puschelberg and Guido foundations for their generous financial contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Banerjee S, 2005, CANCER RES, V65, P9064, DOI 10.1158/0008-5472.CAN-05-1330; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; De la O JP, 2009, GASTROENTEROLOGY, V136, P1499, DOI 10.1053/j.gastro.2009.03.022; De La O JP, 2009, CELL CYCLE, V8, P1860, DOI 10.4161/cc.8.12.8744; Fendrich V, 2010, GUT, V59, P630, DOI 10.1136/gut.2009.188961; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Maliekal TT, 2008, ONCOGENE, V27, P5110, DOI 10.1038/onc.2008.224; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Oishi H, 2010, PANCREAS, V39, P897, DOI 10.1097/MPA.0b013e3181ce7185; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Ristorcelli E, 2010, EXPERT OPIN THER TAR, V14, P541, DOI 10.1517/14728221003769895; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Vincent DF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000575; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Wang ZW, 2010, CURR PROTEIN PEPT SC, V11, P398, DOI 10.2174/138920310791824039; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Yao J, 2010, MED ONCOL, V27, P1017, DOI 10.1007/s12032-009-9326-5; You L, 2010, CHINESE MED J-PEKING, V123, P1210, DOI 10.3760/cma.j.issn.0366-6999.2010.09.020	50	39	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20537	10.1371/journal.pone.0020537	http://dx.doi.org/10.1371/journal.pone.0020537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673986	Green Published, gold, Green Submitted			2022-12-27	WOS:000291355500022
J	Alvarez-Alfageme, F; Maharramov, J; Carrillo, L; Vandenabeele, S; Vercammen, D; Van Breusegem, F; Smagghe, G				Alvarez-Alfageme, Fernando; Maharramov, Jafar; Carrillo, Laura; Vandenabeele, Steven; Vercammen, Dominique; Van Breusegem, Frank; Smagghe, Guy			Potential Use of a Serpin from Arabidopsis for Pest Control	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITOR; DIGESTIVE PROTEINASES; CRYSTAL-STRUCTURE; CHYMOTRYPSIN-LIKE; MYZUS-PERSICAE; INSECT; PLANTS; LEPIDOPTERA; ADAPTATION; ENZYME	Although genetically modified (GM) plants expressing toxins from Bacillus thuringiensis (Bt) protect agricultural crops against lepidopteran and coleopteran pests, field-evolved resistance to Bt toxins has been reported for populations of several lepidopteran species. Moreover, some important agricultural pests, like phloem-feeding insects, are not susceptible to Bt crops. Complementary pest control strategies are therefore necessary to assure that the benefits provided by those insectresistant transgenic plants are not compromised and to target those pests that are not susceptible. Experimental GM plants producing plant protease inhibitors have been shown to confer resistance against a wide range of agricultural pests. In this study we assessed the potential of AtSerpin1, a serpin from Arabidopsis thaliana (L). Heynh., for pest control. In vitro assays were conducted with a wide range of pests that rely mainly on either serine or cysteine proteases for digestion and also with three non-target organisms occurring in agricultural crops. AtSerpin1 inhibited proteases from all pest and non-target species assayed. Subsequently, the cotton leafworm Spodoptera littoralis Boisduval and the pea aphid Acyrthosiphon pisum (Harris) were fed on artificial diets containing AtSerpin1, and S. littoralis was also fed on transgenic Arabidopsis plants overproducing AtSerpin1. AtSerpin1 supplied in the artificial diet or by transgenic plants reduced the growth of S. littoralis larvae by 65% and 38%, respectively, relative to controls. Nymphs of A. pisum exposed to diets containing AtSerpin1 suffered high mortality levels (LC50 = 637 mu g ml(-1)). The results indicate that AtSerpin1 is a good candidate for exploitation in pest control.	[Alvarez-Alfageme, Fernando; Maharramov, Jafar; Carrillo, Laura; Smagghe, Guy] Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium; [Vandenabeele, Steven; Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent, VIB Dept Plant Syst Biol, B-9000 Ghent, Belgium; [Vandenabeele, Steven; Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Alvarez-Alfageme, F (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	fernando.alvarez@art.admin.ch; guy.smagghe@ugent.be	Van Breusegem, Frank/Y-2999-2019; Smagghe, Guy/AAE-8914-2019; Van Breusegem, Frank/AAJ-2647-2020; Carrillo, Laura/K-8472-2017	Smagghe, Guy/0000-0001-8334-3313; Van Breusegem, Frank/0000-0002-3147-0860; Carrillo, Laura/0000-0003-2215-322X; Alvarez, Fernando/0000-0001-8932-3823	Ghent University; Industrial Research Fund (IOF); Multidisciplinary Research Partnership Ghent Bio-economy, of COST Action [862]; Fund for Scientific Research-Flanders (FWO-Vlaanderen); BELSPO [12TKM106]; Marie Curie Fellowship [MOIF-CT-2004]	Ghent University(Ghent University); Industrial Research Fund (IOF); Multidisciplinary Research Partnership Ghent Bio-economy, of COST Action; Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); BELSPO(Belgian Federal Science Policy Office); Marie Curie Fellowship(European Commission)	The authors acknowledge the support of Ghent University, particularly the Industrial Research Fund (IOF) and the Multidisciplinary Research Partnership Ghent Bio-economy, of COST Action 862 to LC, and of Fund for Scientific Research-Flanders (FWO-Vlaanderen) to DV. SV was recipient of a BELSPO grant (12TKM106) and a Marie Curie Fellowship (MOIF-CT-2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Al-Khunaizi M, 2002, BIOCHEMISTRY-US, V41, P3189, DOI 10.1021/bi015999x; Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; BEWLEY GC, 1968, COMP BIOCHEM PHYSIOL, V25, P1061, DOI 10.1016/0010-406X(68)90591-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes G., 2005, AgBioForum, V8, P187; Bruning M, 2007, BIOCHEM J, V401, P325, DOI 10.1042/BJ20060648; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowgill SE, 2002, MOL ECOL, V11, P821, DOI 10.1046/j.1365-294X.2002.01482.x; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; De Leo F, 2001, INSECT BIOCHEM MOLEC, V31, P593, DOI 10.1016/S0965-1748(00)00164-8; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; Deraison C, 2004, INSECT MOL BIOL, V13, P165, DOI 10.1111/j.0962-1075.2004.00474.x; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Dutton A, 2005, ENTOMOL EXP APPL, V114, P161, DOI 10.1111/j.1570-7458.2005.00239.x; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; LEE MJ, 1995, INSECT BIOCHEM MOLEC, V25, P49, DOI 10.1016/0965-1748(94)00042-G; Malone LA, 2000, APIDOLOGIE, V31, P25, DOI 10.1051/apido:2000104; Malone Louise A., 2008, V5, P357, DOI 10.1007/978-1-4020-8373-0_13; Marchetti S, 2000, THEOR APPL GENET, V101, P519, DOI 10.1007/s001220051511; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; Mulligan EA, 2010, PEST MANAG SCI, V66, P325, DOI 10.1002/ps.1879; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Novillo C, 1997, ARCH INSECT BIOCHEM, V36, P181, DOI 10.1002/(SICI)1520-6327(1997)36:3<181::AID-ARCH3>3.0.CO;2-X; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Ortego F, 1996, ARCH INSECT BIOCHEM, V33, P163, DOI 10.1002/(SICI)1520-6327(1996)33:2&lt;163::AID-ARCH6&gt;3.0.CO;2-Z; Pilcher CD, 1997, J ECON ENTOMOL, V90, P669, DOI 10.1093/jee/90.2.669; Rahbe Y, 2003, INSECT BIOCHEM MOLEC, V33, P299, DOI 10.1016/S0965-1748(02)00244-8; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rasmussen SK, 1996, PLANT MOL BIOL, V30, P673, DOI 10.1007/BF00049343; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Ribeiro APO, 2006, J APPL ENTOMOL, V130, P84, DOI 10.1111/j.1439-0418.2005.01021.x; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Shahidi-Noghabi S, 2008, PHYTOCHEMISTRY, V69, P2972, DOI 10.1016/j.phytochem.2008.09.012; Toenniessen GH, 2003, CURR OPIN PLANT BIOL, V6, P191, DOI 10.1016/S1369-5266(03)00002-5; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Yoo BC, 2000, J BIOL CHEM, V275, P35122, DOI 10.1074/jbc.M006060200; ZWILLING R, 1972, COMP BIOCHEM PHYSIOL, V43, P419, DOI 10.1016/0305-0491(72)90302-1	57	22	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20278	10.1371/journal.pone.0020278	http://dx.doi.org/10.1371/journal.pone.0020278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655276	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600035
J	Chen, ZS; Xiao, YN; Zhang, JJ; Li, J; Liu, YX; Zhao, YY; Ma, CC; Luo, J; Qiu, YM; Huang, G; Korteweg, C; Gu, J				Chen, Zhengshan; Xiao, Yanna; Zhang, Junjun; Li, Jing; Liu, Yuxuan; Zhao, Yingying; Ma, Changchun; Luo, Jin; Qiu, Yamei; Huang, Guowei; Korteweg, Christine; Gu, Jiang			Transcription Factors E2A, FOXO1 and FOXP1 Regulate Recombination Activating Gene Expression in Cancer Cells	PLOS ONE			English	Article							ALPHA HEAVY-CHAIN; V(D)J RECOMBINATION; IMMUNOGLOBULIN-G; B-CELLS; LYMPHOCYTE DEVELOPMENT; NONLYMPHOID CELLS; RAG-2 PROMOTER; PROTEINS; REARRANGEMENT; CARCINOMAS	It has long been accepted that immunoglobulins (Igs) were produced by B lymphoid cells only. Recently Igs have been found to be expressed in various human cancer cells and promote tumor growth. Recombination activating gene 1 (RAG1) and RAG2, which are essential enzymes for initiating variable-diversity-joining segment recombination, have also been found to be expressed in cancer cells. However, the mechanism of RAG activation in these cancer cells has not been elucidated. Here, we investigated the regulatory mechanism of RAG expression in four human cancer cell lines by analyzing transcription factors that induce RAG activation in B cells. By RT-PCR, Western blot and immunofluorescence, we found that transcription factors E2A, FOXO1 and FOXP1 were expressed and localized to the nuclei of these cancer cells. Overexpression of E2A, FOXO1 or Foxp1 increased RAG expression, while RNA interference of E2A, FOXO1 or FOXP1 decreased RAG expression in the cancer cells. Chromatin immunoprecipitation experiments showed acetylation of RAG enhancer (Erag) and E2A, FOXO1 or FOXP1 were bound to Erag in vivo. These results indicate that in these cancer cells the transcription factors E2A, FOXO1 and FOXP1 regulate RAG expression, which initiates Ig gene rearrangement much in the way similar to B lymphocytes.	[Chen, Zhengshan; Xiao, Yanna; Zhang, Junjun; Li, Jing; Ma, Changchun; Luo, Jin; Qiu, Yamei; Huang, Guowei; Korteweg, Christine; Gu, Jiang] Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China; [Liu, Yuxuan; Zhao, Yingying; Gu, Jiang] Peking Beijing Univ, Dept Pathol, Hlth Sci Ctr, Beijing, Peoples R China	Shantou University; Peking University	Chen, ZS (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Ma, Changchun/AAI-4282-2020; Liu, Yuxuan/F-4226-2018	Gu, Jiang/0000-0002-0706-8329; Liu, Yuxuan/0000-0003-4426-9290	National Natural Science Foundation of China [81001199, 81030033, 30971150, 30950110335]; Guangdong Colleges and Universities [LYM10079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Colleges and Universities	This work was supported by grants (81001199 to ZC, 81030033, 30971150 to JG, 30950110335 to KC) from the National Natural Science Foundation of China, and grant LYM10079 to ZC from the Innovative Talents Program of Guangdong Colleges and Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2010, MOL VIS, V16, P408; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Banham AH, 2001, CANCER RES, V61, P8820; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Deng Yu-qing, 2006, Zhonghua Zhongliu Zazhi, V28, P88; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; Geng LY, 2007, WORLD J GASTROENTERO, V13, P2305, DOI 10.3748/wjg.v13.i16.2305; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2009, J HISTOCHEM CYTOCHEM, V57, P339, DOI 10.1369/jhc.2008.951434; Iacobucci I, 2008, BLOOD, V112, P3847, DOI 10.1182/blood-2007-09-112631; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kishi H, 2002, BLOOD, V99, P576, DOI 10.1182/blood.V99.2.576; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Lauring J, 1999, MOL CELL BIOL, V19, P2601; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Qiu XY, 2003, CANCER RES, V63, P6488; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wei XC, 2005, EUR J IMMUNOL, V35, P612, DOI 10.1002/eji.200425185; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009	44	17	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20475	10.1371/journal.pone.0020475	http://dx.doi.org/10.1371/journal.pone.0020475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655267	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600076
J	Moodley, P; Shah, NS; Tayob, N; Connolly, C; Zetola, N; Gandhi, N; Friedland, G; Sturm, AW				Moodley, Prashini; Shah, N. Sarita; Tayob, Nabihah; Connolly, Cathy; Zetola, Nicola; Gandhi, Neel; Friedland, Gerald; Sturm, A. Willem			Spread of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa	PLOS ONE			English	Article								Background: In 2005 a cluster of 53 HIV-infected patients with extensively drug-resistant tuberculosis (XDR-TB) was detected in the Msinga sub-district, the catchment area for the Church of Scotland Hospital (CoSH) in Tugela Ferry, in KwaZulu-Natal province (KZN), South Africa. KZN is divided into 11 healthcare districts. We sought to determine the distribution of XDR TB cases in the province in relation to population density. Methods: In this cross-sectional study, the KZN tuberculosis laboratory database was analysed. Results of all patients with a sputum culture positive for Mycobacterium tuberculosis from January 2006 to June 2007 were included. Drug-susceptibility test results for isoniazid, rifampicin, ethambutol, streptomycin, kanamycin and ofloxacin were available for all patients as well as the location of the hospital where their clinical diagnosis was made. Findings: In total, 20858 patients attending one of 73 hospitals or their adjacent clinics had cultures positive for M. tuberculosis. Of these, 4170 (20%) were MDR-TB cases. Four hundred and forty three (11%) of the MDR tuberculosis cases displayed the XDR tuberculosis susceptibility profile. Only 1429 (34%) of the MDR-TB patients were seen at the provincial referral hospital for treatment. The proportion of XDR-TB amongst culture-confirmed cases was highest in the Msinga subdistrict (19.6%), followed by the remaining part of the Umzinyati district (5.9%) and the other 10 districts (1.1%). The number of hospitals with at least one XDR-TB case increased from 18 (25%) to 58 (80%) during the study period. Interpretation: XDR-TB is present throughout KZN. More than 65% of all diagnosed MDR-TB cases, including XDR-TB patients, were left untreated and likely remained in the community as a source of infection.	[Moodley, Prashini; Shah, N. Sarita; Gandhi, Neel; Friedland, Gerald; Sturm, A. Willem] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Moodley, Prashini; Sturm, A. Willem] Univ KwaZulu Natal, Dept Infect Prevent & Control, Durban, South Africa; [Moodley, Prashini; Sturm, A. Willem] KwaZulu Natal Dept Hlth, Durban, South Africa; [Shah, N. Sarita; Gandhi, Neel] Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA; [Shah, N. Sarita; Gandhi, Neel] Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA; [Shah, N. Sarita; Gandhi, Neel] Albert Einstein Coll Med, Div Epidemiol, Bronx, NY 10467 USA; [Shah, N. Sarita; Gandhi, Neel; Friedland, Gerald] Tugela Ferry Care & Res TF CaRes Collaborat, Tugela Ferry, Kwazulu Natal, South Africa; [Tayob, Nabihah; Connolly, Cathy] MRC, Durban, Kwazulu Natal, South Africa; [Zetola, Nicola] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Friedland, Gerald] Yale Univ, Sch Med, Yale AIDS Program, New Haven, CT USA	University of Kwazulu Natal; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Yale University	Moodley, P (corresponding author), KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa.	moodleyp@ukzn.ac.za		Moodley, Pravi/0000-0002-9946-8783	NIAID NIH HHS [R01 AI097045] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097045] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*DEP HLTH S AFR, 2007, NAT HIV SYPH PREV SU; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; HACEK D, 1992, CLIN MICROBIOLOGY PR, V1; HARRISON D, 2009, REPORT OVERVIEW HLTH; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; *STAT S AFR, 2003, STAT REL P0302; WEYER K, 2003, SURVEY TUBERCULOSIS; WHO, 2009, WHOHTMTB2009411	9	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e17513	10.1371/journal.pone.0017513	http://dx.doi.org/10.1371/journal.pone.0017513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655324	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600002
J	Liu, ZN; Tang, R; Zhou, ZY; Song, ZC; Wang, HC; Gu, Y				Liu, Zhengni; Tang, Rui; Zhou, Zhiyuan; Song, Zhicheng; Wang, Huichun; Gu, Yan			Comparison of Two Porcine-Derived Materials for Repairing Abdominal Wall Defects in Rats	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; INCISIONAL HERNIA REPAIR; MODEL; MATRIX	Objective: The purpose of this study was to compare the mechanical properties, host responses and incorporation of porcine small intestine submucosa (PSIS) and porcine acellular dermal matrix (PADM) in a rat model of abdominal wall defect repair. Materials and Methods: Prior to implantation, PSIS and PADM were prepared and evaluated in terms of structure and mechanical properties. Full-thickness abdominal wall defects were created in 50 Sprague-Dawley rats, and were repaired using either PSIS or PADM. Rats were sacrificed 1, 2, 4, 8 and 12 weeks post-repair and examined for herniation, infection, adhesions, contraction, and changes in the thickness and strength of the tissues incorporated at the defect sites. Histopathology and immunohistochemistry were performed to analyze inflammatory responses, collagen deposition and vascularization. Results: PADM showed more dense collagen deposition and stronger mechanical properties than PSIS prior to implantation (P < 0.01). However, the mechanical properties observed after integration with the surrounding native tissues was similar for PADM and PSIS. Both PADM and PSIS showed significant contraction by week 12. However, PADM tissue induced less adhesion and increased in thickness more slowly, and showed less infiltration by foreign giant cells, polymorphonuclear cells, and mononuclear cells. Improved remodeling of host tissue was observed after PSIS implantation, which was apparent from the orientation of bands of fibrous connective tissue, intermixed with newly formed blood vessels by Week 12. Conclusion: PSIS showed weaker mechanical properties prior to implantation. However, after implantation PSIS induced more pronounced host responses and showed better incorporation into host tissues than PADM.	[Liu, Zhengni] Shanghai Jiao Tong Univ, Dept Gen Surg, Shanghai Hosp 9, Sch Med, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Hernia & Abdominal Wall Surg Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, ZN (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Shanghai Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	yangu@sjtu.edu.cn	liu, zhengni/ABB-8664-2020; Gu, Yan/AFQ-1163-2022	liu, zhengni/0000-0002-7262-2568; 	Shanghai Jiao Tong University [YG2009MS36]	Shanghai Jiao Tong University	This work was supported by a grant from the Medicine-Engineering Project, Shanghai Jiao Tong University (YG2009MS36) (website: http://foundation. sjtu.edu.cn/Foundation/article_show.php?id=135&type=2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ASTM, 2002, ANN BOOK ASTM STAND, V7, P1; Ayubi FS, 2008, HERNIA, V12, P373, DOI 10.1007/s10029-008-0359-z; Butler CE, 2006, CLIN PLAST SURG, V33, P199, DOI 10.1016/j.cps.2005.12.009; Eriksen J R, 2007, Hernia, V11, P481, DOI 10.1007/s10029-007-0282-8; Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154; Iannitti DA, 2008, J AM COLL SURGEONS, V206, P83, DOI 10.1016/j.jamcollsurg.2007.07.030; JENKINS SD, 1983, SURGERY, V94, P392; Lai JY, 2003, J PEDIATR SURG, V38, P1752, DOI 10.1016/j.jpedsurg.2003.08.019; Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012; MacLeod TM, 2004, BURNS, V30, P431, DOI 10.1016/j.burns.2004.01.018; Meyer T, 2006, PEDIATR SURG INT, V22, P369, DOI 10.1007/s00383-006-1658-z; Petter-Puchner AH, 2008, J SURG RES, V145, P105, DOI 10.1016/j.jss.2007.03.090; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Wasserberg N, 2007, J SURG RES, V141, P294, DOI 10.1016/j.jss.2006.12.541	14	23	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20520	10.1371/journal.pone.0020520	http://dx.doi.org/10.1371/journal.pone.0020520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637777	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200076
J	Nascimbeni, M; Pol, S; Saunier, B				Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand			Distinct CD4(+)CD8(+) Double-Positive T Cells in the Blood and Liver of Patients during Chronic Hepatitis B and C	PLOS ONE			English	Article							PERIPHERAL-BLOOD; IMMUNE-RESPONSES; MEMORY CELLS; IN-VIVO; VIRUS; LYMPHOCYTES; LINEAGE	CD4(+) and CD8(+) T cells, the main effectors of adaptive cellular immune responses, differentiate from immature, non-functional CD4(+) CD8(+) double-positive T (DPT) cells in the thymus. Increased proportions of circulating DPT lymphocytes have been observed during acute viral infections; in chronic viral diseases, the role and repartition of extra-thymic DPT cells remain largely uncharacterized. We performed a phenotypic analysis of DPT cells in blood and liver from patients chronically infected by hepatitis C (HCV) or B (HBV) viruses. The highest percentages of DPT cells, predominantly CD4(high)CD8(low), were observed in patients infected by HCV, while HBV-infected patients mostly displayed CD4(low)CD8(high) and CD4(high)CD8(high) DPT cells. All proportions of DPT cells were higher in liver than in blood with, for each subpopulation referred to above, a correlation between their frequencies in these two compartments. In HCV patients, intra-hepatic DPT cells displayed more heterogeneous activation, differentiation and memory phenotypes than in the blood; most of them expressed CD1a, a marker of T cell development in the thymus. Ex vivo, the inoculation of liver slices with HCV produced in cell culture was accompanied by a disappearance of CD8(high) cells, suggesting a direct effect of the virus on the phenotype of DPT cells in the liver. Our results suggest that, in half of the patients, chronic HCV infection promotes the production of DPT cells, perhaps by their re-induction in the thymus and selection in the liver.	[Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand] Paris Descartes Univ, Fac Med, Paris, France; [Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand] CNRS, Inst Cochin, UMR8104, Paris, France; [Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand] INSERM, U1016, Paris, France; [Pol, Stanislas] Cochin Hosp, AP HP, Hepatol Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Nascimbeni, M (corresponding author), Paris Descartes Univ, Fac Med, Paris, France.	bertrand.saunier@inserm.fr		Saunier, Bertrand/0000-0002-0700-3082	Roche	Roche(Roche Holding)	MN was a recipient of a fellowship from Roche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Beq S, 2009, BLOOD, V114, P816, DOI 10.1182/blood-2008-11-191288; BLUE ML, 1985, J IMMUNOL, V134, P2281; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fritz EA, 2008, VIRAL IMMUNOL, V21, P355, DOI 10.1089/vim.2008.0023; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Howe R, 2009, JAIDS-J ACQ IMM DEF, V50, P444, DOI 10.1097/QAI.0b013e31819aa8c4; Hughes GJ, 2008, AIDS, V22, P57, DOI 10.1097/QAD.0b013e3282f151b9; Jimenez E, 2002, J IMMUNOL, V168, P5005, DOI 10.4049/jimmunol.168.10.5005; Lima M, 2003, AM J PATHOL, V163, P763, DOI 10.1016/S0002-9440(10)63703-0; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Nam KH, 2000, INT IMMUNOL, V12, P1095, DOI 10.1093/intimm/12.7.1095; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Periwal SB, 1999, J VIROL, V73, P7633; Rahemtullah A, 2008, LEUKEMIA LYMPHOMA, V49, P1870, DOI 10.1080/10428190802308728; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Triyatni M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001333; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x	30	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20145	10.1371/journal.pone.0020145	http://dx.doi.org/10.1371/journal.pone.0020145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647449	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500027
J	Marjaneh, MM; Kirk, EP; Posch, MG; Ozcelik, C; Berger, F; Hetzer, R; Otway, R; Butler, TL; Blue, GM; Griffiths, LR; Fatkin, D; Martinson, JJ; Winlaw, DS; Feneley, MP; Harvey, RP				Marjaneh, Mahdi Moradi; Kirk, Edwin P.; Posch, Maximilian G.; Ozcelik, Cemil; Berger, Felix; Hetzer, Roland; Otway, Robyn; Butler, Tanya L.; Blue, Gillian M.; Griffiths, Lyn R.; Fatkin, Diane; Martinson, Jeremy J.; Winlaw, David S.; Feneley, Michael P.; Harvey, Richard P.			Investigation of Association between PFO Complicated by Cryptogenic Stroke and a Common Variant of the Cardiac Transcription Factor GATA4	PLOS ONE			English	Article							PATENT FORAMEN OVALE; CONGENITAL HEART-DISEASE; ATRIAL SEPTAL-DEFECTS; RISK-FACTOR; MUTATIONS; MIGRAINE; NKX2.5; ECHOCARDIOGRAPHY; LIPOPROTEIN(A); GATA-4/5/6	Patent foramen ovale (PFO) is associated with clinical conditions including cryptogenic stroke, migraine and varicose veins. Data from studies in humans and mouse suggest that PFO and the secundum form of atrial septal defect (ASDII) exist in an anatomical continuum of septal dysmorphogenesis with a common genetic basis. Mutations in multiple members of the evolutionarily conserved cardiac transcription factor network, including GATA4, cause or predispose to ASDII and PFO. Here, we assessed whether the most prevalent variant of the GATA4 gene, S377G, was significantly associated with PFO or ASD. Our analysis of world indigenous populations showed that GATA4 S377G was largely Caucasian-specific, and so subjects were restricted to those of Caucasian descent. To select for patients with larger PFO, we limited our analysis to those with cryptogenic stroke in which PFO was a subsequent finding. In an initial study of Australian subjects, we observed a weak association between GATA4 S377G and PFO/Stroke relative to Caucasian controls in whom ASD and PFO had been excluded (OR = 2.16; p = 0.02). However, in a follow up study of German Caucasians no association was found with either PFO or ASD. Analysis of combined Australian and German data confirmed the lack of a significant association. Thus, the common GATA4 variant S377G is likely to be relatively benign in terms of its participation in CHD and PFO/Stroke.	[Marjaneh, Mahdi Moradi; Otway, Robyn; Fatkin, Diane; Feneley, Michael P.; Harvey, Richard P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Marjaneh, Mahdi Moradi; Kirk, Edwin P.; Fatkin, Diane; Feneley, Michael P.; Harvey, Richard P.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia; [Posch, Maximilian G.; Ozcelik, Cemil] Charite, ECRC, D-13353 Berlin, Germany; [Posch, Maximilian G.; Berger, Felix; Hetzer, Roland] Deutsch Herzzentrum Berlin, Berlin, Germany; [Butler, Tanya L.; Blue, Gillian M.; Winlaw, David S.] Childrens Hosp, Heart Ctr Children, Westmead, NSW, Australia; [Butler, Tanya L.; Winlaw, David S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Griffiths, Lyn R.] Griffith Univ, Genom Res Ctr, Gold Coast, Australia; [Fatkin, Diane] St Vincents Hosp, Dept Cardiol, Darlinghurst, NSW 2010, Australia; [Martinson, Jeremy J.] Univ Pittsburgh, Pittsburgh, PA USA	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; University of Sydney; University of Sydney; Griffith University; St Vincents Hospital Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marjaneh, MM (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	r.harvey@victorchang.edu.au	Ward, Tanya/J-4882-2015; Winlaw, David/B-9405-2019; Winlaw, David S/F-8365-2016	Ward, Tanya/0000-0003-1576-521X; Winlaw, David/0000-0001-8005-3361; Winlaw, David S/0000-0001-8005-3361; Martinson, Jeremy/0000-0003-4673-7238; Kirk, Edwin/0000-0002-4662-0024; Berger, Felix/0000-0001-7881-1557; Blue, Gillian M/0000-0002-1480-9535; Harvey, Richard/0000-0002-9950-9792	National Institutes of Health, USA (NIHLB) [ID 1RO1HL68885-01]; German Helmholtz Association [VH-VI-152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068885] Funding Source: NIH RePORTER	National Institutes of Health, USA (NIHLB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Helmholtz Association(Helmholtz Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: The study was supported by a grant from the National Institutes of Health, USA (NIHLB; 2002-2004; ID 1RO1HL68885-01) (http://www.nhlbi.nih.gov/funding/index.htm). The German study was supported by the German Helmholtz Association (VH-VI-152) http://www.helmholtz.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Arquizan C, 2001, STROKE, V32, P1563, DOI 10.1161/01.STR.32.7.1563; Aslam F, 2006, SOUTH MED J, V99, P1367, DOI 10.1097/01.smj.0000251839.59000.47; Balzer David T., 2004, Curr Treat Options Cardiovasc Med, V6, P417, DOI 10.1007/s11936-004-0025-4; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; BELKIN RN, 1986, AM J CARDIOL, V57, P310, DOI 10.1016/0002-9149(86)90909-4; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; BRIDGES ND, 1992, CIRCULATION, V86, P1902, DOI 10.1161/01.CIR.86.6.1902; Butler TL, 2010, GENET TEST MOL BIOMA, V14, P797, DOI 10.1089/gtmb.2010.0028; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Centers for Disease Control and Prevention; National Center for Injury Prevention Control, 2007, WISQARS LEAD CAUS DE; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chen XN, 1999, GENOME RES, V9, P492; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dalla Volta Giorgio, 2005, J Headache Pain, V6, P328, DOI 10.1007/s10194-005-0223-9; De Castro S, 2000, STROKE, V31, P2407, DOI 10.1161/01.STR.31.10.2407; Di Tullio Marco R, 2002, Curr Cardiol Rep, V4, P141; DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; FELDT RH, 1971, MAYO CLIN PROC, V46, P794; Ferrarini Giovanni, 2005, J Headache Pain, V6, P71, DOI 10.1007/s10194-005-0154-5; Garg P, 2010, CIRCULATION, V121, P1406, DOI 10.1161/CIRCULATIONAHA.109.895110; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HANLEY PC, 1985, J AM COLL CARDIOL, V6, P1370, DOI 10.1016/S0735-1097(85)80228-X; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Kasahara H, 2004, CARDIOVASC RES, V64, P40, DOI 10.1016/j.cardiores.2004.06.004; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kirk EP, 2006, CIRC RES, V98, P651, DOI 10.1161/01.RES.0000209965.59312.aa; Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Lippi G, 2003, CRIT REV CL LAB SCI, V40, P1, DOI 10.1080/713609328; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Marcovina SM, 1998, AM J CARDIOL, V82, p57U, DOI 10.1016/S0002-9149(98)00954-0; Martinson JJ, 2000, AIDS, V14, P483, DOI 10.1097/00002030-200003310-00003; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; McMahon CJ, 2002, HEART, V87, P256, DOI 10.1136/heart.87.3.256; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Musolino R, 2003, CEREBROVASC DIS, V15, P121, DOI 10.1159/000067139; Negi S, 2004, BIOCHEM J, V379, P151, DOI 10.1042/BJ20030985; Ng MYM, 2005, J MED GENET, V42, P235, DOI 10.1136/jmg.2004.024075; Onorato Eustaquio, 2003, J Interv Cardiol, V16, P43; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Poirier O, 2003, EUR J HUM GENET, V11, P659, DOI 10.1038/sj.ejhg.5201023; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; RANOUX D, 1993, STROKE, V24, P31, DOI 10.1161/01.STR.24.1.31; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2004, AM J PATHOL, V164, P2117, DOI 10.1016/S0002-9440(10)63770-4; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Sarkozy A, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.026740; Schluterman MK, 2007, AM J MED GENET A, V143A, P817, DOI 10.1002/ajmg.a.31652; Schneider B, 1996, AM J CARDIOL, V77, P1202, DOI 10.1016/S0002-9149(96)00163-4; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schuchlenz HW, 2000, AM J MED, V109, P456, DOI 10.1016/S0002-9343(00)00530-1; Schwerzmann M, 2001, ANN INTERN MED, V134, P21, DOI 10.7326/0003-4819-134-1-200101020-00009; Schwerzmann M, 2004, NEUROLOGY, V62, P1399, DOI 10.1212/01.WNL.0000120677.64217.A9; Sherin Chikhani, 2008, Open Neurol J, V2, P35, DOI 10.2174/1874205X00802010035; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Wilmshurst PT, 2004, HEART, V90, P1315, DOI 10.1136/hrt.2003.025700; Wright DD, 2010, J VASC SURG, V51, P104, DOI 10.1016/j.jvs.2009.08.008; ZABALGOITIAREYES M, 1990, AM J CARDIOL, V66, P761, DOI 10.1016/0002-9149(90)91146-W	67	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20711	10.1371/journal.pone.0020711	http://dx.doi.org/10.1371/journal.pone.0020711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673957	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000291356400021
J	Pazirandeh, A; Sultana, T; Mirza, M; Rozell, B; Hultenby, K; Wallis, K; Vennstrom, B; Davis, B; Arner, A; Heuchel, R; Lohr, M; Philipson, L; Sollerbrant, K				Pazirandeh, Ahmad; Sultana, Taranum; Mirza, Momina; Rozell, Bjorn; Hultenby, Kjell; Wallis, Karin; Vennstrom, Bjorn; Davis, Ben; Arner, Anders; Heuchel, Rainer; Lohr, Matthias; Philipson, Lennart; Sollerbrant, Kerstin			Multiple Phenotypes in Adult Mice following Inactivation of the Coxsackievirus and Adenovirus Receptor (Car) Gene	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULES; TIGHT JUNCTION; ENDOTHELIAL-CELLS; TISSUE-INJURY; GERM-CELLS; EXPRESSION; PANCREAS; PROTEIN; MOUSE; VIRUS	To determine the normal function of the Coxsackievirus and Adenovirus Receptor (CAR), a protein found in tight junctions and other intercellular complexes, we constructed a mouse line in which the CAR gene could be disrupted at any chosen time point in a broad spectrum of cell types and tissues. All knockouts examined displayed a dilated intestinal tract and atrophy of the exocrine pancreas with appearance of tubular complexes characteristic of acinar-to-ductal metaplasia. The mice also exhibited a complete atrio-ventricular block and abnormal thymopoiesis. These results demonstrate that CAR exerts important functions in the physiology of several organs in vivo.	[Pazirandeh, Ahmad] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Sultana, Taranum; Mirza, Momina; Sollerbrant, Kerstin] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Sultana, Taranum; Mirza, Momina; Sollerbrant, Kerstin] Univ Hosp, Stockholm, Sweden; [Rozell, Bjorn; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Rozell, Bjorn; Hultenby, Kjell] Univ Hosp, Huddinge, Sweden; [Wallis, Karin; Vennstrom, Bjorn; Philipson, Lennart] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Davis, Ben; Arner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Heuchel, Rainer; Lohr, Matthias] Karolinska Inst, Dept Clin Sci Intervent & Technol, Huddinge, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Pazirandeh, A (corresponding author), Ludwig Inst Canc Res, Stockholm Branch, S-10401 Stockholm, Sweden.	kerstin.sollerbrant@ki.se	Löhr, Matthias/A-3692-2012; Heuchel, Rainer/P-7875-2019	Löhr, Matthias/0000-0002-7647-198X; Heuchel, Rainer/0000-0002-2782-585X	Swedish Cancer Society [100344]; Swedish Heart-Lung Foundation; Swedish Research Council; RMT Swedish Association of People with Stomach and Bowel Diseases; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); RMT Swedish Association of People with Stomach and Bowel Diseases; Karolinska Institutet(Karolinska Institutet)	This work was supported by: 1. The Swedish Cancer Society (100344) (www.cancerfonden.se); 2. The Swedish Heart-Lung Foundation; 3. The Swedish Research Council; 4. RMT Swedish Association of People with Stomach and Bowel Diseases; 5. The Karolinska Institutet (core facility for mouse physiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders M, 2003, CANCER RES, V63, P2088; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Bockman DE, 2003, LAB INVEST, V83, P853, DOI 10.1097/01.LAB.0000074918.31303.5A; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Carson SD, 1999, J VIROL, V73, P7077, DOI 10.1128/JVI.73.8.7077-7079.1999; Caruso L, 2010, J MOL CELL CARDIOL, V48, P1194, DOI 10.1016/j.yjmcc.2010.01.022; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Farmer C, 2009, EXP CELL RES, V315, P2637, DOI 10.1016/j.yexcr.2009.06.008; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; Hatcher JP, 2001, BEHAV BRAIN RES, V125, P43, DOI 10.1016/S0166-4328(01)00275-3; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Hutchin ME, 2000, HUM GENE THER, V11, P2365, DOI 10.1089/104303400750038471; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Ito M, 2000, CIRC RES, V86, P275, DOI 10.1161/01.RES.86.3.275; Jimenez RE, 1999, AM J PATHOL, V154, P1223, DOI 10.1016/S0002-9440(10)65374-6; Kallewaard NL, 2009, CELL HOST MICROBE, V6, P91, DOI 10.1016/j.chom.2009.05.018; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Mirza M, 2007, ENDOCRINOLOGY, V148, P5459, DOI 10.1210/en.2007-0359; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Nalbantoglu J, 1999, HUM GENE THER, V10, P1009, DOI 10.1089/10430349950018409; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Piron J, 2008, MOL THER, V16, P1937, DOI 10.1038/mt.2008.209; POUND AW, 1981, BRIT J EXP PATHOL, V62, P547; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Rebel VI, 2000, STEM CELLS, V18, P176, DOI 10.1634/stemcells.18-3-176; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROSENBERG L, 1983, J SURG RES, V35, P63, DOI 10.1016/0022-4804(83)90127-0; ROSENBERG L, 1984, AM J SURG, V147, P146, DOI 10.1016/0002-9610(84)90049-7; Shaw CA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-42; Shaw CA, 2006, AM J PATHOL, V169, P2148, DOI 10.2353/ajpath.2006.060570; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Vincent T, 2004, J VIROL, V78, P8047, DOI 10.1128/JVI.78.15.8047-8058.2004; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	51	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20203	10.1371/journal.pone.0020203	http://dx.doi.org/10.1371/journal.pone.0020203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674029	Green Published, gold, Green Submitted			2022-12-27	WOS:000291355500007
J	Okamoto, Y; Shirakashi, Y; Ihara, M; Urushitani, M; Oono, M; Kawamoto, Y; Yamashita, H; Shimohama, S; Kato, S; Hirano, A; Tomimoto, H; Ito, H; Takahashi, R				Okamoto, Yoko; Shirakashi, Yoshitomo; Ihara, Masafumi; Urushitani, Makoto; Oono, Miki; Kawamoto, Yasuhiro; Yamashita, Hirofumi; Shimohama, Shun; Kato, Shinsuke; Hirano, Asao; Tomimoto, Hidekazu; Ito, Hidefumi; Takahashi, Ryosuke			Colocalization of 14-3-3 Proteins with SOD1 in Lewy Body-Like Hyaline Inclusions in Familial Amyotrophic Lateral Sclerosis Cases and the Animal Model	PLOS ONE			English	Article							CU/ZN-SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; GENE; 14-3-3-PROTEINS; ACCUMULATION; INVOLVEMENT; INTERACTS; POSTERIOR; MUTATION; DISEASE	Background and Purpose: Cu/Zn superoxide dismutase (SOD1) is a major component of Lewy body-like hyaline inclusion (LBHI) found in the postmortem tissue of SOD1-linked familial amyotrophic lateral sclerosis (FALS) patients. In our recent studies, 14-3-3 proteins have been found in the ubiquitinated inclusions inside the anterior horn cells of spinal cords with sporadic amyotrophic lateral sclerosis (ALS). To further investigate the role of 14-3-3 proteins in ALS, we performed immunohistochemical analysis of 14-3-3 proteins and compared their distributions with those of SOD1 in FALS patients and SOD1-overexpressing mice. Methods: We examined the postmortem brains and the spinal cords of three FALS cases (A4V SOD1 mutant). Transgenic mice expressing the G93A mutant human SOD1 (mutant SOD1-Tg mice), transgenic mice expressing the wild-type human SOD1 (wild-type SOD1-Tg mice), and non-Tg wild-type mice were also subjected to the immunohistochemical analysis. Results: In all the FALS patients, LBHIs were observed in the cytoplasm of the anterior horn cells, and these inclusions were immunopositive intensely for pan 14-3-3, 14-3-3 beta, and 14-3-3 gamma. In the mutant SOD1-Tg mice, a high degree of immunoreactivity for misfolded SOD1 (C4F6) was observed in the cytoplasm, with an even greater degree of immunoreactivity present in the cytoplasmic aggregates of the anterior horn cells in the lumbar spinal cord. Furthermore, we have found increased 14-3-3 beta and 14-3-3 gamma immunoreactivities in the mutant SOD1-Tg mice. Double immunofluorescent staining showed that C4F6 and 14-3-3 proteins were partially co-localized in the spinal cord with FALS and the mutant SOD1-Tg mice. In comparison, the wild-type SOD1-Tg and non-Tg wild-type mice showed no or faint immunoreactivity for C4F6 and 14-3-3 proteins (pan 14-3-3, 14-3-3 beta, and 14-3-3 gamma) in any neuronal compartments. Discussion: These results suggest that 14-3-3 proteins may be associated with the formation of SOD1-containing inclusions, in FALS patients and the mutant SOD1-Tg mice.	[Okamoto, Yoko; Shirakashi, Yoshitomo; Ihara, Masafumi; Oono, Miki; Kawamoto, Yasuhiro; Yamashita, Hirofumi; Ito, Hidefumi; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan; [Urushitani, Makoto; Oono, Miki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Kato, Shinsuke] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neuropathol, Tottori 680, Japan; [Hirano, Asao] Montefiore Med Ctr, Dept Pathol, Div Neuropathol, New York, NY USA; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie, Japan	Kyoto University; Shiga University of Medical Science; Sapporo Medical University; Tottori University; Montefiore Medical Center; Mie University	Ihara, M (corresponding author), Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan.	ihara@kuhp.kyoto-u.ac.jp	Ihara, Masafumi/O-5020-2019; Shirakashi, Yoshitomo/F-2831-2014	Ihara, Masafumi/0000-0002-7102-4048; Urushitani, Makoto/0000-0003-2773-9836; Shirakashi, Yoshitomo/0000-0002-3605-6909	Grants-in-Aid for Scientific Research [23390233, 23300131] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Berg D, 2003, ANN NEUROL, V54, P135, DOI 10.1002/ana.10621; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Byrne S, 2010, J NEUROL NEUROSURG P; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; CEBALLOSPICOT I, 1991, BRAIN RES, V552, P198, DOI 10.1016/0006-8993(91)90084-9; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kawamoto Y, 2005, ACTA NEUROPATHOL, V110, P203, DOI 10.1007/s00401-005-1039-z; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P531, DOI 10.1007/s00401-004-0923-2; Kawamoto Y, 2002, ANN NEUROL, V52, P722, DOI 10.1002/ana.10361; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; MIZUSAWA H, 1989, ACTA NEUROPATHOL, V79, P37, DOI 10.1007/BF00308955; MURAYAMA S, 1989, ACTA NEUROPATHOL, V78, P143, DOI 10.1007/BF00688202; Nakano I, 1984, NEUROL MED CHIR TOKY, V20, P458; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Santpere G, 2009, NEUROSCIENCE, V161, P663, DOI 10.1016/j.neuroscience.2009.05.001; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Shirakashi Y, 2006, ACTA NEUROPATHOL, V112, P681, DOI 10.1007/s00401-006-0132-2; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Yamashita H, 2007, J NEUROCHEM, V102, P1497, DOI 10.1111/j.1471-4159.2007.04534.x	27	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20427	10.1371/journal.pone.0020427	http://dx.doi.org/10.1371/journal.pone.0020427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655264	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600066
J	Patel, KN; Liu, Q; Meeker, S; Undem, BJ; Dong, XZ				Patel, Kush N.; Liu, Qin; Meeker, Sonya; Undem, Bradley J.; Dong, Xinzhong			Pirt, a TRPV1 Modulator, Is Required for Histamine-Dependent and -Independent Itch	PLOS ONE			English	Article							SCRATCHING BEHAVIOR; MAST-CELLS; ATOPIC-DERMATITIS; INTRADERMAL SEROTONIN; RECEPTOR ANTAGONISTS; CAPSAICIN RECEPTOR; NC/NGA MICE; ION-CHANNEL; DRY SKIN; ENDOTHELIN-1	Itch, or pruritus, is an important clinical problem whose molecular basis has yet to be understood. Recent work has begun to identify genes that contribute to detecting itch at the molecular level. Here we show that Pirt, known to play a vital part in sensing pain through modulation of the transient receptor potential vanilloid 1 (TRPV1) channel, is also necessary for proper itch sensation. Pirt(-/-) mice exhibit deficits in cellular and behavioral responses to various itch-inducing compounds, or pruritogens. Pirt contributes to both histaminergic and nonhistaminergic itch and, crucially, is involved in forms of itch that are both TRPV1-dependent and -independent. Our findings demonstrate that the function of Pirt extends beyond nociception via TRPV1 regulation to its role as a critical component in several itch signaling pathways.	[Patel, Kush N.; Liu, Qin; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Meeker, Sonya; Undem, Bradley J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Dong, Xinzhong] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Patel, KN (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	xdong2@jhmi.edu			NIH [NS054791, GM087369]; National Science Foundation; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants from the NIH to XD (NS054791 and GM087369). XD is an Early Career Scientist of the Howard Hughes Medical Institute. KNP was supported by a Graduate Research Fellowship from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABILA B, 1994, AFR J MED MED SCI, V32, P139; Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dunford PJ, 2007, J ALLERGY CLIN IMMUN, V119, P176, DOI 10.1016/j.jaci.2006.08.034; EZEAMUZIE CI, 1990, J TROP MED HYG, V93, P423; FERREIRA SH, 1989, J CARDIOVASC PHARM, V13, pS220, DOI 10.1097/00005344-198900135-00065; Gokin AP, 2001, J NEUROSCI, V21, P5358, DOI 10.1523/JNEUROSCI.21-14-05358.2001; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hashimoto Y, 2005, J PHARMACOL SCI, V98, P90, DOI 10.1254/jphs.SC0040209; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Matsushima H, 2004, EUR J IMMUNOL, V34, P1910, DOI 10.1002/eji.200424912; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; McQueen DS, 2007, BRIT J PHARMACOL, V151, P278, DOI 10.1038/sj.bjp.0707216; Metz M, 2006, AM J PATHOL, V169, P815, DOI 10.2353/ajpath.2006.060037; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; MNYIKA KS, 1991, J TROP MED HYG, V94, P27; Namer B, 2008, PAIN, V137, P41, DOI 10.1016/j.pain.2007.08.008; Nojima H, 2004, NEUROSCI LETT, V361, P79, DOI 10.1016/j.neulet.2003.12.013; Oikonomopoulou K, 2006, BIOL CHEM, V387, P677, DOI 10.1515/BC.2006.086; Patel KN, 2011, ACS CHEM NEUROSCI, V2, P17, DOI 10.1021/cn100085g; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; PEREIRA U, 2010, EXPT MODELS ITCH, P51; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Slominski A, 2004, BBA-GENE STRUCT EXPR, V1680, P67, DOI 10.1016/j.bbaexp.2004.09.002; Sowunmi A, 2000, ANN TROP MED PARASIT, V94, P209, DOI 10.1080/00034980050006375; Steinhoff M, 2006, J INVEST DERMATOL, V126, P1705, DOI 10.1038/sj.jid.5700231; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Takano N, 2006, BRIT J DERMATOL, V154, P426, DOI 10.1111/j.1365-2133.2005.07070.x; Takano N, 2003, EUR J PHARMACOL, V471, P223, DOI 10.1016/S0014-2999(03)01828-4; Thomsen JS, 2001, ACTA DERM-VENEREOL, V81, P250, DOI 10.1080/00015550152572868; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Walther Andreas, 2002, Pathophysiology, V8, P161, DOI 10.1016/S0928-4680(02)00006-8; WILSON SR, 2011, NAT NEUROSC IN PRESS; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; YAMAZAKI M, 1994, BLOOD, V83, P3509; Yatsuzuka R, 2007, EUR J PHARMACOL, V565, P225, DOI 10.1016/j.ejphar.2007.02.062; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	58	44	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20559	10.1371/journal.pone.0020559	http://dx.doi.org/10.1371/journal.pone.0020559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655234	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600097
J	Huang, PW; Galloway, CA; Yoon, Y				Huang, Pinwei; Galloway, Chad A.; Yoon, Yisang			Control of Mitochondrial Morphology Through Differential Interactions of Mitochondrial Fusion and Fission Proteins	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; MAMMALIAN-CELLS; GTPASE ACTIVITY; EMBRYONIC-DEVELOPMENT; DOMAIN INTERACTIONS; DRP1; PHOSPHORYLATION; MITOFUSIN-2	Mitochondria in mammals are organized into tubular networks that undergo frequent shape change. Mitochondrial fission and fusion are the main components mediating the mitochondrial shape change. Perturbation of the fission/fusion balance is associated with many disease conditions. However, underlying mechanisms of the fission/fusion balance are not well understood. Mitochondrial fission in mammals requires the dynamin-like protein DLP1/Drp1 that is recruited to the mitochondrial surface, possibly through the membrane-anchored protein Fis1 or Mff. Additional dynamin-related GTPases, mitofusin (Mfn) and OPA1, are associated with the outer and inner mitochondrial membranes, respectively, and mediate fusion of the respective membranes. In this study, we found that two heptad-repeat regions (HR1 and HR2) of Mfn2 interact with each other, and that Mfn2 also interacts with the fission protein DLP1. The association of the two heptad-repeats of Mfn2 is fusion inhibitory whereas a positive role of the Mfn2/DLP1 interaction in mitochondrial fusion is suggested. Our results imply that the differential binding of Mfn2-HR1 to HR2 and DLP1 regulates mitochondrial fusion and that DLP1 may act as a regulatory factor for efficient execution of both fusion and fission of mitochondria.	[Huang, Pinwei; Galloway, Chad A.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Mitochondrial Res & Innovat Grp, Dept Anesthesiol,Dept Pharmacol & Physiol, Rochester, NY 14627 USA	University of Rochester	Huang, PW (corresponding author), Univ Rochester, Sch Med & Dent, Mitochondrial Res & Innovat Grp, Dept Anesthesiol,Dept Pharmacol & Physiol, Rochester, NY 14627 USA.	yisang_yoon@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020	Galloway, Chad/0000-0002-1978-7339; Yoon, Yisang/0000-0002-1618-5439	National Institute of Diabetes and Digestive and Kidney Diseases [DK061991, DK078618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061991, R01DK078618] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases (DK061991 and DK078618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; GUNTHRIE C, 1991, GUIDE YEAST GENETICS; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Honda S, 2005, J CELL SCI, V118, P3153, DOI 10.1242/jcs.02449; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pfanner N, 2004, SCIENCE, V305, P1723, DOI 10.1126/science.1104244; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; YOON Y, 2010, MITOCHONDRIAL DYNAMI; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	51	71	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20655	10.1371/journal.pone.0020655	http://dx.doi.org/10.1371/journal.pone.0020655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647385	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052500070
J	Chavez, JD; Hoopmann, MR; Weisbrod, CR; Takara, K; Bruce, JE				Chavez, Juan D.; Hoopmann, Michael R.; Weisbrod, Chad R.; Takara, Kohji; Bruce, James E.			Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa Cells	PLOS ONE			English	Article							RNA EXPRESSION LEVELS; DRUG-RESISTANCE; MESSENGER-RNA; CANCER-CELLS; MASS-SPECTROMETRY; ALDOSE REDUCTASE; DNA-DAMAGE; PROTEIN; COMPLEX; IDENTIFICATION	Cisplatin along with other platinum based drugs are some of the most widely used chemotherapeutic agents. However drug resistance is a major problem for the successful chemotherapeutic treatment of cancer. Current evidence suggests that drug resistance is a multifactorial problem due to changes in the expression levels and activity of a wide number of proteins. A majority of the studies to date have quantified mRNA levels between drug resistant and drug sensitive cell lines. Unfortunately mRNA levels do not always correlate with protein expression levels due to post-transcriptional changes in protein abundance. Therefore global quantitative proteomics screens are needed to identify the protein targets that are differentially expressed in drug resistant cell lines. Here we employ a quantitative proteomics technique using stable isotope labeling with amino acids in cell culture (SILAC) coupled with mass spectrometry to quantify changes in protein levels between cisplatin resistant (HeLa/CDDP) and sensitive HeLa cells in an unbiased fashion. A total of 856 proteins were identified and quantified, with 374 displaying significantly altered expression levels between the cell lines. Expression level data was then integrated with a network of protein-protein interactions, and biological pathways to obtain a systems level view of proteome changes which occur with cisplatin resistance. Several of these proteins have been previously implicated in resistance towards platinum-based and other drugs, while many represent new potential markers or therapeutic targets.	[Chavez, Juan D.; Hoopmann, Michael R.; Weisbrod, Chad R.; Bruce, James E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Takara, Kohji] Himeji Dokkyo Univ, Dept Pharmaceut Sci, Himeji, Hyogo, Japan	University of Washington; University of Washington Seattle; Himeji Dokkyo University	Chavez, JD (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jimbruce@u.washington.edu		Hoopmann, Michael/0000-0001-7029-7792; Chavez, Juan/0000-0001-8849-0304	US National Institutes of Health [R01GM086688, R01RR023334, S10RR025107]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023334, S10RR025107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086688] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the US National Institutes of Health through grants: R01GM086688, R01RR023334, and S10RR025107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Chung YM, 2001, ANTICANCER RES, V21, P1129; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deutsch E. W., PROTEOMICS, V10, P1150; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Florczyk U, 2011, CANCER LETT, V300, P40, DOI 10.1016/j.canlet.2010.09.003; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Han EKH, 2000, BRIT J CANCER, V83, P83; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; Hoopmann MR, 2007, ANAL CHEM, V79, P5620, DOI 10.1021/ac0700833; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jordan P, 1998, NUCLEIC ACIDS RES, V26, P2831, DOI 10.1093/nar/26.12.2831; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Lee EK, 2002, ANTI-CANCER DRUG, V13, P859, DOI 10.1097/00001813-200209000-00012; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Mencia N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-250; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Nomura M, 2005, ANTICANCER RES, V25, P2729; PAK JH, CANC INVESTIGATION, V29, P21; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; ROHWER N, PLOS ONE, V5; ROSENBERG JM, 1993, MOL PHARMACOL, V43, P491; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santos JSD, 2000, BBA-MOL CELL RES, V1498, P181, DOI 10.1016/S0167-4889(00)00095-1; Saraswat M, 2006, MED SCI MONITOR, V12, pCR525; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Takara K, 2006, CANCER CHEMOTH PHARM, V58, P785, DOI 10.1007/s00280-006-0226-5; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Toshimitsu H, 2004, CANCER LETT, V211, P69, DOI 10.1016/j.canlet.2004.01.038; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; VIDAL M, CELL, V144, P986; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P19, DOI 10.1001/archotol.132.1.19; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Xu RH, 2005, CANCER RES, V65, P613; Xu Y, CANC RES, V70, P2455; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang JT, 2007, CANCER TREAT REV, V33, P741, DOI 10.1016/j.ctrv.2007.07.018	57	31	33	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19892	10.1371/journal.pone.0019892	http://dx.doi.org/10.1371/journal.pone.0019892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637840	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200018
J	Guo, L; Liang, TM; Gu, WJ; Xu, YM; Bai, YF; Lu, ZH				Guo, Li; Liang, Tingming; Gu, Wanjun; Xu, Yuming; Bai, Yunfei; Lu, Zuhong			Cross-Mapping Events in miRNAs Reveal Potential miRNA-Mimics and Evolutionary Implications	PLOS ONE			English	Article							TINY RNAS; MICRORNA; IDENTIFICATION; BIOMARKERS; SIRNAS; CANCER; SITES	MicroRNAs (miRNAs) have important roles in various biological processes. miRNA cross-mapping is a prevalent phenomenon where miRNA sequence originating from one genomic region is mapped to another location. To have a better understanding of this phenomenon in the human genome, we performed a detailed analysis in this paper using public miRNA high-throughput sequencing data and all known human miRNAs. We observed widespread cross-mapping events between miRNA precursors (pre-miRNAs), other non-coding RNAs (ncRNAs) and the opposite strands of pre-miRNAs by analyzing the high-throughput sequencing data. Computational analysis on all known human miRNAs also confirmed that many of them could be involved in cross-mapping events. The processing or decay of both ncRNAs and pre-miRNA opposite strand transcripts may contribute to miRNA enrichment, although some might be miRNA-mimics due to miRNA mis-annotation. Comparing to canonical miRNAs, miRNAs involved in cross-mapping events between pre-miRNAs and other ncRNAs normally had shorter lengths (17-19 nt), lower prediction scores and were classified as pseudo miRNA precursors. Notably, 4.9% of all human miRNAs could be accurately mapped to the opposite strands of pre-miRNAs, which showed that both strands of the same genomic region had the potential to produce mature miRNAs and simultaneously implied some potential miRNA precursors. We proposed that the cross-mapping events are more complex than we previously thought. Sequence similarity between other ncRNAs and pre-miRNAs and the specific stem-loop structures of pre-miRNAs may provide evolutionary implications.	[Guo, Li; Xu, Yuming; Bai, Yunfei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Liang, Tingming] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Peoples R China; [Liang, Tingming] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Aquat Crustacean Dis, Nanjing, Peoples R China; [Gu, Wanjun; Lu, Zuhong] Southeast Univ, Key Lab Child Dev & Learning Sci, Minist Educ, Nanjing, Peoples R China	Southeast University - China; Nanjing Normal University; Nanjing Normal University; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	zhlu@seu.edu.cn	Gu, Wanjun/B-3998-2010; Lu, Zuhong/A-5448-2013; Gu, Wanjun/P-5389-2019; Liang, Tingming/ACL-6141-2022	Gu, Wanjun/0000-0003-4501-0539; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393, 30900836, 60971021]; Innovation Project for Graduate Students of Jiangsu Province [CX10B_081Z]; Scientific Research Foundation of Graduate School of Southeast University; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project for Graduate Students of Jiangsu Province; Scientific Research Foundation of Graduate School of Southeast University; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation	This work was supported by projects 30871393, 30900836 and 60971021 of the National Natural Science Foundation of China and funded by Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation. The work was also supported by a research grant from the Innovation Project for Graduate Students of Jiangsu Province (No. CX10B_081Z) and the Scientific Research Foundation of Graduate School of Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Contu R, 2010, CIRC RES, V107, P573, DOI 10.1161/CIRCRESAHA.110.227983; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guo L, 2011, BIOSYSTEMS, V104, P87, DOI 10.1016/j.biosystems.2011.01.004; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wang JB, 2010, CANCER LETT, V297, P137, DOI 10.1016/j.canlet.2010.07.018; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352	36	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20517	10.1371/journal.pone.0020517	http://dx.doi.org/10.1371/journal.pone.0020517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637827	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200075
J	Hollingsworth, PM; Graham, SW; Little, DP				Hollingsworth, Peter M.; Graham, Sean W.; Little, Damon P.			Choosing and Using a Plant DNA Barcode	PLOS ONE			English	Article							CHLOROPLAST GENOME SEQUENCES; SPECIES IDENTIFICATION; NONCODING REGIONS; LAND PLANTS; GENE FLOW; UNIVERSAL PRIMERS; PLASTID GENOME; NUCLEAR GENES; DIVERSITY; MARKERS	The main aim of DNA barcoding is to establish a shared community resource of DNA sequences that can be used for organismal identification and taxonomic clarification. This approach was successfully pioneered in animals using a portion of the cytochrome oxidase 1 (CO1) mitochondrial gene. In plants, establishing a standardized DNA barcoding system has been more challenging. In this paper, we review the process of selecting and refining a plant barcode; evaluate the factors which influence the discriminatory power of the approach; describe some early applications of plant barcoding and summarise major emerging projects; and outline tool development that will be necessary for plant DNA barcoding to advance.	[Hollingsworth, Peter M.] Royal Bot Garden Edinburgh, Genet & Conservat Sect, Edinburgh, Midlothian, Scotland; [Graham, Sean W.] Univ British Columbia, Bot Gardens, Vancouver, BC V5Z 1M9, Canada; [Graham, Sean W.] Univ British Columbia, Ctr Plant Res, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada; [Graham, Sean W.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Little, Damon P.] New York Bot Garden, Cullman Program Mol Systemat, Bronx, NY 10458 USA	University of British Columbia; University of British Columbia; University of British Columbia; New York Botanical Garden	Hollingsworth, PM (corresponding author), Royal Bot Garden Edinburgh, Genet & Conservat Sect, Edinburgh, Midlothian, Scotland.	P.Hollingsworth@rbge.org.uk	Graham, Sean W/L-3944-2014	Graham, Sean W/0000-0001-8209-5231; Hollingsworth, Peter/0000-0003-0602-0654	Consortium for the Barcode of Life; Sloan Foundation; Genome Canada; Gordon and Betty Moore Foundation; Ferguson Bequest; Scottish Government's Rural and Environment Research and Analysis Directorate	Consortium for the Barcode of Life(Smithsonian InstitutionSmithsonian National Museum of Natural History); Sloan Foundation(Alfred P. Sloan Foundation); Genome Canada(Genome Canada); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Ferguson Bequest; Scottish Government's Rural and Environment Research and Analysis Directorate	The authors are grateful to the Consortium for the Barcode of Life, the Sloan Foundation, Genome Canada, The Gordon and Betty Moore Foundation, the Ferguson Bequest and the Scottish Government's Rural and Environment Research and Analysis Directorate for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2010, MOL PHYLOGENET EVOL, V54, P235, DOI 10.1016/j.ympev.2009.08.008; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ansell SW, 2007, J EVOLUTION BIOL, V20, P2400, DOI 10.1111/j.1420-9101.2007.01397.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; Bleeker W, 2008, BIOL CONSERV, V141, P692, DOI 10.1016/j.biocon.2007.12.015; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Du FK, 2009, MOL ECOL, V18, P1396, DOI 10.1111/j.1365-294X.2009.04107.x; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Fazekas AJ, 2010, TAXON, V59, P694, DOI 10.1002/tax.593002; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ferri G, 2009, INT J LEGAL MED, V123, P395, DOI 10.1007/s00414-009-0356-5; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Golden JL, 2000, EVOLUTION, V54, P1566; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; HARMON L, 2010, RARE FLOWERS C UNPUB; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM., 2007, GENOME SOC POL, V3, P44, DOI 10.1186/1746-5354-3-2-44; Jaakola L, 2010, FOOD CHEM, V123, P494, DOI 10.1016/j.foodchem.2010.04.069; JEANSON ML, 2011, DNA BARCODING NEW TO; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; LIDHOLM J, 1991, CURR GENET, V20, P161, DOI 10.1007/BF00312780; LIDHOLM J, 1991, MOL GEN GENET, V226, P345, DOI 10.1007/BF00260645; Liston A, 2007, MOL ECOL, V16, P3926, DOI 10.1111/j.1365-294X.2007.03461.x; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Long DG, 2006, J BRYOL, V28, P108, DOI 10.1179/174328206X105399; McNeal JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005982; Miwa H, 2009, GENE, V441, P169, DOI 10.1016/j.gene.2008.11.020; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Moller M., 2000, Edinburgh Journal of Botany, V57, P151, DOI 10.1017/S096042860000010X; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Naciri Y, 2010, MOL ECOL RESOUR, V10, P728, DOI 10.1111/j.1755-0998.2009.02816.x; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nicolalde-Morejon F, 2010, MITOCHONDR DNA, V21, P51, DOI 10.3109/19401736.2010.539215; NICOLALDEMOREJO.F, 2010, CLADISTICS, V26, P1; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Ogden Rob, 2010, Endangered Species Research, V9, P255, DOI 10.3354/esr00141; Okuyama Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-105; Palme AE, 2003, HEREDITY, V91, P465, DOI 10.1038/sj.hdy.6800307; Pang XH, 2010, PLANTA MED, V76, P1784, DOI 10.1055/s-0030-1249806; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schmickl R, 2009, PLANT SYST EVOL, V282, P229, DOI 10.1007/s00606-008-0030-2; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw AJ, 2001, J BIOGEOGR, V28, P253; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Squirrell J, 2001, AM J BOT, V88, P1409, DOI 10.2307/3558447; Srirama R, 2010, J ETHNOPHARMACOL, V130, P208, DOI 10.1016/j.jep.2010.04.042; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; Stech M, 2011, MOL ECOL RESOUR, V11, P404, DOI 10.1111/j.1755-0998.2010.02938.x; Stech M, 2010, PHYTOTAXA, V9, P196; Steele PR, 2011, AM J BOT, V98, P415, DOI 10.3732/ajb.1000296; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Valentini A., 2010, Diversity, V2, P610; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; von Crautlein M, 2011, BIODIVERS CONSERV, V20, P373, DOI 10.1007/s10531-010-9964-0; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wicke S, 2009, ANAL JARDIN BOT MAD, V66, P285, DOI 10.3989/ajbm.2231; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	115	729	822	10	266	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19254	10.1371/journal.pone.0019254	http://dx.doi.org/10.1371/journal.pone.0019254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637336	gold, Green Published			2022-12-27	WOS:000291052200009
J	Zheng, AJ; Li, JK; Begna, D; Fang, Y; Feng, M; Song, FF				Zheng, Aijuan; Li, Jianke; Begna, Desalegn; Fang, Yu; Feng, Mao; Song, Feifei			Proteomic Analysis of Honeybee (Apis mellifera L.) Pupae Head Development	PLOS ONE			English	Article							IN-SITU LOCALIZATION; CELL-DEATH; HYPOPHARYNGEAL GLAND; PROTEIN EXPRESSION; GENE-EXPRESSION; DROSOPHILA; BEE; BRAIN; SHOCK; STORAGE	The honeybee pupae development influences its future adult condition as well as honey and royal jelly productions. However, the molecular mechanism that regulates honeybee pupae head metamorphosis is still poorly understood. To further our understand of the associated molecular mechanism, we investigated the protein change of the honeybee pupae head at 5 time-points using 2-D electrophoresis, mass spectrometry, bioinformatics, quantitative real-time polymerase chain reaction and Western blot analysis. Accordingly, 58 protein spots altered their expression across the 5 time points (13-20 days), of which 36 proteins involved in the head organogenesis were upregulated during early stages (13-17 days). However, 22 proteins involved in regulating the pupae head neuron and gland development were upregulated at later developmental stages (19-20 days). Also, the functional enrichment analysis further suggests that proteins related to carbohydrate metabolism and energy production, development, cytoskeleton and protein folding were highly involved in the generation of organs and development of honeybee pupal head. Furthermore, the constructed protein interaction network predicted 33 proteins acting as key nodes of honeybee pupae head growth of which 9 and 4 proteins were validated at gene and protein levels, respectively. In this study, we uncovered potential protein species involved in the formation of honeybee pupae head development along with their specific temporal requirements. This first proteomic result allows deeper understanding of the proteome profile changes during honeybee pupae head development and provides important potential candidate proteins for future reverse genetic research on honeybee pupae head development to improve the performance of related organs.	[Zheng, Aijuan; Li, Jianke; Begna, Desalegn; Fang, Yu; Feng, Mao; Song, Feifei] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing, Peoples R China; [Zheng, Aijuan] Chinese Acad Agr Sci, Feed Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS	Zheng, AJ (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing, Peoples R China.	apislijk@126.com	Li, Jianke/K-8139-2013	Begna, Desalegn/0000-0001-6792-2630	Modern Agro-industry Technology Research System [CARS-45]; National Natural Science Foundation of China [30972148]	Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-45) and the National Natural Science Foundation of China (No. 30972148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao CK, 2007, J CELL BIOL, V176, P843, DOI 10.1083/jcb.200611155; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; *CONS THGS, 2006, NATURE, V444, P512; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; De Moraes RLMS, 2000, CELL BIOL INT, V24, P737, DOI 10.1006/cbir.2000.0534; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Garcia L, 2009, J PROTEOME RES, V8, P1464, DOI 10.1021/pr800823r; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goel M, 2001, J BIOL CHEM, V276, P38762, DOI 10.1074/jbc.M104125200; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gregorc A, 1999, CELL BIOL INT, V23, P211, DOI 10.1006/cbir.1999.0344; Gregorc A, 1998, CELL BIOL INT, V22, P137, DOI 10.1006/cbir.1998.0232; Gregorc A, 2000, CELL BIOL INT, V24, P319, DOI 10.1006/cbir.1999.0490; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hasegawa M, 2009, INSECT BIOCHEM MOLEC, V39, P661, DOI 10.1016/j.ibmb.2009.08.001; Haslbeck M, 2006, INT J BIOL MACROMOL, V38, P107, DOI 10.1016/j.ijbiomac.2006.01.013; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; JAY S. CAMERON, 1962, BEE WORLD, V43, P119; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; KLOPPENBURG P, 1995, J COMP NEUROL, V363, P333, DOI 10.1002/cne.903630213; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; LEVENBOOK IS, 1985, J BIOL STAND, V13, P135, DOI 10.1016/S0092-1157(85)80019-6; Li J, 2009, INSECT MOL BIOL, V18, P1, DOI 10.1111/j.1365-2583.2008.00849.x; Li J, 2007, APIDOLOGIE, V38, P545, DOI 10.1051/apido:2007047; LIN HF, 1994, DEVELOPMENT, V120, P947; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martins JR, 2008, J INSECT PHYSIOL, V54, P867, DOI 10.1016/j.jinsphys.2008.03.009; MILNE CP, 1984, J HERED, V75, P509, DOI 10.1093/oxfordjournals.jhered.a110003; NEUKIRCH A, 1982, J COMP PHYSIOL, V146, P35, DOI 10.1007/BF00688714; PATERSON J, 1991, GENETICS, V129, P1073; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pinter M, 1998, INSECT BIOCHEM MOLEC, V28, P91, DOI 10.1016/S0965-1748(97)00095-7; Pinto LZ, 2002, J INSECT PHYSIOL, V48, P783, DOI 10.1016/S0022-1910(02)00103-8; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SEVERSON DW, 1990, EXPERIENTIA, V46, P737, DOI 10.1007/BF01939951; Shao R., 1992, Journal of Fujian Agricultural College, V21, P101; Silva-Zacarin ECM, 2006, APIDOLOGIE, V37, P507, DOI 10.1051/apido:2006030; Smith P D, 1980, Basic Life Sci, V15, P175; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; TAYLOR DJ, 1992, J COMP PHYSIOL A, V170, P715, DOI 10.1007/BF00198982; Trieselmann N, 2002, CURR BIOL, V12, P1124, DOI 10.1016/S0960-9822(02)00934-X; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; WANG Z, 1993, UPTAKE METABOLISM ST, P1; WARN RM, 1985, EXP CELL RES, V157, P355, DOI 10.1016/0014-4827(85)90120-X; Wulfkuhle JD, 1998, CELL MOTIL CYTOSKEL, V40, P119, DOI 10.1002/(SICI)1097-0169(1998)40:2<119::AID-CM2>3.0.CO;2-A	63	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20428	10.1371/journal.pone.0020428	http://dx.doi.org/10.1371/journal.pone.0020428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637821	Green Submitted, gold, Green Published			2022-12-27	WOS:000291052200064
J	Chaturvedi, AK; Lazzell, AL; Saville, SP; Wormley, FL; Monteagudo, C; Lopez-Ribot, JL				Chaturvedi, Ashok K.; Lazzell, Anna L.; Saville, Stephen P.; Wormley, Floyd L., Jr.; Monteagudo, Carlos; Lopez-Ribot, Jose L.			Validation of the Tetracycline Regulatable Gene Expression System for the Study of the Pathogenesis of Infectious Disease	PLOS ONE			English	Article							CANDIDA-ALBICANS; FILAMENTOUS FORMS; DOXYCYCLINE; EPIDEMIOLOGY; MINOCYCLINE; VIRULENCE; SURVIVAL; STRAIN; CELLS; MODEL	Understanding the pathogenesis of infectious disease requires the examination and successful integration of parameters related to both microbial virulence and host responses. As a practical and powerful method to control microbial gene expression, including in vivo, the tetracycline-regulatable system has recently gained the favor of many investigative groups. However, some immunomodulatory effects of the tetracyclines, including doxycycline, could potentially limit its use to evaluate host responses during infection. Here we have used a well-established murine model of disseminated candidiasis, which is highly dependent on both the virulence displayed by the fungal cells and on the host immune status, to validate the use of this system. We demonstrate that the pathogenesis of the wild type C. albicans CAF2-1 strain, which does not contain any tet-regulatable element, is not affected by the presence of doxycycline. Moreover levels of key cytokines, chemokines and many other biomarkers, as determined by multi-analyte profiling, remain essentially unaltered by the presence of the antibiotic during infection. Our results indicate that the levels of doxycycline needed to control the tetracycline regulatable promoter gene expression system have no detectable effect on global host responses during candidiasis. Because tet-regulatable systems are now being increasingly used in a variety of pathogenic microorganisms, these observations have wide implications in the field of infectious diseases.	[Chaturvedi, Ashok K.; Lazzell, Anna L.; Saville, Stephen P.; Wormley, Floyd L., Jr.; Lopez-Ribot, Jose L.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Chaturvedi, Ashok K.; Lazzell, Anna L.; Saville, Stephen P.; Wormley, Floyd L., Jr.; Lopez-Ribot, Jose L.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Monteagudo, Carlos] Univ Valencia, Fac Med & Odontol, Dept Patol, Valencia, Spain	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Valencia	Chaturvedi, AK (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	jose.lopezribot@utsa.edu	Monteagudo, Carlos/GWU-8534-2022; Lopez-Ribot, Jose L/D-2048-2010; , Monteagudo/H-6555-2016	Lopez-Ribot, Jose/0000-0003-1992-3270	Public Health Service from National Institute of Allergy and Infectious Diseases [RO1AI064562, RO1AI063256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064562, R01AI063256] Funding Source: NIH RePORTER	Public Health Service from National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service Grants numbered RO1AI064562 and RO1AI063256 from the National Institute of Allergy and Infectious Diseases to JLLR and SPS respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2002, ANN MED, V34, P2, DOI 10.1080/078538902317338580; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; D'Agostino P, 1998, EUR J PHARMACOL, V346, P283, DOI 10.1016/S0014-2999(98)00046-6; Dunston CR, 2011, PROTEOMICS, V11, P42, DOI 10.1002/pmic.201000273; Eger K, 2004, BIOCHEM BIOPH RES CO, V323, P979, DOI 10.1016/j.bbrc.2004.08.187; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; FONZI WA, 1993, GENETICS, V134, P717; GILBERTSONBEADLING S, 1995, CANCER CHEMOTH PHARM, V36, P418, DOI 10.1007/BF00686191; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Meissner M, 2007, APPL MICROBIOL BIOT, V75, P963, DOI 10.1007/s00253-007-0946-4; Nakayama H, 1998, MICROBIOL-UK, V144, P2407, DOI 10.1099/00221287-144-9-2407; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Odds FC, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1009; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Saville SP, 2008, INFECT IMMUN, V76, P97, DOI 10.1128/IAI.00982-07; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Spellberg B, 2003, INFECT IMMUN, V71, P5756, DOI 10.1128/IAI.71.10.5756-5764.2003; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Vogt K, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-1; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6	37	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20449	10.1371/journal.pone.0020449	http://dx.doi.org/10.1371/journal.pone.0020449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633704	Green Submitted, gold, Green Published			2022-12-27	WOS:000291006500064
J	Mazzariol, S; Di Guardo, G; Petrella, A; Marsili, L; Fossi, CM; Leonzio, C; Zizzo, N; Vizzini, S; Gaspari, S; Pavan, G; Podesta, M; Garibaldi, F; Ferrante, M; Copat, C; Traversa, D; Marcer, F; Airoldi, S; Frantzis, A; Quiros, YD; Cozzi, B; Fernandez, A				Mazzariol, Sandro; Di Guardo, Giovanni; Petrella, Antonio; Marsili, Letizia; Fossi, Cristina M.; Leonzio, Claudio; Zizzo, Nicola; Vizzini, Salvatrice; Gaspari, Stefania; Pavan, Gianni; Podesta, Michela; Garibaldi, Fulvio; Ferrante, Margherita; Copat, Chiara; Traversa, Donato; Marcer, Federica; Airoldi, Sabina; Frantzis, Alexandros; De Beraldo Quiros, Yara; Cozzi, Bruno; Fernandez, Antonio			Sometimes Sperm Whales (Physeter macrocephalus) Cannot Find Their Way Back to the High Seas: A Multidisciplinary Study on a Mass Stranding	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; NORTH-SEA; GENETIC DIVERSITY; MARINE MAMMALS; METHYL MERCURY; HEAVY-METALS; HABITAT USE; CETACEANS; ATLANTIC; METHYLMERCURY	Background: Mass strandings of sperm whales (Physeter macrocephalus) remain peculiar and rather unexplained events, which rarely occur in the Mediterranean Sea. Solar cycles and related changes in the geomagnetic field, variations in water temperature and weather conditions, coast geographical features and human activities have been proposed as possible causes. In December 2009, a pod of seven male sperm whales stranded along the Adriatic coast of Southern Italy. This is the sixth instance from 1555 in this basin. Methodology/Principal Findings: Complete necropsies were performed on three whales whose bodies were in good condition, carrying out on sampled tissues histopathology, virology, bacteriology, parasitology, and screening of veins looking for gas emboli. Furthermore, samples for age determination, genetic studies, gastric content evaluation, stable isotopes and toxicology were taken from all the seven specimens. The animals were part of the same group and determined by genetic and photo-identification to be part of the Mediterranean population. Causes of death did not include biological agents, or the "gas and fat embolic syndrome", associated with direct sonar exposure. Environmental pollutant tissue concentrations were relatively high, in particular organochlorinated xenobiotics. Gastric content and morphologic tissue examinations showed a prolonged starvation, which likely caused, at its turn, the mobilization of lipophilic contaminants from the adipose tissue. Chemical compounds subsequently entered the blood circulation and may have impaired immune and nervous functions. Conclusions/Significance: A multi-factorial cause underlying this sperm whales' mass stranding is proposed herein based upon the results of postmortem investigations as well as of the detailed analyses of the geographical and historical background. The seven sperm whales took the same "wrong way" into the Adriatic Sea, a potentially dangerous trap for Mediterranean sperm whales. Seismic surveys should be also regarded as potential co-factors, even if no evidence of direct impact has been detected.	[Mazzariol, Sandro] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy; [Di Guardo, Giovanni; Traversa, Donato] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Petrella, Antonio] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Marsili, Letizia; Fossi, Cristina M.; Leonzio, Claudio] Univ Siena, Dept Environm Sci, I-53100 Siena, Italy; [Zizzo, Nicola] Univ Bari, Dept Vet Publ Hlth, Valenzano, Italy; [Vizzini, Salvatrice] Univ Palermo, Dept Earth & Marine Sci, Palermo, Italy; [Gaspari, Stefania] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Pavan, Gianni] Univ Pavia, Dept Anim Biol, Interdisciplinary Ctr Bioacoust, I-27100 Pavia, Italy; [Podesta, Michela] Museum Nat Hist Milan, Milan, Italy; [Garibaldi, Fulvio] Univ Genoa, Dept Study Terr & Its Resources, Genoa, Italy; [Ferrante, Margherita; Copat, Chiara] Univ Catania, Dept Anat Diagnost Pathol Forens Med Hyg & Publ H, Catania, Italy; [Marcer, Federica; Cozzi, Bruno] Univ Padua, Dept Expt Vet Sci, Legnaro, Italy; [Airoldi, Sabina] Tethys Res Inst, Milan, Italy; [Frantzis, Alexandros] Pelagos Cetacean Res Inst, Vouliagmeni, Greece; [De Beraldo Quiros, Yara; Fernandez, Antonio] Univ Las Palmas Gran Canaria, Dept Morphol, Las Palmas Gran Canaria, Spain	University of Padua; University of Teramo; IZS Puglia e Basilicata; University of Siena; Universita degli Studi di Bari Aldo Moro; University of Palermo; University of Florence; University of Pavia; University of Genoa; University of Catania; University of Padua; Universidad de Las Palmas de Gran Canaria	Mazzariol, S (corresponding author), Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy.	sandro.mazzariol@unipd.it	Pavan, Gianni/M-4619-2015; Ferrante, Margherita/B-2781-2011; Marsili, Letizia/AAB-7138-2019; Copat, Chiara/H-2192-2013; Fernandez, Antonio/G-3448-2015; de Quirós, Yara Bernaldo/A-3628-2015; Cozzi, Bruno/H-9618-2019; Marsili, Letizia/AAC-3836-2022	Pavan, Gianni/0000-0002-4599-9028; Ferrante, Margherita/0000-0001-7596-2464; Copat, Chiara/0000-0002-2262-6050; Fernandez, Antonio/0000-0001-5281-0521; de Quirós, Yara Bernaldo/0000-0002-2611-0406; Cozzi, Bruno/0000-0002-7531-7040; Marsili, Letizia/0000-0002-2474-4587; Frantzis, Alexandros/0000-0001-7117-062X; Fossi, Maria Cristina/0000-0003-0836-4020; Traversa, Donato/0000-0003-3411-1326; NICOLA, ZIZZO/0000-0002-1434-415X; Mazzariol, Sandro/0000-0002-4756-1871	Italian Ministry of the Environment; University of Padova	Italian Ministry of the Environment; University of Padova	The study was funded by the Italian Ministry of the Environment, and partially funded by the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWSKY CR, 1981, HUM PATHOL, V12, P753, DOI 10.1016/S0046-8177(81)80179-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aznar FJ, 2005, DIS AQUAT ORGAN, V67, P239, DOI 10.3354/dao067239; Azzellino A, 2008, DEEP-SEA RES PT I, V55, P296, DOI 10.1016/j.dsr.2007.11.006; BALLSCHMITER K, 1980, FRESEN Z ANAL CHEM, V302, P20, DOI 10.1007/BF00469758; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2011, MAMMAL REV, V41, P276, DOI 10.1111/j.1365-2907.2010.00171.x; Beineke A, 2005, ENVIRON SCI TECHNOL, V39, P3933, DOI 10.1021/es048709j; Beineke A, 2007, VET IMMUNOL IMMUNOP, V117, P254, DOI 10.1016/j.vetimm.2007.03.009; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Belliere EN, 2010, ARCH VIROL, V155, P1307, DOI 10.1007/s00705-010-0697-x; Berube M, 1996, MOL ECOL, V5, P283; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Bustamante P, 1998, SCI TOTAL ENVIRON, V220, P71, DOI 10.1016/S0048-9697(98)00250-2; Byczkowski JZ, 2001, RISK ANAL, V21, P869, DOI 10.1111/0272-4332.215158; Capelli R, 2008, SCI TOTAL ENVIRON, V390, P569, DOI 10.1016/j.scitotenv.2007.10.036; Chapman L, 2000, ENVIRON HEALTH PERSP, V108, P29, DOI [10.2307/3454631, 10.2307/3454292]; Cheng JP, 2009, ENVIRON INT, V35, P619, DOI 10.1016/j.envint.2008.12.006; Clarke M.R, 1986, HDB IDENTIFICATION C; Coccini T, 2007, TOXICOLOGY, V238, P34, DOI 10.1016/j.tox.2007.05.018; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P219, DOI 10.1177/33.3.2579122; Das K, 2003, MAR ENVIRON RES, V56, P349, DOI 10.1016/S0141-1136(02)00308-2; Das Krishna, 2006, BMC Ecology, V6, P2, DOI 10.1186/1472-6785-6-2; de Stephanis R, 2008, MAR ECOL PROG SER, V353, P275, DOI 10.3354/meps07164; Debier C, 2006, AQUAT TOXICOL, V80, P149, DOI 10.1016/j.aquatox.2006.08.002; DEQUIROS YB, 2009, 23 ANN C EUR CET SOC; DISCIARA GN, 2006, STATUS DISTRIBUTION, P48; DROUOT V, 2004, J MAR BIOL ASSOC UK, V87, P195; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Evans K, 2004, MAR POLLUT BULL, V48, P486, DOI 10.1016/j.marpolbul.2003.08.026; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Frodello JP, 2000, ENVIRON POLLUT, V108, P447, DOI 10.1016/S0269-7491(99)00221-3; Gannier A, 2002, MAR ECOL PROG SER, V243, P281, DOI 10.3354/meps243281; GANNIER A, 2006, J MAR BIOL ASSOC UK, V5468, P1; Goldoni M, 2008, FOOD CHEM TOXICOL, V46, P808, DOI 10.1016/j.fct.2007.09.104; Griest W. H., 1983, HDB POLYCYCLIC AROMA, P95; Havarinasab S, 2007, TOXICOL APPL PHARM, V221, P21, DOI 10.1016/j.taap.2007.02.009; Hoelzel AR, 2002, J EVOLUTION BIOL, V15, P567, DOI 10.1046/j.1420-9101.2002.00419.x; Holsbeek L, 1999, MAR POLLUT BULL, V38, P304, DOI 10.1016/S0025-326X(98)00150-7; Ikemoto T, 2004, ARCH ENVIRON CON TOX, V47, P402, DOI 10.1007/s00244-004-3188-9; Jacobsen JK, 2010, MAR POLLUT BULL, V60, P765, DOI 10.1016/j.marpolbul.2010.03.008; Jauniaux T, 1998, J WILDLIFE DIS, V34, P99, DOI 10.7589/0090-3558-34.1.99; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; KENNEDY S, 1991, VET PATHOL, V28, P1, DOI 10.1177/030098589102800101; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; Lyrholm T, 1996, MOL BIOL EVOL, V13, P1318, DOI 10.1093/oxfordjournals.molbev.a025578; Marcoux M, 2007, MAR ECOL PROG SER, V333, P309, DOI 10.3354/meps333309; Marsili L, 2001, CHEMOSPHERE, V44, P147, DOI 10.1016/S0045-6535(00)00206-X; Marsili L, 1997, ENVIRON MONIT ASSESS, V45, P129, DOI 10.1023/A:1005786627533; Miller PJO, 2009, DEEP-SEA RES PT I, V56, P1168, DOI 10.1016/j.dsr.2009.02.008; Nigro M, 1996, MAR ECOL PROG SER, V135, P137, DOI 10.3354/meps135137; Pantoja S, 2002, DEEP-SEA RES PT I, V49, P1609, DOI 10.1016/S0967-0637(02)00066-3; Pavan G, 2000, J ACOUST SOC AM, V107, P3487, DOI 10.1121/1.429419; Pierce GJ, 2007, FISH RES, V87, P219, DOI 10.1016/j.fishres.2007.06.001; Praca E, 2008, OCEAN SCI, V4, P49, DOI 10.5194/os-4-49-2008; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Richard KR, 1996, P NATL ACAD SCI USA, V93, P8792, DOI 10.1073/pnas.93.16.8792; Ruiz-Cooley RI, 2004, MAR ECOL PROG SER, V277, P275, DOI 10.3354/meps277275; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Sundaram B, 2006, J THEOR BIOL, V238, P764, DOI 10.1016/j.jtbi.2005.06.022; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Vanselow KH, 2005, J SEA RES, V53, P319, DOI 10.1016/j.seares.2004.07.006; Vanselow Klaus Heinrich, 2009, Open Marine Biology Journal, V3, P89; Whitehead H, 1998, SCIENCE, V282, P1708, DOI 10.1126/science.282.5394.1708; Whitehead H, 2004, J ANIM ECOL, V73, P190, DOI 10.1111/j.1365-2656.2004.00798.x; Whitehead H., 2003, SPERM WHALES SOCIAL; Wolfe MF, 1998, ENVIRON TOXICOL CHEM, V17, P146, DOI [10.1897/1551-5028(1998)017&lt;0146:EOMOWA&gt;2.3.CO;2, 10.1002/etc.5620170203]; Woshner VM, 2002, TOXICOL PATHOL, V30, P209, DOI 10.1080/019262302753559542; Wright AJ, 2005, MAR MAMMAL SCI, V21, P145, DOI 10.1111/j.1748-7692.2005.tb01214.x	74	72	76	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19417	10.1371/journal.pone.0019417	http://dx.doi.org/10.1371/journal.pone.0019417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21673789	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200005
J	Schneider, UV; Geci, I; Johnk, N; Mikkelsen, ND; Pedersen, EB; Lisby, G				Schneider, Uffe V.; Geci, Imrich; Johnk, Nina; Mikkelsen, Nikolaj D.; Pedersen, Erik B.; Lisby, Gorm			Increasing the Analytical Sensitivity by Oligonucleotides Modified with Para- and Ortho-Twisted Intercalating Nucleic Acids - TINA	PLOS ONE			English	Article							THERMAL-STABILITY; DNA; TRIPLEXES; RESISTANT; ANALOGS; DESIGN; RNA	The sensitivity and specificity of clinical diagnostic assays using DNA hybridization techniques are limited by the dissociation of double-stranded DNA (dsDNA) antiparallel duplex helices. This situation can be improved by addition of DNA stabilizing molecules such as nucleic acid intercalators. Here, we report the synthesis of a novel ortho-Twisted Intercalating Nucleic Acid (TINA) amidite utilizing the phosphoramidite approach, and examine the stabilizing effect of ortho-and para-TINA molecules in antiparallel DNA duplex formation. In a thermal stability assay, ortho-and para-TINA molecules increased the melting point (Tm) of Watson-Crick based antiparallel DNA duplexes. The increase in Tm was greatest when the intercalators were placed at the 5' and 3' termini (preferable) or, if placed internally, for each half or whole helix turn. Terminally positioned TINA molecules improved analytical sensitivity in a DNA hybridization capture assay targeting the Escherichia coli rrs gene. The corresponding sequence from the Pseudomonas aeruginosa rrs gene was used as cross-reactivity control. At 150 mM ionic strength, analytical sensitivity was improved 27-fold by addition of ortho-TINA molecules and 7-fold by addition of para-TINA molecules (versus the unmodified DNA oligonucleotide), with a 4-fold increase retained at 1 M ionic strength. Both intercalators sustained the discrimination of mismatches in the dsDNA (indicated by Delta Tm), unless placed directly adjacent to the mismatch - in which case they partly concealed DTm (most pronounced for para-TINA molecules). We anticipate that the presented rules for placement of TINA molecules will be broadly applicable in hybridization capture assays and target amplification systems.	[Schneider, Uffe V.; Johnk, Nina; Mikkelsen, Nikolaj D.; Lisby, Gorm] QuantiBact Inc, Hvidovre, Denmark; [Geci, Imrich; Pedersen, Erik B.] Univ So Denmark, Nucle Acid Ctr, Odense, Denmark; [Geci, Imrich; Pedersen, Erik B.] Univ So Denmark, Dept Chem, Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Schneider, UV (corresponding author), QuantiBact Inc, Hvidovre, Denmark.	uvs@quantibact.com	Schneider, Uffe Vest/GPT-3115-2022; Lisby, Gorm/GMX-0386-2022; Géci, Imrich/HHS-6507-2022; Pedersen, Erik B./M-4573-2017	Schneider, Uffe Vest/0000-0003-1372-7885; Géci, Imrich/0000-0003-0059-9693; Pedersen, Erik B./0000-0002-7917-2379	QuantiBact Inc.	QuantiBact Inc.	This work was funded by QuantiBact Inc. The authors UVS, NJ, NDM and GL are employed by QuantiBact Inc. The funder therefore had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 1996, P NATL ACAD SCI USA, V93, P3199, DOI 10.1073/pnas.93.8.3199; Benner SA, 1998, PURE APPL CHEM, V70, P263, DOI 10.1351/pac199870020263; Christensen UB, 2004, NUCLEOS NUCLEOT NUCL, V23, P207, DOI 10.1081/NCN-120027829; Christensen UB, 2002, NUCLEIC ACIDS RES, V30, P4918, DOI 10.1093/nar/gkf624; Cogoi S, 2009, J MED CHEM, V52, P564, DOI 10.1021/jm800874t; EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062; Filichev VV, 2005, J AM CHEM SOC, V127, P14849, DOI 10.1021/ja053645d; Filichev Vyacheslav V, 2008, Nucleic Acids Symp Ser (Oxf), P347, DOI 10.1093/nass/nrn175; Filichev VV, 2008, CHEM-EUR J, V14, P9968, DOI 10.1002/chem.200800380; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Geci I, 2006, BIOCONJUGATE CHEM, V17, P950, DOI 10.1021/bc060058o; Hanley BP, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-31; Matray TJ, 1998, J AM CHEM SOC, V120, P6191, DOI 10.1021/ja9803310; Moreau V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp661; Morita K, 2002, BIOORG MED CHEM LETT, V12, P73, DOI 10.1016/S0960-894X(01)00683-7; Narayanan S, 2004, NUCLEIC ACIDS RES, V32, P2901, DOI 10.1093/nar/gkh600; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Osman AMA, 2008, BIOORGAN MED CHEM, V16, P9937, DOI 10.1016/j.bmc.2008.10.037; Paramasivam M, 2008, NUCLEIC ACIDS RES, V36, P3494, DOI 10.1093/nar/gkn242; Schneider UV, 2010, NUCLEIC ACIDS RES, V38, P4394, DOI 10.1093/nar/gkq188; Schneider UV, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-4; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; STIRCHAK EP, 1989, NUCLEIC ACIDS RES, V17, P6129, DOI 10.1093/nar/17.15.6129	23	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20565	10.1371/journal.pone.0020565	http://dx.doi.org/10.1371/journal.pone.0020565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673988	Green Published, gold, Green Submitted			2022-12-27	WOS:000291355500024
J	Bilgmann, K; Moller, LM; Harcourt, RG; Kemper, CM; Beheregaray, LB				Bilgmann, Kerstin; Moeller, Luciana M.; Harcourt, Robert G.; Kemper, Catherine M.; Beheregaray, Luciano B.			The Use of Carcasses for the Analysis of Cetacean Population Genetic Structure: A Comparative Study in Two Dolphin Species	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MITOCHONDRIAL-DNA; TURSIOPS-TRUNCATUS; BIOPSY SYSTEM; LAGENORHYNCHUS-OBSCURUS; SOUTHEASTERN AUSTRALIA; COMPUTER-PROGRAM; SOUTH-AUSTRALIA; KILLER WHALES; ORCINUS-ORCA	Advances in molecular techniques have enabled the study of genetic diversity and population structure in many different contexts. Studies that assess the genetic structure of cetacean populations often use biopsy samples from free-ranging individuals and tissue samples from stranded animals or individuals that became entangled in fishery or aquaculture equipment. This leads to the question of how representative the location of a stranded or entangled animal is with respect to its natural range, and whether similar results would be obtained when comparing carcass samples with samples from free-ranging individuals in studies of population structure. Here we use tissue samples from carcasses of dolphins that stranded or died as a result of bycatch in South Australia to investigate spatial population structure in two species: coastal bottlenose (Tursiops sp.) and short-beaked common dolphins (Delphinus delphis). We compare these results with those previously obtained from biopsy sampled free-ranging dolphins in the same area to test whether carcass samples yield similar patterns of genetic variability and population structure. Data from dolphin carcasses were gathered using seven microsatellite markers and a fragment of the mitochondrial DNA control region. Analyses based on carcass samples alone failed to detect genetic structure in Tursiops sp., a species previously shown to exhibit restricted dispersal and moderate genetic differentiation across a small spatial scale in this region. However, genetic structure was correctly inferred in D. delphis, a species previously shown to have reduced genetic structure over a similar geographic area. We propose that in the absence of corroborating data, and when population structure is assessed over relatively small spatial scales, the sole use of carcasses may lead to an underestimate of genetic differentiation. This can lead to a failure in identifying management units for conservation. Therefore, this risk should be carefully assessed when planning population genetic studies of cetaceans.	[Bilgmann, Kerstin; Moeller, Luciana M.; Beheregaray, Luciano B.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Bilgmann, Kerstin; Moeller, Luciana M.; Beheregaray, Luciano B.] Macquarie Univ, Dept Biol Sci, Mol Ecol Lab, Sydney, NSW 2109, Australia; [Bilgmann, Kerstin; Moeller, Luciana M.; Harcourt, Robert G.] Macquarie Univ, Grad Sch Environm, Marine Mammal Res Grp, Sydney, NSW 2109, Australia; [Kemper, Catherine M.] S Australian Museum, Adelaide, SA 5000, Australia	Flinders University South Australia; Macquarie University; Macquarie University	Bilgmann, K (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	kerstin.bilgmann@mq.edu.au	Beheregaray, Luciano B/A-8621-2008; Beheregaray, Luciano/AAY-6384-2021	Beheregaray, Luciano B/0000-0003-0944-3003; Beheregaray, Luciano/0000-0003-0944-3003; Bilgmann, Kerstin/0000-0003-0681-2301; Moller, Luciana/0000-0002-7293-5847; Harcourt, Robert/0000-0003-4666-2934	Macquarie University; Graduate School of Environment and the Linnean Society of New South Wales; international Macquarie University	Macquarie University; Graduate School of Environment and the Linnean Society of New South Wales; international Macquarie University	The project was funded by Macquarie University, the Graduate School of Environment and the Linnean Society of New South Wales. K.B. was supported by an international Macquarie University Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Bilgmann K, 2007, MAR ECOL PROG SER, V341, P265, DOI 10.3354/meps341265; Bilgmann K, 2007, MAR MAMMAL SCI, V23, P218, DOI 10.1111/j.1748-7692.2006.00099.x; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P1; Dalebout ML, 2005, MOL ECOL, V14, P3353, DOI 10.1111/j.1365-294X.2005.02676.x; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Domingo Mariano, 2001, P425; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Evans Karen, 2003, P400; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gilson A, 1998, CALIF FISH GAME, V84, P159; GIMENEZ J, 2011, VET REC, V168, P101, DOI DOI 10.1136/VR.C5284; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hamer DJ, 2008, BIOL CONSERV, V141, P2865, DOI 10.1016/j.biocon.2008.08.024; Harlin AD, 1999, MAR MAMMAL SCI, V15, P409, DOI 10.1111/j.1748-7692.1999.tb00810.x; Hoelzel AR, 1992, MOL ECOL, V1, P119, DOI 10.1111/j.1365-294X.1992.tb00163.x; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; HOELZEL AR, 1994, ANNU REV ECOL SYST, V25, P377; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kemper C., 2003, MARINE MAMMALS FISHE; Kemper C. M., 2005, Australian Mammalogy, V27, P37; Kemper C. M., 2001, Journal of Cetacean Research and Management, V3, P283; Kingston SE, 2004, J HERED, V95, P1, DOI 10.1093/jhered/esh010; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Lavery TJ, 2008, SCI TOTAL ENVIRON, V390, P77, DOI 10.1016/j.scitotenv.2007.09.016; Lazaro M, 2004, MAR MAMMAL SCI, V20, P201, DOI 10.1111/j.1748-7692.2004.tb01151.x; Moeller LM, 2008, MOL PHYLOGENET EVOL, V49, P674, DOI 10.1016/j.ympev.2008.08.011; Moller LM, 2001, MAR MAMMAL SCI, V17, P249, DOI 10.1111/j.1748-7692.2001.tb01269.x; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; OPORTO JA, 1990, REUN ESP MAM AQ AM V; Parsons KM, 2002, BIOL CONSERV, V108, P175, DOI 10.1016/S0006-3207(02)00103-9; Parsons KM, 1999, MOL ECOL, V8, P1766, DOI 10.1046/j.1365-294x.1999.00723-8.x; Perrin W.F., 1994, GILLNETS CETACEANS; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Schneider S., 2000, ARLEQUIN VER 2 000 S; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; SHAUGHNESSY P, 2003, MARINE MAMMALS FISHE; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Valsecchi E, 2004, ANIM CONSERV, V7, P139, DOI 10.1017/S1367943004001325; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WADE PR, 1995, FISH B-NOAA, V93, P345; Wang JY, 1999, MOL ECOL, V8, P1603, DOI 10.1046/j.1365-294x.1999.00741.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weller David W., 1997, Aquatic Mammals, V23, P49; WHITEHEAD H, 1990, MAR MAMMAL SCI, V6, P316, DOI 10.1111/j.1748-7692.1990.tb00361.x	68	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20103	10.1371/journal.pone.0020103	http://dx.doi.org/10.1371/journal.pone.0020103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655285	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600020
J	Buric, M; Hulak, M; Kouba, A; Petrusek, A; Kozak, P				Buric, Milos; Hulak, Martin; Kouba, Antonin; Petrusek, Adam; Kozak, Pavel			A Successful Crayfish Invader Is Capable of Facultative Parthenogenesis: A Novel Reproductive Mode in Decapod Crustaceans	PLOS ONE			English	Article							MARMORKREBS MARBLED CRAYFISH; POPULATION; CAMBARIDAE; PHILIPPI; ASTACIDA; GERMANY; THREAT; FORM	Biological invasions are impacting biota worldwide, and explaining why some taxa tend to become invasive is of major scientific interest. North American crayfish species, particularly of the family Cambaridae, are prominent invaders in freshwaters, defying the "tens rule" which states that only a minority of species introduced to new regions become established, and only a minority of those become invasive and pests. So far, success of cambarid invaders has largely been attributed to rapid maturation, high reproductive output, aggressiveness, and tolerance to pollution. We provide experimental evidence that females of one cambarid species particularly widespread in Europe, the spiny-cheek crayfish Orconectes limosus, are capable of facultative parthenogenesis. Such reproductive mode has never before been recognized in decapods, the most diverse crustacean order. As shown by analysis of seven microsatellite loci, crayfish females kept physically separated from males produced genetically homogeneous offspring identical with maternal individuals; this suggests they reproduced by apomixis, unlike those females which mated with males and had a diverse offspring. Further research is needed to clarify what environmental conditions are necessary for a switch to parthenogenesis in O. limosus, and what role it plays in natural crayfish populations. However, if such reproductive plasticity is present in other cambarid crayfish species, it may contribute to the overwhelming invasive success of this group.	[Buric, Milos; Hulak, Martin; Kouba, Antonin; Kozak, Pavel] Univ S Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, S Bohemian Res Ctr Aquaculture & Biodivers Hydroc, Vodnany, Czech Republic; [Buric, Milos; Hulak, Martin; Kouba, Antonin; Kozak, Pavel] Univ S Bohemia Ceske Budejovice, Res Inst Fish Culture & Hydrobiol, Vodnany, Czech Republic; [Petrusek, Adam] Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic	University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Charles University Prague	Buric, M (corresponding author), Univ S Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, S Bohemian Res Ctr Aquaculture & Biodivers Hydroc, Vodnany, Czech Republic.	buric@vurh.jcu.cz	Kouba, Antonín/C-9338-2015; Kozák, Pavel/G-5025-2015; Petrusek, Adam/A-3510-2008; Buric, Milos/F-8114-2015	Kouba, Antonín/0000-0001-8118-8612; Kozák, Pavel/0000-0002-6985-1538; Petrusek, Adam/0000-0001-5150-4370; Buric, Milos/0000-0003-2220-5579	Czech Ministry of Education, Youth and Sports [MSM0021620828, MSM6007665809]; CENAKVA [CZ.1.05/2.1.00/01.0024]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA601870701]	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); CENAKVA; Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	The research was funded by the Czech Ministry of Education, Youth and Sports (projects MSM0021620828 and MSM6007665809) (http://www.msmt.cz/), the project CENAKVA No. CZ.1.05/2.1.00/01.0024 (http://www.msmt.cz/areas-of-work/research-and-development-for-innovations-operational?highlightWords = VaVpI) and the Grant Agency of the Academy of Sciences of the Czech Republic (IAA601870701) (http://www.gaav.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAUGH D W, 1973, Southwestern Naturalist, V18, P97, DOI 10.2307/3669916; ANDREWS EA, 1907, YOUNG CRAYFISHES AST, V35; Aquiloni L, 2009, FRESHWATER BIOL, V54, P1510, DOI 10.1111/j.1365-2427.2009.02169.x; Buric M, 2010, ZOOLOGY, V113, P301, DOI 10.1016/j.zool.2010.06.001; Buric M, 2010, ZOOL STUD, V49, P28; Chapman DD, 2007, BIOL LETTERS, V3, P425, DOI 10.1098/rsbl.2007.0189; Chucholl C, 2010, AQUAT INVASIONS, V5, P405, DOI 10.3391/ai.2010.5.4.10; De Meester Luc, 2004, P122; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; Filipova L, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011025; Filipova L, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009024; Galeotti P, 2006, P ROY SOC B-BIOL SCI, V273, P1105, DOI 10.1098/rspb.2005.3345; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; Hamr P, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P585; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich D.M., 2006, P49; Hulak M, 2010, J APPL GENET, V51, P73, DOI 10.1007/BF03195713; Jones JPG, 2009, BIOL INVASIONS, V11, P1475, DOI 10.1007/s10530-008-9334-y; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin P, 2010, AQUAT INVASIONS, V5, P397, DOI 10.3391/ai.2010.5.4.09; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; MOGIE M, 1986, BIOL J LINN SOC, V28, P321, DOI 10.1111/j.1095-8312.1986.tb01761.x; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Noro C, 2008, ACTA ZOOL-STOCKHOLM, V89, P59, DOI 10.1111/j.1463-6395.2007.00294.x; RUDOLPH EH, 1995, J CRUSTACEAN BIOL, V15, P720, DOI 10.2307/1548821; RUDOLPH EH, 1995, CRUSTACEANA, V68, P705, DOI 10.1163/156854095X01916; Sagi A, 1996, BIOL BULL, V190, P16, DOI 10.2307/1542672; Scholtz G, 2003, NATURE, V421, P806, DOI 10.1038/421806a; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; Yue GH, 2008, INT J BIOL SCI, V4, P279; Yue GH, 2010, BIOL INVASIONS, V12, P2697, DOI 10.1007/s10530-009-9675-1	32	46	48	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20281	10.1371/journal.pone.0020281	http://dx.doi.org/10.1371/journal.pone.0020281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655282	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600036
J	Girdwood, D; Xirodimas, DP; Gordon, C				Girdwood, David; Xirodimas, Dimitris P.; Gordon, Colin			The Essential Functions of NEDD8 Are Mediated via Distinct Surface Regions, and Not by Polyneddylation in Schizosaccharomyces pombe	PLOS ONE			English	Article							UBIQUITIN-BINDING DOMAINS; SACCHAROMYCES-CEREVISIAE; MULTIUBIQUITIN CHAINS; POLYUBIQUITIN CHAIN; CULLIN NEDDYLATION; MODIFIER NEDD8; PROTEIN; LIGASE; ACTIVATION; CUL1	The ubiquitin-like protein NEDD8 is highly conserved in eukaryotes, from man to Schizosaccharomyces pombe. NEDD8 conjugation to cullin proteins is a prerequisite for cullin based E3 ubiquitin ligase activity, and essential for S. pombe viability. Here, we have performed alanine scanning mutagenesis of all conserved surface residues and show that the majority of essential residues were located around the hydrophobic patch and the C-terminus. However, we further identified essential residues not previously reported to be involved in ubiquitin ligase regulation that importantly do not prevent Ned8p conjugation. We also find that mutation of all conserved lysine residues in Ned8p, did not affect yeast viability, suggesting that mono-neddylation is sufficient for yeast viability under most conditions.	[Girdwood, David; Gordon, Colin] Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Xirodimas, Dimitris P.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	University of Edinburgh; University of Dundee	Girdwood, D (corresponding author), Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	davidgirdwood@gmail.com		Xirodimas, Dimitris/0000-0001-9275-1140	Medical Research Council; RUBICON network of excellence; Association for International Cancer Research; Medical Research Council [MC_U127584486] Funding Source: researchfish; MRC [MC_U127584486] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RUBICON network of excellence; Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, http://www.mrc.ac.uk/index.htm; RUBICON network of excellence, http://www.rubicon-net. org/; and the Association for International Cancer Research, http://www.aicr.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Reverter D, 2005, J MOL BIOL, V345, P141, DOI 10.1016/j.jmb.2004.10.022; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20089	10.1371/journal.pone.0020089	http://dx.doi.org/10.1371/journal.pone.0020089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655279	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600019
J	Miyamoto, K; Yumine, N; Mimura, K; Nagahama, M; Li, JH; McClane, BA; Akimoto, S				Miyamoto, Kazuaki; Yumine, Natsuko; Mimura, Kanako; Nagahama, Masahiro; Li, Jihong; McClane, Bruce A.; Akimoto, Shigeru			Identification of Novel Clostridium perfringens Type E Strains That Carry an Iota Toxin Plasmid with a Functional Enterotoxin Gene	PLOS ONE			English	Article							ENCODING PLASMIDS; CPE LOCUS; DIVERSITY; SPORULATION; PREVALENCE	Clostridium perfringens enterotoxin (CPE) is a major virulence factor for human gastrointestinal diseases, such as food poisoning and antibiotic associated diarrhea. The CPE-encoding gene (cpe) can be chromosomal or plasmid-borne. Recent development of conventional PCR cpe-genotyping assays makes it possible to identify cpe location (chromosomal or plasmid) in type A isolates. Initial studies for developing cpe genotyping assays indicated that all cpe-positive strains isolated from sickened patients were typable by cpe-genotypes, but surveys of C. perfringens environmental strains or strains from feces of healthy people suggested that this assay might not be useful for some cpe-carrying type A isolates. In the current study, a pulsed-field gel electrophoresis Southern blot assay showed that four cpe-genotype untypable isolates carried their cpe gene on a plasmid of similar to 65 kb. Complete sequence analysis of the similar to 65 kb variant cpe-carrying plasmid revealed no intact IS elements and a disrupted cytosine methyltransferase (dcm) gene. More importantly, this plasmid contains a conjugative transfer region, a variant cpe gene and variant iota toxin genes. The toxin genes encoded by this plasmid are expressed based upon the results of RT-PCR assays. The similar to 65 kb plasmid is closely related to the pCPF4969 cpe plasmid of type A isolates. MLST analyses indicated these isolates belong to a unique cluster of C. perfringens. Overall, these isolates carrying a variant functional cpe gene and iota toxin genes represent unique type E strains.	[Miyamoto, Kazuaki; Yumine, Natsuko; Mimura, Kanako; Akimoto, Shigeru] Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan; [Nagahama, Masahiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima 770, Japan; [Li, Jihong; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Wakayama Medical University; Tokushima Bunri University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Miyamoto, K (corresponding author), Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan.	kazuaki@wakayama-med.ac.jp			National Institute of Allergy and Infectious Diseases [R37 AI19844-29, R01 AI056177-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056177, R37AI019844] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this study were supported by grants R37 AI19844-29 and R01 AI056177-08 from the National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript, and no additional external funding was received for this study.	Billington SJ, 1998, INFECT IMMUN, V66, P4531; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295; Gurjar A, 2010, INFECT IMMUN, V78, P4860, DOI 10.1128/IAI.00715-10; Harry KH, 2009, J BACTERIOL, V191, P2728, DOI 10.1128/JB.01839-08; Heikinheimo A, 2006, EMERG INFECT DIS, V12, P1724, DOI 10.3201/eid1211.060478; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Li JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010932; Li JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006249; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; Miki Y, 2008, APPL ENVIRON MICROB, V74, P5366, DOI 10.1128/AEM.00783-08; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Mueller-Spitz SR, 2010, APPL ENVIRON MICROB, V76, P5556, DOI 10.1128/AEM.01702-09; Parsons JA, 2007, J BACTERIOL, V189, P7782, DOI 10.1128/JB.00783-07; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	25	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20376	10.1371/journal.pone.0020376	http://dx.doi.org/10.1371/journal.pone.0020376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655254	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000291097600058
J	Oosthuizen, JL; Gomez, P; Ruan, J; Hackett, TL; Moore, MM; Knight, DA; Tebbutt, SJ				Oosthuizen, Jean L.; Gomez, Pol; Ruan, Jian; Hackett, Tillie L.; Moore, Margo M.; Knight, Darryl A.; Tebbutt, Scott J.			Dual Organism Transcriptomics of Airway Epithelial Cells Interacting with Conidia of Aspergillus fumigatus	PLOS ONE			English	Article							IN-VITRO; PATHOGEN INTERACTIONS; ALVEOLAR MACROPHAGES; FUNCTIONAL GENOMICS; GENE-EXPRESSION; INFECTION; HOST; INNATE; A549; VIRULENCE	Background: Given the complex nature of the responses that can occur in host-pathogen interactions, dual transcriptomics offers a powerful method of elucidating these interactions during infection. The gene expression patterns of Aspergillus fumigatus conidia or host cells have been reported in a number of previous studies, but each focused on only one of the interacting organisms. In the present study, we profiled simultaneously the transcriptional response of both A. fumigatus and human airway epithelial cells (AECs). Methodology: 16HBE14o-transformed bronchial epithelial cells were incubated with A. fumigatus conidia at 37 degrees C for 6 hours, followed by genome-wide transcriptome analysis using human and fungal microarrays. Differentially expressed gene lists were generated from the microarrays, from which biologically relevant themes were identified. Human and fungal candidate genes were selected for validation, using RT-qPCR, in both 16HBE14o- cells and primary AECs co-cultured with conidia. Principal Findings: We report that ontologies related to the innate immune response are activated by co-incubation with A. fumigatus condia, and interleukin-6 (IL-6) was confirmed to be up-regulated in primary AECs via RT-qPCR. Concomitantly, A. fumigatus was found to up-regulate fungal pathways involved in iron acquisition, vacuolar acidification, and formate dehydrogenase activity. Conclusion: To our knowledge, this is the first study to apply a dual organism transcriptomics approach to interactions of A. fumigatus conidia and human airway epithelial cells. The up-regulation of IL-6 by epithelia and simultaneous activation of several pathways by fungal conidia warrants further investigation as we seek to better understand this interaction in both health and disease. The cellular response of the airway epithelium to A. fumigatus is important to understand if we are to improve host-pathogen outcomes.	[Oosthuizen, Jean L.; Gomez, Pol; Ruan, Jian; Hackett, Tillie L.; Knight, Darryl A.; Tebbutt, Scott J.] Providence Hlth Care, Inst HEART LUNG Hlth, UBC James Hogg Res Ctr, Vancouver, BC, Canada; [Hackett, Tillie L.; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Tebbutt, Scott J.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Simon Fraser University; University of British Columbia	Oosthuizen, JL (corresponding author), Providence Hlth Care, Inst HEART LUNG Hlth, UBC James Hogg Res Ctr, Vancouver, BC, Canada.	scott.tebbutt@hli.ubc.ca		Tebbutt, Scott/0000-0002-7908-1581	National Sanitarium Association (Canada); Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; UBC Faculty of Medicine; Canadian Institute of Health Research/Canadian Lung Association/IMPACT; Michael Smith Foundation	National Sanitarium Association (Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UBC Faculty of Medicine; Canadian Institute of Health Research/Canadian Lung Association/IMPACT(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research)	This research was supported by funding from the National Sanitarium Association (Canada), the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca/e/193.html), and the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/). JLO was the recipient of a UBC Faculty of Medicine Summer Student Research Program Award. TLH is the recipient of Canadian Institute of Health Research/Canadian Lung Association/IMPACT and Michael Smith Foundation for Health Research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AddrizzoHarris DJ, 1997, CHEST, V111, P612, DOI 10.1378/chest.111.3.612; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Botterel F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-97; Bruns S, 2010, PROTEOMICS, V10, P3097, DOI 10.1002/pmic.201000129; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Cortez KJ, 2006, INFECT IMMUN, V74, P2353, DOI 10.1128/IAI.74.4.2353-2365.2006; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; Gomez P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-358; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; IbrahimGranet O, 1997, MICROBIOL-SGM, V143, P2247, DOI 10.1099/00221287-143-7-2247; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kauffman HF, 2003, CURR ALLERGY ASTHM R, V3, P101, DOI 10.1007/s11882-003-0021-x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee Sang Hoon, 2004, Korean Journal of Internal Medicine, V19, P38; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melin P, 2004, MICROBIOL-SGM, V150, P743, DOI 10.1099/mic.0.26807-0; Motley ST, 2004, CELL MICROBIOL, V6, P849, DOI 10.1111/j.1462-5822.2004.00407.x; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2010, MICROBES INFECT, V12, P1035, DOI 10.1016/j.micinf.2010.07.005; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shankar J, 2008, J ALLERGY CLIN IMMUN, V121, pS134, DOI 10.1016/j.jaci.2007.12.536; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	45	57	239	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20527	10.1371/journal.pone.0020527	http://dx.doi.org/10.1371/journal.pone.0020527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655222	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600088
J	Rohn, TT; Catlin, LW				Rohn, Troy T.; Catlin, Lindsey W.			Immunolocalization of Influenza A Virus and Markers of Inflammation in the Human Parkinson's Disease Brain	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; NEUROINFLAMMATION; NEUROPROTECTION; MODEL	Although much is known regarding the molecular mechanisms leading to neuronal cell loss in Parkinson's disease (PD), the initiating event has not been identified. Prevailing theories including a chemical insult or infectious agent have been postulated as possible triggers, leading to neuroinflammation. We present immunohistochemical data indicating the presence of influenza A virus within the substantia nigra pars compacta (SNpc) from postmortem PD brain sections. Influenza A virus labeling was identified within neuromelanin granules as well as on tissue macrophages in the SNpc. Further supporting a role for neuroinflammation in PD was the identification of T-lymphocytes that colocalized with an antibody to caspase-cleaved Beclin-1 within the SNpc. The presence of influenza A virus together with macrophages and T-lymphocytes may contribute to the neuroinflammation associated with this disease.	[Rohn, Troy T.; Catlin, Lindsey W.] Boise State Univ, Dept Biol, Boise, ID 83725 USA	Idaho; Boise State University	Rohn, TT (corresponding author), Boise State Univ, Dept Biol, Boise, ID 83725 USA.	trohn@boisestate.edu			KO Dementia Foundation, Boise Idaho; NASA [NNX10AN29A]	KO Dementia Foundation, Boise Idaho; NASA(National Aeronautics & Space Administration (NASA))	This work was funded by KO Dementia Foundation, Boise Idaho and a NASA grant, NNX10AN29A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Goldsmith JR, 1997, ENVIRON RES, V73, P156, DOI 10.1006/enrs.1997.3696; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kaczmarek M, 2010, COMMUN DIS INTELL, V34, P8; Kokoulina P, 2010, NEURODEGENER DIS, V7, P243, DOI 10.1159/000287952; Kumar A, 2004, ARCH NEUROL-CHICAGO, V61, P1057, DOI 10.1001/archneur.61.7.1057; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Miklossy J, 2006, EXP NEUROL, V197, P275, DOI 10.1016/j.expneurol.2005.10.034; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; RAVENHOLT RT, 1982, LANCET, V2, P860; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Rohn T.T., 2009, INT J PHYSL PATH PHA, V1, P24; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; ROHN TT, 2010, NEUROBIOL DIS; SCHWARTZ J, 1979, ANN NEUROL, V6, P261, DOI 10.1002/ana.410060314; Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Villoslada P, 2008, CLIN IMMUNOL, V128, P294, DOI 10.1016/j.clim.2008.04.003; WETMUR JG, 1979, ARCH NEUROL-CHICAGO, V36, P462, DOI 10.1001/archneur.1979.00500440032004; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yamada T, 1996, Parkinsonism Relat Disord, V2, P113, DOI 10.1016/1353-8020(96)00006-5; Yang QA, 2010, NEUROSCIENTIST, V16, P335, DOI 10.1177/1073858409357118; 2011, ANN INTERN MED, V154, P168	32	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20495	10.1371/journal.pone.0020495	http://dx.doi.org/10.1371/journal.pone.0020495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655265	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600079
J	Yang, JJ; Ii, M; Kamei, N; Alev, C; Kwon, SM; Kawamoto, A; Akimaru, H; Masuda, H; Sawa, Y; Asahara, T				Yang, Junjie; Ii, Masaaki; Kamei, Naosuke; Alev, Cantas; Kwon, Sang-Mo; Kawamoto, Atsuhiko; Akimaru, Hiroshi; Masuda, Haruchika; Sawa, Yoshiki; Asahara, Takayuki			CD34(+) Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone Marrow	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CORONARY-ARTERY-DISEASE; NEOVASCULARIZATION CAPACITY; MYOCARDIAL-INFARCTION; ISCHEMIA; VIVO; TRANSPLANTATION; VASCULOGENESIS; ANGIOGENESIS; RECRUITMENT	Background: Endothelial progenitor cells (EPCs) were shown to have angiogenic potential contributing to neovascularization. However, a clear definition of mouse EPCs by cell surface markers still remains elusive. We hypothesized that CD34 could be used for identification and isolation of functional EPCs from mouse bone marrow. Methodology/Principal Findings: CD34(+) cells, c-Kit(+)/Sca-1(+)/Lin(-) (KSL) cells, c-Kit(+)/Lin(-) (KL) cells and Sca-1(+)/Lin(-) (SL) cells were isolated from mouse bone marrow mononuclear cells (BMMNCs) using fluorescent activated cell sorting. EPC colony forming capacity and differentiation capacity into endothelial lineage were examined in the cells. Although CD34(+) cells showed the lowest EPC colony forming activity, CD34(+) cells exhibited under endothelial culture conditions a more adherent phenotype compared with the others, demonstrating the highest mRNA expression levels of endothelial markers vWF, VE-cadherin, and Flk-1. Furthermore, a dramatic increase in immediate recruitment of cells to the myocardium following myocardial infarction and systemic cell injection was observed for CD34(+) cells comparing with others, which could be explained by the highest mRNA expression levels of key homing-related molecules Integrin beta 2 and CXCR4 in CD34(+) cells. Cell retention and incorporation into the vasculature of the ischemic myocardium was also markedly increased in the CD34(+) cell-injected group, giving a possible explanation for significant reduction in fibrosis area, significant increase in neovascularization and the best cardiac functional recovery in this group in comparison with the others. Conclusion: These findings suggest that mouse CD34(+) cells may represent a functional EPC population in bone marrow, which could benefit the investigation of therapeutic EPC biology.	[Yang, Junjie; Kamei, Naosuke; Alev, Cantas; Kawamoto, Atsuhiko; Akimaru, Hiroshi; Asahara, Takayuki] RIKEN Ctr Dev Biol, Grp Vasc Regenerat Res, Inst Biomed Res & Innovation, Kobe, Hyogo, Japan; [Yang, Junjie; Sawa, Yoshiki] Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Osaka, Japan; [Ii, Masaaki] Osaka Med Coll, Grp Translat Stem Cell Res, Dept Pharmacol, Osaka, Japan; [Kamei, Naosuke] Hiroshima Univ, Dept Orthoped Surg, Grad Sch Biomed Sci, Hiroshima, Japan; [Alev, Cantas] RIKEN Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan; [Kwon, Sang-Mo] CHA Univ, Dept Biomed Sci, CHA Stem Cell Inst, Seoul, South Korea; [Masuda, Haruchika; Asahara, Takayuki] Tokai Univ, Dept Regenerat Med, Sch Med, Kanagawa 2591100, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Osaka University; Osaka Medical College; Hiroshima University; RIKEN; Pochon Cha University; Tokai University	Yang, JJ (corresponding author), RIKEN Ctr Dev Biol, Grp Vasc Regenerat Res, Inst Biomed Res & Innovation, Kobe, Hyogo, Japan.	sawasec@surg1.med.osaka-u.ac.jp; asa777@is.icc.u-tokai.ac.jp	Alev, Cantas/W-1493-2018; Yang, Junjie/ABA-4361-2021	Alev, Cantas/0000-0002-4879-8782; Yang, Junjie/0000-0002-6822-6423; Kawamoto, Atsuhiko/0000-0002-2733-8015	Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	This work was supported by research funding from the Ministry of Health, Labor and Welfare Organization in Japan, and the Foundation of Biomedical Research and Innovation of Kobe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RG, 1986, BLOOD, V67, P842; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Eguchi M, 2008, J MOL CELL CARDIOL, V45, P661, DOI 10.1016/j.yjmcc.2008.08.002; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kamei N, 2010, STEM CELLS, V28, P365, DOI 10.1002/stem.243; Kawamoto A, 2001, CIRCULATION, V103, P634; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; Lee SP, 2006, CIRCULATION, V114, P150, DOI 10.1161/CIRCULATIONAHA.105.595918; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nonaka-Sarukawa M, 2007, INT J CARDIOL, V119, P344, DOI 10.1016/j.ijcard.2006.07.191; Ott I, 2005, FASEB J, V19, P992, DOI 10.1096/fj.04-3219fje; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Shintani Satoshi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS123, DOI 10.1038/ncpcardio0430; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tanaka R, 2008, PLAST RECONSTR SURG, V121, P1929, DOI 10.1097/PRS.0b013e3181715218; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wood HB, 1997, BLOOD, V90, P2300; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003	47	94	105	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20219	10.1371/journal.pone.0020219	http://dx.doi.org/10.1371/journal.pone.0020219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655289	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600030
J	Zheng, M; Lv, LL; Ni, J; Ni, HF; Li, Q; Ma, KL; Liu, BC				Zheng, Min; Lv, Lin-Li; Ni, Jie; Ni, Hai-Feng; Li, Qing; Ma, Kun-Ling; Liu, Bi-Cheng			Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy	PLOS ONE			English	Article							EXPRESSION; MOLECULES; SEDIMENT; APOPTOSIS; GENES; CELLS	Background: Podocyte injury and subsequent excretion in urine play a crucial role in the pathogenesis and progression of diabetic nephropathy (DN). Quantification of messenger RNA (mRNA) expression in urinary sediment by real-time PCR is emerging as a noninvasive method of screening DN-associated biomarkers. We hypothesized that the urinary mRNA profile of podocyte-associated molecules may provide important clinical insight into the different stages of diabetic nephropathy. Methods: DN patients (N = 51) and healthy controls (N = 13) were enrolled in this study. DN patients were divided into a normoalbuminuria group (UAE<30 mg/g, n = 17), a microalbuminuria group (UAE 30 similar to 300 mg/g, n = 15), and a macroalbuminuria group (UAE>300 mg/g, n = 19), according to their urinary albumin excretion (UAE). Relative mRNA abundance of synaptopodin, podocalyxin, CD2-AP, alpha-actin4, and podocin were quantified, and correlations between target mRNAs and clinical parameters were examined. Results: The urinary mRNA levels of all genes studied were significantly higher in the DN group compared with controls (p<0.05), and mRNA levels increased with DN progression. Urinary mRNA levels of all target genes positively correlated with both UAE and BUN. The expression of podocalyxin, CD2-AP, alpha-actin4, and podocin mRNA correlated with serum creatinine (r = 0.457, p = 0.001; r = 0.329, p = 0.01; r = 0.286, p = 0.021; r = 0.357, p = 0.006, respectively). Furthermore, podocalyxin mRNA was found to negatively correlate with eGFR (r = -0.349, p = 0.01). Conclusion: The urinary mRNA profiles of synaptopodin, podocalyxin, CD2-AP, alpha-actin4, and podocin were found to increase with the progression of DN, which suggested that quantification of podocyte-associated molecules will be useful biomarkers of DN.	[Zheng, Min; Lv, Lin-Li; Ni, Jie; Ni, Hai-Feng; Li, Qing; Ma, Kun-Ling; Liu, Bi-Cheng] Southeast Univ, Sch Med, Inst Nephrol, Zhong Da Hosp, Nanjing, Peoples R China	Southeast University - China	Liu, BC (corresponding author), Southeast Univ, Sch Med, Inst Nephrol, Zhong Da Hosp, Nanjing, Peoples R China.	Liubc64@yahoo.com.cn			China National Natural Scientific Fund [30870953]	China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC))	This study was supported by the China National Natural Scientific Fund (No. 30870953) to Prof. Bi-Cheng Liu as PI. (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US REN DAT SYST USRD; Camici M, 2007, BIOMED PHARMACOTHER, V61, P245, DOI 10.1016/j.biopha.2006.12.009; Chan RWY, 2007, RHEUMATOLOGY, V46, P44, DOI 10.1093/rheumatology/kel192; Chan RWY, 2006, NEPHROL DIAL TRANSPL, V21, P1534, DOI 10.1093/ndt/gfk102; Dagogo-Jack S, 2006, J NATL MED ASSOC, V98, P415; Dai HY, 2011, AM J MED SCI, V341, P207, DOI 10.1097/MAJ.0b013e3182010da9; Ichikawa L, 2005, CURR OPIN NEPHROL HY, V14, P205; Ihalmo P, 2008, DIABETOLOGIA, V51, P86, DOI 10.1007/s00125-007-0854-2; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mas VR, 2005, TRANSPLANTATION, V80, P1686, DOI 10.1097/01.tp.0000185472.79948.db; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Miyauchi M, 2009, INTERNAL MED, V48, P1615, DOI 10.2169/internalmedicine.48.2137; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Reidy K, 2009, AM J KIDNEY DIS, V54, P590, DOI 10.1053/j.ajkd.2009.07.003; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Teiken JM, 2008, ANAT REC, V291, P114, DOI 10.1002/ar.20625; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Wang G, 2007, J RHEUMATOL, V34, P2358; Wang G, 2007, NEPHRON CLIN PRACT, V106, P169, DOI 10.1159/000104428; Wang G, 2010, RENAL FAILURE, V32, P372, DOI 10.3109/08860221003611737; White KE, 2004, NEPHROL DIAL TRANSPL, V19, P1437, DOI 10.1093/ndt/gfh129; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009	32	77	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20431	10.1371/journal.pone.0020431	http://dx.doi.org/10.1371/journal.pone.0020431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655212	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600067
J	Rodriguez-Navarro, A				Rodriguez-Navarro, Alonso			A Simple Index for the High-Citation Tail of Citation Distribution to Quantify Research Performance in Countries and Institutions	PLOS ONE			English	Article							H-INDEX; BIBLIOMETRIC INDICATORS; REVOLUTIONARY SCIENCE; SCIENTIFIC IMPACT; CO-AUTHORSHIP; NOBEL-PRIZES; REVIEWS	Background: Conventional scientometric predictors of research performance such as the number of papers, citations, and papers in the top 1% of highly cited papers cannot be validated in terms of the number of Nobel Prize achievements across countries and institutions. The purpose of this paper is to find a bibliometric indicator that correlates with the number of Nobel Prize achievements. Methodology/Principal Findings: This study assumes that the high-citation tail of citation distribution holds most of the information about high scientific performance. Here I propose the x-index, which is calculated from the number of national articles in the top 1% and 0.1% of highly cited papers and has a subtractive term to discount highly cited papers that are not scientific breakthroughs. The x-index, the number of Nobel Prize achievements, and the number of national articles in Nature or Science are highly correlated. The high correlations among these independent parameters demonstrate that they are good measures of high scientific performance because scientific excellence is their only common characteristic. However, the x-index has superior features as compared to the other two parameters. Nobel Prize achievements are low frequency events and their number is an imprecise indicator, which in addition is zero in most institutions; the evaluation of research making use of the number of publications in prestigious journals is not advised. Conclusion: The x-index is a simple and precise indicator for high research performance.	Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain	Universidad Politecnica de Madrid	Rodriguez-Navarro, A (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain.	alonso.rodriguez@upm.es	Rodriguez-Navarro, Alonso/AAB-4574-2019	Rodriguez-Navarro, Alonso/0000-0003-0462-223X				Abt HA, 2000, SCIENTOMETRICS, V48, P65, DOI 10.1023/A:1005680318379; Abt HA, 2007, SCIENTOMETRICS, V72, P105, DOI 10.1007/s11192-007-1686-z; Aksnes DW, 2004, SCIENTOMETRICS, V59, P213, DOI 10.1023/B:SCIE.0000018529.58334.eb; Aksnes DW, 2003, RES EVALUAT, V12, P159, DOI 10.3152/147154403781776645; Aksnes DW, 2004, RES EVALUAT, V13, P33, DOI 10.3152/147154404781776563; Albarran P, 2010, SCIENTOMETRICS, V85, P329, DOI 10.1007/s11192-010-0223-7; Allen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005910; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; Anastasiadis AD, 2010, SCIENTOMETRICS, V83, P205, DOI 10.1007/s11192-009-0023-0; Anastasiadis AD, 2009, BRAZ J PHYS, V39, P511, DOI 10.1590/S0103-97332009000400031; Charlton BG, 2008, MED HYPOTHESES, V70, P465, DOI 10.1016/j.mehy.2007.12.004; Charlton BG, 2007, MED HYPOTHESES, V68, P931, DOI 10.1016/j.mehy.2006.12.006; Charlton BG, 2007, MED HYPOTHESES, V68, P471, DOI 10.1016/j.mehy.2006.11.003; Egghe L, 2008, INFORM PROCESS MANAG, V44, P770, DOI 10.1016/j.ipm.2007.05.003; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Garfield, 1973, ESSAYS INFORM SCI, V1, P406; GARFIELD E, 1992, THEOR MED, V13, P117, DOI 10.1007/BF02163625; GARFIELD E, 1973, CURR CONTENTS, V5, P5; Gingras Y, 2010, SCIENTOMETRICS, V82, P401, DOI 10.1007/s11192-009-0035-9; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; Glanzel W, 2001, SCIENTOMETRICS, V50, P199, DOI 10.1023/A:1010561321723; Hall BH, 2005, RAND J ECON, V36, P16; Harnad S, 2009, SCIENTOMETRICS, V79, P147, DOI 10.1007/s11192-009-0409-z; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Iglesias JE, 2007, SCIENTOMETRICS, V73, P303, DOI 10.1007/s11192-007-1805-x; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lewison G, 2009, RES EVALUAT, V18, P25, DOI 10.3152/095820209X410406; Martin BR, 1996, SCIENTOMETRICS, V36, P343, DOI 10.1007/BF02129599; Norris M, 2010, J DOC, V66, P681, DOI 10.1108/00220411011066790; Norris M, 2010, J INFORMETR, V4, P221, DOI 10.1016/j.joi.2009.11.001; Oppenheim C, 1997, J DOC, V53, P477, DOI 10.1108/EUM0000000007207; Perc M, 2010, J INFORMETR, V4, P358, DOI 10.1016/j.joi.2010.03.001; Persson O, 2010, SCIENTOMETRICS, V83, P397, DOI 10.1007/s11192-009-0007-0; Phelan TJ, 1999, SCIENTOMETRICS, V45, P117, DOI 10.1007/BF02458472; Prathap G, 2010, SCIENTOMETRICS, V85, P185, DOI 10.1007/s11192-010-0192-x; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Raghuraman KP, 2010, CURR SCI INDIA, V99, P577; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Rinia EJ, 1998, RES POLICY, V27, P95, DOI 10.1016/S0048-7333(98)00026-2; RODRIGRIGUEZNAV.A, 2011, J DOCUMENTA IN PRESS; Rodriguez-Navarro A, 2009, J AM SOC INF SCI TEC, V60, P1845, DOI 10.1002/asi.21104; Schmoch U, 2008, SCIENTOMETRICS, V74, P361, DOI 10.1007/s11192-007-1818-5; Schreiber M, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/30002; Schreiber M, 2009, J AM SOC INF SCI TEC, V60, P1274, DOI 10.1002/asi.21057; Schubert A, 2007, SCIENTOMETRICS, V70, P201, DOI 10.1007/s11192-007-0112-x; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sidiropoulos A, 2007, SCIENTOMETRICS, V72, P253, DOI 10.1007/s11192-007-1722-z; Tijssen RJW, 2003, RES EVALUAT, V12, P91, DOI 10.3152/147154403781776690; Tijssen RJW, 2002, SCIENTOMETRICS, V54, P381, DOI 10.1023/A:1016082432660; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; van Leeuwen TN, 2003, SCIENTOMETRICS, V57, P257, DOI 10.1023/A:1024141819302; Van Noorden R, 2010, NATURE, V465, P864, DOI 10.1038/465864a; Zhang C, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004881, 10.1371/journal.pone.0005429]	56	24	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20510	10.1371/journal.pone.0020510	http://dx.doi.org/10.1371/journal.pone.0020510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XV	21647383	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500067
J	Brilli, F; Ruuskanen, TM; Schnitzhofer, R; Muller, M; Breitenlechner, M; Bittner, V; Wohlfahrt, G; Loreto, F; Hansel, A				Brilli, Federico; Ruuskanen, Taina M.; Schnitzhofer, Ralf; Mueller, Markus; Breitenlechner, Martin; Bittner, Vinzenz; Wohlfahrt, Georg; Loreto, Francesco; Hansel, Armin			Detection of Plant Volatiles after Leaf Wounding and Darkening by Proton Transfer Reaction "Time-of-Flight" Mass Spectrometry (PTR-TOF)	PLOS ONE			English	Article							DIFFERENT ENVIRONMENTAL-CONDITIONS; ORGANIC-COMPOUND EMISSIONS; DIMETHYLALLYL DIPHOSPHATE; LIPOXYGENASE PATHWAY; ISOPRENE EMISSION; GREEN LEAVES; SIGNALS; MAIZE; INDUCTION; PRODUCTS	Proton transfer reaction-time of flight (PTR-TOF) mass spectrometry was used to improve detection of biogenic volatiles organic compounds (BVOCs) induced by leaf wounding and darkening. PTR-TOF measurements unambiguously captured the kinetic of the large emissions of green leaf volatiles (GLVs) and acetaldehyde after wounding and darkening. GLVs emission correlated with the extent of wounding, thus confirming to be an excellent indicator of mechanical damage. Transient emissions of methanol, C5 compounds and isoprene from plant species that do not emit isoprene constitutively were also detected after wounding. In the strong isoprene-emitter Populus alba, light-dependent isoprene emission was sustained and even enhanced for hours after photosynthesis inhibition due to leaf cutting. Thus isoprene emission can uncouple from photosynthesis and may occur even after cutting leaves or branches, e. g., by agricultural practices or because of abiotic and biotic stresses. This observation may have important implications for assessments of isoprene sources and budget in the atmosphere, and consequences for tropospheric chemistry.	[Brilli, Federico; Schnitzhofer, Ralf; Mueller, Markus] Ionicon Analyt GmbH, Innsbruck, Austria; [Ruuskanen, Taina M.; Schnitzhofer, Ralf; Breitenlechner, Martin; Bittner, Vinzenz; Hansel, Armin] Univ Innsbruck, Inst Ion Phys & Appl Phys, A-6020 Innsbruck, Austria; [Wohlfahrt, Georg] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Loreto, Francesco] CNR, IPP, Florence, Italy; [Ruuskanen, Taina M.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Mueller, Markus] Inst Rech Catalyse & Environm Lyon IRCELYON, CNRS, Villeurbanne, France	University of Innsbruck; University of Innsbruck; Consiglio Nazionale delle Ricerche (CNR); University of Helsinki; Centre National de la Recherche Scientifique (CNRS)	Brilli, F (corresponding author), Ionicon Analyt GmbH, Innsbruck, Austria.	armin.hansel@uibk.ac.at	Brilli, Federico/O-6475-2015; Mueller, Markus/L-1699-2014; Wohlfahrt, Georg/D-2409-2009; Breitenlechner, Martin/AAA-3402-2021; Loreto, Francesco/B-7477-2015; Hansel, Armin/F-3915-2010	Brilli, Federico/0000-0002-2563-6086; Mueller, Markus/0000-0003-4110-8950; Wohlfahrt, Georg/0000-0003-3080-6702; Loreto, Francesco/0000-0002-9171-2681; Hansel, Armin/0000-0002-1062-2394; Breitenlechner, Martin/0000-0002-2382-6660	Austrian National Science Fund [L518-N20]; company Ionicon Analytik; European Commission [218065]; Austrian Science Fund (FWF) [L 518, P 23267] Funding Source: researchfish	Austrian National Science Fund(Austrian Science Fund (FWF)); company Ionicon Analytik; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian National Science Fund by the Translational Research-Programme (L518-N20) and partly by the company Ionicon Analytik as one of the partners involved in the Marie Curie Industry-Academia Partnership and Pathways (IAPP) project 218065 "PTR-TOF" funded by the European Commission within the Seventh Framework Programme (FP7 - People). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Beauchamp J, 2005, PLANT CELL ENVIRON, V28, P1334, DOI 10.1111/j.1365-3040.2005.01383.x; Behnke K, 2009, TREE PHYSIOL, V29, P725, DOI 10.1093/treephys/tpp009; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Capitani D, 2009, PLANT PHYSIOL, V149, P1638, DOI 10.1104/pp.108.128884; Charron CS, 1996, J AM SOC HORTIC SCI, V121, P483, DOI 10.21273/JASHS.121.3.483; CROFT KPC, 1993, PLANT PHYSIOL, V101, P13, DOI 10.1104/pp.101.1.13; De Gouw JA, 2000, ENVIRON SCI TECHNOL, V34, P2640, DOI 10.1021/es991219k; DIEUAIDE M, 1992, PLANT PHYSIOL, V99, P595, DOI 10.1104/pp.99.2.595; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Fall R, 2001, ATMOS ENVIRON, V35, P3905, DOI 10.1016/S1352-2310(01)00141-8; Fall R, 1999, J GEOPHYS RES-ATMOS, V104, P15963, DOI 10.1029/1999JD900144; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; Farag MA, 2002, PHYTOCHEMISTRY, V61, P545, DOI 10.1016/S0031-9422(02)00240-6; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fisher AJ, 2003, PHYTOCHEMISTRY, V62, P159, DOI 10.1016/S0031-9422(02)00521-6; Graus M, 2004, PLANT PHYSIOL, V135, P1967, DOI 10.1104/pp.104.043240; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; Guenther A., 2006, ATMOS CHEM PHYS, V6, P3181, DOI [10.5194/acp-6-3181-2006, DOI 10.5194/ACP-6-3181-2006, DOI 10.5194/ACPD-6-107-2006]; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; HATANAKA A, 1987, CHEM PHYS LIPIDS, V44, P341, DOI 10.1016/0009-3084(87)90057-0; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; Heiden AC, 2003, J ATMOS CHEM, V45, P143, DOI 10.1023/A:1024069605420; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Higgins R, 2007, PLANTA, V225, P1535, DOI 10.1007/s00425-006-0440-8; Holzinger R, 2000, J GEOPHYS RES-ATMOS, V105, P20573, DOI 10.1029/2000JD900296; Jardine K, 2009, PLANT BIOLOGY, V11, P591, DOI 10.1111/j.1438-8677.2008.00155.x; Jia WS, 2007, PLANT PHYSIOL, V143, P68, DOI 10.1104/pp.106.089110; Karl T, 2002, PLANT CELL ENVIRON, V25, P1121, DOI 10.1046/j.1365-3040.2002.00889.x; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; LORETO F, 1993, PLANTA, V189, P420, DOI 10.1007/BF00194440; Loreto F, 2006, PLANT CELL ENVIRON, V29, P1820, DOI 10.1111/j.1365-3040.2006.01561.x; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Milburn J. A., 1979, WATER FLOW IN PLANTS; Muller M, 2010, ATMOS MEAS TECH, V3, P387, DOI 10.5194/amt-3-387-2010; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Nogues I, 2006, PLANT PHYSIOL, V141, P721, DOI 10.1104/pp.105.073213; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Sharkey TD, 1996, TRENDS PLANT SCI, V1, P78, DOI 10.1016/S1360-1385(96)80038-0; SILVER GM, 1991, PLANT PHYSIOL, V97, P1588, DOI 10.1104/pp.97.4.1588; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9	56	132	134	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20419	10.1371/journal.pone.0020419	http://dx.doi.org/10.1371/journal.pone.0020419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637822	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200062
J	Cooper, TF; Lai, M; Ulstrup, KE; Saunders, SM; Flematti, GR; Radford, B; van Oppen, MJH				Cooper, Timothy F.; Lai, Michael; Ulstrup, Karin E.; Saunders, Sandra M.; Flematti, Gavin R.; Radford, Ben; van Oppen, Madeleine J. H.			Symbiodinium Genotypic and Environmental Controls on Lipids in Reef Building Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; STYLOPHORA-PISTILLATA; ALGAL ENDOSYMBIONTS; LIGHT REGIMES; ZOOXANTHELLAE; GROWTH; PHOTOBIOLOGY; FLEXIBILITY; IRRADIANCE; DIVERSITY	Background: Lipids in reef building corals can be divided into two classes; non-polar storage lipids, e. g. wax esters and triglycerides, and polar structural lipids, e. g. phospholipids and cholesterol. Differences among algal endosymbiont types are known to have important influences on processes including growth and the photobiology of scleractinian corals yet very little is known about the role of symbiont types on lipid energy reserves. Methodology/Principal Findings: The ratio of storage lipid and structural lipid fractions of Scott Reef corals were determined by thin layer chromatography. The lipid fraction ratio varied with depth and depended on symbiont type harboured by two corals (Seriatopora hystrix and Pachyseris speciosa). S. hystrix colonies associated with Symbiodinium C1 or C1/C# at deep depths (<23 m) had lower lipid fraction ratios (i.e. approximately equal parts of storage and structural lipids) than those with Symbiodinium D1 in shallow depths (<23 m), which had higher lipid fraction ratios (i.e. approximately double amounts of storage relative to structural lipid). Further, there was a non-linear relationship between the lipid fraction ratio and depth for S. hystrix with a modal peak at similar to 23 m coinciding with the same depth as the shift from clade D to C types. In contrast, the proportional relationship between the lipid fraction ratio and depth for P. speciosa, which exhibited high specificity for Symbiodinium C3 like across the depth gradient, was indicative of greater amounts of storage lipids contained in the deep colonies. Conclusions/Significance: This study has demonstrated that Symbiodinium exert significant controls over the quality of coral energy reserves over a large-scale depth gradient. We conclude that the competitive advantages and metabolic costs that arise from flexible associations with divergent symbiont types are offset by energetic trade-offs for the coral host.	[Cooper, Timothy F.; Radford, Ben] UWA Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia; [Lai, Michael; Saunders, Sandra M.; Flematti, Gavin R.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia; [Ulstrup, Karin E.] DHI Water & Environm, Perth, WA, Australia; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; University of Western Australia; Australian Institute of Marine Science	Cooper, TF (corresponding author), UWA Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia.	t.cooper@aims.gov.au	van Oppen, Madeleine JH/C-3261-2008; Cooper, Timothy/B-8168-2008; Flematti, Gavin R/J-2018-2012	Flematti, Gavin/0000-0003-2545-6939; van Oppen, Madeleine/0000-0003-4607-0744	Woodside Energy Ltd	Woodside Energy Ltd	This study was funded by Woodside Energy Ltd (as operator of the Browse LNG Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; BRINKMAN R, 2009, SRRPRPRT025 AIMS; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; HARLAND AD, 1992, MAR BIOL, V112, P253, DOI 10.1007/BF00702469; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2010, J EXP MAR BIOL ECOL, V391, P143, DOI 10.1016/j.jembe.2010.06.019; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Muscatine L, 1980, PRIMARY PRODUCTIVITY, P381; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; PORTER JW, 1974, ZOOPLANKTON FEEDING; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saunders SM, 2005, ENVIRON CHEM, V2, P331, DOI 10.1071/EN05043; TOMASCIK T, 1985, MAR BIOL, V87, P143, DOI 10.1007/BF00539422; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P2617, DOI 10.1098/rspb.2001.2007; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Zhu M, 2005, ECOL MODEL, V187, P524, DOI 10.1016/j.ecolmodel.2005.01.049	45	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20434	10.1371/journal.pone.0020434	http://dx.doi.org/10.1371/journal.pone.0020434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637826	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200065
J	Yoshida, T; Suga, M; Arima, K; Muranaka, Y; Tanaka, T; Eguchi, S; Lin, C; Yoshida, S; Ishikawa, M; Higuchi, Y; Seo, T; Ueoka, Y; Tomotake, M; Kaneda, Y; Darby, D; Maruff, P; Iyo, M; Kasai, K; Higuchi, T; Sumiyoshi, T; Ohmori, T; Takahashi, K; Hashimoto, K				Yoshida, Taisuke; Suga, Motomu; Arima, Kunimasa; Muranaka, Yasuko; Tanaka, Tsunehiko; Eguchi, Satoshi; Lin, Crystal; Yoshida, Sumiko; Ishikawa, Masanori; Higuchi, Yuko; Seo, Tomonori; Ueoka, Yoshinori; Tomotake, Masahito; Kaneda, Yasuhiro; Darby, David; Maruff, Paul; Iyo, Masaomi; Kasai, Kiyoto; Higuchi, Teruhiko; Sumiyoshi, Tomiki; Ohmori, Tetsuro; Takahashi, Kiyohisa; Hashimoto, Kenji			Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CONSENSUS COGNITIVE BATTERY; ALZHEIMERS-DISEASE; MATRICS; INDIVIDUALS; IMPAIRMENT; DEFICITS; VERSION; RELIABILITY; SENSITIVITY	Background: The CogState Schizophrenia Battery (CSB), a computerized cognitive battery, covers all the same cognitive domains as the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery but is briefer to conduct. The aim of the present study was to evaluate the criterion and construct validity of the Japanese language version of the CSB (CSB-J) in Japanese patients with schizophrenia. Methodology/Principal Findings: Forty Japanese patients with schizophrenia and 40 Japanese healthy controls with matching age, gender, and premorbid intelligence quotient were enrolled. The CSB-J and the Brief Assessment of Cognition in Schizophrenia, Japanese-language version (BACS-J) were performed once. The structure of the CSB-J was also evaluated by a factor analysis. Similar to the BACS-J, the CSB-J was sensitive to cognitive impairment in Japanese patients with schizophrenia. Furthermore, there was a significant positive correlation between the CSB-J composite score and the BACS-J composite score. A factor analysis showed a three-factor model consisting of memory, speed, and social cognition factors. Conclusions/Significance: This study suggests that the CSB-J is a useful and rapid automatically administered computerized battery for assessing broad cognitive domains in Japanese patients with schizophrenia.	[Yoshida, Taisuke; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Yoshida, Taisuke; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Suga, Motomu; Eguchi, Satoshi; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Arima, Kunimasa; Lin, Crystal; Yoshida, Sumiko; Ishikawa, Masanori] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan; [Higuchi, Teruhiko] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Muranaka, Yasuko; Higuchi, Yuko; Seo, Tomonori; Sumiyoshi, Tomiki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan; [Tanaka, Tsunehiko; Ueoka, Yoshinori; Tomotake, Masahito; Ohmori, Tetsuro] Univ Tokushima, Dept Psychiat, Course Integrated Brain Sci, Inst Hlth Biosci,Grad Sch, Tokushima 770, Japan; [Kaneda, Yasuhiro] Iwaki Clin, Dept Psychiat, Tokushima, Japan; [Darby, David; Maruff, Paul] CogState Ltd, Melbourne, Vic, Australia; [Takahashi, Kiyohisa] Japan Fdn Neurosci & Mental Hlth, Tokyo, Japan	Chiba University; Chiba University; University of Tokyo; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; University of Toyama; Tokushima University; CogState Limited	Yoshida, T (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Maruff, Paul/ABA-1673-2020; Sumiyoshi, Tomiki/K-4507-2019; Maruff, Paul/AAD-2454-2021; KANEDA, Yasuhiro/AAH-2441-2020; Hashimoto, Kenji/I-5800-2015	Maruff, Paul/0000-0002-6947-9537; Kaneda, Yasuhiro/0000-0003-0513-262X; Hashimoto, Kenji/0000-0002-8892-0439; Kasai, Kiyoto/0000-0002-4443-4535	Japan Foundation for Neuroscience and Mental Health (Tokyo, Japan)	Japan Foundation for Neuroscience and Mental Health (Tokyo, Japan)	This study was supported by a grant from Japan Foundation for Neuroscience and Mental Health (Tokyo, Japan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. David Darby and Paul Maruff are employees of CogState Ltd., who contributed to the analysis of the study.	ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; Allen DN, 2007, SCHIZOPHR RES, V93, P325, DOI 10.1016/j.schres.2007.02.008; Bralet MC, 2007, EUR PSYCHIAT, V22, P365, DOI 10.1016/j.eurpsy.2007.02.001; Brazo P, 2002, EUR PSYCHIAT, V17, P155, DOI 10.1016/S0924-9338(02)00648-X; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1120, DOI 10.1093/schbul/sbm083; BUCHANAN RW, 2011, SCHIZOPHR B IN PRESS; Censits DM, 1997, SCHIZOPHR RES, V24, P289, DOI 10.1016/S0920-9964(96)00091-6; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Goldstein G, 2005, ARCH CLIN NEUROPSYCH, V20, P153, DOI 10.1016/j.acn.2004.03.008; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 1999, SCHIZOPHRENIA BULL, V25, P309, DOI 10.1093/oxfordjournals.schbul.a033380; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hashimoto Kenji, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P171, DOI 10.2174/1568015054863828; Hashimoto K, 2011, CURR PHARM DESIGN, V17, P112, DOI 10.2174/138161211795049598; Hyman SE, 2003, SCIENCE, V299, P350, DOI 10.1126/science.1077141; Ishikawa M, 2011, CURR PHARM DESIGN, V17, P121, DOI 10.2174/138161211795049561; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kaneda Y, 2000, No To Shinkei, V52, P163; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2008, SCHIZOPHR RES, V102, P108, DOI 10.1016/j.schres.2008.03.024; Keefe RSE, 2011, SCHIZOPHR RES, V125, P161, DOI 10.1016/j.schres.2010.09.015; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kern RS, 2004, SCHIZOPHR RES, V72, P11, DOI 10.1016/j.schres.2004.09.004; Lim YY, 2009, BEHAV RES METHODS, V41, P1190, DOI 10.3758/BRM.41.4.1190; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Pantelis C, 1997, BRAIN, V120, P1823, DOI 10.1093/brain/120.10.1823; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Pietrzak RH, 2009, HUM PSYCHOPHARM CLIN, V24, P113, DOI 10.1002/hup.998; Pinkham AE, 2008, AM J PSYCHIAT, V165, P639, DOI 10.1176/appi.ajp.2007.07101604; Pinkham AE, 2006, PSYCHIAT RES, V143, P167, DOI 10.1016/j.psychres.2005.09.005; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Seltzer J, 1997, SCHIZOPHR RES, V23, P131, DOI 10.1016/S0920-9964(96)00094-1; Shamsi S, 2011, SCHIZOPHR RES, V126, P257, DOI 10.1016/j.schres.2010.08.007; Snyder PJ, 2008, PSYCHIAT RES, V160, P316, DOI 10.1016/j.psychres.2007.07.011; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243	41	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20469	10.1371/journal.pone.0020469	http://dx.doi.org/10.1371/journal.pone.0020469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XS	21637776	gold, Green Published			2022-12-27	WOS:000291052200068
J	Zong, ZY; Peng, CH; Lu, XJ				Zong, Zhiyong; Peng, Chunhong; Lue, Xiaoju			Diversity of SCCmec Elements in Methicillin-Resistant Coagulase-Negative Staphylococci Clinical Isolates	PLOS ONE			English	Article							CASSETTE-CHROMOSOME-MEC; GENETIC DIVERSITY; AUREUS; EPIDERMIDIS; SAPROPHYTICUS; STRAINS; PSEUDINTERMEDIUS; IDENTIFICATION; HAEMOLYTICUS; INFECTIONS	Background: Methicillin-resistant coagulase-negative staphylococci (MR-CoNS) are opportunistic pathogens and serve as a large reservoir of staphylococcal cassette chromosome mec (SCCmec). Characterization of SCCmec in MR-CoNS can generate useful information on the mobilization and evolution of this element. Methodology/Principal Findings: Non-repetitive MR-CoNS clinical isolates (n=84; 39 S. epidermidis, 19 S. haemolyticus, 9 S. hominis, 6 S. capitis, 4 S. warneri, 2 S. cohnii, 2 S. saprophyticus, 1 S. kloosii, 1 S. simulans and 1 S. massiliensis) were collected. All isolates could grow on plates with 4 mg/L cefoxitin and all had mecA as detected by PCR. Strain typing using RAPD and ERIC-PCR revealed that almost all isolates were of different strains. SCCmec typing was performed using multiplex PCR published previously. For isolates in which SCCmec could not be typed, the mec complex classes were determined by additional PCR and the ccr genes were amplified with published or newly-designed primers and then sequenced. SCCmec types were assigned for 63 isolates by multiplex PCR and were assigned for 14 other isolates by PCR targeting mec and ccr. Among 77 isolates with determined SCCmec types, 54 had a single type, including type III (n = 19), IV (n = 14), V (n = 10), II (n = 2), I (n = 1), VIII (n = 1) and five unnamed types (n = 7), while 23 isolates had two types, III+V (n = 12), II+V (n = 8), II+IV (n = 2) or IV+V (n = 1). The five unnamed types were assigned UT1 (class A mec, ccrA1/ccrB4), UT2 (class C1 mec, ccrA4/ccrB4), UT3 (class A mec, ccrA5/ccrB3), UT4 (class C2 mec, ccrA2/ccrB2 plus ccrC1) and UT5 (class A mec, ccrA1/ccrB1 plus ccrC1). Conclusions/Significance: SCCmec types III, IV and V were prevalent in MR-CoNS and many isolates could harbor more than one type. Several new types of SCCmec were identified, highlighting the great genetic diversity and the need of developing classification schemes for SCCmec in MR-CoNS.	[Zong, Zhiyong; Lue, Xiaoju] Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China; [Peng, Chunhong] Sichuan Univ, W China Hosp, Dept Resp Med, Chengdu 610064, Peoples R China; [Zong, Zhiyong] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Peoples R China; [Peng, Chunhong] Peoples Hosp Guizhou Prov, Dept Emergence, Guiyang, Peoples R China	Sichuan University; Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China.	zongzhiy@scu.edu.cn	Zong, Zhiyong/C-6142-2013	ZONG, ZHIYONG/0000-0002-7675-260X	National Natural Science Foundation of China [30900052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by a grant from the National Natural Science Foundation of China (project no. 30900052). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Masalma M, 2010, INT J SYST EVOL MICR, V60, P1066, DOI 10.1099/ijs.0.006486-0; BARBIER F, 2010, J ANTIMICROB CHEMOTH; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Casey AL, 2006, J INFECTION, V52, P282, DOI 10.1016/j.jinf.2005.06.005; Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Ender M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-62; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Higashide M, 2008, ANTIMICROB AGENTS CH, V52, P2061, DOI 10.1128/AAC.01150-07; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Ibrahem S, 2008, CLIN MICROBIOL INFEC, V14, P1020, DOI 10.1111/j.1469-0691.2008.02080.x; Ibrahem S, 2009, J CLIN MICROBIOL, V47, P32, DOI 10.1128/JCM.01085-08; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Soderquist B, 2009, CLIN MICROBIOL INFEC, V15, P1176, DOI 10.1111/j.1469-0691.2009.02771.x; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang Y, 2009, J APPL MICROBIOL, V107, P1375, DOI 10.1111/j.1365-2672.2009.04322.x; Zong ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014016	34	90	94	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20191	10.1371/journal.pone.0020191	http://dx.doi.org/10.1371/journal.pone.0020191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637845	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200037
J	Sargeant, D; Deverasetty, S; Luo, Y; Baleta, AV; Zobrist, S; Rathnayake, V; Russo, JC; Vyas, J; Muesing, MA; Schiller, MR				Sargeant, David; Deverasetty, Sandeep; Luo, Yang; Baleta, Angel Villahoz; Zobrist, Stephanie; Rathnayake, Viraj; Russo, Jacqueline C.; Vyas, Jay; Muesing, Mark A.; Schiller, Martin R.			HIVToolbox, an Integrated Web Application for Investigating HIV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DNA-BINDING; NUCLEAR IMPORT; REVERSE-TRANSCRIPTASE; SEQUENCE ALIGNMENT; MINIMOTIF MINER; CATALYTIC CORE; PROTEIN DATA; DOMAIN; ACETYLATION	Many bioinformatic databases and applications focus on a limited domain of knowledge federating links to information in other databases. This segregated data structure likely limits our ability to investigate and understand complex biological systems. To facilitate research, therefore, we have built HIVToolbox, which integrates much of the knowledge about HIV proteins and allows virologists and structural biologists to access sequence, structure, and functional relationships in an intuitive web application. HIV-1 integrase protein was used as a case study to show the utility of this application. We show how data integration facilitates identification of new questions and hypotheses much more rapid and convenient than current approaches using isolated repositories. Several new hypotheses for integrase were created as an example, and we experimentally confirmed a predicted CK2 phosphorylation site. Weblink: [http://hivtoolbox.bio-toolkit.com]	[Sargeant, David; Deverasetty, Sandeep; Baleta, Angel Villahoz; Zobrist, Stephanie; Rathnayake, Viraj; Russo, Jacqueline C.; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Luo, Yang; Muesing, Mark A.] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Vyas, Jay] Univ Connecticut Hlth Ctr, Dept Mol Microbial & Struct Biol, Farmington, CT USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut	Sargeant, D (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689, AI078708, AI078708S, AI065321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078708, R21AI065321, F32AI007870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [grant number GM079689, AI078708, AI078708S] to MRS and [grant number AI065321] to MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CBN: IUPAC-IUB Commission on Biochemical Nomenclature (CBN), 1970, BIOCHEM J, V120, P449; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Dampier W, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-47; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; Davey NE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-14; Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x; Doherty RS, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-18; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Evans P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008942; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; FRIBORG J, 1995, J ACQ IMMUN DEF SYND, V8, P10; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gille C, 2006, PROTEIN SCI, V15, P208, DOI 10.1110/ps.051882006; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Klenchin VA, 2008, NUCLEIC ACIDS RES, V36, P5855, DOI 10.1093/nar/gkn577; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; LEITNER T, 2005, THEORETICAL BIOL BIO; Levin A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-112; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Meehan AM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000522; Meggio F, 2001, MOL CELL BIOCHEM, V227, P145, DOI 10.1023/A:1013177326481; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Nathanson N, 1999, SCIENCE, V284, P1619, DOI 10.1126/science.284.5420.1619; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Swingler S, 1997, J VIROL, V71, P4372, DOI 10.1128/JVI.71.6.4372-4377.1997; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Topper M, 2007, J VIROL, V81, P3012, DOI 10.1128/JVI.02257-06; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vyas J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp616; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	63	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20122	10.1371/journal.pone.0020122	http://dx.doi.org/10.1371/journal.pone.0020122			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647445	Green Published, gold			2022-12-27	WOS:000291006500026
J	Tuke, PW; Tettmar, KI; Tamuri, A; Stoye, JP; Tedder, RS				Tuke, Philip W.; Tettmar, Kate I.; Tamuri, Asif; Stoye, Jonathan P.; Tedder, Richard S.			PCR Master Mixes Harbour Murine DNA Sequences. Caveat Emptor!	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; XMRV INFECTION; MOUSE DNA; PREVALENCE; CONTAMINATION; RETROVIRUS; FAILURE; ABSENCE	Background: XMRV is the most recently described retrovirus to be found in Man, firstly in patients with prostate cancer (PC) and secondly in 67% of patients with chronic fatigue syndrome (CFS) and 3.7% of controls. Both disease associations remain contentious. Indeed, a recent publication has concluded that "XMRV is unlikely to be a human pathogen". Subsequently related but different polytropic MLV (pMLV) sequences were also reported from the blood of 86.5% of patients with CFS. and 6.8% of controls. Consequently we decided to investigate blood donors for evidence of XMRV/pMLV. Methodology/Principal Findings: Testing of cDNA prepared from the whole blood of 80 random blood donors, generated gag PCR signals from two samples (7C and 9C). These had previously tested negative for XMRV by two other PCR based techniques. To test whether the PCR mix was the source of these sequences 88 replicates of water were amplified using Invitrogen Platinum Taq (IPT) and Applied Biosystems Taq Gold LD (ABTG). Four gag sequences (2D, 3F, 7H, 12C) were generated with the IPT, a further sequence (12D) by ABTG re-amplification of an IPT first round product. Sequence comparisons revealed remarkable similarities between these sequences, endogeous MLVs and the pMLV sequences reported in patients with CFS. Conclusions/Significance: Methodologies for the detection of viruses highly homologous to endogenous murine viruses require special caution as the very reagents used in the detection process can be a source of contamination and at a level where it is not immediately apparent. It is suggested that such contamination is likely to explain the apparent presence of pMLV in CFS.	[Tuke, Philip W.; Tettmar, Kate I.; Tedder, Richard S.] Natl Hlth Serv Blood & Transplant, Natl Transfus Microbiol Labs, London, England; [Tedder, Richard S.] Hlth Protect Agcy, Ctr Infect, Virus Reference Dept, Blood Borne Virus Unit, London, England; [Tamuri, Asif] Natl Inst Med Res, MRC, Div Math Biol, London NW7 1AA, England; [Stoye, Jonathan P.] Natl Inst Med Res, MRC, Div Virol, London NW7 1AA, England	NHS Blood & Transplant (NHSBT); Health Protection Agency; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Tuke, PW (corresponding author), Natl Hlth Serv Blood & Transplant, Natl Transfus Microbiol Labs, London, England.	philip.tuke@hpa.org.uk		Tamuri, Asif/0000-0001-6633-3789; Tedder, Richard/0000-0002-9672-5721; Stoye, Jonathan/0000-0003-3377-323X	NHS Blood and Transplant; Medical Research Council [U117512710]; Medical Research Council [MC_U117512710] Funding Source: researchfish; MRC [MC_U117512710] Funding Source: UKRI	NHS Blood and Transplant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NHS Blood and Transplant and the Medical Research Council (file reference U117512710 to JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Mikovits JA, 2010, AIDS REV, V12, P149; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255	25	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19953	10.1371/journal.pone.0019953	http://dx.doi.org/10.1371/journal.pone.0019953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647447	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500013
J	Muller, K; Matuschewski, K; Silvie, O				Mueller, Katja; Matuschewski, Kai; Silvie, Olivier			The Puf-Family RNA-Binding Protein Puf2 Controls Sporozoite Conversion to Liver Stages in the Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSCRIPTION FACTOR; SEXUAL DEVELOPMENT; MESSENGER-RNA; DNA-BINDING; PUMILIO; MOSQUITO; IDENTIFICATION; TRANSFORMATION; RECOGNITION	Malaria is a vector-borne infectious disease caused by unicellular, obligate intracellular parasites of the genus Plasmodium. During host switch the malaria parasite employs specialized latent stages that colonize the new host environment. Previous work has established that gametocytes, sexually differentiated stages that are taken up by the mosquito vector, control expression of genes required for mosquito colonization by translational repression. Sexual parasite development is controlled by a DEAD-box RNA helicase of the DDX6 family, termed DOZI. Latency of sporozoites, the transmission stage injected during an infectious blood meal, is controlled by the eIF2alpha kinase IK2, a general inhibitor of protein synthesis. Whether RNA-binding proteins participate in translational regulation in sporozoites remains to be studied. Here, we investigated the roles of two RNA-binding proteins of the Puf-family, Plasmodium Puf1 and Puf2, during sporozoite stage conversion. Our data reveal that, in the rodent malaria parasite P. berghei, Puf2 participates in the regulation of IK2 and inhibits premature sporozoite transformation. Inside mosquito salivary glands puf2(-) sporozoites transform over time to round forms resembling early intra-hepatic stages. As a result, mutant parasites display strong defects in initiating a malaria infection. In contrast, Puf1 is dispensable in vivo throughout the entire Plasmodium life cycle. Our findings support the notion of a central role for Puf2 in parasite latency during switch between the insect and mammalian hosts.	[Mueller, Katja; Matuschewski, Kai; Silvie, Olivier] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany	Max Planck Society	Muller, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	olivier.silvie@inserm.fr	Silvie, Olivier/K-7290-2017; Silvie, Olivier/AAF-5437-2021	Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; Matuschewski, Kai/0000-0001-6147-8591; Muller, Katja/0000-0001-5100-0981	Max Planck Society; European Commission (EviMalaR) [34]; Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; Marie Curie Intra-European fellowship; EMBO	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission (EviMalaR)(European CommissionEuropean Commission Joint Research Centre); Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; Marie Curie Intra-European fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the Max Planck Society, and in part by grants from the European Commission (EviMalaR, #34), the Joachim Siebeneicher Foundation and the Chica and Heinz Schaller Foundation. OS was a recipient of a Marie Curie Intra-European fellowship and an EMBO Long-Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Coleman BI, 2008, CELL MICROBIOL, V10, P1935, DOI 10.1111/j.1462-5822.2008.01203.x; Cui LW, 2002, NUCLEIC ACIDS RES, V30, P4607, DOI 10.1093/nar/gkf600; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Fan Q, 2004, DNA CELL BIOL, V23, P753, DOI 10.1089/dna.2004.23.753; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hegge S, 2010, FASEB J, V24, P5003, DOI 10.1096/fj.10-164814; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Kaiser K, 2003, J EXP MED, V197, P1045, DOI 10.1084/jem.20022100; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Miao J, 2010, J CELL SCI, V123, P1039, DOI 10.1242/jcs.059824; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; QUENAULT T, 2010, TRENDS CELL BIOL; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	46	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19860	10.1371/journal.pone.0019860	http://dx.doi.org/10.1371/journal.pone.0019860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21673790	gold, Green Submitted, Green Published			2022-12-27	WOS:000290720200041
J	Cai, WD; Leung, HC				Cai, Weidong; Leung, Hoi-Chung			Rule-Guided Executive Control of Response Inhibition: Functional Topography of the Inferior Frontal Cortex	PLOS ONE			English	Article							STOP-SIGNAL TASK; VENTROLATERAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; COGNITIVE CONTROL; GO/NO-GO; PSYCHOPHYSIOLOGICAL INTERACTIONS; TARGET DETECTION; NEURAL BASIS; PERFORMANCE; MRI	Background: The human inferior frontal cortex (IFC) is a large heterogeneous structure with distinct cytoarchitectonic subdivisions and fiber connections. It has been found involved in a wide range of executive control processes from target detection, rule retrieval to response control. Since these processes are often being studied separately, the functional organization of executive control processes within the IFC remains unclear. Methodology/Principal Findings: We conducted an fMRI study to examine the activities of the subdivisions of IFC during the presentation of a task cue (rule retrieval) and during the performance of a stop-signal task (requiring response generation and inhibition) in comparison to a not-stop task (requiring response generation but not inhibition). We utilized a mixed event-related and block design to separate brain activity in correspondence to transient control processes from rule-related and sustained control processes. We found differentiation in control processes within the IFC. Our findings reveal that the bilateral ventral-posterior IFC/anterior insula are more active on both successful and unsuccessful stop trials relative to not-stop trials, suggesting their potential role in the early stage of stopping such as triggering the stop process. Direct countermanding seems to be outside of the IFC. In contrast, the dorsal-posterior IFC/inferior frontal junction (IFJ) showed transient activity in correspondence to the infrequent presentation of the stop signal in both tasks and the left anterior IFC showed differential activity in response to the task cues. The IFC subdivisions also exhibited similar but distinct patterns of functional connectivity during response control. Conclusions/Significance: Our findings suggest that executive control processes are distributed across the IFC and that the different subdivisions of IFC may support different control operations through parallel cortico-cortical and cortico-striatal circuits.	[Cai, Weidong; Leung, Hoi-Chung] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Cai, Weidong] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Cai, WD (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	w2cai@ucsd.edu; hoi-chung.leung@stonybrook.edu	Cai, Weidong/H-5497-2011		State University of New York at Stony Brook; NIH [DA023044]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023044] Funding Source: NIH RePORTER	State University of New York at Stony Brook; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the State University of New York at Stony Brook (http://www.stonybrook.edu/) and NIH DA023044 (http://drugabuse.gov/nidahome.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2009, NEUROSCI BIOBEHAV R, V33, P611, DOI 10.1016/j.neubiorev.2008.10.003; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Cai WD, 2009, BRAIN RES, V1261, P20, DOI 10.1016/j.brainres.2008.12.073; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Donohue SE, 2005, NEUROIMAGE, V26, P1140, DOI 10.1016/j.neuroimage.2005.03.019; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hirose S, 2009, NEUROIMAGE, V47, P442, DOI 10.1016/j.neuroimage.2009.04.094; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kim J, 2008, MAGN RESON IMAGING, V26, P583, DOI 10.1016/j.mri.2007.10.011; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Logan GD, 1984, PSYCHOL REV, V91, P195; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rushworth MFS, 2005, J NEUROSCI, V25, P11628, DOI 10.1523/JNEUROSCI.2765-05.2005; Sakagami M, 2001, J NEUROSCI, V21, P4801, DOI 10.1523/JNEUROSCI.21-13-04801.2001; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Simons JS, 2005, NEUROPSYCHOLOGIA, V43, P1774, DOI 10.1016/j.neuropsychologia.2005.02.004; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Wang M, 2000, EUR J NEUROSCI, V12, P3787, DOI 10.1046/j.1460-9568.2000.00238.x; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	64	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20840	10.1371/journal.pone.0020840	http://dx.doi.org/10.1371/journal.pone.0020840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673969	gold, Green Submitted, Green Published			2022-12-27	WOS:000291356400032
J	Uliczka, F; Pisano, F; Kochut, A; Opitz, W; Herbst, K; Stolz, T; Dersch, P				Uliczka, Frank; Pisano, Fabio; Kochut, Annika; Opitz, Wiebke; Herbst, Katharina; Stolz, Tatjana; Dersch, Petra			Monitoring of Gene Expression in Bacteria during Infections Using an Adaptable Set of Bioluminescent, Fluorescent and Colorigenic Fusion Vectors	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PROMOTER-PROBE VECTORS; YERSINIA-ENTEROCOLITICA; ESCHERICHIA-COLI; LIVING CELLS; PROTEIN; GFP; CONSTRUCTION; FAMILY; EVOLUTION	A family of versatile promoter-probe plasmids for gene expression analysis was developed based on a modular expression plasmid system (pZ). The vectors contain different replicons with exchangeable antibiotic cassettes to allow compatibility and expression analysis on a low-, midi-and high-copy number basis. Suicide vector variants also permit chromosomal integration of the reporter fusion and stable vector derivatives can be used for in vivo or in situ expression studies under non-selective conditions. Transcriptional and translational fusions to the reporter genes gfp(mut3.1), amCyan, dsRed2, luxCDABE, phoA or lacZ can be constructed, and presence of identical multiple cloning sites in the vector system facilitates the interchange of promoters or reporter genes between the plasmids of the series. The promoter of the constitutively expressed gapA gene of Escherichia coli was included to obtain fluorescent and bioluminescent expression constructs. A combination of the plasmids allows simultaneous detection and gene expression analysis in individual bacteria, e. g. in bacterial communities or during mouse infections. To test our vector system, we analyzed and quantified expression of Yersinia pseudotuberculosis virulence genes under laboratory conditions, in association with cells and during the infection process.	[Uliczka, Frank; Pisano, Fabio; Kochut, Annika; Opitz, Wiebke; Herbst, Katharina; Stolz, Tatjana; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Lower Saxony, Germany; [Uliczka, Frank; Dersch, Petra] Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, Braunschweig, Lower Saxony, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Uliczka, F (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Lower Saxony, Germany.	petra.dersch@helmholtz-hzi.de		Dersch, Petra/0000-0001-8177-3280	BMBF [TP1]; Deutsche Forschungsgemeinschaft [SFB621 TP-B10, SPP1316]; Fonds der Chemischen Industrie; HBRS; "Excellence Initiative" of the German Government	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); HBRS; "Excellence Initiative" of the German Government	This work was supported by a grant from the BMBF (Zoonosis Program FBI-Zoo, TP1), the Deutsche Forschungsgemeinschaft (SFB621 TP-B10 and SPP1316) and the Fonds der Chemischen Industrie. W. Opitz was supported by a fellowship from the HBRS - PhD Program "Infection Biology" at the Medical School Hannover funded by the "Excellence Initiative" of the German Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Goulding A, 2008, PROTEIN ENG DES SEL, V21, P101, DOI 10.1093/protein/gzm075; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Hughes KT, 2007, METHOD ENZYMOL, V421, P140, DOI 10.1016/S0076-6879(06)21013-9; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Jakobs S, 2000, FEBS LETT, V479, P131, DOI 10.1016/S0014-5793(00)01896-2; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Karunakaran R, 2005, MICROBIOL-SGM, V151, P3249, DOI 10.1099/mic.0.28311-0; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Matthysse AG, 1996, FEMS MICROBIOL LETT, V145, P87, DOI 10.1016/0378-1097(96)00392-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; METCALF WW, 1993, GENE, V129, P17, DOI 10.1016/0378-1119(93)90691-U; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Sambrook J., MOL CLONING LAB MANU; Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k; SILHAVY TJ, 1985, MICROBIOL REV, V49, P398, DOI 10.1128/MMBR.49.4.398-418.1985; SILHAVY TJ, EXPT GENE FUSIONS; SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992; Strauch E, 2000, J BIOTECHNOL, V79, P63, DOI 10.1016/S0168-1656(00)00216-9; Trcek J, 2010, FEMS MICROBIOL LETT, V307, P201, DOI 10.1111/j.1574-6968.2010.01983.x; Valdivia RH, 1997, TRENDS MICROBIOL, V5, P360, DOI 10.1016/S0966-842X(97)01111-6; Viallet PM, 2003, CURR PROTEIN PEPT SC, V4, P375, DOI 10.2174/1389203033487045; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	38	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20425	10.1371/journal.pone.0020425	http://dx.doi.org/10.1371/journal.pone.0020425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673990	Green Submitted, Green Published, gold			2022-12-27	WOS:000291355500018
J	Das, A; Dey, N; Ghosh, A; Das, T; Chatterjee, IB				Das, Archita; Dey, Neekkan; Ghosh, Arunava; Das, Tanusree; Chatterjee, Indu B.			NAD(P)H: Quinone Oxidoreductase 1 Deficiency Conjoint with Marginal Vitamin C Deficiency Causes Cigarette Smoke Induced Myelodysplastic Syndromes	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; ASCORBIC-ACID; GENETIC SUSCEPTIBILITY; ACUTE-LEUKEMIA; LUNG-CANCER; BENZENE; RISK; APOPTOSIS; MECHANISM; DNA	Background: The etiology of myelodysplastic syndromes (MDS) is largely unknown. Exposure to cigarette smoke (CS) is reported to be associated with MDS risk. There is inconsistent evidence that deficiency of NAD(P)H-quinone: oxidoreductase 1 (NQO1) increases the risk of MDS. Earlier we had shown that CS induces toxicity only in marginal vitamin C-deficient guinea pigs but not in vitamin C-sufficient ones. We therefore considered that NQO1 deficiency along with marginal vitamin C deficiency might produce MDS in CS-exposed guinea pigs. Methodology and Principal Findings: Here we show that CS exposure for 21 days produces MDS in guinea pigs having deficiency of NQO1 (fed 3 mg dicoumarol/day) conjoint with marginal vitamin C deficiency (fed 0.5 mg vitamin C/day). As evidenced by morphology, histology and cytogenetics, MDS produced in the guinea pigs falls in the category of refractory cytopenia with unilineage dysplasia (RCUD): refractory anemia; refractory thrombocytopenia that is associated with ring sideroblasts, micromegakaryocytes, myeloid hyperplasia and aneuploidy. MDS is accompanied by increased CD34(+) cells and oxidative stress as shown by the formation of protein carbonyls and 8-oxodeoxyguanosine. Apoptosis precedes MDS but disappears later with marked decrease in the p53 protein. MDS produced in the guinea pigs are irreversible. MDS and all the aforesaid pathophysiological events do not occur in vitamin C-sufficient guinea pigs. However, after the onset of MDS vitamin C becomes ineffective. Conclusions and Significance: CS exposure causes MDS in guinea pigs having deficiency of NQO1 conjoint with marginal vitamin C deficiency. The syndromes are not produced in singular deficiency of NQO1 or marginal vitamin C deficiency. Our results suggest that human smokers having NQO1 deficiency combined with marginal vitamin C deficiency are likely to be at high risk for developing MDS and that intake of a moderately large dose of vitamin C would prevent MDS.	[Das, Archita; Dey, Neekkan; Ghosh, Arunava; Chatterjee, Indu B.] Univ Calcutta, Coll Sci, Dept Biotechnol, Kolkata, W Bengal, India; [Das, Archita; Dey, Neekkan; Ghosh, Arunava; Chatterjee, Indu B.] Univ Calcutta, Coll Sci, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, W Bengal, India; [Das, Tanusree] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, A (corresponding author), Univ Calcutta, Coll Sci, Dept Biotechnol, Kolkata, W Bengal, India.	ibc123@rediffmail.com	DAS, ARCHITA/ABD-5437-2020; Ghosh, Arunava/I-5939-2019	Ghosh, Arunava/0000-0001-9550-1366; Dey, Neekkan/0000-0002-4042-7215	Juthika Research Foundation; Calcutta University	Juthika Research Foundation; Calcutta University(University of Calcutta)	This research was supported by Juthika Research Foundation and Phulrenu Guha Research Fellowship of Calcutta University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2010, LEUKEMIA, V24, P1, DOI 10.1038/leu.2009.157; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; ATTAR EC, 2008, HARRISONS MANUAL ONC, P289; AUL C, 1992, BRIT J HAEMATOL, V82, P358, DOI 10.1111/j.1365-2141.1992.tb06430.x; Bain BJ, 2006, DACIE LEWIS PRACTICA, V4, P60; Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21; Bauer AK, 2003, CANCER RES, V63, P929; Bjork J, 2000, EPIDEMIOLOGY, V11, P285, DOI 10.1097/00001648-200005000-00010; Bjork J, 2009, LEUKEMIA RES, V33, P788, DOI 10.1016/j.leukres.2008.10.009; Blagosklonny MV, 2000, LEUKEMIA, V14, P2017, DOI 10.1038/sj.leu.2401979; Bogdanovic AD, 1997, LEUKEMIA, V11, P656, DOI 10.1038/sj.leu.2400640; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; CARSON DA, 1995, LANCET, V346, P1009, DOI 10.1016/S0140-6736(95)91693-8; CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Chatterjee IB, 2005, US Patent, Patent No. [6,929,012, 6929012, 6,929, 012]; Dey N, 2010, J BIOSCIENCES, V35, P217, DOI 10.1007/s12038-010-0026-2; Fontenay M, 2008, HAEMATOL-HEMATOL J, V93, P1288, DOI 10.3324/haematol.13563; Frei B, 2008, P NATL ACAD SCI USA, V105, P11037, DOI 10.1073/pnas.0806433105; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Gava A, 1998, GENET MOL BIOL, V21, P77, DOI 10.1590/S1415-47571998000100013; GOGNA A, 2008, JIACM, V9, P143; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Head K A, 1998, Altern Med Rev, V3, P174; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Hwang ES, 2007, TOXICOLOGY, V229, P1, DOI 10.1016/j.tox.2006.10.013; Iskander K, 2005, CHEM-BIOL INTERACT, V153, P147, DOI 10.1016/j.cbi.2005.03.019; Jankowska AM, 2008, LEUKEMIA, V22, P551, DOI 10.1038/sj.leu.2405055; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lee KW, 2003, AM J CLIN NUTR, V78, P1074, DOI 10.1093/ajcn/78.6.1074; Lichtman MA, 2007, LEUKEMIA, V21, P1137, DOI 10.1038/sj.leu.2404698; Long DJ, 2002, CANCER RES, V62, P3030; MA X, 2009, AM J EPIDEMIOLOGY; Nebert DW, 2002, GENET MED, V4, P62, DOI 10.1097/00125817-200203000-00003; Panda K, 1999, FREE RADICAL BIO MED, V27, P1064, DOI 10.1016/S0891-5849(99)00154-9; Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5; Park DJ, 1996, SEMIN HEMATOL, V33, P256; Pasqualetti P, 1997, BRIT J HAEMATOL, V97, P659, DOI 10.1046/j.1365-2141.1997.942910.x; Platzbecker U, 2007, CANCER TREAT REV, V33, pS53, DOI 10.1016/j.ctrv.2007.07.021; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Rajnoldi AC, 2005, ANN HEMATOL, V84, P429, DOI 10.1007/s00277-005-1034-4; Reis SC, 2009, NEOPLASMA, V56, P435, DOI 10.4149/neo_2009_05_435; Ross D, 2005, CHEM-BIOL INTERACT, V153, P137, DOI 10.1016/j.cbi.2005.03.018; RUSSELL WO, 1952, CANCER RES, V12, P216; SEO IS, 1993, MAYO CLIN PROC, V68, P47, DOI 10.1016/S0025-6196(12)60018-4; Shetty V, 2000, BLOOD, V96, P1388, DOI 10.1182/blood.V96.4.1388.h8001388_1388_1392; Smith MT, 1996, ENVIRON HEALTH PERSP, V104, P1219, DOI 10.2307/3433166; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Smith MT, 1999, P NATL ACAD SCI USA, V96, P7624, DOI 10.1073/pnas.96.14.7624; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; Steiner M, 1999, CANCER LETT, V135, P67; Stepanov I, 2006, NICOTINE TOB RES, V8, P309, DOI 10.1080/14622200500490151; Stewart B. W., 2003, WORLD CANC REPORT, P21; Strom SS, 2008, SEMIN HEMATOL, V45, P8, DOI 10.1053/j.seminhematol.2007.10.003; Strom SS, 2005, LEUKEMIA, V19, P1912, DOI 10.1038/sj.leu.2403945; SULLIVAN AB, 1976, J PHYS CHEM-US, V80, P2671, DOI 10.1021/j100565a010; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; VEENBAIGENT MJ, 1975, ANN NY ACAD SCI, V258, P339, DOI 10.1111/j.1749-6632.1975.tb29294.x; WALDO AL, 1955, CANCER, V8, P187, DOI 10.1002/1097-0142(1955)8:1<187::AID-CNCR2820080126>3.0.CO;2-S; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wright JL, 2002, CHEST, V121, p188S, DOI 10.1378/chest.121.5_suppl.188S; Yin L, 2001, LUNG CANCER-J IASLC, V33, P133, DOI 10.1016/S0169-5002(01)00182-9	68	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20590	10.1371/journal.pone.0020590	http://dx.doi.org/10.1371/journal.pone.0020590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655231	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600105
J	Dmitrieva, NI; Burg, MB				Dmitrieva, Natalia I.; Burg, Maurice B.			Increased Insensible Water Loss Contributes to Aging Related Dehydration	PLOS ONE			English	Article							VASOPRESSIN; AGE; SENESCENCE; DELETION; BARRIER	Dehydration with aging is attributed to decreased urine concentrating ability and thirst. We further investigated by comparing urine concentration and water balance in 3, 18 and 27 month old mice, consuming equal amounts of water. During water restriction, 3 month old mice concentrate their urine sufficiently to maintain water balance (stable weight). 18 month old mice concentrate their urine as well, but still lose weight (negative water balance). 27 month old mice do not concentrate their urine as well and lose even more weight than the 18 month old mice, indicating a larger negative water balance. Negative water balance in older mice is accompanied by increased vasopressin excretion, providing further evidence of dehydration. All 3 groups maintain water balance while consuming only the water in gel food containing 56% water. However, both older groups excrete a smaller volume of urine of higher osmolality, indicating greater extra urinary water loss. Since their feces also contain less water, the excess water lost by the older mice apparently is through other routes, presumably insensible loss through the respiratory tract and skin. The greater insensible water loss occurs at an earlier age (18 months) than decreased urine concentrating ability (27 months). We propose that insensible water loss through skin and respiration increases with age, making a major contribution to aging related dehydration.	[Dmitrieva, Natalia I.; Burg, Maurice B.] NHLBI, Lab Kidney & Electrolyte Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Dmitrieva, NI (corresponding author), NHLBI, Lab Kidney & Electrolyte Metab, NIH, Bldg 10, Bethesda, MD 20892 USA.	dmitrien@nhlbi.nih.gov	Dmitrieva, Natalia/Q-9175-2019; Dmitrieva, Natalia/A-2924-2013	Dmitrieva, Natalia/0000-0001-8074-6950; Dmitrieva, Natalia/0000-0001-8074-6950	National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001283, ZIAHL006131] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Program of the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Dmitrieva NI, 2007, CELL CYCLE, V6, P3108, DOI 10.4161/cc.6.24.5084; Dmitrieva NI, 2009, AGING-US, V1, P245, DOI 10.18632/aging.100022; Farahmand S, 2009, SKIN RES TECHNOL, V15, P392, DOI 10.1111/j.1600-0846.2009.00376.x; Frolkis VV, 1999, ARCH GERONTOL GERIAT, V29, P193; GEELEN G, 1992, AM J PHYSIOL, V262, pR826, DOI 10.1152/ajpregu.1992.262.5.R826; GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919; GILLOOLY M, 1993, THORAX, V48, P39, DOI 10.1136/thx.48.1.39; Guyton AC, 2000, TXB MED PHYSL, P263; Imhof R. E., 2009, International Journal of Cosmetic Science, V31, P97, DOI 10.1111/j.1468-2494.2008.00476.x; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010; Kenney WL, 2001, MED SCI SPORT EXER, V33, P1524, DOI 10.1097/00005768-200109000-00016; Knepper MA, 2008, NAT MED, V14, P14, DOI 10.1038/nm0108-14; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Machado M., 2010, International Journal of Cosmetic Science, V32, P397, DOI 10.1111/j.1468-2494.2010.00587.x; ONEILL PA, 1992, MED LAB SCI, V49, P291; ROWE JW, 1976, NEPHRON, V17, P270, DOI 10.1159/000180731; Sands JM, 2009, SEMIN NEPHROL, V29, P579, DOI 10.1016/j.semnephrol.2009.07.004; Shirreffs SM, 2003, EUR J CLIN NUTR, V57, pS6, DOI 10.1038/sj.ejcn.1601895; Tian Y, 2004, AM J PHYSIOL-RENAL, V287, pF797, DOI 10.1152/ajprenal.00403.2003; Torres VE, 2009, KIDNEY INT, V76, P925, DOI 10.1038/ki.2009.325; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20691	10.1371/journal.pone.0020691	http://dx.doi.org/10.1371/journal.pone.0020691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655199	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600123
J	Fritsch, C; Coeurdassier, M; Giraudoux, P; Raoul, F; Douay, F; Rieffel, D; de Vaufleury, A; Scheifler, R				Fritsch, Clementine; Coeurdassier, Michael; Giraudoux, Patrick; Raoul, Francis; Douay, Francis; Rieffel, Dominique; de Vaufleury, Annette; Scheifler, Renaud			Spatially Explicit Analysis of Metal Transfer to Biota: Influence of Soil Contamination and Landscape	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; WHITE-TOOTHED SHREW; SMALL MAMMALS; CLETHRIONOMYS-GLAREOLUS; CROCIDURA-RUSSULA; HEAVY-METALS; BODY BURDENS; HOST FACTORS; FOOD-CHAIN; EXPOSURE	Concepts and developments for a new field in ecotoxicology, referred to as "landscape ecotoxicology,'' were proposed in the 1990s; however, to date, few studies have been developed in this emergent field. In fact, there is a strong interest in developing this area, both for renewing the concepts and tools used in ecotoxicology as well as for responding to practical issues, such as risk assessment. The aim of this study was to investigate the spatial heterogeneity of metal bioaccumulation in animals in order to identify the role of spatially explicit factors, such as landscape as well as total and extractable metal concentrations in soils. Over a smelter-impacted area, we studied the accumulation of trace metals (TMs: Cd, Pb and Zn) in invertebrates (the grove snail Cepaea sp and the glass snail Oxychilus draparnaudi) and vertebrates (the bank vole Myodes glareolus and the greater white-toothed shrew Crocidura russula). Total and CaCl2-extractable concentrations of TMs were measured in soils from woody patches where the animals were captured. TM concentrations in animals exhibited a high spatial heterogeneity. They increased with soil pollution and were better explained by total rather than CaCl2-extractable TM concentrations, except in Cepaea sp. TM levels in animals and their variations along the pollution gradient were modulated by the landscape, and this influence was species and metal specific. Median soil metal concentrations (predicted by universal kriging) were calculated in buffers of increasing size and were related to bioaccumulation. The spatial scale at which TM concentrations in animals and soils showed the strongest correlations varied between metals, species and landscapes. The potential underlying mechanisms of landscape influence (community functioning, behaviour, etc.) are discussed. Present results highlight the need for the further development of landscape ecotoxicology and multi-scale approaches, which would enhance our understanding of pollutant transfer and effects in ecosystems.	[Fritsch, Clementine; Coeurdassier, Michael; Giraudoux, Patrick; Raoul, Francis; Rieffel, Dominique; de Vaufleury, Annette; Scheifler, Renaud] Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France; [Douay, Francis] Univ Lille Nord France, Lille, France; [Douay, Francis] LGCgE, EA 4515, Lille, France	INRAE; Universite de Franche-Comte; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Fritsch, C (corresponding author), Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France.	clementine.fritsch@univ-fcomte.fr	Giraudoux, Patrick/B-9274-2011; Raoul, Francis/H-7706-2012; Scheifler, Renaud/H-2971-2014	Giraudoux, Patrick/0000-0003-2376-0136; Raoul, Francis/0000-0001-9566-9599; Scheifler, Renaud/0000-0002-9620-0204; FRITSCH, Clementine/0000-0003-2062-5799	ANR (Agence Nationale de la Recherche) [ANR-05-ECCO-004]; ADEME (Agence de l'Environnement et de la Maitrise de l'Energie) [0572C0058]; Conseil Regional de Franche-Comte	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ADEME (Agence de l'Environnement et de la Maitrise de l'Energie); Conseil Regional de Franche-Comte(Region Bourgogne-Franche-Comte)	The STARTT research programme was financially supported by ANR (Agence Nationale de la Recherche - http://www.agence-nationale-recherche.fr - contract n<SUP>o</SUP>ANR-05-ECCO-004) and ADEME (Agence de l'Environnement et de la Maitrise de l'Energie - http://www.ademe.fr - contract n<SUP>o</SUP>0572C0058). CF was financially supported by a grant from ADEME and the Conseil Regional de Franche-Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt KF, 1998, ACTA THERIOL, V43, P379, DOI 10.4098/AT.arch.98-49; *AFNOR, 1996, X31147 NF AFNOR; Ares J, 2003, ENVIRON TOXICOL CHEM, V22, P945, DOI 10.1002/etc.5620220501; Baker S, 2003, ECOTOX ENVIRON SAFE, V56, P6, DOI 10.1016/S0147-6513(03)00046-0; Barnthouse Lawrence W., 2008, P1; BAUR A, 1993, MALACOLOGIA, V35, P89; BERGER B, 1993, ENVIRON MONIT ASSESS, V25, P65, DOI 10.1007/BF00549793; Bleeker EAJ, 2007, ENVIRON POLLUT, V148, P824, DOI 10.1016/j.envpol.2007.01.034; Burel F, 2004, LANDSCAPE URBAN PLAN, V67, P195, DOI 10.1016/S0169-2046(03)00039-2; Burel F., 2003, LANDSCAPE ECOLOGY CO; Burger J, 2003, ECOTOX ENVIRON SAFE, V56, P20, DOI 10.1016/S0147-6513(03)00047-2; Cairns J, 1996, ECOL APPL, V6, P790, DOI 10.2307/2269484; CAMERON RAD, 1977, J ANIM ECOL, V46, P173, DOI 10.2307/3954; Carlsen TM, 2004, ENVIRON TOXICOL CHEM, V23, P798, DOI 10.1897/02-202; Chaline J, 1974, PROIES RAPACES; CHARISSOU I, 1999, SUPPLEMENT SCI REV E, V44, P1; CLIFFORD PA, 1995, ENVIRON TOXICOL CHEM, V14, P895, DOI [10.1897/1552-8618(1995)14[895:AATQSC]2.0.CO;2, 10.1002/etc.5620140523]; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; Dallinger R, 2004, ECOTOXICOLOGY, V13, P757, DOI 10.1007/s10646-003-4474-4; Damek-Poprawa M, 2004, ENVIRON RES, V96, P72, DOI 10.1016/j.envres.2004.02.003; Danson FM, 2003, PARASITOLOGY, V127, pS133, DOI 10.1017/S0031182003003639; de la Pena NM, 2003, LANDSCAPE ECOL, V18, P265, DOI 10.1023/A:1024452930326; de Vaufleury AG, 2000, CHEMOSPHERE, V40, P275, DOI 10.1016/S0045-6535(99)00246-5; Douay F, 2009, SCI TOTAL ENVIRON, V407, P5564, DOI 10.1016/j.scitotenv.2009.06.015; Douay F, 2008, WATER AIR SOIL POLL, V188, P247, DOI 10.1007/s11270-007-9541-7; Ettler V, 2005, CHEMOSPHERE, V58, P1449, DOI 10.1016/j.chemosphere.2004.09.084; Fairbrother A, 2007, ECOTOX ENVIRON SAFE, V68, P145, DOI 10.1016/j.ecoenv.2007.03.015; Fowler D, 1998, WATER AIR SOIL POLL, V105, P459, DOI 10.1023/A:1005043829181; Fowler D., 2003, BIOGEOCHEMICAL INVES, V4, P483, DOI DOI 10.1023/B:WAF0.0000028373.02470.BA; Frangi JP, 1997, SCI TOTAL ENVIRON, V205, P71, DOI 10.1016/S0048-9697(97)00184-8; Fritsch C, 2011, ECOTOXICOLOGY, V20, P739, DOI 10.1007/s10646-011-0619-z; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Fritsch C, 2010, ENVIRON POLLUT, V158, P827, DOI 10.1016/j.envpol.2009.09.027; Gaines KF, 2005, SCI TOTAL ENVIRON, V341, P15, DOI 10.1016/j.scitotenv.2004.09.017; Giraudoux P, 2002, NATO SCI SER I LIFE, V341, P251; Grafen A., 2002, MODERN STAT LIFE SCI; Harmsen J., 2008, ISODIS17402; Harmsen J, 2007, J ENVIRON QUAL, V36, P1420, DOI 10.2134/jeq2006.0492; Hendrickx F, 2004, ENVIRON POLLUT, V127, P335, DOI 10.1016/j.envpol.2003.09.001; Hispard F., 2007, ENVIRON INT, V34, P381; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Hope BK, 2001, RISK ANAL, V21, P1001, DOI 10.1111/0272-4332.216169; Hope BK, 2000, RISK ANAL, V20, P573, DOI 10.1111/0272-4332.205053; Hope BK, 2006, ENVIRON INT, V32, P983, DOI 10.1016/j.envint.2006.06.005; Kapusta P, 2003, APPL SOIL ECOL, V23, P187, DOI 10.1016/S0929-1393(03)00064-7; Kapustka Larry, 2008, Integrated Environmental Assessment and Management, V4, P290, DOI 10.1897/IEAM_2007-084.1; Kerney MP., 2006, GUIDE ESCARGOTS LIMA; Kitron U, 2006, GEOSPATIAL HEALTH, V1, P49, DOI 10.4081/gh.2006.280; Kooistra L, 2005, ENVIRON SCI TECHNOL, V39, P2177, DOI 10.1021/es049814w; Kooistra L, 2001, ENVIRON MANAGE, V28, P359, DOI 10.1007/s0026702433; KOZAKIEWICZ M, 1976, Acta Theriologica, V21, P314; Kozakiewicz Michal, 2000, Polish Journal of Ecology, V48, P149; Le Louarn H., 2003, RONGEURS FRANCE FAUN; Lidicker WZ, 2008, BIOL REV, V83, P71, DOI 10.1111/j.1469-185X.2007.00032.x; Loos M, 2009, ENVIRON TOXICOL CHEM, V28, P2378, DOI 10.1897/09-028.1; LUGONMOULIN N, 2003, MUSARAIGNES BIOL ECO; Magiera T, 2007, ENVIRON MONIT ASSESS, V125, P19, DOI 10.1007/s10661-006-9235-4; MAHTFELD K, 2000, IMPACT INTRO GASTROP; Marinussen MPJC, 1996, ECOL MODEL, V87, P83, DOI 10.1016/0304-3800(94)00207-X; MASON CF, 1970, OECOLOGIA, V4, P358, DOI 10.1007/BF00393394; Meers E, 2007, ENVIRON EXP BOT, V60, P385, DOI 10.1016/j.envexpbot.2006.12.010; Migeon A, 2009, WATER AIR SOIL POLL, V204, P89, DOI 10.1007/s11270-009-0029-5; Milton A, 2003, ARCH ENVIRON CON TOX, V44, P405, DOI 10.1007/s00244-002-2014-5; Monteiro MS, 2008, ENVIRON TOXICOL CHEM, V27, P2548, DOI 10.1897/08-154.1; Notten MJM, 2005, ENVIRON POLLUT, V138, P178, DOI 10.1016/j.envpol.2005.01.011; Paillat G, 1996, ACTA OECOL, V17, P553; Peakall D, 2003, ECOTOX ENVIRON SAFE, V56, P110, DOI 10.1016/S0147-6513(03)00055-1; Peijnenburg WJGM, 2003, ECOTOX ENVIRON SAFE, V56, P63, DOI 10.1016/S0147-6513(03)00051-4; POLLARD E, 1970, J APPL ECOL, V7, P549, DOI 10.2307/2401977; Purucker ST, 2007, ECOL MODEL, V204, P180, DOI 10.1016/j.ecolmodel.2006.12.032; R Development Core Team, 2006, R LANG ENV STAT COMP; Rieuwerts J, 1996, APPL GEOCHEM, V11, P17, DOI 10.1016/0883-2927(95)00050-X; Rogival D, 2007, ENVIRON POLLUT, V145, P516, DOI 10.1016/j.envpol.2006.04.019; Sadowska ET, 2008, PHYSIOL BIOCHEM ZOOL, V81, P627, DOI 10.1086/590164; Sanchez-Chardi A, 2007, CHEMOSPHERE, V68, P703, DOI 10.1016/j.chemosphere.2007.01.042; Sanchez-Chardi A, 2007, ENVIRON POLLUT, V145, P7, DOI 10.1016/j.envpol.2006.02.033; Sanchez-Chardi A, 2009, CHEMOSPHERE, V76, P387, DOI 10.1016/j.chemosphere.2009.03.036; Scheifler R, 2006, ENVIRON TOXICOL CHEM, V25, P815, DOI 10.1897/04-675R.1; Schipper AM, 2008, ENVIRON TOXICOL CHEM, V27, P919, DOI 10.1897/07-252.1; Shore R. F., 2001, ECOTOXICOLOGY WILD M; Smith PN, 2007, ENVIRON POLLUT, V150, P41, DOI 10.1016/j.envpol.2007.06.009; Smith R, 2005, SOIL USE MANAGE, V21, P527, DOI 10.1079/SUM2005345; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; Sterckeman T, 2002, WATER AIR SOIL POLL, V135, P173, DOI 10.1023/A:1014758811194; TALMAGE SS, 1991, REV ENVIRON CONTAM T, V119, P47; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; van den Brink N, 2010, ENVIRON POLLUT, V158, P245, DOI 10.1016/j.envpol.2009.07.013; van Gestel CAM, 2008, SCI TOTAL ENVIRON, V406, P385, DOI 10.1016/j.scitotenv.2008.05.050; VERMEULEN F, 2009, SPATIALLY EXPLICIT E; Vermeulen F, 2009, ENVIRON POLLUT, V157, P3098, DOI 10.1016/j.envpol.2009.05.017; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; VONPROSCHWITZ T, 1994, J CONCHOL, V35, P183; Vuilleumier S, 2007, ECOL MODEL, V201, P369, DOI 10.1016/j.ecolmodel.2006.10.002; Wallace WG, 1998, MAR ECOL PROG SER, V172, P225, DOI 10.3354/meps172225; Wallace WG, 2003, MAR ECOL PROG SER, V257, P125, DOI 10.3354/meps257125; Wijnhoven S, 2007, ARCH ENVIRON CON TOX, V52, P603, DOI 10.1007/s00244-006-0124-1; Wijnhoven S, 2006, HYDROBIOLOGIA, V565, P135, DOI 10.1007/s10750-005-1910-x; WILLIAMSON P, 1979, J MOLLUS STUD, V45, P52; WILLIAMSON P, 1980, OECOLOGIA, V44, P213, DOI 10.1007/BF00572682; WILLIAMSON P, 1976, OIKOS, V27, P493, DOI 10.2307/3543468; WOLDA H, 1971, OECOLOGIA, V7, P361, DOI 10.1007/BF00345860; Woodbury PB, 2003, ENVIRON TOXICOL CHEM, V22, P977, DOI 10.1002/etc.5620220504	102	36	39	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20682	10.1371/journal.pone.0020682	http://dx.doi.org/10.1371/journal.pone.0020682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655187	Green Published, gold			2022-12-27	WOS:000291097600122
J	van Rijn, S; Swaab, H; Magnee, M; van Engeland, H; Kemner, C				van Rijn, Sophie; Swaab, Hanna; Magnee, Maurice; van Engeland, Herman; Kemner, Chantal			Psychophysiological Markers of Vulnerability to Psychopathology in Men with an Extra X Chromosome (XXY)	PLOS ONE			English	Article							EYE-MOVEMENT DYSFUNCTION; SCHIZOTYPAL PERSONALITY-DISORDER; IMPAIRED PREPULSE INHIBITION; SENSORIMOTOR GATING DEFICITS; SMOOTH-PURSUIT; STARTLE RESPONSE; SCHIZOPHRENIA-PATIENTS; KLINEFELTER-SYNDROME; ACOUSTIC STARTLE; P50 SUPPRESSION	Studying genetically defined syndromes associated with increased risk for psychopathology may help in understanding neurodevelopmental mechanisms related to risk for psychopathology. Klinefelter syndrome (47,XXY) is one of the most common sex chromosomal aneuploidies (1 in 650 male births) and associated with increased vulnerability for psychopathology, including psychotic symptoms. Yet, it remains unknown whether this increased risk is associated with underlying psychophysiological mechanisms that are typically deficient in individuals with psychotic disorders. The present study assessed three "classic" psychophysiological markers of psychosis in Klinefelter syndrome (KS): smooth pursuit eye movements (SPEM), prepulse inhibition (PPI) and P50 suppression. Fourteen adults with KS and 15 non-clinical adults participated in the study. Data on SPEM (reflecting visuo-motor control) as well as PPI and P50 suppression (reflecting sensory gating) were collected. Dysfunctions in SPEM were observed in individuals with KS, with less smooth pursuit as expressed in lower position gain. Also, reduced sensory gating in individuals with KS was suggested by significantly reduced prepulse inhibition of the startle response (PPI) (effect size 1.6). No abnormalities were found in suppression of the P50 (effect size 0.6). We speculate that impairments in these psychophysiological mechanisms may reflect core brain dysfunctions that may also mediate the described increased vulnerability for psychotic symptoms in KS. Although speculative, such deficit specific, rather than disorder specific, psychophysiological dysfunctions in KS might convey vulnerability to other types of psychopathology as well. As KS already can be diagnosed prenatally, the predictive value of childhood impairments in prepulse inhibition and smooth pursuit for development of psychopathology later in life could be assessed. In sum, studying individuals with KS may prove to be an avenue of research leading to new hypotheses and insights into "at risk" pathways to psychopathology.	[van Rijn, Sophie; Swaab, Hanna] Leiden Univ, Leiden, Netherlands; [van Rijn, Sophie; Swaab, Hanna] Univ Med Ctr Leiden, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Magnee, Maurice; van Engeland, Herman; Kemner, Chantal] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University; Utrecht University Medical Center	van Rijn, S (corresponding author), Leiden Univ, Leiden, Netherlands.	srijn@fsw.leidenuniv.nl	Swaab, Hanna/AAD-2555-2019	van rijn, sophie/0000-0002-9179-7515; Swaab, Hanna/0000-0003-3697-060X	VENI [016.095.060]; Netherlands Organization for Scientific Research (NWO)	VENI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by a VENI grant (grant number 016.095.060 to SvR) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; Aukes MF, 2008, BIOL PSYCHIAT, V64, P128, DOI 10.1016/j.biopsych.2007.12.013; BARNEVELD PS, SCHIZOPHR RES; BISHOP DVM, ARCH DIS CH IN PRESS; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Bojesen A, 2006, J CLIN ENDOCR METAB, V91, P1254, DOI 10.1210/jc.2005-0697; Boks MPM, 2007, SCHIZOPHR RES, V93, P399, DOI 10.1016/j.schres.2007.03.015; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Bruining H, 2009, PEDIATRICS, V123, pE865, DOI 10.1542/peds.2008-1954; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; CADENHEAD KS, 1993, AM J PSYCHIAT, V150, P1862; Cadenhead KS, 2001, BIOL PSYCHIAT, V49, p126S; Calkins ME, 2000, AM J MED GENET, V97, P72, DOI 10.1002/(SICI)1096-8628(200021)97:1<72::AID-AJMG10>3.0.CO;2-L; Calkins ME, 1998, BIOL PSYCHIAT, V43, p126S, DOI 10.1016/S0006-3223(98)90868-X; Calkins ME, 2008, BRAIN COGNITION, V68, P436, DOI 10.1016/j.bandc.2008.09.001; Cannon TD, 2005, CURR OPIN PSYCHIATR, V18, P135, DOI 10.1097/00001504-200503000-00005; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; CLEMENTZ BA, 1990, PSYCHOL BULL, V108, P77, DOI 10.1037/0033-2909.108.1.77; Dawson ME, 2000, PSYCHIAT RES, V96, P187, DOI 10.1016/S0165-1781(00)00208-0; de Leeuw AS, 2010, INT CLIN PSYCHOPHARM, V25, P232, DOI 10.1097/YIC.0b013e328338c4f0; DELISI LE, 1994, SCHIZOPHRENIA BULL, V20, P495, DOI 10.1093/schbul/20.3.495; Ettinger U, 2004, J PSYCHIATR RES, V38, P177, DOI 10.1016/S0022-3956(03)00105-5; Ettinger U, 2001, SCHIZOPHR RES, V49, P214; Gooding DC, 2000, PSYCHIAT RES, V93, P41, DOI 10.1016/S0165-1781(00)00113-X; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GRATTON G, 1989, PSYCHOPHYSIOLOGY, V26, P222, DOI 10.1111/j.1469-8986.1989.tb03160.x; Hoenig K, 2005, BIOL PSYCHIAT, V57, P1153, DOI 10.1016/j.biopsych.2005.01.040; Holahan ALV, 2005, SCHIZOPHR RES, V76, P43, DOI 10.1016/j.schres.2004.10.005; Hutton S, 1998, NEUROLOGY, V50, P604, DOI 10.1212/WNL.50.3.604; Jha P, 2007, EUR CHILD ADOLES PSY, V16, P305, DOI 10.1007/s00787-007-0601-8; Karoumi B, 2001, PSYCHIAT RES, V101, P209, DOI 10.1016/S0165-1781(01)00227-X; Kemner C, 2002, J CLIN PSYCHIAT, V63, P214; Kumari V, 2005, PSYCHOPHYSIOLOGY, V42, P588, DOI 10.1111/j.1469-8986.2005.00346.x; Kumari V, 2005, NEUROIMAGE, V26, P1052, DOI 10.1016/j.neuroimage.2005.03.002; KUMARI V, 2005, PROGR SCHIZOPHRENIA; Kumra S, 1998, J AM ACAD CHILD PSY, V37, P292, DOI 10.1097/00004583-199803000-00014; Kumra S, 2001, AM J PSYCHIAT, V158, P1291, DOI 10.1176/appi.ajp.158.8.1291; LEE NR, J INT NEURO IN PRESS, P1; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; Oranje B, 1999, BIOL PSYCHIAT, V45, P883, DOI 10.1016/S0006-3223(98)00128-0; Oranje B, 2006, PSYCHIAT RES, V143, P147, DOI 10.1016/j.psychres.2005.11.002; PERRY W, 1994, AM J PSYCHIAT, V151, P363; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Ross RG, 2003, J AM ACAD CHILD PSY, V42, P468, DOI 10.1097/01.CHI.0000046818.95464.42; SIEVER LJ, 1984, AM J PSYCHIAT, V141, P1560; Smyrnis N, 2007, EXP BRAIN RES, V179, P397, DOI 10.1007/s00221-006-0797-8; SWAAB H, EXECUTIVE FUNC UNPUB; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; TARTAGLIA N, 2010, PEDIATR ENDOCR REV P, V1, P151; Toal F, 2009, BRIT J PSYCHIAT, V194, P418, DOI 10.1192/bjp.bp.107.049007; van Kampen D, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-27; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; Van Rijn S, 2006, BRIT J PSYCHIAT, V189, P459, DOI 10.1192/bjp.bp.105.008961; Vorstman JAS, 2009, NEUROPSYCHOPHARMACOL, V34, P739, DOI 10.1038/npp.2008.132; Wynn JK, 2004, BIOL PSYCHIAT, V55, P518, DOI 10.1016/j.biopsych.2003.10.018	64	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20292	10.1371/journal.pone.0020292	http://dx.doi.org/10.1371/journal.pone.0020292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655260	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600038
J	Wang, Y; Wu, CG; Ji, ZH; Wang, BH; Liang, YC				Wang, Yao; Wu, Chunguo; Ji, Zhaohua; Wang, Binghong; Liang, Yanchun			Non-Parametric Change-Point Method for Differential Gene Expression Detection	PLOS ONE			English	Article							CANCER; PATTERNS; MICROARRAYS; INFERENCE; BIOLOGY	Background: We proposed a non-parametric method, named Non-Parametric Change Point Statistic (NPCPS for short), by using a single equation for detecting differential gene expression (DGE) in microarray data. NPCPS is based on the change point theory to provide effective DGE detecting ability. Methodology: NPCPS used the data distribution of the normal samples as input, and detects DGE in the cancer samples by locating the change point of gene expression profile. An estimate of the change point position generated by NPCPS enables the identification of the samples containing DGE. Monte Carlo simulation and ROC study were applied to examine the detecting accuracy of NPCPS, and the experiment on real microarray data of breast cancer was carried out to compare NPCPS with other methods. Conclusions: Simulation study indicated that NPCPS was more effective for detecting DGE in cancer subset compared with five parametric methods and one non-parametric method. When there were more than 8 cancer samples containing DGE, the type I error of NPCPS was below 0.01. Experiment results showed both good accuracy and reliability of NPCPS. Out of the 30 top genes ranked by using NPCPS, 16 genes were reported as relevant to cancer. Correlations between the detecting result of NPCPS and the compared methods were less than 0.05, while between the other methods the values were from 0.20 to 0.84. This indicates that NPCPS is working on different features and thus provides DGE identification from a distinct perspective comparing with the other mean or median based methods.	[Wang, Yao; Wu, Chunguo; Ji, Zhaohua; Liang, Yanchun] Jilin Univ, Coll Comp Sci & Technol, Natl Educ Minist, Key Lab Symbol Computat & Knowledge Engn, Changchun, Jilin, Peoples R China; [Ji, Zhaohua] Inner Mongolia Xingan Vocat & Tech Coll, Wulanhaote, Peoples R China; [Wu, Chunguo; Wang, Binghong] Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China; [Wu, Chunguo; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China	Jilin University; University of Shanghai for Science & Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liang, YC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Natl Educ Minist, Key Lab Symbol Computat & Knowledge Engn, Changchun, Jilin, Peoples R China.	ycliang@jlu.edu.cn	Wu, Chunguo/A-6901-2008	Wu, Chunguo/0000-0002-7805-8224	National Natural Science Foundation of China (NSFC) [61073075, 60803052, 10872077, 91024026]; National High-Tech R&D Program of China [2009AA02Z307]; Jilin University [200903173]; Colleges and Universities of Inner Mongolia Autonomous Region of China [NJ10320]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); Jilin University(Jilin University); Colleges and Universities of Inner Mongolia Autonomous Region of China	This work was supported by funds from National Natural Science Foundation of China (NSFC) (61073075, 60803052, 10872077, and 91024026), http://www.nsfc.gov.cn/Portal0/default106.htm; the National High-Tech R&D Program of China (2009AA02Z307), http://www.863.gov.cn/; Jilin University ("985" project, "211" project, Scientific Frontier and Interdisciplinary Subject Project (200903173)); the Science-Technology Research Project of Colleges and Universities of Inner Mongolia Autonomous Region of China (NJ10320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEVILLE M, 1993, DETECTION ABRUPT CHA; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottardo R, 2006, BIOMETRICS, V62, P10, DOI 10.1111/j.1541-0420.2005.00397.x; Hu JH, 2008, BIOINFORMATICS, V24, P2193, DOI 10.1093/bioinformatics/btn372; Lian H, 2008, BIOSTATISTICS, V9, P411, DOI 10.1093/biostatistics/kxm042; Lyons-Weiler J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-110; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Magic Z, 2007, J BUON, V12, pS39; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Pan Wei, 2003, Functional & Integrative Genomics, V3, P117; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Storey JD, 2003, SAM THRESHOLDING FAL; Tan ZP, 2000, J CHINA U SCI TECHNO, V6, P270; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-87	22	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20060	10.1371/journal.pone.0020060	http://dx.doi.org/10.1371/journal.pone.0020060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655325	Green Published, gold			2022-12-27	WOS:000291097600017
J	Gravel, D; Canard, E; Guichard, F; Mouquet, N				Gravel, Dominique; Canard, Elsa; Guichard, Frederic; Mouquet, Nicolas			Persistence Increases with Diversity and Connectance in Trophic Metacommunities	PLOS ONE			English	Article							FOOD-WEB COMPLEXITY; FORAGING ADAPTATION; NETWORK STRUCTURE; STABILITY; MODELS; COMMUNITY; DYNAMICS; DISPERSAL; BALANCE; CHAOS	Background: We are interested in understanding if metacommunity dynamics contribute to the persistence of complex spatial food webs subject to colonization-extinction dynamics. We study persistence as a measure of stability of communities within discrete patches, and ask how do species diversity, connectance, and topology influence it in spatially structured food webs. Methodology/Principal Findings: We answer this question first by identifying two general mechanisms linking topology of simple food web modules and persistence at the regional scale. We then assess the robustness of these mechanisms to more complex food webs with simulations based on randomly created and empirical webs found in the literature. We find that linkage proximity to primary producers and food web diversity generate a positive relationship between complexity and persistence in spatial food webs. The comparison between empirical and randomly created food webs reveal that the most important element for food web persistence under spatial colonization-extinction dynamics is the degree distribution: the number of prey species per consumer is more important than their identity. Conclusions/Significance: With a simple set of rules governing patch colonization and extinction, we have predicted that diversity and connectance promote persistence at the regional scale. The strength of our approach is that it reconciles the effect of complexity on stability at the local and the regional scale. Even if complex food webs are locally prone to extinction, we have shown their complexity could also promote their persistence through regional dynamics. The framework we presented here offers a novel and simple approach to understand the complexity of spatial food webs.	[Gravel, Dominique] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Gravel, Dominique] Univ Quebec, Ctr Etud Foret, Rimouski, PQ G5L 3A1, Canada; [Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Canard, Elsa; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France; [Guichard, Frederic] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; University of Quebec; University of Quebec; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; McGill University	Gravel, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	dominique_gravel@uqar.qc.ca	MOUQUET, Nicolas/AAL-1440-2021	Mouquet, Nicolas/0000-0003-1840-6984	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair program; James S. McDonnell Foundation; NSERC; le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); CRNS;  [ANR-BACH-09-JCJC-0110-01]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); James S. McDonnell Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); CRNS; 	D. Gravel was supported by a post-doctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chair program. This work was also supported by research grants from the James S. McDonnell Foundation, NSERC, and le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) to F. Guichard. N. Mouquet is supported by the CRNS and research grant ANR-BACH-09-JCJC-0110-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; CALCAGNO V, 2011, P ROY SOC IN PRESS B; Cohen J.E., 1990, COMMUNITY FOOD WEBS; COHEN JE, 1984, ANN PROBAB, V12, P283, DOI 10.1214/aop/1176993291; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Cuddington K, 2005, ECOLOGICAL PARADIGMS; DEANGELIS DL, 1975, ECOLOGY, V56, P238; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2006, SFI S SCI C, P27; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fussmann GF, 2002, ECOL LETT, V5, P394, DOI 10.1046/j.1461-0248.2002.00329.x; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; GRAVEL D, BIOGEOGRAPH IN PRESS; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; HAYDON D, 1994, AM NAT, V144, P14, DOI 10.1086/285658; Holt Robert D., 1997, P149, DOI 10.1016/B978-012323445-2/50010-9; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUTCHINSON GE, 1959, AM NAT, V93, P149; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jansen VAA, 2003, ECOL LETT, V6, P498, DOI 10.1046/j.1461-0248.2003.00464.x; Jansen VAA, 1995, OIKOS, V74, P384, DOI 10.2307/3545983; Jansen Vincent A.A., 2000, P183, DOI 10.1017/CBO9780511525537.013; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Koelle K, 2005, ECOL LETT, V8, P167, DOI 10.1111/j.1461-0248.2004.00703.x; Kondoh M, 2006, J THEOR BIOL, V238, P646, DOI 10.1016/j.jtbi.2005.06.028; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; LAWLOR LR, 1978, AM NAT, V112, P445, DOI 10.1086/283286; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; May R.M., 1973, STABILITY COMPLEXITY; May RM, 2001, STABILITY COMPLEXITY; May RM, 2009, PHILOS T R SOC B, V364, P1643, DOI 10.1098/rstb.2008.0280; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2002, ECOL LETT, V5, P37, DOI 10.1046/j.1461-0248.2002.00280.x; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; MOUQUET N, 2005, METACOMMUNITIES FRAM; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Odum E. P., 1953, FUNDAMENTALS ECOLOGY; PACALA SW, 1990, NATURE, V344, P150, DOI 10.1038/344150a0; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Pillai P, 2010, THEOR ECOL-NETH, V3, P223, DOI 10.1007/s12080-009-0065-1; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; PIMM SL, 1982, FOOD WEBS; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; SOLE RV, 1992, PHYS LETT A, V166, P123, DOI 10.1016/0375-9601(92)90546-X; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; SOLE RV, 2006, SELF ORG COMPLEX ECO; Stouffer DB, 2010, ECOL LETT, V13, P154, DOI 10.1111/j.1461-0248.2009.01407.x; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Winemiller K. O., 2005, DYNAMIC FOOD WEBS MU	77	69	70	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19374	10.1371/journal.pone.0019374	http://dx.doi.org/10.1371/journal.pone.0019374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637749	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500003
J	Gulia-Nuss, M; Robertson, AE; Brown, MR; Strand, MR				Gulia-Nuss, Monika; Robertson, Anne E.; Brown, Mark R.; Strand, Michael R.			Insulin-Like Peptides and the Target of Rapamycin Pathway Coordinately Regulate Blood Digestion and Egg Maturation in the Mosquito Aedes aegypti	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; DROSOPHILA; PROTEIN; METABOLISM; EXPRESSION; MIDGUT; ACTIVATION; ANAUTOGENY; GROWTH; FLIES	Background: Mosquitoes are insects that vector many serious pathogens to humans and other vertebrates. Most mosquitoes must feed on the blood of a vertebrate host to produce eggs. In turn, multiple cycles of blood feeding promote frequent contacts with hosts and make mosquitoes ideal disease vectors. Both hormonal and nutritional factors are involved in regulating egg development in the mosquito, Aedes aegypti. However, the processes that regulate digestion of the blood meal remain unclear. Methodology/Principal Findings: Here we report that insulin peptide 3 (ILP3) directly stimulated late phase trypsin-like gene expression in blood fed females. In vivo knockdown of the mosquito insulin receptor (MIR) by RNA interference (RNAi) delayed but did not fully inhibit trypsin-like gene expression in the midgut, ecdysteroid (ECD) production by ovaries, and vitellogenin (Vg) expression by the fat body. In contrast, in vivo treatment with double-stranded MIR RNA and rapamycin completely blocked egg production. In vitro experiments showed that amino acids did not simulate late phase trypsin-like gene expression in the midgut or ECD production by the ovaries. However, amino acids did enhance ILP3-mediated stimulation of trypsin-like gene expression and ECD production. Conclusions/Significance: Overall, our results indicate that ILPs from the brain synchronize blood meal digestion and amino acid availability with ovarian ECD production to maximize Vg expression by the fat body. The activation of digestion by ILPs may also underlie the growth promoting effects of insulin and TOR signaling in other species.	[Gulia-Nuss, Monika; Robertson, Anne E.; Brown, Mark R.; Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Brown, Mark R.; Strand, Michael R.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Gulia-Nuss, M (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mrbrown@uga.edu; mrstrand@uga.edu	Gulia-Nuss, Monika/V-6809-2019	Gulia-Nuss, Monika/0000-0001-7095-1037	National Insitututes of Health [AI03108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033108] Funding Source: NIH RePORTER	National Insitututes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Insitututes of Health (AI03108) (MRB and MRS) provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Briegel H, 2003, J VECTOR ECOL, V28, P1; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Graf R, 1998, J INSECT PHYSIOL, V44, P451, DOI 10.1016/S0022-1910(98)00042-0; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Lu SJ, 2006, INSECT BIOCHEM MOLEC, V36, P336, DOI 10.1016/j.ibmb.2006.01.011; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; ROY SG, 2011, INSECT BIOC IN PRESS; Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	33	114	117	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20401	10.1371/journal.pone.0020401	http://dx.doi.org/10.1371/journal.pone.0020401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647424	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500056
J	Elberse, KEM; van de Pol, I; Witteveen, S; van der Heide, HGJ; Schot, CS; van Dijk, A; van der Ende, A; Schouls, LM				Elberse, Karin E. M.; van de Pol, Ingrid; Witteveen, Sandra; van der Heide, Han G. J.; Schot, Corrie S.; van Dijk, Anita; van der Ende, Arie; Schouls, Leo M.			Population Structure of Invasive Streptococcus pneumoniae in the Netherlands in the Pre-Vaccination Era Assessed by MLVA and Capsular Sequence Typing	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; MULTIPLEX PCR; UNITED-STATES; SEROTYPES; DIVERSITY; CPSB; ASSOCIATIONS; CHILDREN; 6C	The introduction of nationwide pneumococcal vaccination may lead to serotype replacement and the emergence of new variants that have expanded their genetic repertoire through recombination. To monitor alterations in the pneumococcal population structure, we have developed and utilized Capsular Sequence Typing (CST) in addition to Multiple-Locus Variable number tandem repeat Analysis (MLVA). To assess the serotype of each isolate CST was used. Based on the determination of the partial sequence of the capsular wzh gene, this method assigns a capsular type of an isolate within a single PCR reaction using multiple primersets. The genetic background of pneumococcal isolates was assessed by MLVA. MLVA and CST were used to create a snapshot of the Dutch pneumococcal population causing invasive disease before the introduction of the 7-valent pneumococcal conjugate vaccine in the Netherlands in 2006. A total of 1154 clinical isolates collected and serotyped by the Netherlands Reference Laboratory for Bacterial Meningitis were included in the snapshot. The CST was successful in discriminating most serotypes present in our collection. MLVA demonstrated that isolates belonging to some serotypes had a relatively high genetic diversity whilst other serotypes had a very homogeneous genetic background. MLVA and CST appear to be valuable tools to determine the population structure of pneumococcal isolates and are useful in monitoring the effects of pneumococcal vaccination.	[Elberse, Karin E. M.; van de Pol, Ingrid; Witteveen, Sandra; van der Heide, Han G. J.; Schot, Corrie S.; van Dijk, Anita; Schouls, Leo M.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Elberse, KEM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands.	Karin.Elberse@RIVM.nl	van der Ende, Arie/A-4346-2012	van der Ende, Arie/0000-0003-1298-3086				AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Borrow R, 2008, INFECT IMMUN, V76, P5305, DOI 10.1128/IAI.00796-08; BRATCHER PE, 2009, MICROBIOLOGY; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Hall LMC, 1996, J CLIN MICROBIOL, V34, P853, DOI 10.1128/JCM.34.4.853-859.1996; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; Kong FR, 2003, J MED MICROBIOL, V52, P1047, DOI 10.1099/jmm.0.05277-0; LUND E, 1960, Bull World Health Organ, V23, P5; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784	33	37	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20390	10.1371/journal.pone.0020390	http://dx.doi.org/10.1371/journal.pone.0020390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637810	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200059
J	Voolstra, CR; Sunagawa, S; Matz, MV; Bayer, T; Aranda, M; Buschiazzo, E; DeSalvo, MK; Lindquist, E; Szmant, AM; Coffroth, MA; Medina, M				Voolstra, Christian R.; Sunagawa, Shinichi; Matz, Mikhail V.; Bayer, Till; Aranda, Manuel; Buschiazzo, Emmanuel; DeSalvo, Michael K.; Lindquist, Erika; Szmant, Alina M.; Coffroth, Mary Alice; Medina, Monica			Rapid Evolution of Coral Proteins Responsible for Interaction with the Environment	PLOS ONE			English	Article							GENE-EXPRESSION; NUCLEOTIDE SUBSTITUTION; INNATE IMMUNITY; TEMPERATURE; STRESS; MECHANISM; HISTORY; IDENTIFICATION; GENERATION; EUKARYOTES	Background: Corals worldwide are in decline due to climate change effects (e. g., rising seawater temperatures), pollution, and exploitation. The ability of corals to cope with these stressors in the long run depends on the evolvability of the underlying genetic networks and proteins, which remain largely unknown. A genome-wide scan for positively selected genes between related coral species can help to narrow down the search space considerably. Methodology/Principal Findings: We screened a set of 2,604 putative orthologs from EST-based sequence datasets of the coral species Acropora millepora and Acropora palmata to determine the fraction and identity of proteins that may experience adaptive evolution. 7% of the orthologs show elevated rates of evolution. Taxonomically-restricted (i.e. lineage-specific) genes show a positive selection signature more frequently than genes that are found across many animal phyla. The class of proteins that displayed elevated evolutionary rates was significantly enriched for proteins involved in immunity and defense, reproduction, and sensory perception. We also found elevated rates of evolution in several other functional groups such as management of membrane vesicles, transmembrane transport of ions and organic molecules, cell adhesion, and oxidative stress response. Proteins in these processes might be related to the endosymbiotic relationship corals maintain with dinoflagellates in the genus Symbiodinium. Conclusion/Relevance: This study provides a birds-eye view of the processes potentially underlying coral adaptation, which will serve as a foundation for future work to elucidate the rates, patterns, and mechanisms of corals' evolutionary response to global climate change.	[Voolstra, Christian R.; Bayer, Till; Aranda, Manuel] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sunagawa, Shinichi] European Mol Biol Lab, Heidelberg, Germany; [Matz, Mikhail V.] Univ Texas Austin, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA; [Buschiazzo, Emmanuel; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [DeSalvo, Michael K.] Univ Calif San Francisco, Dept Anesthesia, UCSF Sch Med, San Francisco, CA 94143 USA; [Lindquist, Erika] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Szmant, Alina M.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Coffroth, Mary Alice] SUNY Buffalo, Grad Program Evolut Ecol & Behav, Buffalo, NY 14260 USA; [Coffroth, Mary Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA	King Abdullah University of Science & Technology; European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Austin; University of California System; University of California Merced; University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of North Carolina; University of North Carolina Wilmington; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Voolstra, CR (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	christian.voolstra@kaust.edu.sa; mmedina@ucmerced.edu	Buschiazzo, Emmanuel/B-5126-2011; Matz, Mikhail V/K-4392-2017; Bayer, Till/H-6826-2016; Voolstra, Christian R/H-7158-2014; Sunagawa, Shinichi/Q-5950-2019; Aranda Lastra, Manuel/D-9530-2011	Matz, Mikhail V/0000-0001-5453-9819; Bayer, Till/0000-0002-4704-2449; Voolstra, Christian R/0000-0003-4555-3795; Sunagawa, Shinichi/0000-0003-3065-0314; Aranda Lastra, Manuel/0000-0001-6673-016X	National Science Foundation [IOS-0644438, OCE-0313708]; Collaborative Travel Fund; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231];  [DEB-1054766]; Direct For Biological Sciences [1402065] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Collaborative Travel Fund; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by DEB-1054766 to M. V. M. and National Science Foundation grants IOS-0644438 and OCE-0313708 to M. M., and by a Collaborative Travel Fund to C. R. V. made by King Abdullah University of Science and Technology (KAUST). The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Asada K., 1987, PHOTOINHIBITION, P227; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; BARTLETT CY, 2009, CONSERV BIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Chen MC, 2003, BIOCHEM BIOPH RES CO, V308, P586, DOI 10.1016/S0006-291X(03)01428-1; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; GAME ET, 2009, ECOL LETT; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hayes ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-150; Heinen TJAJ, 2009, CURR BIOL, V19, P1527, DOI 10.1016/j.cub.2009.07.049; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Portune KJ, 2010, MAR GENOM, V3, P51, DOI 10.1016/j.margen.2010.03.002; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; Reynolds WS, 2000, COMP BIOCHEM PHYS A, V126, P33, DOI 10.1016/S0742-8413(00)00099-2; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Sunagawa S, 2008, COMP BIOCHEM PHYS B, V151, P133, DOI 10.1016/j.cbpb.2008.06.007; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tautz D, 1998, PHILOS T ROY SOC B, V353, P231, DOI 10.1098/rstb.1998.0205; Team RDC, 2019, R LANG ENV STAT COMP; Telford MJ, 2007, CURR BIOL, V17, pR945, DOI 10.1016/j.cub.2007.09.023; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; VOOLSTRA CR, 2008, COMP BIOCH PHYSL D; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; WEEKS R, 2009, CONSERV BIOL; Wilkinson C., 2004, STATUS CORAL REEFS W; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wilson GA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000324; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	79	67	67	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20392	10.1371/journal.pone.0020392	http://dx.doi.org/10.1371/journal.pone.0020392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633702	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500059
J	Bhandari, RK; Sadler-Riggleman, I; Clement, TM; Skinner, MK				Bhandari, Ramji K.; Sadler-Riggleman, Ingrid; Clement, Tracy M.; Skinner, Michael K.			Basic Helix-Loop-Helix Transcription Factor TCF21 Is a Downstream Target of the Male Sex Determining Gene SRY	PLOS ONE			English	Article							TESTICULAR SERTOLI-CELLS; FETAL LEYDIG-CELLS; TESTIS DEVELOPMENT; EMBRYONIC TESTIS; DIFFERENTIATION; MICE; ACTIVATION; EXPRESSION; PROTEINS; SOX9	The cascade of molecular events involved in mammalian sex determination has been shown to involve the SRY gene, but specific downstream events have eluded researchers for decades. The current study identifies one of the first direct downstream targets of the male sex determining factor SRY as the basic-helix-loop-helix (bHLH) transcription factor TCF21. SRY was found to bind to the Tcf21 promoter and activate gene expression. Mutagenesis of SRY/SOX9 response elements in the Tcf21 promoter eliminated the actions of SRY. SRY was found to directly associate with the Tcf21 promoter SRY/SOX9 response elements in vivo during fetal rat testis development. TCF21 was found to promote an in vitro sex reversal of embryonic ovarian cells to induce precursor Sertoli cell differentiation. TCF21 and SRY had similar effects on the in vitro sex reversal gonadal cell transcriptomes. Therefore, SRY acts directly on the Tcf21 promoter to in part initiate a cascade of events associated with Sertoli cell differentiation and embryonic testis development.	[Bhandari, Ramji K.; Sadler-Riggleman, Ingrid; Clement, Tracy M.; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA	Washington State University	Bhandari, RK (corresponding author), Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA.	skinner@wsu.edu			National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health (NIH) grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum IB, 2010, J ANDROL, V31, P11, DOI 10.2164/jandrol.109.008318; Barsoum IB, 2009, DEV BIOL, V329, P96, DOI 10.1016/j.ydbio.2009.02.025; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Candiani G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013430; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Chaudhary J, 1999, BIOL REPROD, V60, P1244, DOI 10.1095/biolreprod60.5.1244; Chaudhary J, 1999, ENDOCRINOLOGY, V140, P1262, DOI 10.1210/en.140.3.1262; CLEMENT TM, 2010, BIOL REPROD UNPUB; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Clement TM, 2010, REPROD TOXICOL, V30, P353, DOI 10.1016/j.reprotox.2010.05.086; Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; Cupp AS, 2003, BIOL REPROD, V68, P2033, DOI 10.1095/biolreprod.102.012617; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; KADESCH T, 1993, CELL GROWTH DIFFER, V4, P49; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kitajima S, 2000, DEVELOPMENT, V127, P3215; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Levine E, 2000, BIOL REPROD, V62, P132, DOI 10.1095/biolreprod62.1.132; Levine E, 2000, BIOL REPROD, V62, P477, DOI 10.1095/biolreprod62.3.477; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SHIMA JE, 2004, BIOL REPROD; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SKINNER MK, 2010, BASIC HELIX LOOP HEL; Stevens JD, 2008, DIFFERENTIATION, V76, P1006, DOI 10.1111/j.1432-0436.2008.00285.x; Tamura M, 2001, MECH DEVELOP, V102, P135, DOI 10.1016/S0925-4773(01)00298-2; Tien JCY, 2009, INT J BIOL SCI, V5, P256; Uzumcu M, 2002, BIOL REPROD, V66, P745, DOI 10.1095/biolreprod66.3.745; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	43	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19935	10.1371/journal.pone.0019935	http://dx.doi.org/10.1371/journal.pone.0019935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21637323	Green Submitted, gold, Green Published			2022-12-27	WOS:000290657500034
J	Lin, KP; Chen, SY; Lai, LC; Huang, YL; Chen, JH; Chen, TF; Sun, Y; Wen, LL; Yip, PK; Chu, YM; Chen, WJ; Chen, YC				Lin, Kun-Pei; Chen, Shih-Yuan; Lai, Liang-Chuan; Huang, Yi-Ling; Chen, Jen-Hau; Chen, Ta-Fu; Sun, Yu; Wen, Li-Li; Yip, Ping-Keung; Chu, Yi-Min; Chen, Wei J.; Chen, Yen-Ching			Genetic Polymorphisms of a Novel Vascular Susceptibility Gene, Ninjurin2 (NINJ2), Are Associated with a Decreased Risk of Alzheimer's Disease	PLOS ONE			English	Article							POSTSTROKE DEMENTIA; ADHESION MOLECULES; PREVALENCE; MECHANISMS; DECLINE; MODEL	Background: Accumulated evidences have shown that vascular risk factors, e. g., hypertension, diabetes mellitus and hyperlipidemia, may be related to the risk of dementia. This study investigated the association between genetic polymorphisms of a vascular susceptibility gene, Ninjurin2 (NINJ2), and the risk of dementia, which has not been explored previously. Methods: A total of 275 Alzheimer's disease (AD) patients and 119 vascular dementia (VaD) patients aged 50 or older were recruited from three teaching hospitals from 2007 to 2010. Healthy controls (n = 423) with the same age of cases were recruited from the health checkup and volunteers worked at the hospital during the same time period. Five common (frequency >5%) haplotype-tagging single nucleotide polymorphisms (htSNPs) in NINJ2 were genotyped to test for the association between sequence variants of NINJ2 and dementia risk, and how vascular risk factors modify this association. Results: Homozygosity of two NINJ2 SNPs was significantly associated with a decreased risk of AD [rs11833579: adjusted odds ratio (AOR) = 0.43; 95% confidence interval (CI) = 0.23-0.80; rs12425791: AOR = 0.33, 95% CI = 0.12-0.96]. Five common haplotypes (cumulative frequency = 97%) were identified. The global test for the association between NINJ2 haplotypes and AD was significant (p = 0.03). Haplotype CAGGA was significantly associated with a decreased risk of AD (AOR = 0.32, 95% CI = 0.11-0.94). No associations were observed for VaD. Conclusion: Inherited polymorphisms of the vascular susceptibility gene NINJ2 were associated with AD risk.	[Lin, Kun-Pei; Chen, Shih-Yuan; Huang, Yi-Ling; Chen, Jen-Hau; Chen, Wei J.; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Kun-Pei; Chen, Jen-Hau] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Lab Med, Taipei, Taiwan; [Yip, Ping-Keung] Cardinal Tiens Hosp, Ctr Neurol Med, Taipei, Taiwan; [Chu, Yi-Min] Cardinal Tiens Hosp, Dept Lab Med, Taipei, Taiwan; [Chen, Wei J.; Chen, Yen-Ching] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Wei J.; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Lin, KP (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Chen, Jen-Hau/AFP-2878-2022; Huang, YiLing/ABH-8788-2020; Lai, Liang-Chuan/B-4768-2009; Chen, Yen-Ching/D-1098-2010	Lai, Liang-Chuan/0000-0002-3913-5338; Chen, Wei Jen/0000-0001-5899-5870; Chen, Ta-Fu/0000-0003-1988-6924; Chen, Yen-Ching/0000-0002-8159-7202	NSC [96-2314-B-002-197, 97-2314-B-002-168-MY3]	NSC(Ministry of Science and Technology, Taiwan)	Funding: Grant support: NSC 96-2314-B-002-197 and 97-2314-B-002-168-MY3. The URL of funder's website is http://web1.nsc.gov.tw/mp.aspx?mp=7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; BURGOON MP, 1995, J CELL BIOL, V130, P733, DOI 10.1083/jcb.130.3.733; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chui H, 2000, NEUROL CLIN, V18, P951, DOI 10.1016/S0733-8619(05)70234-6; Claassen JAHR, 2006, J GERONTOL A-BIOL, V61, P267, DOI 10.1093/gerona/61.3.267; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Fonseca ACRG, 2009, J ALZHEIMERS DIS, V17, P503, DOI 10.3233/JAD-2009-1067; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hajjar IM, 2008, AM J ALZHEIMERS DIS, V23, P77, DOI 10.1177/1533317507309803; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hoyert Donna L, 2005, Natl Vital Stat Rep, V53, P1; Iemolo Francesco, 2009, Immun Ageing, V6, P13, DOI 10.1186/1742-4933-6-13; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Roman Gustavo C, 2005, Cerebrovasc Dis, V20 Suppl 2, P91, DOI 10.1159/000089361; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Stozicka Z, 2007, ACTA VIROL, V51, P205; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20573	10.1371/journal.pone.0020573	http://dx.doi.org/10.1371/journal.pone.0020573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674003	Green Submitted, gold, Green Published			2022-12-27	WOS:000291356400008
J	Lurie, G; Wilkens, LR; Thompson, PJ; Shvetsov, YB; Matsuno, RK; Carney, ME; Palmieri, RT; Wu, AH; Pike, MC; Pearce, CL; Menon, U; Gentry-Maharaj, A; Gayther, SA; Ramus, SJ; Whittemore, AS; McGuire, V; Sieh, W; Pharoah, PDP; Song, HL; Gronwald, J; Jakubowska, A; Cybulski, C; Lubinski, J; Schildkraut, JM; Berchuck, A; Kjaer, SK; Hogdall, E; Fasching, PA; Beckmann, MW; Ekici, AB; Hein, A; Chenevix-Trench, G; Webb, PM; Beesley, J; Goodman, MT				Lurie, Galina; Wilkens, Lynne R.; Thompson, Pamela J.; Shvetsov, Yurii B.; Matsuno, Rayna K.; Carney, Michael E.; Palmieri, Rachel T.; Wu, Anna H.; Pike, Malcolm C.; Pearce, Celeste L.; Menon, Usha; Gentry-Maharaj, Aleksandra; Gayther, Simon A.; Ramus, Susan J.; Whittemore, Alice S.; McGuire, Valerie; Sieh, Weiva; Pharoah, Paul D. P.; Song, Honglin; Gronwald, Jacek; Jakubowska, Anna; Cybulski, Cezary; Lubinski, Jan; Schildkraut, Joellen M.; Berchuck, Andrew; Kjaer, Susanne Kruger; Hogdall, Estrid; Fasching, Peter A.; Beckmann, Matthias W.; Ekici, Arif B.; Hein, Alexander; Chenevix-Trench, Georgia; Webb, Penelope M.; Beesley, Jonathan; Goodman, Marc T.		Australian Ovarian Canc Study Grp; Australian Canc Study Grp; Ovarian Canc Assoc Consortium	Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ER-BETA; GENETIC POLYMORPHISMS; DOWN-REGULATION; CARCINOGENESIS; SUSCEPTIBILITY; BREAST; CELLS	The association of ovarian carcinoma risk with the polymorphism rs1271572 in the estrogen receptor beta (ESR2) gene was examined in 4946 women with primary invasive ovarian carcinoma and 6582 controls in a pooled analysis of ten case-control studies within the Ovarian Cancer Association Consortium (OCAC). All participants were non-Hispanic white women. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression adjusted for site and age. Women with the TT genotype were at increased risk of ovarian carcinoma compared to carriers of the G allele (OR = 1.10; 95%; CI: 1.01-1.21; p = 0.04); the OR was 1.09 (CI: 0.99-1.20; p = 0.07) after excluding data from the center (Hawaii) that nominated this SNP for OCAC genotyping A stronger association of rs1271572 TT versus GT/GG with risk was observed among women aged <= 50 years versus older women (OR = 1.35; CI: 1.12-1.62; p = 0.002; p for interaction = 0.02) that remained statistically significant after excluding Hawaii data (OR = 1.34; CI: 1.11-1.61; p = 0.009). No heterogeneity of the association was observed by study, menopausal status, gravidity, parity, use of contraceptive or menopausal hormones, tumor histological type, or stage at diagnosis. This pooled analysis suggests that rs1271572 might influence the risk of ovarian cancer, in particular among younger women.	[Lurie, Galina; Wilkens, Lynne R.; Thompson, Pamela J.; Shvetsov, Yurii B.; Matsuno, Rayna K.; Goodman, Marc T.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Matsuno, Rayna K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Carney, Michael E.] Univ Hawaii, John A Burns Sch Med, Dept Obstet & Gynecol, Honolulu, HI 96822 USA; [Palmieri, Rachel T.; Schildkraut, Joellen M.; Berchuck, Andrew] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Wu, Anna H.; Pike, Malcolm C.; Pearce, Celeste L.; Gayther, Simon A.; Ramus, Susan J.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Menon, Usha; Gentry-Maharaj, Aleksandra] UCL, Dept Gynecol Oncol, EGA Inst Womens Hlth, London, England; [Whittemore, Alice S.; McGuire, Valerie; Sieh, Weiva] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Pharoah, Paul D. P.; Song, Honglin] Univ Cambridge, Dept Oncol, Cambridge, England; [Gronwald, Jacek; Jakubowska, Anna; Cybulski, Cezary; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Kjaer, Susanne Kruger; Hogdall, Estrid] Danish Canc Soc, Inst Canc Epidemiol, Dept Viruses Hormones & Canc, Copenhagen, Denmark; [Kjaer, Susanne Kruger] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Gynecol Clin, DK-2100 Copenhagen, Denmark; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Beckmann, Matthias W.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Nurnberg, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Nurnberg, Germany; [Chenevix-Trench, Georgia; Webb, Penelope M.; Beesley, Jonathan] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [Australian Ovarian Canc Study Grp; Australian Canc Study Grp] Peter MacCallum Canc Study, Melbourne, Vic, Australia	Cancer Research Center of Hawaii; University of Hawaii System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Hawaii System; Duke University; University of Southern California; Memorial Sloan Kettering Cancer Center; University of London; University College London; Stanford University; University of Cambridge; Pomeranian Medical University; Danish Cancer Society; Rigshospitalet; University of Copenhagen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of Erlangen Nuremberg; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center	Lurie, G (corresponding author), Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA.	GLurie@crch.hawaii.edu	Johnatty, Sharon E/R-8890-2016; Jakubowska, Anna/O-8050-2014; Garcia-Closas, Montserrat/AAZ-6930-2021; Ramus, Susan/AAG-8352-2019; Pharoah, Paul/V-6658-2019; Ekici, Arif B/C-3971-2013; Menon, Usha/C-4716-2008; Fasching, Peter A/ABH-9912-2020; Gronwald, Jacek/A-4576-2017; Brinton, Louise A/G-7486-2015; Bowtell, David/H-1007-2016; Shvetsov, Yurii/ABA-3196-2020; Hein, Alexander/F-6999-2010; Chenevix-Trench, Georgia/AAV-2014-2020; Webb, Penelope/D-5736-2013; Van Den Berg, David J/G-8598-2017	Johnatty, Sharon E/0000-0002-7888-1966; Jakubowska, Anna/0000-0002-5650-0501; Garcia-Closas, Montserrat/0000-0003-1033-2650; Ramus, Susan/0000-0003-0005-7798; Pharoah, Paul/0000-0001-8494-732X; Ekici, Arif B/0000-0001-6099-7066; Menon, Usha/0000-0003-3708-1732; Fasching, Peter A/0000-0003-4885-8471; Gronwald, Jacek/0000-0002-3643-2871; Brinton, Louise A/0000-0003-3853-8562; Bowtell, David/0000-0001-9089-7525; Hein, Alexander/0000-0003-2601-3398; Chenevix-Trench, Georgia/0000-0002-1878-2587; Webb, Penelope/0000-0003-0733-5930; Van Den Berg, David J/0000-0002-5404-5218; Lubinski, Jan/0000-0003-2931-3003; Hogdall, Claus/0000-0002-5959-8874; Weber, Rachel/0000-0001-7119-7734; Beesley, Jonathan/0000-0003-1942-325X; Goodman, Marc/0000-0002-4839-3021; Hogdall, Estrid/0000-0003-4689-5658; Kjaer, Susanne/0000-0002-8347-1398	Ovarian Cancer Association Consortium; U.S. National Institutes of Health [R01 CA58598, N01-CN-55424, N01-PC-67001]; USC: Public Health Service [CA14089, CA17054, CA61132, CA63464, N01-PC-67010, R03-CA113148]; California Department of Health Services [050-E8709]; UKO: Cancer Research UK; Eve Appeal; OAK Foundation; Department of Health's NIHR Biomedical Research Centre; STA: the U. S. National Institutes of Health/National Cancer Institute [U01CA71966, R01CA16056, U01CA69417, K07CA143047]; SEA: Cancer Research United Kingdom; POL: U.S. National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics (POL) National Cancer Institute [R01-CA-76016 (NCO)]; NCO: the National Cancer Institute [R01-CA-76016]; MAL: Mermaid 1; Danish Cancer Society; National Cancer Institute [R01-CA-61107]; Australian Ovarian Cancer Study; Australian Cancer Study: US Army Medical Research and Material Command [DAMD17-01-1-0729]; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; USC [00-01389V-20170, 2110200]; U.S. Public Health Service [CA14089, CA17054, CA61132, CA63464, N01-PC-67010, R03-CA113148]; National Health and Medical Research Council of Australia [199600, 400281]; The Francis Crick Institute [10124] Funding Source: researchfish; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067001, N01PC067010] Funding Source: NIH RePORTER; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA063464, ZIACP010126, P30CA016056, R01CA058598, K07CA143047, R01CA063464, R01CA061107, R01CA061132, P01CA017054, U01CA071966, R01CA076016, R03CA113148, P30CA014089, U01CA069417] Funding Source: NIH RePORTER	Ovarian Cancer Association Consortium; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC: Public Health Service; California Department of Health Services; UKO: Cancer Research UK; Eve Appeal; OAK Foundation; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); STA: the U. S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SEA: Cancer Research United Kingdom; POL: U.S. National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics (POL) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCO: the National Cancer Institute; MAL: Mermaid 1; Danish Cancer Society(Danish Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Ovarian Cancer Study; Australian Cancer Study: US Army Medical Research and Material Command; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Queensland(Cancer Council Queensland); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); USC; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The Francis Crick Institute; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: The Ovarian Cancer Association Consortium: a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith. HAW: the U. S. National Institutes of Health (R01 CA58598, N01-CN-55424, N01-PC-67001); USC: Public Health Service grants CA14089, CA17054, CA61132, CA63464, N01-PC-67010 and R03-CA113148, and California Department of Health Services sub-contract 050-E8709; UKO: Cancer Research UK, the Eve Appeal, the OAK Foundation and the Department of Health's NIHR Biomedical Research Centre funding scheme; STA: the U. S. National Institutes of Health/National Cancer Institute: U01CA71966, R01CA16056, U01CA69417, and K07CA143047; SEA: Cancer Research United Kingdom; POL: Intramural Funds from the U. S. National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics (POL) National Cancer Institute R01-CA-76016 (NCO); NCO: the National Cancer Institute R01-CA-76016; MAL: Mermaid 1, the Danish Cancer Society and the National Cancer Institute R01-CA-61107; The Australian Ovarian Cancer Study and Australian Cancer Study: US Army Medical Research and Material Command (DAMD17-01-1-0729), Cancer Council Victoria, Cancer Council Queensland, Cancer Council New South Wales, Cancer Council South Australia, Cancer Council Tasmania and Cancer Foundation of Western Australia, USC: the California Cancer Research Program grants 00-01389V-20170 and 2110200, U. S. Public Health Service grants CA14089, CA17054, CA61132, CA63464, N01-PC-67010 and R03-CA113148, and California Department of Health Services sub-contract 050-E8709 the National Health and Medical Research Council of Australia (199600 and 400281). PMW and GCT are funded by fellowships from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Bardin A, 2004, CANCER RES, V64, P5861, DOI 10.1158/0008-5472.CAN-04-0552; Berchuck A, 2008, ADV EXP MED BIOL, V622, P53, DOI 10.1007/978-0-387-68969-2_5; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Drummond AE, 1999, MOL CELL ENDOCRINOL, V149, P153, DOI 10.1016/S0303-7207(98)00247-0; Drummond AE, 2010, J ENDOCRINOL, V205, P15, DOI 10.1677/JOE-09-0379; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; Fixemer T, 2003, PROSTATE, V54, P79, DOI 10.1002/pros.10171; Foley EF, 2000, CANCER RES, V60, P245; HENDERSON BE, 1988, CANCER RES, V48, P246; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Li AJ, 2003, AM J OBSTET GYNECOL, V189, P22, DOI 10.1067/mob.2003.328; Li LC, 2000, BIOCHEM BIOPH RES CO, V275, P682, DOI 10.1006/bbrc.2000.3363; Lindgren PR, 2004, MOL CELL ENDOCRINOL, V221, P97, DOI 10.1016/j.mce.2004.02.020; Lurie G, 2009, CANCER CAUSE CONTROL, V20, P47, DOI 10.1007/s10552-008-9216-8; Park BW, 2003, BREAST CANCER RES TR, V80, P79, DOI 10.1023/A:1024406223619; Pearce CL, 2009, BRIT J CANCER, V100, P412, DOI 10.1038/sj.bjc.6604820; Pearce CL, 2008, CANCER EPIDEM BIOMAR, V17, P393, DOI 10.1158/1055-9965.EPI-07-2512; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sun Ying-hao, 2005, Zhonghua Wai Ke Za Zhi, V43, P948; Treeck O, 2007, J ENDOCRINOL, V193, P421, DOI 10.1677/JOE-07-0087; Tung KH, 2004, AM J EPIDEMIOL, V159, P750, DOI 10.1093/aje/kwh103; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109	26	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20703	10.1371/journal.pone.0020703	http://dx.doi.org/10.1371/journal.pone.0020703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673961	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400020
J	Nistor, G; Siegenthaler, MM; Poirier, SN; Rossi, S; Poole, AJ; Charlton, ME; McNeish, JD; Airriess, CN; Keirstead, HS				Nistor, Gabriel; Siegenthaler, Monica M.; Poirier, Stephane N.; Rossi, Sharyn; Poole, Aleksandra J.; Charlton, Maura E.; McNeish, John D.; Airriess, Chris N.; Keirstead, Hans S.			Derivation of High Purity Neuronal Progenitors from Human Embryonic Stem Cells	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SPINAL-CORD-INJURY; NEURAL INDUCTION; DIFFERENTIATION; PATHWAY; PHENOTYPES; CARCINOMA; PROMOTES; RECOVERY; MODEL	The availability of human neuronal progenitors (hNPs) in high purity would greatly facilitate neuronal drug discovery and developmental studies, as well as cell replacement strategies for neurodegenerative diseases and conditions, such as spinal cord injury, stroke, Parkinson's disease, Alzheimer's disease, and Huntington's disease. Here we describe for the first time a method for producing hNPs in large quantity and high purity from human embryonic stem cells (hESCs) in feeder-free conditions, without the use of exogenous noggin, sonic hedgehog or analogs, rendering the process clinically compliant. The resulting population displays characteristic neuronal-specific markers. When allowed to spontaneously differentiate into neuronal subtypes in vitro, cholinergic, serotonergic, dopaminergic and/or noradrenergic, and medium spiny striatal neurons were observed. When transplanted into the injured spinal cord the hNPs survived, integrated into host tissue, and matured into a variety of neuronal subtypes. Our method of deriving neuronal progenitors from hESCs renders the process amenable to therapeutic and commercial use.	[Nistor, Gabriel; Rossi, Sharyn; Keirstead, Hans S.] Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Sch Med,CIRM I, Irvine, CA 92717 USA; [Siegenthaler, Monica M.; Poole, Aleksandra J.; Airriess, Chris N.] Calif Stem Cell Inc, Irvine, CA USA; [Poirier, Stephane N.; Charlton, Maura E.; McNeish, John D.] Pfizer Regenerat Med, Cambridge, MA USA	University of California System; University of California Irvine; Pfizer	Nistor, G (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Sch Med,CIRM I, Sue & Bill Gross Hall, Irvine, CA 92717 USA.	hansk@uci.edu						ABREUVILLACA Y, 2010, BEHAV BRAIN RES; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Axell MZ, 2009, J NEUROSCI METH, V184, P275, DOI 10.1016/j.jneumeth.2009.08.015; Bentz K, 2006, CELL PHYSIOL BIOCHEM, V18, P275, DOI 10.1159/000097674; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; De Smaele E, 2008, NEOPLASIA, V10, P89, DOI 10.1593/neo.07891; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Fan GF, 2005, J BIOL CHEM, V280, P40337, DOI 10.1074/jbc.M506810200; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Keirstead HS, 2001, J NEUROSCI RES, V63, P233, DOI 10.1002/1097-4547(20010201)63:3<233::AID-JNR1016>3.0.CO;2-B; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Lenka N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001349; Lupi O, 2007, INT J DERMATOL, V46, P1113, DOI 10.1111/j.1365-4632.2007.03391.x; Marsh D, 2008, CANCER RES, V68, P3295, DOI 10.1158/0008-5472.CAN-08-0174; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Okano H, 2002, J CELL SCI, V115, P1355; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Satoh K, 2008, ONCOL REP, V19, P1185; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	30	30	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20692	10.1371/journal.pone.0020692	http://dx.doi.org/10.1371/journal.pone.0020692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673956	Green Published, gold			2022-12-27	WOS:000291356400017
J	Leonard, TCM; Caughy, MO; Mays, JK; Murdoch, JC				Leonard, Tammy C. M.; Caughy, Margaret O'Brien; Mays, Judith K.; Murdoch, James C.			Systematic Neighborhood Observations at High Spatial Resolution: Methodology and Assessment of Potential Benefits	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; MENTAL-HEALTH; OBESITY; CHILDREN; INCOME; ASSOCIATIONS; DEPRESSION; DISORDERS	There is a growing body of public health research documenting how characteristics of neighborhoods are associated with differences in the health status of residents. However, little is known about how the spatial resolution of neighborhood observational data or community audits affects the identification of neighborhood differences in health. We developed a systematic neighborhood observation instrument for collecting data at very high spatial resolution (we observe each parcel independently) and used it to collect data in a low-income minority neighborhood in Dallas, TX. In addition, we collected data on the health status of individuals residing in this neighborhood. We then assessed the inter-rater reliability of the instrument and compared the costs and benefits of using data at this high spatial resolution. Our instrument provides a reliable and cost-effect method for collecting neighborhood observational data at high spatial resolution, which then allows researchers to explore the impact of varying geographic aggregations. Furthermore, these data facilitate a demonstration of the predictive accuracy of self-reported health status. We find that ordered logit models of health status using observational data at different spatial resolution produce different results. This implies a need to analyze the variation in correlative relationships at different geographic resolutions when there is no solid theoretical rational for choosing a particular resolution. We argue that neighborhood data at high spatial resolution greatly facilitates the evaluation of alternative geographic specifications in studies of neighborhood and health.	[Leonard, Tammy C. M.; Mays, Judith K.; Murdoch, James C.] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Richardson, TX 75083 USA; [Caughy, Margaret O'Brien] Univ Texas Sch Publ Hlth, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Leonard, TCM (corresponding author), Univ Texas Dallas, Sch Econ Polit & Policy Sci, Richardson, TX 75083 USA.	Leonard@utdallas.edu		Leonard, Tammy/0000-0002-8621-9358	National Science Foundation [NSF/SES-0827350]; Institute for Urban Policy Research at the University of Texas at Dallas; Foundation for Community Empowerment Dallas, Texas; Direct For Social, Behav & Economic Scie [0827350] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute for Urban Policy Research at the University of Texas at Dallas; Foundation for Community Empowerment Dallas, Texas; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by funding from the National Science Foundation (NSF/SES-0827350), the Institute for Urban Policy Research at the University of Texas at Dallas, and the Foundation for Community Empowerment Dallas, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Beyers JM, 2003, AM J COMMUN PSYCHOL, V31, P35, DOI 10.1023/A:1023018502759; BOONEHEINONEN J, 2010, HLTH PLACE, V16; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Burdette HL, 2005, PEDIATRICS, V116, P657, DOI 10.1542/peds.2004-2443; Caughy MO, 2008, AM J COMMUN PSYCHOL, V42, P39, DOI 10.1007/s10464-008-9185-9; Caughy MO, 2007, HEALTH PLACE, V13, P788, DOI 10.1016/j.healthplace.2007.01.006; Caughy MO, 2001, HEALTH PLACE, V7, P225, DOI 10.1016/S1353-8292(01)00012-0; Chaix B, 2005, AM J EPIDEMIOL, V162, P171, DOI 10.1093/aje/kwi175; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Franzini L, 2005, SOC SCI MED, V61, P1135, DOI 10.1016/j.socscimed.2005.02.010; Franzini L., 2007, AM J PUBLIC HEALTH, V99, P271; Freisthler B, 2007, SOC WORK, V52, P7, DOI 10.1093/sw/52.1.7; Gee GC, 2002, AM J PUBLIC HEALTH, V92, P615, DOI 10.2105/AJPH.92.4.615; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Guo JY, 2007, J TRANSP GEOGR, V15, P31, DOI 10.1016/j.jtrangeo.2005.11.001; Gutman LM, 2004, DEV PSYCHOPATHOL, V16, P967, DOI 10.1017/S095457940404009X; Kipke MD, 2007, J ADOLESCENT HEALTH, V40, P325, DOI 10.1016/j.jadohealth.2006.10.021; Kohen DE, 2002, CHILD DEV, V73, P1844, DOI 10.1111/1467-8624.t01-1-00510; Leventhal T, 2003, AM J PUBLIC HEALTH, V93, P1576, DOI 10.2105/AJPH.93.9.1576; Malmstrom M, 1999, AM J PUBLIC HEALTH, V89, P1181, DOI 10.2105/AJPH.89.8.1181; MARTINEZ P, 1993, PSYCHIATRY, V56, P22; Molnar BE, 2004, AM J HEALTH PROMOT, V18, P378, DOI 10.4278/0890-1171-18.5.378; Moudon Anne Vernez, 2006, J Phys Act Health, V3, pS99, DOI 10.1123/jpah.3.s1.s99; Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001; Nelson MC, 2006, AM J PREV MED, V31, P109, DOI 10.1016/j.amepre.2006.03.026; O'Campo P, 2000, J URBAN HEALTH, V77, P34, DOI 10.1007/BF02350961; OCampo P, 1997, AM J PUBLIC HEALTH, V87, P1113, DOI 10.2105/AJPH.87.7.1113; Openshaw S., 1981, QUANTITATIVE GEOGRAP, P60; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Rauh VA, 2008, ANN NY ACAD SCI, V1136, P276, DOI 10.1196/annals.1425.032; Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304; Ross NA, 2004, SOC SCI MED, V59, P1485, DOI 10.1016/j.socscimed.2004.01.016; Schaefer-McDaniel N, 2010, SOC SCI MED, V70, P277, DOI 10.1016/j.socscimed.2009.10.018; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Wickrama KAT, 2006, J YOUTH ADOLESCENCE, V35, P647, DOI 10.1007/s10964-006-9050-9; Wright R. J., 2003, Neighborhoods and health, P233; Xue YG, 2005, ARCH GEN PSYCHIAT, V62, P554, DOI 10.1001/archpsyc.62.5.554; Yen IH, 1999, AM J EPIDEMIOL, V149, P898	41	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20225	10.1371/journal.pone.0020225	http://dx.doi.org/10.1371/journal.pone.0020225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774BE	21673983	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500009
J	Pompei, S; Loreto, V; Tria, F				Pompei, Simone; Loreto, Vittorio; Tria, Francesca			On the Accuracy of Language Trees	PLOS ONE			English	Article							DIVERGENCE TIMES; DISTANCE; PHYLOGENY; EVOLUTION; EXPLORATIONS; ALGORITHMS	Historical linguistics aims at inferring the most likely language phylogenetic tree starting from information concerning the evolutionary relatedness of languages. The available information are typically lists of homologous (lexical, phonological, syntactic) features or characters for many different languages: a set of parallel corpora whose compilation represents a paramount achievement in linguistics. From this perspective the reconstruction of language trees is an example of inverse problems: starting from present, incomplete and often noisy, information, one aims at inferring the most likely past evolutionary history. A fundamental issue in inverse problems is the evaluation of the inference made. A standard way of dealing with this question is to generate data with artificial models in order to have full access to the evolutionary process one is going to infer. This procedure presents an intrinsic limitation: when dealing with real data sets, one typically does not know which model of evolution is the most suitable for them. A possible way out is to compare algorithmic inference with expert classifications. This is the point of view we take here by conducting a thorough survey of the accuracy of reconstruction methods as compared with the Ethnologue expert classifications. We focus in particular on state-of-the-art distance-based methods for phylogeny reconstruction using worldwide linguistic databases. In order to assess the accuracy of the inferred trees we introduce and characterize two generalizations of standard definitions of distances between trees. Based on these scores we quantify the relative performances of the distance-based algorithms considered. Further we quantify how the completeness and the coverage of the available databases affect the accuracy of the reconstruction. Finally we draw some conclusions about where the accuracy of the reconstructions in historical linguistics stands and about the leading directions to improve it.	[Pompei, Simone; Loreto, Vittorio; Tria, Francesca] ISI, Complex Syst Lagrange Lab, Turin, Italy; [Pompei, Simone] Univ Turin, Dept Phys, Turin, Italy; [Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	University of Turin; Sapienza University Rome	Pompei, S (corresponding author), ISI, Complex Syst Lagrange Lab, Turin, Italy.	fra_trig@yahoo.it						Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; Bakker D, 2009, LINGUIST TYPOL, V13, P169, DOI DOI 10.1515/LITY.2009.009; BRYANT D, 2000, P 11 ANN ACM SIAM S, P258; Bryant D., 2005, EVOLUTION CULTURAL D, P67; CHRISTIANSEN C, 2005, P WORKSH ALG BIOINF, P77; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Dunn M, 2008, LANGUAGE, V84, P710; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Holman EW, 2008, FOLIA LINGUIST, V42, P331, DOI 10.1515/FLIN.2008.331; Joseph B. D., 2004, HDB HIST LINGUISTICS; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Nerbonne J, 1999, NINTH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS, P281; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Petroni F, 2010, PHYSICA A, V389, P2280, DOI 10.1016/j.physa.2010.02.004; Pompei S, 2010, MATH MOD METH APPL S, V20, P1511, DOI 10.1142/S0218202510004672; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; RANDERS M, 2006, THESIS U AARHUS; Renfrew C., 2000, TIME DEPTH HIST LING; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Serva M, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/68005; SWADESH M, 1952, P AM PHILOS SOC, V96, P453; Swadesh M, 1955, INT J AM LINGUIST, V21, P121, DOI 10.1086/464321; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; TRIA F, 2010, P BIOCOMP2010 2010 I; Tria F, 2010, MOL BIOL EVOL, V27, P2587, DOI 10.1093/molbev/msq154; WICHMANN S, 2010, DIACHRONICA COMMEMOR, V27; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011	34	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20109	10.1371/journal.pone.0020109	http://dx.doi.org/10.1371/journal.pone.0020109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674034	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500005
J	Stein, M; van Veen, TAB; Hauer, RNW; de Bakker, JMT; van Rijen, HVM				Stein, Mera; van Veen, Toon A. B.; Hauer, Richard N. W.; de Bakker, Jacques M. T.; van Rijen, Harold V. M.			A 50% Reduction of Excitability but Not of Intercellular Coupling Affects Conduction Velocity Restitution and Activation Delay in the Mouse Heart	PLOS ONE			English	Article							FAILING HUMAN HEART; GAP-JUNCTIONS; IMPULSE PROPAGATION; CARDIAC CONDUCTION; CELL-SIZE; MICE; EXPRESSION; CONNEXIN43; DISEASE; SODIUM	Introduction: Computer simulations suggest that intercellular coupling is more robust than membrane excitability with regard to changes in and safety of conduction. Clinical studies indicate that SCN5A (excitability) and/or Connexin43 (Cx43, intercellular coupling) expression in heart disease is reduced by approximately 50%. In this retrospective study we assessed the effect of reduced membrane excitability or intercellular coupling on conduction in mouse models of reduced excitability or intercellular coupling. Methods and Results: Epicardial activation mapping of LV and RV was performed on Langendorff-perfused mouse hearts having the following: 1) Reduced excitability: Scn5a haploinsufficient mice; and 2) reduced intercellular coupling: Cx43(CreER(T)/fl) mice, uninduced (50% Cx43) or induced (10% Cx43) with Tamoxifen. Wild type (WT) littermates were used as control. Conduction velocity (CV) restitution and activation delay were determined longitudinal and transversal to fiber direction during S(1)S(1) pacing and S(1)S(2) premature stimulation until the effective refractory period. In both animal models, CV restitution and activation delay in LV were not changed compared to WT. In contrast, CV restitution decreased and activation delay increased in RV during conduction longitudinal but not transverse to fiber direction in Scn5a heterozygous animals compared to WT. In contrast, a 50% reduction of intercellular coupling did not affect either CV restitution or activation delay. A decrease of 90% Cx43, however, resulted in decreased CV restitution and increased activation delay in RV, but not LV. Conclusion: Reducing excitability but not intercellular coupling by 50% affects CV restitution and activation delay in RV, indicating a higher safety factor for intercellular coupling than excitability in RV.	[Stein, Mera; van Veen, Toon A. B.; de Bakker, Jacques M. T.; van Rijen, Harold V. M.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands; [Stein, Mera; Hauer, Richard N. W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [de Bakker, Jacques M. T.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [de Bakker, Jacques M. T.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Stein, M (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands.	h.v.m.vanrijen@umcutrecht.nl		van Rijen, Harold/0000-0001-6740-7428	Netherlands Heart Foundation [2003B128]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Netherlands Heart Foundation (grant No. 2003B128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; FRAME LH, 1988, CIRCULATION, V78, P1277, DOI 10.1161/01.CIR.78.5.1277; Jongsma HJ, 2000, CIRC RES, V86, P1193, DOI 10.1161/01.RES.86.12.1193; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kostin S, 2003, MOL CELL BIOCHEM, V242, P135, DOI 10.1023/A:1021154115673; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Morley GE, 1999, J CARDIOVASC ELECTR, V10, P1361, DOI 10.1111/j.1540-8167.1999.tb00192.x; PETERS NS, 1993, CIRCULATION, V88, P864, DOI 10.1161/01.CIR.88.3.864; Pinski SL, 2000, J ELECTROCARDIOL, V33, P103, DOI 10.1054/jclc.2000.20332; Potse M, 2002, COMPUT METH PROG BIO, V69, P225, DOI 10.1016/S0169-2607(02)00014-7; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; SAUMAREZ RC, 1995, CIRCULATION, V92, P2565, DOI 10.1161/01.CIR.92.9.2565; Shaw RM, 1997, CIRC RES, V81, P727; Spach MS, 2000, CIRC RES, V86, P302, DOI 10.1161/01.RES.86.3.302; Spach MS, 2001, J ELECTROCARDIOL, V34, P69, DOI 10.1054/jelc.2001.28833; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; STEIN M, 2006, NETHERLANDS HEART J, V14; Stein M, 2008, HEART RHYTHM, V5, P438, DOI 10.1016/j.hrthm.2007.10.033; Stein M, 2009, CARDIOVASC RES, V83, P52, DOI 10.1093/cvr/cvp124; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Rijen HVM, 2006, ADV CARDIOL, V42, P150, DOI 10.1159/000092567; van Rijen HVM, 2005, CARDIOVASC RES, V66, P9, DOI 10.1016/j.cardiores.2005.02.003; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; van Veen TAB, 2005, CIRCULATION, V112, P1927, DOI 10.1161/CIRCULATIONAHA.105.539072	26	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20310	10.1371/journal.pone.0020310	http://dx.doi.org/10.1371/journal.pone.0020310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673812	Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900013
J	Chen, CF; Chu, CY; Chen, TH; Lee, SJ; Shen, CN; Hsiao, CD				Chen, Chi-Fang; Chu, Che-Yu; Chen, Te-Hao; Lee, Shyh-Jye; Shen, Chia-Ning; Hsiao, Chung-Der			Establishment of a Transgenic Zebrafish Line for Superficial Skin Ablation and Functional Validation of Apoptosis Modulators In Vivo	PLOS ONE			English	Article							SUICIDE GENE-THERAPY; ESCHERICHIA-COLI NITROREDUCTASE; UVB-INDUCED APOPTOSIS; EXPRESSING BACTERIAL NITROREDUCTASE; HUMAN CANCER-CELLS; SUBCELLULAR-LOCALIZATION; TARGETED DISRUPTION; FLUORESCENT PROTEIN; SIGNAL TRANSDUCER; TRANSCRIPTION 3	Background: Zebrafish skin is composed of enveloping and basal layers which form a first-line defense system against pathogens. Zebrafish epidermis contains ionocytes and mucous cells that aid secretion of acid/ions or mucous through skin. Previous studies demonstrated that fish skin is extremely sensitive to external stimuli. However, little is known about the molecular mechanisms that modulate skin cell apoptosis in zebrafish. Methodology/Principal Findings: This study aimed to create a platform to conduct conditional skin ablation and determine if it is possible to attenuate apoptotic stimuli by overexpressing potential apoptosis modulating genes in the skin of live animals. A transgenic zebrafish line of Tg(krt4:NTR-hKikGR)(cy17) (killer line), which can conditionally trigger apoptosis in superficial skin cells, was first established. When the killer line was incubated with the prodrug metrodinazole, the superficial skin displayed extensive apoptosis as judged by detection of massive TUNEL-and active caspase 3-positive signals. Great reductions in NTR-hKikGR(+) fluorescent signals accompanied epidermal cell apoptosis. This indicated that NTR-hKikGR(+) signal fluorescence can be utilized to evaluate apoptotic events in vivo. After removal of metrodinazole, the skin integrity progressively recovered and NTR-hKikGR(+) fluorescent signals gradually restored. In contrast, either crossing the killer line with testing lines or transiently injecting the killer line with testing vectors that expressed human constitutive active Akt1, mouse constitutive active Stat3, or HPV16 E6 element displayed apoptosis-resistant phenotypes to cytotoxic metrodinazole as judged by the loss of reduction in NTR-hKikGR(+) fluorescent signaling. Conclusion/Significance: The killer/testing line binary system established in the current study demonstrates a nitroreductase/metrodinazole system that can be utilized to conditionally perform skin ablation in a real-time manner, and provides a valuable tool to visualize and quantify the anti-apoptotic potential of interesting target genes in vivo. The current work identifies a potential use for transgenic zebrafish as a high-throughput platform to validate potential apoptosis modulators in vivo.	[Chen, Chi-Fang; Shen, Chia-Ning] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Chen, Chi-Fang; Chu, Che-Yu; Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Chen, Te-Hao] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Shen, Chia-Ning] Acad Sinica, Genome Res Ctr, Taipei 115, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	National Taiwan Ocean University; Chung Yuan Christian University; National Museum of Marine Biology & Aquarium; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Chung Yuan Christian University	Chen, CF (corresponding author), Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan.	cnshen@gate.sinica.edu.tw; cdhsiao@cycu.edu.tw	SHEN, CHIA-NING/C-6878-2011; Lee, Shyh-Jye/C-6092-2008; Hsiao, Chung-Der/W-4535-2019	SHEN, CHIA-NING/0000-0002-0747-217X; Lee, Shyh-Jye/0000-0001-8452-9152; Hsiao, Chung-Der/0000-0002-6398-8672	National Science Council [NSC 96-2321-B-033-002-MY2, NSC 97-2622-B-001-002-CC1]; Mackay Memorial Hospital [MMH-CY-9905]; Academia Sinica [5202402020]	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Academia Sinica(Academia Sinica - Taiwan)	This work was supported in part by the National Science Council grant (NSC 96-2321-B-033-002-MY2) and the Mackay Memorial Hospital grant (MMH-CY-9905) to C-DH, the National Science Council grant (NSC 97-2622-B-001-002-CC1) and the Summit Project Grants of Academia Sinica #5202402020 to C-NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED FE, 1993, CANCER RES, V53, P2249; ALHASSAN JM, 1985, MAR BIOL, V88, P117, DOI 10.1007/BF00397158; Allen SM, 2003, CANCER RES, V63, P567; ANDERS K, 1994, DIS AQUAT ORGAN, V19, P215, DOI 10.3354/dao019215; Bilsland AE, 2003, ONCOGENE, V22, P370, DOI 10.1038/sj.onc.1206168; Bridgewater JA, 1997, HUM GENE THER, V8, P709, DOI 10.1089/hum.1997.8.6-709; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chung-Faye GA, 2000, MOL MED TODAY, V6, P82, DOI 10.1016/S1357-4310(99)01598-1; Cui W, 1999, GENE THER, V6, P764, DOI 10.1038/sj.gt.3300873; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; D'Errico M, 2007, MUTAT RES-FUND MOL M, V614, P37, DOI 10.1016/j.mrfmmm.2006.06.009; Decraene D, 2004, J INVEST DERMATOL, V123, P207, DOI 10.1111/j.0022-202X.2004.22702.x; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; Felmer RN, 2004, BIOL RES, V37, P449, DOI 10.4067/S0716-97602004000300009; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; GENTEN F, 2009, ATLAS FISH HISTOLOGY, V215; Giannetti L, 2004, ONCOL REP, V11, P401; Grohmann M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-301; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Grove JI, 2003, CANCER RES, V63, P5532; Guerra RR, 2008, J FISH BIOL, V73, P572, DOI 10.1111/j.1095-8649.2008.01950.x; Hakkinen J, 2003, AQUAT TOXICOL, V63, P159, DOI 10.1016/S0166-445X(02)00173-X; Hirata T, 2003, AM J PHYSIOL-REG I, V284, pR1199, DOI 10.1152/ajpregu.00267.2002; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Hsu CC, 2010, MAR BIOTECHNOL, V12, P466, DOI 10.1007/s10126-009-9248-4; Hu B, 2010, ORAL ONCOL, V46, P31, DOI 10.1016/j.oraloncology.2009.09.008; Hu SY, 2010, MAR BIOTECHNOL, V12, P569, DOI 10.1007/s10126-009-9244-8; Ingham PW, 2009, HUM MOL GENET, V18, pR107, DOI 10.1093/hmg/ddp091; Jaberipour M, 2010, BIOCHEM PHARMACOL, V79, P102, DOI 10.1016/j.bcp.2009.07.025; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Jarrom D, 2009, BIOCHEMISTRY-US, V48, P7665, DOI 10.1021/bi900674m; Ju BS, 1999, DEV GENET, V25, P158, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;158::AID-DVG10&gt;3.0.CO;2-6; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim DJ, 2009, MOL CARCINOGEN, V48, P873, DOI 10.1002/mc.20527; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; Kwak SP, 2007, J NEUROSCI RES, V85, P1183, DOI 10.1002/jnr.21223; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Le Tissier PR, 2005, MOL ENDOCRINOL, V19, P1251, DOI 10.1210/me.2004-0223; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Macary G, 2010, VIRCHOWS ARCH, V456, P325, DOI 10.1007/s00428-009-0840-9; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Morrison RN, 2008, J FISH DIS, V31, P699, DOI 10.1111/j.1365-2761.2008.00934.x; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Noga EJ, 1996, MAR POLLUT BULL, V32, P219, DOI 10.1016/0025-326X(95)00114-3; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; Pai CW, 2010, TRANSGENIC RES, V19, P655, DOI 10.1007/s11248-009-9350-4; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pileri SA, 1997, J PATHOL, V183, P116; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Plumb JA, 2001, ONCOGENE, V20, P7797, DOI 10.1038/sj.onc.1204954; Pretti C, 2009, ECOTOX ENVIRON SAFE, V72, P1170, DOI 10.1016/j.ecoenv.2008.09.010; Race PR, 2007, J MOL BIOL, V368, P481, DOI 10.1016/j.jmb.2007.02.012; REIMCHEN TE, 1988, CAN J ZOOL, V66, P2036, DOI 10.1139/z88-299; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002; Silva MT, 2008, CURR PHARM DESIGN, V14, P170; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Spooner RA, 2000, CANCER GENE THER, V7, P1348, DOI 10.1038/sj.cgt.0238; Spooner RA, 2001, INT J CANCER, V93, P123, DOI 10.1002/ijc.1288; Springer CJ, 2000, ADV EXP MED BIOL, V465, P403; Suzuki A, 2003, CANCER RES, V63, P674; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Vogelbein WK, 2001, ENVIRON HEALTH PERSP, V109, P687, DOI 10.2307/3454914; Wang YH, 2006, TOXICOL LETT, V163, P191, DOI 10.1016/j.toxlet.2005.10.024; Wilson WR, 2002, CANCER RES, V62, P1425	71	33	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20654	10.1371/journal.pone.0020654	http://dx.doi.org/10.1371/journal.pone.0020654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655190	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600117
J	Ma, L; Wen, ZS; Liu, Z; Hu, Z; Ma, J; Chen, XQ; Liu, YQ; Pu, JX; Xiao, WL; Sun, HD; Zhou, GB				Ma, Liang; Wen, Zhe-Sheng; Liu, Zi; Hu, Zheng; Ma, Jun; Chen, Xiao-Qin; Liu, Yong-Qiang; Pu, Jian-Xin; Xiao, Wei-Lie; Sun, Han-Dong; Zhou, Guang-Biao			Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer	PLOS ONE			English	Article							PHOSPHO-AKT; SMOKING; SURVIVAL	Background: Lung cancer is the leading cause of cancer deaths worldwide, with a five-year overall survival rate of only 15%. Cancerous inhibitor of PP2A (CIP2A) is a human oncoprotein inhibiting PP2A in many human malignancies. However, whether CIP2A can be a new drug target for lung cancer is largely unclear. Methodology/Principal Findings: Normal and malignant lung tissues were derived from 60 lung cancer patients from southern China. RT-PCR, Western blotting and immunohistochemistry were used to evaluate the expression of CIP2A. We found that among the 60 patients, CIP2A was undetectable or very low in paratumor normal tissues, but was dramatically elevated in tumor samples in 38 (63.3%) patients. CIP2A overexpression was associated with cigarette smoking. Silencing CIP2A by siRNA inhibited the proliferation and clonogenic activity of lung cancer cells. Intriguingly, we found a natural compound, rabdocoetsin B which is extracted from a Traditional Chinese Medicinal herb Rabdosia coetsa, could induce down-regulation of CIP2A and inactivation of Akt pathway, and inhibit proliferation and induce apoptosis in a variety of lung cancer cells. Conclusions/Significance: Our findings strongly indicate that CIP2A could be an effective target for lung cancer drug development, and the therapeutic potentials of CIP2A-targeting agents warrant further investigation.	[Ma, Liang; Liu, Zi; Liu, Yong-Qiang; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Mol Carcinogenesis & Targeted Therapy Canc, Beijing, Peoples R China; [Ma, Liang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wen, Zhe-Sheng; Ma, Jun; Chen, Xiao-Qin] Sun Yat Sen Univ, Canc Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Zheng] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Pu, Jian-Xin; Xiao, Wei-Lie; Sun, Han-Dong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Ma, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Mol Carcinogenesis & Targeted Therapy Canc, Beijing, Peoples R China.	hdsun@mail.kib.ac.cn; gbzhou@ioz.ac.cn	Zhou, Guang-Biao/ABG-5795-2021; Zhou, Guangbiao/J-6575-2017	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133	National Key Program for Basic Research (973) [2010CB529201]; Chinese Academy of Sciences [KSCX1-YW-R-26, KSCX2-YW-R-235]; National Natural Science Foundation of China [81071930, 30871110]; National Major Scientific and Technological Program for Drug Discovery [2009ZX09103-101]; Science and Technology Planning Project of Guangzhou [2009Y-C011-2]	National Key Program for Basic Research (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Program for Drug Discovery; Science and Technology Planning Project of Guangzhou	This work was supported in part by the National Key Program for Basic Research (973, 2010CB529201), the Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-26 and KSCX2-YW-R-235), the National Natural Science Foundation of China (81071930, 30871110), the National Major Scientific and Technological Program for Drug Discovery (2009ZX09103-101), and the Science and Technology Planning Project of Guangzhou (2009Y-C011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile JR, 2010, CANCER BIOL THER, V10, P700, DOI 10.4161/cbt.10.7.13151; Brognard J, 2001, CANCER RES, V61, P3986; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; CHEN YP, 2011, ACTA BOT SIN, V32, P292; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; DONG QZ, 2010, ANN SURG ONCOL, P1; FENG T, 2009, CHIN J BIOTECH, V25, P1218; Garcia M, 2007, GLOBAL CANC FACTS FI; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Hu Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006257; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; PENG B, 2010, AACR 101 ANN M; QU W, 2010, MED ONCOL, P1; REMMELE W, 1987, PATHOLOGE, V8, P138; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Zhao DP, 2010, J MED MICROBIOL, V59, P259, DOI 10.1099/jmm.0.014704-0; ZHOU GB, 2010, AACR 101 ANN M 2010, pLB45	29	63	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20159	10.1371/journal.pone.0020159	http://dx.doi.org/10.1371/journal.pone.0020159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655278	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600025
J	Menendez-Castro, C; Fahlbusch, F; Cordasic, N; Amann, K; Munzel, K; Plank, C; Wachtveitl, R; Rascher, W; Hilgers, KF; Hartner, A				Menendez-Castro, Carlos; Fahlbusch, Fabian; Cordasic, Nada; Amann, Kerstin; Muenzel, Kathrin; Plank, Christian; Wachtveitl, Rainer; Rascher, Wolfgang; Hilgers, Karl F.; Hartner, Andrea			Early and Late Postnatal Myocardial and Vascular Changes in a Protein Restriction Rat Model of Intrauterine Growth Restriction	PLOS ONE			English	Article							AORTIC-WALL THICKNESS; OSTEOPONTIN EXPRESSION; ADULT HYPERTENSION; CARDIAC FIBROSIS; CELL-GROWTH; HYPOXIA; HEART; LEADS; CARDIOMYOCYTES; RETARDATION	Intrauterine growth restriction (IUGR) is a risk factor for cardiovascular disease in later life. Early structural and functional changes in the cardiovascular system after IUGR may contribute to its pathogenesis. We tested the hypothesis that IUGR leads to primary myocardial and vascular alterations before the onset of hypertension. A rat IUGR model of maternal protein restriction during gestation was used. Dams were fed low protein (LP; casein 8.4%) or isocaloric normal protein diet (NP; casein 17.2%). The offspring was reduced to six males per litter. Immunohistochemical and real-time PCR analyses were performed in myocardial and vascular tissue of neonates and animals at day 70 of life. In the aortas of newborn IUGR rats expression of connective tissue growth factor (CTGF) was induced 3.2-fold. At day 70 of life, the expression of collagen I was increased 5.6-fold in aortas of IUGR rats. In the hearts of neonate IUGR rats, cell proliferation was more prominent compared to controls. At day 70 the expression of osteopontin was induced 7.2-fold. A 3- to 7-fold increase in the expression of the profibrotic cytokines TGF-beta and CTGF as well as of microfibrillar matrix molecules was observed. The myocardial expression and deposition of collagens was more prominent in IUGR animals compared to controls at day 70. In the low-protein diet model, IUGR leads to changes in the expression patterns of profibrotic genes and discrete structural abnormalities of vessels and hearts in adolescence, but, with the exception of CTGF, not as early as at the time of birth. Invasive and non-invasive blood pressure measurements confirmed that IUGR rats were normotensive at the time point investigated and that the changes observed occurred independently of an increased blood pressure. Hence, altered matrix composition of the vascular wall and the myocardium may predispose IUGR animals to cardiovascular disease later in life.	[Menendez-Castro, Carlos; Fahlbusch, Fabian; Muenzel, Kathrin; Plank, Christian; Wachtveitl, Rainer; Rascher, Wolfgang; Hartner, Andrea] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany; [Cordasic, Nada; Hilgers, Karl F.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Menendez-Castro, C (corresponding author), Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany.	carlos.menendez-castro@uk-erlangen.de		Fahlbusch, Fabian/0000-0001-5480-0204	"Frieda und Johannes Marohn-Stiftung'' of the University of Erlangen-Nurnberg; University of Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB 423, A2, B13, Z2]	"Frieda und Johannes Marohn-Stiftung'' of the University of Erlangen-Nurnberg; University of Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This study was supported by a grant from the "Frieda und Johannes Marohn-Stiftung'' of the University of Erlangen-Nurnberg to A. H. and K. F. H., an ELAN grant from the University of Erlangen-Nurnberg to C. M.-C. and by a grant from the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB 423, Project A2 to A. H., B13 to C. P. and Z2 to K. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Behr TM, 2000, CIRCULATION, V102, P1315, DOI 10.1161/01.CIR.102.11.1315; Bouzeghrane F, 2005, AM J PHYSIOL-HEART C, V289, pH982, DOI 10.1152/ajpheart.00151.2005; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Briscoe TA, 2004, AM J OBSTET GYNECOL, V191, P847, DOI 10.1016/j.ajog.2004.01.050; Brodszki J, 2005, CIRCULATION, V111, P2623, DOI 10.1161/CIRCULATIONAHA.104.490326; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; de las Heras N, 2006, J RENIN-ANGIO-ALDO S, V7, P192, DOI 10.3317/jraas.2006.037; Doherty CB, 2003, PLACENTA, V24, P34, DOI 10.1053/plac.2002.0858; Ergaz Z, 2005, REPROD TOXICOL, V20, P301, DOI 10.1016/j.reprotox.2005.04.007; Fan WH, 2000, EUR J CELL BIOL, V79, P915, DOI 10.1078/0171-9335-00122; FOMOVSKY GM, 2009, J MOL CELL CARDIOL; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Goodfellow J, 1998, CARDIOVASC RES, V40, P600, DOI 10.1016/S0008-6363(98)00197-7; Hartner A, 2001, AM J KIDNEY DIS, V38, P153, DOI 10.1053/ajkd.2001.25209; Hui AY, 2006, LIVER INT, V26, P125, DOI 10.1111/j.1478-3231.2005.01202.x; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Konishi A, 2003, J STEROID BIOCHEM, V85, P439, DOI 10.1016/S0960-0760(03)00198-5; LangleyEvans SC, 1997, CLIN SCI, V93, P423, DOI 10.1042/cs0930423; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; Lim KJ, 2006, PEDIATR RES, V60, P83, DOI 10.1203/01.pdr.0000220361.08181.c3; Lim K, 2010, ANAT REC, V293, P431, DOI 10.1002/ar.21084; Lopes SMCDS, 2004, DEV DYNAM, V231, P542, DOI 10.1002/dvdy.20162; Martyn CN, 1997, LANCET, V350, P953, DOI 10.1016/S0140-6736(96)10508-0; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nuesken KD, 2008, ENDOCRINOLOGY, V149, P1056, DOI 10.1210/en.2007-0891; Oemar BS, 1997, CIRCULATION, V95, P831; Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Satoh M, 2005, EUR J HEART FAIL, V7, P755, DOI 10.1016/j.ejheart.2004.10.019; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Skilton MR, 2006, CLIN SCI, V111, P281, DOI 10.1042/CS20060036; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Swali A, 2010, J PHYSIOL-LONDON, V588, P3809, DOI 10.1113/jphysiol.2010.194928; Tamura A, 2003, CIRC J, V67, P742; TAPANAINEN PJ, 1994, PEDIATR RES, V36, P152, DOI 10.1203/00006450-199408000-00004; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Uno Y, 2000, J VESTIBUL RES-EQUIL, V10, P283; Vehaskari VM, 2005, J AM SOC NEPHROL, V16, P2545, DOI 10.1681/ASN.2005030300; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wang ZH, 2009, AM J PHYSIOL-HEART C, V296, pH1321, DOI 10.1152/ajpheart.00440.2008; WIGGLESWORTH JS, 1964, J PATHOL BACTERIOL, V88, P1, DOI 10.1002/path.1700880102; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; ZEMAN FJ, 1967, J NUTR, V93, P167, DOI 10.1093/jn/93.2.167	59	40	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20369	10.1371/journal.pone.0020369	http://dx.doi.org/10.1371/journal.pone.0020369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655297	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600055
J	Stenkova, AM; Isaeva, MP; Shubin, FN; Rasskazov, VA; Rakin, AV				Stenkova, Anna M.; Isaeva, Marina P.; Shubin, Felix N.; Rasskazov, Valeri A.; Rakin, Alexander V.			Trends of the Major Porin Gene (ompF) Evolution: Insight from the Genus Yersinia	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; POSITIVE SELECTION; NEISSERIA-GONORRHOEAE; FORMING PROTEINS; 16S RDNA; RECOMBINATION; ENTEROCOLITICA; BACTERIA; STRAINS	OmpF is one of the major general porins of Enterobacteriaceae that belongs to the first line of bacterial defense and interactions with the biotic as well as abiotic environments. Porins are surface exposed and their structures strongly reflect the history of multiple interactions with the environmental challenges. Unfortunately, little is known on diversity of porin genes of Enterobacteriaceae and the genus Yersinia especially. We analyzed the sequences of the ompF gene from 73 Yersinia strains covering 14 known species. The phylogenetic analysis placed most of the Yersinia strains in the same line assigned by 16S rDNA-gyrB tree. Very high congruence in the tree topologies was observed for Y. enterocolitica, Y. kristensenii, Y. ruckeri, indicating that intragenic recombination in these species had no effect on the ompF gene. A significant level of intra- and interspecies recombination was found for Y. aleksiciae, Y. intermedia and Y. mollaretii. Our analysis shows that the ompF gene of Yersinia has evolved with nonrandom mutational rate under purifying selection. However, several surface loops in the OmpF porin contain positively selected sites, which very likely reflect adaptive diversification Yersinia to their ecological niches. To our knowledge, this is a first investigation of diversity of the porin gene covering the whole genus of the family Enterobacteriaceae. This study demonstrates that recombination and positive selection both contribute to evolution of ompF, but the relative contribution of these evolutionary forces are different among Yersinia species.	[Stenkova, Anna M.; Isaeva, Marina P.; Rasskazov, Valeri A.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia; [Shubin, Felix N.] Russian Acad Med Sci, Siberian Branch, Sci Res Inst Epidemiol & Microbiol, Vladivostok, Russia; [Rakin, Alexander V.] Univ Munich, Max von Pettenkofer Inst Hyg & Clin Microbiol, Munich, Germany	Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Russian Academy of Medical Sciences; University of Munich	Stenkova, AM (corresponding author), Russian Acad Sci, Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia.	stenkova@gmail.com	Rasskazov, Valery/M-8853-2013; Issaeva, Marina/H-6167-2014; Stenkova, Anna/H-5978-2014	Issaeva, Marina/0000-0002-2395-0485; Stenkova, Anna/0000-0002-4889-9006; Shubin, Felix/0000-0003-2668-2989	Presidium of the Russian Academy of Sciences [05-I-P10-018]	Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This study was partly funded by the following grant: The program of Presidium of the Russian Academy of Sciences "Molecular and cell biology" 05-I-P10-018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-48; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Bodilis J, 2006, ENVIRON MICROBIOL, V8, P1544, DOI 10.1111/j.1462-2920.2006.01045.x; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; BRZOSTEK K, 1989, RES MICROBIOL, V140, P599, DOI 10.1016/0923-2508(89)90192-7; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chevalier S, 2007, ENVIRON MICROBIOL, V9, P824, DOI 10.1111/j.1462-2920.2006.01191.x; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Demarta A, 2004, FEMS MICROBIOL LETT, V238, P423, DOI 10.1016/j.femsle.2004.08.005; Derrick JP, 1999, INFECT IMMUN, V67, P2406, DOI 10.1128/IAI.67.5.2406-2413.1999; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guzev KV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1104, DOI 10.1007/s10541-005-0231-z; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; IBRAHIM A, 1993, FEMS MICROBIOL LETT, V114, P173, DOI 10.1016/0378-1097(93)90515-4; Ibrahim A, 1997, FEMS MICROBIOL LETT, V146, P73, DOI 10.1111/j.1574-6968.1997.tb10173.x; Isabel S, 2008, J BACTERIOL, V190, P7548, DOI 10.1128/JB.01067-08; Issaeva MP, 2003, ADV EXP MED BIOL, V529, P257; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kotetishvili M, 2005, J CLIN MICROBIOL, V43, P2674, DOI 10.1128/JCM.43.6.2674-2684.2005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981; Loftus CG, 2002, DIGEST DIS SCI, V47, P2805, DOI 10.1023/A:1021081911456; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Merhej V, 2008, INT J SYST EVOL MICR, V58, P779, DOI 10.1099/ijs.0.65219-0; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Neubauer H, 2000, INT J MED MICROBIOL, V290, P61; Nielsen R, 1998, GENETICS, V148, P929; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2000, MOL BIOL EVOL, V17, P423, DOI 10.1093/oxfordjournals.molbev.a026322; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SMITH JM, 1992, J MOL EVOL, V34, P126; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Sprague LD, 2005, INT J SYST EVOL MICR, V55, P831, DOI 10.1099/ijs.0.63220-0; Sprague LD, 2008, INT J SYST EVOL MICR, V58, P952, DOI 10.1099/ijs.0.65417-0; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Sulakvelidze A, 2000, MICROBES INFECT, V2, P497, DOI 10.1016/S1286-4579(00)00311-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ursing J, 1995, CONTRIB TO MICROBIOL, V13, P112; Urwin R, 2002, MOL BIOL EVOL, V19, P1686, DOI 10.1093/oxfordjournals.molbev.a003991; van Putten JPM, 1998, J EXP MED, V188, P941, DOI 10.1084/jem.188.5.941; Vostrikova OP, 2006, RUSS J BIOORG CHEM+, V32, P333, DOI 10.1134/S1068162006040030; Vostrikova OP, 2003, ADV EXP MED BIOL, V529, P261; WEISS MS, 1992, J MOL BIOL, V227, P493, DOI 10.1016/0022-2836(92)90903-W; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	61	25	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20546	10.1371/journal.pone.0020546	http://dx.doi.org/10.1371/journal.pone.0020546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655186	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600094
J	Xu, L; Xu, W; Wen, ZK; Xiong, SD				Xu, Lin; Xu, Wei; Wen, Zhenke; Xiong, Sidong			In Situ Prior Proliferation of CD4(+) CCR6(+) Regulatory T Cells Facilitated by TGF-beta Secreting DCs Is Crucial for Their Enrichment and Suppression in Tumor Immunity	PLOS ONE			English	Article							EXPRESSION DEFINES; RECRUITMENT; SUBSETS; NAIVE	Background: CD4(+) CD25(+) regulatory T cells (Tregs), a heterogeneous population, were enrichment in tumor mass and played an important role in modulating anti-tumor immunity. Recently, we reported a Treg subset, CCR6(+) Tregs but not CCR6(-)Tregs, were enriched in tumor mass and closely related to poor prognosis of breast cancer patients. However, the underlying mechanism remains elusive. Here, we carefully evaluate the enrichment of CCR6(+) Tregs in tumor mass during progression of breast cancer and explore its possible mechanism. Methodology/Principal Findings: The frequency of CCR6(+) Tregs in tumor infiltrating lymphocytes (TILs) was analyzed at early stage and at late stage of tumor in a murine breast cancer model by FACS respectively. The expansion of CCR6(+) Tregs and their CCR6(-) counterpart in tumor mass were determined by BrdU incorporation assay. The effect and its possible mechanism of tumor-resident antigen presenting cells (APCs) on the proliferation of CCR6(+) Tregs also were evaluated. The role of local expansion of CCR6(+) Tregs in their enrichment and suppression in vivo also was evaluated in adoptive cell transfer assay. We found that the prior enrichment of CCR6(+) Tregs but not CCR6(-) Tregs in tumor mass during progression of murine breast cancer, which was dependent on the dominant proliferation of CCR6(+) Tregs in situ. Further study demonstrated that tumor-resident DCs triggered the proliferation of CCR6(+) Treg cells in TGF-b dependent manner. Adoptive transfer of CCR6(+) Tregs was found to potently inhibit the function of CD8(+) T cells in vivo, which was dependent on their proliferation and subsequently enrichment in tummor mass. Conclusions/Significance: Our finding suggested that CCR6(+) Tregs, a distinct subset of Tregs, exert its predominant suppressive role in tumor immunity through prior in situ expansion, which might ultimately provide helpful thoughts for the designing of Treg-based immunotherapy for tumor in the future.	[Xu, Lin; Wen, Zhenke; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Lin; Wen, Zhenke; Xiong, Sidong] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China; [Xu, Lin] Zunyi Med Coll, Dept Immunol, Zunyi, Guizhou Prov, Peoples R China	Fudan University; Fudan University; Soochow University - China; Soochow University - China; Zunyi Medical University	Xu, L (corresponding author), Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sdxiong@suda.edu.cn			Major State Basic Research Development Program of China [2007CB512401]; NSFC [81072413]; Jiangsu "Pan-Deng" Project [BK2010004]; Jiangsu High Level "Shuang-Chuang" Project; Program for Shanghai Outstanding Medical Academic Leader [LJ06011]	Major State Basic Research Development Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu "Pan-Deng" Project; Jiangsu High Level "Shuang-Chuang" Project; Program for Shanghai Outstanding Medical Academic Leader	This work was funded by Major State Basic Research Development Program of China (2007CB512401, http://www.973.gov.cn/AreaBook.aspx), China NSFC grant (81072413, http://www.nsfc.gov.cn/Portal0/default124.htm; Grant No. 30901318, http://www.nsfc.gov.cn/Portal0/default124.htm), Jiangsu "Pan-Deng" Project (BK2010004, http://www.jstd.gov.cn/kjgl/gxjs/xgzcgd/20090616/185505964.html), Jiangsu High Level "Shuang-Chuang" Project (http:/www.jstd.gov.cn), and the Program for Shanghai Outstanding Medical Academic Leader (LJ06011, http://www.12333sh.gov.cn/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBARA V, 2006, CANCER RES, V66, P4488; BYRNE JA, 1988, J IMMUNOL, V141, P3249; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CROFT M, 1994, J IMMUNOL, V152, P2675; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Fainaru O, 2010, FASEB J, V24, P1411, DOI 10.1096/fj.09-147025; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Lamprecht B, 2008, BLOOD, V112, P3339, DOI 10.1182/blood-2008-01-134783; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Rivino L, 2010, J EXP MED, V207, P565, DOI 10.1084/jem.20091021; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tosello V, 2008, CLIN IMMUNOL, V126, P291, DOI 10.1016/j.clim.2007.11.008; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; XU L, 2009, CANCER BIOL THER, V4, P293; XU L, 2009, CHIN J CANC BIOTHER, V16, P485; XU L, 2008, ACTA ACAD MED ZUNYI, V31, P116; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; XUN RL, 2007, P NATL ACAD SCI USA, V104, P2821; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang XS, 2010, J LEUKOCYTE BIOL, V88, P393, DOI 10.1189/jlb.0909633; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	32	17	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20282	10.1371/journal.pone.0020282	http://dx.doi.org/10.1371/journal.pone.0020282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655250	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600037
J	Bacchetti, P; Boylan, R; Astemborski, J; Shen, H; Mehta, SH; Thomas, DL; Terrault, NA; Monto, A				Bacchetti, Peter; Boylan, Ross; Astemborski, Jacquie; Shen, Hui; Mehta, Shruti H.; Thomas, David L.; Terrault, Norah A.; Monto, Alexander			Progression of Biopsy-Measured Liver Fibrosis in Untreated Patients with Hepatitis C Infection: Non-Markov Multistate Model Analysis	PLOS ONE			English	Article							INJECTION-DRUG USERS; UNITED-STATES; VIRUS-INFECTION; DISEASE; CLASSIFICATION; IMPUTATION; DIAGNOSIS; SEVERITY; RISKS; AGE	Background: Fibrosis stages from liver biopsies reflect liver damage from hepatitis C infection, but analysis is challenging due to their ordered but non-numeric nature, infrequent measurement, misclassification, and unknown infection times. Methods: We used a non-Markov multistate model, accounting for misclassification, with multiple imputation of unknown infection times, applied to 1062 participants of whom 159 had multiple biopsies. Odds ratios (OR) quantified the estimated effects of covariates on progression risk at any given time. Results: Models estimated that progression risk decreased the more time participants had already spent in the current stage, African American race was protective (OR 0.75, 95% confidence interval 0.60 to 0.95, p = 0.018), and older current age increased risk (OR 1.33 per decade, 95% confidence interval 1.15 to 1.54, p = 0.0002). When controlled for current age, older age at infection did not appear to increase risk (OR 0.92 per decade, 95% confidence interval 0.47 to 1.79, p = 0.80). There was a suggestion that co-infection with human immunodeficiency virus increased risk of progression in the era of highly active antiretroviral treatment beginning in 1996 (OR 2.1, 95% confidence interval 0.97 to 4.4, p = 0.059). Other examined risk factors may influence progression risk, but evidence for or against this was weak due to wide confidence intervals. The main results were essentially unchanged using different assumed misclassification rates or imputation of age of infection. Discussion: The analysis avoided problems inherent in simpler methods, supported the previously suspected protective effect of African American race, and suggested that current age rather than age of infection increases risk. Decreasing risk of progression with longer time already spent in a stage was also previously found for post-transplant progression. This could reflect varying disease activity, with recent progression indicating active disease and high risk, while longer time already spent in a stage indicates quiescent disease and low risk.	[Bacchetti, Peter; Boylan, Ross] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Astemborski, Jacquie; Thomas, David L.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Astemborski, Jacquie; Mehta, Shruti H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shen, Hui; Terrault, Norah A.; Monto, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shen, Hui; Monto, Alexander] San Francisco VA Med Ctr, Div Gastroenterol, San Francisco, CA USA; [Terrault, Norah A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Bacchetti, P (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	peter@biostat.ucsf.edu			United States National Institutes of Health [R01AI069952, R01DA016078, R01DA004334, R01DA012568, R01AA012879, P30DK26743, M01RR00079, U19AI40034]; Veterans Administration [CX000295]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069952, U19AI040034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078, R01DA004334, R01DA012568] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000295] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grant R01AI069952 from the United States National Institutes of Health. The studies providing data were supported by grants R01DA016078, R01DA004334, R01DA012568, R01AA012879, P30DK26743, M01RR00079, and U19AI40034 from the United States NIH and by Veterans Administration Merit grant CX000295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacchetti P, 2003, EMERG INFECT DIS, V9, P1611, DOI 10.3201/eid0912.030361; Bacchetti P, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-145; Bacchetti P, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1213; Bacchetti P, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1139; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Cross T, 2008, HEPATOL RES, V38, P762, DOI 10.1111/j.1872-034X.2008.00364.x; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Deuffic-Burban S, 2002, J VIRAL HEPATITIS, V9, P114, DOI 10.1046/j.1365-2893.2002.00340.x; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ishida JH, 2008, CLIN GASTROENTEROL H, V6, P69, DOI 10.1016/j.cgh.2007.10.021; Jackson CH, 2003, J ROY STAT SOC D-STA, V52, P193, DOI 10.1111/1467-9884.00351; Jackson CH, 2002, STAT MED, V21, P113, DOI 10.1002/sim.886; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Monto A, 2004, HEPATOLOGY, V39, P826, DOI 10.1002/hep.20127; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Okafor O, 2004, REV ESP PATOL, V37, P269; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rai R, 2002, HEPATOLOGY, V35, P1247, DOI 10.1053/jhep.2002.33151; Rid A, 2010, JAMA-J AM MED ASSOC, V304, P1472, DOI 10.1001/jama.2010.1414; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Terrault NA, 2008, CLIN GASTROENTEROL H, V6, P1403, DOI 10.1016/j.cgh.2008.08.006; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20104	10.1371/journal.pone.0020104	http://dx.doi.org/10.1371/journal.pone.0020104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637766	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500029
J	Chapman, TJ; Lambert, K; Topham, DJ				Chapman, Timothy J.; Lambert, Kris; Topham, David J.			Rapid Reactivation of Extralymphoid CD4 T Cells during Secondary Infection	PLOS ONE			English	Article							RESPIRATORY VIRUS-INFECTIONS; NONLYMPHOID TISSUES; INFLUENZA INFECTION; CUTTING EDGE; LUNG AIRWAYS; RESPONSES; IMMUNITY; ANTIGEN; RECRUITMENT; IL-10	After infection, extralymphoid tissues are enriched with effector and memory T cells of a highly activated phenotype. The capacity for rapid effector cytokine response from extralymphoid tissue-memory T cells suggests these cells may perform a 'sentinel' function in the tissue. While it has been demonstrated that extralymphoid CD4+ T cells can directly respond to secondary infection, little is known about how rapidly this response is initiated, and how early activation of T cells in the tissue may affect the innate response to infection. Here we use a mouse model of secondary heterosubtypic influenza infection to show that CD4(+) T cells in the lung airways are reactivated within 24 hours of secondary challenge. Airway CD4(+) T cells initiate an inflammatory cytokine and chemokine program that both alters the composition of the early innate response and contributes to the reduction of viral titers in the lung. These results show that, unlike a primary infection, extralymphoid tissue-memory CD4(+) T cells respond alongside the innate response during secondary infection, thereby shaping the overall immune profile in the airways. These data provide new insights into the role of extralymphoid CD4(+) T cells during secondary immune responses.	[Chapman, Timothy J.; Lambert, Kris; Topham, David J.] Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Rochester, NY 14627 USA	University of Rochester	Chapman, TJ (corresponding author), Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	david_topham@urmc.rochester.edu		Chapman, Timothy/0000-0002-2337-2136	National Institutes of Health [R01-AG021970, N01-AI50020, HHSN266200700008C]; NIH/NRSA [2T32AI007169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants R01-AG021970 and N01-AI50020 and HHSN266200700008C. TJC is supported by NIH/NRSA training grant #2T32AI007169. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cauley LS, 2002, J IMMUNOL, V169, P6655, DOI 10.4049/jimmunol.169.12.6655; Chapman TJ, 2010, J IMMUNOL, V184, P3841, DOI 10.4049/jimmunol.0902281; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Chiu BC, 2007, AM J PATHOL, V171, P829, DOI 10.2353/ajpath.2007.061122; Deepe GS, 2003, J IMMUNOL, V171, P5353, DOI 10.4049/jimmunol.171.10.5353; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kradin RL, 2004, EXP MOL PATHOL, V76, P205, DOI 10.1016/j.yexmp.2003.12.010; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; LIANG SH, 1994, J IMMUNOL, V152, P1653; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Richter M, 2007, J IMMUNOL, V178, P4506, DOI 10.4049/jimmunol.178.7.4506; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Wakim LM, 2008, J IMMUNOL, V181, P5837, DOI 10.4049/jimmunol.181.9.5837; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Welsh RM, 2007, NAT REV MICROBIOL, V5, P555, DOI 10.1038/nrmicro1709; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wissinger EL, 2008, J IMMUNOL, V180, P2957, DOI 10.4049/jimmunol.180.5.2957; Woodland David L, 2005, Proc Am Thorac Soc, V2, P126	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20493	10.1371/journal.pone.0020493	http://dx.doi.org/10.1371/journal.pone.0020493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647373	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500065
J	Lech, M; Rommele, C; Kulkarni, OP; Susanti, HE; Migliorini, A; Garlanda, C; Mantovani, A; Anders, HJ				Lech, Maciej; Roemmele, Christoph; Kulkarni, Onkar P.; Susanti, Heni Eka; Migliorini, Adriana; Garlanda, Cecilia; Mantovani, Alberto; Anders, Hans-Joachim			Lack of the Long Pentraxin PTX3 Promotes Autoimmune Lung Disease but not Glomerulonephritis in Murine Systemic Lupus Erythematosus	PLOS ONE			English	Article							SERUM-AMYLOID-P; C-REACTIVE PROTEIN; APOPTOTIC CELLS; PULMONARY INFLAMMATION; INNATE IMMUNITY; COMPLEMENT ACTIVATION; MRL-(FAS)LPR MICE; DENDRITIC CELLS; PRONE MICE; LPR MICE	The long pentraxin PTX3 has multiple roles in innate immunity. For example, PTX3 regulates C1q binding to pathogens and dead cells and regulates their uptake by phagocytes. It also inhibits P-selectin-mediated recruitment of leukocytes. Both of these mechanisms are known to be involved in autoimmunity and autoimmune tissue injury, e. g. in systemic lupus erythematosus, but a contribution of PTX3 is hypothetical. To evaluate a potential immunoregulatory role of PTX3 in autoimmunity we crossed Ptx3-deficient mice with Fas-deficient (lpr) C57BL/6 (B6) mice with mild lupus-like autoimmunity. PTX3 was found to be increasingly expressed in kidneys and lungs of B6lpr along disease progression. Lack of PTX3 impaired the phagocytic uptake of apoptotic T cells into peritoneal macrophages and selectively expanded CD4/CD8 double negative T cells while other immune cell subsets and lupus autoantibody production remained unaffected. Lack of PTX3 also aggravated autoimmune lung disease, i.e. peribronchial and perivascular CD3+ T cell and macrophage infiltrates of B6lpr mice. In contrast, histomorphological and functional parameters of lupus nephritis remained unaffected by the Ptx3 genotype. Together, PTX3 specifically suppresses autoimmune lung disease that is associated with systemic lupus erythematosus. Vice versa, loss-of-function mutations in the Ptx3 gene might represent a genetic risk factor for pulmonary (but not renal) manifestations of systemic lupus or other autoimmune diseases.	[Lech, Maciej; Roemmele, Christoph; Kulkarni, Onkar P.; Susanti, Heni Eka; Migliorini, Adriana; Anders, Hans-Joachim] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Garlanda, Cecilia; Mantovani, Alberto] IRCCS, Ist Clin Humanitas, Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Rozzano, Italy	University of Munich; IRCCS Humanitas Research Hospital; University of Milan	Lech, M (corresponding author), Univ Munich, Med Poliklin, Pettenkoferstr 8A, D-8000 Munich, Germany.	hjanders@med.uni-muenchen.de	Römmele, Christoph/GLN-4996-2022; Lech, Maciej/AAJ-7899-2021; Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022; Anders, Hans-Joachim/ABD-6247-2021	Römmele, Christoph/0000-0002-8745-8510; Lech, Maciej/0000-0002-4293-2733; Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X; Susanti, Eka/0000-0003-3713-3707; Migliorini, Adriana/0000-0002-1024-6042; Anders, Hans-Joachim/0000-0003-2434-2956	Deutsche Forschungsgemeinschaft [AN372/11-1, GRK 1202]; European Commission	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was supported by a grant from the Deutsche Forschungsgemeinschaft (AN372/11-1 and GRK 1202) to H.J.A. and European Commission (ERC project HIIS to A. Montovani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2008, EUR J IMMUNOL, V38, P3487, DOI 10.1002/eji.200838604; Anders HJ, 2009, TRENDS MOL MED, V15, P553, DOI 10.1016/j.molmed.2009.10.004; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; BECKER GJ, 1980, ANN RHEUM DIS, V39, P50, DOI 10.1136/ard.39.1.50; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; DEGUCHI Y, 1991, CLIN EXP IMMUNOL, V85, P392; Enocsson H, 2009, ARTHRITIS RHEUM, V60, P3755, DOI 10.1002/art.25042; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; GUTIERREZRAMOS JC, 1990, NATURE, V346, P271, DOI 10.1038/346271a0; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harari OA, 2001, RHEUMATOLOGY, V40, P889, DOI 10.1093/rheumatology/40.8.889; Hollan I, 2010, ARTHRIT CARE RES, V62, P378, DOI 10.1002/acr.20094; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jaillon S, 2009, CELL DEATH DIFFER, V16, P465, DOI 10.1038/cdd.2008.173; KAKKANAIAH VN, 1990, J AUTOIMMUN, V3, P271, DOI 10.1016/0896-8411(90)90146-J; Kanta H, 2009, GENES IMMUN, V10, P390, DOI 10.1038/gene.2009.6; Kim N, 2002, J AUTOIMMUN, V19, P215, DOI 10.1006/jaut.2002.0617; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Kulkarni O, 2008, FRONT BIOSCI-LANDMRK, V13, P3312; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Kulkarni OP, 2010, AM J PATHOL, V176, P2840, DOI 10.2353/ajpath.2010.091227; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lech M, 2010, J PATHOL, V220, P596, DOI 10.1002/path.2678; Lloyd CM, 1997, J CLIN INVEST, V100, P963, DOI 10.1172/JCI119647; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Patole PS, 2007, J AUTOIMMUN, V29, P52, DOI 10.1016/j.jaut.2007.04.004; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rovere P, 2000, BLOOD, V96, P4300; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Shiozawa F, 2004, ARTHRITIS RES THER, V6, pR78, DOI 10.1186/ar1029; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; SINGER PA, 1990, J AUTOIMMUN, V3, P123, DOI 10.1016/0896-8411(90)90136-G; SUNDERRAJAN EV, 1986, AM J PATHOL, V124, P353; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; Voss A, 2008, J RHEUMATOL, V35, P625	53	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20118	10.1371/journal.pone.0020118	http://dx.doi.org/10.1371/journal.pone.0020118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637713	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500033
J	Mongin, E; Auer, TO; Bourrat, F; Gruhl, F; Dewar, K; Blanchette, M; Wittbrodt, J; Ettwiller, L				Mongin, Emmanuel; Auer, Thomas O.; Bourrat, Franck; Gruhl, Franziska; Dewar, Ken; Blanchette, Mathieu; Wittbrodt, Joachim; Ettwiller, Laurence			Combining Computational Prediction of Cis-Regulatory Elements with a New Enhancer Assay to Efficiently Label Neuronal Structures in the Medaka Fish	PLOS ONE			English	Article							GENOME; GENE; IDENTIFICATION; TRANSGENESIS; DOWNSTREAM; SEQUENCES; ALIGNMENT; CIRCUITS; INSIGHTS; REVEALS	The developing vertebrate nervous system contains a remarkable array of neural cells organized into complex, evolutionarily conserved structures. The labeling of living cells in these structures is key for the understanding of brain development and function, yet the generation of stable lines expressing reporter genes in specific spatio-temporal patterns remains a limiting step. In this study we present a fast and reliable pipeline to efficiently generate a set of stable lines expressing a reporter gene in multiple neuronal structures in the developing nervous system in medaka. The pipeline combines both the accurate computational genome-wide prediction of neuronal specific cis-regulatory modules (CRMs) and a newly developed experimental setup to rapidly obtain transgenic lines in a cost-effective and highly reproducible manner. 95% of the CRMs tested in our experimental setup show enhancer activity in various and numerous neuronal structures belonging to all major brain subdivisions. This pipeline represents a significant step towards the dissection of embryonic neuronal development in vertebrates.	[Mongin, Emmanuel; Blanchette, Mathieu] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Auer, Thomas O.; Gruhl, Franziska; Wittbrodt, Joachim; Ettwiller, Laurence] Heidelberg Univ, Ctr Organismal Studies COS, Heidelberg, Germany; [Bourrat, Franck] CNRS, DEPSN Inst Fessard, MSNC INRA Grp, UPR2197, Gif Sur Yvette, France; [Dewar, Ken] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Wittbrodt, Joachim] Inst Toxicol & Genet, KIT, Eggenstein Leopoldshafen, Germany	McGill University; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Karlsruhe Institute of Technology	Mongin, E (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.	blanchem@mcb.mcgill.ca; Jochen.Wittbrodt@COS.uni-Heidelberg.de; Laurence.Ettwiller@cos.uni-heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377; Auer, Thomas Oliver/0000-0003-3442-0567; Ettwiller, Laurence/0000-0002-3957-6539; Gruhl, Franziska/0000-0002-2613-7211	genome Quebec/Canada; European Community [FP7/2007-2013]; EMBO;  [DFG-SFB488 TP17-TP8]	genome Quebec/Canada; European Community(European Commission); EMBO(European Molecular Biology Organization (EMBO)); 	EM is supported by funding from genome Quebec/Canada. LE and JW are supported by the European Community's Seventh Framework Programme (FP7/2007-2013) CISSTEM and DFG-SFB488 TP17-TP8. This work was also supported in part by the EMBO Short-term Fellowships program (EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cooke JE, 2001, DEVELOPMENT, V128, P571; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Haudry Y, 2008, NUCLEIC ACIDS RES, V36, pD847, DOI 10.1093/nar/gkm797; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez RE, 2004, DEVELOPMENT, V131, P4511, DOI 10.1242/dev.01297; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loosli F, 2001, DEVELOPMENT, V128, P4035; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moens CB, 1996, DEVELOPMENT, V122, P3981; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Paten B, 2009, BIOINFORMATICS, V25, P295, DOI 10.1093/bioinformatics/btn630; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Philippakis AA, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P519; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19747	10.1371/journal.pone.0019747	http://dx.doi.org/10.1371/journal.pone.0019747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637758	Green Published, gold			2022-12-27	WOS:000291052500011
J	Venn, A; Tambutte, E; Holcomb, M; Allemand, D; Tambutte, S				Venn, Alexander; Tambutte, Eric; Holcomb, Michael; Allemand, Denis; Tambutte, Sylvie			Live Tissue Imaging Shows Reef Corals Elevate pH under Their Calcifying Tissue Relative to Seawater	PLOS ONE			English	Article							SCLERACTINIAN CORALS; CARBONIC-ACID; CALCIFICATION; PHOTOSYNTHESIS; SKELETON; DISSOCIATION; MECHANISMS; BIOMINERALIZATION; ULTRASTRUCTURE; LOCALIZATION	The threat posed to coral reefs by changes in seawater pH and carbonate chemistry (ocean acidification) raises the need for a better mechanistic understanding of physiological processes linked to coral calcification. Current models of coral calcification argue that corals elevate extracellular pH under their calcifying tissue relative to seawater to promote skeleton formation, but pH measurements taken from the calcifying tissue of living, intact corals have not been achieved to date. We performed live tissue imaging of the reef coral Stylophora pistillata to determine extracellular pH under the calcifying tissue and intracellular pH in calicoblastic cells. We worked with actively calcifying corals under flowing seawater and show that extracellular pH (pHe) under the calicoblastic epithelium is elevated by similar to 0.5 and similar to 0.2 pH units relative to the surrounding seawater in light and dark conditions respectively. By contrast, the intracellular pH (pHi) of the calicoblastic epithelium remains stable in the light and dark. Estimates of aragonite saturation states derived from our data indicate the elevation in subcalicoblastic pHe favour calcification and may thus be a critical step in the calcification process. However, the observed close association of the calicoblastic epithelium with the underlying crystals suggests that the calicoblastic cells influence the growth of the coral skeleton by other processes in addition to pHe modification. The procedure used in the current study provides a novel, tangible approach for future investigations into these processes and the impact of environmental change on the cellular mechanisms underpinning coral calcification.	[Venn, Alexander; Tambutte, Eric; Holcomb, Michael; Allemand, Denis; Tambutte, Sylvie] CSM, Monaco, Monaco; [Venn, Alexander; Tambutte, Eric; Allemand, Denis; Tambutte, Sylvie] LEA CSM CNRS BIOSENSIB, Monaco, Monaco		Venn, A (corresponding author), CSM, Monaco, Monaco.	alex@centrescientifique.mc			government of the Principality of Monaco; NSF	government of the Principality of Monaco; NSF(National Science Foundation (NSF))	Research was funded by the government of the Principality of Monaco. Michael Holcomb received support from an NSF international research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 1998, CAN J BOT, V76, P925, DOI 10.1139/b98-086; Allison N, 2010, GEOCHIM COSMOCHIM AC, V74, P1790, DOI 10.1016/j.gca.2009.12.030; [Anonymous], 2007, CO2SYS XLS CALCULATO; BARNES DJ, 1970, SCIENCE, V170, P1305, DOI 10.1126/science.170.3964.1305; BARNES DJ, 1972, PROC R SOC SER B-BIO, V182, P331, DOI 10.1098/rspb.1972.0083; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; Clode PL, 2002, TISSUE CELL, V34, P187, DOI 10.1016/S0040-8166(02)00031-9; COHEN A, 2009, OCEANOGRAPHY, V0022; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; CONSTANTZ B R, 1986, Palaios, V1, P152, DOI 10.2307/3514508; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Dewitt S, 2011, J MICROSC-OXFORD, V241, P221, DOI 10.1111/j.1365-2818.2010.03451.x; DICKSON AG, 1990, J PHYS CHEM-US, V94, P7978, DOI 10.1021/j100383a042; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Furla P, 2000, J EXP BIOL, V203, P3445; Gaillardet J, 1995, EARTH PLANET SC LETT, V136, P665, DOI 10.1016/0012-821X(95)00180-K; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holcomb M, 2009, GEOCHIM COSMOCHIM AC, V73, P4166, DOI 10.1016/j.gca.2009.04.015; Honisch B, 2004, GEOCHIM COSMOCHIM AC, V68, P3675, DOI 10.1016/j.gca.2004.03.002; IP YK, 1991, MAR BIOL, V111, P191, DOI 10.1007/BF01319700; ISA Y, 1986, MAR BIOL, V93, P91, DOI 10.1007/BF00428658; Johnston I.S., 1980, International Review of Cytology, V67, P171; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; LETISSIER MDA, 1988, MAR BIOL, V98, P493, DOI 10.1007/BF00391540; Marshall AT, 2007, J EXP BIOL, V210, P2453, DOI 10.1242/jeb.003343; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Raz-Bahat M, 2006, CELL TISSUE RES, V325, P361, DOI 10.1007/s00441-006-0182-8; Reynaud S, 2004, CORAL REEFS, V23, P539, DOI 10.1007/s00338-004-0399-5; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Sinclair DJ, 2006, GEOCHIM COSMOCHIM AC, V70, P3855, DOI 10.1016/j.gca.2006.05.019; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; Venn AA, 2009, P NATL ACAD SCI USA, V106, P16574, DOI 10.1073/pnas.0902894106; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; WHITAKER JE, 1991, ANAL BIOCHEM, V194, P330, DOI 10.1016/0003-2697(91)90237-N; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010; [No title captured]	50	183	186	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20013	10.1371/journal.pone.0020013	http://dx.doi.org/10.1371/journal.pone.0020013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637757	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500024
J	Crabtree-Ramirez, B; Caro-Vega, Y; Shepherd, BE; Wehbe, F; Cesar, C; Cortes, C; Padgett, D; Koenig, S; Gotuzzo, E; Cahn, P; McGowan, C; Masys, D; Sierra-Madero, J				Crabtree-Ramirez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Wehbe, Firas; Cesar, Carina; Cortes, Claudia; Padgett, Denis; Koenig, Serena; Gotuzzo, Eduardo; Cahn, Pedro; McGowan, Catherine; Masys, Daniel; Sierra-Madero, Juan		CCASAnet Team	Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LATE DIAGNOSIS; HIV-INFECTION; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; AIDS; CONSEQUENCES; MORTALITY; ENGLAND; ACCESS	Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initiation in HIV-infected subjects in developing countries. Data from Latin America and the Caribbean is still lacking. Our main objective was to determine the frequency, risk factors and trends in time for being late HAART initiator (LHI) in this region. Methodology: Cross-sectional analysis from 9817 HIV-infected treatment-naive patients initiating HAART at 6 sites (Argentina, Chile, Haiti, Honduras, Peru and Mexico) from October 1999 to July 2010. LHI had CD4(+) count <= 200cells/mm(3) prior to HAART. Late testers (LT) were those LHI who initiated HAART within 6 months of HIV diagnosis. Late presenters (LP) initiated after 6 months of diagnosis. Prevalence, risk factors and trends over time were analyzed. Principal Findings: Among subjects starting HAART (n = 9817) who had baseline CD4+ available (n = 8515), 76% were LHI: Argentina (56%[95% CI: 52-59]), Chile (80%[95% CI: 77-82]), Haiti (76%[95% CI: 74-77]), Honduras (91%[95% CI: 87-94]), Mexico (79%[95% CI: 75-83]), Peru (86%[95% CI: 84-88]). The proportion of LHI statistically changed over time (except in Honduras) (p <= 0.02; Honduras p=0.7), with a tendency towards lower rates in recent years. Males had increased risk of LHI in Chile, Haiti, Peru, and in the combined site analyses (CSA). Older patients were more likely LHI in Argentina and Peru (OR 1.21 per +10-year of age, 95% CI: 1.02-1.45; OR 1.20, 95% CI: 1.02-1.43; respectively), but not in CSA (OR 1.07, 95% CI: 0.94-1.21). Higher education was associated with decreased risk for LHI in Chile (OR 0.92 per +1-year of education, 95% CI: 0.87-0.98) (similar trends in Mexico, Peru, and CSA). LHI with date of HIV-diagnosis available, 55% were LT and 45% LP. Conclusion: LHI was highly prevalent in CCASAnet sites, mostly due to LT; the main risk factors associated were being male and older age. Earlier HIV-diagnosis and earlier treatment initiation are needed to maximize benefits from HAART in the region.	[Crabtree-Ramirez, Brenda; Caro-Vega, Yanink; Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Shepherd, Bryan E.; Wehbe, Firas; McGowan, Catherine; Masys, Daniel] Vanderbilt Univ, Nashville, TN USA; [Cortes, Claudia] Univ Chile, Fdn Arriaran, Santiago, Chile; [Padgett, Denis] Inst Honduren Seguro Social & Hosp Escuela, Tegucigalpa, Honduras; [Koenig, Serena] Cornell Univ, GHESKIO Weill Med Coll, Port Au Prince, Haiti; [Koenig, Serena] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Gotuzzo, Eduardo] Inst Med Trop Alexander von Humboldt, Lima, Peru	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Vanderbilt University; Universidad de Chile; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidad Peruana Cayetano Heredia	Crabtree-Ramirez, B (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico.	jsmadero@yahoo.com	Wehbe, Firas/Q-6176-2019; Cesar, Carina/H-2831-2019; Cortes, Claudia P/AAF-7326-2020; Sierra Madero, Juan/AAW-8825-2021	Wehbe, Firas/0000-0002-3984-9584; Cortes, Claudia P/0000-0001-9101-9783; Caro-Vega, Yanink/0000-0003-3806-5806; Crabtree-Ramirez, Brenda/0000-0002-2587-1123	National Institutes of Health [1-U01-AI069923]; Pfizer; MSD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); MSD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Cooperative Agreement (1-U01-AI069923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BCR: speaker for BMS and MSD and grant for clinical trial of MSD; C. Cortes: speaker for MSD and GSK; EG: received grants from Pfizer and MSD; PC: board membership of MSD, GSK, Pfizer, Tibotec, Shering Plough, and speaker for Abbot, Tibotec, BMS, GSK, MSD, Pfizer and Boeringer Ingelheim; JSM: speaker for ViiV and Stendahl and has received grant for research from Pfizer. Authors YCV, BES, FW, C. Cesar, DP, SK, CM, and DM have no conflict of interest.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Bonjour Maeva A, 2008, AIDS Res Ther, V5, P6, DOI 10.1186/1742-6405-5-6; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; *CENSIDA, 2008, GUIA MAN ANT PERS CO; Cesar C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010490; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; *EACS, 2009, CLIN MAN TREATM HIV; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Friedman J H, 1984, 1 STANF U LAB COMP S; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Harrell FE, 2001, REGRESSION MODELING; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Mills EJ, 2011, AIDS, V25, P851, DOI 10.1097/QAD.0b013e32834564e9; *MIN SAL, 2005, GUI CLIN SINDR INM A; *MIN SAL, 2007, REC TRAT ANT 2007; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; *OARAC, 2009, GUID US ANT AG HIV 1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Sabin CA, 2010, AIDS, V24, P723, DOI 10.1097/QAD.0b013e328333fa0f; *SADI, 2007, REC SEG TRAT INF HIV; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2010, ANT THER HIV INF AD; WHO, 2004, SCAL ANT THER RES LI; World Health Organization, 2006, ANT THER HIV INF AD; Zala Carlos, 2008, Medscape J Med, V10, P78, DOI 10.1186/1758-2652-10-4-78	45	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20272	10.1371/journal.pone.0020272	http://dx.doi.org/10.1371/journal.pone.0020272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637802	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200046
J	Flamant, C; Branger, B; Sylvie, NTT; de La Rochebrochard, E; Savagner, C; Berlie, I; Roze, JC				Flamant, Cyril; Branger, Bernard; Sylvie Nguyen The Tich; de La Rochebrochard, Elise; Savagner, Christophe; Berlie, Isabelle; Roze, Jean-Christophe			Parent-Completed Developmental Screening in Premature Children: A Valid Tool for Follow-Up Programs	PLOS ONE			English	Article							INFANT DEVELOPMENT-II; PRETERM INFANTS; DEVELOPMENT INVENTORY; BAYLEY SCALES; QUESTIONNAIRE; BIRTH; AGES; EPIPAGE; RISK	Our goals were to (1) validate the parental Ages and Stages Questionnaires (ASQ) as a screening tool for psychomotor development among a cohort of ex-premature infants reaching 2 years, and (2) analyse the influence of parental socioeconomic status and maternal education on the efficacy of the questionnaire. A regional population of 703 very preterm infants (<35 weeks gestational age) born between 2003 and 2006 were evaluated at 2 years by their parents who completed the ASQ, by a pediatric clinical examination, and by the revised Brunet Lezine psychometric test with establishment of a DQ score. Detailed information regarding parental socio-economic status was available for 419 infants. At 2 years corrected age, 630 infants (89.6%) had an optimal neuromotor examination. Overall ASQ scores for predicting a DQ score <= 85 produced an area under the receiver operator curve value of 0.85 (95% Confidence Interval: 0.82-0.87). An ASQ cut-off score of <= 220 had optimal discriminatory power for identifying a DQ score <= 85 with a sensitivity of 0.85 (95% Cl: 0.75-0.91), a specificity of 0.72 (95% Cl: 0.69-0.75), a positive likelihood ratio of 3, and a negative likelihood ratio of 0.21. The median value for ASQ was not significantly associated with socio-economic level or maternal education. ASQ is an easy and reliable tool regardless of the socio-economic status of the family to predict normal neurologic outcome in ex-premature infants at 2 years of age. ASQ may be beneficial with a low-cost impact to some follow-up programs, and helps to establish a genuine sense of parental involvement.	[Flamant, Cyril; Roze, Jean-Christophe] Univ Hosp, Dept Neonatal Med, Nantes, France; [Flamant, Cyril; Roze, Jean-Christophe] Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC004, Nantes, France; [Flamant, Cyril; Branger, Bernard; Sylvie Nguyen The Tich; Savagner, Christophe; Berlie, Isabelle; Roze, Jean-Christophe] Loire Infant Follow Up Team LIFT Network, Pays De Loire, France; [Sylvie Nguyen The Tich; Savagner, Christophe; Berlie, Isabelle] Univ Hosp, Dept Neonatal Med, Angers, France; [de La Rochebrochard, Elise] CESP, Natl Inst Hlth & Med Res, U1018, Le Kremlin Bicetre, France; [de La Rochebrochard, Elise] Univ Paris Sud, UMRS 1018, F-94275 Le Kremlin Bicetre, France; [de La Rochebrochard, Elise] Ined, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Flamant, C (corresponding author), Univ Hosp, Dept Neonatal Med, Nantes, France.	cyril.flamant@chu-nantes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021; de La Rochebrochard, Elise/O-5802-2015	de La Rochebrochard, Elise/0000-0002-1639-7335; Roze, Jean-Christophe/0000-0003-3367-512X	Assurance Maladie	Assurance Maladie	The only funding for this study was received by "Pays de Loire network of care" from Assurance Maladie. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolus R, 2002, ACTA PAEDIATR, V91, P1101, DOI 10.1080/080352502760311610; Council on ChildrenWith Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for ChildrenWith Special Needs Project Advisory Committee, 2006, PEDIATRICS, V118, P405; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; Doig KB, 1999, J PEDIATR-US, V135, P358, DOI 10.1016/S0022-3476(99)70134-4; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Fouron JC, 2001, AM J OBSTET GYNECOL, V184, P630, DOI 10.1067/mob.2001.110696; GLASCOE FP, 1995, PEDIATRICS, V95, P829; GOTTFRIED AW, 1984, J PEDIATR PSYCHOL, V9, P219, DOI 10.1093/jpepsy/9.2.219; Heiser A, 2000, DEV MED CHILD NEUROL, V42, P21, DOI 10.1017/S0012162200000050; Janson H, 2004, ACTA PAEDIATR, V93, P1525, DOI 10.1080/08035250410033051; Johnson S, 2004, DEV MED CHILD NEUROL, V46, P389, DOI 10.1017/S0012162204000635; Johnson S, 2008, DEV MED CHILD NEUROL, V50, P58, DOI 10.1111/j.1469-8749.2007.02010.x; JOSSE AR, MED SCI SPORTS EXERC, V42, P1122; Kerstjens JM, 2009, EARLY HUM DEV, V85, P443, DOI 10.1016/j.earlhumdev.2009.03.001; Klamer A, 2005, ACTA PAEDIATR, V94, P1327, DOI 10.1080/08035250510042825; Liao HF, 2005, J FORMOS MED ASSOC, V104, P731; Marks K, 2009, PEDIATRICS, V123, P1516, DOI 10.1542/peds.2008-2051; Roze JC, 2007, ARCH PEDIATRIE, V14, pS65, DOI 10.1016/S0929-693X(07)80014-5; Sices L, 2009, PEDIATRICS, V124, pE640, DOI 10.1542/peds.2008-2628; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Squires JK, 1998, EARLY CHILD RES Q, V13, P345, DOI 10.1016/S0885-2006(99)80043-X; Vincer MJ, 2005, PEDIATRICS, V116, pE864, DOI 10.1542/peds.2005-0447; Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407	24	89	90	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20004	10.1371/journal.pone.0020004	http://dx.doi.org/10.1371/journal.pone.0020004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XS	21637833	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200025
J	Hamidi, H; Gustafason, D; Pellegrini, M; Gasson, J				Hamidi, Habib; Gustafason, Derek; Pellegrini, Matteo; Gasson, Judith			Identification of Novel Targets of CSL-Dependent Notch Signaling in Hematopoiesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VITRO DIFFERENTIATION; FACTOR-BINDING SITES; MODEL-BASED ANALYSIS; ZONE B-CELLS; RBP-J-KAPPA; T-CELLS; TRANSCRIPTION FACTORS; GENE-EXPRESSION	Somatic activating mutations in the Notch1 receptor result in the overexpression of activated Notch1, which can be tumorigenic. The goal of this study is to understand the molecular mechanisms underlying the phenotypic changes caused by the overexpression of ligand independent Notch 1 by using a tetracycline inducible promoter in an in vitro embryonic stem (ES) cells/OP9 stromal cells coculture system, recapitulating normal hematopoiesis. First, an in silico analysis of the promoters of Notch regulated genes (previously determined by microarray analysis) revealed that the motifs recognized by regulatory proteins known to mediate hematopoiesis were overrepresented. Notch 1 does not bind DNA but instead binds the CSL transcription factor to regulate gene expression. The in silico analysis also showed that there were putative CSL binding sites observed in the promoters of 28 out of 148 genes. A custom ChIP-chip array was used to assess the occupancy of CSL in the promoter regions of the Notch1 regulated genes in vivo and showed that 61 genes were bound by activated Notch responsive CSL. Then, comprehensive mapping of the CSL binding sites genome-wide using ChIP-seq analysis revealed that over 10,000 genes were bound within 10 kb of the TSS (transcription start site). The majority of the targets discovered by ChIP-seq belong to pathways that have been shown by others to crosstalk with Notch signaling. Finally, 83 miRNAs were significantly differentially expressed by greater than 1.5-fold during the course of in vitro hematopoiesis. Thirty one miRNA were up-regulated and fifty two were down-regulated. Overexpression of Notch1 altered this pattern of expression of microRNA: six miRNAs were up-regulated and four were down regulated as a result of activated Notch1 overexpression during the course of hematopoiesis. Time course analysis of hematopoietic development revealed that cells with Notch 1 overexpression mimic miRNA expression of cells in a less mature stage, which is consistent with our previous biological characterization.	[Hamidi, Habib; Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gustafason, Derek; Pellegrini, Matteo] Univ Calif Los Angeles, DOE Inst Genom & Prote, Los Angeles, CA USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hamidi, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jgasson@mednet.ucla.edu	Hamidi, Habib/H-8030-2016	Hamidi, Habib/0000-0003-0196-9852; Pellegrini, Matteo/0000-0001-9355-9564				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Binor E, 2005, DEV NEUROSCI-BASEL, V27, P306, DOI 10.1159/000086710; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boggs K, 2009, CELL BIOL INT, V33, P318, DOI 10.1016/j.cellbi.2008.12.005; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Di Marcotullio L, 2006, MOL NEUROBIOL, V34, P193, DOI 10.1385/MN:34:3:193; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Era T, 2000, BLOOD, V95, P870, DOI 10.1182/blood.V95.3.870.003k44_870_878; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Ganapati U, 2007, STEM CELLS, V25, P1872, DOI 10.1634/stemcells.2006-0547; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hertzog P, 2008, IMMUNITY, V29, P663, DOI 10.1016/j.immuni.2008.10.006; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; HROMAS R, 1995, CANCER RES, V55, P3610; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Iida S, 2008, GENES CELLS, V13, P313, DOI 10.1111/j.1365-2443.2008.01173.x; ISHIGAKI T, 2009, ADV HEMATOL; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitajima K, 2003, METHOD ENZYMOL, V365, P72; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; MEIERSTIEGEN F, PLOS ONE, V5; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Olsen AL, 2006, BLOOD, V107, P1265, DOI 10.1182/blood-2005-09-3621; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rasmussen KJ, 2008, AM J MED GENET A, V146A, P261, DOI 10.1002/ajmg.a.32110; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; Small D, 2003, J BIOL CHEM, V278, P16405, DOI 10.1074/jbc.M300464200; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Vincentz JW, 2008, DEV DYNAM, V237, P3809, DOI 10.1002/dvdy.21803; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang JF, 2004, DEV BIOL, V266, P178, DOI 10.1016/j.ydbio.2003.10.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	118	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20022	10.1371/journal.pone.0020022	http://dx.doi.org/10.1371/journal.pone.0020022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637838	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200027
J	Heymans, JJ; Mackinson, S; Sumaila, UR; Dyck, A; Little, A				Heymans, Johanna Jacomina; Mackinson, Steven; Sumaila, Ussif Rashid; Dyck, Andrew; Little, Alyson			The Impact of Subsidies on the Ecological Sustainability and Future Profits from North Sea Fisheries	PLOS ONE			English	Article							ECOSYSTEM; MANAGEMENT; ECOSIM; ECOPATH; MODELS; GULF	Background: This study examines the impact of subsidies on the profitability and ecological stability of the North Sea fisheries over the past 20 years. It shows the negative impact that subsidies can have on both the biomass of important fish species and the possible profit from fisheries. The study includes subsidies in an ecosystem model of the North Sea and examines the possible effects of eliminating fishery subsidies. Methodology/Principal Findings: Hindcast analysis between 1991 and 2003 indicates that subsidies reduced the profitability of the fishery even though gross revenue might have been high for specific fisheries sectors. Simulations seeking to maximise the total revenue between 2004 and 2010 suggest that this can be achieved by increasing the effort of Nephrops trawlers, beam trawlers, and the pelagic trawl-and-seine fleet, while reducing the effort of demersal trawlers. Simulations show that ecological stability can be realised by reducing the effort of the beam trawlers, Nephrops trawlers, pelagic- and demersal trawl-and-seine fleets. This analysis also shows that when subsidies are included, effort will always be higher for all fleets, because it effectively reduces the cost of fishing. Conclusions/Significance: The study found that while removing subsidies might reduce the total catch and revenue, it increases the overall profitability of the fishery and the total biomass of commercially important species. For example, cod, haddock, herring and plaice biomass increased over the simulation when optimising for profit, and when optimising for ecological stability, the biomass for cod, plaice and sole also increased. When subsidies are eliminated, the study shows that rather than forcing those involved in the fishery into the red, fisheries become more profitable, despite a decrease in total revenue due to a loss of subsidies from the government.	[Heymans, Johanna Jacomina] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Mackinson, Steven; Little, Alyson] Cefas, Lowestoft, Suffolk, England; [Sumaila, Ussif Rashid; Dyck, Andrew] UBC Fisheries Ctr, Vancouver, BC, Canada; [Little, Alyson] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	UHI Millennium Institute; Centre for Environment Fisheries & Aquaculture Science; University of British Columbia; University of Aberdeen	Heymans, JJ (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	sheilaheymans@yahoo.com	Sumaila, U. Rashid/ABE-6475-2020; Heymans, Johanna J/H-4848-2012	Heymans, Johanna J/0000-0002-7290-8988; Mackinson, Steven/0000-0002-0262-1180; Barratt, Alyson/0000-0002-7663-7070	Oak Foundation; European Research Development Fund; Scottish Association for Marine Science; European Union [226675]; Pew Charitable Trusts, Philadelphia; United Kingdom Department for Environment Food and Rural Affairs [M1202]; NERC [dml010007] Funding Source: UKRI; Natural Environment Research Council [dml010007] Funding Source: researchfish	Oak Foundation; European Research Development Fund; Scottish Association for Marine Science; European Union(European Commission); Pew Charitable Trusts, Philadelphia; United Kingdom Department for Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was fifty percent funded by the Oak Foundation. Match funding for J.J. Heymans was obtained from the European Research Development Fund, the Scottish Association for Marine Science, and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP> 226675. U.R. Sumaila and A. Dyck were match funded by the Global Ocean Economics Project funded by the Pew Charitable Trusts, Philadelphia. S. Mackinson was match funded from the United Kingdom Department for Environment Food and Rural Affairs project M1202. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christensen V, 2004, B MAR SCI, V74, P549; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V., 2005, ECOPATH ECOSIM USERS; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Cotter J, 2010, FISH FISH, V11, P210, DOI 10.1111/j.1467-2979.2009.00351.x; ENGELHARD CH, 2011, ICES J MARI IN PRESS, DOI DOI 10.1093/ICESJMS/FSR1031; *EU, 2008, 0802 SGECA EU; Heymans JJ, 2007, ECOSYSTEMS, V10, P488, DOI 10.1007/s10021-007-9034-y; Heymans JJ, 2009, PROG OCEANOGR, V83, P417, DOI 10.1016/j.pocean.2009.07.013; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Knudsen S, 2010, OCEAN COAST MANAGE, V53, P252, DOI 10.1016/j.ocecoaman.2010.04.008; MACKINSON S, 2007, CEFAS SCI SERIES TEC, V142; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; Milazzo M, 1998, WTP406; Moxnes E, 2000, SYST DYNAM REV, V16, P325, DOI 10.1002/sdr.201; NICOLSON JR, 1999, SHETLAND FISHERMEN C; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; *OECD, 2006, REV FISH OECD COUNTR; *OECD, 2003, LIBERALISING FISHERI; Pascoe S, 2008, AQUAT LIVING RESOUR, V21, P223, DOI 10.1051/alr:2008041; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Stouten H, 2008, AQUAT LIVING RESOUR, V21, P247, DOI 10.1051/alr:2008037; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Sumaila UR, 2007, FISH RES, V88, P1, DOI 10.1016/j.fishres.2007.08.017; Tinch R., 2009, SINK SWIM EC WHALING; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Walters C, 2008, B MAR SCI, V83, P251; WALTERS CJ, 2002, USE ECOSYSTEM MODELS, V10, P11	33	21	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20239	10.1371/journal.pone.0020239	http://dx.doi.org/10.1371/journal.pone.0020239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637848	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200041
J	Mirzasoleiman, B; Jalili, M				Mirzasoleiman, Baharan; Jalili, Mahdi			Failure Tolerance of Motif Structure in Biological Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; ORGANIZATION; ROBUSTNESS; ERROR; TOOL	Complex networks serve as generic models for many biological systems that have been shown to share a number of common structural properties such as power-law degree distribution and small-worldness. Real-world networks are composed of building blocks called motifs that are indeed specific subgraphs of (usually) small number of nodes. Network motifs are important in the functionality of complex networks, and the role of some motifs such as feed-forward loop in many biological networks has been heavily studied. On the other hand, many biological networks have shown some degrees of robustness in terms of their efficiency and connectedness against failures in their components. In this paper we investigated how random and systematic failures in the edges of biological networks influenced their motif structure. We considered two biological networks, namely, protein structure network and human brain functional network. Furthermore, we considered random failures as well as systematic failures based on different strategies for choosing candidate edges for removal. Failure in the edges tipping to high degree nodes had the most destructive role in the motif structure of the networks by decreasing their significance level, while removing edges that were connected to nodes with high values of betweenness centrality had the least effect on the significance profiles. In some cases, the latter caused increase in the significance levels of the motifs.	[Mirzasoleiman, Baharan; Jalili, Mahdi] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology	Mirzasoleiman, B (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.	mjalili@sharif.edu		Jalili, Mahdi/0000-0002-0517-9420	Sharif University of Technology	Sharif University of Technology	This work was funded by Sharif University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G., 2006, RHYTHMS BRAIN; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; ERDOS P, 1960, B INT STATIST INST, V38, P343; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jalili M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001059; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; KNYAZEVA MG, 2008, NEUROBIOLOGY AGING; Lodato I, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/28001; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salehi M, 2010, PHYSICA A, V389, P5521, DOI 10.1016/j.physa.2010.08.001; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang Lan V, 2005, J Biol, V4, P6, DOI 10.1186/jbiol23	54	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20512	10.1371/journal.pone.0020512	http://dx.doi.org/10.1371/journal.pone.0020512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637829	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200074
J	Tootle, TL; Williams, D; Hubb, A; Frederick, R; Spradling, A				Tootle, Tina L.; Williams, Dianne; Hubb, Alexander; Frederick, Rebecca; Spradling, Allan			Drosophila Eggshell Production: Identification of New Genes and Coordination by Pxt	PLOS ONE			English	Article							OVARIAN FOLLICULAR DEVELOPMENT; ECDYSONE-RECEPTOR ECR; STEROIDOGENIC GENES; REPRODUCTIVE-TRACT; PROSTAGLANDIN E-2; OOCYTE MATURATION; BREAST-CANCER; BOMBYX-MORI; OOGENESIS; EXPRESSION	Drosophila ovarian follicles complete development using a spatially and temporally controlled maturation process in which they resume meiosis and secrete a multi-layered, protective eggshell before undergoing arrest and/or ovulation. Microarray analysis revealed more than 150 genes that are expressed in a stage-specific manner during the last 24 hours of follicle development. These include all 30 previously known eggshell genes, as well as 19 new candidate chorion genes and 100 other genes likely to participate in maturation. Mutations in pxt, encoding a putative Drosophila cyclooxygenase, cause many transcripts to begin expression prematurely, and are associated with eggshell defects. Somatic activity of Pxt is required, as RNAi knockdown of pxt in the follicle cells recapitulates both the temporal expression and eggshell defects. One of the temporally regulated genes, cyp18a1, which encodes a cytochromome P450 protein mediating ecdysone turnover, is downregulated in pxt mutant follicles, and cyp18a1 mutation itself alters eggshell gene expression. These studies further define the molecular program of Drosophila follicle maturation and support the idea that it is coordinated by lipid and steroid hormonal signals.	[Tootle, Tina L.; Hubb, Alexander] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Williams, Dianne; Frederick, Rebecca; Spradling, Allan] Carnegie Inst, Howard Hughes Med Inst, Dept Embryol, Baltimore, MD USA	University of Iowa; Carnegie Institution for Science; Howard Hughes Medical Institute	Tootle, TL (corresponding author), Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	tina-tootle@uiowa.edu	Tootle, Tina/AAE-1220-2019	Tootle, Tina/0000-0002-1515-9538	Howard Hughes Medical Institute; NRSA through the National Cancer Institute; Anatomy and Cell Biology Department, University of Iowa	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NRSA through the National Cancer Institute; Anatomy and Cell Biology Department, University of Iowa	The project was funded by Howard Hughes Medical Institute, a NRSA through the National Cancer Institute, and start-up funds from the Anatomy and Cell Biology Department, University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; Attar E, 2009, J CLIN ENDOCR METAB, V94, P623, DOI 10.1210/jc.2008-1180; Berg CA, 2008, TISSUE ENG PT A, V14, P1479, DOI 10.1089/ten.tea.2008.0124; Bernardi F, 2007, DEV GENES EVOL, V217, P529, DOI 10.1007/s00427-007-0164-1; Bernardi F, 2009, DEV BIOL, V328, P541, DOI 10.1016/j.ydbio.2009.01.013; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Brodie AMH, 2001, J STEROID BIOCHEM, V79, P41, DOI 10.1016/S0960-0760(01)00131-5; Bulin C, 2005, ARTERIOSCL THROM VAS, V25, P84, DOI 10.1161/01.ATV.0000146814.81581.68; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; Cavaliere V, 2008, DEV DYNAM, V237, P2061, DOI 10.1002/dvdy.21625; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DOWNS SM, 1983, J EXP ZOOL, V228, P99, DOI 10.1002/jez.1402280111; Ebert AD, 2005, EUR J OBSTET GYN R B, V122, P144, DOI 10.1016/j.ejogrb.2005.04.017; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Fakhouri M, 2006, DEV BIOL, V293, P127, DOI 10.1016/j.ydbio.2006.01.028; FUCHS AR, 1987, J STEROID BIOCHEM, V27, P1073, DOI 10.1016/0022-4731(87)90192-0; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Karuppu D, 2002, BREAST CANCER RES TR, V76, P103, DOI 10.1023/A:1020531329686; Kolahi KS, 2009, DEV BIOL, V331, P129, DOI 10.1016/j.ydbio.2009.04.028; Konstandi OA, 2005, INSECT BIOCHEM MOLEC, V35, P1043, DOI 10.1016/j.ibmb.2005.04.005; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; LeMosy EK, 2000, DEV BIOL, V217, P352, DOI 10.1006/dbio.1999.9562; Li JY, 1996, INSECT BIOCHEM MOLEC, V26, P309, DOI 10.1016/0965-1748(95)00099-2; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lister AL, 2008, GEN COMP ENDOCR, V159, P46, DOI 10.1016/j.ygcen.2008.07.017; Machado E, 2007, INSECT BIOCHEM MOLEC, V37, P876, DOI 10.1016/j.ibmb.2007.04.003; Nogueron MI, 2000, DEV BIOL, V225, P459, DOI 10.1006/dbio.2000.9805; PARKS S, 1987, GENE DEV, V1, P497, DOI 10.1101/gad.1.5.497; Pascucci T, 1996, DEV BIOL, V177, P590, DOI 10.1006/dbio.1996.0188; PETRI WH, 1976, DEV BIOL, V49, P185, DOI 10.1016/0012-1606(76)90266-9; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Prosperi JR, 2006, PROSTAG OTH LIPID M, V81, P55, DOI 10.1016/j.prostaglandins.2006.07.003; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; ROBINSON DS, 1968, HISTOCHEMISTRY, V13, P97; Slonina D, 2009, PROSTAG OTH LIPID M, V90, P69, DOI 10.1016/j.prostaglandins.2009.08.006; SPRADLING AC, 1979, CELL, V16, P589, DOI 10.1016/0092-8674(79)90032-1; Spradling Allan C., 1993, P1; Stevens LM, 2003, CURR BIOL, V13, P1058, DOI 10.1016/S0960-9822(03)00379-8; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Szafer-Glusman E, 2008, CURR BIOL, V18, P1426, DOI 10.1016/j.cub.2008.08.061; Takahashi T, 2006, J BIOL CHEM, V281, P37117, DOI 10.1074/jbc.M608202200; TOLIAS PP, 1993, MOL CELL BIOL, V13, P5898, DOI 10.1128/MCB.13.9.5898; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Waring GL, 2000, INT REV CYTOL, V198, P67; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Yakoby N, 2008, DEV CELL, V15, P725, DOI 10.1016/j.devcel.2008.09.008; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739	59	75	78	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19943	10.1371/journal.pone.0019943	http://dx.doi.org/10.1371/journal.pone.0019943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637834	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200021
J	Dobson, RCJ; Giron, I; Hudson, AO				Dobson, Renwick C. J.; Giron, Irma; Hudson, Andre O.			L,L-Diaminopimelate Aminotransferase from Chlamydomonas reinhardtii: A Target for Algaecide Development	PLOS ONE			English	Article							LL-DIAMINOPIMELATE AMINOTRANSFERASE; CIRCULAR-DICHROISM SPECTRA; SIZE-DISTRIBUTION ANALYSIS; DIHYDRODIPICOLINATE SYNTHASE; CRYSTAL-STRUCTURE; BIOSYNTHESIS PATHWAY; LYSINE BIOSYNTHESIS; ESCHERICHIA-COLI; EVOLUTION; ANALOGS	In some bacterial species and photosynthetic cohorts, including algae, the enzyme L, L-diaminopimelate aminotransferase (DapL) (E.C. 2.6.1.83) is involved in the anabolism of the essential amino acid L-lysine. DapL catalyzes the conversion of tetrahydrodipicolinate (THDPA) to L,L-diaminopimelate (L,L-DAP), in one step bypassing the DapD, DapC and DapE enzymatic reactions present in the acyl DAP pathways. Here we present an in vivo and in vitro characterization of the DapL ortholog from the alga Chlamydomonas reinhardtii (Cr-DapL). The in vivo analysis illustrated that the enzyme is able to functionally complement the E. coli dap auxotrophs and was essential for plant development in Arabidopsis. In vitro, the enzyme was able to inter-convert THDPA and L,L-DAP, showing strong substrate specificity. Cr-DapL was dimeric in both solution and when crystallized. The structure of Cr-DapL was solved in its apo form, showing an overall architecture of a a/b protein with each monomer in the dimer adopting a pyridoxal phosphate-dependent transferase-like fold in a V-shaped conformation. The active site comprises residues from both monomers in the dimer and shows some rearrangement when compared to the apo-DapL structure from Arabidopsis. Since animals do not possess the enzymatic machinery necessary for the de novo synthesis of the amino acid L-lysine, enzymes involved in this pathway are attractive targets for the development of antibiotics, herbicides and algaecides.	[Dobson, Renwick C. J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 1, New Zealand; [Giron, Irma; Hudson, Andre O.] Rochester Inst Technol, Sch Biol Sci, Rochester, NY 14623 USA	University of Melbourne; University of Canterbury; Rochester Institute of Technology	Dobson, RCJ (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.	rdobson@unimelb.edu.au; aohsbi@rit.edu	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Hudson, Andre/0000-0001-5690-4322	C.R. Roper Bequest for fellowship; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	C.R. Roper Bequest for fellowship; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	R.C.J.D. acknowledges the C.R. Roper Bequest for fellowship support. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baizman ER, 2000, MICROBIOL-SGM, V146, P3129, DOI 10.1099/00221287-146-12-3129; BERGES DA, 1986, J BIOL CHEM, V261, P6160; Boughton BA, 2008, BIOORGAN MED CHEM, V16, P9975, DOI 10.1016/j.bmc.2008.10.026; Boughton BA, 2008, BIOORG MED CHEM LETT, V18, P460, DOI 10.1016/j.bmcl.2007.11.108; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan CG, 2010, BIOORGAN MED CHEM, V18, P2141, DOI 10.1016/j.bmc.2010.02.001; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hudson AO, 2008, J BACTERIOL, V190, P3256, DOI 10.1128/JB.01381-07; Hudson AO, 2011, ACTA CRYSTALLOGR F, V67, P140, DOI 10.1107/S174430911004844X; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; LAM LKP, 1988, J BIOL CHEM, V263, P11814; Laue T.M., 1992, COMPUTER AIDED INTER; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu YC, 2010, J BACTERIOL, V192, P3304, DOI 10.1128/JB.00172-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; McElver J, 2001, GENETICS, V159, P1751; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; MISONO H, 1976, BIOCHEM BIOPH RES CO, V72, P89, DOI 10.1016/0006-291X(76)90964-5; Mitsakos V, 2008, BIOORG MED CHEM LETT, V18, P842, DOI 10.1016/j.bmcl.2007.11.026; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Rupp B, 2010, BIOMOLECULAR CRYSTALLOGRAPHY: PRINCIPLES, PRACTICE, AND APPLICATION TO STRUCTURAL BIOLOGY, P1; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Turner JJ, 2005, BIOORG MED CHEM LETT, V15, P995, DOI 10.1016/j.bmcl.2004.12.043; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Watanabe N, 2008, J MOL BIOL, V384, P1314, DOI 10.1016/j.jmb.2008.10.022; Watanabe N, 2007, J MOL BIOL, V371, P685, DOI 10.1016/j.jmb.2007.05.061; Weyand S, 2007, J MOL BIOL, V367, P825, DOI 10.1016/j.jmb.2007.01.023	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20439	10.1371/journal.pone.0020439	http://dx.doi.org/10.1371/journal.pone.0020439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633707	Green Published, gold			2022-12-27	WOS:000291006500063
J	Kausrud, KL; Gregoire, JC; Skarpaas, O; Erbilgin, N; Gilbert, M; Okland, B; Stenseth, NC				Kausrud, Kyrre L.; Gregoire, Jean-Claude; Skarpaas, Olav; Erbilgin, Nadir; Gilbert, Marius; Okland, Bjorn; Stenseth, Nils Chr.			Trees Wanted-Dead or Alive! Host Selection and Population Dynamics in Tree-Killing Bark Beetles	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; IPS-TYPOGRAPHUS COLEOPTERA; REPRODUCTIVE SUCCESS; SPRUCE; CURCULIONIDAE; AGGREGATION; ATTRACTION; PHEROMONE; PATTERNS; ECOLOGY	Bark beetles (Coleoptera: Curculionidae, Scolytinae) feed and breed in dead or severely weakened host trees. When their population densities are high, some species aggregate on healthy host trees so that their defences may be exhausted and the inner bark successfully colonized, killing the tree in the process. Here we investigate under what conditions participating with unrelated conspecifics in risky mass attacks on living trees is an adaptive strategy, and what this can tell us about bark beetle outbreak dynamics. We find that the outcome of individual host selection may deviate from the ideal free distribution in a way that facilitates the emergence of tree-killing (aggressive) behavior, and that any heritability on traits governing aggressiveness seems likely to exist in a state of flux or cycles consistent with variability observed in natural populations. This may have implications for how economically and ecologically important species respond to environmental changes in climate and landscape (forest) structure. The population dynamics emerging from individual behavior are complex, capable of switching between "endemic" and "epidemic" regimes spontaneously or following changes in host availability or resistance. Model predictions are compared to empirical observations, and we identify some factors determining the occurrence and self-limitation of epidemics.	[Kausrud, Kyrre L.; Stenseth, Nils Chr.] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Kausrud, Kyrre L.; Okland, Bjorn] Norwegian Forest & Landscape Inst, As, Norway; [Gregoire, Jean-Claude; Gilbert, Marius] Univ Libre Bruxelles, Brussels, Belgium; [Skarpaas, Olav] Norwegian Inst Nat Res, N-0315 Oslo, Norway; [Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium	University of Oslo; The Norwegian Forest & Landscape Institute; Universite Libre de Bruxelles; Norwegian Institute Nature Research; University of Alberta; Fonds de la Recherche Scientifique - FNRS	Kausrud, KL (corresponding author), Univ Oslo, Dept Biol, CEES, Oslo, Norway.	n.c.stenseth@bio.uio.no	Stenseth, Nils Chr./G-5212-2016; Erbilgin, Nadir/F-3675-2014; Lundquist, John/B-6433-2012; Grégoire, Jean-Claude/F-4397-2011	Stenseth, Nils Chr./0000-0002-1591-5399; Erbilgin, Nadir/0000-0001-9912-8095; Gilbert, Marius/0000-0003-3708-3359; Gregoire, Jean-Claude/0000-0002-3346-4130; Kausrud, Kyrre/0000-0002-2738-7351; Skarpaas, Olav/0000-0001-9727-1672	Research Council of Norway (RCN) [170801]; Centre for Ecological and Evolutionary Synthesis (CEES); Norwegian Forest and Landscape Institute	Research Council of Norway (RCN)(Research Council of Norway); Centre for Ecological and Evolutionary Synthesis (CEES); Norwegian Forest and Landscape Institute	This work was funded by the Research Council of Norway (RCN) Project no. 170801, the Centre for Ecological and Evolutionary Synthesis (CEES), and the Norwegian Forest and Landscape Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2008, ENVIRON ENTOMOL, V37, P817, DOI 10.1603/0046-225X(2008)37[817:LOGDIA]2.0.CO;2; ANDERBRANT O, 1985, OIKOS, V45, P89, DOI 10.2307/3565226; Aukema BH, 2004, OECOLOGIA, V138, P253, DOI 10.1007/s00442-003-1433-y; Aukema BH, 2008, ECOGRAPHY, V31, P348, DOI 10.1111/j.0906-7590.2007.05453.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; BOURTZIS K, INSECT SYMBIOSIS CRC; BYERS JA, 1984, J CHEM ECOL, V10, P861, DOI 10.1007/BF00987969; Byers JA, 1999, J CHEM ECOL, V25, P985, DOI 10.1023/A:1020869422943; BYERS JA, 1984, ENVIRON ENTOMOL, V13, P1191, DOI 10.1093/ee/13.5.1191; BYERS JA, CHEM ECOLOGY BARK BE, P89; Campbell SA, 2006, ECOL ENTOMOL, V31, P437, DOI 10.1111/j.1365-2311.2006.00809.x; Carroll A. L., 2006, IMPACTS CLIMATE CHAN; CHRISTIANSEN E, SPRUCE BARK BEETLE E, P479; Cressman R, 2006, AM NAT, V168, P384, DOI 10.1086/506970; DEJONG MCM, 1986, ENTOMOL EXP APPL, V41, P121, DOI 10.1007/BF00195567; DEJONG MCM, 1988, OIKOS, V51, P88, DOI 10.2307/3565811; Erbilgin N, 2003, AGR FOREST ENTOMOL, V5, P269, DOI 10.1046/j.1461-9563.2003.00186.x; Erbilgin N, 2007, AGR FOREST ENTOMOL, V9, P135, DOI 10.1111/j.1461-9563.2007.00329.x; Eriksson M, 2008, FOREST ECOL MANAG, V255, P1336, DOI 10.1016/j.foreco.2007.10.043; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Franklin AJ, 2001, J CHEM ECOL, V27, P2425, DOI 10.1023/A:1013619313415; Franklin Anne J., 2000, Agricultural and Forest Entomology, V2, P259, DOI 10.1046/j.1461-9563.2000.00075.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GREGOIRE JC, 1996, PHEROMONE MASS TRAPP; Haugen TO, 2006, P ROY SOC B-BIOL SCI, V273, P2917, DOI 10.1098/rspb.2006.3659; Hedgren PO, 2004, FOREST ECOL MANAG, V203, P241, DOI 10.1016/j.foreco.2004.07.055; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Hulcr J, 2006, J APPL ENTOMOL, V130, P275, DOI 10.1111/j.1439-0418.2006.01069.x; McGregor M., 1985, WO46 USDA FOR SERV G, P16; NELSON WA, 2005, 819 NRC; Nelson WA, 2008, J APPL ECOL, V45, P248, DOI 10.1111/j.1365-2664.2007.01374.x; Okland B, 2006, ECOLOGY, V87, P283, DOI 10.1890/05-0135; Okland B, 2004, AGR FOREST ENTOMOL, V6, P141, DOI 10.1111/j.1461-9555.2004.00214.x; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Piel F, 2005, AGR FOREST ENTOMOL, V7, P161, DOI 10.1111/j.1461-9555.2005.00262.x; Powell JA, 1996, J THEOR BIOL, V179, P243, DOI 10.1006/jtbi.1996.0064; Pureswaran DS, 2008, NATURWISSENSCHAFTEN, V95, P33, DOI 10.1007/s00114-007-0292-5; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa Kenneth F., 1993, P103; Raffa KF, 2005, RECENT ADV PHYTOCHEM, V39, P79; Raffa KF, 2001, CHEMOECOLOGY, V11, P49, DOI 10.1007/PL00001833; Robins GL, 1997, ECOL ENTOMOL, V22, P329, DOI 10.1046/j.1365-2311.1997.00068.x; Saint-Germain M, 2007, AGR FOREST ENTOMOL, V9, P227, DOI 10.1111/j.1461-9563.2007.00337.x; Salle A, 2007, BIOL J LINN SOC, V90, P239, DOI 10.1111/j.1095-8312.2007.00720.x; Sun Xiao-ling, 2006, Journal of Forestry Research (Harbin), V17, P65, DOI 10.1007/s11676-006-0016-2; Taylor P, 2000, BIOL PHILOS, V15, P197, DOI 10.1023/A:1006684801878; van Baalen M, 1999, AM NAT, V154, P69, DOI 10.1086/303215; Wallin KF, 2004, ECOL MONOGR, V74, P101, DOI 10.1890/02-4004; Wallin KF, 2002, ENVIRON ENTOMOL, V31, P1276, DOI 10.1603/0046-225X-31.6.1276; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; WESLIEN J, 1994, ENTOMOL EXP APPL, V71, P133, DOI 10.1007/BF02382381; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; ZHANG QH, 1992, J APPL ECOL, V29, P672, DOI 10.2307/2404475	53	24	24	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e18274	10.1371/journal.pone.0018274	http://dx.doi.org/10.1371/journal.pone.0018274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647433	Green Published, gold, Green Accepted			2022-12-27	WOS:000291006500002
J	Tan, JQ; Ma, Z; Gao, XC; Wu, YH; Fang, F				Tan, Jieqing; Ma, Zheng; Gao, Xiaochao; Wu, Yanhong; Fang, Fang			Gender Difference of Unconscious Attentional Bias in High Trait Anxiety Individuals	PLOS ONE			English	Article							THREATENING FACIAL EXPRESSIONS; SELECTIVE ATTENTION; TIME-COURSE; EMOTIONAL INFORMATION; SEX-DIFFERENCES; COGNITIVE BIAS; DEPRESSION; PERCEPTION; VIGILANCE; RESPONSES	By combining binocular suppression technique and a probe detection paradigm, we investigated attentional bias to invisible stimuli and its gender difference in both high trait anxiety (HTA) and low trait anxiety (LTA) individuals. As an attentional cue, happy or fearful face pictures were presented to HTAs and LTAs for 800 ms either consciously or unconsciously (through binocular suppression). Participants were asked to judge the orientation of a gabor patch following the face pictures. Their performance was used to measure attentional effect induced by the cue. We found gender differences of attentional effect only in the unconscious condition with HTAs. Female HTAs exhibited difficulty in disengaging attention from the location where fearful faces were presented, while male HTAs showed attentional avoidance of it. Our results suggested that the failure to find attentional avoidance of threatening stimuli in many previous studies might be attributed to consciously presented stimuli and data analysis regardless of participants' gender. These findings also contributed to our understanding of gender difference in anxiety disorder.	[Tan, Jieqing; Ma, Zheng; Gao, Xiaochao; Wu, Yanhong; Fang, Fang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wu, Yanhong] Capital Normal Univ, Learning & Cognit Lab, Beijing, Peoples R China; [Ma, Zheng] Peking Univ, Yuanpei Coll, Beijing 100871, Peoples R China	Peking University; Capital Normal University; Peking University	Tan, JQ (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	wuyh@pku.edu.cn			Natural Science Foundation of China [31070982, 30770711, 30470568]; Major State Basic Research Development Program of China (973) [2009CB320901]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973)(National Basic Research Program of China)	Work was funded by Natural Science Foundation of China http://www.nsfc.gov.cn/ (31070982, 30770711, 30470568); Major State Basic Research Development Program of China (973) www.most.gov.cn/ (2009CB320901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Beck AT, 1985, ANXIETY DISORDERS PH; Bekker MHJ, 1996, CLIN PSYCHOL REV, V16, P129, DOI 10.1016/0272-7358(96)00012-8; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Broadbent D, 1988, COGNITION EMOTION, V2, P165, DOI 10.1080/02699938808410922; CASTLE DJ, 1995, AUST NZ J PSYCHIAT, V29, P114, DOI 10.3109/00048679509075899; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Ellenbogen MA, 2002, PSYCHOPHYSIOLOGY, V39, P723, DOI 10.1111/1469-8986.3960723; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Fredrikson M, 1996, BEHAV RES THER, V34, P33, DOI 10.1016/0005-7967(95)00048-3; Gibbs NA, 1996, CLIN PSYCHOL REV, V16, P729, DOI 10.1016/S0272-7358(96)00043-8; Goos LM, 2002, J NONVERBAL BEHAV, V26, P27, DOI 10.1023/A:1014418503754; Jansson B, 2005, PERS INDIV DIFFER, V39, P1373, DOI 10.1016/j.paid.2005.04.013; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Koster EHW, 2005, BEHAV RES THER, V43, P1087, DOI 10.1016/j.brat.2004.08.004; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Kowler E., 1995, VIS COGN, V2, P215; MACLEOD C, 1992, BEHAV RES THER, V30, P151, DOI 10.1016/0005-7967(92)90138-7; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; Mayer B, 1999, CLIN PSYCHOL REV, V19, P571, DOI 10.1016/S0272-7358(98)00060-9; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McClure EB, 2004, BIOL PSYCHIAT, V55, P1047, DOI 10.1016/j.biopsych.2004.02.013; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; MOGG K, 1995, BEHAV RES THER, V33, P927, DOI 10.1016/0005-7967(95)00031-R; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; MOGG K, 1993, J ABNORM PSYCHOL, V102, P304, DOI 10.1037/0021-843X.102.2.304; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Osorio LC, 2003, PERS INDIV DIFFER, V34, P831, DOI 10.1016/S0191-8869(02)00074-0; Rachman S. J., 1998, ANXIETY; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Simonds VA, 2003, J AFFECT DISORDERS, V77, P197, DOI 10.1016/S0165-0327(02)00113-1; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Waters AM, 2009, J BEHAV THER EXP PSY, V40, P306, DOI 10.1016/j.jbtep.2008.12.008; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.; Yovel I, 2005, PERS INDIV DIFFER, V38, P785, DOI 10.1016/j.paid.2004.06.003; ZHEN X, 1993, CHINESE J CLIN PSYCH, V17, P60; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20305	10.1371/journal.pone.0020305	http://dx.doi.org/10.1371/journal.pone.0020305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IJ	21647221	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800042
J	Herder, C; Baumert, J; Zierer, A; Roden, M; Meisinger, C; Karakas, M; Chambless, L; Rathmann, W; Peters, A; Koenig, W; Thorand, B				Herder, Christian; Baumert, Jens; Zierer, Astrid; Roden, Michael; Meisinger, Christa; Karakas, Mahir; Chambless, Lloyd; Rathmann, Wolfgang; Peters, Annette; Koenig, Wolfgang; Thorand, Barbara			Immunological and Cardiometabolic Risk Factors in the Prediction of Type 2 Diabetes and Coronary Events: MONICA/KORA Augsburg Case-Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MIDDLE-AGED MEN; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROSIS RISK; SERUM CONCENTRATIONS; EUROPEAN-SOCIETY; BIOMARKERS; POPULATION; MELLITUS	Background: This study compares inflammation-related biomarkers with established cardiometabolic risk factors in the prediction of incident type 2 diabetes and incident coronary events in a prospective case-cohort study within the population-based MONICA/KORA Augsburg cohort. Methods and Findings: Analyses for type 2 diabetes are based on 436 individuals with and 1410 individuals without incident diabetes. Analyses for coronary events are based on 314 individuals with and 1659 individuals without incident coronary events. Mean follow-up times were almost 11 years. Areas under the receiver-operating characteristic curve (AUC), changes in Akaike's information criterion (Delta AIC), integrated discrimination improvement (IDI) and net reclassification index (NRI) were calculated for different models. A basic model consisting of age, sex and survey predicted type 2 diabetes with an AUC of 0.690. Addition of 13 inflammation-related biomarkers (CRP, IL-6, IL-18, MIF, MCP-1/CCL2, IL-8/CXCL8, IP-10/CXCL10, adiponectin, leptin, RANTES/CCL5, TGF-beta 1, sE-selectin, sICAM-1; all measured in nonfasting serum) increased the AUC to 0.801, whereas addition of cardiometabolic risk factors (BMI, systolic blood pressure, ratio total/HDL-cholesterol, smoking, alcohol, physical activity, parental diabetes) increased the AUC to 0.803 (Delta AUC [95% CI] 0.111 [0.092-0.149] and 0.113 [0.093-0.149], respectively, compared to the basic model). The combination of all inflammation-related biomarkers and cardiometabolic risk factors yielded a further increase in AUC to 0.847 (Delta AUC [95% CI] 0.044 [0.028-0.066] compared to the cardiometabolic risk model). Corresponding AUCs for incident coronary events were 0.807, 0.825 (Delta AUC [95% CI] 0.018 [0.013-0.038] compared to the basic model), 0.845 (Delta AUC [95% CI] 0.038 [0.028-0.059] compared to the basic model) and 0.851 (Delta AUC [95% CI] 0.006 [0.003-0.021] compared to the cardiometabolic risk model), respectively. Conclusions: Inclusion of multiple inflammation-related biomarkers into a basic model and into a model including cardiometabolic risk factors significantly improved the prediction of type 2 diabetes and coronary events, although the improvement was less pronounced for the latter endpoint.	[Herder, Christian; Roden, Michael] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Baumert, Jens; Zierer, Astrid; Meisinger, Christa; Peters, Annette; Thorand, Barbara] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Dusseldorf, Germany; [Karakas, Mahir; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Chambless, Lloyd] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; Ulm University; University of North Carolina; University of North Carolina Chapel Hill; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Herder, C (corresponding author), Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.	wolfgang.koenig@uniklinik-ulm.de	Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014; Roden, Michael/AAD-3843-2019; Peters, Annette/A-6117-2011	Thorand, Barbara/0000-0002-8416-6440; Peters, Annette/0000-0001-6645-0985; Koenig, Wolfgang/0000-0002-2064-9603; Meisinger, Christa/0000-0002-9026-6544	German Research Foundation [TH-784/2-1, TH-784/2-2]; University of Ulm; Federal Ministry of Health; Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg (formerly GSF National Research Center for Environment and Health); Helmholtz Zentrum Munchen; Federal Ministry of Education and Research, Berlin	German Research Foundation(German Research Foundation (DFG)); University of Ulm; Federal Ministry of Health; Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg (formerly GSF National Research Center for Environment and Health)(Helmholtz Association); Helmholtz Zentrum Munchen(Helmholtz Association); Federal Ministry of Education and Research, Berlin	Funding: This study was supported by research grants from the German Research Foundation (TH-784/2-1 and TH-784/2-2) and by additional funds provided by the University of Ulm, the Federal Ministry of Health, the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia, and the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg (formerly GSF National Research Center for Environment and Health). The MONICA/KORA Augsburg cohort study was financed by the Helmholtz Zentrum Munchen and supported by grants from the Federal Ministry of Education and Research, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Burnham K. P., 1998, MODEL SELECTION INFE; Chambless LE, 2006, STAT MED, V25, P3474, DOI 10.1002/sim.2299; Chambless LE, 2011, STAT MED, V30, P22, DOI 10.1002/sim.4026; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Efron B., 1993, INTRO BOOTSTRAP, P168; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Hense HW, 1998, CVD PREVENTION, V1, P318; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2008, EUR J ENDOCRINOL, V158, pR1, DOI 10.1530/EJE-07-0686; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Herder C, 2009, DIABETES CARE, V32, P1921, DOI 10.2337/dc09-0476; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; Schaeffler V, 1996, ANN NUTR METAB, V40, P129, DOI 10.1159/000177906; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	46	67	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e19852	10.1371/journal.pone.0019852	http://dx.doi.org/10.1371/journal.pone.0019852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674000	Green Published, Green Submitted, gold			2022-12-27	WOS:000291356400001
J	Rojsitthisak, P; Jongaroonngamsang, N; Romero, RM; Haworth, IS				Rojsitthisak, Pornchai; Jongaroonngamsang, Nutthapon; Romero, Rebecca M.; Haworth, Ian S.			HPLC-UV, MALDI-TOF-MS and ESI-MS/MS Analysis of the Mechlorethamine DNA Crosslink at a Cytosine-Cytosine Mismatch Pair	PLOS ONE			English	Article							IONIZATION-MASS-SPECTROMETRY; ASSISTED LASER-DESORPTION; NUCLEAR-MAGNETIC-RESONANCE; CENTER-DOT-T; TRINUCLEOTIDE REPEATS; LIQUID-CHROMATOGRAPHY; GENETIC-RECOMBINATION; REPLICATION FIDELITY; HUMAN-DISEASE; INTERSTRAND	Background: Mechlorethamine [ClCH2CH2N(CH3)CH2CH2Cl], a nitrogen mustard alkylating agent, has been proven to form a DNA interstrand crosslink at a cytosine-cytosine (C-C) mismatch pair using gel electrophoresis. However, the atomic connectivity of this unusual crosslink is unknown. Methodology/Principal Findings: HPLC-UV, MALDI-TOF-MS, and ESI-MS/MS were used to determine the atomic connectivity of the DNA C-C crosslink formed by mechlorethamine, MALDI-TOF-MS of the HPLC-purified reaction product of mechlorethamine with the DNA duplex d[CTCACACCGTGGTTC]center dot d[GAACCACCGTGTGAG] (underlined bases are a C-C mismatch pair) indicated formation of an interstrand crosslink at m/z 9222.088 [M-2H+Na](+). Following enzymatic digestion of the crosslinked duplex by snake venom phosphodiesterase and calf intestinal phosphatase, ESI-MS/MS indicated the presence of dC-mech-dC [mech = CH2CH2N(CH3)CH2CH2] at m/z 269.2 [M](2+) (expected m/z 269.6, exact mass 539.27) and its hydrolytic product dC-mech-OH at m/z 329.6 [M](+) (expected m/z 329.2). Fragmentation of dC-mech-dC gave product ions at m/z 294.3 and 236.9 [M](+), which are both due to loss of the 4-amino group of cytosine (as ammonia), in addition to dC and dC+HN(CH3)CH = CH2, respectively. The presence of m/z 269.2 [M](2+) and loss of ammonia exclude crosslink formation at cytosine N-4 or O-2 and indicate crosslinking through cytosine N-3 with formation of two quaternary ammonium ions. Conclusions: Our results provide an important addition to the literature, as the first example of the use of HPLC and MS for analysis of a DNA adduct at the N-3 position of cytosine.	[Rojsitthisak, Pornchai; Jongaroonngamsang, Nutthapon] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Food & Pharmaceut Chem, Bangkok, Thailand; [Romero, Rebecca M.; Haworth, Ian S.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	Chulalongkorn University; University of Southern California	Rojsitthisak, P (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Food & Pharmaceut Chem, Bangkok, Thailand.	pornchai.r@chula.ac.th	Rojsitthisak, Pornchai/S-4772-2019	Rojsitthisak, Pornchai/0000-0003-1391-6993				Balcome S, 2004, CHEM RES TOXICOL, V17, P950, DOI 10.1021/tx0499463; Boulard Y, 1997, J MOL BIOL, V268, P331, DOI 10.1006/jmbi.1997.0975; Cao HC, 2006, J AM SOC MASS SPECTR, V17, P1335, DOI 10.1016/j.jasms.2006.05.019; Chao MR, 2007, BIOCHEM J, V402, P483, DOI 10.1042/BJ20061447; Chou SH, 1996, J MOL BIOL, V264, P981, DOI 10.1006/jmbi.1996.0691; CUMMINGS J, 1993, J CHROMATOGR-BIOMED, V618, P251, DOI 10.1016/0378-4347(93)80037-5; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Darlow JM, 1998, J MOL BIOL, V275, P17, DOI 10.1006/jmbi.1997.1452; FIELDS EK, 1968, ADV PHYS ORGANIC CHE, V6, P2; GACY AM, 1995, CELL, V81, P533; GAO XL, 1995, J AM CHEM SOC, V117, P8883, DOI 10.1021/ja00139a035; Gaskell M, 2007, NUCLEIC ACIDS RES, V35, P5014, DOI 10.1093/nar/gkm526; Goggin M, 2007, CHEM RES TOXICOL, V20, P839, DOI 10.1021/tx700020q; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Gupta R, 2005, J INORG BIOCHEM, V99, P552, DOI 10.1016/j.jinorgbio.2004.11.001; Gut IG, 2004, HUM MUTAT, V23, P437, DOI 10.1002/humu.20023; HARTLEY JA, 1993, J CHROMATOGR-BIOMED, V618, P277, DOI 10.1016/0378-4347(93)80038-6; Hecker KH, 2000, J BIOCHEM BIOPH METH, V46, P83, DOI 10.1016/S0165-022X(00)00133-0; HILLENKAMP F, 1990, BIOLOGICAL MASS SPECTROMETRY /, P49; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Jongaroonngamsang N, 2010, J HEALTH RES, V24, P155; Lee AM, 2006, J MOL BIOL, V360, P343, DOI 10.1016/j.jmb.2006.04.065; Mariappan SVS, 1996, NUCLEIC ACIDS RES, V24, P784, DOI 10.1093/nar/24.4.784; Mariappan SVS, 1998, J MOL BIOL, V283, P111, DOI 10.1006/jmbi.1998.1990; Miketova P, 1997, MOL BIOTECHNOL, V8, P249, DOI 10.1007/BF02760778; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Monsandl T, 2010, AUST J CHEM, V63, P1076, DOI 10.1071/CH09640; Nakayabu M, 1998, NUCLEIC ACIDS RES, V26, P1980, DOI 10.1093/nar/26.8.1980; Noll DM, 2001, J AM CHEM SOC, V123, P3405, DOI 10.1021/ja003340t; NORDHOFF E, 1992, RAPID COMMUN MASS SP, V6, P771, DOI 10.1002/rcm.1290061212; NORDHOFF E, 1994, NUCLEIC ACIDS RES, V22, P2460, DOI 10.1093/nar/22.13.2460; Park S, 2005, J AM CHEM SOC, V127, P14355, DOI 10.1021/ja051979x; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; RINK SM, 1993, J AM CHEM SOC, V115, P2551, DOI 10.1021/ja00060a001; RINK SM, 1995, BIOCHEMISTRY-US, V34, P1439, DOI 10.1021/bi00004a039; Rojsitthisak P, 2001, NUCLEIC ACIDS RES, V29, P4716, DOI 10.1093/nar/29.22.4716; Romero RM, 1999, BIOCHEMISTRY-US, V38, P3641, DOI 10.1021/bi981935j; Romero RM, 2001, ARCH BIOCHEM BIOPHYS, V386, P143, DOI 10.1006/abbi.2000.2198; SARMA MH, 1987, BIOCHEMISTRY-US, V26, P7707, DOI 10.1021/bi00398a026; Singh R, 2006, CARCINOGENESIS, V27, P178, DOI 10.1093/carcin/bgi260; Singh R, 2005, CHEM RES TOXICOL, V18, P249, DOI 10.1021/tx049793j; Tost J, 2006, J MASS SPECTROM, V41, P981, DOI 10.1002/jms.1096; Tretyakova N, 2007, CHEM RES TOXICOL, V20, P284, DOI 10.1021/tx060204e; Tu YP, 1996, RAPID COMMUN MASS SP, V10, P1093, DOI 10.1002/(SICI)1097-0231(19960715)10:9<1093::AID-RCM628>3.0.CO;2-S; Wang YS, 2003, ANAL CHEM, V75, P6306, DOI 10.1021/ac034683n; Wang YS, 2004, J AM SOC MASS SPECTR, V15, P1565, DOI 10.1016/j.jasms.2004.07.012; Weaver SLW, 2007, ASTROPHYS J LETT, V671, pL153, DOI 10.1086/525042; Wilds CJ, 2006, TETRAHEDRON LETT, V47, P9125, DOI 10.1016/j.tetlet.2006.10.074; Wilds CJ, 2004, J AM CHEM SOC, V126, P9257, DOI 10.1021/ja0498540; WU KJ, 1994, ANAL CHEM, V66, P1637, DOI 10.1021/ac00082a007; Yu A, 1997, BIOCHEMISTRY-US, V36, P3687, DOI 10.1021/bi9625410	53	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20745	10.1371/journal.pone.0020745	http://dx.doi.org/10.1371/journal.pone.0020745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673963	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400026
J	Amengual, J; Gouranton, E; van Helden, YGJ; Hessel, S; Ribot, J; Kramer, E; Kiec-Wilk, B; Razny, U; Lietz, G; Wyss, A; Dembinska-Kiec, A; Palou, A; Keijer, J; Landrier, JF; Bonet, ML; von Lintig, J				Amengual, Jaume; Gouranton, Erwan; van Helden, Yvonne G. J.; Hessel, Susanne; Ribot, Joan; Kramer, Evelien; Kiec-Wilk, Beata; Razny, Ursula; Lietz, Georg; Wyss, Adrian; Dembinska-Kiec, Aldona; Palou, Andreu; Keijer, Jaap; Landrier, Jean Francois; Luisa Bonet, M.; von Lintig, Johannes			Beta-Carotene Reduces Body Adiposity of Mice via BCMO1	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; ACID-METABOLIZING ENZYME; RETINOIC ACID; DIABETES-MELLITUS; LEPTIN EXPRESSION; SERUM CAROTENOIDS; PPAR-GAMMA; IN-VITRO; IDENTIFICATION; TISSUE	Evidence from cell culture studies indicates that beta-carotene-(BC)-derived apocarotenoid signaling molecules can modulate the activities of nuclear receptors that regulate many aspects of adipocyte physiology. Two BC metabolizing enzymes, the BC-15,15'-oxygenase (Bcmo1) and the BC-9',10'-oxygenase (Bcdo2) are expressed in adipocytes. Bcmo1 catalyzes the conversion of BC into retinaldehyde and Bcdo2 into beta-10'-apocarotenal and beta-ionone. Here we analyzed the impact of BC on body adiposity of mice. To genetically dissect the roles of Bcmo1 and Bcdo2 in this process, we used wild-type and Bcmo1(-/-) mice for this study. In wild-type mice, BC was converted into retinoids. In contrast, Bcmo1(-/-) mice showed increased expression of Bcdo2 in adipocytes and beta-10'-apocarotenol accumulated as the major BC derivative. In wild-type mice, BC significantly reduced body adiposity (by 28%), leptinemia and adipocyte size. Genome wide microarray analysis of inguinal white adipose tissue revealed a generalized decrease of mRNA expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) target genes. Consistently, the expression of this key transcription factor for lipogenesis was significantly reduced both on the mRNA and protein levels. Despite beta-10'-apocarotenoid production, this effect of BC was absent in Bcmo1(-/-) mice, demonstrating that it was dependent on the Bcmo1-mediated production of retinoids. Our study evidences an important role of BC for the control of body adiposity in mice and identifies Bcmo1 as critical molecular player for the regulation of PPAR gamma activity in adipocytes	[Amengual, Jaume; Ribot, Joan; Palou, Andreu; Luisa Bonet, M.] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca, Spain; [Amengual, Jaume; Ribot, Joan; Palou, Andreu; Luisa Bonet, M.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Palma de Mallorca, Spain; [Amengual, Jaume; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Gouranton, Erwan; Keijer, Jaap; Landrier, Jean Francois] Univ Aix Marseille I & II, INRA, UMR Nutriments Lipid & Prevent Malad Metab 1260, Marseille, France; [van Helden, Yvonne G. J.] Wageningen Univ, Wageningen, Netherlands; [van Helden, Yvonne G. J.] Univ Maastricht, Maastricht, Netherlands; [van Helden, Yvonne G. J.; Kramer, Evelien] RIKILT Inst Food Safety, Wageningen, Netherlands; [Hessel, Susanne; von Lintig, Johannes] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany; [Kiec-Wilk, Beata; Razny, Ursula; Dembinska-Kiec, Aldona] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Lietz, Georg] Newcastle Univ, Sch AFRD, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wyss, Adrian] DSM Nutr Prod, R&D Human Nutr & Hlth, Kaiseraugst, Switzerland	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Case Western Reserve University; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Wageningen University & Research; Maastricht University; Wageningen University & Research; University of Freiburg; Jagiellonian University; Collegium Medicum Jagiellonian University; Newcastle University - UK; DSM NV	Amengual, J (corresponding author), Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca, Spain.	luisabonet@uib.es; johannes.vonlintig@case.edu	Lietz, Georg/A-4084-2012; Razny, Urszula/U-2550-2019; Landrier, Jean-Francois/AAH-2757-2019; Bonet, M.Luisa/H-6722-2015; Palou, Andreu/K-9881-2014; Ribot, Joan/L-2224-2014; Keijer, Jaap/J-8089-2013	Landrier, Jean-Francois/0000-0002-8690-8014; Bonet, M.Luisa/0000-0002-8698-0630; Palou, Andreu/0000-0002-0295-4452; Ribot, Joan/0000-0003-4460-9371; Razny, Urszula/0000-0003-1864-8449; von Lintig, Johannes/0000-0002-2079-2143; Keijer, Jaap/0000-0002-9720-7491	EU [FOOD-CT-2004-506360]; NuGO; Spanish Government (Ministerio de Educacion y Ciencia) [AGL2006-04887/ALI, AGL2009-11277/ALI]; INRA; INSERM (France); Instituto de Salud Carlos III (Spanish Government); VLAG/Nutrim	EU(European Commission); NuGO; Spanish Government (Ministerio de Educacion y Ciencia)(Spanish Government); INRA; INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Instituto de Salud Carlos III (Spanish Government)(Instituto de Salud Carlos III); VLAG/Nutrim	This work was developed as part of The European Nutrigenomics Organisation (Network of Excellence, EU Contract FOOD-CT-2004-506360) Focus Team 9 "Window of Benefit for Carotenoids" coordinated by Georg Lietz, and has been sponsored in part by NuGO. It has also been supported by the Spanish Government (Ministerio de Educacion y Ciencia, grant AGL2006-04887/ALI and AGL2009-11277/ALI to Andreu Palou) and by INRA and INSERM (France). CIBERobn is an initiative of the Instituto de Salud Carlos III (Spanish Government). Jaap Keijer, Andreu Palou and Aldona Dembinska-Kiec are members of Mitofood (Cost Action F0602). Jaume Amengual was a fellow from the Spanish Government. Yvonne van Helden is supported by VLAG/Nutrim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; EROGLU A, ARCH BIOCH IN PRESS; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783; Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Grimaldi PA, 2007, CELL MOL LIFE SCI, V64, P2459, DOI 10.1007/s00018-007-7278-5; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hollung K, 2004, J CELL BIOCHEM, V92, P307, DOI 10.1002/jcb.20047; KAMEI Y, 1994, LIFE SCI, V55, pPL307, DOI 10.1016/0024-3205(94)90073-6; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Landrier JF, 2008, FREE RADICAL RES, V42, P523, DOI 10.1080/10715760802098859; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lindshield BL, 2008, J NUTR, V138, P2367, DOI 10.3945/jn.108.099663; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Mercader J, 2008, CELL PHYSIOL BIOCHEM, V22, P363, DOI 10.1159/000149815; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; van Helden YGJ, 2010, CELL MOL LIFE SCI, V67, P2039, DOI 10.1007/s00018-010-0341-7; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Ylonen K, 2003, AM J CLIN NUTR, V77, P1434; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	53	105	112	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20644	10.1371/journal.pone.0020644	http://dx.doi.org/10.1371/journal.pone.0020644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673813	Green Published, gold			2022-12-27	WOS:000291309900025
J	Shimada, T; Fujita, N; Yamamoto, K; Ishihama, A				Shimada, Tomohiro; Fujita, Nobuyuki; Yamamoto, Kaneyoshi; Ishihama, Akira			Novel Roles of cAMP Receptor Protein (CRP) in Regulation of Transport and Metabolism of Carbon Sources	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; MAJOR FACILITATOR SUPERFAMILY; CATABOLITE ACTIVATOR PROTEIN; POLYMERASE-ALPHA-SUBUNIT; RNA-POLYMERASE; PHOSPHOTRANSFERASE SYSTEM; TRANSCRIPTION ACTIVATION; MOLECULAR CHARACTERIZATION; SIGNAL-TRANSDUCTION; ABC TRANSPORTERS	CRP (cAMP receptor protein), the global regulator of genes for carbon source utilization in the absence of glucose, is the best-studied prokaryotic transcription factor. A total of 195 target promoters on the Escherichia coli genome have been proposed to be under the control of cAMP-bound CRP. Using the newly developed Genomic SELEX screening system of transcription factor-binding sequences, however, we have identified a total of at least 254 CRP-binding sites. Based on their location on the E. coli genome, we predict a total of at least 183 novel regulation target operons, altogether with the 195 hitherto known targets, reaching to the minimum of 378 promoters as the regulation targets of cAMP-CRP. All the promoters selected from the newly identified targets and examined by using the lacZ reporter assay were found to be under the control of CRP, indicating that the Genomic SELEX screening allowed to identify the CRP targets with high accuracy. Based on the functions of novel target genes, we conclude that CRP plays a key regulatory role in the whole processes from the selective transport of carbon sources, the glycolysis-gluconeogenesis switching to the metabolisms downstream of glycolysis, including tricarboxylic acid (TCA) cycle, pyruvate dehydrogenase (PDH) pathway and aerobic respiration. One unique regulation mode is that a single and the same CRP molecule bound within intergenic regions often regulates both of divergently transcribed operons.	[Shimada, Tomohiro; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo, Japan; [Shimada, Tomohiro; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Micronanotechnol Res Ctr, Tokyo, Japan; [Fujita, Nobuyuki] Natl Inst Technol & Evaluat, Dept Biotechnol, Shibuya Ku, Tokyo, Japan	Hosei University; Hosei University	Shimada, T (corresponding author), Hosei Univ, Dept Frontier Biosci, Tokyo, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014	Shimada, Tomohiro/0000-0002-8361-0730	Ministry of Education, Culture, Sports, Science and Technology of Japan [21710198, 17076016, 8310133, 21241047]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid 21710198, 17076016, 8310133 and 21241047 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BOITEUX A, 1983, BIOCHEM J, V211, P631, DOI 10.1042/bj2110631; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Charbit A, 1996, J BIOL CHEM, V271, P9997, DOI 10.1074/jbc.271.17.9997; COOPER RA, 1967, PROC R SOC SER B-BIO, V168, P263, DOI 10.1098/rspb.1967.0065; DALDAL F, 1983, J MOL BIOL, V168, P285, DOI 10.1016/S0022-2836(83)80019-9; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; FELDHEIM DA, 1990, J BACTERIOL, V172, P5459, DOI 10.1128/jb.172.9.5459-5469.1990; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; GEERSE RH, 1989, MOL GEN GENET, V218, P348, DOI 10.1007/BF00331288; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; HARMAN JG, 2001, BIOCHIM BIOPHYS ACTA, V154, P1; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; IIDA A, 1993, J BACTERIOL, V175, P5375, DOI 10.1128/JB.175.17.5375-5383.1993; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; ISHIHAMA A, 2009, CELLULAR MOL BIOL; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Ishii D, 2009, BIOSCI BIOTECH BIOCH, V73, P2528, DOI 10.1271/bbb.90421; KATZ J, 1967, BIOCHEMISTRY-US, V6, P2227, DOI 10.1021/bi00859a046; KIM J, 1992, P NATL ACAD SCI USA, V89, P770; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KREBS A, 1980, CAN J BIOCHEM CELL B, V58, P309, DOI 10.1139/o80-041; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Lin SH, 2003, BIOCHEMISTRY-US, V42, P4809, DOI 10.1021/bi027259+; LINTON KJ, 1988, MOL MICROBIOL, V28, P5; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Miller JH, EXPT MOL GENETICS; MORI K, 1985, J BIOL CHEM, V260, P4838; Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami K, 1997, P NATL ACAD SCI USA, V94, P1709, DOI 10.1073/pnas.94.5.1709; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; Ogasawara H, 2007, J BACTERIOL, V189, P5534, DOI 10.1128/JB.00229-07; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PARKINSON G, 1996, J MOL BIOL, V304, P847; PASSNER JM, 1997, P NATL ACAD SCI USA, V94, P843; PASTAN I, 1970, SCIENCE, V169, P339, DOI 10.1126/science.169.3943.339; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Pyles EA, 1996, BIOCHEMISTRY-US, V35, P1162, DOI 10.1021/bi952187q; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; Saier MH, 1998, BIOTECHNOL BIOENG, V58, P170, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<170::AID-BIT9>3.0.CO;2-I; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2007, MOL MICROBIOL, V66, P744, DOI 10.1111/j.1365-2958.2007.05954.x; Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; Teramoto J, 2010, NUCLEIC ACIDS RES, V38, P3605, DOI 10.1093/nar/gkq077; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Wu LF, 1995, BIOCHIMIE, V77, P744, DOI 10.1016/0300-9084(96)88192-2; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; ZUBAY G, 1970, P NATL ACAD SCI USA, V66, P104, DOI 10.1073/pnas.66.1.104	72	164	164	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20081	10.1371/journal.pone.0020081	http://dx.doi.org/10.1371/journal.pone.0020081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673794	Green Published, gold, Green Submitted			2022-12-27	WOS:000291309900002
J	Chen, B; Jia, TL; Ma, RH; Zhang, B; Kang, L				Chen, Bing; Jia, Tieliu; Ma, Ronghui; Zhang, Bo; Kang, Le			Evolution of Hsp70 Gene Expression: A Role for Changes in AT-Richness within Promoters	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; DROSOPHILA; GC; REGION; ZESTE; INDUCTION; PATTERNS; SEQUENCE; DOMAINS	In disparate organisms adaptation to thermal stress has been linked to changes in the expression of genes encoding heat-shock proteins (Hsp). The underlying genetics, however, remain elusive. We show here that two AT-rich sequence elements in the promoter region of the hsp70 gene of the fly Liriomyza sativae that are absent in the congeneric species, Liriomyza huidobrensis, have marked cis-regulatory consequences. We studied the cis-regulatory consequences of these elements (called ATRS1 and ATRS2) by measuring the constitutive and heat-shock-induced luciferase luminescence that they drive in cells transfected with constructs carrying them modified, deleted, or intact, in the hsp70 promoter fused to the luciferase gene. The elements affected expression level markedly and in different ways: Deleting ATRS1 augmented both the constitutive and the heat-shock-induced luminescence, suggesting that this element represses transcription. Interestingly, replacing the element with random sequences of the same length and A+T content delivered the wild-type luminescence pattern, proving that the element's high A+T content is crucial for its effects. Deleting ATRS2 decreased luminescence dramatically and almost abolished heat-shock inducibility and so did replacing the element with random sequences matching the element's length and A+T content, suggesting that ATRS2's effects on transcription and heat-shock inducibility involve a common mechanism requiring at least in part the element's specific primary structure. Finally, constitutive and heat-shock luminescence were reduced strongly when two putative binding sites for the Zeste transcription factor identified within ATRS2 were altered through site-directed mutagenesis, and the heat-shock-induced luminescence increased when Zeste was over-expressed, indicating that Zeste participates in the effects mapped to ATRS2 at least in part. AT-rich sequences are common in promoters and our results suggest that they should play important roles in regulatory evolution since they can affect expression markedly and constrain promoter DNA in at least two different ways.	[Chen, Bing; Jia, Tieliu; Ma, Ronghui; Zhang, Bo; Kang, Le] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Chen, B (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	lkang@ioz.ac.cn	ma, rong/GVU-3096-2022; Kang, Le/ABD-1116-2022; Chen, Bing/C-4837-2019	Kang, Le/0000-0003-4262-2329; Chen, Bing/0000-0002-1238-3948	State Key Basic Research and Development Projects [2009CB119204]; National Natural Science Foundation of China [30970343]	State Key Basic Research and Development Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by State Key Basic Research and Development Projects (2009CB119204) and National Natural Science Foundation of China (30970343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1994, J BIOL CHEM, V269, P4804; Antezana MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002145; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; Bernardi G., 2005, STRUCTURAL EVOLUTION; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen B, 2007, J EVOLUTION BIOL, V20, P2056, DOI 10.1111/j.1420-9101.2007.01348.x; Chen B, 2005, OECOLOGIA, V144, P187, DOI 10.1007/s00442-005-0051-2; Chen B, 2008, CELL STRESS CHAPERON, V13, P11, DOI 10.1007/s12192-007-0002-4; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Delaney SK, 2007, PLANT CELL PHYSIOL, V48, P1426, DOI 10.1093/pcp/pcm111; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Forde B G, 1994, Results Probl Cell Differ, V20, P87; Graze RM, 2009, GENETICS, V183, P547, DOI 10.1534/genetics.109.105957; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Kube D, 1999, GENES IMMUN, V1, P105, DOI 10.1038/sj.gene.6363641; LANEY JD, 1992, GENE DEV, V6, P1531, DOI 10.1101/gad.6.8.1531; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerman DN, 2005, MOL BIOL EVOL, V22, P776, DOI 10.1093/molbev/msi063; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Mason PB, 1997, J BIOL CHEM, V272, P33227, DOI 10.1074/jbc.272.52.33227; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MCINTOSH AH, 1983, APPL ENTOMOL ZOOL, V18, P262, DOI 10.1303/aez.18.262; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; Michaud S, 1997, CELL MOL LIFE SCI, V53, P104, DOI 10.1007/PL00000572; MIRAULT ME, 1982, EMBO J, V1, P1279, DOI 10.1002/j.1460-2075.1982.tb00025.x; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; SPSS Inc, 1998, SPSS BAS 8 0 WIND US; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tajbakhsh J, 2000, EXP CELL RES, V255, P229, DOI 10.1006/excr.1999.4780; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Walser JC, 2006, PLOS GENET, V2, P1541, DOI 10.1371/journal.pgen.0020165; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; WU CT, 1989, TRENDS GENET, V5, P189, DOI 10.1016/0168-9525(89)90074-7; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang H, 2009, IN VITRO CELL DEV-AN, V45, P201, DOI 10.1007/s11626-009-9177-6; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101	48	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20308	10.1371/journal.pone.0020308	http://dx.doi.org/10.1371/journal.pone.0020308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655251	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600041
J	Hamid, MMA; Remarque, EJ; van Duivenvoorde, LM; van der Werff, N; Walraven, V; Faber, BW; Kocken, CHM; Thomas, AW				Hamid, Muzamil Mahdi Abdel; Remarque, Edmond J.; van Duivenvoorde, Leonie M.; van der Werff, Nicole; Walraven, Vanessa; Faber, Bart W.; Kocken, Clemens H. M.; Thomas, Alan W.			Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT (TM) Protects against Blood-Stage Challenge in Rhesus Macaques	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MALARIA VACCINE; FALCIPARUM MALARIA; MEROZOITE ANTIGEN; CLINICAL-TRIAL; IMMUNOGENICITY; ANTIBODIES; CANDIDATE; IMMUNITY; MONKEYS	Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading blood stage vaccine candidate. Plasmodium knowlesi AMA1 (PkAMA1) was produced and purified using similar methodology as for clinical grade PfAMA1 yielding a pure, conformational intact protein. Combined with the adjuvant CoVaccine HT (TM), PkAMA1 was found to be highly immunogenic in rabbits and the efficacy of the PkAMA1 was subsequently tested in a rhesus macaque blood-stage challenge model. Six rhesus monkeys were vaccinated with PkAMA1 and a control group of 6 were vaccinated with PfAMA1. A total of 50 mu g AMA1 was administered intramuscularly three times at 4 week intervals. One of six rhesus monkeys vaccinated with PkAMA1 was able to control parasitaemia, upon blood stage challenge with P. knowlesi H-strain. Four out of the remaining five showed a delay in parasite onset that correlated with functional antibody titres. In the PfAMA1 vaccinated control group, five out of six animals had to be treated with antimalarials 8 days after challenge; one animal did not become patent during the challenge period. Following a rest period, animals were boosted and challenged again. Four of the six rhesus monkeys vaccinated with PkAMA1 were able to control the parasitaemia, one had a delayed onset of parasitaemia and one animal was not protected, while all control animals required treatment. To confirm that the control of parasitaemia was AMA1-related, animals were allowed to recover, boosted and re-challenged with P. knowlesi Nuri strain. All control animals had to be treated with antimalarials by day 8, while five out of six PkAMA1 vaccinated animals were able to control parasitaemia. This study shows that: i) Yeast-expressed PkAMA1 can protect against blood stage challenge; ii) Functional antibody levels as measured by GIA correlated inversely with the day of onset and iii) GIA IC(50) values correlated with estimated in vivo growth rates.	[Hamid, Muzamil Mahdi Abdel; Remarque, Edmond J.; van Duivenvoorde, Leonie M.; van der Werff, Nicole; Walraven, Vanessa; Faber, Bart W.; Kocken, Clemens H. M.; Thomas, Alan W.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands		Hamid, MMA (corresponding author), Univ Khartoum, Inst Endem Dis, Khartoum, Sudan.	Remarque@bprc.nl	Remarque, Ed/AAE-8643-2020; /AAF-6018-2020; Abdel Hamid, Muzamil Mahdi/E-7234-2019	Abdel Hamid, Muzamil Mahdi/0000-0002-6157-4388; Faber, Bart/0000-0001-6808-1204; Kocken, Clemens/0000-0002-4784-1734	European Malaria Vaccine Initiative (EMVI) [0006/2001]	European Malaria Vaccine Initiative (EMVI)	This work was funded by the European Malaria Vaccine Initiative (EMVI) grant number 0006/2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Blom AG, 2004, VACCINE, V23, P743, DOI 10.1016/j.vaccine.2004.07.021; Breman JG, 2009, J INFECT DIS, V200, P317, DOI 10.1086/600121; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; Butcher GA, 2010, T ROY SOC TROP MED H, V104, P75, DOI 10.1016/j.trstmh.2009.05.017; BUTCHER GA, 1972, IMMUNOLOGY, V23, P503; Butcher GA, 1996, PARASITOL TODAY, V12, P378, DOI 10.1016/0169-4758(96)10062-4; COATNEY GR, 1971, PRIMATE MALARIAS; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; DEANS JA, 1984, MOL BIOCHEM PARASIT, V11, P189, DOI 10.1016/0166-6851(84)90065-3; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Deloron P, 1997, CLIN EXP IMMUNOL, V110, P212; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Guilbride DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010685; HAMID MMA, 2011, MALARIA J, V10, P1; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hilgers Luuk A T, 2006, Vaccine, V24 Suppl 2, pS2; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lalitha PV, 2004, INFECT IMMUN, V72, P4464, DOI 10.1128/IAI.72.8.4464-4470.2004; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; OUATTARA A, 2010, AM SOC TROP MED HYG; Pierce MA, 2010, VACCINE, V28, P2236, DOI 10.1016/j.vaccine.2009.12.049; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; THERA MA, 2010, AM SOC TROP MED HYG; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Xu HJ, 2000, J IMMUNOL, V165, P389, DOI 10.4049/jimmunol.165.1.389	44	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20547	10.1371/journal.pone.0020547	http://dx.doi.org/10.1371/journal.pone.0020547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655233	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600095
J	Laverty, C; Li, F; Belikoff, EJ; Scott, MJ				Laverty, Corey; Li, Fang; Belikoff, Esther J.; Scott, Maxwell J.			Abnormal Dosage Compensation of Reporter Genes Driven by the Drosophila Glass Multiple Reporter (GMR) Enhancer-Promoter	PLOS ONE			English	Article							CHROMATIN ENTRY SITE; X-CHROMOSOMAL GENES; DNA-BINDING PROTEIN; MSL COMPLEX; LETHAL COMPLEX; ANALYSIS REVEALS; GAGA FACTOR; EXPRESSION; MELANOGASTER; TARGET	In Drosophila melanogaster the male specific lethal (MSL) complex is required for upregulation of expression of most X-linked genes in males, thereby achieving X chromosome dosage compensation. The MSL complex is highly enriched across most active X-linked genes with a bias towards the 3' end. Previous studies have shown that gene transcription facilitates MSL complex binding but the type of promoter did not appear to be important. We have made the surprising observation that genes driven by the glass multiple reporter (GMR) enhancer-promoter are not dosage compensated at X-linked sites. The GMR promoter is active in all cells in, and posterior to, the morphogenetic furrow of the developing eye disc. Using phiC31 integrase-mediated targeted integration, we measured expression of lacZ reporter genes driven by either the GMR or armadillo (arm) promoters at each of three X-linked sites. At all sites, the arm-lacZ reporter gene was dosage compensated but GMR-lacZ was not. We have investigated why GMR-driven genes are not dosage compensated. Earlier or constitutive expression of GMR-lacZ did not affect the level of compensation. Neither did proximity to a strong MSL binding site. However, replacement of the hsp70 minimal promoter with a minimal promoter from the X-linked 6-Phosphogluconate dehydrogenase gene did restore partial dosage compensation. Similarly, insertion of binding sites for the GAGA and DREF factors upstream of the GMR promoter led to significantly higher lacZ expression in males than females. GAGA and DREF have been implicated to play a role in dosage compensation. We conclude that the gene promoter can affect MSL complex-mediated upregulation and dosage compensation. Further, it appears that the nature of the basal promoter and the presence of binding sites for specific factors influence the ability of a gene promoter to respond to the MSL complex.	[Laverty, Corey; Li, Fang; Belikoff, Esther J.; Scott, Maxwell J.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Laverty, C (corresponding author), EMBL, Heidelberg, Germany.	mjscott3@ncsu.edu	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735	Massey University	Massey University	CL was supported by a doctoral scholarship from Massey University. There was no other funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bello B, 1998, DEVELOPMENT, V125, P2193; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Fagegaltier D, 2004, PLOS BIOL, V2, P1854, DOI 10.1371/journal.pbio.0020341; Fitzsimons HL, 1999, GENETICA, V105, P215, DOI 10.1023/A:1003801402153; Furuhashi H, 2006, DEVELOPMENT, V133, P4475, DOI 10.1242/dev.02620; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; GERGEN JP, 1987, GENETICS, V117, P477; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; GLASER RL, 1986, EMBO J, V5, P747, DOI 10.1002/j.1460-2075.1986.tb04277.x; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Greenberg AJ, 2004, GENETICS, V166, P279, DOI 10.1534/genetics.166.1.279; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; GUTIERREZ AG, 1989, DEV GENET, V10, P155, DOI 10.1002/dvg.1020100305; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HAY BA, 1994, DEVELOPMENT, V120, P2121; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Henry RA, 2001, J BIOL CHEM, V276, P31953, DOI 10.1074/jbc.M103008200; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Horn C, 2003, GENETICS, V163, P647; Horn C, 2003, NAT BIOTECHNOL, V21, P64, DOI 10.1038/nbt769; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kelley RL, 2003, GENETICS, V164, P565; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Kind J, 2007, GENE DEV, V21, P2030, DOI 10.1101/gad.430807; Kotlikova IV, 2006, GENETICS, V172, P963, DOI 10.1534/genetics.105.045286; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Laverty C, 2010, CURR OPIN GENET DEV, V20, P171, DOI 10.1016/j.gde.2010.01.007; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lerach S, 2005, GENESIS, V43, P213, DOI 10.1002/gene.20172; LUCCHESI JC, 1987, ADV GENET, V24, P371, DOI 10.1016/S0065-2660(08)60013-9; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; McAnally AA, 2010, GENOME BIOL EVOL, V2, P44, DOI 10.1093/gbe/evp054; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Moore SA, 2010, J BIOL CHEM, V285, P40879, DOI 10.1074/jbc.M110.134312; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Oh H, 2004, CURR BIOL, V14, P481, DOI 10.1016/j.cub.2004.03.004; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Plautz JD, 1996, GENE, V173, P83, DOI 10.1016/0378-1119(95)00700-8; QIAN S, 1995, GENETICS, V139, P733; ROBERTS DB, 1979, NATURE, V280, P691, DOI 10.1038/280691a0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sass GL, 2003, P NATL ACAD SCI USA, V100, P8287, DOI 10.1073/pnas.1332749100; Schiemann AH, 2010, BIOCHEM BIOPH RES CO, V402, P699, DOI 10.1016/j.bbrc.2010.10.088; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Scott MJ, 2004, INSECT BIOCHEM MOLEC, V34, P185, DOI 10.1016/j.ibmb.2003.11.001; SCOTT MJ, 1991, GENE, V109, P177, DOI 10.1016/0378-1119(91)90607-D; Seto H, 2006, GENES CELLS, V11, P499, DOI 10.1111/j.1365-2443.2006.00956.x; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SIMCOX AA, 1985, MOL CELL BIOL, V5, P3397, DOI 10.1128/MCB.5.12.3397; SIMON JA, 1987, NUCLEIC ACIDS RES, V15, P2971, DOI 10.1093/nar/15.7.2971; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Spierer A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000066; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Stenberg P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000465; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Weake VM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-35; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	80	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20455	10.1371/journal.pone.0020455	http://dx.doi.org/10.1371/journal.pone.0020455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655213	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600073
J	Welin, A; Eklund, D; Stendahl, O; Lerm, M				Welin, Amanda; Eklund, Daniel; Stendahl, Olle; Lerm, Maria			Human Macrophages Infected with a High Burden of ESAT-6-Expressing M. tuberculosis Undergo Caspase-1-and Cathepsin B-Independent Necrosis	PLOS ONE			English	Article							INTERNUCLEOSOMAL DNA CLEAVAGE; NECROTIC CELL-DEATH; MYCOBACTERIUM-TUBERCULOSIS; CALMETTE-GUERIN; PORE FORMATION; APOPTOSIS; INFLAMMASOME; VIRULENCE; ACTIVATION; SECRETION	Mycobacterium tuberculosis (Mtb) infects lung macrophages, which instead of killing the pathogen can be manipulated by the bacilli, creating an environment suitable for intracellular replication and spread to adjacent cells. The role of host cell death during Mtb infection is debated because the bacilli have been shown to be both anti-apoptotic, keeping the host cell alive to avoid the antimicrobial effects of apoptosis, and pro-necrotic, killing the host macrophage to allow infection of neighboring cells. Since mycobacteria activate the NLRP3 inflammasome in macrophages, we investigated whether Mtb could induce one of the recently described inflammasome-linked cell death modes pyroptosis and pyronecrosis. These are mediated through caspase-1 and cathepsin-B, respectively. Human monocyte-derived macrophages were infected with virulent (H37Rv) Mtb at a multiplicity of infection (MOI) of 1 or 10. The higher MOI resulted in strongly enhanced release of IL-1 beta, while a low MOI gave no IL-1 beta response. The infected macrophages were collected and cell viability in terms of the integrity of DNA, mitochondria and the plasma membrane was determined. We found that infection with H37Rv at MOI 10, but not MOI 1, over two days led to extensive DNA fragmentation, loss of mitochondrial membrane potential, loss of plasma membrane integrity, and HMGB1 release. Although we observed plasma membrane permeabilization and IL-1 beta release from infected cells, the cell death induced by Mtb was not dependent on caspase-1 or cathepsin B. It was, however, dependent on mycobacterial expression of ESAT-6. We conclude that as virulent Mtb reaches a threshold number of bacilli inside the human macrophage, ESAT-6-dependent necrosis occurs, activating caspase-1 in the process.	[Welin, Amanda; Eklund, Daniel; Stendahl, Olle; Lerm, Maria] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lerm, Maria] Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden	Linkoping University; Karolinska Institutet	Welin, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	daniel.eklund@liu.se	Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Lerm, Maria/0000-0002-5092-9892; Eklund, Daniel/0000-0002-6045-4800	Swedish Research Council [529-2003-5994, 2005-7046, 2006-5968]; SIDA/SAREC; ULF; Ekhaga Foundation; Carl Trygger Foundation; King Gustaf V 80-Year Memorial Foundation; County Council of Ostergotland; Swedish Heart Lung Foundation; Oskar II Jubilee Foundation; Clas Groschinsky Foundation; Soderbergs Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); SIDA/SAREC; ULF; Ekhaga Foundation; Carl Trygger Foundation; King Gustaf V 80-Year Memorial Foundation; County Council of Ostergotland; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Oskar II Jubilee Foundation; Clas Groschinsky Foundation; Soderbergs Foundation	This work was supported by grants from the Swedish Research Council (#529-2003-5994, #2005-7046, #2006-5968), SIDA/SAREC, ULF, Ekhaga Foundation, Carl Trygger Foundation, King Gustaf V 80-Year Memorial Foundation, County Council of Ostergotland, Swedish Heart Lung Foundation, Oskar II Jubilee Foundation, Clas Groschinsky Foundation, and the Soderbergs Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; BARNES PF, 1992, J IMMUNOL, V149, P541; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; COLLINS RJ, 1992, INT J RADIAT BIOL, V61, P451, DOI 10.1080/09553009214551201; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Dong Z, 1997, AM J PATHOL, V151, P1205; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gan HX, 2005, J INFECT DIS, V191, P1292, DOI 10.1086/428906; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee Jinhee, 2010, J Cell Death, V3, P1; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mihalik R, 2004, CELL DEATH DIFFER, V11, P1357, DOI 10.1038/sj.cdd.4401493; Mishra BB, 2010, CELL MICROBIOL; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Welin A, 2008, INFECT IMMUN, V76, P2882, DOI 10.1128/IAI.01549-07; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079	60	97	105	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20302	10.1371/journal.pone.0020302	http://dx.doi.org/10.1371/journal.pone.0020302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637850	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200049
J	Cebulski, J; Malouin, J; Pinches, N; Cascio, V; Austriaco, N				Cebulski, James; Malouin, Joshua; Pinches, Nathan; Cascio, Vincent; Austriaco, Nicanor			Yeast Bax Inhibitor, Bxi1p, Is an ER-Localized Protein That Links the Unfolded Protein Response and Programmed Cell Death in Saccharomyces cerevisiae	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; DOWN-REGULATION; INDUCED APOPTOSIS; PROSTATE-CANCER; PLANT HOMOLOG; BI-1; SUPPRESSOR; REGULATOR; OVEREXPRESSION	Bax inhibitor-1 (BI-1) is an anti-apoptotic gene whose expression is upregulated in a wide range of human cancers. Studies in both mammalian and plant cells suggest that the BI-1 protein resides in the endoplasmic reticulum and is involved in the unfolded protein response (UPR) that is triggered by ER stress. It is thought to act via a mechanism involving altered calcium dynamics. In this paper, we provide evidence that the Saccharomyces cerevisiae protein encoded by the open reading frame, YNL305C, is a bona fide homolog for BI-1. First, we confirm that yeast cells from two different strain backgrounds lacking YNL305C, which we have renamed BXI1, are more sensitive to heat-shock induced cell death than wildtype controls even though they have indistinguishable growth rates at 30 degrees C. They are also more susceptible both to ethanol-induced and to glucose-induced programmed cell death. Significantly, we show that Bxi1p-GFP colocalizes with the ER localized protein Sec63p-RFP. We have also discovered that Delta bxi1 cells are not only more sensitive to drugs that induce ER stress, but also have a decreased unfolded protein response as measured with a UPRE-lacZ reporter. Finally, we have discovered that deleting BXI1 diminishes the calcium signaling response in response to the accumulation of unfolded proteins in the ER as measured by a calcineurin-dependent CDRE-lacZ reporter. In toto, our data suggests that the Bxi1p, like its metazoan homologs, is an ER-localized protein that links the unfolded protein response and programmed cell death.	[Cebulski, James; Malouin, Joshua; Pinches, Nathan; Cascio, Vincent; Austriaco, Nicanor] Providence Coll, Dept Biol, Providence, RI 02918 USA	Providence College	Cebulski, J (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.	naustria@providence.edu		Austriaco, Nicanor/0000-0003-1854-8181	NIGMS [R15 GM094712]; NSF [MRI-R2 0959354]; NIH [2 P20 RR016457]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430, R15GM094712] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors' laboratory is supported by the following grants awarded to N. Austriaco: NIGMS R15 GM094712 (http://www.nigms.nih.gov/), NSF MRI-R2 0959354 (http://www.nsf.gov/), and NIH Grant 2 P20 RR016457 to the Rhode Island INBRE Program (http://www.uri.edu/inbre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; Amberg DC., 2005, METHODS YEAST GENETI; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bolduc N, 2002, FEBS LETT, V532, P111, DOI 10.1016/S0014-5793(02)03650-5; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Cowling RT, 1998, MOL MEMBR BIOL, V15, P177, DOI 10.3109/09687689709044319; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Granot D, 1997, CELL DEATH DIFFER, V4, P555, DOI 10.1038/sj.cdd.4400280; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; Harima Y, 2004, INT J RADIAT ONCOL, V60, P237, DOI 10.1016/j.ijrobp.2004.02.047; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kitagaki H, 2007, FEBS LETT, V581, P2935, DOI 10.1016/j.febslet.2007.05.048; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Kotsafti A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-35; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Li XY, 2010, CELL BIOL INT, V34, P1099, DOI 10.1042/CBI20090400; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; ROBINSON KS, 2011, ONCOGENE        0207, DOI DOI 10.1038/ONC.2010.636; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Schmits R, 2002, INT J CANCER, V98, P73, DOI 10.1002/ijc.10170; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villalva C, 2002, BRIT J HAEMATOL, V118, P791, DOI 10.1046/j.1365-2141.2002.03671.x; WALTER L, 1995, GENOMICS, V28, P301, DOI 10.1006/geno.1995.1145; WALTER L, 1994, MAMM GENOME, V5, P216, DOI 10.1007/BF00360548; Watanabe N, 2008, PLANT SIGNAL BEHAV, V3, P564, DOI 10.4161/psb.3.8.5709; Welsh JB, 2001, CANCER RES, V61, P5974; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	49	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20882	10.1371/journal.pone.0020882	http://dx.doi.org/10.1371/journal.pone.0020882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673967	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400036
J	Childs, AJ; Cowan, G; Kinnell, HL; Anderson, RA; Saunders, PTK				Childs, Andrew J.; Cowan, Gillian; Kinnell, Hazel L.; Anderson, Richard A.; Saunders, Philippa T. K.			Retinoic Acid Signalling and the Control of Meiotic Entry in the Human Fetal Gonad	PLOS ONE			English	Article							GERM-CELL DIFFERENTIATION; SOMATIC-CELLS; SUPPRESSES MEIOSIS; HUMAN OVARY; MOUSE; EXPRESSION; MICE; INITIATION; RECEPTORS; ACTIVIN	The development of mammalian fetal germ cells along oogenic or spermatogenic fate trajectories is dictated by signals from the surrounding gonadal environment. Germ cells in the fetal testis enter mitotic arrest, whilst those in the fetal ovary undergo sex-specific entry into meiosis, the initiation of which is thought to be mediated by selective exposure of fetal ovarian germ cells to mesonephros-derived retinoic acid (RA). Aspects of this model are hard to reconcile with the spatiotemporal pattern of germ cell differentiation in the human fetal ovary, however. We have therefore examined the expression of components of the RA synthesis, metabolism and signalling pathways, and their downstream effectors and inhibitors in germ cells around the time of the initiation of meiosis in the human fetal gonad. Expression of the three RA-synthesising enzymes, ALDH1A1, 2 and 3 in the fetal ovary and testis was equal to or greater than that in the mesonephros at 8-9 weeks gestation, indicating an intrinsic capacity within the gonad to synthesise RA. Using immunohistochemistry to detect RA receptors RAR alpha, beta and RXR alpha, we find germ cells to be the predominant target of RA signalling in the fetal human ovary, but also reveal widespread receptor nuclear localization indicative of signalling in the testis, suggesting that human fetal testicular germ cells are not efficiently shielded from RA by the action of the RA-metabolising enzyme CYP26B1. Consistent with this, expression of CYP26B1 was greater in the human fetal ovary than testis, although the sexually-dimorphic expression patterns of the germ cell-intrinsic regulators of meiotic initiation, STRA8 and NANOS2, appear conserved. Finally, we demonstrate that RA induces a two-fold increase in STRA8 expression in cultures of human fetal testis, but is not sufficient to cause widespread meiosis-associated gene expression. Together, these data indicate that while local production of RA within the fetal ovary may be important in regulating the onset of meiosis in the human fetal ovary, mechanisms other than CYP26B1-mediated metabolism of RA may exist to inhibit the entry of germ cells into meiosis in the human fetal testis.	[Childs, Andrew J.; Cowan, Gillian; Kinnell, Hazel L.; Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, Med Res Council, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Biol, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Edinburgh	Childs, AJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Med Res Council, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	a.childs@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; Childs, Andrew/0000-0003-3937-4037	Medical Research Council [U.1276.00.002.00005.01, U.1276.00.002.00001.01]; Medical Research Scotland [354FRG]; MRC [G1100357, MC_U127685844, G1002033, G1100356] Funding Source: UKRI; Medical Research Council [G1002033, MC_U127685844, G1100357, G1100356] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council (www.mrc.ac.uk) core funding to PTKS (U.1276.00.002.00005.01) and RAA (U.1276.00.002.00001.01). AJC is supported by Medical Research Scotland (www.medicalresearchscotland.com research grant 354FRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bowles J, 2009, DEV DYNAM, V238, P2073, DOI 10.1002/dvdy.22024; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Childs AJ, 2010, DEV DYNAM, V239, P1211, DOI 10.1002/dvdy.22252; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; Cowan G, 2010, REPRODUCTION, V139, P749, DOI 10.1530/REP-09-0532; Cupp AS, 1999, ENDOCRINOLOGY, V140, P2343, DOI 10.1210/en.140.5.2343; da Silva SJM, 2004, DEV BIOL, V266, P334, DOI 10.1016/j.ydbio.2003.10.030; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Le Bouffant R, 2010, HUM REPROD, V25, P2579, DOI 10.1093/humrep/deq195; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Morita Y, 1999, ENDOCRINOLOGY, V140, P2696, DOI 10.1210/en.140.6.2696; Niederreither K, 2002, DEVELOPMENT, V129, P3563; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Polkinghorne J, 1989, REV GUIDANCE RES USE; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wendling O, 1999, P NATL ACAD SCI USA, V96, P547, DOI 10.1073/pnas.96.2.547	36	102	109	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20249	10.1371/journal.pone.0020249	http://dx.doi.org/10.1371/journal.pone.0020249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674038	Green Submitted, gold, Green Published			2022-12-27	WOS:000291355500010
J	Lytkin, NI; Mcvoy, L; Weitkamp, JH; Aliferis, CF; Statnikov, A				Lytkin, Nikita I.; McVoy, Lauren; Weitkamp, Joern-Hendrik; Aliferis, Constantin F.; Statnikov, Alexander			Expanding the Understanding of Biases in Development of Clinical-Grade Molecular Signatures: A Case Study in Acute Respiratory Viral Infections	PLOS ONE			English	Article							MARKOV BLANKET INDUCTION; FALSE DISCOVERY RATE; FEATURE-SELECTION; CAUSAL DISCOVERY; LOCAL CAUSAL; MICROARRAY; CANCER; PATTERNS; PITFALLS	Background: The promise of modern personalized medicine is to use molecular and clinical information to better diagnose, manage, and treat disease, on an individual patient basis. These functions are predominantly enabled by molecular signatures, which are computational models for predicting phenotypes and other responses of interest from high-throughput assay data. Data-analytics is a central component of molecular signature development and can jeopardize the entire process if conducted incorrectly. While exploratory data analysis may tolerate suboptimal protocols, clinical-grade molecular signatures are subject to vastly stricter requirements. Closing the gap between standards for exploratory versus clinically successful molecular signatures entails a thorough understanding of possible biases in the data analysis phase and developing strategies to avoid them. Methodology and Principal Findings: Using a recently introduced data-analytic protocol as a case study, we provide an in-depth examination of the poorly studied biases of the data-analytic protocols related to signature multiplicity, biomarker redundancy, data preprocessing, and validation of signature reproducibility. The methodology and results presented in this work are aimed at expanding the understanding of these data-analytic biases that affect development of clinically robust molecular signatures. Conclusions and Significance: Several recommendations follow from the current study. First, all molecular signatures of a phenotype should be extracted to the extent possible, in order to provide comprehensive and accurate grounds for understanding disease pathogenesis. Second, redundant genes should generally be removed from final signatures to facilitate reproducibility and decrease manufacturing costs. Third, data preprocessing procedures should be designed so as not to bias biomarker selection. Finally, molecular signatures developed and applied on different phenotypes and populations of patients should be treated with great caution.	[Lytkin, Nikita I.; Aliferis, Constantin F.; Statnikov, Alexander] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [McVoy, Lauren; Aliferis, Constantin F.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Weitkamp, Joern-Hendrik] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37212 USA; [Weitkamp, Joern-Hendrik] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Aliferis, Constantin F.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; Vanderbilt University; Vanderbilt University; Vanderbilt University; New York University	Lytkin, NI (corresponding author), NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA.	Alexander.Statnikov@med.nyu.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020	Weitkamp, Joern-Hendrik/0000-0002-6654-4823	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K08HD061607]; National Center for Research Resources, National Institutes of Health [1UL1RR029893]; National Library of Medicine, National Institutes of Health [R56 LM007948-04A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R56LM007948] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	JHW was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grant K08HD061607. CFA and AS were supported in part by the grant 1UL1RR029893 from the National Center for Research Resources, National Institutes of Health. CFA was also supported in part by the grant R56 LM007948-04A1 from the National Library of Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Aliferis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004922; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anderson TW., 2003, INTRO MULTIVARIATE S, V3; Azuaje F, 2005, DATA ANALYSIS AND VISUALIZATION IN GENOMICS AND PROTEOMICS, P1, DOI 10.1002/0470094419; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Gonzalez FJ, 2006, ANNU REV PHARMACOL, V46, P41, DOI 10.1146/annurev.pharmtox.45.120403.100007; Guyon I, 2008, CH CRC DATA MIN KNOW, P63; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Janzing D., 2010, JMLR WORKSHOP C P, V6, P1; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu Z, 2004, CLIN IMMUNOL, V112, P225, DOI 10.1016/j.clim.2004.03.017; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Somorjai RL, 2003, BIOINFORMATICS, V19, P1484, DOI 10.1093/bioinformatics/btg182; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Statnikov A., 2010, J MACHINE LEARNING R, V6, P249; Statnikov A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000958; Statnikov Alexander, 2010, BMC Res Notes, V3, P264, DOI 10.1186/1756-0500-3-264; Statnikov A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000790; Statnikov A, 2010, CELL HOST MICROBE, V7, P100, DOI 10.1016/j.chom.2010.01.003; Tsamardinos I., 2003, P 9 INT WORKSH ART I; Vapnik VN, 1998, STAT LEARNING THEORY; Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	40	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20662	10.1371/journal.pone.0020662	http://dx.doi.org/10.1371/journal.pone.0020662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673802	Green Published, gold, Green Submitted			2022-12-27	WOS:000291309900027
J	Angel, R; Matthies, D; Conrad, R				Angel, Roey; Matthies, Diethart; Conrad, Ralf			Activation of Methanogenesis in Arid Biological Soil Crusts Despite the Presence of Oxygen	PLOS ONE			English	Article							CARBON-ISOTOPE FRACTIONATION; METHANOSARCINA-BARKERI; ANAEROBIC-BACTERIA; ARCHAEAL COMMUNITY; NEGEV DESERT; RICE; DIVERSITY; RESPONSES; SEDIMENT; EXPOSURE	Methanogenesis is traditionally thought to occur only in highly reduced, anoxic environments. Wetland and rice field soils are well known sources for atmospheric methane, while aerated soils are considered sinks. Although methanogens have been detected in low numbers in some aerated, and even in desert soils, it remains unclear whether they are active under natural oxic conditions, such as in biological soil crusts (BSCs) of arid regions. To answer this question we carried out a factorial experiment using microcosms under simulated natural conditions. The BSC on top of an arid soil was incubated under moist conditions in all possible combinations of flooding and drainage, light and dark, air and nitrogen headspace. In the light, oxygen was produced by photosynthesis. Methane production was detected in all microcosms, but rates were much lower when oxygen was present. In addition, the delta C-13 of the methane differed between the oxic/oxygenic and anoxic microcosms. While under anoxic conditions methane was mainly produced from acetate, it was almost entirely produced from H-2/CO2 under oxic/oxygenic conditions. Only two genera of methanogens were identified in the BSC-Methanosarcina and Methanocella; their abundance and activity in transcribing the mcrA gene (coding for methyl-CoM reductase) was higher under anoxic than oxic/oxygenic conditions, respectively. Both methanogens also actively transcribed the oxygen detoxifying gene catalase. Since methanotrophs were not detectable in the BSC, all the methane produced was released into the atmosphere. Our findings point to a formerly unknown participation of desert soils in the global methane cycle.	[Angel, Roey; Conrad, Ralf] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Matthies, Diethart] Univ Marburg, Dept Ecol, Marburg, Germany	Max Planck Society; Philipps University Marburg	Conrad, R (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	conrad@mpi-marburg.mpg.de	Angel, Roey/T-3597-2017	Angel, Roey/0000-0002-2804-9661; Matthies, Diethart/0000-0003-2439-0501	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank Prof. Peter Frenzel of the Max-Planck-Institute for Terrestrial Microbiology in Marburg, Germany for his help in designing the microcosms and Horst Henseling for constructing them; Dr. Osnat Gillor of Ben Gurion University of the Negev, Israel for her assistance in the soil sampling; The Institute for Soil Science and Forest Nutrition (IBW) at the University of Gottingen, Germany for determining the isotopic signature of the soil organic carbon. RA was supported by a fellowship of the Max Planck Society.	Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Angel R, 2009, ENVIRON MICROBIOL, V11, P2598, DOI 10.1111/j.1462-2920.2009.01984.x; Banning N, 2005, ENVIRON MICROBIOL, V7, P947, DOI 10.1111/j.1462-2920.2004.00766.x; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2009, LIMNOL OCEANOGR, V54, P457, DOI 10.4319/lo.2009.54.2.0457; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; FETZER S, 1993, FEMS MICROBIOL ECOL, V12, P107; Garcia-Pichel F, 2002, ENCY ENV MICROBIOLOG; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GELWICKS JT, 1994, APPL ENVIRON MICROB, V60, P467, DOI 10.1128/AEM.60.2.467-472.1994; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P4552, DOI 10.1128/AEM.63.11.4552-4557.1997; JEFFRIES DL, 1993, NEW PHYTOL, V125, P163, DOI 10.1111/j.1469-8137.1993.tb03874.x; KRZYCKI JA, 1987, APPL ENVIRON MICROB, V53, P2597, DOI 10.1128/AEM.53.10.2597-2599.1987; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; LANGE OL, 1994, FUNCT ECOL, V8, P253, DOI 10.2307/2389909; Liu CT, 2008, CURR MICROBIOL, V56, P214, DOI 10.1007/s00284-007-9059-7; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Murase J, 2007, ENVIRON MICROBIOL, V9, P3025, DOI 10.1111/j.1462-2920.2007.01414.x; Nisbet EG, 1999, P ROY SOC B-BIOL SCI, V266, P2375, DOI 10.1098/rspb.1999.0934; Oremland R.S., 1988, BIOL ANAEROBIC MICRO; PETERS V, 1995, APPL ENVIRON MICROB, V61, P1673, DOI 10.1128/AEM.61.4.1673-1676.1995; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; SAKAI S, 2010, INT J SYST EVOL MICR; SCHONHEIT P, 1981, FEMS MICROBIOL LETT, V12, P347, DOI 10.1016/0378-1097(81)90216-0; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; VERSTRAETE MM, 1991, VEGETATIO, V91, P3, DOI 10.1007/BF00036043; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Wilske B, 2008, BIOGEOSCIENCES, V5, P1411, DOI 10.5194/bg-5-1411-2008; Yuan YL, 2009, ENV MICROBIOL REP, V1, P347, DOI 10.1111/j.1758-2229.2009.00036.x; Zaady E, 2010, SEDIMENTOLOGY, V57, P351, DOI 10.1111/j.1365-3091.2009.01081.x; Zehnder AJB, 1988, BIOL ANAEROBIC MICRO, P1; Zhang WW, 2006, J IND MICROBIOL BIOT, V33, P784, DOI 10.1007/s10295-006-0114-3; Zinder Stephen H., 1993, P128	45	159	168	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20453	10.1371/journal.pone.0020453	http://dx.doi.org/10.1371/journal.pone.0020453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655270	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600072
J	Deleidi, M; Cooper, O; Hargus, G; Levy, A; Isacson, O				Deleidi, Michela; Cooper, Oliver; Hargus, Gunnar; Levy, Adam; Isacson, Ole			Oct4-Induced Reprogramming Is Required for Adult Brain Neural Stem Cell Differentiation into Midbrain Dopaminergic Neurons	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; PARKINSONS-DISEASE; PROGENITOR CELLS; MAMMALIAN BRAIN; IN-VITRO; EPIGENETIC REGULATION; NEUROTROPHIC FACTOR; GENE-EXPRESSION; RAT MODEL; FATE	Neural stem cells (NSCs) lose their competency to generate region-specific neuronal populations at an early stage during embryonic brain development. Here we investigated whether epigenetic modifications can reverse the regional restriction of mouse adult brain subventricular zone (SVZ) NSCs. Using a variety of chemicals that interfere with DNA methylation and histone acetylation, we showed that such epigenetic modifications increased neuronal differentiation but did not enable specific regional patterning, such as midbrain dopaminergic (DA) neuron generation. Only after Oct-4 overexpression did adult NSCs acquire a pluripotent state that allowed differentiation into midbrain DA neurons. DA neurons derived from Oct4-reprogrammed NSCs improved behavioural motor deficits in a rat model of Parkinson's disease (PD) upon intrastriatal transplantation. Here we report for the first time the successful differentiation of SVZ adult NSCs into functional region-specific midbrain DA neurons, by means of Oct-4 induced pluripotency.	[Deleidi, Michela; Cooper, Oliver; Hargus, Gunnar; Levy, Adam; Isacson, Ole] Harvard Univ, McLean Hosp, Sch Med, Ctr Neuroregenerat Res, Belmont, MA 02178 USA; [Deleidi, Michela; Cooper, Oliver; Hargus, Gunnar; Levy, Adam; Isacson, Ole] Harvard Univ, Sch Med, Udall Parkinsons Dis Res Ctr Excellence, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Deleidi, M (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Ctr Neuroregenerat Res, Belmont, MA 02178 USA.	ole_isacson@hms.harvard.edu		Deleidi, Michela/0000-0003-0357-0124; Cooper, Oliver/0000-0001-6567-7491; /0000-0003-2460-5090; Isacson, Ole/0000-0001-8091-8302	Udall Parkinson's Disease Center of Excellence [P50 NS39793]; Michael Stern Foundation [WX81XWH-05-1-0555]; Orchard Foundation; Poul Hansen Family; Consolidated Anti-Aging Foundation; Harold and Ronna Cooper Family; Deutsche Forschungsgemeinschaft [HA5589/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	Udall Parkinson's Disease Center of Excellence; Michael Stern Foundation; Orchard Foundation; Poul Hansen Family; Consolidated Anti-Aging Foundation; Harold and Ronna Cooper Family; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants to O.I. from the Udall Parkinson's Disease Center of Excellence Grant P50 NS39793, Michael Stern Foundation (WX81XWH-05-1-0555), Orchard Foundation, Poul Hansen Family, the Consolidated Anti-Aging Foundation and the Harold and Ronna Cooper Family, postdoctoral fellowship HA5589/1-1 from the Deutsche Forschungsgemeinschaft (to G. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Daadi MM, 1999, J NEUROSCI, V19, P4484; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; Di Stefano B, 2009, STEM CELLS DEV, V18, P707, DOI 10.1089/scd.2008.0180; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Jain M, 2003, EXP NEUROL, V182, P113, DOI 10.1016/S0014-4886(03)00055-4; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kim JB, 2008, NATURE; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Papanikolaou T, 2008, STEM CELLS DEV, V17, P157, DOI 10.1089/scd.2007.0090; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192	47	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19926	10.1371/journal.pone.0019926	http://dx.doi.org/10.1371/journal.pone.0019926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655272	Green Published, gold			2022-12-27	WOS:000291097600011
J	Koog, YH; We, SR; Min, BI				Koog, Yun Hyung; We, Seo Ryang; Min, Byung-Il			Three-Armed Trials Including Placebo and No-Treatment Groups May Be Subject to Publication Bias: Systematic Review	PLOS ONE			English	Review							ELECTRICAL NERVE-STIMULATION; ANTIDEPRESSANT TRIALS; ACUPUNCTURE TREATMENT; COMPARING PLACEBO; CLINICAL-TRIALS; FUNNEL PLOTS; PAIN RELIEF; METAANALYSIS; ACUPRESSURE; NAUSEA	Background: It has been argued that placebos may not have important clinical impacts in general. However, there is increasing evidence of a publication bias among trials published in journals. Therefore, we explored the potential for publication bias in randomized trials with active treatment, placebo, and no-treatment groups. Methods: Three-armed randomized trials of acupuncture, acupoint stimulation, and transcutaneous electrical stimulation were obtained from electronic databases. Effect sizes between treatment and placebo groups were calculated for treatment effect, and effect sizes between placebo and no-treatment groups were calculated for placebo effect. All data were then analyzed for publication bias. Results: For the treatment effect, small trials with fewer than 100 patients per arm showed more benefits than large trials with at least 100 patients per arm in acupuncture and acupoint stimulation. For the placebo effect, no differences were found between large and small trials. Further analyses showed that the treatment effect in acupuncture and acupoint stimulation may be subject to publication bias because study design and any known factors of heterogeneity were not associated with the small study effects. In the simulation, the magnitude of the placebo effect was smaller than that calculated after considering publication bias. Conclusions: Randomized three-armed trials, which are necessary for estimating the placebo effect, may be subject to publication bias. If the magnitude of the placebo effect is assessed in an intervention, the potential for publication bias should be investigated using data related to the treatment effect.	[Koog, Yun Hyung; We, Seo Ryang] Medifarm Hosp, Honam Res Ctr, Sunchon, South Korea; [Min, Byung-Il] Kyung Hee Univ, Dept EW Med, Grad Sch, Seoul, South Korea; [Min, Byung-Il] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Koog, YH (corresponding author), Medifarm Hosp, Honam Res Ctr, Sunchon, South Korea.	samlungchim@hanmail.net; mbi@khu.ac.kr						Alkaissi A, 1999, ACTA ANAESTH SCAND, V43, P270, DOI 10.1034/j.1399-6576.1999.430306.x; Alkaissi A, 2002, CAN J ANAESTH, V49, P1034, DOI 10.1007/BF03017897; ALTMAN DG, 2003, BMJ-BRIT MED J, V325, P219; Arai YCP, 2008, BRIT J ANAESTH, V100, P78, DOI 10.1093/bja/aem306; Aune A, 1998, SCAND J PRIM HEALTH, V16, P37; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Breit R, 2004, J ARTHROPLASTY, V19, P45, DOI 10.1016/S0883-5403(03)00458-3; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Cho HJ, 2005, PSYCHOSOM MED, V67, P301, DOI 10.1097/01.psy.0000156969.76986.e0; Defrin R, 2005, PAIN, V115, P152, DOI 10.1016/j.pain.2005.02.018; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUNDEE JW, 1986, BRIT MED J, V293, P583, DOI 10.1136/bmj.293.6547.583; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ernst E, 2008, J POSTGRAD MED, V54, P214, DOI 10.4103/0022-3859.41806; Facco E, 2008, HEADACHE, V48, P398, DOI 10.1111/j.1526-4610.2007.00916.x; Fanti L, 2003, AM J GASTROENTEROL, V98, P312, DOI 10.1016/S0002-9270(02)05899-9; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freire AO, 2007, SLEEP MED, V8, P43, DOI 10.1016/j.sleep.2006.04.009; GALLOWAY DJ, 1984, SURG GYNECOL OBSTET, V159, P453; Gioia L, 2006, J CATARACT REFR SURG, V32, P1951, DOI 10.1016/j.jcrs.2006.06.027; Gosman-Hedstrom G, 1998, STROKE, V29, P2100, DOI 10.1161/01.STR.29.10.2100; GOTZSCHE PC, 1994, LANCET, V344, P925; HAUSER W, 2011, PAIN; Hrobjartsson A, 2002, J CLIN EPIDEMIOL, V55, P430, DOI 10.1016/S0895-4356(01)00496-6; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; JOHN C, 2001, NEW ENGL J MED, V344, P1630; Johnstone PAS, 2003, J UROLOGY, V169, P1037, DOI 10.1097/01.ju.0000044925.03113.ab; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kemeny ME, 2007, J ALLERGY CLIN IMMUN, V119, P1375, DOI 10.1016/j.jaci.2007.03.016; Koog YH, 2010, CLIN REHABIL, V24, P685, DOI 10.1177/0269215510367557; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Maa SH, 2007, J CLIN NURS, V16, P794, DOI 10.1111/j.1365-2702.2005.01515.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Madsen MV, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3115; MCMILLAN CM, 1994, PHYSIOTHERAPY, V80, P5; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; NAUMANN VC, 1989, Z PHYSIOTHER, V41, P9; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Presser M, 2000, PAIN CLINIC, V12, P77, DOI 10.1163/156856900750229816; Roschke J, 2000, J AFFECT DISORDERS, V57, P73, DOI 10.1016/S0165-0327(99)00061-0; Rosler A, 2003, J ALTERN COMPLEM MED, V9, P847, DOI 10.1089/107555303771952190; Rusy LM, 2002, ANESTHESIOLOGY, V96, P300, DOI 10.1097/00000542-200202000-00013; Schuler MS, 2005, J AM GERIATR SOC, V53, P549, DOI 10.1111/j.1532-5415.2005.53178_6.x; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SMITH GD, 1994, BMJ-BRIT MED J, V308, P72, DOI 10.1136/bmj.308.6921.72; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Tang JL, 2005, PLOS MED, V2, P1226, DOI 10.1371/journal.pmed.0020409; Tarcin Orhan, 2004, Turk J Gastroenterol, V15, P258; Tonella Rodrigo Marques, 2006, Rev. Bras. Anestesiol., V56, P630, DOI 10.1590/S0034-70942006000600007; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Weber S, 2010, STATA J, V10, P331, DOI 10.1177/1536867X1001000302; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Ziaei S, 2006, INT J GYNECOL OBSTET, V92, P71, DOI 10.1016/j.ijgo.2005.09.008	64	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20679	10.1371/journal.pone.0020679	http://dx.doi.org/10.1371/journal.pone.0020679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655196	gold, Green Published			2022-12-27	WOS:000291097600120
J	Pantazopoulos, H; Dolatshad, H; Davis, FC				Pantazopoulos, Harry; Dolatshad, Hamid; Davis, Fred C.			A Fear-Inducing Odor Alters PER2 and c-Fos Expression in Brain Regions Involved in Fear Memory	PLOS ONE			English	Article							INTRINSIC CIRCADIAN CLOCK; ACCESSORY BASAL NUCLEI; HIPPOCAMPAL-FORMATION; BASOLATERAL AMYGDALA; RHYTHMIC EXPRESSION; GENE-EXPRESSION; RAT; FOOD; PROTEIN; RECONSOLIDATION	Evidence demonstrates that rodents learn to associate a foot shock with time of day, indicating the formation of a fear related time-stamp memory, even in the absence of a functioning SCN. In addition, mice acquire and retain fear memory better during the early day compared to the early night. This type of memory may be regulated by circadian pacemakers outside of the SCN. As a first step in testing the hypothesis that clock genes are involved in the formation of a time-stamp fear memory, we exposed one group of mice to fox feces derived odor (TMT) at ZT 0 and one group at ZT 12 for 4 successive days. A separate group with no exposure to TMT was also included as a control. Animals were sacrificed one day after the last exposure to TMT, and PER2 and c-Fos protein were quantified in the SCN, amygdala, hippocampus, and piriform cortex. Exposure to TMT had a strong effect at ZT 0, decreasing PER2 expression at this time point in most regions except the SCN, and reversing the normal rhythm of PER2 expression in the amygdala and piriform cortex. These changes were accompanied by increased c-Fos expression at ZT0. In contrast, exposure to TMT at ZT 12 abolished the rhythm of PER2 expression in the amygdala. In addition, increased c-Fos expression at ZT 12 was only detected in the central nucleus of the amygdala in the TMT12 group. TMT exposure at either time point did not affect PER2 or c-Fos in the SCN, indicating that under a light-dark cycle, the SCN rhythm is stable in the presence of repeated exposure to a fear-inducing stimulus. Taken together, these results indicate that entrainment to a fear-inducing stimulus leads to changes in PER2 and c-Fos expression that are detected 24 hours following the last exposure to TMT, indicating entrainment of endogenous oscillators in these regions. The observed effects on PER2 expression and c-Fos were stronger during the early day than during the early night, possibly to prepare appropriate systems at ZT 0 to respond to a fear-inducing stimulus.	[Pantazopoulos, Harry; Dolatshad, Hamid; Davis, Fred C.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Pantazopoulos, Harry] McLean Hosp, Lab Translat Neurosci, Belmont, MA 02178 USA; [Pantazopoulos, Harry] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Northeastern University; Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Pantazopoulos, H (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	hantazo@mclean.harvard.edu	Pantazopoulos, Harry/M-1435-2016	Pantazopoulos, Harry/0000-0002-0540-1589; Dolatshad, Hamid/0000-0002-4724-1720; Pantazopoulos, Harry/0000-0002-8905-8377	NIH [R01MH06879601]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH Grant R01MH06879601 to Fred C. Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2009, BIOL PSYCHIAT, V65, P829, DOI 10.1016/j.biopsych.2008.12.019; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bando H, 2007, J NEUROSCI, V27, P4359, DOI 10.1523/JNEUROSCI.4131-06.2007; BELING INGEBORG, 1929, ZEITSCHR VERGLEICH PHYSIOL, V9, P259, DOI 10.1007/BF00340159; Benes FM, 2000, ANN NY ACAD SCI, V911, P293; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Buron G, 2007, BEHAV NEUROSCI, V121, P1063, DOI 10.1037/0735-7044.121.5.1063; Cain SW, 2008, NEUROBIOL LEARN MEM, V89, P591, DOI 10.1016/j.nlm.2007.07.011; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; CAMPEAU S, 1991, BRAIN RES, V565, P349, DOI 10.1016/0006-8993(91)91669-R; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Desgranges B, 2008, BRAIN RES, V1236, P166, DOI 10.1016/j.brainres.2008.07.123; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Endres T, 2009, J EXP BIOL, V212, P2324, DOI 10.1242/jeb.028498; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Frigato E, 2009, BIOCHEM BIOPH RES CO, V378, P108, DOI 10.1016/j.bbrc.2008.11.006; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Funk D, 2000, BRAIN RES, V866, P262, DOI 10.1016/S0006-8993(00)02249-6; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Geyfman M, 2009, J INVEST DERMATOL, V129, P1063, DOI 10.1038/jid.2008.384; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Holahan MR, 2004, BEHAV BRAIN RES, V152, P109, DOI 10.1016/j.bbr.2003.09.031; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Kajiwara R, 2007, EUR J NEUROSCI, V25, P3648, DOI 10.1111/j.1460-9568.2007.05610.x; King JA, 2005, PSYCHONEUROENDOCRINO, V30, P333, DOI 10.1016/j.psyneuen.2004.09.005; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kudo T, 2011, J NEUROSCI, V31, P2746, DOI 10.1523/JNEUROSCI.5792-10.2011; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Li ZX, 2007, BIOCHEM BIOPH RES CO, V359, P491, DOI 10.1016/j.bbrc.2007.05.156; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Miller JP, 2005, NEUROBIOL AGING, V26, P1107, DOI 10.1016/j.neurobiolaging.2004.08.008; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Nathan SV, 2004, ANN NY ACAD SCI, V1032, P179, DOI 10.1196/annals.1314.015; O'Brien J, 2007, HIPPOCAMPUS, V17, P1149, DOI 10.1002/hipo.20346; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTERSEN OP, 1982, J COMP NEUROL, V205, P30, DOI 10.1002/cne.902050104; Pagani JH, 2009, BRAIN RES, V1286, P133, DOI 10.1016/j.brainres.2009.06.062; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitkanen A, 2002, HIPPOCAMPUS, V12, P186, DOI 10.1002/hipo.1099; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2009, NEUROSCI LETT, V457, P58, DOI 10.1016/j.neulet.2009.03.083; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SHERMAN H, J CELL MOL MED; Sothern RB, 2009, CLIN TER, V160, pE25; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sumova A, 1998, BRAIN RES, V801, P254, DOI 10.1016/S0006-8993(98)00619-2; SUZUKI N, CEREB CORTEX; Thompson BL, 2004, BEHAV BRAIN RES, V149, P209, DOI 10.1016/S0166-4328(03)00216-X; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020	83	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20658	10.1371/journal.pone.0020658	http://dx.doi.org/10.1371/journal.pone.0020658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655193	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600118
J	Qi, M; Wang, P; O'Toole, N; Barboza, PS; Ungerfeld, E; Leigh, MB; Selinger, LB; Butler, G; Tsang, A; McAllister, TA; Forster, RJ				Qi, Meng; Wang, Pan; O'Toole, Nicholas; Barboza, Perry S.; Ungerfeld, Emilio; Leigh, Mary Beth; Selinger, L. Brent; Butler, Greg; Tsang, Adrian; McAllister, Tim A.; Forster, Robert J.			Snapshot of the Eukaryotic Gene Expression in Muskoxen Rumen-A Metatranscriptomic Approach	PLOS ONE			English	Article							POLYPLASTRON-MULTIVESICULATUM; SEQUENCE SIMILARITY; DEGRADING ENZYMES; RNA GENES; BACTERIAL; DIVERSITY; INSIGHTS; FERMENTATION; RUMINICOLA; HYDROLASES	Background: Herbivores rely on digestive tract lignocellulolytic microorganisms, including bacteria, fungi and protozoa, to derive energy and carbon from plant cell wall polysaccharides. Culture independent metagenomic studies have been used to reveal the genetic content of the bacterial species within gut microbiomes. However, the nature of the genes encoded by eukaryotic protozoa and fungi within these environments has not been explored using metagenomic or metatranscriptomic approaches. Methodology/Principal Findings: In this study, a metatranscriptomic approach was used to investigate the functional diversity of the eukaryotic microorganisms within the rumen of muskoxen (Ovibos moschatus), with a focus on plant cell wall degrading enzymes. Polyadenylated RNA (mRNA) was sequenced on the Illumina Genome Analyzer II system and 2.8 gigabases of sequences were obtained and 59129 contigs assembled. Plant cell wall degrading enzyme modules including glycoside hydrolases, carbohydrate esterases and polysaccharide lyases were identified from over 2500 contigs. These included a number of glycoside hydrolase family 6 (GH6), GH48 and swollenin modules, which have rarely been described in previous gut metagenomic studies. Conclusions/Significance: The muskoxen rumen metatranscriptome demonstrates a much higher percentage of cellulase enzyme discovery and an 8.7x higher rate of total carbohydrate active enzyme discovery per gigabase of sequence than previous rumen metagenomes. This study provides a snapshot of eukaryotic gene expression in the muskoxen rumen, and identifies a number of candidate genes coding for potentially valuable lignocellulolytic enzymes.	[Qi, Meng; Wang, Pan; Ungerfeld, Emilio; McAllister, Tim A.; Forster, Robert J.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Wang, Pan; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [O'Toole, Nicholas; Butler, Greg; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Barboza, Perry S.; Leigh, Mary Beth] Univ Alaska, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK 99775 USA	Agriculture & Agri Food Canada; University of Lethbridge; Concordia University - Canada; University of Alaska System; University of Alaska Fairbanks	Qi, M (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	Robert.Forster@agr.gc.ca	Ungerfeld, Emilio/AAB-2460-2019; Forster, Robert J/J-4408-2012; McAllister, Tim A./R-9201-2017	Ungerfeld, Emilio/0000-0002-5422-5462; Forster, Robert J/0000-0002-0562-8628; O'Toole, Nicholas/0000-0001-5245-7393; Selinger, Leonard/0000-0001-8205-8334; McAllister, Tim A./0000-0002-8266-6513	Canadian Triticale Biorefinery Initiative; Alberta Innovates Bio Solutions; Genome Canada; Genome Quebec; Genome Alberta; Cellulosic Biofuel Network of Agriculture and Agri-Food Canada	Canadian Triticale Biorefinery Initiative; Alberta Innovates Bio Solutions; Genome Canada(Genome Canada); Genome Quebec; Genome Alberta; Cellulosic Biofuel Network of Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was supported by the Canadian Triticale Biorefinery Initiative (http://www.ctbi.ca/) and Cellulosic Biofuel Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada, Alberta Innovates Bio Solutions (http://www.albertainnovates.ca), Genome Canada (http:// www.genomecanada.ca/), Genome Quebec (http://www.genomequebec.com/v2009/home/), and Genome Alberta (http://www.genomealberta.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P497, DOI 10.1086/501058; Bera-Maillet C, 2005, FEMS MICROBIOL LETT, V244, P149, DOI 10.1016/j.femsle.2005.01.035; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cai SC, 2010, APPL ENVIRON MICROB, V76, P3818, DOI 10.1128/AEM.03124-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Crater AR, 2007, COMP BIOCHEM PHYS A, V146, P233, DOI 10.1016/j.cbpa.2006.10.019; Devillard E, 1999, FEMS MICROBIOL LETT, V181, P145, DOI 10.1111/j.1574-6968.1999.tb08837.x; Eddy Sean R, 2009, Genome Inform, V23, P205; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; HUNGATE RE, 1964, ANNU REV MICROBIOL, V18, P131, DOI 10.1146/annurev.mi.18.100164.001023; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/j.jmb.2007.08.007; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Nicholson MJ, 2005, MICROBIOL-SGM, V151, P121, DOI 10.1099/mic.0.27353-0; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orpin C., 1997, RUMEN MICROBIAL ECOS, P140, DOI [10.1016/0378-1097(87)90045-0, DOI 10.1007/978-94-009-1453-7-4, DOI 10.1016/0378-1097(87)90045-0]; Orpin C. G., 1988, The rumen microbial ecosystem., P129; ORPIN CG, 1975, J GEN MICROBIOL, V91, P249, DOI 10.1099/00221287-91-2-249; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Qi M, 2005, J BACTERIOL, V187, P3739, DOI 10.1128/JB.187.11.3739-3751.2005; Rezaeian M, 2004, MYCOL RES, V108, P1227, DOI 10.1017/S0953756204000929; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Steenbakkers PJM, 2001, J BACTERIOL, V183, P5325, DOI 10.1128/JB.183.18.5325-5333.2001; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; WANG P, 2011, CAN J MICRO IN PRESS; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Williams A.G., 1997, RUMEN MICROBIAL ECOS, P73, DOI DOI 10.1007/978-94-009-1453-7_3; WILLIAMS AG, 1984, CAN J ANIM SCI, V64, P58, DOI 10.4141/cjas84-156; WILLIAMS AG, 1986, MICROBIOL REV, V50, P25, DOI 10.1128/MMBR.50.1.25-49.1986; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	63	95	100	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20521	10.1371/journal.pone.0020521	http://dx.doi.org/10.1371/journal.pone.0020521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655220	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000291097600086
J	Perez, T; Garcia, GC; Eguiluz, VM; Vicente, R; Pipa, G; Mirasso, C				Perez, Toni; Garcia, Guadalupe C.; Eguiluz, Victor M.; Vicente, Raul; Pipa, Gordon; Mirasso, Claudio			Effect of the Topology and Delayed Interactions in Neuronal Networks Synchronization	PLOS ONE			English	Article							LONG	As important as the intrinsic properties of an individual nervous cell stands the network of neurons in which it is embedded and by virtue of which it acquires great part of its responsiveness and functionality. In this study we have explored how the topological properties and conduction delays of several classes of neural networks affect the capacity of their constituent cells to establish well-defined temporal relations among firing of their action potentials. This ability of a population of neurons to produce and maintain a millisecond-precise coordinated firing (either evoked by external stimuli or internally generated) is central to neural codes exploiting precise spike timing for the representation and communication of information. Our results, based on extensive simulations of conductance-based type of neurons in an oscillatory regime, indicate that only certain topologies of networks allow for a coordinated firing at a local and long-range scale simultaneously. Besides network architecture, axonal conduction delays are also observed to be another important factor in the generation of coherent spiking. We report that such communication latencies not only set the phase difference between the oscillatory activity of remote neural populations but determine whether the interconnected cells can set in any coherent firing at all. In this context, we have also investigated how the balance between the network synchronizing effects and the dispersive drift caused by inhomogeneities in natural firing frequencies across neurons is resolved. Finally, we show that the observed roles of conduction delays and frequency dispersion are not particular to canonical networks but experimentally measured anatomical networks such as the macaque cortical network can display the same type of behavior.	[Perez, Toni] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Garcia, Guadalupe C.] Jacobs Univ Bremen, Sch Sci & Engn, Bremen, Germany; [Eguiluz, Victor M.; Mirasso, Claudio] Inst Fis Interdisciplinar Sistemas Complejos CSIC, Palma de Mallorca, Spain; [Vicente, Raul] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Vicente, Raul] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Pipa, Gordon] Univ Osnabrueck, Inst Cognit Sci, Osnabruck, Germany	Lehigh University; Jacobs University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Max Planck Society; University Osnabruck	Perez, T (corresponding author), Lehigh Univ, Dept Phys, Bldg 16, Bethlehem, PA 18015 USA.	amp609@lehigh.edu	Perez, Toni/G-6815-2011; Mirasso, Claudio R/B-8661-2008; Eguíluz, Víctor M./B-9655-2008; Vicente, Raul/E-1566-2011; Pipa, Gordon/M-1813-2014	Eguíluz, Víctor M./0000-0003-1133-1289; Vicente, Raul/0000-0002-2497-0007; Pipa, Gordon/0000-0002-3416-2652; Mirasso, Claudio/0000-0003-2980-7038; Garcia, Guadalupe Clara/0000-0002-2227-2483	MEC Ministerio de Educacion y Ciencia (Spain) [FIS2007-60327]; Hertie Foundation (Germany); Mathers Foundation (USA)	MEC Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Hertie Foundation (Germany); Mathers Foundation (USA)	MEC Ministerio de Educacion y Ciencia (Spain) through project FISICOS (FIS2007-60327), the Hertie Foundation (Germany) and the Mathers Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Atay FM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.144101; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Buzsaki G., 2006, RHYTHMS BRAIN; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Dayan P, 2001, COMPUTATIONAL NEUROS; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Eguiluz VM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056113; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Ernst U, 1998, PHYS REV E, V57, P2150, DOI 10.1103/PhysRevE.57.2150; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; GUTTMAN S, 1980, J PHYSL, V305, P377; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; LAKSHMANAN M, 2011, SPRINGER SER SYNERG; Liang XM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066202; MANRUBIA SC, 2004, EMERGENCE DYNAMICAL; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Pikovsky AS, 1997, PHYSICA D, V104, P219, DOI 10.1016/S0167-2789(96)00301-6; Reddy DVR, 2000, PHYS REV LETT, V85, P3381, DOI 10.1103/PhysRevLett.85.3381; RINZEL J, 1980, MATH BIOSCI, V49, P27, DOI 10.1016/0025-5564(80)90109-1; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Stepan G, 2009, PHILOS T R SOC A, V367, P1059, DOI 10.1098/rsta.2008.0279; Strogatz S. H., 2003, SYNC; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2010, PHYSICA A, V389, P3299, DOI 10.1016/j.physa.2010.03.031; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang XJ, 1996, J NEUROSCI, V16, P6402; WATTS D, 1998, NATURE, V393, P40910; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040	39	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19900	10.1371/journal.pone.0019900	http://dx.doi.org/10.1371/journal.pone.0019900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637767	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500015
J	Samadi, N; Bekele, RT; Goping, IS; Schang, LM; Brindley, DN				Samadi, Nasser; Bekele, Raie T.; Goping, Ing Swie; Schang, Luis M.; Brindley, David N.			Lysophosphatidate Induces Chemo-Resistance by Releasing Breast Cancer Cells from Taxol-Induced Mitotic Arrest	PLOS ONE			English	Article							LIPID PHOSPHATE PHOSPHATASE-1; SPHINGOSINE 1-PHOSPHATE; MICROTUBULE ALTERATIONS; AUTOTAXIN NPP-2; OVARIAN-CANCER; S-PHASE; ACID; APOPTOSIS; PACLITAXEL; INHIBITOR	Background: Taxol is a microtubule stabilizing agent that arrests cells in mitosis leading to cell death. Taxol is widely used to treat breast cancer, but resistance occurs in 25-69% of patients and it is vital to understand how Taxol resistance develops to improve chemotherapy. The effects of chemotherapeutic agents are overcome by survival signals that cancer cells receive. We focused our studies on autotaxin, which is a secreted protein that increases tumor growth, aggressiveness, angiogenesis and metastasis. We discovered that autotaxin strongly antagonizes the Taxol-induced killing of breast cancer and melanoma cells by converting the abundant extra-cellular lipid, lysophosphatidylcholine, into lysophosphatidate. This lipid stimulates specific G-protein coupled receptors that activate survival signals. Methodology/Principal Findings: In this study we determined the basis of these antagonistic actions of lysophosphatidate towards Taxol-induced G2/M arrest and cell death using cultured breast cancer cells. Lysophosphatidate does not antagonize Taxol action in MCF-7 cells by increasing Taxol metabolism or its expulsion through multi-drug resistance transporters. Lysophosphatidate does not lower the percentage of cells accumulating in G2/M by decreasing exit from S-phase or selective stimulation of cell death in G2/M. Instead, LPA had an unexpected and remarkable action in enabling MCF-7 and MDA-MB-468 cells, which had been arrested in G2/M by Taxol, to normalize spindle structure and divide, thus avoiding cell death. This action involves displacement of Taxol from the tubulin polymer fraction, which based on inhibitor studies, depends on activation of LPA receptors and phosphatidylinositol 3-kinase. Conclusions/Significance: This work demonstrates a previously unknown consequence of lysophosphatidate action that explains why autotaxin and lysophosphatidate protect against Taxol-induced cell death and promote resistance to the action of this important therapeutic agent.	[Samadi, Nasser; Bekele, Raie T.; Goping, Ing Swie; Schang, Luis M.; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Sch Mol & Syst Med, Edmonton, AB, Canada	University of Alberta	Samadi, N (corresponding author), Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Sch Mol & Syst Med, Edmonton, AB, Canada.	david.brindley@ualberta.ca	Schang, Luis/F-9576-2012	samadi, nasser/0000-0001-7960-6432; Schang, Luis Maria/0000-0002-5789-8590	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by the Canadian Institutes of Health Research. This agency had no role in the study design, data collection and analysis, decision to publish, provided the original author and source are credited.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Bergstralh DT, 2006, CANCER TREAT REV, V32, P166, DOI 10.1016/j.ctrv.2006.01.004; Blajeski AL, 2001, EXP CELL RES, V270, P277, DOI 10.1006/excr.2001.5349; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Cheng H, 2009, J CLIN ONCOL, V27; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Fujino H, 2001, J CHROMATOGR B, V757, P143, DOI 10.1016/S0378-4347(01)00141-4; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; GOMEZMUNOZ A, 1995, J BIOL CHEM, V270, P26318, DOI 10.1074/jbc.270.44.26318; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hembruff SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-318; Imai A, 2000, J CLIN ENDOCR METAB, V85, P3370, DOI 10.1210/jc.85.9.3370; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JI C, 2010, ONCOGENE; Kavallaris M, 2001, CANCER RES, V61, P5803; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Krajewski S, 1999, ENDOCR-RELAT CANCER, V6, P29, DOI 10.1677/erc.0.0060029; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marchetti P, 2002, CRIT REV ONCOL HEMAT, V44, pS3; Martin A, 1997, ONCOGENE, V14, P1571, DOI 10.1038/sj.onc.1200987; Martinez R, 2009, TOXICOL LETT, V190, P86, DOI 10.1016/j.toxlet.2009.07.010; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Mickley L, 2001, MAMM GENOME, V12, P86, DOI 10.1007/s003350010237; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Montenarh M, 2010, CELL TISSUE RES, V342, P139, DOI 10.1007/s00441-010-1068-3; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morris KE, 2006, J BIOL CHEM, V281, P9297, DOI 10.1074/jbc.M511710200; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nam SW, 2001, CANCER RES, V61, P6938; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; SAMADI N, 2010, BIOCHIMIE; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; Singh R, 2001, CARCINOGENESIS, V22, P1863, DOI 10.1093/carcin/22.11.1863; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tanyi JL, 2003, CLIN CANCER RES, V9, P3534; Tanyi JL, 2003, CANCER RES, V63, P1073; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Terry NHA, 2006, NAT PROTOC, V1, P859, DOI 10.1038/nprot.2006.113; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Yamane K, 2005, CLIN CANCER RES, V11, P2355, DOI 10.1158/1078-0432.CCR-04-1734; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196	60	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20608	10.1371/journal.pone.0020608	http://dx.doi.org/10.1371/journal.pone.0020608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647386	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500069
J	Khaidakov, M; Mitra, S; Kang, BY; Wang, XW; Kadlubar, S; Novelli, G; Raj, V; Winters, M; Carter, WC; Mehta, JL				Khaidakov, Magomed; Mitra, Sona; Kang, Bum-Yong; Wang, Xianwei; Kadlubar, Susan; Novelli, Giuseppe; Raj, Vinay; Winters, Maria; Carter, Weleetka C.; Mehta, Jawahar L.			Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; DENSITY-LIPOPROTEIN RECEPTOR-1; ARTERY ENDOTHELIAL-CELLS; STEAROYL-COA DESATURASE; LECTIN-LIKE; BREAST-CANCER; CYCLIN D2; EXPRESSION; LOX-1; ABROGATION	Recent studies have linked expression of lectin-like ox-LDL receptor 1 (OLR1) to tumorigenesis. We analyzed microarray data from Olr1 knockout (KO) and wild type (WT) mice for genes involved in cellular transformation and evaluated effects of OLR1 over-expression in normal mammary epithelial cells (MCF10A) and breast cancer cells (HCC1143) in terms of gene expression, migration, adhesion and transendothelial migration. Twenty-six out of 238 genes were inhibited in tissues of OLR1 KO mice; the vast majority of OLR1 sensitive genes contained NF-kB binding sites in their promoters. Further studies revealed broad inhibition of NF-kB target genes outside of the transformation-associated gene pool, with enrichment themes of defense response, immune response, apoptosis, proliferation, and wound healing. Transcriptome of Olr1 KO mice also revealed inhibition of de novo lipogenesis, rate-limiting enzymes fatty acid synthase (Fasn), stearoyl-CoA desaturase (Scd1) and ELOVL family member 6 (Elovl6), as well as lipolytic phospholipase A2 group IVB (Pla2g4b). In studies comparing MCF10A and HCC1143, the latter displayed 60% higher OLR1 expression. Forced over-expression of OLR1 resulted in upregulation of NF-kB (p65) and its target pro-oncogenes involved in inhibition of apoptosis (BCL2, BCL2A1, TNFAIP3) and regulation of cell cycle (CCND2) in both cell lines. Basal expression of FASN, SCD1 and PLA2G4B, as well as lipogenesis transcription factors PPARA, SREBF2 and CREM, was higher in HCC1143 cells. Over-expression of OLR1 in HCC1143 cells also enhanced cell migration, without affecting their adherence to TNF alpha-activated endothelium or transendothelial migration. On the other hand, OLR1 neutralizing antibody inhibited both adhesion and transmigration of untreated HCC1143 cells. We conclude that OLR1 may act as an oncogene by activation of NF-kB target genes responsible for proliferation, migration and inhibition of apoptosis and de novo lipogenesis genes.	[Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Winters, Maria; Carter, Weleetka C.; Mehta, Jawahar L.] Coll Med, Dept Internal Med, Little Rock, AR USA; [Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Winters, Maria; Carter, Weleetka C.; Mehta, Jawahar L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Kadlubar, Susan; Raj, Vinay] Univ Arkansas Med Sci, Coll Med, Div Med Genet, Little Rock, AR 72205 USA; [Kang, Bum-Yong] Emory Univ, Atlanta, GA 30322 USA; [Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Genet, Rome, Italy	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; Emory University; University of Rome Tor Vergata	Khaidakov, M (corresponding author), Coll Med, Dept Internal Med, Little Rock, AR USA.	mkhaidakov@uams.edu; Mehtajl@uams.edu	Mehta, jl/AAB-8832-2019; Novelli, Giuseppe/A-5195-2013; Mehta, JL/AAG-7572-2020; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Wang, Xianwei/AAN-8915-2020	Mehta, jl/0000-0003-0384-2097; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Wang, Xianwei/0000-0002-1490-8736				Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Brinkley TE, 2008, OBESITY, V16, P1454, DOI 10.1038/oby.2008.213; Chen MY, 2000, ARTERIOSCL THROM VAS, V20, P1107, DOI 10.1161/01.ATV.20.4.1107; Cleary MP, 2010, VET PATHOL, V47, P202, DOI 10.1177/0300985809357753; Evron E, 2001, CANCER RES, V61, P2782; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Hu CP, 2008, HYPERTENSION, V52, P556, DOI 10.1161/HYPERTENSIONAHA.108.115287; Hu C, 2008, J MOL CELL CARDIOL, V44, P76, DOI 10.1016/j.yjmcc.2007.10.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaattela M, 1996, J IMMUNOL, V156, P1166; Kang BY, 2010, PHYSIOL GENOMICS, V42, P42, DOI 10.1152/physiolgenomics.00009.2010; Kobayashi T, 2009, BIOCHEM BIOPH RES CO, V387, P196, DOI 10.1016/j.bbrc.2009.06.146; Li DY, 2000, CIRCULATION, V102, P1970, DOI 10.1161/01.CIR.102.16.1970; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Romieu I, 2009, SALUD PUBLICA MEXICO, V51, pS172, DOI 10.1590/S0036-36342009000800007; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; UTSUGI T, 1991, CANCER RES, V51, P3062; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-120; Xie QH, 2004, DNA CELL BIOL, V23, P111, DOI 10.1089/104454904322759920; Yamanaka S, 1998, GENOMICS, V54, P191, DOI 10.1006/geno.1998.5561; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	31	75	80	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20277	10.1371/journal.pone.0020277	http://dx.doi.org/10.1371/journal.pone.0020277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637860	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052200047
J	Raju, HB; Hu, Y; Vedula, A; Dubovy, SR; Goldberg, JL				Raju, Hemalatha B.; Hu, Ying; Vedula, Anil; Dubovy, Sander R.; Goldberg, Jeffrey L.			Evaluation of Magnetic Micro- and Nanoparticle Toxicity to Ocular Tissues	PLOS ONE			English	Article							CELLS; RABBIT; MODEL; RATS	Purpose: Magnetic nanoparticles (MNPs) may be used for focal delivery of plasmids, drugs, cells, and other applications. Here we ask whether such particles are toxic to ocular structures. Methods: To evaluate the ocular toxicity of MNPs, we asked if either 50 nm or 4 mu m magnetic particles affect intraocular pressure, corneal endothelial cell count, retinal morphology including both cell counts and glial activation, or photoreceptor function at different time points after injection. Sprague-Dawley rats (n = 44) were injected in the left eye with either 50 nm (3 mu l, 1.65 mg) or 4 mu m (3 mu l, 1.69 mg) magnetic particles, and an equal volume of PBS into the right eye. Electroretinograms (ERG) were used to determine if MNPs induce functional changes to the photoreceptor layers. Enucleated eyes were sectioned for histology and immunofluorescence. Results: Compared to control-injected eyes, MNPs did not alter IOP measurements. ERG amplitudes for a-waves were in the 100-250 mu V range and b-waves were in the 500-600 mu V range, with no significant differences between injected and non-injected eyes. Histological sectioning and immunofluorescence staining showed little difference in MNP-injected animals compared to control eyes. In contrast, at 1 week, corneal endothelial cell numbers were significantly lower in the 4 mu m magnetic particle-injected eyes compared to either 50 nm MNP- or PBS-injected eyes. Furthermore, iron deposition was detected after 4 mu m magnetic particle but not 50 nm MNP injection. Conclusions: Intravitreal or anterior chamber injections of MNPs showed little to no signs of toxicity on retinal structure, photoreceptor function or aqueous drainage in the eye. Our results suggest that MNPs are safe for intraocular use.	[Raju, Hemalatha B.; Hu, Ying; Vedula, Anil; Dubovy, Sander R.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Raju, HB (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jgoldberg@med.miami.edu		Goldberg, Jeffrey/0000-0002-1390-7360	NEI [R21-EY017971, P30 EY014801]; NATIONAL EYE INSTITUTE [P30EY014801, R21EY017971] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors gratefully acknowledge funding from the NEI R21-EY017971 (JLG) and P30 EY014801 (Miami), the Hope for Vision Foundation (JLG), and an unrestricted grant from Research to Prevent Blindness to the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakri SJ, 2008, RETINA-J RET VIT DIS, V28, P147, DOI 10.1097/IAE.0b013e3180dc9360; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5; Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t; DECLERCQ SS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1051, DOI 10.1001/archopht.1977.04450060138014; Gallo JM, 1997, CANCER RES, V57, P3063; HAFELI UO, 2009, MOL PHARM; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; KNAVE, 1969, ACTA OPHTHALMOL S, V100; Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0; Lacava ZGM, 2004, SPECTROSC-INT J, V18, P597, DOI 10.1155/2004/186521; Lattuada M, 2007, LANGMUIR, V23, P2158, DOI 10.1021/la062092x; Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030; MEYER LA, 1988, INVEST OPHTH VIS SCI, V29, P940; Oweida AJ, 2004, MOL IMAGING, V3, P85, DOI 10.1162/1535350041464856; PETER PA, 1957, AM J OPHTHALMOL, V44, P198, DOI 10.1016/0002-9394(57)90448-8; POTTS, 1972, ASSESSMENT VISUAL FU; Raju HB, 2008, EXPERT REV OPHTHALMO, V3, P431, DOI 10.1586/17469899.3.4.431; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schutt W, 1997, HYBRIDOMA, V16, P109, DOI 10.1089/hyb.1997.16.109; Sha O., 2006, Neuroembryology and Aging, V4, P183, DOI 10.1159/000118928	22	62	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e17452	10.1371/journal.pone.0017452	http://dx.doi.org/10.1371/journal.pone.0017452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637340	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200003
J	Vrana, NE; Dupret, A; Coraux, C; Vautier, D; Debry, C; Lavalle, P				Vrana, Nihal Engin; Dupret, Agnes; Coraux, Christelle; Vautier, Dominique; Debry, Christian; Lavalle, Philippe			Hybrid Titanium/Biodegradable Polymer Implants with an Hierarchical Pore Structure as a Means to Control Selective Cell Movement	PLOS ONE			English	Article							TISSUE ENGINEERING SCAFFOLDS; POLYELECTROLYTE MULTILAYERS; TRACHEAL PROSTHESIS; FREEZE-EXTRACTION; EPITHELIAL-CELLS; PHASE-SEPARATION; POROUS TITANIUM; REPAIR; BIOMATERIALS; PEPTIDE	In order to improve implant success rate, it is important to enhance their responsiveness to the prevailing conditions following implantation. Uncontrolled movement of inflammatory cells and fibroblasts is one of these in vivo problems and the porosity properties of the implant have a strong effect on these. Here, we describe a hybrid system composed of a macroporous titanium structure filled with a microporous biodegradable polymer. This polymer matrix has a distinct porosity gradient to accommodate different cell types (fibroblasts and epithelial cells). The main clinical application of this system will be the prevention of restenosis due to excessive fibroblast migration and proliferation in the case of tracheal implants. Methodology/Principal Findings: A microbead-based titanium template was filled with a porous Poly (L-lactic acid) (PLLA) body by freeze-extraction method. A distinct porosity difference was obtained between the inner and outer surfaces of the implant as characterized by image analysis and Mercury porosimetry (9.8 +/- 2.2 mu m vs. 36.7 +/- 11.4 mu m, p <= 0.05). On top, a thin PLLA film was added to optimize the growth of epithelial cells, which was confirmed by using human respiratory epithelial cells. To check the control of fibroblast movement, PKH26 labeled fibroblasts were seeded onto Titanium and Titanium/PLLA implants. The cell movement was quantified by confocal microscopy: in one week cells moved deeper in Ti samples compared to Ti/PLLA. Conclusions: In vitro experiments showed that this new implant is effective for guiding different kind of cells it will contact upon implantation. Overall, this system would enable spatial and temporal control over cell migration by a gradient ranging from macroporosity to nanoporosity within a tracheal implant. Moreover, mechanical properties will be dependent mainly on the titanium frame. This will make it possible to create a polymeric environment which is suitable for cells without the need to meet mechanical requirements with the polymeric structure.	[Vrana, Nihal Engin; Dupret, Agnes; Vautier, Dominique; Debry, Christian; Lavalle, Philippe] INSERM, Inst Natl Sante & Rech Med, U977, Strasbourg, France; [Vautier, Dominique; Lavalle, Philippe] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Dupret, Agnes; Debry, Christian] Hop Univ Strasbourg, Hop Hautepierre, Serv Otorhinolaryngol & Chirurg Cervicofaciale, Strasbourg, France; [Coraux, Christelle] INSERM, Inst Natl Sante & Rech Med, U903, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne	Vrana, NE (corresponding author), INSERM, Inst Natl Sante & Rech Med, U977, Strasbourg, France.	philippe.lavalle@inserm.fr	Vrana, Nihal Engin/A-2029-2010; Lavalle, Philippe/E-6328-2016; Dupret-Bories, Agnes/O-6327-2014; CORAUX, Christelle/P-5668-2016	Vrana, Nihal Engin/0000-0002-5398-6710; Lavalle, Philippe/0000-0001-8798-912X; Dupret-Bories, Agnes/0000-0002-7068-3500; CORAUX, Christelle/0000-0001-5345-5074	Region Alsace; Pole Materiaux et Nanosciences d'Alsace (PMNA); CNRS; INSERM; Louis Pasteur University; Alsace Region	Region Alsace(Region Grand-Est); Pole Materiaux et Nanosciences d'Alsace (PMNA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Louis Pasteur University; Alsace Region(Region Grand-Est)	The study was funded by Region Alsace and Pole Materiaux et Nanosciences d'Alsace (PMNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. A. Walder for providing titanium samples, to Dr. M. Erhardt for his help with SEM images (IBMP, Strasbourg Esplanade Cellular Imaging Facility, funded by CNRS, INSERM, Louis Pasteur University and Alsace Region). We thank K. Benmlih for the build-up of the Teflon molds.	Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321; Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446; Budyanto L, 2009, J MATER SCI-MATER M, V20, P105, DOI 10.1007/s10856-008-3545-8; Coraux C, 2005, M S-MED SCI, V21, P1063; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; Fuchs JR, 2003, J PEDIATR SURG, V38, P984, DOI 10.1016/S0022-3468(03)00139-8; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; GROSSIN L, 2009, ADV MAT, V21; Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6; Kanzaki M, 2006, TISSUE ENG, V12, P1275, DOI 10.1089/ten.2006.12.1275; Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008; Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com; Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015; Moroni L, 2007, TISSUE ENG, V13, P2483, DOI 10.1089/ten.2006.0385; Muller S, 2008, ADV FUNCT MATER, V18, P1767, DOI 10.1002/adfm.200701233; Papenburg BJ, 2010, ACTA BIOMATER, V6, P2477, DOI 10.1016/j.actbio.2009.12.051; Pavia FC, 2008, J BIOMED MATER RES A, V86A, P459, DOI 10.1002/jbm.a.31621; Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012; Schultz P, 2007, EUR ARCH OTO-RHINO-L, V264, P433, DOI 10.1007/s00405-006-0195-7; Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049; Schultz P, 2004, EUR ARCH OTO-RHINO-L, V261, P484, DOI 10.1007/s00405-003-0717-5; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Skowron-Zwarg M, 2007, EXP CELL RES, V313, P2695, DOI 10.1016/j.yexcr.2007.02.035; WOLF MH, 2008, EUROPEAN CELLS MAT, V15, P1; Zani BG, 2008, P NATL ACAD SCI USA, V105, P7046, DOI 10.1073/pnas.0802463105	31	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20480	10.1371/journal.pone.0020480	http://dx.doi.org/10.1371/journal.pone.0020480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637824	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200070
J	Ma, B; Guo, JW; Qi, GQ; Li, HM; Peng, JY; Zhang, YL; Ding, YQ; Yang, KH				Ma, Bin; Guo, Jiwu; Qi, Guoqing; Li, Haimin; Peng, Jiye; Zhang, Yulong; Ding, Yanqin; Yang, Kehu			Epidemiology, Quality and Reporting Characteristics of Systematic Reviews of Traditional Chinese Medicine Interventions Published in Chinese Journals	PLOS ONE			English	Article							METAANALYSES	Background: Systematic reviews (SRs) of TCM have become increasingly popular in China and have been published in large numbers. This review provides the first examination of epidemiological characteristics of these SRs as well as compliance with the PRISMA and AMSTAR guidelines. Objectives: To examine epidemiological and reporting characteristics as well as methodological quality of SRs of TCM published in Chinese journals. Methods: Four Chinese databases were searched (CBM, CSJD, CJFD and Wanfang Database) for SRs of TCM, from inception through Dec 2009. Data were extracted into Excel spreadsheets. The PRISMA and AMSTAR checklists were used to assess reporting characteristics and methodological quality, respectively. Results: A total of 369 SRs were identified, most (97.6%) of which used the terms systematic review or meta-analysis in the title. None of the reviews had been updated. Half (49.8%) were written by clinicians and nearly half (47.7%) were reported in specialty journals. The impact factors of 45.8% of the journals published in were zero. The most commonly treated conditions were diseases of the circulatory and digestive disease. Funding sources were not reported for any reviews. Most (68.8%) reported information about quality assessment, while less than half (43.6%) reported assessing for publication bias. Statistical mistakes appeared in one-third (29.3%) of reviews and most (91.9%) did not report on conflict of interest. Conclusions: While many SRs of TCM interventions have been published in Chinese journals, the quality of these reviews is troubling. As a potential key source of information for clinicians and researchers, not only were many of these reviews incomplete, some contained mistakes or were misleading. Focusing on improving the quality of SRs of TCM, rather than continuing to publish them in great quantity, is urgently needed in order to increase the value of these studies.	[Ma, Bin; Guo, Jiwu; Qi, Guoqing; Zhang, Yulong; Ding, Yanqin; Yang, Kehu] Lanzhou Univ, Evidence Based Med Ctr, Inst Tradit Chinese & Western Med, Sch Basic Med Sci, Lanzhou 730000, Gansu, Peoples R China; [Guo, Jiwu; Zhang, Yulong] Lanzhou Univ, Sch Clin Med 2, Lanzhou 730000, Gansu, Peoples R China; [Peng, Jiye] Lib Lanzhou Univ, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Ma, B (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Inst Tradit Chinese & Western Med, Sch Basic Med Sci, Lanzhou 730000, Gansu, Peoples R China.	kehuyangebm2006@126.com		Guo, Jiwu/0000-0002-7496-8300				Bessa-Nogueira Ricardo V, 2008, BMC Oral Health, V8, P27, DOI 10.1186/1472-6831-8-27; CHEN ZF, 1999, TRAD CHINESE MED RES, V12, P20; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; [李廷谦 LI Tingqian], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P180; LIU JP, 2007, ZHONGGUO ZHONG XI YI, V4, P306; LIU K, 2010, J LIAO NING MED U, V3, P259; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; OXMAN AD, 1994, BMJ-BRIT MED J, V309, P648, DOI 10.1136/bmj.309.6955.648; Petticrew M, 2001, BMJ-BRIT MED J, V322, P98, DOI 10.1136/bmj.322.7278.98; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; WANG XP, 2010, MED INFORM, V8, P2537; XIONG J, 2010, CHIN J EVID BASED ME, V9, P44; ZHZANG JH, 2007, J ALTERN COMPLEM MED, V13, P797	19	45	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20185	10.1371/journal.pone.0020185	http://dx.doi.org/10.1371/journal.pone.0020185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633698	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500038
J	Shaye, DD; Greenwald, I				Shaye, Daniel D.; Greenwald, Iva			OrthoList: A Compendium of C. elegans Genes with Human Orthologs	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SYSTEMATIC ANALYSIS; IDENTIFICATION; SIGNAL; EVOLUTION; PATHWAY; INTERFERENCE; LIN-12/NOTCH; RECEPTORS; NEMATODES	Background: C. elegans is an important model for genetic studies relevant to human biology and disease. We sought to assess the orthology between C. elegans and human genes to understand better the relationship between their genomes and to generate a compelling list of candidates to streamline RNAi-based screens in this model. Results: We performed a meta-analysis of results from four orthology prediction programs and generated a compendium, "OrthoList", containing 7,663 C. elegans protein-coding genes. Various assessments indicate that OrthoList has extensive coverage with low false-positive and false-negative rates. Part of this evaluation examined the conservation of components of the receptor tyrosine kinase, Notch, Wnt, TGF-beta and insulin signaling pathways, and led us to update compendia of conserved C. elegans kinases, nuclear hormone receptors, F-box proteins, and transcription factors. Comparison with two published genome-wide RNAi screens indicated that virtually all of the conserved hits would have been obtained had just the OrthoList set (similar to 38% of the genome) been targeted. We compiled Ortholist by InterPro domains and Gene Ontology annotation, making it easy to identify C. elegans orthologs of human disease genes for potential functional analysis. Conclusions: We anticipate that OrthoList will be of considerable utility to C. elegans researchers for streamlining RNAi screens, by focusing on genes with apparent human orthologs, thus reducing screening effort by similar to 60%. Moreover, we find that OrthoList provides a useful basis for annotating orthology and reveals more C. elegans orthologs of human genes in various functional groups, such as transcription factors, than previously described.	[Shaye, Daniel D.; Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10027 USA; [Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY USA; [Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Shaye, DD (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10027 USA.	ds451@columbia.edu; isg4@columbia.edu	Shaye, Daniel/AAY-5351-2020	Shaye, Daniel/0000-0002-3962-6903	Howard Hughes Medical Institute; National Institutes of Health [CA09538]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Howard Hughes Medical Institute and also supported by National Institutes of Health grant CA09538 to IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antebi Adam, 2006, WormBook, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; CESC, 1998, SCIENCE, V282, P2012; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GERSTEIN MB, 2010, SCIENCE; GREENWALD I, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK; Hardin J, 2008, CURR OPIN GENET DEV, V18, P362, DOI 10.1016/j.gde.2008.06.006; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hu Patrick J, 2007, WormBook, P1; Hueber SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010820; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Manning Gerard, 2005, WormBook, P1; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Merrihew GE, 2008, GENOME RES, V18, P1660, DOI 10.1101/gr.077644.108; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Newfeld SJ, 1999, GENETICS, V152, P783; Oosterveen T, 2007, DEV BIOL, V308, P438, DOI 10.1016/j.ydbio.2007.05.043; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Savage-Dunn Cathy, 2005, WormBook, P1; Schwarz Erich M, 2005, WormBook, P1; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Sonnhammer ELL, 1997, GENOMICS, V46, P200, DOI 10.1006/geno.1997.4989; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Sundaram Meera V, 2006, WormBook, P1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Thomas James H., 2008, Briefings in Functional Genomics & Proteomics, V7, P211, DOI 10.1093/bfgp/eln022; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031	57	270	5536	1	245	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20085	10.1371/journal.pone.0020085	http://dx.doi.org/10.1371/journal.pone.0020085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647448	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500024
J	Chandra, A; Srivastava, RK; Kashyap, MP; Kumar, R; Srivastava, RN; Pant, AB				Chandra, Abhijit; Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Kumar, Raj; Srivastava, Rajeshwar Nath; Pant, Aditya Bhushan			The Anti-Inflammatory and Antibacterial Basis of Human Omental Defense: Selective Expression of Cytokines and Antimicrobial Peptides	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; MESSENGER-RNA; RELEASE; IL-8; ADIPOCYTES; ADIPOKINES; MECHANISM; INFECTION; PATHWAYS	Background: The wound healing properties of the human omentum are well known and have extensively been exploited clinically. However, the underlying mechanisms of these effects are not well understood. We hypothesize that the omentum tissue promotes wound healing via modulation of anti-inflammatory pathways, and because the omentum is rich in adipocytes, the adipocytes may modulate the anti-inflammatory response. Factors released by human omentum may affect healing, inflammation and immune defense. Methodology: Six human omentum tissues (non obese, free from malignancy, and any other systemic disorder) were obtained during diagnostic laparoscopies having a negative outcome. Healthy oral mucosa (obtained from routine oral biopsies) was used as control. Cultured adipocytes derived from human omentum were exposed to lipopolysaccharide (LPS) (1-50 ng/mL) for 12-72 hours to identify the non-cytotoxic doses. Levels of expression (mRNA and protein) were carried out for genes associated with pro-and anti-inflammatory cytokine responses and antibacterial/antimicrobial activity using qRT-PCR, western blotting, and cell-based ELISA assays. Results: The study shows significant higher levels of expression (mRNA and protein) of several specific cytokines, and antibacterial peptides in the omentum tissues when compared to oral sub-mucosal tissues. In the validation studies, primary cultures of adipocytes, derived from human omentum were exposed to LPS (5 and 10 ng/mL) for 24 and 48 h. The altered expressions were more pronounced in cultured adipocytes cells when exposed to LPS as compared to the omentum tissue. Conclusions/Significance: Perhaps, this is the first report that provides evidence of expressional changes in pro-and anti-inflammatory cytokines and antibacterial peptides in the normal human omentum tissue as well as adipocytes cultured from this tissue. The study provides new insights on the molecular and cellular mechanisms of healing and defense by the omentum, and suggests the potential applicability of cultured adipocytes derived from the omentum for future therapeutic applications.	[Chandra, Abhijit] CSM Med Univ, Dept Surg Gastroenterol, Erstwhile KG Med Coll, Lucknow, Uttar Pradesh, India; [Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Pant, Aditya Bhushan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap] CSIR, New Delhi, India; [Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Srivastava, Rajeshwar Nath] CSM Med Univ, Dept Orthopaed Surg, Erstwhile KG Med Coll, Lucknow, Uttar Pradesh, India	King George's Medical University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; Geisinger Commonwealth School of Medicine; King George's Medical University	Chandra, A (corresponding author), CSM Med Univ, Dept Surg Gastroenterol, Erstwhile KG Med Coll, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Srivastava, Ritesh/V-6029-2019; Kashyap, Mahendra/G-4305-2011	Kashyap, Mahendra/0000-0001-7924-4793	Council of Scientific & Industrtail Research, New Delhi, India [SIP-08]	Council of Scientific & Industrtail Research, New Delhi, India	The financial support by Council of Scientific & Industrtail Research, New Delhi, India, through Supra-Institutional Project SIP-08 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassols J, 2009, J CELL BIOCHEM, V107, P1107, DOI 10.1002/jcb.22208; Bender TO, 2007, INT J ARTIF ORGANS, V30, P199, DOI 10.1177/039139880703000304; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Diesen DL, 2008, J PEDIATR SURG, V43, P2308, DOI 10.1016/j.jpedsurg.2008.08.025; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Fain JN, 2005, BIOCHEM PHARMACOL, V69, P1315, DOI 10.1016/j.bcp.2005.02.009; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Fain JN, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-4; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; KASHYAP MP, 2010, PLOS ONE, V6; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kuniyoshi Yukio, 2005, Asian Cardiovasc Thorac Ann, V13, P11; Liebermann-Meffert D, 2000, SURG CLIN N AM, V80, P275, DOI 10.1016/S0039-6109(05)70406-0; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Mattacks CA, 1999, CYTOKINE, V11, P334, DOI 10.1006/cyto.1998.0442; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; MELZIG MF, 1995, PHARMAZIE, V50, P558; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Oudhoff MJ, 2010, BIOL CHEM, V391, P541, DOI 10.1515/BC.2010.057; Paslakis G, 2010, NEPHRON EXP NEPHROL, V115, pE96, DOI 10.1159/000313490; Puma F, 2003, J THORAC CARDIOV SUR, V126, P1998, DOI 10.1016/S0022-5223(03)00709-8; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sewter CP, 1999, J ENDOCRINOL, V163, P33, DOI 10.1677/joe.0.1630033; SHIMOTSUMA M, 1991, CELL TISSUE RES, V264, P599, DOI 10.1007/BF00319049; Sopasakis VR, 2005, INT J OBESITY, V29, P1144, DOI 10.1038/sj.ijo.0803002; Srivastava RK, 2010, TOXICOL IND HEALTH, V26, P575, DOI 10.1177/0748233710374464; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Yoshida K, 1997, ANN THORAC SURG, V63, P858, DOI 10.1016/S0003-4975(96)01122-8; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983; ZHU S, 2011, MOL CELL BI IN PRESS	33	28	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20446	10.1371/journal.pone.0020446	http://dx.doi.org/10.1371/journal.pone.0020446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647223	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800051
J	Rantamaki, T; Vesa, L; Antila, H; Di Lieto, A; Tammela, P; Schmitt, A; Lesch, KP; Rios, M; Castren, E				Rantamaki, Tomi; Vesa, Liisa; Antila, Hanna; Di Lieto, Antonio; Tammela, Paivi; Schmitt, Angelika; Lesch, Klaus-Peter; Rios, Maribel; Castren, Eero			Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; NEURONAL PLASTICITY; MOOD DISORDERS; MESSENGER-RNA; MOUSE-BRAIN; RAT-BRAIN; ACTIVATION; DEPRESSION; MICE; INSENSITIVITY	Background: Antidepressant drugs (ADs) have been shown to activate BDNF (brain-derived neurotrophic factor) receptor TrkB in the rodent brain but the mechanism underlying this phenomenon remains unclear. ADs act as monoamine reuptake inhibitors and after prolonged treatments regulate brain bdnf mRNA levels indicating that monoamine-BDNF signaling regulate AD-induced TrkB activation in vivo. However, recent findings demonstrate that Trk receptors can be transactivated independently of their neurotrophin ligands. Methodology: In this study we examined the role of BDNF, TrkB kinase activity and monoamine reuptake in the AD-induced TrkB activation in vivo and in vitro by employing several transgenic mouse models, cultured neurons and TrkB-expressing cell lines. Principal Findings: Using a chemical-genetic TrkB(F616A) mutant and TrkB overexpressing mice, we demonstrate that ADs specifically activate both the maturely and immaturely glycosylated forms of TrkB receptors in the brain in a TrkB kinase dependent manner. However, the tricyclic AD imipramine readily induced the phosphorylation of TrkB receptors in conditional bdnf(-/-) knock-out mice (132.4+/-8.5% of control; P = 0.01), indicating that BDNF is not required for the TrkB activation. Moreover, using serotonin transporter (SERT) deficient mice and chemical lesions of monoaminergic neurons we show that neither a functional SERT nor monoamines are required for the TrkB phosphorylation response induced by the serotonin selective reuptake inhibitors fluoxetine or citalopram, or norepinephrine selective reuptake inhibitor reboxetine. However, neither ADs nor monoamine transmitters activated TrkB in cultured neurons or cell lines expressing TrkB receptors, arguing that ADs do not directly bind to TrkB. Conclusions: The present findings suggest that ADs transactivate brain TrkB receptors independently of BDNF and monoamine reuptake blockade and emphasize the need of an intact tissue context for the ability of ADs to induce TrkB activity in brain.	[Rantamaki, Tomi; Vesa, Liisa; Antila, Hanna; Di Lieto, Antonio; Castren, Eero] Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, Helsinki, Finland; [Tammela, Paivi] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Schmitt, Angelika; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Wurzburg, Germany; [Rios, Maribel] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Sigrid Juselius Foundation; University of Helsinki; University of Helsinki; University of Wurzburg; Tufts University	Rantamaki, T (corresponding author), Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, Helsinki, Finland.	tomi.rantamaki@helsinki.fi	Lesch, Klaus-Peter/J-4906-2013; Yan, Shuo/B-8381-2009; Tammela, Päivi/A-4670-2010	Lesch, Klaus-Peter/0000-0001-8348-153X; Tammela, Päivi/0000-0003-4697-8066; Rantamaki, Tomi/0000-0002-0052-1434; Castren, Eero/0000-0002-1402-2791; Antila, Hanna/0000-0001-8317-4564	Sigrid Juselius Foundation; Academy of Finland; Finnish Cultural Foundation; Finnish Graduate School for Neuroscience (FGSN); Deutsche Forschungsgemeinschaft [Le 629/4-2]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Graduate School for Neuroscience (FGSN); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Sigrid Juselius Foundation (EC), Academy of Finland (EC), Finnish Cultural Foundation (TR), the Finnish Graduate School for Neuroscience (FGSN; LV) and the Deutsche Forschungsgemeinschaft (Le 629/4-2; KPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Koponen E, 2004, MOL BRAIN RES, V130, P81, DOI 10.1016/j.molbrainres.2004.07.010; Koponen E, 2004, MOL CELL NEUROSCI, V26, P166, DOI 10.1016/j.mcn.2004.01.006; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lobato KR, 2008, PROG NEURO-PSYCHOPH, V32, P994, DOI 10.1016/j.pnpbp.2008.01.012; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; LUCCHELLI A, 1995, BRIT J PHARMACOL, V114, P1017, DOI 10.1111/j.1476-5381.1995.tb13307.x; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Miranda C, 2002, J BIOL CHEM, V277, P6455, DOI 10.1074/jbc.M110016200; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; PHILLIS JW, 1982, COMP BIOCHEM PHYS C, V72, P179, DOI 10.1016/0306-4492(82)90082-X; Pires VA, 2009, BEHAV PHARMACOL, V20, P134, DOI 10.1097/FBP.0b013e32832a80bf; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Raabe R, 2008, J BIOPHYS; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rammes G, 2007, MOL NEUROBIOL, V35, P160, DOI 10.1007/s12035-007-0006-1; Rantamaki T, 2006, NEUROPHARMACOLOGY, V50, P421, DOI 10.1016/j.neuropharm.2005.10.001; Rantamaki T, 2008, EXPERT OPIN THER TAR, V12, P705, DOI [10.1517/14728222.12.6.705 , 10.1517/14728220802121472]; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saarelainen T, 2001, CELL MOL NEUROBIOL, V21, P429, DOI 10.1023/A:1012775808253; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Sebastiao AM, 2009, BRIT J PHARMACOL, V158, P15, DOI 10.1111/j.1476-5381.2009.00157.x; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Vesa J, 2000, J BIOL CHEM, V275, P24414, DOI 10.1074/jbc.M001641200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Wyneken U, 2006, NEUROPSYCHOPHARMACOL, V31, P2415, DOI 10.1038/sj.npp.1301052	49	89	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20567	10.1371/journal.pone.0020567	http://dx.doi.org/10.1371/journal.pone.0020567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666748	Green Submitted, gold, Green Published			2022-12-27	WOS:000291607000012
J	Mai, V; Young, CM; Ukhanova, M; Wang, XY; Sun, YJ; Casella, G; Theriaque, D; Li, N; Sharma, R; Hudak, M; Neu, J				Mai, Volker; Young, Christopher Michael; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun; Casella, George; Theriaque, Douglas; Li, Nan; Sharma, Renu; Hudak, Mark; Neu, Josef			Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PRETERM INFANTS; METAGENOMICS; COLONIZATION; NEONATE	Intestinal luminal microbiota likely contribute to the etiology of necrotizing enterocolitis (NEC), a common disease in preterm infants. Microbiota development, a cascade of initial colonization events leading to the establishment of a diverse commensal microbiota, can now be studied in preterm infants using powerful molecular tools. Starting with the first stool and continuing until discharge, weekly stool specimens were collected prospectively from infants with gestational ages <= 32 completed weeks or birth weights <= 1250 g. High throughput 16S rRNA sequencing was used to compare the diversity of microbiota and the prevalence of specific bacterial signatures in nine NEC infants and in nine matched controls. After removal of short and low quality reads we retained a total of 110,021 sequences. Microbiota composition differed in the matched samples collected 1 week but not <72 hours prior to NEC diagnosis. We detected a bloom (34% increase) of Proteobacteria and a decrease (32%) in Firmicutes in NEC cases between the 1 week and <72 hour samples. No significant change was identified in the controls. At both time points, molecular signatures were identified that were increased in NEC cases. One of the bacterial signatures detected more frequently in NEC cases (p<0.01) matched closest to gamma-Proteobacteria. Although this sequence grouped to the well-studied Enterobacteriaceae family, it did not match any sequence in Genbank by more than 97%. Our observations suggest that abnormal patterns of microbiota and potentially a novel pathogen contribute to the etiology of NEC.	[Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Young, Christopher Michael; Li, Nan; Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL USA; [Sharma, Renu; Hudak, Mark] Univ Florida, Dept Pediat, Jacksonville, FL USA; [Casella, George] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Casella, George] Univ Florida, Genet Inst, Gainesville, FL USA; [Theriaque, Douglas] Univ Florida, Clin & Translat Sci Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mai, V (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	vmai@ufl.edu	Neu, Josef/AAI-2799-2020; Wang, Xiaoyu/J-4101-2018	Wang, Xiaoyu/0000-0002-4504-7799; Young, Christopher/0000-0002-1677-7178	National Institute of Child Health and Human Development [RO1 HD 059143]; National Institutes of Health (NIH); National Center for Research Resources (NCRR) [1UL 1RR029890]; American Cancer Society [MRSGT CCE-107301]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062362] Funding Source: National Science Foundation	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This work was supported by the National Institute of Child Health and Human Development, grant number RO1 HD 059143 and the National Institutes of Health (NIH) and National Center for Research Resources (NCRR) CTSA grant 1UL 1RR029890. Dr. Mai was also supported by a grant from the American Cancer Society MRSGT CCE-107301. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Caicedo RA, 2005, PEDIATR RES, V58, P625, DOI 10.1203/01.PDR.0000180533.09295.84; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2008, NUTR REV, V66, P658, DOI 10.1111/j.1753-4887.2008.00119.x; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37	28	422	435	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20647	10.1371/journal.pone.0020647	http://dx.doi.org/10.1371/journal.pone.0020647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674011	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400012
J	Zhang, QF; Zhang, YL; Huang, YF; Xue, XY; Yan, H; Sun, XD; Wang, J; McCutchan, TF; Pan, WQ				Zhang, Qingfeng; Zhang, Yilong; Huang, Yufu; Xue, Xiangyang; Yan, He; Sun, Xiaodong; Wang, Jian; McCutchan, Thomas F.; Pan, Weiqing			From In Vivo to In Vitro: Dynamic Analysis of Plasmodium falciparum var Gene Expression Patterns of Patient Isolates during Adaptation to Culture	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; CHONDROITIN-SULFATE-A; FREQUENT RECOMBINATION EVENTS; SEVERE CHILDHOOD MALARIA; PAPUA-NEW-GUINEA; ANTIGENIC VARIATION; FUNCTIONAL SPECIALIZATION; DIFFERENTIAL EXPRESSION; INFECTED ERYTHROCYTES; TANZANIAN CHILDREN	Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), encoded by the var gene family, plays a crucial role in disease virulence through its involvement in binding to various host cellular receptors during infection. Growing evidence suggests that differential expression of the various var subgroups may be involved in parasite virulence. To further explore this issue, we have collected isolates from symptomatic patients in south China-Myanmar border, and characterized their sequence diversity and transcription profiles over time of var gene family, and cytoadherence properties from the time of their initial collection and extending through a two month period of adaptation to culture. Initially, we established a highly diverse, DBL alpha (4 cysteines) subtype-enriched, but unique local repertoire of var-DBL1 alpha sequences by cDNA cloning and sequencing. Next we observed a rapid transcriptional decline of upsA- and upsB-subtype var genes at ring stage through qRT-PCR assays, and a switching event from initial ICAM-I binding to the CD36-binding activity during the first week of adaptive cultivation in vitro. Moreover, predominant transcription of upsA var genes was observed to be correlated with those isolates that showed a higher parasitemia at the time of collection and the ICAM-1-binding phenotype in culture. Taken together, these data indicate that the initial stage of adaptive process in vitro significantly influences the transcription of virulence-related var subtypes and expression of PfEMP1 variants. Further, the specific upregulation of the upsA var genes is likely linked to the rapid propagation of the parasite during natural infection due to the A-type PfEMP1 variant-mediated growth advantages.	[Zhang, Qingfeng; Zhang, Yilong; Xue, Xiangyang; Yan, He; Pan, Weiqing] Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China; [Huang, Yufu; McCutchan, Thomas F.; Pan, Weiqing] Second Mil Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China; [Sun, Xiaodong; Wang, Jian] Yunnan Inst Parasit Dis, Puer, Peoples R China	Tongji University; Naval Medical University	Zhang, QF (corresponding author), Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China.	wqpan0912@yahoo.com.cn		ZHANG, Qingfeng/0000-0002-8759-9102	National Basic Research Program (973 Program) in China [2007CB513100]; Shanghai Leading Academic Discipline Project [B901]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	Funding: This work is supported by grants from the National Basic Research Program (973 Program) in China (2007CB513100) and Shanghai Leading Academic Discipline Project (No. B901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Dahlback M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-78; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; FELGER I, 1993, EXP PARASITOL, V77, P372, DOI 10.1006/expr.1993.1094; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250; Kalmbach Y, 2010, J INFECT DIS, V202, P313, DOI 10.1086/653586; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes S, 2007, MOL MICROBIOL, V63, P1237, DOI 10.1111/j.1365-2958.2007.05587.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su Xin-zhuan, 2002, Methods Mol Med, V72, P131, DOI 10.1385/1-59259-271-6:131; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van Noort SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009778; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Zhang QF, 2007, VACCINE, V25, P2112, DOI 10.1016/j.vaccine.2006.11.015; Zhou Shui-sen, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P401; ZHOU SS, 2009, ZHONGGUO JI SHENG CH, V27	61	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20591	10.1371/journal.pone.0020591	http://dx.doi.org/10.1371/journal.pone.0020591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674009	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400010
J	Maloney, A; Herskowitz, LJ; Koch, SJ				Maloney, Andy; Herskowitz, Lawrence J.; Koch, Steven J.			Effects of Surface Passivation on Gliding Motility Assays	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; BETA-CASEIN; OPTICAL TWEEZERS; K-CASEIN; MOTOR; MICROTUBULES; STABILIZATION; TEMPERATURE; ASSOCIATION	In this study, we report differences in the observed gliding speed of microtubules dependent on the choice of bovine casein used as a surface passivator. We observed differences in both speed and support of microtubules in each of the assays. Whole casein, comprised of alpha(s1), alpha(s2), beta, and kappa casein, supported motility and averaged speeds of 96 +/- 67 nm/s. Alpha casein can be purchased as a combination of alpha(s1) and alpha(s2) and supported gliding motility and average speeds of 949 +/- 4 nm/s. Beta casein did not support motility very well and averaged speeds of 870 +/- 30 nm/s. Kappa casein supported motility very poorly and we were unable to obtain an average speed. Finally, we observed that mixing alpha, beta, and kappa casein with the proportions found in bovine whole casein supported motility and averaged speeds of 966 +/- 6 nm/s.	[Maloney, Andy] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; Univ New Mexico, Ctr High Technol Mat, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Maloney, A (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.	amaloney@unm.edu		Koch, Steven/0000-0001-9027-7502; Maloney, Andy/0000-0002-8981-4611	DTRA [HDTRA-1-09-1-0018]; INCBN, NSF [DGE-0549500]	DTRA(United States Department of DefenseDefense Threat Reduction Agency); INCBN, NSF	The experiments were funded by DTRA grant number "HDTRA-1-09-1-0018" and the INCBN from a NSF Grant "DGE-0549500". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BINGHAM EW, 1971, J DAIRY SCI, V54, P1077, DOI 10.3168/jds.S0022-0302(71)85974-X; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bohm KJ, 1997, CELL MOTIL CYTOSKEL, V37, P226, DOI 10.1002/(SICI)1097-0169(1997)37:3<226::AID-CM4>3.0.CO;2-4; Bohm KJ, 2000, FEBS LETT, V466, P59, DOI 10.1016/S0014-5793(99)01757-3; Bohm KJ, 2000, CELL BIOL INT, V24, P335, DOI 10.1006/cbir.1999.0515; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Castro JS, 2010, COLLOID SURFACE B, V76, P199, DOI 10.1016/j.colsurfb.2009.10.033; Castro JS, 2009, MAT SCI ENG C-BIO S, V29, P1609, DOI 10.1016/j.msec.2008.12.026; FIAT AM, 1989, MOL CELL BIOCHEM, V87, P5, DOI 10.1007/BF00421079; Foss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001476; Fox P. F., 1998, DAIRY CHEM BIOCH, P347; Fox P F, 1998, MILK PROTEINS DAIRY, P146; Gagliano J, 2010, EUR BIOPHYS J BIOPHY, V39, P801, DOI 10.1007/s00249-009-0560-8; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; HERSKOWITZ LJ, THESIS; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Huang YM, 2005, IEEE T ADV PACKAGING, V28, P564, DOI 10.1109/TADVP.2005.858330; Leclerc E, 1997, PHYS REV LETT, V78, P150, DOI 10.1103/PhysRevLett.78.150; Mahamdeh M, 2009, OPT EXPRESS, V17, P17190, DOI 10.1364/OE.17.017190; MALONEY A, 2010, CORRECTED SPEED EFFE; Moorjani SG, 2003, NANO LETT, V3, P633, DOI 10.1021/nl034001b; O'Connell JE, 2003, J COLLOID INTERF SCI, V258, P33, DOI 10.1016/S0021-9797(02)00066-8; OLMSTED JB, 1975, BIOCHEMISTRY-US, V14, P2996, DOI 10.1021/bi00684a032; Ozeki T, 2009, BIOPHYS J, V96, P3305, DOI 10.1016/j.bpj.2008.12.3960; PAYENS TAJ, 1963, BIOCHIM BIOPHYS ACTA, V71, P517, DOI 10.1016/0006-3002(63)91124-7; Phadungath C., 2005, SONGKLANAKARIN J SCI, V27, P201; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Silverman B.W., 1986, DENSITY ESTIMATION S; THOMPSON MP, 1969, J DAIRY SCI, V52, P1166, DOI 10.3168/jds.S0022-0302(69)86719-6; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; VATER W, 1995, J CELL SCI, V108, P1063; Verma Vivek, 2008, J Biol Eng, V2, P14, DOI 10.1186/1754-1611-2-14; Walstra P, 1999, INT DAIRY J, V9, P189, DOI 10.1016/S0958-6946(99)00059-X; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; ZITTLE CA, 1963, J DAIRY SCI, V46, P1189, DOI 10.3168/jds.S0022-0302(63)89243-7; ZITTLE CA, 1961, J DAIRY SCI, V44, P2101, DOI 10.3168/jds.S0022-0302(61)90026-1	45	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e19522	10.1371/journal.pone.0019522	http://dx.doi.org/10.1371/journal.pone.0019522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674032	gold, Green Published, Green Submitted			2022-12-27	WOS:000291355500003
J	Carbone, MA; Chen, YH; Hughes, GA; Weinreb, RN; Zabriskie, NA; Zhang, K; Anholt, RRH				Carbone, Mary Anna; Chen, Yuhong; Hughes, Guy A.; Weinreb, Robert N.; Zabriskie, Norman A.; Zhang, Kang; Anholt, Robert R. H.			Genes of the Unfolded Protein Response Pathway Harbor Risk Alleles for Primary Open Angle Glaucoma	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; ER STRESS; MYOCILIN; ASSOCIATION; MUTATIONS; PATHOGENESIS; OPTINEURIN; MUTANTS; QUALITY; SHESIS	The statistical power of genome-wide association (GWA) studies to detect risk alleles for human diseases is limited by the unfavorable ratio of SNPs to study subjects. This multiple testing problem can be surmounted with very large population sizes when common alleles of large effects give rise to disease status. However, GWA approaches fall short when many rare alleles may give rise to a common disease, or when the number of subjects that can be recruited is limited. Here, we demonstrate that this multiple testing problem can be overcome by a comparative genomics approach in which an initial genome-wide screen in a genetically amenable model organism is used to identify human orthologues that may harbor risk alleles for adult-onset primary open angle glaucoma (POAG). Glaucoma is a major cause of blindness, which affects over 60 million people worldwide. Several genes have been associated with juvenile onset glaucoma, but genetic factors that predispose to adult onset primary open angle glaucoma (POAG) remain largely unknown. Previous genome-wide analysis in a Drosophila ocular hypertension model identified transcripts with altered regulation and showed induction of the unfolded protein response (UPR) upon overexpression of transgenic human glaucoma-associated myocilin (MYOC). We selected 16 orthologous genes with 62 polymorphic markers and identified in two independent human populations two genes of the UPR that harbor POAG risk alleles, BIRC6 and PDIA5. Thus, effectiveness of the UPR in response to accumulation of misfolded or aggregated proteins may contribute to the pathogenesis of POAG and provide targets for early therapeutic intervention.	[Carbone, Mary Anna; Anholt, Robert R. H.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Carbone, Mary Anna; Anholt, Robert R. H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Chen, Yuhong; Hughes, Guy A.; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA; [Chen, Yuhong] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai Med Sch, Shanghai 200433, Peoples R China; [Weinreb, Robert N.; Zhang, Kang] Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Weinreb, Robert N.; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Zabriskie, Norman A.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Zhang, Kang] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu, Sichuan, Peoples R China; [Zhang, Kang] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of California System; University of California San Diego; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Sichuan University; Sichuan University; University of North Carolina; North Carolina State University	Carbone, MA (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	anholt@ncsu.edu	Zhang, Kang/Y-2740-2019; Anholt, Robert/S-5977-2019	Zhang, Kang/0000-0002-4549-1697; 	National Institutes of Health [EY015873, EY018660, EY019270, EY014428, EY021374]; Research to Prevent Blindness; Chinese National 985 Project; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY014428, R01EY019270, R01EY015873, R01EY018660, R01EY021374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Chinese National 985 Project; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health (EY015873 to RRHA; EY018660, EY019270, EY014428, EY021374 to KZ), Research to Prevent Blindness, Chinese National 985 Project to Sichuan University and West China Hospital (KZ), and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research ( KZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Borras T, 2003, GENETICS, V163, P637; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Johnson DH, 2000, ARCH OPHTHALMOL-CHIC, V118, P974; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kumar A, 2007, MOL VIS, V13, P667; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Liu Cui-Hua, 2007, Chang Gung Med J, V30, P469; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mozaffarieh M, 2008, MOL VIS, V14, P224; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Julvez LP, 2010, J GLAUCOMA, V19, P587, DOI 10.1097/IJG.0b013e3181ccb77f; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sharts-Hopko NC, 2009, AM J NURS, V109, P40, DOI 10.1097/01.NAJ.0000345434.37734.ee; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Wang L, 2007, MOL VIS, V13, P618; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	34	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20649	10.1371/journal.pone.0020649	http://dx.doi.org/10.1371/journal.pone.0020649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655191	Green Published, gold			2022-12-27	WOS:000291097600115
J	Carson, WF; Ito, T; Schaller, M; Cavassani, KA; Chensue, SW; Kunkel, SL				Carson, William F.; Ito, Toshihiro; Schaller, Matthew; Cavassani, Karen A.; Chensue, Stephen W.; Kunkel, Steven L.			Dysregulated Cytokine Expression by CD4+T cells from Post-Septic Mice Modulates both Th1 and Th2-Mediated Granulomatous Lung Inflammation	PLOS ONE			English	Article							POLYMICROBIAL SEPSIS; INTERFERON-GAMMA; INDUCED IMMUNOSUPPRESSION; DENDRITIC CELLS; T-LYMPHOCYTES; MOUSE MODEL; IFN-GAMMA; MYCOBACTERIAL; INTERLEUKIN-4; APOPTOSIS	Previous epidemiological studies in humans and experimental studies in animals indicate that survivors of severe sepsis exhibit deficiencies in the activation and effector function of immune cells. In particular, CD4+ T lymphocytes can exhibit reduced proliferative capacity and improper cytokine responses following sepsis. To further investigate the cell-intrinsic defects of CD4+ T cells following sepsis, splenic CD4+ T cells from sham surgery and post-septic mice were transferred into lymphopenic mice. These recipient mice were then subjected to both TH1-(purified protein derivative) and TH2-(Schistosoma mansoni egg antigen) driven models of granulomatous lung inflammation. Post-septic CD4+ T cells mediated smaller TH1 and larger TH2 lung granulomas as compared to mice receiving CD4+ T cells from sham surgery donors. However, cytokine production by lymph node cells in antigen restimulation assays indicated increased pan-specific cytokine expression by post-septic CD4+ T cell recipient mice in both TH1 and TH2 granuloma models. These include increased production of T(H)2 cytokines in TH1 inflammation, and increased production of T(H)1 cytokines in TH2 inflammation. These results suggest that cell-intrinsic defects in CD4+ T cell effector function can have deleterious effects on inflammatory processes post-sepsis, due to a defect in the proper regulation of TH-specific cytokine expression.	[Carson, William F.; Ito, Toshihiro; Schaller, Matthew; Cavassani, Karen A.; Chensue, Stephen W.; Kunkel, Steven L.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Chensue, Stephen W.] Healthcare Syst, Vet Affairs Ann Arbor, Dept Pathol & Lab Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Carson, WF (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	wfcarson@umich.edu	Schaller, Matthew/AAL-7640-2020	Carson, William F/0000-0001-9459-3924	National Institutes of Health (NIH) [HL031237, HL089216, HL31963, HL007517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, P01HL031963, T32HL007517, R01HL089216] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grants HL031237, HL089216, HL31963 and HL007517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala A, 1999, IMMUNOLOGY, V97, P45; AYALA A, 1994, J SURG RES, V56, P579, DOI 10.1006/jsre.1994.1092; Ayala A, 2001, CYTOKINE, V14, P37, DOI 10.1006/cyto.2001.0848; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamim CF, 2005, BLOOD, V105, P3588, DOI 10.1182/blood-2004-08-3251; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; CAVASSANI KA, 2010, BLOOD; Chensue SW, 1996, J IMMUNOL, V157, P4602; CHENSUE SW, 1995, J IMMUNOL, V154, P5969; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Chiu BC, 2003, AM J RESP CELL MOL, V29, P106, DOI 10.1165/rcmb.2002-0241OC; Co DO, 2004, IMMUNOL LETT, V92, P135, DOI 10.1016/j.imlet.2003.11.023; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Ding YL, 2004, SHOCK, V22, P137, DOI 10.1097/01.shk.0000131194.80038.3f; Duan XB, 2008, J LEUKOCYTE BIOL, V83, P305, DOI 10.1189/jlb.0407228; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Ferguson NR, 1999, INTENS CARE MED, V25, P106, DOI 10.1007/s001340050795; Flohe SB, 2006, J LEUKOCYTE BIOL, V79, P473, DOI 10.1189/jlb.0705413; Hirata M, 2001, PARASITE IMMUNOL, V23, P271, DOI 10.1046/j.1365-3024.2001.00382.x; Ito T, 2007, EUR J IMMUNOL, V37, P2847, DOI 10.1002/eji.200737603; Joshi AD, 2008, EUR J IMMUNOL, V38, P3436, DOI 10.1002/eji.200838629; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; McDunn JE, 2006, J AM COLL SURGEONS, V203, P365, DOI 10.1016/j.jamcollsurg.2006.05.304; Murphey ED, 2004, SHOCK, V21, P415, DOI 10.1097/00024382-200405000-00004; NAPOLITANO LM, 1995, J TRAUMA, V39, P104, DOI 10.1097/00005373-199507000-00014; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Patenaude J, 2010, CELL MOL LIFE SCI, V67, P1315, DOI 10.1007/s00018-009-0251-8; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rezende SA, 1997, INFECT IMMUN, V65, P3457, DOI 10.1128/IAI.65.8.3457-3461.1997; Roth G, 2003, BIOCHEM BIOPH RES CO, V308, P840, DOI 10.1016/S0006-291X(03)01482-7; Ruth JH, 2000, CYTOKINE, V12, P432, DOI 10.1006/cyto.1999.0595; Smith PM, 2009, J IMMUNOL, V183, P3317, DOI 10.4049/jimmunol.0901504; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; Wen HT, 2008, J LEUKOCYTE BIOL, V83, P439, DOI 10.1189/jlb.0607357; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wen HT, 2006, AM J PATHOL, V168, P1940, DOI 10.2353/ajpath.2006.051155; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	46	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20385	10.1371/journal.pone.0020385	http://dx.doi.org/10.1371/journal.pone.0020385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655295	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600062
J	Guo, WX; Crossey, EL; Zhang, L; Zucca, S; George, OL; Valenzuela, CF; Zhao, XY				Guo, Weixiang; Crossey, Erin L.; Zhang, Li; Zucca, Stefano; George, Olivia L.; Valenzuela, C. Fernando; Zhao, Xinyu			Alcohol Exposure Decreases CREB Binding Protein Expression and Histone Acetylation in the Developing Cerebellum	PLOS ONE			English	Article							RUBINSTEIN-TAYBI-SYNDROME; NEUROTROPHIN RECEPTOR EXPRESSION; NEONATAL-RAT CEREBELLUM; CENTRAL-NERVOUS-SYSTEM; BRAIN GROWTH SPURT; ETHANOL EXPOSURE; SPECTRUM DISORDERS; DNA METHYLATION; PURKINJE-CELL; EPIGENETIC REGULATION	Background: Fetal alcohol exposure affects 1 in 100 children making it the leading cause of mental retardation in the US. It has long been known that alcohol affects cerebellum development and function. However, the underlying molecular mechanism is unclear. Methodology/Principal Findings: We demonstrate that CREB binding protein (CBP) is widely expressed in granule and Purkinje neurons of the developing cerebellar cortex of naive rats. We also show that exposure to ethanol during the 3(rd) trimester-equivalent of human pregnancy reduces CBP levels. CBP is a histone acetyltransferase, a component of the epigenetic mechanism controlling neuronal gene expression. We further demonstrate that the acetylation of both histone H3 and H4 is reduced in the cerebellum of ethanol-treated rats. Conclusions/Significance: These findings indicate that ethanol exposure decreases the expression and function of CBP in the developing cerebellum. This effect of ethanol may be responsible for the motor coordination deficits that characterize fetal alcohol spectrum disorders.	[Guo, Weixiang; Crossey, Erin L.; Zhang, Li; Zucca, Stefano; George, Olivia L.; Valenzuela, C. Fernando; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico	Guo, WX (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	fvalenzuela@salud.unm.edu; xzhao@waisman.wisc.edu	Zucca, Stefano/G-2459-2015	Zucca, Stefano/0000-0002-8781-3295	NIH [P20 AA017068, MH078972, MH080434, AA14973, AA15614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080434, R01MH078972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014973, R01AA015614, P20AA017068, R37AA015614, R56AA014973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grants P20 AA017068 to X.Z. and C.F.V, MH078972 and MH080434 to X.Z, and AA14973 and AA15614 to C.F.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Auger AP, 2002, ENDOCRINOLOGY, V143, P3009, DOI 10.1210/en.143.8.3009; Backman C, 1998, ALCOHOL CLIN EXP RES, V22, P1137, DOI 10.1111/j.1530-0277.1998.tb03713.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Carloni S, 2004, J NEUROCHEM, V89, P197, DOI 10.1111/j.1471-4159.2004.02341.x; Chan HM, 2001, J CELL SCI, V114, P2363; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Chu J, 2007, ACTA NEUROPATHOL, V113, P659, DOI 10.1007/s00401-007-0199-4; Connor PD, 2006, NEUROPSYCHOLOGIA, V44, P744, DOI 10.1016/j.neuropsychologia.2005.07.016; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Dohrman DP, 1997, ALCOHOL CLIN EXP RES, V21, P882; Galindo R, 2006, ALCOHOL, V40, P111, DOI 10.1016/j.alcohol.2006.11.001; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Green JT, 2004, CEREBELLUM, V3, P178, DOI 10.1080/14734220410017338; Gruol DL, 2006, J NEUROSCI RES, V83, P1381, DOI 10.1002/jnr.20844; GRUOL DL, 1994, BRAIN RES, V634, P283, DOI 10.1016/0006-8993(94)91931-3; HAMRE KM, 1993, ALCOHOL CLIN EXP RES, V17, P610, DOI 10.1111/j.1530-0277.1993.tb00808.x; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Hennekam RCM, 2006, EUR J HUM GENET, V14, P981, DOI 10.1038/sj.ejhg.5201594; Holmes MC, 2006, MOL CELL ENDOCRINOL, V248, P9, DOI 10.1016/j.mce.2005.12.002; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Koibuchi N, 2008, CEREBELLUM, V7, P530, DOI 10.1007/s12311-008-0069-1; Kumada T, 2007, J NEUROSCI RES, V85, P465, DOI 10.1002/jnr.21149; Kumar A, 2010, ALCOHOL CLIN EXP RES, V34, P928, DOI 10.1111/j.1530-0277.2010.01166.x; Lefebvre T, 2009, J NEUROCHEM, V110, P976, DOI 10.1111/j.1471-4159.2009.06197.x; Lewis B, 2007, PHARMACOL BIOCHEM BE, V88, P114, DOI 10.1016/j.pbb.2007.07.012; Li Z, 2002, DEV BRAIN RES, V139, P237, DOI 10.1016/S0165-3806(02)00573-4; Light KE, 2002, BRAIN RES, V924, P71, DOI 10.1016/S0006-8993(01)03224-3; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Moore DB, 2004, J NEUROBIOL, V60, P114, DOI 10.1002/neu.20010; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Morte B, 2004, ENDOCRINOLOGY, V145, P1386, DOI 10.1210/en.2003-1123; Nishihara E, 2003, J NEUROSCI, V23, P213; Nishihara E, 2008, CEREBELLUM, V7, P48, DOI 10.1007/s12311-008-0018-z; Norman AL, 2009, DEV DISABIL RES REV, V15, P209, DOI 10.1002/ddrr.72; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Ramadoss J, 2008, AM J PHYSIOL-REG I, V295, pR596, DOI 10.1152/ajpregu.90321.2008; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Renthal W, 2009, SEMIN CELL DEV BIOL, V20, P387, DOI 10.1016/j.semcdb.2009.01.005; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Siler-Marsiglio KI, 2005, BRAIN RES, V1052, P202, DOI 10.1016/j.brainres.2005.06.030; Soscia SJ, 2006, CELL MOL LIFE SCI, V63, P2039, DOI 10.1007/s00018-006-6208-2; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Stanton ME, 1998, ALCOHOL CLIN EXP RES, V22, P270, DOI 10.1111/j.1530-0277.1998.tb03649.x; Stromberg H, 1999, BRAIN RES, V818, P510, DOI 10.1016/S0006-8993(98)01219-0; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; Tsirigotis M, 2006, NEUROPATH APPL NEURO, V32, P26, DOI 10.1111/j.1365-2990.2005.00694.x; Tsutsui K, 2008, MOL NEUROBIOL, V37, P116, DOI 10.1007/s12035-008-8024-1; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Yalcin A, 2003, J NEUROCHEM, V84, P397, DOI 10.1046/j.1471-4159.2003.01540.x; Yamamoto M, 1999, NEUROTOXICOL TERATOL, V21, P141, DOI 10.1016/S0892-0362(98)00048-8; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236	64	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19351	10.1371/journal.pone.0019351	http://dx.doi.org/10.1371/journal.pone.0019351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655322	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600005
J	Yu, CS; Lu, CH				Yu, Chin-Sheng; Lu, Chih-Hao			Identification of Antifreeze Proteins and Their Functional Residues by Support Vector Machine and Genetic Algorithms based on n-Peptide Compositions	PLOS ONE			English	Article							DISULFIDE CONNECTIVITY; BINDING; PREDICTION; FOLD	For the first time, multiple sets of n-peptide compositions from antifreeze protein (AFP) sequences of various cold-adapted fish and insects were analyzed using support vector machine and genetic algorithms. The identification of AFPs is difficult because they exist as evolutionarily divergent types, and because their sequences and structures are present in limited numbers in currently available databases. Our results reveal that it is feasible to identify the shared sequential features among the various structural types of AFPs. Moreover, we were able to identify residues involved in ice binding without requiring knowledge of the three-dimensional structures of these AFPs. This approach should be useful for genomic and proteomic studies involving cold-adapted organisms.	[Yu, Chin-Sheng] Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Masters Program Biomed Informat & Biomed Engn, Taichung 40724, Taiwan; [Lu, Chih-Hao] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan	Feng Chia University; Feng Chia University; China Medical University Taiwan	Yu, CS (corresponding author), Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan.	yucs@fcu.edu.tw			National Science Council, Taiwan; National Science Council; China Medical University, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This work was supported by grants from the National Science Council, Taiwan to CSY and the National Science Council and China Medical University, Taiwan to CHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YC, 2005, PROTEINS, V61, P507, DOI 10.1002/prot.20627; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Doxey AC, 2006, NAT BIOTECHNOL, V24, P852, DOI 10.1038/nbt1224; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Fan Y, 2002, PLANT CELL REP, V21, P296, DOI 10.1007/s00299-002-0495-3; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Graether SP, 1999, J BIOL CHEM, V274, P11842, DOI 10.1074/jbc.274.17.11842; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; GRIFFITH M, 1995, BIOTECHNOL ADV, V13, P375, DOI 10.1016/0734-9750(95)02001-J; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hamada T, 2006, PROTEIN SCI, V15, P1010, DOI 10.1110/ps.051700406; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Knight CA, 2000, NATURE, V406, P249, DOI 10.1038/35018671; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Lu CH, 2007, PROTEINS, V67, P262, DOI 10.1002/prot.21309; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; RUBINSKY B, 1992, CRYOBIOLOGY, V29, P69, DOI 10.1016/0011-2240(92)90006-N; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu CS, 2003, PROTEINS, V50, P531, DOI 10.1002/prot.10313	38	21	24	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20445	10.1371/journal.pone.0020445	http://dx.doi.org/10.1371/journal.pone.0020445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655262	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600071
J	Mulampaka, SN; Dixit, NM				Mulampaka, Shiva Naresh; Dixit, Narendra M.			Estimating the Threshold Surface Density of Gp120-CCR5 Complexes Necessary for HIV-1 Envelope-Mediated Cell-Cell Fusion	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; NONHUMAN PRIMATE HOSTS; CD4(+) T-CELLS; LIVING CELLS; GLYCOPROTEIN TRIMERS; MEMBRANE-FUSION; DOWN-REGULATION; 6-HELIX BUNDLE; MULTIPLE CCR5	Reduced expression of CCR5 on target CD4(+) cells lowers their susceptibility to infection by R5-tropic HIV-1, potentially preventing transmission of infection and delaying disease progression. Binding of the HIV-1 envelope (Env) protein gp120 with CCR5 is essential for the entry of R5 viruses into target cells. The threshold surface density of gp120-CCR5 complexes that enables HIV-1 entry remains poorly estimated. We constructed a mathematical model that mimics Env-mediated cell-cell fusion assays, where target CD4(+)CCR5(+) cells are exposed to effector cells expressing Env in the presence of a coreceptor antagonist and the fraction of target cells fused with effector cells is measured. Our model employs a reaction network-based approach to describe protein interactions that precede viral entry coupled with the ternary complex model to quantify the allosteric interactions of the coreceptor antagonist and predicts the fraction of target cells fused. By fitting model predictions to published data of cell-cell fusion in the presence of the CCR5 antagonist vicriviroc, we estimated the threshold surface density of gp120-CCR5 complexes for cell-cell fusion as similar to 20 mu m(-2). Model predictions with this threshold captured data from independent cell-cell fusion assays in the presence of vicriviroc and rapamycin, a drug that modulates CCR5 expression, as well as assays in the presence of maraviroc, another CCR5 antagonist, using sixteen different Env clones derived from transmitted or early founder viruses. Our estimate of the threshold surface density of gp120-CCR5 complexes necessary for HIV-1 entry thus appears robust and may have implications for optimizing treatment with coreceptor antagonists, understanding the non-pathogenic infection of non-human primates, and designing vaccines that suppress the availability of target CD4(+)CCR5(+) cells.	[Mulampaka, Shiva Naresh; Dixit, Narendra M.] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India; [Dixit, Narendra M.] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Mulampaka, SN (corresponding author), Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.	narendra@chemeng.iisc.ernet.in			National Institutes of Health [AI065334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grant AI065334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Chang MI, 2005, J VIROL, V79, P14748, DOI 10.1128/JVI.79.23.14748-14755.2005; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Dobrowsky TM, 2008, J VIROL, V82, P7022, DOI 10.1128/JVI.00053-08; Dobrowsky TM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000855; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Heredia A, 2008, P NATL ACAD SCI USA, V105, P20476, DOI 10.1073/pnas.0810843106; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hu QX, 2010, J GEN VIROL, V91, P2965, DOI 10.1099/vir.0.025270-0; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Ketas TJ, 2007, VIROLOGY, V364, P281, DOI 10.1016/j.virol.2007.02.022; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Lineberger JE, 2002, J VIROL, V76, P3522, DOI 10.1128/JVI.76.7.3522-3533.2002; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Magnus C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000713; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Markosyan RM, 2009, J VIROL, V83, P10048, DOI 10.1128/JVI.00316-09; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Napier C, 2005, BIOCHEM PHARMACOL, V71, P163, DOI 10.1016/j.bcp.2005.10.024; Pandrea I, 2008, J VIROL, V82, P5501, DOI 10.1128/JVI.02555-07; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pandrea Ivona, 2010, Curr HIV/AIDS Rep, V7, P28, DOI 10.1007/s11904-009-0034-8; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2007, J MOL BIOL, V374, P64, DOI 10.1016/j.jmb.2007.09.016; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Steffens CM, 2003, J VIROL, V77, P4985, DOI 10.1128/JVI.77.8.4985-4991.2003; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Trister AD, 2008, BIOPHYS J, V95, P40, DOI 10.1529/biophysj.107.118430; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Yang XZ, 2006, J VIROL, V80, P4388, DOI 10.1128/JVI.80.9.4388-4395.2006; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Zaitseva M, 2003, BBA-BIOMEMBRANES, V1614, P51, DOI 10.1016/S0005-2736(03)00162-7; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19941	10.1371/journal.pone.0019941	http://dx.doi.org/10.1371/journal.pone.0019941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647388	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000291052500019
J	Sadlova, J; Yeo, M; Seblova, V; Lewis, MD; Mauricio, I; Volf, P; Miles, MA				Sadlova, Jovana; Yeo, Matthew; Seblova, Veronika; Lewis, Michael D.; Mauricio, Isabel; Volf, Petr; Miles, Michael A.			Visualisation of Leishmania donovani Fluorescent Hybrids during Early Stage Development in the Sand Fly Vector	PLOS ONE			English	Article							PARASITIC PROTOZOA; GENETIC EXCHANGE; CLONAL THEORY; CUTANEOUS LEISHMANIASIS; PHLEBOTOMUS-PAPATASI; TRYPANOSOMA-BRUCEI; V. GUYANENSIS; TRANSMISSION; BRAZILIENSIS; VIANNIA	Background: The Leishmania protozoan parasites cause devastating human diseases. Leishmania have been considered to replicate clonally, without genetic exchange. However, an accumulation of evidence indicates that there are inter-specific and intra-specific hybrids among natural populations. The first and so far only experimental proof of genetic exchange was obtained in 2009 when double drug resistant Leishmania major hybrids were produced by co-infecting sand flies with two strains carrying different drug resistance markers. However, the location and timing of hybridisation events in sand flies has not been described. Methodology/Principal Findings: Here we have co-infected Phlebotomus perniciosus and Lutzomyia longipalpis with transgenic promastigotes of Leishmania donovani strains carrying hygromycin or neomycin resistance genes and red or green fluorescent markers. Fed females were dissected at different times post bloodmeal (PBM) and examined by fluorescent microscopy or fluorescent activated cell sorting (FACS) followed by confocal microscopy. In mixed infections strains LEM3804 and Gebre-1 reached the cardia and stomodeal valves more rapidly than strains LEM4265 and LV9. Hybrids unequivocally expressing both red and green fluorescence were seen in single flies of both vectors tested, co-infected with LEM4265 and Gebre-1. The hybrids were present as short (procyclic) promastigotes 2 days PBM in the semi-digested blood in the endoperitrophic space. Recovery of a clearly co-expressing hybrid was also achieved by FACS. However, hybrids could not sustain growth in vitro. Conclusions/Significance: For the first time, we observed L. donovani hybrids in the sand fly vector, 2 days PBM and described the morphological stages involved. Fluorescence microscopy in combination with FACS allows visualisation and recovery of the progeny of experimental crosses but on this occasion the hybrids were not viable in vitro. Nevertheless, genetic exchange in L. donovani has profound epidemiological significance, because it facilitates the emergence and spread of new phenotypic traits.	[Sadlova, Jovana; Seblova, Veronika; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Yeo, Matthew; Lewis, Michael D.; Miles, Michael A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England; [Mauricio, Isabel] Inst Higiene & Med, Lisbon, Portugal	Charles University Prague; University of London; London School of Hygiene & Tropical Medicine	Sadlova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	Matthew.yeo@lshtm.ac.uk	Sadlova, Jovana/C-1327-2012; Seblova, Veronika/C-5029-2014; Mauricio, Isabel/H-5272-2011; Volf, Petr/C-4300-2012	Sadlova, Jovana/0000-0002-0432-2707; Mauricio, Isabel/0000-0002-7748-4643; Volf, Petr/0000-0003-1790-1123; Lewis, Michael/0000-0001-9540-3280	Wellcome Trust; Ministry of Education [LC06009, MSM0021620828]	Wellcome Trust(Wellcome TrustEuropean Commission); Ministry of Education	The work was financed by Wellcome Trust and JS, VS and PV were also funded by Ministry of Education (projects LC06009, MSM0021620828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Banuls AL, 1999, AM J TROP MED HYG, V61, P838, DOI 10.4269/ajtmh.1999.61.838; Bates PA, 2004, CURR MOL MED, V4, P601, DOI 10.2174/1566524043360285; BELLI AA, 1994, PARASITOLOGY, V109, P435, DOI 10.1017/S0031182000080689; Benkova I, 2007, J MED ENTOMOL, V44, P150, DOI 10.1603/0022-2585(2007)44[150:EOTOMO]2.0.CO;2; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Cihakova J, 1997, ANN TROP MED PARASIT, V91, P267, DOI 10.1080/00034989761120; Delgado O, 1997, MEM I OSWALDO CRUZ, V92, P581, DOI 10.1590/S0074-02761997000500002; DUJARDIN JC, 1995, ACTA TROP, V59, P293, DOI 10.1016/0001-706X(95)00094-U; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; GIBSON W, 1994, MOL BIOCHEM PARASIT, V64, P241, DOI 10.1016/0166-6851(94)00017-4; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; Miles MA, 2009, SCIENCE, V324, P187, DOI 10.1126/science.1172789; Myskova J, 2008, J MED ENTOMOL, V45, P133, DOI 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439; Rougeron V, 2009, P NATL ACAD SCI USA, V106, P10224, DOI 10.1073/pnas.0904420106; Sadlova J, 2009, CELL TISSUE RES, V337, P313, DOI 10.1007/s00441-009-0802-1; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1991, BIOSCIENCE, V41, P767, DOI 10.2307/1311726; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; Volf P, 2009, SCIENCE, V324, P1644, DOI 10.1126/science.324_1644b; WALTERS LL, 1993, J EUKARYOT MICROBIOL, V40, P196, DOI 10.1111/j.1550-7408.1993.tb04904.x; Yeo M, 2007, INT J PARASITOL, V37, P111, DOI 10.1016/j.ijpara.2006.08.002	32	55	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19851	10.1371/journal.pone.0019851	http://dx.doi.org/10.1371/journal.pone.0019851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637755	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500014
J	Vincent, O; Roditchev, I; Marmottant, P				Vincent, Olivier; Roditchev, Ivan; Marmottant, Philippe			Spontaneous Firings of Carnivorous Aquatic Utricularia Traps: Temporal Patterns and Mechanical Oscillations	PLOS ONE			English	Article								Aquatic species of Utricularia are carnivorous plants living in environments poor in nutrients. Their trapping mechanism has fascinated generations of scientists and is still debated today. It was reported recently that Utricularia traps can fire spontaneously. We show here that these spontaneous firings follow an unexpected diversity of temporal patterns, from "metronomic" traps which fire at fixed time intervals to "random" patterns, displaying more scattered firing times. Some "bursting" traps even combine both aspects, with groups of fast regular firings separated by a variable amount of time. We propose a physical model to understand these very particular behaviors, showing that a trap of Utricularia accomplishes mechanical oscillations, based on continuous pumping and sudden opening of the trap door ( buckling). We isolate the key parameters governing these oscillations and discuss the effect of their fluctuations.	[Vincent, Olivier; Roditchev, Ivan; Marmottant, Philippe] Univ Grenoble 1, CNRS, UMR 5588, Lab Interdisciplinaire Phys, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Vincent, O (corresponding author), Univ Grenoble 1, CNRS, UMR 5588, Lab Interdisciplinaire Phys, Grenoble, France.	philippe.marmottant@ujf-grenoble.fr	Marmottant, Philippe/D-6808-2012; Vincent, Olivier/AAD-5124-2020	Vincent, Olivier/0000-0002-8876-6072	French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	This work was funded by the French Ministry of Higher Education and Research (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec L, 2011, AQUAT BOT, V94, P44, DOI 10.1016/j.aquabot.2010.09.004; Darwin C., 1875, INSECTIVOROUS PLANTS; Gordon E, 2007, REV BIOL TROP, V55, P795; HEIDEJORGENSEN HS, 1981, PARASITISME CARNIVOI; Joyeux M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021911; Juniper B. E., 1989, CARNIVOROUS PLANTS; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lloyd F.E., 1942, CARNIVOROUS PLANTS; SASAGO A, 1985, BOT MAG TOKYO, V98, P55, DOI 10.1007/BF02488906; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; SYDENHAM P, 1975, FUNCTIONAL PLANT BIO, V2, P335; TREAT M, 1876, HARPERS NEW MONTHLY, V52, P382; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292	13	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20205	10.1371/journal.pone.0020205	http://dx.doi.org/10.1371/journal.pone.0020205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647417	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500042
J	Tellier, A; Pfaffelhuber, P; Haubold, B; Naduvilezhath, L; Rose, LE; Stadler, T; Stephan, W; Metzler, D				Tellier, Aurelien; Pfaffelhuber, Peter; Haubold, Bernhard; Naduvilezhath, Lisha; Rose, Laura E.; Staedler, Thomas; Stephan, Wolfgang; Metzler, Dirk			Estimating Parameters of Speciation Models Based on Refined Summaries of the Joint Site-Frequency Spectrum	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-GENETICS; WILD TOMATOES; DIVERGENCE; MIGRATION; SELECTION; POLYMORPHISM; HISTORY; SAMPLES; NUMBER	Understanding the processes and conditions under which populations diverge to give rise to distinct species is a central question in evolutionary biology. Since recently diverged populations have high levels of shared polymorphisms, it is challenging to distinguish between recent divergence with no (or very low) inter-population gene flow and older splitting events with subsequent gene flow. Recently published methods to infer speciation parameters under the isolation-migration framework are based on summarizing polymorphism data at multiple loci in two species using the joint site-frequency spectrum (JSFS). We have developed two improvements of these methods based on a more extensive use of the JSFS classes of polymorphisms for species with high intra-locus recombination rates. First, using a likelihood based method, we demonstrate that taking into account low-frequency polymorphisms shared between species significantly improves the joint estimation of the divergence time and gene flow between species. Second, we introduce a local linear regression algorithm that considerably reduces the computational time and allows for the estimation of unequal rates of gene flow between species. We also investigate which summary statistics from the JSFS allow the greatest estimation accuracy for divergence time and migration rates for low (around 10) and high (around 100) numbers of loci. Focusing on cases with low numbers of loci and high intra-locus recombination rates we show that our methods for the estimation of divergence time and migration rates are more precise than existing approaches.	[Tellier, Aurelien; Naduvilezhath, Lisha; Rose, Laura E.; Stephan, Wolfgang; Metzler, Dirk] LMU Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany; [Pfaffelhuber, Peter] Univ Freiburg, Fac Math & Phys, Freiburg, Germany; [Haubold, Bernhard] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Poln, Germany; [Staedler, Thomas] ETH, Inst Integrat Biol, Zurich, Switzerland	University of Munich; University of Freiburg; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tellier, A (corresponding author), LMU Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany.	tellier@biologie.uni-muenchen.de	Stephan, Wolfgang/GOV-6503-2022; Städler, Thomas/B-7286-2009; Metzler, Dirk/K-2797-2014; Tellier, Aurelien/C-3852-2017	Städler, Thomas/0000-0003-4513-8583; Metzler, Dirk/0000-0003-1027-135X; Tellier, Aurelien/0000-0002-8895-0785	DFG Forschergruppe [1078]; DFG [STE 325/9, STE 325/13]; Swiss National Science Foundation [31003A_130702]; Volkswagen Foundation [I/82752]	DFG Forschergruppe(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Volkswagen Foundation(Volkswagen)	This work was supported by grants of the DFG Forschergruppe 1078, "Natural selection in structured populations", to D. M., P. P., and L. E. R.; DFG grants STE 325/9 and STE 325/13 to W. S.; Swiss National Science Foundation grant 31003A_130702 to T. S.; and Volkswagen Foundation grant I/82752 to A.T.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2003, GENETICS, V165, P1289; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Coyne J.A., 2004, SPECIATION; EFRON B, 1985, BIOMETRIKA, V72, P45, DOI 10.1093/biomet/72.1.45; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Garrigan D, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-72; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen JD, 2008, MOL BIOL EVOL, V25, P438, DOI 10.1093/molbev/msm273; Joyce P, 2008, STAT APPL GENET MOL, V7; Karlis D, 2005, STAT COMPUT, V15, P255, DOI 10.1007/s11222-005-4069-4; KIMURA M, 1969, GENETICS, V61, P893; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; McCullagh P, 1989, GEN LINEAR MODELS; Nielsen R, 2001, GENETICS, V158, P885; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nunes MA, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1576; Pawitan Y, 2001, ALL LIKELIHOOD STAT; R Development Core Team, 2005, R LANG ENV STAT COMP; Roselius K, 2005, GENETICS, V171, P753, DOI 10.1534/genetics.105.043877; Stadler T, 2005, EVOLUTION, V59, P1268, DOI 10.1111/j.0014-3820.2005.tb01777.x; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephan W, 1998, GENETICS, V150, P1585; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TELLIER A, 2011, HEREDITY IN PRESS, DOI DOI 10.1038/HDY.2010.2175; Thornton KR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-35; Wakeley J, 1997, GENETICS, V145, P847; Wang Y, 2010, GENETICS, V184, P363, DOI 10.1534/genetics.109.110528; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017	38	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e18155	10.1371/journal.pone.0018155	http://dx.doi.org/10.1371/journal.pone.0018155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637331	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200006
J	Viana-Pereira, M; Lee, A; Popov, S; Bax, DA; Al-Sarraj, S; Bridges, LR; Stavale, JN; Hargrave, D; Jones, C; Reis, RM				Viana-Pereira, Marta; Lee, Alicia; Popov, Sergey; Bax, Dorine A.; Al-Sarraj, Safa; Bridges, Leslie R.; Stavale, Joao N.; Hargrave, Darren; Jones, Chris; Reis, Rui M.			Microsatellite Instability in Pediatric High Grade Glioma Is Associated with Genomic Profile and Differential Target Gene Inactivation	PLOS ONE			English	Article							DNA MISMATCH REPAIR; 5 MONONUCLEOTIDE REPEATS; ENDOMETRIAL TUMORS; COLORECTAL CANCERS; LYNCH-SYNDROME; CELL-LINES; MUTATION; DAMAGE; TEMOZOLOMIDE; METHYLATION	High grade gliomas (HGG) are one of the leading causes of cancer-related deaths in children, and there is increasing evidence that pediatric HGG may harbor distinct molecular characteristics compared to adult tumors. We have sought to clarify the role of microsatellite instability (MSI) in pediatric versus adult HGG. MSI status was determined in 144 patients (71 pediatric and 73 adults) using a well established panel of five quasimonomorphic mononucleotide repeat markers. Expression of MLH1, MSH2, MSH6 and PMS2 was determined by immunohistochemistry, MLH1 was assessed for mutations by direct sequencing and promoter methylation using MS-PCR. DNA copy number profiles were derived using array CGH, and mutations in eighteen MSI target genes studied by multiplex PCR and genotyping. MSI was found in 14/71 (19.7%) pediatric cases, significantly more than observed in adults (5/73, 6.8%; p = 0.02, Chi-square test). MLH1 expression was downregulated in 10/13 cases, however no mutations or promoter methylation were found. MSH6 was absent in one pediatric MSI-High tumor, consistent with an inherited mismatch repair deficiency associated with germline MSH6 mutation. MSI was classed as Type A, and associated with a remarkably stable genomic profile. Of the eighteen classic MSI target genes, we identified mutations only in MSH6 and DNAPKcs and described a polymorphism in MRE11 without apparent functional consequences in DNA double strand break detection and repair. This study thus provides evidence for a potential novel molecular pathway in a proportion of gliomas associated with the presence of MSI.	[Viana-Pereira, Marta; Reis, Rui M.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Viana-Pereira, Marta; Lee, Alicia; Popov, Sergey; Bax, Dorine A.; Jones, Chris] Inst Canc Res, Sect Paediat Oncol, Surrey, England; [Popov, Sergey; Hargrave, Darren; Jones, Chris] Royal Marsden Hosp, Surrey, England; [Al-Sarraj, Safa] Kings Coll Hosp London, Dept Clin Neuropathol, London, England; [Bridges, Leslie R.] St George Hosp, London, England; [Stavale, Joao N.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Reis, Rui M.] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil	Universidade do Minho; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; St Georges University London; Universidade Federal de Sao Paulo (UNIFESP); Hospital de Cancer de Barretos	Viana-Pereira, M (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	chris.jones@icr.ac.uk; rreis@ecsaude.uminho.pt	Hargrave, Darren R/H-1066-2014; Viana-Pereira, Marta/E-1317-2014; Reis, Rui M/C-2859-2009; Jones, Chris/ABE-6059-2021; Reis, Rui Manuel/B-1744-2018; Reis, Rui Manuel/AAD-6470-2020	Hargrave, Darren R/0000-0001-8219-9807; Viana-Pereira, Marta/0000-0003-3087-0624; Reis, Rui M/0000-0002-9639-7940; Jones, Chris/0000-0001-8118-2296; Reis, Rui Manuel/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940	British Council; Portuguese Council of Rectors; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/29145/2006]	British Council(The British Council in India); Portuguese Council of Rectors; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The authors acknowledge the British Council and the Portuguese Council of Rectors, Treaty of Windsor Anglo-Portuguese Joint Research Programme (R.M. Reis, C. Jones). M. Viana-Pereira is funded by a PhD fellowship '[SFRH/BD/29145/2006]' of Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu A, 2007, EUR J HUM GENET, V15, P922, DOI 10.1038/sj.ejhg.5201858; Alonso M, 2001, CANCER RES, V61, P2124; Amariglio N, 1995, CANCER GENET CYTOGEN, V84, P56, DOI 10.1016/0165-4608(95)00085-2; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Cheng Y, 1999, HUM PATHOL, V30, P1284, DOI 10.1016/S0046-8177(99)90057-6; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DAMS E, 1995, CANCER RES, V55, P1547; de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2; Duval A, 2002, CANCER RES, V62, P1609; Duval A, 2002, CANCER RES, V62, P2447; Eckert A, 2007, BRAIN PATHOL, V17, P146, DOI 10.1111/j.1750-3639.2007.00049.x; Fallik D, 2003, CANCER RES, V63, P5738; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Giunti L, 2009, EUR J HUM GENET, V17, P919, DOI 10.1038/ejhg.2008.271; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Ham MF, 2006, CANCER SCI, V97, P226, DOI 10.1111/j.1349-7006.2006.00165.x; Hegde M, 2005, J MOL DIAGN, V7, P525, DOI 10.1016/S1525-1578(10)60584-3; Hegde MR, 2005, CLIN CANCER RES, V11, P4689, DOI 10.1158/1078-0432.CCR-04-2025; Izumoto S, 1997, CANCER LETT, V112, P251, DOI 10.1016/S0304-3835(96)04583-1; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Kanamori M, 2000, ONCOGENE, V19, P1564, DOI 10.1038/sj.onc.1203454; Karran P, 1996, SEMIN CANCER BIOL, V7, P15, DOI 10.1006/scbi.1996.0003; Lee HS, 2007, INT J ONCOL, V31, P859; Leung SY, 1998, AM J PATHOL, V153, P1181, DOI 10.1016/S0002-9440(10)65662-3; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li HR, 2004, CANCER RES, V64, P4760, DOI 10.1158/0008-5472.CAN-04-0975; Martinez R, 2005, J CANCER RES CLIN, V131, P87, DOI 10.1007/s00432-004-0592-5; Maxwell JA, 2008, CLIN CANCER RES, V14, P4859, DOI 10.1158/1078-0432.CCR-07-4807; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mori Y, 2002, CANCER RES, V62, P3641; Oda S, 2005, NUCLEIC ACIDS RES, V33, P1628, DOI 10.1093/nar/gki303; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pollack IF, 2010, PEDIATR BLOOD CANCER, V55, P1066, DOI 10.1002/pbc.22634; REMVIKOS Y, 1995, GENE CHROMOSOME CANC, V12, P272, DOI 10.1002/gcc.2870120406; Sobrido MJ, 2000, J NEUROL NEUROSUR PS, V69, P369, DOI 10.1136/jnnp.69.3.369; The WHO, 2020, CLASSIFICATION TUMOU; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Viana-Pereira M, 2009, NEURO-ONCOLOGY, V11, P458, DOI 10.1215/15228517-2008-115; Vladimirova V, 2008, NEUROPATH APPL NEURO, V34, P547, DOI 10.1111/j.1365-2990.2007.00919.x; Wong YF, 2006, CARCINOGENESIS, V27, P951, DOI 10.1093/carcin/bgi333; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20588	10.1371/journal.pone.0020588	http://dx.doi.org/10.1371/journal.pone.0020588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637783	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200081
J	Yu, W; Hegarty, JP; Berg, A; Chen, X; West, G; Kelly, AA; Wang, YH; Poritz, LS; Koltun, WA; Lin, ZW				Yu, Wei; Hegarty, John P.; Berg, Arthur; Chen, Xi; West, Gail; Kelly, Ashley A.; Wang, Yunhua; Poritz, Lisa S.; Koltun, Walter A.; Lin, Zhenwu			NKX2-3 Transcriptional Regulation of Endothelin-1 and VEGF Signaling in Human Intestinal Microvascular Endothelial Cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; GROWTH-FACTOR; DIFFERENTIAL EXPRESSION; LEUKOCYTE ADHESION; IMMUNE; GENES; IMMUNOREACTIVITY; ANGIOGENESIS; HEART	Background: NKX2-3 is associated with inflammatory bowel disease (IBD). NKX2-3 is expressed in microvascular endothelial cells and the muscularis mucosa of the gastrointestinal tract. Human intestinal microvascular endothelial cells (HIMECs) are actively involved in the pathogenesis of IBD and IBD-associated microvascular dysfunction. To understand the cellular function of NKX2-3 and its potential role underlying IBD pathogenesis, we investigated the genes regulated by NKX2-3 in HIMEC using cDNA microarray. Methodology/Principal Findings: NKX2-3 expression was suppressed by shRNA in two HIMEC lines and gene expression was profiled by cDNA microarray. Pathway Analysis was used to identify gene networks according to biological functions and associated pathways. Validation of microarray and genes expression in intestinal tissues was assessed by RT-PCR. NKX2-3 regulated genes are involved in immune and inflammatory response, cell proliferation and growth, metabolic process, and angiogenesis. Several inflammation and angiogenesis related signaling pathways that play important roles in IBD were regulated by NKX2-3, including endothelin-1 and VEGF-PI3K/AKT-eNOS. Expression levels of NKX2-3, VEGFA, PI3K, AKT, and eNOS are increased in intestinal tissues from IBD patients and expression levels of EDN1 are decreased in intestinal tissues from IBD patients. These results demonstrated the important roles of NKX2-3, VEGF, PI3K, AKT, eNOS, and EDN1 in IBD pathogenesis. Correlation analysis showed a positive correlation between mRNA expression of NKX2-3 and VEGFA and a negative correlation between mRNA expression of NKX2-3 and EDN1 in intestinal tissues from IBD patients. Conclusion/Relevance: NKX2-3 may play an important role in IBD pathogenesis by regulating endothelin-1 and VEGF signaling in HIMECs.	[Yu, Wei; Hegarty, John P.; Kelly, Ashley A.; Wang, Yunhua; Poritz, Lisa S.; Koltun, Walter A.; Lin, Zhenwu] Penn State Univ, Dept Surg, Hershey, PA 17033 USA; [Berg, Arthur] Penn State Univ, Ctr Stat Genet, Dept Publ Hlth Sci, Hershey, PA USA; [Poritz, Lisa S.] Penn State Univ, Dept Cellular & Mol Physiol, Hershey, PA USA; [Chen, Xi] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [West, Gail] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Vanderbilt University; Cleveland Clinic Foundation	Yu, W (corresponding author), Penn State Univ, Dept Surg, Hershey, PA 17033 USA.	wkoltun@hmc.psu.edu; zlin@hmc.psu.edu	yu, wei/B-5859-2011	Hegarty, John/0000-0003-3401-848X; Berg, Arthur/0000-0002-4097-7348	Philadelphia Health Care Trust; Milton S. Hershey Medical Center; Penn State College of Medicine; Milton S. Hershey Penn State College of Medicine Surgery Research Feasibility [942-82HY, 1940]	Philadelphia Health Care Trust; Milton S. Hershey Medical Center; Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Milton S. Hershey Penn State College of Medicine Surgery Research Feasibility	This work was supported by a grant from the Philadelphia Health Care Trust (WAK), the Carlino fund for IBD research at the Milton S. Hershey Medical Center (WAK), Penn State College of Medicine, and the Milton S. Hershey Penn State College of Medicine Surgery Research Feasibility Grant (WY). Budget: 942-82HY, Fund: 1940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2006, MOL PHARMACOL, V69, P975, DOI 10.1124/mol.105.018846; Binion DG, 1997, GASTROENTEROLOGY, V112, P1895, DOI 10.1053/gast.1997.v112.pm9178682; Boros M, 1998, GASTROENTEROLOGY, V114, P103, DOI 10.1016/S0016-5085(98)70638-9; Buchberger A, 1996, MECH DEVELOP, V56, P151, DOI 10.1016/0925-4773(96)00521-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Danese S, 2007, CURR OPIN GASTROEN, V23, P384, DOI 10.1097/MOG.0b013e32810c8de3; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Deban L, 2008, AM J PATHOL, V172, P1457, DOI 10.2353/ajpath.2008.070593; Fiocchi C, 1997, AM J PHYSIOL-GASTR L, V273, pG769, DOI 10.1152/ajpgi.1997.273.4.G769; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Fu YC, 1998, DEVELOPMENT, V125, P4439; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Hatoum OA, 2005, INFLAMM BOWEL DIS, V11, P304, DOI 10.1097/01.MIB.0000160772.78951.61; Kang YS, 2006, J MOL ENDOCRINOL, V36, P377, DOI 10.1677/jme.1.02033; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kocher AA, 2006, J MOL CELL CARDIOL, V40, P455, DOI 10.1016/j.yjmcc.2005.11.013; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Lee Yong C, 2005, Curr Opin Investig Drugs, V6, P1124; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; McCartney SA, 2002, LIFE SCI, V71, P1893, DOI 10.1016/S0024-3205(02)01923-9; MURCH SH, 1992, LANCET, V339, P381, DOI 10.1016/0140-6736(92)90077-G; OIKONOMOU KA, INFLAMM BOWEL DIS; Oktar BK, 2000, AM J PHYSIOL-GASTR L, V279, pG483, DOI 10.1152/ajpgi.2000.279.3.G483; Pabst O, 1997, DEV DYNAM, V209, P29; Pabst O, 1999, DEVELOPMENT, V126, P2215; RACHMILEWITZ D, 1992, LANCET, V339, P1062, DOI 10.1016/0140-6736(92)90589-U; Ramsauer M, 2002, J CLIN INVEST, V110, P1615, DOI 10.1172/JCI200217326; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tarlinton D, 2003, J IMMUNOL, V170, P4002, DOI 10.4049/jimmunol.170.8.4002; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; VILLARREAL G, BIOCH BIOPHYS RES CO, V391, P984; Wang CC, 2000, DEV BIOL, V224, P152, DOI 10.1006/dbio.2000.9749; Yu W, 2010, DIGEST DIS SCI, V55, P3171, DOI 10.1007/s10620-010-1138-0; Yu W, 2010, MOL GENET METAB, V100, P88, DOI 10.1016/j.ymgme.2010.02.001; Yu W, 2009, J CROHNS COLITIS, V3, P189, DOI 10.1016/j.crohns.2009.04.003	40	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20454	10.1371/journal.pone.0020454	http://dx.doi.org/10.1371/journal.pone.0020454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637825	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200066
J	Caneparo, L; Pantazis, P; Dempsey, W; Fraser, SE				Caneparo, Luca; Pantazis, Periklis; Dempsey, William; Fraser, Scott E.			Intercellular Bridges in Vertebrate Gastrulation	PLOS ONE			English	Article							ZEBRAFISH GASTRULATION; FLUORESCENT PROTEIN; CELLS; MORPHOGENESIS; MOVEMENTS; DYNAMICS; SEQUENCE; ELEMENT; RED	The developing zebrafish embryo has been the subject of many studies of regional patterning, stereotypical cell movements and changes in cell shape. To better study the morphological features of cells during gastrulation, we generated mosaic embryos expressing membrane attached Dendra2 to highlight cellular boundaries. We find that intercellular bridges join a significant fraction of epiblast cells in the zebrafish embryo, reaching several cell diameters in length and spanning across different regions of the developing embryos. These intercellular bridges are distinct from the cellular protrusions previously reported as extending from hypoblast cells (1-2 cellular diameters in length) or epiblast cells (which were shorter). Most of the intercellular bridges were formed at pre-gastrula stages by the daughters of a dividing cell maintaining a membrane tether as they move apart after mitosis. These intercellular bridges persist during gastrulation and can mediate the transfer of proteins between distant cells. These findings reveal a surprising feature of the cellular landscape in zebrafish embryos and open new possibilities for cell-cell communication during gastrulation, with implications for modeling, cellular mechanics, and morphogenetic signaling.	[Caneparo, Luca] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Caneparo, L (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	caneparo@caltech.edu	Fraser, Scott/Y-3406-2019; Pantazis, Periklis/AAR-1795-2021	Fraser, Scott/0000-0002-5377-0223; Pantazis, Periklis (Laki)/0000-0002-8367-9332	Caltech Biological Imaging Center; iFReC; German Science Foundation (Deutsche Forschungsgemeinschaft); Caltech Rosen Scholar Fellowship for Biological Engineering	Caltech Biological Imaging Center; iFReC; German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Caltech Rosen Scholar Fellowship for Biological Engineering	LC is supported by the Caltech Biological Imaging Center and by iFReC. PP is supported by a German Science Foundation (Deutsche Forschungsgemeinschaft) Postdoctoral Fellowship. WD is supported by a Caltech Rosen Scholar Fellowship for Biological Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Concha ML, 1998, DEVELOPMENT, V125, P983; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; KAGEYAMA T, 1987, J EXP ZOOL, V244, P243, DOI 10.1002/jez.1402440208; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; LIAW CW, 1986, J IMMUNOL, V137, P1037; MILLER J, 1995, DEVELOPMENT, V121, P2501; Plachta N, 2011, NAT CELL BIOL, V13, DOI 10.1038/ncb0311-337; Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SCHOENWOLF GC, 1992, CURR TOP DEV BIOL, V27, P129, DOI 10.1016/S0070-2153(08)60534-7; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shih J, 1996, DEVELOPMENT, V122, P1313; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; TRINKAUS JP, 1973, DEV BIOL, V30, P68, DOI 10.1016/0012-1606(73)90049-3; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; WARGA RM, 1990, DEVELOPMENT, V108, P569; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	26	57	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20230	10.1371/journal.pone.0020230	http://dx.doi.org/10.1371/journal.pone.0020230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647454	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500043
J	Salloum, M; van der Mee-Marquet, N; Valentin-Domelier, AS; Quentin, R				Salloum, Mazen; van der Mee-Marquet, Nathalie; Valentin-Domelier, Anne-Sophie; Quentin, Roland			Diversity of Prophage DNA Regions of Streptococcus agalactiae Clonal Lineages from Adults and Neonates with Invasive Infectious Disease	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; NONPREGNANT ADULTS; MOLECULAR CHARACTERIZATION; SEROTYPE-V; TYPING SYSTEM; STRAINS; SEQUENCE; BACTERIOPHAGE; EMERGENCE; GENOME	The phylogenetic position and prophage DNA content of the genomes of 142 S. agalactiae (group-B streptococcus, GBS) isolates responsible for bacteremia and meningitis in adults and neonates were studied and compared. The distribution of the invasive isolates between the various serotypes, sequence types (STs) and clonal complexes (CCs) differed significantly between adult and neonatal isolates. Use of the neighbor-net algorithm with the PHI test revealed evidence for recombination in the population studied (PHI, P = 2.01 x 10(-6)), and the recombination-mutation ratio (R/M) was 6:7. Nevertheless, the estimated R/M ratio differed between CCs. Analysis of the prophage DNA regions of the genomes of the isolates assigned 90% of the isolates to five major prophage DNA groups: A to E. The mean number of prophage DNA fragments amplified per isolate varied from 2.6 for the isolates of prophage DNA group E to 4.0 for the isolates of prophage DNA group C. The isolates from adults and neonates with invasive diseases were distributed differently between the various prophage DNA groups (P<0.00001). Group C prophage DNA fragments were found in 52% of adult invasive isolates, whereas 74% of neonatal invasive isolates had prophage DNA fragments of groups A and B. Differences in prophage DNA content were also found between serotypes, STs and CCs (P<0.00001). All the ST-1 and CC1 isolates, mostly of serotype V, belonged to the prophage DNA group C, whereas 84% of the ST-17 and CC17 isolates, all of serotype III, belonged to prophage DNA groups A and B. These data indicate that the transduction mechanisms, i.e., gene transfer from one bacterium to another by a bacteriophage, underlying genetic recombination in S. agalactiae species, are specific to each intraspecies lineage and population of strains responsible for invasive diseases in adults and neonates.	[Salloum, Mazen; van der Mee-Marquet, Nathalie; Valentin-Domelier, Anne-Sophie; Quentin, Roland] Univ Tours, EA Bacteries & Risque Maternofoetal 3854, Inst Federat Rech Agents Transmissibles & Infecti, UFR Med, Tours, France; [van der Mee-Marquet, Nathalie; Valentin-Domelier, Anne-Sophie] CHRU, Hop Trousseau, Serv Bacteriol & Hyg Hosp, Tours, France	Universite de Tours; CHU Tours	Salloum, M (corresponding author), Univ Tours, EA Bacteries & Risque Maternofoetal 3854, Inst Federat Rech Agents Transmissibles & Infecti, UFR Med, Tours, France.	n.vandermee@chu-tours.fr		Valentin, Anne-Sophie/0000-0001-8662-097X	University National research source for EA 3854 (University of Tours, France) [IFR136]	University National research source for EA 3854 (University of Tours, France)	Funding was received from University National research source for EA 3854 of IFR136 (University of Tours, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Safadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010794; ANTHONY BF, 1979, J PEDIATR-US, V95, P431, DOI 10.1016/S0022-3476(79)80530-2; ANTHONY BF, 1977, ANNU REV MED, V28, P355, DOI 10.1146/annurev.me.28.020177.002035; BAND JD, 1981, AM J DIS CHILD, V135, P355, DOI 10.1001/archpedi.1981.02130280045015; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Blancas D, 2004, EUR J CLIN MICROBIOL, V23, P168, DOI 10.1007/s10096-003-1098-9; Blumberg HM, 1996, J INFECT DIS, V173, P365, DOI 10.1093/infdis/173.2.365; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; BOYER KM, 1980, AM J DIS CHILD, V134, P964, DOI 10.1001/archpedi.1980.02130220042013; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chen Y, 2005, PLOS BIOL, V3, P1276, DOI 10.1371/journal.pbio.0030229; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; COLEMAN D, 1991, MOL MICROBIOL, V5, P933, DOI 10.1111/j.1365-2958.1991.tb00768.x; Domelier AS, 2008, J ANTIMICROB CHEMOTH, V62, P1227, DOI 10.1093/jac/dkn388; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; EICKHOFF TC, 1964, NEW ENGL J MED, V271, P1221, DOI 10.1056/NEJM196412102712401; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Feil EJ, 2000, GENETICS, V154, P1439; HARRISON LH, 1995, J INFECT DIS, V171, P513, DOI 10.1093/infdis/171.2.513; Hery-Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4668, DOI 10.1128/AEM.02604-06; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Kong FR, 2002, J CLIN MICROBIOL, V40, P216, DOI 10.1128/JCM.40.1.216-226.2002; LEE CY, 1986, P NATL ACAD SCI USA, V83, P5474, DOI 10.1073/pnas.83.15.5474; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; NOYA FJD, 1987, J INFECT DIS, V155, P1135, DOI 10.1093/infdis/155.6.1135; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; QUENTIN R, 2006, B EPIDEMIOL HEBDO, V45, P352; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; RUSSELL H, 1969, J GEN VIROL, V5, P315, DOI 10.1099/0022-1317-5-2-315; Salloum M, 2010, J CLIN MICROBIOL, V48, P1261, DOI 10.1128/JCM.01820-09; SCHWARTZ B, 1991, JAMA-J AM MED ASSOC, V266, P1112, DOI 10.1001/jama.266.8.1112; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; STRINGER J, 1980, J MED MICROBIOL, V13, P133, DOI 10.1099/00222615-13-1-133; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Takahashi S, 1998, J INFECT DIS, V177, P1116, DOI 10.1086/517408; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; van der Mee-Marquet N, 2006, J CLIN MICROBIOL, V44, P1049, DOI 10.1128/JCM.44.3.1049-1058.2006; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08	50	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20256	10.1371/journal.pone.0020256	http://dx.doi.org/10.1371/journal.pone.0020256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633509	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500049
J	Weibrecht, I; Grundberg, I; Nilsson, M; Soderberg, O				Weibrecht, Irene; Grundberg, Ida; Nilsson, Mats; Soderberg, Ola			Simultaneous Visualization of Both Signaling Cascade Activity and End-Point Gene Expression in Single Cells	PLOS ONE			English	Article							IN-SITU DETECTION; PROXIMITY LIGATION; PADLOCK PROBES; MOLECULES; KINASE	We have developed an approach for simultaneous detection of individual endogenous protein modifications and mRNA molecules in single cells in situ. For this purpose we combined two methods previously developed in our lab: in situ proximity ligation assay for the detection of individual protein interactions and -modifications and in situ detection of single mRNA molecules using padlock probes. As proof-of-principle, we demonstrated the utility of the method for simultaneous detection of phosphorylated PDGFR beta and DUSP6/MKP-3 mRNA molecules in individual human fibroblasts upon PDGF-BB stimulation. Further we applied drugs disrupting the PDGFR beta signaling pathway at various sites to show that this combined method can concurrently monitor the molecular effect of the drugs, i.e. inhibition of downstream signaling from the targeted node in the signaling pathway. Due to its ability to detect different types of molecules in single cells in situ the method presented here can contribute to a deeper understanding of cell-to-cell variations and can be applied to e.g. pinpoint effector sites of drugs in a signaling pathway.	[Weibrecht, Irene; Grundberg, Ida; Nilsson, Mats; Soderberg, Ola] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden	Uppsala University	Weibrecht, I (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden.	ola.soderberg@igp.uu.se	Söderberg, Ola/O-5130-2017	Söderberg, Ola/0000-0003-2883-1925	Knut and Alice Wallenberg Foundation; The Swedish Foundation for Strategic Research; Swedish Research Council; European Union [259796]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission)	This work was funded by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), The Swedish Foundation for Strategic Research (http://www.stratresearch.se/), the Swedish Research Council (http://www.vr.se/), and the European Union Seventh Framework Programme (http://cordis.europa.eu/fp7/home_en.html) under grant agreement no. 259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchdunger E, 1996, CANCER RES, V56, P100; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/NMETH.1448, 10.1038/nmeth.1448]; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Nilsson M, 1997, NAT GENET, V16, P252, DOI 10.1038/ng0797-252; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Team RDC, 2010, R LANG ENV STAT COMP	15	11	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20148	10.1371/journal.pone.0020148	http://dx.doi.org/10.1371/journal.pone.0020148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647446	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500029
J	Wijndaele, K; Brage, S; Besson, H; Khaw, KT; Sharp, SJ; Luben, R; Bhaniani, A; Wareham, NJ; Ekelund, U				Wijndaele, Katrien; Brage, Soren; Besson, Herve; Khaw, Kay-Tee; Sharp, Stephen J.; Luben, Robert; Bhaniani, Amit; Wareham, Nicholas J.; Ekelund, Ulf			Television Viewing and Incident Cardiovascular Disease: Prospective Associations and Mediation Analysis in the EPIC Norfolk Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIORS; TIME SPENT; MORTALITY; RISK; OBESITY; EXERCISE; WEIGHT; GAIN	Background: Although television viewing time is detrimentally associated with intermediate cardiovascular risk factors, the relationship with incident total (i.e. combined fatal and non-fatal) cardiovascular disease (CVD), non-fatal CVD and coronary heart disease is largely unknown. This study examined whether television viewing time is associated with these three outcomes, independently of physical activity energy expenditure and other confounding variables. Methodology/Principal Findings: A population-based cohort of 12,608 men and women (aged 61.4 +/- 9.0), free from stroke, myocardial infarction and cancer at baseline in 1998-2000 were followed up until 2007 (6.9 +/- 1.9 years). Participants self-reported education, smoking, alcohol use, antihypertensive, lipid lowering and antidepressant medication, disease history, total energy intake, sleep duration, physical activity and television viewing. BMI, waist circumference, blood pressure, triglycerides, HDL cholesterol and glycated haemoglobin (HbA(1c)) were measured by standardized procedures; a clustered metabolic risk score was constructed. Every one hour/day increase in television viewing was associated with an increased hazard for total (HR = 1.06, 95% CI = 1.03-1.08; 2,620 cases), non-fatal CVD (HR = 1.06, 95% CI = 1.03-1.09; 2,134 cases), and coronary heart disease (HR = 1.08, 95% CI = 1.03-1.13; 940 cases), independent of gender, age, education, smoking, alcohol, medication, diabetes status, CVD family history, sleep duration and physical activity energy expenditure. Energy intake, BMI, waist circumference, blood pressure, triglycerides, HDL cholesterol, HbA(1c) and the clustered metabolic risk score only partially mediated these associations. Conclusions: These results indicate that the most prevalent leisure time (sedentary) behaviour, television viewing, independently contributes to increased CVD risk. Recommendations on reducing television viewing time should be considered.	[Wijndaele, Katrien; Brage, Soren; Besson, Herve; Sharp, Stephen J.; Wareham, Nicholas J.; Ekelund, Ulf] Med Res Council Epidemiol Unit, Cambridge, England; [Wijndaele, Katrien] Res Fdn Flanders, Brussels, Belgium; [Wijndaele, Katrien] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Khaw, Kay-Tee; Luben, Robert; Bhaniani, Amit] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Ghent University; University of Cambridge	Wijndaele, K (corresponding author), Med Res Council Epidemiol Unit, Cambridge, England.	ulf.ekelund@mrc-epid.cam.ac.uk	Luben, Robert N/H-5519-2015; Wijndaele, Katrien/H-5465-2013; Brage, Soren/C-6415-2013; Khaw, Kay-Tee/AAZ-3209-2021; Ekelund, Ulf/AAE-8471-2019	Luben, Robert N/0000-0002-5088-6343; Wijndaele, Katrien/0000-0003-2199-7981; Brage, Soren/0000-0002-1265-7355; Ekelund, Ulf/0000-0003-2115-9267	Cancer Research Campaign; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Europe Against Cancer Programme Commission of the European Union; Ministry of Agriculture, Fisheries and Food; MRC [MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_U106179473, MC_U106179471, G0401527, G1000143] Funding Source: researchfish	Cancer Research Campaign(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Department of Health; Europe Against Cancer Programme Commission of the European Union; Ministry of Agriculture, Fisheries and Food; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EPIC-Norfolk is funded by Cancer Research Campaign; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Europe Against Cancer Programme Commission of the European Union and the Ministry of Agriculture, Fisheries and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2010, INT J EPIDEMIOL, V26, P670, DOI [DOI 10.1093/IJE/DYQ105, 10.1093/ije/26.3.670]; *AUST BUR STAT, 2008, AUST US THEIR TIM 20; Ball K, 2002, INT J OBESITY, V26, P1570, DOI 10.1038/sj.ijo.0802150; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; Blanck HM, 2007, OBESITY, V15, P1578, DOI 10.1038/oby.2007.187; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; CLARK BK, 2010, RELATIONSHIP TELEVIS, DOI DOI 10.1249/MSS.0B013E3182019510; Day N, 1999, BRIT J CANCER, V80, P95; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Office for National Statistics, 2006, TIM US SURV 2005 WE; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Research NM, 2000, NIELS REP TEL; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; STAMATAKIS E, 2011, EUR HEART J, V27, P1610; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Tendera M, 2006, EUR HEART J, V27, P1521, DOI 10.1093/eurheartj/ehl075; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e	30	82	82	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20058	10.1371/journal.pone.0020058	http://dx.doi.org/10.1371/journal.pone.0020058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21647437	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500022
J	Wootton, BM; Titov, N; Dear, BF; Spence, J; Kemp, A				Wootton, Bethany M.; Titov, Nickolai; Dear, Blake F.; Spence, Jay; Kemp, Alice			The Acceptability of Internet-Based Treatment and Characteristics of an Adult Sample with Obsessive Compulsive Disorder: An Internet Survey	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH TREATMENT; RITUAL PREVENTION; CONTROLLED-TRIAL; EXPOSURE; CLINICIAN; INTERVIEW; SCALE	Background: Obsessive-compulsive disorder (OCD) is a disabling anxiety disorder, but most individuals delay seeking treatment. Internet-based cognitive behavioural therapy (iCBT) is an innovative service delivery method that may help to improve access to care, but the acceptability to consumers of such programs has not yet been established. Methodology: People with symptoms of OCD were invited to complete an online survey enquiring about demographic characteristics, symptom severity, and acceptability of Internet-based treatment. Demographic and symptom severity data were compared with people with OCD identified in a national epidemiological survey and with a sample of patients with OCD from a specialist outpatient anxiety clinic. Participants: 129 volunteers to an online Internet survey, 135 patients at a specialist anxiety disorders outpatient clinic, and 297 cases identified in a national epidemiological survey. Main Measures: Demographic characteristics, and severity of symptoms as measured by the Kessler 10-Item scale, the 12-item World Health Organisation Disability Assessment Schedule - Second Edition and the Yale Brown Obsessive Compulsive Scale - Self Report Version. Principal Findings: The Internet sample was similar demographically but reported more severe symptoms than the comparison groups, although had similar severity of symptoms of OCD compared with other clinical samples reported in the literature. Participants reported Internet-based treatment for OCD would be highly acceptable. Conclusions: Internet-based treatment may reduce barriers to accessing treatment to people with OCD. Individuals in this study were similar demographically to other samples and had similar severity of symptoms as those identified in other clinical samples, suggesting that Internet-based treatment using techniques employed in face-to-face treatment may be effective in this group. Internet-based treatments for OCD need to be developed and evaluated.	[Wootton, Bethany M.; Titov, Nickolai; Spence, Jay] Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia; [Titov, Nickolai; Dear, Blake F.] Macquarie Univ, Dept Psychol, Ctr Emot Hlth, N Ryde, NSW 2109, Australia; [Titov, Nickolai; Dear, Blake F.; Kemp, Alice] St Vincents Hosp, Clin Res Unit Anxiety & Depress CRUfAD, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Macquarie University; St Vincents Hospital Sydney	Wootton, BM (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia.	nick.titov@mq.edu.au		Titov, Nickolai/0000-0002-7268-729X; Woottonb, Bethany/0000-0002-0751-8529; Dear, Blake/0000-0001-9324-3092; Wootton, Bethany/0000-0001-9036-0699				Abramowitz JS, 1996, BEHAV THER, V27, P583, DOI 10.1016/S0005-7894(96)80045-1; [Anonymous], PLOS ONE; Aydos L, 2009, AUSTRALAS PSYCHIATRY, V17, P488, DOI 10.1080/10398560903284943; Bachofen M, 1999, J CLIN PSYCHIAT, V60, P545, DOI 10.4088/JCP.v60n0807; Baer L., 1991, GETTING CONTROL OVER; Baer L, 2008, J CLIN PSYCHIAT, V69, P676, DOI 10.4088/JCP.v69n0423a; Blanco C, 2006, J CLIN PSYCHIAT, V67, P946, DOI 10.4088/JCP.v67n0611; Crino R, 2005, AM J PSYCHIAT, V162, P876, DOI 10.1176/appi.ajp.162.5.876; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Federici A, 2010, J ANXIETY DISORD, V24, P729, DOI 10.1016/j.janxdis.2010.05.005; Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151; Gava I., 2009, PSYCHOL TREATMENTS V; Goodwin R, 2002, ACTA PSYCHIAT SCAND, V106, P143, DOI 10.1034/j.1600-0447.2002.01221.x; Greist JH, 2002, J CLIN PSYCHIAT, V63, P138, DOI 10.4088/JCP.v63n0209; GRIEST JH, 1998, MD COMPUT, V15, P149; GUN SY, 2011, AUSTRALASIA IN PRESS; Headspace, 2020, HEADSP NAT YOUTH MEN; Houghton S, 2010, BRIT J CLIN PSYCHOL, V49, P473, DOI 10.1348/014466509X475414; Kenwright M, 2005, J CLIN PSYCHOL, V61, P1499, DOI 10.1002/jclp.20204; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klein B., 2010, J APPL PSYCHOL, V6, P27, DOI [10.7790/ejap.v6i1.184, DOI 10.7790/EJAP.V6I1.184]; Mancebo MC, 2006, J CLIN PSYCHIAT, V67, P1713, DOI 10.4088/JCP.v67n1107; Marques L, 2010, DEPRESS ANXIETY, V27, P470, DOI 10.1002/da.20694; Olafsson RP, 2010, J PSYCHOPATHOL BEHAV, V32, P226, DOI 10.1007/s10862-009-9146-0; Perini S, 2008, E J APPL PSYCHOL, V4, P18; Rosa-Alcazar AI, 2008, CLIN PSYCHOL REV, V28, P1310, DOI 10.1016/j.cpr.2008.07.001; Rosenfeld R., 1992, PSYCHOL ASSESSMENT, V4, P329, DOI [DOI 10.1037/1040-3590.4.3.329, https://doi.org/10.1037/1040-3590.4.3.329]; Rush B, 2004, APPROVED TELEHEALTH; *SPSS INC, SPSS 18 WIND; Steketee G, 1996, BEHAV RES THER, V34, P675, DOI 10.1016/0005-7967(96)00036-8; Titov N, 2010, PLOS ONE, V5; Titov N, 2007, AUST NZ J PSYCHIAT, V41, P95, DOI 10.1080/00048670601109873; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; van Oppen P, 2010, J CLIN PSYCHIAT, V71, P1158, DOI 10.4088/JCP.08m04990blu; Wangberg SC, 2007, CYBERPSYCHOL BEHAV, V10, P418, DOI 10.1089/cpb.2006.9937; Wells M, 2007, CYBERPSYCHOL BEHAV, V10, P453, DOI 10.1089/cpb.2006.9933; Whitfield G, 2004, BEHAV COGN PSYCHOTH, V32, P57, DOI 10.1017/S1352465804001031; *WHO, 1997, CID AUT VERS 2 1 ADM; *WHO, 2006, WHO COMP INT DIAGN I; *WHO, 2009, WHO DIS ASS SCHED	40	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20548	10.1371/journal.pone.0020548	http://dx.doi.org/10.1371/journal.pone.0020548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774BE	21673987	Green Published, gold			2022-12-27	WOS:000291355500023
J	Fabricius-Bjerre, S; Jensen, RB; Faerch, K; Larsen, T; Molgaard, C; Michaelsen, KF; Vaag, A; Greisen, G				Fabricius-Bjerre, Signe; Jensen, Rikke Beck; Faerch, Kristine; Larsen, Torben; Molgaard, Christian; Michaelsen, Kim Fleischer; Vaag, Allan; Greisen, Gorm			Impact of Birth Weight and Early Infant Weight Gain on Insulin Resistance and Associated Cardiovascular Risk Factors in Adolescence	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CATCH-UP GROWTH; GLUCOSE-TOLERANCE; CHILDHOOD GROWTH; METABOLIC RISK; LATER LIFE; FETAL; SENSITIVITY; OBESITY; SECRETION	Background: Low birth weight followed by accelerated weight gain during early childhood has been associated with adverse metabolic and cardiovascular outcomes later in life. The aim of this study was to examine the impact of early infant weight gain on glucose metabolism and cardiovascular risk factors in adolescence and to study if the effect differed between adolescents born small for gestational age (SGA) vs. appropriate for gestational age (AGA). Methodology/Principal Findings: Data from 30 SGA and 57 AGA healthy young Danish adolescents were analysed. They had a mean age of 17.6 years and all were born at term. Data on early infant weight gain from birth to three months as well as from birth to one year were available in the majority of subjects. In adolescence, glucose metabolism was assessed by a simplified intravenous glucose tolerance test and body composition was assessed by dual-energy X-ray absorptiometry. Blood pressures as well as plasma concentrations of triglycerides and cholesterol were measured. Early infant weight gain from birth to three months was positively associated with the fasting insulin concentration, HOMA-IR, basal lipid levels and systolic blood pressure at 17 years. There was a differential effect of postnatal weight gain on HOMA-IR in AGA and SGA participants (P for interaction = 0.03). No significant associations were seen between postnatal weight gain and body composition or parameters of glucose metabolism assessed by the simplified intravenous glucose tolerance test. In subgroup analysis, all associations with early infant weight gain were absent in the AGA group, but the associations with basal insulin and HOMA-IR were still present in the SGA group. Conclusion: This study suggests that accelerated growth during the first three months of life may confer an increased risk of later metabolic disturbances - particularly of glucose metabolism - in individuals born SGA.	[Fabricius-Bjerre, Signe; Greisen, Gorm] Rigshosp, Univ Dept Neonatol, DK-2100 Copenhagen, Denmark; [Jensen, Rikke Beck] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Faerch, Kristine; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Larsen, Torben] Holbaek Cent Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark; [Molgaard, Christian; Michaelsen, Kim Fleischer] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Frederiksberg, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; Holbaek Hospital; University of Copenhagen	Fabricius-Bjerre, S (corresponding author), Rigshosp, Univ Dept Neonatol, DK-2100 Copenhagen, Denmark.	greisen@rh.dk	Mølgaard, Christian/D-2052-2014; Greisen, Gorm/AAA-6463-2022; Jensen, Rikke Beck/AAB-3236-2020	Mølgaard, Christian/0000-0002-5311-9457; Greisen, Gorm/0000-0001-8042-3262; Vaag, Allan Arthur/0000-0002-3690-2191; Jensen, Rikke Beck/0000-0002-4522-672X; Faerch, Kristine/0000-0002-6127-0448; Michaelsen, Kim F/0000-0003-0449-0839	Novo Nordisk; Lundbek Foundation; Danish Health Insurance Foundation; European Union [005272]; Danish Diabetes Association	Novo Nordisk(Novo Nordisk); Lundbek Foundation; Danish Health Insurance Foundation; European Union(European Commission); Danish Diabetes Association	Novo Nordisk, the Lundbek Foundation, the Danish Health Insurance Foundation, an EXGENESIS grant (005272) from the European Union and the Danish Diabetes Association supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Andersen E, 1982, Ugeskr Laeger, V144, P1760; Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; COLLE E, 1976, PEDIATRICS, V57, P363; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; GALVIN P, 1992, DIABETIC MED, V9, P921, DOI 10.1111/j.1464-5491.1992.tb01732.x; Harder T, 1999, Endocr Regul, V33, P25; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jimenez-Chillaron Josep C, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P23, DOI 10.1097/MED.0b013e328013da8e; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kensara OA, 2005, AM J CLIN NUTR, V82, P980; Larsen T, 1997, EARLY HUM DEV, V47, P157, DOI 10.1016/S0378-3782(96)01780-X; LARSEN T, 1992, BRIT J OBSTET GYNAEC, V99, P469, DOI 10.1111/j.1471-0528.1992.tb13783.x; LARSEN T, 1990, EARLY HUM DEV, V24, P37, DOI 10.1016/0378-3782(90)90004-3; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Levy-Marchal C, 2004, PEDIATR DIABETES, V5, P147, DOI 10.1111/j.1399-543X.2004.00057.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Pilgaard K, 2010, DIABETOLOGIA, V53, P2526, DOI 10.1007/s00125-010-1917-3; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Ridgway CL, 2011, DIABETES CARE, V34, P187, DOI 10.2337/dc10-1178; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; WARSOF SL, 1977, AM J OBSTET GYNECOL, V128, P881, DOI 10.1016/0002-9378(77)90058-8	46	115	119	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20595	10.1371/journal.pone.0020595	http://dx.doi.org/10.1371/journal.pone.0020595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655104	Green Published, Green Submitted, gold			2022-12-27	WOS:000291310600017
J	Yadav, V; Panilaitis, B; Shi, H; Numuta, K; Lee, K; Kaplan, DL				Yadav, Vikas; Panilaitis, Bruce; Shi, Hai; Numuta, Keiji; Lee, Kyongbum; Kaplan, David L.			N-acetylglucosamine 6-Phosphate Deacetylase (nagA) Is Required for N-acetyl Glucosamine Assimilation in Gluconacetobacter xylinus	PLOS ONE			English	Article							ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE; CHITIN OLIGOSACCHARIDES; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; MARINE-BACTERIA; CELL-WALL; IDENTIFICATION; BIOSYNTHESIS; MUTANTS	Metabolic pathways for amino sugars (N-acetylglucosamine; GlcNAc and glucosamine; Gln) are essential and remain largely conserved in all three kingdoms of life, i.e., microbes, plants and animals. Upon uptake, in the cytoplasm these amino sugars undergo phosphorylation by phosphokinases and subsequently deacetylation by the enzyme N-acetylglucosamine 6-phosphate deacetylase (nagA) to yield glucosamine-6-phosphate and acetate, the first committed step for both GlcNAc assimilation and amino-sugar-nucleotides biosynthesis. Here we report the cloning of a DNA fragment encoding a partial nagA gene and its implications with regard to amino sugar metabolism in the cellulose producing bacterium Glucoacetobacter xylinus (formally known as Acetobacter xylinum). For this purpose, nagA was disrupted by inserting tetracycline resistant gene (nagA:: tet(r); named as Delta nagA) via homologous recombination. When compared to glucose fed conditions, the UDP-GlcNAc synthesis and bacterial growth (due to lack of GlcNAc utilization) was completely inhibited in nagA mutants. Interestingly, that inhibition occured without compromising cellulose production efficiency and its molecular composition under GlcNAc fed conditions. We conclude that nagA plays an essential role for GlcNAc assimilation by G. xylinus thus is required for the growth and survival for the bacterium in presence of GlcNAc as carbon source. Additionally, G. xylinus appears to possess the same molecular machinery for UDP-GlcNAc biosynthesis from GlcNAc precursors as other related bacterial species.	[Yadav, Vikas; Panilaitis, Bruce; Numuta, Keiji; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Shi, Hai; Lee, Kyongbum; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA	Tufts University; Tufts University	Yadav, V (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Danna farber Canc Inst, Boston, MA 02163 USA.	david.kaplan@tufts.edu	Lee, Kyongbum/D-9230-2013; Shi, Hai/K-6254-2012	Lee, Kyongbum/0000-0002-0699-8057	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; Camacho F, 1996, J CHEM TECHNOL BIOT, V67, P350, DOI 10.1002/(SICI)1097-4660(199612)67:4<350::AID-JCTB564>3.0.CO;2-9; CARR JG, 1958, NATURE, V182, P265, DOI 10.1038/182265b0; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; Ferreira FM, 2000, ACTA CRYSTALLOGR D, V56, P670, DOI 10.1107/S0907444900003668; Ferreira FM, 2006, J MOL BIOL, V359, P308, DOI 10.1016/j.jmb.2006.03.024; FLORENCE VF, 2004, J BIOL CHEM, V279, P2809; Freese EB, 1970, J BACTERIOL, V101, P1046, DOI 10.1128/JB.101.3.1046-1062.1970; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; HOLTJE, 1985, MOL CYTOLOGY ESCHERI, P77; Iida A, 2009, MICROBIOL-SGM, V155, P3021, DOI 10.1099/mic.0.028613-0; IMADA A, 1977, J GEN MICROBIOL, V100, P329, DOI 10.1099/00221287-100-2-329; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; Lee JW, 2001, APPL ENVIRON MICROB, V67, P3970, DOI 10.1128/AEM.67.9.3970-3975.2001; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MOBLEY HLT, 1982, J BACTERIOL, V150, P8, DOI 10.1128/JB.150.1.8-15.1982; OGAWA R, 1992, INT J BIOL MACROMOL, V14, P343, DOI 10.1016/S0141-8130(05)80076-5; Park JT, 2001, J BACTERIOL, V183, P3842, DOI 10.1128/JB.183.13.3842-3847.2001; PLUMBRIDGE JA, 1990, J BACTERIOL, V172, P2728, DOI 10.1128/jb.172.5.2728-2735.1990; RAETZ CRH, 1987, ESCHERICHIA COLI SAL, V1, P498; Riemann L, 2002, APPL ENVIRON MICROB, V68, P5554, DOI 10.1128/AEM.68.11.5554-5562.2002; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Shigematsu T, 2005, J BIOSCI BIOENG, V99, P415, DOI 10.1263/jbb.99.415; Shirai A, 1997, CARBOHYD POLYM, V32, P223, DOI 10.1016/S0144-8617(97)00009-X; SHIRAI A, 1994, INT J BIOL MACROMOL, V16, P297, DOI 10.1016/0141-8130(94)90059-0; Span PN, 2001, CLIN CHEM, V47, P944; Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; WHITE RJ, 1967, BIOCHEM J, V118, P89; WONG HC, 1990, P NATL ACAD SCI USA, V87, P8130, DOI 10.1073/pnas.87.20.8130; YADAV V, 2010, APPL ENV MI IN PRESS	42	20	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e18099	10.1371/journal.pone.0018099	http://dx.doi.org/10.1371/journal.pone.0018099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655093	gold, Green Published, Green Submitted			2022-12-27	WOS:000291310600001
J	Chen, H; Sun, YM; Dong, RQ; Yang, SS; Pan, CY; Xiang, D; Miao, MY; Jiao, BH				Chen, Huan; Sun, Yimin; Dong, Ruiqi; Yang, Shengsheng; Pan, Chuanyong; Xiang, Dao; Miao, Mingyong; Jiao, Binghua			Mir-34a Is Upregulated during Liver Regeneration in Rats and Is Associated with the Suppression of Hepatocyte Proliferation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GROWTH-FACTOR; DOWN-REGULATION; CELL LINE; ACTIVIN-B; EXPRESSION; MICRORNAS; BETA; HEPATECTOMY; FOLLISTATIN	Background: MicroRNAs are a class of small regulatory RNAs that modulate a variety of biological processes, including cellular differentiation, apoptosis, metabolism and proliferation. This study aims to explore the effect of miR-34a in hepatocyte proliferation and its potential role in liver regeneration termination. Methodology/Principal Finding: MiR-34a was highly induced after partial hepatectomy. Overexpression of miR-34a in BRL3A cells could significantly inhibit cell proliferation and down-regulate the expression of inhibin bB (INHBB) and Met. In BRL3A cells, INHBB was identified as a direct target of miR-34a by luciferase reporter assay. More importantly, INHBB siRNA significantly repressed cell proliferation. A decrease of INHBB and Met was detected in regenerating liver. Conclusion/Significance: MiR-34a expression was upregulated during the late phase of liver regeneration. MiR-34amediated regulation of INHBB and Met may collectively contribute to the suppression of hepatocyte proliferation.	[Chen, Huan; Dong, Ruiqi; Yang, Shengsheng; Pan, Chuanyong; Miao, Mingyong; Jiao, Binghua] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Sun, Yimin] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Xiang, Dao] Second Mil Med Univ, Dept Cellular Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Chen, H (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	miaomy@163.com; jiaobh@uninet.com.cn		Chen, Huan/0000-0001-8648-1631	National Natural Science Foundation of China [30800553]; Science and Technology Commission Foundation of Shanghai [10JC1417400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Foundation of Shanghai	This work was financially supported by National Natural Science Foundation of China (No. 30800553) and Basic Research Program of Science and Technology Commission Foundation of Shanghai (No. 10JC1417400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Arora V, 2000, DRUG METAB DISPOS, V28, P131; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Endo D, 2006, ENDOCR J, V53, P73, DOI 10.1507/endocrj.53.73; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gold EJ, 2005, J MOL ENDOCRINOL, V34, P505, DOI 10.1677/jme.1.01657; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Higgins GM, 1931, ARCH PATHOL, V12, P186; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Niimi S, 2002, BIOL PHARM BULL, V25, P437, DOI 10.1248/bpb.25.437; Oe S, 2004, HEPATOLOGY, V40, P1098, DOI 10.1002/hep.20426; Russell CE, 1999, MOL CELL ENDOCRINOL, V148, P129, DOI 10.1016/S0303-7207(98)00226-3; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Takamura K, 2005, J SURG RES, V126, P3, DOI 10.1016/j.jss.2005.01.002; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; YUAN B, 2011, FEBS LETT, DOI DOI 10.1016/J.FEBSLET.2011.1002.1031; Zhong Z, 2010, LIVER TRANSPLANT, V16, P181, DOI 10.1002/lt.21966	30	81	89	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20238	10.1371/journal.pone.0020238	http://dx.doi.org/10.1371/journal.pone.0020238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655280	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600032
J	Desvars, A; Jego, S; Chiroleu, F; Bourhy, P; Cardinale, E; Michault, A				Desvars, Amelie; Jego, Sylvaine; Chiroleu, Frederic; Bourhy, Pascale; Cardinale, Eric; Michault, Alain			Seasonality of Human Leptospirosis in Reunion Island (Indian Ocean) and Its Association with Meteorological Data	PLOS ONE			English	Article							RISK-FACTORS; OUTBREAK; EPIDEMIOLOGY; RATS	Background: Leptospirosis is a disease which occurs worldwide but particularly affects tropical areas. Transmission of the disease is dependent on its excretion by reservoir animals and the presence of moist environment which allows the survival of the bacteria. Methods and Findings: A retrospective study was undertaken to describe seasonal patterns of human leptospirosis cases reported by the Centre National de References des Leptospiroses (CNRL, Pasteur Institute, Paris) between 1998 and 2008, to determine if there was an association between the occurrence of diagnosed cases and rainfall, temperature and global solar radiation (GSR). Meteorological data were recorded in the town of Saint-Benoit (Meteo France "Beaufonds-Miria'' station), located on the windward (East) coast. Time-series analysis was used to identify the variables that best described and predicted the occurrence of cases of leptospirosis on the island. Six hundred and thirteen cases were reported during the 11-year study period, and 359 cases (58.56%) were diagnosed between February and May. A significant correlation was identified between the number of cases in a given month and the associated cumulated rainfall as well as the mean monthly temperature recorded 2 months prior to diagnosis (r = 0.28 and r = 0.23 respectively). The predictive model includes the number of cases of leptospirosis recorded 1 month prior to diagnosis (b = 0.193), the cumulated monthly rainfall recorded 2 months prior to diagnosis (b = 0.145), the average monthly temperature recorded 0 month prior to diagnosis (b = 3.836), and the average monthly GSR recorded 0 month prior to diagnosis (b = -1.293). Conclusions: Leptospirosis has a seasonal distribution in Reunion Island. Meteorological data can be used to predict the occurrence of the disease and our statistical model can help to implement seasonal prevention measures.	[Desvars, Amelie; Cardinale, Eric] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, UMR CMAEE, St Clotilde, Reunion, France; [Desvars, Amelie; Cardinale, Eric] Ctr Reg Rech & Veille Malad Emergentes Ocean Indi, St Clotilde, Reunion, France; [Jego, Sylvaine; Chiroleu, Frederic] CIRAD, UMR Peuplement Vegetaux & Bioagresseurs Milieu Tr, St Pierre, Reunion, France; [Bourhy, Pascale] Ctr Natl Reference Leptospiroses, Inst Pasteur, Unite Postulante Biol Spirochetes, Paris, France; [Desvars, Amelie; Michault, Alain] CHR, GHSR, Lab Bacteriol Parasitol Virol Hyg, St Pierre, Reunion, France	CIRAD; CIRAD; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Reunion	Desvars, A (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, UMR CMAEE, St Clotilde, Reunion, France.	amelie.desvars@cirad.fr		Desvars-Larrive, Amelie/0000-0001-7671-696X; CHIROLEU, Frederic/0000-0002-4874-5357				Agesilas F, 2005, ARCH PEDIATRIE, V12, P1344, DOI 10.1016/j.arcped.2005.04.084; BARCELLOS C, 2001, CAD SAUDE PUBLICA S, V17; Brod CS, 2005, REV SOC BRAS MED TRO, V38, P294, DOI 10.1590/S0037-86822005000400003; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Douglin CP, 1997, EMERG INFECT DIS, V3, P78, DOI 10.3201/eid0301.970114; DUVAL G, 1991, REV EPIDEMIOL SANTE, V39, P135; EVERARD COR, 1992, J TROP MED HYG, V95, P13; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Gaynor K, 2007, AM J TROP MED HYG, V76, P882, DOI 10.4269/ajtmh.2007.76.882; Henrmann-Storck C, 2005, W INDIAN MED J, V54, P42; HIRSCHAUER C, 2009, B EPIDEMIOLOGIQUE HE, V48, P508; *INSEE, 2010, TABL EC REUN TER ED; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lhomme V, 1996, MED MALADIES INFECT, V26, P94, DOI 10.1016/S0399-077X(96)80161-2; MAILLOUX M, 1983, B SOC PATHOL EXOT, V76, P729; McCurry J, 2009, LANCET, V374, P1489, DOI 10.1016/S0140-6736(09)61888-2; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Mohan ARM, 2009, ACTA TROP, V112, P260, DOI 10.1016/j.actatropica.2009.08.007; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Pappachan MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1054, DOI 10.1136/jech.2003.018556; Perrocheau A, 1997, EUR J EPIDEMIOL, V13, P161, DOI 10.1023/A:1007300514760; Picardeau M., 2008, Bulletin Epidemiologique Hebdomadaire, P329; Priya CG, 2007, J POSTGRAD MED, V53, P236; RAUNET M, 1991, PHYS ENV SOILS REUNI; Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399; Sehgal SC, 2002, NATL MED J INDIA, V15, P22; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Shumway R.H., 2006, TIME SERIES ANAL ITS; SMITH CE, 1961, B WORLD HEALTH ORGAN, V24, P35; Storck CH, 2008, EPIDEMIOL INFECT, V136, P1407, DOI 10.1017/S0950268807000052; Tassinari WS, 2008, TROP MED INT HEALTH, V13, P503, DOI 10.1111/j.1365-3156.2008.02028.x; Weekes CC, 1997, VET MICROBIOL, V57, P215, DOI 10.1016/S0378-1135(97)00127-2; *WHO, 1999, WKLY EP REC, V74, P267	36	61	62	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20377	10.1371/journal.pone.0020377	http://dx.doi.org/10.1371/journal.pone.0020377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655257	Green Published, gold			2022-12-27	WOS:000291097600059
J	Galan, JM; Latek, MM; Rizi, SMM				Galan, Jose M.; Latek, Maciej M.; Rizi, Seyed M. Mussavi			Axelrod's Metanorm Games on Networks	PLOS ONE			English	Article							SOCIAL DILEMMAS; PUBLIC-GOODS; PRISONERS-DILEMMA; NORM ENFORCEMENT; GROUP IDENTITY; GROUP-SIZE; COOPERATION; PUNISHMENT; EVOLUTION; RECIPROCITY	Metanorms is a mechanism proposed to promote cooperation in social dilemmas. Recent experimental results show that network structures that underlie social interactions influence the emergence of norms that promote cooperation. We generalize Axelrod's analysis of metanorms dynamics to interactions unfolding on networks through simulation and mathematical modeling. Network topology strongly influences the effectiveness of the metanorms mechanism in establishing cooperation. In particular, we find that average degree, clustering coefficient and the average number of triplets per node play key roles in sustaining or collapsing cooperation.	[Galan, Jose M.] Univ Burgos, Dept Ingn Civil, Area Org Empresas, Burgos, Spain; [Galan, Jose M.] Social Syst Engn Ctr INSISOC, Valladolid, Spain; [Latek, Maciej M.; Rizi, Seyed M. Mussavi] George Mason Univ, Dept Computat Social Sci, Fairfax, VA 22030 USA	Universidad de Burgos; George Mason University	Galan, JM (corresponding author), Univ Burgos, Dept Ingn Civil, Area Org Empresas, Burgos, Spain.	jmgalan@ubu.es	Galán, José Manuel/B-9782-2009	Galán, José Manuel/0000-0003-3360-7602	Spanish MICINN [CSD2010-00034, DPI2010-16920]; Junta de Castilla y Leon [BU034A08, GREX251-2009]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	JMG is supported by the Spanish MICINN projects CSD2010-00034 (CONSOLIDER-INGENIO 2010) and DPI2010-16920, and by the Junta de Castilla y Leon, references BU034A08 and GREX251-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, LOGIC COLLECTIVE ACT; [Anonymous], 1995, EVOLUTIONARY GAME TH; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; Bicchieri C, 2002, RATION SOC, V14, P192, DOI 10.1177/1043463102014002003; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BREWER MB, 1986, J PERS SOC PSYCHOL, V50, P543, DOI 10.1037/0022-3514.50.3.543; Carpenter J, 2004, J EVOL ECON, V14, P407, DOI 10.1007/s00191-004-0212-1; Cinyabuguma M, 2005, J PUBLIC ECON, V89, P1421, DOI 10.1016/j.jpubeco.2004.05.011; Cinyabuguma M, 2006, EXP ECON, V9, P265, DOI 10.1007/s10683-006-9127-z; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Coleman J., 1990, FDN SOCIAL THEORY; Colman AM, 2013, GAME THEORY ITS APPL; Cornes R., 1986, THEORY EXTERNALITIES; Dawes RM, 2000, INT J PSYCHOL, V35, P111, DOI 10.1080/002075900399402; De Jong Kenneth A., 2006, EVOLUTIONARY COMPUTA, DOI 10.1145/1274000.1274109; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99; Elster J., 2006, HDB EC GIVING ALTRUI, V1, P183, DOI 10.1016/S1574-0714(06)01003-7; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Galan JM, 2005, JASSS-J ARTIF SOC S, V8; Galan JM, 2009, JASSS-J ARTIF SOC S, V12; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2006, J THEOR BIOL, V240, P627, DOI 10.1016/j.jtbi.2005.10.024; Hechter M., 2001, SOCIAL NORMS; Heckathorn DD, 1998, RATION SOC, V10, P451, DOI 10.1177/104346398010004004; Heckathorn DD., 1989, RATION SOC, V1, P78, DOI [10.1177/1043463189001001006, DOI 10.1177/1043463189001001006]; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Horne C, 2004, SOC FORCES, V82, P1037, DOI 10.1353/sof.2004.0041; Horne C, 2002, RATION SOC, V14, P285, DOI 10.1177/1043463102014003002; Horne C, 2001, SOC PSYCHOL QUART, V64, P253, DOI 10.2307/3090115; Horne C, 2008, RATION SOC, V20, P147, DOI 10.1177/1043463108089543; Horne C, 2007, RATION SOC, V19, P139, DOI 10.1177/1043463107077386; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; Izquierdo LR, 2009, JASSS-J ARTIF SOC S, V12; Izquierdo SS, 2010, J THEOR BIOL, V267, P76, DOI 10.1016/j.jtbi.2010.07.039; Izquierdo SS, 2008, JASSS-J ARTIF SOC S, V11; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; KRAMER RM, 1984, J PERS SOC PSYCHOL, V46, P1044, DOI 10.1037/0022-3514.46.5.1044; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Martinez FL, 2007, REV INT SOCIOL, V65, P131; Lozano S, 2008, J ECON INTERACT COOR, V3, P183, DOI 10.1007/s11403-008-0041-7; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Opp KD, 2002, RATION SOC, V14, P131, DOI 10.1177/1043463102014002001; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poza DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017661; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; RAPOPORT A, 1989, J PERS SOC PSYCHOL, V56, P748, DOI 10.1037/0022-3514.56.5.748; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Roca CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015210; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Young H.P., 2008, NEW PALGRAVE DICT EC	88	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20474	10.1371/journal.pone.0020474	http://dx.doi.org/10.1371/journal.pone.0020474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655211	gold, Green Published			2022-12-27	WOS:000291097600075
J	Machado, L; Guiney, H; Mitchell, A				Machado, Liana; Guiney, Hayley; Mitchell, Andrew			Famous Faces Demand Attention Due to Reduced Inhibitory Processing	PLOS ONE			English	Article							TOP-DOWN SUPPRESSION; PARKINSONS-DISEASE; UNFAMILIAR FACES; STIMULI; TASK; INFORMATION; FAMILIARITY; PERCEPTION; MECHANISMS; FMRI	People have particular difficulty ignoring distractors that depict faces. This phenomenon has been attributed to the high level of biological significance that faces carry. The current study aimed to elucidate the mechanism by which faces gain processing priority. We used a focused attention paradigm that tracks the influence of a distractor over time and provides a measure of inhibitory processing. Upright famous faces served as test stimuli and inverted versions of the faces as well as upright non-face objects served as control stimuli. The results revealed that although all of the stimuli elicited similar levels of distraction, only inverted distractor faces and non-face objects elicited inhibitory effects. The lack of inhibitory effects for upright famous faces provides novel evidence that reduced inhibitory processing underlies the mandatory nature of face processing.	[Machado, Liana] Univ Otago, Dept Psychol, Dunedin, New Zealand; Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand	University of Otago; University of Otago	Machado, L (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	liana@psy.otago.ac.nz	Machado, Liana J/B-8140-2009; Machado, Liana/M-7311-2019; Guiney, Hayley/D-4610-2017	Machado, Liana J/0000-0002-0856-3831; Machado, Liana/0000-0002-0856-3831; Guiney, Hayley/0000-0003-1311-8625	University of Otago	University of Otago	A University of Otago Research Grant funded this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Bindemann M, 2007, J VISION, V7, DOI 10.1167/7.10.15; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; Devue C, 2009, PERCEPTION, V38, P552, DOI 10.1068/p6049; Diedrichsen J, 2000, J EXP PSYCHOL HUMAN, V26, P113, DOI 10.1037/0096-1523.26.1.113; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Fenske MJ, 2005, PSYCHOL SCI, V16, P753, DOI 10.1111/j.1467-9280.2005.01609.x; Finkbeiner M, 2009, PSYCHOL SCI, V20, P42, DOI 10.1111/j.1467-9280.2008.02256.x; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Jackson MC, 2006, PERCEPT PSYCHOPHYS, V68, P543, DOI 10.3758/BF03208757; Jenkins R, 2003, PERCEPT PSYCHOPHYS, V65, P298, DOI 10.3758/BF03194801; Khurana B, 2000, J EXP PSYCHOL HUMAN, V26, P246, DOI 10.1037/0096-1523.26.1.246; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Machado L, 2004, Q J EXP PSYCHOL-A, V57, P1173, DOI 10.1080/02724980343000710; Machado L, 2007, J EXP PSYCHOL HUMAN, V33, P1045, DOI 10.1037/0096-1523.33.5.1045; Machado L, 2009, NEUROPSYCHOLOGIA, V47, P1756, DOI 10.1016/j.neuropsychologia.2009.02.018; Mari-Beffa P, 2005, NEUROPSYCHOLOGIA, V43, P638, DOI 10.1016/j.neuropsychologia.2004.07.006; Murray JE, 2011, PSYCHOL RES-PSYCH FO, V75, P324, DOI 10.1007/s00426-010-0310-7; Nieuwenhuis S, 2005, NAT NEUROSCI, V8, P1631, DOI 10.1038/nn1205-1631; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Riesenhuber M, 2009, ACTA PSYCHOL, V132, P286, DOI 10.1016/j.actpsy.2009.07.004; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Tipper SP, 2003, PSYCHOL SCI, V14, P19, DOI 10.1111/1467-9280.01413; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Zanto TP, 2010, CORTEX, V46, P564, DOI 10.1016/j.cortex.2009.08.003	29	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20544	10.1371/journal.pone.0020544	http://dx.doi.org/10.1371/journal.pone.0020544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655232	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600092
J	Sun, HG; Hu, YP; Gu, ZN; Wilson, MD; Chen, YQ; Rudel, LL; Willingham, MC; Edwards, IJ				Sun, Haiguo; Hu, Yunping; Gu, Zhennan; Wilson, Martha D.; Chen, Yong Q.; Rudel, Lawrence L.; Willingham, Mark C.; Edwards, Iris J.			Endogenous Synthesis of n-3 Polyunsaturated Fatty Acids in Fat-1 Mice Is Associated with Increased Mammary Gland and Liver Syndecan-1	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BREAST-CANCER CELLS; TRANSGENIC MICE; DOCOSAHEXAENOIC ACID; NUDE-MICE; CLINICAL-SIGNIFICANCE; REDUCED EXPRESSION; GROWTH-FACTOR; CORE PROTEIN; MENHADEN OIL	Long chain n-3 PUFA have been shown to have chemopreventive properties against breast cancer through various mechanisms. One pathway, studied in human breast cancer cell lines, involves upregulation of the proteoglycan, syndecan-1 (SDC-1) by n-3 PUFA-enriched LDL. Using Fat-1 mice that are able to convert n-6 to n-3 PUFA, we tested whether SDC-1 level in vivo is elevated in mammary glands due to endogenously synthesized rather than LDL-derived n-3 PUFA. Female Fat-1 and wild type (wt) mice were fed an n-6 PUFA-enriched diet for 7 weeks. Fatty acid analysis of plasma lipoproteins showed that total n-6 PUFA reflected dietary intake similarly in both genotypes (VLDL, 36.2 +/- 2.2 and 40.9 +/- 3.9; LDL, 49.0 +/- 3.3 and 48.1 +/- 2.0; HDL, 54.6 +/- 1.2 and 58.2 +/- 1.3, mean +/- SEM percent of total fatty acids for Fat-1 and wt animals respectively). Lipoprotein percent n-3 PUFA was also similar between groups. However, phospholipids and triglycerides extracted from mammary and liver tissues demonstrated significantly higher n-3 PUFA and a corresponding decrease in the ratio n-6/n-3 PUFA in Fat-1 compared to wt mice. This was accompanied by higher SDC-1 in mammary glands and livers of Fat-1 mice, thus demonstrating that endogenously synthesized n-3 PUFA may upregulate SDC-1 in the presence of high dietary n-6 PUFA.	[Sun, Haiguo; Hu, Yunping; Wilson, Martha D.; Rudel, Lawrence L.; Willingham, Mark C.; Edwards, Iris J.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [Gu, Zhennan; Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA	Wake Forest University; Wake Forest University	Sun, HG (corresponding author), Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA.	iedwards@wfubmc.edu	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Institutes of Health [R01CA115958, P01CA106742, R01CA107668, P01-HL-49373]; NATIONAL CANCER INSTITUTE [R01CA115958, P01CA106742, R01CA107668] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following grants from the National Institutes of Health: R01CA115958 (IJE), P01CA106742 (YQC, IJE), R01CA107668 (YQC) and P01-HL-49373 (LLR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELELA SH, 1989, CANCER RES, V49, P1434; ABOUELELA SH, 1988, LIPIDS, V23, P948, DOI 10.1007/BF02536342; Anttonen A, 1999, BRIT J CANCER, V79, P558, DOI 10.1038/sj.bjc.6690088; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Bougnoux P, 2009, BRIT J CANCER, V101, P1978, DOI 10.1038/sj.bjc.6605441; BOUGNOUX P, PROG LIPID RES, V49, P76; BRADEN LM, 1986, LIPIDS, V21, P285, DOI 10.1007/BF02536414; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chen YQ, 2006, JAMA-J AM MED ASSOC, V296, P282, DOI 10.1001/jama.296.3.282-a; Davies EJ, 2004, CLIN CANCER RES, V10, P5178, DOI 10.1158/1078-0432.CCR-03-0103; Dhodapkar MV, 1998, BLOOD, V91, P2679, DOI 10.1182/blood.V91.8.2679.2679_2679_2688; Edwards IJ, 2004, CLIN CANCER RES, V10, P8275, DOI 10.1158/1078-0432.CCR-04-1357; Edwards IJ, 2008, J BIOL CHEM, V283, P18441, DOI 10.1074/jbc.M802107200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fujiya M, 2001, JPN J CANCER RES, V92, P1074, DOI 10.1111/j.1349-7006.2001.tb01062.x; HU Y, NEOPLASIA, V12, P826; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; HURSTING SD, 1990, PREV MED, V19, P242, DOI 10.1016/0091-7435(90)90025-F; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; INKI P, 1994, BRIT J CANCER, V70, P319, DOI 10.1038/bjc.1994.300; ISHIKAWA T, EXP CELL RES, V316, P951; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; JURKOWSKI JJ, 1985, J NATL CANCER I, V74, P1145; KAIZER L, 1989, NUTR CANCER, V12, P61, DOI 10.1080/01635588909514002; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Liu YE, 2007, FEBS J, V274, P3351, DOI 10.1111/j.1742-4658.2007.05869.x; Loussouarn D, 2008, BRIT J CANCER, V98, P1993, DOI 10.1038/sj.bjc.6604400; Lu Y, 2008, MOL CANCER THER, V7, P3203, DOI 10.1158/1535-7163.MCT-08-0494; Ma DWL, 2006, LIPIDS, V41, P35, DOI 10.1007/s11745-006-5067-9; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; MALI M, 1994, J BIOL CHEM, V269, P27795; Matsumoto A, 1997, INT J CANCER, V74, P482, DOI 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; NOGUCHI M, 1995, ONCOLOGY, V52, P458; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; ORR SK, NEUROCHEM RES, V35, P811; Pulkkinen JO, 1997, ACTA OTO-LARYNGOL, V117, P312, DOI 10.3109/00016489709117794; Reddy B S, 1980, Adv Cancer Res, V32, P237, DOI 10.1016/S0065-230X(08)60363-2; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; ROSE DP, 1993, CANCER RES, V53, P4686; ROSE DP, 1993, JNCI-J NATL CANCER I, V85, P1743, DOI 10.1093/jnci/85.21.1743; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; SASAKI S, 1993, PREV MED, V22, P187, DOI 10.1006/pmed.1993.1016; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Sun HG, 2005, CANCER RES, V65, P4442, DOI 10.1158/0008-5472.CAN-04-4200; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Wiksten JP, 2001, INT J CANCER, V95, P1, DOI 10.1002/1097-0215(20010120)95:1<1::AID-IJC1000>3.0.CO;2-5; Xia SH, 2005, CARCINOGENESIS, V26, P779, DOI 10.1093/carcin/bgi019; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Yee LD, 2005, J NUTR, V135, P983, DOI 10.1093/jn/135.5.983	71	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20502	10.1371/journal.pone.0020502	http://dx.doi.org/10.1371/journal.pone.0020502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655218	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600082
J	Mih, JD; Sharif, AS; Liu, F; Marinkovic, A; Symer, MM; Tschumperlin, DJ				Mih, Justin D.; Sharif, Asma S.; Liu, Fei; Marinkovic, Aleksandar; Symer, Matthew M.; Tschumperlin, Daniel J.			A Multiwell Platform for Studying Stiffness-Dependent Cell Biology	PLOS ONE			English	Article							SUBSTRATE FLEXIBILITY; CREASING INSTABILITY; MATRIX STIFFNESS; SOFT; MORPHOLOGY; HYDROGELS; FIBROSIS; CULTURE	Adherent cells are typically cultured on rigid substrates that are orders of magnitude stiffer than their tissue of origin. Here, we describe a method to rapidly fabricate 96 and 384 well platforms for routine screening of cells in tissue-relevant stiffness contexts. Briefly, polyacrylamide (PA) hydrogels are cast in glass-bottom plates, functionalized with collagen, and sterilized for cell culture. The Young's modulus of each substrate can be specified from 0.3 to 55 kPa, with collagen surface density held constant over the stiffness range. Using automated fluorescence microscopy, we captured the morphological variations of 7 cell types cultured across a physiological range of stiffness within a 384 well plate. We performed assays of cell number, proliferation, and apoptosis in 96 wells and resolved distinct profiles of cell growth as a function of stiffness among primary and immortalized cell lines. We found that the stiffness-dependent growth of normal human lung fibroblasts is largely invariant with collagen density, and that differences in their accumulation are amplified by increasing serum concentration. Further, we performed a screen of 18 bioactive small molecules and identified compounds with enhanced or reduced effects on soft versus rigid substrates, including blebbistatin, which abolished the suppression of lung fibroblast growth at 1 kPa. The ability to deploy PA gels in multiwell plates for high throughput analysis of cells in tissue-relevant environments opens new opportunities for the discovery of cellular responses that operate in specific stiffness regimes.	[Mih, Justin D.; Sharif, Asma S.; Liu, Fei; Marinkovic, Aleksandar; Symer, Matthew M.; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mih, JD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dtschump@hsph.harvard.edu		Symer, Matthew/0000-0003-2722-8155	U.S. National Institutes of Health [GM-073628, HL-092961]; Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM073628] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the U.S. National Institutes of Health (GM-073628 and HL-092961) and the Scleroderma Foundation to D.J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARATYNSCHAUS Y, PREPARATION COMPLAIN; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Chen WLK, 2010, BIOMATERIALS, V31, P2489, DOI 10.1016/j.biomaterials.2009.12.002; CRETU A, 2010, STUDYING EFFECTS MAT; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Jachowicz J, 2007, SKIN RES TECHNOL, V13, P299, DOI 10.1111/j.1600-0846.2007.00229.x; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saha K, 2010, BIOPHYS J, V99, pL94, DOI 10.1016/j.bpj.2010.09.045; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Trujillo V, 2008, SOFT MATTER, V4, P564, DOI 10.1039/b713263h; Tse JR, 2010, CURR PROTOC CELL BIO, V47, DOI [10.1002/0471143030.cb1016-47, DOI 10.1002/0471143030.CB1016-47]; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; 6846881	34	118	118	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19929	10.1371/journal.pone.0019929	http://dx.doi.org/10.1371/journal.pone.0019929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637769	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500018
J	Nilsson, EE; Schindler, R; Savenkova, MI; Skinner, MK				Nilsson, Eric E.; Schindler, Ryan; Savenkova, Marina I.; Skinner, Michael K.			Inhibitory Actions of Anti-Mullerian Hormone (AMH) on Ovarian Primordial Follicle Assembly	PLOS ONE			English	Article							DIFFERENTIAL SUBCELLULAR-LOCALIZATION; NECROSIS-FACTOR-ALPHA; FGF ANTISENSE GENE; GERM-CELLS; NEST BREAKDOWN; TGF-BETA; IN-VITRO; MOUSE; GROWTH; PROGESTERONE	The current study was designed to investigate the actions of Anti-Mullerian Hormone (AMH) on primordial follicle assembly. Ovarian primordial follicles develop from the breakdown of oocyte nests during fetal development for the human and immediately after birth in rodents. AMH was found to inhibit primordial follicle assembly and decrease the initial primordial follicle pool size in a rat ovarian organ culture. The AMH expression was found to be primarily in the stromal tissue of the ovaries at this period of development, suggesting a stromal-epithelial cell interaction for primordial follicle assembly. AMH was found to promote alterations in the ovarian transcriptome during primordial follicle assembly with over 200 genes with altered expression. A gene network was identified suggesting a potential central role for the Fgf2/Nudt6 antisense transcript in the follicle assembly process. A number of signal transduction pathways are regulated by AMH actions on the ovarian transcriptome, in particular the transforming growth factor - beta (TGF beta) signaling process. AMH is the first hormone/protein shown to have an inhibitory action on primordial follicle assembly. Due to the critical role of the primordial follicle pool size for female reproduction, elucidation of factors, such as AMH, that regulate the assembly process will provide insights into potential therapeutics to manipulate the pool size and female reproduction.	[Nilsson, Eric E.; Schindler, Ryan; Savenkova, Marina I.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Nilsson, EE (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020; Savenkova, Marina/AAN-9927-2021		National Institutes of Health, NICHD	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a National Institutes of Health, NICHD grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguma-Nibasheka M, 2007, MOL CELL ENDOCRINOL, V267, P127, DOI 10.1016/j.mce.2007.01.008; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Coulson-Thomas VJ, 2010, EXP CELL RES, V316, P3207, DOI 10.1016/j.yexcr.2010.08.005; de Bruin JP, 2002, BIOL REPROD, V66, P1151, DOI 10.1095/biolreprod66.4.1151; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Erickson Gregory F, 2003, Reprod Biol Endocrinol, V1, P9, DOI 10.1186/1477-7827-1-9; Faddy MJ, 1996, HUM REPROD, V11, P1484; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; GONDOS B, 1973, Z ZELLFORSCH MIK ANA, V138, P23, DOI 10.1007/BF00307075; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Gougeon A, 2000, MOL CELL ENDOCRINOL, V163, P33, DOI 10.1016/S0303-7207(00)00220-3; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Klattig J, 2007, SEX DEV, V1, P271, DOI 10.1159/000108929; Knee R, 1997, P NATL ACAD SCI USA, V94, P4943, DOI 10.1073/pnas.94.10.4943; KONISHI I, 1986, J ANAT, V148, P121; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; LEE MM, 1993, ENDOCR REV, V14, P152, DOI 10.1210/er.14.2.152; Mark-Kappeler CJ, 2010, TOXICOL APPL PHARM, V249, P1, DOI 10.1016/j.taap.2010.08.024; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Morrison LJ, 2002, BIOL REPROD, V66, P450, DOI 10.1095/biolreprod66.2.450; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; Nilsson EE, 2006, REPRODUCTION, V132, P877, DOI 10.1530/REP-06-0045; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Nilsson EE, 2009, MOL CELL ENDOCRINOL, V313, P9, DOI 10.1016/j.mce.2009.09.004; ODOR DL, 1969, AM J ANAT, V124, P163, DOI 10.1002/aja.1001240204; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; Piprek RP, 2009, FOLIA BIOL-KRAKOW, V57, P105, DOI 10.3409/fb57_3-4.105-113; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; SAKAI T, 1955, JAPANESE J VET RES, V3, P183; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; Schlessinger D, 2010, J ANDROL, V31, P16, DOI 10.2164/jandrol.109.008201; Sforza C, 1998, MARC MALPIG SYMP SER, V6, P51; SHIMA JE, 2004, BIOL REPROD; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Tanaka Y, 2001, REPRODUCTION, V121, P777, DOI 10.1530/rep.0.1210777; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Trombly DJ, 2009, ENDOCRINOLOGY, V150, P1014, DOI 10.1210/en.2008-0213; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Visser JA, 2005, MOL CELL ENDOCRINOL, V234, P81, DOI 10.1016/j.mce.2004.09.008; Visser JA, 2003, MOL CELL ENDOCRINOL, V211, P65, DOI 10.1016/j.mce.2003.09.012; Wenner CE, 2003, J CELL PHYSIOL, V196, P42, DOI 10.1002/jcp.10243; Yang MY, 2008, BIOL REPROD, V78, P1153, DOI 10.1095/biolreprod.107.066688; Zhang SC, 2007, J MOL MED, V85, P1215, DOI 10.1007/s00109-007-0219-9; Zhang SC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-10; Zhao P, 2008, ENDOCRINOLOGY, V149, P2782, DOI 10.1210/en.2007-1662	67	76	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20087	10.1371/journal.pone.0020087	http://dx.doi.org/10.1371/journal.pone.0020087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637711	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500028
J	Hommais, F; Zghidi-Abouzid, O; Oger-Desfeux, C; Pineau-Chapelle, E; Van Gijsegem, F; Nasser, W; Reverchon, S				Hommais, Florence; Zghidi-Abouzid, Ouafa; Oger-Desfeux, Christine; Pineau-Chapelle, Emilie; Van Gijsegem, Frederique; Nasser, William; Reverchon, Sylvie			lpxC and yafS are the Most Suitable Internal Controls to Normalize Real Time RT-qPCR Expression in the Phytopathogenic Bacteria Dickeya dadantii	PLOS ONE			English	Article							HOUSEKEEPING GENES; GLOBAL REGULATOR; PLANT PATHOGEN; VIRULENCE; PCR; TRANSCRIPTION; PHASE; FIS	Background: Quantitative RT-PCR is the method of choice for studying, with both sensitivity and accuracy, the expression of genes. A reliable normalization of the data, using several reference genes, is critical for an accurate quantification of gene expression. Here, we propose a set of reference genes, of the phytopathogenic bacteria Dickeya dadantii and Pectobacterium atrosepticum, which are stable in a wide range of growth conditions. Results: We extracted, from a D. dadantii micro-array transcript profile dataset comprising thirty-two different growth conditions, an initial set of 49 expressed genes with very low variation in gene expression. Out of these, we retained 10 genes representing different functional categories, different levels of expression (low, medium, and high) and with no systematic variation in expression correlating with growth conditions. We measured the expression of these reference gene candidates using quantitative RT-PCR in 50 different experimental conditions, mimicking the environment encountered by the bacteria in their host and directly during the infection process in planta. The two most stable genes (ABF-0017965 (lpxC) and ABF-0020529 (yafS) were successfully used for normalization of RT-qPCR data. Finally, we demonstrated that the ortholog of lpxC and yafS in Pectobacterium atrosepticum also showed stable expression in diverse growth conditions. Conclusions: We have identified at least two genes, lpxC (ABF-0017965) and yafS (ABF-0020509), whose expressions are stable in a wide range of growth conditions and during infection. Thus, these genes are considered suitable for use as reference genes for the normalization of real-time RT-qPCR data of the two main pectinolytic phytopathogenic bacteria D. dadantii and P. atrosepticum and, probably, of other Enterobacteriaceae. Moreover, we defined general criteria to select good reference genes in bacteria.	[Hommais, Florence; Zghidi-Abouzid, Ouafa; Nasser, William; Reverchon, Sylvie] Univ Lyon 1, Unite Microbiol, Pathogenie CNRS INSA UCBL UMR 5240, F-69622 Villeurbanne, France; [Hommais, Florence; Zghidi-Abouzid, Ouafa; Nasser, William; Reverchon, Sylvie] Univ Lyon, Lyon, France; [Hommais, Florence; Zghidi-Abouzid, Ouafa; Nasser, William; Reverchon, Sylvie] INSA Lyon, Villeurbanne, France; [Oger-Desfeux, Christine] Univ Lyon 1, IFR41, F-69622 Villeurbanne, France; [Pineau-Chapelle, Emilie; Van Gijsegem, Frederique] UMR 217 INRA AgroParisTech UPMC P6, Lab Interact Plantes Pathogenes, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; AgroParisTech; INRAE; UDICE-French Research Universities; Sorbonne Universite	Hommais, F (corresponding author), Univ Lyon 1, Unite Microbiol, Pathogenie CNRS INSA UCBL UMR 5240, F-69622 Villeurbanne, France.	hommais@univ-lyon1.fr	Van Gijsegem, Frederique/D-1103-2017; Hommais, Florence/D-2785-2019; NASSER, William/C-9611-2019; Sylvie, Reverchon/P-7932-2016	Hommais, Florence/0000-0003-2151-3545; NASSER, William/0000-0001-9848-3597; Sylvie, Reverchon/0000-0002-0478-3474	French ANR [ANR-07-BLAN-0212]; Centre National de la Recherche Scientifique	French ANR(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the French ANR Blanc Regupath 2007 Program, N<SUP>o</SUP>ANR-07-BLAN-0212, and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Dorman CJ, 2009, NUCLEIC ACIDS RES, V37, P672, DOI 10.1093/nar/gkn996; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; HINTON JCD, 1989, MOL GEN GENET, V217, P141, DOI 10.1007/BF00330953; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; HUGOUVIEUXCOTTEPATTAT N, 1992, J BACTERIOL, V174, P7807, DOI 10.1128/JB.174.23.7807-7818.1992; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kepseu WD, 2010, J BIOL CHEM, V285, P28565, DOI 10.1074/jbc.M110.114710; Lautier T, 2007, MOL MICROBIOL, V66, P1474, DOI 10.1111/j.1365-2958.2007.06012.x; Lautier T, 2007, MOL MICROBIOL, V66, P1491, DOI 10.1111/j.1365-2958.2007.06010.x; Lebeau A, 2008, ENVIRON MICROBIOL, V10, P545, DOI 10.1111/j.1462-2920.2007.01473.x; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reverchon S, 2010, MOL MICROBIOL, V78, P1018, DOI 10.1111/j.1365-2958.2010.07388.x; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wisniewski JP, 2004, PLANT MOL BIOL, V56, P325, DOI 10.1007/s11103-004-3414-x	27	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20269	10.1371/journal.pone.0020269	http://dx.doi.org/10.1371/journal.pone.0020269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637857	Green Submitted, gold, Green Published			2022-12-27	WOS:000291052200045
J	Ope, MO; Katz, MA; Aura, B; Gikunju, S; Njenga, MK; Ng'ang'a, Z; Vulule, J; Breiman, RF; Feikin, DR				Ope, Maurice O.; Katz, Mark A.; Aura, Barrack; Gikunju, Stella; Njenga, M. Kariuki; Ng'ang'a, Zipporah; Vulule, John; Breiman, Robert F.; Feikin, Daniel R.			Risk Factors for Hospitalized Seasonal Influenza in Rural Western Kenya	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; TYPE-1 INFECTION; SWINE INFLUENZA; HIGH PREVALENCE; MORTALITY; MORBIDITY; HUMANS; EPIDEMIOLOGY	Background: Risk factors for influenza hospitalization in Africa are unknown, including the role of HIV. Methods: We conducted a case-control study of risk factors for hospitalized seasonal influenza among persons in rural western Kenya, a high HIV prevalence area, from March 2006-August 2008. Eligible cases were >= five years old, admitted to health facilities with respiratory symptoms, and had nasopharyngeal/oropharyngeal swab specimens that tested positive for influenza A or B by real-time reverse transcription-PCR. Three randomly selected age- ,sex-and neighborhood-matched controls were enrolled per case. A structured questionnaire was administered and home-based HIV testing was performed. Risk factors were evaluated using conditional logistic regression. Results: A total of 64 cases (38 with influenza A and 26 with influenza B) and 190 controls were enrolled. The median age was 16 years (range 5-69 years). Among cases, 24.5% were HIV-infected versus 12.5% of controls (p = 0.004). Among persons >= 18 years old, 13 (59%) of 22 tested cases were HIV-positive compared with 15 (24%) of 62 tested controls (p = 0.005). In multivariable analysis, HIV-infection was associated with hospitalization due to influenza [adjusted Odds Ratio (aOR) 3.56, 95% CI 1.25-10.1]. The mean CD4 count among HIV-infected cases and controls was similar (399 vs. 387, respectively, p = 0.89). Chronic lung disease (aOR 6.83, 95% CI 1.37-34.0) was also associated with influenza hospitalization in multivariable analysis. Active pulmonary tuberculosis was associated with influenza hospitalization in bivariate, but not multivariable, analysis. Conclusions: People with HIV infection and chronic lung disease were at increased risk of hospitalized influenza in rural Kenya. HIV infection is common in many parts of sub-Saharan Africa. Influenza vaccine might prevent severe influenza in these risk groups.	[Ope, Maurice O.] Minist Publ Hlth & Sanitat, Dept Dis Surveillance & Response, Nairobi, Kenya; [Ope, Maurice O.] Ctr Dis Control & Prevent, Field Epidemiol & Lab Management Training Program, Nairobi, Kenya; [Ope, Maurice O.; Ng'ang'a, Zipporah] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Katz, Mark A.] Ctr Dis Control & Prevent, Global Dis Detect Div, Influenza Program, Nairobi, Kenya; [Aura, Barrack; Gikunju, Stella; Njenga, M. Kariuki; Breiman, Robert F.; Feikin, Daniel R.] Ctr Dis Control & Prevent, Int Emerging Infect Program, Nairobi, Kenya; [Aura, Barrack; Gikunju, Stella; Vulule, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya	Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute	Ope, MO (corresponding author), Minist Publ Hlth & Sanitat, Dept Dis Surveillance & Response, Nairobi, Kenya.	dfeikin@cdc.gov			U.S. Centers for Disease Control and Prevention	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The project was funded by funding from the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; Bender JM, 2009, PEDIATR EMERG CARE, V25, P369, DOI 10.1097/PEC.0b013e3181a792a9; Boschini A, 2006, J MED VIROL, V78, P1218, DOI 10.1002/jmv.20684; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; *IFPMA, 2010, P 7 C OPT CONTR INFL; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Li GX, 2009, J CLIN VIROL, V46, P275, DOI 10.1016/j.jcv.2009.07.015; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; National AIDS and STI Control Programme, 2008, KEN AIDS IND SURV 20; Neuzil KM, 2003, JAIDS-J ACQ IMM DEF, V34, P304, DOI 10.1097/00126334-200311010-00008; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Tasker SA, 1999, ANN INTERN MED, V131, P430, DOI 10.7326/0003-4819-131-6-199909210-00006; World Health Organization, 2008, HIV AIDS EP SURV REP; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; 2002, WKLY EPIDEMIOL REC, V77, P350	29	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20111	10.1371/journal.pone.0020111	http://dx.doi.org/10.1371/journal.pone.0020111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637856	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200033
J	Iwai, A; Takegami, T; Shiozaki, T; Miyazaki, T				Iwai, Atsushi; Takegami, Tsutomu; Shiozaki, Takuya; Miyazaki, Tadaaki			Hepatitis C Virus NS3 Protein Can Activate the Notch-Signaling Pathway through Binding to a Transcription Factor, SRCAP	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; P53 TUMOR-SUPPRESSOR; CELL-LINE; NONSTRUCTURAL PROTEIN-3; CORE PROTEIN; SUBCELLULAR-LOCALIZATION; MEDIATED TRANSCRIPTION; SERINE PROTEINASE; INDUCED APOPTOSIS; EXPRESSION	Persistent infections of hepatitis C virus (HCV) are known to be a major risk factor for causing hepatocellular carcinomas. Nonstructural protein 3 (NS3) of HCV has serine protease and RNA helicase domains, and is essential for the viral replication. Further, NS3 is also considered to be involved in the development of HCV-induced hepatocellular carcinomas. In this report, we focus on the function of NS3 protein, and propose a novel possible molecular mechanism which is thought to be related to the tumorigenesis caused by the persistent infection of HCV. We identified SRCAP (Snf2-related CBP activator protein) as a NS3 binding protein using yeast two-hybrid screening, and a co-immunoprecipitation assay demonstrated that NS3 can bind to SRCAP in mammalian cells. The results of a reporter gene assay using Hes-1 promoter which is known to be a target gene activated by Notch, indicate that NS3 and SRCAP cooperatively activate the Hes-1 promoter in Hep3B cells. In addition, we show in this report that also p400, which is known as a protein closely resembling SRCAP, would be targeted by NS3. NS3 exhibited binding activity also to the 1449-1808 region of p400 by a co-immunoprecipitation assay, and further the activation of the Notch-mediated transcription of Hes-1 promoter by NS3 decreased significantly by the combined silencing of SRCAP and p400 mRNA using short hairpin RNA. These results suggest that the HCV NS3 protein is involved in the activation of the Notch-signaling pathway through the targeting to both SRCAP and p400.	[Iwai, Atsushi; Shiozaki, Takuya; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan; [Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan	Hokkaido University; Kanazawa Medical University	Iwai, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan.	takegami@kanazawa-med.ac.jp	Iwai, Atsushi/I-6469-2019; Miyazaki, Tadaaki/D-9368-2012	Iwai, Atsushi/0000-0002-1491-4693	High-Tech Research Center of Kanazawa Medical University [H2010-10]	High-Tech Research Center of Kanazawa Medical University	Funding: The present work was supported by a Grant for Project Research from the High-Tech Research Center of Kanazawa Medical University (H2010-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Aizaki H, 1998, HEPATOLOGY, V27, P621, DOI 10.1002/hep.510270242; Aizaki H, 2002, HEPATOLOGY, V36, P1431, DOI 10.1053/jhep.2002.36937; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Borowski P, 1997, J VIROL, V71, P2838, DOI 10.1128/JVI.71.4.2838-2843.1997; Borowski P, 1999, J BIOL CHEM, V274, P30722, DOI 10.1074/jbc.274.43.30722; Cantarini MC, 2006, HEPATOLOGY, V44, P446, DOI 10.1002/hep.21272; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Fujita T, 1996, BIOCHEM BIOPH RES CO, V229, P825, DOI 10.1006/bbrc.1996.1887; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Gao J, 2008, DIGEST LIVER DIS, V40, P114, DOI 10.1016/j.dld.2007.08.001; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Ghosh AK, 2000, J BIOL CHEM, V275, P7184, DOI 10.1074/jbc.275.10.7184; Giovannini C, 2006, ANTICANCER RES, V26, P2123; Giovannini C, 2009, J HEPATOL, V50, P969, DOI 10.1016/j.jhep.2008.12.032; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Ishido S, 1998, FEBS LETT, V438, P258, DOI 10.1016/S0014-5793(98)01312-X; Iwai A, 2003, MICROBIOL IMMUNOL, V47, P601, DOI 10.1111/j.1348-0421.2003.tb03423.x; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kwun HJ, 2001, J GEN VIROL, V82, P2235, DOI 10.1099/0022-1317-82-9-2235; Lang SE, 2003, ONCOGENE, V22, P2836, DOI 10.1038/sj.onc.1206376; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Park JH, 2006, MOL CELL BIOL, V26, P4006, DOI 10.1128/MCB.02185-05; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Qi RZ, 2003, CANCER RES, V63, P8323; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Ray RB, 1996, J VIROL, V70, P4438, DOI 10.1128/JVI.70.7.4438-4443.1996; Ray RB, 1997, J BIOL CHEM, V272, P10983; SAKAMURO D, 1995, J VIROL, V69, P3893, DOI 10.1128/JVI.69.6.3893-3896.1995; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; SHIMOTOHNO K, 1995, J HEPATOL, V22, P87; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tsuchihara K, 1999, VIROLOGY, V258, P100, DOI 10.1006/viro.1999.9694; TSUKIYAMAKOHARA K, 1991, VIRUS GENES, V5, P243, DOI 10.1007/BF00568974; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Xu HY, 2008, SCAND J GASTROENTERO, V43, P1522, DOI 10.1080/00365520802321188; Xu XQ, 2003, VIROLOGY, V313, P615, DOI 10.1016/S0042-6822(03)00386-6; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	62	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20718	10.1371/journal.pone.0020718	http://dx.doi.org/10.1371/journal.pone.0020718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673954	Green Published, gold			2022-12-27	WOS:000291356400023
J	Medie, FM; Ben Salah, I; Henrissat, B; Raoult, D; Drancourt, M				Medie, Felix Mba; Ben Salah, Iskandar; Henrissat, Bernard; Raoult, Didier; Drancourt, Michel			Mycobacterium tuberculosis Complex Mycobacteria as Amoeba-Resistant Organisms	PLOS ONE			English	Article							FREE-LIVING AMEBAS; ENVIRONMENTAL MYCOBACTERIA; ACANTHAMOEBA-POLYPHAGA; SP-NOV; INFECTIONS; MASSILIENSE; COCULTURE; OUTBREAK; MARINUM; DICTYOSTELIUM	Background: Most environmental non-tuberculous mycobacteria have been demonstrated to invade amoebal trophozoites and cysts, but such relationships are largely unknown for members of the Mycobacterium tuberculosis complex. An environmental source has been proposed for the animal Mycobacterium bovis and the human Mycobacterium canettii. Methodology/Principal Findings: Using optic and electron microscopy and co-culture methods, we observed that 89 +/- 0.6% of M. canettii, 12.4 +/- 0.3% of M. tuberculosis, 11.7 +/- 2% of M. bovis and 11.2 +/- 0.5% of Mycobacterium avium control organisms were phagocytized by Acanthamoeba polyphaga, a ratio significantly higher for M. canettii (P = 0.03), correlating with the significantly larger size of M. canetti organisms (P = 0.035). The percentage of intraamoebal mycobacteria surviving into cytoplasmic vacuoles was 32 +/- 2% for M. canettii, 26 +/- 1% for M. tuberculosis, 28 +/- 2% for M. bovis and 36 +/- 2% for M. avium (P = 0.57). M. tuberculosis, M. bovis and M. avium mycobacteria were further entrapped within the double wall of <1% amoebal cysts, but no M. canettii organisms were observed in amoebal cysts. The number of intracystic mycobacteria was significantly (P = 10(-6)) higher for M. avium than for the M. tuberculosis complex, and sub-culturing intracystic mycobacteria yielded significantly more (P = 0.02) M. avium organisms (34x10(4) CFU/mL) than M. tuberculosis (42x10(1) CFU/mL) and M. bovis (35x10(1) CFU/mL) in the presence of a washing fluid free of mycobacteria. Mycobacteria survived in the cysts for up to 18 days and cysts protected M. tuberculosis organisms against mycobactericidal 5 mg/mL streptomycin and 2.5% glutaraldehyde. Conclusions/Significance: These data indicate that M. tuberculosis complex organisms are amoeba-resistant organisms, as previously demonstrated for non-tuberculous, environmental mycobacteria. Intercystic survival of tuberculous mycobacteria, except for M. canettii, protect them against biocides and could play a role in their life cycle.	[Medie, Felix Mba; Ben Salah, Iskandar; Raoult, Didier; Drancourt, Michel] Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 189,IFR 48,Fac Med, Marseille, France; [Medie, Felix Mba; Henrissat, Bernard] Univ Aix Marseille 2, UMR CNRS 6098, AFMB, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Medie, FM (corresponding author), Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 189,IFR 48,Fac Med, Marseille, France.	Michel.Drancourt@univmed.fr	Henrissat, Bernard/J-2475-2012; RAOULT, Didier/A-8434-2008	Henrissat, Bernard/0000-0002-3434-8588; RAOULT, Didier/0000-0002-0633-5974; Mba Medie, Felix/0000-0002-8265-4563				Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2003, INFECT GENET EVOL, V2, P193, DOI 10.1016/S1567-1348(02)00100-4; Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; Astagneau P, 2001, LANCET, V358, P747, DOI 10.1016/S0140-6736(01)05843-3; Ben Salah I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-99; CANETTI G, 1970, LILLE MED, V15, P280; Chilima BZ, 2006, APPL ENVIRON MICROB, V72, P2343, DOI 10.1128/AEM.72.4.2343-2350.2006; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2003, INFECT CONT HOSP EP, V24, P784, DOI 10.1086/502137; Hagedorn M, 2007, CELL MICROBIOL, V9, P2716, DOI 10.1111/j.1462-5822.2007.00993.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Koeck JL, 2011, CLIN MICROBIOL INFEC, V17, P1013, DOI 10.1111/j.1469-0691.2010.03347.x; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; Medie FM, 2011, PROTEIN EXPRES PURIF, V75, P172, DOI 10.1016/j.pep.2010.08.015; Medie FM, 2010, MICROBIOL-SGM, V156, P1468, DOI 10.1099/mic.0.037812-0; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Taylor SJ, 2003, APPL ENVIRON MICROB, V69, P4316, DOI 10.1128/AEM.69.7.4316-4319.2003; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Vincent V, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P573; Winthrop KL, 2002, NEW ENGL J MED, V346, P1366, DOI 10.1056/NEJMoa012643	32	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20499	10.1371/journal.pone.0020499	http://dx.doi.org/10.1371/journal.pone.0020499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673985	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500020
J	Lim, S; Yoon, JW; Kang, SM; Choi, SH; Cho, BJ; Kim, M; Park, HS; Cho, HJ; Shin, H; Kim, YB; Kim, HS; Jang, HC; Park, KS				Lim, Soo; Yoon, Ji Won; Kang, Seon Mee; Choi, Sung Hee; Cho, Bong Jun; Kim, Min; Park, Ho Seon; Cho, Hyun Ju; Shin, Hayley; Kim, Young-Bum; Kim, Hyo Soo; Jang, Hak Chul; Park, Kyong Soo			EGb761, a Ginkgo Biloba Extract, Is Effective Against Atherosclerosis In Vitro, and in a Rat Model of Type 2 Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTOR; NEOINTIMAL HYPERPLASIA; MOLECULAR-MECHANISMS; BALLOON ANGIOPLASTY; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; ADIPONECTIN; RESTENOSIS; DISEASE	Background: EGb761, a standardized Ginkgo biloba extract, has antioxidant and antiplatelet aggregation and thus might protect against atherosclerosis. However, molecular and functional properties of EGb761 and its major subcomponents have not been well characterized. We investigated the effect of EGb761 and its major subcomponents (bilobalide, kaemferol, and quercetin) on preventing atherosclerosis in vitro, and in a rat model of type 2 diabetes. Methods and Results: EGb761 (100 and 200 mg/kg) or normal saline (control) were administered to Otsuka Long-Evans Tokushima Fatty rats, an obese insulin-resistant rat model, for 6 weeks (from 3 weeks before to 3 weeks after carotid artery injury). Immunohistochemical staining was performed to investigate cell proliferation and apoptosis in the injured arteries. Cell migration, caspase-3 activity and DNA fragmentation, monocyte adhesion, and ICAM-1/VCAM-1 levels were explored in vitro. Treatment with EGb761 dose-dependently reduced intima-media ratio, proliferation of vascular smooth muscle cells (VSMCs) and induced greater apoptosis than the controls. Proliferation and migration of VSMCs in vitro were also decreased by the treatment of EGb761. Glucose homeostasis and circulating adiponectin levels were improved, and plasma hsCRP concentrations were decreased in the treatment groups. Caspase-3 activity and DNA fragmentation increased while monocyte adhesion and ICAM-1/VCAM-1 levels decreased significantly. Among subcomponents of EGb761, kaemferol and quercetin reduced VSMC migration and increased caspase activity. Conclusions: EGb761 has a protective role in the development of atherosclerosis and is a potential therapeutic agent for preventing atherosclerosis.	[Lim, Soo; Yoon, Ji Won; Kang, Seon Mee; Choi, Sung Hee; Cho, Bong Jun; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Lim, Soo; Yoon, Ji Won; Kang, Seon Mee; Choi, Sung Hee; Kim, Min; Park, Ho Seon; Cho, Hyun Ju; Kim, Hyo Soo; Jang, Hak Chul; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Shin, Hayley] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	kspark@snu.ac.kr	Choi, Sung-hee/J-5689-2012; Jang, Hak Chul/D-9637-2012; Lim, Soo/AAU-8107-2020; Park, Kyong Soo/C-2265-2008	Jang, Hak Chul/0000-0002-4188-6536; Lim, Soo/0000-0002-4137-1671; Park, Kyong Soo/0000-0003-3597-342X; Park, Ho Seon/0000-0003-1200-4626; CHOI, SUNG HEE/0000-0003-0740-8116	Korean Society of Lipidology and Atherosclerosis; Korea Science and Engineering Foundation [M10642140004-06N4214-00410]; Ministry of Information and Communication/Institute for Information Technology Advancement [2006-S075-01]	Korean Society of Lipidology and Atherosclerosis; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Information and Communication/Institute for Information Technology Advancement	This work was supported by the Korean Society of Lipidology and Atherosclerosis (2008), the Korea Science and Engineering Foundation grants (M10642140004-06N4214-00410) and the Information Technology R&D program of Ministry of Information and Communication/Institute for Information Technology Advancement (2006-S075-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Boveris AD, 2007, PHYTOTHER RES, V21, P735, DOI 10.1002/ptr.2153; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Choi SE, 2007, J ETHNOPHARMACOL, V110, P49, DOI 10.1016/j.jep.2006.09.001; CLOWES AW, 1983, LAB INVEST, V49, P327; Defeudis FV, 2002, PHARMACOL RES, V46, P565, DOI 10.1016/S1043-6618(02)00233-5; Ferns GAA, 2000, INT J EXP PATHOL, V81, P63, DOI 10.1046/j.1365-2613.2000.00143.x; Gohil K, 2002, CELL MOL BIOL, V48, P625; Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kim KS, 2005, ORAL ONCOL, V41, P383, DOI 10.1016/j.oraloncology.2004.09.013; Kudolo GB, 2005, DIABETES RES CLIN PR, V68, P29, DOI 10.1016/j.diabres.2004.08.007; Kudolo GB, 2001, J CLIN PHARMACOL, V41, P600, DOI 10.1177/00912700122010483; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Lim S, 2006, ARTERIOSCL THROM VAS, V26, P808, DOI 10.1161/01.ATV.0000204634.26163.a7; Lim S, 2008, ATHEROSCLEROSIS, V196, P398, DOI 10.1016/j.atherosclerosis.2006.11.017; Lim S, 2009, ATHEROSCLEROSIS, V206, P411, DOI 10.1016/j.atherosclerosis.2009.02.031; Liu FY, 2008, PHYTOTHER RES, V22, P506, DOI 10.1002/ptr.2353; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Mahadevan S, 2008, J FOOD SCI, V73, pR14, DOI 10.1111/j.1750-3841.2007.00597.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moreno PR, 1996, CIRCULATION, V94, P3098, DOI 10.1161/01.CIR.94.12.3098; Moreno PR, 1999, J AM COLL CARDIOL, V34, P1045, DOI 10.1016/S0735-1097(99)00338-1; Mori E, 2002, CIRCULATION, V105, P2905, DOI 10.1161/01.CIR.0000018603.67989.71; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; Orban Z, 1999, J CLIN ENDOCR METAB, V84, P2126, DOI 10.1210/jc.84.6.2126; Oyama Y, 1996, BRAIN RES, V712, P349, DOI 10.1016/0006-8993(95)01440-3; Pasceri V, 2000, CIRCULATION, V102, P2165; PEPYS MB, 1985, INT REV EXP PATHOL, V27, P83; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Rapin JR, 1997, DRUG DEVELOP RES, V40, P68; Rodriguez M, 2007, ATHEROSCLEROSIS, V192, P438, DOI 10.1016/j.atherosclerosis.2007.02.021; Rogers C, 1996, ARTERIOSCL THROM VAS, V16, P1312, DOI 10.1161/01.ATV.16.10.1312; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Smith JV, 2004, APPL MICROBIOL BIOT, V64, P465, DOI 10.1007/s00253-003-1527-9; Smith PF, 1996, J ETHNOPHARMACOL, V50, P131, DOI 10.1016/0378-8741(96)01379-7; Tanaka S, 2004, YAKUGAKU ZASSHI, V124, P605, DOI 10.1248/yakushi.124.605; Valli G, 2002, J AM COLL CARDIOL, V39, P1083, DOI 10.1016/S0735-1097(02)01749-7; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; Welt FGP, 2000, ARTERIOSCL THROM VAS, V20, P2553, DOI 10.1161/01.ATV.20.12.2553; Wolbink GJ, 1996, J IMMUNOL, V157, P473; Zhang Q, 2009, ACTA PHARMACOL SIN, V30, P1674, DOI 10.1038/aps.2009.173; Zietz B, 2003, FEBS LETT, V545, P103, DOI 10.1016/S0014-5793(03)00568-4; Zimmermann M, 2002, CELL MOL BIOL, V48, P613	51	33	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20301	10.1371/journal.pone.0020301	http://dx.doi.org/10.1371/journal.pone.0020301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655098	gold, Green Submitted, Green Published			2022-12-27	WOS:000291310600008
J	Bober, M; Morgelin, M; Olin, AI; von Pawel-Rammingen, U; Collin, M				Bober, Marta; Morgelin, Matthias; Olin, Anders I.; von Pawel-Rammingen, Ulrich; Collin, Mattias			The Membrane Bound LRR Lipoprotein Slr, and the Cell Wall-Anchored M1 Protein from Streptococcus pyogenes Both Interact with Type I Collagen	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; GROUP-A-STREPTOCOCCI; LISTERIA-MONOCYTOGENES; SURFACE-PROTEINS; CYSTEINE PROTEINASE; COMPLETE GENOME; BINDING; FAMILY; IDENTIFICATION; PATHOGENS	Streptococcus pyogenes is an important human pathogen and surface structures allow it to adhere to, colonize and invade the human host. Proteins containing leucine rich repeats (LRR) have been indentified in mammals, viruses, archaea and several bacterial species. The LRRs are often involved in protein-protein interaction, are typically 20-30 amino acids long and the defining feature of the LRR motif is an 11-residue sequence LxxLxLxxNxL (x being any amino acid). The streptococcal leucine rich (Slr) protein is a hypothetical lipoprotein that has been shown to be involved in virulence, but at present no ligands for Slr have been identified. We could establish that Slr is a membrane attached horseshoe shaped lipoprotein by homology modeling, signal peptidase II inhibition, electron microscopy (of bacteria and purified protein) and immunoblotting. Based on our previous knowledge of LRR proteins we hypothesized that Slr could mediate binding to collagen. We could show by surface plasmon resonance that recombinant Slr and purified M1 protein bind with high affinity to collagen I. Isogenic slr mutant strain (MB1) and emm1 mutant strain (MC25) had reduced binding to collagen type I as shown by slot blot and surface plasmon resonance. Electron microscopy using gold labeled Slr showed multiple binding sites to collagen I, both to the monomeric and the fibrillar structure, and most binding occurred in the overlap region of the collagen I fibril. In conclusion, we show that Slr is an abundant membrane bound lipoprotein that is co-expressed on the surface with M1, and that both these proteins are involved in recruiting collagen type I to the bacterial surface. This underlines the importance of S. pyogenes interaction with extracellular matrix molecules, especially since both Slr and M1 have been shown to be virulence factors.	[Bober, Marta; Morgelin, Matthias; Olin, Anders I.; Collin, Mattias] Lund Univ, Div Infect Med, Dept Clin Sci, Biomed Ctr, Lund, Sweden; [von Pawel-Rammingen, Ulrich] Umea Univ, Dept Mol Biol, Umea, Sweden	Lund University; Umea University	Bober, M (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Biomed Ctr, Lund, Sweden.	marta.bober@med.lu.se	Collin, Mattias/C-6398-2009	Collin, Mattias/0000-0002-6166-7410	Swedish Research Council [2005-4791, 2010-57X-20240, 7480]; Foundations of Crafoord, Jeansson, Wiberg, Kock, Bergvall, Osterlund, Soderberg; Swedish Society for Medicine; Royal Physiografic Society; King Gustaf V Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Crafoord, Jeansson, Wiberg, Kock, Bergvall, Osterlund, Soderberg; Swedish Society for Medicine; Royal Physiografic Society(Royal Society of London); King Gustaf V Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	This work was supported by grants from the Swedish Research Council (projects 2005-4791 and 2010-57X-20240 to MC, and 7480 to MM), the Foundations of Crafoord, Jeansson, Wiberg, Kock, Bergvall, Osterlund, Soderberg, the Swedish Society for Medicine, the Royal Physiografic Society, King Gustaf V Memorial Fund, the Medical Faculty at Lund University, and Hansa Medical AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; ELLEN RP, 1972, INFECT IMMUN, V5, P826, DOI 10.1128/IAI.5.5.826-830.1972; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gase K, 1997, MED MICROBIOL IMMUN, V186, P63, DOI 10.1007/s004300050047; Harlow E., 1988, ANTIBODIES LAB MANUA; Harrington DJ, 2000, INFECT IMMUN, V68, P6048, DOI 10.1128/IAI.68.10.6048-6051.2000; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Jin MS, 2008, CURR OPIN IMMUNOL, V20, P414, DOI 10.1016/j.coi.2008.06.002; Kedzierski L, 2004, ARCH IMMUNOL THER EX, V52, P104; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOSTRZYNSKA M, 1989, FEMS MICROBIOL LETT, V59, P229; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Le Bourhis L, 2007, MICROBES INFECT, V9, P629, DOI 10.1016/j.micinf.2007.01.014; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; SCHALEN C, 1995, APMIS, V103, P59, DOI 10.1111/j.1699-0463.1995.tb01080.x; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Sook BR, 2008, BIOCHEMISTRY-US, V47, P2678, DOI 10.1021/bi701604y; SPEZIALE P, 1987, FEMS MICROBIOL LETT, V48, P47, DOI 10.1016/0378-1097(87)90133-9; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; STONE J, 1998, THESIS MO U MISSOURI; Suvorov AN, 1996, J BACTERIOL, V178, P5546, DOI 10.1128/jb.178.18.5546-5549.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Waldemarsson J, 2006, J BACTERIOL, V188, P378, DOI 10.1128/JB.188.2.378-388.2006; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	52	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20345	10.1371/journal.pone.0020345	http://dx.doi.org/10.1371/journal.pone.0020345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655249	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600047
J	Francius, G; Polyakov, P; Merlin, J; Abe, Y; Ghigo, JM; Merlin, C; Beloin, C; Duval, JFL				Francius, Gregory; Polyakov, Pavel; Merlin, Jenny; Abe, Yumiko; Ghigo, Jean-Marc; Merlin, Christophe; Beloin, Christophe; Duval, Jerome F. L.			Bacterial Surface Appendages Strongly Impact Nanomechanical and Electrokinetic Properties of Escherichia coli Cells Subjected to Osmotic Stress	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; LACTIC-ACID BACTERIA; ELECTROPHORETIC MOBILITY; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; MECHANICAL-PROPERTIES; MYXOCOCCUS-XANTHUS; PILUS STRUCTURE; OUTER-MEMBRANE; IV PILUS	The physicochemical properties and dynamics of bacterial envelope, play a major role in bacterial activity. In this study, the morphological, nanomechanical and electrohydrodynamic properties of Escherichia coli K-12 mutant cells were thoroughly investigated as a function of bulk medium ionic strength using atomic force microscopy (AFM) and electrokinetics (electrophoresis). Bacteria were differing according to genetic alterations controlling the production of different surface appendages (short and rigid Ag43 adhesins, longer and more flexible type 1 fimbriae and F pilus). From the analysis of the spatially resolved force curves, it is shown that cells elasticity and turgor pressure are not only depending on bulk salt concentration but also on the presence/absence and nature of surface appendage. In 1 mM KNO3, cells without appendages or cells surrounded by Ag43 exhibit large Young moduli and turgor pressures (similar to 700-900 kPa and similar to 100-300 kPa respectively). Under similar ionic strength condition, a dramatic similar to 50% to similar to 70% decrease of these nanomechanical parameters was evidenced for cells with appendages. Qualitatively, such dependence of nanomechanical behavior on surface organization remains when increasing medium salt content to 100 mM, even though, quantitatively, differences are marked to a much smaller extent. Additionally, for a given surface appendage, the magnitude of the nanomechanical parameters decreases significantly when increasing bulk salt concentration. This effect is ascribed to a bacterial exoosmotic water loss resulting in a combined contraction of bacterial cytoplasm together with an electrostatically-driven shrinkage of the surface appendages. The former process is demonstrated upon AFM analysis, while the latter, inaccessible upon AFM imaging, is inferred from electrophoretic data interpreted according to advanced soft particle electrokinetic theory. Altogether, AFM and electrokinetic results clearly demonstrate the intimate relationship between structure/flexibility and charge of bacterial envelope and propensity of bacterium and surface appendages to contract under hypertonic conditions.	[Francius, Gregory; Polyakov, Pavel; Abe, Yumiko; Merlin, Christophe] Nancy Univ, CNRS, UMR7564, Lab Chim Phys & Microbiol Environm, Villers Les Nancy, France; [Merlin, Jenny; Duval, Jerome F. L.] Nancy Univ, CNRS, UMR7569, Lab Environm & Mineralurgie, Vandoeuvre Les Nancy, France; [Ghigo, Jean-Marc; Beloin, Christophe] Inst Pasteur, Unite Genet Biofilms, Paris, France; [Ghigo, Jean-Marc; Beloin, Christophe] CNRS, URA 2172, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Francius, G (corresponding author), Nancy Univ, CNRS, UMR7564, Lab Chim Phys & Microbiol Environm, Villers Les Nancy, France.	gregory.francius@lcpme.cnrs-nancy.fr; jerome.duval@ensg.inpl-nancy.fr	Merlin, Christophe/ABG-7344-2021; Francius, Gregory/A-4246-2015; GHIGO, Jean-Marc/AAP-4011-2021; Francius, Gregory/P-6058-2019; Jerome, Duval/H-6421-2011; BELOIN, Christophe/F-9284-2012	Merlin, Christophe/0000-0002-9261-5322; Francius, Gregory/0000-0001-8533-9449; GHIGO, Jean-Marc/0000-0001-6528-118X; Francius, Gregory/0000-0001-8533-9449; Jerome, Duval/0000-0002-5458-3761; BELOIN, Christophe/0000-0002-0344-3443	French program [ANR-07-JCJC-0024-01 PHYSCHEMBACT]	French program	This work was financially supported by the French program ANR-07-JCJC-0024-01 PHYSCHEMBACT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAKO K, 1983, MICROBIOL IMMUNOL, V27, P95, DOI 10.1111/j.1348-0421.1983.tb03571.x; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; ASCHER U, 1981, ACM T MATH SOFTWARE, V7, P209, DOI 10.1145/355945.355950; BARTLETT D, 1989, NATURE, V342, P572, DOI 10.1038/342572a0; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Beveridge T J, 1981, Int Rev Cytol, V72, P229, DOI 10.1016/S0074-7696(08)61198-5; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Boulbitch A, 2000, J ELECTRON MICROSC, V49, P459, DOI 10.1093/oxfordjournals.jmicro.a023829; Boulbitch A, 2000, PHYS REV LETT, V85, P5246, DOI 10.1103/PhysRevLett.85.5246; Boulbitch AA, 1998, PHYS REV E, V57, P2123, DOI 10.1103/PhysRevE.57.2123; CAFFREY P, 1989, J BACTERIOL, V171, P3634, DOI 10.1128/jb.171.7.3634-3640.1989; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHEMERIS N A, 1979, Mikrobiologiya, V48, P99; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; CROSS SE, 2005, ATOMIC FORCE MICROSC, pS1; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Dionisio F, 2002, GENETICS, V162, P1525; Dufrene YF, 2001, ULTRAMICROSCOPY, V86, P113, DOI 10.1016/S0304-3991(00)00079-6; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Dufrene YF, 2008, NAT PROTOC, V3, P1132, DOI 10.1038/nprot.2008.101; Duval J. F. L., 2007, ENV COLLOIDS PARTICL, V10, P315; Duval JFL, 2010, CURR OPIN COLLOID IN, V15, P184, DOI 10.1016/j.cocis.2009.12.002; Duval JFL, 2006, LANGMUIR, V22, P3533, DOI 10.1021/la0528293; Duval JFL, 2005, LANGMUIR, V21, P11268, DOI 10.1021/la051735q; Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004; Fan TH, 2003, LANGMUIR, V19, P10930, DOI 10.1021/la035663j; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Francius G, 2007, J PHYS CHEM C, V111, P8299, DOI 10.1021/jp070435+; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; GALLY D, 1993, J BACTERIOL, V175, P3121, DOI 10.1128/JB.175.10.3121-3130.1993; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Hyono A, 2009, LANGMUIR, V25, P10873, DOI 10.1021/la900087c; JACOBSON A, 1972, J VIROL, V10, P835, DOI 10.1128/JVI.10.4.835-843.1972; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; KLEMM P, 1987, MOL GEN GENET, V208, P439, DOI 10.1007/BF00328136; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; Langlet J, 2008, BIOPHYS J, V94, P3293, DOI 10.1529/biophysj.107.115477; LAWN AM, 1966, J GEN MICROBIOL, V45, P377, DOI 10.1099/00221287-45-2-377; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; MARQUIS RE, 1968, J BACTERIOL, V95, P775, DOI 10.1128/JB.95.3.775-781.1968; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Miyazaki J, 2002, FEMS IMMUNOL MED MIC, V33, P23, DOI 10.1111/j.1574-695X.2002.tb00567.x; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; OBARA M, 1992, BIOCHEM BIOPH RES CO, V186, P645, DOI 10.1016/0006-291X(92)90795-M; Ohshima H, 1995, ADV COLLOID INTERFAC, V62, P189, DOI 10.1016/0001-8686(95)00279-Y; Ohshima H, 2003, J COLLOID INTERF SCI, V258, P252, DOI 10.1016/S0021-9797(02)00169-8; Ohshima H, 2001, COLLOID POLYM SCI, V279, P88, DOI 10.1007/s003960000399; Ohshima H, 1997, COLLOID POLYM SCI, V275, P480, DOI 10.1007/s003960050107; PARANCHYCH W, 1988, ADV MICROB PHYSIOL, V29, P53, DOI 10.1016/S0065-2911(08)60346-X; Pelling AE, 2005, P NATL ACAD SCI USA, V102, P6484, DOI 10.1073/pnas.0501207102; POLYAKOV P, PLOS ONE IN PRESS; Pouttu R, 2000, ADV EXP MED BIOL, V485, P63; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5; Schar-Zammaretti P, 2002, ABSTR PAP AM CHEM S, V224, pU397; Schmid T, 2008, ANAL BIOANAL CHEM, V391, P1899, DOI 10.1007/s00216-008-2100-2; Shamrock VJ, 2009, FEMS YEAST RES, V9, P391, DOI 10.1111/j.1567-1364.2009.00495.x; Silverman PM, 2010, INTEGR BIOL-UK, V2, P25, DOI 10.1039/b917761b; Silverman PM, 1997, MOL MICROBIOL, V23, P423, DOI 10.1046/j.1365-2958.1997.2411604.x; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H; STUART MAC, 1985, COLLOID SURFACE, V15, P49; STUART MAC, 1984, COLLOID POLYM SCI, V262, P423, DOI 10.1007/BF01410263; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; THWAITES JJ, 1991, ADV MICROB PHYSIOL, V32, P173, DOI 10.1016/S0065-2911(08)60008-9; THWAITES JJ, 1985, P NATL ACAD SCI USA, V82, P2163, DOI 10.1073/pnas.82.7.2163; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005; Ubbink J, 2007, CURR OPIN COLLOID IN, V12, P263, DOI 10.1016/j.cocis.2007.08.004; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004; Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Viota J. L., 2009, J COLLOID INTERF SCI, V332, P215; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; Wang YA, 2009, J MOL BIOL, V385, P22, DOI 10.1016/j.jmb.2008.10.054; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999	103	66	66	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20066	10.1371/journal.pone.0020066	http://dx.doi.org/10.1371/journal.pone.0020066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655293	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600018
J	Hersh, AL; Shapiro, DJ; Newland, JG; Polgreen, PM; Beekmann, SE; Shah, SS				Hersh, Adam L.; Shapiro, Daniel J.; Newland, Jason G.; Polgreen, Philip M.; Beekmann, Susan E.; Shah, Samir S.			Variability in Pediatric Infectious Disease Consultants' Recommendations for Management of Community-Acquired Pneumonia	PLOS ONE			English	Article							GUIDELINES; SOCIETY; SUSCEPTIBILITY; EPIDEMIOLOGY; STEWARDSHIP; RESISTANCE; CHILDREN; AMERICA	Background: Community-acquired pneumonia (CAP) is a common childhood infection. CAP complications, such as parapneumonic empyema (PPE), are increasing and are frequently caused by antibiotic-resistant organisms. No clinical guidelines currently exist for management of pediatric CAP and no published data exist about variations in antibiotic prescribing patterns. Our objectives were to describe variation in CAP clinical management for hospitalized children by pediatric infectious disease consultants and to examine associations between recommended antibiotic regimens and local antibiotic resistance levels. Methods: We surveyed pediatric members of the Emerging Infections Network, which consists of 259 pediatric infectious disease physicians. Participants responded regarding their recommended empiric antibiotic regimens for hospitalized children with CAP with and without PPE and their recommendations for duration of therapy. Participants also provided information about the prevalence of penicillin non-susceptible S. pneumoniae and methicillin-resistant S. aureus (MRSA) in their community. Results: We received 148 responses (57%). For uncomplicated CAP, respondents were divided between recommending beta-lactams alone (55%) versus beta-lactams in combination with another class (40%). For PPE, most recommended a combination of a beta-lactam plus an anti-MRSA agent, however, they were divided between clindamycin (44%) and vancomycin (57%). The relationship between reported antibiotic resistance and empiric regimen was mixed. We found no relationship between aminopenicillin use and prevalence of penicillin non-suscepetible S. pneumoniae or clindamycin use and clindamycin resistance, however, respondents were more likely to recommend an anti-MRSA agent when MRSA prevalence increased. Conclusions: Substantial variability exists in recommendations for CAP management. Development of clinical guidelines via antimicrobial stewardship programs and dissemination of data about local antibiotic resistance patterns represent opportunities to improve care.	[Hersh, Adam L.] Univ Utah, Salt Lake City, UT 84112 USA; [Shapiro, Daniel J.] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Newland, Jason G.] Childrens Mercy Hosp & Clin, Kansas City, MO USA; [Polgreen, Philip M.; Beekmann, Susan E.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Shah, Samir S.] Childrens Hosp Philadelphia, Div Infect Dis, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; Children's Mercy Hospital; University of Iowa; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hersh, AL (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	adam.hersh@hsc.utah.edu	Shah, Samir/B-2661-2015	Shah, Samir/0000-0001-7902-7000; Polgreen, Philip/0000-0002-0630-5898	Centers for Disease Control and Prevention (CDC) [U50 CCU112346]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grant/cooperative agreement number U50 CCU112346 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLASCHKE AJ, 2010, PEDIAT INFECT DIS J; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Cardoso MRA, 2008, ARCH DIS CHILD, V93, P221, DOI 10.1136/adc.2006.111625; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Furuno JP, 2006, PHARMACOEPIDEM DR S, V15, P1, DOI 10.1002/pds.1135; GERBER JS, 2010, PEDIATRICS; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; Herigon JC, 2010, PEDIATRICS, V125, pE1294, DOI 10.1542/peds.2009-2867; Hersh AL, 2009, INFECT CONT HOSP EP, V30, P1211, DOI 10.1086/648088; Kaplan SL, 2005, PEDIATR INFECT DIS J, V24, P457, DOI 10.1097/01.inf.0000164162.00163.9d; Kollef MH, 2008, CLIN INFECT DIS, V47, pS3, DOI 10.1086/590061; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Li STT, 2010, PEDIATRICS, V125, P26, DOI 10.1542/peds.2009-0184; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mermel LA, 2008, CLIN INFECT DIS, V46, P1789, DOI 10.1086/588050; Metlay JP, 2002, J GEN INTERN MED, V17, P87, DOI 10.1046/j.1525-1497.2002.10711.x; Mulholland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004875.pub3; MUSZYNSKI JA, 2010, PEDIAT INFECT DIS J; Newland JG, 2010, PEDIATR INFECT DIS J, V29, P862, DOI 10.1097/INF.0b013e3181ef2507; Patel SJ, 2010, INFECT CONT HOSP EP, V31, P1298, DOI 10.1086/657334; Pogue JM, 2011, INFECT CONT HOSP EP, V32, P289, DOI 10.1086/658665; Rosen J, 2010, J CLIN MICROBIOL, V48, P3372, DOI 10.1128/JCM.01012-10; Schultz KD, 2004, PEDIATRICS, V113, P1735, DOI 10.1542/peds.113.6.1735; WILLIAMS DJ, 2011, ARCH PEDIAT ADOLESC; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	26	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20325	10.1371/journal.pone.0020325	http://dx.doi.org/10.1371/journal.pone.0020325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655259	gold, Green Published			2022-12-27	WOS:000291097600044
J	Reyal, F; Rouzier, R; Depont-Hazelzet, B; Bollet, MA; Pierga, JY; Alran, S; Salmon, RJ; Fourchotte, V; Vincent-Salomon, A; Sastre-Garau, X; Antoine, M; Uzan, S; Sigal-Zafrani, B; De Rycke, Y				Reyal, Fabien; Rouzier, Roman; Depont-Hazelzet, Berenice; Bollet, Marc A.; Pierga, Jean-Yves; Alran, Severine; Salmon, Remy J.; Fourchotte, Virginie; Vincent-Salomon, Anne; Sastre-Garau, Xavier; Antoine, Martine; Uzan, Serge; Sigal-Zafrani, Brigitte; De Rycke, Yann			The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma	PLOS ONE			English	Article							HORMONE-RECEPTOR; CANCER PATIENTS; METASTASES; PREDICTORS; INVOLVEMENT; PORTRAITS; HER-2; RISK	Introduction: Several authors have underscored a strong relation between the molecular subtypes and the axillary status of breast cancer patients. The aim of our work was to decipher the interaction between this classification and the probability of a positive sentinel node biopsy. Materials and Methods: Our dataset consisted of a total number of 2654 early-stage breast cancer patients. Patients treated at first by conservative breast surgery plus sentinel node biopsies were selected. A multivariate logistic regression model was trained and validated. Interaction covariate between ER and HER2 markers was a forced input of this model. The performance of the multivariate model in the training and the two validation sets was analyzed in terms of discrimination and calibration. Probability of axillary metastasis was detailed for each molecular subtype. Results: The interaction covariate between ER and HER2 status was a stronger predictor (p = 0.0031) of positive sentinel node biopsy than the ER status by itself (p = 0.016). A multivariate model to determine the probability of sentinel node positivity was defined with the following variables; tumour size, lympho-vascular invasion, molecular subtypes and age at diagnosis. This model showed similar results in terms of discrimination (AUC = 0.72/0.73/0.72) and calibration (HL p = 0.28/0.05/0.11) in the training and validation sets. The interaction between molecular subtypes, tumour size and sentinel nodes status was approximated. Discussion: We showed that biologically-driven analyses are able to build new models with higher performance in terms of breast cancer axillary status prediction. The molecular subtype classification strongly interacts with the axillary and distant metastasis process.	[Reyal, Fabien; Depont-Hazelzet, Berenice; Alran, Severine; Salmon, Remy J.; Fourchotte, Virginie] Inst Curie, Dept Surg, Paris, France; [Rouzier, Roman; Uzan, Serge] Hop Tenon, Dept Gynaecol, F-75970 Paris, France; [Rouzier, Roman; Uzan, Serge] Univ Paris 06, AP HP, Paris, France; [Bollet, Marc A.] Inst Curie, Dept Med Oncol, Paris, France; [Pierga, Jean-Yves] Inst Curie, Dept Radiat Oncol, Paris, France; [Vincent-Salomon, Anne; Sastre-Garau, Xavier; Sigal-Zafrani, Brigitte] Inst Curie, Dept Tumour Biol, Paris, France; [Antoine, Martine] Hop Tenon, Dept Pathol, F-75970 Paris, France; [De Rycke, Yann] Inst Curie, Dept Biostat, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.	Fabien.reyal@curie.net	; Rouzier, Roman/G-2953-2018	Sastre-Garau, Xavier/0000-0001-5992-2083; Rouzier, Roman/0000-0002-8167-6808				Bader AA, 2002, BREAST CANCER RES TR, V76, P11, DOI 10.1023/A:1020231300974; Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-Y; Crabb SJ, 2008, CLIN BREAST CANCER, V8, P249, DOI 10.3816/CBC.2008.n.028; Fehm T, 2005, STRAHLENTHER ONKOL, V181, P580, DOI 10.1007/s00066-005-1374-y; Freneaux P, 2002, MODERN PATHOL, V15, P641, DOI 10.1038/modpathol.3880580; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Gonzalez-Vela MC, 1999, PATHOL RES PRACT, V195, P611, DOI 10.1016/S0344-0338(99)80126-5; Guarnieri A, 2001, EUR J SURG, V167, P255, DOI 10.1080/110241501300091381; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Lee JH, 2010, CANCER RES TREAT, V42, P30, DOI 10.4143/crt.2010.42.1.30; Liu H, 2008, HUM PATHOL, V39, P167, DOI 10.1016/j.humpath.2007.06.012; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Olivotto IA, 1998, CANCER-AM CANCER SOC, V83, P948, DOI 10.1002/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.3.CO;2-D; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RAVDIN PM, 1994, J NATL CANCER I, V86, P1771, DOI 10.1093/jnci/86.23.1771; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rivadeneira DE, 2000, J AM COLL SURGEONS, V191, P1, DOI 10.1016/S1072-7515(00)00310-0; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Van Calster B, 2009, BREAST CANCER RES TR, V113, P181, DOI 10.1007/s10549-008-9914-7; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; VANDIEST PJ, 1991, J CLIN PATHOL, V44, P416, DOI 10.1136/jcp.44.5.416; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yip CH, 2009, WORLD J SURG, V33, P54, DOI 10.1007/s00268-008-9782-7	29	87	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20297	10.1371/journal.pone.0020297	http://dx.doi.org/10.1371/journal.pone.0020297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655258	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600039
J	Rooney, PJ; Neal, LM; Knoll, LJ				Rooney, Peggy J.; Neal, Lori M.; Knoll, Laura J.			Involvement of a Toxoplasma gondii Chromatin Remodeling Complex Ortholog in Developmental Regulation	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASES; SWIRM DOMAIN; GENES; PROTEIN; IDENTIFICATION; TRANSCRIPTION; LOCALIZATION; BRADYZOITES; INFECTION; REVEALS	The asexual cycle of the parasite Toxoplasma gondii has two developmental stages: a rapidly replicating form called a tachyzoite and a slow growing cyst form called a bradyzoite. While the importance of ATP-independent histone modifications for gene regulation in T. gondii have been demonstrated, ATP-dependent chromatin remodeling pathways have not been examined. In this study we characterized C9, an insertional mutant showing reduced expression of bradyzoite differentiation marker BAG1, in cultured human fibroblasts. This mutant contains an insertion in the gene encoding TgRSC8, which is homologous to the Saccharomyces cerevisiae proteins Rsc8p (remodel the structure of chromatin complex subunit 8) and Swi3p (switch/sucrose non-fermentable [SWI/SNF]) of ATP-dependent chromatin-remodeling complexes. In the C9 mutant, TgRSC8 is the downstream open reading frame on a dicistronic transcript. Though protein was expressed from the downstream gene of the dicistron, TgRSC8 levels were decreased in C9 from those of wild-type parasites, as determined by western immunoblot and flow cytometry. As TgRSC8 localized to the parasite nucleus, we postulated a role in gene regulation. Transcript levels of several markers were assessed by quantitative PCR to test this hypothesis. The C9 mutant displayed reduced steady state transcript levels of bradyzoite-induced genes BAG1, LDH2, SUSA1, and ENO1, all of which were significantly increased with addition of TgRSC8 to the mutant. Transcript levels of some bradyzoite markers were unaltered in C9, or unable to be increased by complementation with TgRSC8, indicating multiple pathways control bradyzoite-upregulated genes. Together, these data suggest a role for TgRSC8 in control of bradyzoite-upregulated gene expression. Thus chromatin remodeling, by both ATP-independent and dependent mechanisms, is an important mode of gene regulation during stage differentiation in parasites.	[Rooney, Peggy J.; Neal, Lori M.; Knoll, Laura J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Rooney, PJ (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	ljknoll@wisc.edu		Rooney, Peggy/0000-0002-2233-3653; Neal, Lori M./0000-0001-5149-9110	National Institute of Allergy and Infectious Diseases (NIAID) [F32AI065023]; National Institute of General Medical Sciences (NIGMS) [T32GM007215-35]; University of Wisconsin Distinguished Graduate/Food Research Institute; American Heart Association [0840059N]; American Cancer Society [RSG-07-202-01-MBC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI065023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin Distinguished Graduate/Food Research Institute; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Service Award number F32AI065023 from the National Institute of Allergy and Infectious Diseases (NIAID) to PJR; molecular biosciences training grant T32GM007215-35 from the National Institute of General Medical Sciences (NIGMS) and University of Wisconsin Distinguished Graduate/Food Research Institute fellowship to LMN; American Heart Association 0840059N and American Cancer Society RSG-07-202-01-MBC to LJK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIGMS, the National Institutes of Health, the University of Wisconsin, American Heart Association or the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bhatti MM, 2006, EUKARYOT CELL, V5, P62, DOI 10.1128/EC.5.1.62-76.2006; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Craver MPJ, 2010, MOL BIOCHEM PARASIT, V169, P120, DOI 10.1016/j.molbiopara.2009.10.006; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dalmasso MC, 2006, MOL BIOCHEM PARASIT, V148, P103, DOI 10.1016/j.molbiopara.2006.03.005; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Ferguson DJP, 2004, INT J PARASITOL, V34, P347, DOI 10.1016/j.ijpara.2003.11.024; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frankel MB, 2007, P NATL ACAD SCI USA, V104, P10181, DOI 10.1073/pnas.0701893104; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Harlow E., 1988, ANTIBODIES LAB MANUA; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Mullapudi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r34; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; Nallani KC, 2005, PARASITOL RES, V95, P236, DOI 10.1007/s00436-004-1291-5; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; PARMLEY SF, 1995, MOL BIOCHEM PARASIT, V73, P253, DOI 10.1016/0166-6851(95)00100-F; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollard AM, 2008, INFECT IMMUN, V76, P103, DOI 10.1128/IAI.01170-07; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Schwarz JA, 2005, MOL BIOCHEM PARASIT, V144, P159, DOI 10.1016/j.molbiopara.2005.08.011; Seeber F, 1997, PARASITOL RES, V83, P309, DOI 10.1007/s004360050254; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Sullivan WJ, 2006, MOL BIOCHEM PARASIT, V148, P109, DOI 10.1016/j.molbiopara.2006.03.010; Tomavo Stanislas, 2007, P285; Treich I, 1997, MOL CELL BIOL, V17, P1768, DOI 10.1128/MCB.17.4.1768; Treich I, 1998, NUCLEIC ACIDS RES, V26, P3739, DOI 10.1093/nar/26.16.3739; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Weiss LM, 1998, INFECT IMMUN, V66, P3295, DOI 10.1128/IAI.66.7.3295-3302.1998; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19570	10.1371/journal.pone.0019570	http://dx.doi.org/10.1371/journal.pone.0019570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655329	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600007
J	Gottlieb, A; Frenkel-Morgenstern, M; Safro, M; Horn, D				Gottlieb, Assaf; Frenkel-Morgenstern, Milana; Safro, Mark; Horn, David			Common Peptides Study of Aminoacyl-tRNA Synthetases	PLOS ONE			English	Article							PHENYLALANYL-TRANSFER-RNA; GLUTAMINYL-TRANSFER-RNA; STRUCTURAL BASIS; GENETIC-CODE; ACTIVE-SITE; EVOLUTION; ORIGIN; ACID; ACTIVATION; TREE	Background: Aminoacyl tRNA synthetases (aaRSs) constitute an essential enzyme super-family, providing fidelity of the translation process of mRNA to proteins in living cells. They are common to all kingdoms and are of utmost importance to all organisms. It is thus of great interest to understand the evolutionary relationships among them and underline signature motifs defining their common domains. Results: We utilized the Common Peptides (CPs) framework, based on extracted deterministic motifs from all aaRSs, to study family-specific properties. We identified novel aaRS-class related signatures that may supplement the current classification methods and provide a basis for identifying functional regions specific to each aaRS class. We exploited the space spanned by the CPs in order to identify similarities between aaRS families that are not observed using sequence alignment methods, identifying different inter-aaRS associations across different kingdom of life. We explored the evolutionary history of the aaRS families and evolutionary origins of the mitochondrial aaRSs. Lastly, we showed that prevalent CPs significantly overlap known catalytic and binding sites, suggesting that they have meaningful functional roles, as well as identifying a motif shared between aaRSs and a the Biotin-[acetyl-CoA carboxylase] synthetase (birA) enzyme overlapping binding sites in both families. Conclusions: The study presents the multitude of ways to exploit the CP framework in order to extract meaningful patterns from the aaRS super-family. Specific CPs, discovered in this study, may play important roles in the functionality of these enzymes. We explored the evolutionary patterns in each aaRS family and tracked remote evolutionary links between these families.	[Gottlieb, Assaf] Tel Aviv Univ, Balvatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Frenkel-Morgenstern, Milana] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Madrid, Spain; [Safro, Mark] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Horn, David] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Centro Nacional de Investigaciones Oncologicas (CNIO); Weizmann Institute of Science; Tel Aviv University	Gottlieb, A (corresponding author), Tel Aviv Univ, Balvatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	assafgot@tau.ac.il		Frenkel-Morgenstern, Milana/0000-0002-0329-4599; Horn, David/0000-0003-2708-186X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; ARTYMIUK PJ, 1994, NAT STRUCT BIOL, V1, P758, DOI 10.1038/nsb1194-758; Austin J, 2002, J BIOL CHEM, V277, P28394, DOI 10.1074/jbc.M204404200; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Brindefalk B, 2007, MOL BIOL EVOL, V24, P743, DOI 10.1093/molbev/msl202; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; Delarue M, 1995, J MOL EVOL, V41, P703; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Gottlieb A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-91; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Iwasaki W, 2006, J MOL BIOL, V360, P329, DOI 10.1016/j.jmb.2006.04.068; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kamtekar S, 2007, P NATL ACAD SCI USA, V104, P2620, DOI 10.1073/pnas.0611504104; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Klipcan L, 2004, J THEOR BIOL, V228, P389, DOI 10.1016/j.jtbi.2004.01.014; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; KUNIK V, 2005, P 2005 IEEE COMP SYS; Kunik V, 2007, PLOS COMPUT BIOL, V3, P1623, DOI 10.1371/journal.pcbi.0030167; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Massey Steven E., 2006, In Silico Biology, V6, P259; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Rinehart J, 2004, J BIOL CHEM, V279, P1161, DOI 10.1074/jbc.M310100200; SAFRO M, 1995, PROTEIN SCI, V4, P2429, DOI 10.1002/pro.5560041122; Safro MG, 2009, MOL BIOL+, V43, P211, DOI 10.1134/S0026893309020046; Siatecka M, 1998, EUR J BIOCHEM, V256, P80, DOI 10.1046/j.1432-1327.1998.2560080.x; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Solan Z, 2005, P NATL ACAD SCI USA, V102, P11629, DOI 10.1073/pnas.0409746102; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Torres-Larios A, 2002, NAT STRUCT BIOL, V9, P343, DOI 10.1038/nsb789; Trifonov EN, 2002, FEBS LETT, V527, P1, DOI 10.1016/S0014-5793(02)03165-4; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; Weingart U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-390; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; Wolf YI, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-14; NUCL ACIDS RES, V38, pD142	55	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20361	10.1371/journal.pone.0020361	http://dx.doi.org/10.1371/journal.pone.0020361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647378	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500053
J	Han, SE; Sundararajan, J; Bowling, DL; Lake, J; Purves, D				Han, Shui' Er; Sundararajan, Janani; Bowling, Daniel Liu; Lake, Jessica; Purves, Dale			Co-Variation of Tonality in the Music and Speech of Different Cultures	PLOS ONE			English	Article							ENGLISH; RHYTHM	Whereas the use of discrete pitch intervals is characteristic of most musical traditions, the size of the intervals and the way in which they are used is culturally specific. Here we examine the hypothesis that these differences arise because of a link between the tonal characteristics of a culture's music and its speech. We tested this idea by comparing pitch intervals in the traditional music of three tone language cultures (Chinese, Thai and Vietnamese) and three non-tone language cultures (American, French and German) with pitch intervals between voiced speech segments. Changes in pitch direction occur more frequently and pitch intervals are larger in the music of tone compared to non-tone language cultures. More frequent changes in pitch direction and larger pitch intervals are also apparent in the speech of tone compared to non-tone language cultures. These observations suggest that the different tonal preferences apparent in music across cultures are closely related to the differences in the tonal characteristics of voiced speech.	[Han, Shui' Er; Sundararajan, Janani; Bowling, Daniel Liu; Purves, Dale] Duke NUS Grad Med Sch, A STAR Neurosci Res Partnership, Neurosci & Behav Disorders Program, Singapore, Singapore; [Bowling, Daniel Liu; Purves, Dale] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Bowling, Daniel Liu; Lake, Jessica; Purves, Dale] Duke Univ, Levine Sci Res Ctr, Ctr Cognit Neurosci, Durham, NC USA; [Lake, Jessica; Purves, Dale] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	National University of Singapore; Duke University; Duke University; Duke University	Han, SE (corresponding author), Duke NUS Grad Med Sch, A STAR Neurosci Res Partnership, Neurosci & Behav Disorders Program, Singapore, Singapore.	purves@neuro.duke.edu		Bowling, Daniel/0000-0002-5303-5472	National Science Foundation; Duke-NUS Graduate Medical School; Division Of Behavioral and Cognitive Sci [0924181] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Duke-NUS Graduate Medical School(National University of Singapore); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work has been supported by grants from the National Science Foundation (http://www.nsf. gov/) and Duke-NUS Graduate Medical School (http://www.duke-nus.edu.sg/web/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry Phillips, 1909, J AM FOLK LORE, V22, P72; Bowling DL, 2010, J ACOUST SOC AM, V127, P491, DOI 10.1121/1.3268504; Brazil D., 1997, COMMUNICATIVE VALUE; Brown Keith, 2008, CONCISE ENCY LANGUAG; Crystal D., 1997, CAMBRIDGE ENCY LANGU; DEAN B, 1985, MONUM NIPPON, V40, P147, DOI 10.2307/2384717; Dowling W. J., 1986, MUSIC COGNITION; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Gill KZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008144; Haviland William, 2007, CULTURAL ANTHR HUMAN; HIRST D, 1999, INTONATION SYSTEMS S; HO LT, 1983, ASIAN MUSIC, V14, P132; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; KEEFE DH, 1991, MUSIC PERCEPT, V8, P449; McGowan RW, 2011, MUSIC PERCEPT, V28, P307, DOI 10.1525/MP.2011.28.3.307; Morton David, 1976, TRADITIONAL MUSIC TH; Patel AD, 2006, J ACOUST SOC AM, V119, P3034, DOI 10.1121/1.2179657; Schwartz DA, 2003, J NEUROSCI, V23, P7160, DOI 10.1523/JNEUROSCI.23-18-07160.2003; Thompson WF, 2005, SEMIOTICA, V156, P203, DOI 10.1515/semi.2005.2005.156.203; von Hippel P, 2000, MUSIC PERCEPT, V18, P59; VONHELMHOLTZ H. L. F., 1954, SENSATIONS TONE; VOS PG, 1989, MUSIC PERCEPT, V6, P383; [No title captured]	23	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20160	10.1371/journal.pone.0020160	http://dx.doi.org/10.1371/journal.pone.0020160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	769XV	21637716	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500036
J	Howell, KR; Kutiyanawalla, A; Pillai, A				Howell, Kristy R.; Kutiyanawalla, Ammar; Pillai, Anilkumar			Long-Term Continuous Corticosterone Treatment Decreases VEGF Receptor-2 Expression in Frontal Cortex	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEDIAL PREFRONTAL CORTEX; NEURONAL CALCIUM SENSOR-1; MEMORY CONSOLIDATION; BASOLATERAL AMYGDALA; CHROMAFFIN CELLS; WORKING-MEMORY; PC12 CELLS; STRESS; PATHWAY	Objective: Stress and increased glucocorticoid levels are associated with many neuropsychiatric disorders including schizophrenia and depression. Recently, the role of vascular endothelial factor receptor-2 (VEGFR2/Flk1) signaling has been implicated in stress-mediated neuroplasticity. However, the mechanism of regulation of VEGF/Flk1 signaling under long-term continuous glucocorticoid exposure has not been elucidated. Material and Methods: We examined the possible effects of long-term continuous glucocorticoid exposure on VEGF/Flk1 signaling in cultured cortical neurons in vitro, mouse frontal cortex in vivo, and in post mortem human prefrontal cortex of both control and schizophrenia subjects. Results: We found that long-term continuous exposure to corticosterone (CORT, a natural glucocorticoid) reduced Flk1 protein levels both in vitro and in vivo. CORT treatment resulted in alterations in signaling molecules downstream to Flk1 such as PTEN, Akt and mTOR. We demonstrated that CORT-induced changes in Flk1 levels are mediated through glucocorticoid receptor (GR) and calcium. A significant reduction in Flk1-GR interaction was observed following CORT exposure. Interestingly, VEGF levels were increased in cortex, but decreased in serum following CORT treatment. Moreover, significant reductions in Flk1 and GR protein levels were found in postmortem prefrontal cortex samples from schizophrenia subjects. Conclusions: The alterations in VEGF/Flk1 signaling following long-term continuous CORT exposure represents a molecular mechanism of the neurobiological effects of chronic stress.	[Howell, Kristy R.; Kutiyanawalla, Ammar; Pillai, Anilkumar] Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA; [Howell, Kristy R.; Kutiyanawalla, Ammar; Pillai, Anilkumar] Charlie Norwood Vet Affairs Med Ctr, Med Res Serv, Augusta, GA USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Howell, KR (corresponding author), Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA.	apillai@georgiahealth.edu	PILLAI, ANILKUMAR/N-4809-2017	Howell, Kristy/0000-0002-0872-5335	NINDS/NIH; National Multiple Sclerosis Society; Department of Veteran Affairs	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Veteran Affairs(US Department of Veterans Affairs)	The authors would also like to acknowledge the Human Brain and Spinal Fluid Resource Center, VA West Los Angeles Healthcare Center, 11301 Wilshire Blvd. Los Angeles, CA 90073 which is supported by NINDS/NIH, National Multiple Sclerosis Society, and Department of Veteran Affairs.	Ardayfio P, 2006, BEHAV NEUROSCI, V120, P249, DOI 10.1037/0735-7044.120.2.249; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Barsegyan A, 2010, P NATL ACAD SCI USA, V107, P16655, DOI 10.1073/pnas.1011975107; Bauer DE, 2009, J NEURAL TRANSM, V116, P487, DOI 10.1007/s00702-008-0143-3; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; CHAO HM, 1989, NEUROENDOCRINOLOGY, V50, P365, DOI 10.1159/000125250; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; ELLIOTT EM, 1993, BRAIN RES, V602, P84, DOI 10.1016/0006-8993(93)90245-I; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Leitch MM, 2003, NEUROPSYCHOPHARMACOL, V28, P119, DOI 10.1038/sj.npp.1300016; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; MALLART A, 1991, J NEUROGENET, V7, P75, DOI 10.3109/01677069109066212; McEuen JG, 2008, J NEUROSCI, V28, P8169, DOI 10.1523/JNEUROSCI.0004-08.2008; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Pan CY, 2002, J NEUROSCI, V22, P2427, DOI 10.1523/JNEUROSCI.22-07-02427.2002; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pillai A, 2008, J NEUROCHEM, V107, P941, DOI 10.1111/j.1471-4159.2008.05665.x; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Qiu JA, 2003, LIFE SCI, V72, P2533, DOI 10.1016/S0024-3205(03)00168-1; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; Scalettar BA, 2002, J CELL SCI, V115, P2399; Seib LM, 2003, NEUROSCI LETT, V337, P29, DOI 10.1016/S0304-3940(02)01287-9; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; SZE PY, 1994, NEUROENDOCRINOLOGY, V59, P457, DOI 10.1159/000126692; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; YOUNG EA, 1995, J NEUROENDOCRINOL, V7, P37, DOI 10.1111/j.1365-2826.1995.tb00665.x; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637	55	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20198	10.1371/journal.pone.0020198	http://dx.doi.org/10.1371/journal.pone.0020198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647420	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500040
J	Peng, H; Sun, LJ; Jia, BB; Lan, XQ; Zhu, B; Wu, YM; Zheng, JL				Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin			HIV-1-Infected and Immune-Activated Macrophages Induce Astrocytic Differentiation of Human Cortical Neural Progenitor Cells via the STAT3 Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; ADULT BRAIN; STEM/PROGENITOR CELLS; PRECURSOR CELLS; STEM-CELLS; NEUROGENESIS; MICROGLIA; INFLAMMATION	Diminished adult neurogenesis is considered a potential mechanism in the pathogenesis of HIV-1-associated dementia (HAD). In HAD, HIV-1-infected and immune-activated brain mononuclear phagocytes (MP; perivascular macrophages and microglia) drive central nervous system (CNS) inflammation and may alter normal neurogenesis. We previously demonstrated HIV-1-infected and lipopolysaccharide (LPS) activated monocyte-derived macrophages (MDM) inhibit human neural progenitor cell (NPC) neurogenesis, while enhancing astrogliogenesis through the secretion of the inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), in vitro and in vivo. Here we further test the hypothesis that HIV-1-infected/activated MDM promote NPC astrogliogenesis via activation of the transcription factor signal transducer and activator of transcription 3 (STAT3), a critical factor for astrogliogenesis. Our results show that LPS-activated MDM-conditioned medium (LPS-MCM) and HIV-infected/LPS-activated MDM-conditioned medium (LPS+HIV-MCM) induced Janus kinase 1 (Jak1) and STAT3 activation. Induction of the Jak-STAT3 activation correlated with increased glia fibrillary acidic protein (GFAP) expression, demonstrating an induction of astrogliogenesis. Moreover, STAT3-targeting siRNA (siSTAT3) decreased MCM-induced STAT3 activation and NPC astrogliogenesis. Furthermore, inflammatory cytokines (including IL-6, IL-1 beta and TNF-alpha) produced by LPS-activated and/or HIV-1-infected MDM may contribute to MCM-induced STAT3 activation and astrocytic differentiation. These observations were confirmed in severe combined immunodeficient (SCID) mice with HIV-1 encephalitis (HIVE). In HIVE mice, siRNA control (without target sequence, sicon) pre-transfected NPCs injected with HIV-1-infected MDM showed more astrocytic differentiation and less neuronal differentiation of NPCs as compared to NPC injection alone. siSTAT3 abrogated HIV-1-infected MDM-induced astrogliogenesis of injected NPCs. Collectively, these observations demonstrate that HIV-1-infected/activated MDM induces NPC astrogliogenesis through the STAT3 pathway. This study generates important data elucidating the role of brain inflammation in neurogenesis and may provide insight into new therapeutic strategies for HAD.	[Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin] Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA; [Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol, Omaha, NE USA; [Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Expt Neurosci, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Peng, H (corresponding author), Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA.	hpeng@unmc.edu; jzheng@unmc.edu			National Institutes of Health [R21 NS066841, R01 NS41858, R01NS61642, P20RR15635, P01NS43985]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041858, R01NS061642, P01NS043985, R21NS066841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants by the National Institutes of Health: R21 NS066841 to HP; R01 NS41858, R01NS61642, P20RR15635 and P01NS43985 to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; CAO F, BIOCH BIOPHYS RES CO, V394, P843; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gendelman H. E, 1997, NEUROLOGY AIDS, P1; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kolson DL, 2000, J CLIN INVEST, V106, P11, DOI 10.1172/JCI10553; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lipton SA, 1997, CURR OPIN NEUROL, V10, P247, DOI 10.1097/00019052-199706000-00014; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 2002, MOL NEUROBIOL, V25, P233; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; OKAMOTO S, 2007, CELL STEM CELL, V1, P1; Peng H, 2005, J NEUROSCI RES, V82, P295, DOI 10.1002/jnr.20629; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Persidsky Y, 1996, AM J PATHOL, V149, P1027; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; Rajan P, 1998, J NEUROSCI, V18, P3620; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Schwartz L, 2006, CURR HIV RES, V4, P319, DOI 10.2174/157016206777709438; Strizki JM, 1996, J VIROL, V70, P7654, DOI 10.1128/JVI.70.11.7654-7662.1996; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Zheng JL, 2001, NEUROTOX RES, V3, P461, DOI 10.1007/BF03033204; Zhu PX, 2008, FASEB J, V22, P3866, DOI 10.1096/fj.08-105908	41	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19439	10.1371/journal.pone.0019439	http://dx.doi.org/10.1371/journal.pone.0019439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637744	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500006
J	Anthony, KG; Strych, U; Yeung, KR; Shoen, CS; Perez, O; Krause, KL; Cynamon, MH; Aristoff, PA; Koski, RA				Anthony, Karen G.; Strych, Ulrich; Yeung, Kacheong R.; Shoen, Carolyn S.; Perez, Oriana; Krause, Kurt L.; Cynamon, Michael H.; Aristoff, Paul A.; Koski, Raymond A.			New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; CYCLOSERINE; INACTIVATION; DERIVATIVES; MECHANISM; ENZYMES; DESIGN; GROWTH; DRUGS	Background: In an effort to discover new drugs to treat tuberculosis (TB) we chose alanine racemase as the target of our drug discovery efforts. In Mycobacterium tuberculosis, the causative agent of TB, alanine racemase plays an essential role in cell wall synthesis as it racemizes L-alanine into D-alanine, a key building block in the biosynthesis of peptidoglycan. Good antimicrobial effects have been achieved by inhibition of this enzyme with suicide substrates, but the clinical utility of this class of inhibitors is limited due to their lack of target specificity and toxicity. Therefore, inhibitors that are not substrate analogs and that act through different mechanisms of enzyme inhibition are necessary for therapeutic development for this drug target. Methodology/Principal Findings: To obtain non-substrate alanine racemase inhibitors, we developed a high-throughput screening platform and screened 53,000 small molecule compounds for enzyme-specific inhibitors. We examined the 'hits' for structural novelty, antimicrobial activity against M. tuberculosis, general cellular cytotoxicity, and mechanism of enzyme inhibition. We identified seventeen novel non-substrate alanine racemase inhibitors that are structurally different than any currently known enzyme inhibitors. Seven of these are active against M. tuberculosis and minimally cytotoxic against mammalian cells. Conclusions/Significance: This study highlights the feasibility of obtaining novel alanine racemase inhibitor lead compounds by high-throughput screening for development of new anti-TB agents.	[Anthony, Karen G.; Yeung, Kacheong R.; Perez, Oriana; Aristoff, Paul A.; Koski, Raymond A.] L2 Diagnost LLC, New Haven, CT USA; [Strych, Ulrich] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Shoen, Carolyn S.; Cynamon, Michael H.] Vet Affairs Med Ctr, Syracuse, NY USA; [Krause, Kurt L.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Houston System; University of Houston; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Otago	Anthony, KG (corresponding author), L2 Diagnost LLC, New Haven, CT USA.	Karen.Anthony@L2dx.com	Krause, Kurt/N-4886-2014	Krause, Kurt/0000-0002-3525-1112; Strych, Ulrich/0000-0001-9455-7683	National Institute of Allergy and Infectious Diseases [R43AI068161]; University of Otago; Robert A. Welch Foundation; National Institutes of Health; Thrash Foundation; Foundation for the Centers for Molecular Research in Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082081, R43AI068161, U54AI057159] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Otago; Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrash Foundation; Foundation for the Centers for Molecular Research in Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R43AI068161 from the National Institute of Allergy and Infectious Diseases as well as the University of Otago, the Robert A. Welch Foundation, the National Institutes of Health, the Thrash Foundation, and the Foundation for the Centers for Molecular Research in Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADET B, 1984, BIOCHEMISTRY-US, V23, P5188, DOI 10.1021/bi00317a016; Blondal K, 2007, B WORLD HEALTH ORGAN, V85, P387, DOI 10.2471/BLT.06.035345; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; Chakrabarti B, 2007, FUTURE MICROBIOL, V2, P51, DOI 10.2217/17460913.2.1.51; COPIE V, 1988, BIOCHEMISTRY-US, V27, P4966, DOI 10.1021/bi00414a002; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; ERION MD, 1987, BIOCHEMISTRY-US, V26, P3417, DOI 10.1021/bi00386a025; ESAKI N, 1986, BIOCHEMISTRY-US, V25, P3261, DOI 10.1021/bi00359a027; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Ginsberg AM, 2010, DRUGS, V70, P2201, DOI 10.2165/11538170-000000000-00000; Ginsberg AM, 2010, TUBERCULOSIS, V90, P162, DOI 10.1016/j.tube.2010.03.003; Heijenoort J.V, 1994, NEW COMPR BIOCH, V27, P39, DOI 10.1016/S0167-7306(08)60406-8; Kim MG, 2003, MED CHEM RES, V12, P130; Kim MG, 2003, J ANTIBIOT, V56, P160, DOI 10.7164/antibiotics.56.160; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; Laughon BE, 2007, CURR TOP MED CHEM, V7, P463, DOI 10.2174/156802607780059736; LeMagueres P, 2005, BIOCHEMISTRY-US, V44, P1471, DOI 10.1021/bi0486583; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; Mustata GI, 2003, BIOPOLYMERS, V70, P186, DOI 10.1002/bip.10425; Mustata GI, 2002, J COMPUT AID MOL DES, V16, P935, DOI 10.1023/A:1023875514454; Neuhaus F, 1967, D CYCLOSERINE O CARB; NEUHAUS F, 1967, ANTIBIOTICS MECH ACT; NEUHAUS FC, 1981, PHARMACOL THERAPEUT, V14, P265, DOI 10.1016/0163-7258(81)90030-9; Ondrechen MJ, 2001, J AM CHEM SOC, V123, P2830, DOI 10.1021/ja0029679; *ORG WH, 2007, WHO FACT SHEET TUB 2; Pucci MJ, 2010, ANTIMICROB AGENTS CH, V54, P3478, DOI 10.1128/AAC.00287-10; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Strych U, 2001, FEMS MICROBIOL LETT, V196, P93, DOI 10.1016/S0378-1097(01)00045-3; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Viskum K, 1997, INT J TUBERC LUNG D, V1, P299; WALSH CT, 1989, J BIOL CHEM, V264, P2393; YEW WW, 1993, CLIN INFECT DIS, V17, P288, DOI 10.1093/clinids/17.2.288; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	30	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20374	10.1371/journal.pone.0020374	http://dx.doi.org/10.1371/journal.pone.0020374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637807	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052200057
J	Iwabuchi, KA; Yamakawa, T; Sato, Y; Ichisaka, T; Takahashi, K; Okita, K; Yamanaka, S				Iwabuchi, Kumiko A.; Yamakawa, Tatsuya; Sato, Yoshiko; Ichisaka, Tomoko; Takahashi, Kazutoshi; Okita, Keisuke; Yamanaka, Shinya			ECAT11/L1td1 Is Enriched in ESCs and Rapidly Activated During iPSCGeneration, but It Is Dispensable for the Maintenance and Induction of Pluripotency	PLOS ONE			English	Article							SELF-RENEWAL; CHAPERONE ACTIVITY; ORF1 PROTEIN; STEM-CELLS; MOUSE; LINE-1; EXPRESSION; RETROTRANSPOSITION; GENERATION; ROLES	The principal factors that lead to proliferation and pluripotency in embryonic stem cells (ESCs) have been vigorously investigated. However, the global network of factors and their full signaling cascade is still unclear. In this study, we found that ECAT11 (L1td1) is one of the ESC-associated transcripts harboring a truncated fragment of ORF-1, a component of theL1 retrotransposable element. We generated an ECAT11 knock-in mouse by replacing its coding region with green fluorescent protein. In the early stage of development, the fluorescence was observed at the inner cell mass of blastocysts and epiblasts. Despite this specific expression, ECAT11-null mice grow normally and are fertile. In addition, ECAT11 was dispensable for both the proliferation and pluripotency of ESCs. We found rapid and robust activation of ECAT11 in fibroblasts after the forced expression of transcription factors that can give rise pluripotency in somatic cells. However, iPS cells could be established from ECAT11-null fibroblasts. Our data demonstrate thedispensability of ECAT11/L1td1 in pluripotency, despite its specific expression.	[Iwabuchi, Kumiko A.; Yamakawa, Tatsuya; Sato, Yoshiko; Ichisaka, Tomoko; Takahashi, Kazutoshi; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Iwabuchi, Kumiko A.; Yamakawa, Tatsuya; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto, Japan; [Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Iwabuchi, KA (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	yamanaka@cira.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090	NIBIO; MEXT; JSPS	NIBIO(National Institute of Biomedical Innovation); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO, a grant from the Leading Project of MEXT, a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of JSPS, Grants-in-Aid for Scientific Research of JSPS and MEXT (to SY). KI was supported by Research Fellowships for Young Scientists from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Benihoud K, 2002, ONCOGENE, V21, P5593, DOI 10.1038/sj.onc.1205730; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Januszyk K, 2007, J BIOL CHEM, V282, P24893, DOI 10.1074/jbc.M702023200; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; PACKER AI, 1993, DEV BIOL, V157, P281, DOI 10.1006/dbio.1993.1133; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	34	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20461	10.1371/journal.pone.0020461	http://dx.doi.org/10.1371/journal.pone.0020461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637830	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200067
J	Zhang, Y; Ma, CJ; Wang, JM; Ji, XJ; Wu, XY; Jia, ZS; Moorman, JP; Yao, ZQ				Zhang, Ying; Ma, Cheng J.; Wang, Jia M.; Ji, Xiao J.; Wu, Xiao Y.; Jia, Zhan S.; Moorman, Jonathan P.; Yao, Zhi Q.			Tim-3 Negatively Regulates IL-12 Expression by Monocytes in HCV Infection	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; T-CELL IMMUNOGLOBULIN; CONTAINING MOLECULE-3 TIM-3; CORE PROTEIN; ELEVATED FREQUENCIES; PD-1 EXPRESSION; DENDRITIC CELLS; GENE FAMILY; CD4(+); ACTIVATION	T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) is a newly identified negative immunomodulator that is up-regulated on dysfunctional T cells during viral infections. The expression and function of Tim-3 on human innate immune responses during HCV infection, however, remains poorly characterized. In this study, we report that Tim-3 is constitutively expressed on human resting CD14(+) monocyte/macrophages (M/M-circle divide) and functions as a cap to block IL-12, a key pro-inflammatory cytokine linking innate and adaptive immune responses. Tim-3 expression is significantly reduced and IL-12 expression increased upon stimulation with Toll-like receptor 4 (TLR4) ligand - lipopolysaccharide (LPS) and TLR7/8 ligand - R848. Notably, Tim-3 is over-expressed on un-stimulated as well as TLR-stimulated M/M-circle divide, which is inversely associated with the diminished IL-12 expression in chronically HCV-infected individuals when compared to healthy subjects. Up-regulation of Tim-3 and inhibition of IL-12 are also observed in M/M-circle divide incubated with HCV-expressing hepatocytes, as well as in primary M/M-circle divide or monocytic THP-1 cells incubated with HCV core protein, an effect that mimics the function of complement C1q and is reversible by blocking the HCV core/gC1qR interaction. Importantly, blockade of Tim-3 signaling significantly rescues HCV-mediated inhibition of IL-12, which is primarily expressed by Tim-3 negative M/M-circle divide. Tim-3 blockade reduces HCV core-mediated expression of the negative immunoregulators PD-1 and SOCS-1 and increases STAT-1 phosphorylation. Conversely, blocking PD-1 or silencing SOCS-1 gene expression also decreases Tim-3 expression and enhances IL-12 secretion and STAT-1 phosphorylation. These findings suggest that Tim-3 plays a crucial role in negative regulation of innate immune responses, through crosstalk with PD-1 and SOCS-1 and limiting STAT-1 phosphorylation, and may be a novel target for immunotherapy to HCV infection.	[Zhang, Ying; Ma, Cheng J.; Wang, Jia M.; Ji, Xiao J.; Wu, Xiao Y.; Moorman, Jonathan P.; Yao, Zhi Q.] E Tennessee State Univ, James H Quillen Coll Med, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA; [Moorman, Jonathan P.; Yao, Zhi Q.] James H Quillen VA Med Ctr, Dept Vet Affairs, Med Serv, Johnson City, TN USA; [Zhang, Ying; Jia, Zhan S.; Yao, Zhi Q.] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Peoples R China	East Tennessee State University; Air Force Military Medical University	Zhang, Y (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA.	Yao@etsu.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health/National Institute of Allergy and Infectious Diseases grant to ZQY/JPM (1R15A1084057-01). This publication is the result of work supported with resources and the use of facilities at the James H. Quillen Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cho HY, 2009, IMMUNOL LETT, V127, P39, DOI 10.1016/j.imlet.2009.08.011; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Eisen-Vandervelde AL, 2004, CLIN IMMUNOL, V111, P16, DOI 10.1016/j.clim.2003.12.003; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Frazier AD, 2010, VIRAL IMMUNOL, V23, P487, DOI 10.1089/vim.2010.0010; Frisancho-Kiss S, 2006, J IMMUNOL, V176, P6411, DOI 10.4049/jimmunol.176.11.6411; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hafler DA, 2008, J EXP MED, V205, P2699, DOI 10.1084/jem.20082429; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Ma CJ, 2011, IMMUNOLOGY, V132, P421, DOI 10.1111/j.1365-2567.2010.03382.x; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moorman J, 2009, IMMUNOLOGY, V128, P227, DOI 10.1111/j.1365-2567.2009.03106.x; Moorman JP, 2011, VACCINE, V29, P3169, DOI 10.1016/j.vaccine.2011.02.052; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; NI L, 2010, IMMUNOLOGY CELL BIOL; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Wakita Takaji, 2009, V510, P305, DOI 10.1007/978-1-59745-394-3_23; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Yao ZQ, 2007, VIRAL IMMUNOL, V20, P276, DOI 10.1089/vim.2006.0096; Yao ZQ, 2011, IMMUNOL INVEST, V40, P243, DOI 10.3109/08820139.2010.534218; Yao ZQ, 2008, IMMUNOLOGY, V125, P197, DOI 10.1111/j.1365-2567.2008.02829.x; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yao ZQ, 2003, VIROLOGY, V314, P271, DOI 10.1016/S0042-6822(03)00419-7; Yao ZQ, 2001, VIRAL IMMUNOL, V14, P277, DOI 10.1089/08828240152716547; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Zhang Y, 2011, J IMMUNOL, V186, P3093, DOI 10.4049/jimmunol.1002006; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	56	66	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19664	10.1371/journal.pone.0019664	http://dx.doi.org/10.1371/journal.pone.0019664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637332	Green Submitted, gold, Green Published			2022-12-27	WOS:000291052200010
J	Jeong, JK; Tremere, LA; Burrows, K; Majewska, AK; Pinaud, R				Jeong, Jin-Kwon; Tremere, Liisa A.; Burrows, Kaiping; Majewska, Ania K.; Pinaud, Raphael			The Mouse Primary Visual Cortex Is a Site of Production and Sensitivity to Estrogens	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; LONG-TERM; IN-SITU; SYNAPTIC PLASTICITY; RAPID ENHANCEMENT; NEURONAL-ACTIVITY; BRAIN AROMATASE; GENE-EXPRESSION; MENSTRUAL-CYCLE; STRIATE CORTEX	The classic female estrogen, 17 beta-estradiol (E2), has been repeatedly shown to affect the perceptual processing of visual cues. Although gonadal E2 has often been thought to influence these processes, the possibility that central visual processing may be modulated by brain-generated hormone has not been explored. Here we show that estrogen-associated circuits are highly prevalent in the mouse primary visual cortex (V1). Specifically, we cloned aromatase, a marker for estrogen-producing neurons, and the classic estrogen receptors (ERs) ER alpha and ER beta, as markers for estrogen-responsive neurons, and conducted a detailed expression analysis via in-situ hybridization. We found that both monocular and binocular V1 are highly enriched in aromatase-and ER-positive neurons, indicating that V1 is a site of production and sensitivity to estrogens. Using double-fluorescence in-situ hybridization, we reveal the neurochemical identity of estrogen-producing and -sensitive cells in V1, and demonstrate that they constitute a heterogeneous neuronal population. We further show that visual experience engages a large population of aromatase-positive neurons and, to a lesser extent, ER-expressing neurons, suggesting that E2 levels may be locally regulated by visual input in V1. Interestingly, acute episodes of visual experience do not affect the density or distribution of estrogen-associated circuits. Finally, we show that adult mice dark-reared from birth also exhibit normal distribution of aromatase and ERs throughout V1, suggesting that the implementation and maintenance of estrogen-associated circuits is independent of visual experience. Our findings demonstrate that the adult V1 is a site of production and sensitivity to estrogens, and suggest that locally-produced E2 may shape visual cortical processing.	[Jeong, Jin-Kwon; Tremere, Liisa A.; Burrows, Kaiping; Pinaud, Raphael] Univ Oklahoma Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Tremere, Liisa A.; Pinaud, Raphael] Univ Oklahoma Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA; [Tremere, Liisa A.; Pinaud, Raphael] Univ Oklahoma Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Majewska, Ania K.] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Majewska, Ania K.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Rochester; University of Rochester	Jeong, JK (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.	raphael-pinaud@ouhsc.edu	Jeong, Jin Kwon/AAU-2951-2020	Majewska, Ania/0000-0002-2167-6849; Jeong, Jin Kwon/0000-0002-5261-4915	NIH/NIDCD [R01-DC-010181]; NIH/NEI [R01-EY-0192277]; Schmitt Foundation; Reynolds Foundation; NATIONAL EYE INSTITUTE [R01EY019277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010181] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Schmitt Foundation; Reynolds Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH/NIDCD (R01-DC-010181) - www.nidcd.nih.gov; NIH/NEI (R01-EY-0192277) - www.nei.nih.gov; Schmitt Foundation (no # available) -http://www.urmc.rochester.edu/smd/nanat/schmitt/history.cfm; Reynolds Foundation (no # available) - http://www.dwreynolds.org/Programs/National/Aging/Aging.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthazart J, 2006, NEUROSCIENCE, V138, P783, DOI 10.1016/j.neuroscience.2005.06.016; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barha CK, 2010, NEUROPSYCHOPHARMACOL, V35, P547, DOI 10.1038/npp.2009.161; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; Chen JR, 2009, CEREB CORTEX, V19, P2719, DOI 10.1093/cercor/bhp048; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; DAVIS M J, 1982, Journal of Auditory Research, V22, P173; FILLIT H, 1986, PSYCHONEUROENDOCRINO, V11, P337, DOI 10.1016/0306-4530(86)90019-3; Foy MR, 2001, NEUROBIOL LEARN MEM, V76, P239, DOI 10.1006/nlme.2001.4018; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; GOULD E, 1990, J NEUROSCI, V10, P1286; Gu Q, 1996, J NEUROSCI, V16, P3620; HERBISON AE, 1995, J NEUROSCI, V15, P2328, DOI 10.1523/JNEUROSCI.15-03-02328.1995; Herbison AE, 1997, BRAIN RES BULL, V44, P321, DOI 10.1016/S0361-9230(97)00210-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kumar A, 2002, J NEUROPHYSIOL, V88, P621, DOI 10.1152/jn.2002.88.2.621; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Luine VN, 2008, J NEUROENDOCRINOL, V20, P866, DOI 10.1111/j.1365-2826.2008.01710.x; MAGGI A, 1984, EUR J PHARMACOL, V103, P165, DOI 10.1016/0014-2999(84)90205-X; Maney DL, 2011, FRONT NEUROENDOCRIN, V32, P287, DOI 10.1016/j.yfrne.2010.12.002; Mazzocco MMM, 2006, CHILD NEUROPSYCHOL, V12, P87, DOI 10.1080/09297040500266951; McCullough LD, 2003, J NEUROSCI, V23, P8701; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Miller TW, 2008, J STEROID BIOCHEM, V112, P95, DOI 10.1016/j.jsbmb.2008.09.001; Milner TA, 2010, BRAIN RES, V1351, P74, DOI 10.1016/j.brainres.2010.06.038; Montoya DAC, 1997, BRAIN RES, V778, P430, DOI 10.1016/S0006-8993(97)01206-7; Morales B, 2002, J NEUROSCI, V22, P8084; Mukai H, 2007, J NEUROCHEM, V100, P950, DOI 10.1111/j.1471-4159.2006.04264.x; Murphy DD, 1998, J NEUROSCI, V18, P2550; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P497, DOI 10.1016/0306-4530(92)90008-U; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Pinaud R, 2003, BRAIN RES BULL, V61, P139, DOI 10.1016/S0361-9230(03)00100-X; Pinaud R, 2002, NEUROSCIENCE, V112, P573, DOI 10.1016/S0306-4522(02)00094-5; PINAUD R, 2006, IMM EARL GEN SENS, pR7; PINAUD R, 2005, PLASTICITY VISUAL SY, P153; Pinaud R, 2008, NAT PROTOC, V3, P1370, DOI 10.1038/nprot.2008.115; Pinaud R, 2010, METHODS MOL BIOL, V611, P115, DOI 10.1007/978-1-60327-345-9_9; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Resnick SM, 2001, ANN NY ACAD SCI, V949, P203; Roselli CE, 2009, SEMIN REPROD MED, V27, P207, DOI 10.1055/s-0029-1216274; Ross J, 2000, MENT RETARD DEV D R, V6, P135, DOI 10.1002/1098-2779(2000)6:2<135::AID-MRDD8>3.0.CO;2-K; SCHUMACHER M, 1989, NEUROENDOCRINOLOGY, V50, P315, DOI 10.1159/000125239; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Snyder MA, 2010, J NEUROSCI METH, V188, P226, DOI 10.1016/j.jneumeth.2010.02.012; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; TREMERE LA, 2005, PLASTICITY VISUAL SY, P229; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; Tremere LA, 2009, J NEUROSCI, V29, P5949, DOI 10.1523/JNEUROSCI.0774-09.2009; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990	70	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20400	10.1371/journal.pone.0020400	http://dx.doi.org/10.1371/journal.pone.0020400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647225	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800048
J	Lindqvist, M; Nookaew, I; Brinkenberg, I; Samuelson, E; Thorn, K; Nielsen, J; Harandi, AM				Lindqvist, Madelene; Nookaew, Intawat; Brinkenberg, Ingrid; Samuelson, Emma; Thorn, Karolina; Nielsen, Jens; Harandi, Ali M.			Unraveling Molecular Signatures of Immunostimulatory Adjuvants in the Female Genital Tract through Systems Biology	PLOS ONE			English	Article							GENE-COEXPRESSION NETWORK; VACCINE ADJUVANTS; IMMUNITY; CELLS; COMPLEMENT; EXPRESSION; CYTOSCAPE; DISCOVERY; RESPONSES; TOPOLOGY	Sexually transmitted infections (STIs) unequivocally represent a major public health concern in both industrialized and developing countries. Previous efforts to develop vaccines for systemic immunization against a large number of STIs in humans have been unsuccessful. There is currently a drive to develop mucosal vaccines and adjuvants for delivery through the genital tract to confer protective immunity against STIs. Identification of molecular signatures that can be used as biomarkers for adjuvant potency can inform rational development of potent mucosal adjuvants. Here, we used systems biology to study global gene expression and signature molecules and pathways in the mouse vagina after treatment with two classes of experimental adjuvants. The Toll-like receptor 9 agonist CpG ODN and the invariant natural killer T cell agonist alpha-galactosylceramide, which we previously identified as equally potent vaginal adjuvants, were selected for this study. Our integrated analysis of genome-wide transcriptome data determined which signature pathways, processes and networks are shared by or otherwise exclusive to these 2 classes of experimental vaginal adjuvants in the mouse vagina. To our knowledge, this is the first integrated genome-wide transcriptome analysis of the effects of immunomodulatory adjuvants on the female genital tract of a mammal. These results could inform rational development of effective mucosal adjuvants for vaccination against STIs.	[Lindqvist, Madelene; Brinkenberg, Ingrid; Samuelson, Emma; Thorn, Karolina; Harandi, Ali M.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Nookaew, Intawat; Nielsen, Jens] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Lindqvist, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	ali.harandi@microbio.gu.se	Nielsen, Jens/Q-1347-2017	Nielsen, Jens/0000-0002-9955-6003	Swedish Research Council Medicine (VR); European Commission; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish federal government; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Chalmers Foundation	Swedish Research Council Medicine (VR)(Swedish Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish federal government; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation	This study was supported by the Swedish Research Council Medicine (VR), EURONANOMED program of the European Commission support to iNanoDCs project, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Swedish federal government under the LUA-ALF agreement, an exploratory grant of MUVAPRED project supported by FP6 program of the European Commission, the Swedish Foundation for Strategic Research MIVAC grant, the Knut and Alice Wallenberg Foundation and the Chalmers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benham AM, 1997, J IMMUNOL, V159, P5896; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROWN KE, CURR OPIN IMMUNOL, V22, P397; CROFT D, NUCL ACIDS RES, V39, pD691; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Gawaz M, 2002, THROMB HAEMOSTASIS, V88, P307; Harandi AM, 2009, EXPERT REV VACCINES, V8, P293, DOI 10.1586/14760584.8.3.293; Hubbell E, 2005, PLIER WHITE PAPER; Kato Atsushi, 2003, BMC Immunol, V4, P8, DOI 10.1186/1471-2172-4-8; Klaschik S, 2007, MOL IMMUNOL, V44, P1095, DOI 10.1016/j.molimm.2006.07.283; Klaschik S, 2009, J LEUKOCYTE BIOL, V85, P788, DOI 10.1189/jlb.1008671; Krawczyk CM, BLOOD, V115, P4742; LAM FW, 2010, AM J PHYSL HEART CIR; Lindqvist M, 2009, VACCINE, V28, P270, DOI 10.1016/j.vaccine.2009.09.083; Lindqvist M, 2009, J IMMUNOL, V182, P6435, DOI 10.4049/jimmunol.0900136; LINHARES IM, AM J OBSTET GYNECOL; Mestecky J, 1999, J INFECT DIS, V179, pS470, DOI 10.1086/314806; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; NOOKAEW I, PLOS ONE, V5; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Sajic D, 2005, IMMUNOLOGY, V114, P213, DOI 10.1111/j.1365-2567.2004.02081.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tengvall S, 2006, J VIROL, V80, P5283, DOI 10.1128/JVI.02013-05; TRAMONT EC, 1989, CLIN MICROBIOL REV, V2, pS74, DOI 10.1128/CMR.2.Suppl.S74-S77.1989; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	36	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20448	10.1371/journal.pone.0020448	http://dx.doi.org/10.1371/journal.pone.0020448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666746	Green Published, gold			2022-12-27	WOS:000291607000007
J	Myers, CN; Berner, GB; Holthoff, JH; Martinez-Fonts, K; Harper, JA; Alford, S; Taylor, MN; Duina, AA				Myers, Catherine N.; Berner, Gary B.; Holthoff, Joseph H.; Martinez-Fonts, Kirby; Harper, Jennifer A.; Alford, Sarah; Taylor, Megan N.; Duina, Andrea A.			Mutant Versions of the S. cerevisiae Transcription Elongation Factor Spt16 Define Regions of Spt16 That Functionally Interact with Histone H3	PLOS ONE			English	Article							N-TERMINAL DOMAIN; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; DNA-POLYMERASE; NUCLEOSOME; YFACT; POB3; NHP6; CHROMATIN; COMPLEX	In eukaryotic cells, the highly conserved FACT (FAcilitates Chromatin Transcription) complex plays important roles in several chromatin-based processes including transcription initiation and elongation. During transcription elongation, the FACT complex interacts directly with nucleosomes to facilitate histone removal upon RNA polymerase II (Pol II) passage and assists in the reconstitution of nucleosomes following Pol II passage. Although the contribution of the FACT complex to the process of transcription elongation has been well established, the mechanisms that govern interactions between FACT and chromatin still remain to be fully elucidated. Using the budding yeast Saccharomyces cerevisiae as a model system, we provide evidence that the middle domain of the FACT subunit Spt16 - the Spt16-M domain - is involved in functional interactions with histone H3. Our results show that the Spt16-M domain plays a role in the prevention of cryptic intragenic transcription during transcription elongation and also suggest that the Spt16-M domain has a function in regulating dissociation of Spt16 from chromatin at the end of the transcription process. We also provide evidence for a role for the extreme carboxy terminus of Spt16 in functional interactions with histone H3. Taken together, our studies point to previously undescribed roles for the Spt16 M-domain and extreme carboxy terminus in regulating interactions between Spt16 and chromatin during the process of transcription elongation.	[Myers, Catherine N.; Berner, Gary B.; Holthoff, Joseph H.; Martinez-Fonts, Kirby; Harper, Jennifer A.; Alford, Sarah; Taylor, Megan N.; Duina, Andrea A.] Hendrix Coll, Dept Biol, Conway, AR 72032 USA		Myers, CN (corresponding author), Hendrix Coll, Dept Biol, Conway, AR 72032 USA.	duina@hendrix.edu			National Science Foundation [0543412, 0919241]; National Center for Research Resources, National Institutes of Health [P20 RR16460]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This material is based upon work supported by the National Science Foundation under grants No. 0543412 and No. 0919241 to AAD (http://www.nsf.gov/) and by National Institutes of Health grant P20 RR16460 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources (http://www.ncrr.nih.gov/research_infrastructure/institutional_development_award/idea_networks_of_biomedical_research_excellence/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 1997, GENOME RES, V7, P843, DOI 10.1101/gr.7.8.843; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Duina AA, 2007, GENETICS, V177, P101, DOI 10.1534/genetics.106.067140; Evans DRH, 1998, GENETICS, V150, P1393; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li-Sucholeiki X C, 2000, Nucleic Acids Res, V28, pE44, DOI 10.1093/nar/28.9.e44; Lloyd A, 2009, EUKARYOT CELL, V8, P257, DOI 10.1128/EC.00348-08; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; O'Donnell AF, 2009, MOL GENET GENOMICS, V282, P487, DOI 10.1007/s00438-009-0480-4; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Rose MD., 1990, METHODS YEAST GENETI; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; WINSTON F, 1992, ANAL SPT GENES GENET, P1271; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20847	10.1371/journal.pone.0020847	http://dx.doi.org/10.1371/journal.pone.0020847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673966	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400033
J	Geissler, M; Dinse, HR; Neuhoff, S; Kreikemeier, K; Meier, C				Geissler, Maren; Dinse, Hubert R.; Neuhoff, Sandra; Kreikemeier, Klaus; Meier, Carola			Human Umbilical Cord Blood Cells Restore Brain Damage Induced Changes in Rat Somatosensory Cortex	PLOS ONE			English	Article							STEM-CELLS; CORTICAL REORGANIZATION; MULTIPLE MECHANISMS; BEHAVIORAL DEFICITS; MONONUCLEAR-CELLS; RECEPTIVE-FIELDS; AUDITORY-CORTEX; STROKE; INJURY; INHIBITION	Intraperitoneal transplantation of human umbilical cord blood (hUCB) cells has been shown to reduce sensorimotor deficits after hypoxic ischemic brain injury in neonatal rats. However, the neuronal correlate of the functional recovery and how such a treatment enforces plastic remodelling at the level of neural processing remains elusive. Here we show by in-vivo recordings that hUCB cells have the capability of ameliorating the injury-related impairment of neural processing in primary somatosensory cortex. Intact cortical processing depends on a delicate balance of inhibitory and excitatory transmission, which is disturbed after injury. We found that the dimensions of cortical maps and receptive fields, which are significantly altered after injury, were largely restored. Additionally, the lesion induced hyperexcitability was no longer observed in hUCB treated animals as indicated by a paired-pulse behaviour resembling that observed in control animals. The beneficial effects on cortical processing were reflected in an almost complete recovery of sensorimotor behaviour. Our results demonstrate that hUCB cells reinstall the way central neurons process information by normalizing inhibitory and excitatory processes. We propose that the intermediate level of cortical processing will become relevant as a new stage to investigate efficacy and mechanisms of cell therapy in the treatment of brain injury.	[Geissler, Maren; Dinse, Hubert R.; Kreikemeier, Klaus] Ruhr Univ Bochum, Inst Neuroinformat, Neural Plast Lab, Bochum, Germany; [Neuhoff, Sandra; Meier, Carola] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Geissler, M (corresponding author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, Bochum, Germany.	hubert.dinse@rub.de		dinse, hubert/0000-0001-9024-0451	Stem cell network North Rhine Westfalia; Deutsche Forschungsgemeinschaft [Di 334/19-1]	Stem cell network North Rhine Westfalia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the "Stem cell network North Rhine Westfalia" to CM, and from the Deutsche Forschungsgemeinschaft to HRD (Di 334/19-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Benali A, 2008, J NEUROSCI, V28, P12284, DOI 10.1523/JNEUROSCI.1952-08.2008; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; CHAPIN JK, 1986, EXP BRAIN RES, V62, P549; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; David-Jurgens M, 2010, CEREB CORTEX, V20, P1208, DOI 10.1093/cercor/bhp185; David-Jurgens M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003399; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; GARDNER EP, 1989, J NEUROPHYSIOL, V62, P1410, DOI 10.1152/jn.1989.62.6.1410; Gervasi NM, 2008, REGEN MED, V3, P907, DOI 10.2217/17460751.3.6.907; Glaser T, 2008, J NEUROL SCI, V265, P47, DOI 10.1016/j.jns.2007.09.018; Hickmott PW, 2010, CEREB CORTEX, V20, P591, DOI 10.1093/cercor/bhp125; HICKS TP, 1983, BRAIN RES, V274, P160, DOI 10.1016/0006-8993(83)90533-4; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Leker RR, 2004, CURR NEUROVASC RES, V1, P421, DOI 10.2174/1567202043361938; LEVINE S, 1960, AM J PATHOL, V36, P1; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Luhmann HJ, 1996, PROG NEUROBIOL, V48, P131, DOI 10.1016/0301-0082(95)00042-9; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McClure MM, 2005, NEUROREPORT, V16, P1309, DOI 10.1097/01.wnr.0000175613.16183.6c; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Reinecke S, 2003, EUR J NEUROSCI, V17, P623, DOI 10.1046/j.1460-9568.2003.02459.x; Robinson S, 2006, J NEUROSURG, V104, P396, DOI 10.3171/ped.2006.104.6.396; Rosenkranz K, 2010, J NEUROSCI RES, V88, P1223, DOI 10.1002/jnr.22292; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Strata F, 2004, NEUROSCIENCE, V129, P141, DOI 10.1016/j.neuroscience.2004.07.024; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Uchino H, 2008, J ANESTH, V22, P253, DOI 10.1007/s00540-008-0617-3; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Voller B, 2006, ANN NEUROL, V59, P385, DOI 10.1002/ana.20689; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Xerri C, 2003, NEUROSCIENCE, V118, P161, DOI 10.1016/S0306-4522(02)00911-9; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20194	10.1371/journal.pone.0020194	http://dx.doi.org/10.1371/journal.pone.0020194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673795	gold, Green Published			2022-12-27	WOS:000291309900004
J	Malla, N; Berg, E; Moens, U; Uhlin-Hansen, L; Winberg, JO				Malla, Nabin; Berg, Eli; Moens, Ugo; Uhlin-Hansen, Lars; Winberg, Jan-Olof			Biosynthesis of Promatrix Metalloproteinase-9/Chondroitin Sulphate Proteoglycan Heteromer Involves a Rottlerin-Sensitive Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; HUMAN NEUTROPHIL GELATINASE; COLLAGEN-BINDING DOMAIN; GENE-EXPRESSION PROFILE; FIBRONECTIN-LIKE DOMAIN; NF-KAPPA-B; MATRIX METALLOPROTEINASES; PHORBOL ESTER; HUMAN-MONOCYTES; IV COLLAGENASE	Background: Previously we have shown that a fraction of the matrix metalloproteinase-9 (MMP-9) synthesized by the macrophage cell line THP-1 was bound to a chondroitin sulphate proteoglycan (CSPG) core protein as a reduction sensitive heteromer. Several biochemical properties of the enzyme were changed when it was bound to the CSPG. Methodology/Principal Findings: By use of affinity chromatography, zymography, and radioactive labelling, various macrophage stimulators were tested for their effect on the synthesis of the proMMP-9/CSPG heteromer and its components by THP-1 cells. Of the stimulators, only PMA largely increased the biosynthesis of the heteromer. As PMA is an activator of PKC, we determined which PKC isoenzymes were expressed by performing RT-PCR and Western Blotting. Subsequently specific inhibitors were used to investigate their involvement in the biosynthesis of the heteromer. Of the inhibitors, only Rottlerin repressed the biosynthesis of proMMP-9/CSPG and its two components. Much lower concentrations of Rottlerin were needed to reduce the amount of CSPG than what was needed to repress the synthesis of the heteromer and MMP-9. Furthermore, Rottlerin caused a minor reduction in the activation of the PKC isoenzymes delta, epsilon, theta and upsilon (PKD3) in both control and PMA exposed cells. Conclusions/Significance: The biosynthesis of the proMMP-9/CSPG heteromer and proMMP-9 in THP-1 cells involves a Rottlerin-sensitive pathway that is different from the Rottlerin sensitive pathway involved in the CSPG biosynthesis. MMP-9 and CSPGs are known to be involved in various physiological and pathological processes. Formation of complexes may influence both the specificity and localization of the enzyme. Therefore, knowledge about biosynthetic pathways and factors involved in the formation of the MMP-9/CSPG heteromer may contribute to insight in the heteromers biological function as well as pointing to future targets for therapeutic agents.	[Malla, Nabin; Berg, Eli; Moens, Ugo; Uhlin-Hansen, Lars; Winberg, Jan-Olof] Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway	UiT The Arctic University of Tromso	Malla, N (corresponding author), Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway.	jan.o.winberg@uit.no			Research Council of Norway; Norwegian Cancer Society; Erna and Olav Aakre Foundation for Cancer Research	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Erna and Olav Aakre Foundation for Cancer Research	This work was supported in part by grants from The Research Council of Norway, The Norwegian Cancer Society, and The Erna and Olav Aakre Foundation for Cancer Research. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bannikov GA, 2007, AM J VET RES, V68, P995, DOI 10.2460/ajvr.68.9.995; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cawston TE, 2003, BIOCHEM SOC SYMP, V70, P125, DOI 10.1042/bss0700125; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; CONQUER JA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P1, DOI 10.1016/0167-4889(92)90021-3; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; DATTA R, 1992, BLOOD, V79, P904; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dieter P, 2000, CELL SIGNAL, V12, P297, DOI 10.1016/S0898-6568(00)00069-3; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Flannery CR, 2006, FRONT BIOSCI-LANDMRK, V11, P544, DOI 10.2741/1818; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; HALLEN A, 1972, J CHROMATOGR, V71, P83, DOI 10.1016/S0021-9673(01)85691-0; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; Hashimoto SI, 2003, SCAND J INFECT DIS, V35, P619, DOI 10.1080/00365540310015926; Hendriks BS, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-23; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Hornebeck W, 2005, PATHOL BIOL, V53, P405, DOI 10.1016/j.patbio.2004.12.015; Huang ZQ, 2011, INT J CARDIOL, V146, P153, DOI 10.1016/j.ijcard.2009.06.023; IKEDA C, 1994, BRAIN RES, V655, P147, DOI 10.1016/0006-8993(94)91608-X; Kang HC, 2004, MOL CELLS, V17, P454; Kim SJ, 1997, BIOCHEM MOL BIOL INT, V43, P1023; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kolset SO, 1999, CELL MOL LIFE SCI, V56, P857, DOI 10.1007/s000180050031; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; KOLSET SO, 1986, BIOCHEM J, V238, P209, DOI 10.1042/bj2380209; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kontny E, 2000, J LEUKOCYTE BIOL, V67, P249, DOI 10.1002/jlb.67.2.249; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Loennechen T, 2003, BIOCHEM PHARMACOL, V66, P2341, DOI 10.1016/j.bcp.2003.08.014; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Malakooti J, 2006, BIOCHEM J, V396, P327, DOI 10.1042/BJ20051391; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Malla N, 2008, CONNECT TISSUE RES, V49, P180, DOI 10.1080/03008200802151755; Malla N, 2008, J BIOL CHEM, V283, P13652, DOI 10.1074/jbc.M709140200; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mathisen B, 2003, CLIN EXP METASTAS, V20, P701, DOI 10.1023/B:CLIN.0000006819.21361.03; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; MOSIOR M, 1995, J BIOL CHEM, V270, P25526, DOI 10.1074/jbc.270.43.25526; MURPHY G, 1994, J BIOL CHEM, V269, P6632; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; O'Sullivan AW, 2009, J SURG RES, V151, P138, DOI 10.1016/j.jss.2008.02.031; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Provatopoulou X, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-390; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shipley JM, 1996, J BIOL CHEM, V271, P4335; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Shirai Y, 1998, JPN J PHARMACOL, V78, P411, DOI 10.1254/jjp.78.411; SILJANDER P, 1993, FEBS LETT, V315, P81, DOI 10.1016/0014-5793(93)81138-P; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; Takizawa T, 2003, INT ARCH ALLERGY IMM, V131, P15, DOI 10.1159/000070476; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; UHLINHANSEN L, 1993, BLOOD, V82, P2880; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; VANRANST M, 1991, CYTOKINE, V3, P231, DOI 10.1016/1043-4666(91)90021-5; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Xu XP, 2004, MATRIX BIOL, V23, P171, DOI 10.1016/j.matbio.2004.05.002; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zhou J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-25; Zu YL, 1996, BLOOD, V87, P5287, DOI 10.1182/blood.V87.12.5287.bloodjournal87125287	101	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20616	10.1371/journal.pone.0020616	http://dx.doi.org/10.1371/journal.pone.0020616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673806	Green Submitted, Green Published, gold			2022-12-27	WOS:000291309900024
J	Feuillie, C; Merheb, MM; Gillet, B; Montagnac, G; Daniel, I; Hanni, C				Feuillie, Cecile; Merheb, Maxime Mohamad; Gillet, Benjamin; Montagnac, Gilles; Daniel, Isabelle; Haenni, Catherine			A Novel SERRS Sandwich-Hybridization Assay to Detect Specific DNA Target	PLOS ONE			English	Article							RESONANCE RAMAN-SCATTERING; POLYMERASE-CHAIN-REACTION; ANCIENT DNA; ENZYMATIC AMPLIFICATION; PCR; SEQUENCE; DAMAGE; VIRUS; EXTRACTION; INHIBITORS	In this study, we have applied Surface Enhanced Resonance Raman Scattering (SERRS) technology to the specific detection of DNA. We present an innovative SERRS sandwich-hybridization assay that allows specific DNA detection without any enzymatic amplification, such as is the case with Polymerase Chain Reaction (PCR). In some substrates, such as ancient or processed remains, enzymatic amplification fails due to DNA alteration (degradation, chemical modification) or to the presence of inhibitors. Consequently, the development of a non-enzymatic method, allowing specific DNA detection, could avoid long, expensive and inconclusive amplification trials. Here, we report the proof of concept of a SERRS sandwich-hybridization assay that leads to the detection of a specific chamois DNA. This SERRS assay reveals its potential as a nonenzymatic alternative technology to DNA amplification methods (particularly the PCR method) with several applications for species detection. As the amount and type of damage highly depend on the preservation conditions, the present SERRS assay would enlarge the range of samples suitable for DNA analysis and ultimately would provide exciting new opportunities for the investigation of ancient DNA in the fields of evolutionary biology and molecular ecology, and of altered DNA in food frauds detection and forensics.	[Feuillie, Cecile; Montagnac, Gilles; Daniel, Isabelle] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, ENS Lyon,Lab Geol Lyon Terre Planetes Environm, F-69365 Lyon, France; [Merheb, Maxime Mohamad; Haenni, Catherine] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, INRA,Inst Genom Fonct Lyon, F-69365 Lyon, France; [Gillet, Benjamin] ENS Lyon, CNRS, Paleogenet UMS PALGENE, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Feuillie, C (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super Lyon, ENS Lyon,Lab Geol Lyon Terre Planetes Environm, F-69365 Lyon, France.	Catherine.Hanni@ens-lyon.fr	Daniel, Isabelle/D-2677-2012; Montagnac, Gilles/S-6440-2019; Gillet, Benjamin/ABD-6704-2020	Daniel, Isabelle/0000-0002-1448-7919; Montagnac, Gilles/0000-0001-9938-0282; 	Institut National des Sciences de l'Univers (INSU); CNRS; ENS de Lyon; INRA; University Lyon 1; ANR	Institut National des Sciences de l'Univers (INSU); CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS de Lyon; INRA; University Lyon 1; ANR(French National Research Agency (ANR))	The Raman spectroscopy facility in Ecole normale superieure de Lyon is supported by the Institut National des Sciences de l'Univers (INSU). This work was supported by the CNRS interdisciplinary programs (Origin of Life and Planets, Interface physics chemistry biology), ENS de Lyon, INRA and University Lyon 1. C.F. was supported by a grant from ENS de Lyon, and M. M. was supported by ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper A, 2004, CURR BIOL, V14, pR431, DOI 10.1016/j.cub.2004.05.037; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Faulds K, 2005, TALANTA, V67, P667, DOI 10.1016/j.talanta.2005.06.019; Faulds K, 2004, ANAL CHEM, V76, P412, DOI 10.1021/ac035060c; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; GILBERT W, 1968, COLD SPRING HARB SYM, V33, P473, DOI 10.1101/SQB.1968.033.01.055; Graham D, 1997, ANAL CHEM, V69, P4703, DOI 10.1021/ac970657b; Graham D, 2008, NAT NANOTECHNOL, V3, P548, DOI 10.1038/nnano.2008.189; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Haller M, 1996, J TRACE MICROPROBE T, V14, P461; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Hudlow WR, 2008, FORENSIC SCI INT-GEN, V2, P108, DOI 10.1016/j.fsigen.2007.09.001; Jiang SC, 2004, J APPL MICROBIOL, V97, P17, DOI 10.1111/j.1365-2672.2004.02269.x; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Maher RC, 2002, CHEM PHYS LETT, V352, P378, DOI 10.1016/S0009-2614(01)01474-9; Mitchell D, 2005, MUTAT RES-FUND MOL M, V571, P265, DOI 10.1016/j.mrfmmm.2004.06.060; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; ORLANDO L, 2000, SOC FRANCAISE GENETI, V16, pR1; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Pafundo S, 2010, ANAL BIOANAL CHEM, V396, P1831, DOI 10.1007/s00216-009-3419-z; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Scheu PM, 1998, FOOD MICROBIOL, V15, P13, DOI 10.1006/fmic.1997.0134; Shutler GG, 1999, J FORENSIC SCI, V44, P623; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stokstad E, 2003, SCIENCE, V300, P407; TANNER NK, 1994, CURR BIOL, V4, P488, DOI 10.1016/S0960-9822(00)00109-3; VALENTINI A, 2006, TRENDS ECOL EVOL, V24, P110; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zhang JM, 2009, SCI CHINA SER C, V52, P568, DOI 10.1007/s11427-009-0069-5	46	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e17847	10.1371/journal.pone.0017847	http://dx.doi.org/10.1371/journal.pone.0017847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655320	gold, Green Published			2022-12-27	WOS:000291097600003
J	Soares, MPM; Silva-Torres, FA; Elias-Neto, M; Nunes, FMF; Simoes, ZLP; Bitondi, MMG				Soares, Michelle P. M.; Silva-Torres, Fernanda A.; Elias-Neto, Moyses; Nunes, Francis M. F.; Simoes, Zila L. P.; Bitondi, Marcia M. G.			Ecdysteroid-Dependent Expression of the Tweedle and Peroxidase Genes during Adult Cuticle Formation in the Honey Bee, Apis mellifera	PLOS ONE			English	Article							ARTHROPOD CUTICULAR PROTEINS; MANDUCA-SEXTA; TOBACCO HORNWORM; DEVELOPMENTAL EXPRESSION; HORMONAL-CONTROL; SCLEROTIZATION; MELANIZATION; SECRETION; MECHANISM; LACCASE-2	Cuticle renewal is a complex biological process that depends on the cross talk between hormone levels and gene expression. This study characterized the expression of two genes encoding cuticle proteins sharing the four conserved amino acid blocks of the Tweedle family, AmelTwdl1 and AmelTwdl2, and a gene encoding a cuticle peroxidase containing the Animal haem peroxidase domain, Ampxd, in the honey bee. Gene sequencing and annotation validated the formerly predicted tweedle genes, and revealed a novel gene, Ampxd, in the honey bee genome. Expression of these genes was studied in the context of the ecdysteroid-coordinated pupal-to-adult molt, and in different tissues. Higher transcript levels were detected in the integument after the ecdysteroid peak that induces apolysis, coinciding with the synthesis and deposition of the adult exoskeleton and its early differentiation. The effect of this hormone was confirmed in vivo by tying a ligature between the thorax and abdomen of early pupae to prevent the abdominal integument from coming in contact with ecdysteroids released from the prothoracic gland. This procedure impaired the natural increase in transcript levels in the abdominal integument. Both tweedle genes were expressed at higher levels in the empty gut than in the thoracic integument and trachea of pharate adults. In contrast, Ampxd transcripts were found in higher levels in the thoracic integument and trachea than in the gut. Together, the data strongly suggest that these three genes play roles in ecdysteroid-dependent exoskeleton construction and differentiation and also point to a possible role for the two tweedle genes in the formation of the cuticle (peritrophic membrane) that internally lines the gut.	[Soares, Michelle P. M.; Silva-Torres, Fernanda A.; Elias-Neto, Moyses; Nunes, Francis M. F.; Simoes, Zila L. P.; Bitondi, Marcia M. G.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo	Soares, MPM (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil.	mmgbit@usp.br	Elias-Neto, Moysés/B-6437-2012; Bitondi, Marcia MG/E-8014-2012; Simoes, Zila Luz Paulino/H-7314-2014; Soares, Michelle/E-1168-2012; Nunes, Francis M. F./F-5871-2010	Bitondi, Marcia MG/0000-0002-5619-6378; Nunes, Francis M. F./0000-0002-7769-3058; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil [05/03926-5, 07/04314-9, 03/10581-9, 07/08300-2, 07/07594-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil - Grant 05/03926-5 and fellowships: MPMS (07/04314-9), FAST (03/10581-9), MEN (07/08300-2), FMFN (07/07594-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1981, J COMP PHYSIOL, V145, P17, DOI 10.1007/BF00782588; Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; BINNINGTON KC, 1988, TISSUE CELL, V20, P405, DOI 10.1016/0040-8166(88)90073-0; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; CURTIS AT, 1984, J INSECT PHYSIOL, V30, P597, DOI 10.1016/0022-1910(84)90043-X; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Dittmer NT, 2004, INSECT BIOCHEM MOLEC, V34, P29, DOI 10.1016/j.ibmb.2003.08.003; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Elias-Neto M, 2009, APIDOLOGIE, V40, P29, DOI 10.1051/apido:2008064; FRAENKEL G, 1963, SCIENCE, V141, P1057, DOI 10.1126/science.141.3585.1057; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; HASSON C, 1987, ARCH INSECT BIOCHEM, V5, P13, DOI 10.1002/arch.940050103; Hepburn H.R., 1985, P1; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Hiruma K, 2010, J INSECT PHYSIOL, V56, P1390, DOI 10.1016/j.jinsphys.2010.03.029; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKE M, 1969, Tissue and Cell, V1, P555, DOI 10.1016/S0040-8166(69)80021-2; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; MESSNER B, 1991, ZOOL JAHRB ALLG ZOOL, V95, P31; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Nijhout H.F., 1994, INSECT HORMONES; Pinto LZ, 2002, J INSECT PHYSIOL, V48, P783, DOI 10.1016/S0022-1910(02)00103-8; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Revest JM, 2000, J BIOL CHEM, V275, P8083, DOI 10.1074/jbc.275.11.8083; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; THOMPSON PR, 1978, J COMP PHYSIOL, V126, P257, DOI 10.1007/BF00688935; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Yamazaki Y, 2011, INSECT BIOCHEM MOLEC, V41, P283, DOI 10.1016/j.ibmb.2011.01.005; YAO Q, PLOS ONE, V5; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YE RD, 1988, J BIOL CHEM, V263, P4869; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005; Zitnan D., 2005, P1; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	64	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20513	10.1371/journal.pone.0020513	http://dx.doi.org/10.1371/journal.pone.0020513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655217	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600085
J	Aguda, BD; Marsh, CB; Thacker, M; Crouser, ED				Aguda, Baltazar D.; Marsh, Clay B.; Thacker, Michael; Crouser, Elliott D.			An In Silico Modeling Approach to Understanding the Dynamics of Sarcoidosis	PLOS ONE			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; DISEASE; INFLIXIMAB; CANCER; CD8	Background: Sarcoidosis is a polygenic disease with diverse phenotypic presentations characterized by an abnormal antigen-mediated Th1 type immune response. At present, progress towards understanding sarcoidosis disease mechanisms and the development of novel treatments is limited by constraints attendant to conducting human research in a rare disease in the absence of relevant animal models. We sought to develop a computational model to enhance our understanding of the pathological mechanisms of and predict potential treatments of sarcoidosis. Methodology/Results: Based upon the literature, we developed a computational model of known interactions between essential immune cells (antigen-presenting macrophages, effector and regulatory T cells) and cytokine mediators (IL-2, TNF alpha, IFN gamma) of granulomatous inflammation during sarcoidosis. The dynamics of these interactions are described by a set of ordinary differential equations. The model predicts bistable switching behavior which is consistent with normal (self-limited) and "sarcoidosis-like'' (sustained) activation of the inflammatory components of the system following a single antigen challenge. By perturbing the influence of model components using inhibitors of the cytokine mediators, distinct clinically relevant disease phenotypes were represented. Finally, the model was shown to be useful for pre-clinical testing of therapies based upon molecular targets and dose-effect relationships. Conclusions/Significance: Our work illustrates a dynamic computer simulation of granulomatous inflammation scenarios that is useful for the investigation of disease mechanisms and for pre-clinical therapeutic testing. In lieu of relevant in vitro or animal surrogates, our model may provide for the screening of potential therapies for specific sarcoidosis disease phenotypes in advance of expensive clinical trials.	[Aguda, Baltazar D.] NCI, Ctr Canc Res, Neurooncol Branch, Bethesda, MD 20892 USA; [Marsh, Clay B.; Crouser, Elliott D.] Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Thacker, Michael] Ohio State Univ, Med Ctr, Dept Elect & Comp Engn, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Aguda, BD (corresponding author), NCI, Ctr Canc Res, Neurooncol Branch, Bethesda, MD 20892 USA.	Elliott.Crouser@osumc.edu	Crouser, Elliott/ABC-2602-2021; Crouser, Elliott/E-2933-2011		American Thoracic Society/Foundation for Sarcoidosis Research (EDC)	American Thoracic Society/Foundation for Sarcoidosis Research (EDC)	Funding was provided by the American Thoracic Society/Foundation for Sarcoidosis Research (EDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2007, PLOS COMPUT BIOL, V3, P1674, DOI 10.1371/journal.pcbi.0030152; Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; Arazi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008447; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Bilate AM, 2010, J CLIN INVEST, V120, P4190, DOI 10.1172/JCI45262; Correale P, 2001, EUR J CANCER, V37, P892, DOI 10.1016/S0959-8049(01)00063-6; Crouser ED, 2010, CHEST, V137, P1432, DOI 10.1378/chest.09-2576; DELEN CI, 2009, RHEUMATOLOGY, V48, P883; Dhaille F, 2010, DERMATOLOGY, V220, P234, DOI 10.1159/000275676; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Idali F, 2008, CLIN EXP IMMUNOL, V152, P127, DOI 10.1111/j.1365-2249.2008.03609.x; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Judson MA, 2008, EUR RESPIR J, V31, P1189, DOI 10.1183/09031936.00051907; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Mariani L, 2004, PROG BIOPHYS MOL BIO, V86, P45, DOI 10.1016/j.pbiomolbio.2004.02.007; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Nagar M, 2010, J IMMUNOL, V184, P3570, DOI 10.4049/jimmunol.0902070; Noor A, 2007, CLIN DERMATOL, V25, P250, DOI 10.1016/j.clindermatol.2007.03.002; Safirstein BH, 2003, CHEST, V123, P301, DOI 10.1378/chest.123.1.301; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009088; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19544	10.1371/journal.pone.0019544	http://dx.doi.org/10.1371/journal.pone.0019544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637752	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500007
J	Baker, EL; Srivastava, J; Yu, DH; Bonnecaze, RT; Zaman, MH				Baker, Erin L.; Srivastava, Jaya; Yu, Dihua; Bonnecaze, Roger T.; Zaman, Muhammad H.			Cancer Cell Migration: Integrated Roles of Matrix Mechanics and Transforming Potential	PLOS ONE			English	Article							INVASIVE BREAST-CANCER; EPITHELIAL ACINI; STIFFNESS; ERBB2; OVEREXPRESSION; PROLIFERATION; PROTEOLYSIS; TRANSITION; STRATEGIES; MOVEMENT	Significant progress has been achieved toward elucidating the molecular mechanisms that underlie breast cancer progression; yet, much less is known about the associated cellular biophysical traits. To this end, we use time-lapsed confocal microscopy to investigate the interplay among cell motility, three-dimensional (3D) matrix stiffness, matrix architecture, and transforming potential in a mammary epithelial cell (MEC) cancer progression series. We use a well characterized breast cancer progression model where human-derived MCF10A MECs overexpress either ErbB2, 14-3-3 zeta, or both ErbB2 and 14-3-3 zeta, with empty vector as a control. Cell motility assays showed that MECs overexpressing ErbB2 alone exhibited notably high migration speeds when cultured atop two-dimensional (2D) matrices, while overexpression of 14-3-3 zeta alone most suppressed migration atop 2D matrices (as compared to non-transformed MECs). Our results also suggest that co-overexpression of the 14-3-3 zeta and ErbB2 proteins facilitates cell migratory capacity in 3D matrices, as reflected in cell migration speed. Additionally, 3D matrices of sufficient stiffness can significantly hinder the migratory ability of partially transformed cells, but increased 3D matrix stiffness has a lesser effect on the aggressive migratory behavior exhibited by fully transformed cells that co-overexpress both ErbB2 and 14-3-3 zeta. Finally, this study shows that for MECs possessing partial or full transforming potential, those overexpressing ErbB2 alone show the greatest sensitivity of cell migration speed to matrix architecture, while those overexpressing 14-3-3 zeta alone exhibit the least sensitivity to matrix architecture. Given the current knowledge of breast cancer mechanobiology, these findings overall suggest that cell motility is governed by a complex interplay between matrix mechanics and transforming potential.	[Baker, Erin L.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Srivastava, Jaya] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Canc Biol Program, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Bonnecaze, Roger T.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Boston University	Baker, EL (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	zaman@bu.edu		Yu, Dihua/0000-0001-6231-9381	United Negro College Fund (UNCF)/Merck Graduate Science Research Dissertation Fellowship; Philanthropic Educational Organization (P.E.O.); Charles Tate Foundation; National Institutes of Health [1R01CA132633]; NATIONAL CANCER INSTITUTE [R01CA132633] Funding Source: NIH RePORTER	United Negro College Fund (UNCF)/Merck Graduate Science Research Dissertation Fellowship; Philanthropic Educational Organization (P.E.O.); Charles Tate Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was made possible by the United Negro College Fund (UNCF)/Merck Graduate Science Research Dissertation Fellowship to ELB, the Philanthropic Educational Organization (P.E.O.) Scholar Award to ELB, the Charles Tate Foundation UT Seed Grant to MHZ and DY, and National Institutes of Health funding (1R01CA132633) to MHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hondermarck H, 2001, PROTEOMICS, V1, P1216, DOI 10.1002/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Ligresti G, 2008, MOL MED REP, V1, P451; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu J, 2010, CELL CYCLE, V9, P421, DOI 10.4161/cc.9.3.10633; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	31	35	35	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20355	10.1371/journal.pone.0020355	http://dx.doi.org/10.1371/journal.pone.0020355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647371	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500050
J	Gar, O; Sargent, DJ; Tsai, CJ; Pleban, T; Shalev, G; Byrne, DH; Zamir, D				Gar, Oron; Sargent, Daniel J.; Tsai, Ching-Jung; Pleban, Tzili; Shalev, Gil; Byrne, David H.; Zamir, Dani			An Autotetraploid Linkage Map of Rose (Rosa hybrida) Validated Using the Strawberry (Fragaria vesca) Genome Sequence	PLOS ONE			English	Article							CONSTRUCTION; RFLP; EVOLUTION; MARKERS; DNA; TETRAPLOIDMAP; SYNTENY; TRAITS; POTATO; AFLP	Polyploidy is a pivotal process in plant evolution as it increase gene redundancy and morphological intricacy but due to the complexity of polysomic inheritance we have only few genetic maps of autopolyploid organisms. A robust mapping framework is particularly important in polyploid crop species, rose included (2n=4x=28), where the objective is to study multiallelic interactions that control traits of value for plant breeding. From a cross between the garden, peach red and fragrant cultivar Fragrant Cloud (FC) and a cut-rose yellow cultivar Golden Gate (GG), we generated an autotetraploid GGFC mapping population consisting of 132 individuals. For the map we used 128 sequence-based markers, 141 AFLP, 86 SSR and three morphological markers. Seven linkage groups were resolved for FC (Total 632 cM) and GG (616 cM) which were validated by markers that segregated in both parents as well as the diploid integrated consensus map. The release of the Fragaria vesca genome, which also belongs to the Rosoideae, allowed us to place 70 rose sequenced markers on the seven strawberry pseudo-chromosomes. Synteny between Rosa and Fragaria was high with an estimated four major translocations and six inversions required to place the 17 non-collinear markers in the same order. Based on a verified linear order of the rose markers, we could further partition each of the parents into its four homologous groups, thus providing an essential framework to aid the sequencing of an autotetraploid genome.	[Gar, Oron; Pleban, Tzili; Shalev, Gil; Zamir, Dani] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Tsai, Ching-Jung; Byrne, David H.] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA	Hebrew University of Jerusalem; Texas A&M University System; Texas A&M University College Station	Gar, O (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel.	zamir@agri.huji.ac.il	Sargent, Daniel James/A-2933-2014; Byrne, David/AAF-6262-2021	Sargent, Daniel James/0000-0002-6686-7147; 	German-Israeli Foundation [I-842-204.12/2004]; The Volkswagen Niedersachsen-Israel Foundation [11-76251-99-6/05ZN20209]; TDA-TIE/BARD [TB-8008-04]; East Malling Trust; BBSRC [BB/E007074/1]; Biotechnology and Biological Sciences Research Council [BB/E007074/1] Funding Source: researchfish	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); The Volkswagen Niedersachsen-Israel Foundation; TDA-TIE/BARD; East Malling Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support for this study was provided by the German-Israeli Foundation (www.gif.org.il) I-842-204.12/2004 and The Volkswagen Niedersachsen-Israel Foundation (www.mwk.niedersachsen.de) 11-76251-99-6/05ZN20209 grants to DZ. Additional support was provided by TDA-TIE/BARD (www.bard-isus.com) TB-8008-04 grants to DZ and DHB, and by the East Malling Trust and BBSRC (www.bbsrc.ac.uk) BB/E007074/1 grants to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALJANABI SM, 1993, GENETICS, V134, P1249; Baker P, 2010, THEOR APPL GENET, V120, P1653, DOI 10.1007/s00122-010-1283-z; BERNATZKY R, 1986, GENETICS, V112, P887; BONIERBALE MW, 1988, GENETICS, V120, P1095; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DASILVA J, 1995, MOL BREEDING, V1, P165, DOI 10.1007/BF01249701; De Winton D, 1931, J GENET, V24, P121, DOI 10.1007/BF03020826; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dugo ML, 2005, THEOR APPL GENET, V111, P511, DOI 10.1007/s00122-005-2042-4; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Foucher F, 2008, GENOME, V51, P827, DOI 10.1139/G08-067; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Gallais A., 2003, QUANTITATIVE GENETIC; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Hackett CA, 2003, J HERED, V94, P358, DOI 10.1093/jhered/esg066; Hackett CA, 2007, J HERED, V98, P727, DOI 10.1093/jhered/esm086; Haldane JBS, 1930, J GENET, V22, P359, DOI 10.1007/BF02984197; HILU KW, 1993, AM J BOT, V80, P1494, DOI 10.2307/2445679; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Julier Bernadette, 2003, BMC Plant Biology, V3, P9, DOI 10.1186/1471-2229-3-9; Kaczmarek M, 2009, GENOME, V52, P620, DOI 10.1139/G09-035; Leach LJ, 2010, P NATL ACAD SCI USA, V107, P4270, DOI 10.1073/pnas.0908477107; Luo MC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-122; Ma N, 2006, J EXP BOT, V57, P2763, DOI 10.1093/jxb/erl033; Mather K, 1935, J GENET, V30, P53, DOI 10.1007/BF02982205; Nybom H, 2006, J EVOLUTION BIOL, V19, P635, DOI 10.1111/j.1420-9101.2005.01010.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Remay A, 2009, THEOR APPL GENET, V119, P767, DOI 10.1007/s00122-009-1087-1; REUVENI R, 1994, J PHYTOPATHOL, V142, P331, DOI 10.1111/j.1439-0434.1994.tb04547.x; Ripol MI, 1999, GENE, V235, P31, DOI 10.1016/S0378-1119(99)00218-8; Roche P, 1997, THEOR APPL GENET, V94, P528, DOI 10.1007/s001220050447; Rousseau-Gueutin M, 2008, GENETICS, V179, P2045, DOI 10.1534/genetics.107.083840; Sargent DJ, 2009, MOL BREEDING, V24, P293, DOI 10.1007/s11032-009-9292-9; Shalit M, 2004, ISR J PLANT SCI, V52, P245, DOI 10.1560/P7G3-FT41-XJCP-1XFM; SHARP PA, 1973, BIOCHEMISTRY-US, V12, P3055, DOI 10.1021/bi00740a018; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; SOBRAL BWS, 1993, THEOR APPL GENET, V86, P105, DOI 10.1007/BF00223814; Spiller M, 2011, THEOR APPL GENET, V122, P489, DOI 10.1007/s00122-010-1463-x; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vilanova S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-67; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WILLIAMS JF, 1989, BIOTECHNIQUES, V7, P762; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; WU KK, 1992, THEOR APPL GENET, V83, P294, DOI 10.1007/BF00224274; Wu RL, 2001, GENETICS, V159, P869; Yan Z, 2005, THEOR APPL GENET, V110, P766, DOI 10.1007/s00122-004-1903-6; Zhang LH, 2006, J AM SOC HORTIC SCI, V131, P380, DOI 10.21273/JASHS.131.3.380	57	50	58	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20463	10.1371/journal.pone.0020463	http://dx.doi.org/10.1371/journal.pone.0020463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647382	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500061
J	Hida, K; Lai, SK; Suk, JS; Won, SY; Boyle, MP; Hanes, J				Hida, Kaoru; Lai, Samuel K.; Suk, Jung Soo; Won, Sang Y.; Boyle, Michael P.; Hanes, Justin			Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients	PLOS ONE			English	Article							CILIATED AIRWAY EPITHELIUM; ADENOASSOCIATED VIRUS; IN-VITRO; RECOMBINANT ADENOVIRUS; INTRACELLULAR TRAFFICKING; POLYMER NANOPARTICLES; DIRECTED EVOLUTION; NONHUMAN-PRIMATES; IMMUNE-RESPONSES; RAPID-TRANSPORT	Norwalk virus and human papilloma virus, two viruses that infect humans at mucosal surfaces, have been found capable of rapidly penetrating human mucus secretions. Viral vectors for gene therapy of Cystic Fibrosis (CF) must similarly penetrate purulent lung airway mucus (sputum) to deliver DNA to airway epithelial cells. However, surprisingly little is known about the rates at which gene delivery vehicles penetrate sputum, including viral vectors used in clinical trials for CF gene therapy. We find that sputum spontaneously expectorated by CF patients efficiently traps two viral vectors commonly used in CF gene therapy trials, adenovirus (d similar to 80 nm) and adeno-associated virus (AAV serotype 5; d similar to 20 nm), leading to average effective diffusivities that are similar to 3,000-fold and 12,000-fold slower than their theoretical speeds in water, respectively. Both viral vectors are slowed by adhesion, as engineered muco-inert nanoparticles with diameters as large as 200 nm penetrate the same sputum samples at rates only similar to 40-fold reduced compared to in pure water. A limited fraction of AAV exhibit sufficiently fast mobility to penetrate physiologically thick sputum layers, likely because of the lower viscous drag and smaller surface area for adhesion to sputum constituents. Nevertheless, poor penetration of CF sputum is likely a major contributor to the ineffectiveness of viral vector based gene therapy in the lungs of CF patients observed to date.	[Hida, Kaoru; Suk, Jung Soo; Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Lai, Samuel K.; Won, Sang Y.; Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD USA; [Lai, Samuel K.; Boyle, Michael P.; Hanes, Justin] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Baltimore, MD USA; [Boyle, Michael P.] Johns Hopkins Univ, Sch Med, Johns Hopkins Adult Cyst Fibrosis Program, Div Pulm & Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Hida, K (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hanes@jhu.edu		Boyle, Michael/0000-0002-9740-1630; Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [NIH EB003558, P01 HL051811-16]; Cystic Fibrosis Foundation [CFF HANES08G0]; Croucher Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Croucher Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by National Institutes of Health grants to J.H. (NIH EB003558, P01 HL051811-16), the Cystic Fibrosis Foundation (CFF HANES08G0) and to S. K. L. (Croucher Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher RC, 1999, J CLIN INVEST, V103, P441, DOI 10.1172/JCI6330; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clunes Mark T, 2007, Drug Discov Today Dis Mech, V4, P63, DOI 10.1016/j.ddmec.2007.09.001; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Conrad CK, 1996, GENE THER, V3, P658; Dasgupta B, 1996, PEDIATR PULM, V22, P161, DOI 10.1002/(SICI)1099-0496(199609)22:3<161::AID-PPUL4>3.0.CO;2-S; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761; Ferrari S, 2002, ADV DRUG DELIVER REV, V54, P1373, DOI 10.1016/S0169-409X(02)00145-X; GaherySegard H, 1997, J CLIN INVEST, V100, P2218, DOI 10.1172/JCI119759; Griesenbach U, 2006, GENE THER, V13, P1061, DOI 10.1038/sj.gt.3302809; Griesenbach U, 2004, GENE THER, V11, pS43, DOI 10.1038/sj.gt.3302368; Grubb BR, 1999, PHYSIOL REV, V79, P193; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hansen J, 2000, J VIROL, V74, P992, DOI 10.1128/JVI.74.2.992-996.2000; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Joseph PM, 2001, HUM GENE THER, V12, P1369, DOI 10.1089/104303401750298535; Kaplan JM, 1996, GENE THER, V3, P117; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Lai SK, 2008, J CONTROL RELEASE, V125, P107, DOI 10.1016/j.jconrel.2007.10.015; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Li WP, 2009, MOL THER, V17, P2067, DOI 10.1038/mt.2009.155; Limberis MP, 2009, MOL THER, V17, P294, DOI 10.1038/mt.2008.261; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Mueller C, 2008, CLIN REV ALLERG IMMU, V35, P164, DOI 10.1007/s12016-008-8080-3; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Perricone MA, 2000, HUM GENE THER, V11, P1997, DOI 10.1089/10430340050143426; Rooney CP, 2002, J VIROL, V76, P10437, DOI 10.1128/JVI.76.20.10437-10443.2002; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; SHEEHAN JK, 1986, BIOCHEM J, V239, P147, DOI 10.1042/bj2390147; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stern M, 1998, GENE THER, V5, P91, DOI 10.1038/sj.gt.3300556; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Suh J, 2007, INT J NANOMED, V2, P735; Suk JS, 2007, EXP BIOL MED, V232, P461; Suk JS, 2011, NANOMEDICINE-UK, V6, P365, DOI 10.2217/NNM.10.123; Suk JS, 2009, BIOMATERIALS, V30, P2591, DOI 10.1016/j.biomaterials.2008.12.076; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Virella-Lowell I, 2000, GENE THER, V7, P1783, DOI 10.1038/sj.gt.3301268; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wagner JA, 1998, LANCET, V351, P1702, DOI 10.1016/S0140-6736(05)77740-0; Walters RW, 2002, J BIOL CHEM, V277, P23709, DOI 10.1074/jbc.M200292200; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; Yan ZY, 2006, J BIOL CHEM, V281, P29684, DOI 10.1074/jbc.M604099200; YANG YP, 1995, NAT MED, V1, P890, DOI 10.1038/nm0995-890; Zahm JM, 2001, AM J RESP CRIT CARE, V163, P1153, DOI 10.1164/ajrccm.163.5.2005002; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	60	48	56	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19919	10.1371/journal.pone.0019919	http://dx.doi.org/10.1371/journal.pone.0019919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637751	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052500017
J	Joshi, A; Zhao, BW; Romanowski, C; Rosen, D; Flomenberg, P				Joshi, Amita; Zhao, Biwei; Romanowski, Cara; Rosen, David; Flomenberg, Phyllis			Comparison of Human Memory CD8 T Cell Responses to Adenoviral Early and Late Proteins in Peripheral Blood and Lymphoid Tissue	PLOS ONE			English	Article							BONE-MARROW; SURFACE EXPRESSION; INFECTIONS; VIRUS; TRANSPLANTATION; IMMUNITY; GENERATION; RECIPIENTS; RECONSTITUTION; MECHANISMS	Treatment of invasive adenovirus (Ad) disease in hematopoietic stem cell transplant (SCT) recipients with capsid protein hexon-specific donor T cells is under investigation. We propose that cytotoxic T cells (CTLs) targeted to the late protein hexon may be inefficient in vivo because the early Ad protein E3-19K downregulates HLA class I antigens in infected cells. In this study, CD8+ T cells targeted to highly conserved HLA A2-restricted epitopes from the early regulatory protein DNA polymerase (P-977) and late protein hexon (H-892) were compared in peripheral blood (PB) and tonsils of naturally infected adults. In tonsils, epitope-specific pentamers detected a significantly higher frequency of P-977+ CD8+ T cells compared to H-892+ CD8+ T cells; this trend was reversed in PB. Tonsil epitope-specific CD8+ T cells expressed IFN-gamma and IL-2 but not perforin or TNF-alpha, whereas PB T cells were positive for IFN-gamma, TNF-alpha, and perforin. Tonsil epitope-specific T cells expressed lymphoid homing marker CCR7 and exhibited lower levels of the activation marker CD25 but higher proliferative potential than PB T cells. Finally, in parallel with the kinetics of mRNA expression, P-977-specific CTLs lysed targets as early as 8 hrs post infection. In contrast, H-892-specific CTLs did not kill unless infected fibroblasts were pretreated with IFN-gamma to up regulate HLA class I antigens, and cytotoxicity was delayed until 16-24 hours. These data show that, in contrast to hexon CTLs, central memory type DNA polymerase CTLs dominate the lymphoid compartment and kill fibroblasts earlier after infection without requiring exogenous IFN-gamma. Thus, use of CTLs targeted to both early and late Ad proteins may improve the efficacy of immunotherapy for life-threatening Ad disease in SCT recipients.	[Joshi, Amita] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Zhao, Biwei; Romanowski, Cara; Flomenberg, Phyllis] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Rosen, David] Thomas Jefferson Univ, Dept Otolaryngol, Philadelphia, PA 19103 USA	Jefferson University; Jefferson University; Jefferson University	Joshi, A (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	phyllis.flomenberg@mail.jci.tju.edu			National Institute of Allergy and Infectious Diseases (NIAID) [AI067684]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067684] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) RO1 grant AI067684 to P.F. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett EM, 1999, J IMMUNOL, V162, P5049; BHAT BM, 1987, J VIROL, V61, P3938, DOI 10.1128/JVI.61.12.3938-3945.1987; Bordigoni Pierre, 2001, Clinical Infectious Diseases, V32, P1290, DOI 10.1086/319984; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; Castiglioni P, 2008, J IMMUNOL, V180, P4956, DOI 10.4049/jimmunol.180.7.4956; Chakrabarti S, 2000, BONE MARROW TRANSPL, V26, P305, DOI 10.1038/sj.bmt.1702508; Chakrabarti S, 2004, LEUKEMIA LYMPHOMA, V45, P873, DOI 10.1080/10428190310001628176; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; Feuchtinger T, 2006, BRIT J HAEMATOL, V134, P64, DOI 10.1111/j.1365-2141.2006.06108.x; Feuchtinger T, 2008, J IMMUNOTHER, V31, P199, DOI 10.1097/CJI.0b013e31815ef862; Flomenberg P, 1996, J VIROL, V70, P6314, DOI 10.1128/JVI.70.9.6314-6322.1996; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; Heemskerk B, 2005, J INFECT DIS, V191, P520, DOI 10.1086/427513; HROMAS R, 1994, BLOOD, V84, P1689, DOI 10.1182/blood.V84.5.1689.bloodjournal8451689; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Joshi A, 2009, J GEN VIROL, V90, P84, DOI 10.1099/vir.0.002493-0; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386; Krawczyk CM, 2007, INFECT IMMUN, V75, P3556, DOI 10.1128/IAI.00086-07; Kring SC, 1996, J VIROL, V70, P5495, DOI 10.1128/JVI.70.8.5495-5502.1996; La Rosa AM, 2001, CLIN INFECT DIS, V32, P871, DOI 10.1086/319352; Leen AA, 2006, BIOL BLOOD MARROW TR, V12, P243, DOI 10.1016/j.bbmt.2005.10.024; Leen AM, 2008, J VIROL, V82, P546, DOI 10.1128/JVI.01689-07; Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475; Lichtenstein DL, 2004, INT REV IMMUNOL, V23, P75, DOI 10.1080/08830180490265556; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Neofytos D, 2007, BIOL BLOOD MARROW TR, V13, P74, DOI 10.1016/j.bbmt.2006.08.040; Olive M, 2002, HUM GENE THER, V13, P1167, DOI 10.1089/104303402320138952; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Symeonidis N, 2007, TRANSPL INFECT DIS, V9, P108, DOI 10.1111/j.1399-3062.2006.00184.x; Tang J, 2006, VIROLOGY, V350, P312, DOI 10.1016/j.virol.2006.01.024; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zandvliet ML, 2010, HAEMATOL-HEMATOL J, V95, P1943, DOI 10.3324/haematol.2010.022947; Zhu FL, 2010, J GEN VIROL, V91, P1577, DOI 10.1099/vir.0.019471-0	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20068	10.1371/journal.pone.0020068	http://dx.doi.org/10.1371/journal.pone.0020068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637763	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500027
J	Lin, A; Jimenez, J; Derr, J; Vera, P; Manapat, ML; Esvelt, KM; Villanueva, L; Liu, DR; Chen, IA				Lin, Abraham; Jimenez, Jose; Derr, Julien; Vera, Pedro; Manapat, Michael L.; Esvelt, Kevin M.; Villanueva, Laura; Liu, David R.; Chen, Irene A.			Inhibition of Bacterial Conjugation by Phage M13 and Its Protein g3p: Quantitative Analysis and Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHANGING EPIDEMIOLOGY; RESISTANCE; PLASMID; INFECTION; KINETICS; BACTERIOPHAGES; PENETRATION; PNEUMONIAE; EVOLUTION	Conjugation is the main mode of horizontal gene transfer that spreads antibiotic resistance among bacteria. Strategies for inhibiting conjugation may be useful for preserving the effectiveness of antibiotics and preventing the emergence of bacterial strains with multiple resistances. Filamentous bacteriophages were first observed to inhibit conjugation several decades ago. Here we investigate the mechanism of inhibition and find that the primary effect on conjugation is occlusion of the conjugative pilus by phage particles. This interaction is mediated primarily by phage coat protein g3p, and exogenous addition of the soluble fragment of g3p inhibited conjugation at low nanomolar concentrations. Our data are quantitatively consistent with a simple model in which association between the pili and phage particles or g3p prevents transmission of an F plasmid encoding tetracycline resistance. We also observe a decrease in the donor ability of infected cells, which is quantitatively consistent with a reduction in pili elaboration. Since many antibiotic-resistance factors confer susceptibility to phage infection through expression of conjugative pili (the receptor for filamentous phage), these results suggest that phage may be a source of soluble proteins that slow the spread of antibiotic resistance genes.	[Lin, Abraham; Jimenez, Jose; Derr, Julien; Vera, Pedro; Villanueva, Laura; Chen, Irene A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Esvelt, Kevin M.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Esvelt, Kevin M.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	Lin, A (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	ichen@post.harvard.edu	Villanueva, Laura/N-3598-2014; Vera, Pedro/AAE-1514-2021; Liu, David R./HCH-3132-2022	Villanueva, Laura/0000-0001-5659-8599; Jimenez, Jose/0000-0002-2700-9473; Esvelt, Kevin/0000-0001-8797-3945; Lin, Abraham/0000-0003-1659-3026; Chen, Irene/0000-0001-6040-7927	Harvard College; Human Frontiers Science Program; Fannie and John Hertz Foundation; NSF; Howard Hughes Medical Institute; NIH [R01GM065400, GM068763]; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400, P50GM068763] Funding Source: NIH RePORTER	Harvard College; Human Frontiers Science Program(Human Frontier Science Program); Fannie and John Hertz Foundation; NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AL received support from the Harvard College Research Program (http://www.seo.harvard.edu). JJ and MLM are fellows of the Foundational Questions in Evolutionary Biology at Harvard University sponsored by the John Templeton Foundation (http://www.fas.harvard.edu/similar to fqeb/). JD received a fellowship from the Human Frontiers Science Program (http://www.hfsp.org/). KME received graduate fellowships from the Fannie and John Hertz Foundation (http://www.hertzfoundation.org/) and the NSF (http://www.nsf.gov/). DRL acknowledges support from the Howard Hughes Medical Institute (http://www.hhmi.org/) and NIH grant R01GM065400 (http://www.nih.gov/). This work was supported by NIH grant GM068763 to the National Centers of Systems Biology. IAC is a Bauer Fellow at Harvard University (http://www.sysbio.harvard.edu/csb). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrup L, 1999, MICROBIOL-UK, V145, P2001, DOI 10.1099/13500872-145-8-2001; Andrup L, 1998, PLASMID, V40, P30, DOI 10.1006/plas.1998.1346; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; BOEKE JD, 1982, MOL GEN GENET, V186, P185, DOI 10.1007/BF00331849; CULLUM J, 1978, PLASMID, V1, P536, DOI 10.1016/0147-619X(78)90010-0; Daehnel K, 2005, MICROBIOL-SGM, V151, P3541, DOI 10.1099/mic.0.28159-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng LW, 1999, VIROLOGY, V253, P271, DOI 10.1006/viro.1998.9509; Frost LS., 1993, BACTERIAL CONJUGATIO, P189; GUINEY DG, 1982, J MOL BIOL, V162, P699, DOI 10.1016/0022-2836(82)90397-7; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Holliger P, 1999, J MOL BIOL, V288, P649, DOI 10.1006/jmbi.1999.2720; INGRAM LC, 1973, ANTIMICROB AGENTS CH, V3, P279, DOI 10.1128/AAC.3.2.279; JACOBSON A, 1972, J VIROL, V10, P835, DOI 10.1128/JVI.10.4.835-843.1972; Kim BC, 2005, J BACTERIOL, V187, P4505, DOI 10.1128/JB.187.13.4505-4513.2005; LEVIN BR, 1979, PLASMID, V2, P247, DOI 10.1016/0147-619X(79)90043-X; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; MAPLE P, 1990, J CHEMOTHERAPY, V2, P280, DOI 10.1080/1120009X.1990.11739031; MARVIN DA, 1969, BACTERIOL REV, V33, P172, DOI 10.1007/BF02702778; May T, 2010, ISME J; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; MEYNELL E, 1968, BACTERIOL REV, V32, P55, DOI 10.1128/MMBR.32.1.55-83.1968; MEYNELL GG, 1968, NATURE, V217, P1184, DOI 10.1038/2171184a0; NOVOTNY C, 1968, J BACTERIOL, V95, P314, DOI 10.1128/JB.95.2.314-326.1968; OU JT, 1973, J BACTERIOL, V114, P1108, DOI 10.1128/JB.114.3.1108-1115.1973; PALCHOUDHURY SR, 1969, MOL GEN GENET, V105, P131, DOI 10.1007/BF00445683; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rozinov MN, 1998, CHEM BIOL, V5, P713, DOI 10.1016/S1074-5521(98)90664-0; RUSSEL M, 2006, BACTERIOPHAGES, P146; RUSSELL SE, 1972, J BACTERIOL, V11, P7; SALIVAR WO, 1964, VIROLOGY, V24, P359, DOI 10.1016/0042-6822(64)90173-4; Sambrook J., 2001, MOL CLONING LAB MANU; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; TOLMASKY ME, 1986, ANTIMICROB AGENTS CH, V30, P315, DOI 10.1128/AAC.30.2.315; TZAGOLOFF H, 1964, VIROLOGY, V24, P372, DOI 10.1016/0042-6822(64)90174-6; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; Webster R, 2001, PHAGE DISPLAY LAB MA, V1st; Williams JJ, 2008, CURR OPIN CHEM BIOL, V12, P389, DOI 10.1016/j.cbpa.2008.06.015; Zhu WM, 2008, ANTIMICROB AGENTS CH, V52, P452, DOI 10.1128/AAC.00908-07	46	51	55	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19991	10.1371/journal.pone.0019991	http://dx.doi.org/10.1371/journal.pone.0019991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637841	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200024
J	Weyman, PD; Vargas, WA; Tong, YK; Yu, JP; Maness, PC; Smith, HO; Xu, Q				Weyman, Philip D.; Vargas, Walter A.; Tong, Yingkai; Yu, Jianping; Maness, Pin-Ching; Smith, Hamilton O.; Xu, Qing			Heterologous Expression of Alteromonas macleodii and Thiocapsa roseopersicina [NiFe] Hydrogenases in Synechococcus elongatus	PLOS ONE			English	Article							BIDIRECTIONAL HYDROGENASE; ACCESSORY GENES; MUTAGENESIS; MATURATION; OXIDATION; CLONING; BBS; CYANOBACTERIA; BIOSYNTHESIS; ALCALIGENES	Oxygen-tolerant [NiFe] hydrogenases may be used in future photobiological hydrogen production systems once the enzymes can be heterologously expressed in host organisms of interest. To achieve heterologous expression of [NiFe] hydrogenases in cyanobacteria, the two hydrogenase structural genes from Alteromonas macleodii Deep ecotype (AltDE), hynS and hynL, along with the surrounding genes in the gene operon of HynSL were cloned in a vector with an IPTG-inducible promoter and introduced into Synechococcus elongatus PCC7942. The hydrogenase protein was expressed at the correct size upon induction with IPTG. The heterologously-expressed HynSL hydrogenase was active when tested by in vitro H-2 evolution assay, indicating the correct assembly of the catalytic center in the cyanobacterial host. Using a similar expression system, the hydrogenase structural genes from Thiocapsa roseopersicina (hynSL) and the entire set of known accessory genes were transferred to S. elongatus. A protein of the correct size was expressed but had no activity. However, when the 11 accessory genes from AltDE were co-expressed with hynSL, the T. roseopersicina hydrogenase was found to be active by in vitro assay. This is the first report of active, heterologously-expressed [NiFe] hydrogenases in cyanobacteria.	[Weyman, Philip D.; Vargas, Walter A.; Tong, Yingkai; Smith, Hamilton O.; Xu, Qing] J Craig Venter Inst, Dept Synthet Biol & Bioenergy, Rockville, MD USA; [Yu, Jianping; Maness, Pin-Ching] Natl Renewable Energy Lab, Golden, CO USA	J. Craig Venter Institute; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Weyman, PD (corresponding author), J Craig Venter Inst, Dept Synthet Biol & Bioenergy, Rockville, MD USA.	qxu2019@gmail.com		Yu, Jianping/0000-0003-0466-3197; Weyman, Philip/0000-0001-5787-0291	U.S. Department of Energy [DE-FG36-05GO15027]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, the Hydrogen, Fuel Cells, and Infrastructure Technology Program (DE-FG36-05GO15027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananyev G, 2008, APPL ENVIRON MICROB, V74, P6102, DOI 10.1128/AEM.01078-08; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; Bascones E, 2000, APPL ENVIRON MICROB, V66, P4292, DOI 10.1128/AEM.66.10.4292-4299.2000; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BOGOROV LV, 1974, MIKROBIOLOGIYA, V43, P326; Boison G, 1996, FEBS LETT, V394, P153, DOI 10.1016/0014-5793(96)00936-2; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CASTENHOLZ RW, 1988, METHOD ENZYMOL, V167, P68; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; COLBEAU A, 1994, GENE, V140, P25, DOI 10.1016/0378-1119(94)90726-9; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Fodor B, 2001, APPL ENVIRON MICROB, V67, P2476, DOI 10.1128/AEM.67.6.2476-2483.2001; FRIEDRICH B, 1984, J BACTERIOL, V158, P331, DOI 10.1128/JB.158.1.331-333.1984; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Kovacs KL, 2002, INT J HYDROGEN ENERG, V27, P1463, DOI 10.1016/S0360-3199(02)00097-6; Maness PC, 2002, APPL ENVIRON MICROB, V68, P2633, DOI 10.1128/AEM.68.6.2633-2636.2002; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Maroti G, 2010, INT J HYDROGEN ENERG, V35, P3358, DOI 10.1016/j.ijhydene.2009.10.059; Maroti G, 2009, APPL ENVIRON MICROB, V75, P5821, DOI 10.1128/AEM.00580-09; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Rakhely G, 1998, J BACTERIOL, V180, P1460, DOI 10.1128/JB.180.6.1460-1465.1998; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; Sambrook J., 2001, MOL CLONING LAB MANU; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vargas WA, 2011, APPL ENVIRON MICROB, V77, P1990, DOI 10.1128/AEM.01559-10; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Weyman PD, 2011, MICROBIOL-SGM, V157, P1363, DOI 10.1099/mic.0.044834-0; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; YAGI K, 1986, BIOCHEM BIOPH RES CO, V137, P114, DOI 10.1016/0006-291X(86)91183-6	39	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20126	10.1371/journal.pone.0020126	http://dx.doi.org/10.1371/journal.pone.0020126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637846	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200035
J	He, XF; Yang, ZY; Tsien, JZ				He, Xiaofu; Yang, Zhiyong; Tsien, Joe Z.			A Hierarchical Probabilistic Model for Rapid Object Categorization in Natural Scenes	PLOS ONE			English	Article							TOP-DOWN FACILITATION; RECOGNITION; REPRESENTATION; TEXTURE; IDENTIFICATION; FEATURES; MEMORY; SHAPE	Humans can categorize objects in complex natural scenes within 100-150 ms. This amazing ability of rapid categorization has motivated many computational models. Most of these models require extensive training to obtain a decision boundary in a very high dimensional (e. g., similar to 6,000 in a leading model) feature space and often categorize objects in natural scenes by categorizing the context that co-occurs with objects when objects do not occupy large portions of the scenes. It is thus unclear how humans achieve rapid scene categorization. To address this issue, we developed a hierarchical probabilistic model for rapid object categorization in natural scenes. In this model, a natural object category is represented by a coarse hierarchical probability distribution (PD), which includes PDs of object geometry and spatial configuration of object parts. Object parts are encoded by PDs of a set of natural object structures, each of which is a concatenation of local object features. Rapid categorization is performed as statistical inference. Since the model uses a very small number (similar to 100) of structures for even complex object categories such as animals and cars, it requires little training and is robust in the presence of large variations within object categories and in their occurrences in natural scenes. Remarkably, we found that the model categorized animals in natural scenes and cars in street scenes with a near human-level performance. We also found that the model located animals and cars in natural scenes, thus overcoming a flaw in many other models which is to categorize objects in natural context by categorizing contextual features. These results suggest that coarse PDs of object categories based on natural object structures and statistical operations on these PDs may underlie the human ability to rapidly categorize scenes.	[He, Xiaofu; Yang, Zhiyong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [He, Xiaofu] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200062, Peoples R China; [Yang, Zhiyong] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA; [Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	He, XF (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@georgiahealth.edu; jtsien@georgiahealth.edu			National Institute of Mental Health (NIMH); National Institute of Aging (NIA); MCG; Georgia Research Alliance	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCG; Georgia Research Alliance	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), MCG fund, and Georgia Research Alliance (All to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allili MS, 2007, PATTERN RECOGN LETT, V28, P1946, DOI 10.1016/j.patrec.2007.05.002; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Boshyan J, 2005, J COGNITIVE NEUROSCI, P148; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Griffin G., 2007, ANN PHYS, P1; Hegde J, 2003, VISUAL NEUROSCI, V20, P313, DOI 10.1017/S0952523803203102; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Knill DC, 1996, PERCEPTION BAYESIAN; LAZEBNIK CSS, 2006, IEEE C COMP VIS PATT, P2169; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mack ML, 2010, J VISION, V10, DOI 10.1167/10.3.11; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Marr D., 1982, VISION COMPUTATIONAL; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Rao R. P., 2002, PROBABILISTIC MODELS; Renninger LW, 2004, VISION RES, V44, P2301, DOI 10.1016/j.visres.2004.04.006; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20002	10.1371/journal.pone.0020002	http://dx.doi.org/10.1371/journal.pone.0020002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647443	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500017
J	Lee, CC; Lin, TW; Ko, TP; Wang, AHJ				Lee, Cheng-Chung; Lin, Ta-Wei; Ko, Tzu-Ping; Wang, Andrew H. -J.			The Hexameric Structures of Human Heat Shock Protein 90	PLOS ONE			English	Article							HSP90 FAMILY; BINDING; MEMBER; DIMERIZATION; INHIBITION; COMPLEXES; SYSTEM; SUITE	Background: The human 90-kDa heat shock protein (HSP90) functions as a dimeric molecular chaperone. HSP90 identified on the cell surface has been found to play a crucial role in cancer invasion and metastasis, and has become a validated anticancer target for drug development. It has been shown to self-assemble into oligomers upon heat shock or divalent cations treatment, but the functional role of the oligomeric states in the chaperone cycle is not fully understood. Principal Findings: Here we report the crystal structure of a truncated HSP90 that contains the middle segment and the carboxy-terminal domain, termed MC-HSP90. The structure reveals an architecture with triangular bipyramid geometry, in which the building block of the hexameric assembly is a dimer. In solution, MC-HSP90 exists in three major oligomer states, namely dimer, tetramer and hexamer, which were elucidated by size exclusion chromatography and analytical ultracentrifugation. The newly discovered HSP90 isoform HSP90N that lacks the N-terminal ATPase domain also exhibited similar oligomerization states as did MC-HSP90. Conclusions: While lacking the ATPase domain, both MC-HSP90 and HSP90N can self-assemble into a hexameric structure, spontaneously. The crystal structure of MC-HSP90 reveals that, in addition to the C-terminal dimerization domain, the residue W320 in the M domain plays a critical role in its oligomerization. This study not only demonstrates how the human MC-HSP90 forms a hexamer, but also justifies the similar formation of HSP90N by using 3D modeling analysis.	[Lee, Cheng-Chung; Lin, Ta-Wei; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Cheng-Chung; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	Lee, CC (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw			National Science Council of Taiwan [NSC97-3112-B-001-035-B4]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC97-3112-B-001-035-B4 to A.H.-J.W.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grammatikakis N, 2002, J BIOL CHEM, V277, P8312, DOI 10.1074/jbc.M109200200; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Koga F, 2009, ANTICANCER RES, V29, P797; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Milicevic Z, 2008, INT J ONCOL, V32, P1169; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Moullintraffort L, 2010, J BIOL CHEM, V285, P15100, DOI 10.1074/jbc.M109.094698; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schweinfest CW, 1998, BBA-GENE STRUCT EXPR, V1398, P18, DOI 10.1016/S0167-4781(98)00031-1; Suzuki S, 2010, BIOCHEM BIOPH RES CO, V398, P525, DOI 10.1016/j.bbrc.2010.06.112; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; Zurawska A, 2008, BBA-PROTEINS PROTEOM, V1784, P1844, DOI 10.1016/j.bbapap.2008.06.013	34	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19961	10.1371/journal.pone.0019961	http://dx.doi.org/10.1371/journal.pone.0019961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647436	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500014
J	Wang, CZ; Neugebauer, U; Burck, J; Myllykoski, M; Baumgartel, P; Popp, J; Kursula, P				Wang, Chaozhan; Neugebauer, Ute; Buerck, Jochen; Myllykoski, Matti; Baumgaertel, Peter; Popp, Juergen; Kursula, Petri			Charge Isomers of Myelin Basic Protein: Structure and Interactions with Membranes, Nucleotide Analogues, and Calmodulin	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTROSCOPY; CIRCULAR-DICHROISM SPECTRA; 18.5 KDA ISOFORM; MULTIPLE-SCLEROSIS; POSTTRANSLATIONAL MODIFICATIONS; SECONDARY STRUCTURE; DODECYLPHOSPHOCHOLINE MICELLES; MOLECULAR-CONFORMATION; COMPLEX-FORMATION; ESCHERICHIA-COLI	As an essential structural protein required for tight compaction of the central nervous system myelin sheath, myelin basic protein (MBP) is one of the candidate autoantigens of the human inflammatory demyelinating disease multiple sclerosis, which is characterized by the active degradation of the myelin sheath. In this work, recombinant murine analogues of the natural C1 and C8 charge components (rmC1 and rmC8), two isoforms of the classic 18.5-kDa MBP, were used as model proteins to get insights into the structure and function of the charge isomers. Various biochemical and biophysical methods such as size exclusion chromatography, calorimetry, surface plasmon resonance, small angle X-ray and neutron scattering, Raman and fluorescence spectroscopy, and conventional as well as synchrotron radiation circular dichroism were used to investigate differences between these two isoforms, both from the structural point of view, and regarding interactions with ligands, including calmodulin (CaM), various detergents, nucleotide analogues, and lipids. Overall, our results provide further proof that rmC8 is deficient both in structure and especially in function, when compared to rmC1. While the CaM binding properties of the two forms are very similar, their interactions with membrane mimics are different. CaM can be used to remove MBP from immobilized lipid monolayers made of synthetic lipids - a phenomenon, which may be of relevance for MBP function and its regulation. Furthermore, using fluorescently labelled nucleotides, we observed binding of ATP and GTP, but not AMP, by MBP; the binding of nucleoside triphosphates was inhibited by the presence of CaM. Together, our results provide important further data on the interactions between MBP and its ligands, and on the differences in the structure and function between MBP charge isomers.	[Wang, Chaozhan; Myllykoski, Matti; Kursula, Petri] Univ Oulu, Dept Biochem, Oulu, Finland; [Neugebauer, Ute; Popp, Juergen] Inst Photon Technol, Jena, Germany; [Buerck, Jochen] Karlsruhe Inst Technol, Inst Biol Interfaces 2, Karlsruhe, Germany; [Baumgaertel, Peter] Helmholtz Zentrum Berlin, Berlin Elect Storage Ring Co Synchrotron Radiat, Berlin, Germany; [Popp, Juergen] Univ Jena, Inst Phys Chem, D-6900 Jena, Germany; [Kursula, Petri] German Elect Synchrotron, Ctr Struct Syst Biol, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; Leibniz Institut fur Photonische Technologien; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Friedrich Schiller University of Jena; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Wang, CZ (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@desy.de	Kursula, Petri/AAF-4563-2020; Popp, Juergen/E-6471-2012; Kursula, Petri/K-1058-2012	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Myllykoski, Matti/0000-0001-6641-5856	Academy of Finland; Sigrid Juselius Foundation; ISA, Arhus	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); ISA, Arhus	This research was funded by the Academy of Finland and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Prof. George Harauz, University of Guelph, Canada, for providing the expression constructs for rmC1 and rmC8. We thank Dr. Vasyl Haramus (GKSS) for help in collecting the SANS data and Prof. Inari Kursula (CSSB-HZI) for helpful discussions. The beamline staff at EMBL-Hamburg, BESSY, MAX-Lab, and ISA, Arhus, are acknowledged for their excellent support.	Bamm VV, 2010, BIOCHEMISTRY-US, V49, P6903, DOI 10.1021/bi100308d; Bates IR, 2003, J BIOL CHEM, V278, P29041, DOI 10.1074/jbc.M302766200; Bates IR, 2002, PROTEIN EXPRES PURIF, V25, P330, DOI 10.1016/S1046-5928(02)00017-7; Bates IR, 2000, PROTEIN EXPRES PURIF, V20, P285, DOI 10.1006/prep.2000.1307; BENJAMINS JA, 1978, NEUROCHEM RES, V3, P137, DOI 10.1007/BF00964057; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs JM, 2005, BIOCHEMISTRY-US, V44, P3524, DOI 10.1021/bi0473760; Boggs JM, 1997, BIOCHEMISTRY-US, V36, P5065, DOI 10.1021/bi962649f; Boggs JM, 2000, BIOCHEMISTRY-US, V39, P7799, DOI 10.1021/bi0002129; BOGGS JM, 1977, BIOCHEMISTRY-US, V16, P5420, DOI 10.1021/bi00644a003; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Cerenius Y, 2000, J SYNCHROTRON RADIAT, V7, P203, DOI 10.1107/S0909049500005331; CHAN KC, 1988, BIOCHEM BIOPH RES CO, V152, P1468, DOI 10.1016/S0006-291X(88)80451-0; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; CHEN MC, 1974, J AM CHEM SOC, V96, P3038, DOI 10.1021/ja00817a003; Chen WQ, 2010, AMINO ACIDS, V39, P859, DOI 10.1007/s00726-010-0542-2; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; GARBAY B, 1988, NEUROCHEM PATHOL, V8, P91; Haas H, 2004, BIOPHYS J, V86, P455, DOI 10.1016/S0006-3495(04)74122-3; HARADA I, 1986, SPECTROCHIM ACTA A, V42, P307, DOI 10.1016/0584-8539(86)80193-3; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2007, NEUROCHEM RES, V32, P137, DOI 10.1007/s11064-006-9108-9; Harauz G, 2009, CURR PROTEIN PEPT SC, V10, P196, DOI 10.2174/138920309788452218; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hill CMD, 2005, BIOCHEM BIOPH RES CO, V329, P362, DOI 10.1016/j.bbrc.2005.01.151; Homchaudhuri L, 2010, BIOCHEMISTRY-US, V49, P8955, DOI 10.1021/bi100988p; Homchaudhuri L, 2009, BIOCHEMISTRY-US, V48, P2385, DOI 10.1021/bi8022587; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KRIGBAUM WR, 1975, BIOCHEMISTRY-US, V14, P2542, DOI 10.1021/bi00682a038; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Libich DS, 2008, BIOPHYS J, V94, P4847, DOI 10.1529/biophysj.107.125823; Libich DS, 2008, EUR BIOPHYS J BIOPHY, V37, P1015, DOI 10.1007/s00249-008-0334-8; Libich David S., 2002, Molecular and Cellular Biochemistry, V241, P45, DOI 10.1023/A:1020883409176; Libich DS, 2003, BIOCHEM BIOPH RES CO, V308, P313, DOI 10.1016/S0006-291X(03)01380-9; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOWDEN JA, 1966, CAN J BIOCHEM CELL B, V44, P567, DOI 10.1139/o66-068; Lutton JD, 2004, EXP BIOL MED, V229, P12, DOI 10.1177/153537020422900102; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010300; Majava V, 2010, AMINO ACIDS, V39, P59, DOI 10.1007/s00726-009-0364-2; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; MENDZ GL, 1984, BIOCHEMISTRY-US, V23, P6041, DOI 10.1021/bi00320a022; MIURA T, 1988, BIOCHEMISTRY-US, V27, P88, DOI 10.1021/bi00401a015; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Moscarello MA, 2007, NEUROCHEM RES, V32, P251, DOI 10.1007/s11064-006-9144-5; Musse AA, 2006, P NATL ACAD SCI USA, V103, P4422, DOI 10.1073/pnas.0509158103; Musse AA, 2008, BIOCHEMISTRY-US, V47, P10372, DOI 10.1021/bi801302b; Myllykoski M, 2009, BIOPHYS CHEM, V144, P130, DOI 10.1016/j.bpc.2009.08.001; Overman SA, 1999, BIOCHEMISTRY-US, V38, P4018, DOI 10.1021/bi982901e; Polverini E, 1999, EUR BIOPHYS J BIOPHY, V28, P351, DOI 10.1007/s002490050218; *R DEV COR TEAM, 2007, J NEUROCHEM, V17, P1121; Reichardt G, 2001, NUCL INSTRUM METH A, V467, P458, DOI 10.1016/S0168-9002(01)00357-6; RYAN CG, 1988, NUCL INSTRUM METH B, V34, P396, DOI 10.1016/0168-583X(88)90063-8; SANKARAM MB, 1989, BIOCHEMISTRY-US, V28, P9699, DOI 10.1021/bi00451a024; SMITH GS, 2010, J NEUROCHEM, V51, P718; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; SURESH S, 2010, BIOCHEMISTRY; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TUMA R, 1995, BIOCHEMISTRY-US, V34, P15150, DOI 10.1021/bi00046a022; Vohnik S, 1998, PROTEIN SCI, V7, P193, DOI 10.1002/pro.5560070120; Wen ZQ, 2007, J PHARM SCI-US, V96, P2861, DOI 10.1002/jps.20895; Wen ZQ, 2001, BIOCHEMISTRY-US, V40, P449, DOI 10.1021/bi0018887; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6	66	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19915	10.1371/journal.pone.0019915	http://dx.doi.org/10.1371/journal.pone.0019915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647440	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500012
J	Chandler, KJ; Barrier, M; Jeffay, S; Nichols, HP; Kleinstreuer, NC; Singh, AV; Reif, DM; Sipes, NS; Judson, RS; Dix, DJ; Kavlock, R; Hunter, ES; Knudsen, TB				Chandler, Kelly J.; Barrier, Marianne; Jeffay, Susan; Nichols, Harriette P.; Kleinstreuer, Nicole C.; Singh, Amar V.; Reif, David M.; Sipes, Nisha S.; Judson, Richard S.; Dix, David J.; Kavlock, Robert; Hunter, Edward S., III; Knudsen, Thomas B.			Evaluation of 309 Environmental Chemicals Using a Mouse Embryonic Stem Cell Adherent Cell Differentiation and Cytotoxicity Assay	PLOS ONE			English	Article							VITRO EMBRYOTOXICITY TESTS; HYPOXIC PULMONARY-HYPERTENSION; ANTIOXIDANT RESPONSE ELEMENT; INDUCIBLE FACTOR 1-ALPHA; YA-SUBUNIT GENE; OXIDATIVE STRESS; TRANSCRIPTIONAL REGULATION; PHENOLIC ANTIOXIDANTS; PREDICTION MODELS; SELF-RENEWAL	The vast landscape of environmental chemicals has motivated the need for alternative methods to traditional whole-animal bioassays in toxicity testing. Embryonic stem (ES) cells provide an in vitro model of embryonic development and an alternative method for assessing developmental toxicity. Here, we evaluated 309 environmental chemicals, mostly food-use pesticides, from the ToxCast (TM) chemical library using a mouse ES cell platform. ES cells were cultured in the absence of pluripotency factors to promote spontaneous differentiation and in the presence of DMSO-solubilized chemicals at different concentrations to test the effects of exposure on differentiation and cytotoxicity. Cardiomyocyte differentiation (alpha, beta myosin heavy chain; MYH6/MYH7) and cytotoxicity (DRAQ5 (TM)/Sapphire700 (TM)) were measured by In-Cell Western (TM) analysis. Half-maximal activity concentration (AC(50)) values for differentiation and cytotoxicity endpoints were determined, with 18% of the chemical library showing significant activity on either endpoint. Mining these effects against the ToxCast Phase I assays (similar to 500) revealed significant associations for a subset of chemicals (26) that perturbed transcription-based activities and impaired ES cell differentiation. Increased transcriptional activity of several critical developmental genes including BMPR2, PAX6 and OCT1 were strongly associated with decreased ES cell differentiation. Multiple genes involved in reactive oxygen species signaling pathways (NRF2, ABCG2, GSTA2, HIF1A) were strongly associated with decreased ES cell differentiation as well. A multivariate model built from these data revealed alterations in ABCG2 transporter was a strong predictor of impaired ES cell differentiation. Taken together, these results provide an initial characterization of metabolic and regulatory pathways by which some environmental chemicals may act to disrupt ES cell growth and differentiation.	[Chandler, Kelly J.; Barrier, Marianne; Jeffay, Susan; Nichols, Harriette P.; Hunter, Edward S., III] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Chandler, Kelly J.; Kleinstreuer, Nicole C.; Reif, David M.; Sipes, Nisha S.; Judson, Richard S.; Dix, David J.; Kavlock, Robert; Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Singh, Amar V.] Lockheed Martin, Res Triangle Pk, NC USA	United States Environmental Protection Agency; United States Environmental Protection Agency; Lockheed Martin	Chandler, KJ (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	chandler.kelly@epa.gov	Kleinstreuer, Nicole/F-7203-2019; Singh, Amar/K-4400-2013	Kleinstreuer, Nicole/0000-0002-7914-3682; Singh, Amar/0000-0003-3780-8233; Judson, Richard/0000-0002-2348-9633; Reif, David/0000-0001-7815-6767	US EPA through Information Technology (IT-ESE) [68-W-04-005]; U.S. EPA, through its Office of Research and Development, Human Health, Cross-ORD, and CompTox	US EPA through Information Technology (IT-ESE); U.S. EPA, through its Office of Research and Development, Human Health, Cross-ORD, and CompTox(United States Environmental Protection Agency)	The U.S. EPA, through its Office of Research and Development, Human Health, Cross-ORD, and CompTox funded and managed the research described here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lockheed Martin is a contractor to the EPA. The work performed by Lockheed Martin on this study is funded by the US EPA through Information Technology (IT-ESE) contract No.: 68-W-04-005, Task Order No. 058: Technical Support for Development of Developmental Systems Toxicity Network (DevToxNet). This work statement includes contributing activities to the present study for text-mining and data visualization.	[Anonymous], TOX TEST 21 CENT VIS; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chapin RE, 2009, TOXICOL SCI, V112, P17, DOI 10.1093/toxsci/kfp202; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Genschow E, 2000, IN VITRO MOL TOXICOL, V13, P51; Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209, DOI 10.1177/026119290403200305; Genschow E, 2002, ATLA-ALTERN LAB ANIM, V30, P151, DOI 10.1177/026119290203000204; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jonker JW, 2007, AM J PHYSIOL-CELL PH, V292, pC2204, DOI 10.1152/ajpcell.00359.2006; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kang BY, 2008, EXP MOL MED, V40, P208, DOI 10.3858/emm.2008.40.2.208; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Knight AW, 2009, REGUL TOXICOL PHARM, V55, P188, DOI 10.1016/j.yrtph.2009.07.004; Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; LI Y, 1992, J BIOL CHEM, V267, P15097; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074; Marx-Stoelting P, 2009, ATLA-ALTERN LAB ANIM, V37, P313, DOI 10.1177/026119290903700314; Nishi H, 2002, CANCER RES, V62, P827; Rotroff DM, 2010, J TOXICOL ENV HEAL B, V13, P329, DOI 10.1080/10937404.2010.483949; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Spielmann Horst, 1997, In Vitro Toxicology, V10, P119; Susanto J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004023; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Thimmulappa RK, 2002, CANCER RES, V62, P5196; van Dartel DAM, 2010, TOXICOL APPL PHARM, V243, P420, DOI 10.1016/j.taap.2009.12.021; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	53	49	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e18540	10.1371/journal.pone.0018540	http://dx.doi.org/10.1371/journal.pone.0018540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666745	gold, Green Submitted, Green Published			2022-12-27	WOS:000291607000003
J	Castle, JC				Castle, John C.			SNPs Occur in Regions with Less Genomic Sequence Conservation	PLOS ONE			English	Article							GENETIC-VARIATION; MOUSE GENOME; DATABASE; SITES; CONSEQUENCES; EUKARYOTES; MUTATIONS; EVOLUTION; SILENCE; MAMMALS	Rates of SNPs (single nucleotide polymorphisms) and cross-species genomic sequence conservation reflect intra-and inter-species variation, respectively. Here, I report SNP rates and genomic sequence conservation adjacent to mRNA processing regions and show that, as expected, more SNPs occur in less conserved regions and that functional regions have fewer SNPs. Results are confirmed using both mouse and human data. Regions include protein start codons, 3' splice sites, 5' splice sites, protein stop codons, predicted miRNA binding sites, and polyadenylation sites. Throughout, SNP rates are lower and conservation is higher at regulatory sites. Within coding regions, SNP rates are highest and conservation is lowest at codon position three and the fewest SNPs are found at codon position two, reflecting codon degeneracy for amino acid encoding. Exon splice sites show high conservation and very low SNP rates, reflecting both splicing signals and protein coding. Relaxed constraint on the codon third position is dramatically seen when separating exonic SNP rates based on intron phase. At polyadenylation sites, a peak of conservation and low SNP rate occurs from 30 to 17 nt preceding the site. This region is highly enriched for the sequence AAUAAA, reflecting the location of the conserved polyA signal. miRNA 3' UTR target sites are predicted incorporating interspecies genomic sequence conservation; SNP rates are low in these sites, again showing fewer SNPs in conserved regions. Together, these results confirm that SNPs, reflecting recent genetic variation, occur more frequently in regions with less evolutionarily conservation.	[Castle, John C.] Rosetta Inpharmat LLC, Seattle, WA USA	Merck & Company	Castle, JC (corresponding author), Johannes Gutenberg Univ Mainz Med, TRON Translat Oncol, Mainz, Rheinland Palat, Germany.	john.castle@tron-mainz.de						Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stratton M, 2008, NAT BIOTECHNOL, V26, P65, DOI 10.1038/nbt0108-65; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055	27	38	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20660	10.1371/journal.pone.0020660	http://dx.doi.org/10.1371/journal.pone.0020660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674007	Green Published, Green Submitted, gold			2022-12-27	WOS:000291356400013
J	Dai, M; Shi, XR				Dai, Min; Shi, Xiaorui			Fibro-Vascular Coupling in the Control of Cochlear Blood Flow	PLOS ONE			English	Article							SPIRAL-LIGAMENT FIBROCYTES; GUINEA-PIG COCHLEA; INNER-EAR; STRIA VASCULARIS; NITRIC-OXIDE; ACOUSTIC EXPOSURE; ARACHIDONIC-ACID; MICE LACKING; ATP RELEASE; IN-VITRO	Background: Transduction of sound in the cochlea is metabolically demanding. The lateral wall and hair cells are critically vulnerable to hypoxia, especially at high sound levels, and tight control over cochlear blood flow (CBF) is a physiological necessity. Yet despite the importance of CBF for hearing, consensus on what mechanisms are involved has not been obtained. Methodology/Principal Findings: We report on a local control mechanism for regulating inner ear blood flow involving fibrocyte signaling. Fibrocytes in the super-strial region are spatially distributed near pre-capillaries of the spiral ligament of the albino guinea pig cochlear lateral wall, as demonstrably shown in transmission electron microscope and confocal images. Immunohistochemical techniques reveal the inter-connected fibrocytes to be positive for Na+/K+ ATPase beta 1 and S100. The connected fibrocytes display more Ca(2+) signaling than other cells in the cochlear lateral wall as indicated by fluorescence of a Ca(2+) sensor, fluo-4. Elevation of Ca(2+) in fibrocytes, induced by photolytic uncaging of the divalent ion chelator o-nitrophenyl EGTA, results in propagation of a Ca(2+) signal to neighboring vascular cells and vasodilation in capillaries. Of more physiological significance, fibrocyte to vascular cell coupled signaling was found to mediate the sound stimulated increase in cochlear blood flow (CBF). Cyclooxygenase-1 (COX-1) was required for capillary dilation. Conclusions/Significance: The findings provide the first evidence that signaling between fibrocytes and vascular cells modulates CBF and is a key mechanism for meeting the cellular metabolic demand of increased sound activity.	[Dai, Min; Shi, Xiaorui] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100730, Peoples R China; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Xiaorui] Shanghai Jiao Tong Univ, Renji Hosp, Dept Otolaryngol, Shanghai 200030, Peoples R China	Oregon Health & Science University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University	Dai, M (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA.	shix@ohsu.edu	Dai, Min/B-9908-2012		National Institutes of Health [NIH NIDCD R03-DC008888, NIH NIDCD DC008888S1, NIH NIDCD R01-DC010844, NIHP30-DC005983, NIDCD R01 DC00105]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010844, R03DC008888, P30DC005983, R01DC000105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants NIH NIDCD R03-DC008888 (XS), NIH NIDCD DC008888S1 (XS), NIH NIDCD R01-DC010844 (XS), NIHP30-DC005983, NIDCD R01 DC00105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 2009, J ASS RES OTOLARYNG; Alkayed NJ, 1996, AM J PHYSIOL-HEART C, V271, pH1541, DOI 10.1152/ajpheart.1996.271.4.H1541; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; AXELSSON A, 1968, ACTA OTO-LARYNGOL, P243; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Dai M, 2009, HEARING RES, V254, P100, DOI 10.1016/j.heares.2009.04.018; Doherty JK, 2004, OTOL NEUROTOL, V25, P457, DOI 10.1097/00129492-200407000-00010; FISCHER MJ, 2010, MICROVASC RES; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; HAMA K, 1977, J NEUROCYTOL, V6, P1, DOI 10.1007/BF01175410; Hirose K, 2003, JARO, V4, P339, DOI 10.1007/s10162-002-3036-4; Jakovcevic D, 2007, CURR TOP DEV BIOL, V79, P75, DOI 10.1016/S0070-2153(06)79004-4; Jiang ZG, 2007, J PHARMACOL EXP THER, V320, P544, DOI 10.1124/jpet.106.115212; Juhn S K, 2001, Int Tinnitus J, V7, P72; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; MILLER JM, 1988, AM J OTOLARYNG, V9, P302, DOI 10.1016/S0196-0709(88)80038-3; Moon SK, 2006, ACTA OTO-LARYNGOL, V126, P564, DOI 10.1080/00016480500452525; Nakashima T, 2003, BRAIN RES REV, V43, P17, DOI 10.1016/S0165-0173(03)00189-9; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; NUTTALL AL, 1987, HEARING RES, V27, P121, DOI 10.1016/0378-5955(87)90013-X; Ostrom RS, 2001, AM J PHYSIOL-CELL PH, V281, pC524, DOI 10.1152/ajpcell.2001.281.2.C524; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Qu CY, 2007, JARO-J ASSOC RES OTO, V8, P205, DOI 10.1007/s10162-007-0072-0; QUIRK WS, 1991, HEARING RES, V52, P217, DOI 10.1016/0378-5955(91)90201-J; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ravnic DJ, 2005, MICROVASC RES, V70, P90, DOI 10.1016/j.mvr.2005.06.002; RYAN AF, 1988, ACTA OTO-LARYNGOL, V105, P232, DOI 10.3109/00016488809097003; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SCHEIBE F, 1993, EUR ARCH OTO-RHINO-L, V250, P281; SCHEIBE F, 1992, HEARING RES, V63, P19, DOI 10.1016/0378-5955(92)90069-Y; SCHUBERT R, ISOLATED VESSELS, P198; Shi XR, 2008, MICROCIRCULATION, V15, P515, DOI 10.1080/10739680802047445; Shi XR, 2003, HEARING RES, V177, P43, DOI 10.1016/S0378-5955(02)00796-7; Shi XR, 2002, HEARING RES, V172, P73, DOI 10.1016/S0378-5955(02)00513-0; Shi XR, 2001, HEARING RES, V153, P23, DOI 10.1016/S0378-5955(00)00254-9; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; SPICER SS, 1991, HEARING RES, V56, P53, DOI 10.1016/0378-5955(91)90153-Z; Suko T, 2000, HEARING RES, V140, P137, DOI 10.1016/S0378-5955(99)00191-4; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Wangemann P, 2002, ADV OTO-RHINO-LARYNG, V59, P51; Wangemann P, 1996, HEARING RES, V95, P49, DOI 10.1016/0378-5955(96)00007-X; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	52	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20652	10.1371/journal.pone.0020652	http://dx.doi.org/10.1371/journal.pone.0020652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673815	Green Published, gold, Green Submitted			2022-12-27	WOS:000291309900026
J	Boinas, FS; Wilson, AJ; Hutchings, GH; Martins, C; Dixon, LJ				Boinas, Fernando S.; Wilson, Anthony J.; Hutchings, Geoff H.; Martins, Carlos; Dixon, Linda J.			The Persistence of African Swine Fever Virus in Field-Infected Ornithodoros erraticus during the ASF Endemic Period in Portugal	PLOS ONE			English	Article								African swine fever (ASF) is an important disease of pigs and outbreaks of ASF have occurred in Europe on multiple occasions. To explore the period for which the European soft tick species Ornithodoros erraticus (Acari: Argasidae) is able to act as a reservoir of African swine fever virus (ASFV) after infected hosts are removed, we collected specimens from farms in the provinces of Alentejo and Algarve in Portugal during the endemic period and tested them subsequently using cell culture and experimental infection. We show that ticks from previously infected farms may contain infectious virus for at least five years and three months after the removal of infectious hosts. Furthermore, in two cases infectious virus was successfully isolated from ticks on restocked farms that had not yet suffered a re-emergence of disease. Experimental transmission to pigs was demonstrated in batches tested up to 380 days after an outbreak. These results clarify the epidemiological role of O. erraticus ticks in the persistence of ASFV in the field, provide additional evidence to support its role in the re-emergence of a sporadic outbreak of ASF in Portugal in 1999 and suggest that the current quarantine legislation and restocking advice when these ticks are present on the pig farm premises is appropriate.	[Boinas, Fernando S.; Martins, Carlos] Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Med Vet, P-1100 Lisbon, Portugal; [Wilson, Anthony J.; Hutchings, Geoff H.; Dixon, Linda J.] Inst Anim Hlth, Vector Borne Dis Programme, Surrey, England	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Boinas, FS (corresponding author), Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Med Vet, P-1100 Lisbon, Portugal.	fboinas@fmv.utl.pt	Boinas, Fernando/AAD-9779-2022; Dixon, Linda K/B-9063-2019	Boinas, Fernando/0000-0001-6259-4404; Dixon, Linda/0000-0003-3845-3016; Martins, Carlos/0000-0001-6600-6163; Wilson, Anthony/0000-0002-2000-2914	Commission of the Economic Communities - Directorate General [ATS/4]; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN [PO/86/00]; Biotechnology and Biological Sciences Research Council [BBS/B/00603]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001040, BBS/E/I/00001003, BBS/E/I/00001409] Funding Source: researchfish; BBSRC [BBS/E/I/00001409] Funding Source: UKRI	Commission of the Economic Communities - Directorate General; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Fernando Boinas was funded by Commission of the Economic Communities - Directorate General VI project ATS/4 and by a Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship (ref PO/86/00). Anthony Wilson is funded by the Biotechnology and Biological Sciences Research Council (grant number BBS/B/00603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOINAS F, 1995, THESIS U READING REA, P240; BOINAS F, 2001, EVALUATION ROLE ORNI, P97; Boinas F. S., 1995, Veterinaria Tecnica, V5, P30; BOOL PH, 1969, B OFF INT EPIZOOT, P819; BOTIJA CS, 1963, B OFF INT EPIZOOT, P895; CAIADO JM, 1988, ACTA VET SCAND, P136; *CEC, 1999, OFFICIAL J EUROPEAN, V310, P71; CEC, 1993, OFFICIAL J EUROPEA L, VL285, P38; *EFSA, 2010, SCI OP AFR SWIN FEV; Encinas-Grandes A, 1993, ANAPORC, V121, P38; ENDRIS RG, 1992, J MED ENTOMOL, V29, P652, DOI 10.1093/jmedent/29.4.652; *EUR COMM, 2002, COUNC DIR 2002 60 EC; *FAO, 2009, FAO AN PROD HLTH MAN; Fernandez Garcia J. M., 1970, AN FAC VET LEON, V16, P195; FERREIRA Tiago Miguel de Lima, 2008, THESIS U TECNICA LIS; MALMQUIST WA, 1960, AM J VET RES, V21, P104; *OFF INT EP, 2009, MAN DIAGN TESTS VACC, P1069; OIE, 2008, MAN DIAGN TESTS VACC; OLEAGAPEREZ A, 1990, VET REC, V126, P32; ORDAS A, 1983, EUR 8466 EN LUXEMBOU, P7; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanchez Botija C., 1982, REV SCI TECH, V1, P1065, DOI [10.20506/rst.1.4.91, DOI 10.20506/RST.1.4.91]; SANCHEZVIZCAINO JM, 1983, CEC PUBLICATION, P297; Tendeiro J., 1962, Bol Pecuario Lisboa, V30, P1; *WORLD ORG AN HLTH, 2007, WEEKLY DIS INFORM, V20; Zimmerman J., 2002, TRENDS EMERGING VIRA	26	80	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20383	10.1371/journal.pone.0020383	http://dx.doi.org/10.1371/journal.pone.0020383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655242	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600061
J	Hogsberg, T; Bjarnsholt, T; Thomsen, JS; Kirketerp-Moller, K				Hogsberg, Trine; Bjarnsholt, Thomas; Thomsen, Jens Schiersing; Kirketerp-Moller, Klaus			Success Rate of Split-Thickness Skin Grafting of Chronic Venous Leg Ulcers Depends on the Presence of Pseudomonas aeruginosa: A Retrospective Study	PLOS ONE			English	Article							CHRONIC WOUNDS; BACTERIAL-COLONIZATION; SURGICAL-TREATMENT; BIOFILMS; MULTIDISCIPLINARY; RESISTANCE; INFECTION; REMOVAL	The last years of research have proposed that bacteria might be involved in and contribute to the lack of healing of chronic wounds. Especially it seems that Pseudomonas aeruginosa play a crucial role in the healing. At Copenhagen Wound Healing Centre it was for many years clinical suspected that once chronic venous leg ulcers were colonized (weeks or months preoperatively) by P. aeruginosa, the success rate of skin grafting deteriorated despite aggressive treatment. To investigate this, a retrospective study was performed on the clinical outcome of 82 consecutive patients with chronic venous leg ulcers on 91 extremities, from the 1(st) of March 2005 until the 31(st) of August 2006. This was achieved by analysing the microbiology, demographic data, smoking and drinking habits, diabetes, renal impairment, co-morbidities, approximated size and age of the wounds, immunosuppressive treatment and complicating factors on the clinical outcome of each patient. The results were evaluated using a Student T-test for continuous parameters, chi-square test for categorical parameters and a logistic regression analysis to predict healing after 12 weeks. The analysis revealed that only 33,3% of ulcers with P. aeruginosa, isolated at least once from 12 weeks prior, to or during surgery, were healed (98% or more) by week 12 follow-up, while 73,1% of ulcers without P. aeruginosa were so by the same time (p = 0,001). Smoking also significantly suppressed the outcome at the 12-week follow-up. Subsequently, a logistic regression analysis was carried out leaving P. aeruginosa as the only predictor left in the model (p = 0,001). This study supports our hypothesis that P. aeruginosa in chronic venous leg ulcers, despite treatment, has considerable impact on partial take or rejection of split-thickness skin grafts.	[Hogsberg, Trine; Thomsen, Jens Schiersing; Kirketerp-Moller, Klaus] Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark; [Bjarnsholt, Thomas] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Bjarnsholt, Thomas] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Kirketerp-Moller, Klaus] Hvidovre Univ Hosp, Dept Orthoped, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Hogsberg, T (corresponding author), Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark.	kkm@dadlnet.dk	Kirketerp-Møller, Klaus/AAW-4256-2020; Bjarnsholt, Thomas/ABD-6178-2021	Kirketerp-Møller, Klaus/0000-0002-3248-8448; Bjarnsholt, Thomas/0000-0002-8003-7414				Bang RL, 1999, BURNS, V25, P242, DOI 10.1016/S0305-4179(98)00167-3; Barret JP, 2003, PLAST RECONSTR SURG, V111, P744, DOI 10.1097/01.PRS.0000041445.76730.23; Bitsch M, 2005, SCAND J PLAST RECONS, V39, P162, DOI 10.1080/02844310510006196; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Boutli-Kasapidou F, 2006, J EUR ACAD DERMATOL, V20, P743, DOI 10.1111/j.1468-3083.2006.01478.x; Bowler PG, 1999, INT J DERMATOL, V38, P573, DOI 10.1046/j.1365-4362.1999.00738.x; BROWSE NL, 1977, BRIT MED J, V1, P478, DOI 10.1136/bmj.1.6059.478; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Burns JL, 2003, CLIN PLAST SURG, V30, P47, DOI 10.1016/S0094-1298(02)00074-3; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dhar S, 2007, BURNS, V33, P872, DOI 10.1016/j.burns.2006.11.012; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; GILLILAND EL, 1988, ANN ROY COLL SURG, V70, P105; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9; Gottrup F, 2001, ARCH SURG-CHICAGO, V136, P765, DOI 10.1001/archsurg.136.7.765; JACKSON DM, 1951, LANCET, V261, P137; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; KIRSNER RS, 1995, DERMATOL SURG, V21, P701, DOI 10.1111/j.1524-4725.1995.tb00273.x; KRIZEK T, 1967, SURG FORUM, P518; LIEDBERG NCF, 1954, SURG GYNECOL OBSTET, V98, P693; Lunt M J, 1999, J Tissue Viability, V9, P45; McGregor A., 2000, FUNDAMENTAL TECHNIQU, P35; Schmeller W, 2000, ACTA DERM-VENEREOL, V80, P267; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; TANNER J C Jr, 1964, Plast Reconstr Surg, V34, P287; TEH BT, 1979, PLAST RECONSTR SURG, V63, P323, DOI 10.1097/00006534-197903000-00005; Thomsen TR, 2010, WOUND REPAIR REGEN, V18, P38, DOI 10.1111/j.1524-475X.2009.00561.x; Unal S, 2005, ANN PLAS SURG, V55, P102, DOI 10.1097/01.sap.0000164531.23770.60; Valerie EJ, 2003, BURNS, V29, P15, DOI 10.1016/S0305-4179(02)00203-6; WILSON GR, 1988, ANN ROY COLL SURG, V70, P217	31	64	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20492	10.1371/journal.pone.0020492	http://dx.doi.org/10.1371/journal.pone.0020492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655269	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600078
J	Kurotaki, N; Tasaki, S; Mishima, H; Ono, S; Imamura, A; Kikuchi, T; Nishida, N; Tokunaga, K; Yoshiura, K; Ozawa, H				Kurotaki, Naohiro; Tasaki, Shinya; Mishima, Hiroyuki; Ono, Shinji; Imamura, Akira; Kikuchi, Taeko; Nishida, Nao; Tokunaga, Katsushi; Yoshiura, Koh-ichiro; Ozawa, Hiroki			Identification of Novel Schizophrenia Loci by Homozygosity Mapping Using DNA Microarray Analysis	PLOS ONE			English	Article							GENOME; GENES; CONSANGUINITY; ASSOCIATION; POPULATIONS; VARIANTS; GENETICS; PDZ-GEF2; ACSL6; JAPAN	The recent development of high-resolution DNA microarrays, in which hundreds of thousands of single nucleotide polymorphisms (SNPs) are genotyped, enables the rapid identification of susceptibility genes for complex diseases. Clusters of these SNPs may show runs of homozygosity (ROHs) that can be analyzed for association with disease. An analysis of patients whose parents were first cousins enables the search for autozygous segments in their offspring. Here, using the Affymetrix (R) Genome-Wide Human SNP Array 5.0 to determine ROHs, we genotyped 9 individuals with schizophrenia (SCZ) whose parents were first cousins. We identified overlapping ROHs on chromosomes 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 16, 17, 19, 20, and 21 in at least 3 individuals. Only the locus on chromosome 5 has been reported previously. The ROHs on chromosome 5q23.3-q31.1 include the candidate genes histidine triad nucleotide binding protein 1 (HINT1) and acyl-CoA synthetase long-chain family member 6 (ACSL6). Other overlapping ROHs may contain novel rare recessive variants that affect SCZ specifically in our samples, given the highly heterozygous nature of SCZ. Analysis of patients whose parents are first cousins may provide new insights for the genetic analysis of psychiatric diseases.	[Kurotaki, Naohiro; Tasaki, Shinya; Ono, Shinji; Imamura, Akira; Kikuchi, Taeko; Ozawa, Hiroki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuropsychiat, Nagasaki 852, Japan; [Mishima, Hiroyuki; Yoshiura, Koh-ichiro] Nagasaki Univ, Dept Human Genet, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Mishima, Hiroyuki] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan	Nagasaki University; Nagasaki University; Nagasaki University; University of Tokyo	Kurotaki, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuropsychiat, Nagasaki 852, Japan.	naokuro@nagasaki-u.ac.jp	Mishima, Hiroyuki/Y-2638-2019; Imamura, Akira/AAA-9481-2021	Mishima, Hiroyuki/0000-0001-5050-2509; Imamura, Akira/0000-0002-6373-7160	Mitsubishi Pharma Research Foundation; Ministry of Health, Labor, and Welfare; Takeda Scientific Foundation; Naito Foundation; Nagasaki University;  [19591363]; Grants-in-Aid for Scientific Research [23791230] Funding Source: KAKEN	Mitsubishi Pharma Research Foundation; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Nagasaki University; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	NK was supported in part by grants from Grant-in-Aid for Scientific Research (No. 19591363) and by grants from the Mitsubishi Pharma Research Foundation. KY was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare, from the Takeda Scientific Foundation, and from the Naito Foundation. This work was also supported by Nagasaki University Global COE program, global strategic center for radiation health risk control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF INC, 2007, AFF GENECHIP CHROM C; ALAWADI SA, 1985, CLIN GENET, V27, P483; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; *BRLMM P, GEN CALL METH SNP 5; Bulayeva KB, 2006, CROAT MED J, V47, P641; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Chen Q, 2008, SCHIZOPHR RES, V106, P200, DOI 10.1016/j.schres.2008.08.006; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GIRARD SL, 2011, CURR OPIN G IN PRESS; Glessner JT, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-236; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Hong HX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S17; IMAIZUMI Y, 1986, CLIN GENET, V30, P230; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Luo XJ, 2008, J MED GENET, V45, P818, DOI 10.1136/jmg.2008.060657; Mansour H, 2010, SCHIZOPHR RES, V120, P108, DOI 10.1016/j.schres.2010.03.026; Mathews CA, 2004, PSYCHIAT GENET, V14, P13, DOI 10.1097/00041444-200403000-00003; McInnes LA, 2001, P NATL ACAD SCI USA, V98, P11485, DOI 10.1073/pnas.191519098; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Pattison JE, 2004, HOMO, V55, P113, DOI 10.1016/j.jchb.2004.04.002; *R DEV COR TEAM R, 2006, LANG ENV STAT COMP; Rudan I, 2006, NAT GENET, V38, P1224, DOI 10.1038/ng1106-1224; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; *USCS, 2006, USCS GEN BIOINF GOLD; Wand MP., 1994, KERNEL SMOOTHING; YANG H, 2011, LOHAS LOSS OF HETERO; 2006, NAT GENET, V38, P851	33	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20589	10.1371/journal.pone.0020589	http://dx.doi.org/10.1371/journal.pone.0020589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655227	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600104
J	Nakamura, Y; Hinoi, E; Takarada, T; Takahata, Y; Yamamoto, T; Fujita, H; Takada, S; Hashizume, S; Yoneda, Y				Nakamura, Yukari; Hinoi, Eiichi; Takarada, Takeshi; Takahata, Yoshifumi; Yamamoto, Tomomi; Fujita, Hiroyuki; Takada, Saya; Hashizume, Syota; Yoneda, Yukio			Positive Regulation by GABA(B)R1 Subunit of Leptin Expression through Gene Transactivation in Adipocytes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; METABOTROPIC GLUTAMATE RECEPTORS; CULTURED CALVARIAL OSTEOBLASTS; PANCREATIC BETA-CELLS; MITOCHONDRIAL BIOGENESIS; 3T3-L1 ADIPOCYTES; COACTIVATOR PGC-1; PROGENITOR CELLS; PROTEIN; GABA	Background: The view that gamma-aminobutyric acid (GABA) plays a functional role in non-neuronal tissues, in addition to an inhibitory neurotransmitter role in the mammalian central nervous system, is prevailing, while little attention has been paid to GABAergic signaling machineries expressed by adipocytes to date. In this study, we attempted to demonstrate the possible functional expression of GABAergic signaling machineries by adipocytes. Methodology/Principal Findings: GABA(B) receptor 1 (GABA(B)R1) subunit was constitutively expressed by mouse embryonic fibroblasts differentiated into adipocytes and adipocytic 3T3-L1 cells in culture, as well as mouse white adipose tissue, with no responsiveness to GABA(B)R ligands. However, no prominent expression was seen with mRNA for GABA(B)R2 subunit required for heteromeric orchestration of the functional GABA(B)R by any adipocytic cells and tissues. Leptin mRNA expression was significantly and selectively decreased in adipose tissue and embryonic fibroblasts, along with drastically reduced plasma leptin levels, in GABA(B)R1-null mice than in wild-type mice. Knockdown by siRNA of GABA(B)R1 subunit led to significant decreases in leptin promoter activity and leptin mRNA levels in 3T3-L1 cells. Conclusions/Significance: Our results indicate that GABA(B)R1 subunit is constitutively expressed by adipocytes to primarily regulate leptin expression at the transcriptional level through a mechanism not relevant to the function as a partner of heterodimeric assembly to the functional GABA(B)R.	[Nakamura, Yukari; Hinoi, Eiichi; Takarada, Takeshi; Takahata, Yoshifumi; Yamamoto, Tomomi; Fujita, Hiroyuki; Takada, Saya; Hashizume, Syota; Yoneda, Yukio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Nakamura, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Takahata, Yoshifumi/AAZ-6869-2021; Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22659065, 22500330]; ONO Medical Research Foundation, Japan; Grants-in-Aid for Scientific Research [09J03309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ONO Medical Research Foundation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aids for Scientific Research to E.H. (No. 22659065) and T.T. (No. 22500330) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and in part by a Research Grant to E. H. from the ONO Medical Research Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Castelli MP, 1999, LIFE SCI, V64, P1321, DOI 10.1016/S0024-3205(99)00067-3; Friedman JM, 2010, NAT MED, V16, P1100, DOI 10.1038/nm1010-1100; Fujimori S, 2002, BIOCHEM BIOPH RES CO, V293, P1445, DOI 10.1016/S0006-291X(02)00405-9; Fuke T, 2010, INT J OBESITY, V34, P670, DOI 10.1038/ijo.2009.295; Fukui M, 2008, J CELL PHYSIOL, V216, P507, DOI 10.1002/jcp.21422; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harris RBS, 2000, ANNU REV NUTR, V20, P45, DOI 10.1146/annurev.nutr.20.1.45; Hinoi E, 2001, BIOCHEM BIOPH RES CO, V281, P341, DOI 10.1006/bbrc.2001.4355; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; KANNER BI, 1994, J EXP BIOL, V196, P237; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Nakamichi N, 2008, J NEUROCHEM, V105, P1996, DOI 10.1111/j.1471-4159.2008.05289.x; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Sullivan R, 2000, J PHARMACOL EXP THER, V293, P460; Sze P Y, 1979, Adv Exp Med Biol, V123, P59; Takarada-Iemata M, 2011, J CELL PHYSIOL, V226, P652, DOI 10.1002/jcp.22390; TANIGUCHI H, 1979, DIABETES, V28, P629, DOI 10.2337/diabetes.28.7.629; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	47	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20167	10.1371/journal.pone.0020167	http://dx.doi.org/10.1371/journal.pone.0020167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655283	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600026
J	Riihimaki, TA; Kukkurainen, S; Varjonen, S; Horha, J; Nyholm, TKM; Kulomaa, MS; Hytonen, VP				Riihimaki, Tiina A.; Kukkurainen, Sampo; Varjonen, Suvi; Horha, Jarno; Nyholm, Thomas K. M.; Kulomaa, Markku S.; Hytonen, Vesa P.			Construction of Chimeric Dual-Chain Avidin by Tandem Fusion of the Related Avidins	PLOS ONE			English	Article							CIRCULARLY PERMUTED AVIDINS; CHICKEN AVIDIN; BIOTIN-BINDING; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; HIGH-AFFINITY; STREPTAVIDIN; PROTEIN; THERMOSTABILITY; STABILITY	Background: Avidin is a chicken egg-white protein with high affinity to vitamin H, also known as D-biotin. Many applications in life science research are based on this strong interaction. Avidin is a homotetrameric protein, which promotes its modification to symmetrical entities. Dual-chain avidin, a genetically engineered avidin form, has two circularly permuted chicken avidin monomers that are tandem-fused into one polypeptide chain. This form of avidin enables independent modification of the two domains, including the two biotin-binding pockets; however, decreased yields in protein production, compared to wt avidin, and complicated genetic manipulation of two highly similar DNA sequences in the tandem gene have limited the use of dual-chain avidin in biotechnological applications. Principal Findings: To overcome challenges associated with the original dual-chain avidin, we developed chimeric dual-chain avidin, which is a tandem fusion of avidin and avidin-related protein 4 (AVR4), another member of the chicken avidin gene family. We observed an increase in protein production and better thermal stability, compared with the original dual-chain avidin. Additionally, PCR amplification of the hybrid gene was more efficient, thus enabling more convenient and straightforward modification of the dual-chain avidin. When studied closer, the generated chimeric dual-chain avidin showed biphasic biotin dissociation. Significance: The improved dual-chain avidin introduced here increases its potential for future applications. This molecule offers a valuable base for developing bi-functional avidin tools for bioseparation, carrier proteins, and nanoscale adapters. Additionally, this strategy could be helpful when generating hetero-oligomers from other oligomeric proteins with high structural similarity.	[Riihimaki, Tiina A.; Kukkurainen, Sampo; Varjonen, Suvi; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Riihimaki, Tiina A.; Kukkurainen, Sampo; Varjonen, Suvi; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ Hosp, Tampere, Finland; [Horha, Jarno; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Nyholm, Thomas K. M.] Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Jyvaskyla; Abo Akademi University	Riihimaki, TA (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Hytonen, Vesa P./E-8855-2013; Kulomaa, Markku S/C-9063-2014; Arola, Suvi A/K-8695-2015	Hytonen, Vesa P./0000-0002-9357-1480; Arola, Suvi A/0000-0003-4087-3837; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [115976, 121236]; National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB)	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB)	Funding by the Academy of Finland (http://www.aka.fi/en-GB/A/; project numbers 115976 and 121236), National Doctoral Programme in Informational and Structural Biology (ISB, http://web.abo.fi/isb/) and Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB, http://www.uta.fi/tutkijakoulut/tgsbb/) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlroth MK, 2000, ANIM GENET, V31, P367, DOI 10.1046/j.1365-2052.2000.00681.x; Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; Aslan FM, 2005, P NATL ACAD SCI USA, V102, P8507, DOI 10.1073/pnas.0503112102; BARBARAKIS MS, 1993, ANAL CHEM, V65, P457, DOI 10.1021/ac00052a024; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; BAYER EA, 1990, METHOD ENZYMOL, V184, P415; DeChancie J, 2007, J AM CHEM SOC, V129, P5419, DOI 10.1021/ja066950n; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Gonzalez M, 1997, J BIOL CHEM, V272, P11288; GREEN N. M., 1970, Methods in Enzymology, V18A, P418, DOI 10.1016/0076-6879(71)18342-5; GREEN NM, 1972, BIOCHEM J, V130, P707, DOI 10.1042/bj1300707; GROMAN EV, 1990, METHOD ENZYMOL, V184, P208; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyre DE, 2006, PROTEIN SCI, V15, P459, DOI 10.1110/ps.051970306; Hytonen VP, 2006, J MOL BIOL, V359, P1352, DOI 10.1016/j.jmb.2006.04.044; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VP, 2003, BIOCHEM J, V372, P219, DOI 10.1042/BJ20021531; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JONES ML, 1995, BIOCHEMISTRY-US, V34, P11750, DOI 10.1021/bi00037a012; KEINANEN RA, 1994, EUR J BIOCHEM, V220, P615, DOI 10.1111/j.1432-1033.1994.tb18663.x; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leppiniemi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016576; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Lin H J, 1979, Methods Enzymol, V62, P287, DOI 10.1016/0076-6879(79)62231-0; MOCK DM, 1990, METHOD ENZYMOL, V184, P234; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SANO T, 1990, J BIOL CHEM, V265, P3369; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEBER PC, 1987, J BIOL CHEM, V262, P12728; Zacco E, 2006, BIOSENS BIOELECTRON, V21, P1291, DOI 10.1016/j.bios.2005.05.016	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20535	10.1371/journal.pone.0020535	http://dx.doi.org/10.1371/journal.pone.0020535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655240	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600090
J	Klumpp, S				Klumpp, Stefan			Growth-Rate Dependence Reveals Design Principles of Plasmid Copy Number Control	PLOS ONE			English	Article							ESCHERICHIA-COLI; ROM PROTEIN; MATHEMATICAL-MODEL; GENE-EXPRESSION; RNA-I; REPLICATION; PBR322; PROMOTERS; KINETICS; BACTERIA	Genetic circuits in bacteria are intimately coupled to the cellular growth rate as many parameters of gene expression are growth-rate dependent. Growth-rate dependence can be particularly pronounced for genes on plasmids; therefore the native regulatory systems of a plasmid such as its replication control system are characterized by growth-rate dependent parameters and regulator concentrations. This natural growth-rate dependent variation of regulator concentrations can be used for a quantitative analysis of the design of such regulatory systems. Here we analyze the growth-rate dependence of parameters of the copy number control system of ColE1-type plasmids in E. coli. This analysis allows us to infer the form of the control function and suggests that the Rom protein increases the sensitivity of control.	[Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Klumpp, Stefan] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego	Klumpp, S (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam, Germany.	klumpp@mpikg.mpg.de	Klumpp, Stefan/AAC-3936-2019; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146	Deutsche Forschungsgemeinschaft [KL818/1-1, 1-2]; National Science Foundation (NSF) through the Center for Theoretical Biological Physics [PHY-0822283]; National Institutes of Health (NIH) [R01GM77298]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077298] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation (NSF) through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The initial phase of this work was supported by Deutsche Forschungsgemeinschaft (fellowship KL818/1-1 and 1-2), by the National Science Foundation (NSF) through the Center for Theoretical Biological Physics (grant PHY-0822283) and by the National Institutes of Health (NIH) through grant R01GM77298 (to Terence Hwa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E., 2006, MOL SYST BIOL, V2, P0028; ATAAI MM, 1986, PLASMID, V16, P204, DOI 10.1016/0147-619X(86)90058-2; Atlung T, 1999, PLASMID, V41, P110, DOI 10.1006/plas.1998.1386; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bremer H, 1996, ESCHERICHIA COLI SAL; BRENDEL V, 1993, J MOL BIOL, V229, P860, DOI 10.1006/jmbi.1993.1092; BRENNER M, 1991, P NATL ACAD SCI USA, V88, P405, DOI 10.1073/pnas.88.2.405; CHURCHWARD G, 1981, J BACTERIOL, V145, P1232, DOI 10.1128/JB.145.3.1232-1238.1981; Ehrenberg M, 1996, BIOPHYS J, V70, P135, DOI 10.1016/S0006-3495(96)79555-3; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Helinski D.R., 1996, ESCHERICHIA COLI SAL, V2, P2295; Jasiecki J, 2003, EMBO REP, V4, P172, DOI 10.1038/sj.embor.embor733; KEASLING JD, 1989, J THEOR BIOL, V136, P487, DOI 10.1016/S0022-5193(89)80161-4; KIM BG, 1990, BIOTECHNOL BIOENG, V36, P233, DOI 10.1002/bit.260360304; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Liang ST, 1998, J BACTERIOL, V180, P6090; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; LINCHAO S, 1987, J BACTERIOL, V169, P1217, DOI 10.1128/jb.169.3.1217-1222.1987; Marguet P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011909; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Paulsson J, 1998, PLASMID, V39, P215, DOI 10.1006/plas.1998.1338; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; SOM T, 1983, P NATL ACAD SCI-BIOL, V80, P3232, DOI 10.1073/pnas.80.11.3232; Summers D.K., 1996, BIOL PLASMIDS; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; TOMIZAWA J, 1990, J MOL BIOL, V212, P695, DOI 10.1016/0022-2836(90)90231-A; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; Wrobel B, 1998, PLASMID, V39, P48, DOI 10.1006/plas.1997.1319; Zhang XY, 1996, J MOL BIOL, V259, P27, DOI 10.1006/jmbi.1996.0299	34	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20403	10.1371/journal.pone.0020403	http://dx.doi.org/10.1371/journal.pone.0020403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647376	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500058
J	Nather, FC; Bueno, JLO; Bigand, E; Droit-Volet, S				Nather, Francisco C.; Bueno, Jose L. O.; Bigand, Emmanuel; Droit-Volet, Sylvie			Time Changes with the Embodiment of Another's Body Posture	PLOS ONE			English	Article							INTERNAL CLOCK; APPARENT MOTION; SPEEDING-UP; PERCEPTION; BISECTION; REPRESENTATIONS; DURATION; MOVEMENT; CHILDREN; EMOTION	The aim of the present study was to investigate whether the perception of presentation durations of pictures of different body postures was distorted as function of the embodied movement that originally produced these postures. Participants were presented with two pictures, one with a low-arousal body posture judged to require no movement and the other with a high-arousal body posture judged to require considerable movement. In a temporal bisection task with two ranges of standard durations (0.4/1.6 s and 2/8 s), the participants had to judge whether the presentation duration of each of the pictures was more similar to the short or to the long standard duration. The results showed that the duration was judged longer for the posture requiring more movement than for the posture requiring less movement. However the magnitude of this overestimation was relatively greater for the range of short durations than for that of longer durations. Further analyses suggest that this lengthening effect was mediated by an arousal effect of limited duration on the speed of the internal clock system.	[Nather, Francisco C.; Bueno, Jose L. O.] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil; [Bigand, Emmanuel] Univ Bourgogne, Inst Univ France, CNRS, LEAD, Dijon, France; [Droit-Volet, Sylvie] Univ Blaise Pascal, CNRS, LAPSCO, Clermont Ferrand, France	Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Nather, FC (corresponding author), Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.	f.nather@hotmail.com; sylvie.droit-volet@univ-bpclermont.fr	Bueno, José Lino Oliveira/F-3200-2015		CAPES; CAPES-COFECUB Program (Brazil-France); CNPq; French National Research Agency [ANR Blan06-2-145908]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-COFECUB Program (Brazil-France)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); French National Research Agency(French National Research Agency (ANR))	This research was supported by a Post-Doctoral Scholarship from CAPES to F. C. Nather, and a CAPES-COFECUB Program (Brazil-France) to J.L.O. Bueno, E. Bigand and S. Droit-Volet. The work was also funded by grants from CNPq to J.L.O. Bueno and from the French National Research Agency (ANR Blan06-2-145908 FaceExpress). The funders paid for the travels of France-Brazil for the researchers, but had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLAN LG, 1991, LEARN MOTIV, V22, P39, DOI 10.1016/0023-9690(91)90016-2; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Block R. A., 1990, COGNITIVE MODELS PSY, P1; Bonnet C, 2005, PERCEPTION, V34, P835, DOI 10.1068/p5039; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Chambon M, 2008, J EXP SOC PSYCHOL, V44, P672, DOI 10.1016/j.jesp.2007.04.014; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Droit-Volet S, 2002, Q J EXP PSYCHOL-B, V55, P193, DOI 10.1080/02724990143000252; Droit-Volet S, 2001, J EXP CHILD PSYCHOL, V80, P142, DOI 10.1006/jecp.2001.2631; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2007, BEHAV PROCESS, V74, P244, DOI 10.1016/j.beproc.2006.09.012; Droit-Volet S, 2009, PHILOS T R SOC B, V364, P1943, DOI 10.1098/rstb.2009.0013; DROITVOLET S, SUBJECTIVE IN PRESS; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; Fraisse, 1967, PSYCHOL TEMPS; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; Garbarini F, 2004, BRAIN COGNITION, V56, P100, DOI 10.1016/j.bandc.2004.06.003; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GROWE B, 2001, DEGAS; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; MARICQ AV, 1981, J EXP PSYCHOL ANIM B, V7, P18, DOI 10.1037/0097-7403.7.1.18; MARQUES L, 1999, DEGAS MOVIMENTO; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; NATHER FC, J STUDY TIM IN PRESS; NATHER FC, 2008, P 24 ANN M SOC PSYCH, P185; Nather Francisco Carlos, 2006, Psicol. Reflex. Crit., V19, P217, DOI 10.1590/S0102-79722006000200007; Penney T.B., 2003, METH NE FRO NEUROSCI, P209, DOI 10.1080/17470218.2015.1023735; Penney TB, 1998, TIMING OF BEHAVIOR, P165; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; SHIFFRAR M, 1993, PSYCHOL SCI, V4, P379, DOI 10.1111/j.1467-9280.1993.tb00585.x; SHIFFRAR M, 1990, PSYCHOL SCI, V1, P257, DOI 10.1111/j.1467-9280.1990.tb00210.x; Strickland C., 2004, ARTE COMENTADA PREHI; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Verfaillie K, 2002, VIS COGN, V9, P217, DOI 10.1080/13506280143000403; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wittmann M, 2009, PHILOS T R SOC B, V364, P1955, DOI 10.1098/rstb.2009.0003; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319	50	44	47	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19818	10.1371/journal.pone.0019818	http://dx.doi.org/10.1371/journal.pone.0019818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XV	21637759	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500012
J	Szalkowski, AM; Anisimova, M				Szalkowski, Adam M.; Anisimova, Maria			Markov Models of Amino Acid Substitution to Study Proteins with Intrinsically Disordered Regions	PLOS ONE			English	Article							UNSTRUCTURED PROTEINS; MAXIMUM-LIKELIHOOD; TANDEM REPEATS; PREDICTION; EVOLUTION; TOOL; IDENTIFICATION; DATABASE; DOMAIN	Background: Intrinsically disordered proteins (IDPs) or proteins with disordered regions (IDRs) do not have a well-defined tertiary structure, but perform a multitude of functions, often relying on their native disorder to achieve the binding flexibility through changing to alternative conformations. Intrinsic disorder is frequently found in all three kingdoms of life, and may occur in short stretches or span whole proteins. To date most studies contrasting the differences between ordered and disordered proteins focused on simple summary statistics. Here, we propose an evolutionary approach to study IDPs, and contrast patterns specific to ordered protein regions and the corresponding IDRs. Results: Two empirical Markov models of amino acid substitutions were estimated, based on a large set of multiple sequence alignments with experimentally verified annotations of disordered regions from the DisProt database of IDPs. We applied new methods to detect differences in Markovian evolution and evolutionary rates between IDRs and the corresponding ordered protein regions. Further, we investigated the distribution of IDPs among functional categories, biochemical pathways and their preponderance to contain tandem repeats. Conclusions: We find significant differences in the evolution between ordered and disordered regions of proteins. Most importantly we find that disorder promoting amino acids are more conserved in IDRs, indicating that in some cases not only amino acid composition but the specific sequence is important for function. This conjecture is also reinforced by the observation that for 27% of our data set IDRs evolve more slowly than the ordered parts of the proteins, while we still support the common view that IDRs in general evolve more quickly. The improvement in model fit indicates a possible improvement for various types of analyses e. g. de novo disorder prediction using a phylogenetic Hidden Markov Model based on our matrices showed a performance similar to other disorder predictors.	[Szalkowski, Adam M.; Anisimova, Maria] Swiss Inst Bioinformat, Lausanne, Switzerland; [Szalkowski, Adam M.; Anisimova, Maria] ETH, Dept Comp Sci, Computat Biochem Res Grp, Zurich, Switzerland	Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich	Szalkowski, AM (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	adam.szalkowski@inf.ethz.ch		Anisimova, Maria/0000-0001-8145-7966	Swiss National Science Foundation [31003A/127325]; Eidgenossische Technische Hochschule (ETH) Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eidgenossische Technische Hochschule (ETH) Zurich(ETH Zurich)	This work was partially supported by the Swiss National Science Foundation grant to M.A. (ref. 31003A/127325). A.S. and M.A. are also funded by the Eidgenossische Technische Hochschule (ETH) Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babon JJ, 2005, FEBS J, V272, P6120, DOI 10.1111/j.1742-4658.2005.05010.x; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2019, DOI 10.1093/nar/20.suppl.2019; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Dimitrieva S, 2010, TRENDS EVOL BIOL, V2, pe1; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hecker J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S9; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huang Y, 2000, J MOL BIOL, V298, P149, DOI 10.1006/jmbi.2000.3637; Huang YQ, 2010, PROTEINS, V78, P3251, DOI 10.1002/prot.22820; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Klosterman PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-428; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LE SQ, 2008, PHILOS T R SOC LON B; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Midic U., 2009, P KDD 09 WORKSH STAT, P27; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; ROMERO P, 2001, PROTEINS NEW YORK, V42, P3848; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Sandhu KS, 2009, J MOL RECOGNIT, V22, P1, DOI 10.1002/jmr.915; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2010, J MOL BIOL, V403, P346, DOI 10.1016/j.jmb.2010.07.044; UVERSKY VN, 2010, CHEM SOC REV; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WHELAN S, 2006, NUCLEIC ACIDS RES, V34; XIE H, 2007, J PROTEOME RES, V6; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	52	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20488	10.1371/journal.pone.0020488	http://dx.doi.org/10.1371/journal.pone.0020488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647374	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052500063
J	Zhang, Z; Norris, J; Schwartz, C; Alexov, E				Zhang, Zhe; Norris, Joy; Schwartz, Charles; Alexov, Emil			In Silico and In Vitro Investigations of the Mutability of Disease-Causing Missense Mutation Sites in Spermine Synthase	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; POLYAMINE BIOSYNTHETIC-ENZYMES; SNYDER-ROBINSON SYNDROME; NON-SYNONYMOUS SNPS; PROTEIN FUNCTION; GENE; DECARBOXYLASE; DEFICIENCY; PREDICTION; BINDING	Background: Spermine synthase (SMS) is a key enzyme controlling the concentration of spermidine and spermine in the cell. The importance of SMS is manifested by the fact that single missense mutations were found to cause Snyder-Robinson Syndrome (SRS). At the same time, currently there are no non-synonymous single nucleoside polymorphisms, nsSNPs (harmless mutations), found in SMS, which may imply that the SMS does not tolerate amino acid substitutions, i.e. is not mutable. Methodology/Principal Findings: To investigate the mutability of the SMS, we carried out in silico analysis and in vitro experiments of the effects of amino acid substitutions at the missense mutation sites (G56, V132 and I150) that have been shown to cause SRS. Our investigation showed that the mutation sites have different degree of mutability depending on their structural micro-environment and involvement in the function and structural integrity of the SMS. It was found that the I150 site does not tolerate any mutation, while V132, despite its key position at the interface of SMS dimer, is quite mutable. The G56 site is in the middle of the spectra, but still quite sensitive to charge residue replacement. Conclusions/Significance: The performed analysis showed that mutability depends on the detail of the structural and functional factors and cannot be predicted based on conservation of wild type properties alone. Also, harmless nsSNPs can be expected to occur even at sites at which missense mutations were found to cause diseases.	[Zhang, Zhe; Alexov, Emil] Clemson Univ, Dept Phys, Clemson, SC 29634 USA; [Norris, Joy; Schwartz, Charles] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Schwartz, Charles] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Clemson University; Greenwood Genetic Center; Clemson University	Zhang, Z (corresponding author), Clemson Univ, Dept Phys, Clemson, SC 29634 USA.	ealexov@clemson.edu	Zhang, Zhe/J-9434-2014	Zhang, Zhe/0000-0002-1952-5726; Zhang, Zhe/0000-0002-0744-1314	NLM/NIH [1R03LM009748, 1R03LM009748-S1]; Clemson University CCIT group, especially Corey Ferrier; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R03LM009748] Funding Source: NIH RePORTER	NLM/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Clemson University CCIT group, especially Corey Ferrier; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	NLM/NIH, grant numbers 1R03LM009748 and 1R03LM009748-S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of Clemson University CCIT group, especially Corey Ferrier, is greatly appreciated. We thank Shawn Witham for reading the manuscript prior to publication and useful suggestions. Dedicated to the memory of Ethan Francis Schwartz (1996-1998).	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Capriotti E, 2005, BIOINFORMATICS, V21, P54, DOI 10.1093/bioinformatics/bti1109; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; GEERTS D, INT J CANC, V126, P2012; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; Heby O, 2003, BIOCHEM SOC T, V31, P415, DOI 10.1042/BST0310415; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Kesler SR, 2009, NEUROGENETICS, V10, P299, DOI 10.1007/s10048-009-0184-2; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Ofiteru A, 2007, FEBS J, V274, P3363, DOI 10.1111/j.1742-4658.2007.05870.x; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; PONDER JW, 1999, TINKER SOFTWARE TOOL; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Wang XJ, 2009, J BIOL CHEM, V284, P930, DOI 10.1074/jbc.M807758200; Wang Z, 2003, PROTEINS, V53, P748, DOI 10.1002/prot.10522; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Ye Yuzhen, 2006, Pac Symp Biocomput, P439, DOI 10.1142/9789812701626_0040; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	39	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20373	10.1371/journal.pone.0020373	http://dx.doi.org/10.1371/journal.pone.0020373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647366	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500054
J	Goes, FS; Rongione, M; Chen, YC; Karchin, R; Elhaik, E; Potash, JB				Goes, Fernando S.; Rongione, Michael; Chen, Yun-Ching; Karchin, Rachel; Elhaik, Eran; Potash, James B.		Bipolar Genome Study	Exonic DNA Sequencing of ERBB4 in Bipolar Disorder	PLOS ONE			English	Article							TRADITIONAL DIAGNOSTIC BOUNDARIES; GENOME-WIDE ASSOCIATION; SCHIZOPHRENIA; GENES; SUSCEPTIBILITY; VARIANTS; NRG1; NEUREGULIN-1; POPULATION; NETWORK	The Neuregulin-ErbB4 pathway plays a crucial role in brain development and constitutes one of the most biologically plausible signaling pathways implicated in schizophrenia and, to a lesser extent, in bipolar disorder (BP). However, recent genome-wide association analyses have not provided evidence for common variation in NRG1 or ERBB4 influencing schizophrenia or bipolar disorder susceptibility. In this study, we investigate the role of rare coding variants in ERBB4 in BP cases with mood-incongruent psychotic features, a form of BP with arguably the greatest phenotypic overlap with schizophrenia. We performed Sanger sequencing of all 28 exons in ERBB4, as well as part of the promoter and part of the 3'UTR sequence, hypothesizing that rare deleterious variants would be found in 188 cases with mood-incongruent psychosis from the GAIN BP study. We found 42 variants, of which 16 were novel, although none were non-synonymous or clearly deleterious. One of the novel variants, present in 11.2% of cases, is located next to an alternative stop codon, which is associated with a shortened transcript of ERBB4 that is not translated. We genotyped this variant in the GAIN BP case-control samples and found a marginally significant association with mood-incongruent psychotic BP compared with controls (additive model: OR = 1.64, P-value = 0.055; dominant model: OR = 1.73. P-value = 0.039). In conclusion, we found no rare variants of clear deleterious effect, but did uncover a modestly associated novel variant that could affect alternative splicing of ERBB4. However, the modest sample size in this study cannot definitively rule out a role for rare variants in bipolar disorder and studies with larger sample sizes are needed to confirm the observed association.	[Goes, Fernando S.; Rongione, Michael; Potash, James B.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Chen, Yun-Ching; Karchin, Rachel] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Chen, Yun-Ching; Karchin, Rachel] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Elhaik, Eran] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Goes, FS (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA.	fgoes1@jhmi.edu	Elhaik, Eran/H-6838-2019; Karchin, Rachel/A-3385-2010; Greenwood, Tiffany/F-6356-2012; Smith, Erin/E-5933-2011; Zhang, Peng/N-2920-2014; McMahon, Francis J/A-7290-2009; Mahon, Pamela Belmonte/O-9806-2018	Elhaik, Eran/0000-0003-4795-1084; Greenwood, Tiffany/0000-0002-6080-6503; Zhang, Peng/0000-0003-1182-1392; McMahon, Francis J/0000-0002-9469-305X; Mahon, Pamela Belmonte/0000-0002-3947-441X; Karchin, Rachel/0000-0002-5069-1239	NIMH [K99 MH086049]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014592, K99MH086049] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by my NIMH grant (K99 MH086049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Bindewald E, 2006, RNA, V12, P342, DOI 10.1261/rna.2164906; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Goes FS, 2007, AM J PSYCHIAT, V164, P236, DOI 10.1176/appi.ajp.164.2.236; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Nicodemus KK, 2010, ARCH GEN PSYCHIAT, V67, P991, DOI 10.1001/archgenpsychiatry.2010.117; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Potash JB, 2007, AM J PSYCHIAT, V164, P1229, DOI 10.1176/appi.ajp.2007.06122045; Potash JB, 2009, NAT REV NEUROL, V5, P299, DOI 10.1038/nrneurol.2009.71; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sanders AR, 2010, AM J PSYCHIAT, V167, P854, DOI 10.1176/appi.ajp.2010.09071050; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shiota S, 2008, J HUM GENET, V53, P929, DOI 10.1007/s10038-008-0332-9; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471	31	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20242	10.1371/journal.pone.0020242	http://dx.doi.org/10.1371/journal.pone.0020242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637803	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000291052200042
J	Hennessey, PT; Ochs, MF; Mydlarz, WW; Hsueh, W; Cope, L; Yu, WN; Califano, JA				Hennessey, Patrick T.; Ochs, Michael F.; Mydlarz, Wojciech W.; Hsueh, Wayne; Cope, Leslie; Yu, Wayne; Califano, Joseph A.			Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts	PLOS ONE			English	Article							DNA METHYLATION; CPG ISLAND; IN-VIVO; LUNG-CANCER; HYPERMETHYLATION; CHEMOTHERAPY; REVEALS; GENES; MODEL	Studies designed to identify novel methylation events related to cancer often employ cancer cell lines in the discovery phase of the experiments and have a relatively low rate of discovery of cancer-related methylation events. An alternative algorithm for discovery of novel methylation in cancer uses primary tumor-derived xenografts instead of cell lines as the primary source of nucleic acid for evaluation. We evaluated DNA extracted from primary head and neck squamous cell carcinomas (HNSCC), xenografts grown from these primary tumors in nude mice, HNSCC-derived cell lines, normal oral mucosal samples, and minimally transformed oral keratinocyte-derived cell lines using Illumina Infinum Humanmethylation 27 genome-wide methylation microarrays. We found > 2,200 statistically significant methylation differences between cancer cell lines and primary tumors and when comparing normal oral mucosa to keratinocyte cell lines. We found no statistically significant promoter methylation differences between primary tumor xenografts and primary tumors. This study demonstrates that tumor-derived xenografts are highly accurate representations of promoter methylation in primary tumors and that cancer derived cell lines have significant drawbacks for discovery of promoter methylation alterations in primary tumors. These findings also support use of primary tumor xenografts for the study of methylation in cancer, drug discovery, and the development of personalized cancer treatments.	[Hennessey, Patrick T.; Mydlarz, Wojciech W.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.; Cope, Leslie] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Ochs, Michael F.; Cope, Leslie] Johns Hopkins Med Inst, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Hsueh, Wayne] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Yu, Wayne] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Hennessey, PT (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu			National Cancer Institute [5P50CA096784-05, RC1DE020324]; NIH [T32DC000027]; Hopkins [CCSG P30CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The following funding sources supported this research: Dr. Califano is supported by a National Cancer Institute SPORE (5P50CA096784-05) and Challenge Grant (RC1DE020324). Drs. Hennessey and Mydlarz are funded in part by a NIH T32 Research Training Grant (T32DC000027). Drs. Ochs and Cope are partially funded by the Hopkins CCSG P30CA006973. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang JC, 2010, MOL CANCER THER, V9, P1443, DOI 10.1158/1535-7163.MCT-09-1048; DONG X, CLIN CANC RES, V16, P1442; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001; Houshdaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009359; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KAWAI J, 1994, MOL CELL BIOL, V14, P7421, DOI 10.1128/MCB.14.11.7421; Kim MM, 2006, ORAL ONCOL, V42, P201, DOI 10.1016/j.oraloncology.2005.07.004; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Koizume S, 2002, NUCLEIC ACIDS RES, V30, P4770, DOI 10.1093/nar/gkf593; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Merk J, 2009, EUR J CARDIO-THORAC, V36, P454, DOI 10.1016/j.ejcts.2009.03.054; Milne ANA, 2007, HUM PATHOL, V38, P903, DOI 10.1016/j.humpath.2006.12.010; Paz MF, 2003, CANCER RES, V63, P1114; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; STRATTON JA, 1986, GYNECOL ONCOL, V25, P302, DOI 10.1016/0090-8258(86)90081-8; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5	32	50	50	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20584	10.1371/journal.pone.0020584	http://dx.doi.org/10.1371/journal.pone.0020584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637785	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200080
J	Tahir, MN; Amin, I; Briddon, RW; Mansoor, S				Tahir, Muhammad Nouman; Amin, Imran; Briddon, Rob W.; Mansoor, Shahid			The Merging of Two Dynasties-Identification of an African Cotton Leaf Curl Disease-Associated Begomovirus with Cotton in Pakistan	PLOS ONE			English	Article							PCR-MEDIATED AMPLIFICATION; DNA-BETA SATELLITE; UNIVERSAL PRIMERS; PALAMPUR VIRUS; 1ST REPORT; GEMINIVIRUS; PROTEIN; BETASATELLITE; SUPPRESSOR; DIVERSITY	Cotton leaf curl disease (CLCuD) is a severe disease of cotton that occurs in Africa and Pakistan/northwestern India. The disease is caused by begomoviruses in association with specific betasatellites that differ between Africa and Asia. During survey of symptomatic cotton in Sindh (southern Pakistan) Cotton leaf curl Gezira virus (CLCuGV), the begomovirus associated with CLCuD in Africa, was identified. However, the cognate African betasatellite (Cotton leaf curl Gezira betasatellite) was not found. Instead, two Asian betasatellites, the CLCuD-associated Cotton leaf curl Multan betasatellite (CLCuMB) and Chilli leaf curl betasatellite (ChLCB) were identified. Inoculation of the experimental plant species Nicotiana benthamiana showed that CLCuGV was competent to maintain both CLCuMB and ChLCB. Interestingly, the enations typical of CLCuD were only induced by CLCuGV in the presence of CLCuMB. Also in infections involving both CLCuMB and ChLCB the enations typical of CLCuMB were less evident. This is the first time an African begomovirus has been identified on the Indian sub-continent, highlight the growing threat of begomoviruses and particularly the threat of CLCuD causing viruses to cotton cultivation in the rest of the world.	[Tahir, Muhammad Nouman; Amin, Imran; Briddon, Rob W.; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan	Pakistan Institute of Engineering & Applied Science	Tahir, MN (corresponding author), Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan.	shahidmansoor7@gmail.com	Briddon, Rob W./I-5921-2012	Briddon, Rob W./0000-0001-8738-0365; Mansoor, Shahid/0000-0001-7418-1826	Higher Education Commission (HEC), Pakistan; HEC; NIBGE; Donald Danforth Plant Science Center, St. Louis, USA	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); HEC; NIBGE; Donald Danforth Plant Science Center, St. Louis, USA	MNT is supported by a Ph.D Fellowship from Higher Education Commission (HEC), Pakistan. RWB is supported by the HEC under the "Foreign Faculty Hiring Program". The work is supported by a collaborative project between NIBGE and the Donald Danforth Plant Science Center, St. Louis, USA under the "Pak-USA linkage program". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahmed MZ, 2011, PEST MANAG SCI, V67, P307, DOI 10.1002/ps.2067; Ali I, 2010, PLANT DIS, V94, P276, DOI 10.1094/PDIS-94-2-0276A; Amin I, 2006, ARCH VIROL, V151, P2055, DOI 10.1007/s00705-006-0773-4; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; Azhar MT, 2010, VIRUS GENES, V41, P417, DOI 10.1007/s11262-010-0521-4; Briddon RW, 2008, ARCH VIROL, V153, P763, DOI 10.1007/s00705-007-0013-6; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon RW, 2003, MOL PLANT PATHOL, V4, P427, DOI [10.1046/j.1364-3703.2003.00188.x, 10.1046/J.1364-3703.2003.00188.X]; Briddon RW, 2003, VIROLOGY, V312, P106, DOI 10.1016/S0042-6822(03)00200-9; Briddon RW, 2002, MOL BIOTECHNOL, V20, P315, DOI 10.1385/MB:20:3:315; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Bull SE, 2003, MOL BIOTECHNOL, V23, P83, DOI 10.1385/MB:23:1:83; Cai JH, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02266.x; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Halley-Stott RP, 2007, ARCH VIROL, V152, P1237, DOI 10.1007/s00705-006-0933-6; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Heydarnejad J, 2009, ARCH VIROL, V154, P1015, DOI 10.1007/s00705-009-0389-6; Hussain M, 2005, J VIROL, V79, P4434, DOI 10.1128/JVI.79.7.4434-4439.2005; Hussain M, 2009, J PHYTOPATHOL, V157, P576, DOI 10.1111/j.1439-0434.2008.01523.x; Idris AM, 2005, VIRUS RES, V109, P19, DOI 10.1016/j.virusres.2004.10.002; Idris AM, 2004, PHYTOPATHOLOGY, V94, P1068, DOI 10.1094/PHYTO.2004.94.10.1068; Idris AM, 2002, VIRUS GENES, V24, P249, DOI 10.1023/A:1015380600089; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; KIRKPATRICK T. W., 1931, BULL ENT RES [LONDON], V22, P323, DOI 10.1017/S0007485300029862; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Liu L, 1997, J GEN VIROL, V78, P2113, DOI 10.1099/0022-1317-78-8-2113; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2003, ARCH VIROL, V148, P1969, DOI 10.1007/s00705-003-0149-y; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; MAYO MA, 2005, 8 REPORT INT COMMITT, P1163; Nahid N, 2008, ARCH VIROL, V153, P1441, DOI 10.1007/s00705-008-0133-7; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Qazi J, 2007, VIRUS RES, V128, P135, DOI 10.1016/j.virusres.2007.04.002; Saeed M, 2005, MOL PLANT MICROBE IN, V18, P7, DOI 10.1094/MPMI-18-0007; Saeed M, 2010, AUSTRALAS PLANT DIS, V5, P55, DOI 10.1071/DN10021; Saunders K, 2004, VIROLOGY, V324, P37, DOI 10.1016/j.virol.2004.03.018; STANLEY J, 2005, VIRUS TAXONOMY, P301; Stonor J, 2003, PLANT PATHOL, V52, P379, DOI 10.1046/j.1365-3059.2003.00854.x; Tahir M, 2010, AUSTRALAS PLANT DIS, V5, P21, DOI 10.1071/DN10009; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915	46	51	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20366	10.1371/journal.pone.0020366	http://dx.doi.org/10.1371/journal.pone.0020366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637815	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200056
J	Dutta, S; Ongarora, BG; Li, HR; Vicente, MDH; Kolli, BK; Chang, KP				Dutta, Sujoy; Ongarora, Benson G.; Li, Hairong; Vicente, Maria da Graca H.; Kolli, Bala K.; Chang, Kwang Poo			Intracellular Targeting Specificity of Novel Phthalocyanines Assessed in a Host-Parasite Model for Developing Potential Photodynamic Medicine	PLOS ONE			English	Article							MHC CLASS-I; CUTANEOUS LEISHMANIASIS; LEISH-F1+MPL-SE VACCINE; DENDRITIC CELLS; SINGLET OXYGEN; CLINICAL-TRIAL; THERAPY; EFFICACY; IMMUNOGENICITY; UROPORPHYRIA	Photodynamic therapy, unlikely to elicit drug-resistance, deserves attention as a strategy to counter this outstanding problem common to the chemotherapy of all diseases. Previously, we have broadened the applicability of this modality to photodynamic vaccination by exploiting the unusual properties of the trypanosomatid protozoa, Leishmania, i.e., their innate ability of homing to the phagolysosomes of the antigen-presenting cells and their selective photolysis therein, using transgenic mutants endogenously inducible for porphyrin accumulation. Here, we extended the utility of this host-parasite model for in vitro photodynamic therapy and vaccination by exploring exogenously supplied photosensitizers. Seventeen novel phthalocyanines (Pcs) were screened in vitro for their photolytic activity against cultured Leishmania. Pcs rendered cationic and soluble (csPcs) for cellular uptake were phototoxic to both parasite and host cells, i.e., macrophages and dendritic cells. The csPcs that targeted to mitochondria were more photolytic than those restricted to the endocytic compartments. Treatment of infected cells with endocytic csPcs resulted in their accumulation in Leishmania-containing phagolysosomes, indicative of reaching their target for photodynamic therapy, although their parasite versus host specificity is limited to a narrow range of csPc concentrations. In contrast, Leishmania pre-loaded with csPc were selectively photolyzed intracellularly, leaving host cells viable. Pre-illumination of such csPc-loaded Leishmania did not hinder their infectivity, but ensured their intracellular lysis. Ovalbumin (OVA) so delivered by photo-inactivated OVA transfectants to mouse macrophages and dendritic cells were co-presented with MHC Class I molecules by these antigen presenting cells to activate OVA epitope-specific CD8+ T cells. The in vitro evidence presented here demonstrates for the first time not only the potential of endocytic csPcs for effective photodynamic therapy against Leishmania but also their utility in photo-inactivation of Leishmania to produce a safe carrier to express and deliver a defined antigen with enhanced cell-mediated immunity.	[Dutta, Sujoy; Kolli, Bala K.; Chang, Kwang Poo] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL USA; [Ongarora, Benson G.; Li, Hairong; Vicente, Maria da Graca H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Louisiana State University System; Louisiana State University	Dutta, S (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL USA.	sujoy.dutta@rosalindfranklin.edu	Li, Hairong/B-5462-2011; Ongarora, Benson Getenga/L-5033-2019		NIH [AI-083951, CA139385]; NATIONAL CANCER INSTITUTE [R21CA139385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083951] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI-083951 to KPC and NIH grant CA139385 to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilov OE, 2006, CHEM BIOL, V13, P839, DOI 10.1016/j.chembiol.2006.06.008; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Asilian A, 2006, CLIN EXP DERMATOL, V31, P634, DOI 10.1111/j.1365-2230.2006.02182.x; Brandonisio O, 2004, MICROBES INFECT, V6, P1402, DOI 10.1016/j.micinf.2004.10.004; CANTI G, 1995, CANCER LETT, V93, P255, DOI 10.1016/0304-3835(95)03818-H; Castro R, 2006, J PARASITOL, V92, P1162, DOI 10.1645/GE-841R.1; CHANG KP, 1983, CIBA F SYMP, V99, P113; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P4474, DOI 10.1128/AAC.49.11.4474-4484.2005; Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07; Dutta S, 2008, EXP PARASITOL, V118, P629, DOI 10.1016/j.exppara.2007.11.013; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Enk CD, 2003, ARCH DERMATOL, V139, P432, DOI 10.1001/archderm.139.4.432; Escobar Patricia, 2006, Biomed., V26, P49; Gardlo K, 2003, J AM ACAD DERMATOL, V48, P893, DOI 10.1067/mjd.2003.218; Gardner DM, 2010, PHOTOCHEM PHOTOBIOL, V86, P645, DOI 10.1111/j.1751-1097.2010.00705.x; Gonzalez U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005067.pub3; Kumari S, 2009, EUR J IMMUNOL, V39, P178, DOI 10.1002/eji.200838389; Li HR, 2008, J MED CHEM, V51, P502, DOI 10.1021/jm070781f; LIU X, 1994, MOL BIOCHEM PARASIT, V66, P201, DOI 10.1016/0166-6851(94)90147-3; Llanos-Cuentas A, 2010, VACCINE, V28, P7427, DOI 10.1016/j.vaccine.2010.08.092; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Lovell JF, 2010, CHEM REV, V110, P2839, DOI 10.1021/cr900236h; McKeown N. B., 1998, PHTHALOCYANINE MAT S; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Morris RL, 2002, PHOTOCHEM PHOTOBIOL, V75, P652, DOI 10.1562/0031-8655(2002)075<0652:TPBRIP>2.0.CO;2; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; QUELLETE M, 2008, LEISHMANIA GENOME, P159; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shen ZH, 1997, J IMMUNOL, V158, P2723; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Varela RE, 2009, EXP PARASITOL, V122, P134, DOI 10.1016/j.exppara.2009.02.012; WHO, 2010, LEISHM BACKGR INF	38	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20786	10.1371/journal.pone.0020786	http://dx.doi.org/10.1371/journal.pone.0020786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673971	gold, Green Published			2022-12-27	WOS:000291356400029
J	Painsipp, E; Kofer, MJ; Sinner, F; Holzer, P				Painsipp, Evelin; Koefer, Martin J.; Sinner, Frank; Holzer, Peter			Prolonged Depression-Like Behavior Caused by Immune Challenge: Influence of Mouse Strain and Social Environment	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ESTROUS-CYCLE; FEMALE RATS; NERVE INJURY; MICE; STRESS; BRAIN; CYTOKINES; ANTIDEPRESSANTS; ACTIVATION	Immune challenge by bacterial lipopolysaccharide (LPS) causes short-term behavioral changes indicative of depression. The present study sought to explore whether LPS is able to induce long-term changes in depression-related behavior and whether such an effect depends on mouse strain and social context. LPS (0.83 mg/kg) or vehicle was administered intraperitoneally to female CD1 and C57BL/6 mice that were housed singly or in groups of 4. Depression-like behavior was assessed with the forced swim test (FST) 1 and 28 days post-treatment. Group-housed CD1 mice exhibited depression-like behavior 1 day post-LPS, an effect that leveled off during the subsequent 28 days, while the behavior of singly housed CD1 mice was little affected. In contrast, singly housed C57BL/6 mice responded to LPS with an increase in depression-like behavior that was maintained for 4 weeks post-treatment and confirmed by the sucrose preference test. Group-housed C57BL/6 mice likewise displayed an increased depression-like behavior 4 weeks post-treatment. The behavioral changes induced by LPS in C57BL/6 mice were associated with a particularly pronounced rise of interleukin-6 in blood plasma within 1 day post-treatment and with changes in the dynamics of the corticosterone response to the FST. The current data demonstrate that immune challenge with LPS is able to induce prolonged depression-like behavior, an effect that depends on genetic background (strain). The discovery of an experimental model of long-term depression-like behavior after acute immune challenge is of relevance to the analysis of the epigenetic and pathophysiologic mechanisms of immune system-related affective disorders.	[Painsipp, Evelin; Koefer, Martin J.; Holzer, Peter] Med Univ Graz, Inst Expt & Clin Pharmacol, Res Unit Translat Neurogastroenterol, Graz, Austria; [Sinner, Frank] Joanneum Res, Hlth Inst Biomed & Hlth Sci, Graz, Austria	Medical University of Graz	Painsipp, E (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Res Unit Translat Neurogastroenterol, Graz, Austria.	peter.holzer@medunigraz.at	Holzer, Peter/F-7578-2011	Holzer, Peter/0000-0002-5754-395X; Sinner, Frank Michael/0000-0002-9292-4512	Zukunftsfonds Steiermark [262]; Austrian Science Funds [L25-B05]	Zukunftsfonds Steiermark; Austrian Science Funds(Austrian Science Fund (FWF))	Funding: This study was supported by the Zukunftsfonds Steiermark (grant 262) and the Austrian Science Funds (http://www.fwf.ac.at/FWF grant L25-B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Anisman H, 2005, CURR PHARM DESIGN, V11, P963, DOI 10.2174/1381612053381701; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Detke MJ, 1995, PSYCHOPHARMACOLOGY B, V21, P66; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Edelsbrunner ME, 2009, BEHAV BRAIN RES, V203, P97, DOI 10.1016/j.bbr.2009.04.025; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Gibb J, 2008, BRAIN BEHAV IMMUN, V22, P573, DOI 10.1016/j.bbi.2007.12.001; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Gorman Jack M, 2006, Gend Med, V3, P93, DOI 10.1016/S1550-8579(06)80199-3; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Hays W., 2007, STATISTICS; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kirk RE, 1995, EXPT DESIGN; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; MAES M, 1995, PSYCHONEUROENDOCRINO, V20, P111, DOI 10.1016/0306-4530(94)00066-J; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; Nappi RE, 1997, NEUROENDOCRINOLOGY, V65, P29, DOI 10.1159/000127162; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; Norman GJ, 2010, PSYCHOSOM MED, V72, P519, DOI 10.1097/PSY.0b013e3181de8678; Painsipp E, 2007, NEUROSCIENCE, V150, P522, DOI 10.1016/j.neuroscience.2007.09.024; PAINSIPP E, 2011, BR J PHARM IN PRESS; Painsipp E, 2010, J PSYCHOPHARMACOL, V24, P1551, DOI 10.1177/0269881109348171; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Pyter LM, 2009, P NATL ACAD SCI USA, V106, P9069, DOI 10.1073/pnas.0811949106; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Sliwowska JH, 2008, PSYCHONEUROENDOCRINO, V33, P1111, DOI 10.1016/j.psyneuen.2008.05.001; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tonelli LH, 2008, NEUROPSYCHOPHARMACOL, V33, P1038, DOI 10.1038/sj.npp.1301488; Valles A, 2002, NEUROSCIENCE, V112, P383, DOI 10.1016/S0306-4522(02)00047-7; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Walf AA, 2009, J PSYCHOPHARMACOL, V23, P442, DOI 10.1177/0269881108089598; Wann BP, 2010, PSYCHONEUROENDOCRINO, V35, P233, DOI 10.1016/j.psyneuen.2009.06.010; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2; YIRMIYA R, 2009, FRONT NEUROSCI, V3, P262; Zhu CB, 2010, NEUROPSYCHOPHARMACOL, V35, P2510, DOI 10.1038/npp.2010.116	50	58	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20719	10.1371/journal.pone.0020719	http://dx.doi.org/10.1371/journal.pone.0020719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673960	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400024
J	Yamada, K; Iwayama, Y; Hattori, E; Iwamoto, K; Toyota, T; Ohnishi, T; Ohba, H; Maekawa, M; Kato, T; Yoshikawa, T				Yamada, Kazuo; Iwayama, Yoshimi; Hattori, Eiji; Iwamoto, Kazuya; Toyota, Tomoko; Ohnishi, Tetsuo; Ohba, Hisako; Maekawa, Motoko; Kato, Tadafumi; Yoshikawa, Takeo			Genome-Wide Association Study of Schizophrenia in Japanese Population	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN; GAP-43 MESSENGER-RNA; PARKINSON-DISEASE; BIPOLAR DISORDER; GENE-EXPRESSION; COMMON VARIANTS; HIPPOCAMPUS; NEURON; ELAVL4; LOCI	Schizophrenia is a devastating neuropsychiatric disorder with genetically complex traits. Genetic variants should explain a considerable portion of the risk for schizophrenia, and genome-wide association study (GWAS) is a potentially powerful tool for identifying the risk variants that underlie the disease. Here, we report the results of a three-stage analysis of three independent cohorts consisting of a total of 2,535 samples from Japanese and Chinese populations for searching schizophrenia susceptibility genes using a GWAS approach. Firstly, we examined 115,770 single nucleotide polymorphisms (SNPs) in 120 patient-parents trio samples from Japanese schizophrenia pedigrees. In stage II, we evaluated 1,632 SNPs (1,159 SNPs of p<0.01 and 473 SNPs of p<0.05 that located in previously reported linkage regions). The second sample consisted of 1,012 case-control samples of Japanese origin. The most significant p value was obtained for the SNP in the ELAVL2 [(embryonic lethal, abnormal vision, Drosophila)-like 2] gene located on 9p21.3 (p = 0.00087). In stage III, we scrutinized the ELAVL2 gene by genotyping gene-centric tagSNPs in the third sample set of 293 family samples (1,163 individuals) of Chinese descent and the SNP in the gene showed a nominal association with schizophrenia in Chinese population (p = 0.026). The current data in Asian population would be helpful for deciphering ethnic diversity of schizophrenia etiology.	[Yamada, Kazuo; Iwayama, Yoshimi; Hattori, Eiji; Toyota, Tomoko; Ohnishi, Tetsuo; Ohba, Hisako; Maekawa, Motoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Saitama, Japan; [Iwamoto, Kazuya; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan	RIKEN; RIKEN	Yamada, K (corresponding author), RIKEN Brain Sci Inst, Lab Mol Psychiat, Saitama, Japan.	takeo@brain.riken.jp	Yoshikawa, Takeo/F-9599-2019; Kato, Tadafumi/J-3583-2014; Ohnishi, Tetsuo/AAC-2767-2022; Ohnishi, Tetsuo/D-3791-2018; Ohnishi, Tetsuo/AAC-5694-2019	Kato, Tadafumi/0000-0001-7856-3952; Ohnishi, Tetsuo/0000-0002-6696-9725; Ohnishi, Tetsuo/0000-0002-6696-9725	RIKEN BSI Funds; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059588, R01MH059566, U01MH046289, U01MH046318, R01MH059565, R01MH059587, U01MH046276, R01MH060879, R01MH059586, R01MH061675, R01MH059571, R01MH060870] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23249060] Funding Source: KAKEN	RIKEN BSI Funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported by RIKEN BSI Funds and was the result of "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Arinami T, 2005, AM J HUM GENET, V77, P937, DOI 10.1086/498122; Blennow K, 1999, J MOL NEUROSCI, V13, P101, DOI 10.1385/JMN:13:1-2:101; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; DeStefano AL, 2008, HUM GENET, V124, P95, DOI 10.1007/s00439-008-0526-4; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kim S, 2010, NEUROPSYCHOPHARMACOL, V35, P473, DOI 10.1038/npp.2009.151; Kim S, 2009, SCHIZOPHRENIA BULL, V35, P1031, DOI 10.1093/schbul/sbp106; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Noureddine MA, 2005, HUM GENET, V117, P27, DOI 10.1007/s00439-005-1259-2; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Pascale A, 2008, CELL MOL LIFE SCI, V65, P128, DOI 10.1007/s00018-007-7017-y; PerroneBizzozero NI, 1996, P NATL ACAD SCI USA, V93, P14182, DOI 10.1073/pnas.93.24.14182; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tian SY, 2007, NEUROSCI LETT, V411, P123, DOI 10.1016/j.neulet.2006.10.031; Webster MJ, 2001, SCHIZOPHR RES, V49, P89, DOI 10.1016/S0920-9964(00)00052-9; Weickert CS, 2001, CEREB CORTEX, V11, P136, DOI 10.1093/cercor/11.2.136; XU B, 2008, NAT GENET; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099	30	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20468	10.1371/journal.pone.0020468	http://dx.doi.org/10.1371/journal.pone.0020468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674006	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400006
J	Hathcock, KS; Farrington, L; Ivanova, I; Livak, F; Selimyan, R; Sen, R; Williams, J; Tai, XG; Hodes, RJ				Hathcock, Karen S.; Farrington, Lila; Ivanova, Irina; Livak, Ferenc; Selimyan, Roza; Sen, Ranjan; Williams, Joy; Tai, Xuguang; Hodes, Richard J.			The Requirement for Pre-TCR during Thymic Differentiation Enforces a Developmental Pause That Is Essential for V-DJ beta Rearrangement	PLOS ONE			English	Article							T-CELL-RECEPTOR; CHAIN GENE REARRANGEMENT; ALLELIC EXCLUSION; V(D)J RECOMBINATION; THYMOCYTE DEVELOPMENT; IMMATURE THYMOCYTES; DEFICIENT MICE; HISTONE H3; CD3-EPSILON-MEDIATED SIGNALS; TRANSCRIPTIONAL REGULATION	T cell development occurs in the thymus and is critically dependent on productive TCR beta rearrangement and pre-TCR expression in DN3 cells. The requirement for pre-TCR expression results in the arrest of thymocytes at the DN3 stage (beta checkpoint), which is uniquely permissive for V-DJ beta recombination; only cells expressing pre-TCR survive and develop beyond the DN3 stage. In addition, the requirement for TCR beta rearrangement and pre-TCR expression enforces suppression of TCR beta rearrangement on a second allele, allelic exclusion, thus ensuring that each T cell expresses only a single TCR beta product. However, it is not known whether pre-TCR expression is essential for allelic exclusion or alternatively if allelic exclusion is enforced by developmental changes that can occur in the absence of pre-TCR. We asked if thymocytes that were differentiated without pre-TCR expression, and therefore without pause at the beta checkpoint, would suppress all V-DJ beta rearrangement. We previously reported that premature CD28 signaling in murine CD4(-)CD8(-) (DN) thymocytes supports differentiation of CD4(+)CD8(+) (DP) cells in the absence of pre-TCR expression. The present study uses this model to define requirements for TCR beta rearrangement and allelic exclusion. We demonstrate that if cells exit the DN3 developmental stage before TCR beta rearrangement occurs, V-DJ beta rearrangement never occurs, even in DP cells that are permissive for D-J beta and TCR alpha rearrangement. These results demonstrate that pre-TCR expression is not essential for thymic differentiation to DP cells or for V-DJ beta suppression. However, the requirement for pre-TCR signals and the exclusion of alternative stimuli such as CD28 enforce a developmental "pause" in early DN3 cells that is essential for productive TCR beta rearrangement to occur.	[Hathcock, Karen S.; Farrington, Lila; Williams, Joy; Tai, Xuguang; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ivanova, Irina; Selimyan, Roza; Sen, Ranjan; Hodes, Richard J.] NIA, Lab Cellular & Mol Biol, NIH, Baltimore, MD 21224 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore	Hathcock, KS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	hathcock@exchange.nih.gov			National Institutes of Health (NIH), National Cancer Institute; National Institute on Aging; NATIONAL CANCER INSTITUTE [ZIABC009265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000383] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All research was funded by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute and National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey JL, 2004, IMMUNOL CELL BIOL, V82, P393, DOI 10.1111/j.0818-9641.2004.01246.x; Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; Chen F, 2001, J IMMUNOL, V166, P1771, DOI 10.4049/jimmunol.166.3.1771; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Falk I, 2001, EUR J IMMUNOL, V31, P3308, DOI 10.1002/1521-4141(200111)31:11<3308::AID-IMMU3308>3.0.CO;2-5; Fournier S, 1997, IMMUNITY, V6, P327, DOI 10.1016/S1074-7613(00)80335-0; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hager-Theodorides AL, 2007, EUR J IMMUNOL, V37, P487, DOI 10.1002/eji.200636503; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; Livak F, 2002, SEMIN IMMUNOL, V14, P297, DOI 10.1016/S1044-5323(02)00063-5; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Senoo M, 1998, INT IMMUNOL, V10, P553, DOI 10.1093/intimm/10.5.553; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; vonBoehmer H, 1995, ANN NY ACAD SCI, V766, P52, DOI 10.1111/j.1749-6632.1995.tb26648.x; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20639	10.1371/journal.pone.0020639	http://dx.doi.org/10.1371/journal.pone.0020639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673984	Green Submitted, Green Published, gold			2022-12-27	WOS:000291355500029
J	Bermudez, Y; Benavente, CA; Meyer, RG; Coyle, WR; Jacobson, MK; Jacobson, EL				Bermudez, Yira; Benavente, Claudia A.; Meyer, Ralph G.; Coyle, W. Russell; Jacobson, Myron K.; Jacobson, Elaine L.			Nicotinic Acid Receptor Abnormalities in Human Skin Cancer: Implications for a Role in Epidermal Differentiation	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; LANGERHANS CELLS; PUMA-G; PHOTODAMAGE; MECHANISMS; EXPRESSION; HM74A; MICE; PCR	Background: Chronic UV skin exposure leads to epidermal differentiation defects in humans that can be largely restored by pharmacological doses of nicotinic acid. Nicotinic acid has been identified as a ligand for the human G-protein-coupled receptors GPR109A and GPR109B that signal through G(i)-mediated inhibition of adenylyl cyclase. We have examined the expression, cellular distribution, and functionality of GPR109A/B in human skin and skin derived epidermal cells. Results: Nicotinic acid increases epidermal differentiation in photodamaged human skin as judged by the terminal differentiation markers caspase 14 and filaggrin. Both GPR109A and GPR109B genes are transcribed in human skin and in epidermal keratinocytes, but expression in dermal fibroblasts is below limits of detection. Receptor transcripts are greatly over-expressed in squamous cell cancers. Receptor protein in normal skin is prominent from the basal through granular layers of the epidermis, with cellular localization more dispersive in the basal layer but predominantly localized at the plasma membrane in more differentiated epidermal layers. In normal human primary and immortalized keratinocytes, nicotinic acid receptors show plasma membrane localization and functional G(i)-mediated signaling. In contrast, in a squamous cell carcinoma derived cell line, receptor protein shows a more diffuse cellular localization and the receptors are nearly non-functional. Conclusions: The results of these studies justify future genetic and pharmacological intervention studies to define possible specific role(s) of nicotinic acid receptors in human skin homeostasis.	[Bermudez, Yira] Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona; University of Arizona	Bermudez, Y (corresponding author), Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA.	elaine.jacobson@pharmacy.arizona.edu		Benavente, Claudia/0000-0002-6875-3186	National Institutes of Health [CA43894, CA106677, CA78447, CA027502, ES06694, HD048837]; NiadynePharma, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048837] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA106677, P01CA027502, T32CA078447, R25CA078447, R01CA043894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NiadynePharma, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health grants CA43894, CA106677, CA78447, CA027502, ES06694, and HD048837. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MKJ and ELJ are principals in NiadynePharma, Inc., whose sponsored research is managed in accordance with the University of Arizona conflict-of-interest policies.	Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BOUKAMP P, 1990, CANCER RES, V50, P2840; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Digby JE, 2009, CURR OPIN LIPIDOL, V20, P321, DOI 10.1097/MOL.0b013e32832d3b9d; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; Jacobson EL, 2007, EXP DERMATOL, V16, P490, DOI 10.1111/j.1600-0625.2007.00553.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; Mudgil AV, 2003, J INVEST DERMATOL, V121, P191, DOI 10.1046/j.1523-1747.2003.12320.x; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; Schaumburg-Lever G., 1983, LIPPINCOTT, P422; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; TANG H, 2008, BIOCH BIOPHYS RES CO; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhou LB, 2007, MOL CELL BIOCHEM, V294, P243, DOI 10.1007/s11010-006-9150-6	26	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20487	10.1371/journal.pone.0020487	http://dx.doi.org/10.1371/journal.pone.0020487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655214	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600077
J	Robillard, JM; Gordon, GR; Choi, HB; Christie, BR; MacVicar, BA				Robillard, Julie M.; Gordon, Grant R.; Choi, Hyun B.; Christie, Brian R.; MacVicar, Brian A.			Glutathione Restores the Mechanism of Synaptic Plasticity in Aged Mice to That of the Adult	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL AREA CA1; NMDA-RECEPTOR; PEROXIDE MODULATION; ASSOCIATIVE MEMORY; REDOX MODULATION; N-ACETYLCYSTEINE; CALCIUM STORES; CA2+ RELEASE; NEURONS	Glutathione (GSH), the major endogenous antioxidant produced by cells, can modulate the activity of N-methyl-D-aspartate receptors (NMDARs) through its reducing functions. During aging, an increase in oxidative stress leads to decreased levels of GSH in the brain. Concurrently, aging is characterized by calcium dysregulation, thought to underlie impairments in hippocampal NMDAR-dependent long-term potentiation (LTP), a form of synaptic plasticity thought to represent a cellular model for memory. Here we show that orally supplementing aged mice with N-acetylcysteine, a precursor for the formation of glutathione, reverses the L-type calcium channel-dependent LTP seen in aged animals to NMDAR-dependent LTP. In addition, introducing glutathione in the intrapipette solution during whole-cell recordings restores LTP obtained in whole-cell conditions in the aged hippocampus. We conclude that aging leads to a reduced redox potential in hippocampal neurons, triggering impairments in LTP.	[Robillard, Julie M.; Gordon, Grant R.; Choi, Hyun B.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC, Canada; [Christie, Brian R.] Univ Victoria, Isl Med Program, Victoria, BC, Canada	University of British Columbia; University of Victoria	Robillard, JM (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC, Canada.	bmacvicar@brain.ubc.ca	Christie, Brian Ross/AAF-3766-2019; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	Christie, Brian Ross/0000-0002-6830-0160; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Robillard, Julie/0000-0001-5765-4927	Canadian Institutes of Health Research; Fondation Leducq; Arthur and June Willms Fellowship; Heart and Stroke Foundation of Canada; Alberta Heritage Foundation for Medical Research; MSFHR; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leducq(Leducq Foundation); Arthur and June Willms Fellowship; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); MSFHR(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by operating Grants from the Canadian Institutes of Health Research to B. A. M. and B. R. C. and by the Fondation Leducq to B. A. M. B. A. M. is a Canada Research Chair. H. B. C. was supported by postdoctoral fellowships from the Arthur and June Willms Fellowship and the Heart and Stroke Foundation of Canada. G.R.J.G. was supported by fellowships from the Alberta Heritage Foundation for Medical Research and MSFHR and Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer-Milian W, 2000, SYNAPSE, V38, P369, DOI 10.1002/1098-2396(20001215)38:4<369::AID-SYN1>3.0.CO;2-Q; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Auerbach JM, 1997, J NEUROSCI, V17, P8695; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodhinathan K, 2010, J NEUROPHYSIOL, V104, P2586, DOI 10.1152/jn.00577.2010; Bodhinathan K, 2010, J NEUROSCI, V30, P1914, DOI 10.1523/JNEUROSCI.5485-09.2010; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Choi YB, 2000, CELL MOL LIFE SCI, V57, P1535, DOI 10.1007/PL00000638; Ercal N, 1996, FREE RADICAL BIO MED, V21, P157, DOI 10.1016/0891-5849(96)00020-2; Foster TC, 2002, PROG BRAIN RES, V138, P283, DOI 10.1016/S0079-6123(02)38083-X; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Fu AL, 2006, BRAIN RES, V1109, P201, DOI 10.1016/j.brainres.2006.06.042; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Hidalgo C, 2004, BIOL RES, V37, P539, DOI 10.4067/S0716-97602004000400007; Hjelmstad GO, 1997, NEURON, V19, P1309, DOI 10.1016/S0896-6273(00)80421-3; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Kamsler A, 2003, J NEUROSCI, V23, P269; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Klann E, 1998, J NEUROPHYSIOL, V80, P452, DOI 10.1152/jn.1998.80.1.452; Knapp LT, 2002, J NEUROSCI, V22, P674, DOI 10.1523/JNEUROSCI.22-03-00674.2002; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; KOLLER KJ, 1985, J NEUROSCI, V5, P2882; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Pessah IN, 2002, FRONT BIOSCI-LANDMRK, V7, pA72, DOI 10.2741/pessah; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Shaw CA, 1998, GLUTATHIONE NERVOUS; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; TANG LH, 1993, J PHYSIOL-LONDON, V465, P303, DOI 10.1113/jphysiol.1993.sp019678; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thiels E, 2000, J NEUROSCI, V20, P7631	42	67	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20676	10.1371/journal.pone.0020676	http://dx.doi.org/10.1371/journal.pone.0020676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655192	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600119
J	Lasiglie, D; Traggiai, E; Federici, S; Alessio, M; Buoncompagni, A; Accogli, A; Chiesa, S; Penco, F; Martini, A; Gattorno, M				Lasiglie, Denise; Traggiai, Elisabetta; Federici, Silvia; Alessio, Maria; Buoncompagni, Antonella; Accogli, Andrea; Chiesa, Sabrina; Penco, Federica; Martini, Alberto; Gattorno, Marco			Role of IL-1 Beta in the Development of Human T(H)17 Cells: Lesson from NLPR3 Mutated Patients	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; GENE-EXPRESSION PROFILES; GROWTH-FACTOR-BETA; HELPER T-CELLS; TGF-BETA; AUTOIMMUNE INFLAMMATION; PERIPHERAL-BLOOD; CIAS1 MUTATIONS; DENDRITIC CELLS	Background: T helper 17 cells (T-H-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1 beta has been indicated as a key cytokine for the commitment to T-H-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1 beta secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. Methodology/Principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T(H)17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1 beta, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1 beta blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T(H)17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T(H)17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T(H)17 frequency were observed in CAPS patients following in vivo IL-1 beta blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1 beta and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. Conclusion/Significance: These findings further support the central role of IL-1 beta in the differentiation of T(H)17 in human inflammatory conditions.	[Lasiglie, Denise; Traggiai, Elisabetta; Federici, Silvia; Buoncompagni, Antonella; Accogli, Andrea; Chiesa, Sabrina; Penco, Federica; Gattorno, Marco] G Gaslini Inst Children, Div Pediat 2, Rheumatol Unit, Genoa, Italy; [Lasiglie, Denise; Martini, Alberto] Univ Genoa, Lab Immunol Rheumat Dis, Dept Pediat, Genoa, Italy; [Alessio, Maria] Federico II Hosp, Dept Pediat, Naples, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Lasiglie, D (corresponding author), G Gaslini Inst Children, Div Pediat 2, Rheumatol Unit, Genoa, Italy.	marcogattorno@ospedale-gaslini.ge.it	Gattorno, Marco/AAL-2974-2020; Chiesa, Sabrina/AAN-7877-2020; Penco, Federica/L-1013-2016	Gattorno, Marco/0000-0003-0704-1916; Penco, Federica/0000-0002-8437-3466; MARTINI, Alberto/0000-0001-7642-1459; Accogli, Andrea/0000-0001-8724-6721; Chiesa, Sabrina/0000-0002-0392-1927	Telethon Italia [NGGP09127]; Ricerca Corrente Ministeriale	Telethon Italia(Fondazione Telethon); Ricerca Corrente Ministeriale	The work was partially supported by Telethon Italia (Grant NGGP09127) and Ricerca Corrente Ministeriale. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Benedetti F, 2005, ARTHRITIS RHEUM-US, V52, P687, DOI 10.1002/art.20946; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; Dinarello CA, 2009, MAYO CLIN PROC, V84, P105, DOI 10.4065/84.2.105; El-Osta H, 2010, MOL CANCER THER, V9, P1485, DOI 10.1158/1535-7163.MCT-10-0156; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Frosch M, 2009, ARTHRITIS RHEUM-US, V60, P883, DOI 10.1002/art.24349; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Lepore L, 2010, J PEDIATR-US, V157, P310, DOI 10.1016/j.jpeds.2010.02.040; Lequerre T, 2008, ANN RHEUM DIS, V67, P302, DOI 10.1136/ard.2007.076034; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Matsubara T, 2006, ARTHRITIS RHEUM-US, V54, P2314, DOI 10.1002/art.21965; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Nowak EC, 2010, IMMUNOLOGY, V131, P169, DOI 10.1111/j.1365-2567.2010.03332.x; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Ogilvie EM, 2007, ARTHRITIS RHEUM-US, V56, P1954, DOI 10.1002/art.22644; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woo P, 2005, ARTHRITIS RES THER, V7, pR1281, DOI 10.1186/ar1826; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7	56	91	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20014	10.1371/journal.pone.0020014	http://dx.doi.org/10.1371/journal.pone.0020014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637346	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200026
J	Niers, TMH; Richel, DJ; Meijers, JCM; Schlingemann, RO				Niers, Tatjana M. H.; Richel, Dick J.; Meijers, Joost C. M.; Schlingemann, Reinier O.			Vascular Endothelial Growth Factor in the Circulation in Cancer Patients May Not Be a Relevant Biomarker	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; RENAL-CELL CARCINOMA; FACTOR VEGF; PLASMA-LEVELS; ANGIOGENESIS; PLATELETS; ACTIVATION; ANTIBODY; LEUKOCYTES; RECEPTORS	Background: Levels of circulating vascular endothelial growth factor (VEGF) have widely been used as biomarker for angiogenic activity in cancer. For this purpose, non-standardized measurements in plasma and serum were used, without correction for artificial VEGF release by platelets activated ex vivo. We hypothesize that "true" circulating (c) VEGF levels in most cancer patients are low and unrelated to cancer load or tumour angiogenesis. Methodology: We determined VEGF levels in PECT, a medium that contains platelet activation inhibitors, in citrate plasma, and in isolated platelets in 16 healthy subjects, 18 patients with metastatic non-renal cancer (non-RCC) and 12 patients with renal cell carcinoma (RCC). In non-RCC patients, circulating plasma VEGF levels were low and similar to VEGF levels in controls if platelet activation was minimized during the harvest procedure by PECT medium. In citrate plasma, VEGF levels were elevated in non-RCC patients, but this could be explained by a combination of increased platelet activation during blood harvesting, and by a two-fold increase in VEGF content of individual platelets (controls: 3.4 IU/10(6), non-RCC: 6.2 IU/10(6) platelets, p = 0.001). In contrast, cVEGF levels in RCC patients were elevated (PECT plasma: 64 pg/ml vs. 21 pg/ml, RCC vs. non-RCC, p, 0.0001), and not related to platelet VEGF concentration. Conclusions: Our findings suggest that "true" freely cVEGF levels are not elevated in the majority of cancer patients. Previously reported elevated plasma VEGF levels in cancer appear to be due to artificial release from activated platelets, which in cancer have an increased VEGF content, during the blood harvest procedure. Only in patients with RCC, which is characterized by excessive VEGF production due to a specific genetic defect, were cVEGF levels elevated. This observation may be related to limited and selective success of anti-VEGF agents, such as bevacizumab and sorafenib, as monotherapy in RCC compared to other forms of cancer.	[Niers, Tatjana M. H.; Richel, Dick J.] Univ Amsterdam, Acad Med Ctr, Dept Oncol, NL-1105 AZ Amsterdam, Netherlands; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Niers, TMH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.schlingemann@amc.uva.nl	Meijers, J.C.M./S-5981-2019	Meijers, J.C.M./0000-0002-4198-6780				Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Caine GJ, 2004, ANN MED, V36, P273, DOI 10.1080/07853890410026098; Davies MM, 2000, BRIT J CANCER, V82, P1004; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; George ML, 2000, CLIN CANCER RES, V6, P3147; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Grothey A, 2008, CANCER J, V14, P170, DOI 10.1097/PPO.0b013e318178d9de; Gunsilius E, 2000, ONCOLOGY-BASEL, V58, P169, DOI 10.1159/000012095; Hyodo I, 1998, EUR J CANCER, V34, P2041, DOI 10.1016/S0959-8049(98)00282-2; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; KAPLAN KL, 1986, CRIT REV ONCOL HEMAT, V5, P235, DOI 10.1016/S1040-8428(86)80040-3; KAPLAN KL, 1981, BLOOD, V57, P199; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Longo R, 2007, CANCER CHEMOTH PHARM, V60, P151, DOI 10.1007/s00280-006-0403-6; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; Presta LG, 1997, CANCER RES, V57, P4593; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Salgado R, 1999, BRIT J CANCER, V80, P892, DOI 10.1038/sj.bjc.6690437; Salven P, 1999, CLIN CANCER RES, V5, P487; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; VERHEUL HM, 1998, ONCOLOGIST, V3, P2; Verheul HMW, 2000, BLOOD, V96, P4216, DOI 10.1182/blood.V96.13.4216; Verheul HMW, 2000, CLIN CANCER RES, V6, P166; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Werther K, 2002, SCAND J CLIN LAB INV, V62, P343, DOI 10.1080/00365510260296492; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yoshikawa T, 2000, CANCER LETT, V153, P7, DOI 10.1016/S0304-3835(99)00426-7	36	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19873	10.1371/journal.pone.0019873	http://dx.doi.org/10.1371/journal.pone.0019873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637343	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200017
J	Peattie, AM; Dirks, JH; Henriques, S; Federle, W				Peattie, Anne M.; Dirks, Jan-Henning; Henriques, Sergio; Federle, Walter			Arachnids Secrete a Fluid over Their Adhesive Pads	PLOS ONE			English	Article							SUCTORIAL ORGAN; COLEOPTERA; ULTRASTRUCTURE; MORPHOLOGY; SOLIFUGAE; FORCE; WET	Background: Many arachnids possess adhesive pads on their feet that help them climb smooth surfaces and capture prey. Spider and gecko adhesives have converged on a branched, hairy structure, which theoretically allows them to adhere solely by dry (solid-solid) intermolecular interactions. Indeed, the consensus in the literature is that spiders and their smooth-padded relatives, the solifugids, adhere without the aid of a secretion. Methodology and Principal Findings: We investigated the adhesive contact zone of living spiders, solifugids and mites using interference reflection microscopy, which allows the detection of thin liquid films. Like insects, all the arachnids we studied left behind hydrophobic fluid footprints on glass (mean refractive index: 1.48-1.50; contact angle: 3.7-11.2 degrees). Fluid was not always secreted continuously, suggesting that pads can function in both wet and dry modes. We measured the attachment forces of single adhesive setae from tarantulas (Grammostola rosea) by attaching them to a bending beam with a known spring constant and filming the resulting deflection. Individual spider setae showed a lower static friction at rest (26% +/- 2.8 SE of the peak friction) than single gecko setae (Thecadactylus rapicauda; 96% +/- 1.7 SE). This may be explained by the fact that spider setae continued to release fluid after isolation from the animal, lubricating the contact zone. Significance: This finding implies that tarsal secretions occur within all major groups of terrestrial arthropods with adhesive pads. The presence of liquid in an adhesive contact zone has important consequences for attachment performance, improving adhesion to rough surfaces and introducing rate-dependent effects. Our results leave geckos and anoles as the only known representatives of truly dry adhesive pads in nature. Engineers seeking biological inspiration for synthetic adhesives should consider whether model species with fluid secretions are appropriate to their design goals.	[Peattie, Anne M.; Dirks, Jan-Henning; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England; [Henriques, Sergio] Univ Evora, Dept Biol, Evora, Portugal	University of Cambridge; University of Evora	Peattie, AM (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	apeattie@gmail.com	Federle, Walter/K-8263-2014; Dirks, Jan-Henning/B-9706-2011	Federle, Walter/0000-0002-6375-3005; 	Royal Society; German National Academic Foundation; Biotechnology and Biological Sciences Research Council [BB/E004156/1]; Cambridge Isaac Newton Trust; Biotechnology and Biological Sciences Research Council [BB/I008667/1] Funding Source: researchfish; BBSRC [BB/E004156/1, BB/I008667/1] Funding Source: UKRI	Royal Society(Royal Society of London); German National Academic Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Isaac Newton Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by fellowships from the Royal Society (to AMP; http://royalsociety.org/Funding/) and the German National Academic Foundation (to J-HD; http://www.studienstiftung.de/), and grants from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/; Grant ID: BB/E004156/1) and the Cambridge Isaac Newton Trust (to WF; http://www.newtontrust.cam.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, FUNCTION EVOLUTION G; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Betz O, 2003, J MORPHOL, V255, P24, DOI 10.1002/jmor.10044; Cushing PE, 2005, ARTHROPOD STRUCT DEV, V34, P397, DOI 10.1016/j.asd.2005.02.002; Dirks JH, 2011, J R SOC INTERFACE, V8, P952, DOI 10.1098/rsif.2010.0575; Dirks JH, 2010, J R SOC INTERFACE, V7, P587, DOI 10.1098/rsif.2009.0308; Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5; Dunlop JA, 2002, EUROPEAN ARACHNOLOGY 2000, P345; EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Federle W, 2006, J EXP BIOL, V209, P2611, DOI 10.1242/jeb.02323; Geiselhardt SF, 2010, J COMP PHYSIOL A, V196, P369, DOI 10.1007/s00359-010-0522-8; Gorb SN, 1998, P ROY SOC B-BIOL SCI, V265, P747, DOI 10.1098/rspb.1998.0356; Gorb SN, 2006, NATURE, V443, P407, DOI 10.1038/443407a; HASENFUSS I, 1977, ZOOMORPHOLOGIE, V87, P51, DOI 10.1007/BF02568741; HILL DE, 1977, ZOOL J LINN SOC-LOND, V60, P319, DOI 10.1111/j.1096-3642.1977.tb00838.x; HOMANN H, 1957, NATURWISSENSCHAFTEN, V44, P318, DOI 10.1007/BF00630926; Kesel AB, 2003, J EXP BIOL, V206, P2733, DOI 10.1242/jeb.00478; Klann AE, 2008, ARTHROPOD STRUCT DEV, V37, P3, DOI 10.1016/j.asd.2007.04.001; LIU TP, 1990, EXP APPL ACAROL, V8, P105, DOI 10.1007/BF01193385; MCFARLANE JS, 1950, PROC R SOC LON SER-A, V202, P224, DOI 10.1098/rspa.1950.0096; Mizutani K, 2006, JSME INT J C-MECH SY, V49, P539, DOI 10.1299/jsmec.49.539; Nachtigall W., 1974, BIOL MECH ATTACHMENT; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Peattie AM, 2009, J COMP PHYSIOL B, V179, P231, DOI 10.1007/s00360-008-0310-8; Perez-Miles F, 2009, NATURE, V461, pE9, DOI 10.1038/nature08404; RADLER J, 1993, J PHYS II, V3, P727; Riskin DK, 2010, BIOL J LINN SOC, V99, P233; Roscoe D.T., 1991, Bulletin of the British Arachnological Society, V8, P224; STORK NE, 1980, J EXP BIOL, V88, P91; Votsch W, 2002, INSECT BIOCHEM MOLEC, V32, P1605, DOI 10.1016/S0965-1748(02)00098-X; Welbourn WC, 2003, EXP APPL ACAROL, V30, P107, DOI 10.1023/B:APPA.0000006545.40017.a0; Weygoldt Peter, 2000, P1; Wilms J, 2008, NATURWISSENSCHAFTEN, V95, P149, DOI 10.1007/s00114-007-0298-z	35	32	34	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20485	10.1371/journal.pone.0020485	http://dx.doi.org/10.1371/journal.pone.0020485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637774	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200071
J	Roxby, AC; Drake, AL; John-Stewart, G; Brown, ER; Matemo, D; Otieno, PA; Farquhar, C				Roxby, Alison C.; Drake, Alison L.; John-Stewart, Grace; Brown, Elizabeth R.; Matemo, Daniel; Otieno, Phelgona A.; Farquhar, Carey			Herpes Simplex Virus Type 2, Genital Ulcers and HIV-1 Disease Progression in Postpartum Women	PLOS ONE			English	Article							CONTROLLED-TRIAL; DOUBLE-BLIND; VIRAL LOAD; RNA LEVELS; INFECTION; ACYCLOVIR; TRANSMISSION; THERAPY; PLASMA; RISK	Background: Co-infection with herpes simplex virus type 2 (HSV-2) has been associated with increased HIV-1 RNA levels and immune activation, two predictors of HIV-1 progression. The impact of HSV-2 on clinical outcomes among HIV-1 infected pregnant women is unclear. Methods: HIV-1 infected pregnant women in Nairobi were enrolled antenatally and HSV-2 serology was obtained. HIV-1 RNA and CD4 count were serially measured for 12-24 months postpartum. Survival analysis using endpoints of death, opportunistic infection (OI), and CD4,200 cells mu L, and linear mixed models estimating rate of change of HIV-1 RNA and CD4, were used to determine associations between HSV-2 serostatus and HIV-1 progression. Results: Among 296 women, 254 (86%) were HSV-2-seropositive. Only 30 (10%) women had prior or current genital ulcer disease (GUD); median baseline CD4 count was 422 cells mu L. Adjusting for baseline CD4, women with GUD were significantly more likely to have incident OIs (adjusted hazard ratio (aHR) 2.79, 95% Cl: 1.33-5.85), and there was a trend for association between HSV-2-seropositivity and incident OIs (aHR 3.83, 95% Cl: 0.93-15.83). Rate of change in CD4 count and HIV-1 RNA did not differ by HSV-2 status or GUD, despite a trend toward higher baseline HIV-1 RNA in HSV-2-seropositive women (4.73 log10 copies/ml vs. 4.47 log10 copies/ml, P = 0.07). Conclusions: HSV-2 was highly prevalent and pregnant HIV-1 infected women with GUD were significantly more likely to have incident OIs than women without GUD, suggesting that clinically evident HSV-2 is a more important predictor of HIV-1 disease progression than asymptomatic HSV-2.	[Roxby, Alison C.; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Drake, Alison L.; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA USA; [John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Matemo, Daniel] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Otieno, Phelgona A.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Kenya Medical Research Institute	Roxby, AC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	aroxby@u.washington.edu	John-Stewart, Grace/U-3351-2019; Brown, Elizabeth/A-8984-2008; John-Stewart, Grace/L-3650-2019	Roxby, Alison/0000-0001-9449-8062	US National Institutes of Health (NIH) [RO1 HD 23412, K24 HD054314-04]; University of Washington Center for AIDS Research (CFAR) [P30 AI027757]; Fogarty International Center; NIH [D43 TW00007]; NIH Fogarty International Center [5 R24 TW007988]; University of Washington CFAR [T32 AI07140-32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023412, K24HD054314] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, P30AI027757] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of Washington CFAR; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by US National Institutes of Health (NIH) research grants RO1 HD 23412 and K24 HD054314-04 and the University of Washington Center for AIDS Research (CFAR) P30 AI027757. ACR was a scholar in the International AIDS Research and Training Program, supported by the Fogarty International Center, NIH (D43 TW00007), and is a Fogarty International Clinical Research Fellow funded under NIH Fogarty International Center grant 5 R24 TW007988. ALD is supported by a University of Washington CFAR Training Grant (T32 AI07140-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumakhan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009973; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Bollen LJM, 2008, AIDS, V22, P1169, DOI 10.1097/QAD.0b013e3282fec42a; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502; COOPER DA, 1993, AIDS, V7, P197, DOI 10.1097/00002030-199302000-00007; Cowan FA, 2008, AIDS, V22, P193, DOI 10.1097/QAD.0b013e3282f2a939; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Drake AL, 2007, OBSTET GYNECOL, V109, P403, DOI 10.1097/01.AOG.0000251511.27725.5c; Duffus WA, 2005, INT J STD AIDS, V16, P733, DOI 10.1258/095646205774763298; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Hitti J, 1997, AM J OBSTET GYNECOL, V177, P450, DOI 10.1016/S0002-9378(97)70214-X; Ioannidis JPA, 1998, J INFECT DIS, V178, P349, DOI 10.1086/515621; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Otieno PA, 2007, J INFECT DIS, V195, P220, DOI 10.1086/510245; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; Schacker T, 2001, Herpes, V8, P46; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; STEIN DS, 1994, ANN INTERN MED, V121, P100, DOI 10.7326/0003-4819-121-2-199407150-00004; Walson JL, 2007, JAIDS-J ACQ IMM DEF, V46, P208, DOI 10.1097/QAI.0b013e318141fcc0; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19947	10.1371/journal.pone.0019947	http://dx.doi.org/10.1371/journal.pone.0019947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637835	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200022
J	Xiong, J; Yuan, DX; Fillingham, JS; Garg, J; Lu, XY; Chang, Y; Liu, YF; Fu, CJ; Pearlman, RE; Miao, W				Xiong, Jie; Yuan, Dongxia; Fillingham, Jeffrey S.; Garg, Jyoti; Lu, Xingyi; Chang, Yue; Liu, Yifan; Fu, Chengjie; Pearlman, Ronald E.; Miao, Wei			Gene Network Landscape of the Ciliate Tetrahymena thermophila	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN FAMILY; DNA ELIMINATION; GENOME REARRANGEMENT; BIOLOGICAL NETWORKS; CELL-CYCLE; COEXPRESSION NETWORK; FUNCTIONAL MODULES; MICROARRAY DATA; HUMAN CDC2; SMALL RNAS	Background: Genome-wide expression data of gene microarrays can be used to infer gene networks. At a cellular level, a gene network provides a picture of the modules in which genes are densely connected, and of the hub genes, which are highly connected with other genes. A gene network is useful to identify the genes involved in the same pathway, in a protein complex or that are co-regulated. In this study, we used different methods to find gene networks in the ciliate Tetrahymena thermophila, and describe some important properties of this network, such as modules and hubs. Methodology/Principal Findings: Using 67 single channel microarrays, we constructed the Tetrahymena gene network (TGN) using three methods: the Pearson correlation coefficient (PCC), the Spearman correlation coefficient (SCC) and the context likelihood of relatedness (CLR) algorithm. The accuracy and coverage of the three networks were evaluated using four conserved protein complexes in yeast. The CLR network with a Z-score threshold 3.49 was determined to be the most robust. The TGN was partitioned, and 55 modules were found. In addition, analysis of the arbitrarily determined 1200 hubs showed that these hubs could be sorted into six groups according to their expression profiles. We also investigated human disease orthologs in Tetrahymena that are missing in yeast and provide evidence indicating that some of these are involved in the same process in Tetrahymena as in human. Conclusions/Significance: This study constructed a Tetrahymena gene network, provided new insights to the properties of this biological network, and presents an important resource to study Tetrahymena genes at the pathway level.	[Xiong, Jie; Yuan, Dongxia; Lu, Xingyi; Chang, Yue; Fu, Chengjie; Miao, Wei] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Xiong, Jie; Lu, Xingyi; Chang, Yue] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Yuan, Dongxia] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Fillingham, Jeffrey S.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Garg, Jyoti; Pearlman, Ronald E.] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Garg, Jyoti; Pearlman, Ronald E.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Liu, Yifan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Toronto Metropolitan University; York University - Canada; York University - Canada; University of Michigan System; University of Michigan	Xiong, J (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	miaowei530@yeah.net	Fu, Cheng-Jie/B-3679-2008	Fu, Cheng-Jie/0000-0001-9357-9661; Xiong, Jie/0000-0001-8923-0424; Liu, Yifan/0000-0002-3896-0002; miao, wei/0000-0003-3440-8322	National Natural Science Foundation of China [31071993]; CAS [KSCX2-YW-G-072]; Canadian Institutes of Health Research [MOP 97799]; Ryerson University; National Institutes of Health [GM087343]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087343] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ryerson University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China (No. 31071993), and Knowledge Innovation Program of CAS (No. KSCX2-YW-G-072) to WM. Funding from the Canadian Institutes of Health Research (MOP 97799) to REP is gratefully acknowledged as is start-up funding from Ryerson University to JSF. The microarray work of YF was supported by National Institutes of Health grant (GM087343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Bowman GR, 2005, J EUKARYOT MICROBIOL, V52, P291, DOI 10.1111/j.1550-7408.2005.00045.x; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Butte A J, 2000, Pac Symp Biocomput, P418; CassidyHanley D, 1997, GENETICS, V146, P135; Cerulo L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-228; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Collins K, 2005, CURR BIOL, V15, pR317, DOI 10.1016/j.cub.2005.04.039; Collins K, 1998, P NATL ACAD SCI USA, V95, P8485, DOI 10.1073/pnas.95.15.8485; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elati M., 2011, UNSUPERVISED LEARNIN, P955, DOI DOI 10.1002/9780470892107.CH41; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; EWEN ME, 1994, CANCER METAST REV, V13, P45, DOI 10.1007/BF00690418; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fillingham JS, 2002, J EUKARYOT MICROBIOL, V49, P99, DOI 10.1111/j.1550-7408.2002.tb00350.x; Foster I, 2002, SCIENCE, V297, P1124, DOI 10.1126/science.1074392; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; HU Q, 1992, MOL CELL BIOL, V12, P971, DOI 10.1128/MCB.12.3.971; Huynen MA, 1999, TRENDS MICROBIOL, V7, P281, DOI 10.1016/S0966-842X(99)01539-5; Kashima H, 2009, BIOINFORMATICS, V25, P2962, DOI 10.1093/bioinformatics/btp494; Khanin R, 2007, METHODS OF MICROARRAY DATA ANALYSIS V, P75, DOI 10.1007/978-0-387-34569-7_6; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Li JL, 1996, NUCLEIC ACIDS RES, V24, P1943, DOI 10.1093/nar/24.10.1943; Liang S, 1998, Pac Symp Biocomput, P18; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Matsuda A, 2010, EUKARYOT CELL, V9, P1087, DOI 10.1128/EC.00379-09; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mohan A, 2006, BRIT J OPHTHALMOL, V90, P889, DOI 10.1136/bjo.2005.089219; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; Noto T, 2010, CELL, V140, P692, DOI 10.1016/j.cell.2010.02.010; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Paggi MG, 1996, J CELL BIOCHEM, V62, P418; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van den Berg RA, 2010, FUNGAL GENET BIOL, V47, P539, DOI 10.1016/j.fgb.2010.03.005; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Wang JYJ, 2001, ACTA ONCOL, V40, P689; Wille A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r92; WIMAN KG, 1993, FASEB J, V7, P841, DOI 10.1096/fasebj.7.10.8393817; Witkin KL, 2007, MOL CELL BIOL, V27, P2074, DOI 10.1128/MCB.02105-06; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	80	21	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20124	10.1371/journal.pone.0020124	http://dx.doi.org/10.1371/journal.pone.0020124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637855	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200034
J	Jha, AR; Nixon, DF; Rosenberg, MG; Martin, JN; Deeks, SG; Hudson, RR; Garrison, KE; Pillai, SK				Jha, Aashish R.; Nixon, Douglas F.; Rosenberg, Michael G.; Martin, Jeffrey N.; Deeks, Steven G.; Hudson, Richard R.; Garrison, Keith E.; Pillai, Satish K.			Human Endogenous Retrovirus K106 (HERV-K106) Was Infectious after the Emergence of Anatomically Modern Humans	PLOS ONE			English	Article							HUMAN GENOME; INSERTIONAL POLYMORPHISMS; RECOMBINATION RATE; HUMAN-POPULATIONS; DNA POLYMORPHISM; EVOLUTION; ELEMENTS; IDENTIFICATION; PERSISTENCE; FAMILIES	HERV-K113 and HERV-K115 have been considered to be among the youngest HERVs because they are the only known full-length proviruses that are insertionally polymorphic and maintain the open reading frames of their coding genes. However, recent data suggest that HERV-K113 is at least 800,000 years old, and HERV-K115 even older. A systematic study of HERV-K HML2 members to identify HERVs that may have infected the human genome in the more recent evolutionary past is lacking. Therefore, we sought to determine how recently HERVs were exogenous and infectious by examining sequence variation in the long terminal repeat (LTR) regions of all full-length HERV-K loci. We used the traditional method of inter-LTR comparison to analyze all full length HERV-Ks and determined that two insertions, HERV-K106 and HERV-K116 have no differences between their 5' and 3' LTR sequences, suggesting that these insertions were endogenized in the recent evolutionary past. Among these insertions with no sequence differences between their LTR regions, HERV-K106 had the most intact viral sequence structure. Coalescent analysis of HERV-K106 3' LTR sequences representing 51 ethnically diverse individuals suggests that HERV-K106 integrated into the human germ line approximately 150,000 years ago, after the emergence of anatomically modern humans.	[Jha, Aashish R.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nixon, Douglas F.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Rosenberg, Michael G.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Martin, Jeffrey N.; Deeks, Steven G.] Univ Calif San Francisco, Div HIV AIDS, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA; [Hudson, Richard R.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Garrison, Keith E.] St Marys Coll Calif, Dept Biol, Moraga, CA USA; [Pillai, Satish K.] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA	University of Chicago; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Chicago; Saint Mary's College of California; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Jha, AR (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	nepaliaashish@gmail.com; satish.pillai@ucsf.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Jha, Aashish/0000-0003-3227-1086	National Institutes of Health [AI076059, AI060379, AI084113]; UCSF CFAR [P-30 AI27763]; UCSF CTSI [UL1 RR024131]; CNICS [R24 AI067039]; NIAID [K24AI069994];  [1K01DA024654]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060379, R01AI060379, R24AI067039, R01AI076059, R56AI084113, P30AI027763, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA024654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF CFAR; UCSF CTSI; CNICS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants AI076059, AI060379, AI084113, UCSF CFAR (P-30 AI27763), UCSF CTSI (UL1 RR024131), CNICS (R24 AI067039), NIAID (K24AI069994), and 1K01DA024654 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; CHRISTENSEN T, 2010, J NEUROIMMUNE PHARM; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DANGEL AW, 1995, IMMUNOGENETICS, V42, P41, DOI 10.1007/BF00164986; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Dolgin ES, 2008, GENETICS, V178, P2169, DOI 10.1534/genetics.107.082743; FU YX, 1993, GENETICS, V133, P693; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Heslin DJ, 2009, J VIROL, V83, P1105, DOI 10.1128/JVI.01439-08; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes JF, 2004, P NATL ACAD SCI USA, V101, P1668, DOI 10.1073/pnas.0307885100; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Jha AR, 2009, MOL BIOL EVOL, V26, P2617, DOI 10.1093/molbev/msp180; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Katzourakis A, 2007, J VIROL, V81, P10712, DOI 10.1128/JVI.00410-07; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lebedev YB, 2000, GENE, V247, P265, DOI 10.1016/S0378-1119(00)00062-7; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macfarlane C, 2004, J MOL EVOL, V59, P642, DOI 10.1007/s00239-004-2656-1; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Moyes D, 2007, TRENDS GENET, V23, P326, DOI 10.1016/j.tig.2007.05.004; Moyes DL, 2005, GENOMICS, V86, P337, DOI 10.1016/j.ygeno.2005.06.004; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; TAJIMA F, 1989, GENETICS, V123, P585; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669	41	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20234	10.1371/journal.pone.0020234	http://dx.doi.org/10.1371/journal.pone.0020234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633511	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500044
J	Morello, N; Bianchi, FT; Marmiroli, P; Tonoli, E; Menendez, VR; Silengo, L; Cavaletti, G; Vercelli, A; Altruda, F; Tolosano, E				Morello, Noemi; Bianchi, Federico Tommaso; Marmiroli, Paola; Tonoli, Elisabetta; Menendez, Virginia Rodriguez; Silengo, Lorenzo; Cavaletti, Guido; Vercelli, Alessandro; Altruda, Fiorella; Tolosano, Emanuela			A Role for Hemopexin in Oligodendrocyte Differentiation and Myelin Formation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR-RELATED PROTEIN-1; PLASMA HEMOPEXIN; ALZHEIMERS-DISEASE; PERIPHERAL-NERVES; IN-VITRO; MICE; HEME; BRAIN; EXPRESSION	Myelin formation and maintenance are crucial for the proper function of the CNS and are orchestrated by a plethora of factors including growth factors, extracellular matrix components, metalloproteases and protease inhibitors. Hemopexin (Hx) is a plasma protein with high heme binding affinity, which is also locally produced in the CNS by ependymal cells, neurons and glial cells. We have recently reported that oligodendrocytes (OLs) are the type of cells in the brain that are most susceptible to lack of Hx, as the number of iron-overloaded OLs increases in Hx-null brain, leading to oxidative tissue damage. In the current study, we found that the expression of the Myelin Basic Protein along with the density of myelinated fibers in the basal ganglia and in the motor and somatosensory cortex of Hx-null mice were strongly reduced starting at 2 months and progressively decreased with age. Myelin abnormalities were confirmed by electron microscopy and, at the functional level, resulted in the inability of Hx-null mice to perform efficiently on the Rotarod. It is likely that the poor myelination in the brain of Hx-null mice was a consequence of defective maturation of OLs as we demonstrated that the number of mature OLs was significantly reduced in mutant mice whereas that of precursor cells was normal. Finally, in vitro experiments showed that Hx promotes OL differentiation. Thus, Hx may be considered a novel OL differentiation factor and the modulation of its expression in CNS may be an important factor in the pathogenesis of human neurodegenerative disorders.	[Morello, Noemi; Bianchi, Federico Tommaso; Silengo, Lorenzo; Altruda, Fiorella; Tolosano, Emanuela] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Marmiroli, Paola; Menendez, Virginia Rodriguez; Cavaletti, Guido] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy; [Tonoli, Elisabetta; Vercelli, Alessandro] Univ Turin, Neurosci Inst Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy	University of Turin; University of Milano-Bicocca; University of Turin	Morello, N (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	emanuela.tolosano@unito.it	Tolosano, Emanuela/A-4684-2015; Tolosano, Emanuela/L-8080-2019; marmiroli, paola/AAB-6077-2022; Cavaletti, Guido/AAA-7063-2022; Vercelli, Alessandro E/A-1926-2012	Tolosano, Emanuela/0000-0002-1622-2340; Tolosano, Emanuela/0000-0002-1622-2340; Cavaletti, Guido/0000-0003-4128-2406; Vercelli, Alessandro E/0000-0002-5909-2128; Bianchi, Federico Tommaso/0000-0002-8385-3310	Italian Ministry of University and Research; Regione Piemonte; Compagnia di San Paolo	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte); Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by the Italian Ministry of University and Research to E.T. and F.A., by "Regione Piemonte" to F.A. and by "Compagnia di San Paolo" to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker WW, 2005, PEDIATR NEPHROL, V20, P1410, DOI 10.1007/s00467-005-1936-3; Bakker WW, 2005, KIDNEY INT, V68, P603, DOI 10.1111/j.1523-1755.2005.00438.x; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bauer Nina G., 2009, Journal of Biology (London), V8, P78, DOI 10.1186/jbiol169; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Camborieux L, 1998, NEUROSCIENCE, V82, P1039; CHEN L, 2010, J NEUROSURG; Cheung PK, 2000, KIDNEY INT, V57, P1512, DOI 10.1046/j.1523-1755.2000.00996.x; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Dedieu S, 2008, CELL ADHES MIGR, V2, P77, DOI 10.4161/cam.2.2.6374; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Dyer CA, 2002, NEUROCHEM RES, V27, P1279, DOI 10.1023/A:1021611430052; Ferreira AA, 2004, J NEUROCYTOL, V33, P225, DOI 10.1023/B:NEUR.0000030697.78488.63; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; HARDY R, 1991, DEVELOPMENT, V111, P1061; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kapojos JJ, 2003, KIDNEY INT, V63, P1681, DOI 10.1046/j.1523-1755.2003.00907.x; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Lees M B, 1984, Prog Clin Biol Res, V146, P257; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Li ZZ, 2000, J NEUROSCI, V20, P4944; LIEM HH, 1975, ACTA HAEMATOL-BASEL, V53, P219; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; MACKLIN WB, 1991, J NEUROCHEM, V56, P163, DOI 10.1111/j.1471-4159.1991.tb02576.x; MADORE N, 1994, J NEUROSCI RES, V39, P186, DOI 10.1002/jnr.490390209; Madore N, 1999, J NEUROCHEM, V72, P708, DOI 10.1046/j.1471-4159.1999.0720708.x; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Roher AE, 2009, BIOMARKERS, V14, P493, DOI 10.3109/13547500903108423; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SKOFF RP, 1976, NATURE, V264, P560, DOI 10.1038/264560a0; Spiller F, 2011, AM J RESP CRIT CARE, V183, P922, DOI 10.1164/rccm.201002-0223OC; SWERTS JP, 1992, J BIOL CHEM, V267, P10596; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Younes-Rapozo V, 2009, INT J DEV NEUROSCI, V27, P757, DOI 10.1016/j.ijdevneu.2009.08.014; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	49	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20173	10.1371/journal.pone.0020173	http://dx.doi.org/10.1371/journal.pone.0020173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633699	Green Published, gold			2022-12-27	WOS:000291006500035
J	Marchesi, JR; Dutilh, BE; Hall, N; Peters, WHM; Roelofs, R; Boleij, A; Tjalsma, H				Marchesi, Julian R.; Dutilh, Bas E.; Hall, Neil; Peters, Wilbert H. M.; Roelofs, Rian; Boleij, Annemarie; Tjalsma, Harold			Towards the Human Colorectal Cancer Microbiome	PLOS ONE			English	Article							PROMOTES COLON TUMORIGENESIS; GRADIENT GEL-ELECTROPHORESIS; HUMAN GASTROINTESTINAL-TRACT; APC(MIN/+) MICE; MUCOSA; CELLS; COMMUNITIES; DIVERSITY; BACTERIA; ACTIVATION	Multiple factors drive the progression from healthy mucosa towards sporadic colorectal carcinomas and accumulating evidence associates intestinal bacteria with disease initiation and progression. Therefore, the aim of this study was to provide a first high-resolution map of colonic dysbiosis that is associated with human colorectal cancer (CRC). To this purpose, the microbiomes colonizing colon tumor tissue and adjacent non-malignant mucosa were compared by deep rRNA sequencing. The results revealed striking differences in microbial colonization patterns between these two sites. Although inter-individual colonization in CRC patients was variable, tumors consistently formed a niche for Coriobacteria and other proposed probiotic bacterial species, while potentially pathogenic Enterobacteria were underrepresented in tumor tissue. As the intestinal microbiota is generally stable during adult life, these findings suggest that CRC-associated physiological and metabolic changes recruit tumor-foraging commensal-like bacteria. These microbes thus have an apparent competitive advantage in the tumor microenvironment and thereby seem to replace pathogenic bacteria that may be implicated in CRC etiology. This first glimpse of the CRC microbiome provides an important step towards full understanding of the dynamic interplay between intestinal microbial ecology and sporadic CRC, which may provide important leads towards novel microbiome-related diagnostic tools and therapeutic interventions.	[Marchesi, Julian R.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Dutilh, Bas E.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Hall, Neil] Univ Liverpool, Sch Biol Sci, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Peters, Wilbert H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Peters, Wilbert H. M.; Roelofs, Rian; Boleij, Annemarie; Tjalsma, Harold] Radboud Univ Nijmegen, Med Ctr, RUCO, NL-6525 ED Nijmegen, Netherlands; [Roelofs, Rian; Boleij, Annemarie; Tjalsma, Harold] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands	Cardiff University; Radboud University Nijmegen; California State University System; San Diego State University; California State University System; San Diego State University; University of Liverpool; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Marchesi, JR (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	H.Tjalsma@labgk.umcn.nl	Marchesi, Julian/AAC-9021-2020; Tjalsma, Harold/I-7146-2012; Hall, Neil/A-8717-2013; Peters, W.H.M./L-4572-2015; Boleij, Annemarie/L-3975-2013; Dutilh, Bas E./B-9719-2011; Marchesi, Julian/D-3731-2009	Hall, Neil/0000-0002-7995-3810; Boleij, Annemarie/0000-0003-4495-5880; Dutilh, Bas E./0000-0003-2329-7890; Marchesi, Julian/0000-0002-7994-5239; Hall, Neil/0000-0003-2808-0009	Dutch Cancer Society (KWF) [KUN 2006-3591]; Dutch Digestive Diseases Foundation (MDLS) [WO 10-53]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Dutch Digestive Diseases Foundation (MDLS)	AB was supported by the Dutch Cancer Society (KWF; Project KUN 2006-3591). Dutch Digestive Diseases Foundation (MDLS; project WO 10-53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Boleij A, 2010, CANCER-AM CANCER SOC, V116, P4014, DOI 10.1002/cncr.25212; Boleij A, 2009, J CLIN MICROBIOL, V47, P516, DOI 10.1128/JCM.01755-08; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Choi EJ, 2009, CHEM-BIOL INTERACT, V177, P7, DOI 10.1016/j.cbi.2008.09.031; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Green GL, 2006, J APPL MICROBIOL, V100, P460, DOI 10.1111/j.1365-2672.2005.02783.x; Hausen HZ, 2006, INT J CANCER, V119, pXI, DOI 10.1002/ijc.22314; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; JIN JS, 2009, INT J SYST EVOL MICR, V4, P4; Kang HY, 2006, DIGEST DIS SCI, V51, P2310, DOI 10.1007/s10620-006-9276-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Maggio-Price L, 2009, AM J PATHOL, V174, P317, DOI 10.2353/ajpath.2009.080485; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nubel U, 1996, J BACTERIOL, V178, P5636; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Righi V, 2009, J PROTEOME RES, V8, P1859, DOI 10.1021/pr801094b; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; Rudi K, 2007, INT J FOOD MICROBIOL, V120, P95, DOI 10.1016/j.ijfoodmicro.2007.06.004; Rudi K, 2007, APPL ENVIRON MICROB, V73, P2727, DOI 10.1128/AEM.01205-06; Rudi K, 2006, INT J SYST EVOL MICR, V56, P1565, DOI 10.1099/ijs.0.63936-0; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P1382, DOI 10.1111/j.1462-2920.2008.01622.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCOTTCONNER CEH, 1995, J AM COLL SURGEONS, V181, P182; Seder CW, 2009, J VASC SURG, V49, P1304, DOI 10.1016/j.jvs.2008.11.058; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tjalsma H, 2006, INT J CANCER, V119, P2127, DOI 10.1002/ijc.22116; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WAISBERG, 2002, ARQ GASTROENTEROL, V39, P177; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	57	367	398	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20447	10.1371/journal.pone.0020447	http://dx.doi.org/10.1371/journal.pone.0020447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647227	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000291005800052
J	Granot, T; Venticinque, L; Tseng, JC; Meruelo, D				Granot, Tomer; Venticinque, Lisa; Tseng, Jen-Chieh; Meruelo, Daniel			Activation of Cytotoxic and Regulatory Functions of NK Cells by Sindbis Viral Vectors	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IN-VIVO; STIMULATORY FACTOR; OVARIAN-CANCER; TUMOR-CELLS; IFN-GAMMA; VIRUS; EXPRESSION; INTERLEUKIN-12; XENOGRAFTS	Oncolytic viruses (OVs) represent a relatively novel anti-cancer modality. Like other new cancer treatments, effective OV therapy will likely require combination with conventional treatments. In order to design combinatorial treatments that work well together, a greater scrutiny of the mechanisms behind the individual treatments is needed. Sindbis virus (SV) based vectors have previously been shown to target and kill tumors in xenograft, syngeneic, and spontaneous mouse models. However, the effect of SV treatment on the immune system has not yet been studied. Here we used a variety of methods, including FACS analysis, cytotoxicity assays, cell depletion, imaging of tumor growth, cytokine blockade, and survival experiments, to study how SV therapy affects Natural Killer (NK) cell function in SCID mice bearing human ovarian carcinoma tumors. Surprisingly, we found that SV anti-cancer efficacy is largely NK cell-dependent. Furthermore, the enhanced therapeutic effect previously observed from Sin/IL12 vectors, which carry the gene for interleukin 12, is also NK cell dependent, but works through a separate IFN gamma-dependent mechanism, which also induces the activation of peritoneal macrophages. These results demonstrate the multimodular nature of SV therapy, and open up new possibilities for potential synergistic or additive combinatorial therapies with other treatments.	[Granot, Tomer; Venticinque, Lisa; Meruelo, Daniel] NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10016 USA; [Granot, Tomer; Venticinque, Lisa; Meruelo, Daniel] NYU, Sch Med, Dept Pathol, New York, NY USA; [Tseng, Jen-Chieh] Dana Farber Canc Inst, Boston, MA 02115 USA	New York University; New York University; Harvard University; Dana-Farber Cancer Institute	Granot, T (corresponding author), NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10016 USA.	DM01@mac.com			U. S. Public Health [CA100687]; National Cancer Institute; National Institutes of Health; Department of Health and Human Services; Litwin Foundation; NATIONAL CANCER INSTITUTE [R01CA100687] Funding Source: NIH RePORTER	U. S. Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Litwin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U. S. Public Health grants CA100687 from the National Cancer Institute, National Institutes of Health, and Department of Health and Human Services. Funding was also provided by a gift from the Litwin Foundation and a Research and License agreement between NYU and CynVec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2009, CANCER GENE THER, V16, P266, DOI 10.1038/cgt.2008.74; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bramson JL, 1996, HUM GENE THER, V7, P1995, DOI 10.1089/hum.1996.7.16-1995; BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Galivo F, 2010, GENE THER, V17, P158, DOI 10.1038/gt.2009.161; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; HABU S, 1981, J IMMUNOL, V127, P34; Heitmeier MR, 1998, J BIOL CHEM, V273, P15301, DOI 10.1074/jbc.273.24.15301; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Hirasawa K, 2003, CANCER RES, V63, P348; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kayagaki N, 1999, J IMMUNOL, V163, P1906; KING DP, 1983, J IMMUNOL, V131, P315; Leonard JP, 1997, BLOOD, V90, P2541; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Shafren DR, 2004, CLIN CANCER RES, V10, P53, DOI 10.1158/1078-0432.CCR-0690-3; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Tseng JC, 2007, GENE THER, V14, P1166, DOI 10.1038/sj.gt.3302973; Tseng JC, 2002, JNCI-J NATL CANCER I, V94, P1790; Tseng JC, 2004, NAT BIOTECHNOL, V22, P70, DOI 10.1038/nbt917; Tseng JC, 2004, CANCER RES, V64, P6684, DOI 10.1158/0008-5472.CAN-04-1924; Tseng JC, 2006, J NUCL MED, V47, P1136; Unno Y, 2005, CLIN CANCER RES, V11, P4553, DOI 10.1158/1078-0432.CCR-04-2610; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vaha-Koskela MJV, 2006, CANCER RES, V66, P7185, DOI 10.1158/0008-5472.CAN-05-2214; Venticinque L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-37; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Worschech A, 2009, CANCER IMMUNOL IMMUN, V58, P1355, DOI 10.1007/s00262-009-0686-7; Worschech A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-301; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	50	16	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20598	10.1371/journal.pone.0020598	http://dx.doi.org/10.1371/journal.pone.0020598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674047	Green Published, gold, Green Submitted			2022-12-27	WOS:000291310600018
J	Fan, RR; Kang, ZF; He, L; Chan, J; Xu, G				Fan, Rongrong; Kang, Zhanfang; He, Lan; Chan, Juliana; Xu, Gang			Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal Non-Diabetic Mice, Possible Contribution of Beta Cell Independent Effects	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PERFUSED RAT PANCREAS; RECEPTOR AGONIST; INSULIN-RELEASE; GENE-EXPRESSION; PROTEIN-KINASE; DIABETIC-RATS; GLP-1; SOMATOSTATIN; TOLERANCE	Aims: Type 2 diabetes is highly prevalent in the elderly population. Glucagon like Peptide-1 mimetic such as exendin-4 augments post-prandial insulin secretion. However, the potential influence of aging on the therapeutic effects of this peptide has not been well studied. In this study, we examined the glucose regulatory effects of exendin-4 in mice with different ages. Methods: We treated 3-month and 20 to 22-month old C57/DBA mice with 10 nM/kg exendin-4 for 10 days with measurements of blood glucose and body weight. We performed OGTT and ITT to evaluate the glucose response and insulin sensitivity. Islet morphology and beta cell mass were measured by immuno-staining and beta cell proliferation was evaluated by BrdU incorporation and PCNA staining. Real-time PCR and western blot were used to measure protein changes in the liver tissue after exendin-4 treatment. Results: Exendin-4 treatment improved glycemic control in both 3-month and 20 to 22-month old mice. In both groups of mice, the blood glucose lowering effect was independent of beta cell function as indicated by unchanged beta cell proliferation, insulin secretion or beta cell mass. Moreover, we found that exendin-4 treatment increased hepatic AKT and FOXO1 phosphorylation and inhibited glucose-6-phosphotase (G6P) and Phosphoenolpyruvate carboxykinase (PEPCK) expression in young mice, but this effect was attenuated in aging mice while the insulin sensitivity showed no change in the young group but significantly improved in aging mice. Conclusion: Based on these data, we conclude that the glucose lowering effect of exendin-4 in normal non-diabetic mice was not blunted by aging. We further showed that although there was slight difference in the glucose modulating mechanism of exendin-4 therapy in young and aged mice, the improved glucose control seemed uncorrelated with increased beta cell mass or insulin secretion.	[Fan, Rongrong; Kang, Zhanfang; He, Lan; Chan, Juliana; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Juliana; Xu, Gang] Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Chan, Juliana; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Xu, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	gangxu@cuhk.edu.hk	Messier, Claude/A-2322-2008; Chan, Juliana/B-7918-2016; Fan, Rongrong/AAG-2200-2019; Fan, Rongrong/N-3446-2017	Messier, Claude/0000-0002-4791-1763; Chan, Juliana/0000-0003-1325-1194; Fan, Rongrong/0000-0002-5707-1497; Fan, Rongrong/0000-0002-5707-1497; Kang, Zhanfang/0000-0001-7010-8701	CUHK; Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Government Research Grant Committee [477008, 478110]; Chinese University of Hong Kong [2041569]	CUHK(Chinese University of Hong Kong); Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Government Research Grant Committee; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the CUHK Focused Investment Scheme and Liao Wun Yuk Diabetes Research Memorial Fund (grant number N/A); the Hong Kong Government Research Grant Committee (Grant Number: 477008 and 478110) and Direct Grant from the Chinese University of Hong Kong (Grant Number: 2041569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahren Bo, 2007, Curr Diab Rep, V7, P340, DOI 10.1007/s11892-007-0056-9; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Dardevet D, 2004, AM J PHYSIOL-ENDOC M, V287, pE75, DOI 10.1152/ajpendo.00035.2004; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; DeOre K, 1997, J GERONTOL A-BIOL, V52, pB245, DOI 10.1093/gerona/52A.5.B245; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Egido EM, 2004, HORM METAB RES, V36, P595, DOI 10.1055/s-2004-825921; EISSELE R, 1994, LIFE SCI, V55, P629, DOI 10.1016/0024-3205(94)00489-7; ENG J, 1992, J BIOL CHEM, V267, P7402; Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x; FERDAOUSSI M, 2008, DIABETES; Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553; Ihm SH, 2007, DIABETES RES CLIN PR, V77, pS150, DOI 10.1016/j.diabres.2007.01.049; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Marzioni M, 2009, GUT, V58, P990, DOI 10.1136/gut.2008.150870; Meneilly GS, 2003, DIABETES CARE, V26, P2835, DOI 10.2337/diacare.26.10.2835; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Samson SL, 2008, MOL THER, V16, P1805, DOI 10.1038/mt.2008.198; Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747; Scrocchi LA, 1998, DIABETES, V47, P632, DOI 10.2337/diabetes.47.4.632; Silvestre RA, 2003, EUR J PHARMACOL, V469, P195, DOI 10.1016/S0014-2999(03)01692-3; Sinclair EM, 2008, GASTROENTEROLOGY, V135, P2096, DOI 10.1053/j.gastro.2008.07.075; SORENSON RL, 1983, DIABETES, V32, P561, DOI 10.2337/diabetes.32.6.561; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Tanigawa K, 1997, PANCREAS, V15, P53, DOI 10.1097/00006676-199707000-00008; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Xu G, 2006, DIABETES RES CLIN PR, V73, P107, DOI 10.1016/j.diabres.2005.11.007; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zheng D, 2009, DIABETES, V58, P352, DOI 10.2337/db08-0875	45	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20443	10.1371/journal.pone.0020443	http://dx.doi.org/10.1371/journal.pone.0020443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655268	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600070
J	Fan, SJ; Marchand, V; Ephrussi, A				Fan, Shih-Jung; Marchand, Virginie; Ephrussi, Anne			Drosophila Ge-1 Promotes P Body Formation and oskar mRNA Localization	PLOS ONE			English	Article							POSTERIOR LOCALIZATION; BINDING-PROTEIN; CELL-FORMATION; GENE; POLE; TRANSLATION; COMPLEX; PLASM; TRANSPORT; COMPONENT	mRNA localization coupled with translational control is a widespread and conserved strategy that allows the localized production of proteins within eukaryotic cells. In Drosophila, oskar (osk) mRNA localization and translation at the posterior pole of the oocyte are essential for proper patterning of the embryo. Several P body components are involved in osk mRNA localization and translational repression, suggesting a link between P bodies and osk RNPs. In cultured mammalian cells, Ge-1 protein is required for P body formation. Combining genetic, biochemical and immunohistochemical approaches, we show that, in vivo, Drosophila Ge-1 (dGe-1) is an essential gene encoding a P body component that promotes formation of these structures in the germline. dGe-1 partially colocalizes with osk mRNA and is required for osk RNP integrity. Our analysis reveals that although under normal conditions dGe-1 function is not essential for osk mRNA localization, it becomes critical when other components of the localization machinery, such as staufen, Drosophila decapping protein 1 and barentsz are limiting. Our findings suggest an important role of dGe-1 in optimization of the osk mRNA localization process required for patterning the Drosophila embryo.	[Fan, Shih-Jung; Marchand, Virginie; Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Fan, SJ (corresponding author), European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany.	ephrussi@embl.de	Ephrussi, Anne/AAG-4075-2020; MARCHAND, Virginie/A-6866-2012; Ephrussi, Anne/ABD-4393-2021	Ephrussi, Anne/0000-0002-5061-4620; Marchand, Virginie/0000-0002-8537-1139	EMBL; Fondation pour la Recherche Medicale	EMBL; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The totality of the work in this manuscript was funded by the EMBL. Shih-Jung Fan was also fully funded by the European Molecular Biology Laboratory (for information about the EMBL, please see http://www.embl.de/aboutus/index.html). Virginie Marchand was supported by a fellowship from the Fondation pour la Recherche Medicale and by the European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Chou TB, 1996, GENETICS, V144, P1673; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; GLOOR GB, 1993, GENETICS, V135, P81; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Jinek M, 2008, RNA, V14, P1991, DOI 10.1261/rna.1222908; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tritschler F, 2007, MOL CELL BIOL, V27, P8600, DOI 10.1128/MCB.01506-07; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	39	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20612	10.1371/journal.pone.0020612	http://dx.doi.org/10.1371/journal.pone.0020612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655181	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600109
J	Kaneko, M; Yamaguchi, K; Eiraku, M; Sato, M; Takata, N; Kiyohara, Y; Mishina, M; Hirase, H; Hashikawa, T; Kengaku, M				Kaneko, Megumi; Yamaguchi, Kazuhiko; Eiraku, Mototsugu; Sato, Motohiko; Takata, Norio; Kiyohara, Yoshimoto; Mishina, Masayoshi; Hirase, Hajime; Hashikawa, Tsutomu; Kengaku, Mineko			Remodeling of Monoplanar Purkinje Cell Dendrites during Cerebellar Circuit Formation	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR DELTA-2; LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; RAT CEREBELLUM; MUTANT MICE; MULTIPLE INNERVATION; SYNAPSE ELIMINATION; ELECTRICAL-ACTIVITY; ADULT CEREBELLUM; INFERIOR OLIVE	Dendrite arborization patterns are critical determinants of neuronal connectivity and integration. Planar and highly branched dendrites of the cerebellar Purkinje cell receive specific topographical projections from two major afferent pathways; a single climbing fiber axon from the inferior olive that extend along Purkinje dendrites, and parallel fiber axons of granule cells that contact vertically to the plane of dendrites. It has been believed that murine Purkinje cell dendrites extend in a single parasagittal plane in the molecular layer after the cell polarity is determined during the early postnatal development. By three-dimensional confocal analysis of growing Purkinje cells, we observed that mouse Purkinje cells underwent dynamic dendritic remodeling during circuit maturation in the third postnatal week. After dendrites were polarized and flattened in the early second postnatal week, dendritic arbors gradually expanded in multiple sagittal planes in the molecular layer by intensive growth and branching by the third postnatal week. Dendrites then became confined to a single plane in the fourth postnatal week. Multiplanar Purkinje cells in the third week were often associated by ectopic climbing fibers innervating nearby Purkinje cells in distinct sagittal planes. The mature monoplanar arborization was disrupted in mutant mice with abnormal Purkinje cell connectivity and motor discoordination. The dendrite remodeling was also impaired by pharmacological disruption of normal afferent activity during the second or third postnatal week. Our results suggest that the monoplanar arborization of Purkinje cells is coupled with functional development of the cerebellar circuitry.	[Kaneko, Megumi; Eiraku, Mototsugu; Kengaku, Mineko] RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama, Japan; [Kiyohara, Yoshimoto; Hashikawa, Tsutomu] RIKEN Brain Sci Inst, Lab Neural Architecture, Wako, Saitama, Japan; [Yamaguchi, Kazuhiko] RIKEN Brain Sci Inst, Lab Memory & Learning, Wako, Saitama, Japan; [Takata, Norio; Hirase, Hajime] RIKEN Brain Sci Inst, Hirase Res Unit, Wako, Saitama, Japan; [Sato, Motohiko; Kengaku, Mineko] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Bunkyo Ku, Tokyo, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Kyoto University; University of Tokyo	Kaneko, M (corresponding author), RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama, Japan.	kengaku@icems.kyoto-u.ac.jp	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905; Eiraku, Mototsugu/0000-0002-9433-9085	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology, Japan [21300120]	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant sponsors: RIKEN Brain Science Institute; the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant number: 21300120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; ALTMAN J, 1972, J COMP NEUROL, V146, P355, DOI 10.1002/cne.901460305; Andjus PR, 2003, NEUROSCIENCE, V121, P563, DOI 10.1016/S0306-4522(03)00556-6; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BERRY M, 1976, BRAIN RES, V116, P361, DOI 10.1016/0006-8993(76)90487-X; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Cajal S.R., 1911, HISTOLOGY NERVOUS SY; CALVET MC, 1985, BRAIN RES, V331, P235, DOI 10.1016/0006-8993(85)91549-5; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Glickstein M, 2009, CORTEX; GOODLETT CR, 1990, DEV BRAIN RES, V53, P131, DOI 10.1016/0165-3806(90)90133-J; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Hirai H, 2008, CEREBELLUM, V7, P273, DOI 10.1007/s12311-008-0012-5; Huckfeldt RM, 2009, NAT NEUROSCI, V12, P35, DOI 10.1038/nn.2236; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kurihara H, 1997, J NEUROSCI, V17, P9613; Long MA, 2002, J NEUROSCI, V22, P10898; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Millard SS, 2008, CURR OPIN NEUROBIOL, V18, P84, DOI 10.1016/j.conb.2008.05.005; Miwa H, 2006, BRAIN RES, V1068, P94, DOI 10.1016/j.brainres.2005.11.036; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Nishiyama H, 2007, NEURON, V56, P472, DOI 10.1016/j.neuron.2007.09.010; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuki G, 2004, J NEUROSCI, V24, P10900, DOI 10.1523/JNEUROSCI.2240-04.2004; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1995, J NEUROSCI, V15, P2040, DOI 10.1523/JNEUROSCI.15-03-02040.1995; Scelfo B, 2005, EUR J NEUROSCI, V21, P971, DOI 10.1111/j.1460-9568.2005.03933.x; Scelfo B, 2003, J NEUROPHYSIOL, V89, P2555, DOI 10.1152/jn.00884.2002; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Stuart G, 2007, DENDRITES; Sugihara I, 1999, J COMP NEUROL, V414, P131; Takayasu Y, 2006, J NEUROSCI, V26, P6563, DOI 10.1523/JNEUROSCI.5342-05.2006; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941	58	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20108	10.1371/journal.pone.0020108	http://dx.doi.org/10.1371/journal.pone.0020108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655286	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600021
J	Schafer, JM; Peters, DE; Morley, T; Liu, SH; Molinolo, AA; Leppla, SH; Bugge, TH				Schafer, Jeffrey M.; Peters, Diane E.; Morley, Thomas; Liu, Shihui; Molinolo, Alfredo A.; Leppla, Stephen H.; Bugge, Thomas H.			Efficient Targeting of Head and Neck Squamous Cell Carcinoma by Systemic Administration of a Dual uPA and MMP-Activated Engineered Anthrax Toxin	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; THERAPY PRODUCES REGRESSIONS; INHIBITORS STEFIN-A; ATHYMIC NUDE-MICE; MATRIX-METALLOPROTEINASE; LETHAL FACTOR; PLASMINOGEN-ACTIVATOR; PROTECTIVE ANTIGEN; CATHEPSIN-B; IN-VIVO	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Although considerable progress has been made in elucidating the etiology of the disease, the prognosis for individuals diagnosed with HNSCC remains poor, underscoring the need for development of additional treatment modalities. HNSCC is characterized by the upregulation of a large number of proteolytic enzymes, including urokinase plasminogen activator (uPA) and an assortment of matrix metalloproteinases (MMPs) that may be expressed by tumor cells, by tumor-supporting stromal cells or by both. Here we explored the use of an intercomplementing anthrax toxin that requires combined cell surface uPA and MMP activities for cellular intoxication and specifically targets the ERK/MAPK pathway for the treatment of HNSCC. We found that this toxin displayed strong systemic anti-tumor activity towards a variety of xenografted human HNSCC cell lines by inducing apoptotic and necrotic tumor cell death, and by impairing tumor cell proliferation and angiogenesis. Interestingly, the human HNSCC cell lines were insensitive to the intercomplementing toxin when cultured ex vivo, suggesting that either the toxin targets the tumor-supporting stromal cell compartment or that the tumor cell requirement for ERK/MAPK signaling differs in vivo and ex vivo. This intercomplementing toxin warrants further investigation as an anti-HNSCC agent.	[Schafer, Jeffrey M.; Peters, Diane E.; Molinolo, Alfredo A.; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Peters, Diane E.] Tufts Univ, Sch Med, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Morley, Thomas; Liu, Shihui; Leppla, Stephen H.] NIAID, Bacterial Toxins & Therapeut Sect, Lab Bacterial Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schafer, JM (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Peters, Diane/0000-0003-4185-6203; Liu, Shihui/0000-0003-3444-1069	NIAID; NIDCR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIAID and NIDCR Intramural Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abi-Habib RJ, 2006, MOL CANCER THER, V5, P2556, DOI 10.1158/1535-7163.MCT-06-0315; Alfano RW, 2008, MOL CANCER THER, V7, P1218, DOI 10.1158/1535-7163.MCT-08-0024; Alfano RW, 2008, CELL CYCLE, V7, P745, DOI 10.4161/cc.7.6.5627; Alfano RW, 2010, MOL CANCER THER, V9, P190, DOI 10.1158/1535-7163.MCT-09-0694; Alfano RW, 2009, MOL CANCER RES, V7, P452, DOI 10.1158/1541-7786.MCR-08-0451; ARORA N, 1993, J BIOL CHEM, V268, P3334; Birkedal-Hansen B, 2000, Oral Dis, V6, P376; BJORLIN G, 1987, ACTA OTO-LARYNGOL, V104, P568, DOI 10.3109/00016488709128290; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Budihna M, 1996, BIOL CHEM H-S, V377, P385, DOI 10.1515/bchm3.1996.377.6.385; Bugge TH, 1997, BLOOD, V90, P4522; BUGGE TH, 2003, HEAD NECK CANC, P137; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Curino A, 2004, ORAL ONCOL, V40, P1026, DOI 10.1016/j.oraloncology.2004.05.011; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emami N, 2008, CLIN CHEM, V54, P1600, DOI 10.1373/clinchem.2008.105189; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Franchi A, 2002, CANCER-AM CANCER SOC, V95, P1902, DOI 10.1002/cncr.10916; Frankel AE, 2002, PROTEIN PEPTIDE LETT, V9, P1, DOI 10.2174/0929866023409048; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Imanishi Y, 2000, HUM PATHOL, V31, P895, DOI 10.1053/hupa.2000.9756; Itaya T, 1996, ACTA OTO-LARYNGOL, P113; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson N, 1997, AM J PATHOL, V151, P499; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kawada A, 1996, BRIT J DERMATOL, V135, P905, DOI 10.1046/j.1365-2133.1996.d01-1093.x; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOS J, 1995, BIOL CHEM H-S, V376, P401, DOI 10.1515/bchm3.1995.376.7.401; KUSUKAWA J, 1993, AM J CLIN PATHOL, V99, P18, DOI 10.1093/ajcp/99.1.18; LEEMANS CR, 2010, NAT REV CAN IN PRESS; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEPPLA SH, 2000, BACTERIAL PROTEIN TO; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; MIYAJIMA Y, 1995, ANN OTO RHINOL LARYN, V104, P678, DOI 10.1177/000348949510400902; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOORE AE, 1955, CANCER RES, V15, P598; MULLER D, 1993, CANCER RES, V53, P165; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; Romer J, 2001, J INVEST DERMATOL, V116, P353, DOI 10.1046/j.1523-1747.2001.01241.x; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schmidt M, 2000, HEAD NECK-J SCI SPEC, V22, P498, DOI 10.1002/1097-0347(200008)22:5<498::AID-HED9>3.0.CO;2-W; Schmidt M, 1999, ACTA OTO-LARYNGOL, V119, P949; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shi ZG, 2007, BIOCHEM J, V407, P153, DOI 10.1042/BJ20071037; Strojan P, 2000, ANTICANCER RES, V20, P3975; Su YP, 2007, CANCER RES, V67, P3329, DOI 10.1158/0008-5472.CAN-06-4642; SUGIURA K, 1955, CANCER RES, V15, P38; SZABO R, 2011, ONCOGENE IN PRESS; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Williams SA, 2007, JNCI-J NATL CANCER I, V99, P376, DOI 10.1093/jnci/djk065; Wong L, 2005, SEMIN ONCOL, V32, P591, DOI 10.1053/j.seminoncol.2005.08.002; Yasuda T, 1997, HEAD NECK-J SCI SPEC, V19, P611; Yoshizaki T, 2001, INT J CANCER, V95, P44, DOI 10.1002/1097-0215(20010120)95:1<44::AID-IJC1008>3.3.CO;2-D	79	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20532	10.1371/journal.pone.0020532	http://dx.doi.org/10.1371/journal.pone.0020532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655226	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600089
J	Szczepaniec, A; Creary, SF; Laskowski, KL; Nyrop, JP; Raupp, MJ				Szczepaniec, Adrianna; Creary, Scott F.; Laskowski, Kate L.; Nyrop, Jan P.; Raupp, Michael J.			Neonicotinoid Insecticide Imidacloprid Causes Outbreaks of Spider Mites on Elm Trees in Urban Landscapes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GALENDROMUS-OCCIDENTALIS; AGRICULTURAL STREAMS; BEETLE COLEOPTERA; JAPANESE-BEETLE; ACARI; IMPACT; ARTHROPODS; TOXICITY; TETRANYCHIDAE	Background: Attempts to eradicate alien arthropods often require pesticide applications. An effort to remove an alien beetle from Central Park in New York City, USA, resulted in widespread treatments of trees with the neonicotinoid insecticide imidacloprid. Imidacloprid's systemic activity and mode of entry via roots or trunk injections reduce risk of environmental contamination and limit exposure of non-target organisms to pesticide residues. However, unexpected outbreaks of a formerly innocuous herbivore, Tetranychus schoenei (Acari: Tetranychidae), followed imidacloprid applications to elms in Central Park. This undesirable outcome necessitated an assessment of imidacloprid's impact on communities of arthropods, its effects on predators, and enhancement of the performance of T. schoenei. Methodology/Principal Findings: By sampling arthropods in elm canopies over three years in two locations, we document changes in the structure of communities following applications of imidacloprid. Differences in community structure were mostly attributable to increases in the abundance of T. schoenei on elms treated with imidacloprid. In laboratory experiments, predators of T. schoenei were poisoned through ingestion of prey exposed to imidacloprid. Imidacloprid's proclivity to elevate fecundity of T. schoenei also contributed to their elevated densities on treated elms. Conclusions/Significance: This is the first study to report the effects of pesticide applications on the arthropod communities in urban landscapes and demonstrate that imidacloprid increases spider mite fecundity through a plant-mediated mechanism. Laboratory experiments provide evidence that imidacloprid debilitates insect predators of spider mites suggesting that relaxation of top-down regulation combined with enhanced reproduction promoted a non-target herbivore to pest status. With global commerce accelerating the incidence of arthropod invasions, prophylactic applications of pesticides play a major role in eradication attempts. Widespread use of neonicotinoid insecticides, however, can disrupt ecosystems tipping the ecological balance in favor of herbivores and creating pest outbreaks.	[Szczepaniec, Adrianna; Creary, Scott F.; Laskowski, Kate L.; Raupp, Michael J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Nyrop, Jan P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	University System of Maryland; University of Maryland College Park; Cornell University	Szczepaniec, A (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ada.s@tamu.edu		Laskowski, Kate/0000-0003-1523-9340; Szczepaniec, Adrianna/0000-0002-9603-4533	USDA [2005-35303-16269]; International Society of Arboriculture Tree Fund; Gahan and Bamford Fellowships	USDA(United States Department of Agriculture (USDA)); International Society of Arboriculture Tree Fund; Gahan and Bamford Fellowships	This work was funded by the National Research Initiative Competitive Grants Program of USDA 2005-35303-16269 and International Society of Arboriculture Tree Fund grants to M.J.R. and Gahan and Bamford Fellowships to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako M, 2006, PEST MANAG SCI, V62, P419, DOI 10.1002/ps.1182; Balder H, 1999, ACTA HORTIC, P189, DOI 10.17660/ActaHortic.1999.496.24; Berenzen N, 2005, ECOTOX ENVIRON SAFE, V60, P37, DOI 10.1016/j.ecoenv.2003.10.010; BERLINER W, 2008, COMMUNICATION; Bostanian NJ, 2009, PEST MANAG SCI, V65, P635, DOI 10.1002/ps.1721; BROWN MW, 1989, ENVIRON ENTOMOL, V18, P600, DOI 10.1093/ee/18.4.600; Cappaert David, 2005, American Entomologist, V51, P152; Chazeau J., 1985, P211; CHIRIBOGA A, 2009, THESIS OHIO STATE U; Cole PG, 2006, AUST J ENTOMOL, V45, P244, DOI 10.1111/j.1440-6055.2006.00534.x; CORN ML, 2002, RL30123 C RES SERV, P1; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Cowles RS, 2006, J ECON ENTOMOL, V99, P1258, DOI 10.1603/0022-0493-99.4.1258; Croft BA, 1997, ENVIRON ENTOMOL, V26, P391, DOI 10.1093/ee/26.2.391; DEBACH P, 1977, CALIF AGR, V31, P8; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; DREISTADT SH, 1986, ENVIRONMENT, V28, P18, DOI 10.1080/00139157.1986.9929921; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; FAIRCHILD WL, 1993, ARCH ENVIRON CON TOX, V25, P170, DOI 10.1007/BF00212128; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Frank Steven, 2007, Arboriculture & Urban Forestry, V33, P392; Gupta G, 2007, J ECON ENTOMOL, V100, P830, DOI 10.1603/0022-0493(2007)100[830:PACIFM]2.0.CO;2; HULL LA, 1976, ENVIRON ENTOMOL, V5, P337, DOI 10.1093/ee/5.2.337; James DG, 2003, EXP APPL ACAROL, V31, P275, DOI 10.1023/B:APPA.0000010383.33351.2f; James DG, 2003, BIOCONTROL SCI TECHN, V13, P253, DOI 10.1080/0958315021000073510; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Kropczynska D, 2002, ACARID PHYLOGENY AND EVOLUTION: ADAPTATION IN MITES AND TICKS, P303; KROPCZYNSKA D, 1988, EXP APPL ACAROL, V5, P65, DOI 10.1007/BF02053818; LEROY M, 1999, ENVIRON ENTOMOL, V28, P735; Letourneau DK, 2001, J APPL ECOL, V38, P557, DOI 10.1046/j.1365-2664.2001.00611.x; LUCK RF, 1975, ECOLOGY, V56, P893, DOI 10.2307/1936299; LUCKEY TD, 1968, J ECON ENTOMOL, V61, P7, DOI 10.1093/jee/61.1.7; MCMURTRY JA, 1970, HILGARDIA, V40, P331, DOI 10.3733/hilg.v40n11p331; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MULLINS JW, 1993, AM CHEM SOC, V524, P183; Papachristos DP, 2008, BIOL CONTROL, V47, P77, DOI 10.1016/j.biocontrol.2008.06.009; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; Prasifka JR, 2005, ENVIRON ENTOMOL, V34, P1181, DOI 10.1603/0046-225X(2005)034[1181:ATEOPM]2.0.CO;2; Pratt P. D., 2000, Journal of Environmental Horticulture, V18, P218; Raupp Michael J., 2004, Journal of Arboriculture, V30, P108; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Raupp Michael J., 2006, Arboriculture & Urban Forestry, V32, P297; RAUPP MJ, 2007, INT RES INV SPEC USD, P59; Rebek EJ, 2003, J ECON ENTOMOL, V96, P446, DOI 10.1603/0022-0493-96.2.446; Rogers MA, 2007, BIOL CONTROL, V42, P172, DOI 10.1016/j.biocontrol.2007.05.006; Rogers ME, 2003, J ECON ENTOMOL, V96, P1412, DOI 10.1603/0022-0493-96.5.1412; Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353; Schafer RB, 2007, SCI TOTAL ENVIRON, V382, P272, DOI 10.1016/j.scitotenv.2007.04.040; Schneider K., 2000, P INT S PLANT HLTH U, P102; Sclar DC, 1998, J ECON ENTOMOL, V91, P250, DOI 10.1093/jee/91.1.250; Shrewsbury PM, 2003, J ECON ENTOMOL, V96, P1675, DOI 10.1603/0022-0493-96.6.1675; Stavrinides MC, 2009, BIOL CONTROL, V48, P267, DOI 10.1016/j.biocontrol.2008.10.017; SUTTMAN CE, 1979, ECOLOGY, V60, P628, DOI 10.2307/1936083; Szczepaniec A, 2009, THESIS U MARYLAND; Szczepaniec Adrianna, 2007, Journal of Environmental Horticulture, V25, P43; Tenczar EG, 2006, J ECON ENTOMOL, V99, P102, DOI 10.1603/0022-0493(2006)099[0102:MOCLBC]2.0.CO;2; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; *USDA APHIS, 2007, ASIAN LONGH BEETL CO; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wang AH, 2005, J ECON ENTOMOL, V98, P1144, DOI 10.1603/0022-0493-98.4.1144; Wu JinCai, 2003, Scientia Agricultura Sinica, V36, P536; YEOMANS JC, 1991, COMMUN SOIL SCI PLAN, V22, P843, DOI 10.1080/00103629109368458; Zar J.H., 2010, BIOSTAT ANAL; [No title captured]	67	69	77	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20018	10.1371/journal.pone.0020018	http://dx.doi.org/10.1371/journal.pone.0020018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655275	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600014
J	Wu, LK; Wang, HB; Zhang, ZX; Lin, R; Zhang, ZY; Lin, WX				Wu, Linkun; Wang, Haibin; Zhang, Zhixing; Lin, Rui; Zhang, Zhongyi; Lin, Wenxiong			Comparative Metaproteomic Analysis on Consecutively Rehmannia glutinosa-Monocultured Rhizosphere Soil	PLOS ONE			English	Article							MICROBIAL BIOMASS; MASS-SPECTROMETRY; PHENOLIC-ACIDS; COMMUNITY; ROOTS; PROTEINS; EXUDATION; SEEDLINGS; NUTRIENT; PLANTS	Background: The consecutive monoculture for most of medicinal plants, such as Rehmannia glutinosa, results in a significant reduction in the yield and quality. There is an urgent need to study for the sustainable development of Chinese herbaceous medicine. Methodology/Principal Findings: Comparative metaproteomics of rhizosphere soil was developed and used to analyze the underlying mechanism of the consecutive monoculture problems of R. glutinosa. The 2D-gel patterns of protein spots for the soil samples showed a strong matrix dependency. Among the spots, 103 spots with high resolution and repeatability were randomly selected and successfully identified by MALDI TOF-TOF MS for a rhizosphere soil metaproteomic profile analysis. These proteins originating from plants and microorganisms play important roles in nutrient cycles and energy flow in rhizospheric soil ecosystem. They function in protein, nucleotide and secondary metabolisms, signal transduction and resistance. Comparative metaproteomics analysis revealed 33 differentially expressed protein spots in rhizosphere soil in response to increasing years of monoculture. Among them, plant proteins related to carbon and nitrogen metabolism and stress response, were mostly up-regulated except a down-regulated protein (glutathione S-transferase) involving detoxification. The phenylalanine ammonia-lyase was believed to participate in the phenylpropanoid metabolism as shown with a considerable increase in total phenolic acid content with increasing years of monoculture. Microbial proteins related to protein metabolism and cell wall biosynthesis, were up-regulated except a down-regulated protein (geranylgeranyl pyrophosphate synthase) functioning in diterpenoid synthesis. The results suggest that the consecutive monoculture of R. glutinosa changes the soil microbial ecology due to the exudates accumulation, as a result, the nutrient cycles are affected, leading to the retardation of plant growth and development. Conclusions/Significance: Our results demonstrated the interactions among plant, soil and microflora in the proteomic level are crucial for the productivity and quality of R. glutinosa in consecutive monoculture system.	[Wu, Linkun; Wang, Haibin; Zhang, Zhixing; Zhang, Zhongyi; Lin, Wenxiong] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China; [Wu, Linkun; Wang, Haibin; Zhang, Zhixing; Lin, Rui; Lin, Wenxiong] Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Fujian, Peoples R China; [Lin, Rui] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Fujian, Peoples R China; [Zhang, Zhongyi] Henan Agr Univ, Inst Chinese Med Mat, Zhengzhou, Henan, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Xiamen University; Henan Agricultural University	Wu, LK (corresponding author), Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China.	lwx@fjau.edu.cn	Wu, Linkun/GLN-5951-2022	Wu, Linkun/0000-0001-6674-5900	National Natural Science Foundation of China [30772729, 30671220, 31070403]; Natural Science Foundation of Fujian province, China [2008J0051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian province, China(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China (Grant no. 30772729, 30671220, 31070403) and the Natural Science Foundation of Fujian province, China (Grant no. 2008J0051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2009, ELECTROPHORESIS, V30, P4149, DOI 10.1002/elps.200900474; Afroz A, 2009, PEPTIDES, V30, P1600, DOI 10.1016/j.peptides.2009.06.005; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Benndorf D, 2009, BIODEGRADATION, V20, P737, DOI 10.1007/s10532-009-9261-3; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Buscot F, 2005, SOIL BIOL, V3, P3; CAKMAK I, 1988, J PLANT PHYSIOL, V132, P356, DOI 10.1016/S0176-1617(88)80120-2; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen Hui, 2007, Yingyong Shengtai Xuebao, V18, P2755; Cho HY, 2005, PESTIC BIOCHEM PHYS, V83, P29, DOI 10.1016/j.pestbp.2005.03.005; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Costa G, 1997, J PLANT NUTR, V20, P883, DOI 10.1080/01904169709365303; CRAMER MD, 1993, ANN BOT-LONDON, V72, P359, DOI 10.1006/anbo.1993.1119; Crowley D, 2001, BOOKS SOIL PLANT ENV, P223; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; FREDRICKSON JK, 1995, MOL ECOL, V4, P619, DOI 10.1111/j.1365-294X.1995.tb00262.x; Giovannetti M, 1996, NEW PHYTOL, V133, P65, DOI 10.1111/j.1469-8137.1996.tb04342.x; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; HE HQ, 2005, CHIN J APPL ECOL, V16, P890; Huang CZ, 2006, J PROTEOME RES, V5, P3268, DOI 10.1021/pr060257h; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; JU HY, 2002, CHINESE J APPL ECOLO, V13, P723; KAPOOR R, 2006, MICROBIAL ACTIVITY R, P55; KITAKAWA M, 1990, NUCLEIC ACIDS RES, V18, P1521, DOI 10.1093/nar/18.6.1521; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kumar RS, 2005, J APPL MICROBIOL, V98, P145, DOI 10.1111/j.1365-2672.2004.02435.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landi L, 2000, BIOL FERT SOILS, V32, P8, DOI 10.1007/s003740000205; Li, 2007, J AGROENVIRONMENT SC, V26, P347; [梁银丽 Liang Yinli], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P134; [刘峰 LIU Feng], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1871; [刘红彦 LIU Hongyan], 2006, [华北农学报, Acta Agriculturae Boreali-Sinica], V21, P131; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Manoharachary C, 2006, SOIL BIOL, V7, P1; MEHARG AA, 1995, PLANT SOIL, V170, P345, DOI 10.1007/BF00010488; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Mirza MS, 2001, PLANT SOIL, V237, P47, DOI 10.1023/A:1013388619231; Neumann G, 2001, BOOKS SOIL PLANT ENV, P41; Neumann G., 2002, Plant roots: the hidden half, P617; Neumann G, 2007, NUTR CYCLING TERREST, P123, DOI DOI 10.1007/978-3-540-68027-7_5; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Phillips DA, 2004, PLANT PHYSIOL, V136, P2887, DOI 10.1104/pp.104.044222; Qi JJ, 2009, COMMUN SOIL SCI PLAN, V40, P1462, DOI 10.1080/00103620902818104; Qu XH, 2008, APPL SOIL ECOL, V39, P172, DOI 10.1016/j.apsoil.2007.12.007; RAJAN S, 1999, CELL, V97, P371; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; REID CPP, 1974, PLANT PHYSIOL, V54, P44, DOI 10.1104/pp.54.1.44; Russo A, 2005, BIOL FERT SOILS, V41, P301, DOI 10.1007/s00374-005-0854-7; Sacchi GA, 2000, PLANT SOIL, V220, P1, DOI 10.1023/A:1004701912815; Sahin F, 2004, PLANT SOIL, V265, P123, DOI 10.1007/s11104-005-0334-8; Scharf B, 2002, J MOL MICROB BIOTECH, V4, P183; Semenov AM, 1999, MICROB ECOL, V37, P116, DOI 10.1007/s002489900136; SHAHIDINOGHABI S, 2010, TOXICITY MODE ACTION; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; [时向东 SHI Xiangdong], 2006, [安徽农业科学, Journal of anhui agricultural sciences], V34, P2043; Shiomi Y, 1999, APPL ENVIRON MICROB, V65, P3996; Siddiki AMAMZ, 2009, J VET SCI, V10, P203, DOI 10.4142/jvs.2009.10.3.203; Taylor EB, 2010, MICROB ECOL, V59, P390, DOI 10.1007/s00248-009-9593-x; Ter Steege MW, 1999, PLANT SOIL, V208, P125, DOI 10.1023/A:1004585200558; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANCURA V, 1967, PLANT SOIL, V27, P319, DOI 10.1007/BF01376325; Wang HB, 2010, ACTA PHYSIOL PLANT, V32, P245, DOI 10.1007/s11738-009-0399-8; WANG HB, 2011, J PROTEOME IN PRESS; [王茹华 WANG RuHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P3152; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Wu FZ, 2009, EUR J SOIL BIOL, V45, P356, DOI 10.1016/j.ejsobi.2009.04.001; [吴凤芝 Wu Fengzhi], 2003, [东北农业大学学报, Journal of Northeast Agricultural University], V34, P114; Wu Zong-wei, 2009, Shengtaixue Zazhi, V28, P660; Yost CK, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-1; ZHANG K, 1994, BIOCHEM PHARMACOL, V47, P2063, DOI 10.1016/0006-2952(94)90082-5; Zhang Zhong-yi, 2003, Zhongguo Zhongyao Zazhi, V28, P207; ZHAO YJ, 1991, J CHIN MED MAT, V14, P3; ZHU GJ, 2007, HENAN SCI, V14, P255	79	100	121	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20611	10.1371/journal.pone.0020611	http://dx.doi.org/10.1371/journal.pone.0020611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655235	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600108
J	Zhou, W; Chen, ZG; Hu, WQ; Shen, M; Zhang, XX; Li, CD; Wen, ZL; Wu, XL; Hu, YP; Zhang, XH; Duan, XZ; Han, XC; Tao, ZH				Zhou, Wu; Chen, Zhanguo; Hu, Wangqiang; Shen, Mo; Zhang, Xiaoxia; Li, Chengdi; Wen, Zhiliang; Wu, Xiuling; Hu, Yuanping; Zhang, Xiaohua; Duan, Xiuzhi; Han, Xiucui; Tao, Zhihua			Association of Short Tandem Repeat Polymorphism in the Promoter of Prostate Cancer Antigen 3 Gene with the Risk of Prostate Cancer	PLOS ONE			English	Article							RADICAL RETROPUBIC PROSTATECTOMY; EXPRESSION; DD3(PCA3); DD3	Background: PCA3 (prostate cancer antigen 3) gene is one of the most prostate cancer-specific genes at present. Consequently, the prostate-specific expression and the sharp up-regulation of PCA3 mRNA in prostate cancer suggest a unique transcriptional regulation, which possibly can be attributed to promoter polymorphism. In our study, we evaluated whether there is polymorphism in PCA3 promoter region and also assess the association of the polymorphism with prostate cancer. Methodology/Principal Findings: We designed a specific primer set to screen the promoter of PCA3 gene by polymerase chain reaction (PCR)-based cloning and sequencing with the DNA extracted from peripheral blood samples of prostate cancer (PCa) cases (n = 186) and healthy control cases (n = 135). Genotype-specific risks were estimated as odds ratios (ORs) with associated 95% confidence intervals (CIs) by chi-square test. Possible deviation of the genotype frequencies from controls and PCa cases expected under Hardy-Weinberg equilibrium was assessed by the chi-square test. Short tandem repeat polymorphism of TAAA was found in the promoter region of PCA3 gene, five polymorphisms and eight genotypes were identified. The eight genotypes were divided into three groups: <= 10TAAA, 11TAAA, >= 12TAAA. The group 11TAAA and >= 12TAAA were associated with higher relative risk for prostate cancer than group <= 10TAAA (OR = 1.76, 95% CI = 1.07-2.89[for group 11TAAA]; OR = 5.28, 95% CI = 1.76-15.89[for group >= 12TAAA]). Conclusions/Significance: The presence of the (TAAA) n short tandem repeat polymorphisms in the PCA3 promoter region may be a risk factor for prostate cancer in the Chinese population.	[Zhou, Wu; Chen, Zhanguo; Hu, Wangqiang; Shen, Mo; Duan, Xiuzhi; Han, Xiucui; Tao, Zhihua] Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaoxia] Ningbo Municipal Hosp Tradit Chinese Med, Dept Lab Med, Ningbo, Zhejiang, Peoples R China; [Li, Chengdi; Wen, Zhiliang] Wenzhou Med Coll, Affiliated Hosp 1, Dept Urol, Wenzhou, Zhejiang, Peoples R China; [Wu, Xiuling] Wenzhou Med Coll, Affiliated Hosp 1, Dept Pathol, Wenzhou, Zhejiang, Peoples R China; [Hu, Yuanping] Wenzhou Med Coll, Affiliated Hosp 1, Dept Ultrasound B, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaohua] Wenzhou Med Coll, Affiliated Hosp 1, Dept Tumor Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhou, W (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China.	wwwtzh@wz.zj.cn			Natural Science Foundation of China [30872421]; Wenzhou Municipal Science and Technology Bureau [Y20090292]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau	This work was supported by grants from the Natural Science Foundation of China (NO. 30872421) and Wenzhou Municipal Science and Technology Bureau (Y20090292). The URL of the Natural Science Foundation of China: http://www.nsfc.gov.cn/Portal0/default124.htm. The URL of Wenzhou Municipal Science and Technology Bureau: http://www.wzkj.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussemakers MJG, 1999, CANCER RES, V59, P5975; Chen Feng-Ping, 2008, Zhonghua Yi Xue Za Zhi, V88, P261; de Kok JB, 2002, CANCER RES, V62, P2695; EPSTEIN JI, 1993, J UROLOGY, V150, P135, DOI 10.1016/S0022-5347(17)35415-0; Floriano-Sanchez E, 2009, CLIN INVEST MED, V32, pE258; Klecka J, 2010, ANTICANCER RES, V30, P665; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633; PAULSON DF, 1990, J UROLOGY, V144, P1180, DOI 10.1016/S0022-5347(17)39686-6; Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4; Tao ZH, 2010, EXP MOL PATHOL, V89, P58, DOI 10.1016/j.yexmp.2010.01.008; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Verhaegh GW, 2000, J BIOL CHEM, V275, P37496, DOI 10.1074/jbc.M006293200; WALSH PC, 1994, J UROLOGY, V152, P1831, DOI 10.1016/S0022-5347(17)32396-0; ZINCKE H, 1994, J UROLOGY, V152, P1850, DOI 10.1016/S0022-5347(17)32399-6	15	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20378	10.1371/journal.pone.0020378	http://dx.doi.org/10.1371/journal.pone.0020378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655300	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600060
J	Gonzalez-Avella, JC; Eguiluz, VM; Marsili, M; Vega-Redondo, F; Miguel, MS				Carlos Gonzalez-Avella, Juan; Eguiluz, Victor M.; Marsili, Matteo; Vega-Redondo, Fernado; San Miguel, Maxi			Threshold Learning Dynamics in Social Networks	PLOS ONE			English	Article							MODELS	Social learning is defined as the ability of a population to aggregate information, a process which must crucially depend on the mechanisms of social interaction. Consumers choosing which product to buy, or voters deciding which option to take with respect to an important issue, typically confront external signals to the information gathered from their contacts. Economic models typically predict that correct social learning occurs in large populations unless some individuals display unbounded influence. We challenge this conclusion by showing that an intuitive threshold process of individual adjustment does not always lead to such social learning. We find, specifically, that three generic regimes exist separated by sharp discontinuous transitions. And only in one of them, where the threshold is within a suitable intermediate range, the population learns the correct information. In the other two, where the threshold is either too high or too low, the system either freezes or enters into persistent flux, respectively. These regimes are generally observed in different social networks (both complex or regular), but limited interaction is found to promote correct learning by enlarging the parameter region where it occurs.	[Carlos Gonzalez-Avella, Juan; Eguiluz, Victor M.; San Miguel, Maxi] UIB, CSIC, IFISC, Palma de Mallorca, Spain; [Marsili, Matteo] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy; [Vega-Redondo, Fernado] European Univ Inst, Florence, Italy; [Vega-Redondo, Fernado] Inst Valenciano Invest Econ, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Abdus Salam International Centre for Theoretical Physics (ICTP); European University Institute	Gonzalez-Avella, JC (corresponding author), UIB, CSIC, IFISC, Palma de Mallorca, Spain.	juancarlos@ifisc.uib-csic.es	Marsili, Matteo/AAX-2124-2021; Eguíluz, Víctor M./B-9655-2008; Edgar, William D/J-8792-2013; San Miguel, Maxi/G-3224-2015	Eguíluz, Víctor M./0000-0003-1133-1289; Edgar, William D/0000-0002-7996-9273; San Miguel, Maxi/0000-0001-6237-425X; Marsili, Matteo/0000-0001-9437-6989	MEC (Spain) [FIS2007-60327]	MEC (Spain)(Spanish Government)	This work is supported by MEC (Spain) through project FISICOS (FIS2007-60327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, THEORY LEARNING GAME; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, J CONFLICT RESOLUT, V51, P905, DOI 10.1177/0022002707307632; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; DeMarzo PM, 2003, Q J ECON, V118, P909, DOI 10.1162/00335530360698469; Duffie D, 2010, AM ECON J-MICROECON, V2, P100, DOI 10.1257/mic.2.1.100; Gale D, 2003, GAME ECON BEHAV, V45, P329, DOI 10.1016/S0899-8256(03)00144-1; Golub B, 2010, AM ECON J-MICROECON, V2, P112, DOI 10.1257/mic.2.1.112; Gonzalez-Avella JC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/013010; Goyal S, 2005, GROUP FORMATION IN ECONOMICS: NETWORKS, CLUBS, AND COALITIONS, P122, DOI 10.1017/CBO9780511614385.005; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Mandra S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056105; MARTINS ML, 1991, PHYS REV LETT, V66, P2045, DOI 10.1103/PhysRevLett.66.2045; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; San Miguel M, 2005, COMPUT SCI ENG, V7, P67, DOI 10.1109/MCSE.2005.114; Suchecki K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036132; Vazquez F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063011; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	23	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20207	10.1371/journal.pone.0020207	http://dx.doi.org/10.1371/journal.pone.0020207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XV	21637714	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500043
J	Gareau, C; Fournier, MJ; Filion, C; Coudert, L; Martel, D; Labelle, Y; Mazroui, R				Gareau, Cristina; Fournier, Marie-Josee; Filion, Christine; Coudert, Laetitia; Martel, David; Labelle, Yves; Mazroui, Rachid			p21(WAF1/CIP1) Upregulation through the Stress Granule-Associated Protein CUGBP1 Confers Resistance to Bortezomib-Mediated Apoptosis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA STABILIZATION; MENTAL-RETARDATION PROTEIN; PANCREATIC-CANCER CELLS; 3/P21 COMPLEX-FORMATION; BINDING PROTEIN; MYOTONIC-DYSTROPHY; GENE-EXPRESSION; CYTOPLASMIC GRANULES; SIGNALING PATHWAYS	Background: p21(WAF1/CIP1) is a well known cyclin-dependent kinase inhibitor induced by various stress stimuli. Depending on the stress applied, p21 upregulation can either promote apoptosis or prevent against apoptotic injury. The stress-mediated induction of p21 involves not only its transcriptional activation but also its posttranscriptional regulation, mainly through stabilization of p21 mRNA levels. We have previously reported that the proteasome inhibitor MG132 induces the stabilization of p21 mRNA, which correlates with the formation of cytoplasmic RNA stress granules. The mechanism underlying p21 mRNA stabilization, however, remains unknown. Methodology/Principal Findings: We identified the stress granules component CUGBP1 as a factor required for p21 mRNA stabilization following treatment with bortezomib (= PS-341/Velcade). This peptide boronate inhibitor of the 26S proteasome is very efficient for the treatment of myelomas and other hematological tumors. However, solid tumors are sometimes refractory to bortezomib treatment. We found that depleting CUGBP1 in cancer cells prevents bortezomib-mediated p21 upregulation. FISH experiments combined to mRNA stability assays show that this effect is largely due to a mistargeting of p21 mRNA in stress granules leading to its degradation. Altering the expression of p21 itself, either by depleting CUGBP1 or p21, promotes bortezomib-mediated apoptosis. Conclusions/Significance: We propose that one key mechanism by which apoptosis is inhibited upon treatment with chemotherapeutic drugs might involve upregulation of the p21 protein through CUGBP1.	[Gareau, Cristina; Fournier, Marie-Josee; Filion, Christine; Coudert, Laetitia; Martel, David; Labelle, Yves; Mazroui, Rachid] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, CHUQ Res Ctr,St Francois Assise Res Ctr CRCHUQ CR, Quebec City, PQ G1K 7P4, Canada	Laval University	Gareau, C (corresponding author), Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, CHUQ Res Ctr,St Francois Assise Res Ctr CRCHUQ CR, Quebec City, PQ G1K 7P4, Canada.	rachid.mazroui@crsfa.ulaval.ca			Canadian Institutes of Health Research grants (CIHR) [MOP-IC093226, MOP-096454]; Canadian Foundation for Inovation (CFI) [MOP-GF091050]; Faculty of Medicine at Laval University; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research grants (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Inovation (CFI)(Canada Foundation for Innovation); Faculty of Medicine at Laval University; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes of Health Research grants (CIHR) (MOP-IC093226 and MOP-096454) and a Canadian Foundation for Inovation (CFI) grant (MOP-GF091050) to R. Mazroui. C. Gareau is recipient of a scholarship from the Faculty of Medicine at Laval University. R. Mazroui is a recipient of a Fonds de la Recherche en Sante du Quebec (FRSQ) research Scholars-Junior 1, and is a new investigator of CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Adnane J, 2000, ONCOGENE, V19, P5338, DOI 10.1038/sj.onc.1203956; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Cusack JC, 2001, CANCER RES, V61, P3535; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Ferrandiz N, 2010, CANCER LETT, V292, P133, DOI 10.1016/j.canlet.2009.11.017; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; HARPER JW, 1993, CELL, V75, P805; Hideshima T, 2001, CANCER RES, V61, P3071; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lazzarini R, 2008, CLIN CANCER RES, V14, P5099, DOI 10.1158/1078-0432.CCR-08-0255; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Lenz HJ, 2003, CANCER TREAT REV, V29, P41, DOI 10.1016/S0305-7372(03)00082-3; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; de Silanes IL, 2009, NUCLEIC ACIDS RES, V37, P2658, DOI 10.1093/nar/gkp123; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Richardson Paul G, 2003, Clin Adv Hematol Oncol, V1, P596; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Salomons FA, 2005, ESSAYS BIOCHEM, V41, P113, DOI 10.1042/EB0410113; Seomun Y, 2005, MOL VIS, V11, P764; Sloss CM, 2008, CLIN CANCER RES, V14, P5116, DOI 10.1158/1078-0432.CCR-07-4506; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Tang ZY, 2008, J SURG RES, V145, P111, DOI 10.1016/j.jss.2007.03.061; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	89	81	86	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20254	10.1371/journal.pone.0020254	http://dx.doi.org/10.1371/journal.pone.0020254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637851	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200044
J	Jawara, M; Awolola, TS; Pinder, M; Jeffries, D; Smallegange, RC; Takken, W; Conway, DJ				Jawara, Musa; Awolola, Taiwo S.; Pinder, Margaret; Jeffries, David; Smallegange, Renate C.; Takken, Willem; Conway, David J.			Field Testing of Different Chemical Combinations as Odour Baits for Trapping Wild Mosquitoes in The Gambia	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; MALARIA MOSQUITO; CARBON-DIOXIDE; SENSU-STRICTO; CULICIDAE; DIPTERA; RESPONSES; BEHAVIOR; YEAST	Odour baited traps have potential use in population surveillance of insect vectors of disease, and in some cases for vector population reduction. Established attractants for human host-seeking mosquitoes include a combination of CO(2) with L-lactic acid and ammonia, on top of which additional candidate compounds are being tested. In this field study in rural Gambia, using Latin square experiments with thorough randomization and replication, we tested nine different leading candidate combinations of chemical odorants for attractiveness to wild mosquitoes including anthropophilic malaria vectors, using modified Mosquito Magnet-X (MM-X) counterflow traps outside experimental huts containing male human sleepers. Highest catches of female mosquitoes, particularly of An. gambiae s.l. and Mansonia species, were obtained by incorporation of tetradecanoic acid. As additional carboxylic acids did not increase the trap catches further, this 'reference blend' (tetradecanoic acid with L-lactic acid, ammonia and CO(2)) was used in subsequent experiments. MM-X traps with this blend caught similar numbers of An. gambiae s.l. and slightly more Mansonia and Culex mosquitoes than a standard CDC light trap, and these numbers were not significantly affected by the presence or absence of human sleepers in the huts. Experiments with CO(2) produced from overnight yeast cultures showed that this organic source was effective in enabling trap attractiveness for all mosquito species, although at a slightly lower efficiency than obtained with use of CO(2) gas cylinders. Although further studies are needed to discover additional chemicals that increase attractiveness, as well as to optimise trap design and CO(2) source for broader practical use, the odour-baited traps described here are safe and effective for sampling host-seeking mosquitoes outdoors and can be incorporated into studies of malaria vector ecology.	[Jawara, Musa; Awolola, Taiwo S.; Pinder, Margaret; Jeffries, David; Conway, David J.] MRC Labs, Banjul, Gambia; [Awolola, Taiwo S.] Nigerian Inst Med Res, Lagos, Nigeria; [Smallegange, Renate C.; Takken, Willem] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	MRC Laboratory Molecular Biology; Wageningen University & Research; University of London; London School of Hygiene & Tropical Medicine	Jawara, M (corresponding author), MRC Labs, Banjul, Gambia.	david.conway@lshtm.ac.uk	Smallegange, Renate C./L-1566-2019	Smallegange, Renate C./0000-0002-6946-9777; Conway, David/0000-0002-8711-3037	Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative (GCGH) [121]; Medical Research Council of the United Kingdom	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative (GCGH)(Bill & Melinda Gates Foundation); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Foundation for the National Institutes of Health and the Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative (GCGH# 121 grant co-ordinated by Dr. Larry Zwiebel), and by the Medical Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Oli K., 2005, Tropical Biomedicine, V22, P249; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; QIU YT, 2010, MED VET ENTOMOL; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Saitoh Y, 2004, J AM MOSQUITO CONTR, V20, P261; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7	22	31	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19676	10.1371/journal.pone.0019676	http://dx.doi.org/10.1371/journal.pone.0019676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637337	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000291052200012
J	Mulckhuyse, M; Belopolsky, AV; Heslenfeld, D; Talsma, D; Theeuwes, J				Mulckhuyse, Manon; Belopolsky, Artem V.; Heslenfeld, Dirk; Talsma, Durk; Theeuwes, Jan			Distribution of Attention Modulates Salience Signals in Early Visual Cortex	PLOS ONE			English	Article							STIMULUS-DRIVEN; SELECTIVE ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; CORTICAL AREAS; CAPTURE; SEARCH; VOLUNTARY; COLOR; INHIBITION	Previous research has shown that the extent to which people spread attention across the visual field plays a crucial role in visual selection and the occurrence of bottom-up driven attentional capture. Consistent with previous findings, we show that when attention was diffusely distributed across the visual field while searching for a shape singleton, an irrelevant salient color singleton captured attention. However, while using the very same displays and task, no capture was observed when observers initially focused their attention at the center of the display. Using event-related fMRI, we examined the modulation of retinotopic activity related to attentional capture in early visual areas. Because the sensory display characteristics were identical in both conditions, we were able to isolate the brain activity associated with exogenous attentional capture. The results show that spreading of attention leads to increased bottom-up exogenous capture and increased activity in visual area V3 but not in V2 and V1.	[Mulckhuyse, Manon; Belopolsky, Artem V.; Heslenfeld, Dirk; Theeuwes, Jan] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Mulckhuyse, Manon; Talsma, Durk] Univ Ghent, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Ghent University	Mulckhuyse, M (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	Manon.Mulckhuyse@UGent.be	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721; Belopolsky, Artem/0000-0003-3606-2134; Talsma, Durk/0000-0002-3435-2317	Human Frontier Science Program [HSFP-RGP39/2005]	Human Frontier Science Program(Human Frontier Science Program)	This research was funded by a grant from Human Frontier Science Program (HSFP-RGP39/2005) to Jan Theeuwes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; FOLK CL, 1994, J EXP PSYCHOL HUMAN, V20, P317, DOI 10.1037/0096-1523.20.2.317; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; GIBSON BS, 2001, ATTRACTION DISTRACTI, P51, DOI DOI 10.1016/S0166-4115(01)80005-4; Hernandez M, 2010, ATTEN PERCEPT PSYCHO, V72, P963, DOI 10.3758/APP.72.4.963; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Muller NG, 2007, J COGNITIVE NEUROSCI, V19, P587, DOI 10.1162/jocn.2007.19.4.587; Mulckhuyse M, 2008, EXP BRAIN RES, V186, P225, DOI 10.1007/s00221-007-1226-3; Munneke J, 2008, BRAIN RES, V1222, P184, DOI 10.1016/j.brainres.2008.05.039; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Talsma D, 2010, J COGNITIVE NEUROSCI, V22, P761, DOI 10.1162/jocn.2009.21223; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Theeuwes J, 2010, ACTA PSYCHOL, V135, P133, DOI 10.1016/j.actpsy.2010.07.006; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Van der Stigchel S, 2009, ACTA PSYCHOL, V132, P201, DOI 10.1016/j.actpsy.2009.07.001; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121	54	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20379	10.1371/journal.pone.0020379	http://dx.doi.org/10.1371/journal.pone.0020379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XS	21637812	Green Published, gold			2022-12-27	WOS:000291052200058
J	Wassenberg, MWM; de Wit, GA; Bonten, MJM				Wassenberg, Marjan W. M.; de Wit, G. Ardine; Bonten, Marc J. M.			Cost-Effectiveness of Preoperative Screening and Eradication of Staphylococcus aureus Carriage	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; NASAL CARRIAGE; PERITONEAL-DIALYSIS; MORTALITY; SURGERY; GENES; RISK	Background: Preoperative screening for nasal S. aureus carriage, followed by eradication treatment of identified carriers with nasal mupirocine ointment and chlorhexidine soap was highly effective in preventing deep-seated S. aureus infections. It is unknown how cost-effectiveness of this intervention is affected by suboptimal S. aureus screening. We determined cost-effectiveness of different preoperative S. aureus screening regimes. Methods: We compared different screening scenarios (ranging from treating all patients without screening to treating only identified S. aureus carriers) to the base case scenario without any screening and treatment. Screening and treatment costs as well as costs and mortality due to deep-seated S. aureus infection were derived from hospital databases and prospectively collected data, respectively. Results: As compared to the base case scenario, all scenarios are associated with improved health care outcomes at reduced costs. Treating all patients without screening is most cost-beneficial, saving (sic)7339 per life year gained, as compared to (sic)3330 when only identified carriers are treated. In sensitivity analysis, outcomes are susceptible to the sensitivity of the screening test and the efficacy of treatment. Reductions in these parameters would reduce the cost-effectiveness of scenarios in which treatment is based on screening. When only identified S. aureus carriers are treated costs of screening should be less than (sic)6.23 to become the dominant strategy. Conclusions: Preoperative screening and eradication of S. aureus carriage to prevent deep-seated S. aureus infections saves both life years and medical costs at the same time, although treating all patients without screening is the dominant strategy, resulting in most health gains and largest savings.	[Wassenberg, Marjan W. M.; Bonten, Marc J. M.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Wassenberg, Marjan W. M.] Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [de Wit, G. Ardine; Bonten, Marc J. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Wassenberg, MWM (corresponding author), Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands.	mbonten@umcutrecht.nl		de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	M.J.M.B. was supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriesse GI, 2009, EUR J CLIN MICROBIOL, V28, P1223, DOI 10.1007/s10096-009-0770-0; Batra R, 2010, CLIN INFECT DIS, V50, P210, DOI 10.1086/648717; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Choudhurry RSR, 2006, J MICROBIOL METH, V65, P354, DOI 10.1016/j.mimet.2005.08.009; *COLL ZORGV, 2010, FARM KOMP 2010; *DUTCH HEALTHC AUT, CI1094B2 DUTCH HEALT; Gold MR, 1996, COST EFFECTIVENESS H; Hacek DM, 2008, CLIN ORTHOP RELAT R, V466, P1349, DOI 10.1007/s11999-008-0210-y; Karra R, 2006, J THORAC CARDIOV SUR, V132, P537, DOI 10.1016/j.jtcvs.2006.04.037; Kluytmans JAJW, 1996, INFECT CONT HOSP EP, V17, P780; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nouwen J, 2006, J CLIN MICROBIOL, V44, P2233, DOI 10.1128/JCM.02083-05; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Smith K, 2008, J ANTIMICROB CHEMOTH, V61, P78, DOI 10.1093/jac/dkm395; Vali L, 2008, J ANTIMICROB CHEMOTH, V61, P524, DOI 10.1093/jac/dkm520; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; White A, 1963, ANTIMICROB AGENTS CH, V161, P667	18	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e14815	10.1371/journal.pone.0014815	http://dx.doi.org/10.1371/journal.pone.0014815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637333	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200002
J	Singhmar, P; Kumar, A				Singhmar, Pooja; Kumar, Arun			Angelman Syndrome Protein UBE3A Interacts with Primary Microcephaly Protein ASPM, Localizes to Centrosomes and Regulates Chromosome Segregation	PLOS ONE			English	Article							TRUNCATING MUTATIONS; NEURONAL PROGENITORS; CITRON-KINASE; BRAIN SIZE; GENE; IDENTIFICATION; CYTOKINESIS; CDK5RAP2; FAMILIES; CELL	Many proteins associated with the phenotype microcephaly have been localized to the centrosome or linked to it functionally. All the seven autosomal recessive primary microcephaly (MCPH) proteins localize at the centrosome. Microcephalic osteodysplastic primordial dwarfism type II protein PCNT and Seckel syndrome (also characterized by severe microcephaly) protein ATR are also centrosomal proteins. All of the above findings show the importance of centrosomal proteins as the key players in neurogenesis and brain development. However, the exact mechanism as to how the loss-of-function of these proteins leads to microcephaly remains to be elucidated. To gain insight into the function of the most commonly mutated MCPH gene ASPM, we used the yeast two-hybrid technique to screen a human fetal brain cDNA library with an ASPM bait. The analysis identified Angelman syndrome gene product UBE3A as an ASPM interactor. Like ASPM, UBE3A also localizes to the centrosome. The identification of UBE3A as an ASPM interactor is not surprising as more than 80% of Angelman syndrome patients have microcephaly. However, unlike in MCPH, microcephaly is postnatal in Angelman syndrome patients. Our results show that UBE3A is a cell cycle regulated protein and its level peaks in mitosis. The shRNA knockdown of UBE3A in HEK293 cells led to many mitotic abnormalities including chromosome missegregation, abnormal cytokinesis and apoptosis. Thus our study links Angelman syndrome protein UBE3A to ASPM, centrosome and mitosis for the first time. We suggest that a defective chromosome segregation mechanism is responsible for the development of microcephaly in Angelman syndrome.	[Singhmar, Pooja; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Singhmar, P (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219	Department of Biotechnology, New Delhi [BT/PR5914/Med/14/715/2005]; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by a grant (number BT/PR5914/Med/14/715/2005) from the Department of Biotechnology, New Delhi to AK, and a Junior Research Fellowship from the Council of Scientific and Industrial Research, New Delhi to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; GONZALEZ C, 1990, J CELL SCI, V96, P605; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Gul A, 2007, J NEUROGENET, V21, P153, DOI 10.1080/01677060701508594; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar A, 2004, CLIN GENET, V66, P341, DOI 10.1111/j.1399-0004.2004.00304.x; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Sarkisian MR, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-08-j0001.2002; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Yang YZ, 2007, J CELL BIOCHEM, V101, P167, DOI 10.1002/jcb.21164; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhang XY, 2009, CELL CYCLE, V8, P1206, DOI 10.4161/cc.8.8.8205; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481	39	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20397	10.1371/journal.pone.0020397	http://dx.doi.org/10.1371/journal.pone.0020397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633703	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500060
J	Chen, T; Xu, Y; Guo, H; Liu, YL; Hu, PT; Yang, XY; Li, XG; Ge, SC; Velu, SE; Nadkarni, DH; Wang, W; Zhang, RW; Wang, H				Chen, Tao; Xu, Yi; Guo, He; Liu, Yanling; Hu, Pingting; Yang, Xinying; Li, Xiaoguang; Ge, Shichao; Velu, Sadanandan E.; Nadkarni, Dwayaja H.; Wang, Wei; Zhang, Ruiwen; Wang, Hui			Experimental Therapy of Ovarian Cancer with Synthetic Makaluvamine Analog: In Vitro and In Vivo Anticancer Activity and Molecular Mechanisms of Action	PLOS ONE			English	Article							MARINE NATURAL-PRODUCTS; CELL-CYCLE ARREST; ZYZZYA-FULIGINOSA; GENUS ZYZZYA; APOPTOSIS; DEATH; PYRROLOIMINOQUINONES; MITOCHONDRIA; ACTIVATION; SURVIVAL	The present study was designed to determine the biological effects of novel marine alkaloid analog 7-(4-fluorobenzylamino)-1,3,4,8-tetrahydropyrrolo[4,3,2-de]quinolin-8(1H)-one (FBA-TPQ) on human ovarian cancer cells for its anti-tumor potential and the underlying mechanisms as a novel chemotherapeutic agent. Human ovarian cancer cells (A2780 and OVCAR-3), and Immortalized non-tumorigenic human Ovarian Surface Epithelial cells (IOSE-144), were exposed to FBA-TPQ for initial cytotoxicity evaluation (via MTS assay kit, Promega). The detailed in-vitro (cell level) and in-vivo (animal model) studies on the antitumor effects and possible underlying mechanisms of action of the compounds were then performed. FBA-TPQ exerted potent cytotoxicity against human ovarian cancer A2780 and OVCAR-3 cells as an effective inhibitor of cell growth and proliferation, while exerting lesser effects on non-tumorigenic IOSE-144 cells. Further study in the more sensitive OVCAR-3 cell line showed that it could potently induce cell apoptosis (Annexin V-FITC assay), G2/M cell cycle arrest (PI staining analysis) and also dose-dependently inhibit OVCAR-3 xenograft tumors' growth on female athymic nude mice (BALB/c, nu/nu). Mechanistic studies (both in vitro and in vivo) revealed that FBA-TPQ might exert its activity through Reactive Oxygen Species (ROS)-associated activation of the death receptor, p53-MDM2, and PI3K-Akt pathways in OVCAR-3 cells, which is in accordance with in vitro microarray (Human genome microarrays, Agilent) data analysis (GEO accession number: GSE25317). In conclusion, FBA-TPQ exhibits significant anticancer activity against ovarian cancer cells, with minimal toxicity to non-tumorigenic human IOSE-144 cells, indicating that it may be a potential therapeutic agent for ovarian cancer.	[Chen, Tao; Xu, Yi; Guo, He; Liu, Yanling; Hu, Pingting; Yang, Xinying; Li, Xiaoguang; Ge, Shichao; Wang, Hui] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Velu, Sadanandan E.; Nadkarni, Dwayaja H.] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA; [Wang, Wei; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Alabama System; University of Alabama Birmingham; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Chen, T (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	liu, yan/HCI-5542-2022	Velu, Sadanandan/0000-0002-0342-2378	Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715]; Ministry of Science and Technology of China [2007CB947100]; Science and Technology Commission of Shanghai Municipality [08391910800, 10391902100]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09102-114, 2009ZX09301-011]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001, CRC2010002]; Director Foundation of INS [20090101]; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS; National Institutes of Health/National Cancer Institute [R01 CA112029, R01 CA121211]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA121211] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; Science and Technology Commission of Xuhui District of Shanghai Municipality; Director Foundation of INS; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS(Chinese Academy of Sciences); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This study was supported by grants from One Hundred Talents Program of the Chinese Academy of Sciences, the National Nature Science Foundation (30870513, 31070680 and 91029715), the Ministry of Science and Technology of China (2007CB947100), the Science and Technology Commission of Shanghai Municipality (08391910800, 10391902100), National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2009ZX09102-114, 2009ZX09301-011), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001, CRC2010002), Director Foundation of INS (20090101), the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS. R.Z. was supported in part by National Institutes of Health/National Cancer Institute grants R01 CA112029 and R01 CA121211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; BARROWS LR, 1993, ANTI-CANCER DRUG DES, V8, P333; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Blunt JW, 2005, NAT PROD REP, V22, P15, DOI 10.1039/b415080p; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CARNEY Jr, 1993, TETRAHEDRON, V49, P8483, DOI 10.1016/S0040-4020(01)96256-8; Casapullo A, 2001, J NAT PROD, V64, P1354, DOI 10.1021/np010053+; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Dijoux MG, 2005, BIOORGAN MED CHEM, V13, P6035, DOI 10.1016/j.bmc.2005.06.019; Engel J, 2002, EUR J CANCER, V38, P2435, DOI 10.1016/S0959-8049(02)00495-1; Godefroy N, 2006, APOPTOSIS, V11, P659, DOI 10.1007/s10495-006-5543-y; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gupta L, 2007, CURR MED CHEM, V14, P1789; Han CT, 2009, AM J PHYSIOL-CELL PH, V297, pC1188, DOI 10.1152/ajpcell.00042.2009; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Huang M, 2008, MOL CANCER THER, V7, P1440, DOI 10.1158/1535-7163.MCT-07-2116; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; RADISKY DC, 1993, J AM CHEM SOC, V115, P1632, DOI 10.1021/ja00058a003; Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039; Schmidt EW, 1995, J NAT PROD, V58, P1861, DOI 10.1021/np50126a008; Shinkre BA, 2008, BIOORGAN MED CHEM, V16, P2541, DOI 10.1016/j.bmc.2007.11.051; Shinkre BA, 2007, BIOORG MED CHEM LETT, V17, P2890, DOI 10.1016/j.bmcl.2007.02.065; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Venables DA, 1997, J NAT PROD, V60, P408, DOI 10.1021/np9607262; Wang W, 2009, CLIN CANCER RES, V15, P3511, DOI 10.1158/1078-0432.CCR-08-2689; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661	34	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20729	10.1371/journal.pone.0020729	http://dx.doi.org/10.1371/journal.pone.0020729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673964	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400025
J	Huang, ZF; Wang, HY; Lu, MF; Sun, CC; Wu, XP; Tan, Y; Ye, CH; Zhu, GH; Wang, XJ; Cai, L; Li, XK				Huang, Zhifeng; Wang, Huiyan; Lu, Meifei; Sun, Chuanchuan; Wu, Xiaoping; Tan, Yi; Ye, Chaohui; Zhu, Guanghui; Wang, Xiaojie; Cai, Lu; Li, Xiaokun			A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol	PLOS ONE			English	Article							SITE-SPECIFIC MODIFICATION; BETA-KLOTHO; METABOLIC-ACTIVITY; FACTOR FAMILY; FGF21; PEGYLATION; ACTIVATION; INCREASES; FGF-21; TISSUE	As one of fibroblast growth factor (FGF) family members, FGF21 has been extensively investigated for its potential as a drug candidate to combat metabolic diseases. In the present study, recombinant human FGF21 (rhFGF21) was modified with polyethylene glycol (PEGylation) in order to increase its in vivo biostabilities and therapeutic potency. At N-terminal residue rhFGF21 was site-selectively PEGylated with mPEG20 kDa-butyraldehyde. The PEGylated rhFGF21 was purified to near homogeneity by Q Sepharose anion-exchange chromatography. The general structural and biochemical features as well as anti-diabetic effects of PEGylated rhFGF21 in a type 2 diabetic rat model were evaluated. By N-terminal sequencing and MALDI-TOF mass spectrometry, we confirmed that PEG molecule was conjugated only to the N-terminus of rhFGF21. The mono-PEGylated rhFGF21 retained the secondary structure, consistent with the native rhFGF21, but its biostabilities, including the resistance to physiological temperature and trypsinization, were significantly enhanced. The in vivo immunogenicity of PEGylated rhFGF21 was significantly decreased, and in vivo half-life time was significantly elongated. Compared to the native form, the PEGylated rhFGF21 had a similar capacity of stimulating glucose uptake in 3T3-L1 cells in vitro, but afforded a significantly long effect on reducing blood glucose and triglyceride levels in the type 2 diabetic animals. These results suggest that the PEGylated rhFGF21 is a better and more effective anti-diabetic drug candidate than the native rhFGF21 currently available. Therefore, the PEGylated rhFGF21 may be potentially applied in clinics to improve the metabolic syndrome for type 2 diabetic patients.	[Huang, Zhifeng; Lu, Meifei; Sun, Chuanchuan; Tan, Yi; Ye, Chaohui; Zhu, Guanghui; Wang, Xiaojie; Cai, Lu; Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Huang, Zhifeng; Lu, Meifei; Sun, Chuanchuan; Tan, Yi; Ye, Chaohui; Zhu, Guanghui; Wang, Xiaojie; Cai, Lu; Li, Xiaokun] Wenzhou Med Coll, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China; [Huang, Zhifeng; Wang, Huiyan; Li, Xiaokun] Jilin Univ, Normal Bethune Med Coll, Changchun 130023, Jilin, Peoples R China; [Wu, Xiaoping; Li, Xiaokun] Jinan Univ, Key Lab, Minist Educ Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China; [Tan, Yi; Cai, Lu] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	Wenzhou Medical University; Wenzhou Medical University; Jilin University; Jinan University; University of Louisville	Huang, ZF (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	L0cai001@louisville.edu; xiaokunli@163.net	Cai, Lu/AAG-9920-2019		Natural Science Foundation of Zhejiang Province of China [Y4100067]; Wenzhou Department of Science and Technology [Y20100004]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Extremely Key Subject Building Project; Wenzhou Medical College	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Wenzhou Department of Science and Technology; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Extremely Key Subject Building Project; Wenzhou Medical College	Funding: This work was supported, in part, by grants from Natural Science Foundation of Zhejiang Province of China (Y4100067) [Z. Huang], Key Grant of Wenzhou Department of Science and Technology (Y20100004) [Z. Huang], Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents [X. Li], Zhejiang Provincial Extremely Key Subject Building Project "Pharmacology and Biochemical Pharmaceutics 2009'', and Start-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical College [L. Cai and X. Li]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD A, 1991, CANCER CELL-MON REV, V3, P239; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029; KATRE NV, 1987, P NATL ACAD SCI USA, V84, P1487, DOI 10.1073/pnas.84.6.1487; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kinstler O, 2002, ADV DRUG DELIVER REV, V54, P477, DOI 10.1016/S0169-409X(02)00023-6; KITAMURA K, 1990, BIOCHEM BIOPH RES CO, V171, P1387, DOI 10.1016/0006-291X(90)90839-F; KUAN CT, 1994, J BIOL CHEM, V269, P7610; KURFURST MM, 1992, ANAL BIOCHEM, V200, P244, DOI 10.1016/0003-2697(92)90460-O; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee BK, 2007, BIOCONJUGATE CHEM, V18, P1728, DOI 10.1021/bc060245m; Marsac Y, 2006, BIOCONJUGATE CHEM, V17, P1492, DOI 10.1021/bc0601931; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Niall H D, 1973, Methods Enzymol, V27, P942; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Scott MD, 2004, TRANSFUS CLIN BIOL, V11, P40, DOI 10.1016/j.tracli.2003.12.005; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Uonaga T, 2010, ISLETS, V2, P247, DOI 10.4161/isl.2.4.12402; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Veronese FM, 2007, BIOCONJUGATE CHEM, V18, P1824, DOI 10.1021/bc070123+; Wang HY, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-14; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Xiao JP, 2008, BIOCONJUGATE CHEM, V19, P1113, DOI 10.1021/bc800063k; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	40	44	51	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20669	10.1371/journal.pone.0020669	http://dx.doi.org/10.1371/journal.pone.0020669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673953	Green Published, Green Submitted, gold			2022-12-27	WOS:000291356400015
J	Emig, D; Sander, O; Mayr, G; Albrecht, M				Emig, Dorothea; Sander, Oliver; Mayr, Gabriele; Albrecht, Mario			Structure Collisions between Interacting Proteins	PLOS ONE			English	Article							INTERACTION NETWORKS; CRYSTAL-STRUCTURE; COMPLEX; GROWTH; INFORMATION; CYCLOPHILIN; PATHWAYS; INSIGHTS; RECEPTOR; DATABASE	Protein-protein interactions take place at defined binding interfaces. One protein may bind two or more proteins at different interfaces at the same time. So far it has been commonly accepted that non-overlapping interfaces allow a given protein to bind other proteins simultaneously while no collisions occur between the binding protein structures. To test this assumption, we performed a comprehensive analysis of structural protein interactions to detect potential collisions. Our results did not indicate cases of biologically relevant collisions in the Protein Data Bank of protein structures. However, we discovered a number of collisions that originate from alternative protein conformations or quaternary structures due to different experimental conditions.	[Emig, Dorothea; Sander, Oliver; Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany	Max Planck Society	Emig, D (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany.	mario.albrecht@mpi-inf.mpg.de	Albrecht, Mario/B-6694-2008	Albrecht, Mario/0000-0002-3103-9624	German National Genome Research Network (NGFN); German Research Foundation (DFG) [KFO 129/1-2]; DFG	German National Genome Research Network (NGFN); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Part of this study was financially supported by the German National Genome Research Network (NGFN) and by the German Research Foundation (DFG), contract number KFO 129/1-2. The work was also conducted in the context of the DFG-funded Cluster of Excellence for Multimodal Computing and Interaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Campagna A, 2008, FEBS LETT, V582, P1231, DOI 10.1016/j.febslet.2008.02.019; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Devos D, 2007, CURR OPIN STRUC BIOL, V17, P370, DOI 10.1016/j.sbi.2007.05.011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; KEARSLEY SK, 1989, ACTA CRYSTALLOGR A, V45, P208, DOI 10.1107/S0108767388010128; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Liang J, 1998, PROTEINS, V33, P1; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Prehna G, 2007, ACTA CRYSTALLOGR D, V63, P628, DOI 10.1107/S0907444907010888; Ramirez F, 2010, TRENDS CELL BIOL, V20, P2, DOI 10.1016/j.tcb.2009.11.003; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e19581	10.1371/journal.pone.0019581	http://dx.doi.org/10.1371/journal.pone.0019581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655095	Green Submitted, Green Published, gold			2022-12-27	WOS:000291310600003
J	Wang, XH; Wiens, M; Schroder, HC; Schlossmacher, U; Pisignano, D; Jochum, KP; Muller, WEG				Wang, Xiaohong; Wiens, Matthias; Schroeder, Heinz C.; Schlossmacher, Ute; Pisignano, Dario; Jochum, Klaus Peter; Mueller, Werner E. G.			Evagination of Cells Controls Bio-Silica Formation and Maturation during Spicule Formation in Sponges	PLOS ONE			English	Article							DEMOSPONGE SUBERITES-DOMUNCULA; AXIAL FILAMENT; TISSUE EVAGINATION; WATER CHANNEL; IN-VITRO; BIOSILICA; EXPRESSION; SPICULOGENESIS; AQUAPORIN-8; MEMBRANE	The enzymatic-silicatein mediated formation of the skeletal elements, the spicules of siliceous sponges starts intracellularly and is completed extracellularly. With Suberites domuncula we show that the axial growth of the spicules proceeds in three phases: (I) formation of an axial canal; (II) evagination of a cell process into the axial canal, and (III) assembly of the axial filament composed of silicatein. During these phases the core part of the spicule is synthesized. Silicatein and its substrate silicate are stored in silicasomes, found both inside and outside of the cellular extension within the axial canal, as well as all around the spicule. The membranes of the silicasomes are interspersed by pores of approximate to 2 nm that are likely associated with aquaporin channels which are implicated in the hardening of the initial bio-silica products formed by silicatein. We can summarize the sequence of events that govern spicule formation as follows: differential GENETIC READOUT (of silicatein) -> FRACTAL ASSOCIATION of the silicateins -> EVAGINATION of cells by hydro-mechanical forces into the axial canal -> and finally PROCESSIVE BIO-SILICA POLYCONDENSATION around the axial canal. We termed this process, occurring sequentially or in parallel, BIO-INORGANIC SELF-ORGANIZATION.	[Wang, Xiaohong] Natl Res Ctr Geoanal, Beijing, Peoples R China; [Wang, Xiaohong; Wiens, Matthias; Schroeder, Heinz C.; Schlossmacher, Ute; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, European Res Council Adv Grant Res Grp, Mainz, Germany; [Pisignano, Dario] Univ Salento, Dipartimento Ingn Innovaz, Lecce, Italy; [Pisignano, Dario] CNR Ist Nanosci, Natl Nanotechnol Lab, Lecce, Italy; [Jochum, Klaus Peter] Max Planck Inst Chem, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Max Planck Society	Wang, XH (corresponding author), Natl Res Ctr Geoanal, Beijing, Peoples R China.	wmueller@uni-mainz.de	wang, jie/GRS-0942-2022; Wang, Zhong Lin/E-2176-2011; Müller, W. E. G./AAR-8651-2020; Pisignano, Dario/M-8309-2015; Wang, Xiaohong/AAR-5526-2020	Wang, Zhong Lin/0000-0002-5530-0380; Müller, W. E. G./0000-0002-8223-3689; Pisignano, Dario/0000-0003-3758-5199; Schroder, Heinz C./0000-0003-0992-6427; Wiens, Matthias/0000-0001-9219-0478	European Research Council [268476 BIOSILICA]; German Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [Schr 277/10-1]; European Commission/EUREKA [4289 - SILIBACTS]; International Human Frontier Science Program; European Commission [244967]; Ministry of Land and Resources of the People's Republic of China [201011005-06]; International S & T Cooperation Program of China [2008DFA00980]	European Research Council(European Research Council (ERC)European Commission); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission/EUREKA(European CommissionEuropean Commission Joint Research Centre); International Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Land and Resources of the People's Republic of China; International S & T Cooperation Program of China	W.E.G.M. is a holder of a European Research Council Advanced Investigator Grant (no 268476 BIOSILICA). This work was supported by grants from the German Bundesministerium fur Bildung und Forschung (project "Center of Excellence BIOTECmarin"), the Deutsche Forschungsgemeinschaft (Schr 277/10-1), the European Commission/EUREKA (EUROSTARS, no. 4289 - SILIBACTS), the International Human Frontier Science Program, the European Commission (project no. 244967 -Mem-S Project), the Public Welfare Project of Ministry of Land and Resources of the People's Republic of China (Grant No. 201011005-06) and the International S & T Cooperation Program of China (Grant No. 2008DFA00980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Calamita G, 2001, EUR J CELL BIOL, V80, P711, DOI 10.1078/0171-9335-00210; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; COLBY MW, 1988, J NON-CRYST SOLIDS, V99, P129, DOI 10.1016/0022-3093(88)90465-6; CREIGHTON JR, 1990, C WORKSH TUNGST OTH; DAVIES JA, 2005, MECH MORPHOGENESIS A; Eckert C, 2006, J HISTOCHEM CYTOCHEM, V54, P1031, DOI 10.1369/jhc.5A6903.2006; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Garrone R., 1981, P495; GIERER A, 1977, Q REV BIOPHYS, V10, P529, DOI 10.1017/S0033583500003218; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; IMSIECKE G, 1995, IN VITRO CELL DEV-AN, V31, P528; Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenz B, 1996, CELL SIGNAL, V8, P517, DOI 10.1016/S0898-6568(96)00108-8; Morgan EF, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P3; Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030; Muller WEG, 2007, EUR J CELL BIOL, V86, P473, DOI 10.1016/j.ejcb.2007.06.002; Muller WEG, 2006, SEMIN CELL DEV BIOL, V17, P481, DOI 10.1016/j.semcdb.2006.05.006; Muller WEG, 2010, FEBS J, V277, P1182, DOI 10.1111/j.1742-4658.2009.07552.x; Muller WEG, 2006, MICRON, V37, P107, DOI 10.1016/j.micron.2005.09.003; Muller WEG, 2005, FEBS J, V272, P3838, DOI 10.1111/j.1742-4658.2005.04795.x; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Muller WEG, 1999, MAR ECOL PROG SER, V178, P205, DOI 10.3354/meps178205; Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3; Muller WEG, 1997, TRENDS GLYCOSCI GLYC, V9, P123; Muller WEG, 2011, BIOCH BIOPH IN PRESS; Muller WEG, 2005, ENCY MOL CELL BIOL M, V13, P269; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Perovic-Ottstadt S, 2005, J EXP BIOL, V208, P637, DOI 10.1242/jeb.01428; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; RIPPE B, 1991, KIDNEY INT, V40, P315, DOI 10.1038/ki.1991.216; Scala F, 2008, BIOMASS BIOENERG, V32, P252, DOI 10.1016/j.biombioe.2007.09.009; Schlossmacher U, 2011, FEBS J, V278, P1145, DOI 10.1111/j.1742-4658.2011.08040.x; Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200; Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h; Schroder HC, 2007, J STRUCT BIOL, V159, P325, DOI 10.1016/j.jsb.2007.01.007; Schroder HC, 2012, SILICON-NETH, V4, P33, DOI 10.1007/s12633-010-9057-4; SCHWAB DW, 1971, BIOL BULL, V140, P125, DOI 10.2307/1540032; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; SHORE RE, 1972, BIOL BULL, V143, P689, DOI 10.2307/1540191; Simpson T., 1984, CELL BIOL SPONGES; Simpson TL, SILICON SILICEOUS ST; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Uriz MJ, 2000, CELL TISSUE RES, V301, P299, DOI 10.1007/s004410000234; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Weissenfels N, 1977, Zoologische Jb (Anat), V98, P355; Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002	50	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20523	10.1371/journal.pone.0020523	http://dx.doi.org/10.1371/journal.pone.0020523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655099	gold, Green Published, Green Submitted			2022-12-27	WOS:000291310600011
J	Gilet, E; Diard, J; Bessiere, P				Gilet, Estelle; Diard, Julien; Bessiere, Pierre			Bayesian Action-Perception Computational Model: Interaction of Production and Recognition of Cursive Letters	PLOS ONE			English	Article							VISUAL-PERCEPTION; MOVEMENT; INFERENCE; INFORMATION; PREDICTION; NOISE	In this paper, we study the collaboration of perception and action representations involved in cursive letter recognition and production. We propose a mathematical formulation for the whole perception-action loop, based on probabilistic modeling and Bayesian inference, which we call the Bayesian Action-Perception (BAP) model. Being a model of both perception and action processes, the purpose of this model is to study the interaction of these processes. More precisely, the model includes a feedback loop from motor production, which implements an internal simulation of movement. Motor knowledge can therefore be involved during perception tasks. In this paper, we formally define the BAP model and show how it solves the following six varied cognitive tasks using Bayesian inference: i) letter recognition (purely sensory), ii) writer recognition, iii) letter production (with different effectors), iv) copying of trajectories, v) copying of letters, and vi) letter recognition (with internal simulation of movements). We present computer simulations of each of these cognitive tasks, and discuss experimental predictions and theoretical developments.	[Gilet, Estelle] CNRS, Estelle Gilet Lab Informat Grenoble, INRIA Rhone Alpes, Montbonnot St Martin, France; [Diard, Julien] Univ Pierre Mendes France, Julien Diard Lab Psychol & NeuroCognit, CNRS, Grenoble, France; [Bessiere, Pierre] CNRS, Pierre Bessiere Lab Informat Grenoble, INRIA Rhone Alpes, Montbonnot St Martin, France; [Bessiere, Pierre] Coll France, CNRS, Lab Physiol Percept & Act, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Gilet, E (corresponding author), CNRS, Estelle Gilet Lab Informat Grenoble, INRIA Rhone Alpes, Montbonnot St Martin, France.	Julien.Diard@upmf-grenoble.fr		Diard, Julien/0000-0003-0673-477X; Bessiere, Pierre/0000-0002-8620-2505	BACS [FP6-IST-027140]	BACS	This work has been supported by the BACS European project (FP6-IST-027140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANQUETIL E, 1995, TRAIT SIGNAL, V12, P561; Artieres T, 2007, IEEE T PATTERN ANAL, V29, P205, DOI 10.1109/TPAMI.2007.38; Aubury M, 1996, J VLSI SIG PROCESS S, V12, P35, DOI 10.1007/BF00936945; Bengio Y., 1995, Advances in Neural Information Processing Systems 7, P427; Bernstein N, 1967, COORDINATION REGULAT; Berthoz A., 2000, BRAINS SENSE MOVEMEN; Bessiere P, 2008, SPRINGER TRAC ADV RO, V46, P1; BESSIERE P, 2004, Patent No. 2004013714; Bessiere P, 2003, RR4730 INRIA; CALVOMERINO B, 2004, ACTION OBSERVATION A; Colas F, 2007, BIOL CYBERN, V97, P461, DOI 10.1007/s00422-007-0183-z; Colas F, 2010, ACTA BIOTHEOR, V58, P191, DOI 10.1007/s10441-010-9101-1; Colas F, 2009, BIOL CYBERN, V100, P203, DOI 10.1007/s00422-009-0292-y; COOPER GF, 1990, ARTIF INTELL, V42, P393, DOI 10.1016/0004-3702(90)90060-D; COOPER LA, 1973, MEM COGNITION, V1, P246, DOI 10.3758/BF03198104; CRETTEZ JP, 1998, RECONNAISSANCE ECRIT; Daunizeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015555; Desmurget M, 1997, J NEUROPHYSIOL, V77, P1644, DOI 10.1152/jn.1997.77.3.1644; DIARD J, 2009, P INT C COGN MOD ICC, P204; EDELMAN S, 1987, BIOL CYBERN, V57, P25, DOI 10.1007/BF00318713; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; GILET E, 2009, THESIS U JOSEPH FOUR; Guigon E, 2008, EUR J NEUROSCI, V27, P1003, DOI 10.1111/j.1460-9568.2008.06028.x; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; James KH, 2009, J EXP PSYCHOL GEN, V138, P416, DOI 10.1037/a0015836; Jaynes E.T., 2003, PROBABILITY THEORY L; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JONES M, BEHAV BRAIN IN PRESS; Kandel S, 2000, PERCEPTION, V29, P953, DOI 10.1068/p2864; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knoblich G, 2002, Q J EXP PSYCHOL-A, V55, P1027, DOI 10.1080/02724980143000631; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; Lebeltel O, 2004, AUTON ROBOT, V16, P49, DOI 10.1023/B:AURO.0000008671.38949.43; Li JL, 2003, VIS COGN, V10, P537, DOI 10.1080/13506280244000195; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; LIBERMAN AM, 1957, J ACOUST SOC AM, V29, P117, DOI 10.1121/1.1908635; Longcamp M, 2006, NEUROIMAGE, V33, P681, DOI 10.1016/j.neuroimage.2006.06.042; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Marr D., 1982, VISION COMPUTATIONAL; Mekhnacha Kamel, 2007, Revue d'Intelligence Artificielle, V21, P295, DOI 10.3166/ria.21.295-332; Meulenbroek RGJ, 1996, PSYCHOL RES-PSYCH FO, V59, P64, DOI 10.1007/BF00419834; Orliaguet JP, 1997, PERCEPTION, V26, P905, DOI 10.1068/p260905; PAILLARD J, 1990, ECRITURE CERVEAU OEI; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Russell S. J, 1995, SER PRENTICE HALL SE; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; SCHOMAKER L, 1993, P 6 INT C HANDWR DRA, V4, P19; SCHWARTZ JL, 2002, PHONETICS PHONOLOGY; Serkhane J, 2005, INTERACTION STUDIES, V6, P253, DOI [10.1007/978-3-540-79007-5_14, DOI 10.1007/978-3-540-79007-5_14, DOI 10.1075/IS.6.2.06SER]; SERRATRICE G, 1993, ECRITURE CERVEAU; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Siciliano B, 2009, ADV TXB CONTR SIG PR, P1; Thrun S., 2005, PROBABILISTIC ROBOTI; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; VUORI V, 2002, THESIS HELSINKI U T; WADA Y, 1995, BIOL CYBERN, V73, P15, DOI 10.1007/BF00199052; WADA Y, 1995, BIOL CYBERN, V73, P3, DOI 10.1007/BF00199051; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; WRIGHT CE, 1990, ATTENTION PERFORM, P294; YACOUBI AE, 1996, THESIS U RENNES, P1	69	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20387	10.1371/journal.pone.0020387	http://dx.doi.org/10.1371/journal.pone.0020387			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	773LX	21674043	gold, Green Submitted, Green Published			2022-12-27	WOS:000291309900016
J	Briggs, J; Paoloni, M; Chen, QR; Wen, XY; Khan, J; Khanna, C				Briggs, Joseph; Paoloni, Melissa; Chen, Qing-Rong; Wen, Xinyu; Khan, Javed; Khanna, Chand			A Compendium of Canine Normal Tissue Gene Expression	PLOS ONE			English	Article							MICROARRAY; PROFILES; MOUSE; MODEL; DOG; TRANSCRIPTOMES; ANNOTATION; BLAST2GO; HEALTHY	Background: Our understanding of disease is increasingly informed by changes in gene expression between normal and abnormal tissues. The release of the canine genome sequence in 2005 provided an opportunity to better understand human health and disease using the dog as clinically relevant model. Accordingly, we now present the first genome-wide, canine normal tissue gene expression compendium with corresponding human cross-species analysis. Methodology/Principal Findings: The Affymetrix platform was utilized to catalogue gene expression signatures of 10 normal canine tissues including: liver, kidney, heart, lung, cerebrum, lymph node, spleen, jejunum, pancreas and skeletal muscle. The quality of the database was assessed in several ways. Organ defining gene sets were identified for each tissue and functional enrichment analysis revealed themes consistent with known physio-anatomic functions for each organ. In addition, a comparison of orthologous gene expression between matched canine and human normal tissues uncovered remarkable similarity. To demonstrate the utility of this dataset, novel canine gene annotations were established based on comparative analysis of dog and human tissue selective gene expression and manual curation of canine probeset mapping. Public access, using infrastructure identical to that currently in use for human normal tissues, has been established and allows for additional comparisons across species. Conclusions/Significance: These data advance our understanding of the canine genome through a comprehensive analysis of gene expression in a diverse set of tissues, contributing to improved functional annotation that has been lacking. Importantly, it will be used to inform future studies of disease in the dog as a model for human translational research and provides a novel resource to the community at large.	[Briggs, Joseph; Khanna, Chand] NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Paoloni, Melissa; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chen, Qing-Rong; Wen, Xinyu; Khan, Javed] NCI, Oncogenom Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Briggs, J (corresponding author), NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	khannac@mail.nih.gov	Khan, Javed/P-9157-2014		NATIONAL CANCER INSTITUTE [ZIGBC010569, ZIASC010366, ZIABC011002] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fernandez-Suarez XM, 2007, CURR PROTOC BIOINFOR; Gallardo-Arrieta F, 2010, PROSTATE, V70, P1402, DOI 10.1002/pros.21175; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holzwarth JA, 2005, J HERED, V96, P817, DOI 10.1093/jhered/esi130; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Khan Javed, 2003, Pharmacogenomics, V4, P245, DOI 10.1517/phgs.4.3.245.22696; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Klopfleisch R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-618; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; O'Donoghue LE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-506; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Paoloni MC, 2007, VET CLIN N AM-SMALL, V37, P1023, DOI 10.1016/j.cvsm.2007.08.003; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thomas R, 2005, GENOME RES, V15, P1831, DOI 10.1101/gr.3825705; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Zheng JY, 2009, CIRCULATION, V119, P2086, DOI 10.1161/CIRCULATIONAHA.108.826230	39	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e17107	10.1371/journal.pone.0017107	http://dx.doi.org/10.1371/journal.pone.0017107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655323	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600001
J	Daltrozzo, J; Signoret, C; Tillmann, B; Perrin, F				Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien			Subliminal Semantic Priming in Speech	PLOS ONE			English	Article							UNCONSCIOUS PERCEPTION; SENSORY DISCRIMINATION; RESPONSE SELECTION; LEXICAL DECISION; MASKED STIMULI; VISUAL-SEARCH; WORD; POTENTIALS; ACTIVATION; PSYCHOPHYSICS	Numerous studies have reported subliminal repetition and semantic priming in the visual modality. We transferred this paradigm to the auditory modality. Prime awareness was manipulated by a reduction of sound intensity level. Uncategorized prime words (according to a post-test) were followed by semantically related, unrelated, or repeated target words (presented without intensity reduction) and participants performed a lexical decision task (LDT). Participants with slower reaction times in the LDT showed semantic priming (faster reaction times for semantically related compared to unrelated targets) and negative repetition priming (slower reaction times for repeated compared to semantically related targets). This is the first report of semantic priming in the auditory modality without conscious categorization of the prime.	[Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien] CNRS, UMR5292, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, Lyon, France; [Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien] INSERM, U1028, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, F-69008 Lyon, France; [Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien] Univ Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Daltrozzo, J (corresponding author), CNRS, UMR5292, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, Lyon, France.	jdaltrozzo@olfac.univ-lyon1.fr	Signoret, Carine/G-1794-2011	Signoret, Carine/0000-0001-8903-7931; , Fabien/0000-0002-1444-3414	French National Agency for Research [ANR-07-JCJC-0095 - CSD 8]	French National Agency for Research(French National Research Agency (ANR))	The work was supported by the French National Agency for Research (ANR-07-JCJC-0095 - CSD 8, www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RL, 2000, PSYCHOL SCI, V11, P118, DOI 10.1111/1467-9280.00226; American National Standards Institute, 2004, AM NAT STAND I S3 6; ANDERSON JE, 1995, PSYCHOPHYSIOLOGY, V32, P177, DOI 10.1111/j.1469-8986.1995.tb03310.x; BEATTIE RC, 1986, OTOL NEUROTOL, V7, P60; Bowman H, 2006, VIS COGN, V13, P401, DOI 10.1080/13506280444000823; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; Dell'Acqua R, 1999, COGNITION, V73, pB1, DOI 10.1016/S0010-0277(99)00049-9; Draine SC, 1998, J EXP PSYCHOL GEN, V127, P286, DOI 10.1037/0096-3445.127.3.286; DUPOUX E, 1993, COGNITIVE MODELS OF SPEECH PROCESSING: THE SECOND SPERLONGA MEETING, P81; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; FERRAND L, 1992, Q J EXP PSYCHOL-A, V45, P353, DOI 10.1080/02724989208250619; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; GOODIN DS, 1987, CAN J NEUROL SCI, V14, P642; GOODIN DS, 1990, J NEUROPHYSIOL, V64, P1270, DOI 10.1152/jn.1990.64.4.1270; Green D. M., 1974, SIGNAL DETECTION THE; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; GREENWALD AG, 1995, J EXP PSYCHOL GEN, V124, P22, DOI 10.1037/0096-3445.124.1.22; GRICE GR, 1982, J EXPT PSYCHOL GEN, V11, P135; Haase SJ, 2001, AM J PSYCHOL, V114, P439, DOI 10.2307/1423690; HERDMAN CM, 1994, J EXP PSYCHOL HUMAN, V20, P575, DOI 10.1037/0096-1523.20.3.575; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOWELL D, 1998, MEETHODES STAT SCI H; HUMPHREYS GW, 1988, J EXP PSYCHOL HUMAN, V14, P203, DOI 10.1037/0096-1523.14.2.203; HUMPHREYS GW, 1983, COGNITIVE PSYCHOL, V15, P151, DOI 10.1016/0010-0285(83)90008-7; JOKEIT H, 1994, P NATL ACAD SCI USA, V91, P6339, DOI 10.1073/pnas.91.14.6339; Kahan TA, 2000, J EXP PSYCHOL LEARN, V26, P1392, DOI 10.1037/0278-7393.26.6.1392; KEWLEYPORT D, 1991, J ACOUST SOC AM, V89, P820, DOI 10.1121/1.1894642; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Klapp ST, 2002, J EXP PSYCHOL GEN, V131, P255, DOI 10.1037//0096-3445.131.2.255; Kouider S, 2005, PSYCHOL SCI, V16, P617, DOI 10.1111/j.1467-9280.2005.01584.x; Kouider S, 2004, PSYCHOL SCI, V15, P75, DOI 10.1111/j.0963-7214.2004.01502001.x; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kouider S, 2010, NEUROIMAGE, V49, P922, DOI 10.1016/j.neuroimage.2009.08.043; Kouider S, 2009, EXP PSYCHOL, V56, P418, DOI 10.1027/1618-3169.56.6.418; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; KRUGER D, 2010, CONSCIOUSNE IN PRESS; LUCE RD, 1978, PERCEPT PSYCHOPHYS, V23, P363, DOI 10.3758/BF03204138; Macmillan N. A., 1991, DETECTION THEORY USE; MACMILLAN NA, 1986, BEHAV BRAIN SCI, V9, P38, DOI 10.1017/S0140525X00021427; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P238, DOI 10.1016/0010-0285(83)90010-5; Mattler U, 2007, J EXP PSYCHOL HUMAN, V33, P83, DOI 10.1037/0096-1523.33.1.83; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; MERIKLE PM, 1990, J EXP PSYCHOL HUMAN, V16, P574, DOI 10.1037/0096-1523.16.3.574; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; MILNER J, 1982, J EXPT PSYCHOL HUMAN, V8, P273; Neri P, 2010, PSYCHON B REV, V17, P802, DOI 10.3758/PBR.17.6.802; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ORTIZ T, 1993, J NEUROPHYSIOL, V69, P211; Reingold EM, 2004, CONSCIOUS COGN, V13, P117, DOI 10.1016/j.concog.2003.11.002; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; SCHEERER E, 1973, PSYCHOL FORSCH, V36, P71, DOI 10.1007/BF00424655; Schiller NO, 1998, J MEM LANG, V39, P484, DOI 10.1006/jmla.1998.2577; Schiller NO, 2000, J EXP PSYCHOL LEARN, V26, P512, DOI 10.1037//0278-7393.26.2.512; Snodgrass M, 2004, PERCEPT PSYCHOPHYS, V66, P888, DOI 10.3758/BF03194982; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; URBAN MJ, 1992, PERCEPT MOTOR SKILL, V74, P515, DOI 10.2466/PMS.74.2.515-541; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Wundt W. M., 1913, GRUNDRISS PSYCHOL	60	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20273	10.1371/journal.pone.0020273	http://dx.doi.org/10.1371/journal.pone.0020273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655277	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600034
J	Narayanan, A; Popova, T; Turell, M; Kidd, J; Chertow, J; Popov, SG; Bailey, C; Kashanchi, F; Kehn-Hall, K				Narayanan, Aarthi; Popova, Taissia; Turell, Michael; Kidd, Jessica; Chertow, Jessica; Popov, Serguei G.; Bailey, Charles; Kashanchi, Fatah; Kehn-Hall, Kylene			Alteration in Superoxide Dismutase 1 Causes Oxidative Stress and p38 MAPK Activation Following RVFV Infection	PLOS ONE			English	Article							RIFT-VALLEY FEVER; AMYOTROPHIC-LATERAL-SCLEROSIS; NONSTRUCTURAL PROTEIN NSS; SIGNALING PATHWAY; INFLUENZA-VIRUS; GREEN TEA; TRANSCRIPTION; DISEASE; CELLS; REPLICATION	Rift Valley fever (RVF) is a zoonotic disease caused by Rift Valley fever virus (RVFV). RVFV is a category A pathogen that belongs to the genus Phlebovirus, family Bunyaviridae. Understanding early host events to an infectious exposure to RVFV will be of significant use in the development of effective therapeutics that not only control pathogen multiplication, but also contribute to cell survival. In this study, we have carried out infections of human cells with a vaccine strain (MP12) and virulent strain (ZH501) of RVFV and determined host responses to viral infection. We demonstrate that the cellular antioxidant enzyme superoxide dismutase 1 (SOD1) displays altered abundances at early time points following exposure to the virus. We show that the enzyme is down regulated in cases of both a virulent (ZH501) and a vaccine strain (MP12) exposure. Our data demonstrates that the down regulation of SOD1 is likely to be due to post transcriptional processes and may be related to up regulation of TNF alpha following infection. We also provide evidence for extensive oxidative stress in the MP12 infected cells. Concomitantly, there is an increase in the activation of the p38 MAPK stress response, which our earlier published study demonstrated to be an essential cell survival strategy. Our data suggests that the viral anti-apoptotic protein NSm may play a role in the regulation of the cellular p38 MAPK response. Alterations in the host protein SOD1 following RVFV infection appears to be an early event that occurs in multiple cell types. Activation of the cellular stress response p38 MAPK pathway can be observed in all cell types tested. Our data implies that maintaining oxidative homeostasis in the infected cells may play an important role in improving survival of infected cells.	[Narayanan, Aarthi; Popova, Taissia; Chertow, Jessica; Popov, Serguei G.; Bailey, Charles; Kashanchi, Fatah; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Turell, Michael] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Kidd, Jessica] MDA ALS Res Ctr, Neurol Inst, New York, NY USA	George Mason University	Narayanan, A (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	fkashanc@gmu.edu	Turell, Michael/ABE-1826-2020; Kehn-Hall, Kylene/I-5752-2013	Turell, Michael/0000-0003-1902-7740; Kehn-Hall, Kylene/0000-0001-8036-7213	US Department of Energy [DE-SC0001599]	US Department of Energy(United States Department of Energy (DOE))	This work was funded by US Department of Energy grant (DE-SC0001599) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo-Salem S, 2006, ANN NY ACAD SCI, V1081, P240, DOI 10.1196/annals.1373.028; Afonso V, 2006, FREE RADICAL BIO MED, V41, P709, DOI 10.1016/j.freeradbiomed.2006.05.014; Agbottah E, 2005, J BIOL CHEM, V280, P3029, DOI 10.1074/jbc.M406435200; Agbottah Emmanuel, 2008, AIDS Res Ther, V5, P12, DOI 10.1186/1742-6405-5-12; Aliev G, 2011, CNS NEUROL DISORD-DR, V10, P147, DOI 10.2174/187152711794480492; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; Fagbo SF, 2002, ANN NY ACAD SCI, V969, P201, DOI 10.1111/j.1749-6632.2002.tb04378.x; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; Guendel I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-7; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.6035; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Kanthasamy A, 2010, NEUROTOXICOLOGY, V31, P555, DOI 10.1016/j.neuro.2009.12.003; Kim YJ, 2010, ANTIVIR RES, V88, P227, DOI 10.1016/j.antiviral.2010.08.016; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; LaBeaud AD, 2007, AM J TROP MED HYG, V76, P795, DOI 10.4269/ajtmh.2007.76.795; LaBeaud AD, 2010, CURR OPIN INFECT DIS, V23, P403, DOI 10.1097/QCO.0b013e32833c3da6; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee BC, 2011, J CELL BIOCHEM, V112, P118, DOI 10.1002/jcb.22896; Lee HP, 2010, EXPERT REV NEUROTHER, V10, P1201, DOI 10.1586/ERN.10.74; Lewinska A, 2010, REDOX REP, V15, P87, DOI 10.1179/174329210X12650506623366; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Muyderman H, 2009, NEUROCHEM RES, V34, P1847, DOI 10.1007/s11064-009-9974-z; Nakatsue T, 1998, BIOCHEM BIOPH RES CO, V253, P59, DOI 10.1006/bbrc.1998.9724; Onizuka S, 2011, J ANESTH, V25, P229, DOI 10.1007/s00540-010-1079-y; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Perry JJP, 2010, ADV EXP MED BIOL, V685, P9; Peviani M, 2010, CNS NEUROL DISORD-DR, V9, P491, DOI 10.2174/187152710791556096; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Sang R C, 2001, East Afr Med J, V78, P655; Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65; Simula MP, 2010, PROTEOM CLIN APPL, V4, P782, DOI 10.1002/prca.201000049; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Vigilanza P, 2008, CELL MOL LIFE SCI, V65, P991, DOI 10.1007/s00018-008-7526-3; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06; Zhu CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003716	54	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20354	10.1371/journal.pone.0020354	http://dx.doi.org/10.1371/journal.pone.0020354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655261	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600051
J	Wolff, JN; White, DJ; Woodhams, M; White, HE; Gemmell, NJ				Wolff, Jonci N.; White, Daniel J.; Woodhams, Michael; White, Helen E.; Gemmell, Neil J.			The Strength and Timing of the Mitochondrial Bottleneck in Salmon Suggests a Conserved Mechanism in Vertebrates	PLOS ONE			English	Article							RANDOM GENETIC DRIFT; RAPID SEGREGATION; PURIFYING SELECTION; POINT MUTATIONS; CONTROL REGION; DNA MUTATIONS; MTDNA; HETEROPLASMY; RECOMBINATION; INHERITANCE	In most species mitochondrial DNA (mtDNA) is inherited maternally in an apparently clonal fashion, although how this is achieved remains uncertain. Population genetic studies show not only that individuals can harbor more than one type of mtDNA (heteroplasmy) but that heteroplasmy is common and widespread across a diversity of taxa. Females harboring a mixture of mtDNAs may transmit varying proportions of each mtDNA type (haplotype) to their offspring. However, mtDNA variants are also observed to segregate rapidly between generations despite the high mtDNA copy number in the oocyte, which suggests a genetic bottleneck acts during mtDNA transmission. Understanding the size and timing of this bottleneck is important for interpreting population genetic relationships and for predicting the inheritance of mtDNA based disease, but despite its importance the underlying mechanisms remain unclear. Empirical studies, restricted to mice, have shown that the mtDNA bottleneck could act either at embryogenesis, oogenesis or both. To investigate whether the size and timing of the mitochondrial bottleneck is conserved between distant vertebrates, we measured the genetic variance in mtDNA heteroplasmy at three developmental stages (female, ova and fry) in chinook salmon and applied a new mathematical model to estimate the number of segregating units (N-e) of the mitochondrial bottleneck between each stage. Using these data we estimate values for mtDNA Ne of 88.3 for oogenesis, and 80.3 for embryogenesis. Our results confirm the presence of a mitochondrial bottleneck in fish, and show that segregation of mtDNA variation is effectively complete by the end of oogenesis. Considering the extensive differences in reproductive physiology between fish and mammals, our results suggest the mechanism underlying the mtDNA bottleneck is conserved in these distant vertebrates both in terms of it magnitude and timing. This finding may lead to improvements in our understanding of mitochondrial disorders and population interpretations using mtDNA data.	[Wolff, Jonci N.; White, Daniel J.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Canterbury, New Zealand; [Wolff, Jonci N.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [White, Daniel J.; Gemmell, Neil J.] Univ Otago, Ctr Reprod & Genom, Dept Anat & Struct Biol, Dunedin, New Zealand; [Woodhams, Michael] Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia; [White, Helen E.] Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England	University of Canterbury; University of New South Wales Sydney; University of Otago; University of Sydney; Salisbury District Hospital	Wolff, JN (corresponding author), Univ Canterbury, Sch Biol Sci, Canterbury, New Zealand.	neil.gemmell@otago.ac.nz	Gemmell, Neil J/C-6774-2009; Woodhams, Michael/J-7529-2014; Wolff, Jonci/M-4639-2017	Gemmell, Neil J/0000-0003-0671-3637; Woodhams, Michael/0000-0002-5204-4123; White, Daniel/0000-0002-8967-5201; Wolff, Jonci/0000-0002-8809-5010	Royal Society of New Zealand [UOC402]; NIWA Silverstream Hatchery team	Royal Society of New Zealand(Royal Society of New Zealand); NIWA Silverstream Hatchery team	This study was funded by a grant to NJG from the Royal Society of New Zealand, Marsden Fund, Grant UOC402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NIWA Silverstream Hatchery team for their support, advice and use of their facilities. For valuable comments, we thank Bill Ballard, Alan Wilton, Lou Puslednik and two annonymous reviewers. We also thank Robbie McPhee for preparing Figure 1. Permissions for this work were covered by ERMA decision GMD00066, MAF permit # 2003018889, the University of Canterbury animal ethics board (permission # 2002/01), and the Fish and Game council of New Zealand.	Aranishi F, 2006, J SCI FOOD AGR, V86, P425, DOI 10.1002/jsfa.2370; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bergstrom CT, 1998, GENETICS, V149, P2135; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Gemmell NJ, 1996, MOL BIOL EVOL, V13, P798, DOI 10.1093/oxfordjournals.molbev.a025640; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; HARRISON RG, 1985, SCIENCE, V228, P1446, DOI 10.1126/science.228.4706.1446; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hendy MD, 2009, BIOL LETTERS, V5, P397, DOI 10.1098/rsbl.2009.0104; Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; HOWELL N, 1992, HUM GENET, V90, P117; HUET M, 1970, BREEDING CULTIVATION; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; KOEHLER CM, 1991, GENETICS, V129, P247; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Lynch M, 1998, GENETICA, V102-3, P29, DOI 10.1023/A:1017022522486; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; MCINTYRE JD, 1991, PACIFIC SALMON CULTU; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066; RAND DM, 1986, GENETICS, V114, P955; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Samuels DC, 2010, NAT GENET, V42, P471, DOI 10.1038/ng0610-471; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Slate J, 2004, TRENDS ECOL EVOL, V19, P561, DOI 10.1016/j.tree.2004.09.001; Smith Lawrence C, 2002, Reprod Biomed Online, V4, P248; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Taylor JS, 2002, J FISH BIOL, V60, P1346, DOI 10.1006/jfbi.2002.1935; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; White DJ, 2009, MOL BIOL EVOL, V26, P1435, DOI 10.1093/molbev/msp073; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488; WILKINSON GS, 1991, GENETICS, V128, P607; Wolff JN, 2008, HEREDITY, V101, P429, DOI 10.1038/hdy.2008.74; Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007; Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023	55	27	27	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20522	10.1371/journal.pone.0020522	http://dx.doi.org/10.1371/journal.pone.0020522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655224	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000291097600087
J	Zhang, W; Cai, HC; Li, FF; Xi, YB; Ma, X; Yan, YB				Zhang, Wang; Cai, Hong-Chen; Li, Fei-Feng; Xi, Yi-Bo; Ma, Xu; Yan, Yong-Bin			The Congenital Cataract-Linked G61C Mutation Destabilizes gamma D-Crystallin and Promotes Non-Native Aggregation	PLOS ONE			English	Article							TRYPTOPHAN FLUORESCENCE-SPECTRA; LOG-NORMAL COMPONENTS; MISSENSE MUTATION; CRYGD MUTATION; CORALLIFORM CATARACT; NUCLEAR CATARACT; ALPHA-CRYSTALLIN; CHINESE FAMILY; GENE CRYGD; LENS CRYSTALLINS	gamma D-crystallin is one of the major structural proteins in human eye lens. The solubility and stability of gamma D-crystallin play a crucial role in maintaining the optical properties of the lens during the life span of an individual. Previous study has shown that the inherited mutation G61C results in autosomal dominant congenital cataract. In this research, we studied the effects of the G61C mutation on gamma D-crystallin structure, stability and aggregation via biophysical methods. CD, intrinsic and extrinsic fluorescence spectroscopy indicated that the G61C mutation did not affect the native structure of gamma D-crystallin. The stability of gamma D-crystallin against heat- or GdnHCl-induced denaturation was significantly decreased by the mutation, while no influence was observed on the acid-induced unfolding. The mutation mainly affected the transition from the native state to the intermediate but not that from the intermediate to the unfolded or aggregated states. At high temperatures, both proteins were able to form aggregates, and the aggregation of the mutant was much more serious than the wild type protein at the same temperature. At body temperature and acidic conditions, the mutant was more prone to form amyloid-like fibrils. The aggregation-prone property of the mutant was not altered by the addition of reductive reagent. These results suggested that the decrease in protein stability followed by aggregation-prone property might be the major cause in the hereditary cataract induced by the G61C mutation.	[Zhang, Wang; Cai, Hong-Chen; Xi, Yi-Bo; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Li, Fei-Feng; Ma, Xu] Natl Res Inst Family Planning, Dept Genet, Beijing, Peoples R China; [Li, Fei-Feng; Ma, Xu] Tsinghua Univ, Peking Union Med Coll, Beijing 100084, Peoples R China; [Xi, Yi-Bo] Lanzhou Univ, Inst Biophys, Lanzhou 730000, Peoples R China	Tsinghua University; National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Lanzhou University	Zhang, W (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	genetic@263.net.cn; ybyan@tsinghua.edu.cn	Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558; Cai, Hongchen/0000-0002-5921-5773; xi, yibo/0000-0002-9709-2698	National Natural Science Foundation of China [30970559]; National Basic Research Program of China [2010CB912402]; National Infrastructure Program of Chinese Genetic Resources [2006DKA21300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Infrastructure Program of Chinese Genetic Resources	This work was supported by the National Natural Science Foundation of China (30970559), National Basic Research Program of China (2010CB912402), and National Infrastructure Program of Chinese Genetic Resources (2006DKA21300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarza J, 2009, BIOCHEMISTRY-US, V48, P7608, DOI 10.1021/bi9007116; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Banh A, 2006, PROG RETIN EYE RES, V25, P189, DOI 10.1016/j.preteyeres.2005.10.001; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAKENHOFF RH, 1990, J MOL BIOL, V216, P519, DOI 10.1016/0022-2836(90)90380-5; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Devi RR, 2008, MOL VIS, V14, P1157; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Graw J, 1997, BIOL CHEM, V378, P1331; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gu F, 2006, MOL VIS, V12, P26; Gu JZ, 2005, MOL VIS, V11, P971; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; He GJ, 2009, FEBS J, V276, P2849, DOI 10.1111/j.1742-4658.2009.07008.x; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Khan AO, 2009, MOL VIS, V15, P1407; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; KUSZAK JR, 1984, SCAN ELECTRON MICROS, P1369; Li FF, 2008, MOL VIS, V14, P378; Mackay DW, 2004, MOL VIS, V10, P155; McManus JJ, 2007, P NATL ACAD SCI USA, V104, P16856, DOI 10.1073/pnas.0707412104; Messina-Baas O, 2006, MOL VIS, V12, P995; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Pang M, 2010, BBA-PROTEINS PROTEOM, V1804, P948, DOI 10.1016/j.bbapap.2010.01.001; Papanikolopoulou K, 2008, MOL VIS, V14, P81; PIATIGORSKY J, 1989, FASEB J, V3, P1933, DOI 10.1096/fasebj.3.8.2656357; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Roshan M, 2010, MOL VIS, V16, P887; Santana A, 2009, MOL VIS, V15, P793; Shentu XC, 2004, MOL VIS, V10, P233; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Su JT, 2007, BIOPHYS J, V92, P578, DOI 10.1529/biophysj.106.093666; Tholozan FMD, 2007, INT J BIOCHEM CELL B, V39, P1754, DOI 10.1016/j.biocel.2007.06.021; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; WANG KY, 1994, J BIOL CHEM, V269, P13601; Xu WZ, 2004, CHINESE MED J-PEKING, V117, P727; Zhang LY, 2007, MOL VIS, V13, P2096; Zhang LY, 2009, MOL VIS, V15, P1521; ZINN K M, 1973, International Ophthalmology Clinics, V13, P143, DOI 10.1097/00004397-197301330-00012	54	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20564	10.1371/journal.pone.0020564	http://dx.doi.org/10.1371/journal.pone.0020564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655238	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600100
J	Amankwah, EK; Wang, QG; Schildkraut, JM; Tsai, YY; Ramus, SJ; Fridley, BL; Beesley, J; Johnatty, SE; Webb, PM; Chenevix-Trench, G; Dale, LC; Lambrechts, D; Amant, F; Despierre, E; Vergote, I; Gayther, SA; Gentry-Maharaj, A; Menon, U; Chang-Claude, J; Wang-Gohrke, S; Anton-Culver, H; Ziogas, A; Dork, T; Durst, M; Antonenkova, N; Bogdanova, N; Brown, R; Flanagan, JM; Kaye, SB; Paul, J; Butzow, R; Nevanlinna, H; Campbell, I; Eccles, DM; Karlan, BY; Gross, J; Walsh, C; Pharoah, PDP; Song, HL; Kjaer, SK; Hogdall, E; Hogdall, C; Lundvall, L; Nedergaard, L; Kiemeney, LALM; Massuger, LFAG; van Altena, AM; Vermeulen, SHHM; Le, ND; Brooks-Wilson, A; Cook, LS; Phelan, CM; Cunningham, JM; Vachon, CM; Vierkant, RA; Iversen, ES; Berchuck, A; Goode, EL; Sellers, TA; Kelemen, LE				Amankwah, Ernest K.; Wang, Qinggang; Schildkraut, Joellen M.; Tsai, Ya-Yu; Ramus, Susan J.; Fridley, Brooke L.; Beesley, Jonathan; Johnatty, Sharon E.; Webb, Penelope M.; Chenevix-Trench, Georgia; Dale, Laura C.; Lambrechts, Diether; Amant, Frederic; Despierre, Evelyn; Vergote, Ignace; Gayther, Simon A.; Gentry-Maharaj, Aleksandra; Menon, Usha; Chang-Claude, Jenny; Wang-Gohrke, Shan; Anton-Culver, Hoda; Ziogas, Argyrios; Doerk, Thilo; Duerst, Matthias; Antonenkova, Natalia; Bogdanova, Natalia; Brown, Robert; Flanagan, James M.; Kaye, Stanley B.; Paul, James; Butzow, Ralf; Nevanlinna, Heli; Campbell, Ian; Eccles, Diana M.; Karlan, Beth Y.; Gross, Jenny; Walsh, Christine; Pharoah, Paul D. P.; Song, Honglin; Kjaer, Susanne Kruger; Hogdall, Estrid; Hogdall, Claus; Lundvall, Lene; Nedergaard, Lotte; Kiemeney, Lambertus A. L. M.; Massuger, Leon F. A. G.; van Altena, Anne M.; Vermeulen, Sita H. H. M.; Le, Nhu D.; Brooks-Wilson, Angela; Cook, Linda S.; Phelan, Catherine M.; Cunningham, Julie M.; Vachon, Celine M.; Vierkant, Robert A.; Iversen, Edwin S.; Berchuck, Andrew; Goode, Ellen L.; Sellers, Thomas A.; Kelemen, Linda E.		Australian Ovarian Canc Study Grp	Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENOME-WIDE ASSOCIATION; TGF-BETA; ORAL-CONTRACEPTIVES; EXPRESSION; DECORIN; RISK; TRENDS; INHIBITION; MORTALITY	Alterations in stromal tissue components can inhibit or promote epithelial tumorigenesis. Decorin (DCN) and lumican (LUM) show reduced stromal expression in serous epithelial ovarian cancer (sEOC). We hypothesized that common variants in these genes associate with risk. Associations with sEOC among Caucasians were estimated with odds ratios (OR) among 397 cases and 920 controls in two U. S.-based studies (discovery set), 436 cases and 1,098 controls in Australia (replication set 1) and a consortium of 15 studies comprising 1,668 cases and 4,249 controls (replication set 2). The discovery set and replication set 1 (833 cases and 2,013 controls) showed statistically homogeneous (P-heterogeneity >= 0.48) decreased risks of sEOC at four variants: DCN rs3138165, rs13312816 and rs516115, and LUM rs17018765 (OR = 0.6 to 0.9; P-trend = 0.001 to 0.03). Results from replication set 2 were statistically homogeneous (P-heterogeneity >= 0.13) and associated with increased risks at DCN rs3138165 and rs13312816, and LUM rs17018765: all ORs = 1.2; P-trend <= 0.02. The ORs at the four variants were statistically heterogeneous across all 18 studies (P-heterogeneity <= 0.03), which precluded combining. In post-hoc analyses, interactions were observed between each variant and recruitment period (P-interaction <= 0.003), age at diagnosis (P-interaction=0.04), and year of diagnosis (P-interaction=0.05) in the five studies with available information (1,044 cases, 2,469 controls). We conclude that variants in DCN and LUM are not directly associated with sEOC, and that confirmation of possible effect modification of the variants by non-genetic factors is required.	[Amankwah, Ernest K.; Wang, Qinggang; Dale, Laura C.; Cook, Linda S.; Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Schildkraut, Joellen M.; Iversen, Edwin S.; Berchuck, Andrew] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Tsai, Ya-Yu; Phelan, Catherine M.; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Div Canc Prevent & Control, Tampa, FL USA; [Ramus, Susan J.; Gayther, Simon A.; Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, UCL EGA Inst Womens Hlth, Dept Gynaecol Oncol, London, England; [Fridley, Brooke L.; Vachon, Celine M.; Vierkant, Robert A.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Beesley, Jonathan; Johnatty, Sharon E.; Webb, Penelope M.; Chenevix-Trench, Georgia] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Campbell, Ian; Australian Ovarian Canc Study Grp] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Lambrechts, Diether] VIB, Louvain, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Louvain, Belgium; [Amant, Frederic; Despierre, Evelyn; Vergote, Ignace] Univ Hosp Leuven, Dept Obstet & Gynecol, Louvain, Belgium; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, Ulm, Germany; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Doerk, Thilo; Bogdanova, Natalia] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany; [Duerst, Matthias] Jena Univ Hosp, Dept Gynaecol, Jena, Germany; [Antonenkova, Natalia; Bogdanova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, BELARUS; [Brown, Robert; Flanagan, James M.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Epigenet Unit, London, England; [Kaye, Stanley B.] Inst Canc Res, Med Sect, Sutton, Surrey, England; [Paul, James] Univ Glasgow, Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Haartman Insitute, Helsinki, Finland; [Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Campbell, Ian] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Eccles, Diana M.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Karlan, Beth Y.; Gross, Jenny; Walsh, Christine] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Pharoah, Paul D. P.; Song, Honglin] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge, England; [Kjaer, Susanne Kruger] Danish Canc Soc, Copenhagen, Denmark; [Kjaer, Susanne Kruger; Hogdall, Claus; Lundvall, Lene] Univ Copenhagen, Rigshosp, Gynecol Clin, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid] Danish Canc Biobank, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Copenhagen, Denmark; [Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Kiemeney, Lambertus A. L. M.; Vermeulen, Sita H. H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Cook, Linda S.] Univ New Mexico, Div Epidemiol & Biostatist, Albuquerque, NM 87131 USA; [Cunningham, Julie M.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA; [Kelemen, Linda E.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary; Duke University; H Lee Moffitt Cancer Center & Research Institute; University of London; University College London; Mayo Clinic; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of California System; University of California Irvine; Hannover Medical School; Friedrich Schiller University of Jena; Imperial College London; University of London; Institute of Cancer Research - UK; Beatson Oncology Centre; University of Glasgow; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Melbourne; Cedars Sinai Medical Center; University of Cambridge; Danish Cancer Society; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; British Columbia Cancer Agency; Simon Fraser University; University of New Mexico; Mayo Clinic; University of Calgary; University of Calgary	Amankwah, EK (corresponding author), Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada.	LKelemen@post.harvard.edu	Verdrengh, Evelien/H-4571-2012; Dörk, Thilo/J-8620-2012; Brooks-Wilson, Angela/E-9399-2012; Eccles, Diana/K-6327-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Vierkant, Robert/AAP-4927-2020; Johnatty, Sharon E/R-8890-2016; Webb, Penelope/D-5736-2013; Fridley, Brooke L/D-8315-2015; Lambrechts, Diether/AAJ-3167-2020; Menon, Usha/C-4716-2008; Ramus, Susan/AAG-8352-2019; Amant, Frédéric/W-7436-2019; Vermeulen, Sita H./L-4716-2015; campbell, Ian G/F-6006-2011; Bowtell, David/H-1007-2016; Kiemeney, Lambertus A./D-3357-2009; van Altena, Anne M/B-9824-2016; Pharoah, Paul/V-6658-2019; Massuger, Leon F.A.G./H-8072-2014; Lester, Jenny/B-5933-2012; Bogdanova, Natalia V./Y-2205-2019	Dörk, Thilo/0000-0002-9458-0282; Brooks-Wilson, Angela/0000-0003-1009-6408; Eccles, Diana/0000-0002-9935-3169; Chenevix-Trench, Georgia/0000-0002-1878-2587; Vierkant, Robert/0000-0001-6242-5221; Johnatty, Sharon E/0000-0002-7888-1966; Webb, Penelope/0000-0003-0733-5930; Fridley, Brooke L/0000-0001-7739-7956; Lambrechts, Diether/0000-0002-3429-302X; Menon, Usha/0000-0003-3708-1732; Ramus, Susan/0000-0003-0005-7798; Amant, Frédéric/0000-0002-5452-4905; Vermeulen, Sita H./0000-0003-4913-8601; Bowtell, David/0000-0001-9089-7525; Kiemeney, Lambertus A./0000-0002-2368-1326; Pharoah, Paul/0000-0001-8494-732X; Hogdall, Claus/0000-0002-5959-8874; Flanagan, James/0000-0003-4955-1383; Brown, Robert/0000-0001-7960-5755; Kjaer, Susanne/0000-0002-8347-1398; Hogdall, Estrid/0000-0003-4689-5658; Beesley, Jonathan/0000-0003-1942-325X; Paul, James/0000-0001-7367-5816; Nevanlinna, Heli/0000-0002-0916-2976; Campbell, Ian/0000-0002-7773-4155	National Health and Medical Research Council, Australia [199600]; Cancer Council Tasmania, Australia; Cancer Foundation of Western Australia, Australia; National Cancer Plan - Action 29, Australia; Alberta Heritage Foundation for Medical Research, Canada; Worksafe BC, Canada; Canadian Institutes of Health Research, Canada; Michael Smith Foundation for Health Research, Canada; Mermaid 1, Denmark; Danish Cancer Society, Denmark; Helsinki University Central Hospital, Finland; Academy of Finland, Finland; Finnish Cancer Society, Finland; European Community, Germany [HEALTH-F2-2009-223175]; Federal Ministry of Education and Research, Germany; Programme of Clinical Biomedical Research, Germany [01 GB 9401]; University of Ulm, Germany [P. 685]; Radboud University Nijmegen Medical Centre, Netherlands; municipality and community health service of Nijmegen, Netherlands; Cancer Research UK, U.K.; Association for International Cancer Research, U.K.; St Andrews, U.K.; Lon V. Smith Foundation, U.K. [LVS-39420]; Eve Appeal, U.K.; OAK Foundation, U.K.; National Institute for Health Research Biomedical Research Centre, U.K.; Ovarian Cancer Research Fund, U.S.; National Institutes of Health, U.S. [R01-CA-61107, R01-CA-122443, R01-CA-76016, CA-58860, CA-92044, P50 CA83636]; Department of Defense, U.S. [W81XWH-06-1-0220, W81XWH-09-OCRP-CONDEV]; American Cancer Society California Division, U.S. [S10P-06-258-01-CCE]; Mayo Foundation, U.S.; L&S Milken Family Foundation, U.S.; NATIONAL CANCER INSTITUTE [R01CA061107, R01CA076016, P50CA083636, R01CA122443, P50CA136393, R25CA147832, U01CA058860, R01CA058860] Funding Source: NIH RePORTER; Cancer Research UK [13086] Funding Source: researchfish; Medical Research Council [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0801875] Funding Source: UKRI	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Tasmania, Australia(Cancer Council Tasmania); Cancer Foundation of Western Australia, Australia; National Cancer Plan - Action 29, Australia; Alberta Heritage Foundation for Medical Research, Canada(Alberta Heritage Foundation for Medical Research); Worksafe BC, Canada; Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research, Canada(Michael Smith Foundation for Health Research); Mermaid 1, Denmark; Danish Cancer Society, Denmark(Danish Cancer Society); Helsinki University Central Hospital, Finland; Academy of Finland, Finland(Academy of Finland); Finnish Cancer Society, Finland; European Community, Germany(European Commission); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Programme of Clinical Biomedical Research, Germany; University of Ulm, Germany; Radboud University Nijmegen Medical Centre, Netherlands(Netherlands Government); municipality and community health service of Nijmegen, Netherlands(Netherlands Government); Cancer Research UK, U.K.(Cancer Research UK); Association for International Cancer Research, U.K.; St Andrews, U.K.; Lon V. Smith Foundation, U.K.; Eve Appeal, U.K.; OAK Foundation, U.K.; National Institute for Health Research Biomedical Research Centre, U.K.(National Institute for Health Research (NIHR)); Ovarian Cancer Research Fund, U.S.; National Institutes of Health, U.S.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense, U.S.(United States Department of Defense); American Cancer Society California Division, U.S.(American Cancer Society); Mayo Foundation, U.S.; L&S Milken Family Foundation, U.S.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Australia: National Health and Medical Research Council (199600), Cancer Council Tasmania, Cancer Foundation of Western Australia; Belgium: National Cancer Plan - Action 29; Canada: Alberta Heritage Foundation for Medical Research, Worksafe BC, Canadian Institutes of Health Research, Michael Smith Foundation for Health Research; Denmark: Mermaid 1, The Danish Cancer Society; Finland: Helsinki University Central Hospital Research Fund, Academy of Finland, the Finnish Cancer Society; Germany: European Community's Seventh Framework Programme (HEALTH-F2-2009-223175), Federal Ministry of Education and Research, Programme of Clinical Biomedical Research (01 GB 9401), University of Ulm (P. 685); Netherlands: Radboud University Nijmegen Medical Centre, the municipality and community health service of Nijmegen; U.K.: Cancer Research UK, Association for International Cancer Research, St Andrews, Lon V. Smith Foundation grant LVS-39420, Eve Appeal, OAK Foundation; National Institute for Health Research Biomedical Research Centre; U.S.: Ovarian Cancer Research Fund, National Institutes of Health (R01-CA-61107, R01-CA-122443, R01-CA-76016, CA-58860, CA-92044, P50 CA83636), Department of Defense (W81XWH-06-1-0220, W81XWH-09-OCRP-CONDEV), American Cancer Society California Division (S10P-06-258-01-CCE), Mayo Foundation, L&S Milken Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beesley J, 2007, CANCER EPIDEM BIOMAR, V16, P2557, DOI 10.1158/1055-9965.EPI-07-0542; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; BISHOP JM, 1995, GENE DEV, V9, P1309, DOI 10.1101/gad.9.11.1309; Bray F, 2005, INT J CANCER, V113, P977, DOI 10.1002/ijc.20649; Bristow RE, 1999, CANCER, V85, P658, DOI 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gerstman B. Burt, 1996, Pharmacoepidemiology and Drug Safety, V5, P141, DOI 10.1002/(SICI)1099-1557(199605)5:3<141::AID-PDS221>3.0.CO;2-8; GERSTMAN BB, 1991, AM J PUBLIC HEALTH, V81, P90, DOI 10.2105/AJPH.81.1.90; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grazio D, 2008, EUR J GYNAECOL ONCOL, V29, P357; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grisaru D, 2007, ONCOL REP, V18, P1347; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Koninger J, 2004, CLIN CANCER RES, V10, P4776, DOI 10.1158/1078-0432.CCR-1190-03; Leygue E, 2000, J PATHOL, V192, P313; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Massague J, 2000, GENE DEV, V14, P627; Matthews T J, 2009, NCHS Data Brief, P1; Merritt MA, 2008, INT J CANCER, V122, P170, DOI 10.1002/ijc.23017; Nash MA, 2002, CLIN CANCER RES, V8, P1754; *NAT CANC I, NAT CANC I SURV EP E; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; PIVER MS, 1991, SEMIN ONCOL, V18, P177; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; RISCH HA, 1994, AM J EPIDEMIOL, V140, P585, DOI 10.1093/oxfordjournals.aje.a117296; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Rodriguez GC, 2002, JNCI-J NATL CANCER I, V94, P50; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; SCAID DJ, 2010, HAPLO STATS; Sellers TA, 2005, CANCER EPIDEM BIOMAR, V14, P2536, DOI 10.1158/1055-9965.EPI-05-0142; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shridhar V, 2001, CANCER RES, V61, P5895; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Whiteman DC, 2003, CANCER EPIDEM BIOMAR, V12, P42; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P244, DOI 10.1080/03008200802147746	47	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19642	10.1371/journal.pone.0019642	http://dx.doi.org/10.1371/journal.pone.0019642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637745	Green Published, gold, Green Accepted			2022-12-27	WOS:000291052500009
J	Chen, K; Pociask, DA; McAleer, JP; Chan, YR; Alcorn, JF; Kreindler, JL; Keyser, MR; Shapiro, SD; Houghton, AM; Kolls, JK; Zheng, MQ				Chen, Kong; Pociask, Derek A.; McAleer, Jeremy P.; Chan, Yvonne R.; Alcorn, John F.; Kreindler, James L.; Keyser, Matthew R.; Shapiro, Steven D.; Houghton, A. McGarry; Kolls, Jay K.; Zheng, Mingquan			IL-17RA Is Required for CCL2 Expression, Macrophage Recruitment, and Emphysema in Response to Cigarette Smoke	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARYL-HYDROCARBON RECEPTOR; T-CELLS; BRONCHOALVEOLAR LAVAGE; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; GENE-EXPRESSION; INFLAMMATION; MICE; AUTOIMMUNITY	Chronic Obstructive Pulmonary Disease (COPD) is characterized by airspace enlargement and peribronchial lymphoid follicles; however, the immunological mechanisms leading to these pathologic changes remain undefined. Here we show that cigarette smoke is a selective adjuvant that augments in vitro and in vivo Th17, but not Th1, cell differentiation via the aryl hydrocarbon receptor. Smoke exposed IL-17RA(-/-) mice failed to induce CCL2 and MMP12 compared to WT mice. Remarkably, in contrast to WT mice, IL-17RA(-/-) mice failed to develop emphysema after 6 months of cigarette smoke exposure. Taken together, these data demonstrate that cigarette smoke is a potent Th17 adjuvant and that IL-17RA signaling is required for chemokine expression necessary for MMP12 induction and tissue emphysema.	[Chen, Kong; Pociask, Derek A.; McAleer, Jeremy P.; Kolls, Jay K.; Zheng, Mingquan] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Chan, Yvonne R.; Alcorn, John F.; Shapiro, Steven D.; Houghton, A. McGarry] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Kreindler, James L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Keyser, Matthew R.] DNASTAR, Madison, WI USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chen, K (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	jkolls@lsuhsc.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304	National Heart Lung and Blood Institute [5R37HL079142, 5R01HL082541]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082541, R21HL104601, R37HL079142] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung and Blood Institute, grants 5R37HL079142 (JKK) and 5R01HL082541 (SDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Barczyk A, 2006, J ALLERGY CLIN IMMUN, V117, P1484, DOI 10.1016/j.jaci.2006.02.013; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Costenbader KH, 2004, ARTHRITIS RHEUM-US, V50, P849, DOI 10.1002/art.20049; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Eustace A, 2010, CHEST; Gebremichael A, 1996, TOXICOL APPL PHARM, V141, P76; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hodge G, 2007, CLIN EXP IMMUNOL, V150, P22, DOI 10.1111/j.1365-2249.2007.03451.x; Hogg J C, 2005, Exp Lung Res, V31 Suppl 1, P72; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Kallberg H, 2010, ANN RHEUM DIS; Kitamura M, 2007, CANCER LETT, V252, P184, DOI 10.1016/j.canlet.2006.11.015; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Majori M, 1999, J ALLERGY CLIN IMMUN, V103, P458, DOI 10.1016/S0091-6749(99)70471-9; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Palmer MT, 2010, NAT IMMUNOL, V11, P36, DOI 10.1038/ni.1802; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PRIDGEON C, 2011, CLIN SCI LOND; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	38	164	167	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20333	10.1371/journal.pone.0020333	http://dx.doi.org/10.1371/journal.pone.0020333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647421	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000291052500046
J	Chen, ZG; Schiffman, M; Herrero, R; DeSalle, R; Anastos, K; Segondy, M; Sahasrabuddhe, VV; Gravitt, PE; Hsing, AW; Burk, RD				Chen, Zigui; Schiffman, Mark; Herrero, Rolando; DeSalle, Rob; Anastos, Kathryn; Segondy, Michel; Sahasrabuddhe, Vikrant V.; Gravitt, Patti E.; Hsing, Ann W.; Burk, Robert D.			Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; MULTIPLE SEQUENCE ALIGNMENT; GRADE CERVICAL LESIONS; HIGH-RISK; GENETIC-HETEROGENEITY; PHYLOGENETIC ANALYSIS; GENITAL-TRACT; INFECTION; TYPE-16; WOMEN	Background: Human papillomavirus 16 (HPV16) species group (alpha-9) of the Alphapapillomavirus genus contains HPV16, HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. These HPVs account for 75% of invasive cervical cancers worldwide. Viral variants of these HPVs differ in evolutionary history and pathogenicity. Moreover, a comprehensive nomenclature system for HPV variants is lacking, limiting comparisons between studies. Methods: DNA from cervical samples previously characterized for HPV type were obtained from multiple geographic regions to screen for novel variants. The complete 8 kb genomes of 120 variants representing the major and minor lineages of the HPV16-related alpha-9 HPV types were sequenced to capture maximum viral heterogeneity. Viral evolution was characterized by constructing phylogenic trees based on complete genomes using multiple algorithms. Maximal and viral region specific divergence was calculated by global and pairwise alignments. Variant lineages were classified and named using an alphanumeric system; the prototype genome was assigned to the A lineage for all types. Results: The range of genome-genome sequence heterogeneity varied from 0.6% for HPV35 to 2.2% for HPV52 and included 1.4% for HPV31, 1.1% for HPV33, 1.7% for HPV58 and 1.1% for HPV67. Nucleotide differences of approximately 1.0% - 10.0% and 0.5%-1.0% of the complete genomes were used to define variant lineages and sublineages, respectively. Each gene/region differs in sequence diversity, from most variable to least variable: noncoding region 1 (NCR1)/noncoding region 2 (NCR2) > upstream regulatory region (URR) > E6/E7 > E2/L2 > E1/L1. Conclusions: These data define maximum viral genomic heterogeneity of HPV16-related alpha-9 HPV variants. The proposed nomenclature system facilitates the comparison of variants across epidemiological studies. Sequence diversity and phylogenies of this clinically important group of HPVs provides the basis for further studies of discrete viral evolution, epidemiology, pathogenesis and preventative/therapeutic interventions.	[Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Schiffman, Mark; Sahasrabuddhe, Vikrant V.; Hsing, Ann W.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Herrero, Rolando] Fdn INCIENSA, Proyect Epidemiol Guanacaste, San Jose, Costa Rica; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Med, New York, NY USA; [Segondy, Michel] Montpellier Univ Hosp, Dept Biol & Pathol, Montpellier, France; [Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN USA; [Gravitt, Patti E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA; [Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA	Yeshiva University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Museum of Natural History (AMNH); Montefiore Medical Center; Universite de Montpellier; CHU de Montpellier; Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Yeshiva University; Yeshiva University	Chen, ZG (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA.	robert.burk@einstein.yu.edu	Schiffman, Mark/B-9766-2015; Chen, Zigui/E-8490-2017	Chen, Zigui/0000-0002-8577-1298	National Cancer Institute [CA78527, AI-51519]; Einstein Cancer Research Center, NCI [P30CA013330]; American Museum of Natural History; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078527, P30CA013330, U01CA078527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Cancer Research Center, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Museum of Natural History; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Cancer Institute (CA78527), the Einstein-Montefiore Center for AIDS funded by the National Institutes of Health (AI-51519), and the Einstein Cancer Research Center (P30CA013330) from the NCI. RD thanks the Louis and Dorothy Cullman Program in Molecular Systematics at the American Museum of Natural History for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; Arias-Pulido H, 2005, VIROLOGY, V338, P22, DOI 10.1016/j.virol.2005.04.022; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Calleja-Macias IE, 2005, J VIROL, V79, P13630, DOI 10.1128/JVI.79.21.13630-13640.2005; Calleja-Macias IE, 2005, J VIROL, V79, P6565, DOI 10.1128/JVI.79.10.6565-6569.2005; Calleja-Macias IE, 2004, VIROLOGY, V319, P315, DOI 10.1016/j.virol.2003.11.009; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chan SY, 1997, VIROLOGY, V239, P296, DOI 10.1006/viro.1997.8896; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; Colwell RK, 2009, ESTIMATES STAT ESTIM; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DEAU MC, 1993, J CLIN MICROBIOL, V31, P2918, DOI 10.1128/JCM.31.11.2918-2926.1993; DEAU MC, 1991, VIROLOGY, V184, P492, DOI 10.1016/0042-6822(91)90419-C; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAUQUET CM, 2005, 8 INT COMM TAX VIR, P239; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gagnon S, 2005, J MED VIROL, V75, P213, DOI 10.1002/jmv.20259; Gagnon S, 2004, J INFECT DIS, V190, P1575, DOI 10.1086/424854; Gagnon S, 2007, JAIDS-J ACQ IMM DEF, V44, P61, DOI 10.1097/01.qai.0000247226.45375.01; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GOLDSBOROUGH MD, 1989, VIROLOGY, V171, P306, DOI 10.1016/0042-6822(89)90545-X; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Herbst LH, 2009, VIROLOGY, V383, P131, DOI 10.1016/j.virol.2008.09.022; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; *ICTV, 2002, INT COD VIR CLASS NO; *INV IHP, 2003, NATURE, V426, P789; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Khouadri S, 2006, J INFECT DIS, V194, P886, DOI 10.1086/507431; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; LIAW KL, 1995, INT J CANCER, V62, P565, DOI 10.1002/ijc.2910620513; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; MARKS M, 2011, INT J CANC; Maver PJ, 2011, J MED VIROL, V83, P461, DOI 10.1002/jmv.21994; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prado JC, 2005, VIROLOGY, V340, P95, DOI 10.1016/j.virol.2005.06.024; Raiol T, 2009, J MED VIROL, V81, P685, DOI 10.1002/jmv.21432; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 2011, MOL BIOL EVOL UNPUB; Terai M, 2002, J VIROL, V76, P10020, DOI 10.1128/JVI.76.19.10020-10023.2002; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Wongworapat K, 2008, SEX TRANSM DIS, V35, P172, DOI 10.1097/OLQ.0b013e318158af65; Woolford L, 2007, J VIROL, V81, P13280, DOI 10.1128/JVI.01662-07; Wu EQ, 2009, J GEN VIROL, V90, P1229, DOI 10.1099/vir.0.008227-0; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	64	102	106	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20183	10.1371/journal.pone.0020183	http://dx.doi.org/10.1371/journal.pone.0020183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21673791	Green Submitted, gold, Green Published			2022-12-27	WOS:000291052500039
J	Sasaki, K; Suzuki, M; Mieda, M; Tsujino, N; Roth, B; Sakurai, T				Sasaki, Koh; Suzuki, Mika; Mieda, Michihiro; Tsujino, Natsuko; Roth, Bryan; Sakurai, Takeshi			Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in Mice	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; OREXIN/HYPOCRETIN NEURONS; RAT-BRAIN; SLEEP; HYPOCRETIN; HOMEOSTASIS; VECTORS; AROUSAL; ROLES; CYCLE	Hypothalamic neurons expressing neuropeptide orexins are critically involved in the control of sleep and wakefulness. Although the activity of orexin neurons is thought to be influenced by various neuronal input as well as humoral factors, the direct consequences of changes in the activity of these neurons in an intact animal are largely unknown. We therefore examined the effects of orexin neuron-specific pharmacogenetic modulation in vivo by a new method called the Designer Receptors Exclusively Activated by Designer Drugs approach (DREADD). Using this system, we successfully activated and suppressed orexin neurons as measured by Fos staining. EEG and EMG recordings suggested that excitation of orexin neurons significantly increased the amount of time spent in wakefulness and decreased both non-rapid eye movement (NREM) and rapid eye movement (REM) sleep times. Inhibition of orexin neurons decreased wakefulness time and increased NREM sleep time. These findings clearly show that changes in the activity of orexin neurons can alter the behavioral state of animals and also validate this novel approach for manipulating neuronal activity in awake, freely-moving animals.	[Sasaki, Koh; Suzuki, Mika; Mieda, Michihiro; Tsujino, Natsuko; Sakurai, Takeshi] Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan; [Roth, Bryan] UNC Chapel Hill Med Sch, Chapel Hill, NC USA	Kanazawa University	Sasaki, K (corresponding author), Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan.	tsakurai@med.kanazawa-u.ac.jp	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Mieda, Michihiro/0000-0002-2451-7034	Cabinet Office, Government of Japan; NIMH [U19MH82441]; Michael Hooker Distinguished Chair in Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER	Cabinet Office, Government of Japan; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Distinguished Chair in Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by Grants-in-Aid for Scientific Research (B) and the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers" as well as by NIMH grant U19MH82441 and the Michael Hooker Distinguished Chair in Pharmacology to BLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; KRASHES MJ, 2011, J CLIN INVEST; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Sakurai Takeshi, 2006, CNS & Neurological Disorders-Drug Targets, V5, P313, DOI 10.2174/187152706777452218; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsujino N, 2005, J NEUROSCI, V25, P7459, DOI 10.1523/JNEUROSCI.1193-05.2005; VANNIMERCIER G, 1984, CR ACAD SCI III-VIE, V298, P195; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	25	176	178	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20360	10.1371/journal.pone.0020360	http://dx.doi.org/10.1371/journal.pone.0020360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647372	Green Published, gold			2022-12-27	WOS:000291052500052
J	Travasso, RDM; Poire, EC; Castro, M; Rodrguez-Manzaneque, JC; Hernandez-Machado, A				Travasso, Rui D. M.; Poire, Eugenia Corvera; Castro, Mario; Rodrguez-Manzaneque, Juan Carlos; Hernandez-Machado, A.			Tumor Angiogenesis and Vascular Patterning: A Mathematical Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; VEGF-A; NORMALIZATION; MECHANISMS; SIMULATION; SWITCH	Understanding tumor induced angiogenesis is a challenging problem with important consequences for diagnosis and treatment of cancer. Recently, strong evidences suggest the dual role of endothelial cells on the migrating tips and on the proliferating body of blood vessels, in consonance with further events behind lumen formation and vascular patterning. In this paper we present a multi-scale phase-field model that combines the benefits of continuum physics description and the capability of tracking individual cells. The model allows us to discuss the role of the endothelial cells' chemotactic response and proliferation rate as key factors that tailor the neovascular network. Importantly, we also test the predictions of our theoretical model against relevant experimental approaches in mice that displayed distinctive vascular patterns. The model reproduces the in vivo patterns of newly formed vascular networks, providing quantitative and qualitative results for branch density and vessel diameter on the order of the ones measured experimentally in mouse retinas. Our results highlight the ability of mathematical models to suggest relevant hypotheses with respect to the role of different parameters in this process, hence underlining the necessary collaboration between mathematical modeling, in vivo imaging and molecular biology techniques to improve current diagnostic and therapeutic tools.	[Travasso, Rui D. M.] Univ Coimbra, Dept Fis, Ctr Fis Computac, P-3000 Coimbra, Portugal; [Poire, Eugenia Corvera] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim & Fis, Mexico City 04510, DF, Mexico; [Castro, Mario] Univ Pontificia Comillas, GISC, Madrid, Spain; [Castro, Mario] Univ Pontificia Comillas, Escuela Tec Sup Ingn ICAI, Grp Dinam No Lineal DNL, Madrid, Spain; [Rodrguez-Manzaneque, Juan Carlos] Univ Granada, Pfizer, Andalusian Govt Ctr Genom & Oncol Res, GENYO, Granada, Spain; [Hernandez-Machado, A.] Univ Barcelona, Fac Fis, Dept ECM, E-08028 Barcelona, Spain	Universidade de Coimbra; Universidad Nacional Autonoma de Mexico; Comillas Pontifical University; Comillas Pontifical University; Pfizer; University of Granada; University of Barcelona	Travasso, RDM (corresponding author), Univ Coimbra, Dept Fis, Ctr Fis Computac, P-3000 Coimbra, Portugal.	rui@teor.fis.uc.pt	Hernandez-Machado, Aurora/H-7425-2012; Travasso, Rui/B-8342-2018; Hernandez-Machado, Aurora/N-3362-2019; Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; Poire, Eugenia Corvera/B-1119-2008; Poire, Eugenia Corvera/Y-6404-2019; Travasso, Rui/A-6774-2011; Castro, Mario/A-3585-2009	Hernandez-Machado, Aurora/0000-0002-0397-5255; Travasso, Rui/0000-0001-6078-0721; Hernandez-Machado, Aurora/0000-0002-0397-5255; Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Poire, Eugenia Corvera/0000-0002-4688-6922; Poire, Eugenia Corvera/0000-0002-4688-6922; Castro, Mario/0000-0003-3288-6144	Fundacao para a Ciencia e Tecnologia [PTDC/SAU-ENB/110354/2009]; Fundacao Calouste Gulbenkian; CONACyT [83149]; Instituto de Salud Carlos III [EMER07/055]; Spanish Ministry of Science and Innovation [FIS2009-12964-C05-02, FIS2009-12964-C05-03]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.mctes.pt), project PTDC/SAU-ENB/110354/2009; Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/), Estimulo a Investigacao Prize; CONACyT (http://www.conacyt.mx/), project 83149; Instituto de Salud Carlos III (http://www.isciii.es/), project EMER07/055; Spanish Ministry of Science and Innovation (http://www.micinn.es/), projects FIS2009-12964-C05-02 and FIS2009-12964-C05-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cai Y, 2009, ACTA MECH SINICA-PRC, V25, P889, DOI 10.1007/s10409-009-0301-3; Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHAPLAIN MAJ, 2003, ANNU REV BIOMED ENG, V8, P233; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FERRARA N, 2008, OVERVIEW CLIN APPL V, P345; Feucht M, 1997, AM J PATHOL, V151, P1407; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gonzalez-Cinca R., 2004, ADV CONDENSED MATTER, P203; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones EAV, 2006, PHYSIOLOGY, V21, P388, DOI 10.1152/physiol.00020.2006; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Markus M, 1999, MATH BIOSCI, V156, P191, DOI 10.1016/S0025-5564(98)10066-4; Mayer RJ, 2004, NEW ENGL J MED, V350, P2406, DOI 10.1056/NEJMe048098; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Painter KJ, 2009, J MATH BIOL, V58, P511, DOI 10.1007/s00285-008-0217-8; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Ropert S, 2006, TARGET ONCOL, V1, P239, DOI 10.1007/s11523-006-0027-0; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; STOKES CL, 1991, J CELL SCI, V99, P419; Tracqui P, 2005, CELL PROLIFERAT, V38, P119, DOI 10.1111/j.1365-2184.2005.00337.x; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971	41	82	83	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19989	10.1371/journal.pone.0019989	http://dx.doi.org/10.1371/journal.pone.0019989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637756	Green Submitted, gold, Green Published			2022-12-27	WOS:000291052500022
J	Verrier, JD; Madorsky, I; Coggin, WE; Geesey, M; Hochman, M; Walling, E; Daroszewski, D; Eccles, KS; Ludlow, R; Semple-Rowland, SL				Verrier, Jonathan D.; Madorsky, Irina; Coggin, William E.; Geesey, Mero; Hochman, Michael; Walling, Elleanor; Daroszewski, Daniel; Eccles, Kristofer S.; Ludlow, Rachel; Semple-Rowland, Susan L.			Bicistronic Lentiviruses Containing a Viral 2A Cleavage Sequence Reliably Co-Express Two Proteins and Restore Vision to an Animal Model of LCA1	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; MOUTH-DISEASE VIRUS; GENE REPLACEMENT THERAPY; RETINAL DEGENERATION; PHOTORECEPTOR DEGENERATION; OPTOKINETIC NYSTAGMUS; MULTIPLE PROTEINS; SIGNAL SEQUENCES; MURINE MODEL; EXPRESSION	The disease processes underlying inherited retinal disease are complex and are not completely understood. Many of the corrective gene therapies designed to treat diseases linked to mutations in genes specifically expressed in photoreceptor cells restore function to these cells but fail to stop progression of the disease. There is growing consensus that effective treatments for these diseases will require delivery of multiple therapeutic proteins that will be selected to treat specific aspects of the disease process. The purpose of this study was to design a lentiviral transgene that reliably expresses all of the proteins it encodes and does so in a consistent manner among infected cells. We show, using both in vitro and in vivo analyses, that bicistronic lentiviral transgenes encoding two fluorescent proteins fused to a viral 2A-like cleavage peptide meet these expression criteria. To determine if this transgene design is suitable for therapeutic applications, we replaced one of the fluorescent protein genes with the gene encoding guanylate cyclase -1 (GC1) and delivered lentivirus carrying this transgene to the retinas of the GUCY1*B avian model of Leber congenital amaurosis -1 (LCA1). GUCY1*B chickens carry a null mutation in the GC1 gene that disrupts photoreceptor function and causes blindness at hatching, a phenotype that closely matches that observed in humans with LCA1. We found that treatment of these animals with the 2A lentivector encoding GC1 restored vision to these animals as evidenced by the presence of optokinetic reflexes. We conclude that 2A-like peptides, with proper optimization, can be successfully incorporated into therapeutic vectors designed to deliver multiple proteins to neural retinal. These results highlight the potential of this vector design to serve as a platform for the development of combination therapies designed to enhance or prolong the benefits of corrective gene therapies.	[Verrier, Jonathan D.; Madorsky, Irina; Coggin, William E.; Geesey, Mero; Hochman, Michael; Walling, Elleanor; Daroszewski, Daniel; Eccles, Kristofer S.; Ludlow, Rachel; Semple-Rowland, Susan L.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Verrier, JD (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA.	rowland@mbi.ufl.edu			NIH [EY11388, EY08571]; NATIONAL EYE INSTITUTE [R01EY011388, P30EY021721, P30EY008571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NIH grants EY11388 (SSR) and an NIH Vision Core Grant EY08571 (http://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Chinnasamy Nachimuthu, 2009, V515, P137, DOI 10.1007/978-1-59745-559-6_9; Chumakov SP, 2010, PLASMID, V63, P143, DOI 10.1016/j.plasmid.2009.12.003; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Coleman JE, 2004, INVEST OPHTH VIS SCI, V45, P3397, DOI 10.1167/iovs.04-0392; CONLEY M, 1980, BRAIN BEHAV EVOLUT, V17, P89, DOI 10.1159/000121792; de Felipe P, 1999, GENE THER, V6, P198, DOI 10.1038/sj.gt.3300811; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Koch KW, 2002, MOL CELL BIOCHEM, V230, P97, DOI 10.1023/A:1014209711793; KOMENDA JK, 1983, BEHAV NEUROSCI, V97, P928, DOI 10.1037/0735-7044.97.6.928; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Negroni M, 2001, NAT REV MOL CELL BIO, V2, P151, DOI 10.1038/35052098; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; Pawlyk BS, 2010, HUM GENE THER, V21, P993, DOI 10.1089/hum.2009.218; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Semple-Rowland SL, 2007, MOL VIS, V13, P2001; Semple-Rowland SL, 2010, MOL VIS, V16, P916; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman A.L., 2007, GENE TRANSFER DELIVE, P137; TAUBER ES, 1968, SCIENCE, V160, P1365, DOI 10.1126/science.160.3834.1365; Williams ML, 2006, PLOS MED, V3, P904, DOI 10.1371/journal.pmed.0030201; Wong ET, 2002, GENE THER, V9, P337, DOI 10.1038/sj.gt.3301667; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7	47	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20553	10.1371/journal.pone.0020553	http://dx.doi.org/10.1371/journal.pone.0020553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647387	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052500068
J	Sudhir, PR; Hsu, CL; Wang, MJ; Wang, YT; Chen, YJ; Sung, TY; Hsu, WL; Yang, UC; Chen, JY				Sudhir, Putty-Reddy; Hsu, Chia-Lang; Wang, Mei-Jung; Wang, Yi-Ting; Chen, Yu-Ju; Sung, Ting-Yi; Hsu, Wen-Lian; Yang, Ueng-Cheng; Chen, Jeou-Yuan			Phosphoproteomics Identifies Oncogenic Ras Signaling Targets and Their Involvement in Lung Adenocarcinomas	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; FUNCTIONAL PROTEOMICS; PHOSPHORYLATION; CANCER; PATHWAYS; MULTIPLE; KINASE; DIFFERENTIATION; TRANSDUCTION; MUTATIONS	Background: Ras is frequently mutated in a variety of human cancers, including lung cancer, leading to constitutive activation of MAPK signaling. Despite decades of research focused on the Ras oncogene, Ras-targeted phosphorylation events and signaling pathways have not been described on a proteome-wide scale. Methodology/Principal Findings: By functional phosphoproteomics, we studied the molecular mechanics of oncogenic Ras signaling using a pathway-based approach. We identified Ras-regulated phosphorylation events (n = 77) using label-free comparative proteomics analysis of immortalized human bronchial epithelial cells with and without the expression of oncogenic Ras. Many were newly identified as potential targets of the Ras signaling pathway. A majority (similar to 60%) of the Ras-targeted events consisted of a [pSer/Thr]-Pro motif, indicating the involvement of proline-directed kinases. By integrating the phosphorylated signatures into the Pathway Interaction Database, we further inferred Ras-regulated pathways, including MAPK signaling and other novel cascades, in governing diverse functions such as gene expression, apoptosis, cell growth, and RNA processing. Comparisons of Ras-regulated phosphorylation events, pathways, and related kinases in lung cancer-derived cells supported a role of oncogenic Ras signaling in lung adenocarcinoma A549 and H322 cells, but not in large cell carcinoma H1299 cells. Conclusions/Significance: This study reveals phosphorylation events, signaling networks, and molecular functions that are regulated by oncogenic Ras. The results observed in this study may aid to extend our knowledge on Ras signaling in lung cancer.	[Sudhir, Putty-Reddy; Wang, Mei-Jung; Chen, Jeou-Yuan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Hsu, Chia-Lang; Yang, Ueng-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Wang, Yi-Ting; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Chen, Jeou-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chen, Jeou-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Sudhir, PR (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	bmchen@ibms.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020; Chen, Joanne Jeou-Yuan/S-7022-2018; Hsu, Chia-Lang/O-1458-2013; Sung, Ting-Yi/AAQ-5413-2021; Chen, Yu-Ju/E-9481-2015	Hsu, Wen-Lian/0000-0001-7061-3513; Hsu, Chia-Lang/0000-0002-7447-8045; Sung, Ting-Yi/0000-0002-6028-0409; Chen, Yu-Ju/0000-0002-3178-6697	National Research Program on Genomic Medicine; Academia Sinica	National Research Program on Genomic Medicine; Academia Sinica(Academia Sinica - Taiwan)	The work was supported in part by the grant to JYC from National Research Program on Genomic Medicine and the post-doctoral fellowship to PRS from the Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Cutillas PR, 2007, MOL CELL PROTEOMICS, V6, P1560, DOI 10.1074/mcp.M700037-MCP200; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lawlor K, 2009, J PROTEOME RES, V8, P1489, DOI 10.1021/pr8008572; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee JL, 2008, MOL CELL BIOL, V28, P5710, DOI 10.1128/MCB.00186-08; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lu XN, 2005, MOL CELL PROTEOMICS, V4, P1948, DOI 10.1074/mcp.M500138-MCP200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; PALMER RH, 1994, FEBS LETT, V356, P5, DOI 10.1016/0014-5793(94)01202-4; Persidis A, 1998, NAT BIOTECHNOL, V16, P1082, DOI 10.1038/3553; Popescu M, 2006, IEEE ACM T COMPUT BI, V3, P263, DOI 10.1109/TCBB.2006.37; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Schreiber TB, 2008, PROTEOMICS, V8, P4416, DOI 10.1002/pmic.200800132; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wilbur WJ, 1996, COMPUT BIOL MED, V26, P209, DOI 10.1016/0010-4825(95)00055-0; WU H, 2009, COMPUTATIONAL STAT D, V54, P767; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zubarev RA, 2008, J PROTEOMICS, V71, P89, DOI 10.1016/j.jprot.2008.01.004	34	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20199	10.1371/journal.pone.0020199	http://dx.doi.org/10.1371/journal.pone.0020199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637843	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200039
J	Cardnell, RJG; Mikkelsen, RB				Cardnell, Robert J. G.; Mikkelsen, Ross B.			Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-KAPPA-B; IONIZING-RADIATION; L-ARGININE; S-NITROSYLATION; CHRONIC HYPOXIA; RECURRENT HEAD; PROTEIN-KINASE; CELL CARCINOMA; BLOOD-FLOW	This study tests whether the nitric oxide synthase (NOS) inhibitor, N-G-nitro-L-arginine (L-NNA), combines favorably with ionizing radiation (IR) in controlling squamous carcinoma tumor growth. Animals bearing FaDu and A431 xenografts were treated with L-NNA in the drinking water. IR exposure was 10 Gy for tumor growth and survival studies and 4 Gy for ex vivo clonogenic assays. Cryosections were examined immunohistochemically for markers of apoptosis and hypoxia. Blood flow was assayed by fluorescent microscopy of tissue cryosections after i.v. injection of fluorospheres. Orally administered L-NNA for 24 hrs reduces tumor blood flow by 80% (p<0.01). Within 24 hrs L-NNA treatment stopped tumor growth for at least 10 days before tumor growth again ensued. The growth arrest was in part due to increased cell killing since a combination of L-NNA and a single 4 Gy IR caused 82% tumor cell killing measured by an ex vivo clonogenic assay compared to 49% by L-NNA or 29% by IR alone. A Kaplan-Meyer analysis of animal survival revealed a distinct survival advantage for the combined treatment. Combining L-NNA and IR was also found to be at least as effective as a single i.p. dose of cisplatin plus IR. In contrast to the in vivo studies, exposure of cells to L-NNA in vitro was without effect on clonogenicity with or without IR. Western and immunochemical analysis of expression of a number of proteins involved in NO signaling indicated that L-NNA treatment enhanced arginase-2 expression and that this may represent vasculature remodeling and escape from NOS inhibition. For tumors such as head and neck squamous carcinomas that show only modest responses to inhibitors of specific angiogenic pathways, targeting NO-dependent pro-survival and angiogenic mechanisms in both tumor and supporting stromal cells may present a potential new strategy for tumor control.	[Cardnell, Robert J. G.; Mikkelsen, Ross B.] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA	Virginia Commonwealth University	Cardnell, RJG (corresponding author), Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA.	rjcardnell@vcu.edu			NIH/NCI [RO1-CA65896, RO1-CA90881, PO1 CA72955, T32-CA113277]; NATIONAL CANCER INSTITUTE [R01CA090881, R01CA065896, P01CA072955, T32CA113277] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI Grants RO1-CA65896, RO1-CA90881, PO1 CA72955 (RBM) and NIH/NCI Training Grant T32-CA113277 (RJGC) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CT, 2007, HEAD NECK-J SCI SPEC, V29, P959, DOI 10.1002/hed.20615; Anselm E, 2005, FASEB J, V19, pA1230; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chen B, 2009, AM J PHYSIOL-LUNG C, V297, pL1151, DOI 10.1152/ajplung.00183.2009; Crokart N, 2005, INT J RADIAT ONCOL, V63, P901, DOI 10.1016/j.ijrobp.2005.02.038; Davis PD, 2002, INT J RADIAT ONCOL, V54, P1532, DOI 10.1016/S0360-3016(02)03925-1; DELAGE B, INT J CANC, V126, P2762; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Fury MG, 2007, INVEST NEW DRUG, V25, P165, DOI 10.1007/s10637-006-9011-x; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; Gorski DH, 1999, CANCER RES, V59, P3374; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hua JY, 2003, ANTICANCER RES, V23, P1433; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Itasaka S, 2007, INT J RADIAT ONCOL, V67, P870, DOI 10.1016/j.ijrobp.2006.10.030; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Jordan BF, 2002, CANCER RES, V62, P3555; Joschko MA, 1997, CANCER CHEMOTH PHARM, V40, P534, DOI 10.1007/s002800050699; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; KING I, 1989, CANCER RES, V49, P5677; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Lammering G, 2001, J NATL CANCER I, V93, P921, DOI 10.1093/jnci/93.12.921; Leach JK, 2002, J BIOL CHEM, V277, P15400, DOI 10.1074/jbc.M110309200; Leach JK, 2001, CANCER RES, V61, P3894; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; MADHOK BM, BR J CANC, V102, P1746; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Milas L, 2000, CLIN CANCER RES, V6, P701; Nelin LD, 2007, AM J PHYSIOL-CELL PH, V293, pC632, DOI 10.1152/ajpcell.00137.2006; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Satriano J, 2004, AMINO ACIDS, V26, P321, DOI 10.1007/s00726-004-0078-4; Sonveaux P, 2003, CANCER RES, V63, P1012; Sonveaux P, 2002, FASEB J, V16, P1979, DOI 10.1096/fj.02-0487fje; Sturla LM, 2005, J BIOL CHEM, V280, P14597, DOI 10.1074/jbc.M413287200; TOBY IT, AM J PHYSL LUNG CELL, V298, pL600; Tozer GM, 2009, CLIN CANCER RES, V15, P3781, DOI 10.1158/1078-0432.CCR-08-2906; Tozer GM, 1997, CANCER RES, V57, P948; Van den Berge DL, 2001, BRIT J CANCER, V84, P1122, DOI 10.1054/bjoc.2000.1719; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Van Waes C, 2005, INT J RADIAT ONCOL, V63, P1400, DOI 10.1016/j.ijrobp.2005.05.007; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Vordermark D, 2003, INT J RADIAT ONCOL, V56, P1184, DOI 10.1016/S0360-3016(03)00289-X; WOOD PJ, 1994, CANCER RES, V54, P6458; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Yan B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r53; Zolzer F, 2002, INT J RADIAT ONCOL, V54, P910, DOI 10.1016/S0360-3016(02)02963-2	49	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20147	10.1371/journal.pone.0020147	http://dx.doi.org/10.1371/journal.pone.0020147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647438	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500028
J	Chen, YC; Aguan, K; Yang, CW; Wang, YT; Pal, NR; Chung, IF				Chen, Yi-Cheng; Aguan, Kripamoy; Yang, Chu-Wen; Wang, Yao-Tsung; Pal, Nikhil R.; Chung, I-Fang			Discovery of Protein Phosphorylation Motifs through Exploratory Data Analysis	PLOS ONE			English	Article							POSITION-WEIGHT MATRIX; PHOSPHOPROTEOME ANALYSIS; SEQUENCE MOTIFS; CLUSTER VALIDITY; KINASE-C; PREDICTION; SITES; IDENTIFICATION; GENOME; TOOL	Background: The need for efficient algorithms to uncover biologically relevant phosphorylation motifs has become very important with rapid expansion of the proteomic sequence database along with a plethora of new information on phosphorylation sites. Here we present a novel unsupervised method, called Motif Finder (in short, F-Motif) for identification of phosphorylation motifs. F-Motif uses clustering of sequence information represented by numerical features that exploit the statistical information hidden in some foreground data. Furthermore, these identified motifs are then filtered to find "actual" motifs with statistically significant motif scores. Results and Discussion: We have applied F-Motif to several new and existing data sets and compared its performance with two well known state-of-the-art methods. In almost all cases F-Motif could identify all statistically significant motifs extracted by the state-of-the-art methods. More importantly, in addition to this, F-Motif uncovers several novel motifs. We have demonstrated using clues from the literature that most of these new motifs discovered by F-Motif are indeed novel. We have also found some interesting phenomena. For example, for CK2 kinase, the conserved sites appear only on the right side of S. However, for CDK kinase, the adjacent site on the right of S is conserved with residue P. In addition, three different encoding methods, including a novel position contrast matrix (PCM) and the simplest binary coding, are used and the ability of F-motif to discover motifs remains quite robust with respect to encoding schemes. Conclusions: An iterative algorithm proposed here uses exploratory data analysis to discover motifs from phosphorylated data. The effectiveness of F-Motif has been demonstrated using several real data sets as well as using a synthetic data set. The method is quite general in nature and can be used to find other types of motifs also. We have also provided a server for F-Motif at http://f-motif.classcloud.org/, http://bio.classcloud.org/f-motif/ or http://ymu.classcloud.org/f-motif/.	[Chen, Yi-Cheng; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chung, I-Fang] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Aguan, Kripamoy] NE Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India; [Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan; [Wang, Yao-Tsung] Natl Ctr High Performance Comp, Software Technol Div, Taichung, Taiwan; [Pal, Nikhil R.] Indian Stat Inst, Elect & Commun Sci Unit, Kolkata 700035, W Bengal, India	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; North Eastern Hill University; Soochow University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Chen, YC (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	ifchung@ym.edu.tw			National Science Council (NSC) [NSC99-2221-E-010-013]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC) (NSC99-2221-E-010-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bezdek J. C., 1999, FUZZY MODELS ALGORIT, V4, DOI 10.1007/b106267; Bezdek JC, 1998, IEEE T SYST MAN CY B, V28, P301, DOI 10.1109/3477.678624; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Claverie JM, 1996, COMPUT APPL BIOSCI, V12, P431; CLAVERIE JM, 1994, COMPUT CHEM, V18, P287, DOI 10.1016/0097-8485(94)85024-0; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Nishida K, 2009, NUCLEIC ACIDS RES, V37, P939, DOI 10.1093/nar/gkn1019; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PAL NR, 1995, IEEE T FUZZY SYST, V3, P370, DOI 10.1109/91.413225; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Qiu P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-29; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Ritz A, 2009, BIOINFORMATICS, V25, P14, DOI 10.1093/bioinformatics/btn569; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; VILLE NJ, 2007, P NATL ACAD SCI USA, V104, P1488; Yoo PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-272; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	43	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20025	10.1371/journal.pone.0020025	http://dx.doi.org/10.1371/journal.pone.0020025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647451	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500019
J	Gambrill, E; Reiman, A				Gambrill, Eileen; Reiman, Amanda			A Propaganda Index for Reviewing Problem Framing in Articles and Manuscripts: An Exploratory Study	PLOS ONE			English	Article							EXTENDED-RELEASE; VENLAFAXINE	Objective: To determine the effectiveness of an index in increasing recognition of misleading problem framing in articles and manuscripts. Design: A propaganda index consisting of 32 items was developed drawing on related literature. Seventeen subjects who review manuscripts for possible publication were requested to read five recent published reports of randomized controlled trials concerning social anxiety and to identify indicators of propaganda (defined as encouraging beliefs and actions with the least thought possible). They then re-read the same five articles using a propaganda index to note instances of propaganda. Data source: Convenience sample of individuals who review manuscripts for possible publication and sample of recent published reports of randomized controlled trials regarding social anxiety in five different journals by different authors, blinded by author and journal. Results: Data showed that there was a high rate of propagandistic problem framing in reports of RCTs regarding social anxiety such as hiding well argued alternative views and vagueness. This occurred in 117 out of 160 opportunities over five research reports. A convenience sample of 17 academics spotted only 4.5 percent of propaganda indicators. This increased to 64 percent with use of the 32 item propaganda index. Use of a propaganda index increased recognition of related indicators. However many instances remained undetected. Conclusion: This propaganda index warrants further exploration as a complement to reporting guidelines such as CONSORT and PRISMA.	[Gambrill, Eileen] Univ Calif Berkeley, Sch Social Welf, Berkeley, CA 94720 USA; [Reiman, Amanda] Berkeley Patients Grp, Berkeley, CA USA	University of California System; University of California Berkeley	Gambrill, E (corresponding author), Univ Calif Berkeley, Sch Social Welf, Berkeley, CA 94720 USA.	gambrill@berkeley.edu			Hutto Patterson Chair in Child and Family Studies	Hutto Patterson Chair in Child and Family Studies	This research was supported by funds from the first author's Chair, The Hutto Patterson Chair in Child and Family Studies. The second author was a 100% FTE employee of the School of Social Welfare, University of California at Berkeley when she joined the project (around April 2009), and participated in conducting the data analysis. Her position carried on until July 2010. Other than funds from the first author's chair, which can be used at the Chairholder's discretion, there was no additional external funding for this study. The Chair funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Brewin CR, 2006, BEHAV RES THER, V44, P765, DOI 10.1016/j.brat.2006.02.005; Conrad P, 2007, MED SOC; Cunningham, 2002, IDEA PROPAGANDA RECO; Ellul J., 1965, PROPAGANDA FORMATION; Gambrill E, 2010, RES SOCIAL WORK PRAC, V20, P302, DOI 10.1177/1049731509347879; GRAY JAM, 2001, EVIDENCE BASED PATIE; Horowitz AV, 2007, LOSS SADNESS PSYCHIA; ILLICH I, 1976, LIMITS MED; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Lane Christopher, 2007, SHYNESS NORMAL BEHAV; Liebowitz MR, 2005, J CLIN PSYCHIAT, V66, P238, DOI 10.4088/JCP.v66n0213; Lo B, 2009, CONFLICT INTEREST ME; McEvoy PM, 2009, J ANXIETY DISORD, V23, P519, DOI 10.1016/j.janxdis.2008.10.008; Mortberg E, 2007, ACTA PSYCHIAT SCAND, V115, P142, DOI 10.1111/j.1600-0447.2006.00839.x; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Payer L., 1992, DIS MONGERS DOCTORS; RENNIE D, 2007, JAMA-J AM MED ASSOC, V298, P20; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Stein MB, 2005, PSYCHOPHARMACOLOGY, V177, P280, DOI 10.1007/s00213-004-1957-9; Woloshin S, 2006, PLOS MED, V3, P452, DOI 10.1371/journal.pmed.0030170; Wolpe J., 1990, PRACTICE BEHAV THERA	22	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19516	10.1371/journal.pone.0019516	http://dx.doi.org/10.1371/journal.pone.0019516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21647426	Green Published, gold			2022-12-27	WOS:000291006500004
J	Dunyo, S; Sirugo, G; Sesay, S; Bisseye, C; Njie, F; Adiamoh, M; Nwakanma, D; Diatta, M; Janha, R; Joof, FS; Temple, B; Snell, P; Conway, D; Walton, R; Cheung, YB; Milligan, P				Dunyo, Samuel; Sirugo, Giorgio; Sesay, Sanie; Bisseye, Cyrille; Njie, Fanta; Adiamoh, Majidah; Nwakanma, Davis; Diatta, Mathurin; Janha, Ramatoulie; Joof, Fatou Sisay; Temple, Beth; Snell, Paul; Conway, David; Walton, Robert; Cheung, Yin Bun; Milligan, Paul			Randomized Trial of Safety and Effectiveness of Chlorproguanil-Dapsone and Lumefantrine-Artemether for Uncomplicated Malaria in Children in The Gambia	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM; ANTIMALARIAL-DRUGS; AFRICAN CHILDREN; BLIND; DEFICIENCY; ARTESUNATE; G6PD; POLYMORPHISM; METABOLISM	Background: Chlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety in G6PD deficient patients. This trial was conducted in 2004 to evaluate the safety and effectiveness of CD and comparison with artemether-lumefantrine (AL) under conditions of routine use in G6PD normal and G6PD deficient patients with uncomplicated malaria in The Gambia. We also examined the effects of a common genetic variant that affects chlorproguanil metabolism on risk of treatment failure. Methods: 1238 children aged 6 months to 10 years with uncomplicated malaria were randomized to receive CD or artemether-lumefantrine (AL) and followed for 28 days. The first dose was supervised, subsequent doses given unsupervised at home. G6PD genotype was determined to assess the interaction between treatment and G6PD status in their effects on anaemia. The main endpoints were clinical treatment failure by day 28, incidence of severe anaemia (Hb<5 g/dL), and haemoglobin concentration on day 3. Findings: One third of patients treated with AL, and 6% of patients treated with CD, did not complete their course of medication. 18% (109/595) of children treated with CD and 6.1% (36/587) with AL required rescue medication within 4 weeks, risk difference 12% (95% CI 8.9%-16%). 23 children developed severe anaemia (17 (2.9%) treated with CD and 6 (1.0%) with AL, risk difference 1.8%, 95% CI 0.3%-3.4%, P = 0.02). Haemoglobin concentration on day 3 was lower among children treated with CD than AL (difference 0.43 g/dL, 95% CI 0.24 to 0.62), and within the CD group was lower among those children who had higher parasite density at enrolment. Only 17 out of 1069 children who were typed were G6PD A-deficient, of these 2/9 treated with CD and 1/8 treated with AL developed severe anaemia. 5/9 treated with CD had a fall of 2 g/dL or more in haemoglobin concentration by day 3. Interpretation: AL was well tolerated and highly effective and when given under operational conditions despite poor adherence to the six-dose regimen. There were more cases of severe malaria and anaemia after CD treatment although G6PD deficiency was uncommon.	[Dunyo, Samuel; Sirugo, Giorgio; Sesay, Sanie; Bisseye, Cyrille; Njie, Fanta; Adiamoh, Majidah; Nwakanma, Davis; Diatta, Mathurin; Janha, Ramatoulie; Joof, Fatou Sisay; Snell, Paul; Conway, David; Walton, Robert] MRC Labs, Banjul, Gambia; [Temple, Beth; Cheung, Yin Bun; Milligan, Paul] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Dunyo, S (corresponding author), MRC Labs, Banjul, Gambia.	paul.milligan@lshtm.ac.uk	Sesay, Sanie Samuel Sogoyan/M-2982-2014; Milligan, Paul/D-8985-2017; Temple, Beth/ABC-6583-2020; Janha, Ramatoulie/CAH-4017-2022; Bisseye, C./AFO-0118-2022; Sirugo, Giorgio/L-1628-2016; Bisseye, Cyrille/AGP-8782-2022; Sirugo, Giorgio/N-9056-2019	Sesay, Sanie Samuel Sogoyan/0000-0001-6233-7854; Milligan, Paul/0000-0003-3430-3395; Temple, Beth/0000-0002-4885-9848; Bisseye, Cyrille/0000-0002-6888-6317; Conway, David/0000-0002-8711-3037; /0000-0003-1151-6400; Nwakanma, Davis/0000-0002-6706-6069; Walton, Robert/0000-0001-7700-1907	Medical Research Council; Medical Research Council [MC_U190081977, G0700837] Funding Source: researchfish; MRC [MC_U190081977, G0700837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council. CD was supplied by GSK pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Amin AA, 2004, TROP MED INT HEALTH, V9, P967, DOI 10.1111/j.1365-3156.2004.01291.x; Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Boxtel C. J. van, 2005, International Journal of Risk & Safety in Medicine, V17, P169; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Krattiger A., 2007, EXECUTIVE GUIDE INTE, P11; Lang T, 2006, LANCET INFECT DIS, V6, P46, DOI 10.1016/S1473-3099(05)70326-1; Lang T, 2003, LANCET INFECT DIS, V3, P162, DOI 10.1016/S1473-3099(03)00547-4; LUZZATTO L, 1998, OXFORD TXB MED, P3537; Luzzatto L, 2010, LANCET, V376, P739, DOI 10.1016/S0140-6736(10)60396-0; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; ROGERS L, 2005, SUNDAY TIMES    0612; Schoepflin S, 2010, AM J TROP MED HYG, V82, P529, DOI 10.4269/ajtmh.2010.09-0334; Sirugo G, 2004, AM J MED GENET A, V128A, P104, DOI 10.1002/ajmg.a.30080; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; Walton R, 2005, NAT GENET, V37, P915, DOI 10.1038/ng0905-915; *WHO, 2008, QSMMCIEA117 WHO; *WHO, 2004, REV SAF CHLORPR TREA; Winstanley P, 1997, T ROY SOC TROP MED H, V91, P322, DOI 10.1016/S0035-9203(97)90093-6; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	35	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e17371	10.1371/journal.pone.0017371	http://dx.doi.org/10.1371/journal.pone.0017371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666744	gold, Green Published, Green Accepted			2022-12-27	WOS:000291607000002
J	Soltani, M; Chen, P				Soltani, M.; Chen, P.			Numerical Modeling of Fluid Flow in Solid Tumors	PLOS ONE			English	Article							INTERSTITIAL PRESSURE; DRUG-DELIVERY; ANTIANGIOGENIC THERAPY; MAMMARY-TUMORS; BRAIN-TISSUE; BLOOD-FLOW; TRANSPORT; MACROMOLECULES; SIMULATION; VASCULATURE	A mathematical model of interstitial fluid flow is developed, based on the application of the governing equations for fluid flow, i.e., the conservation laws for mass and momentum, to physiological systems containing solid tumors. The discretized form of the governing equations, with appropriate boundary conditions, is developed for a predefined tumor geometry. The interstitial fluid pressure and velocity are calculated using a numerical method, element based finite volume. Simulations of interstitial fluid transport in a homogeneous solid tumor demonstrate that, in a uniformly perfused tumor, i.e., one with no necrotic region, because of the interstitial pressure distribution, the distribution of drug particles is non-uniform. Pressure distribution for different values of necrotic radii is examined and two new parameters, the critical tumor radius and critical necrotic radius, are defined. Simulation results show that: 1) tumor radii have a critical size. Below this size, the maximum interstitial fluid pressure is less than what is generally considered to be effective pressure (a parameter determined by vascular pressure, plasma osmotic pressure, and interstitial osmotic pressure). Above this size, the maximum interstitial fluid pressure is equal to effective pressure. As a consequence, drugs transport to the center of smaller tumors is much easier than transport to the center of a tumor whose radius is greater than the critical tumor radius; 2) there is a critical necrotic radius, below which the interstitial fluid pressure at the tumor center is at its maximum value. If the tumor radius is greater than the critical tumor radius, this maximum pressure is equal to effective pressure. Above this critical necrotic radius, the interstitial fluid pressure at the tumor center is below effective pressure. In specific ranges of these critical sizes, drug amount and therefore therapeutic effects are higher because the opposing force, interstitial fluid pressure, is low in these ranges.	[Soltani, M.; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Soltani, M (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1991, MICROVASC RES, V41, P5, DOI 10.1016/0026-2862(91)90003-T; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bear J., 1988, DYNAMICS UIDS POROUS; Blakeslee S., 1989, IMPENETRABLE TUMORS; BOUCHER Y, 1990, CANCER RES, V50, P4478; BUTLER TP, 1975, CANCER RES, V35, P3084; CAMPBELL N, 1996, BIOLOGY; Chapman SJ, 2008, B MATH BIOL, V70, P2334, DOI 10.1007/s11538-008-9349-7; Curry F, 1984, HDB PHYSL 2; De Boer R., 2000, THEORY POROUS MEDIA; Goh YMF, 2001, PHARM RES-DORDR, V18, P761, DOI 10.1023/A:1011076110317; GOLDACRE RJ, 1962, BRIT J CANCER, V16, P306, DOI 10.1038/bjc.1962.36; GROSS JF, 1979, TUMOR BLOOD CIRCULAT; Gullino PM, 1975, EXTRACELLULAR COMPAR; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; JAIN RK, 1988, CANCER RES, V48, P7022; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; JAIN RK, 1987, CANCER RES, V47, P3039; Jain RK, 1984, IEEE T SONICS ULTRAS, V31; JAIN RK, 1988, VASCULAR ENDOTHELIUM, P215; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; JONES PL, 1986, CANCER IMMUNOL IMMUN, V22, P139; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; NETTI PA, 1995, CANCER RES, V55, P5451; Netti PA, 1999, P NATL ACAD SCI USA, V96, P3137, DOI 10.1073/pnas.96.6.3137; Pozrikidis C, 2003, ANN BIOMED ENG, V31, P181, DOI 10.1114/1.1540103; SALATHE EP, 1976, MICROVASC RES, V11, P1, DOI 10.1016/0026-2862(76)90072-8; SALTZMAN WM, 1991, CHEM ENG SCI, V46, P2429, DOI 10.1016/0009-2509(91)80036-X; SANDS H, 1988, CANCER RES, V48, P188; SCHEIDEGGER AE, 1963, PHYS OW POROUS MEDIA; Soltani M, 2009, ADV SCI LETT, V2, P347, DOI 10.1166/asl.2009.1044; Starling E H, 1896, J Physiol, V19, P312; Tan WHK, 2003, BIOTECHNOL BIOENG, V82, P278, DOI 10.1002/bit.10571; Tan WHK, 2003, J PHARM SCI, V92, P773, DOI 10.1002/jps.10351; Teo CS, 2005, CHEM ENG SCI, V60, P4803, DOI 10.1016/j.ces.2005.04.008; Wang CH, 1998, CHEM ENG SCI, V53, P3579, DOI 10.1016/S0009-2509(98)00173-0; Wang CH, 1999, J CONTROL RELEASE, V61, P21, DOI 10.1016/S0168-3659(99)00098-X; WIIG H, 1982, SCAND J CLIN LAB INV, V42, P159; YOUNG JS, 1950, J PATHOL BACTERIOL, V62, P313, DOI 10.1002/path.1700620303; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003	43	127	127	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20344	10.1371/journal.pone.0020344	http://dx.doi.org/10.1371/journal.pone.0020344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673952	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400004
J	Baiser, B; Ardeshiri, RS; Ellison, AM				Baiser, Benjamin; Ardeshiri, Roxanne S.; Ellison, Aaron M.			Species Richness and Trophic Diversity Increase Decomposition in a Co-Evolved Food Web	PLOS ONE			English	Article							PLANT SARRACENIA-PURPUREA; ECOSYSTEM FUNCTION; FUNCTIONAL DIVERSITY; TOP-DOWN; POPULATION-DYNAMICS; BIODIVERSITY; COMMUNITY; MUTUALISM; CONSEQUENCES; PRODUCTIVITY	Ecological communities show great variation in species richness, composition and food web structure across similar and diverse ecosystems. Knowledge of how this biodiversity relates to ecosystem functioning is important for understanding the maintenance of diversity and the potential effects of species losses and gains on ecosystems. While research often focuses on how variation in species richness influences ecosystem processes, assessing species richness in a food web context can provide further insight into the relationship between diversity and ecosystem functioning and elucidate potential mechanisms underpinning this relationship. Here, we assessed how species richness and trophic diversity affect decomposition rates in a complete aquatic food web: the five trophic level web that occurs within water-filled leaves of the northern pitcher plant, Sarracenia purpurea. We identified a trophic cascade in which top-predators - larvae of the pitcher-plant mosquito - indirectly increased bacterial decomposition by preying on bactivorous protozoa. Our data also revealed a facultative relationship in which larvae of the pitcher-plant midge increased bacterial decomposition by shredding detritus. These important interactions occur only in food webs with high trophic diversity, which in turn only occur in food webs with high species richness. We show that species richness and trophic diversity underlie strong linkages between food web structure and dynamics that influence ecosystem functioning. The importance of trophic diversity and species interactions in determining how biodiversity relates to ecosystem functioning suggests that simply focusing on species richness does not give a complete picture as to how ecosystems may change with the loss or gain of species.	[Baiser, Benjamin; Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Ardeshiri, Roxanne S.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Harvard University; University of California System; University of California Berkeley	Baiser, B (corresponding author), Harvard Univ, Petersham, MA USA.	bbaiser@fas.harvard.edu		Ellison, Aaron/0000-0003-4151-6081	NSF [DEB 05-41680]	NSF(National Science Foundation (NSF))	NSF grant DEB 05-41680 http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Baiser B, 2011, GLOBAL ECOL BIOGEOGR, V20, P134, DOI 10.1111/j.1466-8238.2010.00583.x; Baiser B, 2010, OIKOS, V119, P1970, DOI 10.1111/j.1600-0706.2010.18557.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bleher B, 2001, OECOLOGIA, V129, P385, DOI 10.1007/s004420100747; Buckley HL, 2010, GLOBAL ECOL BIOGEOGR, V19, P711, DOI 10.1111/j.1466-8238.2010.00554.x; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ellis BK, 2011, P NATL ACAD SCI USA, V108, P1070, DOI 10.1073/pnas.1013006108; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Fashing NJ, 1998, EXP APPL ACAROL, V22, P435, DOI 10.1023/A:1006081622519; FASHING NJ, 2004, BIOL SARRACENIOPUS D, P299; FORSYTH AB, 1975, CAN J ZOOL, V53, P174, DOI 10.1139/z75-022; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; HEPBURN JS, 1927, T WAGNER FREE I SCI, V11, P49; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; Hoekman D, 2009, J N AM BENTHOL SOC, V28, P552, DOI 10.1899/08-131.1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; LAWLER SP, 1993, J ANIM ECOL, V62, P711, DOI 10.2307/5391; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Miller TE, 2002, COMMUNITY ECOL, V3, P109, DOI 10.1556/ComEc.3.2002.1.13; MORIN PJ, 1995, ANNU REV ECOL SYST, V26, P505, DOI 10.1146/annurev.es.26.110195.002445; Mouquet N, 2008, FUNCT ECOL, V22, P728, DOI 10.1111/j.1365-2435.2008.01421.x; Naeem S, 2002, ECOLOGY, V83, P2925; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2008, AM NAT, V171, P568, DOI 10.1086/587068; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; SWAN JMA, 1970, ECOLOGY, V51, P829, DOI 10.2307/1933975; Thompson R, 2007, BIODIVERS CONSERV, V16, P1359, DOI 10.1007/s10531-005-6232-9; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wall DH, 1999, BIOSCIENCE, V49, P109, DOI 10.2307/1313536; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Yodzis P, 1999, OIKOS, V87, P327, DOI 10.2307/3546748	65	32	34	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20672	10.1371/journal.pone.0020672	http://dx.doi.org/10.1371/journal.pone.0020672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673992	gold, Green Published, Green Submitted			2022-12-27	WOS:000291355500030
J	Mantell, BS; Stefanovic-Racic, M; Yang, X; Dedousis, N; Sipula, IJ; O'Doherty, RM				Mantell, Benjamin S.; Stefanovic-Racic, Maja; Yang, Xiao; Dedousis, Nikolas; Sipula, Ian J.; O'Doherty, Robert M.			Mice Lacking NKT Cells but with a Complete Complement of CD8(+) T-Cells Are Not Protected against the Metabolic Abnormalities of Diet-Induced Obesity	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; INDUCED HEPATIC STEATOSIS; MURINE FATTY LIVERS; ADIPOSE-TISSUE; GLUCOSE-INTOLERANCE; SKELETAL-MUSCLE; OB/OB MICE; INFLAMMATION; INFILTRATION; LYMPHOCYTES	The contribution of natural killer T (NKT) cells to the pathogenesis of metabolic abnormalities of obesity is controversial. While the combined genetic deletion of NKT and CD8(+) T-cells improves glucose tolerance and reduces inflammation, interpretation of these data have been complicated by the recent observation that the deletion of CD8(+) T-cells alone reduces obesity-induced inflammation and metabolic dysregulation, leaving the issue of the metabolic effects of NKT cell depletion unresolved. To address this question, CD1d null mice (CD1d(-)/(-)), which lack NKT cells but have a full complement of CD8(+) T-cells, and littermate wild type controls (WT) on a pure C57BL/6J background were exposed to a high fat diet, and glucose intolerance, insulin resistance, dyslipidemia, inflammation, and obesity were assessed. Food intake (15.5 +/- 4.3 vs 15.3 +/- 1.8 kcal/mouse/day), weight gain (21.8 +/- 1.8 vs 22.8 +/- 1.4 g) and fat mass (18.6 +/- 1.9 vs 19.5 +/- 2.1 g) were similar in CD1d(-)/(-) and WT, respectively. As would be expected from these data, metabolic rate (3.0 +/- 0.1 vs 2.9 +/- 0.2 ml O-2/g/h) and activity (21.6 +/- 4.3 vs 18.5 +/- 2.6 beam breaks/min) were unchanged by NKT cell depletion. Furthermore, the degree of insulin resistance, glucose intolerance, liver steatosis, and adipose and liver inflammatory marker expression (TNF alpha, IL-6, IL-10, IFN-gamma, MCP-1, MIP1 alpha) induced by high fat feeding in CD1d(-)/(-) were not different from WT. We conclude that deletion of NKT cells, in the absence of alterations in the CD8(+) T-cell population, is insufficient to protect against the development of the metabolic abnormalities of diet-induced obesity.	[Mantell, Benjamin S.; Stefanovic-Racic, Maja; Yang, Xiao; Dedousis, Nikolas; Sipula, Ian J.; O'Doherty, Robert M.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA; [O'Doherty, Robert M.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Doherty, RM (corresponding author), Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA.	rmo1@pitt.edu	Mantell, Benjamin/ABE-2117-2020	Mantell, Benjamin/0000-0002-7700-6975	NIH [RO1 DK058855, K08 DK67272, F30 DK085865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067272, R01DK058855, F30DK085865] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIH RO1 DK058855 (to ROD) NIH K08 DK67272 (to M.S.R.), and NIH F30 DK085865 (to BSM).	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Dube JJ, 2007, AM J PHYSIOL-REG I, V293, pR642, DOI 10.1152/ajpregu.00133.2007; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Miyazaki Y, 2008, SCAND J IMMUNOL, V67, P230, DOI 10.1111/j.1365-3083.2007.02062.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603	25	108	110	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e19831	10.1371/journal.pone.0019831	http://dx.doi.org/10.1371/journal.pone.0019831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674035	gold, Green Published, Green Submitted			2022-12-27	WOS:000291355500004
J	Etheridge, T; Nemoto, K; Hashizume, T; Mori, C; Sugimoto, T; Suzuki, H; Fukui, K; Yamazaki, T; Higashibata, A; Szewczyk, NJ; Higashitani, A				Etheridge, Timothy; Nemoto, Kanako; Hashizume, Toko; Mori, Chihiro; Sugimoto, Tomoko; Suzuki, Hiromi; Fukui, Keiji; Yamazaki, Takashi; Higashibata, Akira; Szewczyk, Nathaniel J.; Higashitani, Atsushi			The Effectiveness of RNAi in Caenorhabditis elegans Is Maintained during Spaceflight	PLOS ONE			English	Article							SPACE-FLIGHT; DURATION SPACEFLIGHT; GENE; INTERFERENCE; EXPRESSION	Background: Overcoming spaceflight-induced (patho)physiologic adaptations is a major challenge preventing long-term deep space exploration. RNA interference (RNAi) has emerged as a promising therapeutic for combating diseases on Earth; however the efficacy of RNAi in space is currently unknown. Methods: Caenorhabditis elegans were prepared in liquid media on Earth using standard techniques and treated acutely with RNAi or a vector control upon arrival in Low Earth Orbit. After culturing during 4 and 8 d spaceflight, experiments were stopped by freezing at -80 degrees C until analysis by mRNA and microRNA array chips, microscopy and Western blot on return to Earth. Ground controls (GC) on Earth were simultaneously grown under identical conditions. Results: After 8 d spaceflight, mRNA expression levels of components of the RNAi machinery were not different from that in GC (e.g., Dicer, Argonaute, Piwi; P>0.05). The expression of 228 microRNAs, of the 232 analysed, were also unaffected during 4 and 8 d spaceflight (P>0.05). In spaceflight, RNAi against green fluorescent protein (gfp) reduced chromosomal gfp expression in gonad tissue, which was not different from GC. RNAi against rbx-1 also induced abnormal chromosome segregation in the gonad during spaceflight as on Earth. Finally, culture in RNAi against lysosomal cathepsins prevented degradation of the muscle-specific alpha-actin protein in both spaceflight and GC conditions. Conclusions: Treatment with RNAi works as effectively in the space environment as on Earth within multiple tissues, suggesting RNAi may provide an effective tool for combating spaceflight-induced pathologies aboard future long-duration space missions. Furthermore, this is the first demonstration that RNAi can be utilised to block muscle protein degradation, both on Earth and in space.	[Etheridge, Timothy; Szewczyk, Nathaniel J.] Univ Nottingham, Div Clin Physiol, Royal Derby Hosp, Derby, England; [Nemoto, Kanako; Mori, Chihiro; Higashitani, Atsushi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Hashizume, Toko] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan; [Sugimoto, Tomoko; Yamazaki, Takashi; Higashibata, Akira] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, ISS Sci Project Off, Tsukuba, Ibaraki, Japan	University of Nottingham; Tohoku University; Advanced Engineering Services Co., Ltd. (A.E.S.); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Etheridge, T (corresponding author), Univ Nottingham, Div Clin Physiol, Royal Derby Hosp, Derby, England.	nathaniel.szewczyk@nottingham.ac.uk; ahigashi@ige.tohoku.ac.jp	Higashitani, Atsushi/G-7086-2015; Higashitani, Atsushi/AAT-9617-2021	Higashitani, Atsushi/0000-0001-6920-0594; Higashitani, Atsushi/0000-0001-6920-0594; Etheridge, Timothy/0000-0002-3588-8711; Szewczyk, Nathaniel/0000-0003-4425-9746	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Japan Space Forum; Medical Research Council UK [G0801271]; National Institutes of Health [NIH NIAMS ARO54342]; Medical Research Council [G0801271] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054342] Funding Source: NIH RePORTER; MRC [G0801271] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Space Forum; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Science, and "Ground-Based Research Announcement for Space Utilization" promoted by the Japan Space Forum. TE was supported by the Medical Research Council UK (G0801271). NJS was supported by the National Institutes of Health (NIH NIAMS ARO54342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Couzin-Frankel J, 2010, SCIENCE, V330, P1163, DOI 10.1126/science.330.6008.1163; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Demling R H, 1999, Adv Wound Care, V12, P1; Durante M, 2003, CYTOGENET GENOME RES, V103, P40, DOI 10.1159/000076288; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fire A, 2005, Q REV BIOPHYS, V38, P303, DOI 10.1017/S0033583505004117; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Hartman PS, 2001, MUTAT RES-FUND MOL M, V474, P47, DOI 10.1016/S0027-5107(00)00154-8; Higashibata A, 2006, J EXP BIOL, V209, P3209, DOI 10.1242/jeb.02365; Higashitani A, 2005, APOPTOSIS, V10, P949, DOI 10.1007/s10495-005-1323-3; HIGASHITANI A, 2010, BIOL SCI SPACE, V23, P183; Kotakis C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-220; Lane HW, 1998, NUTR RES, V18, P1923, DOI 10.1016/S0271-5317(98)00162-6; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Praitis V, 2001, GENETICS, V157, P1217; Sasagawa Y, 2003, GENES CELLS, V8, P857, DOI 10.1046/j.1365-2443.2003.00682.x; Selch F, 2008, ADV SPACE RES, V41, P807, DOI 10.1016/j.asr.2007.11.015; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; STEFFEN JM, 1986, AM J PHYSIOL, V251, pR1059, DOI 10.1152/ajpregu.1986.251.6.R1059; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Szewczyk NJ, 2005, ASTROBIOLOGY, V5, P690, DOI 10.1089/ast.2005.5.690; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104	27	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20459	10.1371/journal.pone.0020459	http://dx.doi.org/10.1371/journal.pone.0020459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673804	Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900021
J	Sihvonen, P; Mutanen, M; Kaila, L; Brehm, G; Hausmann, A; Staude, HS				Sihvonen, Pasi; Mutanen, Marko; Kaila, Lauri; Brehm, Gunnar; Hausmann, Axel; Staude, Hermann S.			Comprehensive Molecular Sampling Yields a Robust Phylogeny for Geometrid Moths (Lepidoptera: Geometridae)	PLOS ONE			English	Article							EMERALD MOTHS; GENERA LEPIDOPTERA; EVOLUTION; CLASSIFICATION; ENNOMINAE; OENOCHROMINAE; BIOGEOGRAPHY; SUBFAMILIES; LARENTIINAE; STERRHINAE	Background: The moth family Geometridae (inchworms or loopers), with approximately 23 000 described species, is the second most diverse family of the Lepidoptera. Apart from a few recent attempts based on morphology and molecular studies, the phylogeny of these moths has remained largely uninvestigated. Methodology/Principal Findings: We performed a rigorous and extensive molecular analysis of eight genes to examine the geometrid affinities in a global context, including a search for its potential sister-taxa. Our maximum likelihood analyses included 164 taxa distributed worldwide, of which 150 belong to the Geometridae. The selected taxa represent all previously recognized subfamilies and nearly 90% of recognized tribes, and originate from all over world. We found the Geometridae to be monophyletic with the Sematuridae+Epicopeiidae clade potentially being its sister-taxon. We found all previously recognized subfamilies to be monophyletic, with a few taxa misplaced, except the Oenochrominae+Desmobathrinae complex that is a polyphyletic assemblage of taxa and the Orthostixinae, which was positioned within the Ennominae. The Sterrhinae and Larentiinae were found to be sister to the remaining taxa, followed by Archiearinae, the polyphyletic assemblage of Oenochrominae+Desmobathrinae moths, Geometrinae and Ennominae. Conclusions/Significance: Our study provides the first comprehensive phylogeny of the Geometridae in a global context. Our results generally agree with the other, more restricted studies, suggesting that the general phylogenetic patterns of the Geometridae are now well-established. Generally the subfamilies, many tribes, and assemblages of tribes were well supported but their interrelationships were often weakly supported by our data. The Eumeleini were particularly difficult to place in the current system, and several tribes were found to be para-or polyphyletic.	[Sihvonen, Pasi] Univ Helsinki, Res Funding Serv, Helsinki, Finland; [Mutanen, Marko] Univ Oulu, Zool Museum, Oulu, Finland; [Kaila, Lauri] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Brehm, Gunnar] Phylet Museum, Inst Spezielle Zool & Evolut Biol, Jena, Germany; [Hausmann, Axel] Staatliche Nat Wissensch Sammlungen Bayerns, Munich, Germany	University of Helsinki; University of Oulu; University of Helsinki	Sihvonen, P (corresponding author), Univ Helsinki, Res Funding Serv, Helsinki, Finland.	pasi.sihvonen@helsinki.fi	Brehm, Gunnar/D-5831-2013	Brehm, Gunnar/0000-0002-7599-2847; Kaila, Lauri/0000-0003-0277-1872; Sihvonen, Pasi/0000-0003-2237-9325	Academy of Finland [1110906]	Academy of Finland(Academy of Finland)	Lauri Kaila was supported by the Academy of Finland (project 1110906, URL: http://www.aka.fi/fi/A/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2001, MOL PHYLOGENET EVOL, V20, P65, DOI 10.1006/mpev.2001.0949; [Anonymous], 2 S NEOTR LEP AR PER; [Anonymous], 1996, LEPIDOPTERA EUROPE D; [Anonymous], GROSS SCHMETTERLINGE; BELJAEV E, 2008, M MEM N A CHOL, V60; BELJAEV E, 2006, TENTATIVE TRIBAL SYS; Beljaev E. A., 2009, Evraziatskii entomologicheskii Zhurnal, V8, P249; BODNER F, 2007, THESIS U WIEN; Canfield MR, 2008, MOL PHYLOGENET EVOL, V49, P477, DOI 10.1016/j.ympev.2008.07.003; Choi Sei-Woong, 2003, Insecta Koreana, V20, P313; Choi SW, 1997, SYST ENTOMOL, V22, P287, DOI 10.1046/j.1365-3113.1997.d01-49.x; COOK MA, 1994, BIOCHEM SYST ECOL, V22, P43, DOI 10.1016/0305-1978(94)90113-9; COOK MA, 1992, SYST ENTOMOL, V17, P219, DOI 10.1111/j.1365-3113.1992.tb00334.x; CRAW RC, 1987, NEW ZEAL J ZOOL, V14, P269, DOI 10.1080/03014223.1987.10422997; Daniels G., 1993, Australian Entomologist, V20, P66; Ferguson D.C., 1985, P1; Ferguson Douglas C., 2008, P1; FLETCHER D. S., 1953, ACTA ZOOL LILLOANA, V13, P367; Fletcher D.S., 1979, GENERIC NAMES MOTHS, V3, P1; Han HX, 2009, J NAT HIST, V43, P885, DOI 10.1080/00222930802702472; Hausmann A., 2001, GEOMETRID MOTHS EURO, V1, P1, DOI DOI 10.1007/978-1-4757-3423-2_; Hausmann Axel, 1996, Nota Lepidopterologica, V19, P91; Hausmann Axel, 1996, Nota Lepidopterologica, V19, P3; Hausmann A, 2009, ZOOTAXA, P1; Hausmann Axel, 2004, V2, P7; Herbulot C., 1961, ALEXANOR, V2, P117; Herbulot C., 1962, ALEXANOR, V2, P147; HODGES RW, 1993, CHECKLIST LEPIDOPTER; Holloway J., 2001, FAUNA MALESIANA HDB, V3; Holloway J. D., 1997, Malayan Nature Journal, V51, P1; Holloway J. D., 1998, Malayan Nature Journal, V52, P1; Holloway J. D., 1996, Malayan Nature Journal, V49, P147; Holloway J.D., 1994, MALAYAN NATURE J, V47, P1; JANSE AJT, 1933, MOTHS S AFRICA, V2; KRUGER M, 2004, ESPERIANA MEMOIR, V1, P241; KULLBERG J, 2001, CHECKLIST FINNISH LE, V6, P45; Lemaire C., 1998, LEPIDOPTERA MOTHS BU, P321; LERAUT P.J.A., 1997, ALEXANOR S; MCQUILLAN PB, 1996, MONOGRAPHS AUSTR LEP, V4, P201; Miller M. A., 2010, CIPRES PORTALS; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1999, EVOLUTION SYSTEMATIC, V1, P301; MINET J, 1999, EVOLUTION SYSTEMATIC, V1, P257; Mironov V., 2003, GEOMETRID MOTHS EURO, V4, P1; MONTGOMERY SL, 1982, ENTOMOL GEN, V8, P27; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; OUNAP E, 2010, THESIS BIOL U TARTUE; Ounap E, 2008, ZOOL SCR, V37, P405, DOI 10.1111/j.1463-6409.2008.00327.x; Ounap E, 2009, AUST J ENTOMOL, V48, P113, DOI 10.1111/j.1440-6055.2009.00695.x; PATOCKA J, 1981, BIOLOGIA, V36, P583; PATOCKA J, 1994, BIOLOGIA, V49, P739; PATOCKA J, 1995, PUPPEN SPANNER LEPID, V45, P231; Pierce F.N., 1914, GENITALIA GROUP GEOM; PINHEY E.C.G., 1975, MOTHS SO AFRICA DESC; Pitkin LM, 2007, ZOOL J LINN SOC-LOND, V150, P343, DOI 10.1111/j.1096-3642.2007.00287.x; Pitkin LM, 2002, ZOOL J LINN SOC-LOND, V135, P121, DOI 10.1046/j.1096-3642.2002.01200.x; Pitkin LM, 1996, ZOOL J LINN SOC-LOND, V118, P309, DOI 10.1006/zjls.1996.0060; Prout LB, 1929, GROSS SCHMETTERLINGE, V16, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Scoble M.J., 2007, ONLINE LIST VALID AV; SCOBLE MJ, 1989, ENTOMOL SCAND, V20, P371; SCOBLE MJ, 1994, ZOOL J LINN SOC-LOND, V111, P99, DOI 10.1006/zjls.1994.1019; Scoble MJ, 2002, ZOOL J LINN SOC-LOND, V134, P257, DOI 10.1046/j.1096-3642.2002.00008.x; Scoble MJ, 1999, GEOMETRID MOTHS WORL, V1 and 2, DOI [10.1071/9780643101050, DOI 10.1071/9780643101050]; Sihvonen P, 2005, ZOOL J LINN SOC-LOND, V143, P473, DOI 10.1111/j.1096-3642.2005.00153.x; Sihvonen P, 2004, SYST ENTOMOL, V29, P324, DOI 10.1111/j.0307-6970.2004.00248.x; Snall N, 2007, BIOL J LINN SOC, V92, P241, DOI 10.1111/j.1095-8312.2007.00834.x; Sommerer Manfred, 1995, Heterocera Sumatrana, V9, P5; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Staude H.S., 2001, Metamorphosis, V12, P125; Staude H.S., 1999, Metamorphosis, V10, P97; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Strutzenberger P, 2010, ZOOL SCR, V39, P603, DOI 10.1111/j.1463-6409.2010.00440.x; Vari L., 2002, CLASSIFICATION CHECK, Vxxii; Viidalepp J., 1996, CHECKLIST GEOMETRIDA; Viidalepp Jaan, 2006, Spixiana, V29, P202; Viidalepp Jaan, 2009, Revue de l'Association Roussillonnaise d'Entomologie, V18, P28; VIVES MORENO A, 1994, CATALOGO SISTEMATICO; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2010, MOL PHYLOGENET EVOL, V55, P929, DOI 10.1016/j.ympev.2010.01.025; Weintraub Jason D., 2004, Fauna of New Zealand, V49, P5; Xue Dayong, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P77; Xue Dayong, 1995, Sinozoologia, V12, P215; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Yen SH, 2007, ZOOL STUD, V46, P262; Young CJ, 2008, ZOOTAXA, P1; Young CJ, 2006, ZOOTAXA, P1; Young CJ, 2003, INSECT SYST EVOL, V34, P81, DOI 10.1163/187631203788964917; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zhang B.C., 1994, INDEX EC IMPORTANT L; 2010, WORLD LIST FAMILY GR	92	95	108	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20356	10.1371/journal.pone.0020356	http://dx.doi.org/10.1371/journal.pone.0020356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673814	Green Published, gold			2022-12-27	WOS:000291309900014
J	Aeby, GS; Williams, GJ; Franklin, EC; Kenyon, J; Cox, EF; Coles, S; Work, TM				Aeby, Greta S.; Williams, Gareth J.; Franklin, Erik C.; Kenyon, Jean; Cox, Evelyn F.; Coles, Steve; Work, Thierry M.			Patterns of Coral Disease across the Hawaiian Archipelago: Relating Disease to Environment	PLOS ONE			English	Article							WHITE-BAND DISEASE; INDO-PACIFIC; ACROPORA-PALMATA; GROWTH ANOMALIES; REEF SYSTEM; KANEOHE BAY; COMMUNITY STRUCTURE; PORITES-COMPRESSA; MODEL SELECTION; PALMYRA ATOLL	In Hawaii, coral reefs occur across a gradient of biological (host abundance), climatic (sea surface temperature anomalies) and anthropogenic conditions from the human-impacted reefs of the main Hawaiian Islands (MHI) to the pristine reefs of the northwestern Hawaiian Islands (NWHI). Coral disease surveys were conducted at 142 sites from across the Archipelago and disease patterns examined. Twelve diseases were recorded from three coral genera (Porites, Montipora, Acropora) with Porites having the highest prevalence. Porites growth anomalies (PorGAs) were significantly more prevalent within and indicative of reefs in the MHI and Porites trematodiasis (PorTrm) was significantly more prevalent within and indicative of reefs in the NWHI. Porites tissue loss syndrome (PorTLS) was also important in driving regional differences but that relationship was less clear. These results highlight the importance of understanding disease ecology when interpreting patterns of disease occurrence. PorTrm is caused by a parasitic flatworm that utilizes multiple hosts during its life cycle (fish, mollusk and coral). All three hosts must be present for the disease to occur and higher host abundance leads to higher disease prevalence. Thus, a high prevalence of PorTrm on Hawaiian reefs would be an indicator of a healthy coral reef ecosystem. In contrast, the high occurrence of PorGAs within the MHI suggests that PorGAs are related, directly or indirectly, to some environmental co-factor associated with increased human population sizes. Focusing on the three indicator diseases (PorGAs, PorTrm, PorTLS) we used statistical modeling to examine the underlying associations between disease prevalence and 14 different predictor variables (biotic and abiotic). All three diseases showed positive associations with host abundance and negative associations with thermal stress. The association with human population density differed among disease states with PorGAs showing a positive and PorTrm showing a negative association, but no significant explanatory power was offered for PorTLS.	[Aeby, Greta S.; Franklin, Erik C.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Williams, Gareth J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Williams, Gareth J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Kenyon, Jean] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Kenyon, Jean] NOAA, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Cox, Evelyn F.] Univ Hawaii W Oahu, Pearl City, HI USA; [Coles, Steve] Bernice P Bishop Museum, Honolulu, HI USA; [Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA	University of Hawaii System; Victoria University Wellington; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; United States Department of the Interior; United States Geological Survey	Aeby, GS (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA.	greta@hawaii.edu; gareth@ucsd.edu	Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090; Kenyon, Jean/0000-0001-7682-475X; Williams, Dr Gareth J./0000-0001-7837-1619; Franklin, Erik/0000-0002-8660-3085	Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA; Hawaii Coral Reef Initiative; National Aeronautics and Space Administration [NAS5-03117]	Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA; Hawaii Coral Reef Initiative; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	GW was supported by a Victoria University of Wellington (VUW) Vice-Chancellor's Strategic Research Scholarship and a New Zealand International Doctoral Research Scholarship. GA was supported by the Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA. Funding for this research came, in part, from the Hawaii Coral Reef Initiative and the Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the officers and crew of the NOAA ships Oscar Elton Sette and Hi'ialakai, for logistic support and field assistance. The Coral Reef Temperature Anomaly Database (CoRTAD) was developed by the NOAA National Oceanographic Data Center and the University of North Carolina, Chapel Hill. It was provided by the NOAA National Oceanographic Data Center at http://www.nodc.noaa.gov/SatelliteData/Cortad/. Human population data was provided by the Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); and Centro Internacional de Agricultura Tropical (CIAT) with funding from the National Aeronautics and Space Administration under Contract NAS5-03117 for the Continued Operation of the Socioeconomic Data and Applications Center (SEDAC). This manuscript was greatly improved by input from two anonymous reviewers.	Aeby G, 2009, P 11 INT COR REEF S, P197; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; AEBY G S, 1992, Bulletin of the Ecological Society of America, V73, P95; AEBY G S, 1991, Pacific Science, V45, P263; Aeby GS, 2007, B MAR SCI, V80, P209; Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887; Aeby Greta S., 1993, P809; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 1998, J PARASITOL, V84, P1259, DOI 10.2307/3284684; Akaike H., 1973, P 2 INT S INF THEOR, P261; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANTONIUS A, 1988, P 6 INT COR REEF S, V3, P145; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; BRAY R, 1989, J NAT HIST, V23, P249; Bruckner AW, 1997, B MAR SCI, V61, P919; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burke L., 2002, REEFS RISK SE ASIA; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BYTHELL J, 1993, MAR POLLUT BULL, V26, P296; CHENG TC, 1974, J INVERTEBR PATHOL, V23, P303, DOI 10.1016/0022-2011(74)90095-0; CIESIN, 2005, CTR INT EARTH SCI IN; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coles SL, 1998, CORAL REEFS, V17, P195, DOI 10.1007/s003380050118; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; FRIEDLANDER A, 2008, STATE CORAL REEF ECO, P219; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Gorley C.K., 2006, GETTING STARTED PRIM; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUNTER CL, 1995, B MAR SCI, V57, P501; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jokiel Paul L., 2007, Pacific Conservation Biology, V13, P60; Kaczmarsky L, 2007, J INVERTEBR PATHOL, V94, P218, DOI 10.1016/j.jip.2006.11.007; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kenyon JC, 2006, PAC SCI, V60, P153, DOI 10.1353/psc.2006.0006; Kenyon Jean C., 2010, Atoll Research Bulletin, P1; Kenyon Jean C., 2006, Atoll Research Bulletin, P505; Lafferty KD, 1997, PARASITOL TODAY, V13, P251, DOI 10.1016/S0169-4758(97)01072-7; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McPeters R.D., 1998, NASATP1998206895; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Palmer CV, 2010, CORAL REEFS, V29, P469, DOI 10.1007/s00338-010-0597-2; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Stimson J, 2011, CORAL REEFS, V30, P133, DOI 10.1007/s00338-010-0672-8; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Vargas-Angel B., 2009, P 11 INT COR REEF S, V1, P175; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Williams GJ, 2011, DIS AQUAT ORGAN, V94, P89, DOI 10.3354/dao02323; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2005, CORAL REEFS, V24, P384, DOI 10.1007/s00338-005-0018-0; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1	90	54	54	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20370	10.1371/journal.pone.0020370	http://dx.doi.org/10.1371/journal.pone.0020370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655248	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600056
J	Askgaard, G; Kristoffersen, US; Mehlsen, J; Kronborg, G; Kjaer, A; Lebech, AM				Askgaard, Gro; Kristoffersen, Ulrik Sloth; Mehlsen, Jesper; Kronborg, Gitte; Kjaer, Andreas; Lebech, Anne-Mette			Decreased Heart Rate Variability in HIV Positive Patients Receiving Antiretroviral Therapy: Importance of Blood Glucose and Cholesterol	PLOS ONE			English	Article							AUTONOMIC DYSFUNCTION; RATE RECOVERY; CARDIOVASCULAR-DISEASE; NEUROPATHY; MORTALITY; RISK; PREDICTOR; IMPACT; AIDS	The presence of autonomic dysfunction in HIV patients is largely unknown. Early studies found autonomic dysfunction in patients with AIDS. Antiretroviral combination therapy (ART) has dramatically changed the course of the disease and improved prognosis and decreased morbidity. Aim: To evaluate whether autonomic dysfunction is present in an ART treated HIV population and if so to identify factors of importance. Methods: HIV patients receiving ART for at least 12 months (n = 97) and an age-matched control group of healthy volunteers (n = 52) were included. All were non-diabetic and had never received medication for hypertension. Following a 10 min resting period a 15 min ECG recording was performed. Heart-rate variability (HRV) analysis was performed in accordance with current guidelines and data reported as mean [interquartile range]. Results: Mean normal-to-normal (NN) and total HRV measured as standard deviation of normal-to-normal (SDNN) was lower in HIV patients compared to controls (905 vs. 982 ms; p<0.001 and 48 vs. 54 ms; p = 0.028, respectively). No differences were found between the groups in parasympathetic activity measured as square root of the mean squared difference of successive NN-intervals (RMSSD) or the percent of differences between adjacent NN intervals greater than 50 ms (pNN50). In the HIV positives, haemoglobin A1c correlated inversely with SDNN, RMSSD and pNN50 (p<0.05). Total cholesterol and LDLC correlated inversely with RMSSD and pNN50 (p<0.05). Neither HIV duration, HIV-RNA, CD4 cell count nor CD4 nadir correlated with time or phase domain HRV variables. Conclusions: Moderate autonomic dysfunction is present in HIV positives patients even with suppressed viral load due to ART. The dysfunction is correlated with HbA1c and hypercholesterolemia but not to duration of HIV or whether the patients were receiving protease inhibitors as part of the ART regime.	[Askgaard, Gro; Kronborg, Gitte; Lebech, Anne-Mette] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; [Kristoffersen, Ulrik Sloth; Kjaer, Andreas] Rigshosp, Clin Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Kristoffersen, Ulrik Sloth; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Mehlsen, Jesper] Frederiksberg Univ Hosp, Dept Clin Physiol & Nucl Med, Frederiksberg, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Askgaard, G (corresponding author), Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark.	lebech@dadlnet.dk	Mehlsen, Jesper/AAA-5848-2022; Askgaard, Gro/AFQ-1824-2022; Kjaer, Andreas/E-8932-2015	Lebech, Anne-Mette/0000-0002-0943-3289; Askgaard, Gro/0000-0003-2775-8754; Kjaer, Andreas/0000-0002-2706-5547	Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; Carl og Ketty Kajsings legat	Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; Carl og Ketty Kajsings legat	Financial support from "Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond" and "Carl og Ketty Kajsings legat" are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cade WT, 2008, HIV MED, V9, P96, DOI 10.1111/j.1468-1293.2007.00524.x; Camm AJ, 1996, EUR HEART J, V17, P354; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cheng YLJ, 2003, DIABETES CARE, V26, P2052, DOI 10.2337/diacare.26.7.2052; Compostella C, 2008, CLIN AUTON RES, V18, P6, DOI 10.1007/s10286-007-0451-y; Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367; Dube M P, 1998, AIDS Clin Care, V10, P41; FREEMAN R, 1990, NEUROLOGY, V40, P575, DOI 10.1212/WNL.40.4.575; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gluck T, 2000, CLIN AUTON RES, V10, P17, DOI 10.1007/BF02291385; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lebech AM, 2007, CLIN PHYSIOL FUNCT I, V27, P363, DOI 10.1111/j.1475-097X.2007.00760.x; Lipinski MJ, 2004, AM J CARDIOL, V93, P445, DOI 10.1016/j.amjcard.2003.10.039; Melli G, 2006, BRAIN, V129, P1330, DOI 10.1093/brain/awl058; Mittal CM, 2004, INT J CARDIOL, V94, P1, DOI 10.1016/j.ijcard.2003.02.002; Neild PJ, 2000, INT J CARDIOL, V74, P133, DOI 10.1016/S0167-5273(00)00232-1; Nzuobontane D, 2002, J ROY SOC MED, V95, P445, DOI 10.1258/jrsm.95.9.445; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peltier AC, 2002, CURR OPIN NEUROL, V15, P633, DOI 10.1097/00019052-200210000-00015; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; RUTTIMANN S, 1991, ARCH INTERN MED, V151, P2441, DOI 10.1001/archinte.151.12.2441; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; SoRelle R, 1998, CIRCULATION, V98, P829, DOI 10.1161/01.CIR.98.9.829; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; WELBY SB, 1991, J INFECTION, V23, P123, DOI 10.1016/0163-4453(91)91958-Z	25	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20196	10.1371/journal.pone.0020196	http://dx.doi.org/10.1371/journal.pone.0020196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655281	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600028
J	Cui, YH; Jin, J; Zhang, XL; Xu, H; Yang, LG; Du, D; Zeng, QW; Tsien, JZ; Yu, HT; Cao, XH				Cui, Yihui; Jin, Jing; Zhang, Xuliang; Xu, Hao; Yang, Liguo; Du, Dan; Zeng, Qingwen; Tsien, Joe Z.; Yu, Huiting; Cao, Xiaohua			Forebrain NR2B Overexpression Facilitating the Prefrontal Cortex Long-Term Potentiation and Enhancing Working Memory Function in Mice	PLOS ONE			English	Article							NR2B-CONTAINING NMDA RECEPTORS; ANTERIOR CINGULATE CORTEX; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; DOPAMINE-RECEPTORS; TEMPORAL CORTEX; ODOR SPAN; MONKEYS; HIPPOCAMPUS	Prefrontal cortex plays an important role in working memory, attention regulation and behavioral inhibition. Its functions are associated with NMDA receptors. However, there is little information regarding the roles of NMDA receptor NR2B subunit in prefrontal cortical synaptic plasticity and prefrontal cortex-related working memory. Whether the up-regulation of NR2B subunit influences prefrontal cortical synaptic plasticity and working memory is not yet clear. In the present study, we measured prefrontal cortical synaptic plasticity and working memory function in NR2B overexpressing transgenic mice. In vitro electrophysiological data showed that overexpression of NR2B specifically in the forebrain region resulted in enhancement of prefrontal cortical long-term potentiation (LTP) but did not alter long-term depression (LTD). The enhanced LTP was completely abolished by a NR2B subunit selective antagonist, Ro25-6981, indicating that overexpression of NR2B subunit is responsible for enhanced LTP. In addition, NR2B transgenic mice exhibited better performance in a set of working memory paradigms including delay no-match-to-place T-maze, working memory version of water maze and odor span task. Our study provides evidence that NR2B subunit of NMDA receptor in prefrontal cortex is critical for prefrontal cortex LTP and prefrontal cortex-related working memory.	[Cui, Yihui; Jin, Jing; Zhang, Xuliang; Xu, Hao; Yang, Liguo; Du, Dan; Zeng, Qingwen; Cao, Xiaohua] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE, Shanghai 200062, Peoples R China; [Cui, Yihui; Jin, Jing; Zhang, Xuliang; Xu, Hao; Yang, Liguo; Du, Dan; Zeng, Qingwen; Cao, Xiaohua] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab STCSM, Shanghai 200062, Peoples R China; [Tsien, Joe Z.] Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Tsien, Joe Z.] Med Coll Georgia, Sch Med, Dept Neurol, Augusta, GA 30912 USA; [Yu, Huiting] Shanghai Municipal Ctr Dis Control & Prevent, Dept Vital Stat, Shanghai, Peoples R China	East China Normal University; East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Shanghai Center for Disease Control & Prevention	Cui, YH (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE, Shanghai 200062, Peoples R China.	xhcao@brain.ecnu.edu.cn	Cui, Yihui/AAB-9328-2022	zhang, xuliang/0000-0002-8952-8009; Cui, Yihui/0000-0002-7362-6237	National Natural Science Fund of China [30670682, 31070993]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from National Natural Science Fund of China (No. 30670682 and No. 31070993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Axmacher N, 2009, J NEUROSCI, V29, P1052, DOI 10.1523/JNEUROSCI.5277-08.2009; Baddeley A. D, 1986, WORKING MEMORY; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; FRENCH GM, 1959, J COMP PHYSIOL PSYCH, V52, P18, DOI 10.1037/h0042491; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J., 2015, PREFRONTAL CORTEX, V5th; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; GRANON S, 1994, BEHAV NEUROSCI, V108, P883, DOI 10.1037/0735-7044.108.5.883; GRAY EG, 1962, J ANAT, V96, P79; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kohr G, 2003, J NEUROSCI, V23, P10791; Lehohla M, 2004, METAB BRAIN DIS, V19, P35, DOI 10.1023/B:MEBR.0000027415.75432.ad; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Morita M, 2004, NEUROSCI LETT, V356, P203, DOI 10.1016/j.neulet.2003.11.066; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Piekema C, 2009, LEARN MEMORY, V16, P231, DOI 10.1101/lm.1283109; Procyk E, 2006, J NEUROSCI, V26, P11313, DOI 10.1523/JNEUROSCI.2157-06.2006; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsukada H, 2005, NEUROPSYCHOPHARMACOL, V30, P1861, DOI 10.1038/sj.npp.1300732; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Wu LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-11; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Young JW, 2007, NEUROPHARMACOLOGY, V52, P634, DOI 10.1016/j.neuropharm.2006.09.006; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	47	82	86	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20312	10.1371/journal.pone.0020312	http://dx.doi.org/10.1371/journal.pone.0020312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655294	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600042
J	Kong, B; Guo, GL				Kong, Bo; Guo, Grace L.			Enhanced In Vitro Refolding of Fibroblast Growth Factor 15 with the Assistance of SUMO Fusion Partner	PLOS ONE			English	Article							INCLUSION-BODY PROTEINS; MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; STEP PURIFICATION; TRANSGENIC MICE; METABOLIC-RATE; EXPRESSION; FIBROBLAST-GROWTH-FACTOR-19; POLYPEPTIDES; FGF-19	Fibroblast growth factor 15 (Fgf15) is the mouse orthologue of human FGF19. Fgf15 is highly expressed in the ileum and functions as an endocrine signal to regulate liver function, including bile acid synthesis, hepatocyte proliferation and insulin sensitivity. In order to fully understand the function of Fgf15, methods are needed to produce pure Fgf15 protein in the prokaryotic system. However, when expressed in Escherichia coli (E. coli), the recombinant Fgf15 protein was insoluble and found only in inclusion bodies. In the current study, we report a method to produce recombinant Fgf15 protein in E. coli through the use of small ubiquitin-related modifier (SUMO) fusion tag. Even though the SUMO has been shown to strongly improve protein solubility and expression levels, our studies suggest that the SUMO does not improve Fgf15 protein solubility. Instead, proper refolding of Fgf15 protein was achieved when Fgf15 was expressed as a partner protein of the fusion tag SUMO, followed by in vitro dialysis refolding. After refolding, the N-terminal SUMO tag was cleaved from the recombinant Fgf15 fusion protein by ScUlp1 (Ubiquitin-Like Protein-Specific Protease 1 from S. cerevisiae). With or without the SUMO tag, the refolded Fgf15 protein was biologically active, as revealed by its ability to reduce hepatic Cyp7a1 mRNA levels in mice. In addition, recombinant Fgf15 protein suppressed Cyp7a1 mRNA levels in a dose-dependent manner. In summary, we have developed a successful method to express functional Fgf15 protein in prokaryotic cells.	[Kong, Bo; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Kong, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	lguo@kumc.edu	Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817	NCRR [P20-RR021940]; NIH [DK081343]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from NCRR P20-RR021940 and NIH grant DK081343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mayer Marcus, 2004, Methods Mol Med, V94, P239; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wingfield P T, 2001, Curr Protoc Protein Sci, VChapter 6, DOI 10.1002/0471140864.ps0605s00; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485	25	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20307	10.1371/journal.pone.0020307	http://dx.doi.org/10.1371/journal.pone.0020307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655243	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600040
J	Parsons, CE; Young, KS; Kumari, N; Stein, A; Kringelbach, ML				Parsons, Christine E.; Young, Katherine S.; Kumari, Nina; Stein, Alan; Kringelbach, Morten L.			The Motivational Salience of Infant Faces Is Similar for Men and Women	PLOS ONE			English	Article							ADULTS RESPONSES; SEX-DIFFERENCES; HEAD SHAPE; ATTRACTIVENESS; BEAUTIFUL; CUTENESS; APPEARANCE; PERCEPTION; PREFERENCE; AGE	Infant facial features are thought to be powerful elicitors of caregiving behaviour. It has been widely assumed that men and women respond in different ways to those features, such as a large forehead and eyes and round protruding cheeks, colloquially described as 'cute'. We investigated experimentally potential differences using measures of both conscious appraisal ('liking') and behavioural responsivity ('wanting') to real world infant and adult faces in 71 non-parents. Overall, women gave significantly higher 'liking' ratings for infant faces (but not adult faces) compared to men. However, this difference was not seen in the 'wanting' task, where we measured the willingness of men and women to key-press to increase or decrease viewing duration of an infant face. Further analysis of sensitivity to cuteness, categorising infants by degree of infantile features, revealed that both men and women showed a graded significant increase in both positive attractiveness ratings and viewing times to the 'cutest' infants. We suggest that infant faces may have similar motivational salience to men and women, despite gender idiosyncrasies in their conscious appraisal.	[Parsons, Christine E.; Young, Katherine S.; Kumari, Nina; Stein, Alan; Kringelbach, Morten L.] Univ Oxford, Univ Dept Psychiat, Oxford, England; [Parsons, Christine E.; Young, Katherine S.; Kumari, Nina; Kringelbach, Morten L.] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aahrus, Denmark	University of Oxford; Aarhus University	Parsons, CE (corresponding author), Univ Oxford, Univ Dept Psychiat, Oxford, England.	Morten.Kringelbach@queens.ox.ac.uk	Parsons, Christine/G-9286-2016; Kringelbach, Morten L/AAF-5508-2020; Parsons, Christine/V-3571-2019; Young, Katherine/O-9198-2017; Kringelbach, Morten/AAW-5847-2021	Parsons, Christine/0000-0003-2856-6308; Parsons, Christine/0000-0003-2856-6308; Young, Katherine/0000-0002-1378-6415; Kringelbach, Morten/0000-0002-3908-6898; Stein, Alan/0000-0001-8207-2822	Wellcome Trust, UK [017571]; TrygFonden Charitable Foundation; Medical Research Council	Wellcome Trust, UK(Wellcome Trust); TrygFonden Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by funding from the Wellcome Trust, UK (017571), the TrygFonden Charitable Foundation, and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ALLEY TR, 1983, MERRILL PALMER QUART, V29, P411; ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BERMAN PW, 1980, PSYCHOL BULL, V88, P668, DOI 10.1037/0033-2909.88.3.668; BERMAN PW, 1975, SEX ROLES, V1, P311; BERRIDGE KC, 2008, PSYCHOPHARM IN PRESS; Bowlby J., 1969, ATTACHMENT AND LOSS; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Casey RJ, 1996, J APPL DEV PSYCHOL, V17, P495, DOI 10.1016/S0193-3973(96)90013-1; Crowder Janel Rae, 2004, J Pediatr Nurs, V19, P257, DOI 10.1016/j.pedn.2004.05.005; Dai XC, 2010, EMOTION, V10, P324, DOI 10.1037/a0017987; Dupuis-Roy N, 2009, J VISION, V9, DOI 10.1167/9.2.10; Eibl-Eibesfeldt I., 1989, HUMAN ETHOLOGY; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; GARDNER BT, 1965, PERCEPT MOTOR SKILL, V20, P135, DOI 10.2466/pms.1965.20.1.135; GEORGHIADES, 2001, EXTENDED YALE FACE D; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; GOLDBERG S, 1982, CHILD DEV, V53, P1544, DOI 10.1111/j.1467-8624.1982.tb03477.x; Harlow HF., 1971, LEARNING LOVE; Hildebrandt K. A., 1981, INFANT MENT HEALTH J, V2, P56, DOI DOI 10.1002/1097-0355(198121)2:1<56::AID-IMHJ2280020109>3.0.C0;2-G; HILDEBRANDT KA, 1978, BEHAV PROCESS, V3, P159, DOI 10.1016/0376-6357(78)90042-6; Hrdy S.B., 2005, ATTACHMENT BONDING N, P9, DOI DOI 10.1016/J.GLOENVCHA.2013.12.001; HUCKSTEDT B, 1965, EXPT UNTERSUCHUNGEN, V12, P421; HUTT C, 1972, HUM DEV, V15, P153, DOI 10.1159/000271239; KARRAKER KH, 1990, BASIC APPL SOC PSYCH, V11, P371, DOI 10.1207/s15324834basp1104_2; Konner M., 2010, EVOLUTION CHILDHOOD; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; LANGLOIS JH, 1995, DEV PSYCHOL, V31, P464, DOI 10.1037/0012-1649.31.3.464; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lorenz K, 1971, STUDIES ANIMAL HUMAN, VII; MAIER RA, 1984, INFANT BEHAV DEV, V7, P403, DOI 10.1016/S0163-6383(84)80002-8; MCCABE V, 1988, SOCIAL APPL ASPECTS, P89; MONEY J, 1975, SEXUAL SIGNATURES BE, P95; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Ramchandani P, 2009, LANCET, V374, P646, DOI 10.1016/S0140-6736(09)60238-5; Rennels JL, 2008, J EXP PSYCHOL HUMAN, V34, P884, DOI 10.1037/0096-1523.34.4.884; RITTER JM, 1991, CHILD DEV, V62, P68, DOI 10.2307/1130705; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; Sprengelmeyer R, 2010, PSYCHOL SCI, V21, P753, DOI 10.1177/0956797610368065; STEPHAN CW, 1984, CHILD DEV, V55, P576, DOI 10.2307/1129969; Volk A, 2002, HUM NATURE-INT BIOS, V13, P437, DOI 10.1007/s12110-002-1002-9; WEYRAUCH, 2004, MIT CBCL FACE RECOGN; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	50	90	94	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20632	10.1371/journal.pone.0020632	http://dx.doi.org/10.1371/journal.pone.0020632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655195	Green Published, gold			2022-12-27	WOS:000291097600111
J	Wright, E; Mugaba, S; Grant, P; Parkes-Ratanshi, R; Van der Paal, L; Grosskurth, H; Kaleebu, P				Wright, Edward; Mugaba, Susan; Grant, Paul; Parkes-Ratanshi, Rosalind; Van der Paal, Lieve; Grosskurth, Heiner; Kaleebu, Pontiano			Coreceptor and Cytokine Concentrations May Not Explain Differences in Disease Progression Observed in HIV-1 Clade A and D Infected Ugandans	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; SYNCYTIUM-INDUCING PHENOTYPE; SUBTYPE-A; ANTIRETROVIRAL THERAPY; SURFACE CXCR4; TROPIC HIV-1; TYPE-1 HIV-1; RURAL UGANDA; CCR5	Background: The use of cellular coreceptors and modulation of cytokine concentrations by HIV to establish a productive infection is well documented. However, it is unknown whether the expression of these proteins affects the course of HIV clade A and D disease, reported to have different progression rates. Methodology/Principal Findings: We investigated whether the number of CD4(+) T-cells expressing CCR5 or CXCR4, the density of these coreceptors and concentrations of specific immune proteins linked to HIV pathogenesis vary between individuals infected with HIV clade A or D. We undertook additional analyses stratifying participants by early (CD4>500 cells/mu l) or late (CD4<200 cells/mu l) disease stage. Whole blood samples were taken from 50 HIV-1 infected individuals drawn from cohorts in rural south-west Uganda. Late stage participants had less than half the number of CD4(+)/CCR5(+) T-cells (p = 0.0113) and 5.6 times fewer CD4(+)/CXCR4(+) cells (p<0.0001) than early stage participants. There was also a statistically significant difference in the density of CXCR4 on CD4(+) cells between clade A and D infected early stage participants (142 [A] vs 84 [D]; p = 0.0146). Across all participants we observed significantly higher concentration of Th(1) cytokines compared to Th(2) (66.4 vs 23.8 pg/ml; p < 0.0001). Plasma concentrations of IFN gamma and IL-2 were 1.8 and 2.4 fold lower respectively in Late-D infected participants compared to Late-A participants. MIP-1 beta levels also decreased from 118.0 pg/ml to 47.1 pg/ml (p = 0.0396) as HIV disease progressed. Conclusions/Significance: We observed specific alterations in the abundance of CD4(+)/CCR5(+) and CD4(+)/CXCR4(+) T-cells, and concentrations of immune proteins across different HIV clades and as infection progresses. Our results suggest that these changes are unlikely to explain the observed differences in disease progression between subtype A and D infections. However, our observations further the understanding of the natural progression of non-clade B HIV infection and how the virus adapts to exploit the host environment.	[Wright, Edward; Mugaba, Susan; Parkes-Ratanshi, Rosalind; Van der Paal, Lieve; Grosskurth, Heiner; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Wright, Edward] UCL, Div Infect & Immun, London, England; [Grant, Paul] Univ Coll London Hosp, Dept Virol, London, England; [Grosskurth, Heiner; Kaleebu, Pontiano] London Sch Hyg & Trop Med, London WC1, England	Uganda Virus Research Institute; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Wright, E (corresponding author), Uganda Virus Res Inst, MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	edward.wright@ucl.ac.uk	Parkes-Ratanshi, Rosalind/AAR-5409-2020	Parkes-Ratanshi, Rosalind/0000-0001-9297-1311; Grosskurth, Heiner/0000-0001-9960-7280; Wright, Edward/0000-0001-7041-5138	Medical Research Council U.K. - MRC/UVRI Uganda Research Unit on AIDS;  [G0801176]; Medical Research Council [G0801176, MC_U950080937] Funding Source: researchfish; MRC [MC_U950080937, G0801176] Funding Source: UKRI	Medical Research Council U.K. - MRC/UVRI Uganda Research Unit on AIDS; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council U.K. - MRC/UVRI Uganda Research Unit on AIDS and grant number G0801176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2006, J VIROL, V80, P10884, DOI 10.1128/JVI.01030-06; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bernstein A, 2008, TRENDS MICROBIOL, V16, P553, DOI 10.1016/j.tim.2008.08.009; Buckton AJ, 2008, J ANTIMICROB CHEMOTH, V62, P1191, DOI 10.1093/jac/dkn412; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Choi B, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-6; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; DELWART EL, 1995, PCR METH APPL, V4, pS202; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Huang W, 2009, AIDS, V23, P1903, DOI 10.1097/QAD.0b013e32832f1802; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2000, AIDS RES HUM RETROV, V16, P393, DOI 10.1089/088922200309052; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; KIWANUKA N, 2008, J INFECT DIS; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kwa D, 2003, AIDS, V17, P981, DOI 10.1097/00002030-200305020-00006; Lelievre JD, 2004, AIDS RES HUM RETROV, V20, P1230, DOI 10.1089/aid.2004.20.1230; Lin YL, 2008, AIDS, V22, P430, DOI 10.1097/QAD.0b013e3282f46a6f; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Morgan D, 2001, INT J STD AIDS, V12, P116, DOI 10.1258/0956462011916758; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Oishi K, 2000, J INTERF CYTOK RES, V20, P597, DOI 10.1089/10799900050044796; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Poveda E, 2007, J MED VIROL, V79, P1040, DOI 10.1002/jmv.20900; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Rizzardini G, 1996, AIDS, V10, P1535, DOI 10.1097/00002030-199611000-00012; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Serwanga J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004188; Simmons G, 1996, J VIROL, V70, P8355, DOI 10.1128/JVI.70.12.8355-8360.1996; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; van Rensburg EJ, 2002, AIDS, V16, P2479, DOI [10.1097/00002030-200212060-00015, 10.1097/01.aids.0000042582.93174.df]; Van Rij RP, 2003, AIDS RES HUM RETROV, V19, P389, DOI 10.1089/088922203765551737; Wakeham K, 2010, J ANTIMICROB CHEMOTH, V65, P316, DOI 10.1093/jac/dkp451; White EJ, 2010, AIDS, V24, P1063, DOI 10.1097/QAD.0b013e328331f717; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19902	10.1371/journal.pone.0019902	http://dx.doi.org/10.1371/journal.pone.0019902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655330	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600010
J	van Gent, M; Bart, MJ; van der Heide, HGJ; Heuvelman, KJ; Kallonen, T; He, QS; Mertsola, J; Advani, A; Hallander, HO; Janssens, K; Hermans, PW; Mooi, FR				van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Kallonen, Teemu; He, Qiushui; Mertsola, Jussi; Advani, Abdolreza; Hallander, Hans O.; Janssens, Koen; Hermans, Peter W.; Mooi, Frits R.			SNP-Based Typing: A Useful Tool to Study Bordetella pertussis Populations	PLOS ONE			English	Article							GEL-ELECTROPHORESIS PROFILES; SINGLE-NUCLEOTIDE POLYMORPHISMS; AGENTS AFFECTING HEALTH; TANDEM-REPEAT ANALYSIS; ANTIGENIC DIVERGENCE; GENETIC DIVERSITY; HOST ADAPTATION; UNITED-KINGDOM; RURAL AREA; VACCINATION	To monitor changes in Bordetella pertussis populations, mainly two typing methods are used; Pulsed-Field Gel Electrophoresis (PFGE) and Multiple-Locus Variable-Number Tandem Repeat Analysis (MLVA). In this study, a single nucleotide polymorphism (SNP) typing method, based on 87 SNPs, was developed and compared with PFGE and MLVA. The discriminatory indices of SNP typing, PFGE and MLVA were found to be 0.85, 0.95 and 0.83, respectively. Phylogenetic analysis, using SNP typing as Gold Standard, revealed false homoplasies in the PFGE and MLVA trees. Further, in contrast to the SNP-based tree, the PFGE- and MLVA-based trees did not reveal a positive correlation between root-to-tip distance and the isolation year of strains. Thus PFGE and MLVA do not allow an estimation of the relative age of the selected strains. In conclusion, SNP typing was found to be phylogenetically more informative than PFGE and more discriminative than MLVA. Further, in contrast to PFGE, it is readily standardized allowing interlaboratory comparisons. We applied SNP typing to study strains with a novel allele for the pertussis toxin promoter, ptxP3, which have a worldwide distribution and which have replaced the resident ptxP1 strains in the last 20 years. Previously, we showed that ptxP3 strains showed increased pertussis toxin expression and that their emergence was associated with increased notification in the Netherlands. SNP typing showed that the ptxP3 strains isolated in the Americas, Asia, Australia and Europe formed a monophyletic branch which recently diverged from ptxP1 strains. Two predominant ptxP3 SNP types were identified which spread worldwide. The widespread use of SNP typing will enhance our understanding of the evolution and global epidemiology of B. pertussis.	[van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Kallonen, Teemu; He, Qiushui; Mertsola, Jussi] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [Kallonen, Teemu] Univ Turku, Turku Grad Sch Biomed Sci, Turku, Finland; [Advani, Abdolreza; Hallander, Hans O.] Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden; [Janssens, Koen] Appl Maths NV, Sint Martens Latem, Belgium; [Hermans, Peter W.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Finland National Institute for Health & Welfare; University of Turku; Swedish Institute for Infectious Disease Control; Radboud University Nijmegen	van Gent, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	frits.mooi@rivm.nl	Kallonen, Teemu/B-5507-2008; Mooi, prof.F.R./L-4528-2015; Hermans, Peter W.M./H-8042-2014; Janssens, Koen Henri/B-8049-2011; Mertsola, Jussi/AAE-3460-2021	Kallonen, Teemu/0000-0003-1741-6486; Janssens, Koen Henri/0000-0002-6752-6408; 				Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Advani A, 2004, J CLIN MICROBIOL, V42, P2890, DOI 10.1128/JCM.42.7.2890-2897.2004; Advani A, 2009, J MICROBIOL METH, V78, P297, DOI 10.1016/j.mimet.2009.06.019; Advani A, 2007, APMIS, V115, P736, DOI 10.1111/j.1600-0463.2007.apm_628.x; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Elomaa A, 2007, VACCINE, V25, P918, DOI 10.1016/j.vaccine.2006.09.012; Elomaa A, 2009, VACCINE, V27, P5443, DOI 10.1016/j.vaccine.2009.07.010; Fingermann M, 2006, VACCINE, V24, P3513, DOI 10.1016/j.vaccine.2006.02.026; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Kurniawan J, 2010, EMERG INFECT DIS, V16, P297, DOI 10.3201/eid1602.081707; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; OCTAVIA S, 2010, MOLBIOLEVOL; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PATEL S, 1978, TROP GEOGR MED, V30, P141; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van Gent M, 2009, VACCINE, V27, P1898, DOI 10.1016/j.vaccine.2009.01.111; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; VOORHOEVE AM, 1978, TROP GEOGR MED, V30, P125; Yao SM, 2005, J CLIN MICROBIOL, V43, P5457, DOI 10.1128/JCM.43.11.5457-5461.2005	43	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20340	10.1371/journal.pone.0020340	http://dx.doi.org/10.1371/journal.pone.0020340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647370	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500048
J	Verga Falzacappa, C; Mangialardo, C; Madaro, L; Ranieri, D; Lupoi, L; Stigliano, A; Torrisi, MR; Bouche, M; Toscano, V; Misiti, S				Verga Falzacappa, Cecilia; Mangialardo, Claudia; Madaro, Luca; Ranieri, Danilo; Lupoi, Lorenzo; Stigliano, Antonio; Torrisi, Maria Rosaria; Bouche, Marina; Toscano, Vincenzo; Misiti, Silvia			Thyroid Hormone T3 Counteracts STZ Induced Diabetes in Mouse	PLOS ONE			English	Article							BETA-CELL GROWTH; KINASE-B; ACTIVATION; SURVIVAL; MASS; APOPTOSIS; INSIGHTS; PATHWAY	This study intended to demonstrate that the thyroid hormone T3 counteracts the onset of a Streptozotocin (STZ) induced diabetes in wild type mice. To test our hypothesis diabetes has been induced in Balb/c male mice by multiple low dose Streptozotocin injection; and a group of mice was contemporaneously injected with T3. After 48 h mice were tested for glucose tolerance test, insulin serum levels and then sacrified. Whole pancreata were utilized for morphological and biochemical analyses, while protein extracts and RNA were utilized for expression analyses of specific molecules. The results showed that islets from T3 treated mice were comparable to age- and sex-matched control, untreated mice in number, shape, dimension, consistency, ultrastructure, insulin and glucagon levels, Tunel positivity and caspases activation, while all the cited parameters and molecules were altered by STZ alone. The T3-induced pro survival effect was associated with a strong increase in phosphorylated Akt. Moreover, T3 administration prevented the STZ-dependent alterations in glucose blood level, both during fasting and after glucose challenge, as well as in insulin serum level. In conclusion we demonstrated that T3 could act as a protective factor against STZ induced diabetes.	[Verga Falzacappa, Cecilia; Mangialardo, Claudia; Misiti, Silvia] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Verga Falzacappa, Cecilia; Toscano, Vincenzo] Fdn Studio Diabete Endocrinol & Metabol, DEM, Rome, Italy; [Madaro, Luca; Bouche, Marina] Univ Roma La Sapienza, Dipartimento Istol & Embriol Med, Rome, Italy; [Ranieri, Danilo; Stigliano, Antonio; Torrisi, Maria Rosaria; Toscano, Vincenzo] Univ Roma La Sapienza, Dipartimento Med Mol, Rome, Italy; [Lupoi, Lorenzo] Univ Cattolica Sacro Cuore, Stabilimento Utilizzaz Anim Lab, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Verga Falzacappa, C (corresponding author), Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy.	silvia.misiti@uniroma1.it	Madaro, Luca/ABE-4683-2021; Verga Falzacappa, Cecilia/C-5581-2017; Madaro, Luca/K-4629-2016; Stigliano, Antonio/AAN-2266-2020	Madaro, Luca/0000-0003-0839-5724; Verga Falzacappa, Cecilia/0000-0001-8957-4550; Madaro, Luca/0000-0003-0839-5724; STIGLIANO, Antonio/0000-0002-7143-0775; Bouche, Marina/0000-0002-0938-5360	Italian Ministry for University and Research [2006064322_004]; Sapienza University of Rome [C26F07MY89, C26A08EY99]; Association Francoise contre les Myopathies (AFM) [13951-2009]; Agenzia Spaziale Italiana (ASI); DEM; Fondazione per lo studio del Diabete; l'Endocrinologia ed il Metabolismo, Roma, Italy	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; Association Francoise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI)); DEM; Fondazione per lo studio del Diabete; l'Endocrinologia ed il Metabolismo, Roma, Italy	This work was supported by the Italian Ministry for University and Research (2006064322_004), by Sapienza University of Rome (C26F07MY89 and C26A08EY99), by Association Francoise contre les Myopathies (AFM, 13951-2009), and by Agenzia Spaziale Italiana (ASI). DEM, Fondazione per lo studio del Diabete, l'Endocrinologia ed il Metabolismo, Roma, Italy, supported CVF with a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Cao X, 2009, BIOCHEM J, V424, P201, DOI 10.1042/BJ20090643; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; FALZACAPPA CV, 2010, ISLETS, V2, P296; FALZACAPPA CV, 2006, J CELL PHYSIOL, V206, P309, DOI [10.1002/jcp.20460, DOI 10.1002/jcp.20460, DOI 10.1002/JCP.20460]; Furuya F, 2009, STEROIDS, V74, P628, DOI 10.1016/j.steroids.2008.10.009; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giannoukakis N, 2000, GENE THER, V7, P2015, DOI 10.1038/sj.gt.3301333; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; MIZRACHI EB, 2001, J CLIN INVEST, V108, P1631; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Ortega E, 2008, EUR J ENDOCRINOL, V158, P217, DOI 10.1530/EJE-07-0592; Pipeleers D, 2008, DIABETES OBES METAB, V10, P54, DOI 10.1111/j.1463-1326.2008.00941.x; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; Verga Falzacappa C, 2009, J CELL BIOCHEM, V106, P835, DOI 10.1002/jcb.22045; Webb P, 2004, EXPERT OPIN INV DRUG, V13, P489, DOI 10.1517/13543784.13.5.489; Zinke A, 2003, EXP CLIN ENDOCR DIAB, V111, P198, DOI 10.1055/s-2003-40463	34	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19839	10.1371/journal.pone.0019839	http://dx.doi.org/10.1371/journal.pone.0019839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637761	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500013
J	Champion, MD				Champion, Mia D.			Host-Pathogen O-Methyltransferase Similarity and Its Specific Presence in Highly Virulent Strains of Francisella tularensis Suggests Molecular Mimicry	PLOS ONE			English	Article							PROTEIN FAMILY; SEQUENCE; EVOLUTION; GENE; EPIDEMIOLOGY; ALIGNMENTS; TULAREMIA; MICE	Whole genome comparative studies of many bacterial pathogens have shown an overall high similarity of gene content (>95%) between phylogenetically distinct subspecies. In highly clonal species that share the bulk of their genomes subtle changes in gene content and small-scale polymorphisms, especially those that may alter gene expression and protein-protein interactions, are more likely to have a significant effect on the pathogen's biology. In order to better understand molecular attributes that may mediate the adaptation of virulence in infectious bacteria, a comparative study was done to further analyze the evolution of a gene encoding an o-methyltransferase that was previously identified as a candidate virulence factor due to its conservation specifically in highly pathogenic Francisella tularensis subsp. tularensis strains. The o-methyltransferase gene is located in the genomic neighborhood of a known pathogenicity island and predicted site of rearrangement. Distinct o-methyltransferase subtypes are present in different Francisella tularensis subspecies. Related protein families were identified in several host species as well as species of pathogenic bacteria that are otherwise very distant phylogenetically from Francisella, including species of Mycobacterium. A conserved sequence motif profile is present in the mammalian host and pathogen protein sequences, and sites of non-synonymous variation conserved in Francisella subspecies specific o-methyltransferases map proximally to the predicted active site of the orthologous human protein structure. Altogether, evidence suggests a role of the F. t. subsp. tularensis protein in a mechanism of molecular mimicry, similar perhaps to Legionella and Coxiella. These findings therefore provide insights into the evolution of niche-restriction and virulence in Francisella, and have broader implications regarding the molecular mechanisms that mediate host-pathogen relationships.				mchampion@tgen.org						BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; *BRENDA, 2011, BRENDA COMPR ENZ INF; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; CASALI N, 2009, HYPERVIRULENT MYCOBA; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Krzywinska E, 2005, MOL MICROBIOL, V56, P1262, DOI 10.1111/j.1365-2958.2005.04608.x; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; KuoLee R, 2007, INFECT IMMUN, V75, P1651, DOI 10.1128/IAI.01834-06; LAIGENG L, 1997, PNAS, V94, P5461; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; MORNER T, 2001, TULAREMIA; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; OLSUFJEV NG, 1982, J HYG EPIDEMIOL MICR, V26; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Plewniak F, 2000, BIOINFORMATICS, V16, P750, DOI 10.1093/bioinformatics/16.9.750; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; SCHMITT D, 1991, J BIOL CHEM, V266, P17416; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; SJOSTEDT A, 2005, FAMILY 17 FRANCISELL; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; *TBDB, 2011, TB DAT INT PLATF TUB; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20295	10.1371/journal.pone.0020295	http://dx.doi.org/10.1371/journal.pone.0020295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637805	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052200048
J	Griffiths, J; Barrero, JM; Taylor, J; Helliwell, CA; Gubler, F				Griffiths, Jayne; Barrero, Jose M.; Taylor, Jennifer; Helliwell, Chris A.; Gubler, Frank			ALTERED MERISTEM PROGRAM 1 Is involved in Development of Seed Dormancy in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID; GENE; ENCODES; AMP1; THALIANA; 8'-HYDROXYLASES; GERMINATION; PEPTIDASE; NETWORKS; MUTANTS	Mutants in the rice PLASTOCHRON 3 and maize VIVIPAROUS 8 genes have been shown to have reduced dormancy and ABA levels. In this study we used several mutants in the orthologous gene ALTERED MERISTEM PROGRAM 1 (AMP1) to determine its role in seed dormancy in Arabidopsis. Here we report that there are accession-specific effects of mutations in AMP1. In one accession, amp1 mutants produce seeds with higher dormancy, while those in two other accessions produce seeds of lower dormancy. These accession-specific effects of mutating AMP1 were shown to extend to ABA levels. We assayed global gene transcription differences in seeds of wild-type and mutant from two accessions demonstrating opposing phenotypes. The transcript changes observed indicate that the amp1 mutation shifts the seed transcriptome from a dormant into an after-ripened state. Specific changes in gene expression in the mutants give insight into the direct and indirect effects that may be contributing to the opposing dormancy phenotypes observed, and reveal a role for AMP1 in the acquisition and/or maintenance of seed dormancy in Arabidopsis.	[Griffiths, Jayne; Barrero, Jose M.; Taylor, Jennifer; Helliwell, Chris A.; Gubler, Frank] CSIRO, Div Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Griffiths, J (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.gubler@csiro.au	Barrero, Jose/X-5090-2019; Barrero, Jose M/B-4607-2009; Frank, Gubler/A-1291-2010; Helliwell, Chris/A-1469-2008; Taylor, Jennifer M/A-1686-2010	Barrero, Jose/0000-0001-7367-2199; Barrero, Jose M/0000-0001-7367-2199; Helliwell, Chris/0000-0001-5943-897X; Taylor, Jennifer M/0000-0003-4231-0181	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by the CSIRO OCE postdoctoral fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Bethke P. C., 2007, Seed development, dormancy and germination, P153; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Cheng WH, 2009, PLANT MOL BIOL, V71, P61, DOI 10.1007/s11103-009-9509-7; Clark SE, 1996, DEVELOPMENT, V122, P1567; Evans MMS, 1997, PLANT J, V12, P769, DOI 10.1046/j.1365-313X.1997.12040769.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; GRIMM B, 1987, EUR J BIOCHEM, V167, P493, DOI 10.1111/j.1432-1033.1987.tb13364.x; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Harari-Steinberg O, 2001, PLANT PHYSIOL, V127, P986, DOI 10.1104/pp.010270; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; HERZOG M, 1995, PLANT MOL BIOL, V27, P743, DOI 10.1007/BF00020227; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Kawakatsu T, 2009, PLANT J, V58, P1028, DOI 10.1111/j.1365-313X.2009.03841.x; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee BH, 2009, J MICROBIOL BIOTECHN, V19, P542, DOI 10.4014/jmb.0901.0082; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mordhorst AP, 1998, GENETICS, V149, P549; Morris K, 2011, PLANT PHYSIOL, V155, P1851, DOI 10.1104/pp.110.169706; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Saibo NJM, 2007, PLANTA, V225, P831, DOI 10.1007/s00425-006-0395-9; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Suzuki M, 2008, CURR OPIN PLANT BIOL, V11, P548, DOI 10.1016/j.pbi.2008.06.015; Suzuki M, 2008, PLANT PHYSIOL, V146, P1193, DOI 10.1104/pp.107.114108; Teng S, 2008, PLANT J, V55, P372, DOI 10.1111/j.1365-313X.2008.03515.x; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	42	22	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20408	10.1371/journal.pone.0020408	http://dx.doi.org/10.1371/journal.pone.0020408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637772	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200061
J	Qazi, H; Shi, ZD; Tarbell, JM				Qazi, Henry; Shi, Zhong-Dong; Tarbell, John M.			Fluid Shear Stress Regulates the Invasive Potential of Glioma Cells via Modulation of Migratory Activity and Matrix Metalloproteinase Expression	PLOS ONE			English	Article							INTERSTITIAL FLOW; VASCULAR NORMALIZATION; GROWTH-FACTOR; UP-REGULATION; COLLAGEN I; GLIOBLASTOMA; CONVECTION; MECHANISM; TUMORS; TISSUE	Background: Glioma cells are exposed to elevated interstitial fluid flow during the onset of angiogenesis, at the tumor periphery while invading normal parenchyma, within white matter tracts, and during vascular normalization therapy. Glioma cell lines that have been exposed to fluid flow forces in vivo have much lower invasive potentials than in vitro cell motility assays without flow would indicate. Methodology/Principal Findings: A 3D Modified Boyden chamber (Darcy flow through collagen/cell suspension) model was designed to mimic the fluid dynamic microenvironment to study the effects of fluid shear stress on the migratory activity of glioma cells. Novel methods for gel compaction and isolation of chemotactic migration from flow stimulation were utilized for three glioma cell lines: U87, CNS-1, and U251. All physiologic levels of fluid shear stress suppressed the migratory activity of U87 and CNS-1 cell lines. U251 motility remained unaltered within the 3D interstitial flow model. Matrix Metalloproteinase (MMP) inhibition experiments and assays demonstrated that the glioma cells depended on MMP activity to invade, and suppression in motility correlated with downregulation of MMP-1 and MMP-2 levels. This was confirmed by RT-PCR and with the aid of MMP-1 and MMP-2 shRNA constructs. Conclusions/Significance: Fluid shear stress in the tumor microenvironment may explain reduced glioma invasion through modulation of cell motility and MMP levels. The flow-induced migration trends were consistent with reported invasive potentials of implanted gliomas. The models developed for this study imply that flow-modulated motility involves mechanotransduction of fluid shear stress affecting MMP activation and expression. These models should be useful for the continued study of interstitial flow effects on processes that affect tumor progression.	[Qazi, Henry; Shi, Zhong-Dong; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Qazi, H (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu	Shi, Zhong-Dong/A-7212-2012		National Heart, Lung, and Blood Institute [RO1-HL-35549, RO1-HL-57093]; NIH/NCI [U54CA137788/U54CA132378]; NATIONAL CANCER INSTITUTE [U54CA137788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057093, R01HL035549] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute Grants RO1-HL-35549 and RO1-HL-57093. This study was also supported in part by the CCNY/MSKCC Partnership for Cancer Research NIH/NCI U54CA137788/U54CA132378.	AASLID R, 1990, ACT NEUR S, V51, P152; Annabi B, 2005, J NEUROCHEM, V94, P906, DOI 10.1111/j.1471-4159.2005.03256.x; Binder DK, 2002, J NEURO-ONCOL, V56, P149, DOI 10.1023/A:1014566604005; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; BRINKMAN HC, 1947, APPL SCI RES, V1, P27; Brockmann MA, 2003, NEUROSURGERY, V52, P1391, DOI 10.1227/01.NEU.0000064806.87785.AB; Camby I, 2005, BIOCHEM BIOPH RES CO, V335, P27, DOI 10.1016/j.bbrc.2005.07.037; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; CHICOINE MR, 1995, CANCER, V75, P2904, DOI 10.1002/1097-0142(19950615)75:12<2904::AID-CNCR2820751218>3.0.CO;2-2; CRAWFORD HC, 1994, INVAS METAST, V14, P234; Dafni H, 2002, CANCER RES, V62, P6731; Friedl P, 1997, CANCER RES, V57, P2061; Garanich JS, 2007, AM J PHYSIOL-HEART C, V292, pH3128, DOI 10.1152/ajpheart.00578.2006; Geer CP, 1997, J NEURO-ONCOL, V32, P193, DOI 10.1023/A:1005761031077; Girton TS, 2002, J BIOMECH ENG-T ASME, V124, P568, DOI 10.1115/1.1504099; HAUWER CD, 1997, BIOCH BIOPHYSICAL RE, V232, P267; HAUWER CD, 1998, J NEUROBIOL, V37, P373; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hetschko H, 2008, FEBS J, V275, P1925, DOI 10.1111/j.1742-4658.2008.06351.x; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hormigo A, 2007, CANCER CELL, V11, P6, DOI 10.1016/j.ccr.2006.12.008; Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053; ITO U, 1988, ACTA NEUROCHIR, V90, P35, DOI 10.1007/BF01541264; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karakiulakis G, 2007, J BIOL CHEM, V282, P908, DOI 10.1074/jbc.M602178200; KRUCZYNSKI A, 1995, INT J ONCOL, V6, P473; LONG DM, 1970, J NEUROSURG, V32, P127, DOI 10.3171/jns.1970.32.2.0127; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; McCready J, 2005, INT J CANCER, V117, P781, DOI 10.1002/ijc.21207; Mollica F, 2003, MICROVASC RES, V65, P56, DOI 10.1016/S0026-2862(02)00012-2; Mourad PD, 2005, SURG NEUROL, V63, P511, DOI 10.1016/j.surneu.2004.08.062; NAKAGAWA T, 1994, J NEUROSURG, V81, P69, DOI 10.3171/jns.1994.81.1.0069; Netti PA, 1996, MICROVASC RES, V52, P27, DOI 10.1006/mvre.1996.0041; Pedersen JA, 2007, J BIOMECH, V40, P1484, DOI 10.1016/j.jbiomech.2006.06.023; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sameshima T, 2000, CANCER LETT, V157, P177, DOI 10.1016/S0304-3835(00)00485-7; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Shi ZD, 2010, AM J PHYSIOL-HEART C, V298, pH127, DOI 10.1152/ajpheart.00732.2009; Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; SMITH DR, 1969, J NEUROSURG, V31, P50, DOI 10.3171/jns.1969.31.1.0050; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sun JX, 2001, CANCER RES, V61, P2276; Takano S, 1996, CANCER RES, V56, P2185; Wang S, 2000, ARTERIOSCL THROM VAS, V20, P2220, DOI 10.1161/01.ATV.20.10.2220; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	56	77	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20348	10.1371/journal.pone.0020348	http://dx.doi.org/10.1371/journal.pone.0020348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637818	Green Published, gold			2022-12-27	WOS:000291052200055
J	Kline, RJ; Khan, IA; Holt, GJ				Kline, Richard J.; Khan, Izhar A.; Holt, G. Joan			Behavior, Color Change and Time for Sexual Inversion in the Protogynous Grouper (Epinephelus adscensionis)	PLOS ONE			English	Article							CORAL-REEF FISH; TELEOST SOCIAL SIGNAL; BLUEHEAD WRASSE; THALASSOMA-BIFASCIATUM; ANTHIAS-SQUAMIPINNIS; PISCES; FEMALE; DICHROMATISM; REPRODUCTION; SERRANIDAE	Hermaphroditism, associated with territoriality and dominance behavior, is common in the marine environment. While male sex-specific coloration patterns have been documented in groupers, particularly during the spawning season, few data regarding social structure and the context for these color displays are available. In the present study, we define the social structure and male typical behavior of rock hind (Epinephelus adscensionis) in the wild. In addition, we detail the captive conditions and time period necessary to induce the onset of the sex-specific coloration and sexual change. At six oil production platform locations in the Gulf of Mexico, rock hind social group size and typical male rock hind social behavior were documented. We observed a rapid temporary color display in rock hind that could be turned on and off within three seconds and was used for confronting territory intruders and displays of aggression towards females. The male-specific "tuxedo" pattern consists of a bright yellow tail, a body with alternating dark brown and white patches and a dark bar extending from the upper mandible to the operculum. Identification and size ranges of male, female and intersex fish collected from oil platforms were determined in conjunction with gonadal histology. Rock hind social order is haremic with one dominant male defending a territory and a linear dominance hierarchy among individuals. In five captive experiments, the largest remaining female rock hind displayed the male specific color pattern within 32d after dominant male removal from the social group. To our knowledge, this is the first evidence in a grouper species of color patterning used to display territoriality and dominance outside of spawning aggregations. The behavioral paradigm described here is a key advance that will enable mechanistic studies of this complex sex change process.	[Kline, Richard J.; Holt, G. Joan] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Khan, Izhar A.] US Fish & Wildlife Serv, Dexter Natl Fish Hatchery & Technol Ctr, Dexter, NM USA	University of Texas System; University of Texas Austin; United States Department of the Interior; US Fish & Wildlife Service	Kline, RJ (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	rjkline@mail.utexas.edu		Kline, Richard/0000-0002-4116-2060; Khan, Izhar/0000-0002-2811-6561	Lund Fellowship in Marine Science; Sid Richardson Foundation	Lund Fellowship in Marine Science; Sid Richardson Foundation	We acknowledge funding from the Lund Fellowship in Marine Science to RJK and from the Sid Richardson Foundation to GJH and IAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund Anders, 1997, P237; Bhandari RK, 2006, ZOOL SCI, V23, P65, DOI 10.2108/zsj.23.65; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Burns KJ, 1998, EVOLUTION, V52, P1219, DOI 10.1111/j.1558-5646.1998.tb01849.x; CARDWELL JR, 1991, GEN COMP ENDOCR, V81, P7, DOI 10.1016/0016-6480(91)90120-U; COLIN PL, 1987, B MAR SCI, V40, P220; DAWKINS MS, 1993, BEHAV PROCESS, V30, P245, DOI 10.1016/0376-6357(93)90136-F; GILMORE GR, 1992, B MAR SCI, V51, P83; Godwin J, 2009, SEMIN CELL DEV BIOL, V20, P264, DOI 10.1016/j.semcdb.2008.12.003; HASTINGS RW, 1976, FISH B-NOAA, V74, P387; Kline RJ, 2008, N AM J AQUACULT, V70, P266, DOI 10.1577/A07-033.1; Kodric-Brown A, 1998, AM ZOOL, V38, P70; Liu M, 2004, J ZOOL, V264, P239, DOI 10.1017/S0952836904005631; Liu M, 2009, AQUACULTURE, V287, P191, DOI 10.1016/j.aquaculture.2008.10.027; LNTNESKY MMF, 1994, BEHAV ECOLOGY, V5, P375; Lutnesky M, 1988, PAC SCI, V42, P46; Mackie MC, 2003, CORAL REEFS, V22, P133, DOI 10.1007/s00338-003-0296-3; MUSKE LE, 1987, J COMP PHYSIOL A, V160, P99, DOI 10.1007/BF00613445; MUSKE LE, 1987, J COMP PHYSIOL A, V160, P89, DOI 10.1007/BF00613444; Neidig CL, 2000, N AM J AQUACULT, V62, P103, DOI 10.1577/1548-8454(2000)062<0103:TFSCSB>2.0.CO;2; Noga E.J., 2000, FISH DIS DIAGNOSIS T; Polovina J, 1987, TROPICAL SNAPPERS GR; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; ROSS RM, 1983, SCIENCE, V221, P574, DOI 10.1126/science.221.4610.574; SADOVY Y, 1994, COPEIA, P511; SADOVY Y, 1987, COPEIA, P136, DOI 10.2307/1446046; Sakai Y, 2003, ZOOL SCI, V20, P627, DOI 10.2108/zsj.20.627; Sakai Y, 2007, J ETHOL, V25, P57, DOI 10.1007/s10164-006-0207-5; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; SHAPIRO DY, 1981, J ZOOL, V193, P105; SHAPIRO DY, 1988, ENVIRON BIOL FISH, V23, P283, DOI 10.1007/BF00005240; SHAPIRO DY, 1981, B MAR SCI, V31, P383; Siebeck UE, 2004, ANIM BEHAV, V68, P273, DOI 10.1016/j.anbehav.2003.11.010; THRESHER RE, 1984, REPRODUCTION REEF FI; Todd BD, 2007, CAN J ZOOL, V85, P1008, DOI 10.1139/Z07-082; WARNER RR, 1982, COPEIA, P653; WARNER RR, 1992, EVOLUTION, V46, P1421, DOI 10.1111/j.1558-5646.1992.tb01134.x; WARNER RR, 1991, BIOL BULL-US, V181, P199, DOI 10.2307/1542090; Yeh SL, 2003, AQUACULTURE, V218, P729, DOI 10.1016/S0044-8486(02)00565-3	41	27	27	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19576	10.1371/journal.pone.0019576	http://dx.doi.org/10.1371/journal.pone.0019576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647429	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500005
J	Lengagne, R; Pommier, A; Caron, J; Douguet, L; Garcette, M; Kato, M; Avril, MF; Abastado, JP; Bercovici, N; Lucas, B; Prevost-Blondel, A				Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Kato, Masashi; Avril, Marie-Francoise; Abastado, Jean-Pierre; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle			T Cells Contribute to Tumor Progression by Favoring Pro-Tumoral Properties of Intra-Tumoral Myeloid Cells in a Mouse Model for Spontaneous Melanoma	PLOS ONE			English	Article							NF-KAPPA-B; SUPPRESSOR-CELLS; MACROPHAGE POLARIZATION; ADAPTIVE IMMUNITY; BEARING HOST; CANCER; ACTIVATION; DISTINCT; MICE; INFLAMMATION	Tumors affect myelopoeisis and induce the expansion of myeloid cells with immunosuppressive activity. In the MT/ret model of spontaneous metastatic melanoma, myeloid cells are the most abundant tumor infiltrating hematopoietic population and their proportion is highest in the most aggressive cutaneous metastasis. Our data suggest that the tumor microenvironment favors polarization of myeloid cells into type 2 cells characterized by F4/80 expression, a weak capacity to secrete IL-12 and a high production of arginase. Myeloid cells from tumor and spleen of MT/ret mice inhibit T cell proliferation and IFN gamma secretion. Interestingly, T cells play a role in type 2 polarization of myeloid cells. Indeed, intra-tumoral myeloid cells from MT/ret mice lacking T cells are not only less suppressive towards T cells than corresponding cells from wild-type MT/ret mice, but they also inhibit more efficiently melanoma cell proliferation. Thus, our data support the existence of a vicious circle, in which T cells may favor cancer development by establishing an environment that is likely to skew myeloid cell immunity toward a tumor promoting response that, in turn, suppresses immune effector cell functions.	[Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Avril, Marie-Francoise; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle] Inst Cochin, INSERM, U1016, Paris, France; [Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Avril, Marie-Francoise; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle] CNRS, UMR8104, Paris, France; [Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Avril, Marie-Francoise; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle] Univ Paris 05, Paris, France; [Kato, Masashi] Chubu Univ, Unit Environm Hlth Sci, Aichi, Japan; [Avril, Marie-Francoise] Hop Cochin, APHP, Serv Dermatol, F-75674 Paris, France; [Abastado, Jean-Pierre] ASTAR, Singapore Immunol Network, BMSI, Singapore, Singapore	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Chubu University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Lengagne, R (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	armelle.blondel@inserm.fr	KATO, Masashi/I-7250-2014; bercovici, nadege/P-5239-2017; Prevost-Blondel, Armelle/N-7643-2017	Prevost-Blondel, Armelle/0000-0002-7268-5905; LUCAS, Bruno/0000-0002-0322-3977; Douguet, Laetitia/0000-0003-4319-491X	Canceropole IDF; Ligue contre le Cancer; CNRS	Canceropole IDF(Region Ile-de-France); Ligue contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by funding from Canceropole IDF, the "Ligue contre le Cancer" and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boonman ZFHM, 2006, INVEST OPHTH VIS SCI, V47, P2959, DOI 10.1167/iovs.05-1427; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Ibe S, 2001, J EXP MED, V194, P1549, DOI 10.1084/jem.194.11.1549; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Lengagne R, 2004, CANCER RES, V64, P1496, DOI 10.1158/0008-5472.CAN-03-2828; Lengagne R, 2008, J IMMUNOL, V180, P130, DOI 10.4049/jimmunol.180.1.130; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Miselis NR, 2008, MOL CANCER THER, V7, P788, DOI 10.1158/1535-7163.MCT-07-0579; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nardin A, 2008, FRONT BIOSCI-LANDMRK, V13, P3494; Oosterling SJ, 2005, J PATHOL, V207, P147, DOI 10.1002/path.1830; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Soudja SM, 2010, CANCER RES, V70, P3515, DOI 10.1158/0008-5472.CAN-09-4354; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; WHITWORTH PW, 1990, CANCER METAST REV, V8, P319, DOI 10.1007/BF00052607; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20235	10.1371/journal.pone.0020235	http://dx.doi.org/10.1371/journal.pone.0020235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633700	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500045
J	Lin, IH; Liu, TT; Teng, YT; Wu, HL; Liu, YM; Wu, KM; Chang, CH; Hsu, MT				Lin, I-Hsuan; Liu, Tze-Tze; Teng, Yu-Ting; Wu, Hui-Lun; Liu, Yen-Ming; Wu, Keh-Ming; Chang, Chuan-Hsiung; Hsu, Ming-Ta			Sequencing and Comparative Genome Analysis of Two Pathogenic Streptococcus gallolyticus Subspecies: Genome Plasticity, Adaptation and Virulence	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; TRANSFER-RNA GENES; BOVIS ENDOCARDITIS; CELL-WALL; COMPETENCE DEVELOPMENT; NUCLEOTIDE-SEQUENCE; MOLECULAR ANALYSIS; SURFACE-PROTEINS; SIGNAL PEPTIDES; LIVER-DISEASE	Streptococcus gallolyticus infections in humans are often associated with bacteremia, infective endocarditis and colon cancers. The disease manifestations are different depending on the subspecies of S. gallolyticus causing the infection. Here, we present the complete genomes of S. gallolyticus ATCC 43143 (biotype I) and S. pasteurianus ATCC 43144 (biotype II.2). The genomic differences between the two biotypes were characterized with comparative genomic analyses. The chromosome of ATCC 43143 and ATCC 43144 are 2,36 and 2,10 Mb in length and encode 2246 and 1869 CDS respectively. The organization and genomic contents of both genomes were most similar to the recently published S. gallolyticus UCN34, where 2073 (92%) and 1607 (86%) of the ATCC 43143 and ATCC 43144 CDS were conserved in UCN34 respectively. There are around 600 CDS conserved in all Streptococcus genomes, indicating the Streptococcus genus has a small core-genome (constitute around 30% of total CDS) and substantial evolutionary plasticity. We identified eight and five regions of genome plasticity in ATCC 43143 and ATCC 43144 respectively. Within these regions, several proteins were recognized to contribute to the fitness and virulence of each of the two subspecies. We have also predicted putative cell-surface associated proteins that could play a role in adherence to host tissues, leading to persistent infections causing sub-acute and chronic diseases in humans. This study showed evidence that the S. gallolyticus still possesses genes making it suitable in a rumen environment, whereas the ability for S. pasteurianus to live in rumen is reduced. The genome heterogeneity and genetic diversity among the two biotypes, especially membrane and lipoproteins, most likely contribute to the differences in the pathogenesis of the two S. gallolyticus biotypes and the type of disease an infected patient eventually develops.	[Lin, I-Hsuan; Chang, Chuan-Hsiung] Natl Yang Ming Univ, Inst BioMed Informat, Taipei 112, Taiwan; [Lin, I-Hsuan] Acad Sinica, Taiwan Int Grad Program, Taipei 115, Taiwan; [Liu, Tze-Tze; Teng, Yu-Ting; Wu, Hui-Lun; Liu, Yen-Ming; Wu, Keh-Ming; Hsu, Ming-Ta] Natl Yang Ming Univ, VGH Yang Ming Genome Res Ctr, Taipei 112, Taiwan; [Chang, Chuan-Hsiung] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Hsu, Ming-Ta] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, IH (corresponding author), Natl Yang Ming Univ, Inst BioMed Informat, Taipei 112, Taiwan.	mth@ym.edu.tw	Lin, I-Hsuan/N-6501-2013	Lin, I-Hsuan/0000-0002-6207-1299	National Science Council, Taiwan [NSC99-3112-B-010-018]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by grants from National Research Program for Genomic Medicine of National Science Council, Taiwan (NSC99-3112-B-010-018) and the Ministry of Education, Taiwan, Aim for the Top University Plan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Ahn SJ, 2006, J BACTERIOL, V188, P6877, DOI 10.1128/JB.00536-06; Ahn SJ, 2010, MICROBIOL-SGM, V156, P3136, DOI 10.1099/mic.0.039586-0; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Avila M, 2009, MICROBIOL-SGM, V155, P2739, DOI 10.1099/mic.0.027789-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; *BAYL COLL MED HGS, 2010, STREPT GALL SUBSP GA; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Beck M, 2008, J CLIN MICROBIOL, V46, P2966, DOI 10.1128/JCM.00078-08; Behrens S, 2001, MICROBIOL-SGM, V147, P75, DOI 10.1099/00221287-147-1-75; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bhat TK, 1998, BIODEGRADATION, V9, P343, DOI 10.1023/A:1008397506963; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bizzini A, 2010, J BACTERIOL, V192, P779, DOI 10.1128/JB.00959-09; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bray BA, 2009, ANTON LEEUW INT J G, V95, P101, DOI 10.1007/s10482-008-9291-6; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui ZL, 2006, ACTA CRYSTALLOGR F, V62, P646, DOI 10.1107/S174430910601904X; Dalrymple BP, 1996, FEMS MICROBIOL LETT, V143, P115, DOI 10.1016/0378-1097(96)00306-0; DARJEE R, 1993, J CLIN PATHOL, V46, P1116, DOI 10.1136/jcp.46.12.1116; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DSOUZA C, 1994, P NATL ACAD SCI USA, V91, P9397, DOI 10.1073/pnas.91.20.9397; Duval X, 2001, CLIN MICROBIOL INFEC, V7, P3, DOI 10.1046/j.1469-0691.2001.00190.x; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; FACKLAM RR, 1972, APPL MICROBIOL, V23, P1131, DOI 10.1128/AEM.23.6.1131-1139.1972; FARROW JAE, 1984, SYST APPL MICROBIOL, V5, P467, DOI 10.1016/S0723-2020(84)80004-1; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; GANESHKUMAR N, 1991, INFECT IMMUN, V59, P1093, DOI 10.1128/IAI.59.3.1093-1099.1991; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gavin PJ, 2003, J CLIN MICROBIOL, V41, P3433, DOI 10.1128/JCM.41.7.3433-3435.2003; Genta PR, 1998, SOUTHERN MED J, V91, P1167, DOI 10.1097/00007611-199812000-00015; Ghuysen Jean-Marie, 1994, Trends in Microbiology, V2, P372, DOI 10.1016/0966-842X(94)90614-9; Ginsburg I, 2002, APMIS, V110, P753, DOI 10.1034/j.1600-0463.2002.1101101.x; Gonzalez-Quintela A, 2001, J INFECTION, V42, P116, DOI 10.1053/jinf.2001.0799; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; Gutierrez-Preciado A, 2007, TRENDS GENET, V23, P422, DOI 10.1016/j.tig.2007.05.005; Haas W, 2004, J BACTERIOL, V186, P8463, DOI 10.1128/JB.186.24.8463-8471.2004; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Henstra SA, 1996, J BACTERIOL, V178, P5586, DOI 10.1128/jb.178.19.5586-5591.1996; Herrero IA, 2002, J CLIN MICROBIOL, V40, P3848, DOI 10.1128/JCM.40.10.3848-3850.2002; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Jean SS, 2004, J FORMOS MED ASSOC, V103, P118; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kitten T, 2000, INFECT IMMUN, V68, P4441, DOI 10.1128/IAI.68.8.4441-4451.2000; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KLEIN RS, 1979, ANN INTERN MED, V91, P560, DOI 10.7326/0003-4819-91-4-560; KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; KNIGHT RG, 1985, INT J SYST BACTERIOL, V35, P357, DOI 10.1099/00207713-35-3-357; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; KOLENBRANDER PE, 1994, INFECT IMMUN, V62, P4469, DOI 10.1128/IAI.62.10.4469-4480.1994; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Kreth J, 2005, MOL MICROBIOL, V57, P392, DOI 10.1111/j.1365-2958.2005.04695.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulkarni R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004752; Kupferwasser I, 1998, HEART, V80, P276, DOI 10.1136/hrt.80.3.276; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Llull Daniel, 2001, Current Molecular Medicine (Hilversum), V1, P475; Lory S, 1998, CURR OPIN MICROBIOL, V1, P27, DOI 10.1016/S1369-5274(98)80139-2; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mitchell LS, 2002, INT J MED MICROBIOL, V292, P75, DOI 10.1078/1438-4221-00193; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Moscoso M, 2009, INT MICROBIOL, V12, P77, DOI 10.2436/20.1501.01.84; MUNRO CL, 1993, MOL MICROBIOL, V8, P133, DOI 10.1111/j.1365-2958.1993.tb01210.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nemoto H, 2008, J MED MICROBIOL, V57, P891, DOI 10.1099/jmm.0.47836-0; Noguchi N, 2007, J GASTROENTEROL, V42, P346, DOI 10.1007/s00535-007-2012-5; Nomura R, 2004, ARCH ORAL BIOL, V49, P783, DOI 10.1016/j.archoralbio.2004.04.001; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Novak P, 2000, MOL CELL, V5, P49, DOI 10.1016/S1097-2765(00)80402-5; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; Onoyama S, 2009, J MED MICROBIOL, V58, P1252, DOI 10.1099/jmm.0.006551-0; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; PARKER MT, 1976, J MED MICROBIOL, V9, P275, DOI 10.1099/00222615-9-3-275; Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivolta C, 1998, MICROBIOL-UK, V144, P877, DOI 10.1099/00221287-144-4-877; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Semedo T, 2003, SYST APPL MICROBIOL, V26, P13, DOI 10.1078/0723202022528942; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shibata Y, 2005, INFECT IMMUN, V73, P3512, DOI 10.1128/IAI.73.6.3512-3520.2005; Shukla A, 2010, ACTA CRYSTALLOGR F, V66, P1421, DOI 10.1107/S1744309110036286; Shun CT, 2005, INFECT IMMUN, V73, P3261, DOI 10.1128/IAI.73.6.3261-3270.2005; Sillanpaa J, 2009, J BACTERIOL, V191, P6643, DOI 10.1128/JB.00909-09; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Sturt AS, 2010, J CLIN MICROBIOL, V48, P2247, DOI 10.1128/JCM.00081-10; Sun XS, 2008, FEBS LETT, V582, P1351, DOI 10.1016/j.febslet.2008.03.020; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2005, MOL BIOL EVOL, V22, P243, DOI 10.1093/molbev/msi011; Tech M, 2005, BIOINFORMATICS, V21, P3568, DOI 10.1093/bioinformatics/bti563; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Tripodi MF, 2005, CLIN MICROBIOL INFEC, V11, P814, DOI 10.1111/j.1469-0691.2005.01248.x; Tripodi MF, 2004, CLIN INFECT DIS, V38, P1394, DOI 10.1086/392503; *UN BIOL BACT INTR, 2010, STREPT GALL SUBSP GA; van der Ploeg JR, 2005, J BACTERIOL, V187, P3980, DOI 10.1128/JB.187.12.3980-3989.2005; Varvio SL, 2009, J INFECT DIS, V200, P1144, DOI 10.1086/605651; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; Waisberg Jaques, 2002, Arq. Gastroenterol., V39, P177, DOI 10.1590/S0004-28032002000300008; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; ZARKIN BA, 1990, ANN SURG, V211, P786, DOI 10.1097/00000658-199006000-00019; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	152	35	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20519	10.1371/journal.pone.0020519	http://dx.doi.org/10.1371/journal.pone.0020519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633709	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500068
J	Simpson, SL; Hayasaka, S; Laurienti, PJ				Simpson, Sean L.; Hayasaka, Satoru; Laurienti, Paul J.			Exponential Random Graph Modeling for Complex Brain Networks	PLOS ONE			English	Article							P-ASTERISK MODELS; LOGISTIC REGRESSIONS; SOCIAL NETWORKS; LOGIT-MODELS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ORGANIZATION; MRI	Exponential random graph models (ERGMs), also known as p* models, have been utilized extensively in the social science literature to study complex networks and how their global structure depends on underlying structural components. However, the literature on their use in biological networks (especially brain networks) has remained sparse. Descriptive models based on a specific feature of the graph (clustering coefficient, degree distribution, etc.) have dominated connectivity research in neuroscience. Corresponding generative models have been developed to reproduce one of these features. However, the complexity inherent in whole-brain network data necessitates the development and use of tools that allow the systematic exploration of several features simultaneously and how they interact to form the global network architecture. ERGMs provide a statistically principled approach to the assessment of how a set of interacting local brain network features gives rise to the global structure. We illustrate the utility of ERGMs for modeling, analyzing, and simulating complex whole-brain networks with network data from normal subjects. We also provide a foundation for the selection of important local features through the implementation and assessment of three selection approaches: a traditional p-value based backward selection approach, an information criterion approach (AIC), and a graphical goodness of fit (GOF) approach. The graphical GOF approach serves as the best method given the scientific interest in being able to capture and reproduce the structure of fitted brain networks.	[Simpson, Sean L.; Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Hayasaka, Satoru; Laurienti, Paul J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Simpson, SL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA.	slsimpso@wfubmc.edu			Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke [NS070917]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917] Funding Source: NIH RePORTER	Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Translational Science Institute of Wake Forest University (Translational Scholar Award, URL: http://www.wfubmc.edu/TSI.htm) and by the National Institute of Neurological Disorders and Stroke (NS070917, URL: http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; HANDCOCK MS, 2008, STATNET SOFTWARE TOO; HANDCOCK MS, 2002, STAT MODELS SOCIAL N, P229; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hunter DR, 2008, J AM STAT ASSOC, V103, P248, DOI 10.1198/016214507000000446; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MORRIS M, 2008, J STAT SOFTWARE, V24; Muller K. E., 2002, REGRESSION ANOVA INT; Pattison P, 1999, BRIT J MATH STAT PSY, V52, P169, DOI 10.1348/000711099159053; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; Rinaldo A, 2009, ELECTRON J STAT, V3, P446, DOI 10.1214/08-EJS350; Robins G, 1999, PSYCHOMETRIKA, V64, P371, DOI 10.1007/BF02294302; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Saul ZM, 2007, BIOINFORMATICS, V23, P2604, DOI 10.1093/bioinformatics/btm370; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van Duijn MAJ, 2009, SOC NETWORKS, V31, P52, DOI 10.1016/j.socnet.2008.10.003; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	38	63	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20039	10.1371/journal.pone.0020039	http://dx.doi.org/10.1371/journal.pone.0020039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647450	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500020
J	Veiga, MI; Ferreira, PE; Jornhagen, L; Malmberg, M; Kone, A; Schmidt, BA; Petzold, M; Bjorkman, A; Nosten, F; Gil, JP				Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Jornhagen, Louise; Malmberg, Maja; Kone, Aminatou; Schmidt, Berit Aydin; Petzold, Max; Bjorkman, Anders; Nosten, Francois; Gil, Jose Pedro			Novel Polymorphisms in Plasmodium falciparum ABC Transporter Genes Are Associated with Major ACT Antimalarial Drug Resistance	PLOS ONE			English	Article							PFMDR1 COPY NUMBER; IN-VIVO SELECTION; ARTEMETHER-LUMEFANTRINE; SUBSTRATE-SPECIFICITY; ARTEMISININ RESISTANCE; CHLOROQUINE RESISTANCE; MEFLOQUINE RESISTANCE; COMBINATION THERAPY; MALARIA PARASITE; AMINO-ACIDS	Chemotherapy is a critical component of malaria control. However, the most deadly malaria pathogen, Plasmodium falciparum, has repeatedly mounted resistance against a series of antimalarial drugs used in the last decades. Southeast Asia is an epicenter of emerging antimalarial drug resistance, including recent resistance to the artemisinins, the core component of all recommended antimalarial combination therapies. Alterations in the parasitic membrane proteins Pgh-1, PfCRT and PfMRP1 are believed to be major contributors to resistance through decreasing intracellular drug accumulation. The pfcrt, pfmdr1 and pfmrp1 genes were sequenced from a set of P. falciparum field isolates from the Thai-Myanmar border. In vitro drug susceptibility to artemisinin, dihydroartemisinin, mefloquine and lumefantrine were assessed. Positive correlations were seen between the in vitro susceptibility responses to artemisinin and dihydroartemisinin and the responses to the arylamino-alcohol quinolines lumefantrine and mefloquine. The previously unstudied pfmdr1 F1226Y and pfmrp1 F1390I SNPs were associated significantly with artemisinin, mefloquine and lumefantrine in vitro susceptibility. A variation in pfmdr1 gene copy number was also associated with parasite drug susceptibility of artemisinin, mefloquine and lumefantrine. Our work unveils new candidate markers of P. falciparum multidrug resistance in vitro, while contributing to the understanding of subjacent genetic complexity, essential for future evidence-based drug policy decisions.	[Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Jornhagen, Louise; Malmberg, Maja; Kone, Aminatou; Schmidt, Berit Aydin; Bjorkman, Anders] Karolinska Inst, Malaria Res Lab, Dept Med, Stockholm, Sweden; [Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Gil, Jose Pedro] Univ Algarve, Drug Resistance & Pharmacogenet Grp, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Faro, Portugal; [Petzold, Max] Nord Sch Publ Hlth, Gothenburg, Sweden; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot Tak, Thailand; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Gil, Jose Pedro] Karolinska Inst, Div Pharmacogenet, Dept Physiol & Pharmacol, Stockholm, Sweden; [Gil, Jose Pedro] SUNY Binghamton, Lab Mol Anthropol & Hlth, Dept Anthropol, Binghamton, NY USA	Karolinska Institutet; Universidade do Algarve; Mahidol University; Mahidol University; University of Oxford; Karolinska Institutet; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Veiga, MI (corresponding author), Karolinska Inst, Malaria Res Lab, Dept Med, Stockholm, Sweden.	Isabel.veiga@ki.se	Veiga, Maria Isabel/H-9922-2018; Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro/AAD-4309-2020; Nosten, Francois/AAC-5509-2019; Ferreira, Pedro/Q-6748-2016; Hua, QX/HGE-3640-2022; Ferreira, Pedro/G-1717-2012; Gil, José Pedro/AAB-6169-2020; Malmberg, Maja/H-1890-2014; Pousao-Ferreira, Pedro/H-3689-2014	Veiga, Maria Isabel/0000-0002-2205-8102; Ferreira, Pedro/0000-0002-2682-7722; Nosten, Francois/0000-0002-7951-0745; Ferreira, Pedro/0000-0002-2682-7722; Ferreira, Pedro/0000-0002-2682-7722; Malmberg, Maja/0000-0002-4506-0408; Kone, Aminatou/0000-0001-7146-6439; Gil, Jose Pedro/0000-0002-6107-9379; Pousao-Ferreira, Pedro/0000-0001-6746-764X	Swedish Development Cooperation Agency-Department for Research Cooperation [SWE 2005-0017, SWE 2005-4596, SWE-2007-174, SWE-2005-4027]; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal-MCES [SFRH/BD/28393/2006, SFRH/BD/28368/2006]; Wellcome Trust of Great Britain	Swedish Development Cooperation Agency-Department for Research Cooperation; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal-MCES(Portuguese Foundation for Science and Technology); Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by project grants from Swedish Development Cooperation Agency-Department for Research Cooperation (SWE 2005-0017, SWE 2005-4596, SWE-2007-174 and SWE-2005-4027). MIV and PEF are recipients of PhD grants from Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal-MCES (ref. SFRH/BD/28393/2006 and ref. SFRH/BD/28368/2006, respectively). The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Tropical Medicine Research Unit, supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Cowman AF, 1995, AUST NZ J MED, V25, P837, DOI 10.1111/j.1445-5994.1995.tb02889.x; Dahlstrom S, 2009, J INFECT DIS, V200, P1456, DOI 10.1086/606009; Daoud R, 2001, J BIOL CHEM, V276, P12324, DOI 10.1074/jbc.M009782200; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Imwong M, 2010, ANTIMICROB AGENTS CH, V54, P2886, DOI 10.1128/AAC.00032-10; Kavishe RA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-205; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; Peel SA, 2001, DRUG RESIST UPDATE, V4, P66, DOI 10.1054/drup.2001.0183; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-89; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rodrigues Coura J, 1987, Mem Inst Oswaldo Cruz, V82, P303; Rohrbach P, 2006, EMBO J, V25, P3000, DOI 10.1038/sj.emboj.7601203; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Uhlemann AC, 2005, J INFECT DIS, V192, P1830, DOI 10.1086/497337; Ursing J, 2006, J INFECT DIS, V194, P716, DOI 10.1086/506456; WHO, WORD MAL REP; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P3049, DOI 10.1128/AAC.00209-10; Zhang DW, 2006, DRUG METAB DISPOS, V34, P539, DOI 10.1124/dmd.105.007740; Zhang DW, 2004, BIOCHEMISTRY-US, V43, P9413, DOI 10.1021/bi0495230	44	68	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20212	10.1371/journal.pone.0020212	http://dx.doi.org/10.1371/journal.pone.0020212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633513	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500042
J	Vilaplana, C; Gil, O; Caceres, N; Pinto, S; Diaz, J; Cardona, PJ				Vilaplana, Cristina; Gil, Olga; Caceres, Neus; Pinto, Sergio; Diaz, Jorge; Cardona, Pere-Joan			Prophylactic Effect of a Therapeutic Vaccine against TB Based on Fragments of Mycobacterium tuberculosis	PLOS ONE			English	Article							DISEASE; IMMUNOTHERAPY; CHEMOTHERAPY; INFECTION; INFANTS; MURINE; MODEL; WORLD	The prophylactic capacity of the RUTI (R) vaccine, based on fragmented cells of Mycobacterium tuberculosis, has been evaluated in respect to aerosol challenge with virulent bacilli. Subcutaneous vaccination significantly reduced viable bacterial counts in both lungs and spleens of C57Bl mice, when challenged 4 weeks after vaccination. RUTI (R) protected the spleen less than BCG. Following a 9 month vaccination-challenge interval, protection was observed for the lungs, but not for the spleen. Survival of infected guinea pigs was prolonged by vaccination given 5 weeks before challenge. Inoculations of RUTI (R) shortly after infection significantly reduced the viable bacterial counts in the lungs, when compared with infected control mice. Thus, vaccination by RUTI (R) has potential for both the prophylaxis and immunotherapy of tuberculosis.	[Vilaplana, Cristina; Gil, Olga; Caceres, Neus; Pinto, Sergio; Diaz, Jorge; Cardona, Pere-Joan] Univ Autonoma Barcelona, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut Germans Trias, Crta Badalona, Catalonia, Spain; [Vilaplana, Cristina; Gil, Olga; Caceres, Neus; Pinto, Sergio; Diaz, Jorge; Cardona, Pere-Joan] CIBER Enfermedades Resp, Bunyola, Balears, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Vilaplana, C (corresponding author), Univ Autonoma Barcelona, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut Germans Trias, Crta Badalona, Catalonia, Spain.	pjcardona.igtp.germanstrias@gencat.cat	Vilaplana, Cristina/K-7216-2012; Cardona, Pere-Joan/A-5258-2011	Vilaplana, Cristina/0000-0002-2808-7270; Cardona, Pere-Joan/0000-0001-5623-7873	Archivel Farma S.L., the Spanish Ministry of Health [FIS 03/0757, CM06/00123]; European Community [HEALTH-2007-2.3.2-2, 200999]; Archivel Farma S.L.	Archivel Farma S.L., the Spanish Ministry of Health(Spanish Government); European Community(European Commission); Archivel Farma S.L.	The research leading to these results has received funding from Archivel Farma S.L., the Spanish Ministry of Health (FIS 03/0757; National Plan I+D+I FIS CM06/00123; CIBERES CRP-TB) and the European Community's Seventh Framework Programme (HEALTH-2007-2.3.2-2) under grant agreement no 200999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. PJC is co-inventor of the patents for RUTI (R) as a therapeutic vaccine, prophylactic vaccine and as primary prophylaxis against TB. Regulatory approval and development is being undertaken by a spin-out biopharma company (Archivel Farma, S.L.) in collaboration with the Institut Germans Trias i Pujol. PJC is the scientific director of this development. Archivel Farma S.L. partly funded this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Azzopardi P, 2009, INT J TUBERC LUNG D, V13, P1331; Beresford B, 2010, CLIN INFECT DIS, V50, pS178, DOI 10.1086/651489; Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Domingo M, 2009, SCAND J IMMUNOL, V69, P500, DOI 10.1111/j.1365-3083.2009.02251.x; Fine P, 2005, BRIT MED J, V331, P647, DOI 10.1136/bmj.331.7518.647; Gil O, 2008, CLIN VACCINE IMMUNOL, V15, P1742, DOI 10.1128/CVI.00255-08; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Marais B, 2010, LANCET; MARTINEZ A, 2005, ARCH BRONCONEUMOL, P27; McShane H, 2009, SWISS MED WKLY, V139, P156, DOI smw-12374; Moreira AL, 2002, INFECT IMMUN, V70, P2100, DOI 10.1128/IAI.70.4.2100-2107.2002; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Rook GAW, 1996, CURR TOP MICROBIOL, V215, P239; *TB PARTN WORK GRO, 2009, TB VACC PIP; Vilaplana C, 2010, VACCINE, V28, P1106, DOI 10.1016/j.vaccine.2009.09.134; World Health Organization, 2009, GLOB TUB CONTR EP ST	23	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20404	10.1371/journal.pone.0020404	http://dx.doi.org/10.1371/journal.pone.0020404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647222	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800049
J	Wobber, V; Hare, B				Wobber, Victoria; Hare, Brian			Psychological Health of Orphan Bonobos and Chimpanzees in African Sanctuaries	PLOS ONE			English	Article							DIFFERENTIALLY REARED CHIMPANZEES; INTELLECTUAL-PERFORMANCE; ABNORMAL BEHAVIORS; WILD-BORN; PAN; DEPRIVATION; COGNITION; LOCATION; HUMANS; RANGE	Background: Facilities across Africa care for apes orphaned by the trade for "bushmeat.'' These facilities, called sanctuaries, provide housing for apes such as bonobos (Pan paniscus) and chimpanzees (Pan troglodytes) who have been illegally taken from the wild and sold as pets. Although these circumstances are undoubtedly stressful for the apes, most individuals arrive at the sanctuaries as infants and are subsequently provided with rich physical and social environments that can facilitate the expression of species-typical behaviors. Methods and Findings: We tested whether bonobo and chimpanzee orphans living in sanctuaries show any behavioral, physiological, or cognitive abnormalities relative to other individuals in captivity as a result of the early-life stress they experience. Orphans showed lower levels of aberrant behaviors, similar levels of average cortisol, and highly similar performances on a broad battery of cognitive tests in comparisons with individuals of the same species who were either living at a zoo or were reared by their mothers at the sanctuaries. Conclusion: Taken together, these results support the rehabilitation strategy used by sanctuaries in the Pan-African Sanctuary Alliance (PASA) and suggest that the orphans we examined did not show long-term signs of stress as a result of their capture. Our findings also show that sanctuary apes are as psychologically healthy as apes in other captive settings and thus represent a valuable resource for non-invasive research.	[Wobber, Victoria] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Harvard University; Duke University; Duke University	Wobber, V (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	wobber@fas.harvard.edu			European Research Commission [233297]; National Science Foundation [NSF-BCS-08-27552, NSF-BCS-10-25172, NSF-BCS-0851291]; L.S.B. Leakey Foundation; Wenner-Gren Foundation	European Research Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation; Wenner-Gren Foundation	This work was supported in part by European Research Commission (http://ec.europa.eu/research/) Advanced Grant Agreement 233297 and National Science Foundation (http://www.nsf.gov) grants NSF-BCS-08-27552 and NSF-BCS-10-25172 to B. H, and an L.S.B. Leakey Foundation Grant (http://www.leakeyfoundation.org), NSF-BCS-0851291 (DDIG), and a Wenner-Gren Foundation Grant (http://www.wennergren.org) to V. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Baker KC, 2000, AM J PRIMATOL, V51, P161, DOI 10.1002/1098-2345(200007)51:3<161::AID-AJP1>3.3.CO;2-X; Baker KC, 1996, APPL ANIM BEHAV SCI, V49, P403, DOI 10.1016/0168-1591(96)01061-1; BAKER KC, 1996, CONTEMP TOP LAB ANIM, V35, P71; Beck Benjamin B., 2010, P332; Beckett C, 2006, CHILD DEV, V77, P696, DOI 10.1111/j.1467-8624.2006.00898.x; Biro D, 2011, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P476; BLOOMSMITH M, 2005, NURSERY REARING NONH, P289; COX D, CHIMP SANCT GUID MAN; DAVENPOR.RK, 1969, AM J MENT DEF, V73, P963; DAVENPORT RK, 1973, DEV PSYCHOL, V9, P343, DOI 10.1037/h0034877; DAVENPORT RK, 1968, AM J MENT DEF, V72, P674; DAVENPORT RK, 1963, ARCH GEN PSYCHIAT, V8, P99; DAVENPORT RK, 1970, CHIMPANZEE, P337; Farmer KH, 2006, INT J PRIMATOL, V27, P747, DOI 10.1007/s10764-006-9041-4; Farmer KH, 2002, AM J PRIMATOL, V58, P117, DOI 10.1002/ajp.10054; FRITZ J, 1992, ZOO BIOL, V11, P313, DOI 10.1002/zoo.1430110503; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gruber T, 2010, ANIM BEHAV, V80, P1023, DOI 10.1016/j.anbehav.2010.09.005; Hanus D, 2008, CURR BIOL, V18, pR370, DOI 10.1016/j.cub.2008.02.039; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Herrmann E, 2010, PSYCHOL SCI, V21, P102, DOI 10.1177/0956797609356511; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Kalcher E, 2008, DEV PSYCHOBIOL, V50, P777, DOI 10.1002/dev.20330; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Law AJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1381, DOI 10.1038/npp.2008.106; LIPSON S F, 1989, American Journal of Human Biology, V1, P249, DOI 10.1002/ajhb.1310010304; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; MAKI S, 1989, ZOO BIOL, V8, P79, DOI 10.1002/zoo.1430080110; MAKI S, 1993, INFANT BEHAV DEV, V16, P373, DOI 10.1016/0163-6383(93)80042-7; Martin P., 1986, MEASURING BEHAV; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; MENZEL EW, 1970, FOLIA PRIMATOL, V12, P273, DOI 10.1159/000155297; Mugisha L, 2010, J MED PRIMATOL, V39, P123, DOI 10.1111/j.1600-0684.2010.00400.x; Nash LT, 1999, AM J PRIMATOL, V48, P15, DOI 10.1002/(SICI)1098-2345(1999)48:1<15::AID-AJP2>3.3.CO;2-I; PAQUETTE D, 1988, ZOO BIOL, V7, P15, DOI 10.1002/zoo.1430070103; Pika S, 2008, AM J PRIMATOL, V70, P207, DOI 10.1002/ajp.20469; Pruetz JD, 2001, CARE MANAGEMENT CAPT, P17; Reimers M, 2007, HORM BEHAV, V51, P428, DOI 10.1016/j.yhbeh.2006.12.011; ROGERS CM, 1971, AM J MENT DEF, V75, P526; SAPOLSKY R, 1994, WHY ZEBRAS DONT GET, P1; SPIJKERMAN R, 1996, EFFECTS PEER ONLY RE; Spijkerman RP, 1997, INT J PRIMATOL, V18, P439, DOI 10.1023/A:1026342602018; Stevens HE, 2009, J AM ACAD CHILD PSY, V48, P114, DOI 10.1097/CHI.0b013e318193064c; Tomasello M, 2005, MONOGR SOC RES CHILD, V70, P1; TURNER CH, 1969, AM J PSYCHIAT, V125, P1531, DOI 10.1176/ajp.125.11.1531; Tutin CEG, 2001, CONSERV BIOL, V15, P1247, DOI 10.1046/j.1523-1739.2001.00046.x; van IJzendoorn MH, 2009, DEV PSYCHOBIOL, V51, P173, DOI 10.1002/dev.20356; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; WALSH S, 1982, AM J PRIMATOL, V3, P315, DOI 10.1002/ajp.1350030131; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wobber V, 2010, P NATL ACAD SCI USA, V107, P12457, DOI 10.1073/pnas.1007411107; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Wrangham R, 2008, INT J PRIMATOL, V29, P3, DOI 10.1007/s10764-008-9237-x; Wrangham Richard, 2010, P370; Wrangham RW, 1992, CHIMPANZEE CONSERVAT, P71	60	63	63	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e17147	10.1371/journal.pone.0017147	http://dx.doi.org/10.1371/journal.pone.0017147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666743	Green Published, gold			2022-12-27	WOS:000291607000001
J	McGowan, EM; Alling, N; Jackson, EA; Yagoub, D; Haass, NK; Allen, JD; Martinello-Wilks, R				McGowan, Eileen M.; Alling, Nikki; Jackson, Elise A.; Yagoub, Daniel; Haass, Nikolas K.; Allen, John D.; Martinello-Wilks, Rosetta			Evaluation of Cell Cycle Arrest in Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls of the MTS Assay	PLOS ONE			English	Article							RECEPTOR-ALPHA; MULTIDRUG TRANSPORTER; PROGESTERONE-RECEPTOR; MULTIPLE-SCLEROSIS; FINGOLIMOD FTY720; RESISTANCE; PROTEIN; MDM2; MECHANISM; GROWTH	Endocrine resistance is a major problem with anti-estrogen treatments and how to overcome resistance is a major concern in the clinic. Reliable measurement of cell viability, proliferation, growth inhibition and death is important in screening for drug treatment efficacy in vitro. This report describes and compares commonly used proliferation assays for induced estrogen-responsive MCF-7 breast cancer cell cycle arrest including: determination of cell number by direct counting of viable cells; or fluorescence SYBR (R) Green (SYBR) DNA labeling; determination of mitochondrial metabolic activity by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay; assessment of newly synthesized DNA using 5-ethynyl-2'-deoxyuridine (EdU) nucleoside analog binding and Alexa Fluor (R) azide visualization by fluorescence microscopy; cell-cycle phase measurement by flow cytometry. Treatment of MCF-7 cells with ICI 182780 (Faslodex), FTY720, serum deprivation or induction of the tumor suppressor p14ARF showed inhibition of cell proliferation determined by the Trypan Blue exclusion assay and SYBR DNA labeling assay. In contrast, the effects of treatment with ICI 182780 or p14ARF-induction were not confirmed using the MTS assay. Cell cycle inhibition by ICI 182780 and p14ARF-induction was further confirmed by flow cytometric analysis and EdU-DNA incorporation. To explore this discrepancy further, we showed that ICI 182780 and p14ARF-induction increased MCF-7 cell mitochondrial activity by MTS assay in individual cells compared to control cells thereby providing a misleading proliferation readout. Interrogation of p14ARF-induction on MCF-7 metabolic activity using TMRE assays and high content image analysis showed that increased mitochondrial activity was concomitant with increased mitochondrial biomass with no loss of mitochondrial membrane potential, or cell death. We conclude that, whilst p14ARF and ICI 182780 stop cell cycle progression, the cells are still viable and potential treatments utilizing these pathways may contribute to drug resistant cells. These experiments demonstrate how the combined measurement of metabolic activity and DNA labeling provides a more reliable interpretation of cancer cell response to treatment regimens.	[McGowan, Eileen M.; Yagoub, Daniel; Martinello-Wilks, Rosetta] Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia; [McGowan, Eileen M.; Jackson, Elise A.; Haass, Nikolas K.; Allen, John D.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Alling, Nikki] Garvan Inst Med Res, Flow Cytometry Unit, Sydney, NSW, Australia; [Jackson, Elise A.; Haass, Nikolas K.; Allen, John D.] Centenary Inst, Sydney, NSW, Australia	University of Technology Sydney; University of Sydney; Garvan Institute of Medical Research; University of Sydney; Centenary Institute	McGowan, EM (corresponding author), Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia.	Eileen.Mcgowan@uts.edu.au	Haass, Nikolas K/M-8507-2015	Haass, Nikolas K/0000-0002-3928-5360; Martiniello-Wilks, Rosetta/0000-0002-0038-3430; McGowan, Eileen/0000-0001-6371-3751	Cancer Institute NSW; Sydney Cancer Center; Royal Prince Alfred Hospital, Sydney; Prostate Cancer Foundation of Australia [PR37]; Rebecca L Cooper Medical Research Foundation; Australian Rotary Health Research Fund; Melanoma and Skin Cancer Research Institute, Australia; Cancer Council New South Wales [RG 09-08]; Priority-Driven Collaborative Cancer Research Scheme/Cancer Australia/Cure Cancer Australia Foundation [570778]; Cancer Institute New South Wales [08/RFG/1-27]; National Health and Medical Research Council [1003637]	Cancer Institute NSW; Sydney Cancer Center; Royal Prince Alfred Hospital, Sydney(University of Sydney); Prostate Cancer Foundation of Australia; Rebecca L Cooper Medical Research Foundation; Australian Rotary Health Research Fund; Melanoma and Skin Cancer Research Institute, Australia; Cancer Council New South Wales(Cancer Council New South Wales); Priority-Driven Collaborative Cancer Research Scheme/Cancer Australia/Cure Cancer Australia Foundation; Cancer Institute New South Wales; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	EMM and JDA are recipients of the Cancer Institute NSW Fellowships. Sydney Cancer Center Research Grants, Royal Prince Alfred Hospital, Sydney, were awarded to EMM and RM-W. Project Grants PR37 (Prostate Cancer Foundation of Australia) and Rebecca L Cooper Medical Research Foundation were awarded to RM-W. The Australian Rotary Health Research Fund Scholarship was awarded to EAJ. NKH is a recipient of the Cameron Fellowship from the Melanoma and Skin Cancer Research Institute, Australia. NKH is CIA on Project Grant RG 09-08 (Cancer Council New South Wales), Project Grant 570778 (Priority-Driven Collaborative Cancer Research Scheme/Cancer Australia/Cure Cancer Australia Foundation), Research Innovation Grant 08/RFG/1-27 (Cancer Institute New South Wales), and Project Grant 1003637 (National Health and Medical Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Allen JD, 2002, CANCER RES, V62, P2294; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dilda PJ, 2005, JNCI-J NATL CANCER I, V97, P1539, DOI 10.1093/jnci/dji316; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Holland ML, 2007, BRIT J PHARMACOL, V152, P815, DOI 10.1038/sj.bjp.0707467; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; McGowan EM, 2007, CANCER RES, V67, P8942, DOI 10.1158/0008-5472.CAN-07-1255; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagahara Y, 2000, J IMMUNOL, V165, P3250, DOI 10.4049/jimmunol.165.6.3250; QUELLE DE, 1995, CELL, V83, P993; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Stam RW, 2004, LEUKEMIA, V18, P78, DOI 10.1038/sj.leu.2403168; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202	23	49	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20623	10.1371/journal.pone.0020623	http://dx.doi.org/10.1371/journal.pone.0020623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673993	Green Published, gold			2022-12-27	WOS:000291355500026
J	Han, WD; Pan, HM; Chen, Y; Sun, J; Wang, YS; Li, J; Ge, WT; Feng, LF; Lin, XY; Wang, XJ; Wang, X; Jin, HC				Han, Weidong; Pan, Hongming; Chen, Yan; Sun, Jie; Wang, Yanshan; Li, Jing; Ge, Weiting; Feng, Lifeng; Lin, Xiaoying; Wang, Xiaojia; Wang, Xian; Jin, Hongchuan			EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; PROTEIN EXPRESSION; RESISTANCE; DEATH; INDUCTION; APOPTOSIS; EFFICACY; TARGET	Epidermal growth factor receptor tyrosine kinase inhibitors gefitinib and erlotinib have been widely used in patients with non-small-cell lung cancer. Unfortunately, the efficacy of EGFR-TKIs is limited because of natural and acquired resistance. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable conditions, autophagy has been proposed to play a role in drug resistance of tumor cells. Whether autophagy can be activated by gefitinib or erlotinib and thereby impair the sensitivity of targeted therapy to lung cancer cells remains unknown. Here, we first report that gefitinib or erlotinib can induce a high level of autophagy, which was accompanied by the inhibition of the PI3K/Akt/mTOR signaling pathway. Moreover, cytotoxicity induced by gefitinib or erlotinib was greatly enhanced after autophagy inhibition by the pharmacological inhibitor chloroquine (CQ) and siRNAs targeting ATG5 and ATG7, the most important components for the formation of autophagosome. Interestingly, EGFR-TKIs can still induce cell autophagy even after EGFR expression was reduced by EGFR specific siRNAs. In conclusion, we found that autophagy can be activated by EGFR-TKIs in lung cancer cells and inhibition of autophagy augmented the growth inhibitory effect of EGFR-TKIs. Autophagy inhibition thus represents a promising approach to improve the efficacy of EGFR-TKIs in the treatment of patients with advanced non-small-cell lung cancer.	[Han, Weidong; Pan, Hongming; Chen, Yan; Li, Jing; Wang, Xian] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jie; Feng, Lifeng; Lin, Xiaoying; Jin, Hongchuan] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Lab Canc Epigenet,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yanshan; Wang, Xiaojia] Zhejiang Chinese Med Univ, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China; [Ge, Weiting] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; Zhejiang Chinese Medical University; Zhejiang University	Pan, HM (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	panhongming@medmail.com.cn; jinhc@srrsh.com	GE, Weiting/AAK-5197-2020; Jin, Hongchuan/C-3686-2009	GE, Weiting/0000-0002-4769-0251; Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097	National Natural Science Foundation of China [30901740]; China National Ministry of Education [20090101120124]; Zhejiang Natural Sciences Foundation [Y2090166]; Zhejiang Education Department [Y200805751]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Ministry of Education; Zhejiang Natural Sciences Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Education Department; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number 30901740, www.nsfc.gov.cn), China National Ministry of Education Grant (grant number 20090101120124, www.moe.edu.cn), Zhejiang Natural Sciences Foundation Grant (grant number Y2090166, www.zjnsf.net:81), and Research Projects of Zhejiang Education Department (grant number Y200805751, www.zjedu.gov.cn) to W. Han, and the Fundamental Research Funds for the Central Universities to H. Jin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Brehmer D, 2005, CANCER RES, V65, P379; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Galluzzi L, 2008, CURR MOL MED, V8, P78; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Ray M, 2009, ONCOLOGIST, V14, P1116, DOI 10.1634/theoncologist.2009-0054; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Spiro SG, 2010, RESPIROLOGY, V15, P44, DOI 10.1111/j.1440-1843.2009.01674.x; Sun SY, 2010, AUTOPHAGY, V6, P184, DOI 10.4161/auto.6.1.10816; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; WU PCC, 2010, GENES CANC, V1, P40; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	36	195	211	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e18691	10.1371/journal.pone.0018691	http://dx.doi.org/10.1371/journal.pone.0018691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655094	Green Published, gold, Green Submitted			2022-12-27	WOS:000291310600002
J	Lim, J; Kong, R; Murugan, E; Ho, CL; Liang, ZX; Yang, D				Lim, Jackwee; Kong, Rong; Murugan, Elavazhagan; Ho, Chun Loong; Liang, Zhao-Xun; Yang, Daiwen			Solution Structures of the Acyl Carrier Protein Domain from the Highly Reducing Type I Iterative Polyketide Synthase CalE8	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CRYSTAL-STRUCTURES; MECHANISM; DYNAMICS; BINDING; ACP; RECOGNITION; REVEAL; THIOESTERASE; FORMS	Biosynthesis of the enediyne natural product calicheamicins gamma(I)(1) in Micromonospora echinospora ssp. calichensis is initiated by the iterative polyketide synthase (PKS) CalE8. Recent studies showed that CalE8 produces highly conjugated polyenes as potential biosynthetic intermediates and thus belongs to a family of highly-reducing (HR) type I iterative PKSs. We have determined the NMR structure of the ACP domain (meACP) of CalE8, which represents the first structure of a HR type I iterative PKS ACP domain. Featured by a distinct hydrophobic patch and a glutamate-residue rich acidic patch, meACP adopts a twisted three-helix bundle structure rather than the canonical four-helix bundle structure. The so-called 'recognition helix' (alpha 2) of meACP is less negatively charged than the typical type II ACPs. Although loop-2 exhibits greater conformational mobility than other regions of the protein with a missing short helix that can be observed in most ACPs, two bulky non-polar residues (Met(992), Phe(996)) from loop-2 packed against the hydrophobic protein core seem to restrict large movement of the loop and impede the opening of the hydrophobic pocket for sequestering the acyl chains. NMR studies of the hydroxybutyryl-and octanoyl-meACP confirm that meACP is unable to sequester the hydrophobic chains in a well-defined central cavity. Instead, meACP seems to interact with the octanoyl tail through a distinct hydrophobic patch without involving large conformational change of loop-2. NMR titration study of the interaction between meACP and the cognate thioesterase partner CalE7 further suggests that their interaction is likely through the binding of CalE7 to the meACP-tethered polyene moiety rather than direct specific protein-protein interaction.	[Lim, Jackwee; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kong, Rong; Murugan, Elavazhagan; Ho, Chun Loong; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lim, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	zxliang@ntu.edu.sg; dbsydw@nus.edu.sg	Liang, Zhao-Xun/A-2191-2011; yang, daiwen/H-8408-2012; Ho, Loong/U-5867-2018; Loong, Ho Chun/AAF-9353-2020	yang, daiwen/0000-0002-6804-0071; Ho, Loong/0000-0003-2846-3392; Liang, Zhao-Xun/0000-0002-3128-1330; Lim, Jackwee/0000-0003-4344-6822	Singapore Ministry of Education (MOE) through an ARC [06/1/22/19/464]; Biomedical Research Coucil, Agency for Science, Technology and Research of Singapore [R154000373305]	Singapore Ministry of Education (MOE) through an ARC(Ministry of Education, Singapore); Biomedical Research Coucil, Agency for Science, Technology and Research of Singapore	This work is supported by Singapore Ministry of Education (MOE) through an ARC grant to Z-X L (Grant Number: 06/1/22/19/464) and by a grant from Biomedical Research Coucil, Agency for Science, Technology and Research of Singapore (R154000373305) to DY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; Belecki K, 2009, J AM CHEM SOC, V131, P12564, DOI 10.1021/ja904391r; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Crump MP, 1996, FEBS LETT, V391, P302, DOI 10.1016/0014-5793(96)00756-9; Evans SE, 2008, CHEMBIOCHEM, V9, P2424, DOI 10.1002/cbic.200800180; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Hadfield AT, 2004, STRUCTURE, V12, P1865, DOI 10.1016/j.str.2004.08.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Horsman GP, 2010, P NATL ACAD SCI USA, V107, P11331, DOI 10.1073/pnas.1003442107; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Kong R, 2008, J AM CHEM SOC, V130, P8142, DOI 10.1021/ja8019643; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Liang ZX, 2010, NAT PROD REP, V27, P499, DOI 10.1039/b908165h; Liew CW, 2010, J MOL BIOL, V404, P291, DOI 10.1016/j.jmb.2010.09.041; Liu W, 2003, P NATL ACAD SCI USA, V100, P11959, DOI 10.1073/pnas.2034291100; Mercer AC, 2007, NAT PROD REP, V24, P750, DOI 10.1039/b603921a; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Murugan E, 2010, PROTEIN EXPRES PURIF, V71, P132, DOI 10.1016/j.pep.2010.01.007; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Sun HH, 2009, CHEM COMMUN, P7399, DOI 10.1039/b916751j; Upadhyay SK, 2009, J BIOL CHEM, V284, P22390, DOI 10.1074/jbc.M109.014829; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d; Zornetzer GA, 2010, BIOCHEMISTRY-US, V49, P470, DOI 10.1021/bi9014659	49	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20549	10.1371/journal.pone.0020549	http://dx.doi.org/10.1371/journal.pone.0020549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674045	Green Published, gold, Green Submitted			2022-12-27	WOS:000291310600014
J	Wei, JCC; Yen, JH; Juo, SHH; Chen, WC; Wang, YS; Chiu, YC; Hsieh, TJ; Guo, YC; Huang, CH; Wong, RH; Wang, HP; Tsai, KL; Wu, YC; Chang, HW; Hsi, E; Chang, WP; Chang, WC				Wei, James Cheng-Chung; Yen, Jeng-Hsien; Juo, Suh-Hang Hank; Chen, Wei-Chiao; Wang, Yu-Shiuan; Chiu, Yi-Ching; Hsieh, Tusty-Jiuan; Guo, Yuh-Cherng; Huang, Chun-Huang; Wong, Ruey-Hong; Wang, Hui-Po; Tsai, Ke-Li; Wu, Yang-Chang; Chang, Hsueh-Wei; Hsi, Edward; Chang, Wei-Pin; Chang, Wei-Chiao			Association of ORAI1 Haplotypes with the Risk of HLA-B27 Positive Ankylosing Spondylitis	PLOS ONE			English	Article							ACTIVATED CALCIUM-CHANNELS; GENE-COMPLEX MEMBERS; CRAC; SUSCEPTIBILITY; POPULATION; CHINESE; TAIWAN; POLYMORPHISMS; RECEPTOR; TARGET	Ankylosing spondylitis (AS) is a chronic inflammation of the sacroiliac joints, spine and peripheral joints. The aetiology of ankylosing spondylitis is still unclear. Previous studies have indicated that genetics factors such as human leukocyte antigen HLA-B27 associates to AS susceptibility. We carried out a case-control study to determine whether the genetic polymorphisms of ORAI1 gene, a major component of store-operated calcium channels that involved the regulation of immune system, is a susceptibility factor to AS in a Taiwanese population. We enrolled 361 AS patients fulfilled the modified New York criteria and 379 controls from community. Five tagging single nucleotides polymorphisms (tSNPs) at ORAI1 were selected from the data of Han Chinese population in HapMap project. Clinical statuses of AS were assessed by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Global Index (BAS-G). Our results indicated that subjects carrying the minor allele homozygote (CC) of the promoter SNP rs12313273 or TT homozygote of the SNP rs7135617 had an increased risk of HLA-B27 positive AS. The minor allele C of 3'UTR SNP rs712853 exerted a protective effect to HLA-B27 positive AS. Furthermore, the rs12313273/rs7135617 pairwise allele analysis found that C-G (OR 1.69, 95% CI 1.27, 2.25; p = 0.0003) and T-T (OR 1.75, 95% CI 1.36, 2.27; p<0.0001) haplotypes had a significantly association with the risk of HLA-B27-positive AS in comparison with the T-G carriers. This is the first study that indicate haplotypes of ORAI1 (rs12313273 and rs7135617) are associated with the risk of HLA-B27 positive AS.	[Wei, James Cheng-Chung; Huang, Chun-Huang; Wong, Ruey-Hong] China Med Univ, Div Allergy Immunol & Rheumatol, Chung Shan Med Univ Hosp, Chung Shan Med Univ,Dept Med,Inst Med,Grad Inst I, Taichung, Taiwan; [Juo, Suh-Hang Hank; Chen, Wei-Chiao; Wang, Yu-Shiuan; Chiu, Yi-Ching; Hsieh, Tusty-Jiuan; Hsi, Edward; Chang, Wei-Chiao] Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank; Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Yen, Jeng-Hsien] Kaohsiung Med Univ Hosp, Div Rheumatol, Dept Internal Med, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Yen, Jeng-Hsien] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Guo, Yuh-Cherng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Neurol, Kaohsiung, Taiwan; [Tsai, Ke-Li] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Wang, Hui-Po] Taipei Med Univ, Dept Pharm, Taipei, Taiwan; [Wu, Yang-Chang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Taipei Medical University; China Medical University Taiwan	Chang, WC (corresponding author), Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan.	wcc@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Hsi, Edward/A-1356-2013; Wei, James Cheng-Chung/AAL-8947-2020; Yen, Jeng-Hsien/A-1335-2010; Wu, Yang-Chang/C-5682-2009; Juo, Suh-Hang/C-9545-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Hsi, Edward/0000-0002-8272-6707; Wei, James Cheng-Chung/0000-0002-1235-0679; Yen, Jeng-Hsien/0000-0002-1291-1739; Wu, Yang-Chang/0000-0001-7815-2686; Wang, Yu-Shiuan/0000-0001-7204-1256; Hsieh, Tusty-Jiuan/0000-0001-5387-6522; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council of Taiwan [NSC 98-2320-B-037 -028 -MY2]; Department of Health, Executive Yuan, Taiwan, ROC [DOH99-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan, ROC	This study was supported by National Science Council of Taiwan (NSC 98-2320-B-037 -028 -MY2); excellence for cancer research center grant (NO.DOH99-TD-C-111-002), Department of Health, Executive Yuan, Taiwan, ROC to W. C. Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chen C, 2010, CLIN IMMUNOL, V136, P442, DOI 10.1016/j.clim.2010.05.003; Chou CT, 2006, ANN RHEUM DIS, V65, P1106, DOI 10.1136/ard.2005.046847; Chou CT, 2001, J IMMUNOL METHODS, V255, P15, DOI 10.1016/S0022-1759(01)00414-8; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Furuichi T, 2008, J HUM GENET, V53, P419, DOI 10.1007/s10038-008-0265-3; Guo ZS, 2010, INT J IMMUNOGENET, V37, P33, DOI 10.1111/j.1744-313X.2009.00889.x; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lee SK, 2010, LIFE SCI, V86, P863, DOI 10.1016/j.lfs.2010.03.022; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; LOPEZ D, 1994, J IMMUNOL, V152, P5557; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Rudwaleit M, 2001, ANN RHEUM DIS, V60, P36, DOI 10.1136/ard.60.1.36; Safrany E, 2009, SCAND J IMMUNOL, V70, P68, DOI 10.1111/j.1365-3083.2009.02265.x; Sanchez A, 2010, J RHEUMATOL, V37, P2345, DOI 10.3899/jrheum.100211; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Shiau MY, 2007, ANN RHEUM DIS, V66, P562, DOI 10.1136/ard.2006.065888; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; van der Heijde D, 1999, J RHEUMATOL, V26, P951; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wei JCC, 2007, CLIN RHEUMATOL, V26, P1685, DOI 10.1007/s10067-007-0573-6; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20426	10.1371/journal.pone.0020426	http://dx.doi.org/10.1371/journal.pone.0020426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21674042	Green Submitted, Green Published, gold			2022-12-27	WOS:000291309900018
J	Zitterbart, DP; Wienecke, B; Butler, JP; Fabry, B				Zitterbart, Daniel P.; Wienecke, Barbara; Butler, James P.; Fabry, Ben			Coordinated Movements Prevent Jamming in an Emperor Penguin Huddle	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; TRANSITION; PARTICLES; DYNAMICS	For Emperor penguins (Aptenodytes forsteri), huddling is the key to survival during the Antarctic winter. Penguins in a huddle are packed so tightly that individual movements become impossible, reminiscent of a jamming transition in compacted colloids. It is crucial, however, that the huddle structure is continuously reorganized to give each penguin a chance to spend sufficient time inside the huddle, compared with time spent on the periphery. Here we show that Emperor penguins move collectively in a highly coordinated manner to ensure mobility while at the same time keeping the huddle packed. Every 30-60 seconds, all penguins make small steps that travel as a wave through the entire huddle. Over time, these small movements lead to large-scale reorganization of the huddle. Our data show that the dynamics of penguin huddling is governed by intermittency and approach to kinetic arrest in striking analogy with inert non-equilibrium systems, including soft glasses and colloids.	[Zitterbart, Daniel P.; Fabry, Ben] Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany; [Zitterbart, Daniel P.] Alfred Wegener Inst Polar & Marine Res AWI, Bremerhaven, Germany; [Wienecke, Barbara] Australian Antarctic Div, Kingston, Tas, Australia; [Butler, James P.] Harvard Univ, Sch Publ Hlth, Mol Integrat Physiol Sci Program, Boston, MA 02115 USA; [Butler, James P.] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA USA; [Butler, James P.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Erlangen Nuremberg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Australian Antarctic Division; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Zitterbart, DP (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany.	daniel.p.zitterbart@physik.uni-erlangen.de	Fabry, Ben/C-5496-2013; Zitterbart, Daniel/N-7489-2013; Fabry, Ben/AAT-5717-2020	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Zitterbart, Daniel/0000-0001-9429-4350				Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Ancel A, 2009, P ROY SOC B-BIOL SCI, V276, P2163, DOI 10.1098/rspb.2009.0140; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Czirok A, 2000, PHYSICA A, V281, P17, DOI 10.1016/S0378-4371(00)00013-3; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Gilbert C, 2007, AM J PHYSIOL-REG I, V292, pR176, DOI 10.1152/ajpregu.00912.2005; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Perc M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/003; Prevost J, 1961, ECOLOGIE MANCHOT EMP; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; TAMBE D, 2010, COLLECTIVE CELL GUID; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	21	33	35	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20260	10.1371/journal.pone.0020260	http://dx.doi.org/10.1371/journal.pone.0020260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673816	Green Published, gold			2022-12-27	WOS:000291309900008
J	Lin, SC; Huang, MH; Tsou, PC; Huang, LM; Chong, P; Wu, SC				Lin, Shih-Chang; Huang, Ming-Hsi; Tsou, Pei-Chun; Huang, Li-Min; Chong, Pele; Wu, Suh-Chin			Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines	PLOS ONE			English	Article							BACTERIOPHAGE-T4 FIBRITIN; HEMAGGLUTININ PROTEINS; CHALLENGE INFECTION; ANTIGENIC STRUCTURE; ANTIBODIES; DOMAIN; RESPONSES; CHICKENS; FERRETS	Background: The highly pathogenic avian influenza (HPAI) H5N1 virus continues to cause disease in poultry and humans. The hemagglutinin (HA) envelope protein is the primary target for subunit vaccine development. Methodology/Principal Findings: We used baculovirus-insect cell expression to obtain trimeric recombinant HA (rHA) proteins from two HPAI H5N1 viruses. We investigated trimeric rHA protein immunogenicity in mice via immunizations, and found that the highest levels of neutralizing antibodies resulted from coupling with a PELC/CpG adjuvant. We also found that the combined use of trimeric rHA proteins with (a) an inactivated H5N1 vaccine virus, or (b) a recombinant adenovirus encoding full-length HA sequences for prime-boost immunization, further improved antibody responses against homologous and heterologous H5N1 virus strains. Data from cross-clade prime-boost immunization regimens indicate that sequential immunization with different clade HA antigens increased antibody responses in terms of total IgG level and neutralizing antibody titers. Conclusion/Significance: Our findings suggest that the use of trimeric rHA in prime-boost vaccine regimens represents an alternative strategy for recombinant H5N1 vaccine development.	[Lin, Shih-Chang; Tsou, Pei-Chun; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Lin, Shih-Chang; Tsou, Pei-Chun; Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Huang, Ming-Hsi; Chong, Pele; Wu, Suh-Chin] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Miaoli County, Taiwan; [Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10764, Taiwan	National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Lin, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Huang, Ming-Hsi/E-3872-2010; Chong, Pele/E-3855-2010; Wu, Suh-Chin/AAV-6233-2021	Huang, Ming-Hsi/0000-0002-9670-3821; HUANG, LI-MIN/0000-0002-9291-260X	National Science Council [NSC98-2321-B-007-003]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council (NSC98-2321-B-007-003) and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez BH, 2008, PROTEIN ENG DES SEL, V21, P11, DOI 10.1093/protein/gzm071; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Ikeno D, 2009, VACCINE, V27, P3121, DOI 10.1016/j.vaccine.2009.01.007; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; King JC, 2009, VACCINE, V27, P6589, DOI 10.1016/j.vaccine.2009.08.032; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Lin YJ, 2008, J VET MED SCI, V70, P1147, DOI 10.1292/jvms.70.1147; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Sabarth N, 2010, VACCINE, V28, P650, DOI 10.1016/j.vaccine.2009.10.105; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466	36	48	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20052	10.1371/journal.pone.0020052	http://dx.doi.org/10.1371/journal.pone.0020052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655326	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600016
J	Roux, O; Cereghino, R; Solano, PJ; Dejean, A				Roux, Olivier; Cereghino, Regis; Solano, Pascal J.; Dejean, Alain			Caterpillars and Fungal Pathogens: Two Co-Occurring Parasites of an Ant-Plant Mutualism	PLOS ONE			English	Article							FUSARIUM-MONILIFORME; PRIORITY; COMPETITION; CECROPIA; DEFENSE; AZTECA; EUPHORBIACEAE; MYRMECOPHYTES; COMMUNITIES; SPECIFICITY	In mutualisms, each interacting species obtains resources from its partner that it would obtain less efficiently if alone, and so derives a net fitness benefit. In exchange for shelter (domatia) and food, mutualistic plant-ants protect their host myrmecophytes from herbivores, encroaching vines and fungal pathogens. Although selective filters enable myrmecophytes to host those ant species most favorable to their fitness, some insects can by-pass these filters, exploiting the rewards supplied whilst providing nothing in return. This is the case in French Guiana for Cecropia obtusa (Cecropiaceae) as Pseudocabima guianalis caterpillars (Lepidoptera, Pyralidae) can colonize saplings before the installation of their mutualistic Azteca ants. The caterpillars shelter in the domatia and feed on food bodies (FBs) whose production increases as a result. They delay colonization by ants by weaving a silk shield above the youngest trichilium, where the FBs are produced, blocking access to them. This probable temporal priority effect also allows female moths to lay new eggs on trees that already shelter caterpillars, and so to occupy the niche longer and exploit Cecropia resources before colonization by ants. However, once incipient ant colonies are able to develop, they prevent further colonization by the caterpillars. Although no higher herbivory rates were noted, these caterpillars are ineffective in protecting their host trees from a pathogenic fungus, Fusarium moniliforme (Deuteromycetes), that develops on the trichilium in the absence of mutualistic ants. Therefore, the Cecropia treelets can be parasitized by two often overlooked species: the caterpillars that shelter in the domatia and feed on FBs, delaying colonization by mutualistic ants, and the fungal pathogen that develops on old trichilia. The cost of greater FB production plus the presence of the pathogenic fungus likely affect tree growth.	[Roux, Olivier; Dejean, Alain] CNRS, Ecol Forets Guyane UMR 8172, Kourou, France; [Cereghino, Regis] CNRS, UMR 5245, EcoLab Lab Ecol Fonct, Toulouse, France; [Cereghino, Regis; Dejean, Alain] Univ Toulouse, UPS, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Roux, O (corresponding author), CNRS, Ecol Forets Guyane UMR 8172, Campus Agron, Kourou, France.	olivier.roux@ird.fr	Roux, Olivier/A-1181-2011; CEREGHINO, Regis/G-9500-2011; Roux, Olivier/I-5675-2016	Roux, Olivier/0000-0001-5440-0219; Cereghino, Regis/0000-0003-3981-3159; Dejean, Alain/0000-0002-3561-2248	European Community	European Community(European Commission)	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane, from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHEM DEFENSES ARTHRO; Belin-Depoux M, 1997, ACTA BOT GALLICA, V144, P289, DOI 10.1080/12538078.1997.10515375; Berenger JM, 1997, CR ACAD SCI III-VIE, V320, P1007, DOI 10.1016/S0764-4469(97)82474-2; BERTNESS MD, 1993, AM NAT, V142, P718, DOI 10.1086/285567; Boulay R, 2009, OECOLOGIA, V161, P529, DOI 10.1007/s00442-009-1404-z; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bronstein Judith L., 2004, P305, DOI 10.1017/CBO9780511542022.022; Brouat C, 2001, P ROY SOC B-BIOL SCI, V268, P2131, DOI 10.1098/rspb.2001.1763; Clement LW, 2008, BEHAV ECOL SOCIOBIOL, V62, P953, DOI 10.1007/s00265-007-0520-1; COLE RJ, 1973, SCIENCE, V179, P1324, DOI 10.1126/science.179.4080.1324; COLEY PD, 1986, OECOLOGIA, V70, P238, DOI 10.1007/BF00379246; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; DAVIDSON DW, 1989, BIOTROPICA, V21, P64, DOI 10.2307/2388444; Davidson DW., 2005, FLORA NEOTROPICA MON, P214; Dejean A, 2008, EVOL ECOL RES, V10, P1217; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2010, NATURWISSENSCHAFTEN, V97, P925, DOI 10.1007/s00114-010-0710-y; Del Val E, 2003, PLANT ECOL, V169, P35, DOI 10.1023/A:1026227811685; Derridj S, 1996, ENTOMOL EXP APPL, V80, P197, DOI 10.1007/BF00194756; Djieto-Lordon C, 2004, ACTA OECOL, V26, P109, DOI 10.1016/j.actao.2004.03.007; Edwards DP, 2006, INSECT SOC, V53, P172, DOI 10.1007/s00040-006-0855-z; Faveri SB, 2004, BIOTROPICA, V36, P641, DOI 10.1111/j.1744-7429.2004.tb00359.x; FOLGARAIT PJ, 1994, FUNCT ECOL, V8, P22, DOI 10.2307/2390107; Fonseca CR, 2003, OIKOS, V102, P407, DOI 10.1034/j.1600-0579.2003.12021.x; Grangier J, 2009, BIOL J LINN SOC, V97, P90, DOI 10.1111/j.1095-8312.2008.01188.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUPTA S, 1991, MYCOPATHOLOGIA, V115, P185, DOI 10.1007/BF00462223; Heil M, 1997, J ECOL, V85, P847, DOI 10.2307/2960606; Heil M, 2000, NATURWISSENSCHAFTEN, V87, P555, DOI 10.1007/s001140050778; Heil M, 2001, OECOLOGIA, V126, P395, DOI 10.1007/s004420000532; Heil M, 1999, NATURWISSENSCHAFTEN, V86, P146, DOI 10.1007/s001140050589; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hodge S, 1996, OIKOS, V76, P350, DOI 10.2307/3546207; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; Jolivet P., 1996, ANTS PLANTS EXAMPLE; Jurgens A, 2006, BIOCHEM SYST ECOL, V34, P97, DOI 10.1016/j.bse.2005.08.005; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; KLEIN RW, 1992, NATURWISSENSCHAFTEN, V79, P422, DOI 10.1007/BF01138577; Ladd B, 2008, OECOLOGIA, V157, P687, DOI 10.1007/s00442-008-1110-2; LaPierre L, 2007, NATURWISSENSCHAFTEN, V94, P997, DOI 10.1007/s00114-007-0270-y; LAWLER SP, 1993, ECOLOGY, V74, P174, DOI 10.2307/1939512; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Letourneau DK, 1998, ECOLOGY, V79, P593, DOI 10.1890/0012-9658(1998)079[0593:ASBAFP]2.0.CO;2; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; Longino JT, 2007, ZOOTAXA, P1; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; LONGINO JT, 1991, ANT - PLANT INTERACTIONS, P271; MAC ARTHUR ROBERT H., 1967; Mack KML, 2008, OIKOS, V117, P310, DOI 10.1111/j.2007.0030-1299.15973.x; MASCHWITZ U, 1984, OECOLOGIA, V64, P78, DOI 10.1007/BF00377547; MASCHWITZ U, 1970, J INSECT PHYSIOL, V16, P387, DOI 10.1016/0022-1910(70)90180-0; McClure M, 2008, CR BIOL, V331, P663, DOI 10.1016/j.crvi.2008.06.008; NELSON PE, 1992, MYCOPATHOLOGIA, V117, P29, DOI 10.1007/BF00497276; Ortius-Lechner D, 2000, J CHEM ECOL, V26, P1667, DOI 10.1023/A:1005543030518; Palmer TM, 2002, OECOLOGIA, V133, P372, DOI 10.1007/s00442-002-1026-1; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Sagers CL, 2000, OECOLOGIA, V123, P582, DOI 10.1007/PL00008863; STOREY GK, 1991, J INVERTEBR PATHOL, V58, P88, DOI 10.1016/0022-2011(91)90166-N; Stow A, 2008, BRAIN BEHAV IMMUN, V22, P1009, DOI 10.1016/j.bbi.2008.03.008; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; VASCONCELOS HL, 1993, OECOLOGIA, V95, P439, DOI 10.1007/BF00321000; Ward Philip S., 1993, Journal of Hymenoptera Research, V2, P117; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]; Yu DW, 1997, ECOL MONOGR, V67, P273, DOI 10.1890/0012-9615(1997)067[0273:ESOSSI]2.0.CO;2; Zientz E, 2005, ARCH MICROBIOL, V184, P199, DOI 10.1007/s00203-005-0041-0	70	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20538	10.1371/journal.pone.0020538	http://dx.doi.org/10.1371/journal.pone.0020538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655182	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600091
J	Salsman, VS; Chow, KKH; Shaffer, DR; Kadikoy, H; Li, XN; Gerken, C; Perlaky, L; Metelitsa, LS; Gao, XH; Bhattacharjee, M; Hirschi, K; Heslop, HE; Gottschalk, S; Ahmed, N				Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Li, Xiao-Nan; Gerken, Claudia; Perlaky, Laszlo; Metelitsa, Leonid S.; Gao, Xiuhua; Bhattacharjee, Meena; Hirschi, Karen; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil			Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTORS; EXPRESSION; GROWTH; MOUSE; MIF; TRAFFICKING; REGRESSION; EOTAXIN; RANTES; CCR3	Cancer cells can live and grow if they succeed in creating a favorable niche that often includes elements from the immune system. While T lymphocytes play an important role in the host response to tumor growth, the mechanism of their trafficking to the tumor remains poorly understood. We show here that T lymphocytes consistently infiltrate the primary brain cancer, medulloblastoma. We demonstrate, both in vitro and in vivo, that these T lymphocytes are attracted to tumor deposits only after the tumor cells have interacted with tumor vascular endothelium. Macrophage Migration Inhibitory Factor (MIF)'' is the key chemokine molecule secreted by tumor cells which induces the tumor vascular endothelial cells to secrete the potent T lymphocyte attractant "Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES)." This in turn creates a chemotactic gradient for RANTES-receptor bearing T lymphocytes. Manipulation of this pathway could have important therapeutic implications.	[Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Gerken, Claudia; Metelitsa, Leonid S.; Gao, Xiuhua; Hirschi, Karen; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Li, Xiao-Nan; Gerken, Claudia; Perlaky, Laszlo; Metelitsa, Leonid S.; Gao, Xiuhua; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Li, Xiao-Nan; Gerken, Claudia; Perlaky, Laszlo; Metelitsa, Leonid S.; Gao, Xiuhua; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Metelitsa, Leonid S.; Gao, Xiuhua; Bhattacharjee, Meena; Hirschi, Karen; Gottschalk, Stephen] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Heslop, Helen E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Salsman, VS (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	nahmed@bcm.edu	Heslop, Helen/AAC-9500-2020; Gottschalk, Stephen/M-9343-2018	Gottschalk, Stephen/0000-0003-3991-7468	Clayton Foundation for Research [P30CA125123]; Dana Foundation; American Brain Tumor Association; Dan L. Duncan Chair; NATIONAL CANCER INSTITUTE [P30CA125123, P01CA094237] Funding Source: NIH RePORTER	Clayton Foundation for Research; Dana Foundation; American Brain Tumor Association; Dan L. Duncan Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors were supported by P30CA125123, grants from the Clayton Foundation for Research, the Dana Foundation, and the American Brain Tumor Association. HEH is supported by a Dan L. Duncan Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SF, 2009, CANCER-AM CANCER SOC, V115, P2891, DOI 10.1002/cncr.24317; Ahmed N, 2007, CANCER RES, V67, P5957, DOI 10.1158/0008-5472.CAN-06-4309; Ahmed N, 2010, CLIN CANCER RES, V16, P474, DOI 10.1158/1078-0432.CCR-09-1322; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Desfrancois J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008437; DONNEM T, 2010, CANCER; Fisher DT, 2006, IMMUNOL INVEST, V35, P251, DOI 10.1080/08820130600745430; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Hansson G K, 1999, Curr Atheroscler Rep, V1, P150, DOI 10.1007/s11883-999-0011-0; HEEGER P, 1992, KIDNEY INT, V41, P220, DOI 10.1038/ki.1992.31; Javeed A, 2008, INFLAMM RES, V57, P45, DOI 10.1007/s00011-007-7110-6; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kwong BY, 2010, J INVEST DERMATOL, V130, P1726, DOI 10.1038/jid.2009.362; Laconi E, 2008, SEMIN CANCER BIOL, V18, P322, DOI 10.1016/j.semcancer.2008.03.019; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Lazovic J, 2008, CLIN CANCER RES, V14, P3832, DOI 10.1158/1078-0432.CCR-07-5067; LEFORT CT, 2010, J VIS EXP; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McDowell KL, 2010, PROSTATE, V70, P377, DOI 10.1002/pros.21071; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Nikitenko LL, 2009, CELL TISSUE RES, V335, P223, DOI 10.1007/s00441-008-0707-4; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sager R, 1992, Cytokines, V4, P96; SAGER R, 1991, ADV EXP MED BIOL, V305, P73; SCHALL TJ, 1992, EUR J IMMUNOL, V22, P1477, DOI 10.1002/eji.1830220621; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Ubogu EE, 2006, CELL IMMUNOL, V243, P19, DOI 10.1016/j.cellimm.2006.12.001; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Vishwanath RP, 2005, J IMMUNOL METHODS, V302, P78, DOI 10.1016/j.jim.2005.04.021; Waldner MJ, 2009, SEMIN IMMUNOPATHOL, V31, P249, DOI 10.1007/s00281-009-0161-8; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Zancope E, 2010, J ORAL PATHOL MED, V39, P162, DOI 10.1111/j.1600-0714.2009.00792.x	48	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20267	10.1371/journal.pone.0020267	http://dx.doi.org/10.1371/journal.pone.0020267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647415	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500044
J	Tavare, R; Sagoo, P; Varama, G; Tanriver, Y; Warely, A; Diebold, SS; Southworth, R; Schaeffter, T; Lechler, RI; Razavi, R; Lombardi, G; Mullen, GED				Tavare, Richard; Sagoo, Pervinder; Varama, Gopal; Tanriver, Yakup; Warely, Alice; Diebold, Sandra S.; Southworth, Richard; Schaeffter, Tobias; Lechler, Robert I.; Razavi, Reza; Lombardi, Giovanna; Mullen, Gregory E. D.			Monitoring of In Vivo Function of Superparamagnetic Iron Oxide Labelled Murine Dendritic Cells during Anti-Tumour Vaccination	PLOS ONE			English	Article							LYMPH-NODES; REPORTER GENE; TRANSPLANTATION; MIGRATION; TRACKING; SURVIVAL; PEPTIDE; HEART; MICE; MRI	Dendritic cells (DCs) generated in vitro to present tumour antigens have been injected in cancer patients to boost in vivo anti-tumour immune responses. This approach to cancer immunotherapy has had limited success. For anti-tumour therapy, delivery and subsequent migration of DCs to lymph nodes leading to effective stimulation of effector T cells is thought to be essential. The ability to non-invasively monitor the fate of adoptively transferred DCs in vivo using magnetic resonance imaging (MRI) is an important clinical tool to correlate their in vivo behavior with response to treatment. Previous reports of superparamagnetic iron oxides (SPIOs) labelling of different cell types, including DCs, have indicated varying detrimental effects on cell viability, migration, differentiation and immune function. Here we describe an optimised labelling procedure using a short incubation time and low concentration of clinically used SPIO Endorem to successfully track murine DC migration in vivo using MRI in a mouse tumour model. First, intracellular labelling of bone marrow derived DCs was monitored in vitro using electron microscopy and MRI relaxometry. Second, the in vitro characterisation of SPIO labelled DCs demonstrated that viability, phenotype and functions were comparable to unlabelled DCs. Third, ex vivo SPIO labelled DCs, when injected subcutaneously, allowed for the longitudinal monitoring by MR imaging of their migration in vivo. Fourth, the SPIO DCs induced the proliferation of adoptively transferred CD4(+) T cells but, most importantly, they primed cytotoxic CD8(+) T cell responses to protect against a B16-Ova tumour challenge. Finally, using anatomical information from the MR images, the immigration of DCs was confirmed by the increase in lymph node size post-DC injection. These results demonstrate that the SPIO labelling protocol developed in this study is not detrimental for DC function in vitro and in vivo has potential clinical application in monitoring therapeutic DCs in patients with cancer.	[Tavare, Richard; Varama, Gopal; Southworth, Richard; Schaeffter, Tobias; Razavi, Reza; Mullen, Gregory E. D.] Kings Coll London, St Thomas Hosp, Dept Imaging Chem & Biol, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Sagoo, Pervinder; Tanriver, Yakup; Lechler, Robert I.; Lombardi, Giovanna] Kings Coll London, Guys Hosp, MRC Ctr Transplantat, London WC2R 2LS, England; [Sagoo, Pervinder] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Warely, Alice] Kings Coll London, Ctr Ultrastructural Imaging, London WC2R 2LS, England; [Diebold, Sandra S.] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunol, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tavare, R (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	giovanna.lombardi@kcl.ac.uk; greg.mullen@kcl.ac.uk	Tanriver, Yakup/AAU-7064-2020; Southworth, Richard/B-7855-2009; Schaeffter, Tobias/AAI-6826-2020; Southworth, Richard/S-1437-2019	Southworth, Richard/0000-0002-7904-8335; Schaeffter, Tobias/0000-0003-1310-2631; Southworth, Richard/0000-0002-7904-8335; Tavare, Richard/0000-0001-5150-5963; Sagoo, Pervinder/0000-0003-2568-9126; Tanriver, Yakup/0000-0002-4806-2548; Razavi, Reza/0000-0003-1065-3008	King's College London, Division of Imaging Sciences; MRC Centre of Transplantation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; British Heart Foundation [RG/08/005/25303] Funding Source: researchfish; Medical Research Council [G0600698B] Funding Source: researchfish	King's College London, Division of Imaging Sciences; MRC Centre of Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support from King's College London, Division of Imaging Sciences, MRC Centre of Transplantation, The Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust and The British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2003, MAGN RESON MED, V49, P1006, DOI 10.1002/mrm.10465; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Chen IY, 2009, MOL IMAGING BIOL, V11, P178, DOI 10.1007/s11307-008-0182-z; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Dekaban GA, 2009, J IMMUNOTHER, V32, P240, DOI 10.1097/CJI.0b013e318197b2a0; Eggert AO, 2002, EUR J IMMUNOL, V32, P122, DOI 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO;2-C; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janikashvili N, 2010, IMMUNOTHERAPY-UK, V2, P57, DOI 10.2217/IMT.09.78; Kuhlpeter R, 2007, RADIOLOGY, V245, P449, DOI 10.1148/radiol.2451061345; Long CM, 2009, CANCER RES, V69, P3180, DOI 10.1158/0008-5472.CAN-08-3691; MAKOWSKI MR, 2010, P ISMRM, V18; Manfredi AA, 2008, J IMMUNOL, V180, P2270, DOI 10.4049/jimmunol.180.4.2270; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rohani R, 2010, MOL IMAGING BIOL; Steitz J, 2006, CANCER GENE THER, V13, P318, DOI 10.1038/sj.cgt.7700894; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Toldbod HE, 2003, SCAND J IMMUNOL, V58, P43, DOI 10.1046/j.1365-3083.2003.01267.x; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; VARMA G, 2010, MAGN RESON MED; Verdijk P, 2007, INT J CANCER, V120, P978, DOI 10.1002/ijc.22385	22	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19662	10.1371/journal.pone.0019662	http://dx.doi.org/10.1371/journal.pone.0019662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637760	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500010
J	Hussein, J; Bell, J; Iang, MD; Mesko, N; Amery, J; Graham, W				Hussein, Julia; Bell, Jacqueline; Iang, Maureen Dar; Mesko, Natasha; Amery, Jenny; Graham, Wendy			An Appraisal of the Maternal Mortality Decline in Nepal	PLOS ONE			English	Article							DEATH	Background: A decline in the national maternal mortality ratio in Nepal has been observed from surveys conducted between 1996 and 2008. This paper aims to assess the plausibility of the decline and to identify drivers of change. Methods: National and sub-national trends in mortality data were investigated using existing demographic and health surveys and maternal mortality and morbidity surveys. Potential drivers of the variation in maternal mortality between districts were identified by regressing district-level indicators from the Nepal demographic health surveys against maternal mortality estimates. Results: A statistically significant decline of the maternal mortality ratio from 539 maternal deaths to 281 per 100,000 (95% Cl 91,507) live births between 1993 and 2003 was demonstrated. The sub-national changes are of similar magnitude and direction to those observed nationally, and in the terai region (plains) the differences are statistically significant with a reduction of 361 per 100,000 live births (95% Cl 36,686) during the same time period. The reduction in fertility, changes in education and wealth, improvements in components of the human development index, gender empowerment and anaemia each explained more than 10% of the district variation in maternal mortality. A number of limitations in each of the data sources used were identified. Of these, the most important relate to the underestimation of numbers of deaths. Conclusion: It is likely that there has been a decline in Nepal's maternal mortality since 1993. This is good news for the country's sustained commitments in this area. Conclusions on the magnitude, pattern of the change and drivers of the decline are constrained by lack of data. We recommend close tracking of maternal mortality and its determinants in Nepal, attention to the communication of future estimates, and various options for bridging data gaps.	[Hussein, Julia; Bell, Jacqueline; Graham, Wendy] Univ Aberdeen, Aberdeen, Scotland; [Iang, Maureen Dar] United Mission Nepal, Kathmandu, Nepal; [Mesko, Natasha] Dept Int Dev Nepal, Kathmandu, Nepal; [Amery, Jenny] Dept Int Dev London, London, England	University of Aberdeen	Hussein, J (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	j.hussein@abdn.ac.uk		Graham, Wendy/0000-0003-1473-5342				Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; *DEP HLTH SERV NEW, 1997, NEP DEM HLTH SURV 19; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; KOLSTEREN P, 2001, STUDIES HLTH SERVICE, V17, P55; Ministry of Health and Population [Nepal] New ERA Macro International Inc, 2007, NEP DEM HLTH SURV 20; Ministry of Health Nepal New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; *MRC BIOST UN, 2010, WINBUGS PROJ; Pant P. D., 2008, INVESTIGATING IMPROV; Reveiz L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003094.pub2; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; Suvedi B. K., 2009, NEPAL MATERNAL MORTA; UNDP, 2009, UNDP HUM DEV REP; *UNDP, 2001, HUM DEV REP HUM DEV; *UNDP, 2010, HUM DEV REP MEAS IN; *UNICEF WHO UNFPA, 1997, GUID MON AV US OBST; WHO, 2010, TRENDS MAT MORT 1990	17	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19898	10.1371/journal.pone.0019898	http://dx.doi.org/10.1371/journal.pone.0019898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637836	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200019
J	Shao, JZ; Zhang, YB; Yu, JL; Guo, L; Ding, Y				Shao, Jinzhen; Zhang, Yubo; Yu, Jianlan; Guo, Lin; Ding, Yi			Isolation of Thylakoid Membrane Complexes from Rice by a New Double-Strips BN/SDS-PAGE and Bioinformatics Prediction of Stromal Ridge Subunits Interaction	PLOS ONE			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; PHOTOSYSTEM-I; PROTEIN COMPLEXES; ARABIDOPSIS-THALIANA; MOLECULAR-DYNAMICS; PROTEOMIC APPROACH; ORYZA-SATIVA; MODEL; CHLOROPLAST; PHOSPHORYLATION	Thylakoid membrane complexes of rice (Oryza sativa L.) play crucial roles in growth and crop production. Understanding of protein interactions within the complex would provide new insights into photosynthesis. Here, a new "Double-Strips BN/SDS-PAGE" method was employed to separate thylakoid membrane complexes in order to increase the protein abundance on 2D-gels and to facilitate the identification of hydrophobic transmembrane proteins. A total of 58 protein spots could be observed and subunit constitution of these complexes exhibited on 2D-gels. The generality of this new approach was confirmed using thylakoid membrane from spinach (Spinacia oleracea) and pumpkin (Cucurita spp). Furthermore, the proteins separated from rice thylakoid membrane were identified by the mass spectrometry (MS). The stromal ridge proteins PsaD and PsaE were identified both in the holo-and core-PSI complexes of rice. Using molecular dynamics simulation to explore the recognition mechanism of these subunits, we showed that salt bridge interactions between residues R19 of PsaC and E168 of PasD as well as R75 of PsaC and E91 of PsaD played important roles in the stability of the complex. This stromal ridge subunits interaction was also supported by the subsequent analysis of the binding free energy, the intramolecular distances and the intramolecular energy.	[Shao, Jinzhen; Zhang, Yubo; Ding, Yi] Wuhan Univ, Coll Life Sci, Dept Genet, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Yu, Jianlan; Guo, Lin] Wuhan Univ, Coll Life Sci, Dept Biochem, Wuhan 430072, Peoples R China; [Shao, Jinzhen] Hubei Normal Univ, Coll Life Sci, Huangshi, Peoples R China	Wuhan University; Wuhan University; Hubei Normal University	Shao, JZ (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yiding@whu.edu.cn	Zhang, Yubo/J-9659-2015	ZHANG, Yubo/0000-0002-7762-0027	973 Program of China [2007CB108705]; National Nature Science Foundation of China [30971740, 30821064]	973 Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The sources of funding are 973 Program of China [2007CB108705] and National Nature Science Foundation of China [30971740, 30821064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Andaluz S, 2006, PHOTOSYNTH RES, V89, P141, DOI 10.1007/s11120-006-9092-6; [Anonymous], 2010, R LANG ENV STAT COMP; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen X, 2007, PLANT SCI, V173, P397, DOI 10.1016/j.plantsci.2007.06.012; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; D'Amici GM, 2008, J PROTEOME RES, V7, P1326, DOI 10.1021/pr700613r; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Granvogl B, 2006, PROTEOMICS, V6, P3681, DOI 10.1002/pmic.200500924; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Komatsu S, 2005, PROTEOMICS, V5, P938, DOI 10.1002/pmic.200401040; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; Law RJ, 2005, J MOL GRAPH MODEL, V24, P157, DOI 10.1016/j.jmgm.2005.05.006; MOLL BA, 1987, PLANT PHYSIOL, V83, P428, DOI 10.1104/pp.83.2.428; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rexroth S, 2003, ELECTROPHORESIS, V24, P2814, DOI 10.1002/elps.200305543; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Sunderhaus Stephanie, 2007, Methods Mol Biol, V372, P315, DOI 10.1007/978-1-59745-365-3_23; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; Thidholm E, 2002, FEBS LETT, V513, P217, DOI 10.1016/S0014-5793(02)02314-1; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Venter H, 2002, BIOCHEM J, V363, P243, DOI 10.1042/0264-6021:3630243; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; ZANETTI G, 1987, EUR J BIOCHEM, V169, P143, DOI 10.1111/j.1432-1033.1987.tb13591.x; Zhang YB, 2010, J PHYS CHEM B, V114, P13839, DOI 10.1021/jp103547s; ZILBER AL, 1988, PLANT PHYSIOL, V88, P810, DOI 10.1104/pp.88.3.810	45	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20342	10.1371/journal.pone.0020342	http://dx.doi.org/10.1371/journal.pone.0020342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637806	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200054
J	Hogg, OT; Barnes, DKA; Griffiths, HJ				Hogg, Oliver T.; Barnes, David K. A.; Griffiths, Huw J.			Highly Diverse, Poorly Studied and Uniquely Threatened by Climate Change: An Assessment of Marine Biodiversity on South Georgia's Continental Shelf	PLOS ONE			English	Article							GEOGRAPHICALLY SEPARATED POPULATIONS; SEAWATER TEMPERATURES; ECOLOGICAL RELEVANCE; SCOTIA SEA; OCEAN; LIMITS; BIOGEOGRAPHY; COMMUNITIES; INDICATORS; EVOLUTION	We attempt to quantify how significant the polar archipelago of South Georgia is as a source of regional and global marine biodiversity. We evaluate numbers of rare, endemic and range-edge species and how the faunal structure of South Georgia may respond to some of the fastest warming waters on the planet. Biodiversity data was collated from a comprehensive review of reports, papers and databases, collectively representing over 125 years of polar exploration. Classification of each specimen was recorded to species level and fully geo-referenced by depth, latitude and longitude. This information was integrated with physical data layers (e.g. temperature, salinity and flow) providing a visualisation of South Georgia's biogeography across spatial, temporal and taxonomic scales, placing it in the wider context of the Southern Hemisphere. This study marks the first attempt to map the biogeography of an archipelago south of the Polar Front. Through it we identify the South Georgian shelf as the most speciose region of the Southern Ocean recorded to date. Marine biodiversity was recorded as rich across taxonomic levels with 17,732 records yielding 1,445 species from 436 families, 51 classes and 22 phyla. Most species recorded were rare, with 35% recorded only once and 86% recorded,10 times. Its marine fauna is marked by the cumulative dominance of endemic and range-edge species, potentially at their thermal tolerance limits. Consequently, our data suggests the ecological implications of environmental change to the South Georgian marine ecosystem could be severe. If sea temperatures continue to rise, we suggest that changes will include depth profile shifts of some fauna towards cooler Antarctic Winter Water (90-150 m), the loss of some range-edge species from regional waters, and the wholesale extinction at a global scale of some of South Georgia's endemic species.	[Hogg, Oliver T.; Barnes, David K. A.; Griffiths, Huw J.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hogg, OT (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	olgg@bas.ac.uk	Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Hogg, Oliver/0000-0003-1146-0590	Darwin Initiative (DEFRA); Government of South Georgia; South Georgia Heritage Trust; South Sandwich Islands; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Darwin Initiative (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Government of South Georgia; South Georgia Heritage Trust; South Sandwich Islands; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from the Darwin Initiative (DEFRA), the Government of South Georgia and South Sandwich Islands, and the South Georgia Heritage Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMO J, 2005, MILLENNIUM ECOSYSTEM, P100; Allcock AL, 1997, MAR BIOL, V129, P97, DOI 10.1007/s002270050150; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; ARNTZ WE, 1999, SCI MAR S1, V63, P1; Arntz Wolf E., 1997, P3; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; BARBER HN, 1959, NATURE, V184, P203, DOI 10.1038/184203a0; Barnes DKA, 2011, ANTARCT SCI, V23, P323, DOI 10.1017/S0954102011000253; Barnes DKA, 2010, GLOBAL CHANGE BIOL, V16, P3164, DOI 10.1111/j.1365-2486.2010.02176.x; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2008, ANTARCT SCI, V20, P263, DOI 10.1017/S0954102008001089; Barnes DKA, 2006, DEEP-SEA RES PT II, V53, P853, DOI 10.1016/j.dsr2.2006.03.008; Barnes DKA, 2009, MAR ECOL PROG SER, V393, P13, DOI 10.3354/meps08246; Barnes DKA, 2009, J BIOGEOGR, V36, P756, DOI 10.1111/j.1365-2699.2008.02030.x; Barnes DKA, 2006, POLAR BIOL, V29, P223, DOI 10.1007/s00300-005-0042-0; Brandon MA, 2004, DEEP-SEA RES PT II, V51, P1301, DOI 10.1016/j.dsr2.2004.06.006; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1988, BRIT ANTARCT SURV B, P65; CLARKE A, 1989, GEOLOGICAL SOC SPECI, V47, P253; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Collins MA, 2006, SCCCAMLRWGFSA0651; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; COOMBS DS, 1966, NATURE, V209, P289, DOI 10.1038/209289b0; Curtis ML, 2010, J STRUCT GEOL, V32, P464, DOI 10.1016/j.jsg.2010.02.002; DAYTON PK, 1994, POLAR OCEANOGRAPY, P631; DEBROYER C, SCAR MARBIN ANTARCTI; DELL RK, 1972, ADV MAR BIOL, V10, P1, DOI 10.1016/S0065-2881(08)60416-2; Eldredge Lucius G., 1995, Bishop Museum Occasional Papers, V41, P3; Fujikura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011836; Gordon DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010905; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Griffiths HJ, 2003, ORG DIVERS EVOL, V3, P207, DOI 10.1078/1439-6092-00079; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 2004, ANTARCT SCI, V16, P11, DOI 10.1017/S0954102004001750; Hofmann EE, 1998, ANTARCT SCI, V10, P406, DOI 10.1017/S0954102098000492; Holeton CL, 2005, POLAR BIOL, V29, P44, DOI 10.1007/s00300-005-0028-y; Hunt BM, 2003, ANTARCT SCI, V15, P333, DOI 10.1017/S0954102003001342; Kaiser M. J., 2005, MARINE ECOLOGY PROCE; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Livermore R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2005GC001224; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Morley SA, 2010, ANTARCT SCI, V22, P774, DOI 10.1017/S0954102010000465; Morley SA, 2009, COMP BIOCHEM PHYS A, V152, P423, DOI 10.1016/j.cbpa.2008.11.015; Mukasa SB, 1996, J S AM EARTH SCI, V9, P349, DOI 10.1016/S0895-9811(96)00019-3; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peck L.S., 2005, R SOC SPEC ISSUE ANT, V17, P495; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Roux A, 2002, ARCH FISH MAR RES, V49, P231; Salisbury EJ, 1926, GEOGR J, V67, P312, DOI 10.2307/1782828; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; SIRENKO BI, 2001, EXPLORATIONS FAUNA S, V51, P1; Smith SDA, 2002, GLOBAL ECOL BIOGEOGR, V11, P67, DOI 10.1046/j.1466-822X.2001.00259.x; Tavares M, 2004, ANTARCT SCI, V16, P129, DOI 10.1017/S0954102004001877; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; THORNHILL DJ, 2008, MOL ECOL, V17, P504; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; YOUNG EF, HIGH RESOLUTION MODE, V2, DOI DOI 10.1016/J.DSR2.2009.11.003; ZELAYA DG, 2000, THESIS U BUENOS AIRE, P144	74	52	54	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19795	10.1371/journal.pone.0019795	http://dx.doi.org/10.1371/journal.pone.0019795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647236	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000291006500008
J	Tullai, JW; Tacheva, S; Owens, LJ; Graham, JR; Cooper, GM				Tullai, John W.; Tacheva, Silvia; Owens, Laura J.; Graham, Julie R.; Cooper, Geoffrey M.			AP-1 Is a Component of the Transcriptional Network Regulated by GSK-3 in Quiescent Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; DNA-BINDING ACTIVITY; C-JUN; SIGNALING PATHWAY; FOS GENE; PHOSPHORYLATION; PROTEIN; ACTIVATION; CREB	Background: The protein kinase GSK-3 is constitutively active in quiescent cells in the absence of growth factor signaling. Previously, we identified a set of genes that required GSK-3 to maintain their repression during quiescence. Computational analysis of the upstream sequences of these genes predicted transcription factor binding sites for CREB, NF kappa B and AP-1. In our previous work, contributions of CREB and NF kappa B were examined. In the current study, the AP-1 component of the signaling network in quiescent cells was explored. Methodology/Principal Findings: Using chromatin immunoprecipitation analysis, two AP-1 family members, c-Jun and JunD, bound to predicted upstream regulatory sequences in 8 of the 12 GSK-3-regulated genes. c-Jun was phosphorylated on threonine 239 by GSK-3 in quiescent cells, consistent with previous studies demonstrating inhibition of c-Jun by GSK-3. Inhibition of GSK-3 attenuated this phosphorylation, resulting in the stabilization of c-Jun. The association of c-Jun with its target sequences was increased by growth factor stimulation as well as by direct GSK-3 inhibition. The physiological role for c-Jun was also confirmed by siRNA inhibition of gene induction. Conclusions/Significance: These results indicate that inhibition of c-Jun by GSK-3 contributes to the repression of growth factor-inducible genes in quiescent cells. Together, AP-1, CREB and NF kappa B form an integrated transcriptional network that is largely responsible for maintaining repression of target genes downstream of GSK-3 signaling.	[Tullai, John W.; Tacheva, Silvia; Owens, Laura J.; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Graham, Julie R.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA	Boston University; Boston University	Tullai, JW (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [R01 CA18689]; American Cancer Society [IRG-72-001-33-IRG]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grant R01 CA18689 (GMC) and by American Cancer Society Grant IRG-72-001-33-IRG (JWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005	35	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20150	10.1371/journal.pone.0020150	http://dx.doi.org/10.1371/journal.pone.0020150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647439	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500030
J	Wu, J; Wang, ZMM; Li, AZ; Benamara, M; Li, SB; Salamo, GJ				Wu, Jiang; Wang, Zhiming M.; Li, Alvason Z.; Benamara, Mourad; Li, Shibin; Salamo, Gregory J.			Nanoscale Footprints of Self-Running Gallium Droplets on GaAs Surface	PLOS ONE			English	Article							HOLED NANOSTRUCTURES	In this work, the nanoscale footprints of self-driven liquid gallium droplet movement on a GaAs (001) surface will be presented and analyzed. The nanoscale footprints of a primary droplet trail and ordered secondary droplets along primary droplet trails are observed on the GaAs surface. A well ordered nanoterrace from the trail is left behind by a running droplet. In addition, collision events between two running droplets are investigated. The exposed fresh surface after a collision demonstrates a superior evaporation property. Based on the observation of droplet evolution at different stages as well as nanoscale footprints, a schematic diagram of droplet evolution is outlined in an attempt to understand the phenomenon of stick-slip droplet motion on the GaAs surface. The present study adds another piece of work to obtain the physical picture of a stick-slip self-driven mechanism in nanoscale, bridging nano and micro systems.	[Wu, Jiang; Wang, Zhiming M.; Li, Alvason Z.; Benamara, Mourad; Li, Shibin; Salamo, Gregory J.] Univ Arkansas, Arkansas Inst Nanoscale Mat Sci & Engn, Fayetteville, AR 72701 USA; [Wang, Zhiming M.] Univ Elect Sci & Technol China, State Key Lab Elect Thin Films & Integrated Devic, Chengdu 610054, Peoples R China	University of Arkansas System; University of Arkansas Fayetteville; University of Electronic Science & Technology of China	Wu, J (corresponding author), Univ Arkansas, Arkansas Inst Nanoscale Mat Sci & Engn, Fayetteville, AR 72701 USA.	zmwang@uark.edu	Wang, Zhiming M/Q-1031-2015; Wu, Jiang/I-7436-2019; Li, Alvason Zhenhua/M-8380-2015; Li, Shibin/J-6289-2017	Wu, Jiang/0000-0003-0679-6196; Li, Alvason Zhenhua/0000-0001-6889-3288; Li, Shibin/0000-0002-0591-5491	Arkansas Biosciences Institute; National Science Foundation [DMR-0520550]	Arkansas Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Arkansas Biosciences Institute and the MRSEC Program of National Science Foundation Grant No. (DMR-0520550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATILLON C, 1995, J CRYST GROWTH, V151, P91, DOI 10.1016/0022-0248(95)00044-5; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Garcia-Sucerquia J, 2011, 3D RES, V2, DOI 10.1007/3DRes.02(2011)2; Heyn C, 2010, NANOSCALE RES LETT, V5, P576, DOI 10.1007/s11671-009-9507-3; Heyn C, 2009, J CRYST GROWTH, V311, P1839, DOI 10.1016/j.jcrysgro.2008.11.001; Hilner E, 2009, NANO LETT, V9, P2710, DOI 10.1021/nl9011886; KOGUCHI N, 1993, JPN J APPL PHYS 1, V32, P2052, DOI 10.1143/JJAP.32.2052; Kumah DP, 2009, NAT NANOTECHNOL, V4, P835, DOI [10.1038/NNANO.2009.271, 10.1038/nnano.2009.271]; Lazar P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.136103; Lee JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285602; Lee J, 2010, IEEE T NANOTECHNOL, V9, P149, DOI 10.1109/TNANO.2009.2028735; Lee JH, 2009, CRYST GROWTH DES, V9, P715, DOI 10.1021/cg701142d; Li AZH, 2010, NANO RES, V3, P490, DOI 10.1007/s12274-010-0009-5; Li AZH, 2009, CRYST GROWTH DES, V9, P2941, DOI 10.1021/cg900189t; Li SS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2778541; Liang BL, 2008, ACS NANO, V2, P2219, DOI 10.1021/nn800224p; Liang BL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455604; LOWES TD, 1993, J APPL PHYS, V73, P4937, DOI 10.1063/1.353812; Merola F, 2011, 3D RES, V2, DOI 10.1007/3DRes.01(2011)3; Mumm F, 2009, ACS NANO, V3, P2647, DOI 10.1021/nn900607p; Ogawa T, 2007, J PHYS D APPL PHYS, V40, P4603, DOI 10.1088/0022-3727/40/15/036; Richardson HH, 2009, NANO LETT, V9, P1139, DOI 10.1021/nl8036905; Somaschini C, 2009, NANO LETT, V9, P3419, DOI 10.1021/nl901493f; Tersoff J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.035702; Tersoff J, 2009, SCIENCE, V324, P236, DOI 10.1126/science.1169546; Wang LQ, 2010, NANOSCALE RES LETT, V5, P1241, DOI 10.1007/s11671-010-9638-6; Wang Z. M., 2005, PHYS STATUS SOLIDI A, V202, P1339; Wang ZM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713745; Wang ZM, 2006, NANOSCALE RES LETT, V1, P57, DOI 10.1007/s11671-006-9002-z; Yakes MK, 2010, ACS NANO, V4, P3877, DOI 10.1021/nn100623q	30	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20765	10.1371/journal.pone.0020765	http://dx.doi.org/10.1371/journal.pone.0020765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673965	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400027
J	Johnston-Monje, D; Raizada, MN				Johnston-Monje, David; Raizada, Manish N.			Conservation and Diversity of Seed Associated Endophytes in Zea across Boundaries of Evolution, Ethnography and Ecology	PLOS ONE			English	Article							PLANT-GROWTH; BACTERIAL ENDOPHYTES; MAYS L.; SP-NOV.; PANTOEA-AGGLOMERANS; ENTEROBACTER-ASBURIAE; ADVENTITIOUS ROOTS; MAIZE; TEOSINTE; IDENTIFICATION	Endophytes are non-pathogenic microbes living inside plants. We asked whether endophytic species were conserved in the agriculturally important plant genus Zea as it became domesticated from its wild ancestors (teosinte) to modern maize (corn) and moved from Mexico to Canada. Kernels from populations of four different teosintes and 10 different maize varieties were screened for endophytic bacteria by culturing, cloning and DNA fingerprinting using terminal restriction fragment length polymorphism (TRFLP) of 16S rDNA. Principle component analysis of TRFLP data showed that seed endophyte community composition varied in relation to plant host phylogeny. However, there was a core microbiota of endophytes that was conserved in Zea seeds across boundaries of evolution, ethnography and ecology. The majority of seed endophytes in the wild ancestor persist today in domesticated maize, though ancient selection against the hard fruitcase surrounding seeds may have altered the abundance of endophytes. Four TRFLP signals including two predicted to represent Clostridium and Paenibacillus species were conserved across all Zea genotypes, while culturing showed that Enterobacter, Methylobacteria, Pantoea and Pseudomonas species were widespread, with gamma-proteobacteria being the prevalent class. Twenty-six different genera were cultured, and these were evaluated for their ability to stimulate plant growth, grow on nitrogen-free media, solubilize phosphate, sequester iron, secrete RNAse, antagonize pathogens, catabolize the precursor of ethylene, produce auxin and acetoin/butanediol. Of these traits, phosphate solubilization and production of acetoin/butanediol were the most commonly observed. An isolate from the giant Mexican landrace Mixteco, with 100% identity to Burkholderia phytofirmans, significantly promoted shoot potato biomass. GFP tagging and maize stem injection confirmed that several seed endophytes could spread systemically through the plant. One seed isolate, Enterobacter asburiae, was able to exit the root and colonize the rhizosphere. Conservation and diversity in Zea-microbe relationships are discussed in the context of ecology, crop domestication, selection and migration.	[Johnston-Monje, David; Raizada, Manish N.] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph	Johnston-Monje, D (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	Raizada@uoguelph.ca		Johnston-Monje, David Morris/0000-0002-5077-4894	Ontario Research Fund; OMAFRA; Canadian Foundation for Innovation; Gerald R. Stephenson Scholarship; Gordon Nixon Leadership Award; Taffy Davison Memorial Research Travel Grant	Ontario Research Fund; OMAFRA; Canadian Foundation for Innovation(Canada Foundation for Innovation); Gerald R. Stephenson Scholarship; Gordon Nixon Leadership Award; Taffy Davison Memorial Research Travel Grant	This work was made possible by generous funding given to MNR by the Ontario Research Fund, OMAFRA New Directions program and Canadian Foundation for Innovation. Additional funding was awarded to DJM by the Gerald R. Stephenson Scholarship, Gordon Nixon Leadership Award, and the Taffy Davison Memorial Research Travel Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Agren GI, 2003, ANN BOT-LONDON, V92, P795, DOI 10.1093/aob/mcg203; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Asis CA, 2004, LETT APPL MICROBIOL, V38, P19, DOI 10.1046/j.1472-765X.2003.01434.x; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; Block CC, 1998, PLANT DIS, V82, P775, DOI 10.1094/PDIS.1998.82.7.775; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Chee-Sanford JC, 2006, WEED SCI, V54, P575, DOI 10.1614/WS-05-055R.1; Chelius MK, 2002, INT J SYST EVOL MICR, V52, P2061, DOI 10.1099/ijs.0.02203-0; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Christensen MJ, 2007, 6 INT S FUNG END GRA, V13, P123; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Conn KL, 1997, CAN J MICROBIOL, V43, P801, DOI 10.1139/m97-117; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; COX CD, 1994, METHOD ENZYMOL, V235, P315; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1989, DOI 10.1128/JCM.00632-07; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Dalton DA, 2006, PLANT-ASSOCIATED BACTERIA, P105; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; Deepa CK, 2010, WORLD J MICROB BIOT, V26, P1233, DOI 10.1007/s11274-009-0293-y; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Drummond A., 2011, GENEIOUS V5 5; DUBOS RJ, 1960, J EXP MED, V111, P407, DOI 10.1084/jem.111.3.407; ELA SW, 1982, PLANT PHYSIOL, V70, P1564, DOI 10.1104/pp.70.5.1564; Puente ME, 2009, ENVIRON EXP BOT, V66, P402, DOI 10.1016/j.envexpbot.2009.04.007; Estrada P, 2002, CAN J MICROBIOL, V48, P285, DOI 10.1139/w02-023; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Feng Y, 2006, J APPL MICROBIOL, V100, P938, DOI 10.1111/j.1365-2672.2006.02843.x; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; FISHER PJ, 1992, NEW PHYTOL, V122, P299, DOI 10.1111/j.1469-8137.1992.tb04234.x; Figueiredo JEF, 2009, BRAZ J MICROBIOL, V40, P522, DOI [10.1590/S1517-83822009000300014, 10.1590/S1517-838220090003000014]; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gai CS, 2009, J MICROBIOL, V47, P448, DOI 10.1007/s12275-008-0303-z; Gibson RW, 2005, ANN APPL BIOL, V147, P153, DOI 10.1111/j.1744-7348.2005.00021.x; Gich Frederic B., 2000, International Microbiology, V3, P103; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Hole R. C., 2004, BARC NEWSL, V249, P91; Holst I, 2007, P NATL ACAD SCI USA, V104, P17608, DOI 10.1073/pnas.0708736104; ILTIS HH, 1979, SCIENCE, V203, P186, DOI 10.1126/science.203.4376.186; Iltis HH, 2000, NOVON, V10, P382, DOI 10.2307/3392992; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Johnston-Monje D, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P713; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Kaga H, 2009, MICROBES ENVIRON, V24, P154, DOI 10.1264/jsme2.ME09113; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Krakat N, 2010, APPL ENVIRON MICROB, V76, P1842, DOI 10.1128/AEM.02397-09; KREMER RJ, 1987, MICROBIAL ECOL, V14, P29, DOI 10.1007/BF02011568; LEVINGS CS, 1992, PLANT MOL BIOL, V19, P135, DOI 10.1007/BF00015611; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lidstrom ME, 2002, J BACTERIOL, V184, P1818, DOI 10.1128/JB.184.7.1818.2002; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Madmony A, 2005, FOLIA MICROBIOL, V50, P209, DOI 10.1007/BF02931568; Mano H., 2006, Microbes and Environments, V21, P86, DOI 10.1264/jsme2.21.86; Mano Y, 2006, PLANT SOIL, V281, P269, DOI 10.1007/s11104-005-4268-y; Mano Y, 2009, PLANT ROOT, V3, P3, DOI 10.3117/plantroot.3.3; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mauricio Sanchez R. A., 2004, Revista Fitotecnia Mexicana, V27, P213; MCINROY JA, 1995, CAN J MICROBIOL, V41, P895, DOI 10.1139/m95-123; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Montanez A, 2009, BIOL FERT SOILS, V45, P253, DOI 10.1007/s00374-008-0322-2; MUNDT JO, 1976, APPL ENVIRON MICROB, V32, P694, DOI 10.1128/AEM.32.5.694-698.1976; Munkacsi AB, 2008, P ROY SOC B-BIOL SCI, V275, P1037, DOI 10.1098/rspb.2007.1636; Nabhan Gary Paul, 2008, RENEWING AM FOOD TRA; Narvaez Gonzalez E.D, 2007, REV FITOTEC MEX, V30, P321; Nassar AH, 2005, BIOL FERT SOILS, V42, P97, DOI 10.1007/s00374-005-0008-y; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; Palus JA, 1996, PLANT SOIL, V186, P135, DOI 10.1007/BF00035067; Perez-Miranda S, 2007, J MICROBIOL METH, V70, P127, DOI 10.1016/j.mimet.2007.03.023; PHALIP V, 1994, J BASIC MICROB, V34, P277, DOI 10.1002/jobm.3620340412; Pirttila AM, 2000, APPL ENVIRON MICROB, V66, P3073, DOI 10.1128/AEM.66.7.3073-3077.2000; Preston GM, 2004, PHILOS T R SOC B, V359, P907, DOI 10.1098/rstb.2003.1384; QuadtHallmann A, 1997, CAN J MICROBIOL, V43, P577, DOI 10.1139/m97-081; QuadtHallmann A, 1996, CAN J MICROBIOL, V42, P1144, DOI 10.1139/m96-146; Rai R, 2007, WORLD J MICROB BIOT, V23, P853, DOI 10.1007/s11274-006-9309-z; Raven P. H., 1999, BIOL PLANTS, V6th; Reis VM, 2004, INT J SYST EVOL MICR, V54, P2155, DOI 10.1099/ijs.0.02879-0; Rice E, 2007, GENET RESOUR CROP EV, V54, P701, DOI 10.1007/s10722-006-0023-3; Riggs PJ, 2001, AUST J PLANT PHYSIOL, V28, P829, DOI 10.1071/PP01045; Rijavec T, 2007, CAN J MICROBIOL, V53, P802, DOI 10.1139/W07-048; Rodriguez H, 2000, J BIOTECHNOL, V84, P155, DOI 10.1016/S0168-1656(00)00347-3; Roesch LFW, 2008, PLANT SOIL, V302, P91, DOI 10.1007/s11104-007-9458-3; Roesch LFW, 2007, REV BRAS CIENC SOLO, V31, P1367, DOI 10.1590/S0100-06832007000600015; Romanovskaya VA, 2001, MICROBIOLOGY+, V70, P221, DOI 10.1023/A:1010441900060; Rosenblueth M, 2004, ARCH MICROBIOL, V181, P337, DOI 10.1007/s00203-004-0661-9; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Ryu J, 2006, J MICROBIOL BIOTECHN, V16, P1622; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Seghers D, 2004, APPL ENVIRON MICROB, V70, P1475, DOI 10.1128/AEM.70.3.1475-1482.2004; SEKELJA M, 2010, ISME J; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Smalla K., 2004, MICROBIAL DIVERSITY, P88, DOI DOI 10.1128/9781555817770.CH9; Soares MMCN, 1999, REV MICROBIOL, V30, P299, DOI 10.1590/S0001-37141999000400002; Torres AR, 2008, J MICROBIOL, V46, P373, DOI 10.1007/s12275-007-0165-9; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Turrent A, 2004, MAIZE BIODIVERSITY E; Vollbrecht E, 2005, BIOCHEM SOC T, V33, P1502, DOI 10.1042/BST20051502; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang K, 2007, NEW PHYTOL, V174, P212, DOI 10.1111/j.1469-8137.2007.01999.x; Wilkes G., 2004, CORN ORIGIN HIST TEC; Yasinok AE, 2008, J AGR SCI-TARIM BILI, V14, P374, DOI 10.1501/Tarimbil_0000001054; Zinniel DK, 2002, APPL ENVIRON MICROB, V68, P2198, DOI 10.1128/AEM.68.5.2198-2208.2002	113	296	327	11	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20396	10.1371/journal.pone.0020396	http://dx.doi.org/10.1371/journal.pone.0020396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673982	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500015
J	Okyar, A; Piccolo, E; Ahowesso, C; Filipski, E; Hossard, V; Guettier, C; La Sorda, R; Tinari, N; Iacobelli, S; Levi, F				Okyar, Alper; Piccolo, Enza; Ahowesso, Constance; Filipski, Elisabeth; Hossard, Virginie; Guettier, Catherine; La Sorda, Rosanna; Tinari, Nicola; Iacobelli, Stefano; Levi, Francis			Strain- and Sex-Dependent Circadian Changes in Abcc2 Transporter Expression: Implications for Irinotecan Chronotolerance in Mouse Ileum	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CLOCK; OXALIPLATIN; MECHANISMS; RHYTHMS; ACID	Background: ATP-binding cassette transporter abcc2 is involved in the cellular efflux of irinotecan. The drug is toxic for mouse ileum, where abcc2 is highly expressed. Here, we investigate whether circadian changes in local abcc2 expression participate in the circadian rhythm of irinotecan toxicity for ileum mucosa, and further assess whether genetic background or sex modify this relation. Methodology/Principal Findings: Ileum mucosa was obtained every 3-4 h for 24 h in male and female B6D2F(1) and B6CBAF(1) mice synchronized with light from Zeitgeber Time (ZT) 0 to ZT12 alternating with 12 h of darkness. Irinotecan (50 mg/kg i.v. daily for 4 days) was administered at the sex-and strain-specific times corresponding to least (ZT11-15) or largest drug-induced body weight loss (ZT23-03-07). Abcc2 expression was determined with qRT-PCR for mRNA and with immunohistochemistry and confocal microscopy for protein. Histopathologic lesions were graded in ileum tissues obtained 2, 4 or 6 days after treatment. Two-to six-fold circadian changes were demonstrated for mRNA and protein mean expressions of abcc2 in mouse ileum (p<0.05). ZT12 corresponded to high mRNA and protein expressions, with circadian waveforms differing according to genetic background and sex. The proportion of mice spared from ileum lesions varied three-fold according to irinotecan timing, with best tolerability at ZT11-15 (p = 0.00003). Irinotecan was also best tolerated in males (p = 0.05) and in B6CBAF(1) (p = 0.0006). Conclusions/Significance: Strain-and sex-dependent circadian patterns in abcc2 expressions displayed robust relations with the chronotolerance of ileum mucosa for irinotecan. This finding has strong potential implications for improving the intestinal tolerability of anticancer drugs through circadian delivery.	[Okyar, Alper; Ahowesso, Constance; Filipski, Elisabeth; Hossard, Virginie; Levi, Francis] Hop Paul Brousse, INSERM, Rythmes Biol & Cancers U776, Villejuif, France; [Okyar, Alper; Ahowesso, Constance; Filipski, Elisabeth; Hossard, Virginie; Levi, Francis] Univ Paris Sud, UMR S0776, Orsay, France; [Levi, Francis] Hop Paul Brousse, AP HP, Unite Chronotherapie, Dept Cancerol, Villejuif, France; [Okyar, Alper] Istanbul Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey; [Piccolo, Enza; La Sorda, Rosanna; Tinari, Nicola; Iacobelli, Stefano] CESI Univ G Annunzio, CINBO, Chieti, Italy; [Guettier, Catherine] Hop Paul Brousse, AP HP, Lab Anat & Cytol Pathol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Istanbul University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Okyar, A (corresponding author), Hop Paul Brousse, INSERM, Rythmes Biol & Cancers U776, Villejuif, France.	francis.levi@inserm.fr	Okyar, Alper/AAD-3114-2020	Tinari, Nicola/0000-0001-8449-5407	European Union through the Network of Excellence BIOSIM [LSHBCT-2004-005137]; Specific Targeted Research Project TEMPO (Temporal Genomics for Tailored Chronotherapeutics) [LSHG-ct-2006-037543]; Temporal Dimension in Functional Genomics [LSSG-CT-2006-037654]; Scientific and Technological Research Council of Turkey (TUBITAK); Istanbul University [UDP-8562/2010]	European Union through the Network of Excellence BIOSIM(European Commission); Specific Targeted Research Project TEMPO (Temporal Genomics for Tailored Chronotherapeutics); Temporal Dimension in Functional Genomics; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Istanbul University(Istanbul University)	The study was funded by the European Union through the Network of Excellence BIOSIM (Biosimulation: a new tool for drug development; contract LSHBCT-2004-005137), the Specific Targeted Research Project TEMPO (Temporal Genomics for Tailored Chronotherapeutics; contract LSHG-ct-2006-037543), the Specific Support Action PROUST (The Temporal Dimension in Functional Genomics; contract LSSG-CT-2006-037654) and by the Scientific and Technological Research Council of Turkey (TUBITAK) and the Research Fund of Istanbul University (UDP-8562/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahowesso C, 2010, TOXICOL LETT, V192, P395, DOI 10.1016/j.toxlet.2009.11.017; AHOWESSO C, 2010, THESIS U PARIS SUD 1; Altinok A, 2009, EUR J PHARM SCI, V36, P20, DOI 10.1016/j.ejps.2008.10.024; Ando H, 2005, CHRONOBIOL INT, V22, P655, DOI 10.1080/07420520500180231; Berggren S, 2007, MOL PHARM, V4, P252, DOI 10.1021/mp0600687; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Clairambault J, 2009, MATH MODEL NAT PHENO, V4, P12, DOI 10.1051/mmnp/20094302; Claudel T, 2007, FEBS LETT, V581, P3626, DOI 10.1016/j.febslet.2007.04.009; DePrins J, 1992, BIOL RHYTHMS CLIN LA, P90; Filipski E, 2004, CHRONOBIOL INT, V21, P613, DOI 10.1081/CBI-120040183; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gotoh Y, 2000, J PHARMACOL EXP THER, V292, P433; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kweekel D, 2008, CANCER TREAT REV, V34, P656, DOI 10.1016/j.ctrv.2008.05.002; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; LEVI F, 2010, CANC SYSTEM IN PRESS; Levi F, 2007, ADV DRUG DELIVER REV, V59, P1015, DOI 10.1016/j.addr.2006.11.001; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Levi F, 2010, ANNU REV PHARMACOL, V50, P377, DOI 10.1146/annurev.pharmtox.48.113006.094626; Maher JM, 2005, DRUG METAB DISPOS, V33, P947, DOI 10.1124/dmd.105.003780; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mottino AD, 2000, J PHARMACOL EXP THER, V293, P717; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohdo S, 1997, J PHARMACOL EXP THER, V283, P1383; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Stearns AT, 2008, J PHARMACOL SCI, V108, P144, DOI 10.1254/jphs.08100SC; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174	34	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20393	10.1371/journal.pone.0020393	http://dx.doi.org/10.1371/journal.pone.0020393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674030	gold, Green Published, Green Submitted			2022-12-27	WOS:000291355500014
J	Strack, S; Petersen, Y; Wagner, A; Roder, IV; Albrizio, M; Reischl, M; Wacker, IU; Wilhelm, C; Rudolf, R				Strack, Siegfried; Petersen, Yvonne; Wagner, Anika; Roeder, Ira V.; Albrizio, Marina; Reischl, Markus; Wacker, Irene U.; Wilhelm, Christoph; Rudolf, Ruediger			A Novel Labeling Approach Identifies Three Stability Levels of Acetylcholine Receptors in the Mouse Neuromuscular Junction In Vivo	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MYOSIN VA; MUSCLE; DEGRADATION; MAINTENANCE; SYNAPSES; DYNAMICS; DENSITY; ALPHA	Background: The turnover of acetylcholine receptors at the neuromuscular junction is regulated in an activity-dependent manner. Upon denervation and under various other pathological conditions, receptor half-life is decreased. Methodology/Principal Findings: We demonstrate a novel approach to follow the kinetics of acetylcholine receptor lifetimes upon pulse labeling of mouse muscles with I-125-alpha-bungarotoxin in vivo. In contrast to previous assays where residual activity was measured ex vivo, in our setup the same animals are used throughout the whole measurement period, thereby permitting a dramatic reduction of animal numbers at increased data quality. We identified three stability levels of acetylcholine receptors depending on the presence or absence of innervation: one pool of receptors with a long half-life of similar to 13 days, a second with an intermediate half-life of similar to 8 days, and a third with a short half-life of similar to 1 day. Data were highly reproducible from animal to animal and followed simple exponential terms. The principal outcomes of these measurements were reproduced by an optical pulse-labeling assay introduced recently. Conclusions/Significance: A novel assay to determine kinetics of acetylcholine receptor turnover with small animal numbers is presented. Our data show that nerve activity acts on muscle acetylcholine receptor stability by at least two different means, one shifting receptor lifetime from short to intermediate and another, which further increases receptor stability to a long lifetime. We hypothesize on possible molecular mechanisms.	[Strack, Siegfried; Petersen, Yvonne; Wagner, Anika; Roeder, Ira V.; Albrizio, Marina; Rudolf, Ruediger] Karlsruhe Inst Technol, Inst Toxikol & Genet, Karlsruhe, Germany; [Reischl, Markus] Karlsruhe Inst Technol, Inst Angew Informat, Karlsruhe, Germany; [Wacker, Irene U.] Karlsruhe Inst Technol, Inst Biol Grenzflachen, Karlsruhe, Germany; [Wilhelm, Christoph] Karlsruhe Inst Technol, Sicherheitsmanagement Anal Labs, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Strack, S (corresponding author), Karlsruhe Inst Technol, Inst Toxikol & Genet, Karlsruhe, Germany.	ruediger.rudolf@kit.edu	Reischl, Markus/H-6970-2013; Rudolf, Rüdiger/A-6476-2009	Reischl, Markus/0000-0002-7780-6374; Rudolf, Rüdiger/0000-0002-0833-1053	Deutsche Forschungsgemeinschaft [RU923/3-1, RU923/4-1]; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	RR was supported by the Deutsche Forschungsgemeinschaft (RU923/3-1, RU923/4-1). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; ANDREOSE JS, 1993, J NEUROSCI, V13, P3433; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2006, MOL NEUROBIOL, V34, P137, DOI 10.1385/MN:34:2:137; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Chang CC, 1999, J BIOMED SCI, V6, P368, DOI 10.1159/000025412; Engel A.G., 2004, MYOLOGY; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; LEVITT TA, 1981, NATURE, V291, P239, DOI 10.1038/291239a0; LINGLE CJ, 1988, INT ANESTHESIOL CLIN, V26, P288, DOI 10.1097/00004311-198802640-00007; LOMO T, 1971, J PHYSIOL-LONDON, V216, pP52; Lu Ju, 2007, Shengli Xuebao, V59, P683; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; SALPETER MM, 1986, J CELL BIOL, V103, P1399, DOI 10.1083/jcb.103.4.1399; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SHYNG SL, 1991, NEURON, V6, P469, DOI 10.1016/0896-6273(91)90254-W; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Xu RF, 1997, J NEUROSCI, V17, P8194; Xu RF, 1999, J CELL PHYSIOL, V181, P107, DOI 10.1002/(SICI)1097-4652(199910)181:1<107::AID-JCP11>3.3.CO;2-0; YAMPOLSKY P, 2010, EUR J NEUROSCI; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014; Yampolsky P, 2010, J BIOL CHEM, V285, P34589, DOI 10.1074/jbc.M110.168880	28	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20524	10.1371/journal.pone.0020524	http://dx.doi.org/10.1371/journal.pone.0020524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655100	Green Published, Green Submitted, gold			2022-12-27	WOS:000291310600012
J	Kiger, L; Tilleman, L; Geuens, E; Hoogewijs, D; Lechauve, C; Moens, L; Dewilde, S; Marden, MC				Kiger, Laurent; Tilleman, Lesley; Geuens, Eva; Hoogewijs, David; Lechauve, Christophe; Moens, Luc; Dewilde, Sylvia; Marden, Michael C.			Electron Transfer Function versus Oxygen Delivery: A Comparative Study for Several Hexacoordinated Globins Across the Animal Kingdom	PLOS ONE			English	Article							LIGAND-BINDING; CAENORHABDITIS-ELEGANS; NEUROGLOBIN OVEREXPRESSION; GENE FAMILY; CYTOGLOBIN; HEMOGLOBINS; EXPRESSION; MECHANISM; PROTEINS; NEURONS	Caenorhabditis elegans globin GLB-26 (expressed from gene T22C1.2) has been studied in comparison with human neuroglobin (Ngb) and cytoglobin (Cygb) for its electron transfer properties. GLB-26 exhibits no reversible binding for O-2 and a relatively low CO affinity compared to myoglobin-like globins. These differences arise from its mechanism of gaseous ligand binding since the heme iron of GLB-26 is strongly hexacoordinated in the absence of external ligands; the replacement of this internal ligand, probably the E7 distal histidine, is required before binding of CO or O-2 as for Ngb and Cygb. Interestingly the ferrous bis-histidyl GLB-26 and Ngb, another strongly hexacoordinated globin, can transfer an electron to cytochrome c (Cyt-c) at a high bimolecular rate, comparable to those of inter-protein electron transfer in mitochondria. In addition, GLB-26 displays an unexpectedly rapid oxidation of the ferrous His-Fe-His complex without O-2 actually binding to the iron atom, since the heme is oxidized by O-2 faster than the time for distal histidine dissociation. These efficient mechanisms for electron transfer could indicate a family of hexacoordinated globin which are functionally different from that of pentacoordinated globins.	[Kiger, Laurent; Lechauve, Christophe; Marden, Michael C.] Univ Paris 06, INSERM, U779, Le Kremlin Bicetre, France; [Kiger, Laurent; Lechauve, Christophe; Marden, Michael C.] Univ Paris 11, INSERM, U779, Le Kremlin Bicetre, France; [Tilleman, Lesley; Geuens, Eva; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Hoogewijs, David] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Hoogewijs, David] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Antwerp; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Kiger, L (corresponding author), Univ Paris 06, INSERM, U779, Le Kremlin Bicetre, France.	Laurent.Kiger@inserm.fr	Marden, Michael/AAA-5923-2020; Hoogewijs, David/L-5144-2016; Kiger, Laurent/Q-1686-2018; Lechauve, Christophe/AAH-8873-2019; Marden, Michael C/G-3139-2012	Marden, Michael C/0000-0002-5254-6385	Inserm, DGA (Delegation Generale pour l'Armement), University Paris VI and XI and the University of Antwerp [07.34.004]; Fund for Scientific Research, Flanders (FWO)	Inserm, DGA (Delegation Generale pour l'Armement), University Paris VI and XI and the University of Antwerp; Fund for Scientific Research, Flanders (FWO)(FWO)	This work was supported by Inserm, DGA (Delegation Generale pour l'Armement) contract No 07.34.004, University Paris VI and XI and the University of Antwerp. DH acknowledges a postdoctoral fellowship from the Fund for Scientific Research, Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bentmann A, 2005, J BIOL CHEM, V280, P20660, DOI 10.1074/jbc.M501338200; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRAECKMAN BP, 2009, WORMBOOK, V16, P10; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; BUTLER J, 1982, J BIOL CHEM, V257, P747; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2006, J BIOL CHEM, V281, P5364, DOI 10.1074/jbc.M509486200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; DREW MC, 1992, SOIL SCI, V154, P259, DOI 10.1097/00010694-199210000-00002; DUSENBERY DB, 1980, J COMP PHYSIOL, V136, P333, DOI 10.1007/BF00657353; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Ertas B, 2011, J BIOL CHEM, V286, P3185, DOI 10.1074/jbc.M110.160341; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Geuens E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-17; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hamdane D, 2005, FEBS J, V272, P2076, DOI 10.1111/j.1742-4658.2005.04635.x; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lechauve C, 2010, FEBS J, V277, P2696, DOI [10.1111/j.1742-4658.2010.07686.x, 10.1111/j.1742-464X.2010.07686.x]; Lee DL, 1976, PHYSL NEMATODES; LEWIN R, 1984, SCIENCE, V226, P328, DOI 10.1126/science.226.4672.328; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Sylvia D.M., 1998, PRINCIPLES APPL SOIL; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; WITTENBERG BA, 1965, BIOCHEM J, V96, P363, DOI 10.1042/bj0960363; Yoon J, 2010, BIOCHEMISTRY-US, V49, P5662, DOI 10.1021/bi100710a; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	56	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20478	10.1371/journal.pone.0020478	http://dx.doi.org/10.1371/journal.pone.0020478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21674044	Green Submitted, Green Published, gold			2022-12-27	WOS:000291309900023
J	Nantel-Vivier, A; Pihl, RO; Young, SN; Parent, S; Belanger, SA; Sutton, R; Dubois, ME; Tremblay, RE; Seguin, JR				Nantel-Vivier, Amelie; Pihl, Robert O.; Young, Simon N.; Parent, Sophie; Belanger, Stacey Ageranioti; Sutton, Rachel; Dubois, Marie-Eve; Tremblay, Richard E.; Seguin, Jean R.			Serotonergic Contribution to Boys' Behavioral Regulation	PLOS ONE			English	Article							CEREBROSPINAL-FLUID MONOAMINE; DEFICIT HYPERACTIVITY DISORDER; INCREASES FEAR RECOGNITION; RAPID TRYPTOPHAN DEPLETION; PHYSICAL AGGRESSION; DEVELOPMENTAL TRAJECTORIES; ANTISOCIAL-BEHAVIOR; EARLY-CHILDHOOD; VERVET MONKEYS; 5-HYDROXYINDOLEACETIC ACID	Objectives: Animal and human adult studies reveal a contribution of serotonin to behavior regulation. Whether these findings apply to children is unclear. The present study investigated serotonergic functioning in boys with a history of behavior regulation difficulties through a double-blind, acute tryptophan supplementation procedure. Method: Participants were 23 boys (age 10 years) with a history of elevated physical aggression, recruited from a community sample. Eleven were given a chocolate milkshake supplemented with 500mg tryptophan, and 12 received a chocolate milkshake without tryptophan. Boys engaged in a competitive reaction time game against a fictitious opponent, which assessed response to provocation, impulsivity, perspective taking, and sharing. Impulsivity was further assessed through a Go/No-Go paradigm. A computerized emotion recognition task and a staged instrumental help incident were also administered. Results: Boys, regardless of group, responded similarly to high provocation by the fictitious opponent. However, boys in the tryptophan group adjusted their level of responding optimally as a function of the level of provocation, whereas boys in the control group significantly decreased their level of responding towards the end of the competition. Boys in the tryptophan group tended to show greater perspective taking, tended to better distinguish facial expressions of fear and happiness, and tended to provide greater instrumental help to the experimenter. Conclusions: The present study provides initial evidence for the feasibility of acute tryptophan supplementation in children and some effect of tryptophan supplementation on children's behaviors. Further studies are warranted to explore the potential impact of increased serotonergic functioning on boys' dominant and affiliative behaviors.	[Nantel-Vivier, Amelie; Pihl, Robert O.; Sutton, Rachel] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Nantel-Vivier, Amelie; Tremblay, Richard E.] INSERM, U669, Paris, France; [Nantel-Vivier, Amelie] Univ Paris 11, Paris, France; [Nantel-Vivier, Amelie] Univ Paris 05, UMR S0669, Paris, France; [Pihl, Robert O.; Young, Simon N.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Parent, Sophie] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Belanger, Stacey Ageranioti] Ctr Hosp Univ CHU St Justine, Dept Pediat, Montreal, PQ, Canada; [Dubois, Marie-Eve] Concordia Univ, Dept Psychol, Ctr Res Human Dev CRDH, Montreal, PQ H3G 1M8, Canada; [Tremblay, Richard E.; Seguin, Jean R.] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Tremblay, Richard E.; Seguin, Jean R.] Ctr Hosp Univ CHU St Justine, Res Ctr, Montreal, PQ, Canada	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; McGill University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Concordia University - Canada; Universite de Montreal; Universite de Montreal; University College Dublin; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Nantel-Vivier, A (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	jean.seguin@umontreal.ca	Young, Simon N/A-1865-2008; Tremblay, Richard E./O-1360-2014; Séguin, Jean R./B-5349-2008; Parent, Sophie/F-1309-2010	Young, Simon N/0000-0001-9666-8096; Séguin, Jean R./0000-0003-3359-6202; 	Fond Quebecois de Recherche Societe et Culture (FQRSC); McGill University; Canadian Institutes of Health Research (CIHR) [MOP-81126]; INSERM	Fond Quebecois de Recherche Societe et Culture (FQRSC); McGill University; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This research was supported by graduate scholarships to Amelie Nantel-Vivier from the Fond Quebecois de Recherche Societe et Culture (FQRSC) and McGill University (Delta Upsilon Scholarship), and research grant #MOP-81126 from the Canadian Institutes of Health Research (CIHR). Manuscript preparation was also supported by Amelie Nantel-Vivier's postdoctoral position at INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AANHET RM, 2006, J PSYCHIATR NEUROSCI, V31, P253; Abelson R. P., 1995, STAT PRINCIPLED ARGU; Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; American Psychological Association, 2002, ETH PRINC PSYCH COD; Attenburrow MJ, 2003, PSYCHOPHARMACOLOGY, V169, P104, DOI 10.1007/s00213-003-1479-x; Berman ME, 2009, PSYCHOL SCI, V20, P714, DOI 10.1111/j.1467-9280.2009.02355.x; Bhagwagar Z, 2004, AM J PSYCHIAT, V161, P166, DOI 10.1176/appi.ajp.161.1.166; Bjork JM, 1999, PSYCHOPHARMACOLOGY, V142, P24, DOI 10.1007/s002130050858; Bongers IL, 2004, CHILD DEV, V75, P1523, DOI 10.1111/j.1467-8624.2004.00755.x; Booij L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011255; Brame B, 2001, J CHILD PSYCHOL PSYC, V42, P503, DOI 10.1111/1469-7610.00744; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; BROWN GL, 1982, AM J PSYCHIAT, V139, P741; Browning M, 2007, J PSYCHOPHARMACOL, V21, P684, DOI 10.1177/0269881106074062; Card NA, 2008, CHILD DEV, V79, P1185, DOI 10.1111/j.1467-8624.2008.01184.x; Carver CS, 2008, PSYCHOL BULL, V134, P912, DOI 10.1037/a0013740; CASTELLANOS FX, 1994, PSYCHIAT RES, V52, P305, DOI 10.1016/0165-1781(94)90076-0; CLEARE AJ, 1995, PSYCHOPHARMACOLOGY, V118, P72, DOI 10.1007/BF02245252; Coccaro EF, 2009, J CLIN PSYCHIAT, V70, P653, DOI 10.4088/JCP.08m04150; Cote SM, 2007, ARCH GEN PSYCHIAT, V64, P1305, DOI 10.1001/archpsyc.64.11.1305; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Eisenberg N, 2002, J PERS SOC PSYCHOL, V82, P993, DOI 10.1037//0022-3514.82.6.993; Fairbanks LA, 2001, NEUROPSYCHOPHARMACOL, V24, P370, DOI 10.1016/S0893-133X(00)00211-6; Finn PR, 1998, AGGRESSIVE BEHAV, V24, P173, DOI 10.1002/(SICI)1098-2337(1998)24:3<173::AID-AB2>3.3.CO;2-N; GHOSE K, 1983, NEUROPSYCHOBIOLOGY, V10, P111, DOI 10.1159/000117996; Harmer CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P148, DOI 10.1038/sj.npp.1300004; Hay DF, 1999, J CHILD PSYCHOL PSYC, V40, P905, DOI 10.1111/1469-7610.00508; HIGLEY JD, 1992, ARCH GEN PSYCHIAT, V49, P436; Higley JD, 1996, ARCH GEN PSYCHIAT, V53, P537; HOYSE SE, 1982, J INT MED RES, V10, P157, DOI 10.1177/030006058201000304; Kamarck TW, 2009, J CONSULT CLIN PSYCH, V77, P174, DOI 10.1037/a0014394; King S, 2009, J CLIN CHILD ADOLESC, V38, P619, DOI 10.1080/15374410903103619; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Krakowski M, 2003, J NEUROPSYCH CLIN N, V15, P294, DOI 10.1176/appi.neuropsych.15.3.294; KRUESI MJP, 1992, ARCH GEN PSYCHIAT, V49, P429; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; MEHLMAN PT, 1994, AM J PSYCHIAT, V151, P1485; MEHLMAN PT, 1995, AM J PSYCHIAT, V152, P907; Moore TM, 2002, AGGRESSIVE BEHAV, V28, P299, DOI 10.1002/ab.90027; Moskowitz DS, 2001, NEUROPSYCHOPHARMACOL, V25, P277, DOI 10.1016/S0893-133X(01)00219-6; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; NEMZER ED, 1986, J AM ACAD CHILD PSY, V25, P509, DOI 10.1016/S0002-7138(10)60010-6; *NICHD, 2004, MON SOC RES CHILD DE, V69; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; PELHAM WE, 1991, J ABNORM CHILD PSYCH, V19, P407, DOI 10.1007/BF00919086; PIHL RO, 1995, PSYCHOPHARMACOLOGY, V119, P353, DOI 10.1007/BF02245849; Pine DS, 1997, ARCH GEN PSYCHIAT, V54, P839; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; RALEIGH MJ, 1985, BRAIN RES, V348, P274, DOI 10.1016/0006-8993(85)90445-7; RALEIGH MJ, 1980, EXP NEUROL, V68, P322, DOI 10.1016/0014-4886(80)90089-8; Renouf A, 2010, J ABNORM CHILD PSYCH, V38, P1109, DOI 10.1007/s10802-010-9432-z; Riddick NV, 2009, NEUROSCIENCE, V158, P1257, DOI 10.1016/j.neuroscience.2008.11.016; Romano E, 2005, J ABNORM CHILD PSYCH, V33, P565, DOI 10.1007/s10802-005-6738-3; Schulz KP, 2001, PSYCHIAT RES, V101, P1, DOI 10.1016/S0165-1781(00)00238-9; SPSS, 2006, SPSS 15 0 WIND; Stadler C, 2007, NEUROPSYCHOBIOLOGY, V56, P104, DOI 10.1159/000112951; STOFF DM, 1992, PSYCHIAT RES, V43, P263, DOI 10.1016/0165-1781(92)90059-C; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; TREMBLAY RE, 1994, ARCH GEN PSYCHIAT, V51, P732; TREMBLAY RE, 1987, INT J BEHAV DEV, V10, P467, DOI 10.1177/016502548701000406; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; TUINIER S, 1995, INT CLIN PSYCHOPHARM, V10, P147, DOI 10.1097/00004850-199510030-00003; van Goozen SHM, 1999, EUR NEUROPSYCHOPHARM, V9, P141, DOI 10.1016/S0924-977X(98)00019-4; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; Westergaard GC, 1999, PSYCHOPHARMACOLOGY, V146, P440, DOI 10.1007/PL00005489; Wood RM, 2006, NEUROPSYCHOPHARMACOL, V31, P1075, DOI 10.1038/sj.npp.1300932; YODYINGYUAD U, 1985, NEUROSCIENCE, V16, P851, DOI 10.1016/0306-4522(85)90099-5; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; YUWILER A, 1981, ARCH GEN PSYCHIAT, V38, P619; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P291, DOI 10.1002/hup.934; Zepf FD, 2008, PHARMACOPSYCHIATRY, V41, P60, DOI 10.1055/s-2007-1004593	74	11	11	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20304	10.1371/journal.pone.0020304	http://dx.doi.org/10.1371/journal.pone.0020304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673801	Green Published, gold, Green Submitted			2022-12-27	WOS:000291309900012
J	Dmitriev, A; Mohapatra, SS; Chong, P; Neely, M; Biswas, S; Biswas, I				Dmitriev, Alexander; Mohapatra, Saswat S.; Chong, Patrick; Neely, Melody; Biswas, Saswati; Biswas, Indranil			CovR-Controlled Global Regulation of Gene Expression in Streptococcus mutans	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; GROUP-B STREPTOCOCCUS; HYALURONIC-ACID CAPSULE; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; RESPONSE REGULATOR; POSITIVE REGULATOR; STREPTOLYSIN-S; M-PROTEIN; PYOGENES	CovR/S is a two-component signal transduction system (TCS) that controls the expression of various virulence related genes in many streptococci. However, in the dental pathogen Streptococcus mutans, the response regulator CovR appears to be an orphan since the cognate sensor kinase CovS is absent. In this study, we explored the global transcriptional regulation by CovR in S. mutans. Comparison of the transcriptome profiles of the wild-type strain UA159 with its isogenic covR deleted strain IBS10 indicated that at least 128 genes (similar to 6.5% of the genome) were differentially regulated. Among these genes, 69 were down regulated, while 59 were up regulated in the IBS10 strain. The S. mutans CovR regulon included competence genes, virulence related genes, and genes encoded within two genomic islands (GI). Genes encoded by the GI TnSmu2 were found to be dramatically reduced in IBS10, while genes encoded by the GI TnSmu1 were up regulated in the mutant. The microarray data were further confirmed by real-time RT-PCR analyses. Furthermore, direct regulation of some of the differentially expressed genes was demonstrated by electrophoretic mobility shift assays using purified CovR protein. A proteomic study was also carried out that showed a general perturbation of protein expression in the mutant strain. Our results indicate that CovR truly plays a significant role in the regulation of several virulence related traits in this pathogenic streptococcus.	[Dmitriev, Alexander; Mohapatra, Saswat S.; Chong, Patrick; Biswas, Saswati; Biswas, Indranil] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA; [Dmitriev, Alexander] Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia; [Neely, Melody] Wayne State Sch Med, Dept Microbiol & Immunol, Detroit, MI USA	University of Kansas; University of Kansas Medical Center; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Wayne State University	Dmitriev, A (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA.	ibiswas@kumc.edu	Neely, Melody N/AAX-1130-2021; Dmitriev, Alexander/C-9407-2012; Mohapatra, Saswat Sourav/B-6487-2011	Neely, Melody N/0000-0003-2125-7836; Mohapatra, Saswat Sourav/0000-0003-2776-1363	National Institute of Dental and Craniofacial Research (NIDCR) [DE016686]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016686] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was made possible by a National Institute of Dental and Craniofacial Research (NIDCR) grant (DE016686) to IB. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Biswas I, 2003, J BACTERIOL, V185, P3081, DOI 10.1128/JB.185.10.3081-3090.2003; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Biswas I, 2007, BIOTECHNIQUES, V42, P487, DOI 10.2144/000112414; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Biswas S, 2005, INFECT IMMUN, V73, P6923, DOI 10.1128/IAI.73.10.6923-6934.2005; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; CARLSSON J, 1994, METABOLIC ACTIVITY O; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MA, 2006, J ANTIMICROB CHEMOTH, V58, P752, DOI 10.1093/jac/dkl319; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Chong P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015528; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; EDGAR WM, 1996, SALIVA ORAL HLTH, P81; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Folio P, 2004, PROTEOMICS, V4, P3187, DOI 10.1002/pmic.200300841; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Gao JX, 2005, J BIOL CHEM, V280, P38948, DOI 10.1074/jbc.M506121200; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Graham MR, 2001, CURR OPIN MICROBIOL, V4, P65, DOI 10.1016/S1369-5274(00)00166-1; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Guillot A, 2003, PROTEOMICS, V3, P337, DOI 10.1002/pmic.200390047; Gusa AA, 2005, MOL MICROBIOL, V56, P1195, DOI 10.1111/j.1365-2958.2005.04623.x; Gusa AA, 2007, J BACTERIOL, V189, P1407, DOI 10.1128/JB.01036-06; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jungblut PR, 2000, MOL MICROBIOL, V36, P710, DOI 10.1046/j.1365-2958.2000.01896.x; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Miyoshi-Akiyama T, 2006, J INFECT DIS, V193, P1677, DOI 10.1086/504263; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Steiner K, 2002, INFECT IMMUN, V70, P3627, DOI 10.1128/IAI.70.7.3627-3636.2002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tadesse S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-105; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; ULLMAN RF, 1988, HEART LUNG, V17, P209; Waterhouse JC, 2007, ORAL MICROBIOL IMMUN, V22, P103, DOI 10.1111/j.1399-302X.2007.00330.x; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.0.28647-0	62	33	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20127	10.1371/journal.pone.0020127	http://dx.doi.org/10.1371/journal.pone.0020127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655290	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600022
J	Hauser, A; Mugenyi, K; Kabasinguzi, R; Kuecherer, C; Harms, G; Kunz, A				Hauser, Andrea; Mugenyi, Kizito; Kabasinguzi, Rose; Kuecherer, Claudia; Harms, Gundel; Kunz, Andrea			Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan Women after Nevirapine Single-Dose Prophylaxis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; PREVENTION; PREGNANCY; INTRAPARTUM; ZIDOVUDINE; MUTATIONS; K103N; POSTPARTUM; HIVNET-012	Background: Nevirapine (NVP) single-dose is still a widely used antiretroviral prophylaxis for the prevention of vertical HIV-1 transmission in resource-limited settings. However, the main disadvantage of the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) NVP is the rapid selection of NVP-resistant virus with negative implications for subsequent NNRTI-based long-term antiretroviral therapy (ART). Here, we analysed the emergence of drug-resistant HIV-1 including minor variants in the early phase after NVP single-dose prophylaxis and the persistence of drug-resistant virus over time. Methods and Findings: NVP-resistant HIV-1 harbouring the K103N and/or Y181C resistance mutations in the HIV-1 reverse transcriptase gene was measured from 1 week up to 18 months after NVP single-dose prophylaxis in 29 Ugandan women using allele-specific PCR assays capable of detecting drug-resistant variants representing less than 1% of the whole viral population. In total, drug-resistant HIV-1 was identified in 18/29 (62%) women; rates increased from 18% to 38% and 44% at week 1, 2, 6, respectively, and decreased to 18%, 25%, 13% and 4% at month 3, 6, 12 and 18, respectively. The proportion of NVP-resistant virus of the total viral population was significantly higher in women infected with subtype D (median 40.5%) as compared to subtype A (median 1.3%; p = 0.032, Mann-Whitney U test). 33% of resistant virus was not detectable at week 2 but was for the first time measurable 6-12 weeks after NVP single-dose prophylaxis. Three (10%) women harboured resistant virus in proportions >10% still at month 6. Conclusions: Current WHO guidelines recommend an additional postnatal intake of AZT and 3TC for one week to avoid NVP resistance formation. Our findings indicate that a 1-week medication might be too short to impede the emergence of NVP resistance in a substantial proportion of women. Furthermore, subsequent NNRTI-based ART should not be started earlier than 12 months after NVP single-dose prophylaxis.	[Hauser, Andrea; Harms, Gundel; Kunz, Andrea] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Hauser, Andrea; Kuecherer, Claudia] Robert Koch Inst, Project HIV Variabil & Mol Epidemiol, D-1000 Berlin, Germany; [Mugenyi, Kizito; Kabasinguzi, Rose] German Tech Cooperat PMTCT Project Western Ugand, Minist Hlth, Ft Portal, Uganda	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hauser, A (corresponding author), Charite, Inst Trop Med & Int Hlth, Berlin, Germany.	andrea-ursula.kunz@charite.de			German Ministry for Economic Cooperation and Development [PN 01.2029.5]; H.W. & J. Hector Stiftung, Germany	German Ministry for Economic Cooperation and Development; H.W. & J. Hector Stiftung, Germany	This work was supported by the German Ministry for Economic Cooperation and Development through the Project PN 01.2029.5 (Prevention of Mother-to Child Transmission of HIV) and by a grant of the H.W. & J. Hector Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V40, P24, DOI 10.1097/01.qai.0000174656.71276.d6; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Farr SL, 2010, JAIDS-J ACQ IMM DEF, V54, P515, DOI 10.1097/QAI.0b013e3181e3a70e; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kunz A, 2009, J ANTIMICROB CHEMOTH, V63, P170, DOI 10.1093/jac/dkn441; Lallemant M, 2010, CLIN INFECT DIS, V50, P898, DOI 10.1086/650745; Lehman DA, 2009, JAIDS-J ACQ IMM DEF, V51, P522, DOI 10.1097/QAI.0b013e3181aa8a22; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Paredes R, 2010, AIDS, V24, P45, DOI 10.1097/QAD.0b013e32832e5303; Pilger D, 2011, ANTIVIR THER, V16, P109, DOI 10.3851/IMP1698; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Townsend CL, 2010, ANTIVIR THER, V15, P775, DOI 10.3851/IMP1613; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759; World Health Organization, 2021, ANT DRUGS TREAT PREG	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20357	10.1371/journal.pone.0020357	http://dx.doi.org/10.1371/journal.pone.0020357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655245	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600052
J	Hygum, K; Lildballe, DL; Greibe, EH; Morkbak, AL; Poulsen, SS; Sorensen, BS; Petersen, TE; Nexo, E				Hygum, Katrine; Lildballe, Dorte L.; Greibe, Eva H.; Morkbak, Anne L.; Poulsen, Steen S.; Sorensen, Boe S.; Petersen, Torben E.; Nexo, Ebba			Mouse Transcobalamin Has Features Resembling both Human Transcobalamin and Haptocorrin	PLOS ONE			English	Article							COBALAMIN-BINDING-PROTEINS; INTRINSIC-FACTOR; PURIFICATION; SERUM; LOCALIZATION; PRINCIPLE; ANALOGS; PLASMA; CELLS; GENE	In humans, the cobalamin (Cbl)-binding protein transcobalamin (TC) transports Cbl from the intestine and into all the cells of the body, whereas the glycoprotein haptocorrin (HC), which is present in both blood and exocrine secretions, is able to bind also corrinoids other than Cbl. The aim of this study is to explore the expression of the Cbl-binding protein HC as well as TC in mice. BLAST analysis showed no homologous gene coding for HC in mice. Submaxillary glands and serum displayed one protein capable of binding Cbl. This Cbl-binding protein was purified from 300 submaxillary glands by affinity chromatography. Subsequent sequencing identified the protein as TC. Further characterization in terms of glycosylation status and binding specificity to the Cbl-analogue cobinamide revealed that mouse TC does not bind Concanavalin A sepharose (like human TC), but is capable of binding cobinamide (like human HC). Antibodies raised against mouse TC identified the protein in secretory cells of the submaxillary gland and in the ducts of the mammary gland, i.e. at locations where HC is also found in humans. Analysis of the TC-mRNA level showed a high TC transcript level in these glands and also in the kidney. By precipitation to insolubilised antibodies against mouse TC, we also showed that >97% of the Cbl-binding capacity and >98% of the Cbl were precipitated in serum. This indicates that TC is the only Cbl-binding protein in the mouse circulation. Our data show that TC but not HC is present in the mouse. Mouse TC is observed in tissues where humans express TC and/or HC. Mouse TC has features in common with both human TC and HC. Our results suggest that the Cbl-binding proteins present in the circulation and exocrine glands may vary amongst species.	[Hygum, Katrine; Lildballe, Dorte L.; Greibe, Eva H.; Morkbak, Anne L.; Sorensen, Boe S.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Poulsen, Steen S.] Univ Copenhagen, Panum Inst, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Petersen, Torben E.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University	Hygum, K (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	e.nexo@dadlnet.dk	Greibe, Eva/E-3375-2018	Greibe, Eva/0000-0002-0417-1195; Poulsen, Steen Seier/0000-0003-4419-4911; Nexo, Ebba/0000-0001-9406-9081; Sorensen, Boe/0000-0002-9472-8099	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 1996, BBA-PROTEIN STRUCT M, V1292, P113, DOI 10.1016/0167-4838(95)00173-5; FRATERSCHRODER M, 1985, BIOCHEM GENET, V23, P139, DOI 10.1007/BF00499119; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; HANSEN M, 1992, SCAND J CLIN LAB INV, V52, P647, DOI 10.3109/00365519209115508; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; JOHNSTON J, 1992, GENOMICS, V12, P459, DOI 10.1016/0888-7543(92)90435-U; KIDRONI G, 1969, BIOCHIM BIOPHYS ACTA, V188, P113, DOI 10.1016/0005-2795(69)90050-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Moestrup SK, 2001, ANNU REV NUTR, V21, P407, DOI 10.1146/annurev.nutr.21.1.407; Moestrup SK, 2006, CURR OPIN HEMATOL, V13, P119, DOI 10.1097/01.moh.0000219654.65538.5b; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1985, BIOCHIM BIOPHYS ACTA, V838, P264, DOI 10.1016/0304-4165(85)90088-1; NEXO E, 1975, SCAND J HAEMATOL, V14, P320; NEXO E, 1981, BIOCHIM BIOPHYS ACTA, V667, P370, DOI 10.1016/0005-2795(81)90204-X; Nielsen R, 2001, J AM SOC NEPHROL, V12, P1099, DOI 10.1681/ASN.V1261099; PETERSEN EA, 1960, PLASMA PROTEIN; RAMANUJAM KS, 1991, BIOCHEM BIOPH RES CO, V179, P543, DOI 10.1016/0006-291X(91)91405-2; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394	22	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20638	10.1371/journal.pone.0020638	http://dx.doi.org/10.1371/journal.pone.0020638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655200	gold, Green Published, Green Submitted			2022-12-27	WOS:000291097600113
J	Indic, P; Salvatore, P; Maggini, C; Ghidini, S; Ferraro, G; Baldessarini, RJ; Murray, G				Indic, Premananda; Salvatore, Paola; Maggini, Carlo; Ghidini, Stefano; Ferraro, Gabriella; Baldessarini, Ross J.; Murray, Greg			Scaling Behavior of Human Locomotor Activity Amplitude: Association with Bipolar Disorder	PLOS ONE			English	Article							TIME-SERIES; DYNAMICS; FLUCTUATIONS; INVARIANCE; UNIPOLAR; DISEASE	Scale invariance is a feature of complex biological systems, and abnormality of multi-scale behaviour may serve as an indicator of pathology. The hypothalamic suprachiasmatic nucleus (SCN) is a major node in central neural networks responsible for regulating multi-scale behaviour in measures of human locomotor activity. SCN also is implicated in the pathophysiology of bipolar disorder (BD) or manic-depressive illness, a severe, episodic disorder of mood, cognition and behaviour. Here, we investigated scaling behaviour in actigraphically recorded human motility data for potential indicators of BD, particularly its manic phase. A proposed index of scaling behaviour (Vulnerability Index [VI]) derived from such data distinguished between: [i] healthy subjects at high versus low risk of mood disorders; [ii] currently clinically stable BD patients versus matched controls; and [iii] among clinical states in BD patients.	[Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Salvatore, Paola; Baldessarini, Ross J.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Salvatore, Paola; Baldessarini, Ross J.] McLean Hosp, Int Consortium Psychot & Bipolar Disorders Res, Belmont, MA 02178 USA; [Salvatore, Paola; Maggini, Carlo; Ghidini, Stefano; Ferraro, Gabriella] Univ Parma, Dept Neurosci, Sect Psychiat, I-43100 Parma, Italy; [Ghidini, Stefano] Forens Hosp, Mental Hlth Dept Reggio Emilia, Reggio Emilia, Italy; [Murray, Greg] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; University of Parma; Swinburne University of Technology	Indic, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	Premananda.Indic@umassmed.edu	Murray, Greg/N-8933-2017	Murray, Greg/0000-0001-7208-5603	Swinburne University of Technology; Beyond Blue: National Depression Initiative; Bruce J Anderson Foundation; McLean Private Donors Bipolar Disorder Research Fund	Swinburne University of Technology; Beyond Blue: National Depression Initiative; Bruce J Anderson Foundation; McLean Private Donors Bipolar Disorder Research Fund	This research was supported, in part, by grants from Swinburne University of Technology and Beyond Blue: National Depression Initiative (to GM), a grant from the Bruce J Anderson Foundation and by the McLean Private Donors Bipolar Disorder Research Fund (to RJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BARBASI AL, 1995, FRACTAL CONCEPTS SUR; Carmona RA, 1999, IEEE T SIGNAL PROCES, V47, P480, DOI 10.1109/78.740131; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; DEPUE RA, 1989, J ABNORM PSYCHOL, V98, P117, DOI 10.1037/0021-843X.98.2.117; Etchegaray JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010303; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Henry BL, 2010, NEUROSCI BIOBEHAV R, V34, P1296, DOI 10.1016/j.neubiorev.2010.04.002; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Indic P, 2005, CHRONOBIOL INT, V22, P613, DOI 10.1080/07420520500180371; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Kantz H., 2004, NONLINEAR TIME SERIE; Klosterkotter J, 1997, NEUROL PSYCHIAT BR, V5, P137; Kodba S, 2005, EUR J PHYS, V26, P205, DOI 10.1088/0143-0807/26/1/021; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; MURRAY G, 2010, PRACTICAL MANAGEMENT, P152; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Papoulis Athanasios, PROBABILITY RANDOM V; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perc M, 2005, EUR J PHYS, V26, P757, DOI 10.1088/0143-0807/26/5/008; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Price TS, 2008, BIOINFORMATICS, V24, P2794, DOI 10.1093/bioinformatics/btn521; PRIESTLEY MB, SPECTRAL ANAL TIME S; Reichart CG, 2005, J AFFECT DISORDERS, V89, P147, DOI 10.1016/j.jad.2005.09.007; ROYBAL K, 2007, P NAT AC SCI US; Stauffer D., 1996, NEWTON MANDELBROT PR; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Williams J, 1988, STRUCTURED INTERVIEW; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	38	32	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20650	10.1371/journal.pone.0020650	http://dx.doi.org/10.1371/journal.pone.0020650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655197	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600116
J	Lages, E; Guttin, A; El Atifi, M; Ramus, C; Ipas, H; Dupre, I; Rolland, D; Salon, C; Godfraind, C; deFraipont, F; Dhobb, M; Pelletier, L; Wion, D; Gay, E; Berger, F; Issartel, JP				Lages, Elodie; Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Ipas, Helene; Dupre, Isabelle; Rolland, Delphine; Salon, Caroline; Godfraind, Catherine; deFraipont, Florence; Dhobb, Mehdi; Pelletier, Laurent; Wion, Didier; Gay, Emmanuel; Berger, Francois; Issartel, Jean-Paul			MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes	PLOS ONE			English	Article							EXPRESSION; GLIOBLASTOMA; SURVIVAL; IDENTIFICATION; MIR-124; TISSUE; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; ANGIOGENESIS	Gliomas such as oligodendrogliomas (ODG) and glioblastomas (GBM) are brain tumours with different clinical outcomes. Histology-based classification of these tumour types is often difficult. Therefore the first aim of this study was to gain microRNA data that can be used as reliable signatures of oligodendrogliomas and glioblastomas. We investigated the levels of 282 microRNAs using membrane-array hybridisation and real-time PCR in ODG, GBM and control brain tissues. In comparison to these control tissues, 26 deregulated microRNAs were identified in tumours and the tissue levels of seven microRNAs (miR-21, miR-128, miR-132, miR-134, miR-155, miR-210 and miR-409-5p) appropriately discriminated oligodendrogliomas from glioblastomas. Genomic, epigenomic and host gene expression studies were conducted to investigate the mechanisms involved in these deregulations. Another aim of this study was to better understand glioma physiopathology looking for targets of deregulated microRNAs. We discovered that some targets of these microRNAs such as STAT3, PTBP1 or SIRT1 are differentially expressed in gliomas consistent with deregulation of microRNA expression. Moreover, MDH1, the target of several deregulated microRNAs, is repressed in glioblastomas, making an intramitochondrial-NAD reduction mediated by the mitochondrial aspartate-malate shuttle unlikely. Understanding the connections between microRNAs and bioenergetic pathways in gliomas may lead to identification of novel therapeutic targets.	[Lages, Elodie; Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Ipas, Helene; Dupre, Isabelle; Rolland, Delphine; Dhobb, Mehdi; Pelletier, Laurent; Wion, Didier; Berger, Francois; Issartel, Jean-Paul] INSERM, Nanomed & Brain Team7, U836, Grenoble, France; [Lages, Elodie; Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Ipas, Helene; Dupre, Isabelle; Rolland, Delphine; Dhobb, Mehdi; Pelletier, Laurent; Wion, Didier; Berger, Francois; Issartel, Jean-Paul] Univ Grenoble 1, Inst Neurosci, Grenoble, France; [Rolland, Delphine] CHU Grenoble, Dept Hematol Oncogenet & Immunol, Lab Hematol Cellulaire & Mol, F-38043 Grenoble, France; [Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Dupre, Isabelle; Rolland, Delphine; Berger, Francois; Issartel, Jean-Paul] Grenoble Inst Neurosci, Grenoble, France; [Salon, Caroline] CHU Grenoble, Dept Pathol, F-38043 Grenoble, France; [Godfraind, Catherine] Catholic Univ Louvain, Pathol Lab, Clin Univ St Luc, B-1200 Brussels, Belgium; [deFraipont, Florence] Univ Grenoble 1, Unite Med Biochim Canc & Biotherapies, Dept Biochim Toxicol & Pharmacol, Ctr Hos Univ,INSERM U823, Grenoble, France; [Gay, Emmanuel] CHU Grenoble, Dept Neurosurg, F-38043 Grenoble, France; [Issartel, Jean-Paul] CNRS, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Lages, E (corresponding author), INSERM, Nanomed & Brain Team7, U836, Grenoble, France.	jean-paul.issartel@ujf-grenoble.fr	Guttin, Audrey/K-8577-2015; de Fraipont, Florence/P-4936-2014; ISSARTEL, Jean-Paul/B-8727-2014; Wion, Didier/M-7045-2018; Rolland, Delphine/C-3101-2011; Rolland, Delphine/ABG-2497-2021	de Fraipont, Florence/0000-0001-9594-6584; Wion, Didier/0000-0001-7144-6470; Rolland, Delphine/0000-0002-7801-6534	Ligue contre le Cancer (comite Isere and Ligue Nationale); Region Rhone-Alpes; Lyon; Auvergne; Rhone-Alpes Canceropole; Institut National du Cancer	Ligue contre le Cancer (comite Isere and Ligue Nationale); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Lyon(Region Auvergne-Rhone-Alpes); Auvergne; Rhone-Alpes Canceropole; Institut National du Cancer(Institut National du Cancer (INCA) France)	This study was supported by grants from the Ligue contre le Cancer (comite Isere and Ligue Nationale) (http://www.ligue-cancer.net/); the Region Rhone-Alpes (http://www.rhonealpes.fr/); the Lyon, Auvergne, Rhone-Alpes Canceropole (http://www.canceropole-clara.com/) and the Institut National du Cancer (http://www.e-cancer.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BELFIORE F, 1995, BIOCHEM MOL MED, V54, P19, DOI 10.1006/bmme.1995.1003; Birner P, 2010, J NEURO-ONCOL, V100, P339, DOI 10.1007/s11060-010-0195-8; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chan SF, 2009, HEALTH ISS CHIN CONT, V2, P1; Chen FX, 2010, J MOL NEUROSCI, V40, P353, DOI 10.1007/s12031-009-9323-3; Cheung HC, 2009, BRAIN, V132, P2277, DOI 10.1093/brain/awp153; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Le QT, 2007, INT J RADIAT ONCOL, V69, P167, DOI 10.1016/j.ijrobp.2007.01.071; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Moser JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013445; Natte R, 2005, BRAIN PATHOL, V15, P192; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Turner JD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09207; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yokota Takanori, 2009, Brain and Nerve (Tokyo), V61, P167; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	67	96	103	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20600	10.1371/journal.pone.0020600	http://dx.doi.org/10.1371/journal.pone.0020600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655185	Green Published, gold			2022-12-27	WOS:000291097600107
J	Yang, H; Zhao, X; Xu, YF; Wang, LL; He, QY; Lundberg, YW				Yang, Hua; Zhao, Xing; Xu, Yinfang; Wang, Lili; He, Quanyuan; Lundberg, Yunxia Wang			Matrix Recruitment and Calcium Sequestration for Spatial Specific Otoconia Development	PLOS ONE			English	Article							X COLLAGEN; INNER-EAR; CARTILAGE MATRIX; SULFATE PROTEOGLYCAN; BINDING-PROPERTIES; PROTEIN SPARC; OSTEOPONTIN; OTOLITH; BONE; PARTICIPATION	Otoconia are bio-crystals anchored to the macular sensory epithelium of the utricle and saccule in the inner ear for motion sensing and bodily balance. Otoconia dislocation, degeneration and ectopic calcification can have detrimental effects on balance and vertigo/dizziness, yet the mechanism underlying otoconia formation is not fully understood. In this study, we show that selected matrix components are recruited to form the crystal matrix and sequester Ca2+ for spatial specific formation of otoconia. Specifically, otoconin-90 (Oc90) binds otolin through both domains (TH and C1q) of otolin, but full-length otolin shows the strongest interaction. These proteins have much higher expression levels in the utricle and saccule than other inner ear epithelial tissues in mice. In vivo, the presence of Oc90 in wildtype (wt) mice leads to an enrichment of Ca2+ in the luminal matrices of the utricle and saccule, whereas absence of Oc90 in the null mice leads to drastically reduced matrix-Ca2+. In vitro, either Oc90 or otolin can increase the propensity of extracellular matrix to calcify in cell culture, and coexpression has a synergistic effect on calcification. Molecular modeling and sequence analysis predict structural features that may underlie the interaction and Ca2+-sequestering ability of these proteins. Together, the data provide a mechanism for the otoconial matrix assembly and the role of this matrix in accumulating micro-environmental Ca2+ for efficient CaCO3 crystallization, thus uncover a critical process governing spatial specific otoconia formation.	[Yang, Hua; Zhao, Xing; Xu, Yinfang; Wang, Lili; Lundberg, Yunxia Wang] Boys Town Natl Res Hosp, Vestibular Neurogenet Lab, Omaha, NE 68131 USA; [He, Quanyuan] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Boys Town National Research Hospital; Baylor College of Medicine	Yang, H (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	yesha.lundberg@boystown.org			National Institute on Deafness and Other Communication Disorders [RO1 DC008603, DC008603-S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008603] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by grants from the National Institute on Deafness and Other Communication Disorders (RO1 DC008603 and DC008603-S1 to Y.W.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; BORDIN S, 1990, J IMMUNOL, V145, P2520; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; CARLSTROM DD, 1963, BIOL BULL, V125, P441, DOI 10.2307/1539358; CHEN Q, 1992, J CELL BIOL, V117, P687, DOI 10.1083/jcb.117.3.687; CHEN Y, 1992, J BIOL CHEM, V267, P24871; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; ENDO S, 1991, ACTA OTO-LARYNGOL, P116; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; GEBB C, 1986, J BIOL CHEM, V261, P6698; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; ITO M, 1994, HISTOCHEM J, V26, P437, DOI 10.1007/BF00160057; KIRSCH T, 1991, FEBS LETT, V294, P149, DOI 10.1016/0014-5793(91)81363-D; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; Laboux O, 2003, J HISTOCHEM CYTOCHEM, V51, P61, DOI 10.1177/002215540305100108; Lu WF, 2010, HEARING RES, V268, P172, DOI 10.1016/j.heares.2010.05.019; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Murayama E, 2004, HISTOCHEM CELL BIOL, V121, P155, DOI 10.1007/s00418-003-0605-5; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; OBRINK B, 1971, BIOCHEM J, V121, P227; Petko JA, 2008, DEV NEUROBIOL, V68, P209, DOI 10.1002/dneu.20587; Pisam M, 2002, CELL TISSUE RES, V310, P163, DOI 10.1007/s00441-002-0622-z; Pote K G, 1993, Physiologist, V36, pS38; POTE KG, 1991, COMP BIOCHEM PHYS B, V98, P287, DOI 10.1016/0305-0491(91)90181-C; RANACHAVEZ VE, 2001, J HISTOCHEM CYTOCHEM, V49, P1099; REICHENBERGER E, 1991, DEV BIOL, V148, P562, DOI 10.1016/0012-1606(91)90274-7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakagami Masafumi, 2000, Medical Electron Microscopy, V33, P3, DOI 10.1007/s007950000001; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1989, CONNECT TISSUE RES, V20, P215, DOI 10.3109/03008208909023890; SCHMID TM, 1984, BIOCHEMISTRY-US, V23, P553, DOI 10.1021/bi00298a024; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x; Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x; SUGA H, 1993, EUR J BIOCHEM, V218, P807, DOI 10.1111/j.1432-1033.1993.tb18435.x; Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004; TAKEMURA T, 1994, HEARING RES, V79, P99, DOI 10.1016/0378-5955(94)90131-7; Thalmann I, 2006, ELECTROPHORESIS, V27, P1598, DOI 10.1002/elps.200500768; Thalmann R, 2011, ACTA OTO-LARYNGOL, V131, P382, DOI 10.3109/00016489.2010.548401; Uma L, 1996, BBA-PROTEIN STRUCT M, V1294, P8, DOI 10.1016/0167-4838(95)00255-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Xu YF, 2010, DEV DYNAM, V239, P2659, DOI 10.1002/dvdy.22405; Zhao X, 2008, JARO-J ASSOC RES OTO, V9, P191, DOI 10.1007/s10162-008-0117-z; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	59	38	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20498	10.1371/journal.pone.0020498	http://dx.doi.org/10.1371/journal.pone.0020498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655225	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600081
J	Fluck, CE; Pandey, AV; Dick, B; Camats, N; Fernandez-Cancio, M; Clemente, M; Gussinye, M; Carrascosa, A; Mullis, PE; Audi, L				Flueck, Christa E.; Pandey, Amit V.; Dick, Bernhard; Camats, Nuria; Fernandez-Cancio, Monica; Clemente, Maria; Gussinye, Miquel; Carrascosa, Antonio; Mullis, Primus E.; Audi, Laura			Characterization of Novel StAR (Steroidogenic Acute Regulatory Protein) Mutations Causing Non-Classic Lipoid Adrenal Hyperplasia	PLOS ONE			English	Article							FAMILIAL GLUCOCORTICOID DEFICIENCY; ACTH RECEPTOR; GENE; MODELS; DOMAIN; TYPE-2; MRAP	Context: Steroidogenic acute regulatory protein (StAR) is crucial for transport of cholesterol to mitochondria where biosynthesis of steroids is initiated. Loss of StAR function causes lipoid congenital adrenal hyperplasia (LCAH). Objective: StAR gene mutations causing partial loss of function manifest atypical and may be mistaken as familial glucocorticoid deficiency. Only a few mutations have been reported. Design: To report clinical, biochemical, genetic, protein structure and functional data on two novel StAR mutations, and to compare them with published literature. Setting: Collaboration between the University Children's Hospital Bern, Switzerland, and the CIBERER, Hospital Vall d'Hebron, Autonomous University, Barcelona, Spain. Patients: Two subjects of a non-consanguineous Caucasian family were studied. The 46,XX phenotypic normal female was diagnosed with adrenal insufficiency at the age of 10 months, had normal pubertal development and still has no signs of hypergonodatropic hypogonadism at 32 years of age. Her 46,XY brother was born with normal male external genitalia and was diagnosed with adrenal insufficiency at 14 months. Puberty was normal and no signs of hypergonadotropic hypogonadism are present at 29 years of age. Results: StAR gene analysis revealed two novel compound heterozygote mutations T44HfsX3 and G221S. T44HfsX3 is a loss-of-function StAR mutation. G221S retains partial activity (similar to 30%) and is therefore responsible for a milder, non-classic phenotype. G221S is located in the cholesterol binding pocket and seems to alter binding/release of cholesterol. Conclusions: StAR mutations located in the cholesterol binding pocket (V187M, R188C, R192C, G221D/S) seem to cause non-classic lipoid CAH. Accuracy of genotype-phenotype prediction by in vitro testing may vary with the assays employed.	[Flueck, Christa E.; Pandey, Amit V.; Mullis, Primus E.] Univ Childrens Hosp Bern, Bern, Switzerland; [Dick, Bernhard] Univ Bern, Inselspital, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Camats, Nuria; Fernandez-Cancio, Monica; Clemente, Maria; Gussinye, Miquel; Carrascosa, Antonio; Audi, Laura] Autonomous Univ Barcelona, Ctr Biomed Res Rare Dis CIBERER, Hosp Vall Hebron, Inst Recerca,Dept Pediat, Barcelona, Spain	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Fluck, CE (corresponding author), Univ Childrens Hosp Bern, Bern, Switzerland.	christa.flueck@dkf.unibe.ch	Audiparera, Laura/H-7291-2012; Audi, Laura/H-7134-2012; Pandey, Amit V/AAO-6442-2020; Camats, Nuria/K-8326-2017; Pandey, Amit V/A-7223-2008; CLEMENTE, MARIA/AAB-3567-2019	Audi, Laura/0000-0002-5031-4097; Pandey, Amit V/0000-0001-8331-5902; Camats, Nuria/0000-0002-4863-8201; Pandey, Amit V/0000-0001-8331-5902; Flueck, Christa/0000-0002-4568-5504; Fernandez Cancio, Monica/0000-0003-1872-3488	Swiss National Science Foundation [31003A-130710]; Spanish CIBERER [INTRA/08/712,1]; AGAUR [2009SGR-31]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish CIBERER; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by grants of the Swiss National Science Foundation (31003A-130710) to CEF and the Spanish CIBERER (INTRA/08/712,1) and AGAUR (2009SGR-31) to AC and LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BY, 2006, J CLIN ENDOCR METAB, V91, P4781, DOI 10.1210/jc.2006-1565; Baker BY, 2005, J BIOL CHEM, V280, P41753, DOI 10.1074/jbc.M510241200; Bose HS, 1997, J CLIN ENDOCR METAB, V82, P1511, DOI 10.1210/jc.82.5.1511; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chan LF, 2008, HORM RES, V69, P75, DOI 10.1159/000111810; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cooray Sadani N., 2008, V13, P99, DOI 10.1159/000134828; Fluck CE, 2005, J CLIN ENDOCR METAB, V90, P5304, DOI 10.1210/jc.205-0847; Genin E, 2002, HUM GENET, V111, P428, DOI 10.1007/s00439-002-0806-3; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; Hirsch A, 2011, J CLIN ENDOCR METAB, V96, pE65, DOI 10.1210/jc.2010-1056; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Joosten RP, 2007, SCIENCE, V317, P195, DOI 10.1126/science.317.5835.195; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; King RD, 1997, COMPUT APPL BIOSCI, V13, P473; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Liu HY, 2001, PROTEINS, V44, P484, DOI 10.1002/prot.1114; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mathieu AP, 2002, J MOL ENDOCRINOL, V29, P327, DOI 10.1677/jme.0.0290327; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Metherell LA, 2009, J CLIN ENDOCR METAB, V94, P3865, DOI 10.1210/jc.2009-0467; Modan-Moses D, 2006, J CLIN ENDOCR METAB, V91, P3713, DOI 10.1210/jc.2006-0687; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Nakae J, 1997, HUM MOL GENET, V6, P571, DOI 10.1093/hmg/6.4.571; Naville D, 1997, BIOCHEM BIOPH RES CO, V230, P7, DOI 10.1006/bbrc.1996.5911; PRADER A, 1955, Helv Paediatr Acta, V10, P397; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Sahakitrungruang T, 2010, J CLIN ENDOCR METAB, V95, P3352, DOI 10.1210/jc.2010-0437; Schweizer RAS, 2004, J BIOL CHEM, V279, P18415, DOI 10.1074/jbc.M313615200; Tanae A, 2000, ENDOCR J, V47, P629, DOI 10.1507/endocrj.47.629; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yaworsky DC, 2005, J BIOL CHEM, V280, P2045, DOI 10.1074/jbc.M410937200	36	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20178	10.1371/journal.pone.0020178	http://dx.doi.org/10.1371/journal.pone.0020178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647419	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500038
J	Johnson, L; Llewellyn, CH; van Jaarsveld, CHM; Cole, TJ; Wardle, J				Johnson, Laura; Llewellyn, Clare H.; van Jaarsveld, Cornelia H. M.; Cole, Tim J.; Wardle, Jane			Genetic and Environmental Influences on Infant Growth: Prospective Analysis of the Gemini Twin Birth Cohort	PLOS ONE			English	Article							BODY-MASS-INDEX; EARLY-CHILDHOOD; WEIGHT; HEIGHT; AGE; HERITABILITY; TRAJECTORIES; ASSOCIATION; CHILDREN; MENARCHE	Objective: Infancy is a critical period during which rapid growth potentially programs future disease risk. Identifying the modifiable determinants of growth is therefore important. To capture the complexity of infant growth, we modeled growth trajectories from birth to six months in order to compare the genetic and environmental influences on growth trajectory parameters with single time-point measures at birth, three and six months of age. Methods: Data were from Gemini, a population sample of 2402 UK families with twins. An average 10 weight measurements per child made by health professionals were available over the first six months. Weights at birth, three and six months were identified. Longitudinal growth trajectories were modeled using SITAR utilizing all available weight measures for each child. SITAR generates three parameters: size (characterizing mean weight throughout infancy), tempo (indicating age at peak weight velocity (PWV)), and velocity (reflecting the size of PWV). Genetic and environmental influences were estimated using quantitative genetic analysis. Results: In line with previous studies, heritability of weight at birth and three months was low (38%), but it was higher at six months (62%). Heritability of the growth trajectory parameters was high for size (69%) and velocity (57%), but low (35%) for tempo. Common environmental influences predominated for tempo (42%). Conclusion: Modeled growth parameters using SITAR indicated that size and velocity were primarily under genetic influence but tempo was predominantly environmentally determined. These results emphasize the importance of identifying specific modifiable environmental determinants of the timing of peak infant growth.	[Johnson, Laura; Llewellyn, Clare H.; van Jaarsveld, Cornelia H. M.; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, London, England; [Johnson, Laura] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Cole, Tim J.] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England	Cancer Research UK; University of London; University College London; University of Cambridge; University of London; University College London	Johnson, L (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, London, England.	j.wardle@ucl.ac.uk	Cole, Tim J/B-7883-2008; Van Jaarsveld, Ellen CHM/A-4632-2016; Johnson, Laura/C-2700-2008	Cole, Tim J/0000-0001-5711-8200; Van Jaarsveld, Ellen CHM/0000-0002-4269-0041; Llewellyn, Clare/0000-0002-0066-2827; Johnson, Laura/0000-0001-8985-3154	Cancer Research UK [C1418/A7974]; Medical Research Council [G0700961]; MRC [G0700961] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Gemini is funded by a grant to JW from Cancer Research UK (C1418/A7974). TJC is funded by a grant from the Medical Research Council (G0700961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAC, 2010, REPR ALSPAC COH; Beardsall K, 2009, J CLIN ENDOCR METAB, V94, P3708, DOI 10.1210/jc.2009-0757; Beath KJ, 2007, STAT MED, V26, P2547, DOI 10.1002/sim.2718; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P953, DOI 10.1079/PHN2005790; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Cole T. J., 2009, SOFTWARE LMS METHOD; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; COLE TJ, 2010, INT J EPIDEMIOL; Count E. W., 1943, HUMAN BIOL, V15, P1; Demerath EW, 2007, AM J HUM BIOL, V19, P692, DOI 10.1002/ajhb.20660; Drewett RF, 2003, APPETITE, V40, P55, DOI 10.1016/S0195-6663(02)00144-7; Dubois L, 2007, TWIN RES HUM GENET, V10, P479, DOI 10.1375/twin.10.3.479; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gielen M, 2008, BEHAV GENET, V38, P44, DOI 10.1007/s10519-007-9170-3; Gillman MW, 2008, AM J CLIN NUTR, V87, P1587, DOI 10.1093/ajcn/87.6.1587; Howe LD, 2009, ARCH DIS CHILD, V94, P950, DOI 10.1136/adc.2009.162552; JENSS RACHEL M., 1937, HUMAN BIOL, V9, P556; KARLBERG J, 1987, ACTA PAEDIATR SCAND, V76, P478, DOI 10.1111/j.1651-2227.1987.tb10503.x; Larnkjaer A, 2010, AM J CLIN NUTR, V91, P1675, DOI 10.3945/ajcn.2009.27956; LEVINE RS, 1987, AM J EPIDEMIOL, V126, P929, DOI 10.1093/oxfordjournals.aje.a114730; Livshits G, 2000, ANN HUM BIOL, V27, P299; Loos RJF, 2005, PAEDIATR PERINAT EP, V19, P15, DOI 10.1111/j.1365-3016.2005.00611.x; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Ong KK, 2007, PLOS MED, V4, P737, DOI 10.1371/journal.pmed.0040132; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Petry CJ, 2010, HORM RES PAEDIAT, V73, P275, DOI 10.1159/000284392; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Pietilainen KH, 2002, OBES RES, V10, P875, DOI 10.1038/oby.2002.120; Pinheiro J., 2019, NLME LINEAR NONLINEA; PLEWIS I, 2007, J SOCIAL RES METHODO, V10, P325; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; R Core Team, 2020, R LANG ENV STAT COMP; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Silva ID, 2002, INT J EPIDEMIOL, V31, P405, DOI 10.1093/intjepid/31.2.405; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; TSE WY, 1989, ACTA PAEDIATR SCAND, P38; TZOULAKI I, 2010, AM J EPIDEMIOL, DOI DOI 10.1093/AJE/KWQ1027; van Baal C G, 1998, Twin Res, V1, P123, DOI 10.1375/twin.1.3.123; van den Berg SM, 2007, BEHAV GENET, V37, P661, DOI 10.1007/s10519-007-9161-4; van Dommelen P, 2004, TWIN RES, V7, P607, DOI 10.1375/1369052042663805; van Dommelen P, 2008, ACTA PAEDIATR, V97, P1099, DOI 10.1111/j.1651-2227.2008.00853.x; van Jaarsveld CHM, 2010, TWIN RES HUM GENET, V13, P72, DOI 10.1375/twin.13.1.72; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; VLIETINCK R, 1989, BEHAV GENET, V19, P151, DOI 10.1007/BF01065890; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748; Whitfield J B, 2001, Twin Res, V4, P365, DOI 10.1375/twin.4.5.365; Williams SM, 2009, OBESITY, V17, P335, DOI 10.1038/oby.2008.547	52	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19918	10.1371/journal.pone.0019918	http://dx.doi.org/10.1371/journal.pone.0019918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637764	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500016
J	Miyamoto, K; Togiya, K				Miyamoto, Kazuhide; Togiya, Kayo			Solution Structure of LC4 Transmembrane Segment of CCR5	PLOS ONE			English	Article							PROTEIN STRUCTURES; HIV-1; INHIBITION; NMR; RECEPTORS; PEPTIDE; CHANNEL; ENTRY	CC-chemokine receptor 5 (CCR5) is a specific co-receptor allowing the entry of human immunodeficiency virus type 1 (HIV-1). The LC4 region in CCR5 is required for HIV-1 entry into the cells. In this study, the solution structure of LC4 in SDS micelles was elucidated by using standard 1H two-dimensional NMR spectroscopy, circular dichroism, and fluorescdence quenching. The LC4 structure adopts two helical structures, whereas the C-terminal part remains unstructured. The positions in which LC4 binds to the HIV-1 inhibitory peptide LC5 were determined by docking calculations in addition to NMR data. The poses showed the importance of the hydrophobic interface of the assembled structures. The solution structure of LC4 elucidated in the present work provides a structural basis for further studies on the HIV-1 inhibitory function of the LC4 region.	[Miyamoto, Kazuhide] Himeji Dokkyo Univ, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan	Himeji Dokkyo University	Miyamoto, K (corresponding author), Himeji Dokkyo Univ, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan.	miyamoto@himeji-du.ac.jp	Miyamoto, Kazuhide/T-4933-2019					Agrawal L, 2004, BLOOD, V103, P1211, DOI 10.1182/blood-2003-08-2669; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; BODENHAUSEN G, 1984, J MAGN RESON, V58, P370, DOI 10.1016/0022-2364(84)90142-2; Chill JH, 2007, BBA-BIOMEMBRANES, V1768, P3260, DOI 10.1016/j.bbamem.2007.08.006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Imai M, 2007, BIOCHEM BIOPH RES CO, V353, P851, DOI 10.1016/j.bbrc.2006.12.084; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li M, 1998, BIOCHEMISTRY-US, V37, P7869, DOI 10.1021/bi9801053; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Miyamoto K, 2001, BIOPOLYMERS, V59, P380, DOI 10.1002/1097-0282(20011015)59:5<380::AID-BIP1035>3.3.CO;2-K; Miyamoto K, 2010, J PEPT SCI, V16, P165, DOI 10.1002/psc.1215; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Schlecht Hans P, 2008, Ther Clin Risk Manag, V4, P473; Tsibris AMN, 2007, ANNU REV MED, V58, P445, DOI 10.1146/annurev.med.58.080105.102908; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xue R, 2009, J STRUCT BIOL, V165, P27, DOI 10.1016/j.jsb.2008.09.008; YANG JT, 1986, METHOD ENZYMOL, V130, P208	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20452	10.1371/journal.pone.0020452	http://dx.doi.org/10.1371/journal.pone.0020452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647380	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500060
J	Pritzkow, S; Wagenfuhr, K; Daus, ML; Boerner, S; Lemmer, K; Thomzig, A; Mielke, M; Beekes, M				Pritzkow, Sandra; Wagenfuehr, Katja; Daus, Martin L.; Boerner, Susann; Lemmer, Karin; Thomzig, Achim; Mielke, Martin; Beekes, Michael			Quantitative Detection and Biological Propagation of Scrapie Seeding Activity In Vitro Facilitate Use of Prions as Model Pathogens for Disinfection	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; STAINLESS-STEEL WIRES; SURGICAL-INSTRUMENTS; INFECTIVITY ASSAY; PROTEIN; INACTIVATION; DECONTAMINATION; PRPSC; TRANSMISSION	Prions are pathogens with an unusually high tolerance to inactivation and constitute a complex challenge to the reprocessing of surgical instruments. On the other hand, however, they provide an informative paradigm which has been exploited successfully for the development of novel broad-range disinfectants simultaneously active also against bacteria, viruses and fungi. Here we report on the development of a methodological platform that further facilitates the use of scrapie prions as model pathogens for disinfection. We used specifically adapted serial protein misfolding cyclic amplification (PMCA) for the quantitative detection, on steel wires providing model carriers for decontamination, of 263K scrapie seeding activity converting normal protease-sensitive into abnormal protease-resistant prion protein. Reference steel wires carrying defined amounts of scrapie infectivity were used for assay calibration, while scrapie-contaminated test steel wires were subjected to fifteen different procedures for disinfection that yielded scrapie titre reductions of <= 10(1)- to >= 10(5.5)-fold. As confirmed by titration in hamsters the residual scrapie infectivity on test wires could be reliably deduced for all examined disinfection procedures, from our quantitative seeding activity assay. Furthermore, we found that scrapie seeding activity present in 263K hamster brain homogenate or multiplied by PMCA of scrapie-contaminated steel wires both triggered accumulation of protease-resistant prion protein and was further propagated in a novel cell assay for 263K scrapie prions, i.e., cerebral glial cell cultures from hamsters. The findings from our PMCA- and glial cell culture assays revealed scrapie seeding activity as a biochemically and biologically replicative principle in vitro, with the former being quantitatively linked to prion infectivity detected on steel wires in vivo. When combined, our in vitro assays provide an alternative to titrations of biological scrapie infectivity in animals that substantially facilitates the use of prions as potentially highly indicative test agents in the search for novel broad-range disinfectants.	[Pritzkow, Sandra; Wagenfuehr, Katja; Daus, Martin L.; Boerner, Susann; Lemmer, Karin; Thomzig, Achim; Beekes, Michael] Robert Koch Inst, Project Grp Immune Def & Pathogenesis, D-1000 Berlin, Germany; [Lemmer, Karin] Robert Koch Inst, Ctr Biol Secur, D-1000 Berlin, Germany; [Mielke, Martin] Robert Koch Inst, Dept Infect Dis, D-1000 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Pritzkow, S (corresponding author), Robert Koch Inst, Project Grp Immune Def & Pathogenesis, P24, D-1000 Berlin, Germany.	BeekesM@rki.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657	German Federal Ministry for Education and Research [PTJ-BIO/0312877]; German Federal Ministry for Economics and Technology [PTJ-FKZ 03VWP0054]; European Commission [SP5A-CT-2007-044438]; European Network of Excellence "NeuroPrion" [FOOD-CT-2004-506579]; Alliance BioSecure Research Foundation (France); Alberta Prion Research Institute (Canada)	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for Economics and Technology; European Commission(European CommissionEuropean Commission Joint Research Centre); European Network of Excellence "NeuroPrion"; Alliance BioSecure Research Foundation (France); Alberta Prion Research Institute (Canada)	This work was supported in part by the German Federal Ministry for Education and Research (PTJ-BIO/0312877), the German Federal Ministry for Economics and Technology (PTJ-FKZ 03VWP0054), the European Commission (SP5A-CT-2007-044438), the European Network of Excellence "NeuroPrion" (FOOD-CT-2004-506579), the Alliance BioSecure Research Foundation (France, Project "PrioGrasp"), and the Alberta Prion Research Institute (Canada, Project "Comprehensive risk assessment of CWD transmission to humans using non-human primates"). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier M, 2004, J HOSP INFECT, V57, P80, DOI 10.1016/j.jhin.2004.01.013; BEEKES M, 1995, J GEN VIROL, V76, P2567, DOI 10.1099/0022-1317-76-10-2567; Beekes Michael, 2004, V11, P117; Beekes M, 2010, J GEN VIROL, V91, P580, DOI 10.1099/vir.0.016337-0; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; Brown P, 2005, LANCET, V365, P122, DOI 10.1016/S0140-6736(05)17700-9; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; EU Directive, 2010, OFFICIAL J EUROPEAN, V276, P33; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Fichet G, 2007, J MICROBIOL METH, V70, P511, DOI 10.1016/j.mimet.2007.06.005; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lehmann S, 2009, J HOSP INFECT, V72, P342, DOI 10.1016/j.jhin.2009.03.024; Lemmer K, 2004, J GEN VIROL, V85, P3805, DOI 10.1099/vir.0.80346-0; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Lipscomb IP, 2006, J HOSP INFECT, V64, P339, DOI 10.1016/j.jhin.2006.08.007; Mahal Sukhvir P., 2008, V459, P49, DOI 10.1007/978-1-59745-234-2_4; McDonnell GE, 2007, ANTISEPSIS DISINFECT; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P2793, DOI 10.1073/pnas.90.7.2793; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Suyama K, 2007, BIOCHEM BIOPH RES CO, V356, P245, DOI 10.1016/j.bbrc.2007.02.113; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Taylor D M, 2004, Contrib Microbiol, V11, P136; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	47	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20384	10.1371/journal.pone.0020384	http://dx.doi.org/10.1371/journal.pone.0020384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647368	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500055
J	Shui, B; Wang, Q; Lee, F; Byrnes, LJ; Chudakov, DM; Lukyanov, SA; Sondermann, H; Kotlikoff, MI				Shui, Bo; Wang, Qi; Lee, Frank; Byrnes, Laura J.; Chudakov, Dmitry M.; Lukyanov, Sergey A.; Sondermann, Holger; Kotlikoff, Michael I.			Circular Permutation of Red Fluorescent Proteins	PLOS ONE			English	Article							MONOMERIC RED; INSERTION	Circular permutation of fluorescent proteins provides a substrate for the design of molecular sensors. Here we describe a systematic exploration of permutation sites for mCherry and mKate using a tandem fusion template approach. Circular permutants retaining more than 60% (mCherry) and 90% (mKate) brightness of the parent molecules are reported, as well as a quantitative evaluation of the fluorescence from neighboring mutations. Truncations of circular permutants indicated essential N- and C-terminal segments and substantial flexibility in the use of these molecules. Structural evaluation of two cp-mKate variants indicated no major conformational changes from the previously reported wild-type structure, and cis conformation of the chromophores. Four cp-mKates were identified with over 80% of native fluorescence, providing important new building blocks for sensor and complementation experiments.	[Shui, Bo; Lee, Frank; Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Wang, Qi; Byrnes, Laura J.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Chudakov, Dmitry M.; Lukyanov, Sergey A.] Russian Acad Sci, Inst Bioorgan Chem, Moscow, Russia	Cornell University; Cornell University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Shui, B (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	mik7@cornell.edu	Wang, Qi/H-9399-2012; Chudakov, Dmitriy M/G-7741-2014; Lukyanov, Sergey/F-9140-2014	Wang, Qi/0000-0002-9703-1676; Chudakov, Dmitriy M/0000-0003-0430-790X; 	National Institutes of Health [R01GM086736]; Russian Academy of Sciences; Russian Foundation for Basic Research [08-04-01702-a]; PEW; National Science Foundation [DMR-0225180]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); PEW; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R01GM086736 from the National Institutes of Health (MIK and HS), grants from the Molecular and Cell Biology Program of the Russian Academy of Sciences and the Russian Foundation for Basic Research (08-04-01702-a)(to DMC), and a PEW Scholar award in Biomedical Sciences (to HS). Structural studies were conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by award DMR-0225180 from the National Science Foundation and RR-01646 from the National Institutes of Health (to CHESS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], GUID REC FLUOR QUANT; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Carlson HJ, 2010, PROTEIN SCI, V19, P1490, DOI 10.1002/pro.428; Chiang JJH, 2006, BIOTECHNOL LETT, V28, P471, DOI 10.1007/s10529-006-0007-6; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gautam Sunita Ghimire, 2009, Front Neuroeng, V2, P14, DOI 10.3389/neuro.16.014.2009; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Li YK, 2008, PHOTOCHEM PHOTOBIOL, V84, P111, DOI 10.1111/j.1751-1097.2007.00206.x; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	25	28	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20505	10.1371/journal.pone.0020505	http://dx.doi.org/10.1371/journal.pone.0020505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647365	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500066
J	Bachmeier, B; Fichtner, I; Killian, PH; Kronski, E; Pfeffer, U; Efferth, T				Bachmeier, Beatrice; Fichtner, Iduna; Killian, Peter H.; Kronski, Emanuel; Pfeffer, Ulrich; Efferth, Thomas			Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; DENSITY-DEPENDENT REGULATION; MATRIX-METALLOPROTEINASE; TUMOR-CELLS; IN-VIVO; TIMP EXPRESSION; POOR-PROGNOSIS; TNF-ALPHA; GENE; ARTEMISININ	Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinically used as anti-malarial agent, has recently revealed remarkable anti-tumor activity offering a role as novel candidate for cancer chemotherapy. We analyzed the anti-tumor effects of artesunate in metastasizing breast carcinoma in vitro and in vivo. Unlike as expected, artesunate induced resistance in highly metastatic human breast cancer cells MDA-MB-231. Likewise acquired resistance led to abolishment of apoptosis and cytotoxicity in pre-treated MDA-MB-231 cells. In contrast, artesunate was more cytotoxic towards the less tumorigenic MDA-MB-468 cells without showing resistance. Unraveling the underlying molecular mechanisms, we found that resistance was induced due to activation of the tumor progression related transcription factors NFkB and AP-1. Thereby transcription, expression and activity of the matrix-degrading enzyme MMP-1, whose function is correlated with increased invasion and metastasis, was up-regulated upon acquisition of resistance. Additionally, activation of the apoptosis-related factor NF kappa B lead to increased expression of ant-apoptotic bcl2 and reduced expression of pro-apoptotic bax. Application of artesunate in vivo in a model of xenografted breast cancer showed, that tumors growth was not efficiently abolished as compared to the control drug doxorubicin. Taken together our in vitro and in vivo results correlate well showing for the first time that artesunate induces resistance in highly metastatic breast tumors.	[Bachmeier, Beatrice; Killian, Peter H.; Kronski, Emanuel] Univ Munich, Dept Clin Chem & Clin Biochem, Munich, Germany; [Bachmeier, Beatrice; Pfeffer, Ulrich] Adv Biotechnol Ctr, Genoa, Italy; [Fichtner, Iduna] Max Delbruck Ctr Mol Med, Dept Expt Pharmacol, Berlin, Germany; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, Mainz, Germany	University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johannes Gutenberg University of Mainz	Bachmeier, B (corresponding author), Univ Munich, Dept Clin Chem & Clin Biochem, Munich, Germany.	efferth@uni-mainz.de	Pfeffer, Ulrich/J-7064-2016	Pfeffer, Ulrich/0000-0003-0872-4671; Efferth, Thomas/0000-0002-3096-3292; Bachmeier, Beatrice/0000-0002-3592-7354				Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Bachmeier BE, 2005, THROMB HAEMOSTASIS, V93, P761, DOI 10.1160/TH04-09-0601; Bachmeier BE, 2005, EXP CELL RES, V305, P83, DOI 10.1016/j.yexcr.2004.12.019; Bachmeier BE, 2000, BIOL CHEM, V381, P509, DOI 10.1515/BC.2000.065; Bachmeier BE, 2007, CELL PHYSIOL BIOCHEM, V19, P137, DOI 10.1159/000099202; Becker M, 2005, MOL CANCER THER, V4, P151; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Berger TG, 2005, ONCOL REP, V14, P1599; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chen H, 2009, ANTI-CANCER DRUG, V20, P131, DOI 10.1097/CAD.0b013e3283212ade; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; DU JH, CANC CHEMOTHER PHARM, V65, P895; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Efferth T, 2005, IN VIVO, V19, P225; Efferth T, 2004, BIOCHEM PHARMACOL, V68, P3, DOI 10.1016/j.bcp.2004.03.003; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; Efferth T, 1996, ARZNEIMITTEL-FORSCH, V46, P196; Efferth T, 2001, INT J ONCOL, V18, P767; El-Deiry Wafik S., 1997, Current Opinion in Oncology, V9, P79; Hernandez-Vargas H, 2007, BREAST CANCER RES TR, V102, P157, DOI 10.1007/s10549-006-9322-9; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Katsman A, 2009, CURR PHARM DESIGN, V15, P792, DOI 10.2174/138161209787582156; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970; Li WD, 2006, INT IMMUNOPHARMACOL, V6, P1243, DOI 10.1016/j.intimp.2006.03.004; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perona R, 2007, CLIN TRANSL ONCOL, V9, P625, DOI 10.1007/s12094-007-0115-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell JS, 2002, CANCER RES, V62, P2318; Sertel S, 2010, CHEM-BIOL INTERACT, V185, P42, DOI 10.1016/j.cbi.2010.02.002; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yang JM, 2003, MOL CANCER RES, V1, P420; ZHANG RD, 1991, INVAS METAST, V11, P204; Zhang Zhu-Yi, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P134	53	63	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20550	10.1371/journal.pone.0020550	http://dx.doi.org/10.1371/journal.pone.0020550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637790	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200078
J	Barrey, E; Saint-Auret, G; Bonnamy, B; Damas, D; Boyer, O; Gidrol, X				Barrey, Eric; Saint-Auret, Gaelle; Bonnamy, Blandine; Damas, Dominique; Boyer, Orane; Gidrol, Xavier			Pre-microRNA and Mature microRNA in Human Mitochondria	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRANSFER-RNA IMPORT; DIFFERENTIAL EXPRESSION; PROTEIN IMPORT; CANCER-CELLS; IDENTIFICATION; TARGETS; PROLIFERATION; TRANSCRIPTION; CARCINOMA	Background: Because of the central functions of the mitochondria in providing metabolic energy and initiating apoptosis on one hand and the role that microRNA (miRNA) play in gene expression, we hypothesized that some miRNA could be present in the mitochondria for post-transcriptomic regulation by RNA interference. We intend to identify miRNA localized in the mitochondria isolated from human skeletal primary muscular cells. Methodology/Principal Findings: To investigate the potential origin of mitochondrial miRNA, we in-silico searched for microRNA candidates in the mtDNA. Twenty five human pre-miRNA and 33 miRNA aligments (E-value<0.1) were found in the reference mitochondrial sequence and some of the best candidates were chosen for a co-localization test. In situ hybridization of pre-mir-302a, pre-let-7b and mir-365, using specific labelled locked nucleic acids and confocal microscopy, demonstrated that these miRNA were localized in mitochondria of human myoblasts. Total RNA was extracted from enriched mitochondria isolated by an immunomagnetic method from a culture of human myotubes. The detection of 742 human miRNA (miRBase) were monitored by RT-qPCR at three increasing mtRNA inputs. Forty six miRNA were significantly expressed (2(nd) derivative method Cp>35) for the smallest RNA input concentration and 204 miRNA for the maximum RNA input concentration. In silico analysis predicted 80 putative miRNA target sites in the mitochondrial genome (E-value<0.05). Conclusions/Significance: The present study experimentally demonstrated for the first time the presence of pre-miRNA and miRNA in the human mitochondria isolated from skeletal muscular cells. A set of miRNA were significantly detected in mitochondria fraction. The origin of these pre-miRNA and miRNA should be further investigate to determine if they are imported from the cytosol and/or if they are partially processed in the mitochondria.	[Barrey, Eric; Bonnamy, Blandine; Damas, Dominique; Boyer, Orane] INSERM, U902, Unite Biol Integrat Adaptat Exercice, Genopole Evry, France; [Barrey, Eric; Saint-Auret, Gaelle; Gidrol, Xavier] CEA, Direct Sci Vivant, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA	Barrey, E (corresponding author), INSERM, U902, Unite Biol Integrat Adaptat Exercice, Genopole Evry, France.	eric.barrey@inserm.fr; xavier.gidrol@cea.fr		Gidrol, Xavier/0000-0002-4233-3749	Genopole d'Evry (ATIGE); "Institut National de la Sante et de la Recherche Medicale" (INSERM); "Commissariat a l'Energie Atomique" (CEA); "Institut de la Recherche Agronomique" (INRA)	Genopole d'Evry (ATIGE); "Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Commissariat a l'Energie Atomique" (CEA)(French Atomic Energy Commission); "Institut de la Recherche Agronomique" (INRA)	This study was supported jointly by the Genopole d'Evry (ATIGE), the "Institut National de la Sante et de la Recherche Medicale" (INSERM), "Commissariat a l'Energie Atomique" (CEA) and the "Institut de la Recherche Agronomique" (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Aude-Garcia C, 2010, BIOCHEM J, V430, P237, DOI 10.1042/BJ20100131; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Cannino G, 2004, NEUROSCIENCE, V128, P91, DOI 10.1016/j.neuroscience.2004.06.018; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen H, 2010, SCI CHINA LIFE SCI, V53, P101, DOI 10.1007/s11427-010-0002-y; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chinnery PF, 1999, J MED GENET, V36, P425; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P70, DOI 10.1016/j.bbrc.2010.09.115; Mokranjac Dejana, 2007, Methods Mol Biol, V372, P277, DOI 10.1007/978-1-59745-365-3_20; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; SHARP MGF, 1992, J PATHOL, V168, P163, DOI 10.1002/path.1711680203; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666	54	196	209	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20220	10.1371/journal.pone.0020220	http://dx.doi.org/10.1371/journal.pone.0020220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637849	Green Published, gold			2022-12-27	WOS:000291052200040
J	Liang, CW; Zhang, XW; Chi, XY; Guan, XY; Li, YX; Qin, S; Shao, HB				Liang, Chengwei; Zhang, Xiaowen; Chi, Xiaoyuan; Guan, Xiangyu; Li, Youxun; Qin, Song; Shao, Hong Bo			Serine/Threonine Protein Kinase SpkG Is a Candidate for High Salt Resistance in the Unicellular Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP PCC-6803; SIGNAL-TRANSDUCTION; GENES; STRESS; EXPRESSION; BACTERIA; COMPETENCE; PERCEPTION; SYSTEMS; XANTHUS	Background: Seven serine/threonine kinase genes have been predicted in unicellular cyanobacterium Synechocystis sp. PCC6803. SpkA and SpkB were shown to be required for cell motility and SpkE has no kinase activity. There is no report whether the other four STKs are involved in stress-mediated signaling in Synechocystis PCC6803. Methodology/Principal Findings: In this paper, we examined differential expression of the other four serine/threonine kinases, SpkC, SpkD, SpkF and SpkG, at seven different stress conditions. The transcriptional level was up-regulated of spkG and down-regulated of spkC under high salt stress condition. Two spk deletion mutants, Delta spkC and Delta spkG, were constructed and their growth characteristic were examined compared to the wild strain. The wild strain and Delta spkC mutant were not affected under high salt stress conditions. In contrast, growth of spkG mutant was completely impaired. To further confirm the function of spkG, we also examined the effect of mutation of spkG on the expression of salt stress-inducible genes. We compared genome-wide patterns of transcription between wild-type Synechocystis sp. PCC6803 and cells with a mutation in the SpkG with DNA microarray analysis. Conclusion: In this study, we first study the spkG gene as sensor of high salt signal. We consider that SpkG play essential roles in Synechocystis sp. for sensing the high salt signal directly, rather than mediating signals among other kinases. Our microarray experiment may help select relatively significant genes for further research on mechanisms of signal transduction of Synechocystis sp. PCC6803 under high salt stress.	[Liang, Chengwei] Qingdao Univ Sci & Technol, Qingdao, Peoples R China; [Liang, Chengwei; Zhang, Xiaowen; Chi, Xiaoyuan; Li, Youxun; Qin, Song] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Zhang, Xiaowen] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Guan, Xiangyu] Ocean Univ China, Qingdao, Peoples R China; [Shao, Hong Bo] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China	Qingdao University of Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ocean University of China; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Liang, CW (corresponding author), Qingdao Univ Sci & Technol, Qingdao, Peoples R China.	sqin@yic.ac.cn			Chinese Academy of Sciences [KZCX2-YW-209]; National Natural Science Foundation of China [40876082, 31000135]; International Innovation Partnership Program; Open Foundation of Chemical Engineering Subject, Qingdao University of Science and Technology	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Innovation Partnership Program; Open Foundation of Chemical Engineering Subject, Qingdao University of Science and Technology	This work is supported by the Key Innovative Project of Chinese Academy of Sciences (KZCX2-YW-209), National Natural Science Foundation of China (40876082 and 31000135), International Innovation Partnership Program, "Typical environmental process and effects on resources," and Open Foundation of Chemical Engineering Subject, Qingdao University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; Kamei A, 2003, CURR MICROBIOL, V46, P296, DOI 10.1007/s00284-002-3887-2; Kamei A, 2002, DNA RES, V9, P71, DOI 10.1093/dnares/9.3.71; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Kim D, 2001, MICROBIOL-SGM, V147, P1197, DOI 10.1099/00221287-147-5-1197; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MANN NH, 1994, MICROBIOL-SGM, V140, P3207, DOI 10.1099/13500872-140-12-3207; Marin K, 2003, P NATL ACAD SCI USA, V100, P9061, DOI 10.1073/pnas.1532302100; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nadvornik R, 1999, J BACTERIOL, V181, P15; Nariya H, 2005, MOL MICROBIOL, V56, P1314, DOI 10.1111/j.1365-2958.2005.04619.x; Neu JM, 2002, MOL MICROBIOL, V44, P417, DOI 10.1046/j.1365-2958.2002.02879.x; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Pandhal Jagroop, 2009, Saline Syst, V5, P8, DOI 10.1186/1746-1448-5-8; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Shao HB, 2008, BIOESSAYS, V30, P634, DOI 10.1002/bies.20770; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995; Zhang XW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-395	31	28	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e18718	10.1371/journal.pone.0018718	http://dx.doi.org/10.1371/journal.pone.0018718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637338	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200008
J	Niehage, C; Steenblock, C; Pursche, T; Bornhauser, M; Corbeil, D; Hoflack, B				Niehage, Christian; Steenblock, Charlotte; Pursche, Theresia; Bornhaeuser, Martin; Corbeil, Denis; Hoflack, Bernard			The Cell Surface Proteome of Human Mesenchymal Stromal Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEINS; EMBRYONIC STEM-CELLS; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; MONOLAYER CULTURES; PROGENITOR-CELL; DENDRITIC CELLS; RECEPTOR CD97; LIGAND CD55	Background: Multipotent human mesenchymal stromal cells (hMSCs) are considered as promising biological tools for regenerative medicine. Their antibody-based isolation relies on the identification of reliable cell surface markers. Methodology/Principal Findings: To obtain a comprehensive view of the cell surface proteome of bone marrow-derived hMSCs, we have developed an analytical pipeline relying on cell surface biotinylation of intact cells using cell impermeable, cleavable sulfo-NHS-SS-biotin to enrich the plasma membrane proteins and mass spectrometry for identification with extremely high confidence. Among the 888 proteins identified, we found approximate to 200 bona fide plasma membrane proteins including 33 cell adhesion molecules and 26 signaling receptors. In total 41 CD markers including 5 novel ones (CD97, CD112, CD239, CD276, and CD316) were identified. The CD markers are distributed homogenously within plastic-adherent hMSC populations and their expression is modulated during the process of adipogenesis or osteogenesis. Moreover, our in silico analysis revealed a significant difference between the cell surface proteome of hMSCs and that of human embryonic stem cells reported previously. Conclusions/Significance: Collectively, our analytical methods not only provide a basis for further studies of mechanisms maintaining the multipotency of hMSCs within their niches and triggering their differentiation after signaling, but also a toolbox for a refined antibody-based identification of hMSC populations from different tissues and their isolation for therapeutic intervention.	[Niehage, Christian; Steenblock, Charlotte; Pursche, Theresia; Corbeil, Denis; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Bornhaeuser, Martin] Univ Hosp Dresden, Dept Hematol & Oncol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Niehage, C (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	Corbeil, Denis/AFL-1008-2022; Steenblock, Charlotte/C-9038-2018; Corbeil, Denis/L-2340-2019; HOFLACK, Bernard/AAZ-6668-2020; Corbeil, Denis/A-6519-2010	Corbeil, Denis/0000-0003-1181-3659; Steenblock, Charlotte/0000-0002-9635-4860	Deutsche Forschungsgemeinschaft [TRR 83, SFB655 B2, SFB655 B3, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1]; Bundesministerium fur Bildung und Forschung [0313815B]; Dresden University of Technology [HWP-1207]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Dresden University of Technology	This work was supported in part by grants from Deutsche Forschungsgemeinschaft (TRR 83)(BH), SFB655 B2 (MB), SFB655 B3 (DC), HO 2584/2-1 (BH), HO 2584/1-1 (BH), HO 2584/6-1 (BH), HO 2584/8-1 (BH), Bundesministerium fur Bildung und Forschung (0313815B, BH) and Dresden University of Technology (HWP-1207, BH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Crop M, 2009, TRANSPL INT, V22, P365, DOI 10.1111/j.1432-2277.2008.00786.x; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Freund D, 2010, CYTOTHERAPY, V12, P131, DOI 10.3109/14653240903476438; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gregory C. A., 2005, SCI STKE, ppe37; Gu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015795; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002; Kettner S, 2007, MOL CELL BIOL, V27, P7718, DOI 10.1128/MCB.00180-07; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee HJ, 2009, ARTHRITIS RHEUM-US, V60, P2325, DOI 10.1002/art.24786; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Liu F, 2008, J BONE MINER METAB, V26, P312, DOI 10.1007/s00774-007-0842-0; Liu Y, 2005, ONCOL REP, V14, P1413; LURIA EA, 1971, TRANSFUSION, V11, P345, DOI 10.1111/j.1537-2995.1971.tb04426.x; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pozzobon M, 2009, STEM CELLS DEV, V18, P497, DOI 10.1089/scd.2008.0003; Qiu HB, 2008, J PROTEOME RES, V7, P1904, DOI 10.1021/pr700651b; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Roche S, 2009, PROTEOMICS, V9, P223, DOI 10.1002/pmic.200800035; Salasznyk RM, 2005, STEM CELLS DEV, V14, P354, DOI 10.1089/scd.2005.14.354; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Santos TM, 2010, TRANSPL P, V42, P563, DOI 10.1016/j.transproceed.2010.01.032; Schindler J, 2006, J NEURAL TRANSM, V113, P995, DOI 10.1007/s00702-006-0508-4; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; van Pel M, 2008, HAEMATOL-HEMATOL J, V93, P1137, DOI 10.3324/haematol.12838; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wang ZY, 2004, BLOOD, V103, P100, DOI 10.1182/blood-2003-04-1063; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zhang AX, 2007, MOL CELL BIOCHEM, V304, P167, DOI 10.1007/s11010-007-9497-3; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	56	77	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20399	10.1371/journal.pone.0020399	http://dx.doi.org/10.1371/journal.pone.0020399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637820	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200060
J	Stepanow, S; Reichwald, K; Huse, K; Gausmann, U; Nebel, A; Rosenstiel, P; Wabitsch, M; Fischer-Posovszky, P; Platzer, M				Stepanow, Stefanie; Reichwald, Kathrin; Huse, Klaus; Gausmann, Ulrike; Nebel, Almut; Rosenstiel, Philip; Wabitsch, Martin; Fischer-Posovszky, Pamela; Platzer, Matthias			Allele-Specific, Age-Dependent and BMI-Associated DNA Methylation of Human MCHR1	PLOS ONE			English	Article							CPG ISLANDS; GENE-EXPRESSION; SEQUENCE; GENOTYPE; EPIGENETICS; STRATEGIES; OBESITY; GENOME	Background: Melanin-concentrating hormone receptor 1 (MCHR1) plays a significant role in regulation of energy balance, food intake, physical activity and body weight in humans and rodents. Several association studies for human obesity showed contrary results concerning the SNPs rs133072 (G/A) and rs133073 (T/C), which localize to the first exon of MCHR1. The variations constitute two main haplotypes (GT, AC). Both SNPs affect CpG dinucleotides, whereby each haplotype contains a potential methylation site at one of the two SNP positions. In addition, 15 CpGs in close vicinity of these SNPs constitute a weak CpG island. Here, we studied whether DNA methylation in this sequence context may contribute to population-and age-specific effects of MCHR1 alleles in obesity. Principal Findings: We analyzed DNA methylation of a 315 bp region of MCHR1 encompassing rs133072 and rs133073 and the CpG island in blood samples of 49 individuals by bisulfite sequencing. The AC haplotype shows a significantly higher methylation level than the GT haplotype. This allele-specific methylation is age-dependent. In young individuals (20-30 years) the difference in DNA methylation between haplotypes is significant; whereas in individuals older than 60 years it is not detectable. Interestingly, the GT allele shows a decrease in methylation status with increasing BMI, whereas the methylation of the AC allele is not associated with this phenotype. Heterozygous lymphoblastoid cell lines show the same pattern of allele-specific DNA methylation. The cell line, which exhibits the highest difference in methylation levels between both haplotypes, also shows allele-specific transcription of MCHR1, which can be abolished by treatment with the DNA methylase inhibitor 5-aza-2'-deoxycytidine. Conclusions: We show that DNA methylation at MCHR1 is allele-specific, age-dependent, BMI-associated and affects transcription. Conceivably, this epigenetic regulation contributes to the age-and/or population specific effects reported for MCHR1 in several human obesity studies.	[Stepanow, Stefanie; Reichwald, Kathrin; Huse, Klaus; Gausmann, Ulrike; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Nebel, Almut; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Ulm, Dept Pediat & Adolescent Med, Ulm, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Kiel; Ulm University	Stepanow, S (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.	stepanow@fli-leibniz.de	Gausmann, Ulrike/H-2595-2012; Rosenstiel, Philip/A-5137-2009; Nebel, Almut/E-4196-2010	Gausmann, Ulrike/0000-0002-2147-960X; Rosenstiel, Philip/0000-0002-9692-8828; Fischer-Posovszky, Pamela/0000-0003-3402-9840; Huse, Klaus/0000-0003-3854-1884	Leibniz Graduate School for Aging and Age-Related Diseases - LGSA	Leibniz Graduate School for Aging and Age-Related Diseases - LGSA	Funding was provided by the Leibniz Graduate School for Aging and Age-Related Diseases - LGSA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2003, ENDOCRINOLOGY, V144, P3943, DOI 10.1210/en.2003-0149; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell CG, 2005, DIABETES, V54, P3049, DOI 10.2337/diabetes.54.10.3049; Bennett-Baker PE, 2003, GENETICS, V165, P2055; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Bradley RL, 2000, DIABETES, V49, P1073, DOI 10.2337/diabetes.49.7.1073; Bradley RL, 2002, AM J PHYSIOL-ENDOC M, V283, pE584, DOI 10.1152/ajpendo.00161.2002; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gibson WT, 2004, OBES RES, V12, P743, DOI 10.1038/oby.2004.89; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gravina S, 2010, PFLUG ARCH EUR J PHY, V459, P247, DOI 10.1007/s00424-009-0730-7; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Luthin DR, 2007, LIFE SCI, V81, P423, DOI 10.1016/j.lfs.2007.05.029; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rutanen J, 2007, OBESITY, V15, P2902, DOI 10.1038/oby.2007.345; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Takai Daiya, 2003, In Silico Biology, V3, P235; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wermter AK, 2005, EUR J ENDOCRINOL, V152, P851, DOI 10.1530/eje.1.01917; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zakharova IS, 2009, CHROMOSOMA, V118, P279, DOI 10.1007/s00412-009-0206-8; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	57	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e17711	10.1371/journal.pone.0017711	http://dx.doi.org/10.1371/journal.pone.0017711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637341	Green Published, gold			2022-12-27	WOS:000291052200004
J	Zheng, XD; Guo, JB; Xu, LP; Li, HL; Zhang, DW; Zhang, K; Sun, F; Wen, TY; Liu, SG; Pang, H				Zheng, Xiangdong; Guo, Jiubiao; Xu, Lipeng; Li, Honglei; Zhang, Dongwei; Zhang, Kai; Sun, Fei; Wen, Tingyi; Liu, Siguo; Pang, Hai			Crystal Structure of a Novel Esterase Rv0045c from Mycobacterium tuberculosis	PLOS ONE			English	Article							AUTOMATED STRUCTURE SOLUTION; ALPHA/BETA-HYDROLASE FOLD; DENSITY MODIFICATION; GENOME SEQUENCE; PROTEINS; DATABASE; DOCKING; ENZYME; FAMILY; SERVER	There are at least 250 enzymes in Mycobacterium tuberculosis (M. tuberculosis) involved in lipid metabolism. Some of the enzymes are required for bacterial survival and full virulence. The esterase Rv0045c shares little amino acid sequence similarity with other members of the esterase/lipase family. Here, we report the 3D structure of Rv0045c. Our studies demonstrated that Rv0045c is a novel member of alpha/beta hydrolase fold family. The structure of esterase Rv0045c contains two distinct domains: the alpha/beta fold domain and the cap domain. The active site of esterase Rv0045c is highly conserved and comprised of two residues: Ser154 and His309. We proposed that Rv0045c probably employs two kinds of enzymatic mechanisms when hydrolyzing C-O ester bonds within substrates. The structure provides insight into the hydrolysis mechanism of the C-O ester bond, and will be helpful in understanding the ester/lipid metabolism in M. tuberculosis.	[Zheng, Xiangdong; Guo, Jiubiao; Xu, Lipeng; Li, Honglei; Pang, Hai] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Zheng, Xiangdong; Guo, Jiubiao; Liu, Siguo] Chinese Acad Agr, Harbin Vet Res Inst, Harbin, Peoples R China; [Zhang, Dongwei] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Zhang, Kai; Sun, Fei] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Wen, Tingyi] Chinese Acad Sci, Inst Microbiol, Dept Ind Microbiol & Biotechnol, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of British Columbia; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zheng, XD (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	siguo_liu@yahoo.com.cn; pangh@xtal.tsinghua.edu.cn	Zhang, Dongwei/AAS-8384-2020; Sun, Fei/C-4190-2015; Wen, Tingyi/M-6095-2014; Zheng, Xiangdong/AAL-4774-2021	Zhang, Dongwei/0000-0002-7793-1482; Sun, Fei/0000-0002-0351-5144; Wen, Tingyi/0000-0003-2583-7088; Guo, Jiubiao/0000-0003-2716-1712; Zhang, Kai/0000-0001-8617-2855	Foundation of State Key Laboratory of Veterinary Biotechnology [SKLVBF2009]; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program [2008ZX09401-05]; National Natural Science Foundation of China [30770439]; Major State Basic Research Development Program of China [2006CB504400]; Tsinghua-Yue-Yuen Medical Sciences Fund [20240000551]	Foundation of State Key Laboratory of Veterinary Biotechnology; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Tsinghua-Yue-Yuen Medical Sciences Fund	This work was financially supported by the Foundation of State Key Laboratory of Veterinary Biotechnology (SKLVBF2009), Harbin Veterinary Research Institute (HVRI), the National Drug Discovery Program (Grant 2008ZX09401-05), the National Natural Science Foundation of China (No. 30770439), the 973 Project of the Major State Basic Research Development Program of China (No. 2006CB504400) and the Tsinghua-Yue-Yuen Medical Sciences Fund (20240000551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin X, 1998, NUCLEIC ACIDS RES, V26, P226, DOI 10.1093/nar/26.1.226; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; Habe H, 2003, BIOCHEM BIOPH RES CO, V303, P631, DOI 10.1016/S0006-291X(03)00375-9; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hubbard TJP, 1998, ACTA CRYSTALLOGR D, V54, P1147, DOI 10.1107/S0907444998009172; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; McCulloch KM, 2010, BIOCHEMISTRY-US, V49, P1226, DOI 10.1021/bi901812p; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MURRAY PR, 2005, MED MICROBIOLOGY; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nardini M, 1999, J BIOL CHEM, V274, P14579, DOI 10.1074/jbc.274.21.14579; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Orengo CA, 1998, ACTA CRYSTALLOGR D, V54, P1155, DOI 10.1107/S0907444998007501; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Ryan KJ., 2004, SHERRIS MED MICROBIO; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041	28	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20506	10.1371/journal.pone.0020506	http://dx.doi.org/10.1371/journal.pone.0020506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637775	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200072
J	Chen, CC; Fernald, RD				Chen, Chun-Chun; Fernald, Russell D.			Visual Information Alone Changes Behavior and Physiology during Social Interactions in a Cichlid Fish (Astatotilapia burtoni)	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; BRAIN SEROTONERGIC ACTIVITY; STRESS COPING STRATEGIES; CHARR SALVELINUS-ALPINUS; JUVENILE RAINBOW-TROUT; MESSENGER-RNA; HAPLOCHROMIS-BURTONI; XIPHOPHORUS-HELLERI; ANOLIS-CAROLINENSIS; AGGRESSIVE-BEHAVIOR	Social behavior can influence physiological systems dramatically yet the sensory cues responsible are not well understood. Behavior of male African cichlid fish, Astatotilapia burtoni, in their natural habitat suggests that visual cues from conspecifics contribute significantly to regulation of social behavior. Using a novel paradigm, we asked whether visual cues alone from a larger conspecific male could influence behavior, reproductive physiology and the physiological stress response of a smaller male. Here we show that just seeing a larger, threatening male through a clear barrier can suppress dominant behavior of a smaller male for up to 7 days. Smaller dominant males being "attacked'' visually by larger dominant males through a clear barrier also showed physiological changes for up to 3 days, including up-regulation of reproductive-and stress-related gene expression levels and lowered plasma 11-ketotestesterone concentrations as compared to control animals. The smaller males modified their appearance to match that of non-dominant males when exposed to a larger male but they maintained a physiological phenotype similar to that of a dominant male. After 7 days, reproductive-and stress-related gene expression, circulating hormone levels, and gonad size in the smaller males showed no difference from the control group suggesting that the smaller male habituated to the visual intruder. However, the smaller male continued to display subordinate behaviors and assumed the appearance of a subordinate male for a full week despite his dominant male physiology. These data suggest that seeing a larger male alone can regulate the behavior of a smaller male but that ongoing reproductive inhibition depends on additional sensory cues. Perhaps, while experiencing visual social stressors, the smaller male uses an opportunistic strategy, acting like a subordinate male while maintaining the physiology of a dominant male.	[Chen, Chun-Chun; Fernald, Russell D.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Fernald, Russell D.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Chen, CC (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27706 USA.	chunchun.cc@gmail.com			National Institute of Neurological Disorder and Stroke [NS34950]; Lucille P. Markey Biomedical Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034950, R56NS034950, R01NS034950] Funding Source: NIH RePORTER	National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lucille P. Markey Biomedical Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Neurological Disorder and Stroke (NS34950) to RDF and Lucille P. Markey Biomedical Research Fellowship to CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday DD, 2003, J FISH BIOL, V62, P486, DOI 10.1046/j.1095-8649.2003.00033.x; Albeck DS, 1997, J NEUROSCI, V17, P4895; ALBONETTI ME, 1994, BEHAV BRAIN RES, V62, P187, DOI 10.1016/0166-4328(94)90027-2; Au TM, 2006, BEHAV BRAIN RES, V170, P342, DOI 10.1016/j.bbr.2006.02.027; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bass AH, 2001, BRAIN BEHAV EVOLUT, V57, P293, DOI 10.1159/000047247; Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016; BLANCHARD DC, 2002, HORMONES BRAIN BEHAV, V1, P735; BUTLER PD, 1990, J NEUROSCI, V10, P176; Chen CC, 2008, GEN COMP ENDOCR, V157, P148, DOI 10.1016/j.ygcen.2008.04.003; Clement TS, 2005, HORM BEHAV, V47, P336, DOI 10.1016/j.yhbeh.2004.11.014; Consten D, 2001, BIOL REPROD, V64, P1063, DOI 10.1095/biolreprod64.4.1063; Cruz EMV, 2007, HORM BEHAV, V51, P611, DOI 10.1016/j.yhbeh.2007.02.010; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; Doyon C, 2005, J ENDOCRINOL, V186, P123, DOI 10.1677/joe.1.06142; Dzieweczynski TL, 2006, GEN COMP ENDOCR, V147, P184, DOI 10.1016/j.ygcen.2005.12.023; Earley RL, 2003, NATURWISSENSCHAFTEN, V90, P226, DOI 10.1007/s00114-003-0415-6; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; Fernald RD, 2002, NOVART FDN SYMP, V244, P169; FERNALD RD, 1985, VISION RES, V25, P155, DOI 10.1016/0042-6989(85)90108-7; Flik G, 2006, GEN COMP ENDOCR, V146, P36, DOI 10.1016/j.ygcen.2005.11.005; Fox HE, 1997, J NEUROSCI, V17, P6463; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P7794, DOI 10.1073/pnas.90.16.7794; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; Godwin J, 2000, BRAIN BEHAV EVOLUT, V55, P77, DOI 10.1159/000006643; Goncalves D, 2007, HORM BEHAV, V51, P534, DOI 10.1016/j.yhbeh.2007.02.003; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hofmann HA, 2000, J NEUROSCI, V20, P4740, DOI 10.1523/JNEUROSCI.20-12-04740.2000; Hoglund E, 2002, J EXP BIOL, V205, P2535; Hoglund E, 2001, PHYSIOL BEHAV, V74, P381, DOI 10.1016/S0031-9384(01)00571-6; Huising M, 2004, J MOL ENDOCRINOL, V32, P627, DOI 10.1677/jme.0.0320627; KINDLER PM, 1991, HORM BEHAV, V25, P410, DOI 10.1016/0018-506X(91)90011-6; Korzan WJ, 2007, BRAIN BEHAV EVOLUT, V70, P257, DOI 10.1159/000105489; Korzan WJ, 2007, BEHAV BRAIN RES, V183, P31, DOI 10.1016/j.bbr.2007.05.021; Korzan WJ, 2000, BRAIN RES, V870, P170, DOI 10.1016/S0006-8993(00)02420-3; Korzan WJ, 2000, HORM BEHAV, V38, P193, DOI 10.1006/hbeh.2000.1619; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Meerlo P, 1997, PSYCHONEUROENDOCRINO, V22, P155, DOI 10.1016/S0306-4530(96)00047-9; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Oliveira RF, 2001, HORM BEHAV, V39, P157, DOI 10.1006/hbeh.2001.1643; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366; Overli O, 2002, HORM BEHAV, V42, P53, DOI 10.1006/hbeh.2002.1796; Parikh VN, 2006, J ENDOCRINOL, V190, P183, DOI 10.1677/joe.1.06755; Parikh VN, 2006, BEHAV BRAIN RES, V166, P291, DOI 10.1016/j.bbr.2005.07.011; Remage-Healey L, 2006, HORM BEHAV, V50, P432, DOI 10.1016/j.yhbeh.2006.05.007; Rosenthal GG, 2000, J BIOSCIENCES, V25, P285, DOI 10.1007/BF02703937; Schiml PA, 2000, HORM BEHAV, V37, P212, DOI 10.1006/hbeh.2000.1575; Schjolden J, 2005, PHYSIOL BIOCHEM ZOOL, V78, P715, DOI 10.1086/432153; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; Semsar K, 2003, J NEUROSCI, V23, P4386; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; SUMMERS CH, 1994, HORM BEHAV, V28, P29, DOI 10.1006/hbeh.1994.1003; Summers CH, 2005, J COMP PHYSIOL A, V191, P241, DOI 10.1007/s00359-004-0554-z; Thompson RR, 2004, HORM BEHAV, V46, P646, DOI 10.1016/j.yhbeh.2004.06.008; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Volpato GL, 2003, BRAZ J MED BIOL RES, V36, P1659, DOI 10.1590/S0100-879X2003001200007; WHITE SA, 1993, J NEUROSCI, V13, P434; White SA, 2002, J EXP BIOL, V205, P2567; WHITE SA, 1995, P NATL ACAD SCI USA, V92, P8363, DOI 10.1073/pnas.92.18.8363; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	68	37	39	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20313	10.1371/journal.pone.0020313	http://dx.doi.org/10.1371/journal.pone.0020313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633515	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500054
J	Nair, S; Kukreja, N; Singh, BP; Arora, N				Nair, Smitha; Kukreja, Neetu; Singh, Bhanu Pratap; Arora, Naveen			Identification of B Cell Epitopes of Alcohol Dehydrogenase Allergen of Curvularia lunata	PLOS ONE			English	Article							MAJOR ALLERGEN; CROSS-REACTIVITY; BINDING-SITES; BIRCH POLLEN; PREDICTION; RESIDUES; ANTIGENICITY; CLONING; ASTHMA	Background/Objective: Epitope identification assists in developing molecules for clinical applications and is useful in defining molecular features of allergens for understanding structure/function relationship. The present study was aimed to identify the B cell epitopes of alcohol dehydrogenase (ADH) allergen from Curvularia lunata using in-silico methods and immunoassay. Method: B cell epitopes of ADH were predicted by sequence and structure based methods and protein-protein interaction tools while T cell epitopes by inhibitory concentration and binding score methods. The epitopes were superimposed on a three dimensional model of ADH generated by homology modeling and analyzed for antigenic characteristics. Peptides corresponding to predicted epitopes were synthesized and immunoreactivity assessed by ELISA using individual and pooled patients' sera. Result: The homology model showed GroES like catalytic domain joined to Rossmann superfamily domain by an alpha helix. Stereochemical quality was confirmed by Procheck which showed 90% residues in most favorable region of Ramachandran plot while Errat gave a quality score of 92.733%. Six B cell (P1-P6) and four T cell (P7-P10) epitopes were predicted by a combination of methods. Peptide P2 (epitope P2) showed E(X)(2)GGP(X)(3)KKI conserved pattern among allergens of pathogenesis related family. It was predicted as high affinity binder based on electronegativity and low hydrophobicity. The computational methods employed were validated using Bet v 1 and Der p 2 allergens where 67% and 60% of the epitope residues were predicted correctly. Among B cell epitopes, Peptide P2 showed maximum IgE binding with individual and pooled patients' sera (mean OD 0.604 +/- 0.059 and 0.506 +/- 0.0035, respectively) followed by P1, P4 and P3 epitopes. All T cell epitopes showed lower IgE binding. Conclusion: Four B cell epitopes of C. lunata ADH were identified. Peptide P2 can serve as a potential candidate for diagnosis of allergic diseases.	[Nair, Smitha; Singh, Bhanu Pratap; Arora, Naveen] CSIR, Inst Genom & Integrat Biol, Allergy & Immunol Lab, Delhi, India; [Kukreja, Neetu] Univ Delhi, Dept Zool, Hindu Coll, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Nair, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Allergy & Immunol Lab, Delhi, India.	naveen@igib.res.in			Council of Scientific and Industrial Research, New Delhi (CSIR Network), India [05]	Council of Scientific and Industrial Research, New Delhi (CSIR Network), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was financed by Council of Scientific and Industrial Research, New Delhi (CSIR Network project 05), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; de Lalla C, 1999, J IMMUNOL, V163, P1725; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; Gupta R, 1999, J ALLERGY CLIN IMMUN, V104, P857, DOI 10.1016/S0091-6749(99)70299-X; Gupta R, 2004, ALLERGY, V59, P421, DOI 10.1046/j.1398-9995.2003.00378.x; Gupta R, 2002, ALLERGY, V57, P636, DOI 10.1034/j.1398-9995.2002.03331.x; GUPTA R, 1999, INDIAN J ALLERGY APP, V13, P45; Hakkaart GAJ, 1998, ALLERGY, V53, P165, DOI 10.1111/j.1398-9995.1998.tb03865.x; HSIEH KH, 1988, J ASTHMA, V25, P73, DOI 10.3109/02770908809071357; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Mine Y, 2003, PROTEIN ENG, V16, P747, DOI 10.1093/protein/gzg095; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reese G, 2001, J CHROMATOGR B, V756, P157, DOI 10.1016/S0378-4347(01)00104-9; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sanchez R, 2000, METH MOL B, V143, P97; Sharma V, 2008, ALLERGY, V63, P189, DOI 10.1111/j.1398-9995.2007.01528.x; Sharma V, 2006, J CLIN IMMUNOL, V26, P360, DOI 10.1007/s10875-006-9032-4; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; SHEN HD, 1991, CLIN EXP ALLERGY, V21, P675, DOI 10.1111/j.1365-2222.1991.tb03195.x; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Sinha N, 2002, BIOPHYS J, V83, P2946, DOI 10.1016/S0006-3495(02)75302-2; Soman KV, 2000, BIOPHYS J, V79, P1601, DOI 10.1016/S0006-3495(00)76410-1; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; VANNEERVEN RJJ, 1993, J IMMUNOL, V151, P2326; Wan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-463; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Williams SC, 1998, J IMMUNOL METHODS, V213, P1, DOI 10.1016/S0022-1759(98)00022-2; Wolff N, 2004, J ALLERGY CLIN IMMUN, V114, P1151, DOI 10.1016/j.jaci.2004.07.038; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; [No title captured]	50	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20020	10.1371/journal.pone.0020020	http://dx.doi.org/10.1371/journal.pone.0020020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647452	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500018
J	Leo, CH; Hart, JL; Woodman, OL				Leo, Chen-Huei; Hart, Joanne L.; Woodman, Owen L.			3 ',4 '-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries	PLOS ONE			English	Article							FACTOR-TYPE RELAXATION; EDHF-TYPE RELAXATION; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HIGH-RISK; ANTIOXIDANT; QUERCETIN; FLAVONOLS; REPERFUSION	Background: 3',4'-Dihydroxyflavonol (DiOHF) is an effective antioxidant that acutely preserves nitric oxide (NO) activity in the presence of elevated reactive oxygen species (ROS). We hypothesized that DiOHF treatment (7 days, 1 mg/kg per day s.c.) would improve relaxation in mesenteric arteries from diabetic rats where endothelial dysfunction is associated with elevated oxidant stress. Methodology/Principal Findings: In mesenteric arteries from diabetic rats there was an increase in ROS, measured by L-012 and 2',7'-dichlorodihydrofluorescein diacetate fluorescence. NADPH oxidase-derived superoxide levels, assayed by lucigenin chemiluminescence, were also significantly increased in diabetic mesenteric arteries (diabetes, 4892 +/- 946 counts/mg versus normal 2486 +/- 344 counts/mg, n = 7-10, p<0.01) associated with an increase in Nox2 expression but DiOHF (2094 +/- 300 counts/mg, n = 10, p<0.001) reversed that effect. Acetylcholine (ACh)-induced relaxation of mesenteric arteries was assessed using wire myography (pEC(50) = 7.94 +/- 0.13 n = 12). Diabetes significantly reduced the sensitivity to ACh and treatment with DiOHF prevented endothelial dysfunction (pEC(50), diabetic 6.86 +/- 0.12 versus diabetic+DiOHF, 7.49 +/- 0.13, n = 11, p<0.01). The contribution of NO versus endothelium-derived hyperpolarizing factor (EDHF) to ACh-induced relaxation was assessed by evaluating responses in the presence of TRAM-34+apamin+iberiotoxin or N-nitro-L-arginine+ODQ respectively. Diabetes impaired the contribution of both NO (maximum relaxation, R-max diabetic 24 +/- 7 versus normal, 68 +/- 10, n = 9-10, p<0.01) and EDHF (pEC(50), diabetic 6.63 +/- 0.15 versus normal, 7.14 +/- 0.12, n = 10-11, p<0.01) to endothelium-dependent relaxation. DiOHF treatment did not significantly affect the EDHF contribution but enhanced NO-mediated relaxation (R-max 69 +/- 66, n = 11, p<0.01). Western blotting demonstrated that diabetes also decreased expression and increased uncoupling of endothelial NO synthase (eNOS). Treatment of the diabetic rats with DiOHF significantly reduced vascular ROS and restored NO-mediated endothelium-dependent relaxation. Treatment of the diabetic rats with DiOHF also increased eNOS expression, both in total and as a dimer. Conclusions/Significance: DiOHF improves NO activity in diabetes by reducing Nox2-dependent superoxide production and preventing eNOS uncoupling to improve endothelial function.	[Leo, Chen-Huei; Hart, Joanne L.; Woodman, Owen L.] Royal Melbourne Inst Technol RMIT Univ, Hlth Innovat Res Inst, Sch Med Sci, Bundoora, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Leo, CH (corresponding author), Royal Melbourne Inst Technol RMIT Univ, Hlth Innovat Res Inst, Sch Med Sci, Bundoora, Vic, Australia.	owen.woodman@rmit.edu.au	Woodman, Owen L/H-7297-2019; leo, Chen huei/ABD-2155-2020	Woodman, Owen L/0000-0003-3759-1396; leo, Chen huei/0000-0003-1424-9694; Hart, Joanne/0000-0002-9473-0383	RMIT University	RMIT University	C. H. Leo is a recipient of RMIT University International Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Chan ECH, 2003, J CARDIOVASC PHARM, V42, P727, DOI 10.1097/00005344-200312000-00006; Chan ECH, 2000, J CARDIOVASC PHARM, V35, P326, DOI 10.1097/00005344-200002000-00023; Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Ding H, 2005, BRIT J PHARMACOL, V146, P1110, DOI 10.1038/sj.bjp.0706417; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Engler MB, 2006, NUTR REV, V64, P109, DOI [10.1301/nr.2006.mar.109-118, 10.1111/j.1753-4887.2006.tb00194.x]; Erlund I, 2000, EUR J CLIN PHARMACOL, V56, P545, DOI 10.1007/s002280000197; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; Geleijnse JM, 2002, AM J CLIN NUTR, V75, P880, DOI 10.1093/ajcn/75.5.880; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hink U, 2001, CIRC RES, V88, pE14; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jiang F, 2008, J PHARMACOL EXP THER, V324, P261, DOI 10.1124/jpet.107.131433; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Leo CH, 2010, AM J PHYSIOL-HEART C, V299, pH502, DOI 10.1152/ajpheart.01197.2009; LEO CH, 2011, EUR J PHARM IN PRESS, P1; Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Ma X, 2008, LIFE SCI, V83, P110, DOI 10.1016/j.lfs.2008.05.010; Machha A, 2007, NITRIC OXIDE-BIOL CH, V16, P442, DOI 10.1016/j.niox.2007.04.001; Makino A, 2000, BRIT J PHARMACOL, V130, P549, DOI 10.1038/sj.bjp.0703354; Malakul W, 2008, CLIN EXP PHARMACOL P, V35, P192, DOI 10.1111/j.1440-1681.2007.04811.x; Matsumoto T, 2003, AM J PHYSIOL-HEART C, V285, pH283, DOI 10.1152/ajpheart.00954.2002; Matsumoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1933, DOI 10.1152/ajpheart.00303.2005; Matsumoto T, 2006, VASC PHARMACOL, V44, P450, DOI 10.1016/j.vph.2006.02.007; MCPHERSON GA, 1992, CLIN EXP PHARMACOL P, V19, P815, DOI 10.1111/j.1440-1681.1992.tb00420.x; Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Qi W, 2009, AM J PATHOL, V175, P1858, DOI 10.2353/ajpath.2009.090263; Qin CX, 2008, J MED CHEM, V51, P1874, DOI 10.1021/jm070352h; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Song YQ, 2009, AM J CLIN NUTR, V90, P429, DOI 10.3945/ajcn.2009.27491; Wang S, 2004, BRIT J PHARMACOL, V142, P443, DOI 10.1038/sj.bjp.0705815; Wang S, 2009, EUR J PHARMACOL, V624, P31, DOI 10.1016/j.ejphar.2009.10.001; Weston AH, 2008, BRIT J PHARMACOL, V154, P652, DOI 10.1038/bjp.2008.108; Willcox BJ, 2008, AM J CARDIOL, V101, p75D, DOI 10.1016/j.amjcard.2008.02.012; Woodman OL, 2005, J CARDIOVASC PHARM, V46, P302, DOI 10.1097/01.fjc.0000175431.62626.07; Woodman OL, 2004, CLIN EXP PHARMACOL P, V31, P786, DOI 10.1111/j.1440-1681.2004.04072.x; Woodman OL, 2009, LIFE SCI, V85, P54, DOI 10.1016/j.lfs.2009.04.012; Yap S, 2010, BIOFACTORS, V36, P350, DOI 10.1002/biof.111	51	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20813	10.1371/journal.pone.0020813	http://dx.doi.org/10.1371/journal.pone.0020813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673968	Green Published, gold			2022-12-27	WOS:000291356400031
J	Thieme, F; Engler, C; Kandzia, R; Marillonnet, S				Thieme, Frank; Engler, Carola; Kandzia, Romy; Marillonnet, Sylvestre			Quick and Clean Cloning: A Ligation-Independent Cloning Strategy for Selective Cloning of Specific PCR Products from Non-Specific Mixes	PLOS ONE			English	Article							RECOMBINANT-DNA; IN-VITRO; AMPLIFICATION; FRAGMENTS; VECTORS	We have developed an efficient strategy for cloning of PCR products that contain an unknown region flanked by a known sequence. As with ligation-independent cloning, the strategy is based on homology between sequences present in both the vector and the insert. However, in contrast to ligation-independent cloning, the cloning vector has homology with only one of the two primers used for amplification of the insert. The other side of the linearized cloning vector has homology with a sequence present in the insert, but nested and non-overlapping with the gene-specific primer used for amplification. Since only specific products contain this sequence, but none of the non-specific products, only specific products can be cloned. Cloning is performed using a one-step reaction that only requires incubation for 10 minutes at room temperature in the presence of T4 DNA polymerase to generate single-stranded extensions at the ends of the vector and insert. The reaction mix is then directly transformed into E. coli where the annealed vector-insert complex is repaired and ligated. We have tested this method, which we call quick and clean cloning (QC cloning), for cloning of the variable regions of immunoglobulins expressed in non-Hodgkin lymphoma tumor samples. This method can also be applied to identify the flanking sequence of DNA elements such as T-DNA or transposon insertions, or be used for cloning of any PCR product with high specificity.	[Thieme, Frank; Engler, Carola; Kandzia, Romy; Marillonnet, Sylvestre] Icon Genet GmbH, Halle, Germany	ICON plc	Thieme, F (corresponding author), Icon Genet GmbH, Halle, Germany.	marillonnet@icongenetics.de		Thieme, Frank/0000-0001-5733-3859	Icon Genetics GmbH	Icon Genetics GmbH	Work was funded by Icon Genetics GmbH. Icon Genetics GmbH employs all the authors of this study, therefore, they had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Ausubel FM, 2010, CURRENT PROTOCOLS MO; Bardoczy V, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-32; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dan Hanhong, 2009, J Biomol Tech, V20, P241; de las Rivas B, 2007, BIOTECHNOL PROGR, V23, P680, DOI 10.1021/bp060318g; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; OCHMAN H, 1988, GENETICS, V120, P621; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSENTHAL A, 1990, NUCLEIC ACIDS RES, V18, P3095, DOI 10.1093/nar/18.10.3095; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; XU G, 2010, NEW PHYTOL; YANG YS, 1993, NUCLEIC ACIDS RES, V21, P1889, DOI 10.1093/nar/21.8.1889	25	29	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20556	10.1371/journal.pone.0020556	http://dx.doi.org/10.1371/journal.pone.0020556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655102	gold, Green Published, Green Submitted			2022-12-27	WOS:000291310600015
J	Sadamoto, H; Saito, K; Muto, H; Kinjo, M; Ito, E				Sadamoto, Hisayo; Saito, Kenta; Muto, Hideki; Kinjo, Masataka; Ito, Etsuro			Direct Observation of Dimerization between Different CREB1 Isoforms in a Living Cell	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; ELEMENT-BINDING PROTEIN; LONG-TERM FACILITATION; RESPONSE ELEMENT; TRANSCRIPTION FACTORS; TARGETED MUTATION; NERVOUS-SYSTEM; MESSENGER-RNA; IN-VIVO; ACTIVATOR	Cyclic AMP-responsive element binding protein 1 (CREB1) plays multiple functions as a transcription factor in gene regulation. CREB1 proteins are also known to be expressed in several spliced isoforms that act as transcriptional activators or repressors. The activator isoforms, possessing the functional domains for kinase induction and for interaction with other transcriptional regulators, act as transcriptional activators. On the other hand, some isoforms, lacking those functional domains, are reported to be repressors that make heterodimers with activator isoforms. The complex and ingenious function for CREB1 arises in part from the variation in their spliced isoforms, which allows them to interact with each other. To date, however, the dimerization between the activator and repressor isoforms has not yet been proved directly in living cells. In this study, we applied fluorescence cross-correlation spectroscopy (FCCS) to demonstrate direct observation of dimerization between CREB1 activator and repressor. The FCCS is a well established spectroscopic method to determine the interaction between the different fluorescent molecules in the aqueous condition. Using differently labeled CREB1 isoforms, we successfully observed the interaction of CREB1 activator and repressor via dimerization in the nuclei of cultured cells. As a result, we confirmed the formation of heterodimer between CREB1 activator and repressor isoforms in living cells.	[Sadamoto, Hisayo; Ito, Etsuro] Tokushima Bunri Univ, Lab Funct Biol, Kagawa Sch Pharmaceut Sci, Sanuki, Japan; [Saito, Kenta] Hokkaido Univ, Nikon Imaging Ctr, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Muto, Hideki; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan	Tokushima Bunri University; Hokkaido University; Hokkaido University	Sadamoto, H (corresponding author), Tokushima Bunri Univ, Lab Funct Biol, Kagawa Sch Pharmaceut Sci, Sanuki, Japan.	sadamotoh@kph.bunri-u.ac.jp	Kinjo, Masataka/F-5267-2011; Saito, Kenta/G-2443-2010	Kinjo, Masataka/0000-0001-8889-8369; Saito, Kenta/0000-0003-4147-255X	Japan Society for the Promotion of Science [10765, 19770059, 21770081, 19370039, 21657022]; Zoological Society of Japan; Grants-in-Aid for Scientific Research [19058001] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Zoological Society of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (Nos. 10765, 19770059, and 21770081 to HS, and Nos. 19370039 and 21657022 to EI) and by an OM Award from the Zoological Society of Japan (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; Hatakeyama D, 2006, J MOL BIOL, V356, P569, DOI 10.1016/j.jmb.2005.12.009; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lee YS, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-3; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; Park H, 2008, MOL CELLS, V26, P87; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; Sadamoto H, 2004, J NEUROBIOL, V58, P455, DOI 10.1002/neu.10296; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Upadhya SC, 2004, J NEUROCHEM, V91, P210, DOI 10.1111/j.1471-4159.2004.02707.x; Wu XL, 1998, J BIOL CHEM, V273, P20820, DOI 10.1074/jbc.273.33.20820; YIN JCP, 1995, MOL CELL BIOL, V15, P5123	25	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20285	10.1371/journal.pone.0020285	http://dx.doi.org/10.1371/journal.pone.0020285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673803	Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900011
J	Liang, Y; Chiu, PH; Yip, KY; Chan, SY				Liang, Ying; Chiu, Peng Hang; Yip, Kit Yan; Chan, Siu Yuen			Subcellular Localization of SUN2 Is Regulated by Lamin A and Rab5	PLOS ONE			English	Article							INNER NUCLEAR-MEMBRANE; PROTEIN; ENVELOPE; MIGRATION; UNC-84; CELLS; MICE; CENTROSOME; EXPRESSION; PROTEOMICS	SUN2 is an inner nuclear membrane protein with a conserved Sad1/UNC-84 homology SUN-domain at the C-terminus. Intriguingly, SUN2 has also been reported to interact with Rab5, which localizes in early endosomes. To clarify the dual subcellular localization of SUN2, we investigated its localization in lamin A/C deficient cells rescued with lamin A or lamin C isoform, and in HeLa cells transfected with Rab5 or its mutants. We found that expression of lamin A but not lamin C partly restored the nuclear envelope localization of SUN2. SUN2 was redistributed to endosomes upon overexpression of Rab5, but remained on the nuclear envelope when the SUN domain was deleted. To explore the physiological function of SUN2 in vesicle trafficking and endocytosis, we demonstrated the colocalization of endogenous SUN2 and Rab5. Moreover, overexpression of SUN2 stimulated the uptake of transferrin while suppression of SUN2 expression attenuated the process. These findings support a role of SUN2 in endocytosis.	[Liang, Ying; Chiu, Peng Hang; Yip, Kit Yan; Chan, Siu Yuen] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Liang, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China.	sychan@hku.hk		Chan, Siu Yuen/0000-0001-7262-1293	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU 7176/01M]; Edward Sai-Kim Hotung Paediatric Education and Research Fund; Faculty Core Imaging Facility of the Li Ka Shing Faculty of Medicine, the University of Hong Kong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Edward Sai-Kim Hotung Paediatric Education and Research Fund; Faculty Core Imaging Facility of the Li Ka Shing Faculty of Medicine, the University of Hong Kong(University of Hong Kong)	This work was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. HKU 7176/01M) and Edward Sai-Kim Hotung Paediatric Education and Research Fund. This work was also supported by the Faculty Core Imaging Facility of the Li Ka Shing Faculty of Medicine, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FROHNERT C, 2010, MOL HUM REPROD; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Harley CA, 2001, J VIROL, V75, P1236, DOI 10.1128/JVI.75.3.1236-1251.2001; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Malone CJ, 1999, DEVELOPMENT, V126, P3171; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sun GF, 2002, BBA-MOL BASIS DIS, V1588, P241, DOI 10.1016/S0925-4439(02)00171-0; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Wang Q, 2006, DNA CELL BIOL, V25, P554, DOI 10.1089/dna.2006.25.554; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	33	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20507	10.1371/journal.pone.0020507	http://dx.doi.org/10.1371/journal.pone.0020507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655223	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600084
J	Pandya, A; Weinstein, MC; Gaziano, TA				Pandya, Ankur; Weinstein, Milton C.; Gaziano, Thomas A.			A Comparative Assessment of Non-Laboratory-Based versus Commonly Used Laboratory-Based Cardiovascular Disease Risk Scores in the NHANES III Population	PLOS ONE			English	Article							COST-EFFECTIVENESS; ABSOLUTE RISK; FOLLOW-UP; PREVENTION; VALIDATION; WORLD	Background: National and international primary CVD risk screening guidelines focus on using total CVD risk scores. Recently, we developed a non-laboratory-based CVD risk score (inputs: age, sex, smoking, diabetes, systolic blood pressure, treatment of hypertension, body-mass index), which can assess risk faster and at lower costs compared to laboratory-based scores (inputs include cholesterol values). We aimed to assess the exchangeability of the non-laboratory-based risk score to four commonly used laboratory-based scores (Framingham CVD [2008, 1991 versions], and Systematic COronary Risk Evaluation [SCORE] for low and high risk settings) in an external validation population. Methods and Findings: Analyses were based on individual-level, score-specific rankings of risk for adults in the Third National Health and Nutrition Examination Survey (NHANES III) aged 25-74 years, without history of CVD or cancer (n = 5,999). Risk characterization agreement was based on overlap in dichotomous risk characterization (thresholds of 10-year risk > 10-20%) and Spearman rank correlation. Risk discrimination was assessed using receiver operator characteristic curve analysis (10-year CVD death outcome). Risk characterization agreement ranged from 91.9-95.7% and 94.2-95.1% with Spearman correlation ranges of 0.957-0.980 and 0.946-0.970 for men and women, respectively. In men, c-statistics for the non-laboratory-based, Framingham (2008, 1991), and SCORE (high, low) functions were 0.782, 0.776, 0.781, 0.785, and 0.785, with p-values for differences relative to the non-laboratory-based score of 0.44, 0.89, 0.68 and 0.65, respectively. In women, the corresponding c-statistics were 0.809, 0.834, 0.821, 0.792, and 0.792, with corresponding p-values of 0.04, 0.34, 0.11 and 0.09, respectively. Conclusions: Every score discriminated risk of CVD death well, and there was high agreement in risk characterization between non-laboratory-based and laboratory-based risk scores, which suggests that the non-laboratory-based score can be a useful proxy for Framingham or SCORE functions in resource-limited settings. Future external validation studies can assess whether the sex-specific risk discrimination results hold in other populations.	[Pandya, Ankur; Weinstein, Milton C.; Gaziano, Thomas A.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Gaziano, TA (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, 665 Huntington Ave, Boston, MA 02115 USA.	tgaziano@partners.org			National Heart, Lung and Blood Institute (NHLBI) [HHSN268200900030C]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TG is partially funded by the National Heart, Lung and Blood Institute (NHLBI) contract HHSN268200900030C. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BAISDEN KL, 2006, ENGIMA SURVEY DATA A, P194; BANK W, 2007, WORLD DEV INDICATORS; Chamnan P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1693; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Ezzati T M, 1992, Vital Health Stat 2, P1; GADDIS ML, 1990, ANN EMERG MED, V19, P1462, DOI 10.1016/S0196-0644(05)82622-8; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; *HLTH PEOPL 2010, 2000, SERV DOHAH; Jackson R, 2006, BMJ-BRIT MED J, V332, P617, DOI 10.1136/bmj.332.7542.617; LITTLE RJA, 1995, SIMULATION STUDY EVA, P257; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Panagiotakos DB, 2006, VASC HEALTH RISK MAN, V2, P309, DOI 10.2147/vhrm.2006.2.3.309; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Raghunathan TE., 2001, SURVEY METHODOL, V27, P10; Rubin DB, 2004, MULTIPLE IMPUTATION; *VIT HLTH, 1994, VIT HLTH STAT, V1, P1; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; World Health Organization, 2007, PREV CARD DIS POCK G	29	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20416	10.1371/journal.pone.0020416	http://dx.doi.org/10.1371/journal.pone.0020416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655241	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600064
J	Berrich, M; Kieda, C; Grillon, C; Monteil, M; Lamerant, N; Gavard, J; Boulouis, HJ; Haddad, N				Berrich, Moez; Kieda, Claudine; Grillon, Catherine; Monteil, Martine; Lamerant, Nathalie; Gavard, Julie; Boulouis, Henri Jean; Haddad, Nadia			Differential Effects of Bartonella henselae on Human and Feline Macro- and Micro-Vascular Endothelial Cells	PLOS ONE			English	Article							CAT-SCRATCH DISEASE; MOLECULAR EPIDEMIOLOGY; BACILLARY ANGIOMATOSIS; PROLIFERATION; INFECTION; EXPRESSION; HETEROGENEITY; ANGIOGENESIS; INDUCTION; DIVERSITY	Bartonella henselae, a zoonotic agent, induces tumors of endothelial cells (ECs), namely bacillary angiomatosis and peliosis in immunosuppressed humans but not in cats. In vitro studies on ECs represent to date the only way to explore the interactions between Bartonella henselae and vascular endothelium. However, no comparative study of the interactions between Bartonella henselae and human (incidental host) ECs vs feline (reservoir host) ECs has been carried out because of the absence of any available feline endothelial cell lines. To this purpose, we have developed nine feline EC lines which allowed comparing the effects of Bartonella strains on human and feline micro-vascular ECs representative of the infection development sites such as skin, versus macro-vascular ECs, such as umbilical vein. Our model revealed intrinsic differences between human (Human Skin Microvascular ECs -HSkMEC and Human Umbilical Vein ECs - iHUVEC) and feline ECs susceptibility to Bartonella henselae infection. While no effect was observed on the feline ECs upon Bartonella henselae infection, the human ones displayed accelerated angiogenesis and wound healing. Noticeable differences were demonstrated between human micro-and macro-vasculature derived ECs both in terms of pseudotube formation and healing. Interestingly, Bartonella henselae effects on human ECs were also elicited by soluble factors. Neither Bartonella henselae-infected Human Skin Microvascular ECs clinically involved in bacillary angiomatosis, nor feline ECs increased cAMP production, as opposed to HUVEC. Bartonella henselae could stimulate the activation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) in homologous cellular systems and trigger VEGF production by HSkMECs only, but not iHUVEC or any feline ECs tested. These results may explain the decreased pathogenic potential of Bartonella henselae infection for cats as compared to humans and strongly suggest that an autocrine secretion of VEGF by human skin endothelial cells might induce their growth and ultimately lead to bacillary angiomatosis formation.	[Berrich, Moez; Monteil, Martine; Boulouis, Henri Jean; Haddad, Nadia] Univ Paris Est, Ecole Natl Vet Alfort, Unite Mixte Rech Biol Mol & Immunol Parasitaires, Maisons Alfort, France; [Kieda, Claudine; Grillon, Catherine; Lamerant, Nathalie] CNRS, Ctr Biophys Mol, Unite Propre Rech 4301, Orleans, France; [Gavard, Julie] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Berrich, M (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, Unite Mixte Rech Biol Mol & Immunol Parasitaires, Maisons Alfort, France.	hjboulouis@vet-alfort.fr	Kieda, Claudine/U-1361-2019; Gavard, Julie/I-5487-2012; Grillon, Catherine/I-4974-2016; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Grillon, Catherine/0000-0001-5019-7831; Gavard, Julie/0000-0003-3107-2026	CNRS; Conseil Regional du Centre; Canceropole GO; Ligue Contre le Cancer (call Ile-de-France); Direction Generale de l'Enseignement et de la Recherche (Ministere de l'Agriculture, de l'Alimentation, de la Peche et des Affaires rurales)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional du Centre(Region Centre-Val de Loire); Canceropole GO; Ligue Contre le Cancer (call Ile-de-France); Direction Generale de l'Enseignement et de la Recherche (Ministere de l'Agriculture, de l'Alimentation, de la Peche et des Affaires rurales)	The authors gratefully acknowledge financial support from the CNRS, the Conseil Regional du Centre, the Canceropole GO, the Ligue Contre le Cancer (call Ile-de-France) and the Direction Generale de l'Enseignement et de la Recherche (Ministere de l'Agriculture, de l'Alimentation, de la Peche et des Affaires rurales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; BIZOUARNE N, 1993, BIOL CELL, V79, P27, DOI 10.1016/0248-4900(93)90259-H; BIZOUARNE N, 1993, BIOL CELL, V79, P209, DOI 10.1016/0248-4900(93)90139-6; Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Breitschwerdt EB, 2008, VET IMMUNOL IMMUNOP, V123, P167, DOI 10.1016/j.vetimm.2008.01.025; Buchmann AU, 2010, VET PATHOL, V47, P163, DOI 10.1177/0300985809354347; Buchmann AU, 2010, J CLIN MICROBIOL, V48, P3295, DOI 10.1128/JCM.00750-10; CARREAU A, 2011, J CELL MOL MED; Cerimele F, 2003, AM J PATHOL, V163, P1321, DOI 10.1016/S0002-9440(10)63491-8; Chang CC, 2002, J INFECT DIS, V186, P1733, DOI 10.1086/345764; CHANG CC, 2010, VET MICROBIOL; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; CONLEY T, 1994, J LAB CLIN MED, V124, P521; Conway EM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-207; Fournier PE, 2002, J CLIN MICROBIOL, V40, P3620, DOI 10.1128/JCM.40.10.3620-3624.2002; Guptill L, 2010, VET CLIN N AM-SMALL, V40, P1073, DOI 10.1016/j.cvsm.2010.07.009; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; Kieda C, 2002, ENDOTHELIUM-J ENDOTH, V9, P247, DOI 10.1080/10623320214736; Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603; KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; LEBOIT PE, 1989, AM J SURG PATHOL, V13, P909, DOI 10.1097/00000478-198911000-00001; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315; McCord AM, 2005, INFECT IMMUN, V73, P5735, DOI 10.1128/IAI.73.9.5735-5742.2005; McCord AM, 2007, DNA CELL BIOL, V26, P657, DOI 10.1089/dna.2007.0592; McCord AM, 2006, INFECT IMMUN, V74, P5185, DOI 10.1128/IAI.00622-06; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; Palmari J, 1996, ANAL CELL PATHOL, V11, P13; Pries A. R., 2006, V176, P1; Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018; Red-Horse K, 2006, J CLIN INVEST, V116, P2585, DOI 10.1172/JCI30058; REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992; Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06; Sander A, 1998, SCAND J INFECT DIS, V30, P387, DOI 10.1080/00365549850160693; Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x; SCHEIDEGGER F, 2010, CELL MICROBIOL; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Woestyn S, 2004, J CLIN MICROBIOL, V42, P1420, DOI 10.1128/JCM.42.4.1420-1427.2004; Yager JA, 2010, VET DERMATOL; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20204	10.1371/journal.pone.0020204	http://dx.doi.org/10.1371/journal.pone.0020204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637717	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500041
J	Swevers, L; Liu, JS; Huvenne, H; Smagghe, G				Swevers, Luc; Liu, Jisheng; Huvenne, Hanneke; Smagghe, Guy			Search for Limiting Factors in the RNAi Pathway in Silkmoth Tissues and the Bm5 Cell Line: The RNA-Binding Proteins R2D2 and Translin	PLOS ONE			English	Article							BOMBYX-MORI; DROSOPHILA; INTERFERENCE; SILKWORM; GENOME; EXPRESSION; SEQUENCE; GENES; METAMORPHOSIS; MECHANISMS	RNA interference (RNAi), an RNA-dependent gene silencing process that is initiated by double-stranded RNA (dsRNA) molecules, has been applied with variable success in lepidopteran insects, in contrast to the high efficiency achieved in the coleopteran Tribolium castaneum. To gain insight into the factors that determine the efficiency of RNAi, a survey was carried out to check the expression of factors that constitute the machinery of the small interfering RNA (siRNA) and microRNA (miRNA) pathways in different tissues and stages of the silkmoth, Bombyx mori. It was found that the dsRNA-binding protein R2D2, an essential component in the siRNA pathway in Drosophila, was expressed at minimal levels in silkmoth tissues. The silkmoth-derived Bm5 cell line was also deficient in expression of mRNA encoding full-length BmTranslin, an RNA-binding factor that has been shown to stimulate the efficiency of RNAi. However, despite the lack of expression of the RNA-binding proteins, silencing of a luciferase reporter gene was observed by co-transfection of luc dsRNA using a lipophilic reagent. In contrast, gene silencing was not detected when the cells were soaked in culture medium supplemented with dsRNA. The introduction of an expression construct for Tribolium R2D2 (TcR2D2) did not influence the potency of luc dsRNA to silence the luciferase reporter. Immunostaining experiments further showed that both TcR2D2 and BmTranslin accumulated at defined locations within the cytoplasm of transfected cells. Our results offer a first evaluation of the expression of the RNAi machinery in silkmoth tissues and Bm5 cells and provide evidence for a functional RNAi response to intracellular dsRNA in the absence of R2D2 and Translin. The failure of TcR2D2 to stimulate the intracellular RNAi pathway in Bombyx cells is discussed.	[Swevers, Luc] Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece; [Liu, Jisheng; Huvenne, Hanneke; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium	National Centre of Scientific Research "Demokritos"; Ghent University	Swevers, L (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece.	swevers@bio.demokritos.gr; guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Liu, Jisheng/0000-0003-0857-4298	Research Council of Ghent University (BOF-UGent); Fund for Scientific Research-Flanders (FWO-Vlaanderen), Brussels, Belgium [F 6/12]; General Secretariat for Research and Technology; Hellenic Republic Ministry of National Education and Religious Affairs, in Greece; University of Ghent in Belgium; Chinese Academy of Sciences (CSC); Research Council of Ghent University	Research Council of Ghent University (BOF-UGent)(Ghent University); Fund for Scientific Research-Flanders (FWO-Vlaanderen), Brussels, Belgium(FWO); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Hellenic Republic Ministry of National Education and Religious Affairs, in Greece; University of Ghent in Belgium; Chinese Academy of Sciences (CSC)(Chinese Academy of Sciences); Research Council of Ghent University(Ghent University)	The authors acknowledge support by the Research Council of Ghent University (BOF-UGent) (www.ugent.be), the Fund for Scientific Research-Flanders (FWO-Vlaanderen F 6/12, Brussels, Belgium) (www.fwo.be) and the General Secretariat for Research and Technology, Hellenic Republic Ministry of National Education and Religious Affairs, in Greece (Aristeia program) (www.gsrt.gr). Luc Swevers acknowledges the support by a scholarship for foreign researcher, special research fund, University of Ghent in Belgium (www.ugent.be). Jisheng Liu is the recipient of a doctoral grant from the Chinese Academy of Sciences (CSC) (cas.cn) and is supported by the Research Council of Ghent University (www.ugent.be). Hanneke Huvenne is a postdoctoral research fellow from the IWT-Vlaanderen (Brussel) (www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck M, 2003, VIROLOGY, V314, P521, DOI 10.1016/S0042-6822(03)00463-X; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; Consortium ISG., 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI DOI 10.1016/J.IBMB.2008.11.004; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Eliahoo E, 2010, NUCLEIC ACIDS RES, V38, P2975, DOI 10.1093/nar/gkp1230; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; Farrell PJ, 2000, PROTEINS, V41, P144, DOI 10.1002/1097-0134(20001001)41:1<144::AID-PROT160>3.3.CO;2-8; Georgomanolis T, 2009, INSECT BIOCHEM MOLEC, V39, P892, DOI 10.1016/j.ibmb.2009.10.006; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; Gupta GD, 2008, FEBS J, V275, P4235, DOI 10.1111/j.1742-4658.2008.06571.x; HANNAN GN, 2009, ECDYSONE STRUCTURES, P205; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Johnson JA, 2010, INSECT BIOCHEM MOLEC, V40, P394, DOI 10.1016/j.ibmb.2010.03.005; JOHNSON R, 1992, VIROLOGY, V190, P815, DOI 10.1016/0042-6822(92)90919-G; Kalidas S, 2008, MECH DEVELOP, V125, P475, DOI 10.1016/j.mod.2008.01.006; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Labropoulou V, 2008, CELL MICROBIOL, V10, P2118, DOI 10.1111/j.1462-5822.2008.01195.x; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Machado E, 2007, INSECT BIOCHEM MOLEC, V37, P876, DOI 10.1016/j.ibmb.2007.04.003; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Posnien N., 2009, COLD SPRING HARB PRO; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Soin T, 2010, PEST MANAG SCI, V66, P1215, DOI 10.1002/ps.1998; Swevers L, 2004, FASEB J, V18, P134, DOI 10.1096/fj.03-0627fje; Swevers L, 1999, INSECT BIOCHEM MOLEC, V29, P955, DOI 10.1016/S0965-1748(99)00059-4; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Rij RP, 2009, TRENDS MICROBIOL, V17, P163, DOI 10.1016/j.tim.2009.01.003; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	59	42	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20250	10.1371/journal.pone.0020250	http://dx.doi.org/10.1371/journal.pone.0020250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637842	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200043
J	Beck, EJ; Mandalia, S; Lo, G; Sharott, P; Youle, M; Anderson, J; Baily, G; Brettle, R; Fisher, M; Gompels, M; Kinghorn, G; Johnson, M; McCarron, B; Pozniak, A; Tang, A; Walsh, J; White, D; Williams, I; Gazzard, B				Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Sharott, Peter; Youle, Mike; Anderson, Jane; Baily, Guy; Brettle, Ray; Fisher, Martin; Gompels, Mark; Kinghorn, George; Johnson, Margaret; McCarron, Brendan; Pozniak, Anton; Tang, Alan; Walsh, John; White, David; Williams, Ian; Gazzard, Brian		NPMS-HHC Steering Grp	Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; HIV-INFECTION; SOUTH-AFRICA; POPULATION	Aim: Calculate time to first-line treatment failure, annual cost and cost-effectiveness of NNRTI versus PIboosted first-line HAART regimens in the UK, 1996-2006. Background: Population costs for HIV services are increasing in the UK and interventions need to be effective and efficient to reduce or stabilize costs. 2NRTIs + NNRTI regimens are cost-effective regimens for first-line HAART, but these regimens have not been compared with first-line PI(boosted) regimens. Methods: Times to first-line treatment failure and annual costs were calculated for first-line HAART regimens by CD4 count when starting HAART (2006 UK prices). Cost-effectiveness of 2NRTIs+NNRTI versus 2NRTIs+PI(boosted) regimens was calculated for four CD4 strata. Results: 55% of 5,541 people living with HIV (PLHIV) started HAART with CD4 count <= 200 cells/mm(3), many of whom were Black Africans. Annual treatment cost decreased as CD4 count increased; most marked differences were observed between starting HAART with CD4 <= 200 cells/mm3 compared with CD4 count >200 cells/mm3. 2NRTI+PI(boosted) and 2NRTI+NNRTI regimens were the most effective regimens across the four CD4 strata; 2NRTI+NNRTI was cost-saving or cost-effective compared with 2NRTI + PI(boosted) regimens. Conclusion: To ensure more effective and efficient provision of HIV services, 2NRTI+NNRTI should be started as first-line HAART regimen at CD4 counts <= 350 cell/mm3, unless specific contra-indications exist. This will increase the number of PLHIV receiving HAART and will initially increase population costs of providing HIV services. However, starting PLHIV earlier on cost-effective regimens will maintain them in better health and use fewer health or social services, thereby generating fewer treatment and care costs, enabling them to remain socially and economically active members of society. This does raise a number of ethical issues, which will have to be acknowledged and addressed, especially in countries with limited resources.	[Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Youle, Mike; Gazzard, Brian] NPMS HHC Coordinating & Analyt Ctr, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Sharott, Peter] London Procurement Programme, London Specialised Commissioning Grp, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, London, England; [Baily, Guy] London Hosp, London E1 1BB, England; [Baily, Guy] Barts Hosp, London, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Fisher, Martin] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [Kinghorn, George] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [McCarron, Brendan] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Pozniak, Anton; Gazzard, Brian] Chelsea & Westminster Hosp, London, England; [Tang, Alan] Royal Berkshire Hosp, Reading, Berks, England; [Walsh, John] St Marys Hosp, London, England; [White, David] Birmingham Heartsland Hosp, Birmingham, W Midlands, England; [Williams, Ian] Mortimer Market Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; Queen Mary University London; University of Brighton; Southmead Hospital; University of Sheffield; James Cook University Hospital; Imperial College London; Royal Berkshire Hospital; Imperial College London	Beck, EJ (corresponding author), NPMS HHC Coordinating & Analyt Ctr, London, England.	becke@unaids.org	Kinghorn, George/AAO-1425-2021; Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Kinghorn, George/0000-0001-6608-5076	Tibotec	Tibotec	During 2008/2009, the NPMS-HHC was financially supported through a non-restrictive grant from Tibotec, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 1999, AIDS, V13, P2157, DOI 10.1097/00002030-199910220-00020; Beck EJ, 1998, PHARMACOECONOMICS, V14, P639, DOI 10.2165/00019053-199814060-00005; Beck EJ, 2004, AIDS, V18, P2411; Beck EJ, 2003, BRIT J SEX MED, V27, P21; BECK EJ, 2010, 18 INT AIDS C VIENN; BECK EJ, 2003, BRIT J SEX MED, V27, P19; BECK EJ, 2008, USE COST HIV SERVICE; BECK EJ, 2006, HIV PANDEMIC LOCAL G, P769; BECK EJ, 2008, DECADE HAART, P45; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Crum-Cianflone NF, 2010, JAIDS-J ACQ IMM DEF, V54, P248, DOI 10.1097/QAI.0b013e3181c8ef22; Ford N, 2009, NEW ENGL J MED, V360, P1808, DOI 10.1056/NEJMp0902820; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; *INSIGHT COMM AD B, 2010, COMM STAT START TRIA; John A, 2010, MED CARE, V48, P1071; Josefsson L, 2010, CURR OPIN INFECT DIS, V23, P628, DOI 10.1097/QCO.0b013e32833ff1d0; Krentz HB, 2008, HIV MED, V9, P721, DOI 10.1111/j.1468-1293.2008.00613.x; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mandalia S, 2002, HIV Med, V3, P254, DOI 10.1046/j.1468-1293.2002.00110.x; Mandalia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015677; NEATON JD, 2009, STRATEGIC TIMING ANT; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; THAKKAR B, 1998, SUGI 23 MARCH 22 25; *UNAIDS PEPFAR, 2007, P WORKSH 15 17 MAY 2; Wagner B, 2010, LANCET, V376, P953, DOI 10.1016/S0140-6736(10)61442-0; WHO, 2010, ANT THER HIV INF AD; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009	36	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20200	10.1371/journal.pone.0020200	http://dx.doi.org/10.1371/journal.pone.0020200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633514	Green Published, Green Accepted, gold			2022-12-27	WOS:000291006500041
J	Mai, XQ; Ge, Y; Tao, L; Tang, HH; Liu, C; Luo, YJ				Mai, Xiaoqin; Ge, Yue; Tao, Lin; Tang, Honghong; Liu, Chao; Luo, Yue-Jia			Eyes Are Windows to the Chinese Soul: Evidence from the Detection of Real and Fake Smiles	PLOS ONE			English	Article							EMOTION RECOGNITION; FACIAL EXPRESSIONS; CULTURAL-DIFFERENCES; UNITED-STATES; ENJOYMENT; FACE; PERCEPTION; AMYGDALA; DAMAGE; JAPAN	How do people interpret the meaning of a smile? Previous studies with Westerners have found that both the eyes and the mouth are crucial in identifying and interpreting smiles, yet less is known about Easterners. Here we reported that when asking the Chinese to judge the Duchenne and non-Duchenne smiles as either real or fake, their accuracy and sensitivity were negatively correlated with their individualism scores but positively correlated with their collectivism scores. However, such correlations were found only for participants who stated the eyes to be the most useful references, but not for those who favored the mouth. Moreover, participants who favored the eyes were more accurate and sensitive than those who favored the mouth. Our results thus indicate that Chinese who follow the typical Eastern decoding process of using the eyes as diagnostic cues to identify and interpret others' facial expressions and social intentions, are particularly accurate and sensitive, the more they self-report greater collectivistic and lower individualistic values.	[Mai, Xiaoqin] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Ge, Yue; Tang, Honghong; Liu, Chao; Luo, Yue-Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tao, Lin] Chinese Univ Hong Kong, Dept Sociol, Hong Kong, Hong Kong, Peoples R China	University of Michigan System; University of Michigan; Beijing Normal University; Chinese University of Hong Kong	Mai, XQ (corresponding author), Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA.	Liuchao@bnu.edu.cn; Luoyj@bnu.edu.cn	Tao, Lin/B-4080-2011; Liu, Chao/E-9068-2017	Tao, Lin/0000-0003-3744-2067; Liu, Chao/0000-0003-1149-2314; Tang, Honghong/0000-0001-7588-0071	NSF China [30930031]; Ministry of Education, China [IRT0710]; National Key Technologies RD Program [2009BAI77B01]; NIH, USA [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	NSF China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); National Key Technologies RD Program(National Key Technology R&D Program); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the NSF China (30930031), the Ministry of Education, China (PCSIRT, IRT0710), National Key Technologies R&D Program (2009BAI77B01), and Global Research Initiative Program, NIH, USA (1R01TW007897) to Yue-Jia Luo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; ADOLPHS R, AMYGDALA FUNCTIONAL, P587; *BBC, SPOT FAK SMIL; Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656; Bellah R., 1985, HABITS HEART INDIVID; Bernstein MJ, 2008, PSYCHOL SCI, V19, P981, DOI 10.1111/j.1467-9280.2008.02187.x; Bernstein MJ, 2010, J EXP SOC PSYCHOL, V46, P196, DOI 10.1016/j.jesp.2009.08.010; Duchenne de Boulogne C.B., 1862, MECH HUMAN FACIAL EX; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; Ekman P., 2002, FACIAL ACTION CODING; Elfenbein HA, 2002, PSYCHOL BULL, V128, P243, DOI 10.1037//0033-2909.128.2.243; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; FRANK MG, 1993, HUMOR, V6, P9, DOI 10.1515/humr.1993.6.1.9; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; KIM MS, 1994, INT J INTERCULT REL, V18, P117, DOI 10.1016/0147-1767(94)90008-6; Kitayama S, 2000, COGNITION EMOTION, V14, P93, DOI 10.1080/026999300379003; Kontsevich LL, 2004, VISION RES, V44, P1493, DOI 10.1016/j.visres.2003.11.027; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Marshall J., 2003, CANONICAL SMILEY 1 L; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Matsumoto D, 2009, J NONVERBAL BEHAV, V33, P181, DOI 10.1007/s10919-009-0068-z; MCSHANE S, 2006, INDIVIDUALISM COLLEC; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; Niedenthal P. M., BEHAV BRAIN IN PRESS; Nugier A, 2009, EUR J SOC PSYCHOL, V39, P1126, DOI 10.1002/ejsp.602; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Pollack A., 1996, NY TIMES, pD5; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; SHWEDER RA, DOES CONCEPT PERSON, P97; Singelis T.M., 1995, CROSS-CULT RES, V29, P240, DOI [10.1177/106939719502900302, DOI 10.1177/106939719502900302]; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; THIBAULT P, WRINKLES EY IN PRESS; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Uchida Y, 2009, PERS SOC PSYCHOL B, V35, P1427, DOI 10.1177/0146167209347322; Williams LM, 2001, J PSYCHOPHYSIOL, V15, P122, DOI 10.1027//0269-8803.15.2.122; Yabar Y, 2007, NEW ZEAL J PSYCHOL, V36, P42; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	47	14	15	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19903	10.1371/journal.pone.0019903	http://dx.doi.org/10.1371/journal.pone.0019903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21647430	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500011
J	Vinot, N; Jouin, M; Lhomme-Duchadeuil, A; Guesnet, P; Alessandri, JM; Aujard, F; Pifferi, F				Vinot, Nina; Jouin, Melanie; Lhomme-Duchadeuil, Adrien; Guesnet, Philippe; Alessandri, Jean-Marc; Aujard, Fabienne; Pifferi, Fabien			Omega-3 Fatty Acids from Fish Oil Lower Anxiety, Improve Cognitive Functions and Reduce Spontaneous Locomotor Activity in a Non-Human Primate	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GLUCOSE-TRANSPORT; BRAIN; NEUROTRANSMISSION; DEFICIENT; MEMORY; SENESCENCE; MECHANISM; BEHAVIOR; RATS	Omega-3 (omega 3) polyunsaturated fatty acids (PUFA) are major components of brain cells membranes. omega 3 PUFA-deficient rodents exhibit severe cognitive impairments (learning, memory) that have been linked to alteration of brain glucose utilization or to changes in neurotransmission processes. omega 3 PUFA supplementation has been shown to lower anxiety and to improve several cognitive parameters in rodents, while very few data are available in primates. In humans, little is known about the association between anxiety and omega 3 fatty acids supplementation and data are divergent about their impact on cognitive functions. Therefore, the development of nutritional studies in non-human primates is needed to disclose whether a long-term supplementation with long-chain omega 3 PUFA has an impact on behavioural and cognitive parameters, differently or not from rodents. We address the hypothesis that omega 3 PUFA supplementation could lower anxiety and improve cognitive performances of the Grey Mouse Lemur (Microcebus murinus), a nocturnal Malagasy prosimian primate. Adult male mouse lemurs were fed for 5 months on a control diet or on a diet supplemented with long-chain omega 3 PUFA (n = 6 per group). Behavioural, cognitive and motor performances were measured using an open field test to evaluate anxiety, a circular platform test to evaluate reference spatial memory, a spontaneous locomotor activity monitoring and a sensory-motor test. omega 3-supplemented animals exhibited lower anxiety level compared to control animals, what was accompanied by better performances in a reference spatial memory task (80% of successful trials vs 35% in controls, p < 0.05), while the spontaneous locomotor activity was reduced by 31% in omega 3-supplemented animals (p < 0.001), a parameter that can be linked with lowered anxiety. The long-term dietary omega 3 PUFA supplementation positively impacts on anxiety and cognitive performances in the adult mouse lemur. The supplementation of human food with omega 3 fatty acids may represent a valuable dietary strategy to improve behavioural and cognitive functions.	[Vinot, Nina; Lhomme-Duchadeuil, Adrien; Aujard, Fabienne; Pifferi, Fabien] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Jouin, Melanie; Guesnet, Philippe; Alessandri, Jean-Marc] INRA, Lab Nutr & Regulat Lipid Fonct Cerebrales, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Vinot, N (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	pifferi@mnhn.fr		Pifferi, Fabien/0000-0001-9316-1935	Groupe Lipides et Nutrition; Centre National de la Recherche Scientifique/Museum National d'Histoire Naturelle; Institut National de la Recherche Agronomique	Groupe Lipides et Nutrition; Centre National de la Recherche Scientifique/Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique	This work was financially supported by the Groupe Lipides et Nutrition, the Centre National de la Recherche Scientifique/Museum National d'Histoire Naturelle, and the Institut National de la Recherche Agronomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri JM, 2004, REPROD NUTR DEV, V44, P509, DOI 10.1051/rnd:2004063; [Anonymous], APPORTS NUTR CONSEIL; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEGIN ME, 2010, RECENT ADV NUTR PREV; Bemrah N, 2009, PUBLIC HEALTH NUTR, V12, P599, DOI 10.1017/S1368980008002681; Carrie I, 2000, J LIPID RES, V41, P473; Chalon S, 1998, J NUTR, V128, P2512, DOI 10.1093/jn/128.12.2512; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chalon S, 2009, NEUROPHARMACOLOGY, V57, P636, DOI 10.1016/j.neuropharm.2009.08.012; da Silva AX, 2002, J NEUROCHEM, V81, P1328; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; DELION S, 1994, J NUTR, V124, P2466, DOI 10.1093/jn/124.12.2466; ENSLEN M, 1991, LIPIDS, V26, P203, DOI 10.1007/BF02543972; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; GUESNET P, 1993, EUR J CLIN NUTR, V47, P700; HARAUMA A, 2011, LIPIDS          0207; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kodas E, 2002, J LIPID RES, V43, P1209, DOI 10.1194/jlr.M200132-JLR200; Kuratko CN, 2009, PROSTAG LEUKOTR ESS, V81, P111, DOI 10.1016/j.plefa.2009.05.007; Lavialle M, 2008, J NUTR, V138, P1719, DOI 10.1093/jn/138.9.1719; Lavialle M, 2010, J NUTR BIOCHEM, V21, P899, DOI 10.1016/j.jnutbio.2009.12.005; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; PICQ JL, 2010, NEUROBIOL AGING 1021; Pifferi F, 2007, PROSTAG LEUKOTR ESS, V77, P279, DOI 10.1016/j.plefa.2007.10.011; Pifferi F, 2005, J NUTR, V135, P2241, DOI 10.1093/jn/135.9.2241; Pifferi F, 2010, NEUROCHEM INT, V56, P703, DOI 10.1016/j.neuint.2010.02.006; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Transler C, 2010, J ATTEN DISORD, V14, P232, DOI 10.1177/1087054709347250; Tsukada H, 2000, BRAIN RES, V862, P180, DOI 10.1016/S0006-8993(00)02115-6; UMEZAWA M, 1995, BRAIN RES, V669, P225, DOI 10.1016/0006-8993(94)01250-L; Weatherall D., USE NONHUMAN PRIMATE	41	55	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20491	10.1371/journal.pone.0020491	http://dx.doi.org/10.1371/journal.pone.0020491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666750	Green Published, gold, Green Submitted			2022-12-27	WOS:000291607000009
J	Campino, S; Auburn, S; Kivinen, K; Zongo, I; Ouedraogo, JB; Mangano, V; Djimde, A; Doumbo, OK; Kiara, SM; Nzila, A; Borrmann, S; Marsh, K; Michon, P; Mueller, I; Siba, P; Jiang, HY; Su, XZ; Amaratunga, C; Socheat, D; Fairhurst, RM; Imwong, M; Anderson, T; Nosten, F; White, NJ; Gwilliam, R; Deloukas, P; MacInnis, B; Newbold, CI; Rockett, K; Clark, TG; Kwiatkowski, DP				Campino, Susana; Auburn, Sarah; Kivinen, Katja; Zongo, Issaka; Ouedraogo, Jean-Bosco; Mangano, Valentina; Djimde, Abdoulaye; Doumbo, Ogobara K.; Kiara, Steven M.; Nzila, Alexis; Borrmann, Steffen; Marsh, Kevin; Michon, Pascal; Mueller, Ivo; Siba, Peter; Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Socheat, Duong; Fairhurst, Rick M.; Imwong, Mallika; Anderson, Timothy; Nosten, Francois; White, Nicholas J.; Gwilliam, Rhian; Deloukas, Panos; MacInnis, Bronwyn; Newbold, Christopher I.; Rockett, Kirk; Clark, Taane G.; Kwiatkowski, Dominic P.			Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; ANTIMALARIAL-DRUG RESISTANCE; MALARIA; GENOME; DIVERSITY; MICROSATELLITE; IDENTIFICATION; SEQUENCE; PCR	The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamics, with practical applications to malaria control. The ability to identify the geographic origin and trace the migratory patterns of parasites with clinically important phenotypes such as drug resistance is particularly relevant. With increasing single-nucleotide polymorphism (SNP) discovery from ongoing Plasmodium genome sequencing projects, a demand for high SNP and sample throughput genotyping platforms for large-scale population genetic studies is required. Low parasitaemias and multiple clone infections present a number of challenges to genotyping P. falciparum. We addressed some of these issues using a custom 384-SNP Illumina GoldenGate assay on P. falciparum DNA from laboratory clones (long-term cultured adapted parasite clones), short-term cultured parasite isolates and clinical (non-cultured isolates) samples from East and West Africa, Southeast Asia and Oceania. Eighty percent of the SNPs (n = 306) produced reliable genotype calls on samples containing as little as 2 ng of total genomic DNA and on whole genome amplified DNA. Analysis of artificial mixtures of laboratory clones demonstrated high genotype calling specificity and moderate sensitivity to call minor frequency alleles. Clear resolution of geographically distinct populations was demonstrated using Principal Components Analysis (PCA), and global patterns of population genetic diversity were consistent with previous reports. These results validate the utility of the platform in performing population genetic studies of P. falciparum.	[Campino, Susana; Auburn, Sarah; Kivinen, Katja; Gwilliam, Rhian; Deloukas, Panos; MacInnis, Bronwyn; Newbold, Christopher I.; Rockett, Kirk; Clark, Taane G.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT 0909, Australia; [Zongo, Issaka; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Mangano, Valentina] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy; [Djimde, Abdoulaye; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Kiara, Steven M.; Nzila, Alexis; Borrmann, Steffen; Marsh, Kevin] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Michon, Pascal; Siba, Peter] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Michon, Pascal; Mueller, Ivo] Divine Word Univ, Fac Hlth Sci, Madang, Papua N Guinea; [Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Anderson, Timothy] SW Fdn Biomed Res, San Antonio, TX 78284 USA; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [White, Nicholas J.] Mahidol Oxford Univ, Res Unit, Fac Trop Med, Bangkok, Thailand; [White, Nicholas J.; Newbold, Christopher I.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Rockett, Kirk; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Wellcome Trust Sanger Institute; Charles Darwin University; Menzies School of Health Research; Sapienza University Rome; University of Bamako; PNG Institute Of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Center Parasitology, Entomology & Malaria Control; Mahidol University; Mahidol University; Texas Biomedical Research Institute; Mahidol University; Mahidol University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Campino, S (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	sc11@sanger.ac.uk	Imwong, Mallika/ABE-6493-2020; mangano, valentina/I-2456-2012; Deloukas, Panos/B-2922-2013; Mueller, Ivo/C-7251-2013; Borrmann, Steffen/G-1838-2013; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; Campino, Susana/AAM-2577-2020; White, Nicholas J/I-4629-2012; Clark, Taane G./AAM-2570-2020; Auburn, Sarah/N-2266-2013	Deloukas, Panos/0000-0001-9251-070X; Mueller, Ivo/0000-0001-6554-6889; Borrmann, Steffen/0000-0001-9189-4393; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Su, Xinzhuan/0000-0003-3246-3248; Auburn, Sarah/0000-0002-4638-536X; Kwiatkowski, Dominic/0000-0002-5023-0176; Newbold, Chris/0000-0002-9274-3789; Kivinen, Katja/0000-0002-1135-7625; Mangano, Valentina D/0000-0002-2021-6162; Ouedraogo, Jean Bosco/0000-0003-0412-8733	Bill and Melinda Gates Foundation; Wellcome Trust; Medical Research Council-UK; European Developing Countries Clinical Trials Partnership; Division of Intramural Research of the National Institutes of Health and National Institute of Allergy and Infectious Diseases-USA; National Health and Medical Research Council-Australia; National Malaria Control Program; National Budget of the Institut de Recherche en Sciences de le Sante-Burkina Faso; Howard Hughes Medical Institution International Scholarship; MRC [G0600718, G19/9] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048071, ZIAAI001000, ZIAAI001066] Funding Source: NIH RePORTER; Medical Research Council [G19/9, G0600718] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Developing Countries Clinical Trials Partnership; Division of Intramural Research of the National Institutes of Health and National Institute of Allergy and Infectious Diseases-USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council-Australia(National Health and Medical Research Council (NHMRC) of Australia); National Malaria Control Program; National Budget of the Institut de Recherche en Sciences de le Sante-Burkina Faso; Howard Hughes Medical Institution International Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was in part funded by the Bill and Melinda Gates Foundation, Wellcome Trust, Medical Research Council-UK, European Developing Countries Clinical Trials Partnership, Division of Intramural Research of the National Institutes of Health and National Institute of Allergy and Infectious Diseases-USA, the National Health and Medical Research Council-Australia, The National Malaria Control Program and the National Budget of the Institut de Recherche en Sciences de le Sante-Burkina Faso. A. A. D. is supported by European and Developing Countries Clinical Trial Partnership Senior Fellowship and Howard Hughes Medical Institution International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Bonizzoni M, 2009, INFECT GENET EVOL, V9, P806, DOI 10.1016/j.meegid.2009.04.015; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Iwagami M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-96; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Leclerc MC, 2002, MICROBES INFECT, V4, P685, DOI 10.1016/S1286-4579(02)01587-3; MU J, NAT GENET, V42, P268; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; ROSARIO V, 1981, SCIENCE, V212, P1037, DOI 10.1126/science.7015505; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wang Y, 2009, J PARASITOL, V95, P253, DOI 10.1645/GE-1706.1; White NJ, 1998, BRIT MED BULL, V54, P703, DOI 10.1093/oxfordjournals.bmb.a011721; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0	26	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20251	10.1371/journal.pone.0020251	http://dx.doi.org/10.1371/journal.pone.0020251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673999	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000291356400003
J	Ng, TFF; Willner, DL; Lim, YW; Schmieder, R; Chau, B; Nilsson, C; Anthony, S; Ruan, YJ; Rohwer, F; Breitbart, M				Ng, Terry Fei Fan; Willner, Dana L.; Lim, Yan Wei; Schmieder, Robert; Chau, Betty; Nilsson, Christina; Anthony, Simon; Ruan, Yijun; Rohwer, Forest; Breitbart, Mya			Broad Surveys of DNA Viral Diversity Obtained through Viral Metagenomics of Mosquitoes	PLOS ONE			English	Article							CULEX-ERYTHROTHORAX; STOOL SAMPLES; VIRUSES; TRANSMISSION; AMPLIFICATION; BLOOD; DENSOVIRUSES; PARVOVIRUS; COMMUNITY; SELECTION	Viruses are the most abundant and diverse genetic entities on Earth; however, broad surveys of viral diversity are hindered by the lack of a universal assay for viruses and the inability to sample a sufficient number of individual hosts. This study utilized vector-enabled metagenomics (VEM) to provide a snapshot of the diversity of DNA viruses present in three mosquito samples from San Diego, California. The majority of the sequences were novel, suggesting that the viral community in mosquitoes, as well as the animal and plant hosts they feed on, is highly diverse and largely uncharacterized. Each mosquito sample contained a distinct viral community. The mosquito viromes contained sequences related to a broad range of animal, plant, insect and bacterial viruses. Animal viruses identified included anelloviruses, circoviruses, herpesviruses, poxviruses, and papillomaviruses, which mosquitoes may have obtained from vertebrate hosts during blood feeding. Notably, sequences related to human papillomaviruses were identified in one of the mosquito samples. Sequences similar to plant viruses were identified in all mosquito viromes, which were potentially acquired through feeding on plant nectar. Numerous bacteriophages and insect viruses were also detected, including a novel densovirus likely infecting Culex erythrothorax. Through sampling insect vectors, VEM enables broad survey of viral diversity and has significantly increased our knowledge of the DNA viruses present in mosquitoes.	[Ng, Terry Fei Fan; Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Willner, Dana L.; Lim, Yan Wei; Chau, Betty; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schmieder, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Lim, Yan Wei; Nilsson, Christina; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Anthony, Simon] San Diego Zoos Inst Conservat Res, Wildlife Dis Labs, San Diego, CA USA	State University System of Florida; University of South Florida; California State University System; San Diego State University; California State University System; San Diego State University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Zoological Society of San Diego	Ng, TFF (corresponding author), Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.	mya@marine.usf.edu	Ng, Terry Fei Fan/H-5305-2019; Breitbart, Mya/B-1366-2009; Rohwer, Forest/AAC-5315-2019	Ng, Terry Fei Fan/0000-0002-4815-8697; Breitbart, Mya/0000-0003-3210-2899; Rohwer, Forest/0000-0003-1548-5429	Canadian Institute for Advanced Research (CIFAR); National Science Foundation [DEB-1025915]; William and Elsie Knight Oceanographic Fellowship	Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); National Science Foundation(National Science Foundation (NSF)); William and Elsie Knight Oceanographic Fellowship	Funding: This work was funded through a grant to FR from the Canadian Institute for Advanced Research (CIFAR) and National Science Foundation grant DEB-1025915 to MB. TFFN was funded by the William and Elsie Knight Oceanographic Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Barreau C, 1997, AM J TROP MED HYG, V57, P126, DOI 10.4269/ajtmh.1997.57.126; Biagini P, 2006, J MED VIROL, V78, P298, DOI 10.1002/jmv.20539; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2010, J GEN VIROL, V91, P74, DOI 10.1099/vir.0.015446-0; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Cheng LP, 2007, SCI CHINA SER C, V50, P70, DOI 10.1007/s11427-007-2036-3; DALMAT HT, 1958, J EXP MED, V108, P9, DOI 10.1084/jem.108.1.9; Davidson I, 2008, VIRUS RES, V137, P1, DOI 10.1016/j.virusres.2008.06.014; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Huang C, 2001, J VIROL METHODS, V94, P121, DOI 10.1016/S0166-0934(01)00279-8; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Leary TP, 1999, J GEN VIROL, V80, P2115, DOI 10.1099/0022-1317-80-8-2115; Li L, 2010, J VIROL, V91, P74; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Lood R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-139; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; NG TFF, 2011, PLOS ONE IN PRESS; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Rwegoshora R. Theophil, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P630; Sambrook J., 2001, MOL CLONING LAB MANU; Schmieder R, 2011, BIOINFORMATICS; Shibata I, 2003, J VET MED SCI, V65, P405, DOI 10.1292/jvms.65.405; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tietze NS, 2003, J AM MOSQUITO CONTR, V19, P134; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Walton WE, 1999, J MED ENTOMOL, V36, P30, DOI 10.1093/jmedent/36.1.30; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	65	164	166	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20579	10.1371/journal.pone.0020579	http://dx.doi.org/10.1371/journal.pone.0020579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674005	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400009
J	Terao, C; Ohmura, K; Katayama, M; Takahashi, M; Kokubo, M; Diop, G; Toda, Y; Yamamoto, N; Shinkura, R; Shimizu, M; Gut, I; Heath, S; Melchers, I; Manabe, T; Lathrop, M; Mimori, T; Yamada, R; Matsuda, F				Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Takahashi, Meiko; Kokubo, Miki; Diop, Gora; Toda, Yoshinobu; Yamamoto, Natsuki; Shinkura, Reiko; Shimizu, Masakazu; Gut, Ivo; Heath, Simon; Melchers, Inga; Manabe, Toshiaki; Lathrop, Mark; Mimori, Tsuneyo; Yamada, Ryo; Matsuda, Fumihiko		Human Dis; Rheumatoid Arthritis RA Clinical	Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis-A Genome-Wide Study Combined with Immunological Analyses	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; CYCLIC CITRULLINATED PEPTIDE; PADI4 GENE; FUNCTIONAL HAPLOTYPE; MULTIPLE-SCLEROSIS; ASSOCIATION; ANTIBODIES; SUSCEPTIBILITY; PHOSPHATASE; POPULATION	Rheumatoid arthritis (RA) is a major cause of adult chronic inflammatory arthritis and a typical complex trait. Although several genetic determinants have been identified, they account for only a part of the genetic susceptibility. We conducted a genome-wide association study of RA in Japanese using 225,079 SNPs genotyped in 990 cases and 1,236 controls from two independent collections (658 cases and 934 controls in collection1; 332 cases and 302 controls in collection2), followed by replication studies in two additional collections (874 cases and 855 controls in collection3; 1,264 cases and 948 controls in collection4). SNPs showing p<0.005 in the first two collections and p<10(-4) by meta-analysis were further genotyped in the latter two collections. A novel risk variant, rs2000811, in intron2 of the myelin basic protein (MBP) at chromosome 18q23 showed strong association with RA (p = 2.7x10(-8), OR 1.23, 95% CI: 1.14-1.32). The transcription of MBP was significantly elevated with the risk allele compared to the alternative allele (p<0.001). We also established by immunohistochemistry that MBP was expressed in the synovial lining layer of RA patients, the main target of inflammation in the disease. Circulating autoantibody against MBP derived from human brain was quantified by ELISA between patients with RA, other connective tissue diseases and healthy controls. As a result, the titer of anti-MBP antibody was markedly higher in plasma of RA patients compared to healthy controls (p<0.001) and patients with other connective tissue disorders (p<0.001). ELISA experiment using citrullinated recombinant MBP revealed that a large fraction of anti-MBP antibody in RA patients recognized citrullinated MBP. This is the first report of a genetic study in RA implicating MBP as a potential autoantigen and its involvement in pathogenesis of the disease.	[Terao, Chikashi; Takahashi, Meiko; Kokubo, Miki; Diop, Gora; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Yamamoto, Natsuki; Shimizu, Masakazu; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Global Ctr Excellence COE Program, Kyoto, Japan; [Kokubo, Miki; Matsuda, Fumihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST Program, Kawaguchi, Saitama, Japan; [Toda, Yoshinobu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto, Japan; [Shinkura, Reiko] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Gut, Ivo; Heath, Simon; Lathrop, Mark] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Melchers, Inga] Univ Med Ctr, Clin Res Unit Rheumatol, Freiburg, Germany; [Manabe, Toshiaki] Kyoto Univ, Grad Sch Med, Lab Diagnost Pathol, Kyoto, Japan; [Lathrop, Mark] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Unit Stat Genet, Kyoto, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, Unite U852, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; Kyoto University; Foundation Jean Dausset-CEPH; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	fumi@genome.med.kyoto-u.ac.jp	Heath, Simon C/J-4138-2012; Matsuda, Fumihiko/B-9893-2009; Gut, Ivo/ABF-3188-2020	Heath, Simon C/0000-0002-9550-0897; Gut, Ivo/0000-0001-7219-632X; Yamada, Ryo/0000-0002-1587-630X; Takahashi, Meiko/0000-0002-8344-5472	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; JSPS; Core Research of Evolutional Science Technology; Solution-Oriented Research for Science and Technology; Japan Science and Technology Agency; MEXT; Ministry of Health, Labour and Welfare in Japan; Institut National de la Sante et de la Recherche Medicale in France; Okawa Foundation for Information and Telecommunications	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research of Evolutional Science Technology; Solution-Oriented Research for Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Institut National de la Sante et de la Recherche Medicale in France; Okawa Foundation for Information and Telecommunications	C.T. is an associate fellow of Global Centers of Excellence program supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (http://www.mext.go.jp/english/). G.D. is a postdoctoral fellow of Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/) and M.A. is a research member of Core University Program supported by JSPS (http://www.jsps.go.jp/english/). The study was supported in part by Core Research of Evolutional Science & Technology (http://www.jst.go.jp/kisoken/crest/en/index.html), Solution-Oriented Research for Science and Technology (http://www.jst.go.jp/kisoken/sorst/en/index.html), Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html), and by grants-in-aid for scientific research from MEXT (http://www.mext.go.jp/english/) and from the Ministry of Health, Labour and Welfare in Japan (http://www.mhlw.go.jp/english/index.html), by the Institut National de la Sante et de la Recherche Medicale in France (http://english.inserm.fr/), and by Okawa Foundation for Information and Telecommunications (http://www.okawa-foundation.or.jp/e/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boire G, 2005, ARTHRITIS RES THER, V7, pR592, DOI 10.1186/ar1719; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Caponi L, 2005, ANN RHEUM DIS, V64, P587, DOI 10.1136/ard.2004.026831; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Lutton JD, 2004, EXP BIOL MED, V229, P12, DOI 10.1177/153537020422900102; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Reindl M, 1999, BRAIN, V122, P2047, DOI 10.1093/brain/122.11.2047; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Suzuki T, 2008, CANCER EPIDEM BIOMAR, V17, P2742, DOI 10.1158/1055-9965.EPI-08-0470; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11	47	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20457	10.1371/journal.pone.0020457	http://dx.doi.org/10.1371/journal.pone.0020457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673997	gold, Green Submitted, Green Published			2022-12-27	WOS:000291355500019
J	Ciaranello, AL; Perez, F; Maruva, M; Chu, J; Engelsmann, B; Keatinge, J; Walensky, RP; Mushavi, A; Mugwagwa, R; Dabis, F; Freedberg, KA				Ciaranello, Andrea L.; Perez, Freddy; Maruva, Matthews; Chu, Jennifer; Engelsmann, Barbara; Keatinge, Jo; Walensky, Rochelle P.; Mushavi, Angela; Mugwagwa, Rumbidzai; Dabis, Francois; Freedberg, Kenneth A.		CEPAC Int Investigators	WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY PROGRAMS; TREATMENT INTERRUPTION STRATEGY; DAR-ES-SALAAM; COST-EFFECTIVENESS; SOUTH-AFRICA; PREGNANT-WOMEN; FOLLOW-UP; RANDOMIZED-TRIAL; ZIDOVUDINE	Background: The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens. Methods: Published HIV and PMTCT models, with local trial and programmatic data, were used to simulate a cohort of HIV-infected, pregnant/breastfeeding women in Zimbabwe (mean age 24.0 years, mean CD4 451 cells/mu L). We compared five PMTCT regimens at a fixed level of PMTCT medication uptake: 1) no antenatal ARVs (comparator); 2) sdNVP; 3) WHO 2010 guidelines using "Option A" (zidovudine during pregnancy/infant NVP during breastfeeding for women without advanced HIV disease; lifelong 3-drug antiretroviral therapy (ART) for women with advanced disease); 4) WHO "Option B" (ART during pregnancy/breastfeeding without advanced disease; lifelong ART with advanced disease); and 5) "Option B+:" lifelong ART for all pregnant/breastfeeding, HIV-infected women. Pediatric (4-6 week and 18-month infection risk, 2-year survival) and maternal (2-and 5-year survival, life expectancy from delivery) outcomes were projected. Results: Eighteen-month pediatric infection risks ranged from 25.8% (no antenatal ARVs) to 10.9% (Options B/B+). Although maternal short-term outcomes (2-and 5-year survival) varied only slightly by regimen, maternal life expectancy was reduced after receipt of sdNVP (13.8 years) or Option B (13.9 years) compared to no antenatal ARVs (14.0 years), Option A (14.0 years), or Option B+ (14.5 years). Conclusions: Replacement of sdNVP with currently recommended regimens for PMTCT (WHO Options A, B, or B+) is necessary to reduce infant HIV infection risk in Zimbabwe. The planned transition to Option A may also improve both pediatric and maternal outcomes.	[Ciaranello, Andrea L.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Perez, Freddy; Dabis, Francois] Univ Bordeaux 2, INSERM, U897, Africa Team,ISPED, F-33076 Bordeaux, France; [Perez, Freddy] Pan Amer Hlth Org, HIV AIDS Unit, Washington, DC USA; [Maruva, Matthews; Keatinge, Jo] Elizabeth Glaser Pediat AIDS Fdn Zimbabwe Cty Off, Harare, Zimbabwe; [Chu, Jennifer; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Engelsmann, Barbara] Org Publ Hlth Intervent & Dev OPHID Trust, Harare, Zimbabwe; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Mushavi, Angela; Mugwagwa, Rumbidzai] Minist Hlth & Child Welf, Harare, Zimbabwe	Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Pan American Health Organization; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ciaranello, AL (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	aciaranello@partners.org	Perez, Freddy/AAN-3893-2020; Anglaret, Xavier/F-7333-2013; , Andrea/ABB-3330-2021; DABIS, FRANCOIS/S-9298-2019	, Andrea/0000-0002-4268-3263; DABIS, FRANCOIS/0000-0002-1614-8857; Lipsitch, Marc/0000-0003-1504-9213; , International Journal of Business and Applied Social Science/0000-0001-7850-0193; Perez, Freddy/0000-0003-2001-0057; Anglaret, Xavier/0000-0003-3319-8423; Walensky, Rochelle P./0000-0002-8795-379X	Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Disease [K01 AI078754, K24 AI062476, R01 AI058736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI078754, UM1AI068632, K24AI062476, U01AI068632, R01AI058736] Funding Source: NIH RePORTER	Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the Elizabeth Glaser Pediatric AIDS Foundation (all authors) and the National Institute of Allergy and Infectious Disease (K01 AI078754 (ALC), K24 AI062476 (KAF), and R01 AI058736 (KAF, RPW, RW, JC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Barker PM, 2010, J ACQ IMMUN DEF SYND, V56, pe45; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chigwedere P, 2008, AIDS RES HUM RETROV, V24, P827, DOI 10.1089/aid.2007.0291; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; Ciaranello AL, 2008, AIDS, V22, P2359, DOI 10.1097/QAD.0b013e3283189bd7; Cleary S, 2005, HLTH SYSTEMS TRUST S; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Dabis F, 2005, AIDS, V19, P309; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; de Vincenzi I, 2010, JAIDS-J ACQ IMM DEF, V54, P533, DOI 10.1097/QAI.0b013e3181e36634; DEVINCENZI I, 2009, KENY 5 IAS C HIV PAT; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; ENGELSMANN B, 2008, MOPE0521 ENHANCING U, P174; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Johri Mira, 2011, Cost Eff Resour Alloc, V9, P3, DOI 10.1186/1478-7547-9-3; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; *KESH BOR STUD GRO, 2011, LANCET INFECT DIS; *KESH BOR STUD GRO, 2010, THLBB105 IMP TRIPL A; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Kuhn L, 2009, JAIDS-J ACQ IMM DEF, V52, P132, DOI 10.1097/QAI.0b013e3181ab6d5e; KUMWENDA J, 2009, WEPDD106 COVERAGE HI; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 1998, LANCET, V352, P597, DOI 10.1016/S0140-6736(98)01419-6; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; MARAZZI MC, 2009, 5 IAS C HIV PATH TRE; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; MARSTON M, 2011, INT J EPIDEMIOL; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MEYERRATH G, 2010, THLBB103 COST EARLY; MOFENSON L, 2009, TUPEC053 INFANT EXTE; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; *NAT I HLTH IMPAAC, 2010, P1077 PROMISE STUD P; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Saba J, 2002, LANCET, V359, P1178; SCHOUTEN E, 2010, MAKING IT HAPPEN REV; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Soorapanth S, 2006, JAIDS-J ACQ IMM DEF, V42, P213, DOI 10.1097/01.qai.0000214812.72916.bc; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thistle P, 2004, Cent Afr J Med, V50, P79; Thistle P, 2007, CLIN INFECT DIS, V44, P111, DOI 10.1086/508869; THOMAS T, 2008, 45ALB PREVENTION MOT; Toro PL, 2010, AIDS, V24, P515, DOI 10.1097/QAD.0b013e3283350ecd; *UNAIDS UNICEF WHO, 2009, CHILDR AIDS 4 STOCKT; United Nations, 2009, WORLD POP PROSP 2008; VYANKANDONDERA J, 2003, N LB7 REDUCING RISK; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2006, ANT DRUGS TREAT PREG; World Bank, 2009, DAT STAT COUNTR CLAS; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43; *ZIMB MIN HLTH, 2009, NAT HIV EST 2009; *ZIMB MIN HLTH CHI, 2008, MAT PER MORT STUD 20; *ZIMB MIN HLTH CHI, 2009, NATL DRUG THER POL A	89	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20224	10.1371/journal.pone.0020224	http://dx.doi.org/10.1371/journal.pone.0020224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655097	Green Submitted, gold, Green Published			2022-12-27	WOS:000291310600006
J	Lo, KA; Bauchmann, MK; Baumann, AP; Donahue, CJ; Thiede, MA; Hayes, LS; des Etages, SAG; Fraenkel, E				Lo, Kinyui Alice; Bauchmann, Mary K.; Baumann, Amy P.; Donahue, Christopher J.; Thiede, Mark A.; Hayes, Lisa S.; des Etages, Shelley Ann G.; Fraenkel, Ernest			Genome-Wide Profiling of H3K56 Acetylation and Transcription Factor Binding Sites in Human Adipocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LARGE GENE LISTS; HEPATIC GLUCONEOGENESIS; HUMAN ADIPOGENESIS; PPAR-GAMMA; HISTONE H3; LYSINE 56; EXPRESSION; SIRT1; METFORMIN	The growing epidemic of obesity and metabolic diseases calls for a better understanding of adipocyte biology. The regulation of transcription in adipocytes is particularly important, as it is a target for several therapeutic approaches. Transcriptional outcomes are influenced by both histone modifications and transcription factor binding. Although the epigenetic states and binding sites of several important transcription factors have been profiled in the mouse 3T3-L1 cell line, such data are lacking in human adipocytes. In this study, we identified H3K56 acetylation sites in human adipocytes derived from mesenchymal stem cells. H3K56 is acetylated by CBP and p300, and deacetylated by SIRT1, all are proteins with important roles in diabetes and insulin signaling. We found that while almost half of the genome shows signs of H3K56 acetylation, the highest level of H3K56 acetylation is associated with transcription factors and proteins in the adipokine signaling and Type II Diabetes pathways. In order to discover the transcription factors that recruit acetyltransferases and deacetylases to sites of H3K56 acetylation, we analyzed DNA sequences near H3K56 acetylated regions and found that the E2F recognition sequence was enriched. Using chromatin immunoprecipitation followed by high-throughput sequencing, we confirmed that genes bound by E2F4, as well as those by HSF-1 and C/EBP alpha, have higher than expected levels of H3K56 acetylation, and that the transcription factor binding sites and acetylation sites are often adjacent but rarely overlap. We also discovered a significant difference between bound targets of C/EBP alpha in 3T3-L1 and human adipocytes, highlighting the need to construct species-specific epigenetic and transcription factor binding site maps. This is the first genome-wide profile of H3K56 acetylation, E2F4, C/EBP alpha and HSF-1 binding in human adipocytes, and will serve as an important resource for better understanding adipocyte transcriptional regulation.	[Lo, Kinyui Alice; Fraenkel, Ernest] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Fraenkel, Ernest] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Bauchmann, Mary K.; Baumann, Amy P.; Donahue, Christopher J.; Thiede, Mark A.] Pfizer Global Res & Dev, Genetically Modified Models Res Ctr Emphasis, Groton, CT USA; [Hayes, Lisa S.; des Etages, Shelley Ann G.] Pfizer Global Res & Dev, Cardiovasc, Metab & Endocrine Dis, Groton, CT USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Pfizer; Pfizer	Lo, KA (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fraenkel-admin@mit.edu		Fraenkel, Ernest/0000-0001-9249-8181	Agency of Science, Technology and Research, Singapore; Eugene Bell Career Development Chair; National Science Foundation [DBI-0821391]; Pfizer Inc.	Agency of Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Eugene Bell Career Development Chair; National Science Foundation(National Science Foundation (NSF)); Pfizer Inc.(Pfizer)	K.A.L is supported by the National Science Scholarship from Agency of Science, Technology and Research, Singapore. E. F. is the recipient of the Eugene Bell Career Development Chair. This work used computing resources funded by the National Science Foundation under Award No. DBI-0821391. This research was funded by Pfizer Inc., and the co-authors who are Pfizer employees were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Butcher NJ, 2010, CARCINOGENESIS, V31, P820, DOI 10.1093/carcin/bgq042; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; Cowherd RM, 1997, BIOCHEM BIOPH RES CO, V237, P470, DOI 10.1006/bbrc.1997.7160; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swart GWM, 1997, BIOL CHEM, V378, P373, DOI 10.1515/bchm.1997.378.5.373; Thomas PD, 2007, CURR OPIN CHEM BIOL, V11, P4, DOI 10.1016/j.cbpa.2006.11.039; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829	31	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e19778	10.1371/journal.pone.0019778	http://dx.doi.org/10.1371/journal.pone.0019778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655096	Green Submitted, Green Published, gold			2022-12-27	WOS:000291310600004
J	Lin, MJ; Cheng, CW; Shen, CKJ				Lin, Meng-Jau; Cheng, Ching-Wei; Shen, C. -K. James			Neuronal Function and Dysfunction of Drosophila dTDP	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; BINDING-PROPERTIES; ACID BINDING; PROTEIN; MICE; FTLD; ALS; INCLUSIONS	Background: TDP-43 is an RNA-and DNA-binding protein well conserved in animals including the mammals, Drosophila, and C. elegans. In mammals, the multi-function TDP-43 encoded by the TARDBP gene is a signature protein of the ubiquitin-positive inclusions (UBIs) in the diseased neuronal/glial cells of a range of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-U). Methodology/Principal Findings: We have studied the function and dysfunction of the Drosophila ortholog of the mammalian TARDBP gene, dTDP, by genetic, behavioral, molecular, and cytological analyses. It was found that depletion of dTDP expression caused locomotion defect accompanied with an increase of the number of boutons at the neuromuscular junctions (NMJ). These phenotypes could be rescued by overexpression of Drosophila dTDP in the motor neurons. In contrast, overexpression of dTDP in the motor neurons also resulted in reduced larval and adult locomotor activities, but this was accompanied by a decrease of the number of boutons and axon branches at NMJ. Significantly, constitutive overexpression of dTDP in the mushroom bodies caused smaller axonal lobes as well as severe learning deficiency. On the other hand, constitutive mushroom body-specific knockdown of dTDP expression did not affect the structure of the mushroom bodies, but it impaired the learning ability of the flies, albeit moderately. Overexpression of dTDP also led to the formation of cytosolic dTDP (+) aggregates. Conclusion/Significance: These data together demonstrate the neuronal functions of dTDP, and by implication the mammalian TDP-43, in learning and locomotion. The effects of mis-expression of dTDP on Drosophila NMJ suggest that eukaryotic TDP-43 guards against over development of the synapses. The conservation of the regulatory pathways of functions and dysfunctions of Drosophila dTDP and mammalian TDP-43 also shows the feasibility of using the flies as a model system for studying the normal TDP-43 function and TDP-43 proteinopathies in the vertebrates including human.	[Lin, Meng-Jau; Cheng, Ching-Wei; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Cheng, Ching-Wei; Shen, C. -K. James] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Lin, MJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		Academia Sinica (AS); National Science Council, Taipei, ROC	Academia Sinica (AS)(Academia Sinica - Taiwan); National Science Council, Taipei, ROC(Ministry of Science and Technology, Taiwan)	This research was supported by the Academia Sinica (AS) and National Science Council, Taipei, ROC. M. -J. Lin was a NSC postdoctoral fellow and C. -K. J. Shen is an AS Investigator Awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kasai T, 2009, ACTA NEUROPATHOL, V117, P55, DOI 10.1007/s00401-008-0456-1; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lee T, 1999, DEVELOPMENT, V126, P4065; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	39	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20371	10.1371/journal.pone.0020371	http://dx.doi.org/10.1371/journal.pone.0020371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673800	Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900015
J	Wang, HY; Lu, HHS; Chueh, TH				Wang, Hsiuying; Lu, Henry Horng-Shing; Chueh, Tung-Hung			Constructing Biological Pathways by a Two-Step Counting Approach	PLOS ONE			English	Article							EXACT CONFIDENCE COEFFICIENTS; GENE REGULATORY NETWORKS; SACCHAROMYCES-CEREVISIAE; BOOLEAN NETWORKS; MAPK PATHWAYS; CELL-CYCLE; INTERVALS; PROPORTIONS; MODEL; HOG	Networks are widely used in biology to represent the relationships between genes and gene functions. In Boolean biological models, it is mainly assumed that there are two states to represent a gene: on-state and off-state. It is typically assumed that the relationship between two genes can be characterized by two kinds of pairwise relationships: similarity and prerequisite. Many approaches have been proposed in the literature to reconstruct biological relationships. In this article, we propose a two-step method to reconstruct the biological pathway when the binary array data have measurement error. For a pair of genes in a sample, the first step of this approach is to assign counting numbers for every relationship and select the relationship with counting number greater than a threshold. The second step is to calculate the asymptotic p-values for hypotheses of possible relationships and select relationships with a large p-value. This new method has the advantages of easy calculation for the counting numbers and simple closed forms for the p-value. The simulation study and real data example show that the two-step counting method can accurately reconstruct the biological pathway and outperform the existing methods. Compared with the other existing methods, this two-step method can provide a more accurate and efficient alternative approach for reconstructing the biological network.	[Wang, Hsiuying; Lu, Henry Horng-Shing; Chueh, Tung-Hung] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan	National Yang Ming Chiao Tung University	Wang, HY (corresponding author), Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan.	wang@stat.nctu.edu.tw	Wang, Hsiuying/CAJ-3855-2022; Wang, Hsiuying/AAB-7115-2021	Wang, Hsiuying/0000-0002-5863-0756	National Science Council [NSC 99-2118-M-009-001-MY2, NSC 98-2118-M-009-004-MY3]; National Center for Theoretical Sciences; Center of Mathematical Modeling and Scientific Computing	National Science Council(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences; Center of Mathematical Modeling and Scientific Computing	National Science Council (NSC 99-2118-M-009-001-MY2, NSC 98-2118-M-009-004-MY3), National Center for Theoretical Sciences, and Center of Mathematical Modeling and Scientific Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akutsu T, 1999, Pac Symp Biocomput, P17; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ay F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007992; BICKEL PJ, 2000, MATH STAT BASIC IDEA, V1; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; CHEN T, 1999, P PAC S BIOC, V4, P29; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; HUBBLE J, 2009, IMPLEMENTATION GENEP; Jensen FV, 2007, BAYESIAN NETWORKS DE; Jensen ST, 2007, ANN APPL STAT, V1, P612, DOI 10.1214/07-AOAS130; Kauffman S, 1971, Curr Top Dev Biol, V6, P145, DOI 10.1016/S0070-2153(08)60640-7; KAUFFMAN SA, 1979, LECT NOTES BIOMATH, V29, P30; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Li LM, 2005, J COMPUT BIOL, V12, P170, DOI 10.1089/cmb.2005.12.170; Li P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S13; Liang S, 1998, Pac Symp Biocomput, P18; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; van Someren E P, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P355; Wang HY, 2008, J MULTIVARIATE ANAL, V99, P896, DOI 10.1016/j.jmva.2007.05.003; Wang HY, 2007, STAT SINICA, V17, P361; Wang HY, 2009, STAT COMPUT, V19, P139, DOI 10.1007/s11222-008-9077-8; Weaver D C, 1999, Pac Symp Biocomput, P112; Wei Z, 2008, ANN APPL STAT, V2, P408, DOI 10.1214/07--AOAS145; XING EP, 2001, BIOINFORMATICS, V17, P306; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	37	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20074	10.1371/journal.pone.0020074	http://dx.doi.org/10.1371/journal.pone.0020074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673799	Green Published, gold, Green Submitted			2022-12-27	WOS:000291309900001
J	Kusters, I; Mukherjee, N; de Jong, MR; Tans, S; Kocer, A; Driessen, AJM				Kusters, Ilja; Mukherjee, Nobina; de Jong, Menno R.; Tans, Sander; Kocer, Armagan; Driessen, Arnold J. M.			Taming Membranes: Functional Immobilization of Biological Membranes in Hydrogels	PLOS ONE			English	Article							FLUORESCENCE-BURST ANALYSIS; MECHANOSENSITIVE CHANNEL MSCL; PREPROTEIN TRANSLOCATION; PROTEIN TRANSLOCATION; SUPPORTED MEMBRANES; CATALYTIC CYCLE; LIPID-BILAYERS; RECONSTITUTION; PORE; EVENTS	Single molecule studies on membrane proteins embedded in their native environment are hampered by the intrinsic difficulty of immobilizing elastic and sensitive biological membranes without interfering with protein activity. Here, we present hydrogels composed of nano-scaled fibers as a generally applicable tool to immobilize biological membrane vesicles of various size and lipid composition. Importantly, membrane proteins immobilized in the hydrogel as well as soluble proteins are fully active. The triggered opening of the mechanosensitive channel of large conductance (MscL) reconstituted in giant unilamellar vesicles (GUVs) was followed in time on single GUVs. Thus, kinetic studies of vectorial transport processes across biological membranes can be assessed on single, hydrogel immobilized, GUVs. Furthermore, protein translocation activity by the membrane embedded protein conducting channel of bacteria, SecYEG, in association with the soluble motor protein SecA was quantitatively assessed in bulk and at the single vesicle level in the hydrogel. This technique provides a new way to investigate membrane proteins in their native environment at the single molecule level by means of fluorescence microscopy.	[Kusters, Ilja; Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Ag Groningen, Netherlands; [Kusters, Ilja; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Ag Groningen, Netherlands; [Mukherjee, Nobina; Kocer, Armagan] Univ Groningen, Dept Membrane Enzymol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [de Jong, Menno R.] BiOMaDe Technol Fdn, Groningen, Netherlands; [Tans, Sander] AMOLF Inst, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; AMOLF	Driessen, AJM (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Ag Groningen, Netherlands.	a.j.m.driessen@rug.nl	Tans, Sander/AAS-2901-2020; Institute, Zernike/W-7033-2019; Kusters, Ilja/J-3492-2019; Driessen, Arnold J.M./D-1876-2012; Kusters, Ilja/A-3256-2012; Kocer, A/M-6371-2013	Kusters, Ilja/0000-0003-3739-8764; Driessen, Arnold J.M./0000-0001-9258-9104; kocer, Armagan/0000-0001-7343-3139; Mukherjee, Nobina/0000-0003-4655-2188	NanoNed; MEDITRANS; NWO VIDI; ERC	NanoNed; MEDITRANS; NWO VIDI(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	This work was funded by NanoNed (IK, MDJ, AJMD), a national nanotechnology program coordinated by the Dutch Ministry of Economical Affairs and the Zernike Institute for Advanced Materials (IK, AJMD), and by the Chemical Sciences division of The Netherlands Organization for Scientific Research (NWO-CW; IK, AJMD). Further, this project was supported by MEDITRANS Sixth Framework Programme (AK,NM), NWO VIDI (AK), ERC-Starting grant (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; Brizard A, 2008, ANGEW CHEM INT EDIT, V47, P2063, DOI 10.1002/anie.200704609; DEVILLE K, 2010, J BIOL CHEM; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dudia A, 2008, NANO LETT, V8, P1105, DOI 10.1021/nl073211b; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Hamai C, 2007, BIOPHYS J, V92, P1988, DOI 10.1529/biophysj.106.093831; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Sackmann E, 2000, TRENDS BIOTECHNOL, V18, P58, DOI 10.1016/S0167-7799(99)01412-2; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Toprak E, 2007, ANNU REV BIOPH BIOM, V36, P349, DOI 10.1146/annurev.biophys.36.040306.132700; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; van den Bogaart G, 2008, METHODS, V46, P123, DOI 10.1016/j.ymeth.2008.06.016; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	29	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20435	10.1371/journal.pone.0020435	http://dx.doi.org/10.1371/journal.pone.0020435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655266	Green Published, gold			2022-12-27	WOS:000291097600068
J	Stindt, J; Ellinger, P; Stross, C; Keitel, V; Haussinger, D; Smits, SHJ; Kubitz, R; Schmitt, L				Stindt, Jan; Ellinger, Philipp; Stross, Claudia; Keitel, Verena; Haeussinger, Dieter; Smits, Sander H. J.; Kubitz, Ralf; Schmitt, Lutz			Heterologous Overexpression and Mutagenesis of the Human Bile Salt Export Pump (ABCB11) Using DREAM (Directed REcombination-Assisted Mutagenesis)	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; YEAST SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; PLASMID CONSTRUCTION; PICHIA-PASTORIS; P-GLYCOPROTEIN; TRANSPORTER; PURIFICATION; DNA; TRANSFORMATION	Homologous recombination in Saccharomyces cerevisiae is a well-studied process. Here, we describe a yeast-recombination-based approach to construct and mutate plasmids containing the cDNA of the human bile salt export pump (BSEP) that has been shown to be unstable in E. coli. Using this approach, we constructed the necessary plasmids for a heterologous overexpression of BSEP in the yeast Pichia pastoris. We then applied a new site-directed mutagenesis method, DREAM (Directed REcombination-Assisted Mutagenesis) that completely bypasses E. coli by using S. cerevisiae as the plasmid host with high mutagenesis efficiency. Finally, we show how to apply this strategy to unstable non-yeast plasmids by rapidly turning an existing mammalian BSEP expression construct into a S. cerevisiae-compatible plasmid and analyzing the impact of a BSEP mutation in several mammalian cell lines.	[Stindt, Jan; Ellinger, Philipp; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-4000 Dusseldorf, Germany; [Stross, Claudia; Keitel, Verena; Haeussinger, Dieter; Kubitz, Ralf] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Stindt, J (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-4000 Dusseldorf, Germany.	lutz.schmitt@hhu.de	Keitel, Verena/AAH-9016-2021; Keitel, Verena/AAF-3471-2019	Keitel, Verena/0000-0003-1383-7662; Stindt, Jan/0000-0002-8760-1989	 [SFB 575];  [A9];  [KFO 217]	; ; 	This work was supported by the SFB 575 "Experimental hepatology" (project A9 to L. S.) and the KFO 217 "Hepatobiliary transport and liver diseases" (project TP1 to R. K. and TP3 to L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG TECHN INC, QUIKCHANGE 2 40 SIT; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Braman J, 1996, Methods Mol Biol, V57, P31; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Byrne JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/hep.22683; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; EVANS GL, 1995, J BIOENERG BIOMEMBR, V27, P43, DOI 10.1007/BF02110330; FEHER Z, 1983, NATURE, V302, P266, DOI 10.1038/302266a0; Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; HATTMAN S, 1978, J BACTERIOL, V135, P1156, DOI 10.1128/JB.135.3.1156-1157.1978; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaiser C., 1994, METHODS YEAST GENETI; Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682; Keitel V, 2009, HEPATOLOGY, V50, P510, DOI 10.1002/hep.23083; KUCHLER K, 1992, P NATL ACAD SCI USA, V89, P2302, DOI 10.1073/pnas.89.6.2302; Lee SH, 2003, BIOCHEM BIOPH RES CO, V306, P644, DOI 10.1016/S0006-291X(03)01029-5; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; PROFFITT JH, 1984, MOL CELL BIOL, V4, P985, DOI 10.1128/MCB.4.5.985; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Singh MV, 2002, ANAL BIOCHEM, V307, P13, DOI 10.1016/S0003-2697(02)00018-0; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; Vu K, 2009, ANAL BIOCHEM, V393, P234, DOI 10.1016/j.ab.2009.06.039; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20562	10.1371/journal.pone.0020562	http://dx.doi.org/10.1371/journal.pone.0020562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655228	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600098
J	Nguyen, TT; Foteinou, PT; Calvano, SE; Lowry, SF; Androulakis, IP				Nguyen, Tung T.; Foteinou, Panagiota T.; Calvano, Steven E.; Lowry, Stephen F.; Androulakis, Ioannis P.			Computational Identification of Transcriptional Regulators in Human Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CELL-DEATH; GENOME-WIDE ANALYSIS; GENE-EXPRESSION DATA; INDUCED APOPTOSIS; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; IMMUNE-RESPONSES; MODULE NETWORKS; T-LYMPHOCYTES	One of the great challenges in the post-genomic era is to decipher the underlying principles governing the dynamics of biological responses. As modulating gene expression levels is among the key regulatory responses of an organism to changes in its environment, identifying biologically relevant transcriptional regulators and their putative regulatory interactions with target genes is an essential step towards studying the complex dynamics of transcriptional regulation. We present an analysis that integrates various computational and biological aspects to explore the transcriptional regulation of systemic inflammatory responses through a human endotoxemia model. Given a high-dimensional transcriptional profiling dataset from human blood leukocytes, an elementary set of temporal dynamic responses which capture the essence of a pro-inflammatory phase, a counter-regulatory response and a dysregulation in leukocyte bioenergetics has been extracted. Upon identification of these expression patterns, fourteen inflammation-specific gene batteries that represent groups of hypothetically 'coregulated' genes are proposed. Subsequently, statistically significant cis-regulatory modules (CRMs) are identified and decomposed into a list of critical transcription factors (34) that are validated largely on primary literature. Finally, our analysis further allows for the construction of a dynamic representation of the temporal transcriptional regulatory program across the host, deciphering possible combinatorial interactions among factors under which they might be active. Although much remains to be explored, this study has computationally identified key transcription factors and proposed a putative time-dependent transcriptional regulatory program associated with critical transcriptional inflammatory responses. These results provide a solid foundation for future investigations to elucidate the underlying transcriptional regulatory mechanisms under the host inflammatory response. Also, the assumption that coexpressed genes that are functionally relevant are more likely to share some common transcriptional regulatory mechanism seems to be promising, making the proposed framework become essential in unravelling context-specific transcriptional regulatory interactions underlying diverse mammalian biological processes.	[Nguyen, Tung T.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; [Foteinou, Panagiota T.; Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Calvano, Steven E.; Lowry, Stephen F.; Androulakis, Ioannis P.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Nguyen, TT (corresponding author), Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA.	yannis@rci.rutgers.edu			National Institutes of Health [GM082974, GM34695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034695, R01GM034695, R01GM082974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TTN, PTF and IPA acknowledge the support from the National Institutes of Health under GM082974. SEC and SFL acknowledge support from the the National Institutes of Health under grant GM34695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Altman RB, 2001, CURR OPIN STRUC BIOL, V11, P340, DOI 10.1016/S0959-440X(00)00212-8; Balmer JE, 2006, BIOL LETTERS, V2, P431, DOI 10.1098/rsbl.2006.0484; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chen XL, 1997, J GEN VIROL, V78, P3277, DOI 10.1099/0022-1317-78-12-3277; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choi D, 2006, GENOMICS, V87, P500, DOI 10.1016/j.ygeno.2005.11.015; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Cuesta N, 2003, J IMMUNOL, V170, P5739, DOI 10.4049/jimmunol.170.11.5739; Cuesta N, 2007, J IMMUNOL, V178, P3602, DOI 10.4049/jimmunol.178.6.3602; Davidson E. H., 2001, DEV EVOLUTION; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Fievez L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000727; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Frech K, 1997, J MOL BIOL, V270, P674, DOI 10.1006/jmbi.1997.1140; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Fussenegger M, 1998, BIOTECHNOL PROGR, V14, P807, DOI 10.1021/bp9800891; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hannenhalli S, 2003, MAMM GENOME, V14, P611, DOI 10.1007/s00335-002-2260-x; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Ilangumaran S, 2003, IMMUNOL REV, V192, P196, DOI 10.1034/j.1600-065X.2003.00020.x; Ivan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r22; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kawai K, 2008, J BIOCHEM, V143, P765, DOI 10.1093/jb/mvn027; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kerhornou A, 2007, BIOINFORMATICS, V23, P1831, DOI 10.1093/bioinformatics/btm252; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kitada S, 2002, ONCOGENE, V21, P3459, DOI 10.1038/sj.onc.1205327; Klepper K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-123; Kuenzli Stephane, 2004, Current Drug Targets - Inflammation and Allergy, V3, P355, DOI 10.2174/1568010042634587; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Long Fan, 2004, In Silico Biology, V4, P395; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Maung AA, 2005, J LEUKOCYTE BIOL, V78, P565, DOI 10.1189/jlb.1204698; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Mostecki J, 2005, J BIOL CHEM, V280, P2596, DOI 10.1074/jbc.M408938200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nelander S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-68; Nguyen TT, 2009, ALGORITHMS, V2, P582, DOI 10.3390/a2010582; Nguyen TT, 2009, OMICS, V13, P219, DOI 10.1089/omi.2008.0074; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Olson EN, 2004, J CLIN INVEST, V113, P1110, DOI 10.1172/JCI200421497; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; Phillips T, 2008, NATURE ED, V1; Piedrafita FJ, 1997, MOL CELL BIOL, V17, P6348, DOI 10.1128/MCB.17.11.6348; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Rodriguez-Caso C, 2005, FEBS J, V272, P6423, DOI 10.1111/j.1742-4658.2005.05041.x; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Saeki K, 1999, BIOCHEM J, V343, P249, DOI 10.1042/0264-6021:3430249; Santos AA, 1996, SHOCK, V6, pS50, DOI 10.1097/00024382-199610001-00010; Schild-Poulter C, 2007, ONCOGENE, V26, P3980, DOI 10.1038/sj.onc.1210165; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Sinha S, 2006, NUCLEIC ACIDS RES, V34, pW555, DOI 10.1093/nar/gkl224; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Szondy Z, 1998, CELL DEATH DIFFER, V5, P4, DOI 10.1038/sj.cdd.4400313; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taniguchi T, 1997, J CELL PHYSIOL, V173, P128, DOI 10.1002/(SICI)1097-4652(199711)173:2<128::AID-JCP8>3.0.CO;2-P; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Tetta C, 2005, Crit Care Resusc, V7, P32; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Tsujimoto K, 2005, J BIOL CHEM, V280, P27638, DOI 10.1074/jbc.M501304200; Van Loo P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r66; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; VANDEVENTER SJH, 1990, BLOOD, V76, P2520; VANZEE KJ, 1995, J IMMUNOL, V154, P1499; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Waleev T, 2006, NUCLEIC ACIDS RES, V34, pW541, DOI 10.1093/nar/gkl342; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r34; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	143	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e18889	10.1371/journal.pone.0018889	http://dx.doi.org/10.1371/journal.pone.0018889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637747	Green Published, gold			2022-12-27	WOS:000291052500001
J	Trindade, J; Loyola, RD				Trindade-Filho, Joaquim; Loyola, Rafael Dias			Performance and Consistency of Indicator Groups in Two Biodiversity Hotspots	PLOS ONE			English	Article							RESERVE SELECTION; CONSERVATION; SURROGATE; DIVERSITY; AREAS; VERTEBRATES; FUTURE; TAXA	Background: In a world limited by data availability and limited funds for conservation, scientists and practitioners must use indicator groups to define spatial conservation priorities. Several studies have evaluated the effectiveness of indicator groups, but still little is known about the consistency in performance of these groups in different regions, which would allow their a priori selection. Methodology/Principal Findings: We systematically examined the effectiveness and the consistency of nine indicator groups in representing mammal species in two top-ranked Biodiversity Hotspots (BH): the Brazilian Cerrado and the Atlantic Forest. To test for group effectiveness we first found the best sets of sites able to maximize the representation of each indicator group in the BH and then calculated the average representation of different target species by the indicator groups in the BH. We considered consistent indicator groups whose representation of target species was not statistically different between BH. We called effective those groups that outperformed the target-species representation achieved by random sets of species. Effective indicator groups required the selection of less than 2% of the BH area for representing target species. Restricted-range species were the most effective indicators for the representation of all mammal diversity as well as target species. It was also the only group with high consistency. Conclusions/Significance: We show that several indicator groups could be applied as shortcuts for representing mammal species in the Cerrado and the Atlantic Forest to develop conservation plans, however, only restricted-range species consistently held as the most effective indicator group for such a task. This group is of particular importance in conservation planning as it captures high diversity of endemic and endangered species.	[Trindade-Filho, Joaquim] Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [Loyola, Rafael Dias] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Trindade, J (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil.	avispa@gmail.com	Filho, Joaquim Trindade/AAP-1545-2021; Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; TRINDADE FILHO, JOAQUIM/0000-0001-5429-3193	CNPq [475886/2009-7, 563621/2010-9]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	R.D.L. research is funded by CNPq (projects # 475886/2009-7 and # 563621/2010-9). J.T.-F. was supported by a CAPES master scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bani L, 2006, CONSERV BIOL, V20, P512, DOI 10.1111/j.1523-1739.2006.00331.x; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Carbayo F, 2011, TRENDS ECOL EVOL, V26, P154, DOI 10.1016/j.tree.2011.01.004; Chiarucci A, 2007, BIODIVERS CONSERV, V16, P525, DOI 10.1007/s10531-006-6733-1; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; de Carvalho RA, 2010, NAT CONSERVACAO, V8, P171, DOI 10.4322/natcon.00802011; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Faith D. P., 1996, Biodiversity Letters, V3, P18, DOI 10.2307/2999706; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; Diniz JAF, 2009, NAT CONSERVACAO, V7, P100; FLYNN DFB, 2008, ECOL LETT, V11, P1; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Jenkins CN, 2010, BIOL CONSERV, V143, P992, DOI 10.1016/j.biocon.2010.01.014; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kubota U, 2007, GLOBAL ECOL BIOGEOGR, V16, P632, DOI 10.1111/j.1466-8238.2007.00319.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Larsen FW, 2009, DIVERS DISTRIB, V15, P70, DOI 10.1111/j.1472-4642.2008.00507.x; Lawler JJ, 2008, ANIM CONSERV, V11, P270, DOI 10.1111/j.1469-1795.2008.00176.x; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loucks C, 2008, J BIOGEOGR, V35, P1337, DOI 10.1111/j.1365-2699.2008.01899.x; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Loyola Rafael D., 2009, Open Ecology Journal, V2, P29, DOI 10.2174/1874213000902010029; Loyola RD, 2009, BIODIVERS CONSERV, V18, P2017, DOI 10.1007/s10531-008-9570-6; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Mace Georgina M., 2006, P17; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pinto MP, 2008, DIVERS DISTRIB, V14, P78, DOI 10.1111/j.1472-4642.2007.00421.x; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rylands AB, 2005, CONSERV BIOL, V19, P612, DOI 10.1111/j.1523-1739.2005.00711.x; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Schmit JP, 2005, BIOL CONSERV, V121, P99, DOI 10.1016/j.biocon.2004.04.013; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Trakhtenbrot A, 2005, ECOL APPL, V15, P335, DOI 10.1890/04-0077; UNDERHILL LG, 1994, BIOL CONSERV, V70, P85, DOI 10.1016/0006-3207(94)90302-6; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004	57	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19746	10.1371/journal.pone.0019746	http://dx.doi.org/10.1371/journal.pone.0019746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637330	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200013
J	Xue, W; Cojocaru, RI; Dudley, VJ; Brooks, M; Swaroop, A; Sarthy, VP				Xue, Wei; Cojocaru, Radu I.; Dudley, V. Joseph; Brooks, Matthew; Swaroop, Anand; Sarthy, Vijay P.			Ciliary Neurotrophic Factor Induces Genes Associated with Inflammation and Gliosis in the Retina: A Gene Profiling Study of Flow-Sorted, Muller Cells	PLOS ONE			English	Article							INTRACELLULAR SIGNALING PATHWAYS; FACTOR PREVENTS DEGENERATION; AAV-MEDIATED DELIVERY; GANGLION-CELLS; PHOTORECEPTOR DEGENERATION; ANIMAL-MODELS; TYROSINE PHOSPHORYLATION; MOUSE PHOTORECEPTORS; ROD PHOTORECEPTORS; PIGMENT EPITHELIUM	Background: Ciliary neurotrophic factor (CNTF), a member of the interleukin-6 cytokine family, has been implicated in the development, differentiation and survival of retinal neurons. The mechanisms of CNTF action as well as its cellular targets in the retina are poorly understood. It has been postulated that some of the biological effects of CNTF are mediated through its action via retinal glial cells; however, molecular changes in retinal glia induced by CNTF have not been elucidated. We have, therefore, examined gene expression dynamics of purified Muller (glial) cells exposed to CNTF in vivo. Methodology/Principal Findings: Muller cells were flow-sorted from mgfap-egfp transgenic mice one or three days after intravitreal injection of CNTF. Microarray analysis using RNA from purified Muller cells showed differential expression of almost 1,000 transcripts with two-to seventeen-fold change in response to CNTF. A comparison of transcriptional profiles from Muller cells at one or three days after CNTF treatment showed an increase in the number of transcribed genes as well as a change in the expression pattern. Ingenuity Pathway Analysis showed that the differentially regulated genes belong to distinct functional types such as cytokines, growth factors, G-protein coupled receptors, transporters and ion channels. Interestingly, many genes induced by CNTF were also highly expressed in reactive Muller cells from mice with inherited or experimentally induced retinal degeneration. Further analysis of gene profiles revealed 20-30% overlap in the transcription pattern among Muller cells, astrocytes and the RPE. Conclusions/Significance: Our studies provide novel molecular insights into biological functions of Muller glial cells in mediating cytokine response. We suggest that CNTF remodels the gene expression profile of Muller cells leading to induction of networks associated with transcription, cell cycle regulation and inflammatory response. CNTF also appears to function as an inducer of gliosis in the retina.	[Xue, Wei; Dudley, V. Joseph; Sarthy, Vijay P.] Northwestern Univ, Dept Ophthalmol, Feinberg Med Sch, Chicago, IL 60611 USA; [Cojocaru, Radu I.; Brooks, Matthew; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Xue, W (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Med Sch, Chicago, IL 60611 USA.	vjsarthy@northwestern.edu		Swaroop, Anand/0000-0002-1975-1141	NIH [EY019325]; National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000450, R01EY019325] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY019325 (VS), unrestricted funds from Research to Prevent Blindness and intramural program of the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Biber K, 2006, CURR DRUG TARGETS, V7, P29, DOI 10.2174/138945006775270196; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Chun MH, 2000, BRAIN RES, V868, P358, DOI 10.1016/S0006-8993(00)02305-2; Cui Q, 2000, NEUROREPORT, V11, P3999, DOI 10.1097/00001756-200012180-00019; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Do Rhee K, 2010, ADV EXP MED BIOL, V664, P647, DOI 10.1007/978-1-4419-1399-9_74; DRAGER UC, 1984, J NEUROSCI, V4, P2025; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Green ES, 2001, MOL THER, V3, P507, DOI 10.1006/mthe.2001.0289; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Howard M, 1994, GUIDEBOOK CYTOKINES; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kirsch M, 1997, J NEUROCHEM, V68, P979; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Lau D, 2000, INVEST OPHTH VIS SCI, V41, P3622; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEWIS GP, 1992, J NEUROSCI, V12, P3968; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; LO AC, 1995, EXP NEUROL, V134, P49, DOI 10.1006/exnr.1995.1035; Machida S, 2001, INVEST OPHTH VIS SCI, V42, P1087; MacLennan AJ, 1996, J NEUROSCI, V16, P621; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Ogilvie JM, 2000, EXP NEUROL, V161, P676, DOI 10.1006/exnr.1999.7291; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Pease ME, 2009, INVEST OPHTH VIS SCI, V50, P2194, DOI 10.1167/iovs.08-3013; Peterson WM, 2000, J NEUROSCI, V20, P4081; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sarthy V., 2001, PERSP VIS R; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Schnitzer J., 1988, Progress in Retinal Research, V7, P209, DOI 10.1016/0278-4327(88)90009-0; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Servidei T, 1998, J BIOL CHEM, V273, P6233, DOI 10.1074/jbc.273.11.6233; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wahlin KJ, 2001, EXP EYE RES, V73, P693, DOI 10.1006/exer.2001.1078; Walsh N, 2001, EXP EYE RES, V72, P495, DOI 10.1006/exer.2000.0984; Wang Y, 2002, CURR EYE RES, V24, P305, DOI 10.1076/ceyr.24.4.305.8408; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Whiteley SJO, 2001, EXP EYE RES, V73, P557, DOI 10.1006/exer.2001.1066; WINTER CG, 1995, P NATL ACAD SCI USA, V92, P5865, DOI 10.1073/pnas.92.13.5865; YI Y, 2006, NAT NEUROSCI, V9, P843; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	89	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20326	10.1371/journal.pone.0020326	http://dx.doi.org/10.1371/journal.pone.0020326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637858	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200052
J	Carnevali, O; Gioacchini, G; Maradonna, F; Olivotto, I; Migliarini, B				Carnevali, Oliana; Gioacchini, Giorgia; Maradonna, Francesca; Olivotto, Ike; Migliarini, Beatrice			Melatonin Induces Follicle Maturation in Danio rerio	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-15; OOCYTE MATURATION; FOLLISTATIN EXPRESSION; LUTEINIZING-HORMONE; ZEBRAFISH OVARY; POTENTIAL ROLE; PHOTOPERIOD; SYSTEM; IDENTIFICATION; MECHANISMS	Most organisms modulate their reproductive activity responding to day length by the nocturnal release of melatonin by the pineal gland. This hormone is also responsible for synchronizing reproduction with specific external environment stimuli in order to optimize reproductive success. The aim of this study was to establish the effect of melatonin on zebrafish reproduction. Adult females were daily exposed, via water, to two different doses (100 nM and 1 mu M) of melatonin. Melatonin led to an increase of the Gonado Somatic Index (GSI) associated with the increase of eggs production, and the raise of gene and protein levels of vitellogenin (VTG) and estradiol receptor alpha (ER alpha) in the liver. The ability of melatonin to increase fecundity was consistent with a significant increase of gene transcription of kiss 1, kiss 2, gnrh3, in the brain, and lh in the pituitary, while in the ovary (in class IIIB follicles), with a significant decrease of two genes codifying for intra-ovarian regulators of premature oocyte maturation, the tgf beta 1 and the bmp15. The reduction in the expression of these two genes was concomitant with the increase of lhr and a modulation of mpr alpha and mpr beta gene transcription, whose proteins are involved in oocyte maturation. Melatonin also exerted a direct action on follicles as shown by the increase of the oocytes undergoing to germinal vesicle break down (GVBD) and modulated mpr alpha and beta gene expression in the in vitro exposure. These data highlight the effects of melatonin in promoting zebrafish reproduction exerting its effects either in the brain-pituitary and in the gonads.	[Carnevali, Oliana; Gioacchini, Giorgia; Maradonna, Francesca; Olivotto, Ike; Migliarini, Beatrice] Univ Politecn Marche, Dipartimento Sci Mare, Ancona, Italy; [Carnevali, Oliana] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	Marche Polytechnic University	Carnevali, O (corresponding author), Univ Politecn Marche, Dipartimento Sci Mare, Ancona, Italy.	o.carnevali@univpm.it	Maradonna, Francesca/AAU-3017-2021; Carnevali, Oliana/P-2751-2015; Gioacchini, Giorgia/AAU-3581-2021; Maradonna, Francesca/AAU-5167-2021; Olivotto, Ike/K-9397-2014	Carnevali, Oliana/0000-0001-5994-0572; Maradonna, Francesca/0000-0001-6677-1017; Olivotto, Ike/0000-0002-0906-4225; Gioacchini, Giorgia/0000-0003-1187-7302	Fondi di Ateneo	Fondi di Ateneo	This work was financially supported by Fondi di Ateneo 2009 to Oliana Carnevali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens I, 2006, TOXICOLOGY, V228, P333, DOI 10.1016/j.tox.2006.09.018; Ansel L, 2010, J BIOL RHYTHM, V25, P81, DOI 10.1177/0748730410361918; Barrett P, 2003, J PINEAL RES, V35, P221, DOI 10.1034/j.1600-079X.2003.00090.x; BARTNESS TJ, 1993, J PINEAL RES, V15, P161; Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; Biran J, 2008, BIOL REPROD, V79, P776, DOI 10.1095/biolreprod.107.066266; Blanco-Vives B, 2009, PHYSIOL BEHAV, V98, P268, DOI 10.1016/j.physbeh.2009.05.015; Bromage N, 2001, AQUACULTURE, V197, P63, DOI 10.1016/S0044-8486(01)00583-X; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Carnevali O, 2010, J APPL ICHTHYOL, V26, P826, DOI 10.1111/j.1439-0426.2010.01549.x; Carnevali O, 2009, J MOL STRUCT, V938, P207, DOI 10.1016/j.molstruc.2009.09.029; CARTER DS, 1983, ENDOCRINOLOGY, V113, P1261, DOI 10.1210/endo-113-4-1261; Chalivoix S, 2010, J NEUROENDOCRINOL, V22, P110, DOI 10.1111/j.1365-2826.2009.01939.x; Chattoraj A, 2005, GEN COMP ENDOCR, V140, P145, DOI 10.1016/j.ygcen.2004.10.013; Chattoraj A, 2008, COMP BIOCHEM PHYS A, V150, P301, DOI 10.1016/j.cbpa.2008.03.014; Chattoraj A, 2009, COMP BIOCHEM PHYS A, V152, P327, DOI 10.1016/j.cbpa.2008.11.010; Chen YJ, 2008, ENDOCRINOLOGY, V149, P4658, DOI 10.1210/en.2008-0063; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Clelland ES, 2007, ENDOCRINOLOGY, V148, P5451, DOI 10.1210/en.2007-0674; Coon SL, 1998, BIOL CELL, V90, P399, DOI 10.1016/S0248-4900(98)80089-0; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; FALCO NJ, 2006, TRENDS ENDOCRIN MET, V181, P81; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Falcon Jack, 2007, Journal de la Societe de Biologie, V201, P21, DOI 10.1051/jbio:2007003; Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420; Giorgini E, 2010, ANAL BIOANAL CHEM, V398, P3063, DOI 10.1007/s00216-010-4234-2; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Goodman RL, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2389; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Khan IA, 1996, GEN COMP ENDOCR, V104, P231, DOI 10.1006/gcen.1996.0166; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Kohli G, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-53; Kulczykowska E, 1998, EXP PHYSIOL, V83, P809, DOI 10.1113/expphysiol.1998.sp004161; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez LC, 2006, INT J BIOCHEM CELL B, V38, P267, DOI 10.1016/j.biocel.2005.09.008; Maradonna F, 2007, BIOMARKERS, V12, P240, DOI 10.1080/13547500601070859; Mazurais D, 2000, GEN COMP ENDOCR, V118, P344, DOI 10.1006/gcen.2000.7472; Moschos S, 2002, FERTIL STERIL, V77, P433, DOI 10.1016/S0015-0282(01)03010-2; Nakamura Y, 2003, FERTIL STERIL, V80, P1012, DOI 10.1016/S0015-0282(03)01008-2; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Pang YF, 2002, ENDOCRINOLOGY, V143, P47, DOI 10.1210/en.143.1.47; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Patino R, 2001, COMP BIOCHEM PHYS B, V129, P427, DOI 10.1016/S1096-4959(01)00344-X; Peng C, 2009, COMP BIOCHEM PHYS A, V153, P83, DOI 10.1016/j.cbpa.2008.09.034; Piccinetti CC, 2010, HORM BEHAV, V58, P780, DOI 10.1016/j.yhbeh.2010.07.013; POPEK W, 2005, ICHTHYOL PISCATOR, V35, P65; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Renuka K, 2010, GEN COMP ENDOCR, V165, P42, DOI 10.1016/j.ygcen.2009.05.020; Sebert ME, 2008, J NEUROENDOCRINOL, V20, P917, DOI 10.1111/j.1365-2826.2008.01744.x; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Takasaki Akihisa, 2003, Reprod Med Biol, V2, P139, DOI 10.1111/j.1447-0578.2003.00035.x; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Tena-Sempere M, 2006, CURR OPIN PEDIATR, V18, P442, DOI 10.1097/01.mop.0000236396.79580.cc; Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; WALLACE RA, 1985, DEV BIOL, V110, P492, DOI 10.1016/0012-1606(85)90106-X; Wang Y, 2004, BIOL REPROD, V71, P2056, DOI 10.1095/biolreprod.104.032649; Wang YJ, 2003, GEN COMP ENDOCR, V134, P308, DOI 10.1016/S0016-6480(03)00275-2; Woo MMM, 2001, J CLIN ENDOCR METAB, V86, P4789, DOI 10.1210/jc.86.10.4789; Wu J, 2000, BIOL REPROD, V63, P320, DOI 10.1095/biolreprod63.1.320; YIE SM, 1995, J CLIN ENDOCR METAB, V80, P1747, DOI 10.1210/jc.80.5.1747; Zhdanova IV, 2008, BRAIN RES BULL, V75, P433, DOI 10.1016/j.brainresbull.2007.10.053; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	65	62	66	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19978	10.1371/journal.pone.0019978	http://dx.doi.org/10.1371/journal.pone.0019978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647435	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500016
J	Plessis, A; Cournol, R; Effroy, D; Perez, VS; Botran, L; Kraepiel, Y; Frey, A; Sotta, B; Cornic, G; Leung, J; Giraudat, J; Marion-Poll, A; North, HM				Plessis, Anne; Cournol, Raphael; Effroy, Delphine; Perez, Viridiana Silva; Botran, Lucy; Kraepiel, Yvan; Frey, Anne; Sotta, Bruno; Cornic, Gabriel; Leung, Jeffrey; Giraudat, Jerome; Marion-Poll, Annie; North, Helen M.			New ABA-Hypersensitive Arabidopsis Mutants Are Affected in Loci Mediating Responses to Water Deficit and Dickeya dadantii Infection	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; CIS-ACTING ELEMENTS; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; DROUGHT; GENE; STRESS; PROTEIN; PLANT; 8'-HYDROXYLASE	On water deficit, abscisic acid (ABA) induces stomata closure to reduce water loss by transpiration. To identify Arabidopsis thaliana mutants which transpire less on drought, infrared thermal imaging of leaf temperature has been used to screen for suppressors of an ABA-deficient mutant (aba3-1) cold-leaf phenotype. Three novel mutants, called hot ABA-deficiency suppressor (has), have been identified with hot-leaf phenotypes in the absence of the aba3 mutation. The defective genes imparted no apparent modification to ABA production on water deficit, were inherited recessively and enhanced ABA responses indicating that the proteins encoded are negative regulators of ABA signalling. All three mutants showed ABA-hypersensitive stomata closure and inhibition of root elongation with little modification of growth and development in non-stressed conditions. The has2 mutant also exhibited increased germination inhibition by ABA, while ABA-inducible gene expression was not modified on dehydration, indicating the mutated gene affects early ABA-signalling responses that do not modify transcript levels. In contrast, weak ABA-hypersensitivity relative to mutant developmental phenotypes suggests that HAS3 regulates drought responses by both ABA-dependent and independent pathways. has1 mutant phenotypes were only apparent on stress or ABA treatments, and included reduced water loss on rapid dehydration. The HAS1 locus thus has the required characteristics for a targeted approach to improving resistance to water deficit. In contrast to has2, has1 exhibited only minor changes in susceptibility to Dickeya dadantii despite similar ABA-hypersensitivity, indicating that crosstalk between ABA responses to this pathogen and drought stress can occur through more than one point in the signalling pathway.	[Plessis, Anne; Cournol, Raphael; Effroy, Delphine; Perez, Viridiana Silva; Botran, Lucy; Frey, Anne; Marion-Poll, Annie; North, Helen M.] AgroParisTech, INRA, Inst Jean Pierre Bourgin, UMR1318, Versailles, France; [Kraepiel, Yvan] Univ Paris 06, Lab Interact Plantes Pathogenes, UMR217, AgroParisTech,INRA, Paris, France; [Sotta, Bruno] Univ Paris 06, Lab Physiol Cellulaire & Mol Plantes UR5, Paris, France; [Cornic, Gabriel] Univ Paris Sud, CNRS, Lab Ecol Systemat & Evolut, UMR8079,IFR 87, Orsay, France; [Leung, Jeffrey; Giraudat, Jerome] CNRS, Inst Sci Vegetal, UPR2355, Gif Sur Yvette, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Plessis, A (corresponding author), INRA, UMR Genet Divers & Ecophysiol Cereales 1095, Clermont Ferrand, France.	helen.north@versailles.inra.fr	Silva-Perez, Viridiana/AAF-9472-2019; North, Helen/AAD-4964-2020; Kraepiel, Yvan/D-5056-2017	Silva-Perez, Viridiana/0000-0001-5653-1802; North, Helen/0000-0002-5749-2603; Kraepiel, Yvan/0000-0003-4043-5896	Genoplante and ANR-Genoplante [AF 2001 073, GNP05037G]; Ministere de l'Enseignement et de la Recherche; la Fondation Etchebes, France; Mexican Secretaria de Educacion Publica	Genoplante and ANR-Genoplante(French National Research Agency (ANR)); Ministere de l'Enseignement et de la Recherche; la Fondation Etchebes, France; Mexican Secretaria de Educacion Publica	This work was supported by the Genoplante and ANR-Genoplante programs (grant number AF 2001 073 and GNP05037G); the Ministere de l'Enseignement et de la Recherche (Doctoral fellowship to A.P.) and la Fondation Etchebes, France and the Mexican Secretaria de Educacion Publica (Master fellowship to V.S.-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/j.1364-3703.2007.00437.x, 10.1111/J.1364-3703.2007.00437.X]; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DETORRESZABALA M, 2009, PLANT J, V59, P375, DOI DOI 10.1111/J.1365-313X.2009.03875.X; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Macquet A, 2007, PLANT CELL, V19, P3990, DOI 10.1105/tpc.107.050179; Marin E, 1997, PLANT PHYSIOL BIOCH, V35, P369; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Mosher S, 2010, PLANT PHYSIOL, V152, P1901, DOI 10.1104/pp.109.152603; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; North HM, 2005, PLANT SCI, V169, P115, DOI 10.1016/j.plantsci.2005.03.002; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Steber CM, 1998, GENETICS, V149, P509; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang YB, 2004, J EXP BOT, V55, P1187, DOI 10.1093/jxb/erh135; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; YAMAGUCHISHINOZAKI K, 1992, NUCLEIC ACIDS RES, V20, P6737, DOI 10.1093/nar/20.24.6737; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296	63	25	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20243	10.1371/journal.pone.0020243	http://dx.doi.org/10.1371/journal.pone.0020243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633512	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500047
J	Tanaka, RJ; Ono, M; Harrington, HA				Tanaka, Reiko J.; Ono, Masahiro; Harrington, Heather A.			Skin Barrier Homeostasis in Atopic Dermatitis: Feedback Regulation of Kallikrein Activity	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTORS; SENSITIVITY-ANALYSIS; POSITIVE FEEDBACK; EPIDERMAL BARRIER; STRATUM-CORNEUM; PROTEOLYTIC CASCADE; HUMAN KERATINOCYTES; SIGNALING PATHWAYS; NETHERTON-SYNDROME; NEGATIVE FEEDBACK	Atopic dermatitis (AD) is a widely spread cutaneous chronic disease characterised by sensitive reactions (eg. eczema) to normally innocuous elements. Although relatively little is understood about its underlying mechanisms due to its complexity, skin barrier dysfunction has been recognised as a key factor in the development of AD. Skin barrier homeostasis requires tight control of the activity of proteases, called kallikreins (KLKs), whose activity is regulated by a complex network of protein interactions that remains poorly understood despite its pathological importance. Characteristic symptoms of AD include the outbreak of inflammation triggered by external (eg. mechanical and chemical) stimulus and the persistence and aggravation of inflammation even if the initial stimulus disappears. These characteristic symptoms, together with some experimental data, suggest the presence of positive feedback regulation for KLK activity by inflammatory signals. We developed simple mathematical models for the KLK activation system to study the effects of feedback loops and carried out bifurcation analysis to investigate the model behaviours corresponding to inflammation caused by external stimulus. The model analysis confirmed that the hypothesised core model mechanisms capture the essence of inflammation outbreak by a defective skin barrier. Our models predicted the outbreaks of inflammation at weaker stimulus and its longer persistence in AD patients compared to healthy control. We also proposed a novel quantitative indicator for inflammation level by applying principal component analysis to microarray data. The model analysis reproduced qualitative AD characteristics revealed by this indicator. Our results strongly implicate the presence and importance of feedback mechanisms in KLK activity regulation. We further proposed future experiments that may provide informative data to enhance the system-level understanding on the regulatory mechanisms of skin barrier in AD and healthy individuals.	[Tanaka, Reiko J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Ono, Masahiro] UCL, Inst Child Hlth, Immunobiol Unit, London, England; [Ono, Masahiro] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Harrington, Heather A.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Imperial College London; University of London; University College London; Kyoto University; Imperial College London	Tanaka, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	r.tanaka@imperial.ac.uk	Ono, Masahiro/H-2378-2011	Ono, Masahiro/0000-0002-9284-7326	EPSRC; Human Frontier Science Program; Leverfulme Trust; EPSRC [EP/G007446/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007446/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontier Science Program(Human Frontier Science Program); Leverfulme Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RJT is supported by EPSRC (www.epsrc.ac.uk) Career Acceleration Fellowship; MO is supported by Human Frontier Science Program (www.hfsp.org) Long-Term Fellowship; HAH is supported by Leverfulme Trust (www.leverhulme.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT S, 1977, SIAM REV, V19, P472, DOI 10.1137/1019070; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Callard RE, 2007, TRENDS IMMUNOL, V28, P294, DOI 10.1016/j.it.2007.05.003; Choi SJ, 2003, J KOREAN MED SCI, V18, P93, DOI 10.3346/jkms.2003.18.1.93; Chu Y, 2007, IET SYST BIOL, V1, P342, DOI 10.1049/iet-syb:20060053; CONRAD E, 2005, OSCILL8 DOCUMENTATIO; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Demerjian M, 2008, AM J PATHOL, V172, P86, DOI 10.2353/ajpath.2008.070161; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Eichenfield Lawrence F, 2003, J Am Acad Dermatol, V49, P1088, DOI 10.1016/S0190-9622(03)02539-8; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Emami N, 2008, J BIOL CHEM, V283, P3031, DOI 10.1074/jbc.M707253200; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GROVES RW, 1995, J IMMUNOL, V154, P4065; Gualandri, 1999, SKIN RES TECHNOL, V5, P221, DOI [10.1111/j.1600-0846.1999.tb00134.x, DOI 10.1111/J.1600-0846.1999.TB00134.X]; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Kim D, 2007, BIOESSAYS, V29, P85, DOI 10.1002/bies.20511; Komatsu N, 2008, J INVEST DERMATOL, V128, P1148, DOI 10.1038/sj.jid.5701153; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Morizane S, 2010, J INVEST DERMATOL, V130, P1297, DOI 10.1038/jid.2009.435; O'Shaughnessy RFL, 2010, HUM MOL GENET, V19, P2594, DOI 10.1093/hmg/ddq145; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Proksch E, 1996, BRIT J DERMATOL, V134, P630, DOI 10.1046/j.1365-2133.1996.66828.x; Proksch E, 2009, J DTSCH DERMATOL GES, V7, P899, DOI 10.1111/j.1610-0387.2009.07157.x; Rattenholl A, 2003, DRUG DEVELOP RES, V59, P408, DOI 10.1002/ddr.10311; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; ROEDL D, 2009, J EURO ACAD DERMATOL; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; SCHMIDT H, 2006, BIOINFORMATICS, V22; SCHULZ BS, 1993, J IMMUNOL, V151, P4399; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200	50	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19895	10.1371/journal.pone.0019895	http://dx.doi.org/10.1371/journal.pone.0019895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647431	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500010
J	Zakharova, A; Kurths, J; Vadivasova, T; Koseska, A				Zakharova, Anna; Kurths, Juergen; Vadivasova, Tatyana; Koseska, Aneta			Analysing Dynamical Behavior of Cellular Networks via Stochastic Bifurcations	PLOS ONE			English	Article							ESCHERICHIA-COLI; TOGGLE SWITCH; DIFFERENTIATION; OSCILLATOR; NOISE; CELLS	The dynamical structure of genetic networks determines the occurrence of various biological mechanisms, such as cellular differentiation. However, the question of how cellular diversity evolves in relation to the inherent stochasticity and intercellular communication remains still to be understood. Here, we define a concept of stochastic bifurcations suitable to investigate the dynamical structure of genetic networks, and show that under stochastic influence, the expression of given proteins of interest is defined via the probability distribution of the phase variable, representing one of the genes constituting the system. Moreover, we show that under changing stochastic conditions, the probabilities of expressing certain concentration values are different, leading to different functionality of the cells, and thus to differentiation of the cells in the various types.	[Zakharova, Anna; Koseska, Aneta] Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany; [Zakharova, Anna; Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kurths, Juergen] Humboldt Univ, Inst Phys, Berlin, Germany; [Vadivasova, Tatyana] Saratov NG Chernyshevskii State Univ, Saratov, Russia	University of Potsdam; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin; Saratov State University	Zakharova, A (corresponding author), Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany.	zakharova-as@mail.ru	Vadivasova, Tatiana/D-2275-2013; Zakharova, Anna/O-1884-2018	Vadivasova, Tatiana/0000-0002-8081-2820	Federal Ministry of Education and Research [0313924]; Federal Ministry of Education and Science of the Russian Federation [14.740.11.0074]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Education and Science of the Russian Federation	A.Z., A. K. and J.K. acknowledge the GoFORSYS project funded by the Federal Ministry of Education and Research, Grant Nr. 0313924. A.Z. and T. V. acknowledge the Federal Ministry of Education and Science of the Russian Federation (state contract Nr 14.740.11.0074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L., 2003, RANDOM DYNAMICAL SYS; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; EBELING W, 1986, Z ANGEW MATH MECH, V66, P141, DOI 10.1002/zamm.19860660303; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GARDINER CW, 1985, HDB STOCHASTICMETHOD; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hirata Y, 2010, CHAOS, V20, DOI 10.1063/1.3329369; HORSTHEMKE W, 1983, SPRINGER SERIES SYNE, V15; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; KANEKO K, 1994, PHYSICA D, V75, P89, DOI 10.1016/0167-2789(94)90277-1; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KHOVANOV IA, 2000, FLUCTUATIONAL ESCAPE, P378; Kloeden PE, 1991, INT J BIFURCAT CHAOS, V1, P277, DOI 10.1142/S021812749100021X; Koseska A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031916; Koseska A, 2010, J THEOR BIOL, V263, P189, DOI 10.1016/j.jtbi.2009.11.007; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kuznetsov A, 2005, SIAM J APPL MATH, V65, P392, DOI 10.1137/S0036139903436029; LEFEVER R, 1986, PHYS REV LETT, V56, P1631, DOI 10.1103/PhysRevLett.56.1631; LLOYD D, 2006, BIO SYSTEMS, V23, P305; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; NAMACHCHIVAYA N, 1990, APPL MATH COMPUT, V38, P101; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; SCHIMANSKYGEIER L, 1993, J STAT PHYS, V70, P141, DOI 10.1007/BF01053959; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Ushakov OV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.123903; WANG Z, 2005, CHEM PHYS LETT, V401; Zakharova A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011106	31	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19696	10.1371/journal.pone.0019696	http://dx.doi.org/10.1371/journal.pone.0019696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647432	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500007
J	Hudson, K; Luo, S; Hagemann, N; Preuss, D				Hudson, Karen; Luo, Song; Hagemann, Nicole; Preuss, Daphne			Changes in Global Gene Expression in Response to Chemical and Genetic Perturbation of Chromatin Structure	PLOS ONE			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; NUCLEOLAR DOMINANCE; METHYLTRANSFERASE; TRANSCRIPTION; SEQUENCE; MUTANTS; DRM; HETEROCHROMATIN; MAINTENANCE	DNA methylation is important for controlling gene expression in all eukaryotes. Microarray analysis of mutant and chemically-treated Arabidopsis thaliana seedlings with reduced DNA methylation revealed an altered gene expression profile after treatment with the DNA methylation inhibitor 5-aza-2' deoxycytidine (5-AC), which included the upregulation of expression of many transposable elements. DNA damage-response genes were also coordinately upregulated by 5-AC treatment. In the ddm1 mutant, more specific changes in gene expression were observed, in particular for genes predicted to encode transposable elements in centromeric and pericentromeric locations. These results confirm that DDM1 has a very specific role in maintaining transcriptional silence of transposable elements, while chemical inhibitors of DNA methylation can affect gene expression at a global level.	[Hudson, Karen; Luo, Song; Hagemann, Nicole; Preuss, Daphne] Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Hudson, K (corresponding author), ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN USA.	dpreuss@chromatininc.com		Hudson, Karen/0000-0002-7402-2275	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The research described herein was supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS F, 2006, P NATL ACAD SCI US; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jordan ND, 2007, PLANT MOL BIOL, V65, P571, DOI 10.1007/s11103-007-9221-4; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Luo S, 2003, P NATL ACAD SCI USA, V100, P11133, DOI 10.1073/pnas.1831011100; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Rocha PSCF, 2005, PLANT CELL, V17, P404, DOI 10.1105/tpc.104.028332; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; ZHANG X, 2006, CELL; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	36	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20587	10.1371/journal.pone.0020587	http://dx.doi.org/10.1371/journal.pone.0020587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673996	Green Published, Green Submitted, gold			2022-12-27	WOS:000291355500025
J	Valenti, MT; Garbin, U; Pasini, A; Zanatta, M; Stranieri, C; Manfro, S; Zucal, C; Carbonare, LD				Valenti, Maria Teresa; Garbin, Ulisse; Pasini, Andrea; Zanatta, Mirko; Stranieri, Chiara; Manfro, Stefania; Zucal, Chiara; Carbonare, Luca Dalle			Role of Ox-PAPCs in the Differentiation of Mesenchymal Stem Cells (MSCs) and Runx2 and PPAR gamma 2 Expression in MSCs-Like of Osteoporotic Patients	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TIME QUANTITATIVE PCR; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; PPAR-GAMMA; ADIPOGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; BONE; MARROW; ADIPOCYTE	Background: Mesenchymal stem cells (MSCs) can differentiate into osteoblasts and adipocytes and conditions causing bone loss may induce a switch from the osteoblast to adipocyte lineage. In addition, the expression of Runx2 and the PPAR gamma 2 transcription factor genes is essential for cellular commitment to an osteogenic and adipogenic differentiation, respectively. Modified lipoproteins derived from the oxidation of arachidonate-containing phospholipids (ox-PAPCs: POVPC, PGPC and PEIPC) are considered important factors in atherogenesis. Methodology: We investigated the effect of ox-PAPCs on osteogenesis and adipogenesis in human mesenchymal stem cells (hMSCs). In particular, we analyzed the transcription factor Runx2 and the PPAR gamma 2 gene expression during osteogenic and adipogenic differentiation in absence and in presence of ox-PAPCs. We also analyzed gene expression level in a panel of osteoblastic and adipogenic differentiation markers. In addition, as circulating blood cells can be used as a "sentinel" that responds to changes in the macro-or micro-environment, we analyzed the Runx2 and the PPAR gamma 2 gene expression in MSCs-like and ox-PAPC levels in serum of osteoporotic patients (OPs). Finally, we examined the effects of sera obtained from OPs in hMSCs comparing the results with age-matched normal donors (NDs). Principal findings: Quantitative RT-PCR demonstrated that ox-PAPCs enhanced PPAR gamma 2 and adipogenic gene expression and reduced Runx2 and osteoblast differentiation marker gene expression in differentiating hMSCs. In OPs, ox-PAPC levels and PPAR gamma 2 expression were higher than in NDs, whereas Runx2 was lower than in ND circulant MSCs-like. Conclusions: Ox-PAPCs affect the osteogenic differentiation by promoting adipogenic differentiation and this effect may appear involved in bone loss in OPs.	[Valenti, Maria Teresa; Garbin, Ulisse; Pasini, Andrea; Zanatta, Mirko; Stranieri, Chiara; Manfro, Stefania; Zucal, Chiara; Carbonare, Luca Dalle] Univ Verona, Sez D, Dept Med, Clin Med Interna, I-37100 Verona, Italy	University of Verona	Valenti, MT (corresponding author), Univ Verona, Sez D, Dept Med, Clin Med Interna, I-37100 Verona, Italy.	luca.dallecarbonare@univr.it	Valenti, Maria Teresa/F-4712-2011; Carbonare, Luca Dalle/E-5720-2011; Stranieri, Chiara/GWV-1749-2022	Zucal, Chiara/0000-0001-8428-2495; Valenti, Maria Teresa/0000-0003-1166-8033				Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; AUBIN JE, 2002, PRINCIPLES BONE BIOL, V1, P59; Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812; BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270; Carbonare LD, 2009, ARTHRITIS RHEUM-US, V60, P3356, DOI 10.1002/art.24884; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; DIVERS J, 2011, J BONE MINER RE 0324; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Karrman A, 2006, ENVIRON SCI TECHNOL, V40, P3742, DOI 10.1021/es060301u; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim SW, 2009, J CELL BIOCHEM, V106, P626, DOI 10.1002/jcb.22042; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee H, 2000, CIRC RES, V87, P516; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mitry RR, 2009, J PEDIATR GASTR NUTR, V48, P604, DOI 10.1097/MPG.0b013e31819114da; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prentice L, 1997, J CLIN ENDOCR METAB, V82, P1288, DOI 10.1210/jc.82.4.1288; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; TAN A, 2011, METABOLISM      0223; THOMA SJ, 1994, BLOOD, V83, P2103; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Toms LML, 2009, ENVIRON SCI TECHNOL, V43, P4194, DOI 10.1021/es900272u; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Valenti MT, 2008, BONE, V43, P1084, DOI 10.1016/j.bone.2008.07.252; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WRONSKI TJ, 1986, BONE, V7, P119, DOI 10.1016/8756-3282(86)90683-6	49	37	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20363	10.1371/journal.pone.0020363	http://dx.doi.org/10.1371/journal.pone.0020363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674037	Green Submitted, Green Published, gold			2022-12-27	WOS:000291355500012
J	Cebrian, E; Uriz, MJ; Garrabou, J; Ballesteros, E				Cebrian, Emma; Jesus Uriz, Maria; Garrabou, Joaquim; Ballesteros, Enric			Sponge Mass Mortalities in a Warming Mediterranean Sea: Are Cyanobacteria-Harboring Species Worse Off?	PLOS ONE			English	Article							CLIMATE-CHANGE; EUNICELLA-SINGULARIS; BENTHIC COMMUNITIES; OCULINA-PATAGONICA; VIBRIO-SHILOI; CORAL; TEMPERATURE; DISEASE; POPULATIONS; SYMBIOSIS	Mass mortality events are increasing dramatically in all coastal marine environments. Determining the underlying causes of mass mortality events has proven difficult in the past because of the lack of prior quantitative data on populations and environmental variables. Four-year surveys of two shallow-water sponge species, Ircinia fasciculata and Sarcotragus spinosulum, were carried out in the western Mediterranean Sea. These surveys provided evidence of two severe sponge die-offs (total mortality ranging from 80 to 95% of specimens) occurring in the summers of 2008 and 2009. These events primarily affected I. fasciculata, which hosts both phototrophic and heterotrophic microsymbionts, while they did not affect S. spinosulum, which harbors only heterotrophic bacteria. We observed a significant positive correlation between the percentage of injured I. fasciculata specimens and exposure time to elevated temperature conditions in all populations, suggesting a key role of temperature in triggering mortality events. A comparative ultrastructural study of injured and healthy I. fasciculata specimens showed that cyanobacteria disappeared from injured specimens, which suggests that cyanobacterial decay could be involved in I. fasciculata mortality. A laboratory experiment confirmed that the cyanobacteria harbored by I. fasciculata displayed a significant reduction in photosynthetic efficiency in the highest temperature treatment. The sponge disease reported here led to a severe decrease in the abundance of the surveyed populations. It represents one of the most dramatic mass mortality events to date in the Mediterranean Sea.	[Cebrian, Emma] Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain; [Jesus Uriz, Maria; Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Girona, Spain; [Garrabou, Joaquim] CSIC, Inst Ciencies Mar, Barcelona, Spain	Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Cebrian, E (corresponding author), Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain.	emma.cebrian@udg.edu	Cebrian, Emma/J-9640-2012; Ballesteros, Enric/K-6497-2012; Uriz, Maria/J-9001-2012; Uriz, Maria J./AGP-4595-2022	Cebrian, Emma/0000-0001-7588-0135; Uriz, Maria J./0000-0002-8169-3173	Fundacion Biodiversidad, EU [ERG-2009-248252]; Ministry of Science and Innovation [CTM2009-08045]; Spanish Ministry of Science and Innovation [C5D2007-00067]; Juan de la Cierva Postdoctoral Fellowship	Fundacion Biodiversidad, EU; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva Postdoctoral Fellowship(Instituto de Salud Carlos III)	Financial support was provided by the Fundacion Biodiversidad, an EU Reintegration grant (ERG-2009-248252), the BioRocK project from the Spanish Ministry of Science and Innovation (CTM2009-08045), and the GRACCIE project C5D2007-00067 from the Spanish Ministry of Science and Innovation. EC was funded by a Juan de la Cierva Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMANDEMARTIN A, 1996, THESIS U LYON LYON; [Anonymous], 1941, ECOLOGY, V22, P415, DOI 10.2307/1930719; ANTONOV J, 1998, TEMPERATURE ATLANTIC, V27; ARILLO A, 1993, MAR BIOL, V117, P159, DOI 10.1007/BF00346438; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Bavestrello Giorgio, 1995, Marine Life, V4, P15; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Cebrian E, 2006, ENVIRON POLLUT, V141, P452, DOI 10.1016/j.envpol.2005.08.070; Cebrian E, 2003, MAR POLLUT BULL, V46, P1273, DOI 10.1016/S0025-326X(03)00190-5; Cebrian E, 2007, ENVIRON TOXICOL CHEM, V26, P2430, DOI 10.1897/07-292.1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2001, ITAL J ZOOL, V68, P131, DOI 10.1080/11250000109356397; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2002, LIMNOL OCEANOGR, V47, P324, DOI 10.4319/lo.2002.47.1.0324; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Cook S., 2002, SYSTEMA PORIFERA GUI, P1021; Cossins A. R., 1987, TEMPERATURE BIOL ANI; De Caralt S, 2008, MAR ECOL PROG SER, V360, P97, DOI 10.3354/meps07365; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Fischer EM, 2009, CLIM DYNAM, V33, P917, DOI 10.1007/s00382-008-0473-8; GAINO E, 1989, DIS AQUAT ORGAN, V6, P67, DOI 10.3354/dao006067; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Galstoff P. S., 1942, P 8 AM SCI C, V3, P411; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Lemloh Marie-Louise, 2009, BMC Ecology, V9, P4, DOI 10.1186/1472-6785-9-4; Leys SP, 1998, BIOL BULL-US, V195, P30, DOI 10.2307/1542773; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Metalpa RR, 2000, CORAL REEFS, V19, P24, DOI 10.1007/s003380050221; Pansini M., 1990, NEW PERSPECTIVES SPO, P404; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Perez T., 2004, B MUS I BIOL U GEN, V68, P517; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Pronzato R, 1999, AQUAT CONSERV, V9, P485, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<485::AID-AQC362>3.3.CO;2-E; PRONZATO R, 1991, B MUSEO I BIOL U GEN, V55, P17; Regoli F, 2004, MAR ECOL PROG SER, V275, P129, DOI 10.3354/meps275129; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; SALOMON S, 2007, INTERGOVERNMENTAL PA; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Simpson T., 1984, CELL BIOL SPONGES; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Toren A, 1998, APPL ENVIRON MICROB, V64, P1379; Torrents O, 2008, J EXP MAR BIOL ECOL, V357, P7, DOI 10.1016/j.jembe.2007.12.006; URIZ MJ, 1992, PSZNI MAR ECOL, V13, P101; Vacelet J., 1994, SPONGES TIME SPACE, P355; VACELET J, 1994, FITCPRAB8853 FAO; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WILKINSON CR, 1987, CORAL REEFS, V5, P183, DOI 10.1007/BF00300961; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	67	116	117	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20211	10.1371/journal.pone.0020211	http://dx.doi.org/10.1371/journal.pone.0020211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673798	Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900006
J	Bonnet, M; Gagnidze, L; Guerin, PJ; Bonte, L; Ramsay, A; Githui, W; Varaine, F				Bonnet, Maryline; Gagnidze, Laramie; Guerin, Philippe J.; Bonte, Laurence; Ramsay, Andrew; Githui, Willie; Varaine, Francis			Evaluation of Combined LED-Fluorescence Microscopy and Bleach Sedimentation for Diagnosis of Tuberculosis at Peripheral Health Service Level	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; SENSITIVITY; OPPORTUNITY	Background: Sputum microscopy is the only diagnostic for tuberculosis (TB) available at peripheral levels of health service in resource-poor countries. Its sensitivity is reduced in high HIV-prevalence settings. Sodium hypochlorite (NaOCl) specimen sedimentation prior microscopy and light-emitting diode (LED)-fluorescence microscopy (FM) can individually improve performance of microscopy. This study aimed to evaluate the performance of combined LED-FM and NaOCl sputum sedimentation for TB detection at peripheral level of health services. Methods: A prospective study was conducted in an urban health clinic in Nairobi, Kenya. Three sputum specimens were collected over 2 days from consecutive TB suspects. Smears were prepared and stained with auramine O and Ziehl-Neelsen (ZN) methods. Bleach (3.5%) was added to the remaining specimen before overnight sedimentation at room temperature. Auramine O staining was performed on smears of sediment. A 4(th) specimen was collected for TB culture. Auramine smears were read under the same microscope as used for ZN smears, but equipped with the LED FluoLED (TM) fluorescence illuminator. Results: 497 patients were included, and 1394 specimens collected. The yield of positive specimen was significantly increased after NaOCl sedimentation (24.9%) compared to direct LED-FM (20.6%) and direct ZN (20.3%). In detecting smear-positive patients, sensitivity was 78.5% for LED-FM after NaOCl sedimentation compared to 73.2% and 72.0% for direct LED-FM (P = 0.06) and direct ZN (P = 0.06), respectively. Specificity was 87.8% for LED-FM after NaOCl sedimentation compared to 96.7% and 95.9% for direct LED-FM (P<0.01) and direct ZN (P<0.01), respectively. Inter-reading agreement (kappa = 0.7) and technicians' acceptability were good. Conclusion: NaOCl sedimentation did not improve the performance of LED-FM in the diagnosis of pulmonary TB at peripheral health service level.	[Bonnet, Maryline; Gagnidze, Laramie; Guerin, Philippe J.] Epictr, Paris, France; [Bonte, Laurence; Varaine, Francis] Med Sans Frontieres, Paris, France; [Ramsay, Andrew] WHO Special Programme Res & Training Trop Dis TDR, UNICEF, UNDP, World Bank, Geneva, Switzerland; [Githui, Willie] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya	Doctors Without Borders; The World Bank; World Health Organization; Kenya Medical Research Institute	Bonnet, M (corresponding author), Epictr, Paris, France.	maryline.bonnet@geneva.msf.org	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres	Medecins Sans Frontieres	The study was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Bonnet M, 2008, CLIN INFECT DIS, V46, P1710, DOI 10.1086/587891; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017214; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; DAVID HL, 1996, BACTERIOLOGY MYCOBAC; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; KUHN, 2010, OPEN MICROBIOLOGY J, V4, P30; Mabaera B, 2007, INT J TUBERC LUNG D, V11, P959; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Merid Y, 2009, INT J TUBERC LUNG D, V13, P136; Minion J, 2009, EXPERT REV MED DEVIC, V6, P596; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, INT J TUBERC LUNG D, V13, P613; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; *STOP TB PARTN RET, 2008, NEW LAB DIAGN TOOLS; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Trusov A, 2009, INT J TUBERC LUNG D, V13, P836; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816; Van Deun A, 2000, INT J TUBERC LUNG D, V4, P371; Van Deun A, 2007, PRIORITIES TUBERCULO, P11	26	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20175	10.1371/journal.pone.0020175	http://dx.doi.org/10.1371/journal.pone.0020175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655284	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600027
J	Lin, HX; Li, Z; Chen, C; Luo, XB; Xiao, JN; Dong, DL; Lu, YJ; Yang, BF; Wang, ZG				Lin, Huixian; Li, Zhe; Chen, Chang; Luo, Xiaobin; Xiao, Jiening; Dong, Deli; Lu, Yanjie; Yang, Baofeng; Wang, Zhiguo			Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether A Go-Go K+ Channel	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNAS; SEE VOL. 227; POTASSIUM CHANNELS; TUMOR-SUPPRESSOR; CELL-CYCLE; DECOY OLIGODEOXYNUCLEOTIDES; ABERRANT EXPRESSION; CANCER PATIENTS; GENES HCN2; PG. 877	The human ether-a-go-go-1 (h-eag1) K+ channel is expressed in a variety of cell lines derived from human malignant tumors and in clinical samples of several different cancers, but is otherwise absent in normal tissues. It was found to be necessary for cell cycle progression and tumorigenesis. Specific inhibition of h-eag1 expression leads to inhibition of tumor cell proliferation. We report here that h-eag1 expression is controlled by the p53-miR-34-E2F1 pathway through a negative feed-forward mechanism. We first established E2F1 as a transactivator of h-eag1 gene through characterizing its promoter region. We then revealed that miR-34, a known transcriptional target of p53, is an important negative regulator of h-eag1 through dual mechanisms by directly repressing h-eag1 at the post-transcriptional level and indirectly silencing h-eag1 at the transcriptional level via repressing E2F1. There is a strong inverse relationship between the expression levels of miR-34 and h-eag1 protein. H-eag1antisense antagonized the growth-stimulating effects and the upregulation of h-eag1 expression in SHSY5Y cells, induced by knockdown of miR-34, E2F1 overexpression, or inhibition of p53 activity. Therefore, p53 negatively regulates h-eag1 expression by a negative feed-forward mechanism through the p53-miR-34-E2F1 pathway. Inactivation of p53 activity, as is the case in many cancers, can thus cause oncogenic overexpression of h-eag1 by relieving the negative feed-forward regulation. These findings not only help us understand the molecular mechanisms for oncogenic overexpression of h-eag1 in tumorigenesis but also uncover the cell-cycle regulation through the p53-miR-34-E2F1-h-eag1 pathway. Moreover, these findings place h-eag1 in the p53-miR-34-E2F1-h-eag1 pathway with h-eag as a terminal effecter component and with miR-34 (and E2F1) as a linker between p53 and h-eag1. Our study therefore fills the gap between p53 pathway and its cellular function mediated by h-eag1.	[Lin, Huixian; Luo, Xiaobin; Xiao, Jiening; Wang, Zhiguo] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Luo, Xiaobin; Wang, Zhiguo] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Li, Zhe; Chen, Chang; Dong, Deli; Lu, Yanjie; Yang, Baofeng] Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin, Heilongjiang, Peoples R China; [Luo, Xiaobin; Lu, Yanjie; Yang, Baofeng; Wang, Zhiguo] Harbin Med Univ, Cardiovasc Res Inst, Key Lab Cardiovasc Res, Minist Educ China, Harbin, Heilongjiang, Peoples R China	Universite de Montreal; Universite de Montreal; Harbin Medical University; Harbin Medical University; Ministry of Education, China	Lin, HX (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	yangbf@ems.hrbmu.edu.cn; wangz@mirna-tech.com	Wang, Zhiguo/GRS-4339-2022; wang, zhiguo/AAN-4182-2021	Wang, Zhiguo/0000-0002-0811-2045; 	Canadian Institute of Health Research; Fonds de la Recherche de l'Institut de Cardiologie de Montreal	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche de l'Institut de Cardiologie de Montreal	This work was supported by the Canadian Institute of Health Research to Z. Wang and Fonds de la Recherche de l'Institut de Cardiologie de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; DeGregori J, 2006, CURR MOL MED, V6, P739; Ding XW, 2008, DIGEST DIS SCI, V53, P2039, DOI 10.1007/s10620-007-0116-7; Ding XW, 2007, MED ONCOL, V24, P345, DOI 10.1007/s12032-007-0015-y; Ding XW, 2007, WORLD J GASTROENTERO, V13, P1257, DOI 10.3748/wjg.v13.i8.1257; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Gao HH, 2006, MOL PHARMACOL, V70, P1621, DOI 10.1124/mol.106.024273; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Kapsimali M, 2010, RES PER NEUROSCI, P9, DOI 10.1007/978-3-642-04298-0_2; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lin HX, 2007, J CELL PHYSIOL, V212, P137, DOI 10.1002/jcp.21015; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Lu YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1053; LUO X, 2007, AM J PHYSIOL, V294, pH1371; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Morishita R, 2001, ANN NY ACAD SCI, V947, P294; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Pardo LA, 2008, CANCER RES, V68, P1611, DOI 10.1158/0008-5472.CAN-07-5710; Patt S, 2004, NEUROSCI LETT, V368, P249, DOI 10.1016/j.neulet.2004.07.001; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rogoff HA, 2004, CELL CYCLE, V3, P845; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wadhwa S, 2009, INT UROL NEPHROL, V41, P251, DOI 10.1007/s11255-008-9459-z; Wang HZ, 2002, CANCER RES, V62, P4843; Wang L, 2007, J NEUROSCI, V27, P12555, DOI 10.1523/JNEUROSCI.3681-07.2007; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	48	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20362	10.1371/journal.pone.0020362	http://dx.doi.org/10.1371/journal.pone.0020362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655246	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600053
J	Nagarkatti-Gude, DR; Jaimez, R; Henderson, SC; Teves, ME; Zhang, ZB; Strauss, JF				Nagarkatti-Gude, David R.; Jaimez, Ruth; Henderson, Scott C.; Teves, Maria E.; Zhang, Zhibing; Strauss, Jerome F., III			Spag16, an Axonemal Central Apparatus Gene, Encodes a Male Germ Cell Nuclear Speckle Protein that Regulates SPAG16 mRNA Expression	PLOS ONE			English	Article							WD-REPEAT; CHLAMYDOMONAS FLAGELLA; SPERM AXONEME; TRANSCRIPTION; MOTILITY; DOMAINS; SPERMATOGENESIS; ASSOCIATION; ARCHITECTURE; DEFICIENCY	Spag16 is the murine orthologue of Chlamydomonas reinhardtii PF20, a protein known to be essential to the structure and function of the "9+2'' axoneme. In Chlamydomonas, the PF20 gene encodes a single protein present in the central pair of the axoneme. Loss of PF20 prevents central pair assembly/integrity and results in flagellar paralysis. Here we demonstrate that the murine Spag16 gene encodes two proteins: 71 kDa SPAG16L, which is found in all murine cells with motile cilia or flagella, and 35 kDa SPAG16S, representing the C terminus of SPAG16L, which is expressed only in male germ cells, and is predominantly found in specific regions within the nucleus that also contain SC35, a known marker of nuclear speckles enriched in pre-mRNA splicing factors. SPAG16S expression precedes expression of SPAG16L. Mice homozygous for a knockout of SPAG16L alone are infertile, but show no abnormalities in spermatogenesis. Mice chimeric for a mutation deleting the transcripts for both SPAG16L and SPAG16S have a profound defect in spermatogenesis. We show here that transduction of SPAG16S into cultured dispersed mouse male germ cells and BEAS-2B human bronchial epithelial cells increases SPAG16L expression, but has no effect on the expression of several other axoneme components. We also demonstrate that the Spag16L promoter shows increased activity in the presence of SPAG16S. The distinct nuclear localization of SPAG16S and its ability to modulate Spag16L mRNA expression suggest that SPAG16S plays an important role in the gene expression machinery of male germ cells. This is a unique example of a highly conserved axonemal protein gene that encodes two protein products with different functions.	[Nagarkatti-Gude, David R.; Zhang, Zhibing; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Nagarkatti-Gude, David R.; Teves, Maria E.; Zhang, Zhibing; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Jaimez, Ruth] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Henderson, Scott C.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Pennsylvania; Pennsylvania Medicine; Virginia Commonwealth University	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	jfstrauss@vcu.edu	Teves, Maria/AAJ-9523-2020; Henderson, Scott/AAP-2785-2021; Nagarkatti-Gude, David/AAF-6996-2020	Teves, Maria/0000-0001-7035-2202; Henderson, Scott/0000-0002-1076-3867; 	National Institutes of Health-NICHD [5R01HD037416, 5F31HD062314, 5D43TW007692]; Virginia Commonwealth University (VCU); NIH-NINDS Center [5P30NS047463]; NIH-NCI Cancer Center [5P30CA016059]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD062314, R01HD037416] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW007692] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Virginia Commonwealth University (VCU); NIH-NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health-NICHD grants 5R01HD037416 (to JFS), 5F31HD062314 (to DRN-G), 5D43TW007692 (to MET) and a Virginia Commonwealth University (VCU) Presidential Research Incentive Program Award (to ZZ). Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). Viruses were amplified and titered at the VCU Macromolecule Core Facility, supported, in part, with funding from NIH-NCI Cancer Center Support Grant (5P30CA016059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMS GMW, 1981, J CELL BIOL, V91, P69, DOI 10.1083/jcb.91.1.69; Bastin P, 2000, MICROBES INFECT, V2, P1865, DOI 10.1016/S1286-4579(00)01344-7; Beissbarth T, 2003, MOL CELL ENDOCRINOL, V212, P29, DOI 10.1016/j.mce.2003.09.023; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, CURR TOP DEV BIOL, V37, P141; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Fajardo MA, 1997, DEV BIOL, V191, P42, DOI 10.1006/dbio.1997.8705; Gallenberger M, 2011, HUM MOL GENET, V20, P422, DOI 10.1093/hmg/ddq478; Horowitz E, 2005, MOL HUM REPROD, V11, P307, DOI 10.1093/molehr/gah163; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hu Y, 2010, J CELL BIOL, V191, P711, DOI 10.1083/jcb.201004041; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Inaba K, 2007, ANN NY ACAD SCI, V1101, P506, DOI 10.1196/annals.1389.017; Kleene KC, 1996, MOL REPROD DEV, V43, P268, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;268::AID-MRD17&gt;3.0.CO;2-#; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Lallena MJ, 1997, J CELL SCI, V110, P239; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lesich KA, 2010, BIOL REPROD, V82, P736, DOI 10.1095/biolreprod.109.080143; LUCK DJL, 1984, J CELL BIOL, V98, P789, DOI 10.1083/jcb.98.3.789; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V39, pD225; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Reddi PP, 2002, J REPROD IMMUNOL, V53, P25, DOI 10.1016/S0165-0378(01)00104-8; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; Smith EF, 1997, MOL BIOL CELL, V8, P455, DOI 10.1091/mbc.8.3.455; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SPECTOR DL, 1993, COLD SPRING HARB SYM, V58, P799, DOI 10.1101/SQB.1993.058.01.087; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254; Zhang ZB, 2004, P NATL ACAD SCI USA, V101, P12946, DOI 10.1073/pnas.0404280101; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002; Zhang ZB, 2008, BIOL REPROD, V79, P75, DOI 10.1095/biolreprod.107.066308; Zhang ZB, 2007, BIOL REPROD, V77, P864, DOI 10.1095/biolreprod.107.063206; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	46	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20625	10.1371/journal.pone.0020625	http://dx.doi.org/10.1371/journal.pone.0020625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655194	Green Published, Green Submitted, gold			2022-12-27	WOS:000291097600110
J	Martel, P; Leo, D; Fulton, S; Berard, M; Trudeau, LE				Martel, Philippe; Leo, Damiana; Fulton, Stephanie; Berard, Maxime; Trudeau, Louis-Eric			Role of Kv1 Potassium Channels in Regulating Dopamine Release and Presynaptic D2 Receptor Function	PLOS ONE			English	Article							GLUTAMATE-DEPENDENT INHIBITION; SUBSTANTIA-NIGRA NEURONS; GATED K+ CHANNELS; IN-VIVO; MEDIATED INHIBITION; CALCIUM-CHANNELS; NERVE-TERMINALS; DEFICIENT MICE; ION CHANNELS; RAT STRIATUM	Dopamine (DA) release in the CNS is critical for motor control and motivated behaviors. Dysfunction of its regulation is thought to be implicated in drug abuse and in diseases such as schizophrenia and Parkinson's. Although various potassium channels located in the somatodendritic compartment of DA neurons such as G-protein-gated inward rectifying potassium channels (GIRK) have been shown to regulate cell firing and DA release, little is presently known about the role of potassium channels localized in the axon terminals of these neurons. Here we used fast-scan cyclic voltammetry to study electrically-evoked DA release in rat dorsal striatal brain slices. We find that although G-protein-gated inward rectifying (GIRK) and ATP-gated (K(ATP)) potassium channels play only a minor role, voltage-gated potassium channels of the Kv1 family play a major role in regulating DA release. The use of Kv subtype-selective blockers confirmed a role for Kv1.2, 1.3 and 1.6, but not Kv1.1, 3.1, 3.2, 3.4 and 4.2. Interestingly, Kv1 blockers also reduced the ability of quinpirole, a D2 receptor agonist, to inhibit evoked DA overflow, thus suggesting that Kv1 channels also regulate presynaptic D2 receptor function. Our work identifies Kv1 potassium channels as key regulators of DA release in the striatum.	[Martel, Philippe; Leo, Damiana; Fulton, Stephanie; Berard, Maxime; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Martel, P (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020	Trudeau, Louis-Eric/0000-0003-4684-1377; Leo, Damiana/0000-0001-9219-5498	Canadian Institutes of Health research (CIHR) [MOP-49591]; Fonds de la Recherche en Sante du Quebec (FRSQ); Universite de Montre al; National Science and Engineering Research Council (NSERC); Department of Foreign Affairs and International Trade of Canada	Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Universite de Montre al; National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Foreign Affairs and International Trade of Canada	This work was supported by grant MOP-49591 from the Canadian Institutes of Health research (CIHR) to LET. LET was supported by a senior scholar award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and also receives support through an infrastructure grant provided by the FRSQ to the Groupe de Recherche sur le Systeme Nerveux Central. PM was supported in part by a COPSE fellowship of the Universite de Montre al. MB was supported by a fellowship from the FRSQ. SF was supported by a National Science and Engineering Research Council (NSERC) postdoctoral fellowship. DL was supported by a postdoctoral fellowship (PDRF) from the Department of Foreign Affairs and International Trade of Canada and by a postdoctoral fellowship from the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1977, N-S ARCH PHARMACOL, V297, P1, DOI 10.1007/BF00508803; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Avshalumov MV, 2003, J NEUROSCI, V23, P2744; Bath BD, 2000, ANAL CHEM, V72, P5994, DOI 10.1021/ac000849y; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399; BOOTH RG, 1990, MOL PHARMACOL, V38, P92; CASS WA, 1991, J NEUROCHEM, V57, P147, DOI 10.1111/j.1471-4159.1991.tb02109.x; CHIODO LA, 1992, SYNAPSE, V11, P294, DOI 10.1002/syn.890110405; Chung YH, 2000, BRAIN RES, V875, P164, DOI 10.1016/S0006-8993(00)02586-5; Congar P, 2002, J NEUROPHYSIOL, V87, P1046, DOI 10.1152/jn.00459.2001; Cragg SJ, 1997, J NEUROSCI, V17, P5738; Davila V, 2003, J NEUROSCI, V23, P5693; DelleDonne KT, 1996, J COMP NEUROL, V371, P552; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; FARNEBO LO, 1971, ACTA PHYSIOL SCAND, P35; Fergus DJ, 2003, PFLUG ARCH EUR J PHY, V445, P697, DOI 10.1007/s00424-002-0994-7; Fulton S, 2011, J BIOL CHEM, V286, P9360, DOI 10.1074/jbc.M110.153262; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Gay EA, 2004, MOL PHARMACOL, V66, P97, DOI 10.1124/mol.66.1.97; Godino MD, 2005, NEUROPHARMACOLOGY, V48, P547, DOI 10.1016/j.neuropharm.2004.11.012; GRACE AA, 1985, BRAIN RES, V333, P285, DOI 10.1016/0006-8993(85)91582-3; Greffrath W, 1998, J PHYSIOL-LONDON, V513, P493, DOI 10.1111/j.1469-7793.1998.493bb.x; Guatteo E, 2004, J NEUROPHYSIOL, V92, P3368, DOI 10.1152/jn.00602.2004; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Inanobe A, 1999, J NEUROSCI, V19, P1006; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; KALIVAS PW, 1991, J NEUROCHEM, V56, P961, DOI 10.1111/j.1471-4159.1991.tb02015.x; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Kuzhikandathil EV, 1998, MOL CELL NEUROSCI, V12, P390, DOI 10.1006/mcne.1998.0722; L'hirondel M, 1998, BRAIN RES, V792, P253, DOI 10.1016/S0006-8993(98)00146-2; LACEY MG, 1988, J PHYSIOL-LONDON, V401, P437, DOI 10.1113/jphysiol.1988.sp017171; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; LIU LX, 1994, SYNAPSE, V17, P230, DOI 10.1002/syn.890170404; LLEDO PM, 1990, NEUROENDOCRINOLOGY, V52, P545, DOI 10.1159/000125650; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Mayfield RD, 2001, MOL PHARMACOL, V59, P113, DOI 10.1124/mol.59.1.113; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; OHara CM, 1996, J PHARMACOL EXP THER, V277, P186; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Phillips PEM, 2002, SYNAPSE, V44, P15, DOI 10.1002/syn.10049; Pothos EN, 1998, J NEUROSCI, V18, P5575; Ralevic V, 2003, EUR J PHARMACOL, V472, P1, DOI 10.1016/S0014-2999(03)01813-2; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Scuvee-Moreau J, 2002, J PHARMACOL EXP THER, V302, P1176, DOI 10.1124/jpet.302.3.1176; Seutin V, 1998, J NEUROPHYSIOL, V80, P3361, DOI 10.1152/jn.1998.80.6.3361; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; STAMFORD JA, 1991, BRIT J PHARMACOL, V102, P45, DOI 10.1111/j.1476-5381.1991.tb12130.x; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Walker QD, 2006, NEUROPSYCHOPHARMACOL, V31, P1193, DOI 10.1038/sj.npp.1300915; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; WERKMAN TR, 1993, MOL PHARMACOL, V44, P430; Wetherington JP, 2002, J NEUROSCI, V22, P1248, DOI 10.1523/JNEUROSCI.22-04-01248.2002; WHITE FJ, 1984, LIFE SCI, V34, P1161, DOI 10.1016/0024-3205(84)90088-2; Yeung SYM, 2005, J NEUROSCI, V25, P8735, DOI 10.1523/JNEUROSCI.2119-05.2005	73	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20402	10.1371/journal.pone.0020402	http://dx.doi.org/10.1371/journal.pone.0020402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647367	gold, Green Published			2022-12-27	WOS:000291052500057
J	Alalade, E; Denny, K; Potter, G; Steffens, D; Wang, LH				Alalade, Emmanuel; Denny, Kevin; Potter, Guy; Steffens, David; Wang, Lihong			Altered Cerebellar-Cerebral Functional Connectivity in Geriatric Depression	PLOS ONE			English	Article							BLOOD-FLOW ABNORMALITIES; MAJOR DEPRESSION; HYPOTHALAMO-CEREBELLAR; RHESUS-MONKEY; UNIPOLAR DEPRESSION; FASTIGIAL NUCLEUS; CINGULATE CORTEX; EXERCISE; PROJECTIONS; AMYGDALA	Although volumetric and activation changes in the cerebellum have frequently been reported in studies on major depression, its role in the neural mechanism of depression remains unclear. To understand how the cerebellum may relate to affective and cognitive dysfunction in depression, we investigated the resting-state functional connectivity between cerebellar regions and the cerebral cortex in samples of patients with geriatric depression (n = 11) and healthy controls (n = 18). Seed-based connectivity analyses were conducted using seeds from cerebellum regions previously identified as being involved in the executive, default-mode, affective- limbic, and motor networks. The results revealed that, compared with controls, individuals with depression show reduced functional connectivity between several cerebellum seed regions, specifically those in the executive and affective- limbic networks with the ventromedial prefrontal cortex (vmPFC) and increased functional connectivity between the motor-related cerebellum seed regions with the putamen and motor cortex. We further investigated whether the altered functional connectivity in depressed patients was associated with cognitive function and severity of depression. A positive correlation was found between the Crus II-vmPFC connectivity and performance on the Hopkins Verbal Learning Test-Revised delayed memory recall. Additionally, the vermis-posterior cinglate cortex (PCC) connectivity was positively correlated with depression severity. Our results suggest that cerebellum-vmPFC coupling may be related to cognitive function whereas cerebellum-PCC coupling may be related to emotion processing in geriatric depression.	[Alalade, Emmanuel] Morehouse Sch Med, Atlanta, GA 30310 USA; [Denny, Kevin; Wang, Lihong] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Potter, Guy; Steffens, David; Wang, Lihong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	Morehouse School of Medicine; Duke University; Duke University	Alalade, E (corresponding author), Morehouse Sch Med, Atlanta, GA 30310 USA.	lihong.wang@duke.edu	Wang, Lihong/D-8960-2011		Paul B. Beeson Career Developmental Awards [K23-AG028982]; National Alliance for Research in Schizophrenia and Depression Young Investigator Award; Duke Silvio O. Conte Center for the Neuroscience of Depression [P50-MH60451]; NIMH [K24 MH70027, K23 MH087741]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087741, P50MH060451, K24MH070027, R25MH071544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028982] Funding Source: NIH RePORTER	Paul B. Beeson Career Developmental Awards; National Alliance for Research in Schizophrenia and Depression Young Investigator Award; Duke Silvio O. Conte Center for the Neuroscience of Depression; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Paul B. Beeson Career Developmental Awards (K23-AG028982), a National Alliance for Research in Schizophrenia and Depression Young Investigator Award (LW), and the Duke Silvio O. Conte Center for the Neuroscience of Depression (P50-MH60451). DC is supported by a NIMH Mid-Career Development Award (K24 MH70027). GP is supported by NIMH Career Development Award (K23 MH087741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREZIK JA, 1984, NEUROSCIENCE, V11, P497, DOI 10.1016/0306-4522(84)90040-X; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; BLUMENTHAL JA, 1989, J GERONTOL, V44, pM147, DOI 10.1093/geronj/44.5.M147; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DelBello MP, 1999, NEUROPSYCHOPHARMACOL, V21, P63, DOI 10.1016/S0893-133X(99)00026-3; Di Francescomarino S, 2009, SPORTS MED, V39, P797, DOI 10.2165/11317750-000000000-00000; DIETRICHS E, 1984, ANAT EMBRYOL, V170, P313, DOI 10.1007/BF00318735; DIETRICHS E, 1984, BRAIN RES, V296, P225, DOI 10.1016/0006-8993(84)90060-X; DOLAN RJ, 1992, J NEUROL NEUROSUR PS, V55, P768, DOI 10.1136/jnnp.55.9.768; Escalona P.R., 1993, DEPRESSION, V1, P156, DOI DOI 10.1002/DEPR.3050010307; Etkin A, 2010, ANXIETY DISORDERS TH, P192; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HAINES DE, 1984, BRAIN BEHAV EVOLUT, V24, P198, DOI 10.1159/000121317; HEATH RG, 1974, EXP NEUROL, V45, P268, DOI 10.1016/0014-4886(74)90118-6; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Kimbrell TA, 2002, BIOL PSYCHIAT, V51, P237, DOI 10.1016/S0006-3223(01)01216-1; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LAYNE C, 1980, J CLIN PSYCHOL, V36, P647, DOI 10.1002/1097-4679(198007)36:3<647::AID-JCLP2270360306>3.0.CO;2-9; Liotti M, 2002, AM J PSYCHIAT, V159, P1830, DOI 10.1176/appi.ajp.159.11.1830; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Ma Qiang, 2008, Neurosci Bull, V24, P265, DOI 10.1007/s12264-008-0402-1; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; QVIST H, 1989, ANAT EMBRYOL, V179, P471, DOI 10.1007/BF00319590; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; SCHMAHMANN JD, 1995, NEUROSCI LETT, V199, P175, DOI 10.1016/0304-3940(95)12056-A; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2000, J NEUROLINGUIST, V13, P189, DOI 10.1016/S0911-6044(00)00011-7; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; SHAH SA, 1992, ACTA PSYCHIAT SCAND, V85, P474, DOI 10.1111/j.1600-0447.1992.tb03214.x; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; STOODLEY CJ, 2011, CEREBELLUM, V11, P352, DOI DOI 10.1007/S12311-011-0260-7; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; VILENSKY JA, 1981, BRAIN RES, V205, P391, DOI 10.1016/0006-8993(81)90348-6; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wolf SA, 2011, BRAIN BEHAV IMMUN, V25, P971, DOI 10.1016/j.bbi.2010.10.014; Worsley KJ, 2001, FUNCTIONAL MRI INTRO	57	104	108	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20035	10.1371/journal.pone.0020035	http://dx.doi.org/10.1371/journal.pone.0020035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637831	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052200028
J	Annala, M; Laurila, K; Lahdesmaki, H; Nykter, M				Annala, Matti; Laurila, Kirsti; Lahdesmaki, Harri; Nykter, Matti			A Linear Model for Transcription Factor Binding Affinity Prediction in Protein Binding Microarrays	PLOS ONE			English	Article							UNIVERSAL DNA MICROARRAYS; IN-VIVO; SITES; SPECIFICITIES; SELECTION; COMPACT; TARGETS; DESIGN	Protein binding microarrays (PBM) are a high throughput technology used to characterize protein-DNA binding. The arrays measure a protein's affinity toward thousands of double-stranded DNA sequences at once, producing a comprehensive binding specificity catalog. We present a linear model for predicting the binding affinity of a protein toward DNA sequences based on PBM data. Our model represents the measured intensity of an individual probe as a sum of the binding affinity contributions of the probe's subsequences. These subsequences characterize a DNA binding motif and can be used to predict the intensity of protein binding against arbitrary DNA sequences. Our method was the best performer in the Dialogue for Reverse Engineering Assessments and Methods 5 (DREAM5) transcription factor/DNA motif recognition challenge. For the DREAM5 bonus challenge, we also developed an approach for the identification of transcription factors based on their PBM binding profiles. Our approach for TF identification achieved the best performance in the bonus challenge.	[Annala, Matti; Laurila, Kirsti; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Sch Sci & Technol, Helsinki, Finland; [Lahdesmaki, Harri; Nykter, Matti] Turku Univ, Turku Ctr Biotechnol, Turku, Finland	Tampere University; Aalto University; University of Turku	Annala, M (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	matti.annala@tut.fi		Nykter, Matti/0000-0001-6956-2843	Academy of Finland [122973, 132877, 134290, 135320, 213462]; EU; Tekes Finland; Tampere Doctoral Programme in Information Science and Engineering (TISE); Otto A. Malm Foundation	Academy of Finland(Academy of Finland); EU(European Commission); Tekes Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Tampere Doctoral Programme in Information Science and Engineering (TISE); Otto A. Malm Foundation	This work was supported by the Academy of Finland (projects 122973, 132877, 134290, 135320, 213462), EU ERASysBio ERA-NET, the Tekes Finland Distinguished Professor programme, the Tampere Doctoral Programme in Information Science and Engineering (TISE), and the Otto A. Malm Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1007/BF00993379; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mintseris J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-429; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nykter M, 2009, ANN NY ACAD SCI, V1158, P205, DOI 10.1111/j.1749-6632.2008.03758.x; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Philippakis AA, 2008, J COMPUT BIOL, V15, P655, DOI 10.1089/cmb.2007.0114; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	42	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20059	10.1371/journal.pone.0020059	http://dx.doi.org/10.1371/journal.pone.0020059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637853	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200031
J	Bejjanki, VR; Clayards, M; Knill, DC; Aslin, RN				Bejjanki, Vikranth Rao; Clayards, Meghan; Knill, David C.; Aslin, Richard N.			Cue Integration in Categorical Tasks: Insights from Audio-Visual Speech Perception	PLOS ONE			English	Article							BAYESIAN INTEGRATION; INFORMATION; INFANTS; FUSION; MODEL; INFERENCE; TEXTURE; SIGNALS; HEARING; SENSES	Previous cue integration studies have examined continuous perceptual dimensions (e. g., size) and have shown that human cue integration is well described by a normative model in which cues are weighted in proportion to their sensory reliability, as estimated from single-cue performance. However, this normative model may not be applicable to categorical perceptual dimensions (e. g., phonemes). In tasks defined over categorical perceptual dimensions, optimal cue weights should depend not only on the sensory variance affecting the perception of each cue but also on the environmental variance inherent in each task-relevant category. Here, we present a computational and experimental investigation of cue integration in a categorical audio-visual (articulatory) speech perception task. Our results show that human performance during audio-visual phonemic labeling is qualitatively consistent with the behavior of a Bayes-optimal observer. Specifically, we show that the participants in our task are sensitive, on a trial-by-trial basis, to the sensory uncertainty associated with the auditory and visual cues, during phonemic categorization. In addition, we show that while sensory uncertainty is a significant factor in determining cue weights, it is not the only one and participants' performance is consistent with an optimal model in which environmental, within category variability also plays a role in determining cue weights. Furthermore, we show that in our task, the sensory variability affecting the visual modality during cue-combination is not well estimated from single-cue performance, but can be estimated from multi-cue performance. The findings and computational principles described here represent a principled first step towards characterizing the mechanisms underlying human cue integration in categorical tasks.	[Bejjanki, Vikranth Rao; Clayards, Meghan; Knill, David C.; Aslin, Richard N.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Bejjanki, VR (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	vrao@bcs.rochester.edu			MURI from the Office of Naval Research, Department of Defense [N00014-07-1-0937]	MURI from the Office of Naval Research, Department of Defense(United States Department of Defense)	This work was supported by MURI grant N00014-07-1-0937 from the Office of Naval Research, Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Banks MS, 1998, VISION RES, V38, P187, DOI 10.1016/S0042-6989(97)00179-X; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Clayards M, 2008, COGNITION, V108, P804, DOI 10.1016/j.cognition.2008.04.004; COHEN MM, 1990, BEHAV RES METH INSTR, V22, P260, DOI 10.3758/BF03203157; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; Desjardins RN, 1997, J EXP CHILD PSYCHOL, V66, P85, DOI 10.1006/jecp.1997.2379; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Holt LL, 2006, J ACOUST SOC AM, V119, P3059, DOI 10.1121/1.2188377; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jacobs RA, 2002, TRENDS COGN SCI, V6, P345, DOI 10.1016/S1364-6613(02)01948-4; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.7.5; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; MASSARO DW, 1983, J EXP PSYCHOL HUMAN, V9, P753, DOI 10.1037/0096-1523.9.5.753; MASSARO DW, 1993, J PHONETICS, V21, P445, DOI 10.1016/S0095-4470(19)30230-X; MASSARO DW, 1984, CHILD DEV, V55, P1777, DOI 10.2307/1129925; MASSARO DW, SPEECH PERCEPTION EA; MASSARO DW, PERCEIVING TALKING F; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Papoulis Athanasios, PROBABILITY RANDOM V; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Remez RE, 2001, PSYCHOL SCI, V12, P24, DOI 10.1111/1467-9280.00305; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schwartz JL, 2006, J ACOUST SOC AM, V120, P1795, DOI 10.1121/1.2258814; Schwartz JL, 2010, J ACOUST SOC AM, V127, P1584, DOI 10.1121/1.3293001; Sekiyama K, 1997, PERCEPT PSYCHOPHYS, V59, P73, DOI 10.3758/BF03206849; Sekiyama K, 2008, DEVELOPMENTAL SCI, V11, P306, DOI 10.1111/j.1467-7687.2008.00677.x; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; SWANSON WH, 1992, PERCEPT PSYCHOPHYS, V51, P409, DOI 10.3758/BF03211637; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	48	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19812	10.1371/journal.pone.0019812	http://dx.doi.org/10.1371/journal.pone.0019812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637344	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200016
J	Woodwark, C; Bateman, A				Woodwark, Cara; Bateman, Alex			The Characterisation of Three Types of Genes that Overlie Copy Number Variable Regions	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; TRANSCRIPTION FACTORS; HUMAN GENOME; EVOLUTION; MICRORNAS; EXPRESSION; TARGETS; DATABASE; TRANSLATION; SHAPES	Background: Due to the increased accuracy of Copy Number Variable region (CNV) break point mapping, it is now possible to say with a reasonable degree of confidence whether a gene (i) falls entirely within a CNV; (ii) overlaps the CNV or (iii) actually contains the CNV. We classify these as type I, II and III CNV genes respectively. Principal Findings: Here we show that although type I genes vary in copy number along with the CNV, most of these type I genes have the same expression levels as wild type copy numbers of the gene. These genes must, therefore, be under homeostatic dosage compensation control. Looking into possible mechanisms for the regulation of gene expression we found that type I genes have a significant paucity of genes regulated by miRNAs and are not significantly enriched for monoallelically expressed genes. Type III genes, on the other hand, have a significant excess of genes regulated by miRNAs and are enriched for genes that are monoallelically expressed. Significance: Many diseases and genomic disorders are associated with CNVs so a better understanding of the different ways genes are associated with normal CNVs will help focus on candidate genes in genome wide association studies.	[Woodwark, Cara; Bateman, Alex] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Woodwark, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	cara@sanger.ac.uk	Bateman, Alex/E-6518-2011; Bateman, Alex/H-2861-2019	Bateman, Alex/0000-0002-6982-4660	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [grant number WT077044/Z/05/Z] http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Necsulea A, 2009, TRENDS GENET, V25, P519, DOI 10.1016/j.tig.2009.10.001; Ohno S., 1970, EVOLUTION GENE DUPLI; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Patthy L, 2003, GENETICA, V118, P217, DOI 10.1023/A:1024182432483; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruault M, 2008, TRENDS GENET, V24, P574, DOI 10.1016/j.tig.2008.08.008; Schuster-Bockler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009474; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	35	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e14814	10.1371/journal.pone.0014814	http://dx.doi.org/10.1371/journal.pone.0014814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637334	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200001
J	Zeiser, E; Frokjaer-Jensen, C; Jorgensen, E; Ahringer, J				Zeiser, Eva; Frokjaer-Jensen, Christian; Jorgensen, Erik; Ahringer, Julie			MosSCI and Gateway Compatible Plasmid Toolkit for Constitutive and Inducible Expression of Transgenes in the C. elegans Germline	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; REQUIREMENTS; VERSION	Here we describe a toolkit for the production of fluorescently tagged proteins in the C. elegans germline and early embryo using Mos1-mediated single copy insertion (MosSCI) transformation. We have generated promoter and 3'UTR fusions to sequences of different fluorescent proteins yielding constructs for germline expression that are compatible with MosSCI MultiSite Gateway vectors. These vectors allow tagged transgene constructs to be inserted as single copies into known sites in the C. elegans genome using MosSCI. We also show that two C. elegans heat shock promoters (Phsp-16.2 and Phsp-16.41) can be used to induce transgene expression in the germline when inserted via MosSCI transformation. This flexible set of new vectors, available to the research community in a plasmid repository, should facilitate research focused on the C. elegans germline and early embryo.	[Zeiser, Eva; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge, England; [Zeiser, Eva; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Frokjaer-Jensen, Christian] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Frokjaer-Jensen, Christian] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Frokjaer-Jensen, Christian; Jorgensen, Erik] Univ Utah, Dept Biol, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	University of Cambridge; University of Cambridge; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Zeiser, E (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	ja219@cam.ac.uk	Frøkjær-Jensen, Christian/ABB-4637-2020	Ahringer, Julie/0000-0002-7074-4051; Frokjaer-Jensen, Christian/0000-0002-3178-0906	Lundbeck Foundation; National Institutes of Health [NIH/NIGMS1R01GM095817-01]; Wellcome Trust [054523]; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CF-J is funded by a fellowship from the Lundbeck Foundation (http://www.lundbeckfonden.dk/en/index.asp). This work was supported by the National Institutes of Health (http://www.nih.gov/) (NIH/NIGMS1R01GM095817-01) to EMJ, and a Wellcome Trust (http://www.wellcome.ac.uk/) Senior Research Fellowship (054523) and core funding from the Wellcome Trust and Cancer Research UK (http://www.cancerresearchuk.org/) to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bazopoulou D, 2009, GENETICA, V137, P39, DOI 10.1007/s10709-009-9361-3; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Kelly WG, 1997, GENETICS, V146, P227; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; OKKEMA PG, 1993, GENETICS, V135, P385; Praitis V, 2001, GENETICS, V157, P1217; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082	15	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20082	10.1371/journal.pone.0020082	http://dx.doi.org/10.1371/journal.pone.0020082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637852	Green Published, gold			2022-12-27	WOS:000291052200032
J	Zavalaga, CB; Dell'Omo, G; Becciu, P; Yoda, K				Zavalaga, Carlos B.; Dell'Omo, Giacomo; Becciu, Paolo; Yoda, Ken			Patterns of GPS Tracks Suggest Nocturnal Foraging by Incubating Peruvian Pelicans (Pelecanus thagus)	PLOS ONE			English	Article							BROWN-PELICAN; WANDERING ALBATROSS; DIVING BEHAVIOR; MARINE PREDATOR; NORTHERN PERU; PREY CAPTURE; SEABIRDS; SEA; ECOLOGY; DEPTH	Most seabirds are diurnal foragers, but some species may also feed at night. In Peruvian pelicans (Pelecanus thagus), the evidence for nocturnal foraging is sparse and anecdotal. We used GPS-dataloggers on five incubating Peruvian pelicans from Isla Lobos de Tierra, Peru, to examine their nocturnality, foraging movements and activities patterns at sea. All instrumented pelicans undertook nocturnal trips during a 5-7 day tracking period. Eighty-seven percent of these trips (n = 13) were strictly nocturnal, whereas the remaining occurred during the day and night. Most birds departed from the island after sunset and returned a few hours after sunrise. Birds traveled south of the island for single-day trips at a maximum range of 82.8 km. Overall, 22% of the tracking period was spent at sea, whereas the remaining time was spent on the island. In the intermediate section of the trip (between inbound and outbound commutes), birds spent 77% of the trip time in floating bouts interspersed by short flying bouts, the former being on average three times longer than the latter. Taken together, the high sinuosity of the bird's tracks during floating bouts, the exclusively nocturnal trips of most individuals, and the fact that all birds returned to the island within a few hours after sunrise suggest that pelicans were actively feeding at night. The nocturnal foraging strategy of Peruvian pelicans may reduce food competition with the sympatric and strictly diurnal Guanay cormorants (Phalacrocorax bougainvillii), Peruvian boobies (Sula variegata) and Blue-footed boobies (S. nebouxii), which were present on the island in large numbers. Likewise, plankton bioluminescence might be used by pelicans as indirect cues to locate anchovies during their upward migration at night. The foraging success of pelicans at night may be enhanced by seizing prey close to the sea surface using a sit-and-wait strategy.	[Zavalaga, Carlos B.; Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Dell'Omo, Giacomo; Becciu, Paolo] Ornis ital, Rome, Italy	Nagoya University	Zavalaga, CB (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan.	cbz3724@alum.uncw.edu	Becciu, Paolo/AAK-6790-2020	Becciu, Paolo/0000-0003-2145-6667; Dell'Omo, Giacomo/0000-0002-9601-9675	Japan Society for the Promotion of Science [71009317, 20519002]; Ornis italica	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ornis italica	The work was funded by Japan Society for the Promotion of Science (for CBZ), Grant No. 71009317; Japan Society for the Promotion of Science (for KY), Grant No. 20519002; and Ornis italica (for GD and PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCOS JM, 2002, MAR BIOL, V141, P177; ARNQVIST G, 1992, CONDOR, V94, P521, DOI 10.2307/1369223; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; DUFFY DC, 1980, IBIS, V122, P521, DOI 10.1111/j.1474-919X.1980.tb00910.x; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; FORBES HO, 1914, IBIS, V2, P403; GALARZA N, 1968, INFORME ESPECIAL I M, V31, P1; GARTHE S, 1996, WATERBIRDS, V19, P232; GUILLEN V, 1990, B LIMA, V67, P85; HAILMAN JACK P., 1964, WILSON BULL, V76, P347; HARPER P C, 1987, Notornis, V34, P169; HARRIS MP, 1970, AUK, V87, P215, DOI 10.2307/4083917; Jahncke J, 2000, WATERBIRDS, V23, P102; Jahncke J., 1998, B I MAR PERU, V17, P15; Joo R, 2011, ECOL MODEL, V222, P1048, DOI 10.1016/j.ecolmodel.2010.08.039; JORDA NR, 1967, CALIFORNIA COOPERATI, V1, P105; Ludynia K, 2010, J ORNITHOL, V151, P103, DOI 10.1007/s10336-009-0431-1; MATHISEN OA, 1989, ICLARM C P, P220; MCMAHON BF, 1992, CONDOR, V94, P101, DOI 10.2307/1368800; McNeil Raymond, 1993, Current Ornithology, V10, P187; Murphy RC, 1936, OCEANIC BIRDS S AM, VII; NELSON JB, 1985, PELICANS CORMORANTS; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; RICHARDSON FRANK, 1939, CONDOR, V41, P13, DOI 10.2307/1364267; ROBERT M, 1989, COLON WATERBIRD, V12, P118, DOI 10.2307/1521322; SCHREIBER RW, 1975, AUK, V92, P649, DOI 10.2307/4084778; Shamoun-Baranes J, 2011, IBIS, V153, P411, DOI 10.1111/j.1474-919X.2010.01096.x; Shealer David A., 2002, P137; Simeone A, 2003, REV CHIL HIST NAT, V76, P323, DOI 10.4067/S0716-078X2003000200016; SQUIRE JL, 1978, FISH B-NOAA, V76, P443; Vogt W., 1942, B COMPANIA ADM GUANO, V18, P3; VOTIERSC, 2004, NATURE, V427, P727; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291; Zavalaga CB, 2010, MAR ECOL PROG SER, V404, P259, DOI 10.3354/meps08490; Zavalaga CB, 1999, S AFR J MARINE SCI, V21, P251	42	25	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19966	10.1371/journal.pone.0019966	http://dx.doi.org/10.1371/journal.pone.0019966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647444	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500015
J	Fernandez-Velasco, M; Ruiz-Hurtado, G; Rueda, A; Neco, P; Mercado-Morales, M; Delgado, C; Napolitano, C; Priori, SG; Richard, S; MariaGomez, A; Benitah, JP				Fernandez-Velasco, Maria; Ruiz-Hurtado, Gema; Rueda, Angelica; Neco, Patricia; Mercado-Morales, Martha; Delgado, Carmen; Napolitano, Carlo; Priori, Silvia G.; Richard, Sylvain; MariaGomez, Ana; Benitah, Jean-Pierre			RyRCa(2+) Leak Limits Cardiac Ca2+ Window Current Overcoming the Tonic Effect of Calmodulinin Mice	PLOS ONE			English	Article							PIG VENTRICULAR MYOCYTES; CHANNEL INACTIVATION; CALCIUM-CHANNELS; RYANODINE RECEPTORS; SARCOPLASMIC-RETICULUM; DEPENDENT INACTIVATION; INTRACELLULAR CA2+; ALPHA(1C) SUBUNIT; HEART-FAILURE; RELEASE	Ca2+ mediates the functional coupling between L-type Ca2+ channel (LTCC) and sarcoplasmic reticulum (SR) Ca2+ release channel (ryanodine receptor, RyR), participating in key pathophysiological processes. This crosstalk manifests as the orthograde Ca2+-induced Ca2+-release (CICR) mechanism triggered by Ca2+ influx, but also as the retrograde Ca2+-dependent inactivation (CDI) of LTCC, which depends on both Ca2+ permeating through the LTCC itself and on SR Ca2+ release through the RyR. This latter effect has been suggested to rely on local rather than global Ca2+ signaling, which might parallel the nanodomain control of CDI carried out through calmodulin (CaM). Analyzing the CICR in catecholaminergic polymorphic ventricular tachycardia (CPVT) mice as a model of RyR-generated Ca2+ leak, we evidence here that increased occurrence of the discrete local SR Ca2+ releases through the RyRs (Ca2+ sparks) causea depolarizing shift in activation and a hyperpolarizing shift inisochronic inactivation of cardiac LTCC current resulting in the reduction of window current. Both increasing fast [Ca2+](i) buffer capacity or depleting SR Ca2+ store blunted these changes, which could be reproduced in WT cells by RyRCa(2+) leak induced with Ryanodol and CaM inhibition. Our results unveiled a new paradigm for CaM-dependent effect on LTCC gating and further the nanodomain Ca2+ control of LTCC, emphasizing the importance of spatio-temporal relationships between Ca2+ signals and CaM function.	[Fernandez-Velasco, Maria; Ruiz-Hurtado, Gema; Rueda, Angelica; Neco, Patricia; Richard, Sylvain; MariaGomez, Ana; Benitah, Jean-Pierre] Univ Montpellier 2, Univ Montpellier 1, INSERM, U637, Montpellier, France; [Fernandez-Velasco, Maria] UAM, Inst Invest Biomed Alberto Sols, CSIC, Madrid, Spain; [Ruiz-Hurtado, Gema; Neco, Patricia; MariaGomez, Ana; Benitah, Jean-Pierre] Univ Paris 11, Fac Pharm, INSERM, U769,IFR141, F-92290 Chatenay Malabry, France; [Rueda, Angelica; Mercado-Morales, Martha] CINVESTAV, Dept Biochem, Mexico City 14000, DF, Mexico; [Delgado, Carmen] Univ Complutense, Dept Farmacol, Fac Med, E-28040 Madrid, Spain; [Napolitano, Carlo; Priori, Silvia G.] Fdn Salvatore Maugeri, Pavia, Italy; [Napolitano, Carlo; Priori, Silvia G.] NYU, Sch Med, Langone Med Ctr, Leon Charney Div Cardiol, New York, NY USA; [Priori, Silvia G.] Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; [Richard, Sylvain] Univ Montpellier 2, Univ Montpellier 1, INSERM, U1046, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Complutense University of Madrid; Istituti Clinici Scientifici Maugeri IRCCS; New York University; NYU Langone Medical Center; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Fernandez-Velasco, M (corresponding author), Univ Montpellier 2, Univ Montpellier 1, INSERM, U637, Montpellier, France.	pierre.benitah@inserm.fr	Ruiz-Hurtado, Gema/C-8254-2011; Delgado, Carmen/H-2251-2016; Napolitano, Carlo/K-4760-2016; Priori, Silvia G G/A-6116-2014; velasco, maria fernandez/AAO-5062-2021; Gomez, Ana M./B-5376-2013; Benitah, Jean-Pierre/L-6060-2018; Richard, Sylvain/C-9695-2016; napolitano, carlo/ABI-4608-2020; Priori, Silvia G/ABH-6894-2020; Rueda, Angelica/G-4055-2012; Rueda, Angelica/AAW-4621-2020	Ruiz-Hurtado, Gema/0000-0003-3482-0915; Delgado, Carmen/0000-0002-0047-4674; Napolitano, Carlo/0000-0002-7643-4628; Priori, Silvia G G/0000-0001-6877-0288; Gomez, Ana M./0000-0003-0009-2884; Benitah, Jean-Pierre/0000-0002-9866-9081; napolitano, carlo/0000-0002-7643-4628; Priori, Silvia G/0000-0001-6877-0288; Rueda, Angelica/0000-0001-8749-8494; Rueda, Angelica/0000-0001-8749-8494; Richard, Sylvain/0000-0001-9460-6705	Inserm; Agence National de la Recherche [ANR-09-GENO-034]; European Union [CT 2005 No018802]; Ministerio de Educacion y Ciencia of Spain; Conacyt [No80960]; Fondation de la Recherche Medicale; Telethon [NoGGP04066, GGP06007]; Ministero dell' Universita e della Ricerca Scientifica e Tecnologica [FIRB RBNE01XMP4_006, RBLA035A4X_002]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Ministerio de Educacion y Ciencia of Spain(Spanish Government); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Telethon(Fondazione Telethon); Ministero dell' Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This research program was funded by Inserm, a grant from the Agence National de la Recherche (ANR-09-GENO-034) and a grant from the European Union (FPG, Life Science Genomics and Biotechnology for Health, contract CT 2005 No018802, CONTICA). MF-V was funded by Ministerio de Educacion y Ciencia of Spain, AR by Conacyt (Project No80960), PN by Fondation de la Recherche Medicale, and Telethon grants NoGGP04066 and GGP06007 and FIRB RBNE01XMP4_006, RBLA035A4X_002 from the Ministero dell' Universita e della Ricerca Scientifica e Tecnologica (to SGP and CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdachiAkahane S, 1996, J GEN PHYSIOL, V108, P435, DOI 10.1085/jgp.108.5.435; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Altamirano J, 2007, AM J PHYSIOL-HEART C, V293, pH563, DOI 10.1152/ajpheart.00469.2006; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Benitah JP, 1999, CIRC RES, V85, P1139; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; COHEN NM, 1988, J PHYSIOL-LONDON, V406, P115, DOI 10.1113/jphysiol.1988.sp017372; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dirksen RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD659, DOI 10.2741/dirksen; FABIATO A, 1985, J GEN PHYSIOL, V85, P291, DOI 10.1085/jgp.85.2.291; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Grantham CJ, 1996, CIRC RES, V79, P194, DOI 10.1161/01.RES.79.2.194; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; HIRANO Y, 1992, CIRC RES, V70, P445, DOI 10.1161/01.RES.70.3.445; Isaev D, 2004, J GEN PHYSIOL, V123, P555, DOI 10.1085/jgp.200308876; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mazur A, 1999, CIRCULATION, V100, P2437, DOI 10.1161/01.CIR.100.24.2437; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Puglisi JL, 1999, CIRC RES, V85, pE7, DOI 10.1161/01.RES.85.6.e7; Qi X, 2009, CIRC-ARRHYTHMIA ELEC, V2, P295, DOI 10.1161/CIRCEP.108.815654; Ramos-Franco J, 2010, PFLUG ARCH EUR J PHY, V460, P767, DOI 10.1007/s00424-010-0839-8; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Sun H, 1997, AM J PHYSIOL-HEART C, V272, pH1625, DOI 10.1152/ajpheart.1997.272.4.H1625; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Villain M, 2000, J BIOL CHEM, V275, P2676, DOI 10.1074/jbc.275.4.2676; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20863	10.1371/journal.pone.0020863	http://dx.doi.org/10.1371/journal.pone.0020863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673970	Green Published, Green Submitted, gold			2022-12-27	WOS:000291356400035
J	Concheri, G; Bertoldi, D; Polone, E; Otto, S; Larcher, R; Squartini, A				Concheri, Giuseppe; Bertoldi, Daniela; Polone, Elisa; Otto, Stefan; Larcher, Roberto; Squartini, Andrea			Chemical Elemental Distribution and Soil DNA Fingerprints Provide the Critical Evidence in Murder Case Investigation	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BACTERIAL; PH	Background: The scientific contribution to the solution of crime cases, or throughout the consequent forensic trials, is a crucial aspect of the justice system. The possibility to extract meaningful information from trace amounts of samples, and to match and validate evidences with robust and unambiguous statistical tests, are the key points of such process. The present report is the authorized disclosure of an investigation, carried out by Attorney General appointment, on a murder case in northern Italy, which yielded the critical supporting evidence for the judicial trial. Methodology/Principal Findings: The proportional distribution of 54 chemical elements and the bacterial community DNA fingerprints were used as signature markers to prove the similarity of two soil samples. The first soil was collected on the crime scene, along a corn field, while the second was found in trace amounts on the carpet of a car impounded from the main suspect in a distant location. The matching similarity of the two soils was proven by crossing the results of two independent techniques: a) elemental analysis via inductively coupled plasma mass spectrometry (ICP-MS) and optical emission spectrometry (ICP-OES) approaches, and b) amplified ribosomal DNA restriction analysis by gel electrophoresis (ARDRA). Conclusions: Besides introducing the novel application of these methods to forensic disciplines, the highly accurate level of resolution observed, opens new possibilities also in the fields of soil typing and tracking, historical analyses, geochemical surveys and global land mapping.	[Concheri, Giuseppe; Polone, Elisa; Squartini, Andrea] Univ Padua, Dipartimento Biotecnol Agr, Padua, Italy; [Otto, Stefan] Natl Res Council CNR, Inst Agroenvironm & Forest Biol, Padua, Italy; [Bertoldi, Daniela; Larcher, Roberto] IASMA Edmund Mach Fdn, San Michele All Adige, Trento, Italy	University of Padua; Fondazione Edmund Mach	Concheri, G (corresponding author), Univ Padua, Dipartimento Biotecnol Agr, Padua, Italy.	squart@unipd.it	Bertoldi, Daniela/E-5566-2014; Concheri, Giuseppe/L-4151-2015; Larcher, Roberto/B-5946-2013; Squartini, Andrea/AAX-9942-2020	Bertoldi, Daniela/0000-0001-7512-1286; Concheri, Giuseppe/0000-0002-5812-8504; Larcher, Roberto/0000-0002-4784-8389; Squartini, Andrea/0000-0002-1961-1165; Otto, Stefan/0000-0002-4341-8517	Prosecutor's Office at the Court of Padova	Prosecutor's Office at the Court of Padova	This work was supported in part by the Prosecutor's Office at the Court of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Carletti P, 2009, PLANT SOIL, V315, P47, DOI 10.1007/s11104-008-9732-z; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Gilbert R. O., 1987, STAT METHODS ENV POL; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; MURRAY R, FORENSIC GEOLOGY EAR; Murray R.C., 2004, EVIDENCE EARTH; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Pye K., 2007, GEOLOGICAL SOIL EVID; PYE K., 2004, SPECIAL PUBLICATIONS, V232; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Ruffell A, 2008, GEOFORENSICS, P332; Ruffell A, 2010, FORENSIC SCI INT, V202, P9, DOI 10.1016/j.forsciint.2010.03.044; VANEECHOUTTE M, 1993, J CLIN MICROBIOL, V31, P2061, DOI 10.1128/JCM.31.8.2061-2065.1993	15	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20222	10.1371/journal.pone.0020222	http://dx.doi.org/10.1371/journal.pone.0020222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674041	Green Submitted, gold, Green Published			2022-12-27	WOS:000291355500008
J	Morgan, K; Dennis, NA; Ruffman, T; Bilkey, DK; McLennan, IS				Morgan, Kirstie; Dennis, Nicola A.; Ruffman, Ted; Bilkey, David K.; McLennan, Ian S.			The Stature of Boys Is Inversely Correlated to the Levels of Their Sertoli Cell Hormones: Do the Testes Restrain the Maturation of Boys?	PLOS ONE			English	Article							MULLERIAN-INHIBITING SUBSTANCE; CHROMATOGRAPHY-MASS-SPECTROMETRY; HEIGHT; STANDARDS; CHILDREN; AGE	The testes of preadolescent boys appear to be dormant, as they produce only trace levels of testosterone [1]. However, they release supra-adult levels of Mullerian Inhibiting Substance (MIS, anti-Mullerian hormone) and lesser levels of inhibin B (InhB), for unknown reasons [2,3]. Boys have a variable rate of maturation, which on average is slower than girls. The height of children relative to their parents is an index of their maturity [4,5]. We report here that a boy's level of MIS and InhB is stable over time and negatively correlates with his height and his height relative to his parent's height. This suggests that boy's with high levels of MIS and InhB are short because they are immature, rather than because they are destined to be short men. The levels of MIS and InhB in the boys did not correlate with known hormonal modulators of growth, and were additive with age and the growth hormone/IGF1 axis as predictors of a boy's height. If MIS and InhB were causal regulators of maturity, then the inter-boy differences in the levels of these hormone produces variation in maturation equivalent to 18-months of development. MIS and InhB may thus account for most of the variation in the rate of male development. If boys lacked these hormones, then an average 5-year-old boy would be over 5 cm taller than age-matched girls, making boys almost as dimorphic as men, for height. This indicates that boys have a high growth potential that is initially suppressed by their testes. The concept of the childhood testes suppressing an adult male feature appears paradoxical. However, the growth of children requires intergenerational transfer of nutrients. Consequently, the MIS/InhB slowing of male growth may have been historically advantageous, as it would minimizes any sex bias in the maternal cost of early child rearing.	[Morgan, Kirstie; Dennis, Nicola A.; McLennan, Ian S.] Univ Otago, Dept Anat & Struct Biol, Brain Hlth Res Ctr, Dunedin, New Zealand; [Morgan, Kirstie; Ruffman, Ted; Bilkey, David K.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago	Morgan, K (corresponding author), Univ Otago, Dept Anat & Struct Biol, Brain Hlth Res Ctr, Dunedin, New Zealand.	ian.mclennan@anatomy.otago.ac.nz		Dennis, Nicola/0000-0002-0658-6140	Royal Society of New Zealand	Royal Society of New Zealand(Royal Society of New Zealand)	The Marsden Fund of the Royal Society of New Zealand supported this work (http://www.royalsociety.org.nz/programmes/funds/marsden/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson AM, 2001, MOL CELL ENDOCRINOL, V180, P103, DOI 10.1016/S0303-7207(01)00520-2; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; HAWKES K, 1995, CURR ANTHROPOL, V36, P688, DOI 10.1086/204420; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Marlowe F.W., 2005, HUNTER GATHERER CHIL, P19; MCLENNAN IS, 1994, PROG NEUROBIOL, V44, P119, DOI 10.1016/0301-0082(94)90035-3; Mircea CN, 2007, J OBSTET GYNAECOL CA, V29, P887, DOI 10.1016/S1701-2163(16)32661-5; Monteilh C, 2011, PAEDIATR PERINAT EP, V25, P75, DOI 10.1111/j.1365-3016.2010.01168.x; Morgan K, 2011, BEHAV BRAIN RES, V221, P304, DOI 10.1016/j.bbr.2011.02.048; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Wang PY, 2009, P NATL ACAD SCI USA, V106, P7203, DOI 10.1073/pnas.0902253106; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; WUDY SA, 1995, PEDIATR RES, V38, P76, DOI 10.1203/00006450-199507000-00013; Wudy SA, 1999, J CLIN ENDOCR METAB, V84, P2724, DOI 10.1210/jc.84.8.2724; Yan W, 2003, APMIS, V111, P174, DOI 10.1034/j.1600-0463.2003.1110121.x	25	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20533	10.1371/journal.pone.0020533	http://dx.doi.org/10.1371/journal.pone.0020533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655101	gold, Green Published, Green Submitted			2022-12-27	WOS:000291310600013
J	Bacon, C; Endris, V; Andermatt, I; Niederkofler, V; Waltereit, R; Bartsch, D; Stoeckli, ET; Rappold, G				Bacon, Claire; Endris, Volker; Andermatt, Irwin; Niederkofler, Vera; Waltereit, Robert; Bartsch, Dusan; Stoeckli, Esther T.; Rappold, Gudrun			Evidence for a Role of srGAP3 in the Positioning of Commissural Axons within the Ventrolateral Funiculus of the Mouse Spinal Cord	PLOS ONE			English	Article							ROUNDABOUT RECEPTOR; ROBO RECEPTORS; GUIDANCE; MIDLINE; SLIT; EXPRESSION; REPULSION; RAC; PROTEINS; WAVE-1	Slit-Robo signaling guides commissural axons away from the floor-plate of the spinal cord and into the longitudinal axis after crossing the midline. In this study we have evaluated the role of the Slit-Robo GTPase activating protein 3 (srGAP3) in commissural axon guidance using a knockout (KO) mouse model. Co-immunoprecipitation experiments confirmed that srGAP3 interacts with the Slit receptors Robo1 and Robo2 and immunohistochemistry studies showed that srGAP3 co-localises with Robo1 in the ventral and lateral funiculus and with Robo2 in the lateral funiculus. Stalling axons have been reported in the floor-plate of Slit and Robo mutant spinal cords but our axon tracing experiments revealed no dorsal commissural axon stalling in the floor plate of the srGAP3 KO mouse. Interestingly we observed a significant thickening of the ventral funiculus and a thinning of the lateral funiculus in the srGAP3 KO spinal cord, which has also recently been reported in the Robo2 KO. However, axons in the enlarged ventral funiculus of the srGAP3 KO are Robo1 positive but do not express Robo2, indicating that the thickening of the ventral funiculus in the srGAP3 KO is not a Robo2 mediated effect. We suggest a role for srGAP3 in the lateral positioning of post crossing axons within the ventrolateral funiculus.	[Bacon, Claire; Endris, Volker; Rappold, Gudrun] Heidelberg Univ, Dept Human Mol Genet, Heidelberg, Germany; [Andermatt, Irwin; Niederkofler, Vera; Stoeckli, Esther T.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Waltereit, Robert; Bartsch, Dusan] Heidelberg Univ, Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg; University of Zurich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Bacon, C (corresponding author), Heidelberg Univ, Dept Human Mol Genet, Heidelberg, Germany.	Claire.bacon@med.uni-heidelberg.de		Stoeckli, Esther/0000-0002-8485-0648	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 488, D. 10040689]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported exclusively by a Sonderforschungsbereich (SFB) 488 grant entitled 'Molecular and cellular bases of neural development' from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de, grant number D. 10040689) to Dr. G. Rappold. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Reeber SL, 2008, J NEUROSCI, V28, P8698, DOI 10.1523/JNEUROSCI.1479-08.2008; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yuasa-Kawada J, 2009, NAT NEUROSCI, V12, P1087, DOI 10.1038/nn.2382; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19887	10.1371/journal.pone.0019887	http://dx.doi.org/10.1371/journal.pone.0019887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655271	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000291097600009
J	Christou, N; Dinov, ID				Christou, Nicolas; Dinov, Ivo D.			Confidence Interval Based Parameter Estimation-A New SOCR Applet and Activity	PLOS ONE			English	Article							HIPPOCAMPAL; DISEASE	Many scientific investigations depend on obtaining data-driven, accurate, robust and computationally-tractable parameter estimates. In the face of unavoidable intrinsic variability, there are different algorithmic approaches, prior assumptions and fundamental principles for computing point and interval estimates. Efficient and reliable parameter estimation is critical in making inference about observable experiments, summarizing process characteristics and prediction of experimental behaviors. In this manuscript, we demonstrate simulation, construction, validation and interpretation of confidence intervals, under various assumptions, using the interactive web-based tools provided by the Statistics Online Computational Resource (http://www.SOCR.ucla.edu). Specifically, we present confidence interval examples for population means, with known or unknown population standard deviation; population variance; population proportion (exact and approximate), as well as confidence intervals based on bootstrapping or the asymptotic properties of the maximum likelihood estimates. Like all SOCR resources, these confidence interval resources may be openly accessed via an Internet-connected Java-enabled browser. The SOCR confidence interval applet enables the user to empirically explore and investigate the effects of the confidence-level, the sample-size and parameter of interest on the corresponding confidence interval. Two applications of the new interval estimation computational library are presented. The first one is a simulation of confidence interval estimating the US unemployment rate and the second application demonstrates the computations of point and interval estimates of hippocampal surface complexity for Alzheimers disease patients, mild cognitive impairment subjects and asymptomatic controls.	[Christou, Nicolas; Dinov, Ivo D.] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Dinov, Ivo D.] Univ Calif Los Angeles, Ctr Computat Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Christou, N (corresponding author), Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA.	dinov@stat.ucla.edu		Dinov, Ivo/0000-0003-3825-4375	NSF [0442992, 0716055, 1023115]; NIH Roadmap for Medical Research [U54 RR021813]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR021813] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	These resources were developed with support from NSF DUE grants 0442992, 0716055, 1023115, and from NIH Roadmap for Medical Research, NCBC Grant U54 RR021813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI-Aziz J., 2010, JSE P, V18, P1; Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; CHE A, 2009, JSS, V30; Dinov I., 2006, J STAT SOFTW, V16, P1; DINOV ID, 2008, J COMPUTERS ED, V50, P284; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; EFRON B, 1985, BIOMETRIKA, V72, P45, DOI 10.1093/biomet/72.1.45; EFRON B, 1984, BETTER BOOTSTRAP CON; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Ferguson T. S., 1996, COURSE LARGE SAMPLE; Hagtvedt R, 2008, TEACH STAT, V30, P53, DOI 10.1111/j.1467-9639.2008.00308.x; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Maronna R.A., 2006, ROBUST STAT; Mega MS, 2005, NEUROIMAGE, V26, P1009, DOI 10.1016/j.neuroimage.2005.03.031; Rice J., 1995, MATH STAT DATA ANAL; SAURO J, 2005, HUM FACT ERG SOC ANN, P2100; Thorne T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-467; Tosun D, 2007, LECT NOTES COMPUT SC, V4792, P891; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wolfram S., 2002, NEW KIND SCI; Xu Y, 2008, NEUROIMAGE, V40, P1003, DOI 10.1016/j.neuroimage.2007.12.034; Yang YL, 2010, PSYCHIAT RES-NEUROIM, V182, P9, DOI 10.1016/j.pscychresns.2009.10.013; ZHANG H, 2004, P 10 ACM SIGKDD INT	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19178	10.1371/journal.pone.0019178	http://dx.doi.org/10.1371/journal.pone.0019178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655319	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600004
J	Diner, P; Vilg, JV; Kjellen, J; Migdal, I; Andersson, T; Gebbia, M; Giaever, G; Nislow, C; Hohmann, S; Wysocki, R; Tamas, MJ; Grotli, M				Diner, Peter; Vilg, Jenny Veide; Kjellen, Jimmy; Migdal, Iwona; Andersson, Terese; Gebbia, Marinella; Giaever, Guri; Nislow, Corey; Hohmann, Stefan; Wysocki, Robert; Tamas, Markus J.; Grotli, Morten			Design, Synthesis, and Characterization of a Highly Effective Hog1 Inhibitor: A Powerful Tool for Analyzing MAP Kinase Signaling in Yeast	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; STRESS; ARREST; PHOSPHORYLATION; SPECIFICITY; RESISTANCE; ARSENITE; SYSTEM; PHASE	The Saccharomyces cerevisiae High-Osmolarity Glycerol (HOG) pathway is a conserved mitogen-activated protein kinase (MAPK) signal transduction system that often serves as a model to analyze systems level properties of MAPK signaling. Hog1, the MAPK of the HOG-pathway, can be activated by various environmental cues and it controls transcription, translation, transport, and cell cycle adaptations in response to stress conditions. A powerful means to study signaling in living cells is to use kinase inhibitors; however, no inhibitor targeting wild-type Hog1 exists to date. Herein, we describe the design, synthesis, and biological application of small molecule inhibitors that are cell-permeable, fast-acting, and highly efficient against wild-type Hog1. These compounds are potent inhibitors of Hog1 kinase activity both in vitro and in vivo. Next, we use these novel inhibitors to pinpoint the time of Hog1 action during recovery from G1 checkpoint arrest, providing further evidence for a specific role of Hog1 in regulating cell cycle resumption during arsenite stress. Hence, we describe a novel tool for chemical genetic analysis of MAPK signaling and provide novel insights into Hog1 action.	[Diner, Peter; Andersson, Terese; Grotli, Morten] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Vilg, Jenny Veide; Kjellen, Jimmy; Hohmann, Stefan; Tamas, Markus J.] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Migdal, Iwona; Wysocki, Robert] Univ Wroclaw, Dept Genet & Cell Physiol, Inst Plant Biol, PL-50138 Wroclaw, Poland; [Gebbia, Marinella; Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Nislow, Corey] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Gothenburg; University of Gothenburg; University of Wroclaw; University of Toronto; University of Toronto	Diner, P (corresponding author), Univ Gothenburg, Dept Chem, Gothenburg, Sweden.	grotli@chem.gu.se	Hohmann, Stefan/K-9895-2013; Dinér, Peter/A-3867-2009; Tamas, Markus J/E-8183-2010; Dinér, Peter/HDM-9110-2022; Grötli, Morten/A-8735-2010; Giaever, Guri/D-3930-2009	Hohmann, Stefan/0000-0002-0809-1985; Dinér, Peter/0000-0001-6782-6622; Tamas, Markus J/0000-0002-0762-7848; Dinér, Peter/0000-0001-6782-6622; Grötli, Morten/0000-0003-3621-4222; Nislow, Corey/0000-0002-4016-8874; Migdal, Iwona/0000-0002-5585-1991; Wysocki, Robert/0000-0002-3274-2629	European Commission [043310]; Chemical Biology Platform at the University of Gothenburg; Olle Engkvist Byggmastare Foundation; Signhild Engkvist Foundation; Polish Ministry of Science and Higher Education [N303027137]; CIHR [81340, 84305]	European Commission(European CommissionEuropean Commission Joint Research Centre); Chemical Biology Platform at the University of Gothenburg; Olle Engkvist Byggmastare Foundation; Signhild Engkvist Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); CIHR(Canadian Institutes of Health Research (CIHR))	This work was financed by the European Commission (the CELLCOMPUT project, Contract No. 043310 to MG and SH), the Chemical Biology Platform at the University of Gothenburg (MG, SH, MJT), the Olle Engkvist Byggmastare Foundation (MJT), the Signhild Engkvist Foundation (JVV), the Polish Ministry of Science and Higher Education (Grant No. N303027137 to IM and RW), and the CIHR (to GG (81340) and CN (84305)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Diner P, 2009, NEW J CHEM, V33, P1010, DOI 10.1039/b818909a; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Goldstein DM, 2010, J MED CHEM, V53, P2345, DOI [10.1021/jm9012906, 10.1021/acs.jmedchem.8b00124]; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Kim JY, 2002, J CELL PHYSIOL, V190, P29, DOI 10.1002/jcp.10049; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Krantz M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.36; Li JP, 2007, J CELL PHYSIOL, V212, P481, DOI 10.1002/jcp.21042; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Migdal I, 2008, EUKARYOT CELL, V7, P1309, DOI 10.1128/EC.00038-08; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; RUDOLF F, 2008, REGULATION MAPK SIGN, P187; SCHRODINGER, 2008, MACROMODEL 9 0; SCHRODINGER, 2008, GLIDE 5 0; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Wolfe JP, 2000, J ORG CHEM, V65, P1158, DOI 10.1021/jo991699y; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	47	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20012	10.1371/journal.pone.0020012	http://dx.doi.org/10.1371/journal.pone.0020012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655328	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600013
J	Slyker, JA; John-Stewart, GC; Dong, T; Lohman-Payne, B; Reilly, M; Atzberger, A; Taylor, S; Maleche-Obimbo, E; Mbori-Ngacha, D; Rowland-Jones, SL				Slyker, Jennifer A.; John-Stewart, Grace C.; Dong, Tao; Lohman-Payne, Barbara; Reilly, Marie; Atzberger, Ann; Taylor, Stephen; Maleche-Obimbo, Elizabeth; Mbori-Ngacha, Dorothy; Rowland-Jones, Sarah L.			Phenotypic Characterization of HIV-Specific CD8(+) T Cells during Early and Chronic Infant HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICAN INFANTS; BREAST-MILK; CYTOMEGALOVIRUS-INFECTION; DISEASE PROGRESSION; TETRAMER BINDING; TYPE-1 INFECTION; FAS LIGAND; VIRAL LOAD; LYMPHOCYTES	Although CD8(+) T cells play an important role in the containment of adult HIV-1 replication, their role in infant HIV-1 infection is not as well understood. Impaired HIV-specific CD8(+) T cell responses may underlie the persistently high viral loads observed in infants. We examined the frequency and phenotype of infant HIV-specific CD8(+) T cells in 7 HIV-infected antiretroviral therapy-naive infants during the first 2 years of life, using class I HLA tetramers and IFN-gamma-ELISPOT. The frequency (0.088-3.9% of CD3(+) CD8(+) cells) and phenotype (CD27(+) CD28(-) 2, CD45RA(+/-), CD57(+/-), HLA-DR+, CD95(+)) of infant HIV-specific CD8(+) T cells were similar to reports in adults undergoing early infection. Unlike adults, at 23-24 months post-infection a high frequency of HIV-specific CD8(+) T cells expressed HLA-DR (mean 80%, range 68-85%) and CD95 (mean 88%, range 79-96%), suggesting sustained activation and vulnerability to apoptosis. Despite comparable expansion of HIV-specific CD8(+) T cells of a similar phenotype to adults during early infection, infant T cells failed to contain HIV-1 replication, and remained persistently activated and vulnerable to apoptosis during chronic infection.	[Slyker, Jennifer A.; Dong, Tao; Rowland-Jones, Sarah L.] Univ Oxford, MRC Human Immunol Unit, Oxford, England; [Slyker, Jennifer A.; John-Stewart, Grace C.; Lohman-Payne, Barbara] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Slyker, Jennifer A.; John-Stewart, Grace C.; Lohman-Payne, Barbara] Univ Washington, Dept Med, Seattle, WA USA; [John-Stewart, Grace C.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lohman-Payne, Barbara; Maleche-Obimbo, Elizabeth; Mbori-Ngacha, Dorothy] Univ Nairobi, Dept Paediat, Nairobi, Kenya; [Reilly, Marie] Karolinska Inst, Stockholm, Sweden; [Atzberger, Ann] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford, England; [Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England	University of Oxford; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Karolinska Institutet; University of Oxford; University of Oxford	Slyker, JA (corresponding author), Univ Oxford, MRC Human Immunol Unit, Oxford, England.	jslyker@uw.edu	John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019; Slyker, Jennifer/J-5439-2018	Dong, Tao/0000-0003-3545-3758	U.S. National Institutes of Child Health and Disease (NICHD) [RO1 HD-23412, K24]; MRC; University of Washington from the National Institutes of Health, USPHS [T32 AI007140]; Fogarty International Center [D43 TW000007]; Office of Research on Women's Health; University of Washington Center for AIDS Research (CFAR), NIH [P30 AI027757]; NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NCCAM); Elizabeth Glaser Pediatric AIDS Foundation; MRC [G0801751, G0600520, G1001046] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023412] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, T32AI007140, K01AI087369] Funding Source: NIH RePORTER; Medical Research Council [G0801751, G1001046, G1000800f, G0600520] Funding Source: researchfish	U.S. National Institutes of Child Health and Disease (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Washington from the National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); University of Washington Center for AIDS Research (CFAR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Elizabeth Glaser Pediatric AIDS Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the U.S. National Institutes of Child Health and Disease (NICHD) through grant # RO1 HD-23412 (PI John-Stewart), K24 (PI John-Stewart) and MRC grant to the Human Immunology Unit of the Weatherall Institute of Molecular Medicine (PI Rowland-Jones). JS was supported by the University of Washington STD and AIDS Research Training Program, T32 AI007140 from the National Institutes of Health, USPHS. JS, BL-P, and EO were scholars in the AIDS International Training and Research Program, NIH Research Grant D43 TW000007, funded by the Fogarty International Center and the Office of Research on Women's Health. SR-J and GJ-S received Elizabeth Glaser Pediatric AIDS Foundation Scientist Awards. This research was supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 1998, J INFECT DIS, V178, P101, DOI 10.1086/515596; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Biggar RJ, 1999, J INFECT DIS, V180, P1838, DOI 10.1086/315122; Biggar RJ, 2001, AIDS, V15, P1311, DOI 10.1097/00002030-200107060-00015; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BUNCE M, 1995, TISSUE ANTIGENS, V46; Chakraborty R, 2005, J IMMUNOL, V174, P8191, DOI 10.4049/jimmunol.174.12.8191; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; DEVANGE P, 1999, J CLIN MICROBIOL, V37, P350; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616; Farquhar C, 2002, J INFECT DIS, V186, P1173, DOI 10.1086/343805; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; HOLM S, 1979, SCAND J STAT, V6, P65; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; John-Stewart GC, 2009, J INFECT DIS, V199, P889, DOI 10.1086/597120; Kaul R, 2001, J CLIN INVEST, V107, P1303, DOI 10.1172/JCI12433; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LIDINJANSSON G, 1994, PEDIATRICS, V94, P815; Lohman BL, 2005, J VIROL, V79, P8121, DOI 10.1128/JVI.79.13.8121-8130.2005; Lohman BL, 2003, J INFECT DIS, V188, P1666, DOI 10.1086/379374; Lohman-Payne B, 2009, CLIN EXP IMMUNOL, V156, P511, DOI 10.1111/j.1365-2249.2009.03937.x; McCloskey TW, 2001, CYTOMETRY, V46, P265, DOI 10.1002/cyto.1167; Miles DJC, 2008, IMMUNOLOGY, V124, P388, DOI 10.1111/j.1365-2567.2007.02787.x; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Obimbo EM, 2009, JAIDS-J ACQ IMM DEF, V51, P209, DOI 10.1097/QAI.0b013e31819c16d8; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pillay T, 2005, J VIROL, V79, P12100, DOI 10.1128/JVI.79.18.12100-12105.2005; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Scott-Algara D, 2005, J CLIN IMMUNOL, V25, P57, DOI 10.1007/s10875-005-0358-3; Scott-Algara D, 2001, J INFECT DIS, V183, P1565, DOI 10.1086/320708; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shalekoff S, 2009, AIDS, V23, P789, DOI 10.1097/QAD.0b013e328329c784; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Tateyama M, 2000, BLOOD, V96, P195, DOI 10.1182/blood.V96.1.195.013k51_195_202; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; World Health Organisation, 2007, WHO CAS DEF HIV SURV	51	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20375	10.1371/journal.pone.0020375	http://dx.doi.org/10.1371/journal.pone.0020375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655252	Green Published, gold, Green Submitted			2022-12-27	WOS:000291097600057
J	Smajs, D; Zobanikova, M; Strouhal, M; Cejkova, D; Dugan-Rocha, S; Pospisilova, P; Norris, SJ; Albert, T; Qin, X; Hallsworth-Pepin, K; Buhay, C; Muzny, DM; Chen, L; Gibbs, RA; Weinstock, GM				Smajs, David; Zobanikova, Marie; Strouhal, Michal; Cejkova, Darina; Dugan-Rocha, Shannon; Pospisilova, Petra; Norris, Steven J.; Albert, Tom; Qin, Xiang; Hallsworth-Pepin, Kym; Buhay, Christian; Muzny, Donna M.; Chen, Lei; Gibbs, Richard A.; Weinstock, George M.			Complete Genome Sequence of Treponema paraluiscuniculi, Strain Cuniculi A: The Loss of Infectivity to Humans Is Associated with Genome Decay	PLOS ONE			English	Article							REPEAT PROTEIN ARP; GENE CONVERSION; TPRK GENE; PALLIDUM; RABBIT; SYPHILIS; IDENTIFICATION; EXPRESSION; EVOLUTION; VENEREAL	Treponema paraluiscuniculi is the causative agent of rabbit venereal spirochetosis. It is not infectious to humans, although its genome structure is very closely related to other pathogenic Treponema species including Treponema pallidum subspecies pallidum, the etiological agent of syphilis. In this study, the genome sequence of Treponema paraluiscuniculi, strain Cuniculi A, was determined by a combination of several high-throughput sequencing strategies. Whereas the overall size (1,133,390 bp), arrangement, and gene content of the Cuniculi A genome closely resembled those of the T. pallidum genome, the T. paraluiscuniculi genome contained a markedly higher number of pseudogenes and gene fragments (51). In addition to pseudogenes, 33 divergent genes were also found in the T. paraluiscuniculi genome. A set of 32 (out of 84) affected genes encoded proteins of known or predicted function in the Nichols genome. These proteins included virulence factors, gene regulators and components of DNA repair and recombination. The majority (52 or 61.9%) of the Cuniculi A pseudogenes and divergent genes were of unknown function. Our results indicate that T. paraluiscuniculi has evolved from a T. pallidum-like ancestor and adapted to a specialized host-associated niche (rabbits) during loss of infectivity to humans. The genes that are inactivated or altered in T. paraluiscuniculi are candidates for virulence factors important in the infectivity and pathogenesis of T. pallidum subspecies.	[Smajs, David; Zobanikova, Marie; Strouhal, Michal; Cejkova, Darina; Pospisilova, Petra] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Dugan-Rocha, Shannon; Qin, Xiang; Buhay, Christian; Muzny, Donna M.; Chen, Lei; Gibbs, Richard A.; Weinstock, George M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Norris, Steven J.] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX USA; [Albert, Tom] NimbleGen Syst Inc, Madison, WI USA; [Hallsworth-Pepin, Kym; Chen, Lei; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Sequencing Ctr, St Louis, MO 63110 USA	Masaryk University Brno; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Roche Holding; Roche NimbleGen; Washington University (WUSTL)	Smajs, D (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.	dsmajs@med.muni.cz	Smajs, David/I-3479-2016; Norris, Steven James/K-6586-2019; Pospisilova, Petra/L-8212-2018; Weinstock, George M/C-6314-2013; Cejkova, Darina/AAA-5820-2022	Norris, Steven James/0000-0002-2501-8034; Weinstock, George M/0000-0002-2997-4592; Cejkova, Darina/0000-0002-6989-6330	U.S. Public Health Service [R01 DE12488, R01 DE13759, R01 AI49252, R03 AI69107]; Grant Agency of the Czech Republic [310/07/0321]; Ministry of Education of the Czech Republic [VZ SM0021622415]; NATIONAL EYE INSTITUTE [R01EY013759] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069107, R01AI049252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012488, R01DE013759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013759] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the U.S. Public Health Service to G. M. W. (R01 DE12488 and R01 DE13759), and S.J.N. (R01 AI49252 and R03 AI69107) and by the grants of the Grant Agency of the Czech Republic (310/07/0321), and the Ministry of Education of the Czech Republic (VZ SM0021622415) to D. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NimbleGen Systems, Inc., provided oligonucleotide arrays and initial analysis of microarray data.	BAKERZANDER SA, 1984, INFECT IMMUN, V46, P116, DOI 10.1128/IAI.46.1.116-121.1984; BASEMAN JB, 1974, INFECT IMMUN, V10, P1062, DOI 10.1128/IAI.10.5.1062-1067.1974; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DIGIACOMO RF, 1985, GENITOURIN MED, V61, P156; DIGIACOMO RF, 1984, BRIT J VENER DIS, V60, P214; DIGIACOMO RF, 1983, LAB ANIM SCI, V33, P562; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Giacani L, 2004, INFECT IMMUN, V72, P6561, DOI 10.1128/IAI.72.11.6561-6576.2004; Giacani L, 2007, FEMS IMMUNOL MED MIC, V51, P289, DOI 10.1111/j.1574-695X.2007.00303.x; Giacani L, 2010, J BACTERIOL, V192, P2645, DOI 10.1128/JB.00159-10; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRAVES S, 1981, BRIT J VENER DIS, V57, P7; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Harper KN, 2008, FEMS IMMUNOL MED MIC, V53, P322, DOI 10.1111/j.1574-695X.2008.00427.x; HOUGEN KH, 1973, ACTA PATH MICRO IM B, VB 81, P15; Jacobsthal E, 1920, DERMATOL WOCHENSCHR, V71, P569; KHAN AS, 1951, AM J HYG, V53, P296, DOI 10.1093/oxfordjournals.aje.a119455; Levaditi C, 1921, CR HEBD ACAD SCI, V172, P1542; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; Morozov V, 1997, TRENDS BIOCHEM SCI, V22, P417, DOI 10.1016/S0968-0004(97)01128-6; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Norris SJ, 2003, MANUAL CLIN MICROBIO, P955; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Peeling RW, 2006, J PATHOL, V208, P224, DOI 10.1002/path.1903; SCHELL RF, 1982, INFECT IMMUN, V37, P617, DOI 10.1128/IAI.37.2.617-621.1982; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; SMITH JL, 1967, BRIT J VENER DIS, V43, P117; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Turner TB, 1957, BIOL TREPONEMATOSES; Weinstock G.M., 2000, VIRULENCE MECH BACTE, V3rd, P251; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	47	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20415	10.1371/journal.pone.0020415	http://dx.doi.org/10.1371/journal.pone.0020415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655244	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600063
J	Das, D; Cherbuin, N; Tan, XY; Anstey, KJ; Easteal, S				Das, Debjani; Cherbuin, Nicolas; Tan, Xiaoyun; Anstey, Kaarin J.; Easteal, Simon			DRD4-exonIII-VNTR Moderates the Effect of Childhood Adversities on Emotional Resilience in Young-Adults	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; DOPAMINE-RECEPTOR D4; SCALE CD-RISC; BEHAVIORAL ACTIVATION; PARENTING QUALITY; GENE; DRD4; ASSOCIATION; INHIBITION; ANXIETY	Most individuals successfully maintain psychological well-being even when exposed to trauma or adversity. Emotional resilience or the ability to thrive in the face of adversity is determined by complex interactions between genetic makeup, previous exposure to stress, personality, coping style, availability of social support, etc. Recent studies have demonstrated that childhood trauma diminishes resilience in adults and affects mental health. The Dopamine receptor D4 (DRD4) exon III variable number tandem repeat (VNTR) polymorphism was reported to moderate the impact of adverse childhood environment on behaviour, mood and other health-related outcomes. In this study we investigated whether DRD4-exIII-VNTR genotype moderates the effect of childhood adversities (CA) on resilience. In a representative population sample (n = 1148) aged 30-34 years, we observed an interactive effect of DRD4 genotype and CA (beta = 0.132; p = 0.003) on resilience despite no main effect of the genotype when effects of age, gender and education were controlled for. The 7-repeat allele appears to protect against the adverse effect of CA since the decline in resilience associated with increased adversity was evident only in individuals without the 7-repeat allele. Resilience was also significantly associated with approach-/avoidance-related personality measures (behavioural inhibition/activation system; BIS/BAS) measures and an interactive effect of DRD4-exIII-VNTR genotype and CA on BAS was observed. Hence it is possible that approach-related personality traits could be mediating the effect of the DRD4 gene and childhood environment interaction on resilience such that when stressors are present, the 7-repeat allele influences the development of personality in a way that provides protection against adverse outcomes.	[Das, Debjani; Tan, Xiaoyun; Easteal, Simon] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cherbuin, Nicolas; Anstey, Kaarin J.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Das, D (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	debjani.das@anu.edu.au	Das, Debjani/A-8162-2008; Anstey, Kaarin/A-3852-2008; Cherbuin, Nicolas/A-8515-2008	Anstey, Kaarin/0000-0002-9706-9316; Cherbuin, Nicolas/0000-0001-6481-0748; Easteal, Simon/0000-0002-0462-502X	NHMRC of Australia Unit [973302]; NHMRC Capacity Building [418020]; NHMRC [471501, 366756]	NHMRC of Australia Unit(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Capacity Building(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by NHMRC of Australia Unit Grant No. 973302. DD is funded by NHMRC Capacity Building Grant No. 418020 in Population Health Research. NC is funded by NHMRC Research Fellowship No. 471501. KA is funded by NHMRC Research Fellowship No. 366756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTEY KJ, 2011, INT J EPIDEMIOL 0224; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Campbell-Sills L, 2004, PSYCHOL ASSESSMENT, V16, P244, DOI 10.1037/1040-3590.16.3.244; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chipman P, 2007, AM J MED GENET B, V144B, P561, DOI 10.1002/ajmg.b.30480; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Das D, 2011, AM J MED GENET B, V156B, P346, DOI 10.1002/ajmg.b.31169; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Engels WR, 2009, GENETICS, V183, P1431, DOI 10.1534/genetics.109.108977; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; FOWLES DC, 1988, PSYCHOPHYSIOLOGY, V25, P373, DOI 10.1111/j.1469-8986.1988.tb01873.x; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Haglund MEM, 2007, DEV PSYCHOPATHOL, V19, P889, DOI 10.1017/S0954579407000430; Jorm A., 1992, INT J METH PSYCH RES, V2, P31; Jorm AF, 2003, AUST NZ J PUBL HEAL, V27, P434, DOI 10.1111/j.1467-842X.2003.tb00423.x; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Karairmak O, 2010, PSYCHIAT RES, V179, P350, DOI 10.1016/j.psychres.2009.09.012; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; Khoshouei MS, 2009, INT J TEST, V9, P60, DOI 10.1080/15305050902733471; Leone L, 2001, EUR J PERSONALITY, V15, P373, DOI 10.1002/per.415; Li T, 1997, MOL PSYCHIATR, V2, P413, DOI 10.1038/sj.mp.4000310; NEUGEBAUER R, 1990, J CLIN EPIDEMIOL, V43, P1337, DOI 10.1016/0895-4356(90)90100-4; Propper C, 2007, DEV PSYCHOBIOL, V49, P619, DOI 10.1002/dev.20249; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; Sheese BE, 2007, DEV PSYCHOPATHOL, V19, P1039, DOI 10.1017/S0954579407000521; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Singh K., 2010, J PSYCHOL, V1, P23, DOI [10.1080/09764224.2010.11885442, DOI 10.1080/09764224.2010.11885442]; Stein DJ, 2009, CNS SPECTRUMS, V14, P41, DOI 10.1017/S1092852900027280; Strobel A, 2003, NEUROPSYCHOBIOLOGY, V47, P52, DOI 10.1159/000068876; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854	40	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20177	10.1371/journal.pone.0020177	http://dx.doi.org/10.1371/journal.pone.0020177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XV	21637770	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052500037
J	Fu, MY; Rao, R; Sudhakar, D; Hogue, CP; Rutta, Z; Morales, S; Gordon, LK; Braun, J; Goodglick, L; Wadehra, M				Fu, Maoyong; Rao, Rajiv; Sudhakar, Deepthi; Hogue, Claire P.; Rutta, Zach; Morales, Shawn; Gordon, Lynn K.; Braun, Jonathan; Goodglick, Lee; Wadehra, Madhuri			Epithelial Membrane Protein-2 Promotes Endometrial Tumor Formation through Activation of FAK and Src	PLOS ONE			English	Article							COLLAGEN GEL CONTRACTION; SURFACE EXPRESSION; GROWTH-FACTOR; SIGNALING COMPLEXES; CELL-MIGRATION; CANCER-CELLS; LIPID RAFTS; 2 EMP2; INTEGRIN; ADHESION	Endometrial cancer is the most common gynecologic malignancy diagnosed among women in developed countries. One recent biomarker strongly associated with disease progression and survival is epithelial membrane protein-2 (EMP2), a tetraspan protein known to associate with and modify surface expression of certain integrin isoforms. In this study, we show using a xenograft model system that EMP2 expression is necessary for efficient endometrial tumor formation, and we have started to characterize the mechanism by which EMP2 contributes to this malignant phenotype. In endometrial cancer cells, the focal adhesion kinase (FAK)/Src pathway appears to regulate migration as measured through wound healing assays. Manipulation of EMP2 levels in endometrial cancer cells regulates the phosphorylation of FAK and Src, and promotes their distribution into lipid raft domains. Notably, cells with low levels of EMP2 fail to migrate and poorly form tumors in vivo. These findings reveal the pivotal role of EMP2 in endometrial cancer carcinogenesis, and suggest that the association of elevated EMP2 levels with endometrial cancer prognosis may be causally linked to its effect on integrin-mediated signaling.	[Fu, Maoyong; Rao, Rajiv; Sudhakar, Deepthi; Hogue, Claire P.; Rutta, Zach; Braun, Jonathan; Goodglick, Lee; Wadehra, Madhuri] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Morales, Shawn; Gordon, Lynn K.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Braun, Jonathan; Goodglick, Lee] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Fu, MY (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA.	mwadehra@mednet.ucla.edu		Braun, Jonathan/0000-0003-1646-2974	National Institutes of Health (NIH) [HD48540, R21 CA131756, CA016042]; Early Detection Research Network NCI [CA86366]; American Cancer Society [RSG-03-160-01-LIB]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048540] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042, U24CA086366, R21CA131756] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors acknowledge the following agencies who have helped support this work: National Institutes of Health (NIH) grants HD48540 (J. Braun), R21 CA131756 (M. Wadehra), CA016042 (University of California at Los Angeles Jonsson Comprehensive Cancer Center flow cytometry core); Early Detection Research Network NCI CA86366 (L. Goodglick); American Cancer Society # RSG-03-160-01-LIB (L. Goodglick). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Agus DB, 1999, CANCER RES, V59, P4761; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J CELL SCI, V114, P4143; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Creasman W T, 2001, J Epidemiol Biostat, V6, P47; Denschlag D, 2007, AM J OBSTET GYNECOL, V196, P546, DOI 10.1016/j.ajog.2007.01.018; Desouki MM, 2004, CLIN CANCER RES, V10, P546, DOI 10.1158/1078-0432.CCR-0661-03; Gossett DR, 2004, INT J GYNECOL CANCER, V14, P145, DOI 10.1111/j.1048-891x.2004.014028.x; Habeeb O, 2010, CANCER-AM CANCER SOC, V116, P4718, DOI 10.1002/cncr.25259; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Kawaguchi T, 2006, CANCER RES, V66, P11331, DOI 10.1158/0008-5472.CAN-06-1540; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Morales SA, 2007, EXP EYE RES, V85, P790, DOI 10.1016/j.exer.2007.08.014; Morales SA, 2009, INVEST OPHTH VIS SCI, V50, P4949, DOI 10.1167/iovs.08-3315; Morales SA, 2009, INVEST OPHTH VIS SCI, V50, P462, DOI 10.1167/iovs.07-1598; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Park DW, 2001, GYNECOL ONCOL, V82, P442, DOI 10.1006/gyno.2001.6294; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Poveda JA, 2008, BBA-BIOMEMBRANES, V1778, P1583, DOI 10.1016/j.bbamem.2008.01.021; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Shimazaki K, 2007, MICROBES INFECT, V9, P1003, DOI 10.1016/j.micinf.2007.04.004; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wadehra M, 2004, MOL BIOL CELL, V15, P2073, DOI 10.1091/mbc.E03-07-0488; Wadehra M, 2003, CLIN IMMUNOL, V107, P129, DOI 10.1016/S1521-6616(03)00048-2; Wadehra M, 2002, J BIOL CHEM, V277, P41094, DOI 10.1074/jbc.M206868200; Wadehra M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-15; Wadehra M, 2006, CANCER-AM CANCER SOC, V107, P90, DOI 10.1002/cncr.21957; Wang CR, 2010, J BIOL CHEM, V285, P29398, DOI 10.1074/jbc.M110.141440; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583	43	21	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19945	10.1371/journal.pone.0019945	http://dx.doi.org/10.1371/journal.pone.0019945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637765	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052500020
J	Leu, HB; Chung, CM; Lin, SJ; Jong, YS; Pan, WH; Chen, JW				Leu, Hsin-Bang; Chung, Chia-Min; Lin, Shing-Jong; Jong, Yuh-Shiun; Pan, Wen-Harn; Chen, Jaw-Wen			Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; INSULIN-RESISTANCE; APM1 GENE; CARDIOVASCULAR RISK; BLOOD-PRESSURE; POPULATION; PROGRAM; LOCUS	Objective: Cardiovascular risk increases with the presence of both metabolic syndrome (MetS) and hypertension (HTN). Although the adiponectin (ADIPOQ) gene has been reported to be involved in MetS, its association with HTN remained undetermined. This study aimed to investigate the association of ADIPOQ gene with the phenotypes of HTN and MetS. Methods: A total of 962 participants from 302 families from the Taiwan young-onset hypertension genetic study were enrolled. Plasma adiponectin were measured, and association analysis was conducted by using GEE regression-based method. Another study, of 1448 unrelated participants, was conducted to replicate the association between ADIPOQ gene and variable phenotypes of MetS with or without HTN. Results: Among 962 subjects from family samples, the lowest plasma adiponectin value was observed in MetS with HTN component (9.3 +/- 0.47 mu g/ml) compared with hypertensives (13.4 +/- 0.74 mu g/ml) or MetS without HTN (11.9 +/- 0.60 mu g/ml, P<0.05). The SNP rs1501299 (G276T) in ADIPOQ gene was found associated with the presence of HTN in MetS (odds ratio for GG+GT vs. TT = 2.46; 95% CI: 1.14-5.3, p = 0.02), but not rs2241766 (T45G). No association of ADIPOQ gene with HTN alone or MetS without HTN was observed. The significant association of the SNP rs1501299 (G276T) with the phenotype of presence of HTN in MetS was confirmed (odds ratio for GG+GT vs. TT = 2.15; 95% CI: 1.1-4.3) in the replication study. Conclusions: ADIPOQ genetic variants were selectively and specifically associated with the concomitant presence of MetS and HTN, suggesting potential genetic linkage between MetS and HTN.	[Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Leu, Hsin-Bang; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Leu, Hsin-Bang; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chung, Chia-Min] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biochem Sci, Taipei 115, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Jong, Yuh-Shiun] Tao Yuan Gen Hosp, Dept Hlth, Tao Yuan, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Leu, HB (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	pan@ibms.sinica.edu.tw; jwchen@vghtpe.gov.tw			Taipei Veterans General Hospital [V96ER2-014, V97C1-125]; National Science Council [97HDP004, 97HDP004-2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This study was partially supported by grants V96ER2-014 and V97C1-125 from the Taipei Veterans General Hospital and grants of 97HDP004 and 97HDP004-2 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Austin MA, 2004, DIABETES, V53, P1166, DOI 10.2337/diabetes.53.4.1166; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chen W, 1999, AM J EPIDEMIOL, V150, P667; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; Filippi E, 2004, EUR J HUM GENET, V12, P199, DOI 10.1038/sj.ejhg.5201120; Furuhashi M, 2005, HYPERTENS RES, V28, P141, DOI 10.1291/hypres.28.141; Gable DR, 2006, ATHEROSCLEROSIS, V188, P231, DOI 10.1016/j.atherosclerosis.2006.02.010; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Iacobellis G, 2006, OBESITY, V14, P368, DOI 10.1038/oby.2006.48; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lin HF, 2005, DIABETOLOGIA, V48, P2006, DOI 10.1007/s00125-005-1892-2; Mancia G, 2007, HYPERTENSION, V49, P40, DOI 10.1161/01.HYP.0000251933.22091.24; Menzaghi C, 2004, PHYSIOL GENOMICS, V19, P170, DOI 10.1152/physiolgenomics.00122.2004; Mohammadzadeh G, 2009, SCAND J CLIN LAB INV, V69, P764, DOI 10.3109/00365510903137237; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Ohashi K, 2004, J AM COLL CARDIOL, V43, P1195, DOI 10.1016/j.jacc.2003.10.049; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Pan WH, 2005, ASIA PAC J CLIN NUTR, V14, P203; Pan WH, 2000, HUM GENET, V107, P210, DOI 10.1007/s004390000365; Qi L, 2005, DIABETES, V54, P1607, DOI 10.2337/diabetes.54.5.1607; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Schillaci G, 2004, J AM COLL CARDIOL, V43, P1817, DOI 10.1016/j.jacc.2003.12.049; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Yang WS, 2006, J MOL MED, V84, P112, DOI 10.1007/s00109-005-0011-7; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	34	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19999	10.1371/journal.pone.0019999	http://dx.doi.org/10.1371/journal.pone.0019999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637762	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052500023
J	Liandris, E; Gazouli, M; Andreadou, M; Sechi, LA; Rosu, V; Ikonomopoulos, J				Liandris, Emmanouil; Gazouli, Maria; Andreadou, Margarita; Sechi, Leonardo A.; Rosu, Valentina; Ikonomopoulos, John			Detection of Pathogenic Mycobacteria Based on Functionalized Quantum Dots Coupled with Immunomagnetic Separation	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; EXTRAPULMONARY DISSEMINATION; TUBERCULOSIS; DNA	Mycobacteria have always proven difficult to identify due to their low growth rate and fastidious nature. Therefore molecular biology and more recently nanotechnology, have been exploited from early on for the detection of these pathogens. Here we present the first stage of development of an assay incorporating cadmium selenide quantum dots (QDs) for the detection of mycobacterial surface antigens. The principle of the assay is the separation of bacterial cells using magnetic beads coupled with genus-specific polyclonal antibodies and monoclonal antibodies for heparin-binding hemagglutinin. These complexes are then tagged with anti-mouse biotinylated antibody and finally streptavidin-conjugated QDs which leads to the detection of a fluorescent signal. For the evaluation of performance, the method under study was applied on Mycobacterium bovis BCG and Mycobacterium tuberculosis ( positive controls), as well as E. coli and Salmonella spp. that constituted the negative controls. The direct observation of the latter category of samples did not reveal fluorescence as opposed to the mycobacteria mentioned above. The minimum detection limit of the assay was defined to 10(4) bacteria/ml, which could be further decreased by a 1 log when fluorescence was measured with a spectrofluorometer. The method described here can be easily adjusted for any other protein target of either the pathogen or the host, and once fully developed it will be directly applicable on clinical samples.	[Liandris, Emmanouil; Andreadou, Margarita; Ikonomopoulos, John] Agr Univ Athens, Dept Anim Sci & Aquaculture, Athens, Greece; [Gazouli, Maria] Univ Athens, Sch Med, Biol Lab, GR-11527 Athens, Greece; [Sechi, Leonardo A.; Rosu, Valentina] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy	Agricultural University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University of Sassari	Liandris, E (corresponding author), Agr Univ Athens, Dept Anim Sci & Aquaculture, Athens, Greece.	ikonomop@aua.gr	Liandris, Emmanouil/AAJ-9737-2021; Gazouli, Maria/W-6245-2019; Sechi, Leonardo Antonio/Y-3109-2018; Liandris, Emmanouil/K-1762-2014; Gazouli, Maria/I-2572-2018	Gazouli, Maria/0000-0002-3295-6811; Liandris, Emmanouil/0000-0003-0918-6633; Gazouli, Maria/0000-0002-3295-6811; sechi, leonardo antonio/0000-0003-0566-2049	European Union [LSHB-CT-2007-036812]	European Union(European Commission)	This work was performed within the context of the NANOMYC project that is supported by the European Union (LSHB-CT-2007-036812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branen JR, 2007, J FOOD PROTECT, V70, P841, DOI 10.4315/0362-028X-70.4.841; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Gazouli M, 2010, J CLIN MICROBIOL, V48, P2830, DOI 10.1128/JCM.00185-10; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Liandris E, 2009, J MICROBIOL METH, V78, P260, DOI 10.1016/j.mimet.2009.06.009; Lin PL, 2008, J MED PRIMATOL, V37, P44, DOI 10.1111/j.1600-0684.2007.00261.x; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pfyffer GE, 2003, MANUAL CLIN MICROBIO, P532; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Serrano-Moreno BA, 2008, ZOONOSES PUBLIC HLTH, V55, P258, DOI 10.1111/j.1863-2378.2008.01125.x; Shin AR, 2006, CLIN VACCINE IMMUNOL, V13, P869, DOI 10.1128/CVI.00103-06; Valanne A, 2005, J VIROL METHODS, V129, P83, DOI 10.1016/j.jviromet.2005.05.012; Zhu L, 2004, APPL ENVIRON MICROB, V70, P597, DOI 10.1128/AEM.70.1.597-598.2004	15	42	47	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20026	10.1371/journal.pone.0020026	http://dx.doi.org/10.1371/journal.pone.0020026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637746	Green Submitted, Green Published, gold			2022-12-27	WOS:000291052500026
J	Corjon, S; Gonzalez, G; Henning, P; Grichine, A; Lindholm, L; Boulanger, P; Fender, P; Hong, SS				Corjon, Stephanie; Gonzalez, Gaelle; Henning, Petra; Grichine, Alexei; Lindholm, Leif; Boulanger, Pierre; Fender, Pascal; Hong, Saw-See			Cell Entry and Trafficking of Human Adenovirus Bound to Blood Factor X Is Determined by the Fiber Serotype and Not Hexon: Heparan Sulfate Interaction	PLOS ONE			English	Article							TARGETED GENE DELIVERY; NUCLEAR-PORE COMPLEX; VIRUS-LIKE PARTICLES; COXSACKIE B VIRUSES; BETULINIC ACID DSB; PENTON BASE; BINDING SITE; INTRACELLULAR TRAFFICKING; VECTOR TRANSDUCTION; TYPE-5 VECTORS	Human adenovirus serotype 5 (HAdV5)-based vectors administered intravenously accumulate in the liver as the result of their direct binding to blood coagulation factor X (FX) and subsequent interaction of the FX-HAdV5 complex with heparan sulfate proteoglycan (HSPG) at the surface of liver cells. Intriguingly, the serotype 35 fiber-pseudotyped vector HAdV5F35 has liver transduction efficiencies 4-logs lower than HAdV5, even though both vectors carry the same hexon capsomeres. In order to reconcile this apparent paradox, we investigated the possible role of other viral capsid proteins on the FX/HSPG-mediated cellular uptake of HAdV5-based vectors. Using CAR-and CD46-negative CHO cells varying in HSPG expression, we confirmed that FX bound to serotype 5 hexon protein and to HAdV5 and HAdV5F35 virions via its Gla-domain, and enhanced the binding of both vectors to surface-immobilized hypersulfated heparin and cellular HSPG. Using penton mutants, we found that the positive effect of FX on HAdV5 binding to HSPG and cell transduction did not depend on the penton base RGD and fiber shaft KKTK motifs. However, we found that FX had no enhancing effect on the HAdV5F35-mediated cell transduction, but a negative effect which did not involve the cell attachment or endocytic step, but the intracellular trafficking and nuclear import of the FX-HAdV5F35 complex. By cellular imaging, HAdV5F35 particles were observed to accumulate in the late endosomal compartment, and were released in significant amounts into the extracellular medium via exocytosis. We showed that the stability of serotype 5 hexon: FX interaction was higher at low pH compared to neutral pH, which could account for the retention of FX-HAdV5F35 complexes in the late endosomes. Our results suggested that, despite the high affinity interaction of hexon capsomeres to FX and cell surface HSPG, the adenoviral fiber acted as the dominant determinant of the internalization and trafficking pathway of HAdV5-based vectors.	[Corjon, Stephanie; Gonzalez, Gaelle; Boulanger, Pierre; Hong, Saw-See] Univ Lyon 1, INRA, UMR 754, F-69365 Lyon, France; [Henning, Petra] Univ Goteborg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Grichine, Alexei] UJF, INSERM, CRI, Inst Albert Bonniot,U823, La Tronche, France; [Lindholm, Leif] Got A Gene AB, Kullavik, Sweden; [Fender, Pascal] UJF, EMBL, CNRS, UMI 3265,Unit Virus Host Interact, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Corjon, S (corresponding author), Univ Lyon 1, INRA, UMR 754, F-69365 Lyon, France.	pfender@embl.fr; saw-see.hong@univ-lyon1.fr	Grichine, Alexei/P-8377-2019; Hong, Saw See/M-9818-2017; Boulanger, Pierre/AFV-2750-2022; Grichine, Alexei/M-3923-2013	Grichine, Alexei/0000-0002-7335-9706; Hong, Saw See/0000-0001-8871-0901; Grichine, Alexei/0000-0002-7335-9706; Fender, Pascal/0000-0002-6698-3367; Henning, Petra/0000-0002-9330-6265	French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM) [TG0801, TG0901]; French Agency for AIDS Research (ANRS, DendrAde); University of Lyon-1; Centre National de la Recherche Scientifique [FRE-3011]; Region Rhone-Alpes; ANRS; Contrat d'Interface HCL-INSERM	French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM); French Agency for AIDS Research (ANRS, DendrAde)(ANRSFrench National Research Agency (ANR)); University of Lyon-1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); ANRS(ANRSFrench National Research Agency (ANR)); Contrat d'Interface HCL-INSERM	The work in France (Lyon and Grenoble) was supported by the French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM contracts TG0801 and TG0901), the French Agency for AIDS Research (ANRS, DendrAde contract 2007-2008), the University of Lyon-1 and the Centre National de la Recherche Scientifique (FRE-3011), and the Region Rhone-Alpes (Cluster 10-Infectiology). SC was the recipient of an ANRS fellowship, and GG of a VLM fellowship. SSH is the recipient of a Contrat d'Interface HCL-INSERM (2008-2012). The funders in France had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work in Sweden for the construction of the chimeric adenoviral vector was supported by Got-a-Gene AB, and potential financial competing interests exist.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Chiu CY, 2001, J VIROL, V75, P5375, DOI 10.1128/JVI.75.11.5375-5380.2001; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Colin M, 2005, MOL THER, V11, P224, DOI 10.1016/j.ymthe.2004.10.007; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; DaFonseca S, 2007, ANTIVIR THER, V12, P1185; DaFonseca S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-162; Darr S, 2009, J GEN VIROL, V90, P2849, DOI 10.1099/vir.0.014514-0; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; DEFER C, 1990, J VIROL, V64, P3661, DOI 10.1128/JVI.64.8.3661-3673.1990; Devaux P, 1996, J GEN VIROL, V77, P1477, DOI 10.1099/0022-1317-77-7-1477; Di Paolo NC, 2007, J VIROL, V81, P12249, DOI 10.1128/JVI.01584-07; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2008, VIROLOGY, V371, P155, DOI 10.1016/j.virol.2007.09.026; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; Gaden F, 2004, J VIROL, V78, P7227, DOI 10.1128/JVI.78.13.7227-7247.2004; Gaden F, 2002, AM J RESP CELL MOL, V27, P628, DOI 10.1165/rcmb.4841; GAGGAR A, 2003, NAT MED, V8, P746; Ganesh S, 2009, HUM GENE THER, V20, P1201, DOI 10.1089/hum.2009.045; Granio O, 2010, HUM GENE THER, V21, P251, DOI 10.1089/hum.2009.056; Granio O, 2009, J VIROL, V83, P6048, DOI 10.1128/JVI.00012-09; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Greig JA, 2009, MOL THER, V17, P1683, DOI 10.1038/mt.2009.152; Henning P, 2005, GENE THER, V12, P211, DOI 10.1038/sj.gt.3302408; Henning P, 2002, HUM GENE THER, V13, P1427, DOI 10.1089/10430340260185067; Henning P, 2006, J GEN VIROL, V87, P3151, DOI 10.1099/vir.0.81992-0; Hong SS, 2003, MOL THER, V7, P692, DOI 10.1016/S1525-0016(03)00067-4; Huang S, 1996, J VIROL, V70, P4502, DOI 10.1128/JVI.70.7.4502-4508.1996; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Karayan L, 1997, J VIROL, V71, P8678, DOI 10.1128/JVI.71.11.8678-8689.1997; KARAYAN L, 1994, VIROLOGY, V202, P782, DOI 10.1006/viro.1994.1400; Kawakami Y, 2003, CANCER RES, V63, P1262; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Leopold PL, 2000, HUM GENE THER, V11, P151, DOI 10.1089/10430340050016238; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; Magnusson MK, 2001, J VIROL, V75, P7280, DOI 10.1128/JVI.75.16.7280-7289.2001; MAGNUSSON MK, 2007, CANCER GENE THER, V14, P1; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Meier O, 2003, J GENE MED, V5, P451, DOI 10.1002/jgm.409; Mitraki A, 2006, ADV PROTEIN CHEM, V73, P97, DOI 10.1016/S0065-3233(06)73004-2; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; Molinier-Frenkel V, 2000, J VIROL, V74, P7678, DOI 10.1128/JVI.74.16.7678-7682.2000; Molinier-Frenkel V, 2003, J BIOL CHEM, V278, P37175, DOI 10.1074/jbc.M303496200; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Murakami S, 2007, GENE THER, V14, P1525, DOI 10.1038/sj.gt.3303019; Myhre S, 2007, GENE THER, V14, P376, DOI 10.1038/sj.gt.3302875; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Parker AL, 2008, CURR OPIN MOL THER, V10, P439; Parker AL, 2007, J VIROL, V81, P3627, DOI 10.1128/JVI.02786-06; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Parker AL, 2009, J VIROL, V83, P479, DOI 10.1128/JVI.01878-08; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Rogee S, 2010, GENE THER, V17, P880, DOI 10.1038/gt.2010.37; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Sakurai F, 2008, BIOL PHARM BULL, V31, P1819, DOI 10.1248/bpb.31.1819; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; THERY C, 2006, CURR PROTOCOLS CEL S, V30; Tomko RP, 2000, EXP CELL RES, V255, P47, DOI 10.1006/excr.1999.4761; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Toyoda E, 2008, INT J ONCOL, V33, P1141, DOI 10.3892/ijo_00000103; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Uil TG, 2009, J GENE MED, V11, P990, DOI 10.1002/jgm.1395; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Vives RR, 2004, VIROLOGY, V321, P332, DOI 10.1016/j.virol.2004.01.015; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Von Seggern DJ, 2000, J VIROL, V74, P354, DOI 10.1128/JVI.74.1.354-362.2000; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WANG H, 2010, NAT MED         1212; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Waszak P, 2007, MOL THER, V15, P2008, DOI 10.1038/sj.mt.6300254; Wickham TJ, 1995, GENE THER, V2, P750; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Zabner J, 1999, J VIROL, V73, P8689, DOI 10.1128/JVI.73.10.8689-8695.1999	105	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e18205	10.1371/journal.pone.0018205	http://dx.doi.org/10.1371/journal.pone.0018205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637339	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000291052200007
J	Haas, JD; Nistala, K; Petermann, F; Saran, N; Chennupati, V; Schmitz, S; Korn, T; Wedderburn, LR; Forster, R; Krueger, A; Prinz, I				Haas, Jan D.; Nistala, Kiran; Petermann, Franziska; Saran, Namita; Chennupati, Vijaykumar; Schmitz, Susanne; Korn, Thomas; Wedderburn, Lucy R.; Foerster, Reinhold; Krueger, Andreas; Prinz, Immo			Expression of miRNAs miR-133b and miR-206 in the Il17a/f Locus Is Co-Regulated with IL-17 Production in alpha beta and gamma delta T Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; MICRORNAS; DIFFERENTIATION; CYTOKINE; INTERLEUKIN-17; REGENERATION; COEXPRESSION; REGULATORS; PLASTICITY; ARTHRITIS	Differentiation of T helper 17 cells (Th17) is a multistep process that involves the cytokines IL-6, TGF-beta, and IL-23 as well as IL-1 beta, IL-21, and TNF-alpha. Thereby, robust induction of the capacity to produce IL-17 involves epigenetic modifications of the syntenic Il17a/f locus. Using inbred mouse strains, we identified co-regulation of gene transcription at the Il17a/f locus with the nearby microRNAs miR-133b and miR-206 that are clustered approximately 45 kb upstream of Il17a/f. Expression of these microRNAs was specific for Th17 as compared to other CD4(+) T cell subsets and this was equally valid for in vitro polarized and ex vivo derived cells. From all factors analyzed, IL-23 was the most important cytokine for the in vitro induction of miR-133b and miR-206 in naive CD4(+) T cells of wild type mice. However, analysis of IL-23R deficient mice revealed that IL-23R signaling was not essential for the induction of miR-133b and miR-206. Importantly, we found a similar co-regulation in CCR6(+) and other gamma delta T cell subsets that are predisposed to production of IL-17. Taken together, we discovered a novel feature of T cell differentiation towards an IL-17-producing phenotype that is shared between alpha beta and gamma delta T cells. Notably, the specific co-regulation of miR-133b and miR-206 with the Il17a/f locus also extended to human Th17 cells. This qualifies expression of miR-133b and miR-206 in T cells as novel biomarkers for Th17-type immune reactions.	[Haas, Jan D.; Saran, Namita; Chennupati, Vijaykumar; Schmitz, Susanne; Foerster, Reinhold; Krueger, Andreas; Prinz, Immo] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany; [Nistala, Kiran; Wedderburn, Lucy R.] UCL, Rheumatol Unit, Inst Child Hlth, London, England; [Petermann, Franziska; Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany	Hannover Medical School; University of London; University College London; Technical University of Munich	Haas, JD (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	prinz.immo@mh-hannover.de	Prinz, Immo/A-3026-2010; Korn, Thomas/AAE-6960-2019; Krueger, Andreas/M-9769-2019; Förster, Reinhold/D-6770-2011; Krueger, Andreas/B-9427-2009	Prinz, Immo/0000-0002-8789-9578; Korn, Thomas/0000-0002-3633-0955; Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334; Wedderburn, Lucy/0000-0002-7495-1429; Forster, Reinhold/0000-0001-6190-7923	German Research Foundation (DFG) [KR2320/2-1, EXC62, SFB621-A14]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, www.dfg.de; Emmy-Noether Program, KR2320/2-1 and EXC62, "Rebirth," A. K.; and SFB621-A14, I.P.). Open Access Publication supported by the DFG. JH, VC and NS are scholars of the Hannover Biomedical Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; INOSE H, 2009, P NATL ACAD SCI US; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KUCHEN S, 2010, IMMUNITY; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; MISSIAGLIA E, 2010, BR J CANC; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Purmann A, 2007, GENOMICS, V89, P580, DOI 10.1016/j.ygeno.2007.01.010; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022	49	40	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20171	10.1371/journal.pone.0020171	http://dx.doi.org/10.1371/journal.pone.0020171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637854	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200036
J	Li, ZD; Wen, JK; Lin, YN; Wang, SH; Xue, P; Zhang, ZP; Zhou, Y; Wang, X; Sui, L; Bi, LJ; Zhang, XE				Li, Zhongdao; Wen, Jikai; Lin, Yaning; Wang, Shihua; Xue, Peng; Zhang, Zhiping; Zhou, Ying; Wang, Xiao; Sui, Li; Bi, Li-Jun; Zhang, Xian-En			A Sir2-Like Protein Participates in Mycobacterial NHEJ	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; YEAST; TUBERCULOSIS; LIGASE; KU; COMPLEXES; MECHANISM	In eukaryotic cells, repair of DNA double-strand breaks (DSBs) by the nonhomologous end-joining (NHEJ) pathway is critical for genome stability. In contrast to the complex eukaryotic repair system, bacterial NHEJ apparatus consists of only two proteins, Ku and a multifunctional DNA ligase (LigD), whose functional mechanism has not been fully clarified. We show here for the first time that Sir2 is involved in the mycobacterial NHEJ repair pathway. Here, using tandem affinity purification (TAP) screening, we have identified an NAD-dependent deacetylase in mycobacteria which is a homologue of the eukaryotic Sir2 protein and interacts directly with Ku. Results from an in vitro glutathione S-transferase (GST) pull-down assay suggest that Sir2 interacts directly with LigD. Plasmid-based end-joining assays revealed that the efficiency of DSB repair in a sir2 deletion mutant was reduced 2-fold. Moreover, the Delta sir2 strain was about 10-fold more sensitive to ionizing radiation (IR) in the stationary phase than the wild-type. Our results suggest that Sir2 may function closely together with Ku and LigD in the nonhomologous end-joining pathway in mycobacteria.	[Li, Zhongdao; Zhang, Zhiping; Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Li, Zhongdao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wen, Jikai] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lin, Yaning; Wang, Shihua] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Xue, Peng; Zhou, Ying; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol & Prote Platform, Beijing 100080, Peoples R China; [Wang, Xiao; Sui, Li] China Inst Atom Energy, Dept Nucl Phys, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Birmingham; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Biophysics, CAS; China Institute of Atomic Energy	Li, ZD (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	blj@sun5.ibp.ac.cn; x.zhang@wh.iov.cn	wen, jikai/AAV-9818-2021; ZHANG, Xian-En/AAJ-5579-2021	wen, jikai/0000-0002-4010-4416; 	National Protein Research Fund [2009CB825402, 2009CB522605, 2006CB910902]; Chinese Academy of Sciences [KSCX2-YW-R-164, KSCX1-YW-R-63]; National Natural Science Foundation of China [30970590]; Chinese Ministry of Health [2008ZX10003-005]	National Protein Research Fund; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Health	This work was supported by the National Protein Research Fund (Grant No: 2009CB825402, 2009CB522605 and 2006CB910902), the Chinese Academy of Sciences (Grant No: KSCX2-YW-R-164 and KSCX1-YW-R-63), the National Natural Science Foundation of China (Grant No: 30970590) and the Key Project Specialized for Infectious Diseases from the Chinese Ministry of Health (2008ZX10003-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3	30	17	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20045	10.1371/journal.pone.0020045	http://dx.doi.org/10.1371/journal.pone.0020045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637345	gold, Green Published			2022-12-27	WOS:000291052200029
J	Monnich, M; Kuriger, Z; Print, CG; Horsfield, JA				Moennich, Maren; Kuriger, Zoe; Print, Cristin G.; Horsfield, Julia A.			A Zebrafish Model of Roberts Syndrome Reveals That Esco2 Depletion Interferes with Development by Disrupting the Cell Cycle	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; DROSOPHILA NIPPED-B; GENE-EXPRESSION; DNA-REPLICATION; SC PHOCOMELIA; HUMAN HOMOLOG; C-MYC; ESTABLISHMENT; ACETYLATION	The human developmental diseases Cornelia de Lange Syndrome (CdLS) and Roberts Syndrome (RBS) are both caused by mutations in proteins responsible for sister chromatid cohesion. Cohesion is mediated by a multi-subunit complex called cohesin, which is loaded onto chromosomes by NIPBL. Once on chromosomes, cohesin binding is stabilized in S phase upon acetylation by ESCO2. CdLS is caused by heterozygous mutations in NIPBL or cohesin subunits SMC1A and SMC3, and RBS is caused by homozygous mutations in ESCO2. The genetic cause of both CdLS and RBS reside within the chromosome cohesion apparatus, and therefore they are collectively known as "cohesinopathies". However, the two syndromes have distinct phenotypes, with differences not explained by their shared ontology. In this study, we have used the zebrafish model to distinguish between developmental pathways downstream of cohesin itself, or its acetylase ESCO2. Esco2 depleted zebrafish embryos exhibit features that resemble RBS, including mitotic defects, craniofacial abnormalities and limb truncations. A microarray analysis of Esco2-depleted embryos revealed that different subsets of genes are regulated downstream of Esco2 when compared with cohesin subunit Rad21. Genes downstream of Rad21 showed significant enrichment for transcriptional regulators, while Esco2-regulated genes were more likely to be involved the cell cycle or apoptosis. RNA in situ hybridization showed that runx1, which is spatiotemporally regulated by cohesin, is expressed normally in Esco2-depleted embryos. Furthermore, myca, which is downregulated in rad21 mutants, is upregulated in Esco2-depleted embryos. High levels of cell death contributed to the morphology of Esco2-depleted embryos without affecting specific developmental pathways. We propose that cell proliferation defects and apoptosis could be the primary cause of the features of RBS. Our results show that mutations in different elements of the cohesion apparatus have distinct developmental outcomes, and provide insight into why CdLS and RBS are distinct diseases.	[Moennich, Maren; Kuriger, Zoe; Horsfield, Julia A.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Print, Cristin G.] Univ Auckland, Sch Biomed Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand	University of Otago; University of Auckland; University of Auckland	Monnich, M (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand.	julia.horsfield@otago.ac.nz	Horsfield, Julia A/B-5091-2012	Horsfield, Julia A/0000-0002-9536-7790; Print, Cristin/0000-0001-8345-7812	Marsden Fund of New Zealand [UOO-037]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by grant # UOO-037 from the Marsden Fund of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We gratefully acknowledge CureKids, the KD Kirkby Trust and Lottery Health NZ for their support of the Otago Zebrafish Facility.	Ball AR, 2008, BIOESSAYS, V30, P5, DOI 10.1002/bies.20691; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Craig JM, 2005, CHROMOSOMA, V114, P252, DOI 10.1007/s00412-005-0010-z; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dorsett D, 2010, CURR BIOL, V20, pR886, DOI 10.1016/j.cub.2010.09.036; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Dorsett D, 2009, ANN NY ACAD SCI, V1151, P22, DOI 10.1111/j.1749-6632.2008.03450.x; Furthauer M., 2001, R01RR15402 NIH; Galloway JL, 2009, NATURE, V460, P400, DOI 10.1038/nature08117; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Gause M, 2010, MOL CELL BIOL, V30, P4940, DOI 10.1128/MCB.00642-10; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; HERRMANN J, 1977, EUR J PEDIATR, V125, P117, DOI 10.1007/BF00489985; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Liu JL, 2010, ADV EXP MED BIOL, V685, P111; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Monnich M, 2009, GENE EXPR PATTERNS, V9, P586, DOI 10.1016/j.gep.2009.08.004; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2010, CURR BIOL, V20, P1787, DOI 10.1016/j.cub.2010.09.006; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Schulz S, 2008, PRENATAL DIAG, V28, P42, DOI 10.1002/pd.1904; Seitan VC, 2006, PLOS BIOL, V4, P1411, DOI 10.1371/journal.pbio.0040242; SHEPARD J, 2004, CELLULAR DEV BIOL, P109; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vega H, 2010, J MED GENET, V47, P30, DOI 10.1136/jmg.2009.068395; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	70	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20051	10.1371/journal.pone.0020051	http://dx.doi.org/10.1371/journal.pone.0020051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637801	Green Published, gold			2022-12-27	WOS:000291052200030
J	Bess, E; Fisslthaler, B; Fromel, T; Fleming, I				Bess, Elke; Fisslthaler, Beate; Froemel, Timo; Fleming, Ingrid			Nitric Oxide-Induced Activation of the AMP-Activated Protein Kinase alpha 2 Subunit Attenuates I kappa B Kinase Activity and Inflammatory Responses in Endothelial Cells	PLOS ONE			English	Article							STRESS-INDUCED ACTIVATION; SHEAR-STRESS; GENE-EXPRESSION; ADIPONECTIN; PHOSPHORYLATION; BRADYKININ; INDUCTION; ISOFORM; ENOS	Background: In endothelial cells, activation of the AMP-activated protein kinase (AMPK) has been linked with anti-inflammatory actions but the events downstream of kinase activation are not well understood. Here, we addressed the effects of AMPK activation/deletion on the activation of NF kappa B and determined whether the AMPK could contribute to the anti-inflammatory actions of nitric oxide (NO). Methodology/Principal Findings: Overexpression of a dominant negative AMPK alpha 2 mutant in tumor necrosis factor-alpha-stimulated human endothelial cells resulted in increased NF kappa B activity, E-selectin expression and monocyte adhesion. In endothelial cells from AMPK alpha 2(-/-) mice the interleukin (IL)-1 beta induced expression of E-selectin was significantly increased. DETA-NO activated the AMPK and attenuated NF kappa B activation/E-selectin expression, effects not observed in human endothelial cells in the presence of the dominant negative AMPK, or in endothelial cells from AMPK alpha 2(-/-) mice. Mechanistically, overexpression of constitutively active AMPK decreased the phosphorylation of I kappa B and p65, indicating a link between AMPK and the I kappa B kinase (IKK). Indeed, IKK (more specifically residues Ser177 and Ser181) was found to be a direct substrate of AMPK alpha 2 in vitro. The hyper-phosphorylation of the IKK, which is known to result in its inhibition, was also apparent in endothelial cells from AMPK alpha 2(+/+) versus AMPK alpha 2(-/-) mice. Conclusions: These results demonstrate that the IKK is a direct substrate of AMPK alpha 2 and that its phosphorylation on Ser177 and Ser181 results in the inhibition of the kinase and decreased NF kappa B activation. Moreover, as NO potently activates AMPK in endothelial cells, a portion of the anti-inflammatory effects of NO are mediated by AMPK.	[Bess, Elke; Fisslthaler, Beate; Froemel, Timo; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany	Goethe University Frankfurt	Fisslthaler, B (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany.	fisslthaler@em.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Fleming, Ingrid/L-1225-2014	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635	European Community [LSHM-CT-2004-005033]; Deutsche Forschungsgemeinschaft [SFB 834/A5, Exzellenzcluster 147]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by EICOSANOX, an integrated project supported by the European Community's sixth Framework Program (Contract No LSHM-CT-2004-005033), by the Deutsche Forschungsgemeinschaft (SFB 834/A5 and Exzellenzcluster 147 "Cardio-Pulmonary Systems"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Cardiovasc Res, V35, P2; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; BUSSE R, 1991, N-S ARCH PHARMACOL, V344, P126; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hattori Y, 2008, FEBS LETT, V582, P1719, DOI 10.1016/j.febslet.2008.04.037; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Li J, 2006, AM J PHYSIOL-HEART C, V291, pH1927, DOI 10.1152/ajpheart.00251.2006; Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; SchiniKerth VB, 1997, ARTERIOSCL THROM VAS, V17, P672, DOI 10.1161/01.ATV.17.4.672; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suzuki K, 2008, AM J HYPERTENS, V21, P451, DOI 10.1038/ajh.2008.6; Tomizawa A, 2009, LIFE SCI, V85, P457, DOI 10.1016/j.lfs.2009.07.012; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; ZEIHER AM, 1995, CIRC RES, V76, P980, DOI 10.1161/01.RES.76.6.980; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200	38	62	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20848	10.1371/journal.pone.0020848	http://dx.doi.org/10.1371/journal.pone.0020848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673972	gold, Green Published, Green Submitted			2022-12-27	WOS:000291356400034
J	Yang, Y; Li, XW; Zhou, F; Jin, Q; Gao, L				Yang, Yu; Li, Xiangwei; Zhou, Feng; Jin, Qi; Gao, Lei			Prevalence of Drug-Resistant Tuberculosis in Mainland China: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MULTIDRUG; EPIDEMIOLOGY	Background: The spread of drug-resistant tuberculosis (TB) is one of the major public health problems in the world. Surveillance of anti-TB drug resistance is important for monitoring TB control strategies. However, the status of drug-resistant TB in China has been reported inconsistently. Methods: We systematically reviewed published studies on drug-resistant TB in China until March 31, 2011, and quantitatively summarized prevalence and patterns of anti-TB drug resistance among new cases and previously treated cases, respectively. Results: Ninety-five eligible articles, published during 1993-2011, were included in this review. The meta-analyses showed that the prevalence of drug-resistant TB in new cases was 27.9% (95% CI, 25.6%-30.2%) (n/N = 27360/104356) and in previously treated cases was 60.3% (95% CI, 56.2%-64.2%) (n/N = 30350/45858). Furthermore, in these two study populations, the prevalence of multiple drug resistance was found to be 5.3% (95% CI, 4.4%-6.4%) (n/N = 8810/101718) and 27.4% (95% CI, 24.1%-30.9%) (n/N = 10486/44530) respectively. However, the results were found to be frequently heterogeneous (p for Q tests <0.001). The most common resistance was observed for isoniazid among both study populations. Different patterns of drug resistance were observed in the subgroup analysis with respect to geographic areas, drug susceptibility testing methods and subject enrollment time. Conclusions: Results of meta-analyses indicated a severe status of drug-resistant TB in China, which attaches an importance to strength TB prevention and control.	[Yang, Yu] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, Y (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China.	jinqi@ipbcams.ac.cn; gaolei@ipbcams.ac.cn	Jin, Qi/B-5379-2009	Yang, Yu/0000-0002-5611-8951	Ministry of Science and Technology, the People's Republic of China [2008ZX10003-005, 2008ZX10003-012]	Ministry of Science and Technology, the People's Republic of China(Ministry of Science and Technology, China)	The work was supported by Eleven Fifth Key Research grant from the Ministry of Science and Technology, the People's Republic of China (NO: 2008ZX10003-005, 2008ZX10003-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammann RH, 2010, MEM I OSWALDO CRUZ, V105, P838, DOI 10.1590/S0074-02762010000600019; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P672; Chinese Ministry of Health, 2010, NAT BAS SURV DRUG RE; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; *GROUP NTS, 2002, CHIN J TUBERC RESP D, V25, P3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu D, 2008, HEALTH POLICY PLANN, V23, P43, DOI 10.1093/heapol/czm038; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Loddenkemper R, 2010, DTSCH ARZTEBL INT, V107, P10, DOI 10.3238/arztebl.2010.0010; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Schatz A, 2005, CLIN ORTHOP RELAT R, P3; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131; Wang D, 2010, JPN J INFECT DIS, V63, P368; *WHO, 2008, WHOHTMTB2008394; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Xu B, 2006, HEALTH POLICY PLANN, V21, P365, DOI 10.1093/heapol/czl019; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	20	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20343	10.1371/journal.pone.0020343	http://dx.doi.org/10.1371/journal.pone.0020343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674033	Green Published, gold, Green Submitted			2022-12-27	WOS:000291355500011
J	Codina, C; Pascalis, O; Mody, C; Toomey, P; Rose, J; Gummer, L; Buckley, D				Codina, Charlotte; Pascalis, Olivier; Mody, Chris; Toomey, Peter; Rose, Jill; Gummer, Laura; Buckley, David			Visual Advantage in Deaf Adults Linked to Retinal Changes	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; SIGNAL-DETECTION ANALYSIS; CONGENITALLY DEAF; GANGLION-CELL; AUDITORY-CORTEX; HEARING; FIELD; ATTENTION; SENSITIVITY	The altered sensory experience of profound early onset deafness provokes sometimes large scale neural reorganisations. In particular, auditory-visual cross-modal plasticity occurs, wherein redundant auditory cortex becomes recruited to vision. However, the effect of human deafness on neural structures involved in visual processing prior to the visual cortex has never been investigated, either in humans or animals. We investigated neural changes at the retina and optic nerve head in profoundly deaf (N = 14) and hearing (N = 15) adults using Optical Coherence Tomography (OCT), an in-vivo light interference method of quantifying retinal micro-structure. We compared retinal changes with behavioural results from the same deaf and hearing adults, measuring sensitivity in the peripheral visual field using Goldmann perimetry. Deaf adults had significantly larger neural rim areas, within the optic nerve head in comparison to hearing controls suggesting greater retinal ganglion cell number. Deaf adults also demonstrated significantly larger visual field areas (indicating greater peripheral sensitivity) than controls. Furthermore, neural rim area was significantly correlated with visual field area in both deaf and hearing adults. Deaf adults also showed a significantly different pattern of retinal nerve fibre layer (RNFL) distribution compared to controls. Significant correlations between the depth of the RNFL at the inferior-nasal peripapillary retina and the corresponding far temporal and superior temporal visual field areas (sensitivity) were found. Our results show that cross-modal plasticity after early onset deafness may not be limited to the sensory cortices, noting specific retinal adaptations in early onset deaf adults which are significantly correlated with peripheral vision sensitivity.	[Codina, Charlotte; Buckley, David] Univ Sheffield, Acad Unit Ophthalmol & Orthopt, Sheffield, S Yorkshire, England; [Pascalis, Olivier] Univ Pierre Mendes France, Lab Psychol & NeuroCognit, Grenoble, France; [Mody, Chris; Toomey, Peter; Rose, Jill; Gummer, Laura] Sheffield Teaching Hosp Trust, Dept Ophthalm Imaging, Sheffield, S Yorkshire, England	University of Sheffield; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Sheffield	Codina, C (corresponding author), Univ Sheffield, Acad Unit Ophthalmol & Orthopt, Sheffield, S Yorkshire, England.	C.Codina@Sheffield.ac.uk		Buckley, David/0000-0001-9140-8543; pascalis, olivier/0000-0003-4609-3233; Codina, Charlotte/0000-0003-0094-3052	Royal National Institute for the Deaf (RNID)	Royal National Institute for the Deaf (RNID)	The Royal National Institute for the Deaf (RNID) funded this work as part of a PhD scholarship given to the first author, Charlotte Codina (nee Westerman). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOV I, 1982, SCIENCE, V217, P265, DOI 10.1126/science.6178160; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bosworth RG, 2002, BRAIN COGNITION, V49, P170, DOI 10.1006/brcg.2001.1498; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; Bowd C, 2006, INVEST OPHTH VIS SCI, V47, P2889, DOI 10.1167/iovs.05-1489; BROSS M, 1980, PERCEPT MOTOR SKILL, V51, P839, DOI 10.2466/pms.1980.51.3.839; BROSS M, 1979, PERCEPT MOTOR SKILL, V48, P187, DOI 10.2466/pms.1979.48.1.187; Brown NL, 2001, DEVELOPMENT, V128, P2497; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Chen TC, 2006, AM J OPHTHALMOL, V141, P1165, DOI 10.1016/j.ajo.2006.01.086; CODINA CJ, 2010, DEVELOPMENTAL SCI, DOI DOI 10.1111/J.1467-7687.2010.01017; Colmenero JM, 2004, EUR J COGN PSYCHOL, V16, P791, DOI 10.1080/09541440340000312; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DeLeon-Ortega J, 2007, AM J OPHTHALMOL, V143, P288, DOI 10.1016/j.ajo.2006.09.045; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dye MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005640; Falchier A, 2002, J NEUROSCI, V22, P5749; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; GARWAYHEATH DF, 2002, IOVS, V13, P2213; Ghadiali Q, 2008, J GLAUCOMA, V17, P333, DOI 10.1097/IJG.0b013e3181650f8b; Halpern SD, 1999, J COGNITIVE NEUROSCI, V11, P521, DOI 10.1162/089892999563580; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; HOLLYFIELD JG, 1983, INVEST OPHTH VIS SCI, V24, P893; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; IKEDA H, 1976, EXP BRAIN RES, V25, P63; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lempert P, 2008, OPHTHALMOLOGY, V115, P2259, DOI 10.1016/j.ophtha.2008.07.016; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; LOMBER SG, 2010, NAT NEUROSCI, V13, P1241; LOVIEKITCHIN JE, 1998, OPHTHALMIC PHYSL, V8, P363; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Miglior S, 2007, AM J OPHTHALMOL, V144, P733, DOI 10.1016/j.ajo.2007.06.035; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; PALLAS SL, 1990, J COMP NEUROL, V298, P50, DOI 10.1002/cne.902980105; Parasnis I, 2003, J SPEECH LANG HEAR R, V46, P1166, DOI 10.1044/1092-4388(2003/091); PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; POIZNER H, 1987, BRAIN LANG, V30, P52, DOI 10.1016/0093-934X(87)90027-7; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Reus NJ, 2004, INVEST OPHTH VIS SCI, V45, P840, DOI 10.1167/iovs.03-0646; SACHS GM, 1984, J COMP NEUROL, V230, P155, DOI 10.1002/cne.902300202; Schlottmann PG, 2004, INVEST OPHTH VIS SCI, V45, P1823, DOI 10.1167/iovs.03-0692; Stevens C, 2006, J COGNITIVE NEUROSCI, V18, P701, DOI 10.1162/jocn.2006.18.5.701; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Strouthidis NG, 2006, INVEST OPHTH VIS SCI, V47, P5356, DOI 10.1167/iovs.05-1660; VARMA R, 1998, AM J OPHTHALMOL, V114, P554; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WIRTSCHAFTER JD, 1982, OPHTHALMOLOGY, V89, P255; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	62	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20417	10.1371/journal.pone.0020417	http://dx.doi.org/10.1371/journal.pone.0020417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673805	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000291309900017
J	Wittkowski, KM; Leonardi, C; Gottlieb, A; Menter, A; Krueger, GG; Tebbey, PW; Belasco, J; Soltani-Arabshahi, R; Gray, J; Horn, L; Krueger, JG				Wittkowski, Knut M.; Leonardi, Craig; Gottlieb, Alice; Menter, Alan; Krueger, Gerald G.; Tebbey, Paul W.; Belasco, Jennifer; Soltani-Arabshahi, Razieh; Gray, John; Horn, Liz; Krueger, James G.		Int Psoriasis Council	Clinical Symptoms of Skin, Nails, and Joints Manifest Independently in Patients with Concomitant Psoriasis and Psoriatic Arthritis	PLOS ONE			English	Article							DISEASE; ASSOCIATION; EPIDEMIOLOGY; PATHOGENESIS; AUTOIMMUNE; EXTENSION; GENETICS; INSIGHTS; FEATURES	This study correlated assessment tools for evaluating the severity of skin, nail, and joint symptoms in patients with psoriasis (Pso) and psoriatic arthritis (PsA). Adults with plaque Pso (with or without PsA) were enrolled from four U. S. institutions. Patients were evaluated using a novel 10-area Linear Psoriasis Area and Severity Index (XL-PASI), Psoriatic Arthritis Assessment (PsAA), Psoriatic Arthritis Screening and Evaluation Questionnaire (PASE), Nail Assessment (NA) and Joint Assessment (JA) tools, Psoriasis Weighted Extent and Severity Index (PWESI), and Lattice Physician Global Assessment (LS-PGA). Correlations between assessment tools and individual items in the assessment tools were performed. Data from 180 patients (55 with PsA) were analyzed. Highest correlations between tools (r = 0.77-0.88) were between the XL-PASI, PWESI and LS-PGA. Individual items in the XL-PASI correlated with items in the PWESI for extent skin symptoms, but not for all body areas. Overall, correlations were seen between hands and feet, between face and scalp, and between buttocks, chest, and back. Only low correlation was seen between items assessing joint symptoms with items assessing skin symptoms. These data support the notion that the complex phenotype of psoriatic disease requires instruments that assess the severity of skin, nails, and joints separately.	[Wittkowski, Knut M.; Belasco, Jennifer; Gray, John; Krueger, James G.] Rockefeller Univ, New York, NY 10021 USA; [Leonardi, Craig] St Louis Univ, Sch Med, St Louis, MO USA; [Gottlieb, Alice] Tufts Univ, Tufts Med Ctr, Boston, MA 02111 USA; [Menter, Alan] Baylor Univ, Med Ctr, Baylor Inst Res, Dermatol Res Ctr, Dallas, TX USA; [Krueger, Gerald G.; Soltani-Arabshahi, Razieh] Univ Utah, Salt Lake City, UT USA; [Tebbey, Paul W.; Horn, Liz; Int Psoriasis Council] Int Psoriasis Council, Dallas, TX USA	Rockefeller University; Saint Louis University; Tufts Medical Center; Tufts University; Baylor University; Baylor University Medical Center; Utah System of Higher Education; University of Utah	Wittkowski, KM (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	jgk@rockefeller.edu	Arabshahi, Razieh Soltani/B-5331-2008; Naldi, Luigi/K-6343-2016	Naldi, Luigi/0000-0002-3160-2835; , International Journal of Business and Applied Social Science/0000-0001-7850-0193	National Institutes of Health [UL1 RR024143]; International Psoriasis Council (IPC); Abbott; Amgen/Pfizer; Astellas; Centocor; Galderma; Janssen-Cilag; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Psoriasis Council (IPC); Abbott(Abbott Laboratories); Amgen/Pfizer(AmgenPfizer); Astellas(Astellas Pharmaceuticals); Centocor; Galderma; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by a National Institutes of Health/Clinical and Translational Science Award (CTSA) grant UL1 RR024143 and an unrestricted educational grant from the International Psoriasis Council (IPC) to KMW and JGK. The project was also supported by unrestricted educational grants to the International Psoriasis Council from Abbott, Amgen/Pfizer, Astellas, Centocor, Galderma and Janssen-Cilag. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Castelino M, 2010, CURR OPIN RHEUMATOL, V22, P152, DOI 10.1097/BOR.0b013e32833669d2; Cohen MR, 1999, J RHEUMATOL, V26, P1752; Dominguez PL, 2009, ARCH DERMATOL RES, V301, P573, DOI 10.1007/s00403-009-0981-3; Duffin KC, 2008, J RHEUMATOL, V35, P1449; Elkayam O, 2000, CLIN RHEUMATOL, V19, P301, DOI 10.1007/PL00011173; Feldman SR, 2005, ANN RHEUM DIS, V64, P65, DOI 10.1136/ard.2004.031237; Gladman DD, 2009, DERMATOL THER, V22, P40, DOI 10.1111/j.1529-8019.2008.01215.x; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Goldstein I, 2008, CLIN IMMUNOL, V128, P75, DOI 10.1016/j.clim.2008.02.014; Gottlieb AB, 2006, J DERMATOL TREAT, V17, P279, DOI 10.1080/09546630600823369; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones SM, 1998, ARTHRITIS RHEUM, V41, pS334; JONES SM, 1994, BRIT J RHEUMATOL, V33, P834; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Makredes M, 2009, J AM ACAD DERMATOL, V61, P405, DOI 10.1016/j.jaad.2009.02.015; McGonagle D, 2009, CURR OPIN RHEUMATOL, V21, P340, DOI 10.1097/BOR.0b013e32832c6ab9; McGonagle D, 2009, DERMATOLOGY, V218, P97, DOI 10.1159/000182250; Morales JF, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1372; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Ramagopalan SV, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-10; Ritchlin C, 2006, RHEUM DIS CLIN N AM, V32, P75, DOI 10.1016/j.rdc.2005.12.003; Ritchlin C, 2007, NAT CLIN PRACT RHEUM, V3, P698, DOI 10.1038/ncprheum0670; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tan AL, 2007, RHEUMATOLOGY, V46, P253, DOI 10.1093/rheumatology/kel214; Tan AL, 2006, ARTHRITIS RHEUM-US, V54, P1328, DOI 10.1002/art.21736; Wilson FC, 2009, ARTHRIT RHEUM-ARTHR, V61, P233, DOI 10.1002/art.24172; Wittkowski K. M., 2006, C P IEEE ENG MED BIO, V1, P3464	33	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20279	10.1371/journal.pone.0020279	http://dx.doi.org/10.1371/journal.pone.0020279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673809	Green Submitted, gold, Green Published			2022-12-27	WOS:000291309900010
J	Brown, RM; Jordan, WC; Faulkes, CG; Jones, CG; Bugoni, L; Tatayah, V; Palma, RL; Nichols, RA				Brown, Ruth M.; Jordan, William C.; Faulkes, Chris G.; Jones, Carl G.; Bugoni, Leandro; Tatayah, Vikash; Palma, Ricardo L.; Nichols, Richard A.			Phylogenetic Relationships in Pterodroma Petrels Are Obscured by Recent Secondary Contact and Hybridization	PLOS ONE			English	Article							ISLAND; MODEL	The classification of petrels (Pterodroma spp.) from Round Island, near Mauritius in the Indian Ocean, has confounded researchers since their discovery in 1948. In this study we investigate the relationships between Round Island petrels and their closest relatives using evidence from mitochondrial DNA sequence data and ectoparasites. Far from providing clear delimitation of species boundaries, our results reveal that hybridization among species on Round Island has led to genetic leakage between populations from different ocean basins. The most common species on the island, Pterodroma arminjoniana, appears to be hybridizing with two rarer species (P. heraldica and P. neglecta), subverting the reproductive isolation of all three and allowing gene flow. P. heraldica and P. neglecta breed sympatrically in the Pacific Ocean, where P. arminjoniana is absent, but no record of hybridization between these two exists and they remain phenotypically distinct. The breakdown of species boundaries in Round Island petrels followed environmental change (deforestation and changes in species composition due to hunting) within their overlapping ranges. Such multi-species interactions have implications not only for conservation, but also for our understanding of the processes of evolutionary diversification and speciation.	[Brown, Ruth M.; Jordan, William C.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Brown, Ruth M.; Faulkes, Chris G.; Nichols, Richard A.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Brown, Ruth M.; Jones, Carl G.; Tatayah, Vikash] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Jones, Carl G.] Durrell Wildlife Conservat Trust, Trinity, Jersey, England; [Bugoni, Leandro] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland; [Bugoni, Leandro] Fundacao Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande, Brazil; [Palma, Ricardo L.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand	Zoological Society of London; University of London; Queen Mary University London; University of Glasgow; Universidade Federal do Rio Grande	Brown, RM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rthbwn@bas.ac.uk	Nichols, Richard Alan/T-4773-2019; Bugoni, Leandro/F-9539-2012; Faulkes, Chris/O-8101-2019	Bugoni, Leandro/0000-0003-0689-7026; Nichols, Richard Alan/0000-0002-4801-9312; Faulkes, Christopher/0000-0002-5228-9075	Natural Environment Research Council; Zoological Society of London; University of London; CAPES Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Zoological Society of London; University of London; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the Natural Environment Research Council, The Zoological Society of London and a grant from the University of London Central Research Fund. Leandro Bugoni received funding from the CAPES Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooke M, 2004, ALBATROSSES PETRELS; Brooke MD, 1996, IBIS, V138, P420, DOI 10.1111/j.1474-919X.1996.tb08060.x; BROOKE MD, 1999, IBIS, V142, P139; Brown RM, 2010, MOL ECOL, V19, P3157, DOI 10.1111/j.1365-294X.2010.04719.x; Bullock D., 1977, Oryx, V14, P51; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer S, 2010, MOL PHYLOGENET EVOL, V55, P1111, DOI 10.1016/j.ympev.2010.01.013; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hume J., 2008, LOST LAND DODO; Imber M. J., 2004, Notornis, V51, P33; IMBER MJ, 1985, IBIS, V127, P197, DOI 10.1111/j.1474-919X.1985.tb05055.x; KING BR, 1991, EMU, V91, P122, DOI 10.1071/MU9910122; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; LLOYD JA, 1846, P VERBEAUX SOC NAT H, V1842, P154; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; McDonald DB, 2008, P NATL ACAD SCI USA, V105, P10837, DOI 10.1073/pnas.0712002105; Murphy R. C., 1952, American Museum Novitates, VNo. 1580, P1; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nunn GB, 1996, AUK, V113, P784; ONLEY D., 2007, FIELD GUIDE ALBATROS; Palma RL, 2000, NEW ZEAL J ZOOL, V27, P229, DOI 10.1080/03014223.2000.9518230; Paterson AM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P287; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price R. D., 2003, CHEWING LICE WORLD C, V24; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2005, MRBAYES 3 1 MANUAL; ROUNTREE FRG, 1952, B MAURIT I, V3, P155; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Timmermann G., 1965, Abhandlungen und Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg NF, V8, P1; Timmermann G., 1960, Zeitschrift fuer Parasitenkunde, V20, P317; Tove Michael H., 2005, Notornis, V52, P56; VINSON J, 1949, P R SOC ARTS SCI MAU, V1, P32; Zino F, 2008, IBIS, V150, P326, DOI 10.1111/j.1474-919X.2007.00794.x	38	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20350	10.1371/journal.pone.0020350	http://dx.doi.org/10.1371/journal.pone.0020350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655247	Green Published, gold			2022-12-27	WOS:000291097600049
J	Cain, DW; Snowden, PB; Sempowski, GD; Kelsoe, G				Cain, Derek W.; Snowden, Pilar B.; Sempowski, Gregory D.; Kelsoe, Garnett			Inflammation Triggers Emergency Granulopoiesis through a Density-Dependent Feedback Mechanism	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; G-CSF; DEFICIENT MICE; C/EBP-BETA; IN-VIVO; NEUTROPHIL MOBILIZATION; CYCLIC NEUTROPENIA; BONE-MARROW; GM-CSF	Normally, neutrophil pools are maintained by homeostatic mechanisms that require the transcription factor C/EBP alpha. Inflammation, however, induces neutrophilia through a distinct pathway of "emergency" granulopoiesis that is dependent on C/EBPb. Here, we show in mice that alum triggers emergency granulopoiesis through the IL-1RI-dependent induction of G-CSF. G-CSF/G-CSF-R neutralization impairs proliferative responses of hematopoietic stem and progenitor cells (HSPC) to alum, but also abrogates the acute mobilization of BM neutrophils, raising the possibility that HSPC responses to inflammation are an indirect result of the exhaustion of BM neutrophil stores. The induction of neutropenia, via depletion with Gr-1 mAb or myeloid-specific ablation of Mcl-1, elicits G-CSF via an IL-1RI-independent pathway, stimulating granulopoietic responses indistinguishable from those induced by adjuvant. Notably, C/EBPb, thought to be necessary for enhanced generative capacity of BM, is dispensable for increased proliferation of HSPC to alum or neutropenia, but plays a role in terminal neutrophil differentiation during granulopoietic recovery. We conclude that alum elicits a transient increase in G-CSF production via IL-1RI for the mobilization of BM neutrophils, but density-dependent feedback sustains G-CSF for accelerated granulopoiesis.	[Cain, Derek W.; Snowden, Pilar B.; Kelsoe, Garnett] Duke Univ, Dept Immunol, Durham, NC 27708 USA; [Sempowski, Gregory D.] Duke Univ Med Ctr, Duke Univ Human Vaccine Inst, Durham, NC USA	Duke University; Duke University	Cain, DW (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27708 USA.	ghkelsoe@duke.edu		Sempowski, Gregory/0000-0003-0391-6594; Kelsoe, Garnett/0000-0002-8770-040X	NIH [AI24335, AI56363, P30-AI051445, UC6-AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607, P30AI051445, U19AI056363, R01AI024335] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI24335 and AI56363 (to G. K.) (http://www.nih.gov/). The Duke Human Vaccine Institute Immune Reconstitution & Biomarker Shared Resource Facility is supported in part by NIH grants P30-AI051445 and UC6-AI058607; residual financial support is generated through user fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Basu S, 2000, BLOOD, V95, P3725; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; BOGGS DR, 1966, ANNU REV PHYSIOL, V28, P39, DOI 10.1146/annurev.ph.28.030166.000351; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; CRADDOCK CG, 1955, J LAB CLIN MED, V45, P881; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; DALE DC, 1988, BLOOD REV, V2, P178, DOI 10.1016/0268-960X(88)90023-9; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KINGSMITH EA, 1970, BLOOD-J HEMATOL, V36, P254, DOI 10.1182/blood.V36.2.254.254; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; METCALF D, 1986, BLOOD, V68, P46; METCALF D, 1987, EXP HEMATOL, V15, P1; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORLEY A, 1970, BLOOD-J HEMATOL, V35, P312, DOI 10.1182/blood.V35.3.312.312; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Ostby I, 2004, J MATH BIOL, V49, P501, DOI 10.1007/s00285-004-0274-6; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; PATT HM, 1957, AM J PHYSIOL, V188, P585, DOI 10.1152/ajplegacy.1957.188.3.585; RUBINOW SI, 1975, J MATH BIOL, V1, P187, DOI 10.1007/BF01273744; SCUMPIA PO, 2010, J IMMUNOL; SHIRAFUJI N, 1989, EXP HEMATOL, V17, P116; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Smith E, 2009, J IMMUNOL, V183, P5685, DOI 10.4049/jimmunol.0900887; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; ULICH TR, 1989, BLOOD, V73, P108; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; VONSCHULTHESS GK, 1982, BLOOD, V59, P27; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	50	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19957	10.1371/journal.pone.0019957	http://dx.doi.org/10.1371/journal.pone.0019957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655273	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600012
J	Chakravarty, MM; Aleong, R; Leonard, G; Perron, M; Pike, GB; Richer, L; Veillette, S; Pausova, Z; Paus, T				Chakravarty, M. Mallar; Aleong, Rosanne; Leonard, Gabriel; perron, Michel; Pike, G. Bruce; Richer, Louis; Veillette, Suzanne; Pausova, Zdenka; Paus, Tomas			Automated Analysis of Craniofacial Morphology Using Magnetic Resonance Images	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GEOMETRIC MORPHOMETRICS; SEXUAL-DIMORPHISM; WHITE-MATTER; MOUSE-BRAIN; DIGIT RATIO; ATLAS; GROWTH; SHAPE; BODY	Quantitative analysis of craniofacial morphology is of interest to scholars working in a wide variety of disciplines, such as anthropology, developmental biology, and medicine. T1-weighted (anatomical) magnetic resonance images (MRI) provide excellent contrast between soft tissues. Given its three-dimensional nature, MRI represents an ideal imaging modality for the analysis of craniofacial structure in living individuals. Here we describe how T1-weighted MR images, acquired to examine brain anatomy, can also be used to analyze facial features. Using a sample of typically developing adolescents from the Saguenay Youth Study (N = 597; 292 male, 305 female, ages: 12 to 18 years), we quantified inter-individual variations in craniofacial structure in two ways. First, we adapted existing nonlinear registration-based morphological techniques to generate iteratively a group-wise population average of craniofacial features. The nonlinear transformations were used to map the craniofacial structure of each individual to the population average. Using voxel-wise measures of expansion and contraction, we then examined the effects of sex and age on inter-individual variations in facial features. Second, we employed a landmark-based approach to quantify variations in face surfaces. This approach involves: (a) placing 56 landmarks (forehead, nose, lips, jaw-line, cheekbones, and eyes) on a surface representation of the MRI-based group average; (b) warping the landmarks to the individual faces using the inverse nonlinear transformation estimated for each person; and (3) using a principal components analysis (PCA) of the warped landmarks to identify facial features (i. e. clusters of landmarks) that vary in our sample in a correlated fashion. As with the voxel-wise analysis of the deformation fields, we examined the effects of sex and age on the PCA-derived spatial relationships between facial features. Both methods demonstrated significant sexual dimorphism in craniofacial structure in areas such as the chin, mandible, lips, and nose.	[Chakravarty, M. Mallar; Aleong, Rosanne; Paus, Tomas] Rotman Res Inst, Toronto, ON, Canada; [Chakravarty, M. Mallar] Hosp Sick Children, Mouse Imaging Ctr MICe, Toronto, ON M5G 1X8, Canada; [Leonard, Gabriel; Pike, G. Bruce; Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [perron, Michel; Veillette, Suzanne] ECOBES, Jonquiere, PQ, Canada; [perron, Michel; Veillette, Suzanne] Univ Quebec Chicoutimi, Saguenay, PQ, Canada; [Richer, Louis] Univ Quebec Chicoutimi, Dept Sci Educ & Psychol, Chicoutimi, PQ, Canada; [Pausova, Zdenka; Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Pausova, Zdenka] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; University of Nottingham; Universite de Montreal	Chakravarty, MM (corresponding author), Rotman Res Inst, Toronto, ON, Canada.	mchakravarty@rotman-baycrest.on.ca	Pike, Bruce/K-5562-2014	Pike, Bruce/0000-0001-8924-683X	Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; Canada Foundation for Innovation under Compute Canada; Government of Ontario, Ontario Research Fund - Research Excellence; University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Foundation for Innovation under Compute Canada; Government of Ontario, Ontario Research Fund - Research Excellence; University of Toronto(University of Toronto)	This work was supported by the Canadian Institutes of Health Research (TP, ZP), Heart and Stroke Foundation of Quebec (ZP), and the Canadian Foundation for Innovation (ZP). Computations were performed on the SciNet supercomputer at the SciNet HPC Consortium. SciNet is funded by the Canada Foundation for Innovation under the auspices of Compute Canada, the Government of Ontario, Ontario Research Fund - Research Excellence and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleong R, 2007, BEHAV RES METHODS, V39, P651, DOI 10.3758/BF03193037; Aleong R, 2010, J COGNITIVE NEUROSCI, V22, P482, DOI 10.1162/jocn.2009.21211; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; BOOKSTEIN FL, 1991, PROG CLIN BIOL RES, V363, P227; BOOKSTEIN FL, 1984, J THEOR BIOL, V107, P475, DOI 10.1016/S0022-5193(84)80104-6; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Chakravarty MM, 2006, LECT NOTES COMPUT SC, V4191, P389; Chakravarty MM, 2009, HUM BRAIN MAPP, V30, P3574, DOI 10.1002/hbm.20780; Chakravarty MM, 2008, MED IMAGE ANAL, V12, P713, DOI 10.1016/j.media.2008.04.003; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Chen XJ, 2006, NEUROIMAGE, V29, P99, DOI 10.1016/j.neuroimage.2005.07.008; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; CLARREN SK, 1987, AM J MED GENET, V26, P651, DOI 10.1002/ajmg.1320260321; COHEN SR, 1995, J CRANIOFAC SURG, V6, P184, DOI 10.1097/00001665-199505000-00002; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cootes T. F., 1998, ACTIVE APPEARANCE MO, P484; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Duchesne S, 2010, NEUROBIOL AGING, V31, P1606, DOI 10.1016/j.neurobiolaging.2008.09.003; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; FREY S, 2011, NEUROIMAGE; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Harvati K, 2010, J HUM EVOL, V59, P445, DOI 10.1016/j.jhevol.2010.06.005; Hellier P, 2003, IEEE T MED IMAGING, V22, P1120, DOI 10.1109/TMI.2003.816961; Hennessy RJ, 2005, J ANAT, V207, P283, DOI 10.1111/j.1469-7580.2005.00444.x; Hennessy RJ, 2004, SCHIZOPHR RES, V67, P261, DOI 10.1016/j.schres.2003.08.003; Hennessy RJ, 2002, BIOL PSYCHIAT, V51, P507, DOI 10.1016/S0006-3223(01)01327-0; Hennessy RJ, 2010, SCHIZOPHR RES, V122, P63, DOI 10.1016/j.schres.2010.05.001; Henriksson KM, 2006, PSYCHIAT RES-NEUROIM, V147, P173, DOI 10.1016/j.pscychresns.2005.02.013; Henriksson KM, 2006, PSYCHIAT RES-NEUROIM, V147, P187, DOI 10.1016/j.pscychresns.2006.03.004; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Joshi S, 2003, MED IMAGE ANAL, V7, P155, DOI 10.1016/S1361-8415(03)00002-1; Kelly BD, 2005, SCHIZOPHR RES, V80, P349, DOI 10.1016/j.schres.2005.07.036; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; MacDonald D, 1998, METHOD IDENTIFYING G; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Miller MI, 2001, INT J COMPUT VISION, V41, P61, DOI 10.1023/A:1011161132514; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Perrin JS, 2009, NEUROIMAGE, V45, P1055, DOI 10.1016/j.neuroimage.2009.01.023; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Schaefer K, 2005, COLLEGIUM ANTROPOL, V29, P415; SCHUMANN G, MOL PSYCHIA IN PRESS; Sforza C, 2010, FORENSIC SCI INT, V200, DOI 10.1016/j.forsciint.2010.04.050; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Suri M, 2005, SEMIN FETAL NEONAT M, V10, P243, DOI 10.1016/j.siny.2004.12.002; Suri S, 2010, ANGLE ORTHOD, V80, P861, DOI 10.2319/111709-650.1; Suri S, 2010, AM J ORTHOD DENTOFAC, V137, P763, DOI 10.1016/j.ajodo.2008.07.020; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	66	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20241	10.1371/journal.pone.0020241	http://dx.doi.org/10.1371/journal.pone.0020241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655288	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000291097600033
J	Peterson, MW; Fairchild, SZ; Otto, TC; Mohtashemi, M; Cerasoli, DM; Chang, WE				Peterson, Matthew W.; Fairchild, Steven Z.; Otto, Tamara C.; Mohtashemi, Mojdeh; Cerasoli, Douglas M.; Chang, Wenling E.			VX Hydrolysis by Human Serum Paraoxonase 1: A Comparison of Experimental and Computational Results	PLOS ONE			English	Article							TRANSITION-STATE DOCKING; ACTIVE-SITE; PREDICTION; STABILITY; PON1	Human Serum paraoxonase 1 (HuPON1) is an enzyme that has been shown to hydrolyze a variety of chemicals including the nerve agent VX. While wildtype HuPON1 does not exhibit sufficient activity against VX to be used as an in vivo countermeasure, it has been suggested that increasing HuPON1's organophosphorous hydrolase activity by one or two orders of magnitude would make the enzyme suitable for this purpose. The binding interaction between HuPON1 and VX has recently been modeled, but the mechanism for VX hydrolysis is still unknown. In this study, we created a transition state model for VX hydrolysis (VXts) in water using quantum mechanical/molecular mechanical simulations, and docked the transition state model to 22 experimentally characterized HuPON1 variants using AutoDock Vina. The HuPON1-VXts complexes were grouped by reaction mechanism using a novel clustering procedure. The average Vina interaction energies for different clusters were compared to the experimentally determined activities of HuPON1 variants to determine which computational procedures best predict how well HuPON1 variants will hydrolyze VX. The analysis showed that only conformations which have the attacking hydroxyl group of VXts coordinated by the sidechain oxygen of D269 have a significant correlation with experimental results. The results from this study can be used for further characterization of how HuPON1 hydrolyzes VX and design of HuPON1 variants with increased activity against VX.	[Peterson, Matthew W.; Fairchild, Steven Z.; Mohtashemi, Mojdeh; Chang, Wenling E.] Mitre Corp, Bedford, MA 01730 USA; [Peterson, Matthew W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Otto, Tamara C.; Cerasoli, Douglas M.] USA, Physiol & Immunol Branch, Div Res, Med Res Inst Chem Def, Aberdeen Proving Ground, MD USA; [Mohtashemi, Mojdeh] MIT Comp Sci & Lab, Cambridge, MA USA; [Chang, Wenling E.] George Mason Univ, Sch Syst Biol, Manassas, VA USA	MITRE Corporation; Boston University; Research Institute of Chemical Defense - China; George Mason University	Peterson, MW (corresponding author), Mitre Corp, Burlington Rd, Bedford, MA 01730 USA.	wchang@mitre.org			Defense Threat Reduction Agency-Joint Science and Technology Office Medical ST Division	Defense Threat Reduction Agency-Joint Science and Technology Office Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	The research was supported by the Defense Threat Reduction Agency-Joint Science and Technology Office Medical S&T Division. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army or the Department of Defense.	Cannard K, 2006, J NEUROL SCI, V249, P86, DOI 10.1016/j.jns.2006.06.008; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Fairchild SZ, 2011, J MOL MODEL, V17, P97, DOI 10.1007/s00894-010-0693-9; Fersht A., 1985, ENZYME STRUCTURE MEC; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Harel Michal, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P347, DOI 10.2478/v10004-007-0028-0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu X, 2009, PROTEINS, V75, P486, DOI 10.1002/prot.22264; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Josse D, 2001, J APPL TOXICOL, V21, pS7, DOI 10.1002/jat.789; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kuo CL, 1998, DRUG METAB DISPOS, V26, P653; MACKNESS B, 2008, PARAOXONASES THEIR R, P151; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Newmark J, 2007, NEUROLOGIST, V13, P20, DOI 10.1097/01.nrl.0000252923.04894.53; Otto TC, 2010, CHEM-BIOL INTERACT, V187, P388, DOI 10.1016/j.cbi.2010.02.022; Otto TC, 2009, BIOCHEMISTRY-US, V48, P10416, DOI 10.1021/bi901161b; Rochu D, 2007, TOXICOLOGY, V233, P47, DOI 10.1016/j.tox.2006.08.037; Rydberg P, 2008, J CHEM THEORY COMPUT, V4, P673, DOI 10.1021/ct700313j; SANAN TT, J PHYS ORGANIC CHEM, V23, P357; Tantillo DJ, 2002, J COMPUT CHEM, V23, P84, DOI 10.1002/jcc.10019; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Yeung DT, 2005, FEBS J, V272, P2225, DOI 10.1111/j.1742-4658.2005.04646.x; Yeung DT, 2004, BBA-PROTEINS PROTEOM, V1702, P67, DOI 10.1016/j.bbapap.2004.08.002; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; AUTODOCKTOOLS 4 2; JAGUAR 7 7	32	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20335	10.1371/journal.pone.0020335	http://dx.doi.org/10.1371/journal.pone.0020335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655255	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600046
J	Bonner, MK; Poole, DS; Xu, T; Sarkeshik, A; Yates, JR; Skop, AR				Bonner, Mary Kate; Poole, Daniel S.; Xu, Tao; Sarkeshik, Ali; Yates, John R., III; Skop, Ahna R.			Mitotic Spindle Proteomics in Chinese Hamster Ovary Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; GENOME DATABASE; CYTOKINESIS; PROTEINS; TAXOL; KINASE; CYCLE; MICROTUBULES; MECHANISMS; RESOURCE	Mitosis is a fundamental process in the development of all organisms. The mitotic spindle guides the cell through mitosis as it mediates the segregation of chromosomes, the orientation of the cleavage furrow, and the progression of cell division. Birth defects and tissue-specific cancers often result from abnormalities in mitotic events. Here, we report a proteomic study of the mitotic spindle from Chinese Hamster Ovary (CHO) cells. Four different isolations of metaphase spindles were subjected to Multi-dimensional Protein Identification Technology (MudPIT) analysis and tandem mass spectrometry. We identified 1155 proteins and used Gene Ontology (GO) analysis to categorize proteins into cellular component groups. We then compared our data to the previously published CHO midbody proteome and identified proteins that are unique to the CHO spindle. Our data represent the first mitotic spindle proteome in CHO cells, which augments the list of mitotic spindle components from mammalian cells.	[Bonner, Mary Kate; Poole, Daniel S.; Skop, Ahna R.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Xu, Tao; Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute	Bonner, MK (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019; Xu, Tao/A-9353-2009; chudobova, ivana/F-8477-2011	Skop, Ahna Renee/0000-0003-3522-4939; 	NSF [0546398]; NHGRI [T32HG002760]; NIH [P41RR0118232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092583] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	ARS and MKB are supported by a NSF CAREER Award (0546398). MKB is also supported by an NHGRI training grant to the Genomic Sciences Training Program T32HG002760. JRY is supported by a NIH grant (P41RR0118232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Austin GE, 1998, AM J CLIN PATHOL, V110, P575, DOI 10.1093/ajcp/110.5.575; Bader JR, 2010, SEMIN CELL DEV BIOL, V21, P269, DOI 10.1016/j.semcdb.2009.12.015; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; COCIORVA D, 2006, CURRENT PROTOCOLS BI; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; DECASTRO IP, 2008, CURR OPIN PHARMACOL, V8, P375; Degenhardt Y, 2010, CLIN CANCER RES, V16, P384, DOI 10.1158/1078-0432.CCR-09-1380; Diop SB, 2008, EMBO REP, V9, P260, DOI 10.1038/embor.2008.8; Doye V, 2011, DEV CELL, V20, P281, DOI 10.1016/j.devcel.2011.02.013; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Foss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001476; Gache V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009248; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Han ZM, 2010, J PROTEOME RES, V9, P6025, DOI 10.1021/pr100827j; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; HO MY, 2010, CANC SCI; Inaki M, 2011, GENES CELLS, V16, P166, DOI 10.1111/j.1365-2443.2010.01479.x; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; KURIYAMA R, 1984, J CELL SCI, V66, P265; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Li J, 2010, J GENET GENOMICS, V37, P159, DOI 10.1016/S1673-8527(09)60034-5; Li R, 2007, CELL MOL LIFE SCI, V64, P3044, DOI 10.1007/s00018-007-7285-6; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Marshall JC, 2010, EUR J CANCER, V46, P1278, DOI 10.1016/j.ejca.2010.02.042; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016; Moniaux N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007077; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1985, J EXP ZOOL, V234, P167, DOI 10.1002/jez.1402340120; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schenk PW, 2004, NEOPLASIA, V6, P297, DOI 10.1593/neo.03406; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; SEWALD N, 2009, PEPTIDES CHEM BIOL, pR16; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; STARGER JM, 1977, P NATL ACAD SCI USA, V74, P2422, DOI 10.1073/pnas.74.6.2422; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Walczak CE, 2000, GENOME BIOL, V1; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	82	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20489	10.1371/journal.pone.0020489	http://dx.doi.org/10.1371/journal.pone.0020489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647379	gold, Green Published			2022-12-27	WOS:000291052500064
J	Peng, XS; Guo, W; Liu, TJ; Wang, X; Tu, XA; Xiong, DF; Chen, S; Lai, YR; Du, H; Chen, GF; Liu, GL; Tang, YB; Huang, SA; Zou, XN				Peng, Xinsheng; Guo, Wei; Liu, Tiejian; Wang, Xi; Tu, Xiang'an; Xiong, Dafu; Chen, Song; Lai, Yingrong; Du, Hong; Chen, Guangfu; Liu, Guanglin; Tang, Yubo; Huang, Shuai; Zou, Xuenong			Identification of miRs-143 and-145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA GENE-EXPRESSION; BREAST-CANCER; CELL INVASION; IN-VITRO; COLORECTAL-CANCER; PROGRESSION; CARCINOMA; TARGETS; GROWTH	The principal problem arising from prostate cancer (PCa) is its propensity to metastasize to bone. MicroRNAs (miRNAs) play a crucial role in many tumor metastases. The importance of miRNAs in bone metastasis of PCa has not been elucidated to date. We investigated whether the expression of certain miRNAs was associated with bone metastasis of PCa. We examined the miRNA expression profiles of 6 primary and 7 bone metastatic PCa samples by miRNA microarray analysis. The expression of 5 miRNAs significantly decreased in bone metastasis compared with primary PCa, including miRs-508-5p, -145, -143, -33a and -100. We further examined other samples of 16 primary PCa and 13 bone metastases using real-time PCR analysis. The expressions of miRs-143 and -145 were verified to down-regulate significantly in metastasis samples. By investigating relationship of the levels of miRs-143 and -145 with clinicopathological features of PCa patients, we found down-regulations of miRs-143 and -145 were negatively correlated to bone metastasis, the Gleason score and level of free PSA in primary PCa. Over-expression miR-143 and -145 by retrovirus transfection reduced the ability of migration and invasion in vitro, and tumor development and bone invasion in vivo of PC-3 cells, a human PCa cell line originated from a bone metastatic PCa specimen. Their upregulation also increased E-cadherin expression and reduced fibronectin expression of PC-3 cells which revealed a less invasive morphologic phenotype. These findings indicate that miRs-143 and -145 are associated with bone metastasis of PCa and suggest that they may play important roles in the bone metastasis and be involved in the regulation of EMT Both of them may also be clinically used as novel biomarkers in discriminating different stages of human PCa and predicting bone metastasis.	[Peng, Xinsheng; Guo, Wei; Chen, Guangfu; Tang, Yubo; Huang, Shuai; Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Orthopaed Res Inst, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Tiejian] Laura Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China; [Wang, Xi; Liu, Guanglin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Tu, Xiang'an] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Dafu; Chen, Song] Second Peoples Hosp Zhuhai City, Dept Surg, Zhuhai, Guangdong, Peoples R China; [Lai, Yingrong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Du, Hong] First Peoples Hosp Guangzhou City, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; South China University of Technology	Peng, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Orthopaed Res Inst, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China.	pengxs66@yahoo.com; zxnong@hotmail.com	peng, Xinsheng/Q-9115-2019		NSFC-Guangdong, China [u0732001]; Natural Science Foundation of Guangdong Province, China [06021290]; Science and Technology planning project of Guangdong Province, China [2008B030301037]; Science and Technology Planning Project of Zhuhai, China	NSFC-Guangdong, China(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology planning project of Guangdong Province, China; Science and Technology Planning Project of Zhuhai, China	NSFC-Guangdong Joint funding, China (No. u0732001); the Natural Science Foundation of Guangdong Province, China (No. 06021290); Science and Technology planning project of Guangdong Province, China (No. 2008B030301037) and Science and Technology Planning Project of Zhuhai, China (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berney DM, 2007, BJU INT, V100, P1240, DOI 10.1111/j.1464-410X.2007.07199.x; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Cai Z, 2010, CANCER LETT, V296, P88, DOI 10.1016/j.canlet.2010.03.020; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan CM, 2010, MOL VIS, V16, P586; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Friedman JM, 2009, CELL CYCLE, V8, P2313, DOI 10.4161/cc.8.15.9168; Fu XP, 2010, MOL BIOSYST, V6, P2561, DOI 10.1039/c0mb00100g; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kano M, 2010, INT J CANC; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mo YY, 1999, EXP CELL RES, V252, P50, DOI 10.1006/excr.1999.4616; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Rieger-Christ KM, 2004, ONCOGENE, V23, P4745, DOI 10.1038/sj.onc.1207629; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Stephenson AJ, 2009, J CLIN ONCOL, V27, P4300, DOI 10.1200/JCO.2008.18.2501; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang M, 2006, CLIN CANCER RES, V12, P2602, DOI 10.1158/1078-0432.CCR-05-2050; Ye L, 2007, INT J MOL MED, V20, P103; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210	81	154	169	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20341	10.1371/journal.pone.0020341	http://dx.doi.org/10.1371/journal.pone.0020341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647377	Green Published, gold			2022-12-27	WOS:000291052500049
J	Suda, M; Takei, Y; Aoyama, Y; Narita, K; Sakurai, N; Fukuda, M; Mikuni, M				Suda, Masashi; Takei, Yuichi; Aoyama, Yoshiyuki; Narita, Kosuke; Sakurai, Noriko; Fukuda, Masato; Mikuni, Masahiko			Autistic Traits and Brain Activation during Face-to-Face Conversations in Typically Developed Adults	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; SPECTRUM QUOTIENT AQ; SOCIAL BRAIN; ASPERGER-SYNDROME; CHILDHOOD AUTISM; PERCEPTION; REACTIVITY; DISORDERS; FLUENCY	Background: Autism spectrum disorders (ASD) are characterized by impaired social interaction and communication, restricted interests, and repetitive behaviours. The severity of these characteristics is posited to lie on a continuum that extends into the general population. Brain substrates underlying ASD have been investigated through functional neuroimaging studies using functional magnetic resonance imaging (fMRI). However, fMRI has methodological constraints for studying brain mechanisms during social interactions (for example, noise, lying on a gantry during the procedure, etc.). In this study, we investigated whether variations in autism spectrum traits are associated with changes in patterns of brain activation in typically developed adults. We used near-infrared spectroscopy (NIRS), a recently developed functional neuroimaging technique that uses near-infrared light, to monitor brain activation in a natural setting that is suitable for studying brain functions during social interactions. Methodology: We monitored regional cerebral blood volume changes using a 52-channel NIRS apparatus over the prefrontal cortex (PFC) and superior temporal sulcus (STS), 2 areas implicated in social cognition and the pathology of ASD, in 28 typically developed participants (14 male and 14 female) during face-to-face conversations. This task was designed to resemble a realistic social situation. We examined the correlations of these changes with autistic traits assessed using the Autism-Spectrum Quotient (AQ). Principal Findings: Both the PFC and STS were significantly activated during face-to-face conversations. AQ scores were negatively correlated with regional cerebral blood volume increases in the left STS during face-to-face conversations, especially in males. Conclusions: Our results demonstrate successful monitoring of brain function during realistic social interactions by NIRS as well as lesser brain activation in the left STS during face-to-face conversations in typically developed participants with higher levels of autistic traits.	[Suda, Masashi; Takei, Yuichi; Aoyama, Yoshiyuki; Narita, Kosuke; Sakurai, Noriko; Fukuda, Masato; Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Gunma, Japan	Gunma University	Suda, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Gunma, Japan.	fkdpsy@med.gunma-u.ac.jp	Takei, Yuichi/AAS-2278-2021		Gunma University; Hitachi Group (Advanced Research Laboratory, Hitachi Ltd, and the Research and Developmental Center, Hitachi Medical Corporation); Grants-in-Aid for Scientific Research [23390286] Funding Source: KAKEN	Gunma University; Hitachi Group (Advanced Research Laboratory, Hitachi Ltd, and the Research and Developmental Center, Hitachi Medical Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Gunma University (Drs. Fukuda and Mikuni) and the Hitachi Group (Advanced Research Laboratory, Hitachi Ltd, and the Research and Developmental Center, Hitachi Medical Corporation) have had an official contract for a collaborative study of the clinical application of near-infrared spectroscopy in psychiatric disorders since 2002. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ardila A, 2008, BRAIN COGNITION, V68, P92, DOI 10.1016/j.bandc.2008.03.003; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Boddaert N, 2003, AM J PSYCHIAT, V160, P2057, DOI 10.1176/appi.ajp.160.11.2057; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2007, J AUTISM DEV DISORD, V37, P523, DOI 10.1007/s10803-006-0182-2; Frith U, 1991, AUTISM ASPERGERS SYN; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P1278, DOI 10.1007/s10803-009-0740-5; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Levitt JG, 2003, BIOL PSYCHIAT, V54, P1355, DOI 10.1016/S0006-3223(03)00688-7; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Meresse IG, 2005, ANN NEUROL, V58, P466, DOI 10.1002/ana.20597; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Suda M, 2008, NEUROSCI RES, V60, P319, DOI 10.1016/j.neures.2007.12.001; Suda M, 2010, J PSYCHIATR RES, V44, P547, DOI 10.1016/j.jpsychires.2009.11.005; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Uehara T, 2007, EAT WEIGHT DISORD-ST, V12, P183, DOI 10.1007/BF03327596; VONDEMHAGEN EA, 2010, CEREB CORTEX; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Williams JHG, 2005, NEUROIMAGE, V25, P133, DOI 10.1016/j.neuroimage.2004.10.047	41	31	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20021	10.1371/journal.pone.0020021	http://dx.doi.org/10.1371/journal.pone.0020021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637754	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500025
J	Klein, D; Weisshardt, P; Kleff, V; Jastrow, H; Jakob, HG; Ergun, S				Klein, Diana; Weisshardt, Philip; Kleff, Veronika; Jastrow, Holger; Jakob, Heinz Guenther; Erguen, Sueleyman			Vascular Wall-Resident CD44+Multipotent Stem Cells Give Rise to Pericytes and Smooth Muscle Cells and Contribute to New Vessel Maturation	PLOS ONE			English	Article							PERIVASCULAR PROGENITOR CELLS; MESENCHYMAL STROMAL CELLS; ENDOTHELIAL-CELLS; GROWTH-FACTOR; ANGIOGENESIS; CANCER	Here, we identify CD44(+)CD90(+)CD73(-)CD34(-)CD45(-) cells within the adult human arterial adventitia with properties of multipotency which were named vascular wall-resident multipotent stem cells (VW-MPSCs). VW-MPSCs exhibit typical mesenchymal stem cell characteristics including cell surface markers in immunostaining and flow cytometric analyses, and differentiation into adipocytes, chondrocytes and osteocytes under culture conditions. Particularly, TGF beta 1 stimulation up-regulates smooth muscle cell markers in VW-MPSCs. Using fluorescent cell labelling and co-localisation studies we show that VW-MPSCs differentiate to pericytes/smooth muscle cells which cover the wall of newly formed endothelial capillary-like structures in vitro. Co-implantation of EGFP-labelled VW-MPSCs and human umbilical vein endothelial cells into SCID mice subcutaneously via Matrigel results in new vessels formation which were covered by pericyte-or smooth muscle-like cells generated from implanted VW-MPSCs. Our results suggest that VW-MPSCs are of relevance for vascular morphogenesis, repair and self-renewal of vascular wall cells and for local capacity of neovascularization in disease processes.	[Klein, Diana; Weisshardt, Philip; Kleff, Veronika; Jastrow, Holger; Erguen, Sueleyman] Univ Hosp Essen, Inst Anat, Essen, N Rhine Westpha, Germany; [Jakob, Heinz Guenther] Univ Hosp Essen, Clin Thorax & Cardiovasc Surg, Essen, N Rhine Westpha, Germany	University of Duisburg Essen; University of Duisburg Essen	Klein, D (corresponding author), Univ Hosp Essen, Inst Anat, Essen, N Rhine Westpha, Germany.	Diana.Klein@uk-essen.de	Klein, Diana/AAB-5251-2020; Klein, Diana/ABC-7916-2020	Klein, Diana/0000-0002-1770-443X; Klein, Diana/0000-0002-1770-443X	Stem Cell Network North Rhine-Westphalia	Stem Cell Network North Rhine-Westphalia	The work was supported by Stem Cell Network North Rhine-Westphalia (D. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Covas DT, 2005, EXP CELL RES, V309, P340, DOI 10.1016/j.yexcr.2005.06.005; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Erguen S, 2008, STEM CELL REV, V4, P169, DOI 10.1007/s12015-008-9028-y; Ergun S, 2007, THROMB HAEMOSTASIS, V98, P930, DOI 10.1160/TH07-04-0318; Ergun S, 2006, CANCER LETT, V238, P180, DOI 10.1016/j.canlet.2005.06.033; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Howson KM, 2005, AM J PHYSIOL-CELL PH, V289, pC1396, DOI 10.1152/ajpcell.00168.2005; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Invernici G, 2007, AM J PATHOL, V170, P1879, DOI 10.2353/ajpath.2007.060646; Kano MR, 2009, CANCER SCI, V100, P173, DOI 10.1111/j.1349-7006.2008.01003.x; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Klein D, 2010, HISTOL HISTOPATHOL, V25, P681, DOI 10.14670/HH-25.681; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; LENNON DP, 2006, CULTURE CELLS TISSUE, P23; Liu JY, 2008, CARDIOVASC RES, V79, P24, DOI 10.1093/cvr/cvn059; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Pasquinelli G, 2007, STEM CELLS, V25, P1627, DOI 10.1634/stemcells.2006-0731; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Potta SP, 2009, HYPERTENSION, V53, P196, DOI 10.1161/HYPERTENSIONAHA.108.121863; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Sainz J, 2006, ARTERIOSCL THROM VAS, V26, P281, DOI 10.1161/01.ATV.0000197793.83391.91; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315	42	127	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20540	10.1371/journal.pone.0020540	http://dx.doi.org/10.1371/journal.pone.0020540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637782	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052200077
J	Roberts, MG; Nishiura, H				Roberts, Michael George; Nishiura, Hiroshi			Early Estimation of the Reproduction Number in the Presence of Imported Cases: Pandemic Influenza H1N1-2009 in New Zealand	PLOS ONE			English	Article							DEPENDENT BRANCHING-PROCESSES; SERIAL INTERVAL; H1N1; AGE; GROWTH; VIRUS; MODEL; TIME; RATES	We analyse data from the early epidemic of H1N1-2009 in New Zealand, and estimate the reproduction number R. We employ a renewal process which accounts for imported cases, illustrate some technical pitfalls, and propose a novel estimation method to address these pitfalls. Explicitly accounting for the infection-age distribution of imported cases and for the delay in transmission dynamics due to international travel, R was estimated to be 1: 25 (95% confidence interval: 1: 07,1: 47). Hence we show that a previous study, which did not account for these factors, overestimated R. Our approach also permitted us to examine the infection-age at which secondary transmission occurs as a function of calendar time, demonstrating the downward bias during the beginning of the epidemic. These technical issues may compromise the usefulness of a well-known estimator of R - the inverse of the moment-generating function of the generation time given the intrinsic growth rate. Explicit modelling of the infection-age distribution among imported cases and the examination of the time dependency of the generation time play key roles in avoiding a biased estimate of R, especially when one only has data covering a short time interval during the early growth phase of the epidemic.	[Roberts, Michael George] Massey Univ, Ctr Math Biol, Inst Informat & Math Sci, Auckland, New Zealand; [Roberts, Michael George] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Nishiura, Hiroshi] Univ Utrecht, Utrecht, Netherlands	Massey University; Massey University; Japan Science & Technology Agency (JST); Utrecht University	Roberts, MG (corresponding author), Massey Univ, Ctr Math Biol, Inst Informat & Math Sci, Auckland, New Zealand.	m.g.roberts@massey.ac.nz		Nishiura, Hiroshi/0000-0003-0941-8537	Health Research Council [10/754]; Japan Science and Technology Agency, Saitama, Japan	Health Research Council; Japan Science and Technology Agency, Saitama, Japan(Japan Science & Technology Agency (JST))	MGR wishes to acknowledge funding from the Health Research Council under contract number 10/754 (www.hrc.govt.nz/index.html). HN receives support from the Japan Science and Technology Agency, Saitama, Japan, through the PRESTO programme (www.jst.go.jp/kisoken/presto/index_e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey N. T. J., 1964, ELEMENTS STOCHASTIC; Boelle P., 2009, EUROSURVEILLANCE, V14; DEMETRIUS L, 1977, P NATL ACAD SCI USA, V74, P384, DOI 10.1073/pnas.74.1.384; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; GREY DR, 1976, J APPL PROBAB, V13, P138, DOI 10.2307/3212674; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; JAGERS P, 1968, THEOR PROBAB APPL+, V13, P225, DOI 10.1137/1113027; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Keyfitz BL, 1997, MATH COMPUT MODEL, V26, P1, DOI 10.1016/S0895-7177(97)00165-9; Lipsitch M, 2004, AM J EPIDEMIOL, V160, P517, DOI 10.1093/aje/kwh256; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Miller JC, 2010, J THEOR BIOL, V262, P107, DOI 10.1016/j.jtbi.2009.08.007; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2010, EUROSURVEILLANCE, V15, P19; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2010, MATH BIOSCI ENG, V7, P851, DOI 10.3934/mbe.2010.7.851; Nishiura H, 2010, J TRAVEL MED, V17, P269, DOI 10.1111/j.1708-8305.2010.00418.x; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Paine S, 2010, EUROSURVEILLANCE, V15, P9; PARTHASARATHY PR, 1991, INT J MATH ED SCI TE, V22, P317; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Roberts MG, 2006, MATH POPUL STUD, V13, P205, DOI 10.1080/08898480600950473; Tomba GS, 2010, MATH BIOSCI, V223, P24, DOI 10.1016/j.mbs.2009.10.004; TULJAPURKAR SD, 1982, J MATH BIOL, V13, P325, DOI 10.1007/BF00276067; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	40	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e17835	10.1371/journal.pone.0017835	http://dx.doi.org/10.1371/journal.pone.0017835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637342	gold, Green Published, Green Submitted			2022-12-27	WOS:000291052200005
J	Scarcelli, N; Barnaud, A; Eiserhardt, W; Treier, UA; Seveno, M; d'Anfray, A; Vigouroux, Y; Pintaud, JC				Scarcelli, Nora; Barnaud, Adeline; Eiserhardt, Wolf; Treier, Urs A.; Seveno, Marie; d'Anfray, Amelie; Vigouroux, Yves; Pintaud, Jean-Christophe			A Set of 100 Chloroplast DNA Primer Pairs to Study Population Genetics and Phylogeny in Monocotyledons	PLOS ONE			English	Article							NONCODING REGIONS; GENOME SEQUENCES; MOLECULAR PHYLOGENY; UNIVERSAL PRIMERS; INVERTED REPEAT; EVOLUTION; GRASSES; POACEAE; RBCL; ORCHIDACEAE	Chloroplast DNA sequences are of great interest for population genetics and phylogenetic studies. However, only a small set of markers are commonly used. Most of them have been designed for amplification in a large range of Angiosperms and are located in the Large Single Copy (LSC). Here we developed a new set of 100 primer pairs optimized for amplification in Monocotyledons. Primer pairs amplify coding (exon) and non-coding regions (intron and intergenic spacer). They span the different chloroplast regions: 72 are located in the LSC, 13 in the Small Single Copy (SSC) and 15 in the Inverted Repeat region (IR). Amplification and sequencing were tested in 13 species of Monocotyledons: Dioscorea abyssinica, D. praehensilis, D. rotundata, D. dumetorum, D. bulbifera, Trichopus sempervirens (Dioscoreaceae), Phoenix canariensis, P. dactylifera, Astrocaryum scopatum, A. murumuru, Ceroxylon echinulatum (Arecaceae), Digitaria excilis and Pennisetum glaucum (Poaceae). The diversity found in Dioscorea, Digitaria and Pennisetum mainly corresponded to Single Nucleotide Polymorphism (SNP) while the diversity found in Arecaceae also comprises Variable Number Tandem Repeat (VNTR). We observed that the most variable loci (rps15-ycf1, rpl32-ccsA, ndhF-rpl32, ndhG-ndhI and ccsA) are located in the SSC. Through the analysis of the genetic structure of a wild-cultivated species complex in Dioscorea, we demonstrated that this new set of primers is of great interest for population genetics and we anticipate that it will also be useful for phylogeny and bar-coding studies.	[Scarcelli, Nora; Barnaud, Adeline; Seveno, Marie; d'Anfray, Amelie; Vigouroux, Yves; Pintaud, Jean-Christophe] IRD, UMR Diversite Adaptat & Dev Plantes DIADE, Montpellier, France; [Eiserhardt, Wolf; Treier, Urs A.] Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Aarhus University	Scarcelli, N (corresponding author), IRD, UMR Diversite Adaptat & Dev Plantes DIADE, Montpellier, France.	nora.scarcelli@ird.fr	vigouroux, Yves/A-9056-2011; Eiserhardt, Wolf L./D-7677-2011; Treier, Urs/A-1913-2012	vigouroux, Yves/0000-0002-8361-6040; Eiserhardt, Wolf L./0000-0002-8136-5233; Treier, Urs/0000-0003-4027-739X; d'Anfray, Amelie/0000-0003-2284-4004; Scarcelli, Nora/0000-0003-4382-9583; barnaud, adeline/0000-0001-9896-1210	EU [212631]; IRD	EU(European Commission); IRD	This study was funded by EU Seventh Framework Programme as part of the project FP7-PALMS (grant agreement 212631) and by annual research budget of IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; Barrett CF, 2009, SYST BOT, V34, P496, DOI 10.1600/036364409789271245; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Caddick LR, 2002, BOT J LINN SOC, V138, P123, DOI 10.1046/j.1095-8339.2002.138002123.x; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Cameron KM, 2006, CLADISTICS, V22, P239, DOI 10.1111/j.1096-0031.2006.00102.x; Chair H, 2005, GENOME, V48, P674, DOI 10.1139/G05-018; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; Couvreur TLP, 2007, SYST BOT, V32, P519, DOI 10.1600/036364407782250526; Cozzolino S, 2003, J MOL EVOL, V57, pS41, DOI 10.1007/s00239-003-0006-3; Cozzolino S, 2003, MOL ECOL, V12, P2783, DOI 10.1046/j.1365-294X.2003.01958.x; Crisp MD, 2010, MOL PHYLOGENET EVOL, V54, P512, DOI 10.1016/j.ympev.2009.09.020; DUVALL MR, 1993, ANN MO BOT GARD, V80, P607, DOI 10.2307/2399849; Ebert D, 2009, MOL ECOL RESOUR, V9, P777, DOI 10.1111/j.1755-0998.2008.02320.x; Espindola A, 2010, BOT J LINN SOC, V163, P14, DOI 10.1111/j.1095-8339.2010.01049.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Goremykin V, 1996, MOL BIOL EVOL, V13, P383, DOI 10.1093/oxfordjournals.molbev.a025597; Graham Sean W., 2006, Aliso, V22, P3; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; Hinchliff CE, 2009, AM J BOT, V96, P1487, DOI 10.3732/ajb.0800252; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Kennedy AH, 2010, SYST BOT, V35, P64, DOI 10.1600/036364410790862489; Kim KJ, 2005, MOL CELLS, V19, P104; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Ohi-Toma T, 2010, SYST BOT, V35, P244, DOI 10.1600/036364410791638315; OLMSTEAD RG, 1993, PLANT MOL BIOL, V22, P1191, DOI 10.1007/BF00028992; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Pintaud J. -C., 2008, P296; Pintaud Jean-Christophe, 2010, P267; Provan J, 2004, MOL ECOL NOTES, V4, P262, DOI 10.1111/j.1471-8286.2004.00636.x; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Roncal Julissa, 2010, P245; Rozen S, 2000, BIOINFORMATICS METHO; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Scarcelli N, 2006, MOL ECOL, V15, P2421, DOI 10.1111/j.1365-294X.2006.02958.x; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Smith CI, 2008, P ROY SOC B-BIOL SCI, V275, P249, DOI 10.1098/rspb.2007.1405; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Sun GL, 2009, BIOCHEM SYST ECOL, V37, P67, DOI 10.1016/j.bse.2008.12.002; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura MN, 2004, J PLANT RES, V117, P109, DOI 10.1007/s10265-003-0133-3; TERAUCHI R, 1992, THEOR APPL GENET, V83, P743, DOI 10.1007/BF00226693; Trenel P, 2007, MOL PHYLOGENET EVOL, V45, P272, DOI 10.1016/j.ympev.2007.03.018; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Yang JB, 2010, TAXON, V59, P1102, DOI 10.1002/tax.594010; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zeng CX, 2010, MOL PHYLOGENET EVOL, V56, P821, DOI 10.1016/j.ympev.2010.03.041; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	70	79	83	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19954	10.1371/journal.pone.0019954	http://dx.doi.org/10.1371/journal.pone.0019954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637837	gold, Green Published			2022-12-27	WOS:000291052200023
J	Yang, Q; Kapoula, Z				Yang, Qing; Kapoula, Zoi			Distinct Control of Initiation and Metrics of Memory-Guided Saccades and Vergence by the FEF: A TMS Study	PLOS ONE			English	Article							FRONTAL EYE FIELD; TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; CORTICAL CONTROL; AREA; MOVEMENT; NEURONS; CHILDREN; FEEDBACK; LATENCY	Background: The initiation of memory guided saccades is known to be controlled by the frontal eye field (FEF). Recent physiological studies showed the existence of an area close to FEF that controls also vergence initiation and execution. This study is to explore the effect of transcranial magnetic simulation (TMS) over FEF on the control of memory-guided saccade-vergence eye movements. Methodology/Principal Findings: Subjects had to make an eye movement in dark towards a target flashed 1 sec earlier (memory delay); the location of the target relative to fixation point was such as to require either a vergence along the median plane, or a saccade, or a saccade with vergence; trials were interleaved. Single pulse TMS was applied on the left or right FEF; it was delivered at 100 ms after the end of memory delay, i.e. extinction of fixation LED that was the "go" signal. Twelve healthy subjects participated in the study. TMS of left or right FEF prolonged the latency of all types of eye movements; the increase varied from 21 to 56 ms and was particularly strong for the divergence movements. This indicates that FEF is involved in the initiation of all types of memory guided movement in the 3D space. TMS of the FEF also altered the accuracy but only for leftward saccades combined with either convergence or divergence; intrasaccadic vergence also increased after TMS of the FEF. Conclusions/Significance: The results suggest anisotropy in the quality of space memory and are discussed in the context of other known perceptual motor anisotropies.	[Yang, Qing; Kapoula, Zoi] Hop Europeen Georges Pompidou, CNRS, UMR 8194, IRIS Grp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Yang, Q (corresponding author), Hop Europeen Georges Pompidou, CNRS, UMR 8194, IRIS Grp, Paris, France.	qing.yang@egp.aphp.fr						Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Busettini C, 2005, J NEUROPHYSIOL, V94, P2312, DOI 10.1152/jn.01337.2004; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Evdokimidis I, 2001, COGNITIVE BRAIN RES, V12, P89, DOI 10.1016/S0926-6410(01)00037-4; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Hausmann M, 2002, NEUROPSYCHOLOGIA, V40, P808, DOI 10.1016/S0028-3932(01)00179-8; JAMPEL RS, 1960, J COMP NEUROL, V115, P371, DOI 10.1002/cne.901150306; Kapoula Z, 2005, ANN NY ACAD SCI, V1039, P184, DOI 10.1196/annals.1325.018; Kapoula Z., 2008, J EYE MOVEMENT RES, V2, P1; Koch G, 2005, NEUROIMAGE, V24, P34, DOI 10.1016/j.neuroimage.2004.09.042; KROMMENHOEK KP, 1994, EXP BRAIN RES, V102, P95, DOI 10.1007/BF00232442; Kumar AN, 2005, ANN NY ACAD SCI, V1039, P466, DOI 10.1196/annals.1325.046; Kurkin S, 2003, ANN NY ACAD SCI, V1004, P262, DOI 10.1196/annals.1303.023; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MURI RM, 1991, EXP BRAIN RES, V86, P219; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Narayanan NS, 2005, NEUROPSYCHOLOGY, V19, P223, DOI 10.1037/0894-4105.19.2.223; Nyffeler T, 2004, EUR J NEUROSCI, V20, P2240, DOI 10.1111/j.1460-9568.2004.03667.x; OHTSUKA K, 1989, OPHTHALMOLOGICA, V198, P53, DOI 10.1159/000309959; OHTSUKA K, 1988, OPHTHALMOLOGICA, V197, P85, DOI 10.1159/000309925; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1993, EXP BRAIN RES, V95, P166; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Ro T, 2002, J CLIN EXP NEUROPSYC, V24, P930, DOI 10.1076/jcen.24.7.930.8385; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Vernet M, 2008, INVEST OPHTH VIS SCI, V49, P230, DOI 10.1167/iovs.07-0854; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Yang Q, 2003, J VISION, V3, P554, DOI 10.1167/3.8.3; Yang Q, 2004, INVEST OPHTH VIS SCI, V45, P2231, DOI 10.1167/iovs.03-1291; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20322	10.1371/journal.pone.0020322	http://dx.doi.org/10.1371/journal.pone.0020322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637804	Green Published, gold, Green Submitted			2022-12-27	WOS:000291052200051
J	Niessner, C; Denzau, S; Gross, JC; Peichl, L; Bischof, HJ; Fleissner, G; Wiltschko, W; Wiltschko, R				Niessner, Christine; Denzau, Susanne; Gross, Julia Christina; Peichl, Leo; Bischof, Hans-Joachim; Fleissner, Gerta; Wiltschko, Wolfgang; Wiltschko, Roswitha			Avian Ultraviolet/Violet Cones Identified as Probable Magnetoreceptors	PLOS ONE			English	Article							MAGNETIC COMPASS ORIENTATION; BLUE-LIGHT; MIGRATORY BIRDS; VISUAL ECOLOGY; CRYPTOCHROME; RETINA; CHICKEN; EXPRESSION; INTENSITY; FIELD	Background: The Radical-Pair-Model postulates that the reception of magnetic compass directions in birds is based on spin-chemical reactions in specialized photopigments in the eye, with cryptochromes discussed as candidate molecules. But so far, the exact subcellular characterization of these molecules in the retina remained unknown. Methodology/Principal Findings: We here describe the localization of cryptochrome 1a (Cry1a) in the retina of European robins, Erithacus rubecula, and domestic chickens, Gallus gallus, two species that have been shown to use the magnetic field for compass orientation. In both species, Cry1a is present exclusively in the ultraviolet/violet (UV/V) cones that are distributed across the entire retina. Electron microscopy shows Cry1a in ordered bands along the membrane discs of the outer segment, and cell fractionation reveals Cry1a in the membrane fraction, suggesting the possibility that Cry1a is anchored along membranes. Conclusions/Significance: We provide first structural evidence that Cry1a occurs within a sensory structure arranged in a way that fulfils essential requirements of the Radical-Pair-Model. Our findings, identifying the UV/V-cones as probable magnetoreceptors, support the assumption that Cry1a is indeed the receptor molecule mediating information on magnetic directions, and thus provide the Radical-Pair-Model with a profound histological background.	[Niessner, Christine; Denzau, Susanne; Gross, Julia Christina; Fleissner, Gerta; Wiltschko, Wolfgang; Wiltschko, Roswitha] JW Goethe Univ Frankfurt, Fachbereich Biowissensch, Frankfurt, Germany; [Peichl, Leo] Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany; [Bischof, Hans-Joachim] Univ Bielefeld, Fak Biol, D-4800 Bielefeld, Germany	Goethe University Frankfurt; Max Planck Society; University of Bielefeld	Niessner, C (corresponding author), JW Goethe Univ Frankfurt, Fachbereich Biowissensch, Frankfurt, Germany.	wiltschko@bio.uni-frankfurt.de	Gross, Julia Christina/AAN-5730-2020	Gross, Julia Christina/0000-0002-8939-5664; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft [Wi 988/8-1, Wi 988/8-2]; Alfons und Gertrud Kassel-Foundation through the Frankfurt International Graduate School of Science	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfons und Gertrud Kassel-Foundation through the Frankfurt International Graduate School of Science	Supported by the Deutsche Forschungsgemeinschaft (grant Wi 988/8-1 and 2 to RW). C.N. was supported by the Alfons und Gertrud Kassel-Foundation through the Frankfurt International Graduate School of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Ahmad M, 2007, PLANTA, V225, P615, DOI 10.1007/s00425-006-0383-0; Eckmeier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003956; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FROST BJ, 1981, EXP BRAIN RES, V43, P173; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Hill E, 2010, J R SOC INTERFACE, V7, pS265, DOI 10.1098/rsif.2009.0378.focus; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schiviz AN, 2008, J COMP NEUROL, V507, P1336, DOI 10.1002/cne.21626; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; Seydewitz V, 2004, INVEST OPHTH VIS SCI, V45, P655, DOI 10.1167/iovs.03-0182; Smith EL, 2002, J EXP BIOL, V205, P3299; Stapput K, 2010, CURR BIOL, V20, P1259, DOI 10.1016/j.cub.2010.05.070; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; Wiltscbko W., 1968, Zeitschrift fuer Tierpsychologie, V25, P537; Wiltschko R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-5; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 2007, J ORNITHOL, V148, pS61, DOI 10.1007/s10336-007-0233-2; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x	41	121	124	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20091	10.1371/journal.pone.0020091	http://dx.doi.org/10.1371/journal.pone.0020091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647441	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500025
J	Yin, M; Liao, ZX; Huang, YJ; Liu, ZS; Yuan, XL; Gomez, D; Wang, LE; Wei, QY				Yin, Ming; Liao, Zhongxing; Huang, Yu-Jing; Liu, Zhensheng; Yuan, Xianglin; Gomez, Daniel; Wang, Li-E; Wei, Qingyi			Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; VOLUME HISTOGRAM ANALYSIS; DNA-REPAIR GENES; RADIATION PNEUMONITIS; CONFORMAL RADIOTHERAPY; SURVIVAL; RAD51; XRCC3; NBS1; PROGNOSIS	The repair of DNA double-strand breaks (DSBs) is the major mechanism to maintain genomic stability in response to irradiation. We hypothesized that genetic polymorphisms in DSB repair genes may affect clinical outcomes among non-small cell lung cancer (NSCLC) patients treated with definitive radio(chemo) therapy. We genotyped six potentially functional single nucleotide polymorphisms (SNPs) (i.e., RAD51 - 135G>C/rs1801320 and -172G>T/rs1801321, XRCC2 4234G>C/rs3218384 and R188H/rs3218536 G>A, XRCC3 T241M/rs861539 and NBN E185Q/rs1805794) and estimated their associations with overall survival (OS) and radiation pneumonitis (RP) in 228 NSCLC patients. We found a predictive role of RAD51 -135G>C SNP in RP development (adjusted hazard ratio [HR] = 0.52, 95% confidence interval [CI], 0.31-0.86, P = 0.010 for CG/CC vs. GG). We also found that RAD51 -135G>C and XRCC2 R188H SNPs were independent prognostic factors for overall survival (adjusted HR = 1.70, 95% CI, 1.14-2.62, P = 0.009 for CG/CC vs. GG; and adjusted HR = 1.70; 95% CI, 1.02-2.85, P = 0.043 for AG vs. GG, respectively) and that the SNP-survival association was most pronounced in the presence of RP. Our study suggests that HR genetic polymorphisms, particularly RAD51 -135G>C, may influence overall survival and radiation pneumonitis in NSCLC patients treated with definitive radio(chemo) therapy. Large studies are needed to confirm our findings.	[Yin, Ming; Huang, Yu-Jing; Liu, Zhensheng; Wang, Li-E; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Liao, Zhongxing; Gomez, Daniel] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology	Yin, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	zliao@mdanderson.org; qwei@mdanderson.org	Wang, Weili/D-1546-2011		National Institutes of Health [R01 ES011740, CA0131274, CA 16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was in part supported by National Institutes of Health grants R01 ES011740 and CA0131274 (to Q. W.) and CA 16672 (to M. D. Anderson Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka P, 2004, MUTAT RES-FUND MOL M, V556, P169, DOI 10.1016/j.mrfmmm.2004.08.002; Araujo FD, 2002, ONCOGENE, V21, P4176, DOI 10.1038/sj.onc.1205539; Armstrong J, 1997, RADIOTHER ONCOL, V44, P17, DOI 10.1016/S0167-8140(97)01907-5; Brown ET, 2009, MOL CARCINOGEN, V48, P105, DOI 10.1002/mc.20463; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Chistiakov DA, 2008, ACTA ONCOL, V47, P809, DOI 10.1080/02841860801885969; Costa S, 2008, BREAST CANCER RES TR, V109, P183, DOI 10.1007/s10549-007-9637-1; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Du LQ, 2010, MED ONCOL; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; Hernando ML, 2001, INT J RADIAT ONCOL, V51, P650, DOI 10.1016/S0360-3016(01)01685-6; Inoue A, 2001, INT J RADIAT ONCOL, V49, P649, DOI 10.1016/S0360-3016(00)00783-5; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kwa SLS, 1998, INT J RADIAT ONCOL, V42, P1, DOI 10.1016/S0360-3016(98)00196-5; Legue F, 2001, CYTOKINE, V16, P232, DOI 10.1006/cyto.2001.0970; Li DH, 2006, CANCER RES, V66, P3323, DOI 10.1158/0008-5472.CAN-05-3032; Liu Liang, 2008, Zhonghua Yi Xue Za Zhi, V88, P378; Maeda T, 2000, JPN J CLIN ONCOL, V30, P534, DOI 10.1093/jjco/hyd139; Meirovitz A, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-16; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Ohnishi K, 2006, RADIAT RES, V166, P454, DOI 10.1667/RR3606.1; Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Tambini CE, 2010, DNA REPAIR, V9, P517, DOI 10.1016/j.dnarep.2010.01.016; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Wang Y, 2000, GENE DEV, V14, P927; WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Xia DH, 2010, MED ONCOL, V27, P697, DOI 10.1007/s12032-009-9271-3; Yamano Mototsugu, 2007, Kurume Medical Journal, V54, P57, DOI 10.2739/kurumemedj.54.57; Yanagisawa T, 1998, ORAL ONCOL, V34, P524, DOI 10.1016/S1368-8375(98)00045-1; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763	40	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20055	10.1371/journal.pone.0020055	http://dx.doi.org/10.1371/journal.pone.0020055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647442	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500021
J	Moretti, P; Cerruti, B; Miguel, MC				Moretti, Paolo; Cerruti, Benedetta; Miguel, M. -Carmen			Yielding and Irreversible Deformation below the Microscale: Surface Effects and Non-Mean-Field Plastic Avalanches	PLOS ONE			English	Article							COLLOIDAL CRYSTALS; DISLOCATION AVALANCHES; SINGLE-CRYSTALS; STRAIN BURSTS; SCALE; FILMS; MODEL; FLOW	Nanoindentation techniques recently developed to measure the mechanical response of crystals under external loading conditions reveal new phenomena upon decreasing sample size below the microscale. At small length scales, material resistance to irreversible deformation depends on sample morphology. Here we study the mechanisms of yield and plastic flow in inherently small crystals under uniaxial compression. Discrete structural rearrangements emerge as a series of abrupt discontinuities in stress-strain curves. We obtain the theoretical dependence of the yield stress on system size and geometry and elucidate the statistical properties of plastic deformation at such scales. Our results show that the absence of dislocation storage leads to crucial effects on the statistics of plastic events, ultimately affecting the universal scaling behavior observed at larger scales.	[Moretti, Paolo; Cerruti, Benedetta; Miguel, M. -Carmen] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Moretti, Paolo] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Cerruti, Benedetta] Inst Canc Res & Treatment, Turin, Italy	University of Barcelona; Universitat Politecnica de Catalunya	Moretti, P (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain.	paolo.moretti@upc.edu	Moretti, Paolo/A-2760-2010; Miguel, M. Carmen/I-3087-2014	Moretti, Paolo/0000-0002-2936-1403; Miguel, M. Carmen/0000-0001-9050-1412	Ministerio de Ciencia e InnovaciA3n (Spain) [FIS2007-66485-C02-02, FIS2010-2178-C02-01, FIS2010-2178-C02-02]; Spanish-Hungarian Integrated Action [HH2008-0002]; Generalitat de Catalunya; Ministerio de Ciencia e InnovaciA3n	Ministerio de Ciencia e InnovaciA3n (Spain); Spanish-Hungarian Integrated Action; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e InnovaciA3n	Financial support by the Ministerio de Ciencia e InnovaciA3n (Spain), under Grants No. FIS2007-66485-C02-02, FIS2010-2178-C02-01 and FIS2010-2178-C02-02 and by a Spanish-Hungarian Integrated Action, under Grant No. HH2008-0002 is acknowledged. M. C. M. also acknowledges the Generalitat de Catalunya and the Ministerio de Ciencia e InnovaciA3n (Programa I3) for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cook RF, 2010, SCIENCE, V328, P183, DOI 10.1126/science.1186023; Csikor FF, 2007, SCIENCE, V318, P251, DOI 10.1126/science.1143719; Dimiduk DM, 2010, PHILOS MAG, V90, P3621, DOI 10.1080/14786431003662572; Dimiduk DM, 2006, SCIENCE, V312, P1188, DOI 10.1126/science.1123889; Greer JR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245410; Hirth J. P., 1972, THEORY DISLOCATIONS; Laurson L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.015501; Love AEH, 1944, TREATISE MATH THEORY, V4; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; MORETTI P, 2011, UNPUB; Nicola L, 2003, J APPL PHYS, V93, P5920, DOI 10.1063/1.1566471; Nix WD, 1998, SCRIPTA MATER, V39, P545, DOI 10.1016/S1359-6462(98)00195-X; Pertsinidis A, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/033; Picallo CB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.155502; Richeton T, 2005, NAT MATER, V4, P465, DOI 10.1038/nmat1393; Richeton T, 2006, MAT SCI ENG A-STRUCT, V424, P190, DOI 10.1016/j.msea.2006.03.072; Schall P, 2006, NATURE, V440, P319, DOI 10.1038/nature04557; Schall P, 2004, SCIENCE, V305, P1944, DOI 10.1126/science.1102186; Schwerdtfeger J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/04/L04001; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Suresh S, 2006, NAT MATER, V5, P253, DOI 10.1038/nmat1621; TEDONE O, 1903, ANN MAT PUR APPL, V8, P129; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Weiss J, 2003, SCIENCE, V299, P89, DOI 10.1126/science.1079312; Weiss J, 1997, J PHYS CHEM B, V101, P6113, DOI 10.1021/jp963157f; Zaiser M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08004; Zaiser M, 2008, PHILOS MAG, V88, P3861, DOI 10.1080/14786430802132522	27	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20418	10.1371/journal.pone.0020418	http://dx.doi.org/10.1371/journal.pone.0020418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666747	Green Published, Green Submitted, gold			2022-12-27	WOS:000291607000006
J	Chakraborty, R; Vepuri, V; Mhatre, SD; Paddock, BE; Miller, S; Michelson, SJ; Delvadia, R; Desai, A; Vinokur, M; Melicharek, DJ; Utreja, S; Khandelwal, P; Ansaloni, S; Goldstein, LE; Moir, RD; Lee, JC; Tabb, LP; Saunders, AJ; Marenda, DR				Chakraborty, Ranjita; Vepuri, Vidya; Mhatre, Siddhita D.; Paddock, Brie E.; Miller, Sean; Michelson, Sarah J.; Delvadia, Radha; Desai, Arkit; Vinokur, Marianna; Melicharek, David J.; Utreja, Suruchi; Khandelwal, Preeti; Ansaloni, Sara; Goldstein, Lee E.; Moir, Robert D.; Lee, Jeremy C.; Tabb, Loni P.; Saunders, Aleister J.; Marenda, Daniel R.			Characterization of a Drosophila Alzheimer's Disease Model: Pharmacological Rescue of Cognitive Defects	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PRECURSOR PROTEIN; AMYLOID HYPOTHESIS; DIMETHYL-SULFOXIDE; COURTSHIP BEHAVIOR; OXIDATIVE STRESS; CALCIUM STORES; BETA-APP; A-BETA; NEURODEGENERATION	Transgenic models of Alzheimer's disease (AD) have made significant contributions to our understanding of AD pathogenesis, and are useful tools in the development of potential therapeutics. The fruit fly, Drosophila melanogaster, provides a genetically tractable, powerful system to study the biochemical, genetic, environmental, and behavioral aspects of complex human diseases, including AD. In an effort to model AD, we over-expressed human APP and BACE genes in the Drosophila central nervous system. Biochemical, neuroanatomical, and behavioral analyses indicate that these flies exhibit aspects of clinical AD neuropathology and symptomology. These include the generation of A beta(40) and A beta(42), the presence of amyloid aggregates, dramatic neuroanatomical changes, defects in motor reflex behavior, and defects in memory. In addition, these flies exhibit external morphological abnormalities. Treatment with a gamma-secretase inhibitor suppressed these phenotypes. Further, all of these phenotypes are present within the first few days of adult fly life. Taken together these data demonstrate that this transgenic AD model can serve as a powerful tool for the identification of AD therapeutic interventions.	[Chakraborty, Ranjita; Vepuri, Vidya; Mhatre, Siddhita D.; Paddock, Brie E.; Miller, Sean; Michelson, Sarah J.; Delvadia, Radha; Desai, Arkit; Vinokur, Marianna; Melicharek, David J.; Utreja, Suruchi; Khandelwal, Preeti; Ansaloni, Sara; Saunders, Aleister J.; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Vepuri, Vidya] Univ Sci Philadelphia, Dept Biol Sci, Philadelphia, PA USA; [Goldstein, Lee E.] Boston Univ, Dept Psychiat, Boston, MA 02215 USA; [Moir, Robert D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Genet & Aging Res Unit,MIND, Boston, MA USA; [Lee, Jeremy C.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Tabb, Loni P.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Saunders, Aleister J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Saunders, Aleister J.; Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Santa Cruz; Drexel University; Drexel University; Drexel University	Chakraborty, R (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	Aleister.Saunders@drexel.edu; dm562@drexel.edu	Mhatre, Siddhita/AAH-8051-2020; Moir, Robert D./M-7612-2017	Mhatre, Siddhita/0000-0001-9939-780X; Moir, Robert D./0000-0001-5431-3553; Saunders, Aleister/0000-0002-7298-7823; Goldstein, Lee/0000-0001-8419-9800	Drexel University; Cure Alzheimer's Fund Investigator Award; National Institutes of Health (NIH) [1R01AI081990-01A1, R21RR026074, R01NS057295]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057295] Funding Source: NIH RePORTER	Drexel University; Cure Alzheimer's Fund Investigator Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from Drexel University's Human Cognition Enhancement Program (to DRM), Cure Alzheimer's Fund Investigator Award and National Institutes of Health (NIH) grant 1R01AI081990-01A1 (to RDM), NIH R21RR026074 (to DRM), and NIH R01NS057295 (to AJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; BONNER JM, 2010, DROSOPHILA MODEL STU; Boulianne GL, 1997, NEUROREPORT, V8, P1025, DOI 10.1097/00001756-199703030-00041; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton SJ, 2003, J NEUROGENET, V17, P91, DOI 10.1080/01677060390228342; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; Chiang HC, 2009, FASEB J, V23, P1969, DOI 10.1096/fj.08-121152; Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; CRYSTAL HA, 1993, ANN NEUROL, V34, P566, DOI 10.1002/ana.410340410; De Strooper B, 2000, J CELL SCI, V113, P1857; Dubnau J, 2001, CURR BIOL, V11, pR240, DOI 10.1016/S0960-9822(01)00115-4; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Folwell J, 2010, EXP NEUROL, V223, P401, DOI 10.1016/j.expneurol.2009.09.014; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gibson GE, 2004, J BIOENERG BIOMEMBR, V36, P335, DOI 10.1023/B:JOBB.0000041764.45552.f3; Gibson GE, 2002, BBA-MOL BASIS DIS, V1586, P177, DOI 10.1016/S0925-4439(01)00091-6; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hong CS, 1997, NEUROREPORT, V8, P665, DOI 10.1097/00001756-199702100-00017; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Ikonomovic MD, 2006, METHOD ENZYMOL, V412, P123, DOI 10.1016/S0076-6879(06)12009-1; Jeibmann A, 2009, INT J MOL SCI, V10, P407, DOI 10.3390/ijms10020407; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; LEBOURG E, 1992, GERONTOLOGY, V38, P71; Lee T, 1999, DEVELOPMENT, V126, P4065; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; LITTLETON JT, 1994, GENETICS, V138, P111; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Nazir A, 2003, TOXICOL MECH METHOD, V13, P147, DOI 10.1080/15376510309846; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Sarantseva S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008191; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tio M, 1997, DEVELOPMENT, V124, P343; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; YAO KM, 1994, J NEUROCHEM, V63, P41; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	74	76	80	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20799	10.1371/journal.pone.0020799	http://dx.doi.org/10.1371/journal.pone.0020799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673973	Green Published, gold, Green Submitted			2022-12-27	WOS:000291356400030
J	Sarker, P; Ahmed, S; Tiash, S; Rekha, RS; Stromberg, R; Andersson, J; Bergman, P; Gudmundsson, GH; Agerberth, B; Raqib, R				Sarker, Protim; Ahmed, Sultan; Tiash, Snigdha; Rekha, Rokeya Sultana; Stromberg, Roger; Andersson, Jan; Bergman, Peter; Gudmundsson, Gudmundur H.; Agerberth, Birgitta; Raqib, Rubhana			Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; CHAIN FATTY-ACIDS; PROTEIN-SYNTHESIS; IMMUNE-RESPONSES; SODIUM-BUTYRATE; GENE-EXPRESSION; CELLS; TRIBUTYRIN; RECEPTORS	Background: Cathelicidins and defensins are endogenous antimicrobial peptides (AMPs) that are downregulated in the mucosal epithelia of the large intestine in shigellosis. Oral treatment of Shigella infected rabbits with sodium butyrate (NaB) reduces clinical severity and counteracts the downregulation of cathelicidin (CAP-18) in the large intestinal epithelia. Aims: To develop novel regimen for treating infectious diseases by inducing innate immunity, we selected sodium 4-phenylbutyrate (PB), a registered drug for a metabolic disorder as a potential therapeutic candidate in a rabbit model of shigellosis. Since acute respiratory infections often cause secondary complications during shigellosis, the systemic effect of PB and NaB on CAP-18 expression in respiratory epithelia was also evaluated. Methods: The readouts were clinical outcomes, CAP-18 expression in mucosa of colon, rectum, lung and trachea (immunohistochemistry and real-time PCR) and release of the CAP-18 peptide/protein in stool (Western blot). Principal findings: Significant downregulation of CAP-18 expression in the epithelia of rectum and colon, the site of Shigella infection was confirmed. Interestingly, reduced expression of CAP-18 was also noticed in the epithelia of lung and trachea, indicating a systemic effect of the infection. This suggests a causative link to acute respiratory infections during shigellosis. Oral treatment with PB resulted in reduced clinical illness and upregulation of CAP-18 in the epithelium of rectum. Both PB and NaB counteracted the downregulation of CAP-18 in lung epithelium. The drug effect is suggested to be systemic as intravenous administration of NaB could also upregulate CAP-18 in the epithelia of lung, rectum and colon. Conclusion: Our results suggest that PB has treatment potential in human shigellosis. Enhancement of CAP-18 in the mucosal epithelia of the respiratory tract by PB or NaB is a novel discovery. This could mediate protection from secondary respiratory infections that frequently are the lethal causes in dysentery.	[Sarker, Protim; Ahmed, Sultan; Tiash, Snigdha; Rekha, Rokeya Sultana; Raqib, Rubhana] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Sarker, Protim; Rekha, Rokeya Sultana; Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Stromberg, Roger] Karolinska Inst, Dept Biosci & Nutr, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Andersson, Jan; Bergman, Peter] Karolinska Inst, Dept Med, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Bergman, Peter] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Gudmundsson, Gudmundur H.] Univ Iceland, Inst Biol, Reykjavik, Iceland	International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Iceland	Sarker, P (corresponding author), Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.	rubhana@icddrb.org	Stromberg, Roger/C-2960-2013; Gudmundsson, Gudmundur H/K-9178-2015	Gudmundsson, Gudmundur H/0000-0001-5793-0565; Bergman, Peter/0000-0003-3306-3713; Raqib, Rubhana/0000-0002-8116-4511	Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC); Swedish Research Council; Cancerfonden; Swedish Strategic Foundation (SSF); Thorsten Foundation; Ragnar Soderberg's Foundation; Swedish Institute; Karolinska Institutet; International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B); Icelandic Centre for Research (RANNIS); University of Iceland	Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Swedish Strategic Foundation (SSF)(Swedish Foundation for Strategic Research); Thorsten Foundation; Ragnar Soderberg's Foundation; Swedish Institute; Karolinska Institutet(Karolinska Institutet); International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B); Icelandic Centre for Research (RANNIS); University of Iceland	The study was supported by the Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC Agreement support; grant 2005-2007), The Swedish Research Council, Cancerfonden, The Swedish Strategic Foundation (SSF), Thorsten and Ragnar Soderberg's Foundations, The Swedish Institute, Karolinska Institutet, International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), The Icelandic Centre for Research (RANNIS) and University of Iceland research fund. ICDDR, B acknowledges with gratitude the commitment of Sida/SAREC to the Centre's research efforts. ICDDR, B also gratefully acknowledges the following donors which provide unrestricted support to the Centre's research efforts: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development, United Kingdom (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; BENNISH ML, 1991, REV INFECT DIS, V13, pS319; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BUTLER T, 1989, PEDIATR INFECT DIS J, V8, P767, DOI 10.1097/00006454-198911000-00008; Carol M, 1998, GUT, V42, P643, DOI 10.1136/gut.42.5.643; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Cunnane G, 1999, ANN RHEUM DIS, V58, P493, DOI 10.1136/ard.58.8.493; Dutta P, 1995, Indian Pediatr, V32, P313; Egorin MJ, 1999, CANCER CHEMOTH PHARM, V43, P445, DOI 10.1007/s002800050922; HALE TL, 1981, INFECT IMMUN, V32, P137, DOI 10.1128/IAI.32.1.137-144.1981; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Heyman SN, 1997, J CLIN GASTROENTEROL, V25, P595, DOI 10.1097/00004836-199712000-00009; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MITRA A K, 1990, Journal of Diarrhoeal Diseases Research, V8, P12; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; Palffy R, 2009, MOL MED, V15, P51, DOI 10.2119/molmed.2008.00087; Patwari A K, 1995, Indian Pediatr, V32, P277; Raqib R, 1996, EUR J IMMUNOL, V26, P1130, DOI 10.1002/eji.1830260526; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schwab M, 2007, MOL IMMUNOL, V44, P2107, DOI 10.1016/j.molimm.2006.09.016; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Su J, 2004, RAPID COMMUN MASS SP, V18, P2217, DOI 10.1002/rcm.1607; Termen S, 2008, MOL IMMUNOL, V45, P3947, DOI 10.1016/j.molimm.2008.06.020; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	64	66	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20637	10.1371/journal.pone.0020637	http://dx.doi.org/10.1371/journal.pone.0020637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673991	gold, Green Published			2022-12-27	WOS:000291355500028
J	Morita, T; Kang, H; Wolfe, J; Jadhav, SP; Feldman, DE				Morita, Takeshi; Kang, Heejae; Wolfe, Jason; Jadhav, Shantanu P.; Feldman, Daniel E.			Psychometric Curve and Behavioral Strategies for Whisker-Based Texture Discrimination in Rats	PLOS ONE			English	Article							NEURAL CODING MECHANISMS; ROUGHNESS DISCRIMINATION; PERCEIVED ROUGHNESS; OBJECT LOCALIZATION; SENSORIMOTOR SYSTEM; VIBRISSAL SYSTEM; ACTIVE TOUCH; BARREL; PERFORMANCE; MOVEMENTS	The rodent whisker system is a major model for understanding neural mechanisms for tactile sensation of surface texture (roughness). Rats discriminate surface texture using the whiskers, and several theories exist for how texture information is physically sensed by the long, moveable macrovibrissae and encoded in spiking of neurons in somatosensory cortex. However, evaluating these theories requires a psychometric curve for texture discrimination, which is lacking. Here we trained rats to discriminate rough vs. fine sandpapers and grooved vs. smooth surfaces. Rats intermixed trials at macrovibrissa contact distance (nose >2 mm from surface) with trials at shorter distance (nose <2 mm from surface). Macrovibrissae were required for distant contact trials, while microvibrissae and non-whisker tactile cues were used for short distance trials. A psychometric curve was measured for macrovibrissa-based sandpaper texture discrimination. Rats discriminated rough P150 from smoother P180, P280, and P400 sandpaper (100, 82, 52, and 35 mm mean grit size, respectively). Use of olfactory, visual, and auditory cues was ruled out. This is the highest reported resolution for rodent texture discrimination, and constrains models of neural coding of texture information.	[Morita, Takeshi] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Morita, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551; Morita, Takeshi/0000-0002-8570-6744	NSF [IOB-0546098]; NINDS [R01 NS072416]; UCSD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072416] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by NSF CAREER Award IOB-0546098 (www.nsf.gov), NINDS R01 NS072416 (www.nih.gov), and by Heiligenberg Chair Research Funds (UCSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Aggestam F, 2007, PHYSIOL BEHAV, V91, P335, DOI 10.1016/j.physbeh.2007.03.015; Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Blake DT, 1997, J NEUROSCI, V17, P7480; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Catania KC, 2005, ANAT REC PART A, V287A, P1038, DOI 10.1002/ar.a.20265; Cybulska-Klosowicz A, 2001, ACTA NEUROBIOL EXP, V61, P73; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Diamond ME, 2010, CURR OPIN NEUROBIOL, V20, P319, DOI 10.1016/j.conb.2010.03.004; GERDJIKOV TV, NEURON, V65, P530; Grant RA, 2009, J NEUROPHYSIOL, V101, P862, DOI 10.1152/jn.90783.2008; Greenspan JD, 1996, PAIN AND TOUCH, P25; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; Haidarliu S, 1997, J COMP NEUROL, V385, P515, DOI 10.1002/(SICI)1096-9861(19970908)385:4<515::AID-CNE3>3.0.CO;2-6; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jadhav SP, 2010, CURR OPIN NEUROBIOL, V20, P313, DOI 10.1016/j.conb.2010.02.014; JADHAV SP, 2009, NAT NEUROSCI; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lottem E, 2008, J NEUROPHYSIOL, V100, P2852, DOI 10.1152/jn.90302.2008; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Moore CI, 2004, J NEUROPHYSIOL, V91, P2390, DOI 10.1152/jn.00925.2003; Neimark MA, 2003, J NEUROSCI, V23, P6499; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Prigg T, 2002, PHYSIOL BEHAV, V77, P671, DOI 10.1016/S0031-9384(02)00917-4; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Vincent S. B., 1912, BEHAV MONOGR, V1, P7; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Yoshioka T, 2001, J NEUROSCI, V21, P6905, DOI 10.1523/JNEUROSCI.21-17-06905.2001	43	49	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20437	10.1371/journal.pone.0020437	http://dx.doi.org/10.1371/journal.pone.0020437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673811	gold, Green Submitted, Green Published			2022-12-27	WOS:000291309900019
J	Zhou, YS; Chen, WN				Zhou, Yusi; Chen, Wei Ning			iTRAQ-Coupled 2-D LC-MS/MS Analysis of Membrane Protein Profile in Escherichia coli Incubated with Apidaecin IB	PLOS ONE			English	Article							UDP-N-ACETYLGLUCOSAMINE; ANTIMICROBIAL PEPTIDES; R-ENANTIOMERS; TACHYPLESIN-I; S-ENANTIOMERS; LIPID-A; BIOSYNTHESIS; CELLS; INDOLICIDIN; FTSH	Apidaecins are a series of proline-rich, 18- to 20-residue antimicrobial peptides produced by insects. They are predominantly active against the Gram-negative bacteria. Previous studies mainly focused on the identification of their internal macromolecular targets, few addressed on the action of apidaecins on the molecules, especially proteins, of bacterial cell membrane. In this study, iTRAQ-coupled 2-D LC-MS/MS technique was utilized to identify altered membrane proteins of Escherichia coli cells incubated with one isoform of apidaecins-apidaecin IB. Cell division protease ftsH, an essential regulator in maintenance of membrane lipid homeostasis, was found to be overproduced in cells incubated with apidaecin IB. Its over-expression intensified the degradation of cytoplasmic protein UDP-3-O-acyl-N-acetylglucosamine deacetylase, which catalyzes the first committed step in the biosynthesis of the lipid A moiety of LPS, and thus leaded to the further unbalanced biosynthesis of LPS and phospholipids. Our findings suggested a new antibacterial mechanism of apidaecins and perhaps, by extension, for other proline-rich antimicrobial peptides.	[Zhou, Yusi; Chen, Wei Ning] Nanyang Technol Univ, Sch Chem & Biomed Engn, Coll Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhou, YS (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Coll Engn, Singapore, Singapore.	WNChen@ntu.edu.sg		, Yang/0000-0002-6620-8897	Nanyang Technological University, Singapore	Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported by Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1995, BBA-BIOMEMBRANES, V1237, P109, DOI 10.1016/0005-2736(95)00087-J; ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; ANDERSON MS, 1985, J BIOL CHEM, V260, P5536; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Arnold T., 2008, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0408s53, DOI 10.1002/0471140864.PS0408S53]; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; IWANAGA S, 1994, CIBA F SYMP, V186, P160; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Kloser A, 1998, MOL MICROBIOL, V27, P1003, DOI 10.1046/j.1365-2958.1998.00746.x; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1082, DOI 10.1023/B:BIRY.0000046881.29486.51; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Morvan A, 1997, J INVERTEBR PATHOL, V69, P177, DOI 10.1006/jipa.1996.4642; MURAKAMI T, 1991, CHEMOTHERAPY, V37, P327, DOI 10.1159/000238875; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; Niu DD, 2009, PROTEOMICS, V9, P3856, DOI 10.1002/pmic.200900071; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Robinson WE, 1998, J LEUKOCYTE BIOL, V63, P94, DOI 10.1002/jlb.63.1.94; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Sui JJ, 2007, J PROTEOME RES, V6, P1643, DOI 10.1021/pr0605926; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhang JH, 2008, PROTEOMICS, V8, P1595, DOI 10.1002/pmic.200700556; Zhang JH, 2009, PROTEOMICS, V9, P2836, DOI 10.1002/pmic.200800911; Zhou YS, 2010, RAPID COMMUN MASS SP, V24, P2787, DOI 10.1002/rcm.4712	36	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20442	10.1371/journal.pone.0020442	http://dx.doi.org/10.1371/journal.pone.0020442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673808	gold, Green Submitted, Green Published			2022-12-27	WOS:000291309900020
J	Gabbe, BJ; Lyons, RA; Lecky, FE; Bouamra, O; Woodford, M; Coats, TJ; Cameron, PA				Gabbe, Belinda J.; Lyons, Ronan A.; Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.; Cameron, Peter A.			Comparison of Mortality Following Hospitalisation for Isolated Head Injury in England and Wales, and Victoria, Australia	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; SYSTEM; CARE; REGISTRY; QUALITY; MANAGEMENT; SURVIVAL; OUTCOMES; TRENDS	Background: Traumatic brain injury (TBI) remains a leading cause of death and disability. The National Institute for Health and Clinical Excellence (NICE) guidelines recommend transfer of severe TBI cases to neurosurgical centres, irrespective of the need for neurosurgery. This observational study investigated the risk-adjusted mortality of isolated TBI admissions in England/Wales, and Victoria, Australia, and the impact of neurosurgical centre management on outcomes. Methods: Isolated TBI admissions (> 15 years, July 2005-June 2006) were extracted from the hospital discharge datasets for both jurisdictions. Severe isolated TBI (AIS severity >3) admissions were provided by the Trauma Audit and Research Network (TARN) and Victorian State Trauma Registry (VSTR) for England/Wales, and Victoria, respectively. Multivariable logistic regression was used to compare risk-adjusted mortality between jurisdictions. Findings: Mortality was 12% (749/6256) in England/Wales and 9% (91/1048) in Victoria for isolated TBI admissions. Adjusted odds of death in England/Wales were higher compared to Victoria overall (OR 2.0, 95% CI: 1.6, 2.5), and for cases <65 years (OR 2.36, 95% CI: 1.51, 3.69). For severe TBI, mortality was 23% (133/575) for TARN and 20% (68/346) for VSTR, with 72% of TARN and 86% of VSTR cases managed at a neurosurgical centre. The adjusted mortality odds for severe TBI cases in TARN were higher compared to the VSTR (OR 1.45, 95% CI: 0.96, 2.19), but particularly for cases <65 years (OR 2.04, 95% CI: 1.07, 3.90). Neurosurgical centre management modified the effect overall (OR 1.12, 95% CI: 0.73, 1.74) and for cases <65 years (OR 1.53, 95% CI: 0.77, 3.03). Conclusion: The risk-adjusted odds of mortality for all isolated TBI admissions, and severe TBI cases, were higher in England/Wales when compared to Victoria. The lower percentage of cases managed at neurosurgical centres in England and Wales was an explanatory factor, supporting the changes made to the NICE guidelines.	[Gabbe, Belinda J.; Cameron, Peter A.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia; [Gabbe, Belinda J.; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Lyons, Ronan A.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.] Univ Manchester, Salford Royal Hosp, Manchester Acad Hlth Sci Ctr,Sch Community Based, Trauma Audit & Res Network,Hlth Sci Res Grp, Salford, Lancs, England; [Lecky, Fiona E.] Salford Royal Hosp, Dept Emergency Med, Salford, Lancs, England; [Coats, Timothy J.] Leicester Royal Infirm, Dept Accid & Emergency, Leicester, Leics, England; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Swansea University; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Leicester; Florey Institute of Neuroscience & Mental Health	Gabbe, BJ (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia.	belinda.gabbe@monash.edu	Coats, Timothy/AAW-1254-2021; Lyons, Ronan/G-7741-2012	Coats, Timothy/0000-0003-2736-2784; Lyons, Ronan/0000-0001-5225-000X; Gabbe, Belinda/0000-0001-7096-7688; Cameron, Peter/0000-0002-1443-557X	Department of Human Services (Victoria); Transport Accident Commission (TAC) Health Research; National Health and Medical Research Council of Australia	Department of Human Services (Victoria); Transport Accident Commission (TAC) Health Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The VSTR is a Department of Human Services (Victoria) and Transport Accident Commission (TAC) Health Research funded and approved initiative. Dr. Belinda Gabbe and Prof. Peter Cameron were supported by a Career Development Award and a Practitioner Fellowship, respectively, from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Coats TJ, 1999, J ACCID EMERG MED, V16, P182; Esposito Thomas J, 2006, Adv Surg, V40, P213, DOI 10.1016/j.yasu.2006.06.002; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; MacLeod JBA, 2004, AM SURGEON, V70, P805; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; O'Reilly GM, 2010, ACAD EMERG MED, V17, P1122, DOI 10.1111/j.1553-2712.2010.00887.x; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20545	10.1371/journal.pone.0020545	http://dx.doi.org/10.1371/journal.pone.0020545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655237	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000291097600093
J	Kuchenreuther, JM; George, SJ; Grady-Smith, CS; Cramer, SP; Swartz, JR				Kuchenreuther, Jon M.; George, Simon J.; Grady-Smith, Celestine S.; Cramer, Stephen P.; Swartz, James R.			Cell-free H-cluster Synthesis and [FeFe] Hydrogenase Activation: All Five CO and CN- Ligands Derive from Tyrosine	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; IN-VITRO SYNTHESIS; ESCHERICHIA-COLI; THIAMINE BIOSYNTHESIS; LIGHT SENSITIVITY; ONLY HYDROGENASE; ACTIVE-SITE; MATURATION; HYDF; PROTEIN	[FeFe] hydrogenases are promising catalysts for producing hydrogen as a sustainable fuel and chemical feedstock, and they also serve as paradigms for biomimetic hydrogen-evolving compounds. Hydrogen formation is catalyzed by the H-cluster, a unique iron-based cofactor requiring three carbon monoxide (CO) and two cyanide (CN-) ligands as well as a dithiolate bridge. Three accessory proteins (HydE, HydF, and HydG) are presumably responsible for assembling and installing the Hcluster, yet their precise roles and the biosynthetic pathway have yet to be fully defined. In this report, we describe effective cell-free methods for investigating H-cluster synthesis and [FeFe] hydrogenase activation. Combining isotopic labeling with FTIR spectroscopy, we conclusively show that each of the CO and CN- ligands derive respectively from the carboxylate and amino substituents of tyrosine. Such in vitro systems with reconstituted pathways comprise a versatile approach for studying biosynthetic mechanisms, and this work marks a significant step towards an understanding of both the proteinprotein interactions and complex reactions required for H-cluster assembly and hydrogenase maturation.	[Kuchenreuther, Jon M.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [George, Simon J.; Cramer, Stephen P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [George, Simon J.; Grady-Smith, Celestine S.; Cramer, Stephen P.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; Stanford University	Kuchenreuther, JM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		George, Simon/0000-0002-4864-5479	DOE; DOE Office of Biological and Environmental Research; National Health Institute [NIH-GM-65440]; National Science Foundation [NSF-CHE-0745353, SPC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065440] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Health Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the DOE BioEnergy Science Program (JRS & SPC), the DOE Office of Biological and Environmental Research (SPC), the National Health Institute (NIH-GM-65440, SPC), and the National Science Foundation (NSF-CHE-0745353, SPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; CHEN JS, HYDROGENASES THEIR C, P57; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Iwuchukwu IJ, 2010, NAT NANOTECHNOL, V5, P73, DOI [10.1038/nnano.2009.315, 10.1038/NNANO.2009.315]; Jones AK, 2002, CHEM COMMUN, P866, DOI 10.1039/b201337a; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Ryde U, 2010, J AM CHEM SOC, V132, P4512, DOI 10.1021/ja909194f; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; THORNELEY RNF, PROKARYOTIC NITROGEN; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhao DH, 2007, J BIOL CHEM, V282, P37016, DOI 10.1074/jbc.M708097200	39	68	69	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20346	10.1371/journal.pone.0020346	http://dx.doi.org/10.1371/journal.pone.0020346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21673792	gold, Green Submitted, Green Published			2022-12-27	WOS:000291097600048
J	Liu, Y; Dong, J; Wu, N; Gao, YP; Zhang, X; Mu, CH; Shao, NS; Fan, M; Yang, G				Liu, Yu; Dong, Jie; Wu, Na; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Fan, Ming; Yang, Guang			The Production of Extracellular Proteins Is Regulated by Ribonuclease III via Two Different Pathways in Staphylococcus aureus	PLOS ONE			English	Article							VIRULENCE FACTORS; RNASE-III; RNAIII; GENE; AGR; BINDING; IDENTIFICATION; PURIFICATION; INHIBITION; BIOGENESIS	Staphylococcus aureus ribonuclease III belongs to the enzyme family known to degrade double-stranded RNAs. It has previously been reported that RNase III cannot influence cell growth but regulates virulence gene expression in S. aureus. Here we constructed an RNase III inactivation mutant (Delta rnc) from S. aureus 8325-4. It was found that the extracellular proteins of Drnc were decreased. Furthermore, we explored how RNase III regulated the production of the extracellular proteins in S. aureus. We found during the lag phase of the bacterial growth cycle RNase III could influence the extracellular protein secretion via regulating the expression of secY2, one component of accessory secretory (sec) pathway. After S. aureus cells grew to exponential phase, RNase III can regulate the expression of extracellular proteins by affecting the level of RNAIII. Further investigation showed that the mRNA stability of secY2 and RNAIII was affected by RNase III. Our results suggest that RNase III could regulate the pathogenicity of S. aureus by influencing the level of extracellular proteins via two different ways respectively at different growth phases.	[Liu, Yu; Dong, Jie; Wu, Na; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Fan, Ming; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Liu, Y (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yanggg@hotmail.com			China National Key Programs on Basic Research [2005CB724600]; National Natural Science Foundation of China [30700007, 30870093]; National High-Tech Research and Development Program [2006AA02Z132, 2006AA02Z323]	China National Key Programs on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from China National Key Programs on Basic Research (2005CB724600, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30700007, 30870093, http://www.nsfc.gov.cn/) and the National High-Tech Research and Development Program (2006AA02Z132, 2006AA02Z323, http://www.most.gov.cn/eng/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chevalier C, 2008, METHOD ENZYMOL, V447, P309, DOI 10.1016/S0076-6879(08)02216-7; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Liu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013069; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Meng WZ, 2008, METHOD ENZYMOL, V447, P119, DOI 10.1016/S0076-6879(08)02207-6; Miller J. H., 1972, ASSAY BETA GALACTOSI, V1972, P352; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHWESINGER MD, 1975, J BACTERIOL, V123, P724, DOI 10.1128/JB.123.2.724-738.1975; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; Tegmark K, 1998, J BACTERIOL, V180, P3181, DOI 10.1128/JB.180.12.3181-3186.1998; Wagner EGH, 2002, ADV GENET, V46, P361; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Xiong YQ, 2002, J INFECT DIS, V186, P668, DOI 10.1086/342046	37	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20554	10.1371/journal.pone.0020554	http://dx.doi.org/10.1371/journal.pone.0020554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655230	Green Submitted, gold, Green Published			2022-12-27	WOS:000291097600096
J	Yuan, Z; Wang, F; Zhao, ZW; Zhao, XY; Qiu, J; Nie, CL; Wei, YQ				Yuan, Zhu; Wang, Fang; Zhao, Zhiwei; Zhao, Xinyu; Qiu, Ji; Nie, Chunlai; Wei, Yuquan			BIM-Mediated AKT Phosphorylation Is a Key Modulator of Arsenic Trioxide-Induced Apoptosis in Cisplatin-Sensitive and -Resistant Ovarian Cancer Cells	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBER; FORKHEAD TRANSCRIPTION FACTOR; BAX-DEPENDENT APOPTOSIS; RICTOR-MTOR COMPLEX; PROAPOPTOTIC ACTIVITY; NEURONAL APOPTOSIS; CARCINOMA CELLS; DOWN-REGULATION; LEUKEMIA-CELLS; ACTIVATION	Background: Chemo-resistance to cisplatin-centered cancer therapy is a major obstacle to the effective treatment of human ovarian cancer. Previous reports indicated that arsenic trioxide (ATO) induces cell apoptosis in both drug-sensitive and resistant ovarian cancer cells. Principal Findings: In this study, we determined the molecular mechanism of ATO-induced apoptosis in ovarian cancer cells. Our data demonstrated that ATO induced cell apoptosis by decreasing levels of phosphorylated AKT (p-AKT) and activating caspase-3 and caspase-9. Importantly, BIM played a critical role in ATO-induced apoptosis. The inhibition of BIM expression prevented AKT dephosphorylation and inhibited caspase-3 activation during cell apoptosis. However, surprisingly, gene silencing of AKT or FOXO3A had little effect on BIM expression and phosphorylation. Moreover, the activation of caspase-3 by ATO treatment improved AKT dephosphorylation, not only by cleaving the regulatory A subunit of protein phosphatase 2A (PP2A), but also by increasing its activation. Furthermore, our data indicated that the c-Jun N-terminal kinases (JNK) pathway is involved in the regulation of BIM expression. Conclusions: We demonstrated the roles of BIM in ATO-induced apoptosis and the molecular mechanisms of BIM expression regulated by ATO during ovarian cancer cell apoptosis. Our findings suggest that BIM plays an important role in regulating p-AKT by activating caspase-3 and that BIM mediates the level of AKT phosphorylation to determine the threshold for overcoming cisplatin resistance in ovarian cancer cells.	[Yuan, Zhu] Sichuan Univ, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Peoples R China; Sichuan Univ, Ctr Canc, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Yuan, Z (corresponding author), Sichuan Univ, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Peoples R China.	niecl1022@scu.du.cn			Natural Science Foundation of China [(NSFC)-81071817/H1609, (NSFC)-30800581, (NSFC)-30900744]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (NSFC)-81071817/H1609, (NSFC)-30800581 and (NSFC)-30900744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2001, CANCER RES, V61, P1862; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Bornstein J, 2005, GYNECOL ONCOL, V99, P726, DOI 10.1016/j.ygyno.2005.07.125; Brancolini Claudio, 2008, Curr Mol Pharmacol, V1, P24; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Cohen MH, 2001, ONCOLOGIST, V6, P4, DOI 10.1634/theoncologist.6-1-4; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; DEL PL, 1997, SCIENCE, V278, P687; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Du YH, 2001, CANCER CHEMOTH PHARM, V47, P481, DOI 10.1007/s002800100278; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Helm CW, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-2; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; OZOLS RF, 1985, SEMIN ONCOL, V12, P21; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ramos AM, 2005, BLOOD, V105, P4013, DOI 10.1182/blood-2004-07-2802; Redondo-Munoz J, 2010, CLIN CANCER RES, V16, P4382, DOI 10.1158/1078-0432.CCR-10-0072; Rudin CM, 2003, CANCER RES, V63, P312; Salzberg M, 2005, ONCOLOGY-BASEL, V68, P293, DOI 10.1159/000086967; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tacka KA, 2004, CHEM RES TOXICOL, V17, P1434, DOI 10.1021/tx0498760; Uslu R, 2000, CLIN CANCER RES, V6, P4957; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; ZHANG N, 2009, CANC SCI	55	67	74	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20586	10.1371/journal.pone.0020586	http://dx.doi.org/10.1371/journal.pone.0020586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655183	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600103
J	Huynh, AS; Abrahams, DF; Torres, MS; Baldwin, MK; Gillies, RJ; Morse, DL				Huynh, Amanda Shanks; Abrahams, Dominique F.; Torres, Monica S.; Baldwin, Margaret K.; Gillies, Robert J.; Morse, David L.			Development of an Orthotopic Human Pancreatic Cancer Xenograft Model Using Ultrasound Guided Injection of Cells	PLOS ONE			English	Article							DELTA-OPIOID RECEPTOR; NUDE-MICE; MOUSE MODEL; GROWTH; TUMORS; LINES	Mice have been employed as models of cancer for over a century, providing significant advances in our understanding of this multifaceted family of diseases. In particular, orthotopic tumor xenograft mouse models are emerging as the preference for cancer research due to increased clinical relevance over subcutaneous mouse models. In the current study, we developed orthotopic pancreatic cancer xenograft models in mice by a minimally invasive method, ultrasound guided injection (USGI) comparable to highly invasive surgical orthotopic injection (SOI) methods. This optimized method prevented injection complications such as recoil of cells through the injection canal or leakage of cells out of the pancreas into the peritoneal cavity. Tumor growth was monitored in vivo and quantified by ultrasound imaging weekly, tumors were also detected by in vivo fluorescence imaging using a tumor targeted molecular probe. The mean tumor volumes for the USGI and SOI models after 2 weeks of tumor growth were 205 mm 3 and 178 mm 3 respectively. By USGI of human pancreatic cancer cell lines, human orthotopic pancreatic cancer xenografts were established. Based on ultrasound imaging, the orthotopic human pancreatic cancer xenograft take rate was 100% for both human pancreatic cancer cell lines used, MiaPaCa-2 and Su86.86, with mean tumor volumes of 28 mm(3) and 30 mm(3). We demonstrated that this USGI method is feasible, reproducible, facile, minimally invasive and improved compared to the highly-invasive SOI method for establishing orthotopic pancreatic tumor xenograft models suitable for molecular imaging.	[Huynh, Amanda Shanks; Gillies, Robert J.; Morse, David L.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Funct & Mol Imaging, Tampa, FL 33612 USA; [Abrahams, Dominique F.; Torres, Monica S.; Baldwin, Margaret K.] Univ S Florida, Div Comparat Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Huynh, AS (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Funct & Mol Imaging, Tampa, FL 33612 USA.	David.Morse@Moffitt.org	Morse, David/L-7277-2018	Huynh, Amanda/0000-0001-8133-1984; Gillies, Robert/0000-0002-8888-7747	NIH/NCI [R01-CA123547]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA123547, R01CA077575, R01CA125627] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: NIH/NCI R01-CA123547 (http://www.nih.gov/, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEKRUSE SF, 1975, SEER CANC STAT REV; Black KC, 2008, MOL IMAGING, V7, P50, DOI 10.2310/7290.2008.0007; Bouvet M, 2002, CANCER RES, V62, P1534; CHEON DJ, ANN REV PATHOL; Ding L, 2007, HEPATOB PANCREAT DIS, V6, P393; Ding Y., PANCREAS, V39, P283; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Hausner SH, 2009, CANCER RES, V69, P5843, DOI 10.1158/0008-5472.CAN-08-4410; Josan JS, 2009, ORG LETT, V11, P2479, DOI 10.1021/ol900200k; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; MACHADO NO, JOP, V11, P377; MARINCOLA FM, 1989, J SURG RES, V47, P520, DOI 10.1016/0022-4804(89)90130-3; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; *REYN, 2005, METHODS MOL MED, V111; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Schneider C, 2004, GUT, V53, P355, DOI 10.1136/gut.2003.026005; Snyder CS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-106; TAFRESHI NK, CANC RES; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Vulfovich M, 2008, EXPERT REV ANTICANC, V8, P993, DOI 10.1586/14737140.8.6.993	23	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20330	10.1371/journal.pone.0020330	http://dx.doi.org/10.1371/journal.pone.0020330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647423	gold, Green Submitted, Green Published			2022-12-27	WOS:000291052500045
J	Zhang, XY; Zhang, Q; Wang, DH				Zhang, Xue-Ying; Zhang, Qiang; Wang, De-Hua			Litter Size Variation in Hypothalamic Gene Expression Determines Adult Metabolic Phenotype in Brandt's Voles (Lasiopodomys brandtii)	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; HIGH-FAT DIET; MATERNAL OBESITY; BODY-WEIGHT; MALE RATS; LEPTIN RESISTANCE; ENERGY-BALANCE; FOOD-INTAKE; GROWTH; THERMOGENESIS	Background: Early postnatal environments may have long-term and potentially irreversible consequences on hypothalamic neurons involved in energy homeostasis. Litter size is an important life history trait and negatively correlated with milk intake in small mammals, and thus has been regarded as a naturally varying feature of the early developmental environment. Here we investigated the long-term effects of litter size on metabolic phenotype and hypothalamic neuropeptide mRNA expression involved in the regulation of energy homeostasis, using the offspring reared from large (10-12) and small (3-4) litter sizes, of Brandt's voles (Lasiopodomys brandtii), a rodent species from Inner Mongolia grassland in China. Methodology/Principal Findings: Hypothalamic leptin signaling and neuropeptides were measured by Real-Time PCR. We showed that offspring reared from small litters were heavier at weaning and also in adulthood than offspring from large litters, accompanied by increased food intake during development. There were no significant differences in serum leptin levels or leptin receptor (OB-Rb) mRNA in the hypothalamus at weaning or in adulthood, however, hypothalamic suppressor of cytokine signaling 3 (SOCS3) mRNA in adulthood increased in small litters compared to that in large litters. As a result, the agouti-related peptide (AgRP) mRNA increased in the offspring from small litters. Conclusions/Significance: These findings support our hypothesis that natural litter size has a permanent effect on offspring metabolic phenotype and hypothalamic neuropeptide expression, and suggest central leptin resistance and the resultant increase in AgRP expression may be a fundamental mechanism underlying hyperphagia and the increased risk of overweight in pups of small litters. Thus, we conclude that litter size may be an important and central determinant of metabolic fitness in adulthood.	[Zhang, Xue-Ying; Zhang, Qiang; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhang, Qiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	wangdh@ioz.ac.cn			National Natural Science Foundation of China [30900175]; Key Project of the National Eleventh-Five Year Research Program of China [2009BAI83B01]; National Science and Technology Ministry [2007BC109103]; Chinese Academy of Sciences [KSCX2-EW-N-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Eleventh-Five Year Research Program of China; National Science and Technology Ministry; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (30900175) and Key Project of the National Eleventh-Five Year Research Program of China (2009BAI83B01) to XYZ, the National Science and Technology Ministry (2007BC109103) and Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-N-005) to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBERT R, 1980, J NUTR, V110, P649, DOI 10.1093/jn/110.4.649; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; CAMERON GN, 1973, J MAMMAL, V54, P489, DOI 10.2307/1379133; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cerf ME, 2010, INT J DEV NEUROSCI, V28, P625, DOI 10.1016/j.ijdevneu.2010.07.226; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Cottrell EC, 2007, P NUTR SOC, V66, P198, DOI 10.1017/S0029665107005447; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; FAUST IM, 1980, J NUTR, V110, P2027, DOI 10.1093/jn/110.10.2027; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Passos MCF, 2009, BRIT J NUTR, V101, P250, DOI 10.1017/S0007114508006521; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HELDMAIER G, 1982, INT J BIOMETEOROL, V26, P339, DOI 10.1007/BF02219505; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hytinantti TK, 2001, ARCH DIS CHILD-FETAL, V85, pF123, DOI 10.1136/fn.85.2.F123; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Koskela E, 1998, OECOLOGIA, V115, P379, DOI 10.1007/s004420050531; Li XS, 2005, HORM BEHAV, V48, P321, DOI 10.1016/j.yhbeh.2005.04.004; Liu H, 2003, J MAMMAL, V84, P1410, DOI 10.1644/BRG-030; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Patterson CM, 2010, ENDOCRINOLOGY, V151, P4270, DOI 10.1210/en.2010-0401; Pereira-Toste F, 2009, HORM METAB RES, V41, P874, DOI 10.1055/s-0029-1234070; Remmers F, 2008, BRIT J NUTR, V99, P1149, DOI 10.1017/S0007114507843546; Rodrigues AL, 2011, J NUTR BIOCHEM, V22, P109, DOI 10.1016/j.jnutbio.2009.11.013; Rodel HG, 2010, PHYSIOL BEHAV, V99, P644, DOI 10.1016/j.physbeh.2010.01.032; RYAN V, 1975, DEV PSYCHOBIOL, V8, P363, DOI 10.1002/dev.420080410; Schmidt I, 2000, PHYSIOL GENOMICS, V3, P113, DOI 10.1152/physiolgenomics.2000.3.2.113; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SMITH TJ, 1982, P NATL ACAD SCI-BIOL, V79, P7537, DOI 10.1073/pnas.79.23.7537; Stockley P, 2002, P NATL ACAD SCI USA, V99, P12932, DOI 10.1073/pnas.192125999; Stofkova A, 2009, Endocr Regul, V43, P99; Tang GB, 2009, AM J PHYSIOL-REG I, V297, pR1293, DOI 10.1152/ajpregu.00185.2009; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Trevenzoli IH, 2010, HORM METAB RES, V42, P483, DOI 10.1055/s-0030-1249103; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Varma A, 2004, AM J PHYSIOL-ENDOC M, V287, pE1132, DOI 10.1152/ajpendo.00228.2004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wang Jianmei, 2006, Acta Theriologica Sinica, V26, P84; Wang ZW, 2000, BIOCHEM BIOPH RES CO, V277, P20, DOI 10.1006/bbrc.2000.3615; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Xiao XQ, 2007, ENDOCRINOLOGY, V148, P4150, DOI 10.1210/en.2007-0373; Zhang XY, 2008, J COMP PHYSIOL B, V178, P637, DOI 10.1007/s00360-008-0255-y; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao ZJ, 2005, PHYSIOL BEHAV, V85, P143, DOI 10.1016/j.physbeh.2005.03.014	57	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19913	10.1371/journal.pone.0019913	http://dx.doi.org/10.1371/journal.pone.0019913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637839	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200020
J	Westmuckett, AD; Thacker, KM; Moore, KL				Westmuckett, Andrew D.; Thacker, Kelly M.; Moore, Kevin L.			Tyrosine Sulfation of Native Mouse Psgl-1 Is Required for Optimal Leukocyte Rolling on P-Selectin In Vivo	PLOS ONE			English	Article							GLYCOPROTEIN LIGAND-1; MONOCLONAL-ANTIBODY; DEFICIENT MICE; ATHEROSCLEROSIS; RECRUITMENT; NEUTROPHILS; BINDING; VENULES; MECHANISMS; PROTEINS	Background: We recently demonstrated that tyrosine sulfation is an important contributor to monocyte recruitment and retention in a mouse model of atherosclerosis. P-selectin glycoprotein ligand-1 (Psgl-1) is tyrosine-sulfated in mouse monocyte/macrophages and its interaction with P-selectin is important in monocyte recruitment in atherosclerosis. However, whether tyrosine sulfation is required for the P-selectin binding function of mouse Psgl-1 is unknown. Here we test the function of native Psgl-1 expressed in leukocytes lacking endogenous tyrosylprotein sulfotransferase (TPST) activity. Methodology/Principal Findings: Psgl-1 function was assessed by examining P-selectin dependent leukocyte rolling in post-capillary venules of C57BL6 mice transplanted with hematopoietic progenitors from wild type (WT -> B6) or Tpst1;Tpst2 double knockout mice (Tpst DKO -> B6) which lack TPST activity. We observed that rolling flux fractions were lower and leukocyte rolling velocities were higher in Tpst DKO -> B6 venules compared to WT -> B6 venules. Similar results were observed on immobilized P-selectin in vitro. Finally, Tpst DKO leukocytes bound less P-selectin than wild type leukocytes despite equivalent surface expression of Psgl-1. Conclusions/Significance: These findings provide direct and convincing evidence that tyrosine sulfation is required for optimal function of mouse Psgl-1 in vivo and suggests that tyrosine sulfation of Psgl-1 contributes to the development of atherosclerosis.	[Westmuckett, Andrew D.; Thacker, Kelly M.; Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Westmuckett, AD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA.	Andrew-Westmuckett@omrf.org			National Institutes of Health [HD056022]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institutes of Health to KLM (HD056022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Borges E, 1997, BLOOD, V90, P1934, DOI 10.1182/blood.V90.5.1934; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Kawar ZS, 2008, GLYCOBIOLOGY, V18, P441, DOI 10.1093/glycob/cwn020; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIPOWSKY HH, 1978, MICROVASC RES, V15, P93, DOI 10.1016/0026-2862(78)90009-2; Long DS, 2004, P NATL ACAD SCI USA, V101, P10060, DOI 10.1073/pnas.0402937101; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Ridger VC, 2005, AM J PATHOL, V166, P945, DOI 10.1016/S0002-9440(10)62314-0; ROSA P, 1992, J BIOL CHEM, V267, P12227; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SCHMIDSCHONBEIN GW, 1980, BLOOD, V56, P866; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sperandio M, 2006, METHOD ENZYMOL, V416, P346, DOI 10.1016/S0076-6879(06)16023-1; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Westmuckett AD, 2009, ARTERIOSCL THROM VAS, V29, P1730, DOI 10.1161/ATVBAHA.109.192963; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Yang J, 1996, BLOOD, V87, P4176, DOI 10.1182/blood.V87.10.4176.bloodjournal87104176; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	38	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20406	10.1371/journal.pone.0020406	http://dx.doi.org/10.1371/journal.pone.0020406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633705	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500061
J	Zhang, XL; Upreti, C; Stanton, PK				Zhang, Xiao-lei; Upreti, Chirag; Stanton, Patric K.			G beta gamma and the C Terminus of SNAP-25 Are Necessary for Long-Term Depression of Transmitter Release	PLOS ONE			English	Article							SCHAFFER COLLATERAL-CA1 SYNAPSES; MEDIATE PRESYNAPTIC INHIBITION; SYNAPTIC DEPRESSION; CALCIUM-CHANNELS; CA2+ CHANNELS; NITRIC-OXIDE; VESICLE POOL; HIPPOCAMPAL SYNAPSES; ADENYLATE-CYCLASE; AMPA RECEPTORS	Background: Short-term presynaptic inhibition mediated by G protein-coupled receptors involves a direct interaction between G proteins and the vesicle release machinery. Recent studies implicate the C terminus of the vesicle-associated protein SNAP-25 as a molecular binding target of G beta gamma that transiently reduces vesicular release. However, it is not known whether SNAP-25 is a target for molecular modifications expressing long-term changes in transmitter release probability. Methodology/Principal Findings: This study utilized two-photon laser scanning microscopy for real-time imaging of action potential-evoked [Ca(2+)] increases, in single Schaffer collateral presynaptic release sites in in vitro hippocampal slices, plus simultaneous recording of Schaffer collateral-evoked synaptic potentials. We used electroporation to infuse small peptides through CA3 cell bodies into presynaptic Schaffer collateral terminals to selectively study the presynaptic effect of scavenging the G-protein G beta gamma. We demonstrate here that the C terminus of SNAP-25 is necessary for expression of LTD, but not long-term potentiation (LTP), of synaptic strength. Using type A botulinum toxin (BoNT/A) to enzymatically cleave the 9 amino acid C-terminus of SNAP-25 eliminated the ability of low frequency synaptic stimulation to induce LTD, but not LTP, even if release probability was restored to pre-BoNT/A levels by elevating extracellular [Ca(2+)]. Presynaptic electroporation infusion of the 14-amino acid C-terminus of SNAP-25 (Ct-SNAP-25), to scavenge G beta gamma, reduced both the transient presynaptic inhibition produced by the group II metabotropic glutamate receptor stimulation, and LTD. Furthermore, presynaptic infusion of mSIRK, a second, structurally distinct G beta gamma scavenging peptide, also blocked the induction of LTD. While G beta gamma binds directly to and inhibit voltage-dependent Ca(2+) channels, imaging of presynaptic [Ca(2+)] with Mg-Green revealed that low-frequency stimulation only transiently reduced presynaptic Ca(2+) influx, an effect not altered by infusion of Ct-SNAP-25. Conclusions/Significance: The C-terminus of SNAP-25, which links synaptotagmin I to the SNARE complex, is a binding target for G beta gamma necessary for both transient transmitter-mediated presynaptic inhibition, and the induction of presynaptic LTD.	[Zhang, Xiao-lei; Upreti, Chirag; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Stanton, Patric K.] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Zhang, XL (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	patric_stanton@nymc.edu			NIH [NS44421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS044421, R01NS044421] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant #NS44421 to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bailey CP, 2008, LEARN MEMORY, V15, P261, DOI 10.1101/lm.810208; Bailey CP, 2003, EUR J NEUROSCI, V17, P903, DOI 10.1046/j.1460-9568.2003.02507.x; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BINZ T, 1994, J BIOL CHEM, V269, P1617; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Braunewell KH, 2001, REV NEUROSCIENCE, V12, P121; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen XK, 2005, NAT NEUROSCI, V8, P1160, DOI 10.1038/nn1529; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gage AT, 1997, HIPPOCAMPUS, V7, P286; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; IZUMI Y, 1993, NEUROREPORT, V4, P1131; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; LAU CG, J NEUROSCI, V30, P242; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Nagy G, 2005, MOL BIOL CELL, V16, P5675, DOI 10.1091/mbc.E05-07-0595; Nicholls RE, 2006, P NATL ACAD SCI USA, V103, P6380, DOI 10.1073/pnas.0601267103; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Photowala H, 2006, P NATL ACAD SCI USA, V103, P4281, DOI 10.1073/pnas.0600509103; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Reyes M, 1996, J NEUROSCI, V16, P5951; Reyes-Harde M, 1999, J NEUROPHYSIOL, V82, P1569, DOI 10.1152/jn.1999.82.3.1569; Santschi L, 1999, J NEUROPHYSIOL, V82, P1577, DOI 10.1152/jn.1999.82.3.1577; Santschi LA, 2006, J NEUROBIOL, V66, P205, DOI 10.1002/neu.20213; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stanton PK, 2005, EUR J NEUROSCI, V22, P2451, DOI 10.1111/j.1460-9568.2005.04437.x; Stanton PK, 2003, J NEUROSCI, V23, P5936; Stanton PK, 1996, J NEUROPHYSIOL, V76, P2097, DOI 10.1152/jn.1996.76.3.2097; Stanton PK, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0002.2001; Stephens GJ, 2005, J PHYSIOL-LONDON, V563, P765, DOI 10.1113/jphysiol.2004.080192; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Yoon EJ, 2007, MOL PHARMACOL, V72, P1210, DOI 10.1124/mol.107.039446; Young SM, 2005, P NATL ACAD SCI USA, V102, P2614, DOI 10.1073/pnas.0409656102; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	64	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20500	10.1371/journal.pone.0020500	http://dx.doi.org/10.1371/journal.pone.0020500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633701	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500066
J	Zhao, X; Mo, DL; Li, AN; Gong, W; Xiao, SQ; Zhang, Y; Qin, LM; Niu, YN; Guo, YX; Liu, XH; Cong, PQ; He, ZY; Wang, C; Li, JQ; Chen, YS				Zhao, Xiao; Mo, Delin; Li, Anning; Gong, Wen; Xiao, Shuqi; Zhang, Yue; Qin, Limei; Niu, Yuna; Guo, Yunxue; Liu, Xiaohong; Cong, Peiqing; He, Zuyong; Wang, Chong; Li, Jiaqi; Chen, Yaosheng			Comparative Analyses by Sequencing of Transcriptomes during Skeletal Muscle Development between Pig Breeds Differing in Muscle Growth Rate and Fatness	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; BINDING-PROTEIN GENE; FIBER TYPE; IN-VITRO; MOLECULAR REGULATION; EXPRESSION PROFILES; INTRAMUSCULAR FAT; WNT/BETA-CATENIN; MYOGENIC CELLS; LANDRACE PIGS	Understanding the dynamics of muscle transcriptome during development and between breeds differing in muscle growth is necessary to uncover the complex mechanism underlying muscle development. Herein, we present the first transcriptome-wide longissimus dorsi muscle development research concerning Lantang (LT, obese) and Landrace (LR, lean) pig breeds during 10 time-points from 35 days-post-coitus (dpc) to 180 days-post-natum (dpn) using Solexa/Illumina's Genome Analyzer. The data demonstrated that myogenesis was almost completed before 77 dpc, but the muscle phenotypes were still changed from 77 dpc to 28 dpn. Comparative analysis of the two breeds suggested that myogenesis started earlier but progressed more slowly in LT than in LR, the stages ranging from 49 dpc to 77 dpc are critical for formation of different muscle phenotypes. 595 differentially expressed myogenesis genes were identified, and their roles in myogenesis were discussed. Furthermore, GSK3B, IKBKB, ACVR1, ITGA and STMN1 might contribute to later myogenesis and more muscle fibers in LR than LT. Some myogenesis inhibitors (ID1, ID2, CABIN1, MSTN, SMAD4, CTNNA1, NOTCH2, GPC3 and HMOX1) were higher expressed in LT than in LR, which might contribute to more slow muscle differentiation in LT than in LR. We also identified several genes which might contribute to intramuscular adipose differentiation. Most important, we further proposed a novel model in which MyoD and MEF2A controls the balance between intramuscular adipogenesis and myogenesis by regulating CEBP family; Myf5 and MEF2C are essential during the whole myogenesis process while MEF2D affects muscle growth and maturation. The MRFs and MEF2 families are also critical for the phenotypic differences between the two pig breeds. Overall, this study contributes to elucidating the mechanism underlying muscle development, which could provide valuable information for pig meat quality improvement. The raw data have been submitted to Gene Expression Omnibus (GEO) under series GSE25406.	[Zhao, Xiao; Mo, Delin; Li, Anning; Gong, Wen; Xiao, Shuqi; Zhang, Yue; Qin, Limei; Niu, Yuna; Guo, Yunxue; Liu, Xiaohong; Cong, Peiqing; He, Zuyong; Chen, Yaosheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chong; Li, Jiaqi] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China Agricultural University	Zhao, X (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	chyaosh@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Wang, Chong/0000-0002-1515-9669; Garrick, Dorian/0000-0001-8640-5372; Chen, Yaosheng/0000-0002-3871-7651; Mo, Delin/0000-0002-8738-4486; Dittmer, Keren/0000-0002-1813-2197; Li, Anning/0000-0001-7695-161X	National Natural Science Foundation of China [U0731003, 31072008]; National High Science and Technology Foundation of China [2006CB102101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Science and Technology Foundation of China	This research was supported by the Joint Funds of the National Natural Science Foundation of China (U0731003), the National High Science and Technology Foundation of China (2006CB102101) and National Natural Science Foundation of China (31072008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CURRENT GENOMICS; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; ASHMORE CR, 1973, J ANIM SCI, V36, P1088, DOI 10.2527/jas1973.3661088x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Aurino S, 2008, Acta Myol, V27, P90; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Balogh A, 1996, EXP CELL RES, V224, P8, DOI 10.1006/excr.1996.0106; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cagnazzo M, 2006, J ANIM SCI, V84, P1; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Cerri PS, 2003, MICRON, V34, P365, DOI 10.1016/S0968-4328(03)00098-2; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Gerbens F, 1998, MAMM GENOME, V9, P1022, DOI 10.1007/s003359900918; Gerbens F, 1999, J ANIM SCI, V77, P846; Gerbens F, 1997, MAMM GENOME, V8, P328, DOI 10.1007/s003359900433; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kim JM, 2010, ANIM GENET, V41, P642, DOI 10.1111/j.1365-2052.2010.02042.x; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Kronnie GT, 2002, J MUSCLE RES CELL M, V23, P65; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; LEFAUCHEUR L, 1986, MEAT SCI, V16, P199, DOI 10.1016/0309-1740(86)90026-4; LI J, 2003, J GENET GENOMICS, V30, P835; Li YH, 2006, FEBS LETT, V580, P5423, DOI 10.1016/j.febslet.2006.09.011; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Macqueen DJ, 2010, BIOCHEM BIOPH RES CO, V400, P599, DOI 10.1016/j.bbrc.2010.08.110; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Newcom DW, 2004, J ANIM SCI, V82, P2264; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; PAS MFW, 2006, ARCH TIERZ DUMMERSTO, V49, P110; PAS MFW, 2005, ARCH ANIM BREED, V48, P141; Pas MFWT, 2005, J MUSCLE RES CELL M, V26, P157, DOI 10.1007/s10974-005-7004-6; PAS MT, 2004, MUSCLE DEV LIVESTOCK, P201; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Rajesh RV, 2010, COMP BIOCHEM PHYS D, V5, P234, DOI 10.1016/j.cbd.2010.06.004; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; SCHULER F, 1995, J CELL SCI, V108, P3795; Shan TZ, 2009, J CELL BIOCHEM, V107, P984, DOI 10.1002/jcb.22203; Shiseki M, 2003, CANCER RES, V63, P2373; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; SUZUKI A, 1991, MEAT SCI, V29, P31, DOI 10.1016/0309-1740(91)90021-H; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; te Pas MFW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-66; Tee JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005880; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; WIGMORE PMC, 1983, J ANAT, V137, P235; Yang H, 2010, ANIM BIOTECHNOL, V21, P64, DOI 10.1080/10495390903385983; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang Suzhen, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P753; Zhao SH, 2003, J ANIM SCI, V81, P2179; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	79	122	132	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19774	10.1371/journal.pone.0019774	http://dx.doi.org/10.1371/journal.pone.0019774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637832	Green Published, Green Submitted, gold			2022-12-27	WOS:000291052200014
J	Zheng, BW; Zhang, QM; Gao, J; Han, HM; Li, M; Zhang, JR; Qi, JX; Yan, JH; Gao, GF				Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Zhang, Jingren; Qi, Jianxun; Yan, Jinghua; Gao, George F.			Insight into the Interaction of Metal Ions with TroA from Streptococcus suis	PLOS ONE			English	Article							TREPONEMA-PALLIDUM TROA; TRANSPORT PROTEIN ZNUA; ZINC-BINDING PROTEIN; CRYSTAL-STRUCTURE; ABC TRANSPORTERS; IRON TRANSPORT; MANGANESE; VIRULENCE; REVEALS; PSAA	Background: The scavenging ability of sufficient divalent metal ions is pivotal for pathogenic bacteria to survive in the host. ATP-binding cassette (ABC)-type metal transporters provide a considerable amount of different transition metals for bacterial growth. TroA is a substrate binding protein for uptake of multiple metal ions. However, the function and structure of the TroA homologue from the epidemic Streptococcus suis isolates (SsTroA) have not been characterized. Methodology/Principal Findings: Here we determined the crystal structure of SsTroA from a highly pathogenic streptococcal toxic shock syndrome (STSS)-causing Streptococcus suis in complex with zinc. Inductively coupled plasma mass spectrometry (ICP-MS) analysis revealed that apo-SsTroA binds Zn2+ and Mn2+. Both metals bind to SsTroA with nanomolar affinity and stabilize the protein against thermal unfolding. Zn2+ and Mn2+ induce distinct conformational changes in SsTroA compared with the apo form as confirmed by both circular dichroism (CD) and nuclear magnetic resonance (NMR) spectra. NMR data also revealed that Zn2+/Mn2+ bind to SsTroA in either the same site or an adjacent region. Finally, we found that the folding of the metal-bound protein is more compact than the corresponding apoprotein. Conclusions/Significance: Our findings reveal a mechanism for uptake of metal ions in S. suis and this mechanism provides a reasonable explanation as to how SsTroA operates in metal transport.	[Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Qi, Jianxun; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Zheng, Beiwen; Han, Huiming; Gao, George F.] Chinese Acad Sci, Coll Life Sci, Grad Univ, Beijing, Peoples R China; [Gao, Jia] Guangxi Univ, Key Lab, Minist Educ Microbial & Plant Genet Engn, Nanning, Guangxi, Peoples R China; [Zhang, Jingren] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi University; Tsinghua University; Chinese Academy of Sciences	Zheng, BW (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021; Georgieva, Angelina/AAC-4823-2021	Georgieva, Angelina/0000-0003-0731-7775	Ministry of Science and Technology (MOST) [2011CB504003, 2006BAD06A04]; National Natural Science Fundation of China (NSFC) [30728014]; NSFC Innovative Research Group [81021003]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	The work was supported by grants from the Ministry of Science and Technology (MOST, Project 973 Grant No. 2011CB504003; National Key Technology R&D Program 2006BAD06A04); J.Z. and G. F. G. have a joint grant by National Natural Science Fundation of China (NSFC, Grant No. 30728014). G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2008, INFECT IMMUN, V76, P1590, DOI 10.1128/IAI.00987-07; Aranda J, 2009, MICROBIOL-SGM, V155, P1580, DOI 10.1099/mic.0.026278-0; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BLANCO DR, 1995, J BACTERIOL, V177, P3556, DOI 10.1128/jb.177.12.3556-3562.1995; BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GARIEPY J, 1985, BIOCHEMISTRY-US, V24, P544, DOI 10.1021/bi00323a045; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazlett KRO, 2003, J BIOL CHEM, V278, P20687, DOI 10.1074/jbc.M300781200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Kamen DE, 2001, PROTEIN SCI, V10, P2123, DOI 10.1110/ps.19801; LANGFORD P, 1991, FEMS MICROBIOL LETT, V77, P347, DOI 10.1016/0378-1097(91)90578-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093; McEwan AG, 2009, MOL MICROBIOL, V72, P812, DOI 10.1111/j.1365-2958.2009.06700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V748, P99, DOI 10.1016/0167-4838(83)90032-8; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Sambrook J., 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	66	100	100	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19510	10.1371/journal.pone.0019510	http://dx.doi.org/10.1371/journal.pone.0019510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611125	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200010
J	Zhang, YJ; Ma, PF; Li, DZ				Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu			High-Throughput Sequencing of Six Bamboo Chloroplast Genomes: Phylogenetic Implications for Temperate Woody Bamboos (Poaceae: Bambusoideae)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GRASS FAMILY POACEAE; NATURAL HYBRIDIZATION; EVOLUTIONARY ANALYSIS; PLASTID GENOMES; GBSSI GENE; DNA; REGIONS; BAMBUSA; NUCLEAR	Background: Bambusoideae is the only subfamily that contains woody members in the grass family, Poaceae. In phylogenetic analyses, Bambusoideae, Pooideae and Ehrhartoideae formed the BEP clade, yet the internal relationships of this clade are controversial. The distinctive life history (infrequent flowering and predominance of asexual reproduction) of woody bamboos makes them an interesting but taxonomically difficult group. Phylogenetic analyses based on large DNA fragments could only provide a moderate resolution of woody bamboo relationships, although a robust phylogenetic tree is needed to elucidate their evolutionary history. Phylogenomics is an alternative choice for resolving difficult phylogenies. Methodology/Principal Findings: Here we present the complete nucleotide sequences of six woody bamboo chloroplast (cp) genomes using Illumina sequencing. These genomes are similar to those of other grasses and rather conservative in evolution. We constructed a phylogeny of Poaceae from 24 complete cp genomes including 21 grass species. Within the BEP clade, we found strong support for a sister relationship between Bambusoideae and Pooideae. In a substantial improvement over prior studies, all six nodes within Bambusoideae were supported with >= 0.95 posterior probability from Bayesian inference and 5/6 nodes resolved with 100% bootstrap support in maximum parsimony and maximum likelihood analyses. We found that repeats in the cp genome could provide phylogenetic information, while caution is needed when using indels in phylogenetic analyses based on few selected genes. We also identified relatively rapidly evolving cp genome regions that have the potential to be used for further phylogenetic study in Bambusoideae. Conclusions/Significance: The cp genome of Bambusoideae evolved slowly, and phylogenomics based on whole cp genome could be used to resolve major relationships within the subfamily. The difficulty in resolving the diversification among three clades of temperate woody bamboos, even with complete cp genome sequences, suggests that these lineages may have diverged very rapidly.	[Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	Chinese Academy of Sciences [KSCX-YW-N-029]; National Natural Science Foundation of China [30990244]; Innovation Teams of Yunnan Province, China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Teams of Yunnan Province, China	This project is supported by the Chinese Academy of Sciences through a project under the knowledge innovation program (KSCX-YW-N-029), National Natural Science Foundation of China (no. 30990244) and a program of Innovation Teams of Yunnan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bystriakova N., 2003, BAMBOO BIODIVERSITY; Bystriakova N., 2004, BAMBOO BIODIVERSITY; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; CLARK LG, 1989, NATL GEOGR RES, V5, P459; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; CUMMINGS MP, 1994, MOL BIOL EVOL, V11, P1; Davis JI, 2010, AM J BOT, V97, P874, DOI 10.3732/ajb.0900228; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Gaut BS, 1997, MOL BIOL EVOL, V14, P769, DOI 10.1093/oxfordjournals.molbev.a025817; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gong X. S., 1994, J WUHAN BOT RES, V12, P277; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INBAR, 1999, SOC ISS CONSTR BAMB; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Judziewicz EJ, 1999, AM BAMBOOS; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li D.-Z., 2006, FLORA CHINA, V22, P7; LI DZ, 1998, BAMBOO CONSERVATION; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RENVOIZE SA, 1992, GRASS EVOLUTION DOME; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun Y, 2005, BIOCHEM GENET, V43, P603, DOI 10.1007/s10528-005-9117-4; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Triplett JK, 2010, AM J BOT, V97, P471, DOI 10.3732/ajb.0900244; Triplett JK, 2010, SYST BOT, V35, P102, DOI 10.1600/036364410790862678; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang HQ, 2008, MOL PHYLOGENET EVOL, V48, P809, DOI 10.1016/j.ympev.2008.06.001; Yang JB, 2010, TAXON, V59, P1102, DOI 10.1002/tax.594010; Zeng CX, 2010, MOL PHYLOGENET EVOL, V56, P821, DOI 10.1016/j.ympev.2010.03.041; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	78	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20596	10.1371/journal.pone.0020596	http://dx.doi.org/10.1371/journal.pone.0020596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21731709	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600106
J	Chan, DSM; Lau, R; Aune, D; Vieira, R; Greenwood, DC; Kampman, E; Norat, T				Chan, Doris S. M.; Lau, Rosa; Aune, Dagfinn; Vieira, Rui; Greenwood, Darren C.; Kampman, Ellen; Norat, Teresa			Red and Processed Meat and Colorectal Cancer Incidence: Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							DOSE-RESPONSE DATA; COLON-CANCER; RISK-FACTORS; PROSPECTIVE COHORT; RECTAL-CANCER; UNITED-STATES; NAT2 POLYMORPHISMS; NETHERLANDS COHORT; DIETARY PATTERNS; WOMENS HEALTH	Background: The evidence that red and processed meat influences colorectal carcinogenesis was judged convincing in the 2007 World Cancer Research Fund/American Institute of Cancer Research report. Since then, ten prospective studies have published new results. Here we update the evidence from prospective studies and explore whether there is a non-linear association of red and processed meats with colorectal cancer risk. Methods and Findings: Relevant prospective studies were identified in PubMed until March 2011. For each study, relative risks and 95% confidence intervals (CI) were extracted and pooled with a random-effects model, weighting for the inverse of the variance, in highest versus lowest intake comparison, and dose-response meta-analyses. Red and processed meats intake was associated with increased colorectal cancer risk. The summary relative risk (RR) of colorectal cancer for the highest versus the lowest intake was 1.22 (95% CI = 1.11-1.34) and the RR for every 100 g/day increase was 1.14 (95% CI = 1.04-1.24). Non-linear dose-response meta-analyses revealed that colorectal cancer risk increases approximately linearly with increasing intake of red and processed meats up to approximately 140 g/day, where the curve approaches its plateau. The associations were similar for colon and rectal cancer risk. When analyzed separately, colorectal cancer risk was related to intake of fresh red meat (RR (for 100 g/day increase) = 1.17, 95% CI = 1.05-1.31) and processed meat (RR (for 50 g/day increase) = 1.18, 95% CI = 1.10-1.28). Similar results were observed for colon cancer, but for rectal cancer, no significant associations were observed. Conclusions: High intake of red and processed meat is associated with significant increased risk of colorectal, colon and rectal cancers. The overall evidence of prospective studies supports limiting red and processed meat consumption as one of the dietary recommendations for the prevention of colorectal cancer.	[Chan, Doris S. M.; Lau, Rosa; Aune, Dagfinn; Vieira, Rui; Norat, Teresa] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Greenwood, Darren C.] Univ Leeds, Biostat Unit, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Kampman, Ellen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Imperial College London; University of Leeds; Wageningen University & Research	Chan, DSM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	t.norat@imperial.ac.uk	Greenwood, Darren C/C-3220-2008; Kampman, E./H-8057-2014	Greenwood, Darren C/0000-0001-7035-3096; 	World Cancer Research Fund International [2007/SP01]	World Cancer Research Fund International(World Cancer Research Fund International (WCRF))	Funding: This work was funded by the World Cancer Research Fund International (Grant number: 2007/SP01) (http://www.wcrf-uk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this review are the opinions of the authors. They may not represent the views of WCRF International/AICR and may differ from those in their future updates of the evidence related to food, nutrition, physical activity and cancer risk.	Alexander DD, 2011, OBES REV, V12, pe472, DOI 10.1111/j.1467-789X.2010.00785.x; Alexander DD, 2010, EUR J CANCER PREV, V19, P328, DOI 10.1097/CEJ.0b013e32833b48fa; *AM I CANC RES WOR, 2003, FOOD NUTR PHYS ACT P; *AM I CANC RES WOR, 2009, POL ACT CANC PREV FO; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Bagnardi V, 2004, AM J EPIDEMIOL, V159, P1077, DOI 10.1093/aje/kwh142; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005; Berndt SI, 2006, CANCER EPIDEM BIOMAR, V15, P2263, DOI 10.1158/1055-9965.EPI-06-0449; Bingham SA, 2002, J NUTR, V132, p3522S, DOI 10.1093/jn/132.11.3522S; Bingham SA, 1999, P NUTR SOC, V58, P243, DOI 10.1017/S0029665199000336; BONNETT R, 1975, J CHEM SOC CHEM COMM, P884, DOI 10.1039/c39750000884; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Brink M, 2005, BRIT J CANCER, V92, P1310, DOI 10.1038/sj.bjc.6602491; Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chan AT, 2005, INT J CANCER, V115, P648, DOI 10.1002/ijc.20890; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Chen J, 1998, CANCER RES, V58, P3307; Chen K, 2003, WORLD J GASTROENTERO, V9, P99, DOI 10.3748/wjg.v9.i1.99; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2003, CANCER RES, V63, P2358; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flood A, 2003, AM J EPIDEMIOL, V158, P59, DOI 10.1093/aje/kwg099; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Gaard M, 1996, EUR J CANCER PREV, V5, P445; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOHM RA, 1994, CANCER RES, V54, P718; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jarvinen R, 2001, BRIT J CANCER, V85, P357, DOI 10.1054/bjoc.2001.1906; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Joosen AMCP, 2009, CARCINOGENESIS, V30, P1402, DOI 10.1093/carcin/bgp130; Kabat GC, 2007, BRIT J CANCER, V97, P118, DOI 10.1038/sj.bjc.6603837; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; KNEKT P, 1994, INT J CANCER, V59, P756, DOI 10.1002/ijc.2910590608; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SA, 2009, NUTR CANCER, V61, P194, DOI 10.1080/01635580802419780; Lin J, 2004, AM J EPIDEMIOL, V160, P1011, DOI 10.1093/aje/kwh319; Luchtenborg M, 2005, CANCER CAUSE CONTROL, V16, P1041, DOI 10.1007/s10552-005-0239-0; Ma J, 2001, J NATL CANCER I, V93, P1330, DOI 10.1093/jnci/93.17.1330; Nothlings U, 2009, CANCER EPIDEM BIOMAR, V18, P2098, DOI 10.1158/1055-9965.EPI-08-1218; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Norat T, 2001, NUTR REV, V59, P37, DOI 10.1111/j.1753-4887.2001.tb06974.x; Oba S, 2006, CANCER LETT, V244, P260, DOI 10.1016/j.canlet.2005.12.037; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Parkin DM, 2009, EUR J CANCER PREV, V18, P179, DOI 10.1097/CEJ.0b013e32830c8d83; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Sato Y, 2006, EUR J CANCER PREV, V15, P211, DOI 10.1097/01.cej.0000197455.87356.05; Sellers TA, 1998, CANCER CAUSE CONTROL, V9, P357; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; SINHA R, 1994, CANCER RES, V54, P6154; Sorensen M, 2008, CANCER LETT, V266, P186, DOI 10.1016/j.canlet.2008.02.046; Spencer EA, 2010, CANCER CAUSE CONTROL, V21, P1417, DOI 10.1007/s10552-010-9569-7; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; Wu K, 2004, CANCER CAUSE CONTROL, V15, P853, DOI 10.1007/s10552-004-1809-2	72	547	563	2	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20456	10.1371/journal.pone.0020456	http://dx.doi.org/10.1371/journal.pone.0020456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674008	Green Published, gold			2022-12-27	WOS:000291356400005
J	Wang, Y; Yan, LL; Jin, ZD; Xin, X				Wang, Yan; Yan, Lingling; Jin, Zhendong; Xin, Xin			Effects of Sleeve Gastrectomy in Neonatally Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							PLASMA GHRELIN CONCENTRATIONS; WEIGHT-LOSS; BETA-CELLS; MODEL; MELLITUS; REGENERATION; MANAGEMENT; EFFICACY; SURGERY	Background: Sleeve gastrectomy (SG) has emerged recently as a stand-alone bariatric procedure to treat morbid obesity and enhance glucose homeostasis. The aim of the study was to evaluate its effects in neonatally streptozotocin (STZ)induced diabetic rats (n-STZ diabetic rats). Methodology and Principal Findings: To induce diabetes, STZ (90 mg/kg) was administered intraperitoneally to 2-day-old male pups. When 12 weeks old, diabetic rats were randomized into sleeve operation group (SLG, n = 6) and sham operation group (SOG, n = 6). Body weights were monitored weekly, and daily consumption of water and food were followed for eight consecutive weeks postoperatively. Serum glucose levels were measured periodically at the 4th and 8th week after surgery. Insulin, ghrelin, glucose-dependent insulinotropic polypeptide (GIP) and Glucagon-like peptide-1 (GLP-1) levels were assayed at the end of the study. Our data showed that SLG rats exhibited significantly lower body weight gain in addition to reduced food and water intakes postoperatively compared to their sham-operation counterparts. However, resolution of diabetes was not observed in our study. Correspondingly, there were no significant differences between SOG rats and SLG rats in glucose metabolism-associated hormones, including insulin, GIP and GLP-1. In contrast, ghrelin level significantly decreased (P<0.01) in SLG group (58.01 +/- 3.75 pg/ml) after SG surgery compared to SOG group (76.36 +/- 3.51 pg/ml). Conclusions: These observations strongly suggest that SG is effective in controlling body weight. However, SG did not achieve resolution or improvement of diabetes in n-STZ diabetic rats.	[Wang, Yan; Jin, Zhendong; Xin, Xin] Tongji Med Coll, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China; [Yan, Lingling] Tongji Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, Y (corresponding author), Tongji Med Coll, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China.	wangyantj2008@yahoo.com.cn						Abbatini F, 2010, SURG ENDOSC, V24, P1005, DOI 10.1007/s00464-009-0715-9; Akkary E, 2008, OBES SURG, V18, P1323, DOI 10.1007/s11695-008-9551-6; Bohdjalian A, 2010, OBES SURG, V20, P535, DOI 10.1007/s11695-009-0066-6; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; CASTELAN JD, 2007, OBES SURG, V17, P957; Chakrabarti S, 2005, J ETHNOPHARMACOL, V97, P117, DOI 10.1016/j.jep.2004.10.025; Chen D, 2005, DIABETES OBES METAB, V7, P307, DOI 10.1111/j.1463-1326.2004.00392.x; Deitel M, 2008, OBES SURG, V18, P487, DOI 10.1007/s11695-008-9471-5; Frezza EE, 2009, OBES SURG, V19, P684, DOI 10.1007/s11695-008-9677-6; Fuks D, 2009, SURGERY, V145, P106, DOI 10.1016/j.surg.2008.07.013; Gelling RW, 2004, ENDOCRINOLOGY, V145, P4575, DOI 10.1210/en.2004-0605; Goitein D, 2009, SURG ENDOSC, V23, P1559, DOI 10.1007/s00464-009-0337-2; Goldfine AB, 2009, NAT MED, V15, P616, DOI 10.1038/nm0609-616; Hemmings SJ, 2000, INT J BIOCHEM CELL B, V32, P905, DOI 10.1016/S1357-2725(00)00019-4; Herron DM, 2009, MT SINAI J MED, V76, P281, DOI 10.1002/msj.20114; Ishii S, 2002, ENDOCRINOLOGY, V143, P4934, DOI 10.1210/en.2002-220612; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Langer FB, 2005, OBES SURG, V15, P1024, DOI 10.1381/0960892054621125; Lee WJ, 2010, SURGERY, V147, P664, DOI 10.1016/j.surg.2009.10.059; Li F, 2009, J GASTROINTEST SURG, V13, P2302, DOI 10.1007/s11605-009-0997-1; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lopez PP, 2009, J SURG RES, V157, P243, DOI 10.1016/j.jss.2008.10.025; Melissas J, 2008, OBES SURG, V18, P1251, DOI 10.1007/s11695-008-9634-4; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Patrikakos P, 2009, OBES SURG, V19, P1586, DOI 10.1007/s11695-009-9965-9; Pereferrer FS, 2008, OBES SURG, V18, P97, DOI 10.1007/s11695-007-9351-4; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rizzello M, 2010, OBES SURG, V20, P50, DOI 10.1007/s11695-009-0017-2; Rosenthal R, 2009, SURG OBES RELAT DIS, V5, P429, DOI 10.1016/j.soard.2008.11.006; Sabbagh C, 2010, OBES SURG, V20, P679, DOI 10.1007/s11695-009-0007-4; Saber AA, 2008, OBES SURG, V18, P121, DOI 10.1007/s11695-007-9308-7; Sammour T, 2010, OBES SURG, V20, P271, DOI 10.1007/s11695-009-0038-x; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021; Tan JT, 2010, OBES SURG, V20, P403, DOI 10.1007/s11695-009-0020-7; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Tsubone T, 2005, AM J PHYSIOL-REG I, V289, pR1703, DOI 10.1152/ajpregu.00773.2004; Vidal J, 2007, OBES SURG, V17, P1069, DOI 10.1007/s11695-007-9180-5; Wang Y, 2009, OBES SURG, V19, P921, DOI 10.1007/s11695-008-9663-z	39	53	64	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16383	10.1371/journal.pone.0016383	http://dx.doi.org/10.1371/journal.pone.0016383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21655253	Green Submitted, gold, Green Published			2022-12-27	WOS:000286522300043
J	Zhang, Y; Chen, W; Li, R; Li, Y; Ge, YB; Chen, GX				Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun			Insulin-Regulated Srebp-1c and Pck1 mRNA Expression in Primary Hepatocytes from Zucker Fatty but Not Lean Rats Is Affected by Feeding Conditions	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; GENE-EXPRESSION; CALORIC RESTRICTION; SIGNALING PATHWAY; MISSENSE MUTATION; ACID SYNTHESIS; X-RECEPTOR; LIVER; OBESITY; RESISTANCE	Insulin regulates the transcription of genes for hepatic glucose and lipid metabolism. We hypothesized that this action may be impaired in hepatocytes from insulin resistant animals. Primary hepatocytes from insulin sensitive Zucker lean (ZL) and insulin resistant Zucker fatty (ZF) rats in ad libitum or after an overnight fasting were isolated, cultured and treated with insulin and other compounds for analysis of gene expression using real-time PCR. The mRNA levels of one insulin-induced (Srebp-1c) and one insulin-suppressed (Pck1) genes in response to insulin, glucagon, and compactin treatments in hepatocytes from ad libitum ZL and ZF rats were analyzed. Additionally, the effects of insulin and T1317 on their levels in hepatocytes from ad libitum or fasted ZL or ZF rats were compared. The mRNA levels of Srebp-1c, Fas, and Scd1, but not that of Insr, Gck and Pck1, were higher in freshly isolated hepatocytes from ad libitum ZF than that from ZL rats. These patterns of Srebp-1c and Pck1 mRNA levels remained in primary hepatocyte cultured in vitro. Insulin's ability to regulate Srebp-1c and Pck1 expression was diminished in hepatocytes from ad libitum ZF, but not ZL rats. Glucagon or compactin suppressed Srebp-1c mRNA expression in lean, but not fatty hepatocytes. However, glucagon induced Pck1 mRNA expression similarly in hepatocytes from ad libitum ZL and ZF rats. Insulin caused the same dose-dependent increase of Akt phosphorylation in hepatocytes from ad libitum ZL and ZF rats. It synergized with T1317 to induce Srebp-1c, and suppressed Pck1 mRNA levels in hepatocytes from fasted, but not that from ad libitum ZF rats. We demonstrated that insulin was unable to regulate its downstream genes' mRNA expression in hepatocytes from ad libitum ZF rats. This impairment can be partially restored in hepatocytes from ZF rats after an overnight fasting, a phenomenon that deserves further investigation.	[Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Ge, Yuebin] S Cent Univ Nationalities, Coll Pharm, Wuhan, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; South Central Minzu University	Zhang, Y (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	American Heart Association [09SDG2140003]; University of Tennessee at Knoxville; Allen Foundation Inc.	American Heart Association(American Heart Association); University of Tennessee at Knoxville; Allen Foundation Inc.	This work was supported by the Scientist Development Grant from American Heart Association (09SDG2140003, to G.C.), a start-up fund from the University of Tennessee at Knoxville (to G.C.), and a research grant from Allen Foundation Inc. (to G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1990, BIOCHEM J, V266, P91, DOI 10.1042/bj2660091; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Chen GX, 2007, BIOCHEM BIOPH RES CO, V361, P805, DOI 10.1016/j.bbrc.2007.07.108; Chen GX, 2009, BIOCHEM J, V419, P645, DOI 10.1042/BJ20082368; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chirieac DV, 2004, AM J PHYSIOL-ENDOC M, V287, pE42, DOI 10.1152/ajpendo.00297.2003; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; CLARK JB, 1982, ENDOCRINOLOGY, V111, P964, DOI 10.1210/endo-111-3-964; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Garnett KE, 2005, J MOL ENDOCRINOL, V35, P13, DOI 10.1677/jme.1.01792; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Horton JD, 2008, SCIENCE, V320, P1433, DOI 10.1126/science.1159651; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; OKAUCHI N, 1995, DIABETES RES CLIN PR, V27, P97, DOI 10.1016/0168-8227(95)01029-D; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; STEVENS J, 1981, MOL CELL BIOCHEM, V37, P177, DOI 10.1007/BF02354886; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Unger RH, 1997, TRENDS ENDOCRIN MET, V8, P276, DOI 10.1016/S1043-2760(97)00094-5; Zhou YP, 1999, METABOLISM, V48, P857, DOI 10.1016/S0026-0495(99)90219-6; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; ZUCKER LM, 1972, J LIPID RES, V13, P234; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093	55	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21342	10.1371/journal.pone.0021342	http://dx.doi.org/10.1371/journal.pone.0021342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731709	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700064
